PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Qin, G; Lo, JW; Marlow, N; Calvert, SA; Greenough, A; Peacock, JL				Qin, Gordon; Lo, Jessica W.; Marlow, Neil; Calvert, Sandy A.; Greenough, Anne; Peacock, Janet L.			Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; FREQUENCY OSCILLATORY VENTILATION; CONTROLLED-TRIAL; FOLLOW-UP; AGE; CORTICOSTEROIDS; PREVENTION; THERAPY; INFANTS	Importance Postnatal dexamethasone is associated with reduction in bronchopulmonary dysplasia. There remains, however, concern that its short-term benefits are accompanied by long-term adverse effects e.g. poorer neurodevelopmental outcomes. Objective Our aim was to determine the effects of administration of postnatal dexamethasone on respiratory and neurodevelopmental outcome at two years of age after adjusting for neonatal and infant risk factors. Materials and methods The study included 412 infants born at 23-28 weeks of gestation, 29% had received postnatal dexamethasone. Two outcomes were examined, respiratory hospital admissions in the past 12 months and neurodevelopmental impairment. Logistic regression, adjusted for sex, birthweight z-score, gestation, maternal smoking, oxygen dependency at 36 weeks, airleak, patent ductus arteriosus, pulmonary haemorrhage, major ultrasound abnormality, mode of ventilation and age at assessment, was undertaken. Results After adjustment, postnatal dexamethasone was associated with significantly increased proportions of both respiratory hospital readmission: (0.35 vs 0.15, difference = 0.20; 95% CI: 0.08, 0.31) and neurodevelopmental impairment (0.59 vs 0.45, difference = 0.14; 95% CI: 0.02, 0.26). Conclusions Postnatal dexamethasone use in extremely preterm infants is associated with increased risks of respiratory hospital admissions and neurodevelopmental impairment. These associations were not explained by excess neonatal morbidities.	[Qin, Gordon; Lo, Jessica W.; Peacock, Janet L.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Qin, Gordon] Queen Alexandra Hosp, Portsmouth, Hants, England; [Lo, Jessica W.; Greenough, Anne] Univ New South Wales, UNSW Med, Sch Psychiat, Randwick, NSW, Australia; [Marlow, Neil] UCL, Inst Womens Hlth, London, England; [Calvert, Sandy A.] St Georges Univ London, Dept Child Hlth, London, England; [Greenough, Anne] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England	University of London; King's College London; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of New South Wales Sydney; University of London; University College London; St Georges University London; University of London; King's College London	Peacock, JL (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London, England.	janet.peacock@kcl.ac.uk	Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; Peacock, Janet/0000-0002-0310-2518; Greenough, Anne/0000-0002-8672-5349	Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC [G1002276] Funding Source: UKRI; Medical Research Council [G1000758, G1000758B, G1002276] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10093] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The original UKOS Study was funded by the Medical Research Council (1997). This secondary analysis was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health. JLP is an NIHR Senior Investigator.	Baud O, 1999, ARCH DIS CHILD-FETAL, V80, pF159; Baud O, 2004, ARCH DIS CHILD-FETAL, V89, P96, DOI 10.1136/adc.2003.028696; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Gross SJ, 2005, PEDIATRICS, V115, P681, DOI 10.1542/peds.2004-0956; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; JONES R, 1991, PEDIATRICS, V88, P421; Jones RAK, 2005, PEDIATRICS, V116, P379, DOI 10.1542/peds.2004-1819; Khalife N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081394; Marlow N, 2006, ARCH DIS CHILD-FETAL, V91, P320, DOI 10.1136/adc.2005.079632; Mieskonen S, 2003, ACTA PAEDIATR, V92, P896, DOI 10.1080/08035250310003451; Nixon PA, 2007, J PEDIATR-US, V150, P345, DOI 10.1016/j.jpeds.2006.12.013; Smith LJ, 2011, J PAEDIATR CHILD H, V47, P448, DOI 10.1111/j.1440-1754.2010.01992.x; Tschanz SA, 1997, PEDIATR PULM, P247; Vyas J, 1997, ARCH DIS CHILD-FETAL, V77, pF147, DOI 10.1136/fn.77.2.F147; Wilson-Costello D, 2009, PEDIATRICS, V123, pe430, DOI 10.1542/peds.2008-1928; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	17	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181176	10.1371/journal.pone.0181176	http://dx.doi.org/10.1371/journal.pone.0181176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723921	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406067800038
J	Soliman, A; Soltani, K; Yin, JJ; Padmanabhan, A; Wang, SW				Soliman, Aiman; Soltani, Kiumars; Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen			Social sensing of urban land use based on analysis of Twitter users' mobility patterns	PLOS ONE			English	Article								A number of recent studies showed that digital footprints around built environments, such as geo-located tweets, are promising data sources for characterizing urban land use. However, challenges for achieving this purpose exist due to the volume and unstructured nature of geo-located social media. Previous studies focused on analyzing Twitter data collectively resulting in coarse resolution maps of urban land use. We argue that the complex spatial structure of a large collection of tweets, when viewed through the lens of individual-level human mobility patterns, can be simplified to a series of key locations for each user, which could be used to characterize urban land use at a higher spatial resolution. Contingent issues that could affect our approach, such as Twitter users' biases and tendencies at locations where they tweet the most, were systematically investigated using 39 million geo-located Tweets and two independent datasets of the City of Chicago: 1) travel survey and 2) parcel-level land use map. Our results support that the majority of Twitter users show a preferential return, where their digital traces are clustered around a few key locations. However, we did not find a general relation among users between the ranks of locations for an individual-based on the density of tweets-and their land use types. On the contrary, temporal patterns of tweeting at key locations were found to be coherent among the majority of users and significantly associated with land use types of these locations. Furthermore, we used these temporal patterns to classify key locations into generic land use types with an overall classification accuracy of 0.78. The contribution of our research is twofold: a novel approach to resolving land use types at a higher resolution, and in-depth understanding of Twitter users' location-related and temporal biases, promising to benefit human mobility and urban studies in general.	[Soliman, Aiman; Soltani, Kiumars; Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen] Univ Illinois, Natl Ctr Supercomp Applicat, CyberGIS Ctr Adv Digital & Spatial Studies, Champaign, IL 61820 USA; [Soltani, Kiumars; Wang, Shaowen] Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA; [Yin, Junjun; Padmanabhan, Anand; Wang, Shaowen] Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wang, SW (corresponding author), Univ Illinois, Natl Ctr Supercomp Applicat, CyberGIS Ctr Adv Digital & Spatial Studies, Champaign, IL 61820 USA.; Wang, SW (corresponding author), Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA.; Wang, SW (corresponding author), Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA.	shaowen@illinois.edu	Yin, Junjun/H-8947-2019	Yin, Junjun/0000-0002-4196-2439	U.S. National Science Foundation [1047916, 1429699, 1443080]; Direct For Computer & Info Scie & Enginr [1429699] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [1443080] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by U.S. National Science Foundation under grant numbers: 1047916,1429699, and 1443080 (SW, AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This material is based in part upon work supported by the U.S. National Science Foundation under grant numbers: 1047916, 1429699, and 1443080. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Insightful comments and feedbacks received from four anonymous reviewers and members of the CyberGIS Center for Advanced Digital and Spatial Studies are greatly appreciated.	Abbas A., 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355622; Bawa-Cavia A., 2011, PERVASIVE PURBA WORK; Bora Nibir, 2014, Social Computing, Behavioral-Cultural Modeling and Prediction. 7th International Conference, SBP 2014. Proceedings: LNCS 8393, P11, DOI 10.1007/978-3-319-05579-4_2; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; CMAP, 2014, CHIC METR AG PLANN 2; CMAP, 2008, CHIC TRAV TRACK HOUS; Dark SJ, 2007, PROG PHYS GEOG, V31, P471, DOI 10.1177/0309133307083294; Efstathiades H, 2015, PROCEEDINGS OF THE 2015 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2015), P218, DOI 10.1145/2808797.2808877; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Frias-Martinez V, 2014, ENG APPL ARTIF INTEL, V35, P237, DOI 10.1016/j.engappai.2014.06.019; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Giorgino T, 2012, PACKAGE DTW, P1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodchild Michael F., 2013, DIALOGUES HUM GEOGR, V3, P280, DOI DOI 10.1177/2043820613513392; Hasan S., 2013, P 2 ACM SIGKDD INT W; Hu TY, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020151; Jiang S, 2012, DATA MIN KNOWL DISC, V25, P478, DOI 10.1007/s10618-012-0264-z; Kunze C, 2015, COMPUT ENVIRON URBAN, V53, P4, DOI 10.1016/j.compenvurbsys.2015.04.002; Liu JJ, 2015, 2015 13TH IEEE INTERNATIONAL CONFERENCE ON DATA ENGINEERING WORKSHOPS (ICDEW), P83, DOI 10.1109/ICDEW.2015.7129551; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Openshaw S., 1984, MODIFIABLE AREAL UNI; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Psyllidis A, 2015, COMM COM INF SC, V527, P21, DOI 10.1007/978-3-662-47386-3_2; R Core Team, 2021, R LANGUAGE ENV STAT; Schade S, 2012, FUTURE INTERNET, V4, P807, DOI 10.3390/fi4030807; Sila-Nowicka K, 2016, BUILT ENV, V42, P415; Silva TH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND COMMUNICATIONS, CONFERENCE ON INTERNET OF THINGS, AND CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (GREENCOM 2012), P382, DOI 10.1109/GreenCom.2012.62; Soliman A, 2016, ARXIV160904373; Soliman A, 2015, P 1 ACM SIGSP INT WO; Soltani K, 2015, P 8 ACM SIGSP INT WO; Soltani K, 2016, P 2016 XSEDE C SCI A; Sparks KA, 2016, P 10 WORKSH GEOGR IN, P2; Thakur GS, 2015, P 23 SIGSPATIAL INT, P11; United Nations, 2015, STESASERA366 UN DEP; Wakamiya S, 2012, P 6 INT C UB INF MAN, P26; Wakamiya S, 2011, LECT NOTES COMPUT SC, V6631, P108, DOI 10.1007/978-3-642-20630-6_7; Wang SW, 2016, GEOJOURNAL, V81, P965, DOI 10.1007/s10708-016-9740-0; Zhan XY, 2014, NETW SPAT ECON, V14, P647, DOI 10.1007/s11067-014-9264-4	42	39	40	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181657	10.1371/journal.pone.0181657	http://dx.doi.org/10.1371/journal.pone.0181657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723936	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800064
J	Martinez-Rivera, FJ; Perez-Laspiur, J; Santiago-Gascot, ME; Aleman-Reyes, AG; Garcia-Santiago, E; Rodriguez-Perez, Y; Cabo-Guadalupe, C; Otero-Pagan, I; Ayala-Pagan, RN; Martinez, M; Cantres-Rosario, YM; Melendez, LM; Barreto-Estrada, JL				Martinez-Rivera, Freddyson J.; Perez-Laspiur, Juliana; Santiago-Gascot, Maria E.; Aleman-Reyes, Abner G.; Garcia-Santiago, Emanuel; Rodriguez-Perez, Yolanda; Cabo-Guadalupe, Cristhian; Otero-Pagan, Inelia; Ayala-Pagan, Roxsana N.; Martinez, Magdiel; Cantres-Rosario, Yisel M.; Melendez, Loyda M.; Barreto-Estrada, Jennifer L.			Differential protein expression profile in the hypothalamic GT1-7 cell line after exposure to anabolic androgenic steroids	PLOS ONE			English	Article							GNRH GENE-EXPRESSION; HUMAN CYTOCHROME-P450 ENZYMES; RECEPTOR EXPRESSION; CEREBROSPINAL-FLUID; HOUSEKEEPING GENES; PROTEOMIC ANALYSIS; STATISTICAL-MODEL; HORMONE NEURONS; F-ACTIN; TESTOSTERONE	The abuse of anabolic androgenic steroids (AAS) has been considered a major public health problem during decades. Supraphysiological doses of AAS may lead to a variety of neuroendocrine problems. Precisely, the hypothalamic-pituitary-gonadal (HPG) axis is one of the body systems that is mainly influenced by steroidal hormones. Fluctuations of the hormonal milieu result in alterations of reproductive function, which are made through changes in hypothalamic neurons expressing gonadotropin-releasing hormone (GnRH). In fact, previous studies have shown that AAS modulate the activity of these neurons through steroid-sensitive afferents. To increase knowledge about the cellular mechanisms induced by AAS in GnRH neurons, we performed proteomic analyses of the murine hypothalamic GT1-7 cell line after exposure to 17a-methyltestosterone (17 alpha-meT; 1 mu M). These cells represent a good model for studying regulatory processes because they exhibit the typical characteristics of GnRH neurons, and respond to compounds that modulate GnRH in vivo. Two-dimensional difference in gel electrophoresis (2D-DIGE) and mass spectrometry analyses identified a total of 17 different proteins that were significantly affected by supraphysiological levels of AAS. Furthermore, pathway analyses showed that modulated proteins were mainly associated to glucose metabolism, drug detoxification, stress response and cell cycle. Validation of many of these proteins, such as GSTM1, ERH, GAPDH, PEBP1 and PDIA6, were confirmed by western blotting. We further demonstrated that AAS exposure decreased expression of estrogen receptors and GnRH, while two important signaling pathway proteins p-ERK, and p-p38, were modulated. Our results suggest that steroids have the capacity to directly affect the neuroendocrine system by modulating key cellular processes for the control of reproductive function.	[Martinez-Rivera, Freddyson J.; Santiago-Gascot, Maria E.; Otero-Pagan, Inelia; Barreto-Estrada, Jennifer L.] Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Perez-Laspiur, Juliana; Rodriguez-Perez, Yolanda; Melendez, Loyda M.] Univ Puerto Rico, Translat Prote Ctr RCMI, Med Sci Campus, San Juan, PR 00936 USA; [Aleman-Reyes, Abner G.; Ayala-Pagan, Roxsana N.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR USA; [Garcia-Santiago, Emanuel; Cabo-Guadalupe, Cristhian] Univ Este, Dept Biotechnol, Carolina, PR USA; [Martinez, Magdiel] Univ Puerto Rico, Dept Physiol & Biophys, Med Sci Campus, San Juan, PR 00936 USA; [Cantres-Rosario, Yisel M.; Melendez, Loyda M.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Barreto-Estrada, JL (corresponding author), Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.	jennifer.barreto1@upr.edu		Cantres-Rosario, Yisel/0000-0002-0630-5695	RCMI Translational Proteomics Center NIMHD [8G12MD007600]; RTRN [U54MD008149]; NIH-NCRR [2P20RR016470]; NIGMS [8P20GM103475]; MBRS-RISE [R25GM061838, R25GM066250]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103475, R25GM066250] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579, G12MD007600, U54MD008149] Funding Source: NIH RePORTER	RCMI Translational Proteomics Center NIMHD; RTRN; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MBRS-RISE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants, RCMI Translational Proteomics Center NIMHD (8G12MD007600), RTRN Small Grants Program (U54MD008149) to JLBE; NIH-NCRR (2P20RR016470) and NIGMS (8P20GM103475) to JLBE and MESG; MBRS-RISE (R25GM061838) to FJMR, and MBRS-RISE (R25GM066250) to EGS and CCG. Authors want to thank, Dr. Scott Shaffer, Director of Proteomics and Mass Spectrometry Facility at University of Massachusetts Medical School and Dr. Richard Noel, Director of Molecular and Genomics Core NIH-RCMI Program (NIMHD MD007579) at the Ponce Health Sciences University. We also thank Namyr Martinez for his technical assistance, and Angelica B. Rolon-Barreto for editorial revision.; This work was funded by RTRN Small Grants Program (U54MD008149) http://grants.rtm.net/index.php/SMALLGRANT20162017, to JLBE; NIH-NCRR (2P20RR016470) http://www.nems.nih.gov/teams/Pages/NCRR.aspx, to JLBE; NIGMS (8P20GM103475) https://www.nigms.nih.gov/Pages/default.aspx to JLBE; MBRS-RISE (R25GM061838) http://mbrsrise.rcm.upr.edu. to FJMR; MBRS-RISE (R25GM066250) http://www.sugam.edu/une/propuestas/rise/rise_index.html. to EGS and CCG; RCMI Translational Proteomics Center NIMHD (8G12MD007600), htp://rcmi.rcm.upr.edu/ resreso/guidelines_rcmi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2003, AM J PHYSIOL-ENDOC M, V285, pE189, DOI 10.1152/ajpendo.00035.2003; Belsham DD, 1998, ENDOCRINOLOGY, V139, P1108, DOI 10.1210/en.139.3.1108; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Brayman MJ, 2012, MOL ENDOCRINOL, V26, P2, DOI 10.1210/me.2011-1015; BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527; Caraci F, 2011, J NEUROSCI RES, V89, P592, DOI 10.1002/jnr.22578; Castoria G, 2014, ROLE NONGENOMIC ANDR, V5, pe1548; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Chen Jie, 2009, Cancer Genomics & Proteomics, V6, P331; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; COHEN JC, 1987, J CLIN ENDOCR METAB, V64, P960, DOI 10.1210/jcem-64-5-960; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Coles BF, 2003, BIOFACTORS, V17, P115, DOI 10.1002/biof.5520170112; Cui H, 2003, MOL CELL ENDOCRINOL, V203, P13, DOI 10.1016/S0303-7207(03)00121-7; Cunningham RL, 2009, ENDOCRINOLOGY, V150, P5539, DOI 10.1210/en.2009-0640; Daly RC, 2001, ARCH GEN PSYCHIAT, V58, P172, DOI 10.1001/archpsyc.58.2.172; de Gooyer ME, 2003, STEROIDS, V68, P235, DOI 10.1016/S0039-128X(02)00184-8; Dodge T, 2011, DRUG ALCOHOL DEPENDE; Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Frankenfeld SP, 2014, J ENDOCRINOL, V220, P143, DOI 10.1530/JOE-13-0259; Fu Q-F, 2015, ALPHA ENOLASE PROMOT, P1; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Gao JC, 2015, COMP BIOCHEM PHYS D, V15, P20, DOI 10.1016/j.cbd.2015.05.001; Garrido P, 2014, METABOLISM, V63, P1178, DOI 10.1016/j.metabol.2014.06.003; Gore AC, 1997, FRONT NEUROENDOCRIN, V18, P209, DOI 10.1006/frne.1996.0149; Gu S, 2011, PAPADOPOULOU N MOL M, V17, P1; HALES TG, 1992, MOL PHARMACOL, V42, P197; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hazard D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-101; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hwang K-A, 2015, J STEROID BIOCHEM, V147, P24; Imperlini E, 2010, PROTEOMICS, V10, P3165, DOI 10.1002/pmic.201000079; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Jin JM, 2014, GENE, V551, P15, DOI 10.1016/j.gene.2014.08.048; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li HS, 2010, EXPERT OPIN DRUG MET, V6, P409, DOI 10.1517/17425251003598886; Liao RS, 2013, ANDROGEN RECEPTOR ME; Liu T, 2015, GENE, V555, P108, DOI 10.1016/j.gene.2014.10.051; Liu X, 2015, INT J ENDOCRINOL, P1; Malorni L, 2006, PROTEOMICS, V6, P5973, DOI 10.1002/pmic.200600333; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martinez-Rivera FJ, 2015, BEHAV PROCESS, V113, P81, DOI 10.1016/j.beproc.2015.01.008; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; McNamara LE, 2010, J R SOC INTERFACE, V7, pS107, DOI 10.1098/rsif.2009.0177.focus; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; Navarro CE, 2003, MOL ENDOCRINOL, V17, P1792, DOI 10.1210/me.2003-0040; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Nishimura M, 2006, BIOCHEM BIOPH RES CO, V346, P1033, DOI 10.1016/j.bbrc.2006.06.012; Onaran I, 2007, ARCH ANDROLOGY, V53, P13, DOI 10.1080/01485010600889134; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Payne JR, 2004, HEART, V90, P473, DOI 10.1136/hrt.2003.025783; Penatti CAA, 2011, NEUROPHARMACOLOGY, V61, P653, DOI 10.1016/j.neuropharm.2011.05.008; Penatti CAA, 2010, J NEUROSCI, V30, P6497, DOI 10.1523/JNEUROSCI.5383-09.2010; Penatti CAA, 2009, J NEUROSCI, V29, P12484, DOI 10.1523/JNEUROSCI.3108-09.2009; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x; Rendic S, 1999, J CHROMATOGR B, V735, P73, DOI 10.1016/S0378-4347(99)00400-4; Riedmaier I, 2009, J CHROMATOGR A, V1216, P8192, DOI 10.1016/j.chroma.2009.01.094; Roy D, 1999, ENDOCRINOLOGY, V140, P5045, DOI 10.1210/en.140.11.5045; Schroder AL, 2009, ENDOCRINE, V35, P211, DOI 10.1007/s12020-009-9154-6; SCHWANZELFUKUDA M, 1992, ENDOCR REV, V13, P623, DOI 10.1210/er.13.4.623; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shakil T, 2002, MOL ENDOCRINOL, V16, P2592, DOI 10.1210/me.2002-0011; Skynner HA, 2006, BRAIN RES, V1102, P12, DOI 10.1016/j.brainres.2006.04.112; Stanton PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041718; Stefansson J, 2016, PSYCHONEUROENDOCRINO, V74, P1, DOI 10.1016/j.psyneuen.2016.08.009; Stella R, 2015, PROTEOMICS, V15, P2332, DOI 10.1002/pmic.201400468; STRAUSS RH, 1985, JAMA-J AM MED ASSOC, V254, P3337, DOI 10.1001/jama.254.23.3337; Suehara Y, 2009, PROTEOM CLIN APPL, V3, P584, DOI 10.1002/prca.200800168; TORANZO D, 1989, MOL ENDOCRINOL, V3, P1748, DOI 10.1210/mend-3-11-1748; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Wada-Kiyama Y, 2013, BIOCHEM BIOPH RES CO, V434, P287, DOI 10.1016/j.bbrc.2013.02.117; WELDER AA, 1995, J PHARMACOL TOX MET, V33, P187, DOI 10.1016/1056-8719(94)00073-D; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; WETSEL WC, 1995, CELL MOL NEUROBIOL, V15, P43, DOI 10.1007/BF02069558; Wiebe JP, 2001, ENDOCRINE, V16, P7, DOI 10.1385/ENDO:16:1:07; WIERMAN ME, 1995, CELL MOL NEUROBIOL, V15, P79, DOI 10.1007/BF02069559; Winters S J, 1990, NIDA Res Monogr, V102, P113; Wood RI, 2004, PHYSIOL BEHAV, V83, P279, DOI 10.1016/j.physbeh.2004.08.012; Yamada M., 2009, J PROTEOM BIOINFORM, V2, P001; YESALIS CE, 1995, SPORTS MED, V19, P326, DOI 10.2165/00007256-199519050-00003; Yuen GS, 2011, BRAIN RES, V1379, P44, DOI 10.1016/j.brainres.2010.07.067; Zarubin T, 2005, CELL RES; Zhang BG, 2013, EUR J CANCER, V49, P3900, DOI 10.1016/j.ejca.2013.07.146; Zhang HL, 2012, CELL PHYSIOL BIOCHEM, V30, P1340, DOI 10.1159/000343323; Zhang YY, 2009, EXPERT OPIN DRUG MET, V5, P621, DOI 10.1517/17425250902967648; Zhao KK, 2013, EUR J OBSTET GYN R B, V171, P301, DOI 10.1016/j.ejogrb.2013.09.026	94	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180409	10.1371/journal.pone.0180409	http://dx.doi.org/10.1371/journal.pone.0180409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719635	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400012
J	Al-Saffar, NMS; Agliano, A; Marshall, LV; Jackson, LE; Balarajah, G; Sidhu, J; Clarke, PA; Jones, C; Workman, P; Pearson, ADJ; Leach, MO				Al-Saffar, Nada M. S.; Agliano, Alice; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.			In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; HIGH-GRADE GLIOMA; BRAIN-TUMORS; CLINICAL-TRIALS; CHILDREN; ADULT; PATHWAY; AGENTS; AKT; PHOSPHOCHOLINE	Recent experimental data showed that the PI3K pathway contributes to resistance to temozolomide (TMZ) in paediatric glioblastoma and that this effect is reversed by combination treatment of TMZ with a PI3K inhibitor. Our aim is to assess whether this combination results in metabolic changes that are detectable by nuclear magnetic resonance (NMR) spectroscopy, potentially providing metabolic biomarkers for PI3K inhibition and TMZ combination treatment. Using two genetically distinct paediatric glioblastoma cell lines, SF188 and KNS42, in vitro H-1-NMR analysis following treatment with the dual pan-Class I PI3K/mTOR inhibitor PI-103 resulted in a decrease in lactate and phosphocholine (PC) levels (P<0.02) relative to control. In contrast, treatment with TMZ caused an increase in glycerolphosphocholine (GPC) levels (P <= 0.05). Combination of PI-103 with TMZ showed metabolic effects of both agents including a decrease in the levels of lactate and PC (P<0.02) while an increase in GPC (P<0.05). We also report a decrease in the protein expression levels of HK2, LDHA and CHKA providing likely mechanisms for the depletion of lactate and PC, respectively. Our results show that our in vitro NMR-detected changes in lactate and choline metabolites may have potential as non-invasive biomarkers for monitoring response to combination of PI3K/mTOR inhibitors with TMZ during clinical trials in children with glioblastoma, subject to further in vivo validation.	[Al-Saffar, Nada M. S.; Agliano, Alice; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Leach, Martin O.] Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK Canc Imaging Ctr, London, England; [Al-Saffar, Nada M. S.; Agliano, Alice; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Jones, Chris; Pearson, Andrew D. J.; Leach, Martin O.] Royal Marsden NHS Fdn Trust, London, England; [Marshall, Lynley V.; Jones, Chris; Pearson, Andrew D. J.] Inst Canc Res, Div Canc Therapeut, London, England; [Marshall, Lynley V.; Jones, Chris] Inst Canc Res, Div Mol Pathol, London, England; [Marshall, Lynley V.; Pearson, Andrew D. J.] Inst Canc Res, Div Clin Studies, London, England; [Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Div Canc Therapeut, London, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Al-Saffar, NMS (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK Canc Imaging Ctr, London, England.; Al-Saffar, NMS (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	Nada.Al-Saffar@icr.ac.uk	leach, martin o/C-2248-2008; Jones, Chris/ABE-6059-2021	leach, martin o/0000-0002-0756-5368; Jones, Chris/0000-0001-8118-2296; Al-Saffar, Nada/0000-0002-1292-0889; Clarke, Paul/0000-0001-9342-1290	Brain Tumour Charity [6/54]; Oak Foundation [OCay-04-169]; Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334, C1060/6916]; Cancer Research UK Life Chair and Programme Grant within a Cancer Research UK ICR Core Award [C347/A15403]; Cancer Research UK [C309/A2187, C309/A8274]; National Health Service; Cancer Research UK [16464] Funding Source: researchfish; The Brain Tumour Charity [6/54] Funding Source: researchfish	Brain Tumour Charity; Oak Foundation; Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK Life Chair and Programme Grant within a Cancer Research UK ICR Core Award; Cancer Research UK(Cancer Research UK); National Health Service; Cancer Research UK(Cancer Research UK); The Brain Tumour Charity	This work was supported by The Brain Tumour Charity grant 6/54 for N.M.S.A, GB and AA; The Oak Foundation grant OCay-04-169 for LVM; Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, C1060/6916 for MOL, NMSA, LEJ and TE; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award (C347/A15403) to AP; Cancer Research UK (C309/A2187, C309/A8274) to PW and PAC. PW is a Cancer Research UK Life Fellow; MOL is an NIHR senior investigator. The Institute of Cancer Research co-authors acknowledge National Health Service funding to the Biomedical Research Centre. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Agnihotri S, 2014, CANCER DISCOV, V4, P1198, DOI 10.1158/2159-8290.CD-14-0157; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Al-Saffar NMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103835; Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Arias-Mendoza F, 2013, ACAD RADIOL, V20, P1122, DOI 10.1016/j.acra.2013.04.013; Bartels U, 2011, CURR ONCOL, V18, pE19; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2010, BRIT J CANCER, V102, P1, DOI 10.1038/sj.bjc.6605457; Beloueche-Babari M, 2011, CELL CYCLE, V10, P2883, DOI 10.4161/cc.10.17.17192; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chaumeil MM, 2015, BRAIN PATHOL, V25, P769, DOI 10.1111/bpa.12310; Chaumeil MM, 2012, NEUROIMAGE, V59, P193, DOI 10.1016/j.neuroimage.2011.07.034; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clarke PA, 2012, J CLIN ONCOL, V30, P331, DOI 10.1200/JCO.2011.38.7167; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173; Gadian DG, 1995, INFORMATION AVAILABL, P29; Figueiras RG, 2011, RADIOGRAPHICS, V31, P2059, DOI 10.1148/rg.317115108; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Glunde K, 2015, EXPERT REV MOL DIAGN, V15, P735, DOI 10.1586/14737159.2015.1039515; Gutte H, 2015, AM J NUCL MED MOLEC, V5, P548; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; Harris LM, 2015, NMR BIOMED, V28, P338, DOI 10.1002/nbm.3255; Hourani R, 2006, J MAGN RESON IMAGING, V23, P99, DOI 10.1002/jmri.20480; Jones C., 2016, NEUROONCOL; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Kwak EL, 2007, CLIN CANCER RES, V13, P5232, DOI 10.1158/1078-0432.CCR-07-1385; Lee SC, 2013, NMR BIOMED, V26, P106, DOI 10.1002/nbm.2825; McKnight TR, 2004, SEMIN ONCOL, V31, P605, DOI 10.1053/j.seminoncol.2004.07.003; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Murphy PS, 2004, BRIT J CANCER, V90, P781, DOI 10.1038/sj.bjc.6601593; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Novaka J, 2014, EUR J RADIOL, V83, pE106, DOI 10.1016/j.ejrad.2013.11.009; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Radoul M, 2016, MOL CANCER THER, V15, P1113, DOI 10.1158/1535-7163.MCT-15-0769; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu ZY, 2015, CANCER LETT, V367, P58, DOI 10.1016/j.canlet.2015.07.007	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180263	10.1371/journal.pone.0180263	http://dx.doi.org/10.1371/journal.pone.0180263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704425	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700034
J	Darter, BJ; Bastian, AJ; Wolf, EJ; Husson, EM; Labrecque, BA; Hendershot, BD				Darter, Benjamin J.; Bastian, Amy J.; Wolf, Erik J.; Husson, Elizabeth M.; Labrecque, Bethany A.; Hendershot, Brad D.			Locomotor adaptability in persons with unilateral transtibial amputation	PLOS ONE			English	Article							SPLIT-BELT TREADMILL; STEP-LENGTH ASYMMETRY; LOWER-LIMB AMPUTEES; MOTOR ADAPTATION; PARKINSONS-DISEASE; KNEE AMPUTEES; ENERGY-COST; WALKING; GAIT; INDIVIDUALS	Background Locomotor adaptation enables walkers to modify strategies when faced with challenging walking conditions. While a variety of neurological injuries can impair locomotor adaptability, the effect of a lower extremity amputation on adaptability is poorly understood. Objective Determine if locomotor adaptability is impaired in persons with unilateral transtibial amputation (TTA). Methods The locomotor adaptability of 10 persons with a TTA and 8 persons without an amputation was tested while walking on a split-belt treadmill with the parallel belts running at the same (tied) or different (split) speeds. In the split condition, participants walked for 15 minutes with the respective belts moving at 0.5 m/s and 1.5 m/s. Temporal spatial symmetry measures were used to evaluate reactive accommodations to the perturbation, and the adaptive/deadaptive response. Results Persons with TTA and the reference group of persons without amputation both demonstrated highly symmetric walking at baseline. During the split adaptation and tied postadaptation walking both groups responded with the expected reactive accommodations. Likewise, adaptive and de-adaptive responses were observed. The magnitude and rate of change in the adaptive and de-adaptive responses were similar for persons with TTA and those without an amputation. Furthermore, adaptability was no different based on belt assignment for the prosthetic limb during split adaptation walking. Conclusions Reactive changes and locomotor adaptation in response to a challenging and novel walking condition were similar in persons with TTA to those without an amputation. Results suggest persons with TTA have the capacity to modify locomotor strategies to meet the demands of most walking conditions despite challenges imposed by an amputation and use of a prosthetic limb.	[Darter, Benjamin J.; Labrecque, Bethany A.] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23284 USA; [Darter, Benjamin J.] Hunter Holmes McGuire Veteran Affairs Med Ctr, Dept Res, Richmond, VA 23224 USA; [Bastian, Amy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Bastian, Amy J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; [Wolf, Erik J.; Husson, Elizabeth M.; Hendershot, Brad D.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA; [Wolf, Erik J.; Hendershot, Brad D.] DoD VA Extrem Trauma & Amputat Ctr Excellence, Bethesda, MD USA; [Husson, Elizabeth M.] Univ Delaware, BADER Consortium, Newark, DC USA; [Hendershot, Brad D.] Uniformed Serv Univ Hlth Sci, Dept Rehabil Med, Bethesda, MD 20814 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Kennedy Krieger Institute; Johns Hopkins University; Walter Reed National Military Medical Center; University of Delaware; Uniformed Services University of the Health Sciences - USA	Darter, BJ (corresponding author), Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23284 USA.; Darter, BJ (corresponding author), Hunter Holmes McGuire Veteran Affairs Med Ctr, Dept Res, Richmond, VA 23224 USA.	bjdarter@vcu.edu	Hendershot, Brad/AAG-7046-2020	Darter, Benjamin/0000-0003-3490-8562	Clinical and Translational Science Awards (CTSA) from National Center for Advancing Translational Sciences [KL2TR000057]; BADER Consortium via the Congressionally Designated Medical Research Program [W81XWH-11-2-0222]; DoD-VA Extremity Trauma and Amputation Center of Excellence [110-417]	Clinical and Translational Science Awards (CTSA) from National Center for Advancing Translational Sciences; BADER Consortium via the Congressionally Designated Medical Research Program; DoD-VA Extremity Trauma and Amputation Center of Excellence	Support for this project was provided, in part, by Clinical and Translational Science Awards (CTSA) No. KL2TR000057 from the National Center for Advancing Translational Sciences, the BADER Consortium via the Congressionally Designated Medical Research Program (Award number W81XWH-11-2-0222), and the DoD-VA Extremity Trauma and Amputation Center of Excellence (Public Law 110-417, National Defense Authorization Act 2009, Section 723). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOONSTRA AM, 1994, SCAND J REHABIL MED, V26, P217; Bruijn SM, 2012, J NEUROPHYSIOL, V108, P1149, DOI 10.1152/jn.00018.2012; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Esposito ER, 2014, J REHABIL RES DEV, V51, P1287, DOI 10.1682/JRRD.2014.06.0141; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; Gajewski Donald, 2006, J Am Acad Orthop Surg, V14, pS183; Gates DH, 2013, GAIT POSTURE, V38, P570, DOI 10.1016/j.gaitpost.2013.01.024; Genin JJ, 2008, EUR J APPL PHYSIOL, V103, P655, DOI 10.1007/s00421-008-0764-0; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Hak L, 2014, PHYS THER, V94, P1480, DOI 10.2522/ptj.20130431; Hoogkamer W, 2015, J NEUROPHYSIOL, V114, P1705, DOI 10.1152/jn.00937.2014; IJ T, 2015, J NEUROENGINEERING R, V12, P70; Isakov E, 1997, SCAND J REHABIL MED, V29, P75; Kannape OA, 2016, IEEE ENG MED BIO, P5469, DOI 10.1109/EMBC.2016.7591964; Layne CS, 2015, SOMATOSENS MOT RES, V32, P31, DOI 10.3109/08990220.2014.949007; Malone LA, 2016, NEUROBIOL LEARN MEM, V128, P1, DOI 10.1016/j.nlm.2015.11.003; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin J., 2010, J PROSTHETICS ORTHOT, V22, P183, DOI [10.1097/JPO.0b013e3181e8fe8a, DOI 10.1097/JPO.0B013E3181E8FE8A]; Mohammadi F, 2015, NEUROREHAB NEURAL RE, V29, P132, DOI 10.1177/1545968314545175; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Mueller MJ, 1998, GAIT POSTURE, V7, P200, DOI 10.1016/S0966-6362(98)00015-0; Munin MC, 2001, J REHABIL RES DEV, V38, P379; Ogawa T, 2014, J NEUROPHYSIOL, V111, P722, DOI 10.1152/jn.00497.2012; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Roemmich RT, 2016, CURR BIOL, V26, P2707, DOI 10.1016/j.cub.2016.08.012; Roemmich RT, 2014, CLIN NEUROPHYSIOL, V125, P313, DOI 10.1016/j.clinph.2013.07.003; Sanderson DJ, 1997, GAIT POSTURE, V6, P126, DOI 10.1016/S0966-6362(97)01112-0; Selgrade BP, 2017, J BIOMECH, V53, P136, DOI 10.1016/j.jbiomech.2017.01.012; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105	37	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181120	10.1371/journal.pone.0181120	http://dx.doi.org/10.1371/journal.pone.0181120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704467	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600061
J	Diestelhorst, J; Junge, N; Schlue, J; Falk, CS; Manns, MP; Baumann, U; Jaeckel, E; Taubert, R				Diestelhorst, Jana; Junge, Norman; Schlue, Jerome; Falk, Christine S.; Manns, Michael P.; Baumann, Ulrich; Jaeckel, Elmar; Taubert, Richard			Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy	PLOS ONE			English	Article							IMMUNE REGULATION; OVERLAP SYNDROME; ALLOGRAFTS; REJECTION; DIAGNOSIS; DISEASES; RECEPTOR; IMPACT	Background & Aims The autoimmune hepatitis (AIH) is a chronic hepatitis driven by the adaptive immunity that affects all age groups. A functional and numerical regulatory T cell (Treg) defect has been reported in pediatric AIH (pAIH), while an intrahepatic increase in adult AIH (aAIH) patients has been detected in current research findings. Methods Therefore, we quantified the intrahepatic numbers of Treg, T and B cells, as well as serum cytokine levels before and during therapy in pAIH. Results We found a disproportional intrahepatic enrichment of Tregs in untreated pAIH compared to pediatric non-alcoholic fatty liver disease. The increase of Treg/ total T cells was even more pronounced than in aAIH due to fewer infiltrating T and B cells. Portal densities of Treg, as well as total T and B cells, declined significantly during therapy. However, portal Treg densities decreased disproportionately, leading to even decreasing ratios of Treg to T and B cells during therapy. Out of 28 serum cytokines IL-2 showed the strongest (10fold) decrease under therapy. This decline of IL-2 was associated with decreasing intrahepatic Treg numbers under therapy. None of the baseline T and B cell infiltration parameters were associated with the subsequent treatment response in pAIH. Conclusions Intrahepatic Tregs are rather enriched in untreated pAIH. The disproportional decrease of Tregs during therapy may be caused by a decrease of IL-2 levels. New therapies should, therefore, aim in strengthening intrahepatic immune regulation.	[Diestelhorst, Jana; Manns, Michael P.; Jaeckel, Elmar; Taubert, Richard] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Diestelhorst, Jana; Junge, Norman; Baumann, Ulrich] Hannover Med Sch, Dept Paediat Kidney Liver & Metab Dis, Pediat Gastroenterol & Hepatol, Hannover, Germany; [Schlue, Jerome] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplantat Immunol, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Taubert, R (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Taubert.richard@mh-hannover.de	Junge, Norman/AAA-5542-2022; Falk, Christine/Q-4143-2016	Junge, Norman/0000-0002-3099-2667; Falk, Christine/0000-0003-1376-7318	German Research Foundation [KFO250, SFBTR127, HA6880/2-1]; Else-KroEner-Fresenius-Foundation, MD dissertation program (KlinStrucMed); Hannover Medical School	German Research Foundation(German Research Foundation (DFG)); Else-KroEner-Fresenius-Foundation, MD dissertation program (KlinStrucMed); Hannover Medical School	The work was supported by grants from the German Research Foundation (KFO250 project 7; SFBTR127 projectA4; HA6880/2-1). JD was supported by the Else-KroEner-Fresenius-Foundation'' as part of the MD dissertation program (KlinStrucMed) and RT was supported by the Young Faculty program from the Hannover Medical School	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Baumann AK, 2016, LIVER TRANSPLANT, V22, P943, DOI 10.1002/lt.24427; Chen YY, 2016, HEPATOLOGY, V64, P138, DOI 10.1002/hep.28517; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Floreani A, 2013, J AUTOIMMUN, V46, P7, DOI 10.1016/j.jaut.2013.08.004; Furukawa A, 2016, TRANSPLANTATION, V100, P2288, DOI 10.1097/TP.0000000000001379; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Grant CR, 2014, HEPATOLOGY, V59, P1007, DOI 10.1002/hep.26583; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Groribaek L, 2014, J HEPATOL, V60, P612, DOI 10.1016/j.jhep.2013.10.020; Hardtke-Wolenski M, 2013, HEPATOLOGY, V58, P718, DOI 10.1002/hep.26380; He Q, 2011, TRANSPL P, V43, P1696, DOI 10.1016/j.transproceed.2011.03.084; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jeffery HC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00334; Junge N, 2016, EUR J PEDIATR, V175, P527, DOI 10.1007/s00431-015-2662-x; Kirstein MM, 2015, HEPATOLOGY, V62, P1524, DOI 10.1002/hep.27983; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036; Liberal R, 2015, HEPATOLOGY, V62, P863, DOI 10.1002/hep.27884; Liberal R, 2012, HEPATOLOGY, V56, P677, DOI 10.1002/hep.25682; Liberal R, 2011, BEST PRACT RES CL GA, V25, P653, DOI 10.1016/j.bpg.2011.09.009; Longhi MS, 2013, J AUTOIMMUN, V41, P146, DOI 10.1016/j.jaut.2012.12.003; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Taubert R, 2012, AM J TRANSPLANT, V12, P3425, DOI 10.1111/j.1600-6143.2012.04264.x; Taubert R, 2015, AM J TRANSPLANT	31	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181107	10.1371/journal.pone.0181107	http://dx.doi.org/10.1371/journal.pone.0181107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700730	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400031
J	Freundt-Revilla, J; Kegler, K; Baumgartner, W; Tipold, A				Freundt-Revilla, Jessica; Kegler, Kristel; Baumgaertner, Wolfgang; Tipold, Andrea			Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system	PLOS ONE			English	Article							RAT SPINAL-CORD; MESSENGER-RNA LEVELS; ENDOCANNABINOID SYSTEM; BASAL GANGLIA; ENDOGENOUS CANNABINOIDS; IMMUNOHISTOCHEMICAL LOCALIZATION; NEURONAL SUBPOPULATIONS; INDUCED ANTINOCICEPTION; GABAERGIC TRANSMISSION; SYNAPTIC-TRANSMISSION	The endocannabinoid system is a regulatory pathway consisting of two main types of cannabinoid receptors (CB1 and CB2) and their endogenous ligands, the endocannabinoids. The CB1 receptor is highly expressed in the central and peripheral nervous systems (PNS) in mammalians and is involved in neuromodulatory functions. Since endocannabinoids were shown to be elevated in cerebrospinal fluid of epileptic dogs, knowledge about the species specific CB receptor expression in the nervous system is required. Therefore, we assessed the spatial distribution of CB1 receptors in the normal canine CNS and PNS. Immunohistochemistry of several regions of the brain, spinal cord and peripheral nerves from a healthy four-week-old puppy, three six-month-old dogs, and one ten-year-old dog revealed strong dot-like immunoreactivity in the neuropil of the cerebral cortex, Cornu Ammonis (CA) and dentate gyrus of the hippocampus, midbrain, cerebellum, medulla oblongata and grey matter of the spinal cord. Dense CB1 expression was found in fibres of the globus pallidus and substantia nigra surrounding immunonegative neurons. Astrocytes were constantly positive in all examined regions. CB1 labelled neurons and satellite cells of the dorsal root ganglia, and myelinating Schwann cells in the PNS. These results demonstrate for the first time the spatial distribution of CB1 receptors in the healthy canine CNS and PNS. These results can be used as a basis for further studies aiming to elucidate the physiological consequences of this particular anatomical and cellular distribution.	[Freundt-Revilla, Jessica; Tipold, Andrea] Univ Vet Med, Dept Small Anim Med & Surg, Hannover Fdn, Hannover, Germany; [Freundt-Revilla, Jessica; Kegler, Kristel; Baumgaertner, Wolfgang; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Germany; [Kegler, Kristel; Baumgaertner, Wolfgang] Univ Vet Med, Hannover Fdn, Dept Pathol, Hannover, Germany; [Kegler, Kristel] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Bern	Freundt-Revilla, J (corresponding author), Univ Vet Med, Dept Small Anim Med & Surg, Hannover Fdn, Hannover, Germany.; Freundt-Revilla, J (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	Jessica.Freundt.Revilla@tiho-hannover.de			Deutscher Akademischer Austauschdienst (DAAD, Germany) [GR 6220 22681]	Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD))	JFR recieved funding from the Deutscher Akademischer Austauschdienst (DAAD, Germany), Grant number: GR 6220 22681, https://www.daad.de. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Ahluwalia J, 2000, NEUROSCIENCE, V100, P685, DOI 10.1016/S0306-4522(00)00389-4; Anday JK, 2005, PHARMACOL RES, V52, P463, DOI 10.1016/j.phrs.2005.07.005; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Bilkei-Gorzo A, 2012, PHILOS T R SOC B, V367, P3326, DOI 10.1098/rstb.2011.0388; Blair RE, 2006, J PHARMACOL EXP THER, V317, P1072, DOI 10.1124/jpet.105.100354; Breivogel CS, 1998, NEUROBIOL DIS, V5, P417, DOI 10.1006/nbdi.1998.0229; Burns HD, 2007, P NATL ACAD SCI USA, V104, P9800, DOI 10.1073/pnas.0703472104; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Condie R, 1996, J BIOL CHEM, V271, P13175, DOI 10.1074/jbc.271.22.13175; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Dall'Aglio C, 2010, VET RES COMMUN, V34, pS9, DOI 10.1007/s11259-010-9379-0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Eggan SM, 2007, CEREB CORTEX, V17, P175, DOI 10.1093/cercor/bhj136; Elphick MR, 2001, PHILOS T R SOC B, V356, P381, DOI 10.1098/rstb.2000.0787; Farquhar-Smith WP, 2000, MOL CELL NEUROSCI, V15, P510, DOI 10.1006/mcne.2000.0844; Fede C, 2016, EUR J HISTOCHEM, V60, P130, DOI 10.4081/ejh.2016.2643; Garcia-Ovejero D, 2013, J COMP NEUROL, V521, P233, DOI 10.1002/cne.23184; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gesell FK, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-262; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hofmann ME, 2013, EXP NEUROL, V244, P43, DOI 10.1016/j.expneurol.2011.11.047; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Kegler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133916; LICHTMAN AH, 1991, J PHARMACOL EXP THER, V258, P517; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; MAILLEUX P, 1992, NEUROSCI LETT, V148, P173, DOI 10.1016/0304-3940(92)90832-R; Malinova L, 2015, SCRIPTA SCI MEDICA, V45, p43 ; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MARTIN BR, 1975, PHARMACOL BIOCHEM BE, V3, P849, DOI 10.1016/0091-3057(75)90116-1; MARTIN WJ, 1995, LIFE SCI, V56, P2103, DOI 10.1016/0024-3205(95)00195-C; Mechoulam R., 1986, CANNABINOIDS THERAPE; Meng XD, 2014, INT J CLIN EXP PATHO, V7, P2825; Mercati F, 2012, ACTA HISTOCHEM, V114, P68, DOI 10.1016/j.acthis.2011.01.003; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Moore SA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00012; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Paniagua-Torija B, 2015, SCI REP-UK, V5, DOI 10.1038/srep17745; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Pirone A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1616-0; Potschka H, 2012, EPILEPTIC DISORD, V14, P226, DOI 10.1684/epd.2012.0532; RAZDAN RK, 1986, PHARMACOL REV, V38, P75; Richardson JD, 1998, EUR J PHARMACOL, V345, P145, DOI 10.1016/S0014-2999(97)01621-X; Richardson JD, 1998, J NEUROSCI, V18, P451; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Romero J, 2002, PHARMACOL THERAPEUT, V95, P137, DOI 10.1016/S0163-7258(02)00253-X; Romero J, 1998, NEUROSCIENCE, V84, P1075, DOI 10.1016/S0306-4522(97)00552-6; Sagan S, 1999, EUR J NEUROSCI, V11, P691, DOI 10.1046/j.1460-9568.1999.00480.x; Salio C, 2002, NEUROSCI LETT, V329, P13, DOI 10.1016/S0304-3940(02)00549-9; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Sanudo-Pena MC, 1999, ACTA PHARMACOL SIN, V20, P1115; Sanudo-Pena MC, 1999, LIFE SCI, V65, P703, DOI 10.1016/S0024-3205(99)00293-3; SanudoPena MC, 1997, J NEUROPHYSIOL, V77, P1635, DOI 10.1152/jn.1997.77.3.1635; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tomas-Roig J, 2016, CNS NEUROSCI THER, V22, P387, DOI 10.1111/cns.12506; Tomlinson L, 2012, TOXICOL SCI, V129, P268, DOI 10.1093/toxsci/kfs217; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Tsou K, 1996, NEUROSCIENCE, V70, P791, DOI 10.1016/S0306-4522(96)83015-6; von Ruden EL, 2015, NEUROBIOL DIS, V73, P334, DOI 10.1016/j.nbd.2014.08.001; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WILSON RS, 1979, J MED CHEM, V22, P886, DOI 10.1021/jm00193a027	92	36	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181064	10.1371/journal.pone.0181064	http://dx.doi.org/10.1371/journal.pone.0181064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700706	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800117
J	Ogden, AJ; Gargouri, M; Park, J; Gang, DR; Kahn, ML				Ogden, Aaron J.; Gargouri, Mahmoud; Park, JeongJin; Gang, David R.; Kahn, Michael L.			Integrated analysis of zone-specific protein and metabolite profiles within nitrogen-fixing Medicago truncatula-Sinorhizobium medicae nodules	PLOS ONE			English	Article							GENE-EXPRESSION; ROOT-NODULE; MELILOTI; LEGUME; PLANT; RHIZOBIUM; INFECTION; TRANSPORT; FIXATION; ORGANOGENESIS	Symbiotic nitrogen fixation (SNF) between rhizobia and legumes requires metabolic coordination within specialized root organs called nodules. Nodules formed in the symbiosis between S. medicae and barrel medic (M. truncatula) are indeterminate, cylindrical, and contain spatially distinct developmental zones. Bacteria in the infection zone II (ZII), interzone II-III (IZ), and nitrogen fixation zone III (ZIII) represent different stages in the metabolic progression from free-living bacteria into nitrogen fixing bacteroids. To better understand the coordination of plant and bacterial metabolism within the nodule, we used liquid and gas chromatography coupled to tandem mass spectrometry (MS) to observe protein and metabolite profiles representative of ZII, IZ, ZIII, whole-nodule, and primary root. Our MS-based approach confidently identified 361 S. medicae proteins and 888 M. truncatula proteins, as well as 160 metabolites from each tissue. The data are consistent with several organ-and zone-specific protein and metabolite localization patterns characterized previously. We used our comprehensive dataset to demonstrate how multiple branches of primary metabolism are coordinated between symbionts and zones, including central carbon, fatty acid, and amino acid metabolism. For example, M. truncatula glycolysis enzymes accumulate from zone I to zone III within the nodule, while equivalent S. medicae enzymes decrease in abundance. We also show the localization of S. medicae's transition to dicarboxylic acid-dependent carbon metabolism within the IZ. The spatial abundance patterns of S. medicae fatty acid (FA) biosynthesis enzymes indicate an increased demand for FA production in the IZ and ZIII as compared to ZI. These observations provide a resource for those seeking to understand coordinated physiological changes during the development of SNF.	[Ogden, Aaron J.; Gang, David R.; Kahn, Michael L.] Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA; [Ogden, Aaron J.; Gargouri, Mahmoud; Park, JeongJin; Gang, David R.; Kahn, Michael L.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Gargouri, Mahmoud] Ctr Biotechnol Borj Cedria, BP 901 Hammam Lif, Ben Arous, Tunisia; [Park, JeongJin] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA	Washington State University; Washington State University; Centre de Biotechnologie de Borj Cedria; University of Virginia	Kahn, ML (corresponding author), Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA.; Kahn, ML (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	kahn@wsu.edu	Gargouri, Mahmoud/AAT-4329-2020	Gargouri, Mahmoud/0000-0002-7476-9854; /0000-0003-0043-4661	US National Science Foundation [DGE-1347973]; Protein Biotechnology predoctoral traineeship; US National Institutes of Health National Institute of General Medical Sciences [T32GM008336]; Waters Synapt G2S LC-IMS-MS [DBI-1229749]; US National Science Foundation; US Department of Energy-Basic Energy Sciences-Physical Biosciences Program [DE-FG03-96ER20225]; College of Agricultural, Human and Natural Resource Sciences at Washington State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Protein Biotechnology predoctoral traineeship; US National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Waters Synapt G2S LC-IMS-MS; US National Science Foundation(National Science Foundation (NSF)); US Department of Energy-Basic Energy Sciences-Physical Biosciences Program(United States Department of Energy (DOE)); College of Agricultural, Human and Natural Resource Sciences at Washington State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AO was supported by predoctoral fellowship #DGE-1347973 from the US National Science Foundation and a Protein Biotechnology predoctoral traineeship from the US National Institutes of Health National Institute of General Medical Sciences #T32GM008336. Acquisition of the Waters Synapt G2S LC-IMS-MS was enabled through grant #DBI-1229749 to DG from the US National Science Foundation. Research support was obtained from grant #DE-FG03-96ER20225 to MK from the US Department of Energy-asic Energy Sciences-Physical Biosciences Program and support from the College of Agricultural, Human and Natural Resource Sciences at Washington State University.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Barker DG, 2006, NOBLE ORGMEDICAGOHAN; Catalano CM, 2004, ELECTROPHORESIS, V25, P519, DOI 10.1002/elps.200305711; DEBILLY F, 1991, PLANT J, V1, P27, DOI 10.1111/j.1365-313X.1991.00027.x; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Foucher F, 2000, PLANT MOL BIOL, V43, P773, DOI 10.1023/A:1006405029600; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Haag AF, 2012, FEMS MICROBIOL REV, P364; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Liu JQ, 2006, PLANT PHYSIOL, V141, P167, DOI 10.1104/pp.106.076711; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Long S, BIOCHEMISTRY AND MOL, P711; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Marx H, 2016, NAT BIOTECHNOL, V34, P1198, DOI 10.1038/nbt.3681; MCDERMOTT TR, 1992, J BACTERIOL, V174, P4790, DOI 10.1128/JB.174.14.4790-4797.1992; Monahan-Giovanelli H, 2006, PLANT PHYSIOL, V140, P661, DOI 10.1104/pp.105.072876; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Patriarca EJ, 2004, INT REV CYTOL, V234, P201, DOI 10.1016/S0074-7696(04)34005-2; Peltzer MD, 2008, MOL PLANT MICROBE IN, V21, P1232, DOI 10.1094/MPMI-21-9-1232; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Queiroux C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-74; Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042; ROLFE BG, 1988, ANNU REV PLANT PHYS, V39, P297, DOI 10.1146/annurev.pp.39.060188.001501; Roux B, 2014, PLANT J, V77, P817, DOI 10.1111/tpj.12442; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; SOUPENE E, 1995, P NATL ACAD SCI USA, V92, P3759, DOI 10.1073/pnas.92.9.3759; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Sulieman S, 2013, CRIT REV BIOTECHNOL, V33, P309, DOI 10.3109/07388551.2012.695770; Temple SJ, 1998, TRENDS PLANT SCI, V3, P51, DOI 10.1016/S1360-1385(97)01159-X; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshioka H, 1999, MOL PLANT MICROBE IN, V12, P263, DOI 10.1094/MPMI.1999.12.4.263; Yurgel SN, 2005, J BACTERIOL, V187, P1161, DOI 10.1128/JB.187.3.1161-1172.2005; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002	48	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180894	10.1371/journal.pone.0180894	http://dx.doi.org/10.1371/journal.pone.0180894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700717	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800093
J	Roy, A; Lim, LZ; Srivastava, S; Lu, YM; Song, JX				Roy, Amrita; Lim, Liangzhong; Srivastava, Shagun; Lu, Yimei; Song, Jianxing			Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants	PLOS ONE			English	Article							NONCOMPETITIVE INHIBITORS; STRUCTURAL BIOLOGY; NS3 PROTEASES; VIRUS; DENGUE; PROTEIN; COMPLEX; DESIGN; TRANSMISSION; ACTIVATION	The recent Zika viral (ZIKV) epidemic has been associated with severe neurological pathologies such as neonatal microcephaly and Guillain-Barre syndrome but unfortunately no vaccine or medication is effectively available yet. Zika NS2B-NS3pro is essential for the proteolysis of the viral polyprotein and thereby viral replication. Thus NS2B-NS3pro represents an attractive target for anti-Zika drug discovery/design. Here, we have characterized the solution conformations and catalytic parameters of both linked and unlinked Zika NS2BNS3pro complexes and found that the unlinked complex manifested well-dispersed NMR spectra. Subsequently with selective isotope-labeling using NMR spectroscopy, we demonstrated that C-terminal residues (R73-K100) of NS2B is highly disordered without any stable tertiary and secondary structures in the Zika NS2B-NS3pro complex in the free state. Upon binding to the well-characterized serine protease inhibitor, bovine pancreatic trypsin inhibitor (BPTI), only the extreme C-terminal residues (L86-K100) remain disordered. Additionally, we have identified five flavonoids and one natural phenol rich in edible plants including fruits and vegetables, which inhibit Zika NS2B-NS3pro in a non-competitive mode, with Ki ranging from 770 nM for Myricetin to 34.02 ae M for Apigenin. Molecular docking showed that they all bind to a pocket on the back of the active site and their structure-activity relationship was elucidated. Our study provides valuable insights into the solution conformation of Zika NS2B-NS3pro and further deciphers its susceptibility towards allosteric inhibition by natural products. As these natural product inhibitors fundamentally differ from the currently-known active site inhibitors in terms of both inhibitory mode and chemical scaffold, our finding might open a new avenue for development of better allosteric inhibitors to fight ZIKV infection.	[Roy, Amrita; Lim, Liangzhong; Srivastava, Shagun; Lu, Yimei; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore	National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.	dbssjx@nus.edu.sg		Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) Tier 3 [R-154002-580-112]; Ministry of Education of Singapore (MOE) Tier 2 [MOE2015-T2-1-111]	Ministry of Education of Singapore (MOE) Tier 3; Ministry of Education of Singapore (MOE) Tier 2	This study is supported by Ministry of Education of Singapore (MOE) Tier 3 Grant R-154002-580-112; Tier 2 Grant MOE2015-T2-1-111 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011; Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002; Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017; Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018; Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116; Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W., 2016, NAT IMMUNOL; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g; de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015; Gupta G., 2015, PLOS ONE, V10; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; Iempridee T, 2008, BBA-GEN SUBJECTS, V1780, P989, DOI 10.1016/j.bbagen.2008.03.018; Jordan J, 2016, CLIN DIS; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Lee H, 2016, ANTIVIR RES; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Ma BY, 2016, NAT CHEM BIOL, V12, P890, DOI 10.1038/nchembio.2212; Ma BY, 2013, TOP CURR CHEM, V337, P123, DOI 10.1007/128_2012_316; Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Organization WH. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005), 2016, EM COMM ZIKV OBS INC; Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Song JX, 1998, BIOCHEM CELL BIOL, V76, P177; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375; Vogiatzoglou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128132; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h	62	53	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180632	10.1371/journal.pone.0180632	http://dx.doi.org/10.1371/journal.pone.0180632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700665	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800059
J	Yoo, HN; Park, KH; Jung, EY; Kim, YM; Kook, SY; Jeon, SJ				Yoo, Ha-Na; Park, Kyo Hoon; Jung, Eun Young; Kim, Yu Mi; Kook, Song Yi; Jeon, Se Jeong			Non-invasive prediction of preterm birth in women with cervical insufficiency or an asymptomatic short cervix (<= 25 mm) by measurement of biomarkers in the cervicovaginal fluid	PLOS ONE			English	Article							D-BINDING PROTEIN; AMNIOTIC-FLUID; MULTIPLE-PROTEINS; LABOR; PREGNANCY; CERCLAGE; LENGTH; PARTURITION; DICKKOPF-3; INFECTION	( Objective To determine whether various proteins in the cervicovaginal fluid (CVF) known to be involved in immune regulation, alone or in combination with clinical risk factors, can predict spontaneous preterm delivery (SPTD) in women with cervical insufficiency or a short cervix (<= 25 mm). Methods This retrospective cohort study included 62 asymptomatic women with cervical insufficiency (n = 27) or an asymptomatic short cervix (n = 35) at 18-27 weeks. CVF swab samples were taken for assays of vitamin D binding protein (VDBP), interleukin (IL)-8, matrix metalloproteinases (MMP)-9, tissue inhibitor of metalloproteinases (TIMP)-1, and Dickkopf-related protein 3 (DKK3) before cervical examination, and maternal blood was collected for the determination of the C-reactive protein (CRP) level. The primary outcome measurement was SPTD at <32 weeks of gestation. Logistic regression analysis and receiver operating characteristic curves were used for the statistical analyses. Results The rate of SPTD at <32 weeks was 40.3% (25/62). The CVF levels of VDBP, TIMP-1, and DKK3, but not IL-8 and MMP-9, were significantly higher in the women who had SPTD at <32 weeks than in those who did not deliver spontaneously at <32 weeks. The women who had SPTD at <32 weeks had a significantly more advanced cervical dilatation at presentation and a higher level of serum CRP. Using the stepwise regression analysis, a prediction model was developed by combining various proteins in the CVF and clinical factors, resulting in the inclusion of cervical dilatation, CVF VDBP, and use of corticosteroids (area under curve, 0.909). Conclusions In women with cervical insufficiency or a short cervix, VDBP, TIMP-1, and DKK3 in the CVF may be useful as non-invasive predictors of SPTD at <32 weeks. A combination of these markers and clinical factors appears to improve the predictability of SPTD compared with the markers alone.	[Yoo, Ha-Na; Park, Kyo Hoon; Jung, Eun Young; Kim, Yu Mi; Kook, Song Yi; Jeon, Se Jeong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org			Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. HI 14C1798).	Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754; Alfirevic Z, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008991.pub2; Athayde N, 1999, J Matern Fetal Med, V8, P213; Boots AB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.004; Brown R, 2013, J OBSTET GYNAECOL CA, V35, P1115, DOI 10.1016/S1701-2163(15)30764-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DiMartino SJ, 1999, J IMMUNOL, V163, P2135; Eckmann-Scholz C, 2016, ARCH GYNECOL OBSTET, V293, P1213, DOI 10.1007/s00404-015-3931-7; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; ELLIOTT JP, 1995, OBSTET GYNECOL, V85, P250, DOI 10.1016/0029-7844(94)00355-H; EMERSON DL, 1985, AM J REPROD IM MIC, V7, P15; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GUHA C, 1995, HEPATOLOGY, V21, P1675; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Jung EY, 2017, REPROD SCI, V24, P142, DOI 10.1177/1933719116651149; Jung EY, 2016, INT J GYNECOL OBSTET, V132, P165, DOI 10.1016/j.ijgo.2015.07.011; Jung EY, 2016, J OBSTET GYNAECOL RE, V42, P158, DOI 10.1111/jog.12882; Jung EY, 2015, ARCH GYNECOL OBSTET, V292, P579, DOI 10.1007/s00404-015-3684-3; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Lee SM, 2016, J OBSTET GYNAECOL RE, V42, P776, DOI 10.1111/jog.12976; Li XQ, 2014, PLACENTA, V35, P291, DOI 10.1016/j.placenta.2014.03.005; LIDEGAARD O, 1994, ACTA OBSTET GYN SCAN, V73, P35, DOI 10.3109/00016349409013390; Liong S, 2015, BJOG-INT J OBSTET GY, V122, P370, DOI 10.1111/1471-0528.12993; Liong S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076490; Locksmith GJ, 2001, AM J OBSTET GYNECOL, V184, P159, DOI 10.1067/mob.2001.108860; Ludwig J, 2015, J IMMUNOL, V194, P2624, DOI 10.4049/jimmunol.1402160; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Meister M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00078; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NWOSU UC, 1976, OBSTET GYNECOL, V47, P137; Romero R, 2006, AM J OBSTET GYNECOL, V194, P1, DOI 10.1016/j.ajog.2005.12.002; Sakai M, 2004, AM J REPROD IMMUNOL, V51, P220, DOI 10.1111/j.1600-0897.2004.00145.x; Suh YH, 2007, J KOREAN MED SCI, V22, P89, DOI 10.3346/jkms.2007.22.1.89; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Xiang TX, 2013, J CELL MOL MED, V17, P1236, DOI 10.1111/jcmm.12099; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	40	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180878	10.1371/journal.pone.0180878	http://dx.doi.org/10.1371/journal.pone.0180878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700733	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800091
J	Wang, J; Jia, Y; Zhao, S; Zhang, X; Wang, X; Han, X; Wang, Y; Ma, M; Shi, J; Liu, L				Wang, J.; Jia, Y.; Zhao, S.; Zhang, X.; Wang, X.; Han, X.; Wang, Y.; Ma, M.; Shi, J.; Liu, L.			BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer	ONCOGENE			English	Article							TUMOR-SUPPRESSOR BIN1; INTEGRATOR 1 BIN1; PD-L1 EXPRESSION; INFILTRATING LYMPHOCYTES; UP-REGULATION; APOPTOSIS; EGFR; ACTIVATION; DOWNSTREAM; MECHANISMS	Non-small cell lung cancer (NSCLC) is one of the most common and malignant carcinoma worldwide, and the incidence and mortality are increasing rapidly. Immunotherapy targeting programmed death 1/programmed death ligand 1 (PD-L1) signaling has shown prominent clinical effects in treating NSCLC; however, a poor understanding of the associated regulating molecular mechanisms of PD-L1 has become one of the biggest obstacles for further improving efficacy. Bridging integrator-1 (BIN1) can regulate numerous cancer-related molecules to exert multiple tumor-suppressing effects by either interacting or not interacting with c-MYC. In the present study, we observed that there exists a negative correlation between the expression of PD-L1 and BIN1 in NSCLC tissues. The expression levels of BIN1 and PD-L1 were significantly related to the tumor, lymph node and metastasis grade (TNM) stage, invasion range and lymph node metastasis. Simultaneously, for NSCLC patients, the expression statuses of BIN1 and PD-L1 might be independent prognostic factors. Furthermore, the expression of tumor-infiltrating lymphocytes was positively associated with BIN1 expression and negatively related to PD-L1 expression in NSCLC tissues. Importantly, we showed that PD-L1 was under the control of BIN1. In addition, the overexpression of BIN1 could inhibit the c-MYC and epithelial growth factor receptor (EGFR)-dependent PD-L1 expression and reverse the suppressive immuno-microenvironment in vivo. Taken together, our findings indicated that BIN1 restoration in NSCLC could reverse PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/mitogen-activated protein kinase pathways.	[Wang, J.; Jia, Y.; Zhang, X.; Wang, X.; Han, X.; Wang, Y.; Liu, L.] Hebei Med Univ, Hosp 4, Dept Tumor Immunotherapy, 169 Tianshan St, Shijiazhuang 050035, Hebei, Peoples R China; [Wang, J.; Jia, Y.; Zhang, X.; Wang, X.; Han, X.; Wang, Y.; Ma, M.; Liu, L.] Hebei Canc Inst, 169 Tianshan St, Shijiazhuang 050035, Hebei, Peoples R China; [Zhao, S.] Hebei Med Univ, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Ma, M.] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Hebei, Peoples R China; [Shi, J.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Mol Biol, Beijing, Peoples R China; [Shi, J.] Peking Union Med Coll, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, L (corresponding author), Hebei Med Univ, Hosp 4, Dept Tumor Immunotherapy, 169 Tianshan St, Shijiazhuang 050035, Hebei, Peoples R China.; Liu, L (corresponding author), Hebei Canc Inst, 169 Tianshan St, Shijiazhuang 050035, Hebei, Peoples R China.	cdlihualiu@aliyun.com			National Natural Science Foundation of China [81201607]; Postdoctoral Fund of China [2013M540883]; Outstanding Youth Foundation of Hebei Province [H2014206320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Fund of China(China Postdoctoral Science Foundation); Outstanding Youth Foundation of Hebei Province	This work was supported by the National Natural Science Foundation of China (81201607), Postdoctoral Fund of China (2013M540883), and Outstanding Youth Foundation of Hebei Province (H2014206320).	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; [Anonymous], 2015, CANCER DISCOV, V5, P1232, DOI 10.1158/2159-8290.CD-ND2015-004; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Barekati Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-244; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cassimere EK, 2009, CELL DEATH DIFFER, V16, P1641, DOI 10.1038/cdd.2009.98; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Concha-Benavente F, 2016, CANCER RES, V76, P1031, DOI 10.1158/0008-5472.CAN-15-2001; Dieci MV, 2014, ANN ONCOL, V25, P611, DOI 10.1093/annonc/mdt556; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DuHadaway JB, 2001, CANCER RES, V61, P3151; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645, DOI 10.6004/jnccn.2013.0084; Fusi A, 2015, LANCET ONCOL, V16, P1285, DOI 10.1016/S1470-2045(15)00307-1; Ge K, 2000, INT J CANCER, V85, P376; Hirano F, 2005, CANCER RES, V65, P1089; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; Jia YL, 2015, INT J CANCER, V137, P1095, DOI 10.1002/ijc.29481; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Liu LH, 2009, CELL IMMUNOL, V258, P181, DOI 10.1016/j.cellimm.2009.05.002; Ma M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31315; Martin-Orozco N, 2006, J IMMUNOL, V177, P8291, DOI 10.4049/jimmunol.177.12.8291; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Pan K, 2012, MOL MED, V18, P507, DOI 10.2119/molmed.2011.00319; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Schumacher K, 2001, CANCER RES, V61, P3932; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Tajiri T, 2003, CLIN CANCER RES, V9, P3345; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Telfer JF, 2005, CELL SIGNAL, V17, P701, DOI 10.1016/j.cellsig.2004.10.009; Wahlin BE, 2007, CLIN CANCER RES, V13, P388, DOI 10.1158/1078-0432.CCR-06-1734; Wang XX, 2017, ONCOTARGET, V8, P19661, DOI 10.18632/oncotarget.14914; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zhao LM, 2015, MOL MED REP, V11, P871, DOI 10.3892/mmr.2014.2874	45	57	64	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6235	6243		10.1038/onc.2017.217	http://dx.doi.org/10.1038/onc.2017.217			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28714960				2022-12-26	WOS:000414774800003
J	Gajiwala, KS; Grodsky, N; Bolanos, B; Feng, JL; Ferre, R; Timofeevski, S; Xu, MR; Murray, BW; Johnson, TW; Al Stewart,				Gajiwala, Ketan S.; Grodsky, Neil; Bolanos, Ben; Feng, Junli; Ferre, RoseAnn; Timofeevski, Sergei; Xu, Meirong; Murray, Brion W.; Johnson, Ted W.; Stewart, Al			The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; GROWTH-ARREST; ACTIVATION; RESISTANCE; CANCER; FAMILY; DISCOVERY; MECHANISM; CELLS; IDENTIFICATION	The receptor tyrosine kinase family consisting of Tyro3, Axl, and Mer (TAM) is one of the most recently identified receptor tyrosine kinase families. TAM receptors are up-regulated postnatally and maintained at high levels in adults. They all play an important role in immunity, but Axl has also been implicated in cancer and therefore is a target in the discovery and development of novel therapeutics. However, of the three members of the TAM family, the Axl kinase domain is the only one that has so far eluded structure determination. To this end, using differential scanning fluorimetry and hydrogen-deuterium exchange mass spectrometry, we show here that a lower stability and greater dynamic nature of the Axl kinase domain may account for its poor crystallizability. Wepresent the first structural characterization of the Axl kinase domain in complex with a smallmolecule macrocyclic inhibitor. The Axl crystal structure revealed two distinct conformational states of the enzyme, providing a first glimpse of what an activeTAMreceptor kinase may look like and suggesting a potential role for the juxtamembrane region in enzyme activity. We noted that the ATP/ inhibitorbinding sites of the TAM members closely resemble each other, posing a challenge for the design of a selective inhibitor. We propose that the differences in the conformational dynamics among the TAM family members could potentially be exploited to achieve inhibitor selectivity for targeted receptors.	[Gajiwala, Ketan S.; Grodsky, Neil; Bolanos, Ben; Feng, Junli; Ferre, RoseAnn; Johnson, Ted W.; Stewart, Al] Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA 92121 USA; [Timofeevski, Sergei; Xu, Meirong; Murray, Brion W.] Pfizer Worldwide Res & Dev, Oncol Res & Dev, San Diego, CA 92121 USA	Pfizer; Pfizer	Gajiwala, KS (corresponding author), Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA 92121 USA.	ketan.gajiwala@pfizer.com						Bailey S., 2013, [No title captured], Patent No. [2013132376 A1, 2013132376, WO2013132376]; Baladi T, 2015, EUR J MED CHEM, V105, P220, DOI 10.1016/j.ejmech.2015.10.003; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Bricogne G, 2016, BUSTER; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feneyrolles C, 2014, MOL CANCER THER, V13, P2141, DOI 10.1158/1535-7163.MCT-13-1083; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Huang XD, 2009, J STRUCT BIOL, V165, P88, DOI 10.1016/j.jsb.2008.10.003; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Johnson TW, 2014, J MED CHEM, V57, P4720, DOI 10.1021/jm500261q; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kimani SG, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0142-1; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu J, 2012, ACS MED CHEM LETT, V3, P129, DOI 10.1021/ml200239k; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mollard A, 2011, ACS MED CHEM LETT, V2, P907, DOI 10.1021/ml200198x; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Northrup AB, 2013, J MED CHEM, V56, P2294, DOI 10.1021/jm301619u; Ostergaard E, 2011, MOL VIS, V17, P1485; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Powell NA, 2012, BIOORG MED CHEM LETT, V22, P190, DOI 10.1016/j.bmcl.2011.11.036; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Rickert KW, 2011, J BIOL CHEM, V286, P11218, DOI 10.1074/jbc.M110.204404; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Tan L, 2016, J MED CHEM, V59, P6807, DOI 10.1021/acs.jmedchem.6b00608; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wang J, 2010, BIOCHEMISTRY-US, V49, P7972, DOI 10.1021/bi100409w; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yao TW, 2017, ONCOTARGET, V8, P583, DOI 10.18632/oncotarget.11882; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	59	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15705	15716		10.1074/jbc.M116.771485	http://dx.doi.org/10.1074/jbc.M116.771485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28724631	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000411512200011
J	Jimenez-Torres, GJ; Wojna, V; Rosario, E; Hechevarria, R; Aleman-Batista, AM; Matos, MR; Madan, A; Skolasky, RL; Acevedo, SF				Jimenez-Torres, Gladys J.; Wojna, Valerie; Rosario, Ernesto; Hechevarria, Rosa; Aleman-Batista, Ada M.; Matos, Miriam Rios; Madan, Alok; Skolasky, Richard L.; Acevedo, Summer F.			Assessing health-related resiliency in HIV plus Latin women: Preliminary psychometric findings	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; BECK DEPRESSION INVENTORY; QUALITY-OF-LIFE; SCALE CD-RISC; PUERTO-RICO; PSYCHOLOGICAL DISTRESS; COGNITIVE IMPAIRMENT; UNITED-STATES; HIV/AIDS; INFECTION	Background HIV-associated vulnerabilities-especially those linked to psychological issues-and limited mental health-treatment resources have the potential to adversely affect the health statuses of individuals. The concept of resilience has been introduced in the literature to shift the emphasis from vulnerability to protective factors. Resilience, however, is an evolving construct and is measured in various ways, though rarely among underserved, minority populations. Herein, we present the preliminary psychometric properties of a sample of HIV-seropositive Puerto Rican women, measured using a newly developed health-related resilience scale. Methods and design The Resilience Scales for Children and Adolescents, an instrument with solid test construction properties, acted as a model in the development (in both English and Spanish) of the HRRS, providing the same dimensions and most of the same subscales. The present sample was nested within the Hispanic-Latino longitudinal cohort of women (HLLC), that is part of the NeuroAIDS Research Program at the University of Puerto Rico (UPR), Medical Sciences Campus (MSC). Forty-five consecutively recruited, HIV+ women from the HLLC completed a demographic survey, the HRRS, and the Beck Depression Inventory-I, Spanish version. Results The results demonstrate excellent overall internal consistency for the total HRRS score (alpha = 0.95). Each of the dimensional scores also evidenced acceptable internal consistency (alpha >= 0.88). All the dimensional and subscale content validity indices were above the 0.42 cut-off. Analysis revealed a significant negative correlation between the HRRS total score and BDI-I-S (r(45) = -0.453, p < 0.003). Conclusion Albeit preliminary in nature, the present study provides support for the HRRS as a measure to assess resilience among individuals living with chronic medical conditions. Minority populations, especially non-English speaking ones, are understudied across the field of medicine, and when efforts are made to include these patient groups, measurement is rarely tailored to their unique cultural and linguistic experiences. The HRRS is a measure that addresses these notable voids in the medical literature.	[Jimenez-Torres, Gladys J.; Madan, Alok] Menninger Clin, Houston, TX USA; [Jimenez-Torres, Gladys J.; Madan, Alok] Baylor Coll Med, Psychiat & Behav Sci, Houston, TX 77030 USA; [Jimenez-Torres, Gladys J.; Rosario, Ernesto] Ponce Sch Med & Hlth Sci, Psychol Dept, Ponce, PR USA; [Wojna, Valerie; Hechevarria, Rosa; Matos, Miriam Rios] Univ Puerto Rico, NeuroAlDS Res Program, San Juan, PR 00936 USA; [Wojna, Valerie] Univ Puerto Rico, Dept Internal Med, Neurol Div, San Juan, PR 00936 USA; [Hechevarria, Rosa] Univ Puerto Rico, Phys Med & Rehabil, San Juan, PR 00936 USA; [Aleman-Batista, Ada M.; Skolasky, Richard L.] Univ Puerto Rico, Sch Hlth Profess, San Juan, PR 00936 USA; [Skolasky, Richard L.] Johns Hopkins Univ, Dept Orthoped Surg & Phys Med & Rehabil, Baltimore, MD USA; [Acevedo, Summer F.] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	Baylor College of Medicine; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Acevedo, SF (corresponding author), UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	sumacea123@gmail.com		Wojna, Valerie/0000-0002-4014-9921	National Center for Research Resources (NCRR) [U54RR026139]; National Institute on Minority Health and Health Disparities (NIMHD) [U54MD007587]; National Institute of Neurological Disorders and Stroke (NINDS) [S11NS046278, U54NS43011]; National Institute of Mental Health (NIMH) Center for Novel Therapeutics [R25MH080661, G12 RR003050]; Menninger Clinic Foundation; McNair Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139, G12RR003050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011, S11NS046278] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health (NIMH) Center for Novel Therapeutics; Menninger Clinic Foundation; McNair Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was funded by National Center for Research Resources (NCRR) grant U54RR026139, the National Institute on Minority Health and Health Disparities (NIMHD) grant U54MD007587, the National Institute of Neurological Disorders and Stroke (NINDS) S11NS046278 and U54NS43011 awarded to the University of Puerto Rico, Medical Science Campus, and National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders Pilot Project grant R25MH080661 part of the G12 RR003050 awarded to John Hopkins University. Additionally, this research was partially supported by the Menninger Clinic Foundation and McNair Medical Institute. Dr. Madan is a McNair Scholar. The study follows the guidelines on good publication practices. The study sponsors were not involved in any aspect of the research activities. Thus, the authors were independent of study sponsors in the context of the research. The authors have no other potential conflicts of interest to disclose.; The study was funded by National Center for Research Resources (NCRR) grant U54RR026139, the National Institute on Minority Health and Health Disparities (NIMHD) grant U54MD007587, the National Institute of Neurological Disorders and Stroke (NINDS) 511NS046278 and U54NS43011 awarded to the University of Puerto Rico, Medical Science Campus, and National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders Pilot Project grant R25MH080661 part of the G12 RR003050 awarded to John Hopkins University. Additionally, this research was partially supported by the Menninger Clinic Foundation and McNair Medical Institute. Dr. Madan is a McNair Scholar. The study follows the guidelines on good publication practices. The study sponsors were not involved in any aspect of the research activities. Thus, the authors were independent of study sponsors in the context of the research. The authors have no other potential conflicts of interest to disclose.	BARTONE PT, 1989, J NERV MENT DIS, V177, P317, DOI 10.1097/00005053-198906000-00001; BERNAL G, 1995, REV LAT AM PSICOL, V27, P207; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonilla J, 2004, J CLIN PSYCHOL, V60, P119, DOI 10.1002/jclp.10195; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Carrico AW, 2011, AIDS, V25, P1113, DOI 10.1097/QAD.0b013e3283463f09; Centers for Disease Control and Prevention, 2010, 40 CDCP; Ciambrone D, 2006, WOMEN HEALTH, V44, P61, DOI 10.1300/J013v44n04_04; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cooperman Nina A, 2003, J Lesbian Stud, V7, P49, DOI 10.1300/J155v07n04_04; Dale S, 2014, AIDS PATIENT CARE ST, V28, P136, DOI 10.1089/apc.2013.0329; Dale SK, 2014, SEX ROLES, V70, P221, DOI 10.1007/s11199-014-0348-x; De Santis Joseph, 2008, Res Theory Nurs Pract, V22, P273, DOI 10.1891/0889-7182.22.4.273; DeFreitas D, 2010, J NATL MED ASSOC, V102, P493, DOI 10.1016/S0027-9684(15)30558-7; DeVellis RF, 2016, SCALE DEV THEORY APP; Ebersohn L, 2011, HEALTH EDUC RES, V26, P596, DOI 10.1093/her/cyr016; Eller LS, 2014, AIDS CARE, V26, P795, DOI 10.1080/09540121.2013.841842; Emlet CA, 2011, GERONTOLOGIST, V51, P101, DOI 10.1093/geront/gnq060; Farber EW, 2000, PSYCHOSOMATICS, V41, P140, DOI 10.1176/appi.psy.41.2.140; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Goldstein S., CREATING CLIN PSYCHO; Gwadz M, 2013, AIDS BEHAV, V17, P801, DOI 10.1007/s10461-012-0194-1; Hjemdal O., 2001, PSYCHOL ASSESSMENT, V38, P310, DOI DOI 10.4236/OJN.2013.32033; Hjemdal Odin, 2015, BMC Psychol, V3, P18, DOI 10.1186/s40359-015-0076-1; Jimenez JC, 2010, AIDS CARE, V22, P1314, DOI 10.1080/09540121003758481; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Luo X, 2003, NEUROLOGY, V60, P1931, DOI 10.1212/01.WNL.0000064396.54554.26; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Morales D, 2013, J NEUROVIROL, V19, P471, DOI 10.1007/s13365-013-0200-z; Morales D, 2012, J NEUROVIROL, V18, P488, DOI 10.1007/s13365-012-0128-8; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Mutumba M, 2016, AIDS CARE, V28, P807, DOI 10.1080/09540121.2015.1131966; Norman LR, 2009, AIDS CARE, V21, P140, DOI 10.1080/09540120801932199; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Prince-Embury S., 2006, RESILIENCY SCALES CH; Rao D, 2007, AIDS PATIENT CARE ST, V21, P339, DOI 10.1089/apc.2006.0124; Roa CR, 2007, HDB STAT PSYCHOMETRI; Roisman GI, 2005, AM PSYCHOL, V60, P264, DOI 10.1037/0003-066X.60.3.264; Rutter M, 2007, CHILD ABUSE NEGLECT, V31, P205, DOI 10.1016/j.chiabu.2007.02.001; Saadat Mina, 2015, J Hum Reprod Sci, V8, P48, DOI 10.4103/0974-1208.153128; Siegel K, 2005, J BEHAV MED, V28, P403, DOI 10.1007/s10865-005-9015-6; Siegel K, 1999, AIDS EDUC PREV, V11, P53; Siegel K, 2007, AIDS BEHAV, V11, P421, DOI 10.1007/s10461-006-9186-3; Simoni Jane M, 2003, Cultur Divers Ethnic Minor Psychol, V9, P3, DOI 10.1037/1099-9809.9.1.3; Smith GC, 2012, ANNU REV GERONTOL GE, V32, P3, DOI 10.1891/0198-8794.32.3; Spector PE, 1992, SUMMATED RATING SCAL; Spies G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004200; Svanberg P.O.G., 1998, J MENT HEALTH, V7, P543, DOI [10.1080/09638239817716, DOI 10.1080/09638239817716]; Thompson B, 2003, SOC WORK HEALTH CARE, V37, P87, DOI 10.1300/J010v37n01_05; Toro GA, 2006, AM J PUBLIC HEALTH, V96, P995, DOI 10.2105/AJPH.2005.071696; Vutien P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003719; Wagnild G M, 1993, J Nurs Meas, V1, P165; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wojna V, 2007, AIDS PATIENT CARE ST, V21, P930, DOI 10.1089/apc.2006.0180; Wojna V, 2006, J NEUROVIROL, V12, P356, DOI 10.1080/13550280600964576; Yu XN, 2014, J SEX MARITAL THER, V40, P1, DOI 10.1080/0092623X.2012.668512; Yuen WWY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-683	61	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181253	10.1371/journal.pone.0181253	http://dx.doi.org/10.1371/journal.pone.0181253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723939	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800041
J	Guan, CM; Dang, R; Cui, Y; Liu, LY; Chen, XB; Wang, XY; Zhu, JL; Li, DG; Li, JW; Wang, DC				Guan, Chunmei; Dang, Rui; Cui, Yu; Liu, Liyan; Chen, Xiaobei; Wang, Xiaoyu; Zhu, Jingli; Li, Donggang; Li, Junwei; Wang, Decai			Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis	PLOS ONE			English	Article							SERUM COPPER; ALUMINUM; NEPRILYSIN; IRON; AGGREGATION; DISORDERS; PEPTIDE; EXCESS; FURIN	The exact cause of Alzheimer's disease (AD) and the role of metals in its etiology remain unclear. We have used an analytical approach, based on inductively coupled plasma mass spectrometry coupled with multivariate statistical analysis, to study the profiles of a wide range of metals in AD patients and healthy controls. AD cannot be cured and the lack of sensitive biomarkers that can be used in the early stages of the disease may contribute to this treatment failure. In the present study, we measured plasma levels of amyloid-beta(1-42)(0.142 +/- 0.029 mu g/ L) and furin(2.292 +/- 1.54 mu g/ L), together with those of the metalloproteinases, insulin-degrading enzyme(1.459 +/- 1.14 mu g/ L) and neprilysin(0.073 +/- 0.015 mu g/ L), in order to develop biomarkers for AD. Partial least squares discriminant analysis models were used to refine intergroup differences and we discovered that four metals(Mn, Al, Li, Cu) in peripheral blood were strongly associated with AD. Aberration in homeostasis of these metals may alter levels of proteinases, such as furin, which are associated with neurodegeneration in AD and can be a used as plasma- based biomarkers.	[Guan, Chunmei; Liu, Liyan; Chen, Xiaobei; Wang, Xiaoyu; Zhu, Jingli; Wang, Decai] Harbin Med Univ, Dept Nutr & Food Hyg, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Dang, Rui] Xinjiang Med Univ, Hobo Coll, Xinjiang, Kelamayi, Peoples R China; [Cui, Yu] Harbin Med Univ, Dept Social Med, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Li, Donggang; Li, Junwei] Inst Qual Supervis & Detect, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Xinjiang Medical University; Harbin Medical University	Wang, DC (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China.	decaiwang@live.cn	张, 西京/HIK-3273-2022		National Natural Science Foundation of China;  [81273193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the National Natural Science Foundation of China and the Grant number is 81273193.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Agarwal R, 2008, INDIAN J CLIN BIOCHE, V23, P369, DOI 10.1007/s12291-008-0081-8; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Ekmekcioglu C, 2001, NAHRUNG, V45, P309, DOI 10.1002/1521-3803(20011001)45:5&lt;309::AID-FOOD309&gt;3.0.CO;2-0; Friedlich AL, 2004, J NEUROSCI, V24, P3453, DOI 10.1523/JNEUROSCI.0297-04.2004; Gao YX, 2007, J ANAL ATOM SPECTROM, V22, P856, DOI 10.1039/b703323k; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Gonzalez-Dominguez R, 2014, METALLOMICS, V6, P292, DOI 10.1039/c3mt00301a; Gray JD, 2013, ACTA PSYCHIAT SCAND, V128, P347, DOI 10.1111/acps.12139; Gupta VB, 2005, CELL MOL LIFE SCI, V62, P143, DOI 10.1007/s00018-004-4317-3; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Kolosova AY, 2006, ANAL BIOANAL CHEM, V384, P286, DOI 10.1007/s00216-005-0103-9; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Long S.E., 2013, ANAL BIOANAL CHEM, V405, P8761; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Pal R, 2014, MOL NEUROBIOL, V49, P1181, DOI 10.1007/s12035-013-8590-8; Pfaender S, 2014, METALLOMICS, V6, P960, DOI 10.1039/c4mt00008k; Ramalingam M, 2012, J NEURAL TRANSM, V119, P891, DOI 10.1007/s00702-011-0758-7; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rusina R, 2011, NEUROTOX RES, V20, P329, DOI 10.1007/s12640-011-9246-y; Schwab C, 2003, ACTA NEUROPATHOL, V106, P278, DOI 10.1007/s00401-003-0735-9; Sharma AK, 2013, METALLOMICS, V5, P1529, DOI 10.1039/c3mt00161j; Silvestri L, 2008, J CELL MOL MED, V12, P1548, DOI 10.1111/j.1582-4934.2008.00356.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Squitti R, 2007, J NEURAL TRANSM, V114, P1589, DOI 10.1007/s00702-007-0777-6; Squitti R, 2006, NEUROLOGY, V67, P76, DOI 10.1212/01.wnl.0000223343.82809.cf; Squitti R, 2005, NEUROLOGY, V64, P1040, DOI 10.1212/01.WNL.0000154531.79362.23; Squitti R, 2006, BIOMARK INSIGHTS, V1, P205; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Wainaina MN, 2014, NEUROSCI BULL, V30, P253, DOI 10.1007/s12264-013-1425-9; Wang DC, 2012, NEUROBIOL AGING, V33, P1057, DOI 10.1016/j.neurobiolaging.2010.09.013; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; ZAPATERO MD, 1995, BIOL TRACE ELEM RES, V47, P235, DOI 10.1007/BF02790122	37	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0178271	10.1371/journal.pone.0178271	http://dx.doi.org/10.1371/journal.pone.0178271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719622	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400002
J	St Pierre, C; Guo, J; Shin, JD; Engstrom, LW; Lee, HH; Herbert, A; Surdi, L; Baker, J; Salmon, M; Shah, S; Ellis, JM; Houshyar, H; Crackower, MA; Kleinschek, MA; Jones, DC; Hicks, A; Zaller, DM; Alves, SE; Ramadas, RA				St Pierre, Cristina; Guo, Jane; Shin, John D.; Engstrom, Laura W.; Lee, Hyun-Hee; Herbert, Alan; Surdi, Laura; Baker, James; Salmon, Michael; Shah, Sanjiv; Ellis, J. Michael; Houshyar, Hani; Crackower, Michael A.; Kleinschek, Melanie A.; Jones, Dallas C.; Hicks, Alexandra; Zaller, Dennis M.; Alves, Stephen E.; Ramadas, Ravisankar A.			A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system	PLOS ONE			English	Article							CYTOKINE PRODUCTION; PHARMACOLOGY; IMMUNOLOGY; BIOLOGY; KINASE; SYK; MECHANISMS; AUTOIMMUNE; EFFICACY; THERAPY	While the immune system is essential for the maintenance of the homeostasis, health and survival of humans, aberrant immune responses can lead to chronic inflammatory and autoimmune disorders. Pharmacological modulation of drug targets in the immune system to ameliorate disease also carry a risk of immunosuppression that could lead to adverse outcomes. Therefore, it is important to understand the 'immune fingerprint' of novel therapeutics as they relate to current and, clinically used immunological therapies to better understand their potential therapeutic benefit as well as immunosuppressive ability that might lead to adverse events such as infection risks and cancer. Since the mechanistic investigation of pharmacological modulators in a drug discovery setting is largely compound- and mechanism-centric but not comprehensive in terms of immune system impact, we developed a human tissue based functional assay platform to evaluate the impact of pharmacological modulators on a range of innate and adaptive immune functions. Here, we demonstrate that it is possible to generate a qualitative and quantitative immune system impact of pharmacological modulators, which might help better understand and predict the benefit-risk profiles of these compounds in the treatment of immune disorders.	[St Pierre, Cristina; Guo, Jane; Shin, John D.; Engstrom, Laura W.; Lee, Hyun-Hee; Salmon, Michael; Houshyar, Hani; Crackower, Michael A.; Kleinschek, Melanie A.; Jones, Dallas C.; Hicks, Alexandra; Zaller, Dennis M.; Alves, Stephen E.; Ramadas, Ravisankar A.] Merck Res Labs, Oncol & Immunol Discovery, Boston, MA 02115 USA; [Herbert, Alan] Merck Res Labs, Genet & Pharmacogen, Boston, MA USA; [Surdi, Laura; Baker, James] Merck Res Labs, Drug Metab & Pharmacokinet, Boston, MA USA; [Shah, Sanjiv] Merck Res Labs, Pharmacol, Boston, MA USA; [Ellis, J. Michael] Merck Res Labs, Exploratory Chem, Boston, MA USA; [Houshyar, Hani] Biogen, Cambridge, MA USA; [Crackower, Michael A.; Zaller, Dennis M.] Celgene, Cambridge, MA USA; [Kleinschek, Melanie A.] Theravance Biopharma, San Francisco, CA USA; [Jones, Dallas C.] Abide Therapeut, San Diego, CA USA; [Hicks, Alexandra] Oncorus, Cambridge, MA USA; [Ramadas, Ravisankar A.] Jounce Therapeut, Cambridge, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Biogen; Bristol-Myers Squibb; Celgene Corporation; Theravance	Ramadas, RA (corresponding author), Merck Res Labs, Oncol & Immunol Discovery, Boston, MA 02115 USA.; Ramadas, RA (corresponding author), Jounce Therapeut, Cambridge, MA USA.	ramadas.pubmed@gmail.com	Herbert, Alan/AAY-4286-2020	Ellis, John/0000-0003-4303-3972; Herbert, Alan/0000-0002-0093-1572	Merck; Sharpe Dohme Co.	Merck(Merck & Company); Sharpe Dohme Co.	All the co-authors in this manuscript are/were employees of Merck, Sharpe & Dohme Co., while this work was performed. Funding for this entire study was provided by Merck, Sharpe & Dohme Co. The funder provided support in the form of salaries for authors (CSP, JG, JDS, LWE, HHL, AH, LS, JB, MS, SS, JME, HH, MAC, MAK, DCJ, AH, DMZ, SEA, RAR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aouar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156063; Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Berg EL, 2014, DRUG DISCOV TODAY, V19, P113, DOI 10.1016/j.drudis.2013.10.003; Boran ADW, 2010, MT SINAI J MED, V77, P333, DOI 10.1002/msj.20191; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Burel JG, 2016, TRENDS IMMUNOL, V37, P53, DOI 10.1016/j.it.2015.11.006; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Danks L, 2011, J BONE MINER RES, V26, P182, DOI 10.1002/jbmr.210; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Eichler HG, 2011, NAT REV DRUG DISCOV, V10, P495, DOI [10.1038/nrd3501, 10.1038/nrd3348]; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Ghoreschi K, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12265; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Hood L, 2004, NAT BIOTECHNOL, V22, P1215, DOI 10.1038/nbt1004-1215; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Kremlitzka M, 2015, CELL MOL LIFE SCI, V72, P2223, DOI 10.1007/s00018-014-1806-x; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-43; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Peterson MC, 2015, CPT-PHARMACOMET SYST, V4, P189, DOI 10.1002/psp4.20; Pirmohamed M, 2014, ANNU REV GENOM HUM G, V15, P349, DOI 10.1146/annurev-genom-090413-025419; SIMONS FER, 1994, NEW ENGL J MED, V330, P1663; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180870	10.1371/journal.pone.0180870	http://dx.doi.org/10.1371/journal.pone.0180870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719615	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400021
J	Hawcutt, DB; Bellis, J; Price, V; Povall, A; Newland, P; Richardson, P; Peak, M; Blair, J				Hawcutt, Daniel B.; Bellis, Jennifer; Price, Victoria; Povall, Anne; Newland, Paul; Richardson, Paul; Peak, Matthew; Blair, Jo			Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; IGF-BINDING PROTEIN-3; BODY-SURFACE AREA; PREPUBERTAL CHILDREN; GH DEFICIENCY; WEIGHT; PHARMACOKINETICS; ADOLESCENTS; BIOACTIVITY; TRENDS	Background Recombinant human growth hormone (rhGH) treatment in children is usually prescribed using actual body weight. This may result in inappropriately high doses in obese children. Methods Retrospective audit of all paediatric patients treated with rhGH 2010-14 at a tertiary paediatric hospital in the UK. Change in height SDS and IGF-I SDS during the first year of treatment was stratified by initial BMI SDS in a mixed cohort, and a subgroup of GH deficient (GHD) patients. Alternative doses for those BMI SDS >= 2.0 (Obese) were calculated using BSA, IBW and LBW. Results 354 patients (133 female) received rhGH, including 213 (60.2%) with GHD. Obesity was present in 40 patients (11.3%) of the unselected cohort, and 32 (15.0%) of the GHD cohort. For GHD patients, gain in height SDS was directly related to BMI SDS, except in obese patients (p<0.05). For both the entire cohort, and GHD patients only, IGF-1 SDS was significantly higher in obese patients (p<0.0001 for both groups). Cross sectional data identified 265 children receiving rhGH, 81 (30.5%) with a BMI-SDS >= 1.75. Alternate prescribing strategies for rhGH prescribing in obese patients suggest a saving of 27% - 38% annually. Conclusions Gain in IGF-I SDS is greater in obese children, and is likely to be related to relatively higher doses of rhGH. Additional gain in height was not achieved at the higher doses administered to obese children. Alternative dosing strategies in the obese patient population should be examined in rigorous clinical trials.	[Hawcutt, Daniel B.] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Bellis, Jennifer; Peak, Matthew] Alder Hey Childrens Hosp, Paediat Med Res Unit, Liverpool, Merseyside, England; [Bellis, Jennifer; Price, Victoria; Povall, Anne; Richardson, Paul; Peak, Matthew] Alder Hey Childrens NHS Fdn Trust Liverpool, Res Dept, Liverpool, Merseyside, England; [Newland, Paul] Alder Hey Childrens NHS Fdn Trust, Dept Biochem, Liverpool, Merseyside, England; [Blair, Jo] Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Blair, J (corresponding author), Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Liverpool, Merseyside, England.	jo.blair@alderhey.nhs.uk		Hawcutt, Dan/0000-0002-8120-6507				Albertsson-Wikland K, 2014, HORM RES PAEDIAT, V82, P158, DOI 10.1159/000363106; Allen DB, 2016, EUR J ENDOCRINOL, V174, pP1, DOI 10.1530/EJE-15-0873; Andersen LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041287; Argente J, 1997, J CLIN ENDOCR METAB, V82, P2076, DOI 10.1210/jc.82.7.2076; Bakker NE, 2015, J CLIN ENDOCR METAB, V100, P3041, DOI 10.1210/jc.2015-1410; Blair JC, 2004, CLIN ENDOCRINOL, V60, P163, DOI 10.1046/j.1365-2265.2004.01957.x; Boyd E, 1935, SURFACE AREA HUMAN B; Callaghan LC, 2015, ANAESTHESIA, V70, P176, DOI 10.1111/anae.12860; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Han PY, 2007, CLIN PHARMACOL THER, V82, P505, DOI 10.1038/sj.clpt.6100381; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; HO KY, 1989, CLIN ENDOCRINOL, V30, P335, DOI 10.1111/j.1365-2265.1989.tb00431.x; HOCHBERG Z, 1992, METABOLISM, V41, P106, DOI 10.1016/0026-0495(92)90198-J; Hughes IP, 2014, CLIN ENDOCRINOL, V80, P384, DOI 10.1111/cen.12315; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P483, DOI 10.1210/jc.2008-1503; MAYER J, 1953, P SOC EXP BIOL MED, V82, P647; Mo DJ, 2014, PITUITARY, V17, P477, DOI 10.1007/s11102-013-0529-6; Murray PG, 2016, ARCH DIS CHILD, V101, P96, DOI 10.1136/archdischild-2014-307228; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pediatric Formulary Committee, 2014, BNF CHILDR 2014 2015; Radetti G, 1998, METABOLISM, V47, P1490, DOI 10.1016/S0026-0495(98)90075-0; Ranke MB, 1999, J CLIN ENDOCR METAB, V84, P1174, DOI 10.1210/jc.84.4.1174; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Schilbach K, 2015, BEST PRACT RES CL EN, V29, P671, DOI 10.1016/j.beem.2015.06.004; Schrier L, 2014, HORM RES PAEDIAT, V81, P319, DOI 10.1159/000357844; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181567	10.1371/journal.pone.0181567	http://dx.doi.org/10.1371/journal.pone.0181567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715498	Green Published, Green Submitted, gold			2022-12-26	WOS:000443975500061
J	Birth, P; Schone, S; Stelzl, U; Meijsing, SH				Birth, Petra; Schoene, Stefanie; Stelzl, Ulrich; Meijsing, Sebastiaan H.			Identification and characterization of BATF3 as a context-specific coactivator of the glucocorticoid receptor	PLOS ONE			English	Article							DNA-BINDING DOMAIN; ACTIVATION DOMAIN; TARGET GENES; PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; REGULATORY MECHANISMS; ISOFORMS; DIMERIZATION; COREGULATOR; RECRUITMENT	The ability of the glucocorticoid receptor (GR) to regulate the transcriptional output of genes relies on its interactions with transcriptional coregulators. However, which coregulators are required for GR-dependent activation is context-dependent and can be influenced by the sequence of the DNA bound by GR and by the nature of the GR isoform responsible for the regulation of a gene. Here, we screened for GR-interacting proteins for which the interaction signal differed between two GR isoforms GR alpha and GR gamma. These isoforms diverge by a single amino acid insertion in a domain, the lever arm, which adopts DNA sequence-specific conformations. We identify Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF3), an AP-1 family transcription factor, as a GR coregulator whose interaction with GR is modulated by the lever arm. Further, a combination of experiments uncovered that BATF3 acts as a gene-specific coactivator of GR whose coactivator potency is influenced by the sequence of the GR binding site. Together, our findings suggest that GR isoform and the sequence of GR binding site influence the interaction of GR with BATF3, which might direct the assembly of gene-specific regulatory complexes to fine-tune the expression of individual GR target genes.	[Birth, Petra; Schoene, Stefanie; Stelzl, Ulrich; Meijsing, Sebastiaan H.] Max Planck Inst Mol Genet, Ihnestr 63-73, Berlin, Germany; [Stelzl, Ulrich] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Inst Pharmaceut Sci, Univ Pl 1, Graz, Austria; [Stelzl, Ulrich] BioTechMed Graz, Univ Pl 1, Graz, Austria	Max Planck Society; University of Graz	Meijsing, SH (corresponding author), Max Planck Inst Mol Genet, Ihnestr 63-73, Berlin, Germany.	meijsing@molgen.mpg.de	Stelzl, Ulrich/J-9506-2015	Stelzl, Ulrich/0000-0003-2500-3585	Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG) [ME4154/1-1]	Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG)	This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG, grant number: ME4154/1-1) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Duma D, 2010, HORM MOL BIOL CLIN I, V3, P319, DOI 10.1515/HMBCI.2010.039; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Love MI, 2016, NUCL ACIDS RES; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; MCEWAN IJ, 1993, MOL CELL BIOL, V13, P399, DOI 10.1128/MCB.13.1.399; Meijsing SH, 2015, ADV EXP MED BIOL, V872, P59, DOI 10.1007/978-1-4939-2895-8_3; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Schone S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12621; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; Thomas-Chollier M, 2013, P NATL ACAD SCI USA, V110, P17826, DOI 10.1073/pnas.1316235110; UEDA K, 1989, ENDOCRINOLOGY, V124, P1042, DOI 10.1210/endo-124-2-1042; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; Wallberg AE, 1999, MOL CELL BIOL, V19, P5952; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Worseck JM, 2012, METHODS MOL BIOL, V812, P63, DOI 10.1007/978-1-61779-455-1_4	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181219	10.1371/journal.pone.0181219	http://dx.doi.org/10.1371/journal.pone.0181219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708849	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649800049
J	Brandstorp-Boesen, J; Falk, RS; Boysen, M; Brondbo, K				Brandstorp-Boesen, Jesper; Falk, Ragnhild Sorum; Boysen, Morten; Brondbo, Kjell			Impact of stage, management and recurrence on survival rates in laryngeal cancer	PLOS ONE			English	Article							TRANSORAL LASER MICROSURGERY; SQUAMOUS-CELL CARCINOMA; ORGAN PRESERVATION; TRENDS; MORTALITY; SUBSITE; GENDER; VOLUME; HEAD	A retrospective, longitudinal study of 1,616 patients with primary laryngeal squamous cell carcinoma (LSCC) at a single center in Norway during 1983-2010 was undertaken to investigate overall survival, disease specific survival, disease-free survival, prognostic factors for overall survival, and impact of recurrence among all-stage laryngeal cancer patients over 15 years' follow-up. The prognostic impact of gender, age, smoking/alcohol, subsite, tumour, node and metastasis staging, period and modality of treatment were evaluated using Kaplan-Meier and Cox proportional hazard analyses. The importance of recurrence on survival was assessed based on case fatality rates. Five-year overall survival was 56.8%, 64.0% and 38.8%, and disease-specific survival was 80.2%, 87% and 61.6%, respectively, for the entire cohort and for glottic and supraglottic LSCC. Old age, advanced-stage LSCC and supraglottic cancer were associated with lower overall survival. The risk of disease-specific death plateaued after five years and varied significantly by subsite. Multivariate analysis of glottic LSCC revealed that surgical treatment improved overall survival, whereas old age, alcohol, T3-T4 status, positive N-status and no treatment were associated with worse survival. In supraglottic LSCC, age, alcohol, and positive N-status had a significant impact on overall survival by multivariate analysis. Five-year overall survival and disease-specific survival among patients with recurrent disease were 34% and 52%, respectively. In conclusion, marked difference in overall survival between glottic and supraglottic LSCC underline the importance of subsite-specific survival analysis. T-status and primary surgical management is essential only for glottic LSCC, emphasizing the importance of correct disease classification. Inferior outcomes in supraglottic LSCC are associated with old age, positive N-status, and improved follow-up routines are necessary. Primary tumor control is essential since recurrence impairs survival considerably in all subsites. The potential benefit of a primary surgical approach towards T3 LSCC awaits further investigation.	[Brandstorp-Boesen, Jesper; Boysen, Morten; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Brandstorp-Boesen, Jesper; Boysen, Morten; Brondbo, Kjell] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Otorhinolaryngol, Oslo, Norway; [Falk, Ragnhild Sorum] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Brandstorp-Boesen, J (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.; Brandstorp-Boesen, J (corresponding author), Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Otorhinolaryngol, Oslo, Norway.	jesper.brandstorp-boesen@medisin.uio.no	Falk, Ragnhild Sørum/H-5613-2019	Falk, Ragnhild Sørum/0000-0001-8398-3492				[Anonymous], 2015, DAHANCA RADIOTHERAPY; Bosetti C, 2006, INT J CANCER, V119, P673, DOI 10.1002/ijc.21855; Brandstorp-Boesen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164068; Brandstorp-Boesen J, 2014, EUR ARCH OTO-RHINO-L, V271, P3233, DOI 10.1007/s00405-014-3100-9; Cancer Registry of Norway, 2015, CANC NORW 2014 CANC; Canis M, 2013, EUR ARCH OTO-RHINO-L, V270, P2719, DOI 10.1007/s00405-013-2382-7; Chatenoud L, 2016, INT J CANCER, V138, P833, DOI 10.1002/ijc.29833; Chen AY, 2007, ARCH OTOLARYNGOL, V133, P1270, DOI 10.1001/archotol.133.12.1270; Chen AY, 2010, CANCER-AM CANCER SOC, V116, P4744, DOI 10.1002/cncr.25364; Dziegielewski PT, 2012, J OTOLARYNGOL-HEAD N, V41, pS56, DOI 10.2310/7070.2011.110081; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Francis E, 2014, LARYNGOSCOPE, V124, P1618, DOI 10.1002/lary.24557; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P1489, DOI 10.1002/hed.21113; Genden EM, 2008, HEAD NECK-J SCI SPEC, V30, P103, DOI 10.1002/hed.20715; Groome PA, 2002, J CLIN EPIDEMIOL, V55, P533, DOI 10.1016/S0895-4356(02)00389-X; Haapaniemi A, 2016, HEAD NECK-J SCI SPEC, V38, P36, DOI 10.1002/hed.23834; Harris BN, 2016, HEAD NECK-J SCI SPEC, V38, P1380, DOI 10.1002/hed.24443; Higgins KM, 2009, J OTOLARYNGOL-HEAD N, V38, P603, DOI 10.2310/7070.2009.080235; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; IBM, 2016, IBM SPSS STAT WINDOW; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Levi F, 2004, ANN ONCOL, V15, P1425, DOI 10.1093/annonc/mdh346; Lyhne NM, 2016, EUR J CANCER, V59, P46, DOI 10.1016/j.ejca.2016.01.020; Megwalu UC, 2014, JAMA OTOLARYNGOL, V140, P855, DOI 10.1001/jamaoto.2014.1671; Peretti G, 2016, HEAD NECK-J SCI SPEC, V38, P1107, DOI 10.1002/hed.24424; Raitiola H, 1999, ACTA OTO-LARYNGOL, V119, P847; ROBIN PE, 1991, CLIN OTOLARYNGOL, V16, P193, DOI 10.1111/j.1365-2273.1991.tb01975.x; Sessions DG, 2005, LARYNGOSCOPE, V115, P1402, DOI 10.1097/01.MLG.0000166896.67924.B7; SILVESTRI F, 1992, ORL J OTO-RHINO-LARY, V54, P43, DOI 10.1159/000276258; StatCorp, 2013, STATA STAT SOFTW REL; STEPHENSON WT, 1991, ARCH OTOLARYNGOL, V117, P774; Succo G, 2014, EUR ARCH OTO-RHINO-L, V271, P2489, DOI 10.1007/s00405-014-3024-4; Timmermans AJ, 2016, LARYNGOSCOPE, V126, pE60, DOI 10.1002/lary.25567; Timmermans AJ, 2015, HEAD NECK-J SCI SPEC, V37, P1495, DOI 10.1002/hed.23789; Vilaseca I, 2016, HEAD NECK-J SCI SPEC, V38, P1050, DOI 10.1002/hed.24408; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402	36	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179371	10.1371/journal.pone.0179371	http://dx.doi.org/10.1371/journal.pone.0179371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708883	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800003
J	Murphy, D; Mattey, D; Hutchinson, D				Murphy, Dan; Mattey, Derek; Hutchinson, David			Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PEPTIDES; RISK; ALLELES; IGA	Objective To analyse the relationship between rheumatoid factor (RF) titre, smoking and HLA- DRB1 alleles coding a | shared epitope (SE) in relation to anti- citrullinated protein antibody (ACPA) positivity in rheumatoid arthritis (RA). Methods RA patients (n = 658) attending rheumatology clinics in Cornwall, UK (cohort 1) were stratified according to RF and ACPA titre, and smoking pack years at diagnosis. A further 409 RA patients from North Staffordshire, UK (cohort 2) were studied to confirm the relationship between RF levels, smoking and ACPA positivity in relation to SE status. Results In cohort 1 there was a trend (p<0.01) of increasing ACPA positivity rates with increasing levels of RF without statistically significant differences between patients who had never smoked and smokers (never smoked: 15/71 (21%) RF - ve, vs. 43/64 (67%) RF weak + ve, vs 88/100 (88%) RF strong + ve, ever smoked: 18/70 (26%) RF - ve vs. 66/83 (80%) RF weak + ve vs. 196/210 (93%) RF strong + ve). No significant gender difference was observed. No significant difference between smoking and ACPA positivity was seen in RF negative patients. Smoking > 20 pack years conferred an increased risk of anti- CCP positive RA (158/200 (79%)), compared to having never smoked (146/235 (62%), p = < 0.01), but this increased risk correlated with smokers' RF positivity as the principal determinant on subsequent regression analysis of cohort 2. In cohort 2, ACPA positivity rates significantly increased with RF positivity and carriage of 1 or 2 SE alleles (p<0.01). Little or no relationship was observed in patients lacking SE. Conclusions ACPA positivity in RA strongly associates with increasing RF titre independent of smoking. This relationship is dependent on carriage of SE alleles. There is no relationship between ACPA and smoking in RF negative patients.	[Murphy, Dan; Hutchinson, David] Royal Cornwall Hosp Trust, Dept Rheumatol, Truro, Cornwall, England; [Murphy, Dan; Hutchinson, David] Univ Exeter, Med Sch, Knowledge Spa, Cornwall Campus, Truro, Cornwall, England; [Mattey, Derek] Haywood Hosp, Haywood Rheumatol Ctr, Stoke On Trent, Staffs, England; [Mattey, Derek] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Royal Cornwall Hospital; University of Exeter; Keele University	Murphy, D (corresponding author), Royal Cornwall Hosp Trust, Dept Rheumatol, Truro, Cornwall, England.; Murphy, D (corresponding author), Univ Exeter, Med Sch, Knowledge Spa, Cornwall Campus, Truro, Cornwall, England.	Daniel.murphy8@nhs.net		Mattey, Derek/0000-0002-4676-5434	Cornwall Arthritis Trust, a registered charity; Haywood Rheumatism Research and Development Foundation	Cornwall Arthritis Trust, a registered charity; Haywood Rheumatism Research and Development Foundation	This work was funded by the the Cornwall Arthritis Trust, a registered charity, and by the Haywood Rheumatism Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badillo-Soto MA, 2016, EUR J RHEUMATOL, V3, P44, DOI 10.5152/eurjrheum.2015.0055; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bengtsson C, 2005, ANN RHEUM DIS, V64, P1588, DOI 10.1136/ard.2004.031666; Brink M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0940-2; Burr ML, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3834; Costenbader KH, 2006, AM J MED, V503, pe501; Di Giuseppe D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4218; Engelmann R, 2010, RHEUMATOLOGY, V49, P1862, DOI 10.1093/rheumatology/keq179; Humphreys JH, 2013, ANN RHEUM DIS, V72, P1315, DOI 10.1136/annrheumdis-2012-201960; Hutchinson D, 2016, ARTHRITIS RHEUMATOL, V68, P2825, DOI 10.1002/art.39832; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Martinsson K, 2017, CLIN EXP IMMUNOL, V188, P53, DOI 10.1111/cei.12901; Mattey DL, 2002, ARTHRIT RHEUM-ARTHR, V47, P403, DOI 10.1002/art.10514; Mewar D, 2008, ANN RHEUM DIS, V67, P980, DOI 10.1136/ard.2007.075382; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Payne S., 1996, POVERTY DEPRIVATION; Pedersen M, 2006, J RHEUMATOL, V33, P1069; PRIGNOT J, 1987, EUR J RESPIR DIS, V70, P1; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Svard A, 2015, ARTHRITIS RHEUMATOL, V67, P2032, DOI 10.1002/art.39170; van Wesemael TJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1177-9; Wang F, 2016, CLIN RHEUMATOL, V35, P2185, DOI 10.1007/s10067-016-3247-4; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016527; Wunderlich C, 2017, SEMIN ARTHRITIS RHEU, V46, P709, DOI 10.1016/j.semarthrit.2016.09.011	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180655	10.1371/journal.pone.0180655	http://dx.doi.org/10.1371/journal.pone.0180655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708862	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000405649800018
J	Visseaux, B; Burdet, C; Voiriot, G; Lescure, FX; Chougar, T; Brugiere, O; Crestani, B; Casalino, E; Charpentier, C; Descamps, D; Timsit, JF; Yazdanpanah, Y; Houhou-Fidouh, N				Visseaux, Benoit; Burdet, Charles; Voiriot, Guillaume; Lescure, Francois-Xavier; Chougar, Taous; Brugiere, Olivier; Crestani, Bruno; Casalino, Enrique; Charpentier, Charlotte; Descamps, Diane; Timsit, Jean-Francois; Yazdanpanah, Yazdan; Houhou-Fidouh, Nadhira			Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; RHINOVIRUS INFECTION; HOSPITALIZED ADULTS; INFLUENZA-A; FAST ASSAY; CHILDREN; IMPACT; PANEL	Background Multiplex PCR tests have improved our understanding of respiratory viruses' epidemiology by allowing their wide range detection. We describe here the burden of these viruses in hospital settings over a five-year period. Methods All respiratory samples from adult patients (>20 years old) tested by multiplex-PCR at the request of physicians, from May 1 2011 to April 30 2016, were included retrospectively. Viral findings are reported by season, patient age group, respiratory tract region (upper or lower) and type of clinical unit (intensive care unit, pneumology unit, lung transplantation unit and other medical units). Results In total, 7196 samples (4958 patients) were included; 29.2% tested positive, with viral coinfections detected in 1.6% of samples. Overall, two viral groups accounted for 60.2% of all viruses identified: picornaviruses (rhinovirus or enterovirus, 34.3%) and influenza (26.6%). Influenza viruses constituted the group most frequently identified in winter (34.4%), in the upper respiratory tract (32%) and in patients over the age of 70 years (36.4%). Picornavirus was the second most frequently identified viral group in these populations and in all other groups, including lower respiratory tract infections (41.3%) or patients in intensive care units (37.6%). Conclusion This study, the largest to date in Europe, provides a broad picture of the distribution of viruses over seasons, age groups, types of clinical unit and respiratory tract regions in the hospital setting. It highlights the burden associated with the neglected picornavirus group. These data have important implications for the future development of vaccines and antiviral drugs.	[Visseaux, Benoit; Chougar, Taous; Charpentier, Charlotte; Descamps, Diane; Houhou-Fidouh, Nadhira] Univ Paris Diderot, Sorbonne Paris Cite, Lab Virol, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Burdet, Charles; Lescure, Francois-Xavier; Yazdanpanah, Yazdan] Univ Paris Diderot, Sorbonne Paris Cite, Serv Malad Infect & Trop, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Voiriot, Guillaume; Timsit, Jean-Francois] Univ Paris Diderot, Sorbonne Paris Cite, Reanimat Med & Infect, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France; [Brugiere, Olivier] Hop Bichat Claude Bernard, AP HP, Serv Pneumol B, Paris, France; [Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Paris, France; [Casalino, Enrique] Hop Bichat Claude Bernard, AP HP, Serv Accueil Urgences, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Visseaux, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lab Virol, IAME,UMR 1137,INSERM,Hop Bichat,AP HP, Paris, France.	benoit.visseaux@aphp.fr; nadira.houhou@aphp.fr	Burdet, Charles/AAF-6975-2021; Voiriot, Guillaume/AIB-6833-2022; Lescure, Xavier/AAM-5261-2020; Casalino, Enrique/GYU-1974-2022	Burdet, Charles/0000-0003-4138-0794; Casalino, Enrique/0000-0002-4352-6729; Visseaux, Benoit/0000-0002-9279-5538				Advani S, 2012, PEDIATR INFECT DIS J, V31, P1221, DOI 10.1097/INF.0b013e318265a804; Anton A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.02.007; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Bennett NJ, 2012, J PEDIATR-US, V161, P814, DOI 10.1016/j.jpeds.2012.05.001; Berry M, 2015, VIRUSES-BASEL, V7, P996, DOI 10.3390/v7030996; Branche AR, 2015, J INFECT DIS, V212, P1692, DOI 10.1093/infdis/jiv252; Caisse nationale d'assurance maladie, 2014, CAMP VACC GRIPP SAIS; Casalegno J-S, 2017, EURO SURVEILL B EUR, V22; Chemaly RF, 2012, BLOOD, V119, P2738, DOI 10.1182/blood-2011-08-371112; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Civardi E, 2013, AM J INFECT CONTROL, V41, P854, DOI 10.1016/j.ajic.2013.01.026; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Das D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.014; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Esposito S, 2015, VIRUSES-BASEL, V7, P6043, DOI 10.3390/v7112925; Gerlier L, 2017, APPL HEALTH ECON HEA, V15, P261, DOI 10.1007/s40258-016-0296-4; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Godbole G, 2013, CURR OPIN PULM MED, V19, P244, DOI 10.1097/MCP.0b013e32835f82a9; Greve FV, 2016, J CLIN VIROL, V83, P37, DOI 10.1016/j.jcv.2016.08.295; Hammond SP, 2012, J CLIN MICROBIOL, V50, P3216, DOI 10.1128/JCM.00538-12; Hofstra JJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1081-y; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Liu T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0388-z; Loubet P, 2017, J CLIN VIROL, V91, P52, DOI 10.1016/j.jcv.2017.04.001; Milstone AM, 2012, AM J INFECT CONTROL, V40, P462, DOI 10.1016/j.ajic.2011.05.024; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Rappo U, 2016, J CLIN MICROBIOL, V54, P2096, DOI 10.1128/JCM.00549-16; Rhedin S, 2015, THORAX, V70, P847, DOI 10.1136/thoraxjnl-2015-206933; Rogers BB, 2015, ARCH PATHOL LAB MED, V139, P636, DOI 10.5858/arpa.2014-0257-OA; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Self WH, 2015, J INFECT DIS; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; To KKW, 2016, J CLIN VIROL, V77, P85, DOI 10.1016/j.jcv.2016.02.014; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; To KKW, 2017, J FORMOS MED ASS; van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415; Visseaux B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172809; Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Zachariah P, 2016, INFLUENZA OTHER RESP, V10, P361, DOI 10.1111/irv.12387	48	39	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180888	10.1371/journal.pone.0180888	http://dx.doi.org/10.1371/journal.pone.0180888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708843	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800027
J	Stamboul, K; Zeller, M; Rochette, L; Cottin, Y; Cochet, A; Leclercq, T; Porot, G; Guenancia, C; Fichot, M; Maillot, N; Vergely, C; Lorgis, L				Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Cochet, Alexandre; Leclercq, Thibault; Porot, Guillaume; Guenancia, Charles; Fichot, Marie; Maillot, Nicolas; Vergely, Catherine; Lorgis, Luc			Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction	PLOS ONE			English	Article							LONG-TERM; LEUKOCYTE; DIMETHYLARGININE; DEFINITION; MORTALITY; DISEASE	Main objective To better understand the role of myeloperoxidases (MPO) in microvascular obstruction (MO) phenomenon and infarct size (IS) using cardiac magnetic resonance (CMR) data in patients with acute myocardial infarction (AMI). Method 40 consecutive patients classified according to the median level of MPO in the culprit artery. A CMR study was performed during the week following AMI and at 6 months, with late gadolinium enhancement sequences. Results Persistent MO was observed in the same proportion (50 vs. 65%, p = 0.728) between the low vs. high MPO group levels. However, the extent of the microvascular obstruction was significantly greater in the high-MPO group (6 (0-9) vs. 16.5 (0-31), p = 0.027), together with a greater infarct size, and a trend towards a lower left ventricular ejection fraction (LVEF) (p = 0.054) at one week. CMR data at 6 months showed that reverse systolic remodeling was two fold more present in the low-MPO group (p = 0.058). Interestingly, the extent of MO (8.5 (6.5-31) vs. 4.1 (3-11.55), p = 0.042) and IS remained significantly greater (24.5 (9.75-35) vs. 7.5 (2.5-18.75), p = 0.022) in the high-MPO group. Moreover, MPO in the culprit artery appeared to correlate positively with MPO in non-culprit arteries and serum, and with troponin levels and peak CK. Conclusion This patient-based study revealed in patients after AMI that high MPO levels in the culprit artery were associated with more severe microvascular obstruction and greater IS. These findings may provide new insights pathophysiology explanation for the adverse prognostic impact of MO.	[Stamboul, Karim; Cottin, Yves; Leclercq, Thibault; Porot, Guillaume; Guenancia, Charles; Fichot, Marie; Maillot, Nicolas; Lorgis, Luc] Univ Hosp, Dept Cardiol, Bd Lattre de Tassigny, Dijon, France; [Stamboul, Karim; Cottin, Yves; Cochet, Alexandre; Guenancia, Charles; Lorgis, Luc] Univ Hosp, MRI Unit, Dijon, France; [Stamboul, Karim; Cottin, Yves; Cochet, Alexandre; Guenancia, Charles; Lorgis, Luc] Univ Hosp, UMR CNRS LE2I 6306, Dijon, France; [Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Guenancia, Charles; Vergely, Catherine; Lorgis, Luc] Univ Burgundy, Lab Cerebrovasc Pathophysiol & Epidemiol PEC2, Dijon, France; [Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Guenancia, Charles; Vergely, Catherine; Lorgis, Luc] Univ Burgundy, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne	Lorgis, L (corresponding author), Univ Hosp, Dept Cardiol, Bd Lattre de Tassigny, Dijon, France.; Lorgis, L (corresponding author), Univ Hosp, MRI Unit, Dijon, France.; Lorgis, L (corresponding author), Univ Hosp, UMR CNRS LE2I 6306, Dijon, France.	luc.lorgis@chu-dijon.fr	COTTIN, YVES/ABA-4622-2020; Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714	University Hospital of Dijon; Faculty of Medicine of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie (FFC)	University Hospital of Dijon; Faculty of Medicine of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie (FFC)	This work was supported by the University Hospital of Dijon, the Faculty of Medicine of Dijon, the Association de Cardiologie de Bourgogne, and by grants from the Union Regionale des Caisses dAssurance Maladie de Bourgogne (URCAM), the Agence Regionale de Sante (ARS) de Bourgogne, the Conseil Regional de Bourgogne and the Federation Francaise de Cardiologie (FFC).	Amir O, 2006, AM J CARDIOL, V98, P754, DOI 10.1016/j.amjcard.2006.04.013; Biere L, 2016, INT J CARDIOL, V209, P17, DOI 10.1016/j.ijcard.2016.02.009; Bodi V, 2016, RADIOLOGY, V278, P54, DOI 10.1148/radiol.2015142674; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Cavusoglu E, 2007, AM J CARDIOL, V99, P1364, DOI 10.1016/j.amjcard.2006.12.060; Durante A, 2015, INT J CARDIOL, V187, P273, DOI 10.1016/j.ijcard.2015.03.359; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; Funayama H, 2010, INT J CARDIOL, V139, P187, DOI 10.1016/j.ijcard.2008.10.018; Goldmann BU, 2009, FREE RADICAL BIO MED, V47, P79, DOI 10.1016/j.freeradbiomed.2009.04.004; Karatzis EN, 2006, AM J CARDIOL, V98, P1424, DOI 10.1016/j.amjcard.2006.06.043; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018; Lorgis L, 2009, BMJ-BRIT MED J, V338, P1605; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Reffelmann T, 2003, CIRCULATION, V108, P2911, DOI 10.1161/01.CIR.0000101917.80668.E1; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Yunoki K, 2010, AM J CARDIOL, V105, P922, DOI 10.1016/j.amjcard.2009.11.013; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zhang CX, 2001, J BIOL CHEM, V276, P27159, DOI 10.1074/jbc.M100191200; Zhang CX, 2001, AM J PHYSIOL-HEART C, V281, pH1469, DOI 10.1152/ajpheart.2001.281.4.H1469	31	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179929	10.1371/journal.pone.0179929	http://dx.doi.org/10.1371/journal.pone.0179929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704420	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700020
J	Yamaoka, M; Shimizu, H; Takahashi, T; Omori, E; Morimatsu, H				Yamaoka, Masakazu; Shimizu, Hiroko; Takahashi, Toru; Omori, Emiko; Morimatsu, Hiroshi			Dynamic changes in Bach1 expression in the kidney of rhabdomyolysis-associated acute kidney injury	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; DELTA-AMINOLEVULINATE SYNTHASE; OXIDATIVE STRESS-RESPONSE; PROTECTIVE ROLE; ERYTHROID-DIFFERENTIATION; HEMORRHAGIC-SHOCK; HEPATOMA-CELLS; NUCLEAR EXPORT; MESSENGER-RNA; INDUCTION	Free heme, a pro-oxidant released from myoglobin, is thought to contribute to the pathogenesis of rhabdomyolysis-associated acute kidney injury (RM-AKI), because renal overexpression of heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, confers protection against RM-AKI. BTB and CNC homology 1 (Bach1) is a heme-responsive transcription factor that represses HO-1. Here, we examined the changes with time in the gene expression of Bach1, HO-1, and d-aminolevulinate synthase (ALAS1, a heme biosynthetic enzyme) in the rat kidney using an RM-AKI model induced by the injection of 50% glycerol (10 mL/kg body weight) into bilateral limbs. We also examined the protein expression of Bach1 in the nucleus and cytosol, and HO-1 in the rat kidney. Glycerol treatment induced significant elevation of serum creatinine kinase and aspartate aminotransferase levels followed by the marked elevation of serum blood urea nitrogen and creatinine levels, which caused serious damage to renal tubules. Following glycerol treatment, HO-1 mRNA and protein levels were significantly up-regulated, while ALAS1 mRNA expression was down-regulated, suggesting an increase in the free renal heme concentration. The Bach1 mRNA level was drastically increased 3 h after glycerol treatment, and the increased level was maintained for 12 h. Nuclear Bach1 protein levels were significantly decreased 3 h after treatment. Conversely, cytosolic Bach1 protein levels abruptly increased after 6 h. In conclusion, we demonstrate the dynamic changes in Bach1 expression in a rat model of RM-AKI. Our findings suggest that the increase in Bach1 mRNA and cytosolic Bach1 protein expression may reflect de novo Bach1 protein synthesis to compensate for the depletion of nuclear Bach1 protein caused by the induction of HO-1 by free heme.	[Yamaoka, Masakazu; Shimizu, Hiroko; Omori, Emiko; Morimatsu, Hiroshi] Okayama Univ, Dept Anesthesiol & Resuscitol, Med Sch, Okayama, Japan; [Takahashi, Toru] Okayama Prefectural Univ, Dept Fac Hlth & Welf Sci, Okayama, Japan	Okayama University; Okayama Prefectural University	Yamaoka, M (corresponding author), Okayama Univ, Dept Anesthesiol & Resuscitol, Med Sch, Okayama, Japan.	mskz16@yahoo.co.jp	Morimatsu, Hiroshi/B-2236-2011	Morimatsu, Hiroshi/0000-0002-6744-0508	Japan Society for the Promotion of Science (JSPS) [JP15K10980, 16K10972]; Grants-in-Aid for Scientific Research [16K10972] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) Grant Number JP15K10980 and 16K10972. The funder had the role in prepraration of the manuscript.	ALAM J, 1989, J BIOL CHEM, V264, P6371; Boutaud O, 2011, FREE RADICAL BIO MED, V51, P1062, DOI 10.1016/j.freeradbiomed.2010.10.704; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; Gburek J, 2003, AM J PHYSIOL-RENAL, V285, pF451, DOI 10.1152/ajprenal.00062.2003; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; IWASA F, 1989, BIOCHEM J, V262, P807, DOI 10.1042/bj2620807; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Maeshima K, 2005, BIOCHEM PHARMACOL, V69, P1667, DOI 10.1016/j.bcp.2005.03.007; Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Nakahira K, 2003, BIOCHEM PHARMACOL, V66, P1091, DOI 10.1016/S0006-2952(03)00444-1; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okada S, 2010, J BIOL CHEM, V285, P23581, DOI 10.1074/jbc.M109.068197; Ozono R, 2006, CURR PHARM BIOTECHNO, V7, P87, DOI 10.2174/138920106776597630; Raval CM, 2012, FREE RADICAL BIO MED, V52, P227, DOI 10.1016/j.freeradbiomed.2011.10.494; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; SHAH SV, 1988, AM J PHYSIOL, V255, pF438, DOI 10.1152/ajprenal.1988.255.3.F438; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Tanioka N, 2014, BIOMED REP, V2, P359, DOI 10.3892/br.2014.235; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973	31	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180934	10.1371/journal.pone.0180934	http://dx.doi.org/10.1371/journal.pone.0180934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704479	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700063
J	Di Simone, N; Di Nicuolo, F; Marana, R; Castellani, R; Ria, F; Veglia, M; Scambia, G; Surbek, D; Barnea, E; Mueller, M				Di Simone, Nicoletta; Di Nicuolo, Fiorella; Marana, Riccardo; Castellani, Roberta; Ria, Francesco; Veglia, Manuela; Scambia, Giovanni; Surbek, Daniel; Barnea, Eytan; Mueller, Martin			Synthetic PreImplantation Factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response	PLOS ONE			English	Article							RECURRENT PREGNANCY LOSS; PLACENTAL WEIGHT/BIRTHWEIGHT RATIO; OXIDATIVE STRESS; TROPHOBLAST INVASION; EMBRYO DEVELOPMENT; T-CELL; EXPRESSION; MODEL; ACTIVATION; PREECLAMPSIA	Maternal control of inflammation is essential during pregnancy and an exaggerated response is one of the underlying causes of fetal loss. Inflammatory response is mediated by multiple factors and Toll-like receptors (TLRs) are central. Activation of TLRs results in NALP-3 mediated assembly of apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1 into the inflammasome and production of pro-inflammatory cytokines IL-1 beta and IL-18. Given that preventing measures are lacking, we investigated PreImplantation Factor (PIF) as therapeutic option as PIF modulates Inflammation in pregnancy. Additionally, synthetic PIF (PIF analog) protects against multiple immune disorders. We used a LPS induced murine model of fetal loss and synthetic PIF reduced this fetal loss and increased the embryo weight significantly. We detected increased PIF expression in the placentae after LPS insult. The LPS induced serum and placenta cytokines were abolished by synthetic PIF treatment and importantly synthetic PIF modulated key members of inflammasome complex NALP-3, ASC, and caspase-1 as well. In conclusion our results indicate that synthetic PIF protects against LPS induced fetal loss, likely through modulation of inflammatory response especially the inflammasome complex. Given that synthetic PIF is currently tested in autoimmune diseases of non-pregnant subjects (clinicaltrials. gov, NCT02239562), therapeutic approach during pregnancy can be envisioned.	[Di Simone, Nicoletta; Di Nicuolo, Fiorella; Marana, Riccardo; Castellani, Roberta; Veglia, Manuela; Scambia, Giovanni] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Dept Obstet & Gynecol, Rome, Italy; [Di Nicuolo, Fiorella; Marana, Riccardo] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Int Sci Inst Paolo VI, ISI, Rome, Italy; [Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy; [Surbek, Daniel; Mueller, Martin] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Barnea, Eytan] SIEP, Cherry Hill, NJ USA; [Barnea, Eytan] BioIncept LLC, Cherry Hill, NJ USA; [Mueller, Martin] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bern; University Hospital of Bern; Yale University	Mueller, M (corresponding author), Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland.; Mueller, M (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	martin.mueller@insel.ch	Barnea, Eytan/AAK-9467-2021; Di Sante, Gabriele/N-5280-2018; Barnea, Eytan/AAC-9910-2021; Mueller, Martin/J-9682-2019; Ria, Francesco/AAD-1174-2022	Barnea, Eytan/0000-0003-4677-4370; Di Sante, Gabriele/0000-0001-6608-3388; Mueller, Martin/0000-0001-5594-0532; Ria, Francesco/0000-0001-7455-4290; Surbek, Daniel/0000-0001-7705-1584; DI SIMONE, NICOLETTA/0000-0003-1273-3335	Universita Cattolica del Sacro Cuore [D1]; Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy	Universita Cattolica del Sacro Cuore; Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy	The work was supported by a research grant from the Universita Cattolica del Sacro Cuore (D1, 2014) and by Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy. Dr. Eytan R. Barnea is the (uncompensated) Chief Scientist for BioIncept, LLC. BioIncept, LLC did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abumaree MH, 2012, J REPROD IMMUNOL, V94, P131, DOI 10.1016/j.jri.2012.03.488; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Al-Amin MM, 2016, NEUROSCIENCE, V318, P84, DOI 10.1016/j.neuroscience.2016.01.002; Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2016, J REPROD IMMUNOL, V114, P58, DOI 10.1016/j.jri.2015.06.002; Barnea ER, 2015, PHARMACOL THERAPEUT, V156, P10, DOI 10.1016/j.pharmthera.2015.10.008; Barnea ER, 2007, ANN NY ACAD SCI, V1110, P602, DOI 10.1196/annals.1423.064; Barnea ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100263; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bersani I, 2015, IMMUNOL RES, V61, P4, DOI 10.1007/s12026-014-8568-2; Chau SE, 2013, HUM REPROD, V28, P1497, DOI 10.1093/humrep/det060; Chen YC, 2016, THROMB HAEMOSTASIS, V115, P1010, DOI 10.1160/TH15-08-0640; Christiansen OB, 2013, MOL IMMUNOL, V55, P8, DOI 10.1016/j.molimm.2012.08.025; Clark DA, 2001, MOL HUM REPROD, V7, P185, DOI 10.1093/molehr/7.2.185; Clark DA, 2004, AM J REPROD IMMUNOL, V52, P370, DOI 10.1111/j.1600-0897.2004.00237.x; Clark DA, 2008, AM J REPROD IMMUNOL, V59, P277, DOI 10.1111/j.1600-0897.2008.00580.x; Clark DA, 2016, J REPROD IMMUNOL, V116, P60, DOI 10.1016/j.jri.2016.04.288; D'Ippolito S, 2016, FERTIL STERIL, V105, P111, DOI 10.1016/j.fertnstert.2015.09.027; de Jongh BE, 2015, MATERN CHILD HLTH J, V19, P1553, DOI 10.1007/s10995-014-1662-1; Dunne A, 2011, BIOCHEM SOC T, V39, P669, DOI 10.1042/BST0390669; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Ghazal S, 2015, EMBO MOL MED, V7, P996, DOI 10.15252/emmm.201505245; Goodale LF, 2017, ONCOTARGET, V8, P32419, DOI 10.18632/oncotarget.16028; Haavaldsen C, 2013, ACTA OBSTET GYN SCAN, V92, P583, DOI 10.1111/aogs.12105; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Hur SK, 2016, P NATL ACAD SCI USA, V113, P10938, DOI 10.1073/pnas.1603066113; Ida A, 2000, J REPROD IMMUNOL, V47, P65, DOI 10.1016/S0165-0378(00)00058-9; Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kiniwa T, 2016, P NATL ACAD SCI USA, V113, P10139, DOI 10.1073/pnas.1600112113; Korucuoglu U, 2010, EUR J OBSTET GYN R B, V149, P77, DOI 10.1016/j.ejogrb.2009.12.007; Kuypers E, 2015, PEDIATR RES, V77, P29, DOI 10.1038/pr.2014.152; Li LP, 2015, MOL HUM REPROD, V21, P369, DOI 10.1093/molehr/gav001; Lissauer D, 2015, EUR J IMMUNOL, V45, P2858, DOI 10.1002/eji.201445404; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; McNamara H, 2014, PAEDIATR PERINAT EP, V28, P97, DOI 10.1111/ppe.12104; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Mueller M, 2015, CELL DEATH DIFFER, V22, P2078, DOI 10.1038/cdd.2015.55; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Nahum R, 2004, HUM REPROD, V19, P715, DOI 10.1093/humrep/deh099; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Perfetto CO, 2015, J ASSIST REPROD GEN, V32, P977, DOI 10.1007/s10815-015-0481-7; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pontillo A, 2013, REPROD SCI, V20, P563, DOI 10.1177/1933719112459240; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Rose DR, 2017, BRAIN BEHAV IMMUN, V63, P60, DOI 10.1016/j.bbi.2016.11.020; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Roussev RG, 2013, REPROD BIOMED ONLINE, V26, P79, DOI 10.1016/j.rbmo.2012.09.017; Shainer R, 2016, ONCOTARGET; Silver RM, 1997, AM J OBSTET GYNECOL, V176, P544, DOI 10.1016/S0002-9378(97)70545-3; Smit AL, 2016, REPROD SCI, V23, P257, DOI 10.1177/1933719115602759; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Su MT, 2011, FERTIL STERIL, V96, P1435, DOI 10.1016/j.fertnstert.2011.09.030; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Xue PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124001	69	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180642	10.1371/journal.pone.0180642	http://dx.doi.org/10.1371/journal.pone.0180642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704412	gold, Green Published			2022-12-26	WOS:000405649600038
J	Ding, M; Yuan, CZ; Gaskins, AJ; Field, AE; Missmer, SA; Michels, KB; Hu, F; Zhang, CL; Gillman, MW; Chavarro, J				Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Zhang, Cuilin; Gillman, Matthew W.; Chavarro, Jorge			Smoking during pregnancy in relation to grandchild birth weight and BMI trajectories	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL SMOKING; CHILD OVERWEIGHT; GRANDMOTHERS SMOKING; DNA METHYLATION; OBESITY; DISEASE; COHORT; RISK; ASSOCIATION	Background Maternal smoking has been linked to lower birth weight and higher risk of childhood obesity. However, it is unknown whether grand-maternal smoking during pregnancy is associated with grandchildren birth weight and body mass index BMI) trajectories. Methods We investigated associations of smoking during pregnancy with birth weight, risks of overweight and BMI trajectories among 46,858 mother-child dyads and 6,583 grandmothermother-child triads of three cohort studies of related individuals. Smoking during pregnancy was reported by mothers, and anthropometric data were provided by participants in each cohort. Results Compared to grandchildren of non-smoking women, grandchildren of women who smoked more than 14 cigarettes per day throughout pregnancy were 70 g 95% CI: 12, 129 g; P for trend = 0.01) heavier at birth, and 18% 95% CI: 4%, 34%; P for trend = 0.01) more likely to become overweight. The mean BMI of grandchildren of women who smoked during pregnancy was 0.45 kg/ m 2 95% CI: 0.14, 0.75 kg/ m 2; P for trend = 0.006) higher through adolescence and young adulthood than that of grandchildren of non-smoking mothers. Conclusions Grandmothers' smoking during pregnancy was associated with higher birth weight, higher risk of overweight, and higher BMI through adolescence and young adulthood.	[Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Hu, Frank; Chavarro, Jorge] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Field, Alison E.; Michels, Karin B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Field, Alison E.; Missmer, Stacey A.; Hu, Frank; Chavarro, Jorge] Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA 02115 USA; [Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Gillman, Matthew W.; Chavarro, Jorge] Harvard Med Sch, Boston, MA 02115 USA; [Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Chavarro, Jorge] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Missmer, Stacey A.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil, 75 Francis St, Boston, MA 02115 USA; [Michels, Karin B.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA; [Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, Bethesda, MD USA; [Gillman, Matthew W.] Harvard Pilgrim HealthCare, Dept Populat Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard Pilgrim Health Care	Chavarro, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	jchavarr@hsph.harvard.edu	Chavarro, Jorge E/AAE-5665-2021; Field, Alison/AAA-4508-2021; Gaskins, Audrey/K-6246-2019	Chavarro, Jorge E/0000-0002-4436-9630; 	National Institutes of Health [UM1-CA176726, P30-DK046200, U54-CA155626, T32-DK007703-16, HL096905, DK084001, MH087786, R37 HD034568, N02-RC-17027, PO 263 MQ 411027]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants UM1-CA176726, P30-DK046200, U54-CA155626, T32-DK007703-16, HL096905, DK084001, MH087786, R37 HD034568, N02-RC-17027 and PO 263 MQ 411027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AK, 2005, AM J CLIN NUTR, V82, P393, DOI 10.1093/ajcn/82.2.393; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P986; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collins JW, 2011, MATERN CHILD HLTH J, V15, P438, DOI 10.1007/s10995-010-0603-x; Dougan MM, 2015, INT J OBESITY; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Harris HR, 2013, INT J OBESITY, V37, P1356, DOI 10.1038/ijo.2013.101; Huang JY, 2015, AM J EPIDEMIOL, V182, P568, DOI 10.1093/aje/kwv148; Hypponen E, 2003, BMJ-BRIT MED J, V327, P898, DOI 10.1136/bmj.327.7420.898; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Lee KW, 2014, ENV HLTH PERSPECT; Lee S, 2012, CANCER CAUSE CONTROL, V23, P117, DOI 10.1007/s10552-012-9914-0; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; McDonald SD, 2006, BJOG-INT J OBSTET GY, V113, P1289, DOI 10.1111/j.1471-0528.2006.01089.x; Michels KB, 2007, INT J OBESITY, V31, P1078, DOI 10.1038/sj.ijo.0803622; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2005, OBES RES, V13, P2021, DOI 10.1038/oby.2005.248; Rillamas-Sun E, 2014, MATERN CHILD HLTH J, V18, P1691, DOI 10.1007/s10995-013-1411-x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SHOPLAND DR, 1990, SEMIN ONCOL, V17, P402; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179368	10.1371/journal.pone.0179368	http://dx.doi.org/10.1371/journal.pone.0179368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700699	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649600007
J	Leuko, S; Koskinen, K; Sanna, L; D'Angeli, IM; De Waele, J; Marcia, P; Moissl-Eichinger, C; Rettberg, P				Leuko, Stefan; Koskinen, Kaisa; Sanna, Laura; D'Angeli, Ilenia M.; De Waele, Jo; Marcia, Paolo; Moissl-Eichinger, Christine; Rettberg, Petra			The influence of human exploration on the microbial community structure and ammonia oxidizing potential of the Su Bentu limestone cave in Sardinia, Italy	PLOS ONE			English	Article							PROFILING BACTERIAL DIVERSITY; FERROMANGANESE DEPOSITS; PHYLOGENETIC DIVERSITY; KARTCHNER CAVERNS; ARCHAEA; OXIDATION; ABUNDANCE; BIOMINERALIZATION; GEOMICROBIOLOGY; NITRIFICATION	The bacterial diversity in the Su Bentu Cave in Sardinia was investigated by means of 16S rRNA gene-based analysis. This 15 km long cave, carved in Jurassic limestone, hosts a variety of calcite speleothems, and a long succession of subterranean lakes with mixed granite and carbonate sands. The lower level is occasionally flooded by a rising groundwater level, but with only scarce input of organic remains (leaves and charcoal fragments). On the quiet cave pools there are visible calcite rafts, whereas walls are locally coated with manganese deposits. In the drier upper levels, where organic input is much more subdued, moonmilk-a hydrated calcium-magnesium carbonate speleothem -can be found. Relative humidity approaches 100% and the measured mean annual cave air temperature is 14.8 degrees C. Samples were obtained in 2014 from calcite rafts, moonmilk, manganese oxide deposits and soil (limestone and granite grains). Microclimatic conditions in the cave near the sampling sites, sample properties, physico-chemical parameters of water, and sediment composition were determined. The microbial community of this system is predominately composed of the phyla Proteobacteria, Actinobacteria, Acidobacteria, Nitrospirae, and Firmicutes. Sampling sites near the entrance of the cave and in close proximity of the underground campsite -located 500 meters deep into the cave -revealed the highest diversity as well as the highest number of human associated microorganisms. Two samples obtained in very close proximity of each other near the campsite, indicate that the human impact is localized and is not distributed freely within the system. Analysis of the abundance of bacterial and archaeal amoA genes revealed a far greater abundance of archaeal amoA genes compared to bacterial representatives. The results of this study highlight that human impact is confined to locations that are utilized as campsites and that exploration leaves little microbial trails. Furthermore, we uncovered a highly specialized microbiome, which is perfectly adapted to survive and thrive in an environment with low nutrient availability.	[Leuko, Stefan; Rettberg, Petra] German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Germany; [Koskinen, Kaisa; Moissl-Eichinger, Christine] Med Univ Graz, Sect Infect Dis & Trop Med, Dept Internal Med, BioTechMed, Graz, Austria; [Sanna, Laura] Natl Res Council Italy, Inst Biometeorol, Sassari, Italy; [D'Angeli, Ilenia M.; De Waele, Jo] Univ Bologna, Italian Inst Speleol, Bologna, Italy; [Marcia, Paolo] Univ Sassari, Dipartimento Sci Nat & Terr, Sassari, Italy	Helmholtz Association; German Aerospace Centre (DLR); Medical University of Graz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Bologna; University of Sassari	Leuko, S (corresponding author), German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Germany.	stefan.leuko@dlr.de	Rettberg, Petra/AAI-4493-2021; Sanna, Laura/C-2560-2013; Moissl-Eichinger, Christine/A-6682-2015; Koskinen, Kaisa/T-9905-2017; De Waele, Jo/A-7509-2008	Rettberg, Petra/0000-0003-4439-2395; Sanna, Laura/0000-0003-4326-1115; Moissl-Eichinger, Christine/0000-0001-6755-6263; Koskinen, Kaisa/0000-0001-5727-8415; De Waele, Jo/0000-0001-5325-5208; D'Angeli, Ilenia M./0000-0002-2471-6236	EUROPLANET [15-EPN-029]; European Union's Horizon 2020 research and innovation program [654208]	EUROPLANET; European Union's Horizon 2020 research and innovation program	Research was conducted in the framework of the ESA CAVES program. Funding for Next generation sequencing was provided by EUROPLANET (15-EPN-029) to SL. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 654208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetutu EM, 2012, INT J SPELEOL, V41, P137, DOI 10.5038/1827-806X.41.2.2; Badino G, 2010, ACTA CARSOLOGICA, V39, P427; Barton H.A., 2007, MICROBE, V2, P132; Barton HA, 2001, GEOMICROBIOL J, V18, P359, DOI 10.1080/01490450152467840; Barton HA, 2014, LIFE EXTREME ENV MIC; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Barton HA, 2007, J CAVE KARST STUD, V69, P163; Barton HA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00615; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Biddau R, 2017, ITAL J GEOSCI, V136, P113, DOI 10.3301/IJG.2016.03; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Cabras S, 2008, ACTA CARSOLOGICA, V37, P227; Cao CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00366; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carmichael MJ, 2013, GEOMICROBIOL J, V30, P779, DOI 10.1080/01490451.2013.769651; Chessa PA, 1999, THEOR APPL CLIMATOL, V63, P195, DOI 10.1007/s007040050103; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Crits-Christoph A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-28; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; de Freitas CR, 2010, ACTA CARSOLOGICA, V39, P477; Dhami NK, 2013, J MICROBIOL BIOTECHN, V23, P707, DOI 10.4014/jmb.1212.11087; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Ercole C., 2001, INT J SPELEOL, V30, P6; Franzini M., 1972, X-RAY SPECTROM, V1, P151, DOI [10.1002/xrs.1300010406, DOI 10.1002/XRS.1300010406]; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P221, DOI 10.1080/01490451.2012.752424; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P205, DOI 10.1080/01490451.2013.777491; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Hose LD, 2000, CHEM GEOL, V169, P399, DOI 10.1016/S0009-2541(00)00217-5; Ikner LA, 2007, MICROB ECOL, V53, P30, DOI 10.1007/s00248-006-9135-8; Jimenez-Lopez C, 2008, INT BIODETER BIODEGR, V62, P352, DOI 10.1016/j.ibiod.2008.03.002; JONES B, 1989, CAN J EARTH SCI, V26, P654, DOI 10.1139/e89-056; Kambura AK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0748-x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LEONI L, 1982, X-RAY SPECTROM, V11, P156, DOI 10.1002/xrs.1300110404; Linan C, 2008, INT J SPELEOL, V37, P99, DOI 10.5038/1827-806X.37.2.2; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Northup DE, 2003, ENVIRON MICROBIOL, V5, P1071, DOI 10.1046/j.1462-2920.2003.00500.x; Northup DE, 2011, KARST MANAGEMENT, P225, DOI 10.1007/978-94-007-1207-2_10; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Ortiz M, 2014, ISME J, V8, P478, DOI 10.1038/ismej.2013.159; Ortiz M, 2013, MICROB ECOL, V65, P371, DOI 10.1007/s00248-012-0143-6; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pasci S, 1997, B SOC GEOL FR, V168, P301; Pasic L, 2010, FEMS MICROBIOL ECOL, V71, P50, DOI 10.1111/j.1574-6941.2009.00789.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Peter H, 2016, ISME J, V10, P1545, DOI 10.1038/ismej.2015.245; Portillo MC, 2011, MICROB ECOL, V61, P182, DOI 10.1007/s00248-010-9731-5; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rusznyak A, 2012, APPL ENVIRON MICROB, V78, P1157, DOI 10.1128/AEM.06568-11; Sanchez-Canete EP, 2013, INT J SPELEOL, V42, P1, DOI 10.5038/1827-806X.42.1.1; Schabereiter-Gurtner C, 2004, FEMS MICROBIOL ECOL, V47, P235, DOI 10.1016/S0168-6496(03)00280-0; Schabereiter-Gurtner C, 2002, ENVIRON MICROBIOL, V4, P392, DOI 10.1046/j.1462-2920.2002.00303.x; Schleper C, 1997, APPL ENVIRON MICROB, V63, P321, DOI 10.1128/AEM.63.1.321-323.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; Stieglmeier M., 2014, PROKARYOTES OTHER MA; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Tisato N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15525; Tomczyk-Zak K, 2015, GEOMICROBIOL J, P1; Trajano E., 2012, ENCY CAVES, V2nd ed., P295; Villalobos M, 2003, GEOCHIM COSMOCHIM AC, V67, P2649, DOI 10.1016/S0016-7037(03)00217-5; Vorkapic D, 2016, CURR GENET, V62, P71, DOI 10.1007/s00294-015-0514-x; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; White WB., 1976, INT BIODETER BIODEGR, P267; Wu YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00244; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhao R, 2016, GEOMICROBIOL J; Zhou JP, 2007, J MICROBIOL, V45, P105; Zimmermann J, 2005, GEOMICROBIOL J, V22, P379, DOI 10.1080/01490450500248986	84	15	16	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180700	10.1371/journal.pone.0180700	http://dx.doi.org/10.1371/journal.pone.0180700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704427	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600044
J	Feraudet-Tarisse, C; Mazuet, C; Pauillac, S; Kruger, M; Lacroux, C; Popoff, MR; Dorner, BG; Andreoletti, O; Plaisance, M; Volland, H; Simon, S				Feraudet-Tarisse, Cecile; Mazuet, Christelle; Pauillac, Serge; Krueger, Maren; Lacroux, Caroline; Popoff, Michel R.; Dorner, Brigitte G.; Andreoletti, Olivier; Plaisance, Marc; Volland, Herve; Simon, Stephanie			Highly sensitive sandwich immunoassay and immunochromatographic test for the detection of Clostridial epsilon toxin in complex matrices	PLOS ONE			English	Article							PERFRINGENS TYPE-D; STAPHYLOCOCCAL-ENTEROTOXIN-B; PORE-FORMING TOXIN; MONOCLONAL-ANTIBODIES; ENZYME IMMUNOASSAYS; GAS-GANGRENE; MEMBRANE; DIAGNOSIS; PEPTIDE; CELLS	Epsilon toxin is one of the four major toxins of Clostridium perfringens. It is the third most potent clostridial toxin after botulinum and tetanus toxins and is thus considered as a potential biological weapon classified as category B by the Centers for Disease Control and Prevention (CDC). In the case of a bioterrorist attack, there will be a need for a rapid, sensitive and specific detection method to monitor food and water contamination by this toxin, and for a simple human diagnostic test. We have produced and characterized five monoclonal antibodies against common epitopes of epsilon toxin and prototoxin. Three of them neutralize the cytotoxic effects of epsilon toxin in vitro. With these antibodies, we have developed highly sensitive tests, overnight and 4-h sandwich enzyme immunoassays and an immunochromatographic test performed in 20 min, reaching detection limits of at least 5 pg/mL (0.15 pM), 30 pg/mL (0.9 pM) and 100 pg/mL (3.5 pM) in buffer, respectively. These tests were also evaluated for detection of epsilon toxin in different matrices: milk and tap water for biological threat detection, serum, stool and intestinal content for human or veterinary diagnostic purposes. Detection limits in these complex matrices were at least 5-fold better than those described in the literature (around 1 to 5 ng/mL), reaching 10 to 300 pg/mL using the enzyme immunoassay and 100 to 2000 pg/mL using the immunochromatographic test.	[Feraudet-Tarisse, Cecile; Plaisance, Marc; Volland, Herve; Simon, Stephanie] Univ Paris Saclay, SPI, INRA, CEA, Gif Sur Yvette, France; [Mazuet, Christelle; Pauillac, Serge; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Krueger, Maren; Dorner, Brigitte G.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Biol Toxins, Berlin, Germany; [Lacroux, Caroline; Andreoletti, Olivier] Ecole Natl Vet Toulouse, INRA, UMR 1225, Interact Hotes Agents Pathogenes, Toulouse, France	CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Robert Koch Institute; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Feraudet-Tarisse, C (corresponding author), Univ Paris Saclay, SPI, INRA, CEA, Gif Sur Yvette, France.	cecile.feraudet-tarisse@cea.fr	Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255; Kruger, Maren/0000-0001-9775-3110; Dorner, Brigitte/0000-0002-5100-2546				Alves GG, 2014, ANAEROBE, V30, P102, DOI 10.1016/j.anaerobe.2014.08.016; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; BULLEN JJ, 1952, J PATHOL BACTERIOL, V64, P201, DOI 10.1002/path.1700640120; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Dupre M, 2015, ANAL CHEM, V87, P8473, DOI 10.1021/acs.analchem.5b01900; ELIDRISSI AH, 1992, VET MICROBIOL, V31, P89, DOI 10.1016/0378-1135(92)90144-I; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; GLEESONWHITE MH, 1955, LANCET, V1, P384; Gokce HI, 2007, TURK J VET ANIM SCI, V31, P355; GRASSI J, 1989, J IMMUNOL METHODS, V123, P193, DOI 10.1016/0022-1759(89)90223-8; HANVANICH M, 1985, J CLIN MICROBIOL, V21, P184, DOI 10.1128/JCM.21.2.184-188.1985; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Khreich N, 2008, ANAL BIOCHEM, V377, P182, DOI 10.1016/j.ab.2008.02.032; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOHN J, 1955, LANCET, V1, P385; Layana JE, 2006, ANAEROBE, V12, P204, DOI 10.1016/j.anaerobe.2006.05.001; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; MARTIN PK, 1994, RES VET SCI, V56, P259, DOI 10.1016/0034-5288(94)90114-7; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; NAGAHAMA M, 1991, FEMS MICROBIOL LETT, V84, P41, DOI [10.1111/j.1574-6968.1991.tb04566.x, 10.1016/S0378-1097(99)00655-2]; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Seyer A, 2012, ANAL CHEM, V84, P5103, DOI 10.1021/ac300880x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Uzal EA, 2003, J VET DIAGN INVEST, V15, P94, DOI 10.1177/104063870301500202; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; vila RA, 2017, BRAZ J MICROBIOL PUB; VISCIDI R, 1984, J IMMUNOL METHODS, V67, P129, DOI 10.1016/0022-1759(84)90092-9; WEDDELL W, 1985, NEW ZEAL VET J, V33, P36, DOI 10.1080/00480169.1985.35148	39	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181013	10.1371/journal.pone.0181013	http://dx.doi.org/10.1371/journal.pone.0181013			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700661	Green Published, gold			2022-12-26	WOS:000405649400027
J	Lomash, RM; Sheng, NY; Li, Y; Nicoll, RA; Roche, KW				Lomash, Richa Madan; Sheng, Nengyin; Li, Yan; Nicoll, Roger A.; Roche, Katherine W.			Phosphorylation of the kainate receptor (KAR) auxiliary subunit Neto2 at serine 409 regulates synaptic targeting of the KAR subunit GluK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; POSTTRANSLATIONAL MODIFICATIONS; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; TRAFFICKING; STARGAZIN; PROTEINS; DISTINCT; MODULATION; PSD-95	Synaptic strength at excitatory synapses is determined by the presence of glutamate receptors (i.e. AMPA, NMDA, and kainate receptors) at the synapse. Synaptic strength is modulated by multiple factors including assembly of different receptor subunits, interaction with auxiliary subunits, and post-translational modifications of either the receptors or their auxiliary subunits. Using mass spectrometry, we found that the intracellular region of neuropilin and tolloid-like proteins (Neto) 1 and Neto2, the auxiliary subunits of kainate receptor (KARs), are phosphorylated by multiple kinases in vitro. Specifically, Neto 2 was phosphorylated at serine 409 (Ser-409) by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and protein kinase A (PKA) both in vitro and in heterologous cells. Interestingly, we observed a substantial increase in Neto2 Ser-409 phosphorylation in the presence of CaMKII, and this phosphorylation was reduced in the presence of the KAR subunit GluK1 or GluK2. We also found endogenous phosphorylation of Neto2 at Ser-409 in the brain. Moreover, Neto2 Ser-409 phosphorylation inhibited synaptic targeting of GluK1 because, unlike WT Neto2 and the phospho-deficient mutant Neto2 S409A, the Neto2 S409D phosphomimetic mutant impeded GluK1 trafficking to synapses. These results support a molecular mechanism by which Neto2 phosphorylation at Ser-409 helps restrict GluK1 targeting to the synapse.	[Lomash, Richa Madan; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Porter Neurosci Res Ctr, Bldg 35,Rm 2C-903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Lomash, Richa Madan/I-1307-2019; Roche, Katherine/W-9893-2019	Sheng, Nengyin/0000-0003-3086-3950	National Institutes of Health NINDS Intramural Research Program; National Institute of Mental Health [R01MH080379-09, R01MH070957-11A1]; National Institutes of Health [ZIA-NS002994-15]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957, R01MH080379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	National Institutes of Health NINDS Intramural Research Program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health NINDS Intramural Research Program (to R. M. L., Y. L., and K. W. R.), National Institute of Mental Health Grants R01MH080379-09 and R01MH070957-11A1 (to N. S. and R. A. N.), and National Institutes of Health Grant ZIA-NS002994-15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bemben MA, 2014, NAT NEUROSCI, V17, P56, DOI 10.1038/nn.3601; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Fisher JL, 2015, NEUROPHARMACOLOGY, V99, P471, DOI 10.1016/j.neuropharm.2015.08.018; Fisher JL, 2012, J NEUROSCI, V32, P12928, DOI 10.1523/JNEUROSCI.2211-12.2012; Hayes DM, 2003, BIOCHEM BIOPH RES CO, V310, P8, DOI 10.1016/j.bbrc.2003.08.115; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Lussier MP, 2014, EUR J NEUROSCI, V39, P1148, DOI 10.1111/ejn.12494; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Pahl S, 2014, MEMBRANES, V4, P565, DOI 10.3390/membranes4030565; Palacios-Filardo J, 2016, CEREB CORTEX, V26, P1464, DOI 10.1093/cercor/bhu244; Park J, 2016, NEURON, V92, P75, DOI 10.1016/j.neuron.2016.09.002; Sheng NY, 2015, ELIFE, V4, DOI 10.7554/eLife.11682; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Tang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051433; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vernon CG, 2017, J NEUROSCI, V37, P3352, DOI 10.1523/JNEUROSCI.2978-16.2017; Wyeth MS, 2014, J NEUROSCI, V34, P622, DOI 10.1523/JNEUROSCI.3098-13.2014; Xu J, 2010, BRAIN RES, V1366, P197, DOI 10.1016/j.brainres.2010.09.087; Zhang W, 2014, EUR J NEUROSCI, V39, P1138, DOI 10.1111/ejn.12519; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	29	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15369	15377		10.1074/jbc.M117.787903	http://dx.doi.org/10.1074/jbc.M117.787903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717010	Green Published, hybrid			2022-12-26	WOS:000410809800018
J	Ewing, TA; Nguyen, QT; Allan, RC; Gygli, G; Romero, E; Binda, C; Fraaije, MW; Mattevi, A; van Berkel, WJH				Ewing, Tom A.; Quoc-Thai Nguyen; Allan, Robert C.; Gygli, Gudrun; Romero, Elvira; Binda, Claudia; Fraaije, Marco W.; Mattevi, Andrea; van Berkel, Willem J. H.			Two tyrosine residues, Tyr-108 and Tyr-503, are responsible for the deprotonation of phenolic substrates in vanillyl-alcohol oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-CRESOL METHYLHYDROXYLASE; CATALYTIC MECHANISM; ACID DECARBOXYLASE; ACTIVE-SITE; PENICILLIUM-SIMPLICISSIMUM; MOLECULAR-GRAPHICS; DATA QUALITY; OXIDOREDUCTASE; SPECIFICITY; BINDING	A number of oxidoreductases from the VAO/para-cresol methylhydroxylase flavoprotein family catalyze the oxidation of para-substituted phenols. One of the best-studied is vanillyl-alcohol oxidase (VAO) from the fungus Penicillium simplicissimum. For oxidation of phenols by VAO to occur, they must first be bound in the active site of the enzyme in their phenolate anion form. The crystal structure of VAO reveals that two tyrosine residues, Tyr-108 and Tyr-503, are positioned to facilitate this deprotonation. To investigate their role in catalysis, we created three VAO variants, Y108F, Y503F, and Y108F/Y503F, and studied their biochemical properties. Steady-state kinetics indicated that the presence of at least one of the tyrosine residues is essential for efficient catalysis by VAO. Stopped-flow kinetics revealed that the reduction of VAO by chavicol or vanillyl alcohol occurs at two different rates: k(obs1), which corresponds to its reaction with the deprotonated form of the substrate, and k(obs2), which corresponds to its reaction with the protonated form of the substrate. In Y108F, Y503F, and Y108F/Y503F, the relative contribution of k(obs2) to the reduction is larger than in wild-type VAO, suggesting deprotonation is impaired in these variants. Binding studies disclosed that the competitive inhibitor isoeugenol is predominantly in its deprotonated form when bound to wild-type VAO, but predominantly in its protonated form when bound to the variants. These results indicate that Tyr-108 and Tyr-503 are responsible for the activation of substrates in VAO, providing new insights into the catalytic mechanism of VAO and related enzymes that oxidize para-substituted phenols.	[Ewing, Tom A.; Allan, Robert C.; Gygli, Gudrun; van Berkel, Willem J. H.] Wageningen Univ & Res, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Quoc-Thai Nguyen; Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 9, I-27100 Pavia, Italy; [Quoc-Thai Nguyen; Romero, Elvira; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; [Quoc-Thai Nguyen] Univ Med & Pharm, Fac Pharm, Ben Nghe Ward, 41 Dinh Tien Hoang St,Dist 1, Ho Chi Minh City, Vietnam	Wageningen University & Research; University of Pavia; University of Groningen; Hochiminh City University of Medicine & Pharmacy	van Berkel, WJH (corresponding author), Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	willem.vanberkel@wur.nl	Mattevi, Andrea/R-4469-2019; van Berkel, Willem J.H./O-2431-2014; mattevi, andrea/K-5464-2012; Gygli, Gudrun/W-9217-2019; Romero, Elvira/AAA-3555-2020	Mattevi, Andrea/0000-0002-9523-7128; van Berkel, Willem J.H./0000-0002-6551-2782; mattevi, andrea/0000-0002-9523-7128; Gygli, Gudrun/0000-0001-9119-1778; Ewing, Tom/0000-0002-6944-887X; Romero, Elvira/0000-0003-4199-9458; Fraaije, Marco/0000-0001-6346-5014; Nguyen, Quoc-Thai/0000-0001-6315-2974	European Community [7551, 10205]	European Community(European Commission)	We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for providing beam time and assistance and the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grants 7551 and 10205) for funding synchrotron trips.	Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bennett JP, 2008, BIOCHEM J, V414, P281, DOI 10.1042/BJ20080714; Brady SF, 2002, J AM CHEM SOC, V124, P9968, DOI 10.1021/ja0268985; Brandt K, 2001, APPL MICROBIOL BIOT, V56, P724, DOI 10.1007/s002530100698; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; Efimov I, 2004, BIOCHEMISTRY-US, V43, P6138, DOI 10.1021/bi035772x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P16620, DOI 10.1021/bi991273d; Ewing TA, 2016, FEBS J, V283, P2546, DOI 10.1111/febs.13762; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Fraaije MW, 1998, EUR J BIOCHEM, V253, P712, DOI 10.1046/j.1432-1327.1998.2530712.x; FRAAIJE MW, 1995, EUR J BIOCHEM, V234, P271, DOI 10.1111/j.1432-1033.1995.271_c.x; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Frank A, 2012, CATAL SCI TECHNOL, V2, P1568, DOI 10.1039/c2cy20015e; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Liu YC, 2011, NAT CHEM BIOL, V7, P304, DOI 10.1038/nchembio.556; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J BIOL CHEM, V286, P23533, DOI 10.1074/jbc.M111.247833; Nguyen QT, 2016, CHEMBIOCHEM, V17, P1359, DOI 10.1002/cbic.201600148; Rachid S, 2010, J BIOL CHEM, V285, P12482, DOI 10.1074/jbc.M109.079707; Rodriguez H, 2010, PROTEINS, V78, P1662, DOI 10.1002/prot.22684; Sheng X, 2015, FEBS J, V282, P4703, DOI 10.1111/febs.13525; Ullmann GM, 2013, BIOL CHEM, V394, P611, DOI 10.1515/hsz-2012-0329; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; van den Heuvel RHH, 1998, J BACTERIOL, V180, P5646, DOI 10.1128/JB.180.21.5646-5651.1998; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	8	8	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14668	14679		10.1074/jbc.M117.778449	http://dx.doi.org/10.1074/jbc.M117.778449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28717004	Green Published, hybrid			2022-12-26	WOS:000408747500031
J	Desoubeaux, G; Piqueras, MD; Pantin, A; Bhattacharya, SK; Peschke, R; Joachim, A; Cray, C				Desoubeaux, Guillaume; Piqueras, Maria del Carmen; Pantin, Ana; Bhattacharya, Sanjoy K.; Peschke, Roman; Joachim, Anja; Cray, Carolyn			Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits	PLOS ONE			English	Article							PET RABBITS; IN-VITRO; ASPERGILLUS-FUMIGATUS; PROTEIN QUANTITATION; POLAR TUBE; EXPRESSION; DIAGNOSIS; FETUIN; CELLS; MICROSPORIDIOSIS	Encephalitozoon cuniculi is a microsporidian species which can induce subclinical to serious disease in mammals including rabbits, a definitive natural host. The pathophysiology of infection has not been comprehensively elucidated. In this exploratory study, we utilized two mass spectrometry approaches: first, the analysis of the humoral response by profiling the microsporidian antigens as revealed by Western blot screening, and second, implementing the iTRAQ (R)-labeling protocol to focus on the changes within the host proteome during infection. Seven E. cuniculi proteins were identified at one-dimensional gel regions where specific seropositive reaction was observed by Western blot, including polar tube protein 3, polar tube protein 2, and for the first time reported: heat shock related 70kDa protein, polysaccharide deacetylase domain-containing protein, zinc finger protein, spore wall and anchoring disk complex protein EnP1, and translation elongation factor 1 alpha. In addition, there was a significant increase of nine host proteins in blood samples from E. cuniculi-diseased rabbits in comparison with non-diseased control subjects undergoing various inflammatory processes. This included serum paraoxonase, alpha-1-antiproteinase F precursor and alpha-1-antiproteinase S-1 which have presumptive catalytic activity likely related to infection control, and cystatin fetuin-B-type, an enzyme regulator that has been poorly studied to date. Notably, 11 proteins were found to be statistically increased in rabbits with neurological versus renal clinical presentation of E. cuniculi infection. Overall, this novel analysis based on mass spectrometry has provided new insights on the inflammatory and humoral responses during E. cuniculi infection in rabbits.	[Desoubeaux, Guillaume; Pantin, Ana; Cray, Carolyn] Univ Miami, Miller Sch Med, Div Comparat Pathol, Dept Pathol & Lab Med, Miami, FL 33136 USA; [Desoubeaux, Guillaume] CHU Tours, Serv Parasitol Mycol Med Trop, Tours, France; [Desoubeaux, Guillaume] Univ Tours, Fac Med, CEPR INSERM U1100, Equipe 3, Tours, France; [Piqueras, Maria del Carmen; Bhattacharya, Sanjoy K.] Univ Miami, Miller Sch Med, Mass Spectrometry Core Facil, Miami, FL 33136 USA; [Peschke, Roman; Joachim, Anja] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria	University of Miami; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Miami; University of Veterinary Medicine Vienna	Desoubeaux, G (corresponding author), Univ Miami, Miller Sch Med, Div Comparat Pathol, Dept Pathol & Lab Med, Miami, FL 33136 USA.; Desoubeaux, G (corresponding author), CHU Tours, Serv Parasitol Mycol Med Trop, Tours, France.; Desoubeaux, G (corresponding author), Univ Tours, Fac Med, CEPR INSERM U1100, Equipe 3, Tours, France.	guillaume.desoubeaux@univ-tours.fr	DESOUBEAUX, Guillaume/J-5026-2015	DESOUBEAUX, Guillaume/0000-0001-7945-9890; CRAY, CAROLYN/0000-0002-7180-153X	NIH center [P30-EY14801]	NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partly supported by NIH center grant P30-EY14801. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi HI, 2014, PATHOL RES INT, V2014; Arredouani M, 2001, REDOX REP, V6, P369; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; COX JC, 1979, J PROTOZOOL, V26, P260, DOI 10.1111/j.1550-7408.1979.tb02776.x; Cray C, 2015, J EXOT PET MED, V24, P356, DOI 10.1053/j.jepm.2015.06.017; Cray C, 2009, AM J VET RES, V70, P478, DOI 10.2460/ajvr.70.4.478; Csokai J, 2009, VET PARASITOL, V163, P18, DOI 10.1016/j.vetpar.2009.03.057; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Desoubeaux G, 2015, J MYCOL MED, V25, P95, DOI 10.1016/j.mycmed.2014.10.018; Desoubeaux G, 2016, PARASITOL RES; Desoubeaux G, 2014, INT J MED MICROBIOL, V304, P327, DOI 10.1016/j.ijmm.2013.11.015; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2010, MICROBES INFECT, V12, P1244, DOI 10.1016/j.micinf.2010.09.010; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Fekkar A, 2012, J PROTEOMICS, V75, P2536, DOI 10.1016/j.jprot.2012.01.040; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gonzales DA, 2010, PROTEOMICS, V10, P4270, DOI 10.1002/pmic.200900768; Grabner DS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-170; Gruber A, 2009, J COMP PATHOL, V140, P31, DOI 10.1016/j.jcpa.2008.09.009; Harcourt-Brown FM, 2003, VET REC, V152, P427, DOI 10.1136/vr.152.14.427; Hardt M, 2005, ANAL CHEM, V77, P4947, DOI 10.1021/ac050161r; Holcapek M, 2012, J CHROMATOGR A, V1259, P3, DOI 10.1016/j.chroma.2012.08.072; Jolly CE, 2010, INT J MICROBIOL, V2010; Jung SH, 2015, CLIN SCI, V129, P27, DOI 10.1042/CS20140462; Keeble E, 2011, IN PRACTICE, V33, P426, DOI 10.1136/inp.d6077; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Khan IA, 2001, MICROBES INFECT, V3, P401, DOI 10.1016/S1286-4579(01)01397-1; Koyama S, 2000, AM J RESP CELL MOL, V22, P75, DOI 10.1165/ajrcmb.22.1.3752; Kucerova Z, 2006, J EUKARYOT MICROBIOL, V53, pS70, DOI 10.1111/j.1550-7408.2006.00177.x; Kunzel F, 2008, VET PARASITOL, V151, P115, DOI 10.1016/j.vetpar.2007.11.005; Kunzel F, 2014, PARASITOL RES, V113, P4457, DOI 10.1007/s00436-014-4130-3; Kunzel F, 2010, PARASITOL RES, V106, P299, DOI 10.1007/s00436-009-1679-3; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Latney L, 2014, VET MED RES REP, V169; Leiro J, 2004, ANTIMICROB AGENTS CH, V48, P2497, DOI 10.1128/AAC.48.7.2497-2501.2004; Li GK, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017254; Maestrini G, 2017, COMP IMMUNOL MICROB, V50, P54, DOI 10.1016/j.cimid.2016.11.012; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Meng FS, 2009, CLIN BIOCHEM, V42, P1025, DOI 10.1016/j.clinbiochem.2009.03.012; NIEDERKORN JY, 1980, INFECT IMMUN, V27, P995, DOI 10.1128/IAI.27.3.995-1002.1980; Omalu I C J, 2007, Indian J Med Microbiol, V25, P209; Peuvel-Fanget I, 2006, INT J PARASITOL, V36, P309, DOI 10.1016/j.ijpara.2005.10.005; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schottelius J, 2000, MEM I OSWALDO CRUZ, V95, P701, DOI 10.1590/S0074-02762000000500015; SPEER CP, 1987, J PEDIATR-US, V111, P667, DOI 10.1016/S0022-3476(87)80240-8; Tao WA, 2003, CURR OPIN BIOTECH, V14, P110, DOI 10.1016/S0958-1669(02)00018-6; Toyotome T, 2012, INT J MED MICROBIOL, V302, P108, DOI 10.1016/j.ijmm.2011.12.001; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Varga M, 2014, VET REC, V174, P347, DOI 10.1136/vr.g2494; Wang H, 2012, CURR MOL MED, V12, P625, DOI 10.2174/156652412800620039; Wasson K, 2000, VET PATHOL, V37, P113, DOI 10.1354/vp.37-2-113; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zhu J, 2016, ENDOCRINE; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0177961	10.1371/journal.pone.0177961	http://dx.doi.org/10.1371/journal.pone.0177961			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723944	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800003
J	Yang, JY; Bae, J; Jung, A; Park, S; Chung, S; Seok, J; Roh, H; Han, Y; Oh, JM; Sohn, S; Jeong, J; Cho, WS				Yang, Jun-Young; Bae, Jiyeong; Jung, Ayoung; Park, Seonyeong; Chung, Seungtae; Seok, Jihyun; Roh, Hangsik; Han, Youngju; Oh, Jae-Min; Sohn, Soojung; Jeong, Jayoung; Cho, Wan-Seob			Surface functionalization-specific binding of coagulation factors by zinc oxide nanoparticles delays coagulation time and reduces thrombin generation potential in vitro	PLOS ONE			English	Article							ZNO NANOPARTICLES; SILVER NANOPARTICLES; CANCER-CELLS; ANTIBACTERIAL ACTIVITY; INFLAMMATORY RESPONSE; CONFORMATIONAL-CHANGE; PROCOAGULANT ACTIVITY; PROTEIN CORONA; HUMAN BLOOD; HERPES	Zinc oxide nanoparticles (ZnO NPs) have many biomedical applications such as chemotherapy agents, vaccine adjuvants, and biosensors but its hemocompatibility is still poorly understood, especially in the event of direct contact of NPs with blood components. Here, we investigated the impact of size and surface functional groups on the platelet homeostasis. ZnO NPs were synthesized in two different sizes (20 and 100 nm) and with three different functional surface groups (pristine, citrate, and L-serine). ZnO NPs were incubated with plasma collected from healthy rats to evaluate the coagulation time, kinetics of thrombin generation, and profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs. Measurements of plasma coagulation time showed that all types of ZnO NPs prolonged both active partial thromboplastin time and prothrombin time in a dose-dependent manner but there was no size-or surface functionalization-specific pattern. The kinetics data of thrombin generation showed that ZnO NPs reduced the thrombin generation potential with functionalization-specificity in the order of pristine > citrate > L-serine but there was no size-specificity. The profile of levels of coagulation factors in the supernatant and coronated onto the ZnO NPs after incubation of platelet-poor plasma with ZnO NPs showed that ZnO NPs reduced the levels of coagulation factors in the supernatant with functionalization-specificity. Interestingly, the pattern of coagulation factors in the supernatant was consistent with the levels of coagulation factors adsorbed onto the NPs, which might imply that ZnO NPs simply adsorb coagulation factors rather than stimulating these factors. The reduced levels of coagulation factors in the supernatant were consistent with the delayed coagulation time and reduced potential for thrombin generation, which imply that the adsorbed coagulation factors are not functional.	[Yang, Jun-Young; Bae, Jiyeong; Jung, Ayoung; Park, Seonyeong; Chung, Seungtae; Seok, Jihyun; Roh, Hangsik; Sohn, Soojung; Jeong, Jayoung] Minist Food & Drug Safety, Natl Inst Food & Drug Safety Evaluat, Toxicol Res Div, Osong, South Korea; [Han, Youngju; Cho, Wan-Seob] Dong A Univ, Sch Hlth Sci, Dept Med Biotechnol, Busan, South Korea; [Oh, Jae-Min] Yonsei Univ, Coll Sci & Technol, Dept Chem & Med Chem, Gangwon Do, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Dong A University; Yonsei University	Jeong, J (corresponding author), Minist Food & Drug Safety, Natl Inst Food & Drug Safety Evaluat, Toxicol Res Div, Osong, South Korea.; Cho, WS (corresponding author), Dong A Univ, Sch Hlth Sci, Dept Med Biotechnol, Busan, South Korea.	Ojjy@korea.kr; wcho@dau.ac.kr	Han, Youngju/GRO-4212-2022; Cho, Wanseob/AAP-5991-2020	Han, Youngju/0000-0002-4351-7478; 	Ministry of Food and Drug Safety [14181MFDS458]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant (14181MFDS458) from Ministry of Food and Drug Safety in 2014-2015.	Ahmad J, 2015, BIOPROC BIOSYST ENG, V38, P155, DOI 10.1007/s00449-014-1254-x; Ali LMA, 2013, J BIOMED NANOTECHNOL, V9, P1272, DOI 10.1166/jbn.2013.1637; Antoine TE, 2016, J IMMUNOL, V196, P4566, DOI 10.4049/jimmunol.1502373; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Ban DK, 2016, COLLOID SURFACE B, V146, P577, DOI 10.1016/j.colsurfb.2016.06.050; Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059; Cho NH, 2011, NAT NANOTECHNOL, V6, P675, DOI [10.1038/NNANO.2011.149, 10.1038/nnano.2011.149]; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Forato LA, 1998, ANAL BIOCHEM, V259, P136, DOI 10.1006/abio.1998.2599; Frohlich E, 2016, CURR MED CHEM, V23, P408, DOI 10.2174/0929867323666160106151428; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Guildford AL, 2009, J R SOC INTERFACE, V6, P1213, DOI [10.1098/rsif.2009.0021, 10.1098/rsif.2008.0021]; Hassan HFH, 2017, CLIN EXP PHARMACOL P, V44, P235, DOI 10.1111/1440-1681.12681; Jun EA, 2011, NANOTOXICOLOGY, V5, P157, DOI 10.3109/17435390.2010.506250; Kim Kyoung-Min, 2012, Toxicology and Environmental Health Sciences, V4, P121, DOI 10.1007/s13530-012-0126-5; Krajewski S, 2013, ACTA BIOMATER, V9, P7460, DOI 10.1016/j.actbio.2013.03.016; Laloy J, 2012, NANOTOXICOLOGY, V6, P213, DOI 10.3109/17435390.2011.569096; Li JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43126; Martinez-Gutierrez F, 2012, NANOMED-NANOTECHNOL, V8, P328, DOI 10.1016/j.nano.2011.06.014; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Mona J, 2013, DIAM RELAT MATER, V39, P73, DOI 10.1016/j.diamond.2013.08.001; Moyano DF, 2014, ACS NANO, V8, P6748, DOI 10.1021/nn5006478; Nadesh R, 2013, J BIOMED MATER RES A, V101, P2957, DOI 10.1002/jbm.a.34591; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Neun BW, 2015, NCL METHOD ITA 12 VE; OECD, 2010, ENV JM MON, V46; Oslakovic C, 2012, NANOMED-NANOTECHNOL, V8, P981, DOI 10.1016/j.nano.2011.12.001; Paino IMM, 2016, ACS APPL MATER INTER, V8, P32699, DOI 10.1021/acsami.6b11950; Pandurangan M, 2016, J PHOTOCH PHOTOBIO B, V158, P206, DOI 10.1016/j.jphotobiol.2016.03.002; Ponnuvel S, 2015, PROTEIN J, V34, P329, DOI 10.1007/s10930-015-9627-9; Ragaseema VM, 2012, BIOMATERIALS, V33, P3083, DOI 10.1016/j.biomaterials.2012.01.005; Raghavendra AJ, 2017, BIOINTERPHASES, V12, DOI 10.1116/1.4977064; Rahimi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17259; Roy R, 2014, TOXICOL LETT, V230, P421, DOI 10.1016/j.toxlet.2014.08.008; Senapati VA, 2015, FOOD CHEM TOXICOL, V85, P61, DOI 10.1016/j.fct.2015.06.018; Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t; Tomaszewski KA, 2015, NANOMEDICINE-UK, V10, P1451, DOI [10.2217/NNM.14.232, 10.2217/nnm.14.232]; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19950; Wahab R, 2014, PHYSICA E, V62, P111, DOI 10.1016/j.physe.2014.04.017; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wangoo N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2902302; Xu XL, 2013, LANGMUIR, V29, P5573, DOI 10.1021/la400378t; Yallapu MM, 2015, BIOMATERIALS, V46, P1, DOI 10.1016/j.biomaterials.2014.12.045	45	13	13	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181634	10.1371/journal.pone.0181634	http://dx.doi.org/10.1371/journal.pone.0181634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723962	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800061
J	Jiang, SK; Sun, SC; Bai, LM; Ding, GH; Wang, TT; Xia, TS; Jiang, H; Zhang, XJ; Zhang, FM				Jiang, Shukun; Sun, Shichen; Bai, Liangming; Ding, Guohua; Wang, Tongtong; Xia, Tianshu; Jiang, Hui; Zhang, Xijuan; Zhang, Fengming			Resequencing and variation identification of whole genome of the japonica rice variety "Longdao24" with high yield	PLOS ONE			English	Article							ORYZA-SATIVA-L.; SUPER HYBRID RICE; NUCLEOTIDE POLYMORPHISMS; READ ALIGNMENT; DRAFT SEQUENCE; GRAIN-YIELD; ASSOCIATION; CULTIVATION	Japonica rice mainly distributes in north of China, which accounts for more than half of the total japonica rice cultivated area of China. High yield, good grain quality and early heading date were the main breeding traits and commercial property in this region. We performed re-sequencing and genome wide variation analysis of one typical northern japonica rice variety Longdao24 and its parents (Longdao5 and Jigeng83) using the Illumina sequencing technology. 53.17 G clean bases were generated and more than 96.8% of the reads were mapped to the genomic reference sequence. An overall average effective depth of 43.67 x coverage was achieved. We identified 420,475 SNPs, 95,624 InDels, and 14,112 SVs in Longdao24 genome with the genomic sequence of the japonica cultivar Nipponbare as reference. We identified 361,117 SNPs and 81,488 InDels between Longdao24 genome and Longdao5 genome. We also detected 428,908 SNPs and 97,209 InDels between Longdao24 genome and Jigeng83 genome. Twenty-two yield related genes, twenty-two grain quality related genes and thirty-nine heading date genes were analyzed in Longdao24. The alleles of Gn1a, EP3, SCM2, Wx, ALK, OsLF and Hd17 came from the female parent Longdao5. The other alleles of qGW8, SSIVa, SBE3, SSIIIb, SSIIc, DTH2, Ehd3 and OsMADS56 came from the male parent Jigeng83. These results will help us to research the genetics basis of yield, grain quality and early heading date in northern rice of China.	[Jiang, Shukun; Sun, Shichen; Bai, Liangming; Ding, Guohua; Wang, Tongtong; Xia, Tianshu; Jiang, Hui; Zhang, Xijuan; Zhang, Fengming] Heilongjiang Acad Agr Sci, Cultivat & Farming Res Inst, Harbin, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences	Jiang, SK (corresponding author), Heilongjiang Acad Agr Sci, Cultivat & Farming Res Inst, Harbin, Heilongjiang, Peoples R China.	sk.jiang@hotmail.com		jiang, shukun/0000-0003-3671-4665	Natural Science Foundation of Heilongjiang Province of China [C2016050]; national key research and development program of China [2016YFD030010404]; Heilongjiang Postdoctoral Financial Assistance [LBH-Q15133]; doctoral Fund of Heilongjiang Academy of Agricultural Sciences [201507-05]; special fund for China Agricultural Research System [CARS-01-43]	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); national key research and development program of China; Heilongjiang Postdoctoral Financial Assistance; doctoral Fund of Heilongjiang Academy of Agricultural Sciences; special fund for China Agricultural Research System	This work was supported by a grant from the Natural Science Foundation of Heilongjiang Province of China (C2016050), The national key research and development program of China (2016YFD030010404), Heilongjiang Postdoctoral Financial Assistance (LBH-Q15133), the doctoral Fund of Heilongjiang Academy of Agricultural Sciences (201507-05) and the special fund for China Agricultural Research System (CARS-01-43).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Cao LY, 2010, RICE SCI, V17, P87, DOI 10.1016/S1672-6308(08)60109-2; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; [陈温福 Chen Wenfu], 2005, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V36, P3; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Gao Q, 2012, J INTEGR PLANT BIOL, V54, P215, DOI 10.1111/j.1744-7909.2012.01115.x; Gao ZY, 2013, P NATL ACAD SCI USA, V110, P14492, DOI 10.1073/pnas.1306579110; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; IRRI, 1994, IRRI REPORTER, V4, P1; [姜树坤 JIANG Shukun], 2006, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V37, P639; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Li M, 2011, PLANT BIOTECHNOL J, V9, P1002, DOI 10.1111/j.1467-7652.2011.00610.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Rao YC, 2014, PLANT CELL REP, V33, P551, DOI 10.1007/s00299-013-1551-x; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tatusov RL, 2010, NUCLEIC ACIDS RES, V28, P33; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang JY, 2009, THEOR APPL GENET, V119, P85, DOI 10.1007/s00122-009-1019-0; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu HH, 2011, PLOS ONE, V3; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan LP, 2015, ENGINEERING, V1, P13, DOI 10.15302/J-ENG-2015021	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181037	10.1371/journal.pone.0181037	http://dx.doi.org/10.1371/journal.pone.0181037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715430	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500024
J	Zufferey, R; Pirani, K; Cheung-See-Kit, M; Lee, S; Williams, TA; Chen, DG; Hossain, MF				Zufferey, Rachel; Pirani, Karim; Cheung-See-Kit, Melanie; Lee, Sungsu; Williams, Tyler A.; Chen, Daniel G.; Hossain, Md Faruk			The Trypanosoma brucei dihydroxyacetonephosphate acyltransferase TbDAT is dispensable for normal growth but important for synthesis of ether glycerophospholipids	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; CHONDRODYSPLASIA PUNCTATA TYPE-2; LEISHMANIA-MAJOR PROMASTIGOTES; PHOSPHATE ACYLTRANSFERASE; BLOOD-STREAM; PHOSPHATIDYLETHANOLAMINE SYNTHESIS; SACCHAROMYCES-CEREVISIAE; LIPID-METABOLISM; KENNEDY PATHWAY; INITIAL STEP	Glycerophospholipids are the most abundant constituents of biological membranes in Trypanosoma brucei, which causes sleeping sickness in humans and nagana in cattle. They are essential cellular components that fulfill various important functions beyond their structural role in biological membranes such as in signal transduction, regulation of membrane trafficking or control of cell cycle progression. Our previous studies have established that the glycerol-3-phosphate acyltransferase TbGAT is dispensable for growth, viability, and ester lipid biosynthesis suggesting the existence of another initial acyltransferase(s). This work presents the characterization of the alternative, dihydroxyacetonephosphate acyltransferase TbDAT, which acylates primarily dihydroxyacetonephosphate and prefers palmitoyl-CoA as an acyl-CoA donor. TbDAT restores the viability of a yeast double null mutant that lacks glycerol-3-phosphate and dihydroxyacetonephosphate acyltransferase activities. A conditional null mutant of TbDAT in T. brucei procyclic form was created and characterized. TbDAT was important for survival during stationary phase and synthesis of ether lipids. In contrast, TbDAT was dispensable for normal growth. Our results show that in T. brucei procyclic forms i) TbDAT but not TbGAT is the physiologically relevant initial acyltransferase and ii) ether lipid precursors are primarily made by TbDAT.	[Zufferey, Rachel; Pirani, Karim] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Zufferey, Rachel; Cheung-See-Kit, Melanie; Lee, Sungsu; Williams, Tyler A.; Chen, Daniel G.; Hossain, Md Faruk] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Kansas State University; Saint John's University	Zufferey, R (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.; Zufferey, R (corresponding author), St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA.	zufferer@stjohns.edu	Hossain, Faruk/J-4741-2019	Hossain, Faruk/0000-0002-3457-7903; zufferey, rachel/0000-0003-1200-3914; Cheung See Kit, Melanie/0000-0002-0511-1506	National Institute of Health [SC3GM113743, T36GM101995]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University	This work was supported by the National Institute of Health, SC3GM113743 to RZ, (https://www.nih.gov); National Institute of Health, T36GM101995 to RZ (https://www.nih.gov/); The lipid analyses described in this work were performed at the Kansas Lipidomics Research Center Analytical Laboratory. Instrument acquisition and method development at the Kansas Lipidomics Research Center was supported by National Science Foundation (EPS 0236913, MCB 0455318, DBI 0521587; https://www.nsf.gov), Kansas Technology Enterprise Corporation (http://cdm16884.contentdm.oclc.org/ui/custom/default/collection/default/resources/custompages/ag), K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475; https://www.nih.gov), and Kansas State University (http://www.k-state.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027802; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; Biermann J, 1999, EUR J BIOCHEM, V261, P492, DOI 10.1046/j.1432-1327.1999.00295.x; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Butikofer P, 1999, J CELL SCI, V112, P1785; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Cronan JE, 2006, CELL, V126, P641, DOI 10.1016/j.cell.2006.08.001; D'Antonio EL, 2013, ARCH BIOCHEM BIOPHYS, V535, P163, DOI 10.1016/j.abb.2013.03.015; Dorninger F, 2015, BBA-MOL CELL BIOL L, V1851, P117, DOI 10.1016/j.bbalip.2014.11.005; Elias ER, 1998, AM J MED GENET, V80, P223, DOI 10.1002/(SICI)1096-8628(19981116)80:3<223::AID-AJMG9>3.0.CO;2-X; Farine L, 2013, BBA-MOL CELL BIOL L, V1831, P533, DOI 10.1016/j.bbalip.2012.09.008; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hajra AK, 1997, BBA-LIPID LIPID MET, V1348, P27, DOI 10.1016/S0005-2760(97)00120-3; Heise N, 1997, MOL BIOCHEM PARASIT, V89, P61, DOI 10.1016/S0166-6851(97)00101-1; JONES CL, 1983, ARCH BIOCHEM BIOPHYS, V226, P155, DOI 10.1016/0003-9861(83)90280-1; KELLEHER M, 1992, P NATL ACAD SCI USA, V89, P6, DOI 10.1073/pnas.89.1.6; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Lee JH, 2007, EUKARYOT CELL, V6, P641, DOI 10.1128/EC.00411-06; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; PARKER HL, 1995, MOL BIOCHEM PARASIT, V69, P269, DOI 10.1016/0166-6851(94)00208-5; Patel N, 2016, J EUKARYOT MICROBIOL, V63, P598, DOI 10.1111/jeu.12309; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Serricchio M, 2011, FEBS J, V278, P1035, DOI 10.1111/j.1742-4658.2011.08012.x; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; SWINKELS BW, 1986, EMBO J, V5, P1291, DOI 10.1002/j.1460-2075.1986.tb04358.x; Sztriha L, 2000, DEV MED CHILD NEUROL, V42, P492, DOI 10.1017/S0012162200000918; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vertommen D, 2008, MOL BIOCHEM PARASIT, V158, P189, DOI 10.1016/j.molbiopara.2007.12.008; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zomer AWM, 1999, MOL BIOCHEM PARASIT, V104, P55, DOI 10.1016/S0166-6851(99)00141-3; ZOMER AWM, 1995, BBA-LIPID LIPID MET, V1257, P167, DOI 10.1016/0005-2760(95)00066-L; Zufferey R, 2006, J BIOL CHEM, V281, P7952, DOI 10.1074/jbc.M512911200; Zufferey R, 2005, MOL MICROBIOL, V56, P800, DOI 10.1111/j.1365-2958.2005.04579.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200; Zufferey R, 2009, MOL BIOCHEM PARASIT, V168, P177, DOI 10.1016/j.molbiopara.2009.08.006	54	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181432	10.1371/journal.pone.0181432	http://dx.doi.org/10.1371/journal.pone.0181432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715456	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500055
J	Zhang, CB; Lin, CJ; Fu, FY; Zhong, XF; Peng, B; Yan, H; Zhang, JY; Zhang, WL; Wang, PN; Ding, XY; Zhang, W; Zhao, LM				Zhang, Chunbao; Lin, Chunjing; Fu, Fuyou; Zhong, Xiaofang; Peng, Bao; Yan, Hao; Zhang, Jingyong; Zhang, Weilong; Wang, Pengnian; Ding, Xiaoyang; Zhang, Wei; Zhao, Limei			Comparative transcriptome analysis of flower heterosis in two soybean F1 hybrids by RNA-seq	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; WATER-STRESS; RICE; CULTIVARS; METALLOENDOPEPTIDASE; IDENTIFICATION; SECRETION; REVEALS; GENOMES	Heterosis has been widely exploited as an approach to enhance crop traits during breeding. However, its underlying molecular genetic mechanisms remain unclear. Recent advances in RNA sequencing technology (RNA-seq) have provided an opportunity to conduct transcriptome profiling for heterosis studies. We used RNA-seq to analyze the flower transcriptomes of two F1 hybrid soybeans (HYBSOY-1 and HYBSOY-5) and their parents. More than 385 million high-quality reads were generated and aligned against the soybean reference genome. A total of 681 and 899 genes were identified as being differentially expressed between HYBSOY-1 and HYBSOY-5 and their parents, respectively. These differentially expressed genes (DEGs) were categorized into four major expression categories with 12 expression patterns. Furthermore, gene ontology (GO) term analysis showed that the DEGs were enriched in the categories metabolic process and catalytic activity, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis found that metabolic pathway and biosynthesis of secondary metabolites were enriched in the two F1 hybrids. Comparing the DEGs of the two F1 hybrids by GO term and KEGG pathway analyses identified 26 common DEGs that showed transgressive up-regulation, and which could be considered potential candidate genes for heterosis in soybean F1 hybrids. This identification of an extensive transcriptome dataset gives a comprehensive overview of the flower transcriptomes in two F1 hybrids, and provides useful information for soybean hybrid breeding. These findings lay the foundation for future studies on molecular mechanisms underlying soybean heterosis.	[Zhang, Chunbao; Lin, Chunjing; Peng, Bao; Yan, Hao; Zhang, Jingyong; Zhang, Weilong; Wang, Pengnian; Ding, Xiaoyang; Zhang, Wei; Zhao, Limei] Jilin Acad Agr Sci, Soybean Res Inst, Natl Engn Res Ctr Soybean, Changchun, Peoples R China; [Fu, Fuyou] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Zhong, Xiaofang] Jilin Acad Agr Sci, Agrobiotechnol Inst, Changchun, Peoples R China	Jilin Academy of Agricultural Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jilin Academy of Agricultural Sciences	Zhao, LM (corresponding author), Jilin Acad Agr Sci, Soybean Res Inst, Natl Engn Res Ctr Soybean, Changchun, Peoples R China.	l_mzhao@126.com	; Fu, Fuyou/B-9754-2016	Zhang, Chunbao/0000-0001-9344-9162; Fu, Fuyou/0000-0002-5020-4496	National Key Research and Development Program of China [2016YFD0101500, 2016YFD0101502]; Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province [2014-2]; National Natural Science Foundation of China [31601322]	National Key Research and Development Program of China; Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2016YFD0101500, 2016YFD0101502), the Returned Overseas Scholars Innovative Entrepreneurship Project of Jilin Province (2014-2), and the National Natural Science Foundation of China (31601322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakir Y., 2016, PLANT GENOME, V9; Bao JY, 2005, PLANT PHYSIOL, V138, P1216, DOI 10.1104/pp.105.060988; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Davenport CB, 1908, SCIENCE, V28, P454, DOI 10.1126/science.28.718.454-b; Delorme VGR, 2000, PLANT PHYSIOL, V123, P917, DOI 10.1104/pp.123.3.917; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fujimoto R, 2012, P NATL ACAD SCI USA, V109, P7109, DOI 10.1073/pnas.1204464109; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; GRAHAM TL, 1991, PLANT PHYSIOL, V95, P594, DOI 10.1104/pp.95.2.594; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hoecker N, 2005, THEOR APPL GENET, V112; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Palmer RG, 2010, PLANT BREEDING REV, V21, P263; Pueppke SG, 1998, PLANT PHYSIOL, V117, P599, DOI 10.1104/pp.117.2.599; Nguyen QT, 2016, CURR GENOMICS, V17, P241, DOI 10.2174/1389202917666160202220238; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; SHULL G.H., 1908, J HERED, V4, P296; Song GS, 2010, MOL PLANT, V3, P1012, DOI 10.1093/mp/ssq046; SUN H, 1994, CHINESE SCI BULL, V39, P175; Sun H, 1994, P WORLD SOYB RES C 5; Thiemann A, 2010, THEOR APPL GENET, V120, P401, DOI 10.1007/s00122-009-1189-9; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang HG, 2007, J INTEGR PLANT BIOL, V49, P1455, DOI 10.1111/j.1672-9072.2007.00553.x; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wu Y, 2016, J INTEGR PLANT BIOL, V58, P150, DOI 10.1111/jipb.12357; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhao L., 2004, CHINESE J OIL CROP S, V3, P4	51	13	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e181061	10.1371/journal.pone.0181061	http://dx.doi.org/10.1371/journal.pone.0181061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708857	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800038
J	Tsuji, M; Kawasaki, T; Matsuda, T; Arai, T; Gojo, S; Takeuchi, JK				Tsuji, Masato; Kawasaki, Takanori; Matsuda, Takeru; Arai, Tomio; Gojo, Satoshi; Takeuchi, Jun K.			Sexual dimorphisms of mRNA and miRNA in human/murine heart disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BIOPSY-PROVEN MYOCARDITIS; RECEPTOR TRANSGENIC MICE; LARGE GENE LISTS; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MICRORNA-150 PROTECTS; GENDER-DIFFERENCES	Background Sexual dimorphisms are well recognized in various cardiac diseases such as ischemic cardiomyopathy (ICM), hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Thorough understanding of the underlying genetic programs is crucial to optimize treatment strategies specified for each gender. By performing meta-analysis and microarray analysis, we sought to comprehensively characterize the sexual dimorphisms in the healthy and diseased heart at the level of both mRNA and miRNA transcriptome. Results Existing mRNA microarray data of both mouse and human heart were integrated, identifying dozens/hundreds of sexually dimorphic genes in healthy heart, ICM, HCM, and DCM. These sexually dimorphic genes overrepresented gene ontologies (GOs) important for cardiac homeostasis. Further, microarray of miRNA, isolated from mouse sham left ventricle (LV) (n = 6 & n = 5 for male & female) and chronic MI LV (n = 19 & n = 19) and from human normal LV (n = 6 & n = 6) and ICM LV (n = 4 & n = 5), was conducted. This revealed that 13 mouse miRNAs are sexually dimorphic in MI and 6 in normal heart. In human, 3 miRNAs were sexually dimorphic in ICM and 15 in normal heart. These data revealed miRNA-mRNA networks that operate in a sexually-biased fashion. Conclusions mRNA and miRNA transcriptome of normal and disease heart show significant sex differences, which might impact the cardiac homeostasis. Together this study provides the first comprehensive picture of the genome-wide program underlying the heart sexual dimorphisms, laying the foundation for gender specific treatment strategies.	[Tsuji, Masato; Takeuchi, Jun K.] Tokyo Med Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Tokyo, Japan; [Tsuji, Masato; Takeuchi, Jun K.] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan; [Kawasaki, Takanori; Gojo, Satoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Matsuda, Takeru] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo, Japan; [Arai, Tomio] Inst Gerontol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Kyoto Prefectural University of Medicine; University of Tokyo; Tokyo Metropolitan Institute of Gerontology	Tsuji, M; Takeuchi, JK (corresponding author), Tokyo Med Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Tokyo, Japan.; Tsuji, M; Takeuchi, JK (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan.	mtsuji172@gmail.com; junjunjunta@gmail.com			Japan Agency for Medical Research and Development [16bk0104012h0004]; Japan Society for the Promotion of Science [25291049]; Takeda Medical Research Foundation; Banyu Life Science Foundation International; Nanken-Kyoten; TMDU	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation; Banyu Life Science Foundation International(Banyu Life Science Foundation International); Nanken-Kyoten; TMDU	This work was supported by the Japan Agency for Medical Research and Development: 16bk0104012h0004 (JT); Japan Society for the Promotion of Science: 25291049 (JT); Takeda Medical Research Foundation: 2013 (JT); and Banyu Life Science Foundation International: 2012 (JT). This study was supported by Nanken-Kyoten, TMDU.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Antoniucci D, 2001, AM J CARDIOL, V87, P289, DOI 10.1016/S0002-9149(00)01360-6; Arimura T, 2013, CARDIOVASC RES, V99, P382, DOI 10.1093/cvr/cvt106; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; BUENO H, 1995, CIRCULATION, V92, P1133, DOI 10.1161/01.CIR.92.5.1133; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Cao QX, 2015, ONCOL REP, V33, P2606, DOI 10.3892/or.2015.3861; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cavasin MA, 2006, AM J PHYSIOL-HEART C, V290, pH2043, DOI 10.1152/ajpheart.01121.2005; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Chen M, 2014, INT J CARDIOL, V173, P65, DOI 10.1016/j.ijcard.2014.02.007; Chen Q, 2010, J MOL CELL CARDIOL, V49, P801, DOI 10.1016/j.yjmcc.2010.08.002; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Chiavacci E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050536; Cocker MS, 2009, HEART, V95, P1925, DOI 10.1136/hrt.2008.164061; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Coronado MJ, 2012, AM J PHYSIOL-HEART C, V302, pH1726, DOI 10.1152/ajpheart.00783.2011; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; Ding W, 2015, CARDIOVASC RES, V106, P131, DOI 10.1093/cvr/cvv030; Duan QL, 2015, J CELL PHYSIOL, V230, P1964, DOI 10.1002/jcp.24942; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fliegner D, 2010, FEMALE SEX ESTROGEN, P1597; Frisancho-Kiss S, 2007, J IMMUNOL, V178, P6710, DOI 10.4049/jimmunol.178.11.6710; Fulminant THE, 1946, AM J, VXXII; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Haddad GE, 2008, PHYSIOL GENOMICS, V33, P267, DOI 10.1152/physiolgenomics.00265.2007; Hammett CJK, 2004, J AM COLL CARDIOL, V44, P2411, DOI 10.1016/j.jacc.2004.09.030; Heidecker B, 2010, EUR HEART J, V31, P1188, DOI 10.1093/eurheartj/ehp549; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Izarra A, 2014, STEM CELL REP, V3, P1029, DOI 10.1016/j.stemcr.2014.10.010; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Johnson BD, 2006, EUR HEART J, V27, P1408, DOI 10.1093/eurheartj/ehl040; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joladarashi D, 2014, INT J MOL SCI, V15, P15891, DOI 10.3390/ijms150915891; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kararigas G, 2011, PHYSIOL GENOMICS, V43, P438, DOI 10.1152/physiolgenomics.00199.2010; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; Kubo T, 2010, J CARDIOL, V56, P314, DOI 10.1016/j.jjcc.2010.07.004; Li MM, 2014, CELL PHYSIOL BIOCHEM, V33, P1988, DOI 10.1159/000362975; Li XB, 2013, ACTA BIOCH BIOPH SIN, V45, P734, DOI 10.1093/abbs/gmt067; LIAO YL, 1995, CIRCULATION, V92, P805, DOI 10.1161/01.CIR.92.4.805; Lin CL, 1999, JPN CIRC J, V63, P859, DOI 10.1253/jcj.63.859; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Liu Z, 2015, CIRC-CARDIOVASC GENE, V8, P11, DOI 10.1161/CIRCGENETICS.114.000598; Lv GW, 2014, J CELL BIOCHEM, V115, P93, DOI 10.1002/jcb.24636; LYDEN DC, 1987, AM J PATHOL, V126, P432; Magnani JW, 2006, AM HEART J, V151, P463, DOI 10.1016/j.ahj.2005.03.037; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Meyer S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/ejhf.15; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Nikolic I, 2007, J MOL CELL CARDIOL, V42, P769, DOI 10.1016/j.yjmcc.2007.01.014; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olson MB, 2003, EUR HEART J, V24, P1506, DOI 10.1016/S0195-668X(03)00279-3; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pilbrow AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039574; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SAINANI GS, 1968, MEDICINE, V47, P133, DOI 10.1097/00005792-196803000-00003; SHAPIRA I, 1987, CHEST, V92, P219, DOI 10.1378/chest.92.2.219; Shioura KM, 2008, AM J PHYSIOL-REG I, V295, pR528, DOI 10.1152/ajpregu.90342.2008; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Tang YP, 2015, CARDIOVASC RES, V106, P387, DOI 10.1093/cvr/cvv121; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; van Rijsingen IAW, 2013, EUR J HEART FAIL, V15, P376, DOI 10.1093/eurjhf/hfs191; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang YT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-72; With C., 1991, IN HOSP 1 YEAR MORTA, P484; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; WOODRUFF JF, 1980, AM J PATHOL, V101, P425; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	99	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0177988	10.1371/journal.pone.0177988	http://dx.doi.org/10.1371/journal.pone.0177988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704447	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700005
J	Xiang, N; Lawrence, KS; Kloepper, JW; Donald, PA; McInroy, JA				Xiang, Ni; Lawrence, Kathy S.; Kloepper, Joseph W.; Donald, Patricia A.; McInroy, John A.			Biological control of Heterodera glycines by spore-forming plant growth-promoting rhizobacteria (PGPR) on soybean	PLOS ONE			English	Article							CYST-NEMATODE; MELOIDOGYNE-INCOGNITA; SYSTEMIC RESISTANCE; BIOCONTROL; BACTERIA; FUNGI	Heterodera glycines, the soybean cyst nematode, is the most economically important plantparasitic nematode on soybean production in the U.S. The objectives of this study were to evaluate the potential of plant growth-promoting rhizobacteria (PGPR) strains for mortality of H. glycines J2 in vitro and for reducing nematode population density on soybean in greenhouse, microplot, and field trials. The major group causing mortality to H. glycines in vitro was the genus Bacillus that consisted of 92.6% of the total 663 PGPR strains evaluated. The subsequent greenhouse, microplot, and field trials indicated that B. velezensis strain Bve2 consistently reduced H. glycines cyst population density at 60 DAP. Bacillus mojavensis strain Bmo3 suppressed H. glycines cyst and total H. glycines population density under greenhouse conditions. Bacillus safensis strain Bsa27 and Mixture 1 (Bve2 + Bal13) reduced H. glycines cyst population density at 60 DAP in the field trials. Bacillus subtilis subsp. subtilis strains Bsssu2 and Bsssu3, and B. velezensis strain Bve12 increased early soybean growth including plant height and plant biomass in the greenhouse trials. Bacillus altitudinis strain Bal13 increased early plant growth on soybean in the greenhouse and microplot trials. Mixture 2 (Abamectin + Bve2 + Bal13) increased early plant growth in the microplot trials at 60 DAP, and also enhanced soybean yield at harvest in the field trials. These results demonstrated that individual PGPR strains and mixtures can reduce H. glycines population density in the greenhouse, microplot, and field conditions, and increased yield of soybean.	[Xiang, Ni; Lawrence, Kathy S.; Kloepper, Joseph W.; Donald, Patricia A.; McInroy, John A.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Lawrence, KS (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lawrekk@auburn.edu	Xiang, Ni/I-3176-2019; Lawrence, Kathy/AAA-3808-2020	Xiang, Ni/0000-0003-0805-7901; Lawrence, Kathy/0000-0002-5358-2011				Askary TH, 2014, BIOCONTROL AGENTS OF PHYTONEMATODES, P446; Burkett-Cadena M, 2008, BIOL CONTROL, V47, P55, DOI 10.1016/j.biocontrol.2008.07.008; Castillo JD, 2013, PLANT DIS, V97, P967, DOI 10.1094/PDIS-10-12-0978-RE; Chen S., 2004, BIOL MANAGEMENT SOYB, P207; Chen SY, 2005, BIOL CONTROL, V32, P208, DOI 10.1016/j.biocontrol.2004.09.013; Hallmann J, 2010, ROOT-KNOT NEMATODES, P380, DOI 10.1079/9781845934927.0380; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Keren-Zur M, 2000, PROC BRIGHTON CROP, V1-3, P47; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; KLOEPPER JW, 1992, PLANT SOIL, V139, P75, DOI 10.1007/BF00012844; Liu K, 2016, BIOL CONTROL, V99, P8, DOI 10.1016/j.biocontrol.2016.04.007; Liu XZ, 2000, BIOL CONTROL, V19, P161, DOI 10.1006/bcon.2000.0855; Micnroy, 2014, P 2014 BELTW COTT C, V1, P258; NASS. National Agricultural Statistics Service | USDA, 2016, CROP PROD 2015 SUMM, P46; NISHIZAWA T, 1987, J NEMATOL, V19, P546; Nitao JK, 2002, NEMATOLOGY, V4, P55, DOI 10.1163/156854102760082203; NOEL GR, 1994, J NEMATOL, V26, P612; Raupach GS, 2000, PLANT DIS, V84, P1073, DOI 10.1094/PDIS.2000.84.10.1073; RIGGS RD, 1991, J NEMATOL, V23, P149; Schrimsher DW, 2014, J NEMATOL, V46, P365; Sharma R. D., 1996, Nematologia Brasileira, V20, P53; Sharma Ravi Datt, 1995, Nematologia Brasileira, V19, P72; Tian HL, 2000, J NEMATOL, V32, P377; Tian HL, 2000, J NEMATOL, V32, P370; TYLKA GL, 1991, J NEMATOL, V23, P122; Wilson MJ, 2013, BIOCONTROL, V58, P715, DOI 10.1007/s10526-013-9511-5; WINSTEAD N. N., 1955, PLANT DIS REPORTER, V39, P9; Wrather A., 2010, PLANT HLTH PROGR; Wrather JA., 2009, EFFECTS DISEASES SOY; Xiang N, 2017, PLANT DIS, V101, P774, DOI 10.1094/PDIS-09-16-1369-RE; Xiang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154818	31	32	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181201	10.1371/journal.pone.0181201	http://dx.doi.org/10.1371/journal.pone.0181201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704498	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700104
J	Liu, W; Ghouri, F; Yu, H; Li, X; Yu, SH; Shahid, MQ; Liu, XD				Liu, Wen; Ghouri, Fozia; Yu, Hang; Li, Xiang; Yu, Shuhong; Shahid, Muhammad Qasim; Liu, Xiangdong			Genome wide re-sequencing of newly developed Rice Lines from common wild rice (Oryza rufipogon Griff.) for the identification of NBS-LRR genes	PLOS ONE			English	Article							BLAST RESISTANCE GENE; BLIGHT RESISTANCE; ASSOCIATION; MARKERS; INDICA; POLYMORPHISMS; CONSERVATION; POPULATION; DIVERSITY; JAPONICA	Common wild rice (Oryza rufipogon Griff.) is an important germplasm for rice breeding, which contains many resistance genes. Re-sequencing provides an unprecedented opportunity to explore the abundant useful genes at whole genome level. Here, we identified the nucleotide-binding site leucine-rich repeat (NBS-LRR) encoding genes by re-sequencing of two wild rice lines (i.e. Huaye 1 and Huaye 2) that were developed from common wild rice. We obtained 128 to 147 million reads with approximately 32.5-fold coverage depth, and uniquely covered more than 89.6% (> = 1 fold) of reference genomes. Two wild rice lines showed high SNP (single-nucleotide polymorphisms) variation rate in 12 chromosomes against the reference genomes of Nipponbare (japonica cultivar) and 93-11 (indica cultivar). InDels (insertion/deletion polymorphisms) count-length distribution exhibited normal distribution in the two lines, and most of the InDels were ranged from -5 to 5 bp. With reference to the Nipponbare genome sequence, we detected a total of 1,209,308 SNPs, 161,117 InDels and 4,192 SVs (structural variations) in Huaye 1, and 1,387,959 SNPs, 180,226 InDels and 5,305 SVs in Huaye 2. A total of 44.9% and 46.9% genes exhibited sequence variations in two wild rice lines compared to the Nipponbare and 93-11 reference genomes, respectively. Analysis of NBS-LRR mutant candidate genes showed that they were mainly distributed on chromosome 11, and NBS domain was more conserved than LRR domain in both wild rice lines. NBS genes depicted higher levels of genetic diversity in Huaye 1 than that found in Huaye 2. Furthermore, protein-protein interaction analysis showed that NBS genes mostly interacted with the cytochrome C protein (Os05g0420600, Os01g0885000 and BGIOSGA038922), while some NBS genes interacted with heat shock protein, DNA-binding activity, Phosphoinositide 3-kinase and a coiled coil region. We explored abundant NBSLRR encoding genes in two common wild rice lines through genome wide re-sequencing, which proved to be a useful tool to exploit elite NBS-LRR genes in wild rice. The data here provide a foundation for future work aimed at dissecting the genetic basis of disease resistance in rice, and the two wild rice lines will be useful germplasm for the molecular improvement of cultivated rice.	[Liu, Wen; Ghouri, Fozia; Yu, Hang; Li, Xiang; Yu, Shuhong; Shahid, Muhammad Qasim; Liu, Xiangdong] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Liu, Wen] Guangdong Agr Ind Business Polytech Coll, Dept Trop Crops, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Shahid, MQ; Liu, XD (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	qasim@scau.edu.cn; xdliu@scau.edu.cn	Shahid, Muhammad Qasim/F-2908-2013; Shahid, Muhammad Qasim/K-2304-2019	Shahid, Muhammad Qasim/0000-0002-6767-4355; Shahid, Muhammad Qasim/0000-0002-6767-4355; Xiang, Li/0000-0003-2757-0305; Ghouri, Fozia/0000-0001-5579-5179	Guangdong provincial key Natural Science Foundation [2014A030311042]; Guangzhou Science and Technology Key Program [201606201026123]	Guangdong provincial key Natural Science Foundation; Guangzhou Science and Technology Key Program	This work was supported by the Guangdong provincial key Natural Science Foundation (2014A030311042 to XD Liu) and the Guangzhou Science and Technology Key Program (Application No. 201606201026123 to XD Liu and MQ Shahid).	Arai-Kichise Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086312; Cheng ZQ, 2012, RICE SCI, V19, P21, DOI 10.1016/S1672-6308(12)60016-X; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gao LZ, 2000, HEREDITAS, V133, P47, DOI 10.1111/j.1601-5223.2000.00047.x; [高明君 Gao Mingjun], 2013, [中国科学. 生命科学, Scientia Sinica Vitae], V43, P1016; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kim SR, 2016, RICE, V9, DOI 10.1186/s12284-016-0084-7; Kottapalli KR, 2007, BIOCHEM BIOPH RES CO, V355, P295, DOI 10.1016/j.bbrc.2007.01.134; Kumari A, 2013, EUR J PLANT PATHOL, V137, P55, DOI 10.1007/s10658-013-0216-5; Liu Ren-Hu, 2003, Yichuan, V25, P317; LIU W, 2015, PLOS ONE, V10; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Lu PL, 2012, GENOME RES, V22, P508, DOI 10.1101/gr.127522.111; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Ngu MeeSiing, 2010, Tropical Plant Biology, V3, P227, DOI 10.1007/s12042-010-9060-3; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Qiu J, 2014, PLANTA, V240, P1353, DOI 10.1007/s00425-014-2159-2; Ramkumar G., 2014, J GENOMES EXOMES, V3, P7; Ray S, 2012, TRANSGENIC RES, V21, P351, DOI 10.1007/s11248-011-9535-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Shirasawa K, 2013, DNA RES, V20, P593, DOI 10.1093/dnares/dst033; Song ZP, 2005, PLANT SPEC BIOL, V20, P83, DOI 10.1111/j.1442-1984.2005.00128.x; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang XM, 2013, PLANT MOL BIOL REP, V31, P649, DOI 10.1007/s11105-012-0537-0; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xie J, 2010, GENET RESOUR CROP EV, V57, P597, DOI 10.1007/s10722-009-9498-z; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yang Y, 2011, J PLANT PHYSIOL, V168, P1701, DOI 10.1016/j.jplph.2011.02.012; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang LG, 2012, PLANT CELL, V24, P4407, DOI 10.1105/tpc.112.102269; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	43	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180662	10.1371/journal.pone.0180662	http://dx.doi.org/10.1371/journal.pone.0180662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700714	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400016
J	Moriuchi, T; Otsuka, N; Hiramatsu, Y; Shibayama, K; Kamachi, K				Moriuchi, Takumi; Otsuka, Nao; Hiramatsu, Yukihiro; Shibayama, Keigo; Kamachi, Kazunari			A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; FILAMENTOUS HEMAGGLUTININ; IMMUNOGLOBULIN-G; IGG ANTIBODIES; WHOLE-CELL; ASSAY; ADOLESCENTS; INFECTION; AVIDITY; SEROEPIDEMIOLOGY	In 2013, national serosurveillance detected a high seroprevalence of antibodies to pertussis toxin ( PT) from Bordetella pertussis among Japanese adults. Thus, we aimed to determine the cause(s) of this high seroprevalence, and analyzed the titers of antibodies to PT and filamentous hemagglutinin (FHA) among adults (35-44 years old), young children (4-7 years old), and older children (10-14 years old). Our quantitative analyses revealed that adults had higher seroprevalences of anti-PT IgG and PT-neutralizing antibodies, and similar titers of anti-FHA IgG, compared to the young and older children. Positive correlations were observed between the titers of PT-neutralizing antibodies and anti-PT IgG in all age groups (rs values of 0.326-0.522), although the correlation tended to decrease with age. The ratio of PT-neutralizing antibodies to anti-PT IgG was significantly different when we compared the serum and purified IgG fractions among adults (p = 0.016), although this result was not observed among young and older children. Thus, it appears that some adults had non-IgG immunoglobulins to PT. Our analyses also revealed that adults had high-avidity anti-PT IgG ( avidity index: 63.5%, similar results were observed among the children); however, the adults had lower-avidity anti-FHA IgG (37.9%, p < 0.05). It is possible that low-avidity antiFHA IgG is related to infection with other respiratory pathogens (e.g., Bordetella parapertussis, Haemophilus influenzae, or Mycoplasma pneumoniae), which produces antibodies to FHA-like proteins. Our observations suggest that these adults had been infected with B. pertussis and other pathogen(s) during their adulthood.	[Moriuchi, Takumi; Otsuka, Nao; Hiramatsu, Yukihiro; Shibayama, Keigo; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Moriuchi, Takumi] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Hiramatsu, Yukihiro] Osaka Univ, Res Inst Microbial Dis, Dept Mol Bacteriol, Osaka, Japan	National Institute of Infectious Diseases (NIID); Saint Marianna University; Osaka University	Kamachi, K (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kamachi@nih.go.jp		Hiramatsu, Yukihiro/0000-0002-6340-864X; Kamachi, Kazunari/0000-0001-5259-1744	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED [14525508, 15545359]	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED (No. 14525508 and 15545359, KK, http://www.amed.go.jp/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2013, J IMMUNOL METHODS, V387, P36, DOI 10.1016/j.jim.2012.09.008; Amirthalingam G, 2013, ARCH DIS CHILD, V98, P552, DOI 10.1136/archdischild-2012-302968; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Barkoff AM, 2012, VACCINE, V30, P6897, DOI 10.1016/j.vaccine.2012.09.003; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dalby T, 2010, APMIS, V118, P968, DOI 10.1111/j.1600-0463.2010.02664.x; Dalby T, 2009, DIAGN MICR INFEC DIS, V63, P354, DOI 10.1016/j.diagmicrobio.2008.12.004; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Dominguez A, 2001, EPIDEMIOL INFECT, V126, P205, DOI 10.1017/S0950268801005325; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; HALLANDER HO, 1991, J INFECT DIS, V163, P1046, DOI 10.1093/infdis/163.5.1046; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Jogi P, 2014, VACCINE, V32, P5311, DOI 10.1016/j.vaccine.2014.07.066; Kamachi K., 2015, New Microbes and New Infections, V8, P70, DOI 10.1016/j.nmni.2015.10.001; Konda T, 2002, VACCINE, V20, P1711, DOI 10.1016/S0264-410X(02)00045-2; Lee SY, 2014, J KOREAN MED SCI, V29, P652, DOI 10.3346/jkms.2014.29.5.652; Li XM, 2015, HUM VACC IMMUNOTHER, V11, P2434, DOI 10.1080/21645515.2015.1062954; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Otsuka N, 2016, MICROBIOL IMMUNOL, V60, P326, DOI 10.1111/1348-0421.12378; Palazzo R, 2016, J MED MICROBIOL, V65, P649, DOI 10.1099/jmm.0.000264; Prelog M, 2013, VACCINE, V31, P387, DOI 10.1016/j.vaccine.2012.10.105; Sakakibara Y, 2016, INTERNAL MED, V55, P3257, DOI 10.2169/internalmedicine.55.6973; SATO H, 1987, INFECT IMMUN, V55, P909, DOI 10.1128/IAI.55.4.909-915.1987; SATO Y, 1991, DEV BIOLOGICALS, V73, P167; Scott S, 2015, PEDIATR INFECT DIS J, V34, P333, DOI 10.1097/INF.0000000000000576; Sheridan SL, 2014, EXPERT REV VACCINES, V13, P1081, DOI 10.1586/14760584.2014.944167; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; TROLLFORS B, 1988, J INFECT DIS, V158, P991, DOI 10.1093/infdis/158.5.991; Van der Wielen M, 2003, VACCINE, V21, P2412, DOI 10.1016/S0264-410X(03)00062-8; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181181	10.1371/journal.pone.0181181	http://dx.doi.org/10.1371/journal.pone.0181181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700751	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800129
J	Rong, YH; Van Slyke, G; Vance, DJ; Westfall, J; Ehrbar, D; Mantis, NJ				Rong, Yinghui; Van Slyke, Greta; Vance, David J.; Westfall, Jennifer; Ehrbar, Dylan; Mantis, Nicholas J.			Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin's binding subunit	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PROTECTIVE IMMUNITY; GALACTOSE; IDENTIFICATION; SURFACE; MICE	Ricin toxin's binding subunit (RTB) is a galactose-/N-acetylgalactosamine (Gal/GalNac)specific lectin that mediates uptake and intracellular trafficking of ricin within mammalian cells. Structurally, RTB consists of two globular domains, each divided into three homologous sub-domains (alpha, beta, gamma). In this report, we describe five new murine IgG monoclonal antibodies (mAbs) against RTB: MH3, 8A1, 8B3, LF1, and LC5. The mAbs have similar binding affinities (K-D) for ricin holotoxin, but displayed a wide range of in vitro toxin-neutralizing activities. Competition ELISAs indicate that the two most potent toxin-neutralizing mAbs (MH3, 8A1), as well as one of the moderate toxin-neutralizing mAbs (LF1), recognize distinct epitopes near the low affinity Gal recognition domain in RTB subdomain 1 alpha. Evaluated in a mouse model of systemic ricin challenge, all five mAbs afforded some benefit against intoxication, but only MH3 was protective. However, neither MH3 nor 24B11, another well-characterized mAb against RTB subdomain 1a, could passively protect mice against a mucosal (intranasal) ricin challenge. This is in contrast to SylH3, a previously characterized mAb directed against an epitope near RTB's high affinity Gal/GalNac recognition element in subdomain 2 gamma, which protected animals against systemic and mucosal ricin exposure. SylH3 was significantly more effective than MH3 and 24B11 at blocking ricin attachment to host cell receptors, suggesting that mucosal immunity to ricin is best imparted by antibodies that target RTB's high affinity Gal/GalNac recognition element in subdomain 2 gamma, not the low affinity Gal recognition domain in subdomain 1 alpha.	[Rong, Yinghui; Van Slyke, Greta; Vance, David J.; Westfall, Jennifer; Ehrbar, Dylan; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12237 USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12237 USA.; Mantis, NJ (corresponding author), SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12222 USA.	nicholas.mantis@health.ny.gov	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Van Slyke, Greta/0000-0003-2646-3030; Ehrbar, Dylan/0000-0001-7872-3338; Mantis, Nicholas/0000-0002-5083-8640; Doering, Jennifer/0000-0001-8749-774X	National Institutes of Allergy and Infectious Diseases [HHSN272201400021C]; National Institutes of Health	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this work was supported by Contract No. HHSN272201400021C from the National Institutes of Allergy and Infectious Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2016, VIRULENCE, P1; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Brey RN, 2016, HUM VACC IMMUNOTHER, V12, P1196, DOI 10.1080/21645515.2015.1124202; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Hayden EC., 2013, NATURE NEWS; Mantis N.J., 2013, CURR PROTOC TOXICOL; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Hara JM, 2014, IMMUNOL LETT, V158, P7, DOI 10.1016/j.imlet.2013.11.009; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Pincus SH, 2015, TOXINS, V7, P2121, DOI 10.3390/toxins7062121; Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; R Core Team, 2014, A LANGUAGE AND ENVIR; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Therneau T. M., 2015, A PACKAGE FOR SURVIV; Therneau T.M., 2000, MODELING SURVIVAL DA; Van Slyke G, 2016, CLIN VACCINE IMMUNOL, V23, P795, DOI 10.1128/CVI.00088-16; WALES R, 1991, J BIOL CHEM, V266, P19172; Yermakova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22721; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180999	10.1371/journal.pone.0180999	http://dx.doi.org/10.1371/journal.pone.0180999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700745	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800112
J	Kitamura, H; Onodera, Y; Murakami, S; Suzuki, T; Motohashi, H				Kitamura, H.; Onodera, Y.; Murakami, S.; Suzuki, T.; Motohashi, H.			IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model	ONCOGENE			English	Article							INTERLEUKIN-11; RESISTANCE; EXPRESSION; CELLS; MICROENVIRONMENT; RECOGNITION; SENSITIVITY; P62/SQSTM1; PROGNOSIS; CARCINOMA	The interaction between cancer cells and their microenvironment is an important determinant of the pathological nature of cancers, particularly their tumorigenic abilities. The KEAP1-NRF2 system, originally identified as a critical defense mechanism against oxidative stress, is often dysregulated in various human cancers forming solid tumors, resulting in the aberrant activation of NRF2. Increased accumulation of NRF2 in cancers is strongly associated with the poor prognoses of cancer patients, including those with lung and breast cancers. Multiple lines of evidence suggest that aberrantly activated NRF2 in cancer cells drives their malignant progression and that the cancer cells consequently develop 'NRF2 addiction.' Although the downstream effectors of NRF2 that are responsible for cancer malignancy have been extensively studied, mechanisms of how NRF2 activation contributes to the aggressive tumorigenesis remains to be elucidated. In this study, we found a significant correlation between NRF2 and IL-11 status in breast cancer patients. Based on a recent report demonstrating that IL-11 is induced downstream of NRF2, we examined the significance of IL-11 in NRF2-driven tumorigenesis with a newly established NRF2 addiction cancer model. Expression of Il11 was elevated during the tumorigenesis of the NRF2 addiction cancer model, but intriguingly, it was hardly detected when the cancer model cells were cultured in vitro. These results imply that a signal originating from the microenvironment cooperates with NRF2 to activate Il11. To the best of our knowledge, this is the first report showing the influence of the microenvironment on the NRF2 pathway in cancer cells and the contribution of NRF2 to the secretory phenotypes of cancers. Disruption of Il11 in the NRF2 addiction cancer model remarkably inhibited the tumorigenesis, suggesting an essential role of IL-11 in NRF2-driven tumorigenesis. Thus, this study suggests that IL-11 is a potential therapeutic target for NRF2-addicted breast cancers.	[Kitamura, H.; Murakami, S.; Motohashi, H.] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi, Japan; [Onodera, Y.] Tohoku Univ, Grad Sch Med, Dept Anat Pathol, Sendai, Miyagi, Japan; [Suzuki, T.] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Kitamura, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi, Japan.; Kitamura, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	hozumim@med.tohoku.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Murakami, Shohei/GPW-9730-2022	Murakami, Shohei/0000-0002-2555-1568	JSPS KAKENHI [JP26860180, 15H04692, 16K15228]; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Mitsubishi Foundation; Naito Foundation; Princess Takamatsu Cancer Research Fund [15-24728]; Grants-in-Aid for Scientific Research [15H04692] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Naito Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Keiko Nakayama for providing a mutant HRAS-expression vector, pMX-puro- HRASG12V, Drs. Norio Suzuki and Masayuki Yamamoto for providing SV40 T antigen expressing vectors, HA-KEAP1 cDNA and intensive discussion, and Drs Tomohiro Nakamura and Atsushi Hozawa for checking the quality of quantitative data and the adequacy of their presentation. We also thank Ms Nao Ohta for technical assistance and the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support. This work was supported by JSPS KAKENHI Grant Numbers JP26860180 (HK), 15H04692 (HM) and 16K15228 (HM), Daiichi Sankyo Foundation of Life Science (HM), the Uehara Memorial Foundation (HM), the Mitsubishi Foundation (HM), the Naito Foundation (HM), and the Princess Takamatsu Cancer Research Fund 15-24728 (HM). The funders had no role in the design of the study, data collection and analysis, decision to publish or preparation of the manuscript.	Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ernst M, 2014, CLIN CANCER RES, V20, P5579, DOI 10.1158/1078-0432.CCR-13-2492; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goto M, 2015, GENES CELLS, V20, P464, DOI 10.1111/gtc.12237; Grivennikov SI, 2013, CANCER CELL, V24, P145, DOI 10.1016/j.ccr.2013.07.018; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanavadi S, 2006, ANN SURG ONCOL, V13, P802, DOI 10.1245/ASO.2006.05.028; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Johnstone CN, 2015, CYTOKINE GROWTH F R, V26, P489, DOI 10.1016/j.cytogfr.2015.07.015; Kanamori M, 2015, NEURO-ONCOLOGY, V17, P555, DOI 10.1093/neuonc/nou282; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Nakayama T, 2007, INT J ONCOL, V30, P825; Nishina T, 2017, J BIOL CHEM, V292, P205, DOI 10.1074/jbc.M116.744755; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; Ohkoshi A, 2013, CANCER PREV RES, V6, P149, DOI 10.1158/1940-6207.CAPR-12-0401-T; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Onodera Y, 2014, ENDOCR-RELAT CANCER, V21, P241, DOI 10.1530/ERC-13-0234; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030; Satoh H, 2016, CANCER RES, V76, P3088, DOI 10.1158/0008-5472.CAN-15-1584; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shin SY, 2012, CARCINOGENESIS, V33, P2467, DOI 10.1093/carcin/bgs297; Shirasaki K, 2014, HEPATOLOGY, V59, P2371, DOI 10.1002/hep.27020; Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Tsuchida K, 2017, FREE RADICAL BIO MED, V103, P236, DOI 10.1016/j.freeradbiomed.2016.12.041; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	52	34	35	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6315	6324		10.1038/onc.2017.236	http://dx.doi.org/10.1038/onc.2017.236			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28714957				2022-12-26	WOS:000414774800010
J	Castro-Fernandez, V; Herrera-Morande, A; Zamora, R; Merino, F; Gonzalez-Ordenes, F; Padilla-Salinas, F; Pereira, HM; Brandao-Neto, J; Garratt, RC; Guixe, V				Castro-Fernandez, Victor; Herrera-Morande, Alejandra; Zamora, Ricardo; Merino, Felipe; Gonzalez-Ordenes, Felipe; Padilla-Salinas, Felipe; Pereira, Humberto M.; Brandao-Neto, Jose; Garratt, Richard C.; Guixe, Victoria			Reconstructed ancestral enzymes reveal that negative selection drove the evolution of substrate specificity in ADP-dependent kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; PYROCOCCUS-FURIOSUS; DISCRETE CHARACTERS; BIFUNCTIONAL ENZYME; BAYESIAN-ESTIMATION; GLUCOKINASE; SEQUENCE; GLUCOKINASE/PHOSPHOFRUCTOKINASE; GLYCOLYSIS; MUTATIONS	One central goal in molecular evolution is to pinpoint the mechanisms and evolutionary forces that cause an enzyme to change its substrate specificity; however, these processes remain largely unexplored. Using the glycolytic ADP-dependent kinases of archaea, including the orders Thermococcales, Methanosarcinales, and Methanococcales, as a model and employing an approach involving paleoenzymology, evolutionary statistics, and protein structural analysis, we could track changes in substrate specificity during ADP-dependent kinase evolution along with the structural determinants of these changes. To do so, we studied five key resurrected ancestral enzymes as well as their extant counterparts. We found that a major shift in function from a bifunctional ancestor that could phosphorylate either glucose or fructose 6-phosphate (fructose6-P) as a substrate to a fructose 6-P-specific enzyme was started by a single amino acid substitution resulting in negative selection with a ground-state mode against glucose and a subsequent 1,600-fold change in specificity of the ancestral protein. This change rendered the residual phosphorylation of glucose a promiscuous and physiologically irrelevant activity, highlighting how promiscuity may be an evolutionary vestige of ancestral enzyme activities, which have been eliminated over time. We also could reconstruct the evolutionary history of substrate utilization by using an evolutionary model of discrete binary characters, indicating that substrate uses can be discretely lost or acquired during enzyme evolution. These findings exemplify how negative selection and subtle enzyme changes can lead to major evolutionary shifts in function, which can subsequently generate important adaptive advantages, for example, in improving glycolytic efficiency in Thermococcales.	[Castro-Fernandez, Victor; Herrera-Morande, Alejandra; Zamora, Ricardo; Merino, Felipe; Gonzalez-Ordenes, Felipe; Padilla-Salinas, Felipe; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago 800003, Chile; [Pereira, Humberto M.; Garratt, Richard C.] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13563120 Sao Paulo, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DF, Oxon, England; [Merino, Felipe] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	Universidad de Chile; Universidade de Sao Paulo; Diamond Light Source; Max Planck Society	Guixe, V (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago 800003, Chile.	vguixe@uchile.cl	Merino, Felipe/D-2740-2013; Zamora, Ricardo A/O-8717-2018; Castro-Fernandez, Victor/K-9621-2018; garratt, richard c/F-6921-2011	Merino, Felipe/0000-0003-4166-8747; Zamora, Ricardo A/0000-0002-7707-7482; Castro-Fernandez, Victor/0000-0002-4309-6415; Brandao-Neto, Jose/0000-0001-6015-320X; Herrera-Morande, Alejandra/0000-0002-4140-0743; garratt, richard/0000-0002-2016-3179	Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile [FONDECYT 1150460, 3160332]	Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile	This work was supported in part by Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile Grants FONDECYT 1150460 (to V. G.) and FONDECYT Postdoctorado 3160332 (to V. C-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allewell NM, 2012, J BIOL CHEM, V287, P1, DOI 10.1074/jbc.R111.307322; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bar-Rogovsky H, 2015, PROTEIN ENG DES SEL, V28, P507, DOI 10.1093/protein/gzv038; Battistuzzi FU, 2009, TIMETREE LIFE, P101; Benner Steven A., 2007, V75, P1; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Castro-Fernandez V, 2014, FEBS J, V281, P2017, DOI 10.1111/febs.12757; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Santiago-Martinez MG, 2016, FEBS J, V283, P1979, DOI 10.1111/febs.13717; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Heilbron K, 2014, GENETICS, V197, P981, DOI 10.1534/genetics.114.163147; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanehisa M., 2016, KYOTO ENCY GENES GEN; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newton MS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0036; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petitjean C, 2015, MOL BIOL EVOL, V32, P1242, DOI 10.1093/molbev/msv015; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tawfik DS, 2014, CURR OPIN CHEM BIOL, V21, P73, DOI 10.1016/j.cbpa.2014.05.008; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	62	8	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15598	15610		10.1074/jbc.M117.790865	http://dx.doi.org/10.1074/jbc.M117.790865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28726643	Green Published, hybrid			2022-12-26	WOS:000411512200002
J	Parajuli, S; Teasley, DC; Murali, B; Jackso, J; Vindigni, A; Stewart, SA				Parajuli, Shankar; Teasley, Daniel C.; Murali, Bhavna; Jackso, Jessica; Vindigni, Alessandro; Stewart, Sheila A.			Human ribonuclease H1 resolves R-loops and thereby enables progression of the DNA replication fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL PAUSE SITES; GENOME INSTABILITY; RNASE H1; CELLS; HYBRIDS; MITOCHONDRIAL; TELOMERES; STRAND; REPAIR; CHROMOSOMES	Faithful DNA replication is essential for genome stability. To ensure accurate replication, numerous complex and redundant replication and repair mechanisms function in tandem with the core replication proteins to ensure DNA replication continues even when replication challenges are present that could impede progression of the replication fork. A unique topological challenge to the replication machinery is posed by RNA-DNA hybrids, commonly referred to as R-loops. Although R-loops play important roles in gene expression and recombination at immunoglobulin sites, their persistence is thought to interfere with DNA replication by slowing or impeding replication fork progression. Therefore, it is of interest to identify DNA-associated enzymes that help resolve replication-impeding R-loops. Here, using DNA fiber analysis, we demonstrate that human ribonuclease H1 (RNH1) plays an important role in replication fork movement in the mammalian nucleus by resolving R-loops. We found that RNH1 depletion results in accumulation of RNA-DNA hybrids, slowing of replication forks, and increased DNA damage. Our data uncovered a role for RNH1 in global DNA replication in the mammalian nucleus. Because accumulation of RNA-DNA hybrids is linked to various human cancers and neurodegenerative disorders, our study raises the possibility that replication fork progression might be impeded, adding to increased genomic instability and contributing to disease.	[Parajuli, Shankar; Teasley, Daniel C.; Murali, Bhavna; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Vindigni, Alessandro; Stewart, Sheila A.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63110 USA; [Jackso, Jessica; Vindigni, Alessandro] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Vindigni, A; Stewart, SA (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63110 USA.; Vindigni, A (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	avindign@slu.edu; sheila.stewart@wustl.edu	Murali, Bhavna/ABA-4295-2021	Stewart, Sheila/0000-0002-2260-9576; Murali, Bhavna/0000-0003-3546-1416	Predoctoral Cancer Biology Pathway grant; Siteman Cancer Center/Barnes Jewish Hospital; National Institutes of Health Molecular Oncology Training Grant [T32CA113275]; National Institutes of Health [R01GM108648]; United States Department of Defense Breast Cancer Research Program Breakthrough Award [BC151728]; National Institutes of Health Grant [CA130919]; American Cancer Society research scholar award; NATIONAL CANCER INSTITUTE [T32CA113275, R01CA130919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108648] Funding Source: NIH RePORTER	Predoctoral Cancer Biology Pathway grant; Siteman Cancer Center/Barnes Jewish Hospital; National Institutes of Health Molecular Oncology Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense Breast Cancer Research Program Breakthrough Award(United States Department of Defense); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society research scholar award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Predoctoral Cancer Biology Pathway grant, Siteman Cancer Center/Barnes Jewish Hospital (to S.P.); National Institutes of Health Molecular Oncology Training Grant T32CA113275 (to B.M.); National Institutes of Health Grant R01GM108648 (to A.V.); United States Department of Defense Breast Cancer Research Program Breakthrough Award BC151728 (to A. V.); National Institutes of Health Grant CA130919 (to S. A. S.); and an American Cancer Society research scholar award (to S. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7720; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; O'Driscoll M., 2017, PATHOLOGICAL CONSEQU; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Richard P, 2017, J MOL BIOL, V429, P3168, DOI 10.1016/j.jmb.2016.08.031; Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008; Sagie S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14015; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH7; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Takikawa M, 2017, NUCLEIC ACIDS RES, V45, P1255, DOI 10.1093/nar/gkw1176; Teasley DC, 2015, J BIOL CHEM, V290, P15133, DOI 10.1074/jbc.M115.647388; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	45	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15216	15224		10.1074/jbc.M117.787473	http://dx.doi.org/10.1074/jbc.M117.787473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717002	hybrid, Green Published			2022-12-26	WOS:000410809800005
J	Cabrera-Becerrill, A; Vargas-De-Leon, C; Hernandez, S; Miramontes, P; Peralta, R				Cabrera-Becerrill, Augusto; Vargas-De-Leon, Cruz; Hernandez, Sergio; Miramontes, Pedro; Peralta, Raul			Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; MUTATION; PREVALENCE; NEOPLASIA; EVOLUTION; SELECTION; DISEASE; GROWTH; DRIVER; GENES	Computational modeling has been applied to simulate the heterogeneity of cancer behavior. The development of Cervical Cancer (CC) is a process in which the cell acquires dynamic behavior from non-deleterious and deleterious mutations, exhibiting chromosomal alterations as a manifestation of this dynamic. To further determine the progression of chromosomal alterations in precursor lesions and CC, we introduce a computational model to study the dynamics of deleterious and non-deleterious mutations as an outcome of tumor progression. The analysis of chromosomal alterations mediated by our model reveals that multiple deleterious mutations are more frequent in precursor lesions than in CC. Cells with lethal deleterious mutations would be eliminated, which would mitigate cancer progression; on the other hand, cells with non-deleterious mutations would become dominant, which could pre-dispose them to cancer progression. The study of somatic alterations through computer simulations of cancer progression provides a feasible pathway for insights into the transformation of cell mechanisms in humans. During cancer progression, tumors may acquire new phenotype traits, such as the ability to invade and metastasize or to become clinically important when they develop drug resistance. Non-deleterious chromosomal alterations contribute to this progression.	[Cabrera-Becerrill, Augusto; Miramontes, Pedro] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Matemat, Mexico City, DF, Mexico; [Vargas-De-Leon, Cruz] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico; [Hernandez, Sergio] Univ Autonoma Ciudad Mexico, Programa Dinam Nolineal, Mexico City, DF, Mexico; [Peralta, Raul] Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos	Peralta, R (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico.	raul.peralta@uaem.mx	Vargas-De-León, Cruz/F-8982-2012	Vargas-De-León, Cruz/0000-0001-9428-3619; Peralta, Raul/0000-0002-6900-4101	PRODEP-SEP, Mexico; PRODEP-SEP [6986]	PRODEP-SEP, Mexico; PRODEP-SEP	This work was partially supported by PRODEP-SEP, Mexico and our wages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RP wishes to thank PRODEP-SEP 6986 for the support. The authors also wish to thank Dr. Mauricio Salcedo for his constructive comments and suggestions.	Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Alloza E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-37; Araujo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072206; Bauer B, 2014, J THEOR BIOL, V358, P52, DOI 10.1016/j.jtbi.2014.05.018; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brown BN, 2011, MATH BIOSCI, V231, P186, DOI 10.1016/j.mbs.2011.03.005; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Caraway NP, 2008, GYNECOL ONCOL, V110, P37, DOI 10.1016/j.ygyno.2008.01.040; Chapa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064091; Chiacchio F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907171; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Ospina MEE, 2013, ARTIF INTELL MED, V57, P31, DOI 10.1016/j.artmed.2012.11.001; Gandolfi G, 2016, PIGM CELL MELANOMA R, V29, P163, DOI 10.1111/pcmr.12436; Giaretta A, 2015, IEEE ENG MED BIO, P6493, DOI 10.1109/EMBC.2015.7319880; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Jalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135183; Kang H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00264; Koutsogiannouli E, 2013, CANCER MED-US, V2, P164, DOI 10.1002/cam4.62; Laczmanska I, 2017, CANCER GENOM PROTEOM, V14, P69, DOI 10.21873/cgp.20019; Ma LN, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-17; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Palaniappan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156665; Pepper John W., AGENT BASED MODELS C; Peralta-Rodriguez R, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-34; Poleszczuk J, 2014, CELL PROLIFERAT, V47, P267, DOI 10.1111/cpr.12101; Policht FA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-432; Pon JR, 2015, ANNU REV PATHOL-MECH, V10, P25, DOI 10.1146/annurev-pathol-012414-040312; Rambaldi D, 2008, TRENDS GENET, V24, P427, DOI 10.1016/j.tig.2008.06.003; Rositch AF, 2014, GYNECOL ONCOL, V132, P767, DOI 10.1016/j.ygyno.2013.12.040; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; Thomas LK, 2014, EUR J CANCER, V50, P85, DOI 10.1016/j.ejca.2013.08.022; Ulam S., 1974, ANN REV BIOL, P255; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wang N, 2014, ONCOL LETT, V7, P1279, DOI 10.3892/ol.2014.1814; Wang ZH, 2015, SEMIN CANCER BIOL, V30, P70, DOI [10.1016/j.semcancer.2014.04.001, 10.1007/978-3-662-43514-4]; Zhang L, 2009, J MATH BIOL, V58, P545, DOI 10.1007/s00285-008-0211-1; Zhang YX, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/3186051	41	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180882	10.1371/journal.pone.0180882	http://dx.doi.org/10.1371/journal.pone.0180882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723940	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800031
J	Hormes, JM; Niemiec, MA				Hormes, Julia M.; Niemiec, Martha A.			Does culture create craving? Evidence from the case of menstrual chocolate craving	PLOS ONE			English	Article							RELAPSE; ASSOCIATION; ANTECEDENTS; VALIDATION; ADDICTION; WOMEN; CYCLE	Craving is considered a key characteristic of diverse pathologies, but evidence suggests it may be a culture-bound construct. Almost 50% of American women crave chocolate specifically around the onset of menstruation. Research does not support popular accounts implicating physiological factors in menstrual chocolate craving etiology. We tested the novel hypothesis that greater menstrual craving prevalence in the U.S. is the product of internalized cultural norms. Women of diverse backgrounds (n = 275) reported on craving frequency and triggers and completed validated measures of acculturation. Foreign-born women were significantly less likely to endorse menstrual chocolate craving (17.3%), compared to women born to U.S.-born parents (32.7%, p = .03) and second generation immigrants (40.9%, p = .001). Second generation immigrant and foreign-born women endorsing menstrual chocolate craving reported significantly greater U.S. acculturation and lower identification with their native culture than non-menstrual cravers (all p < .001). Findings inform our understanding of food cravings, with important implications for the study of cravings in other domains.	[Hormes, Julia M.; Niemiec, Martha A.] SUNY Albany, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hormes, JM (corresponding author), SUNY Albany, Albany, NY 12222 USA.	jhormes@albany.edu		Hormes, Julia/0000-0002-5693-2945				American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Berlin FS, 2014, J AM ACAD PSYCHIATRY, V42, P404; Bottlender M, 2004, ALCOHOL ALCOHOLISM, V39, P357, DOI 10.1093/alcalc/agh073; Carpenter MJ, 2006, NICOTINE TOB RES, V8, P627, DOI 10.1080/14622200600910793; Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002; Epstein E. E., 2006, J SUBST USE, V11, P323, DOI DOI 10.1080/14659890500419717; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franklin TR, 2004, NICOTINE TOB RES, V6, P171, DOI 10.1080/14622200310001656984; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Greeno CG, 2000, J CONSULT CLIN PSYCH, V68, P95, DOI 10.1037/0022-006X.68.1.95; Hormes JM, 2014, HUM HEALT HANDB, P137, DOI 10.3920/978-90-8686-767-7_9; Hormes JM, 2014, ADDICTION, V109, P2079, DOI 10.1111/add.12713; Hormes JM, 2011, APPETITE, V57, P1, DOI 10.1016/j.appet.2011.03.008; Hormes JM, 2010, ADDICT BEHAV, V35, P459, DOI 10.1016/j.addbeh.2009.12.031; Hormes JM, 2009, APPETITE, V53, P256, DOI 10.1016/j.appet.2009.07.003; JOHNSON TM, 1987, CULT MED PSYCHIAT, V11, P337, DOI 10.1007/BF00048518; Lane SP, 2016, CLIN PSYCHOL SCI, V4, P775, DOI 10.1177/2167702615616132; Luhrmann TM, 2007, CULT MED PSYCHIAT, V31, P135, DOI 10.1007/s11013-007-9049-z; Meule A., 2014, CURR ADDICT REP, V1, P193, DOI [10.1007/s40429-014-0021-z, DOI 10.1007/S40429-014-0021-Z]; Orloff NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01076; Osman JL, 2006, APPETITE, V47, P290, DOI 10.1016/j.appet.2006.04.008; Parker S, 2003, APPETITE, V40, P193, DOI 10.1016/S0195-6663(02)00160-5; Pilver CE, 2011, J AFFECT DISORDERS, V130, P334, DOI 10.1016/j.jad.2010.10.013; Potenza MN, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00164; RODIN J, 1991, APPETITE, V17, P177, DOI 10.1016/0195-6663(91)90020-S; RODIN M, 1992, SOC SCI MED, V35, P49, DOI 10.1016/0277-9536(92)90118-A; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; Serre F, 2015, DRUG ALCOHOL DEPEN, V148, P1, DOI 10.1016/j.drugalcdep.2014.12.024; Sinha R, 2007, DRUG ALCOHOL REV, V26, P25, DOI 10.1080/09595230601036960; Stephenson M, 2000, PSYCHOL ASSESSMENT, V12, P77, DOI 10.1037/1040-3590.12.1.77; Tavares H, 2005, ALCOHOL CLIN EXP RES, V29, P1427, DOI 10.1097/01.alc.0000175071.22872.98; Trotzke P, 2014, PSYCHOSOM MED, V76, P694, DOI 10.1097/PSY.0000000000000126; Waters A, 2001, INT J EAT DISORDER, V29, P17, DOI 10.1002/1098-108X(200101)29:1<17::AID-EAT3>3.0.CO;2-R; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17; Witkiewitz K, 2010, J CONSULT CLIN PSYCH, V78, P362, DOI 10.1037/a0019172; Zea Maria Cecilia, 2003, Cultur Divers Ethnic Minor Psychol, V9, P107, DOI 10.1037/1099-9809.9.2.107; Zellner DA, 1999, APPETITE, V33, P61, DOI 10.1006/appe.1999.0234	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181445	10.1371/journal.pone.0181445	http://dx.doi.org/10.1371/journal.pone.0181445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723930	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800049
J	Huang, ZZ; Yu, L; Huang, P; Liang, LJ; Guo, Q				Huang, Zhong-Zhou; Yu, Liang; Huang, Ping; Liang, Li-Jun; Guo, Qing			Charged amino acid variability related to N-glyco - sylation and epitopes in A/H3N2 influenza: Hem - agglutinin and neuraminidase	PLOS ONE			English	Article							RECEPTOR-BINDING; GLOBULAR HEAD; VIRUS; HEMAGGLUTININ; EVOLUTION; SUBSTITUTIONS; VACCINE; GENES; CHINA	Background The A/H3N2 influenza viruses circulated in humans have been shown to undergo antigenic drift, a process in which amino acid mutations result from nucleotide substitutions. There are few reports regarding the charged amino acid mutations. The purpose of this paper is to explore the relations between charged amino acids, N-glycosylation and epitopes in hemagglutinin (HA) and neuraminidase (NA). Methods A total of 700 HA genes (691 NA genes) of A/H3N2 viruses were chronologically analyzed for the mutational variants in amino acid features, N-glycosylation sites and epitopes since its emergence in 1968. Results It was found that both the number of HA N-glycosylation sites and the electric charge of HA increased gradually up to 2016. The charges of HA and HA1 increased respectively 1.54fold (+7.0 /+17.8) and 1.08-fold (+8.0/+16.6) and the number of NGS in nearly doubled (7/12). As great diversities occurred in 1990s, involving Epitope A, B and D mutations, the charged amino acids in Epitopes A, B, C and D in HA(1) mutated at a high frequency in global circulating strains last decade. The charged amino acid mutations in Epitopes A (T135K) has shown high mutability in strains near years, resulting in a decrease of NGT(135-135). Both K158N and K160T not only involved mutations charged in epitope B, but also caused a gain of NYT158-160. Epitope B and its adjacent N-glycosylation site NYT158-160 mutated more frequently, which might be under greater immune pressure than the rest. Conclusions The charged amino acid mutations in A/H3N2 Influenza play a significant role in virus evolution, which might cause an important public health issue. Variability related to both the epitopes (A and B) and N-glycosylation is beneficial for understanding the evolutionary mechanisms, disease pathogenesis and vaccine research.	[Huang, Zhong-Zhou; Guo, Qing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Huang, Zhong-Zhou; Yu, Liang; Huang, Ping; Liang, Li-Jun] Guangdong Prov Ctr Dis Control & Prevent, Key Lab Emergency Pathogen Detect, Guangzhou, Guangdong, Peoples R China; [Yu, Liang; Huang, Ping] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University	Guo, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China.; Huang, P (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Key Lab Emergency Pathogen Detect, Guangzhou, Guangdong, Peoples R China.; Huang, P (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	pphuang1@163.com; guoqingzsy@163.com		HUang, Ping/0000-0002-6333-8338	Natural Science Foundation of Guangdong Province [2016A030313775]; Guangzhou Science and Technology Program planning projects [2014J4100084]; National Natural Science Foundation of China [30972757]; National Transfer Payments Funding for the 2015 Influenza Survey	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology Program planning projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transfer Payments Funding for the 2015 Influenza Survey	The Natural Science Foundation of Guangdong Province (2016A030313775), URL:http://www.gdstc.gov.cn/; The Guangzhou Science and Technology Program planning projects (2014J4100084), URL:http://www.gzsi.gov.cn/; The National Natural Science Foundation of China (30972757), URL:http://www.nsfc.gov.cn/; The National Transfer Payments Funding for the 2015 Influenza Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RS, 2015, PROTEIN SCI, V24, P1820, DOI 10.1002/pro.2775; Alymova IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep36216; Arinaminpathy N, 2010, DYNAMICS GLYCOPROTEI, V5; Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Beuttemmuller EA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0503-9; Broberg E, 2015, EURO SURVEILL, V20; Cai JH, 2014, J MED VIROL, V86, P1026, DOI 10.1002/jmv.23854; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Cui HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27360; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; Davlin SL, 2016, MMWR-MORBID MORTAL W, V65, P567, DOI 10.15585/mmwr.mm6522a3; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Huang P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-47; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kim DS, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0468-5; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kratsch C, 2016, VIRUS EVOLUTION, V2, pv25; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Li Y, 2013, J VIROL, V87, P9904, DOI 10.1128/JVI.01023-13; Pentiah K, 2015, GLYCOBIOLOGY, V25, P124, DOI 10.1093/glycob/cwu097; Schicker RS, 2016, MMWR-MORBID MORTAL W, V65, P1157, DOI 10.15585/mmwr.mm6542a1; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Sugaya N, 2016, EURO SURVEILL, V21; Wang X, 2016, J VIROL, P1512; Wu CL, 2016, J INFECTION, V72, P369, DOI 10.1016/j.jinf.2015.12.013; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	30	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0178231	10.1371/journal.pone.0178231	http://dx.doi.org/10.1371/journal.pone.0178231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708860	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649800001
J	Klockmann, M; Kleinschmidt, F; Fischer, K				Klockmann, Michael; Kleinschmidt, Friederike; Fischer, Klaus			Carried over: Heat stress in the egg stage reduces subsequent performance in a butterfly	PLOS ONE			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; THERMAL TOLERANCE; TRANSGENERATIONAL PLASTICITY; ULTRAVIOLET-RADIATION; REACTION NORMS; CLIMATE-CHANGE; TEMPERATURE; RESPONSES; DROSOPHILA	Increasing heat stress caused by anthropogenic climate change may pose a substantial challenge to biodiversity due to associated detrimental effects on survival and reproduction. Therefore, heat tolerance has recently received substantial attention, but its variation throughout ontogeny and effects carried over from one developmental stage to another remained largely neglected. To explore to what extent stress experienced early in life affects later life stages, we here investigate effects of heat stress experienced in the egg stage throughout ontogeny in the tropical butterfly Bicyclus anynana. We found that detrimental effects of heat stress in the egg stage were detectable in hatchlings, larvae and even resulting adults, as evidenced by decreased survival, growth, and body mass. This study shows that even in holometabalous insects with discrete life stages effects of stress experienced early in life are carried over to later stages, substantially reducing subsequent fitness. We argue that such effects need to be considered when trying to forecast species responses to climate change.	[Klockmann, Michael; Kleinschmidt, Friederike; Fischer, Klaus] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Klockmann, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	Michael.klockmann@uni-greifswald.de			German Research Council [DFG Fi 846/8-1, DFG GRK2010]	German Research Council(German Research Foundation (DFG))	We acknowledge financial support from the German Research Council (DFG Fi 846/8-1). MK is associated doctoral researcher of the research training group RESPONSE funded by the German Research Council (DFG GRK2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Brakefield Paul M., 1997, V83, P65; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dmitriew C, 2005, OECOLOGIA, V142, P150, DOI 10.1007/s00442-004-1712-2; Donelson JM, 2016, EVOL APPL, V9, P1072, DOI 10.1111/eva.12386; DYTHAM C., 2003, P R SOC LOND, V270, P147, DOI DOI 10.1098/RSBL.2003.0049; English S, 2016, ECOL ENTOMOL, V41, P618, DOI 10.1111/een.12333; Fischer J, 2014, GLOBAL CHANGE BIOL, V20, P2108, DOI 10.1111/gcb.12472; Fischer K, 2004, HEREDITY, V92, P163, DOI 10.1038/sj.hdy.6800382; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fischer K, 2002, OECOLOGIA, V131, P375, DOI 10.1007/s00442-002-0913-9; Fischer K, 2000, OIKOS, V90, P372, DOI 10.1034/j.1600-0706.2000.900218.x; Fischer K, 2014, J EXP BIOL, V217, P2892, DOI 10.1242/jeb.106245; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Fox CW, 1997, EVOLUTION, V51, P1005, DOI 10.1111/j.1558-5646.1997.tb03683.x; Franke K, 2014, J THERM BIOL, V41, P88, DOI 10.1016/j.jtherbio.2014.02.006; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Moresino RDH, 2011, J EXP MAR BIOL ECOL, V407, P363, DOI 10.1016/j.jembe.2011.07.019; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Hopwood PE, 2016, ECOL ENTOMOL, V41, P96, DOI 10.1111/een.12275; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Klockmann M, 2016, BIOL J LINN SOC; Klockmann M, 2017, GLOBAL CHANGE BIOL, V23, P686, DOI 10.1111/gcb.13407; Klose MK, 2004, INTEGR COMP BIOL, V44, P14, DOI 10.1093/icb/44.1.14; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Krebs RA, 1995, BIOL J LINN SOC, V56, P517, DOI 10.1111/j.1095-8312.1995.tb01108.x; Larsen T., 1999, BUTTERFLIES KENYA TH; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Levy O, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0837; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Marshall DJ, 2008, ECOLOGY, V89, P418, DOI 10.1890/07-0449.1; Marshall DJ, 2011, CURR BIOL, V21, pR718, DOI 10.1016/j.cub.2011.08.022; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Nielsen ME, 2015, OECOLOGIA, V177, P171, DOI 10.1007/s00442-014-3123-3; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Pahkala M, 2001, P ROY SOC B-BIOL SCI, V268, P1699, DOI 10.1098/rspb.2001.1725; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; Pincebourde S, 2015, ECOLOGY, V96, P986, DOI 10.1890/14-0744.1; Potter K, 2009, J EXP BIOL, V212, P3448, DOI 10.1242/jeb.033365; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; Radchuk V, 2013, J ANIM ECOL, V82, P275, DOI 10.1111/j.1365-2656.2012.02029.x; Rukke BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127555; Russell J, 2009, MAR BIOL, V156, P579, DOI 10.1007/s00227-008-1109-6; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; SIBLY RM, 1994, FUNCT ECOL, V8, P486, DOI 10.2307/2390073; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Vonesh JR, 2005, OECOLOGIA, V143, P280, DOI 10.1007/s00442-004-1806-x; Weinig C, 2001, EVOLUTION, V55, P930, DOI 10.1554/0014-3820(2001)055[0930:PPEILC]2.0.CO;2; Wijngaarden PJ, 2002, J EVOLUTION BIOL, V15, P290, DOI 10.1046/j.1420-9101.2002.00380.x; Zhang W, 2015, OECOLOGIA, V179, P947, DOI 10.1007/s00442-015-3409-0; Zhang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10436; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	75	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180968	10.1371/journal.pone.0180968	http://dx.doi.org/10.1371/journal.pone.0180968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708887	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800035
J	Moutier, W; Duforet-Gaurier, L; Thyssen, M; Loisel, H; Meriaux, X; Courcot, L; Dessailly, D; Reve, AH; Gregori, G; Alvain, S; Barani, A; Brutier, L; Dugenne, M				Moutier, William; Duforet-Gaurier, Lucile; Thyssen, Melilotus; Loisel, Hubert; Meriaux, Xavier; Courcot, Lucie; Dessailly, David; Reve, Anne-Helene; Gregori, Gerald; Alvain, Severine; Barani, Aude; Brutier, Laurent; Dugenne, Mathilde			Evolution of the scattering properties of phytoplankton cells from flow cytometry measurements	PLOS ONE			English	Article							LIGHT-SCATTERING; OPTICAL-PROPERTIES; REFRACTIVE-INDEX; DIEL VARIATIONS; INDIVIDUAL PARTICLES; MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; AQUATIC PARTICLES; BIOLOGICAL CELLS; SIZE	After the exponential growth phase, variability in the scattering efficiency of phytoplankton cells over their complete life cycle is not well characterised. Bulk measurements are impacted by senescent cells and detritrus. Thus the analysis of the evolution of the optical properties thanks to their morphological and/or intra-cellular variations remains poorly studied. Using the Cytosense flow cytometer (CytoBuoy b. v., NL), the temporal course of the forward and sideward efficiencies of two phytoplankton species (Thalassiosira pseudonana and Chlamydomonas concordia) were analyzed during a complete life-cycle. These two species differ considerably from a morphological point of view. Over the whole experiment, the forward and sideward efficiencies of Thalassiosira pseudonana were, on average, respectively 2.2 and 1.6 times higher than the efficiencies of Chlamydomonas concordia. Large intra-species variability of the efficiencies were observed over the life cycle of the considered species. It highlights the importance of considering the optical properties of phytoplankton cells as a function of the population growth stage of the considered species. Furthermore, flow cytometry measurements were combined with radiative transfer simulations and biogeochemical and optical measurements. Results showed that the real refractive index of the chloroplast is a key parameter driving the sideward signal and that a simplistic two-layered model (cytoplasm-chloroplast) seems particularly appropriate to represent the phytoplankton cells.	[Moutier, William; Duforet-Gaurier, Lucile; Loisel, Hubert; Meriaux, Xavier; Courcot, Lucie; Dessailly, David; Brutier, Laurent] Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR 8187, F-62930 Wimereux, France; [Thyssen, Melilotus; Gregori, Gerald; Barani, Aude; Dugenne, Mathilde] Aix Marseille Univ, Univ Toulon, CNRS, Mediterranean Inst Oceanog,IRD,MIO UM 110, F-13288 Marseille, France; [Reve, Anne-Helene] Univ Lille, UMR CNRS LOG 8187, F-62930 Wimereux, France; [Alvain, Severine] CNRS, UMR CNRS LOG 8187, F-62930 Wimereux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Moutier, W (corresponding author), Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR 8187, F-62930 Wimereux, France.	william.moutier@gmail.com	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; ALVAIN, Severine/0000-0001-6316-6284	CNES/TOSCA program	CNES/TOSCA program(Centre National D'etudes Spatiales)	This work was supported by CNES/TOSCA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 1996, J PLANKTON RES, V18, P2223, DOI 10.1093/plankt/18.12.2223; ACKLESON SG, 1990, NETH J SEA RES, V25, P11, DOI 10.1016/0077-7579(90)90004-Z; ACKLESON SG, 1988, APPL OPTICS, V27, P1270, DOI 10.1364/AO.27.001270; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bernard S, 2009, BIOGEOSCIENCES DISCU, V6, P1497, DOI DOI 10.5194/BGD-6-1497-2009; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; Bohren CF, 1998, WILEY SCI PAPER BACK; Boss E, 2009, OPT EXPRESS, V17, P9408, DOI 10.1364/OE.17.009408; BRATBAK G, 1994, MICROBIAL ECOL, V28, P209, DOI 10.1007/BF00166811; BRICAUD A, 1992, P SOC PHOTO-OPT INS, V1750, P27, DOI 10.1117/12.140669; CARDER KL, 1972, LIMNOL OCEANOGR, V17, P833, DOI 10.4319/lo.1972.17.6.0833; CUNNINGHAM A, 1992, J PLANKTON RES, V14, P223, DOI 10.1093/plankt/14.2.223; Dall'Olmo G, 2009, BIOGEOSCIENCES, V6, P947, DOI 10.5194/bg-6-947-2009; DUBELAAR GBJ, 1987, CYTOMETRY, V8, P405, DOI 10.1002/cyto.990080410; Dubelaar GBJ, 2000, SCI MAR, V64, P135, DOI 10.3989/scimar.2000.64n2135; Duforet-Gaurier L, 2015, OPT EXPRESS, V23, P31510, DOI 10.1364/OE.23.031510; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; GEIDER RJ, 1987, MAR BIOL, V96, P299, DOI 10.1007/BF00427030; Green RE, 2003, LIMNOL OCEANOGR, V48, P2377, DOI 10.4319/lo.2003.48.6.2377; Green RE, 2003, APPL OPTICS, V42, P526, DOI 10.1364/AO.42.000526; Hatcher A, 2001, J SEA RES, V46, P1, DOI 10.1016/S1385-1101(01)00066-1; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; HITCHCOCK GL, 1982, J PLANKTON RES, V4, P363, DOI 10.1093/plankt/4.2.363; Janssen Meike, 2001, International Microbiology, V4, P27; KITCHEN JC, 1992, LIMNOL OCEANOGR, V37, P1680, DOI 10.4319/lo.1992.37.8.1680; LORENZEN CARL J., 1966, DEEP SEA RES, V13, P223, DOI 10.1016/0011-7471(66)91102-8; Mas S, 2008, J PHYCOL, V44, P551, DOI 10.1111/j.1529-8817.2008.00501.x; Matthews M. W., 2013, BIOGEOSCI DISCUSS, V10, P10531, DOI DOI 10.5194/BGD-10-10531-2013; MEYER RA, 1975, BIOPHYS J, V15, P191, DOI 10.1016/S0006-3495(75)85811-5; MEYER RA, 1979, APPL OPTICS, V18, P585, DOI 10.1364/AO.18.000585; Mishchenko M.I., 2002, SCATTERING ABSORPTIO; Mishchenko MI, 2000, APPL OPTICS, V39, P1026, DOI 10.1364/AO.39.001026; Moutier W, 2016, OPT EXPRESS, V24, P24188, DOI 10.1364/OE.24.024188; OSBORNE BA, 1986, BRIT PHYCOL J, V21, P303, DOI 10.1080/00071618600650361; OSBORNE BA, 1989, MAR BIOL, V100, P151, DOI 10.1007/BF00391954; Pena O, 2009, COMPUT PHYS COMMUN, V180, P2348, DOI 10.1016/j.cpc.2009.07.010; Preisendorfer R. W., 1961, APPL RAD TRANSFER TH; Preisendorfer R. W., 1976, HYDROLOGIC OPTICS, V1; QUINBYHUNT MS, 1989, LIMNOL OCEANOGR, V34, P1587, DOI 10.4319/lo.1989.34.8.1587; Quirantes A, 2006, J QUANT SPECTROSC RA, V100, P315, DOI 10.1016/j.jqsrt.2005.11.048; Quirantes A, 2004, J QUANT SPECTROSC RA, V89, P311, DOI 10.1016/j.jqsrt.2004.05.031; ROSEN BH, 1984, J PHYCOL, V20, P173, DOI 10.1111/j.0022-3646.1984.00173.x; STEPHENS FC, 1995, MAR BIOL, V122, P325; Stramski D, 1997, LIMNOL OCEANOGR, V42, P538, DOI 10.4319/lo.1997.42.3.0538; Stramski D, 1999, DEEP-SEA RES PT I, V46, P335, DOI 10.1016/S0967-0637(98)00065-X; STRAMSKI D, 1993, LIMNOL OCEANOGR, V38, P1347, DOI 10.4319/lo.1993.38.7.1347; Sullivan J. M., 2013, MEASURING OPTICAL BA, P189; Svensen O, 2007, APPL OPTICS, V46, P5762, DOI 10.1364/AO.46.005762; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Tassan S, 2002, J PLANKTON RES, V24, P757, DOI 10.1093/plankt/24.8.757; Vaillancourt RD, 2004, J PLANKTON RES, V26, P191, DOI 10.1093/plankt/fbh012; Volten H, 1998, LIMNOL OCEANOGR, V43, P1180, DOI 10.4319/lo.1998.43.6.1180; Whitmire AL, 2010, OPT EXPRESS, V18, P15073, DOI 10.1364/OE.18.015073; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wilhelm SW, 1999, NATURE, V399, P541; Witkowski K, 1998, LIMNOL OCEANOGR, V43, P859, DOI 10.4319/lo.1998.43.5.0859; Xu YL, 2001, J QUANT SPECTROSC RA, V70, P395, DOI 10.1016/S0022-4073(01)00019-X; Yang W, 2003, APPL OPTICS, V42, P1710, DOI 10.1364/AO.42.001710; ZANEVELD JRV, 1995, J GEOPHYS RES-OCEANS, V100, P13309, DOI 10.1029/95JC00451; [No title captured]	61	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181180	10.1371/journal.pone.0181180	http://dx.doi.org/10.1371/journal.pone.0181180			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708882	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649800046
J	Ric, A; Torrents, C; Goncalves, B; Torres-Ronda, L; Sampaio, J; Hristovski, R				Ric, Angel; Torrents, Carlota; Goncalves, Bruno; Torres-Ronda, Lorena; Sampaio, Jaime; Hristovski, Robert			Dynamics of tactical behaviour in association football when manipulating players' space of interaction	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; NEUROBIOLOGICAL SYSTEMS; MOVEMENT BEHAVIOR; DECISION-MAKING; TEAM SPORTS; PERFORMANCE; CONSTRAINTS; STATISTICS; CREATIVITY; POSITION	The analysis of positional data in association football allows the spatial distribution of players during matches to be described in order to improve the understanding of tactical-related constraints on the behavioural dynamics of players. The aim of this study was to identify how players' spatial restrictions affected the exploratory tactical behaviour and constrained the perceptual-motor workspace of players in possession of the ball, as well as inter-player passing interactions. Nineteen professional outfield male players were divided into two teams of 10 and 9 players, respectively. The game was played under three spatial constraints: a) players were not allowed to move out of their allocated zones, except for the player in possession of the ball; b) players were allowed to move to an adjacent zone, and; c) non-specific spatial constraints. Positional data was captured using a 5 Hz interpolated GPS tracking system and used to define the configuration states of players for each second in time. The configuration state comprised 37 categories derived from tactical actions, distance from the nearest opponent, distance from the target and movement speed. Notational analysis of players in possession of the ball allowed the mean time of ball possession and the probabilities of passing the ball between players to be calculated. The results revealed that the players' long-term exploratory behaviour decreased and their short-term exploration increased when restricting their space of interaction. Relaxing players' positional constraints seemed to increase the speed of ball flow dynamics. Allowing players to move to an adjacent sub-area increased the probabilities of interaction with the full-back during play buildup. The instability of the coordinative state defined by being free from opponents when players had the ball possession was an invariant feature under all three task constraints. By allowing players to move to adjacent sub-areas, the coordinative state became highly unstable when the distance from the target decreased. Ball location relative to the scoring zone and interpersonal distance constitute key environmental information that constrains the players' coordinative behaviour. Based on our results, dynamic overlap is presented as a good option to capture tactical performance. Moreover, the selected collective (i.e. relational) variables would allow coaches to identify the effects of training drills on teams and players' behaviour. More research is needed considering these type variables to understand how the manipulation of constraints induce a more stable or flexible dynamical structure of tactical behaviour.	[Ric, Angel; Torrents, Carlota] Univ Lleida, Natl Inst Phys Educ Catalonia INEFC, Complex Syst Sport Res Grp, Lleida, Spain; [Goncalves, Bruno; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci, Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal; [Torres-Ronda, Lorena] Texas A&M Univ, Dept Hlth & Kinesiol, Exercise & Sport Nutr Lab, College Stn, TX USA; [Hristovski, Robert] St Cyril & Methodious Univ, Fac Phys Educ Sport & Hlth, Skopje, Macedonia	Universitat de Lleida; University of Tras-os-Montes & Alto Douro; Texas A&M University System; Texas A&M University College Station; Saints Cyril & Methodius University of Skopje	Ric, A (corresponding author), Univ Lleida, Natl Inst Phys Educ Catalonia INEFC, Complex Syst Sport Res Grp, Lleida, Spain.	angelric10@outlook.com	Hristovski, Robert/L-4116-2015; Ric, Angel/F-8977-2016; Sampaio, Jaime/B-7392-2008; Gonçalves, Bruno/M-5361-2013; Ric, Angel/AAR-6566-2020; Torrents, Carlota/AAX-6166-2020	Hristovski, Robert/0000-0001-6805-2833; Ric, Angel/0000-0003-4944-4529; Sampaio, Jaime/0000-0003-2335-9991; Gonçalves, Bruno/0000-0001-7874-4104; Ric, Angel/0000-0003-4944-4529; Torrents, Carlota/0000-0003-4912-2802				Aguiar M, 2015, J SPORT SCI, V33, P1259, DOI 10.1080/02640414.2015.1022571; Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Balague A N, 2014, APUNT ED FISICA DEPO, V116, P60; Balescu R, 1975, NASA STI RECON TEC A, V76, P32809; Bourbousson J, 2014, INT J SPORTS SCI COA, V9, P1393, DOI 10.1260/1747-9541.9.6.1393; Bruineberg J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00599; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Cintia P, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P392; Correa UC, 2016, J SPORT SCI, V34, P2321, DOI 10.1080/02640414.2016.1232488; Costa I.T., 2011, MOTRICIDADE, V7, P69, DOI [DOI 10.6063/MOTRICIDADE.7(1).121, 10.6063/motricidade.121, DOI 10.6063/MOTRICIDADE.121]; Cotta C., 2010, J SYSTEMS SCI COMPLE, V26, P21, DOI DOI 10.1007/S11424-013-2291-2; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duarte R, 2012, J SPORT SCI, V30, P871, DOI 10.1080/02640414.2012.675081; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Gama J, 2014, INT J PERF ANAL SPOR, V14, P692, DOI 10.1080/24748668.2014.11868752; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B, 2017, PLOONE PUBLIC LIB, V12; Grund TU, 2012, SOC NETWORKS, V34, P682, DOI 10.1016/j.socnet.2012.08.004; Gyarmati L., P 2014 KDD WORKSH LA; Haken H., 1987, APPROACH SELF ORG SE, P417; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hristovski R., 2012, OPEN SPORTS SCI J S, V5, P26, DOI [10.2174/1875399X01205010026, DOI 10.2174/1875399X01205010026]; Hristovski R., 2009, PERSPECTIVES COGNITI, P43; Hristovski R., 2013, COMPLEX SYSTEMS SPOR, P261; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Hughes M., 2004, NOTATIONAL ANAL SPOR; James N., 2006, INT J PERF ANAL SPOR, V6, P67, DOI [https://doi.org/10.1080/24748668.2006.11868373, DOI 10.1080/24748668.2006.11868373, 10.1080/24748668.2006.11868373]; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kempe M., 2012, SPORTS PHYS, V4, P35, DOI 10.5923/s.sports.201401.05; Kempe M., 2014, INT J SPORT SCI, V4, P35, DOI [10.5923/s.sports.201401.05, DOI 10.5923/S.SPORTS.201401.05]; Kugler PN, 1987, RESOURCES ECOLOGICAL; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; McGarry T., 2009, INT J PERF ANAL SPOR, V9, P128, DOI [10.1186/s12913-016-1423-5, DOI 10.1080/24748668.2009.11868469]; Narizuka T, 2014, PHYSICA A, V412, P157, DOI 10.1016/j.physa.2014.06.037; NEWELL KM, 1991, NATO ADV SCI I D-BEH, V62, P95; Passos P, 2008, J SPORT SCI, V26, P1421, DOI 10.1080/02640410802208986; Passos P, 2009, J MOTOR BEHAV, V41, P445, DOI 10.3200/35-08-061; Pinder RA, 2012, J SCI MED SPORT, V15, P437, DOI 10.1016/j.jsams.2012.01.002; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Ric A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyd.2016.01513; Ric A, 2016, J SPORT SCI, V34, P1723, DOI 10.1080/02640414.2015.1136068; Sampaio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132894; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Santos SDL, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.01282, 10.3389/fpsyg.2076.01282]; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; SILVA P, 2015, INT J PERF ANAL SPOR, P641; Silva P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1813-5; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Silva P, 2014, INT J SPORTS SCI COA, V9, P993, DOI 10.1260/1747-9541.9.5.993; Tenga A., 2003, INT J PERF ANAL SPOR, V3, P90; Torrents C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168866; Martin CT, 2015, PSYCHOL AESTHET CREA, V9, P65, DOI 10.1037/a0038706; Travassos B, 2012, HUM MOVEMENT SCI, V31, P932, DOI 10.1016/j.humov.2011.10.004; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Travassos B, 2014, HUM MOVEMENT SCI, V38, P241, DOI 10.1016/j.humov.2014.10.005; Travassos B, 2012, INT J SPORTS SCI COA, V7, P677, DOI 10.1260/1747-9541.7.4.677; Vilar L, 2014, INT J SPORTS SCI COA, V9, P1007, DOI 10.1260/1747-9541.9.5.1007; Vilar L, 2014, EUR J SPORT SCI, V14, P28, DOI 10.1080/17461391.2012.725103; Vilar L, 2013, J SYST SCI COMPLEX, V26, P73, DOI 10.1007/s11424-013-2286-z; Wang Q, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2197, DOI 10.1145/2783258.2788577; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	64	33	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180773	10.1371/journal.pone.0180773	http://dx.doi.org/10.1371/journal.pone.0180773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708868	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800021
J	Pinna, C; Carta, L; Deiana, V; Camarda, I				Pinna, Claudia; Carta, Luisa; Deiana, Vitale; Camarda, Ignazio			Phyto-toponyms of Arbutus unedo L. and their distribution in Sardinia (Italy)	PLOS ONE			English	Article							GEOGRAPHICAL FEATURES; PLACE-NAMES; EXAMPLE	The study shows the results of an inventory of place names connected to Arbutus unedo L., a Mediterranean species, widespread throughout Sardinia. The main aim was to compare the past distribution of place names, referring to the strawberry tree, to the current distribution of the species on the island. In addition, we investigated the meaning and the diversity of these local place names in the various communities. The result was a collection of 432 phyto-toponyms. 248 of them were used for an analysis of their distribution in the habitats, indicated on the Map of the Nature System in Sardinia, defined on the basis of the current vegetation typology. The persistence of the species in the various habitats was either confirmed or negated with in site investigations and interviews. 47.5% of municipalities have place names related to the strawberry tree. Of the 248 phyto-toponyms, 127 fall in the habitats where the species currently persists proving a correspondence between their regional distribution and the current distribution of the species. The remaining 121 phyto-toponyms fall in habitats where the strawberry tree is currently absent. Most of them are found in man-made habitats where man has transformed the forest cover which previously included the strawberry tree. This study also contributes to promoting and conserving the linguistic heritage of local communities.	[Pinna, Claudia; Carta, Luisa; Deiana, Vitale; Camarda, Ignazio] Univ Sassari, Dept Agr, Viale Italia, Sassari, Italy	University of Sassari	Pinna, C (corresponding author), Univ Sassari, Dept Agr, Viale Italia, Sassari, Italy.	clpinna@uniss.it						A.A.V.V, 1916, NOTES QUERIES MEDIUM, VII; Andre J., 1985, NOMES PLANTES ROME A; [Anonymous], 2002, 8 UN C STAND GEOGR N; Associazione archeologica etnografica abbasantese, 1993, TOP TERR ABB; Bacchetta G, 2000, RENDICONTI SEMINARIO, V70, P200; Barrera-Bassols N, 2006, CATENA, V65, P118, DOI 10.1016/j.catena.2005.11.001; Blasco Ferrer Eduardo, 1984, STORIA LINGUISTICA S; Boillat S, 2013, ENVIRON MANAGE, V51, P663, DOI 10.1007/s00267-012-9969-4; Burrill MF, 1956, TOPONYMIC GENERICS, VI; Burrill MF, 1956, TOPONYMIC GENERICS, VII; Camarda I, 2006, P 4 INT C ETHN AUG 2, P527; Camarda I., 1992, PICCOLI ARBUSTI LIAN; Camarda I, 2015, ISPRA SERIE, V222; Camarda I., 2010, CHISTIONARE NATURA L; Camarda I., 2008, ALBERI ARBUSTI SPONT; Camarda I., 1990, B SOC SARDA SCI NAT, V27, P147; Camarda I, 2014, QUAD BOT AMB APPL, V25, P125; Camarda I., 1998, PIANO PAESAGGISTICO; CAMARDA I, 1983, ALBERI ARBUSTI SPONT; Caria R., 1990, IL MONDO CALIC STUDI; Conedera M, 2007, J HIST GEOGR, V33, P729, DOI 10.1016/j.jhg.2006.11.002; Contini M, 2001, DICT LANGUES MONDE; Contini M., 1993, PARLARE SCRIVERE SAR; Cuccu I., 1989, TOPONOMASTICA TERRIT; Dedola S., 2001, SENTIERO SARDEGNA SE; Durmishi I., 2013, ANGLISTICUM J IJLLIS, V2, P60; Elwes HJ, 1906, TREES GREAT BRITAIN, VIII; ESRI, 2010, RCGIS DESKTOP 10 0 S, P380; Farina L., 2002, BOCABOLARIU; Ferrer E Blasco, 2010, PALEOSARDO ORIGINI L; Fidalgo HC, 2015, CUADERNOS GEOGRAFICO, V54, P220; Frigau C, TOPONIMI TERRITORIO; Gasperini L., 1992, ATT 9 CONV AFR ROM 1, P571; Gomila RR, 2005, INT CART C LA COR SP; Gelabert MG, 2009, DOC ANAL GEOGR, V55, P93; Hough Carole, 2016, OXFORD HDB NAMES NAM; Hunn E., 1996, J LINGUIST ANTHROPOL, V6, P3, DOI [DOI 10.1525/JLIN.1996.6.1.3, 10.1525/jlin.1996.6.1.3]; Imazato S., 2013, SEMESTRALE STUDI RIC, V2, P27; Joyce PW, 1883, ORIGIN HIST IRISH NA, VII; Logus Nioi O., 2007, MICROTOPONIMI NURRI; Luo W, 2010, GEOJOURNAL, V75, P93, DOI 10.1007/s10708-009-9291-8; Manos G., 1993, VILLAGRANDE STRISAIL; Marcialis E., 2005, VOCABOLARI; Maxia Mauro, 2010, STUDI SARDO CORSI DI; Maxia Mauro, 1994, NOMI LUOGO ANGLONA B; Miglior I., 1989, SARDEGNA D PAESI SCO; Muller-Wille L., 1989, B SOC SUISSE AM, V53-54, P17; Negre E., 1996, TOPONYMIE GENERATE F, V194; Negre E., 1996, TOPONYMIE GENERATE F, V2; Nieto Ballester E, 2013, SEMESTRALE STUDI RIC, P123; Nocentini A, TOPONOMASTICA IGM FI; Panedda Dionigi, 1991, NOMI GEOGRAFICI AGRO; Patil DA, 2015, INT DAILY J SPECIES, V12, P6; Paulis G., 1992, NOMI POPOLARI PIANTE; Paulis G, 2004, ATT CONV GALL LING D, P15; Paulis Giulio, 1987, NOMI LUOGO SARDEGNA, VI; Pegorier A, 2006, NOMS LIEUX FRANCE GL; Penko Seidl N, 2015, ANN SERIES HIST SOCI, V25, P595; Perkovsky E. E., 2015, Vestnik Zoologii, V49, P407, DOI 10.1515/vzoo-2015-0046; Piante Camarda I, 2005, BIOL VEGETALE BENI C, VII, P336; Pinna A, 2 TERRITOR ATZARA TR; Pittau M, 2004, LINGUA CIVILTA SARDE; Pittau M., 2014, VOCABOLARIO LINGUA S; Pittau M, 2011, TOPONIMI SARDEGNA SI; Pittau M., NOMI PIANTE PROTOSAR; Plaisant L, 2007, MANNU SORTU OLIVI MI; Poddie R., 2010, TONARA NOMI LUOGO RI; Puddu M., 2002, DITZIONA A RIU SA LI; Quezel P., 1976, FOR TS MAQUIS M DITE, VVolume 2, P9; R Core Team, 2018, R LANG ENV STAT COMP; Radding L, 2010, GEOGR REV, V100, P394, DOI 10.1111/j.1931-0846.2010.00043.x; Rodriguez JF, 2013, SABUCO REV ESTUDIOS, V9, P133; Rubattu A., 2001, DIZIONARIO UNIVERSAL; Scully RW, 1916, FLORA COUNTY KERRY, P179; SEALY JR, 1950, J ECOL, V38, P223, DOI 10.2307/2256540; SEALY JR, 1949, J ECOL, V37, P365, DOI 10.2307/2256613; Shi GH, 2015, ENTROPY-SWITZ, V17, P984, DOI 10.3390/e17030984; Smith D, 2016, J CULT GEOGR, V33, P1, DOI 10.1080/08873631.2015.1060689; Spiggia S., 1997, API NELLA TRADIZIONE, P90; Sweeney S, 2017, LANDSCAPE ECOLOGY, V22, P1007; Tagliavini C., ORIGINI LINGUE NEOLA; Tamine M., 2013, P 2 INT C ON ICON MA, P384; Tichelaar T., 2002, TOPONYMY LANGUAGE, P1; Tort J., 2009, P 23 INT C ON SCI, P976; Trischitta D., 1983, TOPONIMI PAESAGGIO N; Tsinkoburova M, 2014, INT MULTI SCI GEOCO, P161; Valdes B, EURO MED PLANTBASE I; Verde A., BOT FILE 4 WINTER 20; Villar L, 2005, ALAZET, V17, P239; Virdis M, 2009, P 1 SEM REG STUD TOP; Wagner Max Leopold, 1960, DIZIONARIO ETIMOLOGI, V1; WAGNER Max Leopold, 1997, LINGUA SARDA STORIA; Wagner ML, 1960, DIZIONARIO ETIMOLOGI, VIII; Wagner ML, 1960, DIZIONARIO ETIMOLOGI, VII; Wolf HeinzJ., 1998, TOPONOMASTICA BARBAR; Zirottu G., 2004, MAMOIADA RACCONTO TE	96	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181174	10.1371/journal.pone.0181174	http://dx.doi.org/10.1371/journal.pone.0181174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704491	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700103
J	Wang, YD; Chen, Y; Mao, L; Zhao, GJ; Hong, GL; Li, MF; Wu, B; Chen, XR; Tan, M; Wang, N; Lu, ZQ				Wang, Yadong; Chen, Yao; Mao, Lu; Zhao, Guangju; Hong, Guangliang; Li, Mengfang; Wu, Bin; Chen, Xiaorong; Tan, Meng; Wang, Na; Lu, Zhongqiu			Effects of hemoperfusion and continuous renal replacement therapy on patient survival following paraquat poisoning	PLOS ONE			English	Article							REGIONAL CITRATE ANTICOAGULATION; STRESS	Mortality in patients with paraquat (PQ) poisoning is related to plasma PQ levels. Concentrations lower than 5,000 ng/mL are considered critical but curable. This study assessed the effects of hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the survival of PQ-poisoned patients with plasma PQ levels below 5,000ng/mL. We analyzed the records of 164 patients with PQ poisoning who were treated at the First Affiliated Hospital of Wenzhou Medical University in China between January 2011 and May 2015. We divided these patients into six sub-groups based on baseline plasma PQ levels and treatment, compared their clinical characteristics, and analyzed their survival rates. Patient subgroups did not differ in terms of age, sex, time between poisoning and hospital admission, or time to first gavage. Biochemical indicators improved over time in all sub-groups following treatment, and the combined HP and CRRT treatment yielded better results than HP or CRRT alone. Fatality rates in the three treatment sub-groups did not differ among patients with baseline plasma PQ levels of 50-1,000 ng/mL, but in patients with 1,000-5,000 ng/mL levels, the mortality rate was 59.2% (HP treatment group), 48% (CRRT treatment group), and 37.9% (combined treatment group). Mortality rates were higher 10-30 days after hospitalization than in the first 10 days after admission. In the early stages of PQ poisoning, CRRT is effective in reducing patient fatality rates, particularly when combined with HP. Our data could be useful in increasing survival in acute PQ poisoning patients.	[Wang, Yadong; Chen, Yao; Mao, Lu; Zhao, Guangju; Hong, Guangliang; Li, Mengfang; Wu, Bin; Chen, Xiaorong; Tan, Meng; Wang, Na; Lu, Zhongqiu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Chen, Yao] Gannan Med Univ, Affiliated Hosp 1, Intens Care Unit, Ganzhou, Jiangxi, Peoples R China; [Mao, Lu] Zhengzhou First Peoples Hosp, Med Grp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China	Wenzhou Medical University; Gannan Medical University	Lu, ZQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou, Zhejiang, Peoples R China.	lzq_640815@163.com		LU, Zhongqiu/0000-0002-0569-4182	fund of the key construction academic subject (Medical Innovation) of Zhejiang province, China [11-CX26]	fund of the key construction academic subject (Medical Innovation) of Zhejiang province, China	This work was supported by fund of the key construction academic subject (Medical Innovation) of Zhejiang province (11-CX26), China. The funder had role in data collection and analysis, decision to publish and preparation of the manuscript.	Amano I, 1991, COMPLICATIONS SIDE S, V49, P649; Amirshahrokhi K, 2013, INT IMMUNOPHARMACOL, V17, P210, DOI 10.1016/j.intimp.2013.06.005; BAUD FJ, 1988, J TOXICOL-CLIN TOXIC, V26, P35, DOI 10.3109/15563658808995396; Chen GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001212; DARKE PGG, 1977, VET REC, V100, P275, DOI 10.1136/vr.100.14.275; Del Rio MJ, 2008, GROWTH FACTORS, V26, P49, DOI 10.1080/08977190801984205; HART TB, 1987, HUM TOXICOL, V6, P13, DOI 10.1177/096032718700600103; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hong GL, 2016, J PHARMACOL TOX MET, V80, P75, DOI 10.1016/j.vascn.2016.05.010; Hong SY, 2002, TOXICOL LETT, V126, P51, DOI 10.1016/S0378-4274(01)00431-3; Hu LF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/298253; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kirwan CJ, 2016, BLOOD PURIFICAT, V42, P349, DOI 10.1159/000452755; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Liu Yao, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P735; MATTHEW H, 1968, BRIT MED J, V3, P759, DOI 10.1136/bmj.3.5621.759; Myung W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128980; Rico MP, 2017, PEDIATR NEPHROL, V32, P703, DOI 10.1007/s00467-016-3544-9; Roebuck KA, 1999, INT J MOL MED, V4, P223; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Seok S, 2012, J KOREAN MED SCI, V27, P993, DOI 10.3346/jkms.2012.27.9.993; Shi XF, 2015, INT J CLIN EXP MED, V8, P14018; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Suh GJ, 2008, AM J EMERG MED, V26, P641, DOI 10.1016/j.ajem.2007.09.022; Sun L, 2014, EXP THER MED, V8, P652, DOI 10.3892/etm.2014.1773; Villa G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1551-7; Wu Y, 2016, EXP THER MED, V12, P2997, DOI 10.3892/etm.2016.3691; Xu XL, 2011, WORLD J EMERG MED, V2, P45, DOI 10.5847/wjem.j.issn.1920-8642.2011.02.008	29	19	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181207	10.1371/journal.pone.0181207	http://dx.doi.org/10.1371/journal.pone.0181207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704509	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700106
J	Wei, CH; Chen, XE; Wang, ZY; Liu, QY; Li, H; Zhang, Y; Ma, JX; Yang, JQ; Zhang, X				Wei, Chunhua; Chen, Xiner; Wang, Zhongyuan; Liu, Qiyan; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian			Genetic mapping of the LOBED LEAF 1 (ClLL1) gene to a 127.6-kb region in watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; LEAF SHAPE EVOLUTION; EXPRESSION; MERISTEM; IDENTIFICATION; ALIGNMENT; GROWTH; LOCUS	The lobed leaf character is a unique morphologic trait in crops, featuring many potential advantages for agricultural productivity. Although the majority of watermelon varieties feature lobed leaves, the genetic factors responsible for lobed leaf formation remain elusive. The F2:3 leaf shape segregating population offers the opportunity to study the underlying mechanism of lobed leaf formation in watermelon. Genetic analysis revealed that a single dominant allele (designated ClLL1) controlled the lobed leaf trait. A large-sized F3:4 population derived from F2:3 individuals was used to map ClLL1. A total of 5,966 reliable SNPs and indels were identified genome-wide via a combination of BSA and RNA-seq. Using the validated SNP and indel markers, the location of ClLL1 was narrowed down to a 127.6-kb region between markers W08314 and W07061, containing 23 putative ORFs. Expression analysis via qRT-PCR revealed differential expression patterns (fold-changes above 2-fold or below 0.5-fold) of three ORFs (ORF3, ORF11, and ORF18) between lobed and nonlobed leaf plants. Based on gene annotation and expression analysis, ORF18 (encoding an uncharacterized protein) and ORF22 (encoding a homeobox-leucine zipper-like protein) were considered as most likely candidate genes. Furthermore, sequence analysis revealed no polymorphisms in cDNA sequences of ORF18; however, two notable deletions were identified in ORF22. This study is the first report to map a leaf shape gene in watermelon and will facilitate cloning and functional characterization of ClLL1 in future studies.	[Wei, Chunhua; Chen, Xiner; Wang, Zhongyuan; Liu, Qiyan; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian] Northwest A&F Univ, Coll Hort, Yangling, Peoples R China	Northwest A&F University - China	Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Peoples R China.	zhangxian098@126.com	chen, xiner/GVU-3933-2022		Scientific Startup Foundation for Doctors of Northwest A and F University [Z109021604]; Basal Research Foundation of Northwest A and F University [Z109021612]; Modern Agro-industry Technology Research System of China [CARS-26-18]	Scientific Startup Foundation for Doctors of Northwest A and F University; Basal Research Foundation of Northwest A and F University; Modern Agro-industry Technology Research System of China	This work was supported by Scientific Startup Foundation for Doctors of Northwest A and F University (Z109021604), Basal Research Foundation of Northwest A and F University (Z109021612), and the Modern Agro-industry Technology Research System of China (No. CARS-26-18).	Andres RJ, 2017, P NATL ACAD SCI USA, V114, pE57, DOI 10.1073/pnas.1613593114; Andres RJ, 2014, THEOR APPL GENET, V127, P167, DOI 10.1007/s00122-013-2208-4; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Chang J, 2016, THEOR APPL GENET, V129, P1531, DOI 10.1007/s00122-016-2722-2; DYUTIN KE, 1979, GENETIKA+, V16, P176; Ferris KG, 2015, ANN BOT-LONDON, V116, P213, DOI 10.1093/aob/mcv080; Gao XW, 2014, EUPHYTICA, V200, P337, DOI 10.1007/s10681-014-1151-z; Goliber T, 1999, CURR TOP DEV BIOL, V43, P259; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Herrington M, 1988, QUEENSLAND J AGR ANI; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Jasinski S, 2007, PLANTA, V226, P1255, DOI 10.1007/s00425-007-0572-5; Jiao KY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0552-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YP, 2014, THEOR APPL GENET, V127, P2243, DOI 10.1007/s00122-014-2376-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082333; Liu HQ, 2015, THEOR APPL GENET, V128, P2375, DOI 10.1007/s00122-015-2592-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ni XY, 2015, EUPHYTICA, V204, P29, DOI 10.1007/s10681-014-1319-6; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Pu HM, 2001, CHIN J OIL CROP SCI, V23, P60; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Saddic LA, 2006, DEVELOPMENT, V133, P1673, DOI 10.1242/dev.02331; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; Sluis A, 2015, TRENDS GENET, V31, P300, DOI 10.1016/j.tig.2015.04.004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Tsukaya Hirokazu, 2013, Arabidopsis Book, V11, pe0163, DOI [10.1199/tab.0072, 10.1199/tab.0163]; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Yu HL, 2013, J EXP BOT, V64, P599, DOI 10.1093/jxb/ers352; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhou CN, 2013, PLANT CELL, V25, P4845, DOI 10.1105/tpc.113.117788	43	17	17	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180741	10.1371/journal.pone.0180741	http://dx.doi.org/10.1371/journal.pone.0180741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704497	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700049
J	Lopez-Rodriguez, R; Hernandez-Bartolome, A; Borque, MJ; Rodriguez-Munoz, Y; Martin-Vilchez, S; Garcia-Buey, L; Gonzalez-Moreno, L; Real-Martinez, Y; de Rueda, PM; Salmeron, J; Vidal-Castineira, JR; Lopez-Larrea, C; Rodrigo, L; Moreno-Otero, R; Sanz-Cameno, P				Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Jesus Borque, Maria; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real-Martinez, Yolanda; Munoz de Rueda, Paloma; Salmeron, Javier; Ramon Vidal-Castineira, Jose; Lopez-Larrea, Carlos; Rodrigo, Luis; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS; RESPONSES; FIBROSIS; INNATE; IL28B; LIVER	Introduction Chronic hepatitis C (CHC) is a major cause of liver disease worldwide which often leads to progressive liver inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). CHC displays heterogeneous progression depending on a broad set of factors, some of them intrinsic to each individual such as the patient's genetic profile. This study aims to evaluate the contribution of certain genetic variants of crucial interferon alpha and lambda signaling pathways to the hepatic necroinflammatory activity (NIA) grade of CHC patients. Methods NIA was evaluated in 119 CHC patients by METAVIR scale and classified as low (NIA = 0-2, n = 80) or high grade (NIA = 3, n = 39). In a candidate gene approach, 64 SNPs located in 30 different genes related to interferon pathways (IL-28B, IFNAR1-2, JAK-STAT and OAS1-3, among others) were genotyped using the Illumina GoldenGate (R) Genotyping Assay. Statistical association was determined by logistic regression and expressed as OR and 95% CI. Those SNPs significantly associated were further adjusted by other covariates. Results Seven SNPs located in IL-28B (rs12979860), JAK1 (rs11576173 and rs1497056), TYK2 (rs280519), OAS1 (rs2057778), SOCS1 (rs33932899) and RNASEL (rs3738579) genes were significantly related to severe NIA grade (p<0.05). Regarding to clinical variables, elevated NIA was notably associated with aspartate aminotransferase (AST) serum levels >40 IU/L (p<0.05) but not with other clinical factors. Multivariate logistic regression analysis of these factors reflected that AST (>40 IU/L), TYK2 rs280519 (G allele) and RNASEL rs3738579 (G allele) were factors independently associated with elevated NIA (p<0.05). AST concentration showed a moderate AUC value (AUC = 0.63), similar to TYK2 (rs280519) and RNASEL (rs3738579) SNPs (AUC = 0.61, both) in the ROC_AUC analysis. Interestingly, the model including all significant variables reached a considerable predictive value (AUC = 0.74). Conclusion The identified genetic variants in interferon signaling pathways may constitute useful prognostic markers of CHC progression. Further validation in larger cohorts of patients is needed.	[Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real-Martinez, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] IIS IP, Inst Invest Sanitaria Princesa, Liver Unit, Gastroenterol Serv, Madrid, Spain; [Jesus Borque, Maria] IIS IP, Inst Invest Sanitaria Princesa, Mol Biol Unit, Madrid, Spain; [Garcia-Buey, Luisa; Munoz de Rueda, Paloma; Salmeron, Javier; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] ISCIII, CIBERehd, Madrid, Spain; [Munoz de Rueda, Paloma; Salmeron, Javier] Hosp Univ San Cecilio, Gastroenterol Unit, Granada, Spain; [Ramon Vidal-Castineira, Jose; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Inmunol Serv, Oviedo, Spain; [Rodrigo, Luis] Hosp Univ Cent Asturias, Digest Serv, Oviedo, Spain; [Lopez-Rodriguez, Rosario] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitario San Cecilio; Central University Hospital Asturias; Central University Hospital Asturias; Complexo Hospitalario Universitario de Santiago de Compostela	Sanz-Cameno, P (corresponding author), IIS IP, Inst Invest Sanitaria Princesa, Liver Unit, Gastroenterol Serv, Madrid, Spain.; Sanz-Cameno, P (corresponding author), ISCIII, CIBERehd, Madrid, Spain.	paloma_march@hotmail.com	Chaparro, María/I-2500-2016; Rodrigo, Luis/A-6278-2010; Lopez-Rodriguez, Rosario/M-3381-2014; Sanz, Paloma/C-7799-2014; López-Rodríguez, Rosario/AAB-2290-2022; Martin-Vilchez, Samuel/AFV-2112-2022	Chaparro, María/0000-0002-9275-4242; Rodrigo, Luis/0000-0003-1717-9345; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Martin-Vilchez, Samuel/0000-0003-0557-7653; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566	Ayudas Investigacion Oncologica AIO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena; Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF [2010-21805]	Ayudas Investigacion Oncologica AIO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena; Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF	This work was supported by Ayudas Investigacion Oncologica AIO-2010 to PSC (https://www.fundacioncientifica.aecc.es/); Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena 2010 to RMO; Ayudas Proyectos de Investigacion Fundacion Mutua Madrilena 2012 to PSC (http://www.fundacionmutua.es/Ayudasa -la-Investigacion.html); Programa Estatal de Investigacion Fundamental Ministerio de Economia Industria y Competitividad SAF 2010-21805 to RMO (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801 432ea0/?vgnextoid=17aba53632295210VgnVCM 1000001d04140aRCRD).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bertino G, 2016, WORLD J HEPATOL, V8, P92, DOI 10.4254/wjh.v8.i2.92; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Friborg J, 2013, VIROLOGY, V444, P384, DOI 10.1016/j.virol.2013.07.005; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jouan L, 2012, J HEPATOL, V56, P70, DOI 10.1016/j.jhep.2011.07.017; Li XL, 2011, WIRES RNA, V2, P58, DOI 10.1002/wrna.32; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Moon J, 2016, BIOCHEM BIOPH RES CO, V474, P428, DOI 10.1016/j.bbrc.2016.05.005; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Reig M, 2016, J HEPATOL, Vxxx, P1; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sato M, 2014, PLOS ONE, V9; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Wirth TC, 2016, ANN ONCOL, V27, P1467, DOI 10.1093/annonc/mdw219; Wong M. T., 2014, CELL MOL IMMUNOL; Zerbino DR, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav119	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180927	10.1371/journal.pone.0180927	http://dx.doi.org/10.1371/journal.pone.0180927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704535	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600052
J	Schenk, D; Song, G; Ke, Y; Wang, ZH				Schenk, Desiree; Song, Gang; Ke, Yue; Wang, Zhaohui			Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2	PLOS ONE			English	Article							HYBRIDIZATION; ENRICHMENT; CAPTURE	Current PCR-based target enrichment methods for next generation sequencing (NGS) of overlapping amplicons often requires separate PCR reactions and subsequent pooling of amplicons from the different reactions. The study presents a novel method, deemed stemloop inhibition mediated amplification (SLIMamp), for amplifying overlapping or tiled amplicons in a single multiplex PCR reaction. During a SLIMamp PCR reaction, a stem loop structure formed by the overlapping amplicon suppresses additional amplification of itself by preventing the annealing of the primers. Using the SLIMamp strategy, we designed a nextgeneration sequencing (NGS) assay to enrich the exon regions of BRCA1 and BRCA2 for sequencing on an Illumina MiSeq system. We used 35 cell line DNAs and 6 patient blood DNAs in the study to evaluate the assay performance. For each sample, all targeted regions were successfully amplified and sequenced with excellent coverage uniformity and specificity. >99% of the total sequencing reads were mapped to the human reference genome (hg19) and >99% of the mapped reads were on the targeted exons. >98% of bases were covered at >0.20x of the mean coverage and >99% are covered at >0.15x of the mean depth. Among 34 independently sequenced samples, all variants were reliably detected with no false positives or false negatives. SLIMamp provides a robust method for singletube multiplex PCR amplification of numerous, overlapping amplicons that tile for targeted next-generation sequencing.	[Schenk, Desiree; Song, Gang; Ke, Yue; Wang, Zhaohui] Pillar Biosci, Dept Res & Dev, Natick, MA 01760 USA		Wang, ZH (corresponding author), Pillar Biosci, Dept Res & Dev, Natick, MA 01760 USA.	wangzh@pillar-biosciences.com			Pillar Biosciences	Pillar Biosciences	This research was supported by Pillar Biosciences. No individual authors received specific funding for this work. Pillar Biosciences provided support in the form of salaries to DS, GS, YK, and ZW.	Balabanski L, 2014, MOL CLIN ONCOL, V2, P435, DOI 10.3892/mco.2014.251; Chong HK, 2014, PLOS ONE, V9; Green A, 2015, J MOL DIAGN, V17, P31, DOI 10.1016/j.jmoldx.2014.09.006; Khodakov D, 2016, ADV DRUG DELIVER REV, V105, P3, DOI 10.1016/j.addr.2016.04.005; Li H., 2013, QUANT BIOL; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825; Strom CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136419; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	10	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181062	10.1371/journal.pone.0181062	http://dx.doi.org/10.1371/journal.pone.0181062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704513	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600056
J	Borgdorff, H; van der Veer, C; van Houdt, R; Alberts, CJ; de Vries, HJ; Bruisten, SM; Snijder, MB; Prins, M; Geerlings, SE; van der Loeff, MFS; van de Wijgert, JHHM				Borgdorff, Hanneke; van der Veer, Charlotte; van Houdt, Robin; Alberts, Catharina J.; de Vries, Henry J.; Bruisten, Sylvia M.; Snijder, Marieke B.; Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim; van de Wijgert, Janneke H. H. M.			The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LONGITUDINAL ANALYSIS; RACIAL-DIFFERENCES; RISK-FACTORS; WOMEN; EPIDEMIOLOGY; HIV; IDENTIFICATION; PREVALENCE; INFECTION	Objective To evaluate whether ethnicity is independently associated with vaginal microbiota (VMB) composition in women living in Amsterdam, the Netherlands, as has been shown for American women. Methods Women (18 -34 years, non-pregnant, N = 610) representing the six largest ethnic groups (Dutch, African Surinamese, South-Asian Surinamese, Turkish, Moroccan, and Ghanaian) were sampled from the population-based HELIUS study. Sampling was performed irrespective of health status or healthcare seeking behavior. DNA was extracted from self-sampled vaginal swabs and sequenced by Illumina MiSeq (16S rRNA gene V3-V4 region). Results The overall prevalence of VMBs not dominated by lactobacilli was 38.5%: 32.2% had a VMB resembling bacterial vaginosis and another 6.2% had a VMB dominated by Bifidobacteriaceae (not including Gardnerella vaginalis), Corynebacterium, or pathobionts (streptococci, staphylococci, Proteus or Enterobacteriaceae). The most prevalent VMB in ethnically Dutch women was a Lactobacillus crispatus-dominated VMB, in African Surinamese and Ghanaian women a polybacterial G. vaginalis-containing VMB, and in the other ethnic groups a L. iners-dominated VMB. After adjustment for sociodemographic, behavioral and clinical factors, African Surinamese ethnicity (adjusted odds ratio (aOR) 5.1, 95% confidence interval (CI) 2.1-12.0) and Ghanaian ethnicity (aOR 4.8, 95% CI 1.8-12.6) were associated with having a polybacterial G. vaginalis-containing VMB, and African Surinamese ethnicity with a L. iners-dominated VMB (aOR 2.8, 95% CI 1.2-6.2). Shorter steady relationship duration, inconsistent condom use with casual partners, and not using hormonal contraception were also associated with having a polybacterial G. vaginalis-containing VMB, but human papillomavirus infection was not. Other sexually transmitted infections were uncommon. Conclusions The overall prevalence of having a VMB not dominated by lactobacilli in this populationbased cohort of women aged 18-34 years in Amsterdam was high (38.5%), and women of sub-Saharan African descent were significantly more likely to have a polybacterial G. vaginalis-containing VMB than Dutch women independent of modifiable behaviors.	[Borgdorff, Hanneke; van de Wijgert, Janneke H. H. M.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Borgdorff, Hanneke; Alberts, Catharina J.; de Vries, Henry J.; Bruisten, Sylvia M.; Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim; van de Wijgert, Janneke H. H. M.] Acad Med Ctr, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands; [van der Veer, Charlotte; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam GGD, Publ Hlth Lab, Amsterdam, Netherlands; [van der Veer, Charlotte; van Houdt, Robin] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands; [Alberts, Catharina J.; de Vries, Henry J.; Prins, Maria; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Dept Infect Dis, Amsterdam, Netherlands; [de Vries, Henry J.] Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Snijder, Marieke B.] Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Snijder, Marieke B.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim] Acad Med Ctr, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	van de Wijgert, JHHM (corresponding author), Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.; van de Wijgert, JHHM (corresponding author), Acad Med Ctr, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands.; van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England.	snijder@amc.uva.nl; j.vandewijgert@liverpool.ac.uk	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Veer, Charlotte/0000-0002-1685-1622; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Alberts, Catharina Johanna/0000-0002-5604-3689	Aids Fonds Netherlands [201102]; Academic Medical Center Amsterdam; Public Health Service of Amsterdam; Dutch Heart Foundation [2010T084]; Netherlands Organization for Health Research and Development [200500003, 7115 0001, 204005002]; European Union (FP-7) [278901]; SURF Foundation	Aids Fonds Netherlands; Academic Medical Center Amsterdam; Public Health Service of Amsterdam; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union (FP-7)(European Commission); SURF Foundation	This work was supported by the Aids Fonds Netherlands [grant number 201102; https://aidsfonds.nl/], the Academic Medical Center Amsterdam [institutional funding; https://www.amc.nl/web/Zorg.htm], the Public Health Service of Amsterdam [institutional funding; http://www.ggd.amsterdam.nl/english/], the Dutch Heart Foundation [grant number 2010T084; https://www.hartstichting.nl/], the Netherlands Organization for Health Research and Development (ZonMw) [grant numbers 200500003, 7115 0001, and 204005002; https://www.zonmw.nl/en/], and the European Union (FP-7) [grant number 278901; https://ec.europa.eu/research/fp7/index_en.cfm]. Some analyses were carried out on the Dutch national e-infrastructure with the support of SURF Foundation [https://www.surf.nl/en]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts CJ, 2016, SEX TRANSM INFECT, V92, P611, DOI 10.1136/sextrans-2015-052397; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doh Kunihiko, 2004, Infect Dis Obstet Gynecol, V12, P79, DOI 10.1080/10647440400003667; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esber A, 2015, J INFECT DIS, V212, P8, DOI 10.1093/infdis/jiv017; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Garland SM, 2002, J REPROD IMMUNOL, V57, P169, DOI 10.1016/S0165-0378(02)00018-9; Gautam R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0831-1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Jespers V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0825-z; Kenyon C, 2015, AIDS, V29, P641, DOI 10.1097/QAD.0000000000000566; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Korshunov V. M., 1999, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P74; Kwatra G, 2016, LANCET INFECT DIS, V16, P1076, DOI 10.1016/S1473-3099(16)30055-X; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Machado A, 2015, J INFECT DIS, V212, P1856, DOI 10.1093/infdis/jiv338; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Ness RB, 2003, J NATL MED ASSOC, V95, P201; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ryckman KK, 2008, J REPROD IMMUNOL, V78, P166, DOI 10.1016/j.jri.2008.01.003; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x	42	87	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181135	10.1371/journal.pone.0181135	http://dx.doi.org/10.1371/journal.pone.0181135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700747	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400033
J	Chen, VCH; Hsu, TC; Chen, LJ; Chou, HC; Weng, JC; Tzang, BS				Chen, Vincent Chin-Hung; Hsu, Tsai-Ching; Chen, Li-Jeng; Chou, Hong-Chun; Weng, Jun-Cheng; Tzang, Bor-Show			Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; LOW-FREQUENCY FLUCTUATION; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; AMYGDALA MORPHOLOGY; ATTENTION; ADHD; CHILDREN; AMPLITUDE; INFLAMMATION	Attention deficit hyperactivity disorder (ADHD) is a global behavior illness among children and adults. To investigate the effects of taurine on resting-state fMRI activity in ADHD, a spontaneously hypertensive rat (SHR) animal model was adopted. Significantly decreased serum C-reactive protein (CRP) was detected in rats of Wistar Kyoto (WKY) high-taurine group and significantly decreased interleukin (IL)-1 beta and CRP were detected in rats of SHR low-taurine and high-taurine groups. Moreover, significantly higher horizontal locomotion was detected in rats of WKY low-taurine and SHR low-taurine groups than in those of controls. In contrast, significantly lower horizontal locomotion was detected in rats of the SHR high-taurine group than in those of the SHR control group. Additionally, significantly lower functional connectivity (FC) and mean amplitude of low-frequency fluctuation (mALFF) in the bilateral hippocampus in rats of WKY high-taurine and SHR high-taurine groups was detected. Notably, the mALFF in rats of the SHR low-taurine and high-taurine groups was significantly lower than in those of the SHR control group. These findings suggest that the administration of a high-dose taurine probably improves hyperactive behavior in SHR rats by ameliorating the inflammatory cytokines and modulating brain functional signals in SHR rats.	[Chen, Vincent Chin-Hung] Chang Gung Univ, Dept Psychiat, Taoyuan, Taiwan; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Hsu, Tsai-Ching; Chen, Li-Jeng; Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Hsu, Tsai-Ching; Tzang, Bor-Show] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Chou, Hong-Chun; Weng, Jun-Cheng] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Weng, Jun-Cheng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung University; Chung Shan Medical University	Tzang, BS (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Tzang, BS (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan.; Weng, JC (corresponding author), Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.; Weng, JC (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Tzang, BS (corresponding author), Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.	jcweng@mail.cgu.edu.tw; bstzang@csmu.edu.tw		Bor-Show, Tzang/0000-0003-0140-9943	Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [CMRPG6E0261]; Ministry of Science and Technology, Taipei, Taiwan [MOST104-2628-E-040-001-MY2]	Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Ministry of Science and Technology, Taipei, Taiwan	This study was funded by Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (CMRPG6E0261). This study was also funded by the Ministry of Science and Technology, Taipei, Taiwan (MOST104-2628-E-040-001-MY2).	Arnsten AFT, 2009, J PEDIATR-US, V154, pS22, DOI 10.1016/j.jpeds.2009.01.018; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bhattarai JP, 2015, NEUROSCI LETT, V608, P51, DOI 10.1016/j.neulet.2015.10.012; Bidri M., 2003, Annales Pharmaceutiques Francaises, V61, P385; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Cortese S, 2012, EUR J PAEDIATR NEURO, V16, P422, DOI 10.1016/j.ejpn.2012.01.009; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; El Idrissi A, 2009, ADV EXP MED BIOL, V643, P207, DOI 10.1007/978-0-387-75681-3_21; Ericson M, 2006, EUR J NEUROSCI, V23, P3225, DOI 10.1111/j.1460-9568.2006.04868.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; GARCIADEYEBENESPROUS J, 1978, N-S ARCH PHARMACOL, V304, P95; Hennig E. M., 1995, Tidsskrift for den Norske Laegeforening, V115, P1632; Holtmann M, 2013, Z KINDER JUG-PSYCH, V41, P393, DOI 10.1024/1422-4917/a000255; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; Kamikawa H, 1998, AM J PHYSIOL-REG I, V275, pR803, DOI 10.1152/ajpregu.1998.275.3.R803; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kontro P, 1987, Adv Exp Med Biol, V217, P347; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Lacosta S, 1998, PSYCHOPHARMACOLOGY, V137, P351, DOI 10.1007/s002130050630; Li F, 2014, RADIOLOGY, V272, P514, DOI 10.1148/radiol.14131622; Li XW, NUTR NEUROSCI; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Lima L, 2001, NUTR NEUROSCI, V4, P439, DOI 10.1080/1028415X.2001.11747379; Lovell B, 2012, PSYCHONEUROENDOCRINO, V37, P534, DOI 10.1016/j.psyneuen.2011.08.003; Mitchell RHB, 2014, J AM ACAD CHILD PSY, V53, P274, DOI 10.1016/j.jaac.2013.11.013; Mitterschiffthaler MT, 2006, J MAGN RESON IMAGING, V23, P851, DOI 10.1002/jmri.20590; O'Shea TM, 2014, PEDIATR RES, V75, P781, DOI 10.1038/pr.2014.41; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Perlov E, 2008, J PSYCHIATR NEUROSCI, V33, P509; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Toyoda A, 2013, ADV EXP MED BIOL, V775, P29, DOI 10.1007/978-1-4614-6130-2_3; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Umehara M, 2013, EUR J PHARMACOL, V702, P250, DOI 10.1016/j.ejphar.2013.01.033; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028; Yue YY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/505479; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang CG, 2007, ANN NUTR METAB, V51, P379, DOI 10.1159/000107687; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zubarev O E, 2011, Ross Fiziol Zh Im I M Sechenova, V97, P1048	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181122	10.1371/journal.pone.0181122	http://dx.doi.org/10.1371/journal.pone.0181122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700674	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800125
J	Krajewska, J; Modrak-Wojcik, A; Arent, ZJ; Wieckowski, D; Zolkiewski, M; Bzowska, A; Kedzierska-Mieszkowska, S				Krajewska, Joanna; Modrak-Wojcik, Anna; Arent, Zbigniew J.; Wieckowski, Daniel; Zolkiewski, Michal; Bzowska, Agnieszka; Kedzierska-Mieszkowska, Sabina			Characterization of the molecular chaperone ClpB from the pathogenic spirochaete Leptospira interrogans	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRESS TOLERANCE; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; ATPASE CLPB; DNAK; ULTRACENTRIFUGATION; THERMOTOLERANCE; OLIGOMERIZATION; VIRULENCE	Leptospira interrogans is a spirochaete responsible for leptospirosis in mammals. The molecular mechanisms of the Leptospira virulence remain mostly unknown. Recently, it has been demonstrated that an AAA + chaperone ClpB ( a member of the Hsp100 family) from L. interrogans (ClpBLi) is not only essential for survival of Leptospira under the thermal and oxidative stresses, but also during infection of a host. The aim of this study was to provide further insight into the role of ClpB in the pathogenic spirochaetes and explore its biochemical properties. We found that a non-hydrolysable ATP analogue, ATP.S, but not AMP-PNP induces the formation of ClpBLi hexamers and stabilizes the associated form of the chaperone. ADP also induces structural changes in ClpBLi and promotes its self-assembly, but does not produce full association into the hexamers. We also demonstrated that ClpBLi exhibits a weak ATPase activity that is stimulated by.-casein and poly-lysine, and may mediate protein disaggregation independently from the DnaK chaperone system. Unexpectedly, the presence of E.coli DnaK/DnaJ/GrpE did not significantly affect the disaggregation activity of ClpBLi and ClpBLi did not substitute for the ClpBEc function in the clpB-null E. coli strain. This result underscores the species-specificity of the ClpB cooperation with the cochaperones and is most likely due to a loss of interactions between the ClpBLi middle domain and the E. coli DnaK. We also found that ClpBLi interacts more efficiently with the aggregated G6PDH in the presence of ATP.S rather than ATP. Our results indicate that ClpB's importance during infection might be due to its role as a molecular chaperone involved in reactivation of protein aggregates.	[Krajewska, Joanna; Wieckowski, Daniel; Kedzierska-Mieszkowska, Sabina] Univ Gdansk, Fac Biol, Dept Gen & Med Biochem, Gdansk, Poland; [Modrak-Wojcik, Anna; Bzowska, Agnieszka] Univ Warsaw, Fac Phys, Inst Expt Phys, Div Biophys, Warsaw, Poland; [Arent, Zbigniew J.] Agr Univ Krakow, Univ Ctr Vet Med UJ UR, Krakow, Poland; [Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Fahrenheit Universities; University of Gdansk; University of Warsaw; Agricultural University Krakow; Kansas State University	Kedzierska-Mieszkowska, S (corresponding author), Univ Gdansk, Fac Biol, Dept Gen & Med Biochem, Gdansk, Poland.	sabina.kedzierska-mieszkowska@biol.ug.edu.pl	Arent, Zbigniew/ABB-8706-2020; Kędzierska-Mieszkowska, Sabina/AAF-2737-2021	Kędzierska-Mieszkowska, Sabina/0000-0001-5756-3013; Arent, Zbigniew/0000-0002-5997-2555; Bzowska, Agnieszka/0000-0002-3976-429X; Krajewska, Joanna/0000-0003-0412-4265	National Science Center (Poland) [2015/17/N/NZ6/03493]; UG grants [538-L130-B588-14, 538-L130-B929-15]; NanoFun laboratories; European Regional Development Fund within Innovation Economy Operational Program [POIG.02.02.00-00-025/09]	National Science Center (Poland); UG grants; NanoFun laboratories; European Regional Development Fund within Innovation Economy Operational Program	This work was supported by the Preludium Grant number 2015/17/N/NZ6/03493 (to JK) from the National Science Center (Poland) and UG grants for Young Scientists numbers 538-L130-B588-14 and 538-L130-B929-15 (to JK). The analytical ultracentrifugation experiments were performed in the NanoFun laboratories co-financed by the European Regional Development Fund within the Innovation Economy Operational Program, project no. POIG.02.02.00-00-025/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2011, VET MICROBIOL, V153, P73, DOI 10.1016/j.vetmic.2011.02.055; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Arent Z, 2013, VET REC, V173, DOI 10.1136/vr.101969; Arent ZJ, 2013, EPIDEMIOL INFECT, V141, P1148, DOI 10.1017/S0950268812002087; Arent ZJ, 2013, VET REC, V172, DOI 10.1136/vr.101239; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chastanet A, 2004, J BACTERIOL, V186, P1165, DOI 10.1128/JB.186.4.1165-1174.2004; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harlow E., 1988, ANTIBODIES LAB MANUA; Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krajewska J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0774-8; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lin JB, 2015, PROTEINS, V83, P2008, DOI 10.1002/prot.24914; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; Ngansop F, 2013, BIOCHEM BIOPH RES CO, V439, P191, DOI 10.1016/j.bbrc.2013.08.064; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; Rosenzweig R, 2015, P NATL ACAD SCI USA, V112, pE6872, DOI 10.1073/pnas.1512783112; Ryan EG, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-8; Schacherl M, 2013, ACTA CRYSTALLOGR D, V69, P2440, DOI 10.1107/S0907444913022683; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlee S, 2004, J MOL BIOL, V336, P275, DOI 10.1016/j.jmb.2003.12.013; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Strub C, 2003, FEBS LETT, V553, P125, DOI 10.1016/S0014-5793(03)00985-2; Sugimoto S, 2006, J BACTERIOL, V188, P8070, DOI 10.1128/JB.00404-06; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Zblewska K, 2014, ARCH BIOCHEM BIOPHYS, V555, P23, DOI 10.1016/j.abb.2014.05.012; Zmijewski MA, 2004, J MOL BIOL, V336, P539, DOI 10.1016/j.jmb.2003.12.053; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	43	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181118	10.1371/journal.pone.0181118	http://dx.doi.org/10.1371/journal.pone.0181118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700685	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800124
J	Hoon, M; Krishnamoorthy, V; Gollisch, T; Falkenburger, B; Varoqueaux, F				Hoon, Mrinalini; Krishnamoorthy, Vidhyasankar; Gollisch, Tim; Falkenburger, Bjoern; Varoqueaux, Frederique			Loss of Neuroligin3 specifically downregulates retinal GABA(Aa)2 receptors without abolishing direction selectivity	PLOS ONE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; MAMMALIAN RETINA; RAT RETINA; GLYCINE RECEPTORS; GANGLION-CELLS; MOUSE MODEL; SYNAPSES; AUTISM; PROTEIN; LOCALIZATION	The postsynaptic adhesion proteins Neuroligins (NLs) are essential for proper synapse function, and their alterations are associated with a variety of neurodevelopmental disorders. It is increasingly clear that each NL isoform occupies specific subsets of synapses and is able to regulate the function of discrete networks. Studies of NL2 and NL4 in the retina in particular have contributed towards uncovering their role in inhibitory synapse function. In this study we show that NL3 is also predominantly expressed at inhibitory postsynapses in the retinal inner plexiform layer (IPL), where it colocalizes with both GABA(A)- and glycinergic receptor clusters in a 3: 2 ratio. In the NL3 deletion-mutant (knockout or KO) mouse, we uncovered a dramatic reduction of the number of GABA(A)alpha 2-subunit containing GABA(A) receptor clusters at the IPL. Retinal activity was thereafter assessed in KO and wild-type (WT) littermates by multi-electrode-array recordings of the output cells of retina, the retinal ganglion cells (RGCs). RGCs in the NL3 KO showed reduced spontaneous activity and an altered response to white noise stimulation. Moreover, upon application of light flashes, the proportion of cells firing at light offset (OFF RGCs) was significantly lower in the NL3 KO compared to WT littermates, whereas the relative number of cells firing at light onset (ON RGCs) increased. Interestingly, although GABA(A)alpha 2-bearing receptors have been related to direction-selective circuits of the retina, features of direction selective-retinal ganglion cells recorded remained unperturbed in the NL3 KO. Together our data underscore the importance of NL3 for the integrity of specific GABA(A)ergic retinal circuits and identifies NL3 as an important regulator of retinal activity.	[Hoon, Mrinalini; Varoqueaux, Frederique] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Hoon, Mrinalini; Varoqueaux, Frederique] Deutsch Forsch Gemeinschaft, Res Ctr Mol Physiol Brain, Gottingen, Germany; [Krishnamoorthy, Vidhyasankar; Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, Gottingen, Germany; [Krishnamoorthy, Vidhyasankar; Gollisch, Tim] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Falkenburger, Bjoern] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Varoqueaux, Frederique] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Hoon, Mrinalini] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Max Planck Society; University of Gottingen; RWTH Aachen University; University of Lausanne; University of Washington; University of Washington Seattle	Hoon, M; Varoqueaux, F (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany.; Hoon, M; Varoqueaux, F (corresponding author), Deutsch Forsch Gemeinschaft, Res Ctr Mol Physiol Brain, Gottingen, Germany.; Varoqueaux, F (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.; Hoon, M (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	mhoon@uw.edu; frederique.varoqueaux@unil.ch	889, CRC/L-1607-2018; Varoqueaux, Frederique/AAC-1834-2021	889, CRC/0000-0002-6678-3138; Varoqueaux, Frederique/0000-0002-3614-3121; Falkenburger, Bjoern/0000-0002-2387-526X; Gollisch, Tim/0000-0003-3998-533X	Cure Autism Now Foundation; Swiss National Science Foundation (Marie-Heim Vogtlin) [PMPDP3_158377]; Hertie Foundation; European Community Grants NEUREST [MEST-CT-2004-504193]; Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft Collaborative Research Center [889]	Cure Autism Now Foundation; Swiss National Science Foundation (Marie-Heim Vogtlin); Hertie Foundation; European Community Grants NEUREST; Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG))	This work was funded by the Cure Autism Now Foundation (F.V.) and the Swiss National Science Foundation (Marie-Heim Vogtlin grant PMPDP3_158377 to F.V.); the Hertie Foundation (M. H.); European Community Grants NEUREST MEST-CT-2004-504193 (to M.H.); the Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain (M. H., B. F. and F.V.); the Deutsche Forschungsgemeinschaft Collaborative Research Center 889, project C1 (T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auferkorte ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035109; Babaev O, 2016, NEUROPHARMACOLOGY, V100, P56, DOI 10.1016/j.neuropharm.2015.06.016; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; Bleckert A, 2011, BIOESSAYS, V33, P61, DOI 10.1002/bies.201000095; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Casini G, 2000, J COMP NEUROL, V421, P275; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Espinosa Felipe, 2015, Front Synaptic Neurosci, V7, P11, DOI 10.3389/fnsyn.2015.00011; Fiscella M, 2015, J NEUROPHYSIOL, V114, P2485, DOI 10.1152/jn.00919.2014; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; Garvert MM, 2013, NEURON, V77, P915, DOI 10.1016/j.neuron.2012.12.030; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hammer M, 2015, CELL REP, V13, P516, DOI 10.1016/j.celrep.2015.09.011; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hoon M, 2014, PROG RETIN EYE RES, V42, P44, DOI 10.1016/j.preteyeres.2014.06.003; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jedlicka P, 2015, BRAIN STRUCT FUNCT, V220, P47, DOI 10.1007/s00429-013-0636-1; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kim JYV, 2016, PAIN, V157, P1314, DOI 10.1097/j.pain.0000000000000513; Klooster J, 2009, J CHEM NEUROANAT, V37, P254, DOI 10.1016/j.jchemneu.2009.02.004; Koulen P, 1998, J NEUROSCI, V18, P10136; Koulen P, 1997, NEUROREPORT, V8, P2845, DOI 10.1097/00001756-199709080-00008; Koulen P, 1996, J NEUROSCI, V16, P2127; Krishnamoorthy V, 2017, ELIFE, V6, DOI [10.7554/eLife.22431, 10.7554/eLife.221431]; Kuhn NK, 2016, J NEUROSCI, V36, P12203, DOI 10.1523/JNEUROSCI.1971-16.2016; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Mazurek M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00092; Nobles RD, 2012, J NEUROSCI, V32, P3321, DOI 10.1523/JNEUROSCI.5341-11.2012; Pei Z, 2015, J NEUROSCI, V35, P13219, DOI 10.1523/JNEUROSCI.0933-15.2015; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rivlin-Etzion M, 2012, NEURON, V76, P518, DOI 10.1016/j.neuron.2012.08.041; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takacs VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072450; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3	59	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181011	10.1371/journal.pone.0181011	http://dx.doi.org/10.1371/journal.pone.0181011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708891	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649800037
J	Loupasakis, K; Kuo, D; Sokhi, UK; Sohn, C; Syracuse, B; Giannopoulou, EG; Park, SH; Kang, H; Ratsch, G; Ivashkiv, LB; Kalliolias, GD				Loupasakis, Konstantinos; Kuo, David; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Kang, Hyelim; Ratsch, Gunnar; Ivashkiv, Lionel B.; Kalliolias, George D.			Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; TRISTETRAPROLIN; TRANSCRIPTION; INFLAMMATION; BINDING	During rheumatoid arthritis (RA), Tumor Necrosis Factor (TNF) activates fibroblast-like synoviocytes (FLS) inducing in a temporal order a constellation of genes, which perpetuate synovial inflammation. Although the molecular mechanisms regulating TNF-induced transcription are well characterized, little is known about the impact of mRNA stability on gene expression and the impact of TNF on decay rates of mRNA transcripts in FLS. To address these issues we performed RNA sequencing and genome-wide analysis of the mRNA stabilome in RA FLS. We found that TNF induces a biphasic gene expression program: initially, the inducible transcriptome consists primarily of unstable transcripts but progressively switches and becomes dominated by very stable transcripts. This temporal switch is due to: a) TNF-induced prolonged stabilization of previously unstable transcripts that enables progressive transcript accumulation over days and b) sustained expression and late induction of very stable transcripts. TNF-induced mRNA stabilization in RA FLS occurs during the late phase of TNF response, is MAPK-dependent, and involves several genes with pathogenic potential such as IL6, CXCL1, CXCL3, CXCL8/IL8, CCL2, and PTGS2. These results provide the first insights into genome-wide regulation of mRNA stability in RA FLS and highlight the potential contribution of dynamic regulation of the mRNA stabilome by TNF to chronic synovitis.	[Loupasakis, Konstantinos; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Ivashkiv, Lionel B.; Kalliolias, George D.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Loupasakis, Konstantinos; Sokhi, Upneet K.; Sohn, Christopher; Syracuse, Bethany; Giannopoulou, Eugenia G.; Park, Sung Ho; Ivashkiv, Lionel B.; Kalliolias, George D.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Kuo, David] Weill Cornell Grad Sch Med Sci, Grad Program Physiol Biophys & Syst Biol, New York, NY USA; [Kuo, David; Ratsch, Gunnar] Sloan Kettering Inst, Computat Biol Program, New York, NY USA; [Giannopoulou, Eugenia G.; Kang, Hyelim] CUNY, New York City Coll Technol, Biol Sci Dept, Brooklyn, NY 11210 USA; [Ratsch, Gunnar] ETH, Dept Comp Sci, Zurich, Switzerland	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kalliolias, GD (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.; Kalliolias, GD (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.	kallioliasg@hss.com	Loupasakis, Konstantinos/AAD-5330-2021; Rätsch, Gunnar/O-5914-2017; Giannopoulou, Evgenia/K-9576-2019; Kalliolias, George D./H-3136-2019	Rätsch, Gunnar/0000-0001-5486-8532; Kalliolias, George D./0000-0002-4427-8245; SOKHI, UPNEET/0000-0001-5907-5646; Kuo, David/0000-0001-9003-9993	Arthritis National Research Foundation; NIH/NIAMS; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER	Arthritis National Research Foundation(National Research Foundation of Korea); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by Arthritis National Research Foundation provided support to GDK. NIH/NIAMS provided support to LBI. Rheumatology Research Foundation provided support to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huynh L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31959; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhong Y, 2016, BIOINFORMATICS	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179762	10.1371/journal.pone.0179762	http://dx.doi.org/10.1371/journal.pone.0179762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708839	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800006
J	Li, N; Li, SM; Zhang, KP; Chen, WJ; Zhang, B; Wang, DW; Liu, DC; Liu, BL; Zhang, HG				Li, Na; Li, Shiming; Zhang, Kunpu; Chen, Wenjie; Zhang, Bo; Wang, Daowen; Liu, Dengcai; Liu, Baolong; Zhang, Huaigang			ThMYC4E, candidate Blue aleurone 1 gene controlling the associated trait in Triticum aestivum	PLOS ONE			English	Article							BLUE-GRAINED WHEAT; REGULATORY GENES; DEVELOPING SEEDS; DIPLOID WHEAT; ANTHOCYANIN; EXPRESSION; BIOSYNTHESIS; CLONING; PURPLE; ORIGIN	Blue aleurone is a useful and interesting trait in common wheat that was derived from related species. Here, transcriptomes of blue and white aleurone were compared for isolating Blue aleurone 1 (Ba1) transferred from Thinopyrum ponticum. In the genes involved in anthocyanin biosynthesis, only a basic helix-loop-helix (bHLH) transcription factor, ThMYC4E, had a higher transcript level in blue aleurone phenotype, and was homologous to the genes on chromosome 4 of Triticum aestivum. ThMYC4E carried the characteristic domains (bHLH-MYC_ N, HLH and ACT-like) of a bHLH transcription factor, and clustered with genes regulating anthocyanin biosynthesis upon phylogenetic analysis. The over-expression of ThMYC4E regulated anthocyanin biosynthesis with the coexpression of the MYB transcription factor ZmC1 from maize. ThM YC4E existed in the genomes of the addition, substitution and near isogenic lines with the blue aleurone trait derived from Th. ponticum, and could not be detected in any germplasm of T. urartu, T. monococcum, T. turgidum, Aegilops tauschii or T. aestivum, with white aleurone. These results suggested that ThMYC4E was candidate Ba1 gene controlling the blue aleurone trait in T. aestivum genotypes carrying Th. ponticum introgression. The ThMYC4E isolation aids in better understanding the genetic mechanisms of the blue aleurone trait and in its more effective use during wheat breeding.	[Li, Na; Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Baolong; Zhang, Huaigang] Qinghai Prov Key Lab Crop Mol Breeding, Xining, Peoples R China; [Li, Na] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Baolong; Zhang, Huaigang] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Xining, Qinghai, Peoples R China; [Zhang, Kunpu; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Liu, Dengcai] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Sichuan Agricultural University	Liu, BL; Zhang, HG (corresponding author), Qinghai Prov Key Lab Crop Mol Breeding, Xining, Peoples R China.; Liu, BL; Zhang, HG (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Xining, Qinghai, Peoples R China.	blliu@nwipb.cas.cn; hgzhang@nwipb.cas.cn	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; Liu, Dengcai/0000-0001-5508-1125; liu, bao long/0000-0002-6756-4033	Ministry of Science and Technology of China [2016YFD0100500]; Basic Research Projects of Qinghai Province [2015-ZJ-701]; West Light Foundation of the Chinese Academy of Sciences; National Natural Science Foundation of China [31071417, 31260322]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08030106]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Basic Research Projects of Qinghai Province; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by the Ministry of Science and Technology of China (2016YFD0100500), the Basic Research Projects of Qinghai Province (2015-ZJ-701), the West Light Foundation of the Chinese Academy of Sciences, the National Natural Science Foundation of China (31071417, 31260322) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA08030106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2003, J AGR FOOD CHEM, V51, P2174, DOI 10.1021/jf021043x; Ahmed N, 2003, BREEDING SCI, V53, P29; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bowen-Forbes CS, 2010, J FOOD COMPOS ANAL, V23, P554, DOI 10.1016/j.jfca.2009.08.012; Buresova V, 2015, THEOR APPL GENET, V128, P273, DOI 10.1007/s00122-014-2427-3; Carpenter R, 1990, GENE DEV, V4, P537; Dorn KM, 2013, PLANT J, V75, P1028, DOI 10.1111/tpj.12267; Dubcovsky J, 1996, GENETICS, V143, P983; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hucl P, 2001, CROP SCI, V41, P1348, DOI 10.2135/cropsci2001.4141348x; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; LI ZS, 1986, CEREAL RES COMMUN, V14, P133; Liu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155428; Metzger RJ, 2004, CROP SCI, V44, P2281, DOI 10.2135/cropsci2004.2281; Mori M, 2009, BIOSCI BIOTECH BIOCH, V73, P2329, DOI 10.1271/bbb.90349; Morrison LA, 2004, CROP SCI, V44, P2063, DOI 10.2135/cropsci2004.2063; Petroni K, 2000, GENETICS, V155, P323; Procissi A, 1997, PLANT CELL, V9, P1547, DOI 10.1105/tpc.9.9.1547; Qiu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151067; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Singh K, 2007, THEOR APPL GENET, V115, P301, DOI 10.1007/s00122-007-0543-z; Styles ED, 2011, GENOME, V15, P59; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TONELLI C, 1991, MOL GEN GENET, V225, P401, DOI 10.1007/BF00261680; Troian V, 2004, J CEREAL SCI, V59, P48; Wang CX, 2007, CHINESE SCI BULL, V52, P3097, DOI 10.1007/s11434-007-0472-x; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Whang SS, 2011, J PLANT BIOL, V54, P209, DOI 10.1007/s12374-011-9158-7; Whelan ED, 2011, GENOME, V32, P30; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Yang GH, 2004, ACTA BOT SIN, V46, P588; Yang GH, 2003, ACTA BOT SIN, V45, P1329; ZELLER FJ, 1991, THEOR APPL GENET, V81, P551, DOI 10.1007/BF00219448; ZEVEN AC, 1991, EUPHYTICA, V56, P243, DOI 10.1007/BF00042371; Zhang N, 2014, MOL BIOL REP, V41, P505, DOI 10.1007/s11033-013-2886-7; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zheng Q, 2006, EUPHYTICA, V152, P51, DOI 10.1007/s10681-006-9176-6; Zheng Q, 2009, J GENET GENOMICS, V36, P575, DOI 10.1016/S1673-8527(08)60149-6; Zhou KJ, 2006, CROP SCI, V46, P250, DOI 10.2135/cropsci2005.0029	43	23	27	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181116	10.1371/journal.pone.0181116	http://dx.doi.org/10.1371/journal.pone.0181116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704468	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700091
J	Singh, C; Levy, WB				Singh, Chandan; Levy, William B.			A consensus layer V pyramidal neuron can sustain interpulse-interval coding	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; SODIUM-CHANNEL; SIMPLE CELLS; DIFFUSION-APPROXIMATION; DIRECTION SELECTIVITY; BAYESIAN-INFERENCE; PERSISTENT SODIUM; MODEL NEURON; POPULATION; NOISE	In terms of a single neuron's long-distance communication, interpulse intervals (IPIs) are an attractive alternative to rate and binary codes. As a proxy for an IPI, a neuron's time-to-spike can be found in the biophysical and experimental intracellular literature. Using the current, consensus layer V pyramidal neuron, the present study examines the feasibility of IPI-coding and examines the noise sources that limit the information rate of such an encoding. In descending order of importance, the noise sources are (i) synaptic variability, (ii) sodium channel shot-noise, followed by (iii) thermal noise. The biophysical simulations allow the calculation of mutual information, which is about 3.0 bits/spike. More importantly, while, by any conventional definition, the biophysical model is highly nonlinear, the underlying function that relates input intensity to the defined output variable is linear. When one assumes the perspective of a neuron coding via first hitting-time, this result justifies a pervasive and simplifying assumption of computational modelers D that a class of cortical neurons can be treated as linearly additive, computational devices.	[Levy, William B.] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA; Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Levy, WB (corresponding author), Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA.	wbl@virginia.edu			US National Science Foundation [1162449]; Department of Neurosurgery	US National Science Foundation(National Science Foundation (NSF)); Department of Neurosurgery	We thank the Department of Neurosurgery for their financial support and also are thankful for the US National Science Foundation Grant 1162449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; [Anonymous], 2001, ION CHANNELS EXCITAB; Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bahl A, 2012, J NEUROSCI METH, V210, P22, DOI 10.1016/j.jneumeth.2012.04.006; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Baranauskas G, 2013, P NATL ACAD SCI USA, V110, P4051, DOI 10.1073/pnas.1215125110; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Barbour A.D., 1992, POISSON APPROXIMATIO; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Berger T, 2010, IEEE T INFORM THEORY, V56, P852, DOI 10.1109/TIT.2009.2037089; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Berry MJ, 1998, J NEUROSCI, V18, P2200; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; CAPOCELLI RM, 1971, KYBERNETIK, V8, P214, DOI 10.1007/BF00288750; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carnevale NT, 2006, NEURON BOOK; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; CHEN LHY, 1975, ANN PROBAB, V3, P534, DOI 10.1214/aop/1176996359; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; CONTI F, 1976, J PHYSIOL-LONDON, V262, P699, DOI 10.1113/jphysiol.1976.sp011616; Cook EP, 2007, PROG BRAIN RES, V165, P1, DOI 10.1016/S0079-6123(06)65001-2; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Ermentrout G., 2010, MATH FDN NEUROSCIENC, V35; Faisal A. A., 2012, COMPUTATIONAL SYSTEM, P227, DOI [10.1007/978-94-007-3858-4-8, DOI 10.1007/978-94-007-3858-4-8]; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Ferster David, 1994, Current Opinion in Neurobiology, V4, P563, DOI 10.1016/0959-4388(94)90058-2; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gerwinn S, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00012; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GIORNO V, 1988, BIOL CYBERN, V58, P387, DOI 10.1007/BF00361346; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; HILLE B, 1978, BIOPHYS J, V22, P283, DOI 10.1016/S0006-3495(78)85489-7; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Iyengar S, 1997, BIOL CYBERN, V77, P289, DOI 10.1007/s004220050390; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jie Xing, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P2964, DOI 10.1109/ISIT.2012.6284081; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Lansky P, 2001, PHYS LETT A, V285, P132, DOI 10.1016/S0375-9601(01)00340-1; LANSKY P, 1995, BIOL CYBERN, V72, P397, DOI 10.1007/BF00201415; Lansky P., 1990, TRENDS BIOL CYBERN, V1, P153; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; LEVY W B, 1988, Society for Neuroscience Abstracts, V14, P168; Levy W. B., 2016, IEEE T MOL BIOL MULT, V2, P154; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; Levy WB, 1990, ELEMENTAL ADAPTIVE P, V187; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McDonnell MD, 2011, BIOL CYBERN, V105, P55, DOI 10.1007/s00422-011-0451-9; Morel D, 2008, BMC NEUROSCI, V9, P1; Morel D, 2007, NEUROCOMPUTING, V70, P1635, DOI 10.1016/j.neucom.2006.10.054; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Reinagel P., 1998, Society for Neuroscience Abstracts, V24, P139; Revah O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132108; RICCIARDI LM, 1979, BIOL CYBERN, V35, P1, DOI 10.1007/BF01845839; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; RIEKE F, 1993, EUROPHYS LETT, V22, P151, DOI 10.1209/0295-5075/22/2/013; Rieke F, 1997, ROB RUYTER STEVENINC; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rotaru DC, 2007, J PHYSIOL-LONDON, V581, P981, DOI 10.1113/jphysiol.2007.130864; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schrodinger E., 1968, STAT THERMODYNAMICS; Sengupta B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003439; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; Steinmetz PN, 2000, J COMPUT NEUROSCI, V9, P133, DOI 10.1023/A:1008967807741; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Sugihara T, 2011, J NEUROPHYSIOL, V106, P374, DOI 10.1152/jn.00928.2010; Sungkar M., 2016, IEEE T MOL BIOL MULT, V2, P166; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Tuckwell H. C., 2005, INTRO THEORETICAL NE, V8; Tuckwell H. C., 2005, INTRO THEORETICAL NE, V2; Tuckwell HC, 2016, ARXIV160404796; van Rossum MCW, 2003, J NEUROPHYSIOL, V89, P2406, DOI 10.1152/jn.01106.2002; Wald A., 1973, SEQUENTIAL ANAL; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Warland DK, 1991, READING SPIKES REAL; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Yarom Y, 2011, PHYSIOL REV, V91, P917, DOI 10.1152/physrev.00019.2010; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	110	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180839	10.1371/journal.pone.0180839	http://dx.doi.org/10.1371/journal.pone.0180839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704450	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700054
J	Rodriguez, A; Tembl, J; Mesa-Gresa, P; Munoz, MA; Montoya, P; Rey, B				Rodriguez, Alejandro; Tembl, Jose; Mesa-Gresa, Patricia; Angel Munoz, Miguel; Montoya, Pedro; Rey, Beatriz			Altered cerebral blood flow velocity features in fibromyalgia patients in resting-state conditions	PLOS ONE			English	Article							LEMPEL-ZIV COMPLEXITY; COGNITIVE TASKS; DOMAIN ANALYSIS; BRAIN ACTIVITY; PAIN; DEPRESSION; RESPONSES; CONNECTIVITY; ENTROPY; EEG	The aim of this study is to characterize in resting-state conditions the cerebral blood flow velocity (CBFV) signals of fibromyalgia patients. The anterior and middle cerebral arteries of both hemispheres from 15 women with fibromyalgia and 15 healthy women were monitored using Transcranial Doppler (TCD) during a 5-minute eyes-closed resting period. Several signal processing methods based on time, information theory, frequency and time-frequency analyses were used in order to extract different features to characterize the CBFV signals in the different vessels. Main results indicated that, in comparison with control subjects, fibromyalgia patients showed a higher complexity of the envelope CBFV and a different distribution of the power spectral density. In addition, it has been observed that complexity and spectral features show correlations with clinical pain parameters and emotional factors. The characterization features were used in a lineal model to discriminate between fibromyalgia patients and healthy controls, providing a high accuracy. These findings indicate that CBFV signals, specifically their complexity and spectral characteristics, contain information that may be relevant for the assessment of fibromyalgia patients in resting-state conditions.	[Rodriguez, Alejandro; Rey, Beatriz] Univ Politecn Valencia, Dept Ingn Graf, Camino Vera S-N, Valencia, Spain; [Tembl, Jose] Hosp Univ & Politecn La Fe, Dept Neurol, Valencia, Spain; [Mesa-Gresa, Patricia] Univ Valencia, Fac Psicol, Dept Psicobiol, Blasco Ibanez 21, Valencia, Spain; [Angel Munoz, Miguel] Univ Granada, Dept Personalidad Evaluac & Tratamientos Psicol, Granada, Spain; [Montoya, Pedro] Univ Illes Balears, IUNICS, Palma De Mallorca, Spain	Universitat Politecnica de Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; University of Granada; Universitat de les Illes Balears	Rey, B (corresponding author), Univ Politecn Valencia, Dept Ingn Graf, Camino Vera S-N, Valencia, Spain.	beareyso@dig.upv.es	Montoya, Pedro/A-4666-2009; Mesa, Patricia/M-3773-2014; Ortega, Alejandro Rodríguez/AAC-2208-2019; Muñoz, Miguel Angel/A-8067-2017; Rey, Beatriz/P-6897-2014	Montoya, Pedro/0000-0001-8652-948X; Ortega, Alejandro Rodríguez/0000-0003-4781-6368; Muñoz, Miguel Angel/0000-0002-8361-7297; Rey, Beatriz/0000-0001-9213-1443				Abasolo D, 2006, MED ENG PHYS, V28, P315, DOI 10.1016/j.medengphy.2005.07.004; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Aleem IS, 2012, ONLINE ENV CONTROL M; Mendez MA, 2012, J PSYCHOPHARMACOL, V26, P636, DOI 10.1177/0269881111408966; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bornas X, 2006, BIOL PSYCHOL, V73, P272, DOI 10.1016/j.biopsycho.2006.05.004; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craggs JG, 2012, J PAIN, V13, P390, DOI 10.1016/j.jpain.2012.01.002; Davis KD, 2000, NEUROL RES, V22, P313; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; Duschek S, 2012, PSYCHOSOM MED, V74, P802, DOI 10.1097/PSY.0b013e3182676d08; Duschek S, 2012, PAIN MED, V13, P419, DOI 10.1111/j.1526-4637.2012.01329.x; Duschek S, 2011, ANN BEHAV MED, V41, P235, DOI 10.1007/s12160-010-9237-x; Fallon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159198; Ferrer V. A., 1993, DOLOR, V8, P153; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Gonzalez-Roldan AM, 2016, PAIN MED, V17, P1058, DOI 10.1093/pm/pnw023; Huang H., 2013, CHARACTERIZATI UNPUB; Huang HR, 2013, ULTRASOUND MED BIOL, V39, P2285, DOI 10.1016/j.ultrasmedbio.2013.06.016; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Kim JY, 2013, PAIN, V154, P1792, DOI 10.1016/j.pain.2013.05.040; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li M, 2014, NEUROSCI RES, V84, P19, DOI 10.1016/j.neures.2014.02.009; Li YJ, 2008, CLIN NEUROPHYSIOL, V119, P1232, DOI 10.1016/j.clinph.2008.01.104; Lu J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00199; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Meagher MW, 2001, PSYCHOSOM MED, V63, P79, DOI 10.1097/00006842-200101000-00010; Montoro CI, 2016, PAIN MED, V17, P2256, DOI 10.1093/pm/pnw082; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Morton DL, 2016, J PAIN RES, V9, P613, DOI 10.2147/JPR.S60433; Myrden AJB, 2011, THESIS; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Rey B, 2010, ULTRASOUND MED BIOL, V36, P383, DOI 10.1016/j.ultrasmedbio.2009.11.001; del Paso GAR, 2015, J CLIN EXP NEUROPSYC, V37, P414, DOI 10.1080/13803395.2015.1023265; del Paso GAR, 2011, J PSYCHOSOM RES, V70, P125, DOI 10.1016/j.jpsychores.2010.09.012; del Paso GAR, 2010, PSYCHOSOM MED, V72, P462, DOI 10.1097/PSY.0b013e3181da91f1; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Sanz J., 2003, ANAL MODIF CONDUCT, P239, DOI DOI 10.6018/ANALESPS.29.1.130532; Sejdic E., 2010, BMC RES, V3, DOI DOI 10.1186/1756-0500-3-269; Sejdic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055405; Sluka KA, 2016, NEUROSCIENCE, V338, P114, DOI 10.1016/j.neuroscience.2016.06.006; Spielberger C. D., 1970, MANUAL STATE TRAIT I; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Ucar M, 2015, J INT MED RES, V43, P679, DOI 10.1177/0300060515587578; Weisenberg M, 1998, PAIN, V76, P365, DOI 10.1016/S0304-3959(98)00069-4; Witting N, 2006, PAIN, V120, P145, DOI 10.1016/j.pain.2005.10.034; Zhang Y, 2015, J AFFECT DISORDERS, V188, P310, DOI 10.1016/j.jad.2015.09.017	65	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180253	10.1371/journal.pone.0180253	http://dx.doi.org/10.1371/journal.pone.0180253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700720	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600024
J	Fatukasi, TV; Cole, SR; Moore, RD; Mathews, WC; Edwards, JK; Eron, JJ				Fatukasi, Terra V.; Cole, Stephen R.; Moore, Richard D.; Mathews, William C.; Edwards, Jessie K.; Eron, Joseph J.		CNICS Investigators	Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients	PLOS ONE			English	Article							VIROLOGICAL SUPPRESSION; INFECTED PATIENTS; DISPARITIES; MORTALITY; TRENDS; CARE; RACE	Prompt initiation of combination antiretroviral therapy (ART) is important to reduce comorbidity and mortality among people living with HIV, especially for those with a low CD4 cell count. However there is evidence that not everyone receives prompt initiation of ART after enrolling into HIV care. The current study investigated factors associated with failure to initiate ART within two years of entering into care among those with a CD4 count at or below 350 cells/mm 3. The sample included 4,907 ART-naive patients with a CD4 count at or below 350 cells/mm 3 enrolled between January 1, 2003 and December 31, 2012 at any of eight clinical sites in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS). The two-year risk of delayed ART initiation was estimated using a log-binomial regression model with stabilized inverse probability of censoring weights for those lost to follow-up. Adjusting for other factors, an earlier enrollment date was the sole demographic characteristic associated with an increased risk of delayed ART initiation. Higher CD4 count, lower viral load, and a prevalent AIDS diagnosis were clinical characteristics associated with delayed ART initiation. Gender, age, race/ethnicity and HIV risk factors such as reported male-to-male sexual contact and injection drug use were not associated with delayed ART initiation. This study identified characteristics of patients for whom treatment was strongly to moderately recommended but who did not initiate ART within two years of entering care. Despite the known benefits of early antiretroviral therapy initiation, a lower viral load measurement may continue to be an important clinical characteristic in the more recent era with current ART initiation guidelines. These findings provide a target for closer monitoring and intervention to reduce disparities in HIV care.	[Fatukasi, Terra V.; Cole, Stephen R.; Edwards, Jessie K.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Moore, Richard D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mathews, William C.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Eron, Joseph J.] Univ North Carolina Chapel Hill, Dept Med, Div Infect Dis, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fatukasi, TV (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.	tvmack@med.unc.edu		Edwards, Jessie/0000-0002-1741-335X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI100654]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, P30AI036214, P30AI027757, P30AI036219, P30AI027763, P30AI050410, P30AI060354, P30AI027767] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this thesis was supported by National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI100654 (https://www.niaid.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abara WE, 2014, AM J PUBLIC HEALTH, V104, pE135, DOI 10.2105/AJPH.2014.302227; Adedinsewo DA, 2014, AIDS PATIENT CARE ST, V28, P613, DOI 10.1089/apc.2014.0194; Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Centers for Disease Control and Prevention, STAT OV; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Hanna DB, 2013, CLIN INFECT DIS, V56, P1174, DOI 10.1093/cid/cit003; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsu LC, 2014, J INFECT DIS, V209, P1310, DOI 10.1093/infdis/jit599; Lemly DC, 2009, J INFECT DIS, V199, P991, DOI 10.1086/597124; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Novak RM, 2015, JAIDS-J ACQ IMM DEF, V70, P23, DOI 10.1097/QAI.0000000000000652; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412	18	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180843	10.1371/journal.pone.0180843	http://dx.doi.org/10.1371/journal.pone.0180843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700693	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800087
J	McDonald, LT; Johnson, SD; Russell, DL; Young, MRI; LaRue, AC				McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; Young, M. Rita I.; LaRue, Amanda C.			Role of a novel immune modulating DDR2-expressing population in silica-induced pulmonary fibrosis	PLOS ONE			English	Article							CELL-POPULATION; DENDRITIC CELLS; MICE; FIBROBLASTS; FIBROCYTES; MECHANISMS; BLEOMYCIN; DYNAMICS	Micro-injuries associated with chronic inhaled particle exposures are linked with activation of the immune response and are thought to contribute to progression of fibrotic disease. In the pulmonary environment, we have previously demonstrated a heterogeneous population of circulating fibroblast precursors (CFPs), which are defined by expression of the pan-leukocyte marker CD45 and the collagen receptor, discoidin domain receptor-2 (DDR2). This population is derived from the hematopoietic stem cell, expresses collagen, and has a fibro-blastic morphology in vitro. Herein, we demonstrate a novel subset of CFPs expressing immune markers CD11b, CD11c, and major histocompatibility complex II (MHC II). The CFP population was skewed toward this immune marker expressing subset in animals with silica-induced pulmonary fibrosis. Data indicate that this CFP subset upregulates co-stimulatory molecules and MHC II expression in response to silica-induced fibrosis in vivo. Functionally, this population was shown to promote T cell skewing away from a Th1 response and toward a pro-inflammatory profile. These studies represent the first direct flow cytometric and functional evaluation of the novel immune marker expressing CFP subset in an exposure-induced model of pulmonary fibrosis. Elucidating the role of this CFP subset may enhance our understanding of the complex immune balance critical to mediating exposures at the pulmonary-host interface and may be a valuable target for the treatment of exposure-induced pulmonary fibrosis.	[McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; Young, M. Rita I.; LaRue, Amanda C.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA; [McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; LaRue, Amanda C.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Young, M. Rita I.] Med Univ South Carolina, Dept Otolaryngol, Charleston, SC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	LaRue, AC (corresponding author), Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA.; LaRue, AC (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	laruerc@musc.edu	McDonald, Lindsay/K-2122-2019	McDonald, Lindsay/0000-0003-3967-4435; Russell, Dayvia/0000-0002-7804-2951; Sidles, Sara/0000-0001-7177-0270	Department of Veterans Affairs, VA Merit Award [BX-002277]; Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	Department of Veterans Affairs, VA Merit Award; Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs, VA Merit Award BX-002277 (ACL). The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government. This work was supported in part by the Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).	Abangan RS, 2010, AM J PATHOL, V176, P1914, DOI 10.2353/ajpath.2010.080839; Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC; Beamer CA, 2007, AM J RESP CELL MOL, V37, P729, DOI 10.1165/rcmb.2007-0099OC; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brass DM, 2010, AM J PHYSIOL-LUNG C, V299, pL664, DOI 10.1152/ajplung.00389.2009; Ebihara Y, 2006, EXP HEMATOL, V34, P219, DOI 10.1016/j.exphem.2005.10.008; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Kang Kyeongah, 2012, Immune Netw, V12, P104, DOI 10.4110/in.2012.12.3.104; KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003; Kuhn C, 1993, Monogr Pathol, P78; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee JE, 2007, BIOCHEM BIOPH RES CO, V352, P244, DOI 10.1016/j.bbrc.2006.11.010; McDonald LT, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/159713; McDonald LT, 2015, NEOPLASIA, V17, P434, DOI 10.1016/j.neo.2015.04.004; MCDONALD LT, 2015, J BONE MARROW RES, V3; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zelko IN, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0478-5	23	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180724	10.1371/journal.pone.0180724	http://dx.doi.org/10.1371/journal.pone.0180724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700752	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800069
J	Rasmussen, SL; Krarup, HB; Sunesen, KG; Johansen, MB; Stender, MT; Pedersen, IS; Madsen, PH; Thorlacius-Ussing, O				Rasmussen, Simon Ladefoged; Krarup, Henrik Bygum; Sunesen, Kare Gotschalck; Johansen, Martin Berg; Stender, Mogens Tornby; Pedersen, Inge Sokilde; Madsen, Poul Henning; Thorlacius-Ussing, Ole			Hypermethylated DNA, a circulating biomarker for colorectal cancer detection	PLOS ONE			English	Article							BLOOD; DIAGNOSIS; TRIAL	Background Colorectal cancer (CRC) is one of the most common cancers in the western world. Screening is an efficient method of reducing cancer-related mortality. Molecular biomarkers for cancer in general and CRC in particular have been proposed, and hypermethylated DNA from stool or blood samples are already implemented as biomarkers for CRC screening. We aimed to evaluate the performance of proven hypermethylated DNA promoter regions as plasma based biomarkers for CRC detection. Methods We conducted a cross-sectional case-control study of 193 CRC patients and 102 colonoscopy-verified healthy controls. Using methylation specific polymerase chain reaction, we evaluated 30 DNA promoter regions previously found to be CRC specific. We used multivariable logistic regression with stepwise backwards selection, and subsequent leave-pair-out cross validation, to calculate the optimism corrected area under the receiver operating characteristics curve (AUC) for all stage as well as early stage CRC. Results None of the individual DNA promoter regions provided an overall sensitivity above 30% at a reasonable specificity. However, seven hypermethylated promoter regions (ALX4, BMP3, NPTX2, RARB, SDC2, SEPT9, and VIM) along with the covariates sex and age yielded an optimism corrected AUC of 0.86 for all stage CRC and 0.85 for early stage CRC. Overall sensitivity for CRC detection was 90.7% at 72.5% specificity using a cut point value of 0.5. Conclusions Individual hypermethylated DNA promoter regions have limited value as CRC screening markers. However, a panel of seven hypermethylated promoter regions show great promise as a model for CRC detection.	[Rasmussen, Simon Ladefoged; Sunesen, Kare Gotschalck; Stender, Mogens Tornby; Thorlacius-Ussing, Ole] Aalborg Univ Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark; [Rasmussen, Simon Ladefoged; Krarup, Henrik Bygum; Pedersen, Inge Sokilde; Madsen, Poul Henning; Thorlacius-Ussing, Ole] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Rasmussen, Simon Ladefoged; Thorlacius-Ussing, Ole] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Krarup, Henrik Bygum; Pedersen, Inge Sokilde; Madsen, Poul Henning] Aalborg Univ Hosp, Sect Mol Diagnost, Clin Biochem, Aalborg, Denmark; [Johansen, Martin Berg] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Rasmussen, SL (corresponding author), Aalborg Univ Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark.; Rasmussen, SL (corresponding author), Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark.; Rasmussen, SL (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	simon.rasmussen@rn.dk	Pedersen, Inge Søkilde/ABB-1019-2020; Johansen, Martin Nygård/L-6845-2014	Pedersen, Inge Søkilde/0000-0002-9902-8040; Johansen, Martin Nygård/0000-0001-9790-0985; Thorlacius-Ussing, Ole/0000-0003-4963-1551; Rasmussen, Simon Ladefoged/0000-0002-2560-4877; Gotschalck, Kare Andersson/0000-0001-5119-2231; Krarup, Henrik/0000-0001-5294-2428	Aalborg University and Aalborg University Hospital; Region Nordjyllands Forskningsfond; Heinrich Kopps Legat; Eva og Henry Frankels Mindefond	Aalborg University and Aalborg University Hospital; Region Nordjyllands Forskningsfond; Heinrich Kopps Legat; Eva og Henry Frankels Mindefond	This study was primarily funded by Aalborg University and Aalborg University Hospital. Grant support was received from Region Nordjyllands Forskningsfond, Heinrich Kopps Legat, and Eva og Henry Frankels Mindefond.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Collins GS, 2015, BRIT J SURG, V102, P148, DOI 10.1002/bjs.9736; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Leong KJ, 2014, BRIT J SURG, V101, P1299, DOI 10.1002/bjs.9571; Lindebjerg J, 2014, DAN MED J, V61; Litovkin K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130651; Melotte V, 2015, CANCER PREV RES, V8, P157, DOI 10.1158/1940-6207.CAPR-14-0198; Oh T, 2013, J MOL DIAGN, P498; Payne SR, 2010, EPIGENOMICS-UK, V2, P575, DOI [10.2217/epi.10.35, 10.2217/EPI.10.35]; Pedersen IS, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-12; Rasmussen SL, 2016, COLORECTAL DIS, V18, P549, DOI 10.1111/codi.13336; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Song MM, 2015, JNCI-J NATL CANCER I, P107; Stender MT, 2008, THROMB HAEMOSTASIS, V99, P396, DOI 10.1160/TH07-06-0397; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050	23	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180809	10.1371/journal.pone.0180809	http://dx.doi.org/10.1371/journal.pone.0180809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700744	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800080
J	Murray, AS; Varela, FA; Hyland, TE; Schoenbeck, AJ; White, JM; Tanabe, LM; Todi, SV; List, K				Murray, Andrew S.; Varela, Fausto A.; Hyland, Thomas E.; Schoenbeck, Andrew J.; White, Jordan M.; Tanabe, Lauren M.; Todi, Sokol V.; List, Karin			Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and-2-mediated cell-surface localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIPTASE; EXPRESSION; PROTEINS; HAI-2; PROSTASIN; VIRUSES; KINASES; DOMAIN; MSPL	TMPRSS13 is a member of the type II transmembrane serine protease (TTSP) family. Although various TTSPs have been characterized in detail biochemically and functionally, the basic properties of TMPRSS13 remain unclear. Here, we investigate the activation, inhibition, post-translational modification, and localization of TMPRSS13. Weshow that TMPRSS13 is a glycosylated, active protease and that its own proteolytic activity mediates zymogen cleavage. Full-length, active TMPRSS13 exhibits impaired cell-surface expression in the absence of the cognate Kunitz-type serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 or HAI-2. Concomitant presence of TMPRSS13 with either HAI-1 or -2 mediates phosphorylation of residues in the intracellular domain of the protease, and it coincides with efficient transport of the protease to the cell surface and its subsequent shedding. Cell-surface labeling experiments indicate that the dominant form of TMPRSS13 on the cell surface is phosphorylated, whereas intracellular TMPRSS13 is predominantly non-phosphorylated. These data provide novel insight into the cellular properties of TMPRSS13 and highlight phosphorylation of TMPRSS13 as a novel post-translational modification of this TTSP family member and potentially other members of this family of proteases.	[Murray, Andrew S.; Varela, Fausto A.; Hyland, Thomas E.; Schoenbeck, Andrew J.; White, Jordan M.; Tanabe, Lauren M.; Todi, Sokol V.; List, Karin] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Murray, Andrew S.; White, Jordan M.; List, Karin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Murray, Andrew S.; White, Jordan M.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI 48201 USA; [Varela, Fausto A.] Wayne State Univ, Sch Med, Pharmacol Grad Program, Detroit, MI 48201 USA; [Murray, Andrew S.; List, Karin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	List, K (corresponding author), Gordon H Scott Hall Basic Med Sci, Dept Pharmacol, Rm 6332,540 East Canfield, Detroit, MI 48201 USA.; List, K (corresponding author), Gordon H Scott Hall Basic Med Sci, Dept Oncol, Rm 6332,540 East Canfield, Detroit, MI 48201 USA.	klist@med.wayne.edu		Murray, Andrew/0000-0002-2899-4970	National Institutes of Health from NCI [R01CA160565, R01CA160565-05S1]; Ruth L. Kirschstein National Research Service [T32CA009531]; NIGMS [R25 GM 058905-15]; NINDS [R01NS086778]; American Cancer Society [126605-PF-14-168-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA160565, T32CA009531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086778] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01CA160565 from NCI (to K. L.), Grant R01CA160565-05S1 from NCI (to K. L. and F. A. V.), Ruth L. Kirschstein National Research Service Award T32CA009531 (to A. S. M.), Grant R25 GM 058905-15 from NIGMS (to F. A. V.), and Grant R01NS086778 from NINDS (to S. V. T.), and American Cancer Society Grant 126605-PF-14-168-01-CSM (to L. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Burgi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158594; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kido H, 2008, FRONT BIOSCI-LANDMRK, V13, P754, DOI 10.2741/2717; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DR, 2001, BBA-GENE STRUCT EXPR, V1518, P204, DOI 10.1016/S0167-4781(01)00184-1; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Madsen DH, 2014, BIOCHEM J, V461, P487, DOI 10.1042/BJ20140337; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Miller GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087675; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Okumura Y, 2010, J VIROL, V84, P5089, DOI 10.1128/JVI.02605-09; Poghosyan Z, 2002, J BIOL CHEM, V277, P4999, DOI 10.1074/jbc.M107430200; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Singh SK, 2016, J AM CHEM SOC, V138, P16004, DOI 10.1021/jacs.6b09611; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	43	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14867	14884		10.1074/jbc.M117.775999	http://dx.doi.org/10.1074/jbc.M117.775999			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28710277	hybrid, Green Published			2022-12-26	WOS:000409902100014
J	Johansen, K; Persson, K; Sonnander, K; Magnusson, M; Sarkadi, A; Lucas, S				Johansen, Kine; Persson, Kristina; Sonnander, Karin; Magnusson, Margaretha; Sarkadi, Anna; Lucas, Steven			Clinical utility of the Structured Observation of Motor Performance in Infants within the child health services	PLOS ONE			English	Article							FULL-TERM INFANTS; CEREBRAL-PALSY; EARLY IDENTIFICATION; DEVELOPMENTAL SURVEILLANCE; NURSES EXPERIENCES; EARLY INTERVENTION; PRETERM; AGES; CARE; MILESTONES	Aim This study aimed to evaluate the clinical utility of the Structured Observation of Motor Performance in Infants (SOMP-I) when used by nurses in routine child healthcare by analyzing the nurses' SOMP-I assessments and the actions taken when motor problems were suspected. Method Infants from three child health centers in Uppsala County, Sweden, were consecutively enrolled in a longitudinal study. The 242 infants were assessed using SOMP-I by the nurse responsible for the infant as part of the regular well-child visits at as close to 2, 4, 6 and 10 months of age as possible. The nurses noted actions taken such as giving advice, scheduling an extra follow-up or referring the infant to specialized care. The infants' motor development was reassessed at 18 months of age through review of medical records or parental report. Results The assessments of level of motor development at 2 and 10 months showed a distribution corresponding to the percentile distribution of the SOMP-I method. Fewer infants than expected were assessed as delayed at 4 and 6 months or deficient in quality at all assessment ages. When an infant was assessed as delayed in level or deficient in quality, the likelihood of the nurse taking actions increased. This increased further if both delay and quality deficit were found at the same assessment or if one or both were found at repeated assessments. The reassessment of the motor development at 18 months did not reveal any missed infants with major motor impairments. Interpretation The use of SOMP-I appears to demonstrate favorable clinical utility in routine child healthcare as tested here. Child health nurses can assess early motor performance using this standardized assessment method, and using the method appears to support them the clinical decision-making.	[Johansen, Kine; Persson, Kristina; Magnusson, Margaretha; Lucas, Steven] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Johansen, Kine; Lucas, Steven] Uppsala Univ, Childrens Hosp, Uppsala, Sweden; [Sonnander, Karin; Sarkadi, Anna] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Johansen, K (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Johansen, K (corresponding author), Uppsala Univ, Childrens Hosp, Uppsala, Sweden.	kine.johansen@kbh.uu.se	Johansen, Kine/AAN-8208-2020	Johansen, Kine/0000-0002-9212-8452	Uppsala University; Uppsala County Council Grants for Healthcare Research; Gillbergska Foundation; Folke Bernadotte Foundation	Uppsala University; Uppsala County Council Grants for Healthcare Research; Gillbergska Foundation; Folke Bernadotte Foundation	This study was funded by Uppsala University and Uppsala County Council Grants for Healthcare Research, the Gillbergska Foundation (www.gillbergska.se) and the Folke Bernadotte Foundation (www.folkebernadottestiftelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 2015, HDB CHILD PSYCHOL DE; Barbara A, 2005, AUSTR OCCUPATIONAL T, V52, P17, DOI [10.1111/j.1440-1630.2005.00476.x, DOI 10.1111/J.1440-1630.2005.00476.X]; Barbosa Vanessa M., 2003, Physical & Occupational Therapy in Pediatrics, V23, P7, DOI 10.1300/J006v23n03_02; Barlow DH, 2005, PSYCHOL ASSESSMENT, V17, P308, DOI 10.1037/1040-3590.17.3.308; Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140; Donnelly Catherine, 2002, Can J Occup Ther, V69, P84; Dosman CF, 2012, PAED CHILD HEALT-CAN, V17, P561, DOI 10.1093/pch/17.10.561; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; DWORKIN PH, 1989, PEDIATRICS, V84, P1000; Feldman DE, 2005, ARCH PEDIAT ADOL MED, V159, P882, DOI 10.1001/archpedi.159.9.882; Glad J., 2013, THESIS; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; GLASCOE FP, 1989, AM J DIS CHILD, V143, P955, DOI 10.1001/archpedi.1989.02150200115029; Guevara JP, 2013, PEDIATRICS, V131, P30, DOI 10.1542/peds.2012-0765; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P707, DOI 10.1017/S0012162200001316; Hadders-Algra M, 2004, J PEDIATR-US, V145, pS12, DOI 10.1016/j.jpeds.2004.05.017; Hadders-Algra M, 2011, DEV MED CHILD NEUROL, V53, P52, DOI 10.1111/j.1469-8749.2011.04064.x; Hadders-Algra Mijna, 2001, Neural Plasticity, V8, P31, DOI 10.1155/NP.2001.31; Halfon N, 2004, PEDIATRICS, V113, P1926; Hatakenaka Y, 2016, PEDIATR NEUROL, V54, P55, DOI 10.1016/j.pediatrneurol.2015.09.008; Hatfield DR, 2007, ADM POLICY MENT HLTH, V34, P283, DOI 10.1007/s10488-006-0110-y; Heineman KR, 2008, J DEV BEHAV PEDIATR, V29, P315, DOI 10.1097/DBP.0b013e318182a4ea; Hielkema T, 2016, DEV MED CHILD NEUROL, V58, P46, DOI [10.1111/dmcn.13047, 10.1111/dmcn.13331]; Hix-Small H, 2007, PEDIATRICS, V120, P381, DOI 10.1542/peds.2006-3583; Hubermann L, 2016, J CHILD NEUROL, V31, P364, DOI 10.1177/0883073815596610; Hunsley J, 2008, GUIDE ASSESSMENTS WO, P44; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Johansen K, 2016, J EVAL CLIN PRACT, V22, P227, DOI 10.1111/jep.12459; Johansen K, 2015, J EVAL CLIN PRACT, V21, P681, DOI 10.1111/jep.12366; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; King TM, 2003, CURR OPIN PEDIATR, V15, P624, DOI 10.1097/00008480-200312000-00014; Law M, 2014, J CHILD NEUROL, V29, P1101, DOI 10.1177/0883073814533151; Lennartsson F, 2011, J PEDIATR NURS, V26, P541, DOI 10.1016/j.pedn.2010.04.005; Lindstrom K, 1997, ACTA PAEDIATR, V86, P736, DOI 10.1111/j.1651-2227.1997.tb08577.x; Magnusson M, 2000, J CLIN NURS, V9, P620; Magnusson M, 2012, SCAND J CARING SCI, V26, P161, DOI 10.1111/j.1471-6712.2011.00910.x; Majnemer A, 1998, Semin Pediatr Neurol, V5, P62, DOI 10.1016/S1071-9091(98)80020-X; Mash EJ, 2005, J CLIN CHILD ADOLESC, V34, P362, DOI 10.1207/s15374424jccp3403_1; McIntyre S, 2011, DEV DISABIL RES REV, V17, P114, DOI 10.1002/ddrr.1106; Montgomery C, 2017, EARLY HUM D IN PRESS; Montgomery C, 2017, ACTA PAEDIATR, V106, P740, DOI 10.1111/apa.13774; Morgan C, 2016, DEV MED CHILD NEUROL, V58, P900, DOI 10.1111/dmcn.13105; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Oberklaid F, 2013, ARCH DIS CHILD, V98, P1008, DOI 10.1136/archdischild-2013-304091; Oberklaid F, 2011, AUST FAM PHYSICIAN, V40, P666; PALFREY JS, 1987, J PEDIATR-US, V111, P651, DOI 10.1016/S0022-3476(87)80238-X; PERSSON K, 1995, EARLY HUM DEV, V40, P127, DOI 10.1016/0378-3782(94)01598-J; Persson K, 1995, EARLY HUM DEV, V43, P205, DOI 10.1016/0378-3782(95)01678-3; Persson K., 2017, STRUCTURED OBSERVATI; Persson K., 1997, PEDIAT PHYS THER, P62; Persson Kristina, 1993, Upsala Journal of Medical Sciences, V98, P65; Ronnqvist L, 2013, FYSIOTERAPI BARN UNG, P21; Rosenbaum P, 2006, EARLY HUM DEV, V82, P167, DOI 10.1016/j.earlhumdev.2006.01.007; Sices L, 2007, J DEV BEHAV PEDIATR, V28, P47, DOI 10.1097/DBP.0b013e31803084c6; Smart A, 2006, INT J QUAL HEALTH C, V18, P377, DOI 10.1093/intqhc/mzl034; Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P323, DOI 10.1111/dmcn.12262; Spittle A, 2016, SEMIN PERINATOL, V40, P542, DOI 10.1053/j.semperi.2016.09.006; Spittle A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub4; Spittle AJ, 2008, DEV MED CHILD NEUROL, V50, P254, DOI 10.1111/j.1469-8749.2008.02025.x; The National Board of Health and Welfare, 2014, VAGL BARNH; The National Board of Health and Welfare, 2013, UPPT UTV HOS BARN UN; Thelen Esther, 1996, DYNAMIC SYSTEMS APPR; Thomas RE, 2016, CHILD CARE HLTH DEV, V42, P382, DOI 10.1111/cch.12333; Trillingsgaard A, 2004, EUR CHILD ADOLES PSY, V13, P39, DOI 10.1007/s00787-004-3006-y; Ulrich BD, 2010, PHYS THER, V90, P1868, DOI 10.2522/ptj.20100040; Vereijken B, 2010, PHYS THER, V90, P1850, DOI 10.2522/ptj.20100019; Wallby T., 2012, THESIS; Woolfenden S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-231	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181398	10.1371/journal.pone.0181398	http://dx.doi.org/10.1371/journal.pone.0181398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723929	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800048
J	Leth, C; Varadharajan, A; Mester, P; Fischaleck, M; Rossmanith, P; Schmoll, F; Fink, M				Leth, Christoph; Varadharajan, Ashok; Mester, Patrick; Fischaleck, Marlis; Rossmanith, Peter; Schmoll, Friedrich; Fink, Maria			Matrixlysis, an improved sample preparation method for recovery of Mycobacteria from animal tissue material	PLOS ONE			English	Article							TUBERCULOSIS; BOVIS; CAPRAE; SEQUENCE; NUMBER; STRATEGY; REGION	Mycobacterium caprae, a member of the Mycobacterium tuberculosis complex, is the main causative agent of bovine tuberculosis in alpine regions. Bacterial culture is the gold standard in bovine tuberculosis diagnostic but takes up to twelve weeks. This increases the time and costs for stocks affected with bovine tuberculosis. Hence this study focused on the implementation of a fast and precise mycobacterial detection method and compared it with currently used methods. Matrix lysis is a chemical lysis using high concentrations of urea to solubilize bovine and red deer tissue and was used to detect even smallest amounts or non-visible lesions of mycobacteria. A total of 64 samples collected from 44 animals (37 red deer and 7 cattle) were tested by Matrix lysis. Forty-three of these samples were used for Mycobacterium tuberculosis complex detection by quantitative PCR and other 21 for subtyping the genetically different variants of M. caprae. Furthermore, three Matrix lysis samples were used for Next Generation Sequencing. Our results confirm that Matrix lysis is a fast and precise method for detecting Mycobacterium tuberculosis complex in native tissue samples. However, at the moment it reaches its limits when the samples were analyzed by Next Generation Sequencing and RD4 subtyping.	[Leth, Christoph; Schmoll, Friedrich; Fink, Maria] Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Lower Austria, Austria; [Leth, Christoph] Univ Appl Sci, FH Campus Wien, Vienna, Austria; [Varadharajan, Ashok; Fischaleck, Marlis] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Rossmanith, Peter] Univ Vet Med, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria	University of Munich; University of Veterinary Medicine Vienna	Fink, M (corresponding author), Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Lower Austria, Austria.	maria.fink@ages.at	Mester, Patrick-Julian/ABC-1614-2020	Mester, Patrick-Julian/0000-0002-3193-4987	Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development	Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development	The financial support by the Austrian Federal Ministry of Science, Research and Economy (www bmwfw gv at) and the National Foundation of Research, Technology and Development (www stiftung-teat) is gratefully acknowledged. The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Broeckl S, 2017, VET RES COMMUN, V41, P113, DOI 10.1007/s11259-017-9679-8; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; de Lisle GW, 2009, NEW ZEAL VET J, V57, P221, DOI 10.1080/00480169.2009.36905; Domogalla J, 2013, J CLIN MICROBIOL, V51, P1381, DOI 10.1128/JCM.02966-12; Fell S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0816-2; Fink M, 2015, EMERG INFECT DIS, V21, P464, DOI 10.3201/eid2103.141119; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; Girardot C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1284-2; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mann E, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-53; Mayrl E, 2009, J FOOD PROTECT, V72, P1225, DOI 10.4315/0362-028X-72.6.1225; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Niemann S, 2000, J CLIN MICROBIOL, V38, P3231, DOI 10.1128/JCM.38.9.3231-3234.2000; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Reddington K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023481; Rettinger A, 2015, TRANSBOUNDARY EMERGI; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Schoepf K., 2012, ISRN VET SCI, V2012; Stewart LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058374; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; World Oranisation of Animal Health (OIE, 2009, OIE TERR MAN 2009	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181157	10.1371/journal.pone.0181157	http://dx.doi.org/10.1371/journal.pone.0181157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723969	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800036
J	Silva, SR; Alvarenga, DO; Aranguren, Y; Penha, HA; Fernandes, CC; Pinheiro, DG; Oliveira, MT; Michael, TP; Miranda, VFO; Varani, AM				Silva, Saura R.; Alvarenga, Danillo O.; Aranguren, Yani; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Michael, Todd P.; Miranda, Vitor F. O.; Varani, Alessandro M.			The mitochondrial genome of the terrestrial carnivorous plant Utricularia reniformis (Lentibulariaceae): Structure, comparative analysis and evolutionary landmarks	PLOS ONE			English	Article							GROUP-I INTRON; BLADDERWORT UTRICULARIA; HORIZONTAL TRANSFER; DNA; MODEL; GENES; VISUALIZATION; ARCHITECTURE; ANNOTATION; SEQUENCES	The carnivorous plants of the family Lentibulariaceae have attained recent attention not only because of their interesting lifestyle, but also because of their dynamic nuclear genome size. Lentibulariaceae genomes span an order of magnitude and include species with the smallest genomes in angiosperms, making them a powerful system to study the mechanisms of genome expansion and contraction. However, little is known about mitochondrial DNA (mtDNA) sequences of this family, and the evolutionary forces that shape this organellar genome. Here we report the sequencing and assembly of the complete mtDNA from the endemic terrestrial Brazilian species Utricularia reniformis. The 857,234bp master circle mitochondrial genome encodes 70 transcriptionaly active genes (42 protein-coding, 25 tRNAs and 3 rRNAs), covering up to 7% of the mtDNA. A ltrA-like protein related to splicing and mobility and a LAGLIDADG homing endonuclease have been identified in intronic regions, suggesting particular mechanisms of genome maintenance. RNA-seq analysis identified properties with putative diverse and important roles in genome regulation and evolution: 1) 672kbp (78%) of the mtDNA is covered by full-length reads; 2) most of the 243kbp intergenic regions exhibit transcripts; and 3) at least 69 novel RNA editing sites in the protein-coding genes. Additional genomic features are hypothetical ORFs (48%), chloroplast insertions, including truncated plastid genes that have been lost from the chloroplast DNA (5%), repeats (5%), relics of transposable elements mostly related to LTR retrotransposons (5%), and truncated mitovirus sequences (0.4%). Phylogenetic analysis based on 32 different Lamiales mitochondrial genomes corroborate that Lentibulariaceae is a monophyletic group. In summary, the U. reniformis mtDNA represents the eighth largest plant mtDNA described to date, shedding light on the genomic trends and evolutionary characteristics and phylogenetic history of the family Lentibulariaceae.	[Silva, Saura R.] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Bot, Botucatu, SP, Brazil; [Alvarenga, Danillo O.; Penha, Helen A.; Fernandes, Camila C.; Pinheiro, Daniel G.; Oliveira, Marcos T.; Varani, Alessandro M.] Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Aranguren, Yani; Miranda, Vitor F. O.] Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Michael, Todd P.] Ibis Biosci, Computat Genom, Carlsbad, CA USA; [Aranguren, Yani] Univ Simon Bolivar, Barranquilla, Colombia; [Michael, Todd P.] J Craig Venter Inst, La Jolla, CA USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; J. Craig Venter Institute	Varani, AM (corresponding author), Univ Estadual Paulista Unesp, Dept Tecnol, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Miranda, VFO (corresponding author), Univ Estadual Paulista Unesp, Dept Biol Aplicada Agr, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.	vmiranda@fcav.unesp.br; amvarani@fcav.unesp.br	Varani, Alessandro M/F-6887-2011; Penha, Helen/R-2585-2016; Miranda, Vitor Fernandes Oliveira/AAG-2437-2020; Oliveira, Marcos Túlio/AAN-2804-2020; Varani, Alessandro/Q-1637-2016; Miranda, Vitor F. O./B-2800-2011; Silva, Saura/I-1953-2015; Alvarenga, Danillo Oliveira/C-3439-2012; Oliveira, Marcos/B-3249-2014; Guariz Pinheiro, Daniel/H-4604-2012	Varani, Alessandro M/0000-0002-8876-3269; Penha, Helen/0000-0002-7156-444X; Miranda, Vitor Fernandes Oliveira/0000-0003-0574-9865; Varani, Alessandro/0000-0002-8876-3269; Miranda, Vitor F. O./0000-0003-0574-9865; Silva, Saura/0000-0002-6333-5268; Alvarenga, Danillo Oliveira/0000-0002-3666-2220; Oliveira, Marcos/0000-0003-4779-5755; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Aranguren-Diaz, Yani/0000-0001-6475-2787	Fundacao de Amparo do Estado de Sao Paulo, FAPESP [13/25164-6]; Ibis Biosciences, an Abbott Laboratories company	Fundacao de Amparo do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ibis Biosciences, an Abbott Laboratories company	This study was funded by Fundacao de Amparo do Estado de Sao Paulo, FAPESP (13/25164-6). Ibis Biosciences, an Abbott Laboratories company, provided support to TM in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adlassnig W, 2005, PLANT SOIL, V274, P127, DOI 10.1007/s11104-004-2754-2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bruenn JA, 2015, PEERJ, V3, DOI 10.7717/peerj.876; Bruhs A, 2011, ADVAN PL BIO, V1, P157; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caravieri FA, 2014, AQUAT BOT, V116, P8, DOI 10.1016/j.aquabot.2013.12.008; Carlsson J, 2011, ADVAN PL BIO, V1, P469; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Cheong WH, 2015, BIOINFORMATICS, V31, P3685, DOI 10.1093/bioinformatics/btv433; Christenhusz MJM, 2015, BOT J LINN SOC, V178, P501, DOI 10.1111/boj.12285; Clivati D, 2014, PLANT BIOLOGY, V16, P677, DOI 10.1111/plb.12091; Clivati D, 2012, AM J BOT, V99, pE375, DOI 10.3732/ajb.1200080; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Alcaraz LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148979; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Ellison AM, 2011, OIKOS, V120, P1721, DOI 10.1111/j.1600-0706.2011.19604.x; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Gualberto JM, 2014, BIOCHIMIE, V100, P107, DOI 10.1016/j.biochi.2013.09.016; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jackman SD, 2016, GENOME BIOL EVOL, V8, P29, DOI 10.1093/gbe/evv244; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Jobson RW, 2002, CLADISTICS, V18, P127, DOI 10.1111/j.1096-0031.2002.tb00145.x; Juniper B, 1989, CARNIVIROROUS PLANTS; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan TY, 2017, P NATL ACAD SCI USA, V114, pE4435, DOI 10.1073/pnas.1702072114; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; Palmer J. D., 1992, MOL SYSTEMATICS PLAN, P36, DOI DOI 10.1007/978-1-4615-3276-7; Park S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-405; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rutishauser R, 2016, ANN BOT-LONDON, V117, P811, DOI 10.1093/aob/mcv172; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Silva SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165176; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Takeuchi Y, 2015, SYST APPL MICROBIOL, V38, P330, DOI 10.1016/j.syapm.2015.05.006; Taylor P, 1989, GENUS UTRICULARIA TA; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang D, 2012, MOL BIOL EVOL, V29, P1707, DOI 10.1093/molbev/mss016; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xi ZX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003265; Yoshihisa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00213	81	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e180484	10.1371/journal.pone.0180484	http://dx.doi.org/10.1371/journal.pone.0180484			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723946	gold, Green Submitted, Green Published			2022-12-26	WOS:000406067800015
J	Yallew, WW; Kumie, A; Yehuala, FM				Yallew, Walelegn Worku; Kumie, Abera; Yehuala, Feleke Moges			Risk factors for hospital-acquired infections in teaching hospitals of Amhara regional state, Ethiopia: A matched-case control study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; BLOOD-STREAM INFECTION; VENTILATOR-ASSOCIATED PNEUMONIA; CONTROL CONSORTIUM INICC; POINT-PREVALENCE SURVEY; LENGTH-OF-STAY; DEVELOPING-COUNTRIES FINDINGS; MULTIDIMENSIONAL APPROACH; NOSOCOMIAL INFECTIONS; BACTERIAL-RESISTANCE	Background Hospital-acquired infection affects hundreds of millions of people worldwide. It is a major global issue for patient safety. Understanding the potential risk factors is important to appreciate the local context. A matched case control study design, which is the first of its kind in the study region, was undertaken to identify risk factors in teaching hospitals of Amhara regional state, Ethiopia. Method A matched case control study design matched with age and hospital type was used. The study was conducted in University of Gondar and Felege-Hiwot medical teaching hospital. Cases were patients who fulfilled the criteria based on CDC definition of hospital-acquired infection and controls were patients admitted to the hospital that stayed for more than 48 hours in the ward in the study period, but who did not develop infection. For one case, four controls were selected. Of 545 patients, 109 were cases and 436 were controls. Conditional logistic regression using STATA 13 was used for data analysis. Result The median length of stay for cases and controls was 7 and 8 days, respectively. Patients admitted in wards with the presence of medical waste container in the room had 82% less chance of developing hospital-acquired infection (AOR 0.18; 95% CI, 0.03-0.98). The odds of developing hospital-acquired infection among immune deficient patients were 2.34 times higher than their counterparts (95% CI; 1.17-4.69). Patients received antimicrobials, central vascular catheter and surgery since admission had 8.63, 6.91 and 2.35 higher odds of developing hospital-acquired infection, respectively. Conclusion Health providers and mangers should consider the provision and availability of healthcare materials and facilities in all of the ward rooms, follow appropriate safe medical procedures for use of external devices on patients, and give attention to the immunocompromised patients for the prevention and control of hospital-acquired infections.	[Yallew, Walelegn Worku] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Kumie, Abera] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Yehuala, Feleke Moges] Univ Gondar, Dept Med Microbiol, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; Addis Ababa University; University of Gondar	Yallew, WW (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	walelegnw@gmail.com	Moges, Feleke/GXW-1995-2022; Kumie, Abera/AAC-8537-2022					Abdella NM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-96; Al-Mousa HH, 2016, AM J INFECT CONTROL, V44, P444, DOI 10.1016/j.ajic.2015.10.031; AL-Rawajfah OM, 2013, AM J INFECT CONTROL, V41, P607, DOI 10.1016/j.ajic.2012.08.014; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Chan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085973; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590/S1020-49892008000700002; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, P1495, DOI 10.1016/j.ajic.2016.08.007; Rosenthal VD, 2015, AM J INFECT CONTROL, V43, P1040, DOI 10.1016/j.ajic.2015.05.042; Deptula A, 2015, J HOSP INFECT, V90, P310, DOI 10.1016/j.jhin.2015.03.005; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; Durlach R, 2012, J HOSP INFECT, V80, P217, DOI 10.1016/j.jhin.2011.12.001; Gailiene G, 2012, MED LITH, V48, P399; Gravel D, 2007, J HOSP INFECT, V66, P243, DOI 10.1016/j.jhin.2007.04.008; Hansen S, 2015, CLIN MICROBIOL INFEC, V21, P1047, DOI 10.1016/j.cmi.2015.09.019; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu BJ, 2013, AM J INFECT CONTROL, V41, P301, DOI 10.1016/j.ajic.2012.03.037; Humphreys H, 2008, J HOSP INFECT, V69, P249, DOI 10.1016/j.jhin.2008.04.021; Jahani-Sherafat S, 2015, J INFECT PUBLIC HEAL, V8, P553, DOI 10.1016/j.jiph.2015.04.028; JIMENEZROMANO E, 1993, EUR J EPIDEMIOL, V9, P263, DOI 10.1007/BF00146261; Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10; Liu JY, 2016, J HOSP INFECT, V93, P271, DOI 10.1016/j.jhin.2016.03.019; Madani Naoufel, 2009, Int Arch Med, V2, P29, DOI 10.1186/1755-7682-2-29; Monistrol O, 2012, CLIN MICROBIOL INFEC, V18, P1212, DOI 10.1111/j.1469-0691.2011.03735.x; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; Mulu W, 2012, ETHIOP J HEALTH SCI, V22, P7; Nigatu Endalafer, 2011, Journal of Infection Prevention, V12, P38, DOI 10.1177/1757177410376680; Oldfield Margaret M, 2009, Intensive Crit Care Nurs, V25, P38, DOI 10.1016/j.iccn.2008.07.001; Rai V., 2016, CANADIAN J INFECT CO, V31, P107, DOI [10.4331/wjbc.v8.i1.95, DOI 10.4331/WJBC.V8.I1.95]; Rasslan Ossama, 2012, J Infect Public Health, V5, P394, DOI 10.1016/j.jiph.2012.07.002; Razine Rachid, 2012, Int Arch Med, V5, P26, DOI 10.1186/1755-7682-5-26; Rosenthal VD, 2012, INFECTION, V40, P517, DOI 10.1007/s15010-012-0278-x; Rosenthal VD, 2012, INFECTION, V40, P415, DOI 10.1007/s15010-012-0246-5; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P497, DOI 10.1016/j.ajic.2011.08.005; Rosenthal VD, 2012, INFECT CONT HOSP EP, V33, P704, DOI 10.1086/666342; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Savolainen-Kopra C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-10; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P318; Stiller A, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0152-1; Szklo M, 2014, EPIDEMIOLOGY BASICS; TADESSE ML, 2014, BMC PUBLIC HEALTH, V14, DOI DOI 10.1186/1471-2458-14-1221; Tao LL, 2012, J CRIT CARE, V27, P440, DOI 10.1016/j.jcrc.2011.12.018; Tao LL, 2011, INT J INFECT DIS, V15, pE774, DOI 10.1016/j.ijid.2011.06.009; Phu VD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147544; World Health Organization, 2009, WHO GUID HAND HYG HL; Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zarb P, 2012, EURO SURVEILL B EUR, V15, P17; Zhang X, 2015, INT J CLIN EXP MED, V8, P16682	51	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181145	10.1371/journal.pone.0181145	http://dx.doi.org/10.1371/journal.pone.0181145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719665	gold, Green Submitted, Green Published			2022-12-26	WOS:000406061400032
J	Hochman, G; Halevi-Tobias, K; Kogan, Y; Agur, Z				Hochman, Gili; Halevi-Tobias, Karin; Kogan, Yuri; Agur, Zvia			Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model	PLOS ONE			English	Article							BETA-CATENIN; SOMATIC MUTATIONS; APC GENE; CANCER; CELLS; MECHANISM; PROTEIN; LEVEL; BINDS; ACTIVATION	Background Despite considerable investigational efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities. Objective & methods Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of pathway activity in colon cancer cells. To this end, we developed and simulated a mathematical model for the Wnt pathway in different APC mutants, with or without the effects of the extracellular inhibitors, Secreted Frizzled-Related Protein1 (sFRP1) and Dickhopf1 (Dkk1). We compared our model predictions to experimental data in the literature. Results Our model accurately predicts T-cell factor (TCF) activity in mutant cells that vary in APC mutation. Model simulations suggest that both sFRP1 and DKK1 can reduce TCF activity in APC (1638N/1572T) and Apc (min/min) mutants, but restoration of normal activity levels is possible only in the former. When applied in combination, synergism between the two inhibitors can reduce their effective doses to one-fourth of the doses required under single inhibitor application. Overall, re-establishment of normal Wnt pathway activity is predicted for every APC mutant in whom TCF activity is increased by up to 11 fold. Conclusions Our work suggests that extracellular inhibitors can effectively restore normal Wnt pathway activity in APC-truncated cancer cells, even though these LoF mutations occur downstream of the inhibitory action. The insufficient activity of the truncated APC can be quantitatively balanced by the upstream intervention. This new concept of upstream intervention to control the effects of downstream mutations may be considered also for other partial LoF mutations in other signaling pathways.	[Hochman, Gili; Halevi-Tobias, Karin; Kogan, Yuri; Agur, Zvia] Inst Med BioMath, Bene Ataroth, Israel		Agur, Z (corresponding author), Inst Med BioMath, Bene Ataroth, Israel.	agur@imbm.org		Agur, Zvia/0000-0001-5701-9149				Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Athar M, 2011, CURR PHARM DESIGN, V17, P631, DOI 10.2174/138161211795222595; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barua D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003217; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Benary U, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00021; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Calin G, 1999, EUR J HUM GENET, V7, P609, DOI 10.1038/sj.ejhg.5200350; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Clements Wilson M, 2003, Clin Colorectal Cancer, V3, P113, DOI 10.3816/CCC.2003.n.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HIGASHI Y, 1982, J BIOCHEM-TOKYO, V91, P2021, DOI 10.1093/oxfordjournals.jbchem.a133895; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kofahl B, 2010, BIOCHEM SOC T, V38, P1281, DOI 10.1042/BST0381281; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lesko AC, 2014, CURR DRUG TARGETS, V15, P90, DOI 10.2174/1389450114666131108155418; Li Q, 2005, CANCER RES, V65, P8622, DOI 10.1158/0008-5472.CAN-05-2145; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prosperi JR, 2014, CURR DRUG TARGETS, V15, P1; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Song JH, 2014, CELL REP, V7, P94, DOI 10.1016/j.celrep.2014.02.043; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takebe N, 2010, CLIN CANCER RES, V16, P3106, DOI 10.1158/1078-0432.CCR-09-2934; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vargas DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005007; Virshup DM, 2015, J CLIN INVEST, V125, P975, DOI 10.1172/JCI80819; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	64	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179888	10.1371/journal.pone.0179888	http://dx.doi.org/10.1371/journal.pone.0179888			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708837	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800008
J	Wang, Y; Yu, B; Wang, L; Yang, M; Xia, ZY; Wei, W; Zhang, FY; Yuan, XC				Wang, Yao; Yu, Bo; Wang, Li; Yang, Ming; Xia, Zhiyin; Wei, Wei; Zhang, Fengyu; Yuan, Xiaochen			Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus	PLOS ONE			English	Article							NF-KAPPA-B; GLYCATION END-PRODUCTS; MESANGIAL CELLS; RENAL-DISEASE; FAT DIET; NEPHROPATHY; RATS; INHIBITION; RECEPTOR; KIDNEY	Objective The NLRP3 inflammasome plays an important role in the pathogenesis of inflammation in diabetic nephropathy (DN). Pioglitazone (PIO) has been found to exert an anti-inflammatory effect in patients with diabetes mellitus, but it is still unclear whether PIO exhibits a similar effect in DN. We aimed to explore the effect and underlying mechanism of PIO on DN, as well as investigate if NLRP3 is a pharmacologic target of PIO. Methods We divided 48 apolipoprotein E (apoE) (-/-) mice into 4 groups: apoE (-/-), apoE (-/-) with PIO, diabetic apoE (-/-), and diabetic apoE (-/-) with PIO. Wild type male C57BL/6 mice were used as controls (n = 8 per group). After 8 weeks of PIO treatment, we examined the baseline characteristics and metabolic parameters of each group, and we used enzymelinked immunosorbent assay (ELISA), western blot, and immunohistochemical staining to evaluate the expression levels of advanced glycation end products (AGEs), receptor for advanced glycation end products (RAGE), NLRP3, nuclear factor D kappa B (NF-kappa B), caspase-1, interleukin (IL)-18, and IL-1 beta in each group. Results Compared to the diabetic apoE (-/-) group, PIO treatment decreased blood glucose, cholesterol, serum blood urea nitrogen (BUN), and creatinine levels. It also depressed the glomerular mesangial expansion. PIO down-regulated expression of AGEs, RAGE, and NF-kappa B, all of which further depressed NLRP3, caspase-1, IL-18, and IL-1 beta levels. Conclusion Pioglitazone can ameliorate diabetic renal damage, and this effect is related to the inhibition of renal AGE/RAGE axis activation and the down-regulation of NF-kappa B expression. These effects lead to a decline in NLRP3 levels and downstream secretion of inflammatory cytokines.	[Wang, Yao; Yang, Ming; Xia, Zhiyin; Wei, Wei] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Nephrol, Yangzhou, Jiangsu, Peoples R China; [Yu, Bo] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Emergency, Yangzhou, Jiangsu, Peoples R China; [Wang, Li; Yuan, Xiaochen] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Cardiol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Fengyu] Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Cent Lab, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Yuan, XC (corresponding author), Yangzhou Univ, Yangzhou Peoples Hosp 1, Affiliated Hosp, Dept Cardiol, Yangzhou, Jiangsu, Peoples R China.	1184806497@qq.com			Foundation of yangzhou-social the development of science and technology research project [YZ2012130]; National Natural Science Foundation of China [81470381]	Foundation of yangzhou-social the development of science and technology research project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Foundation of yangzhou-social the development of science and technology research project, YZ2012130 (http://kjj.yangzhou.gov.cn/kjj/index.shtml) and the National Natural Science Foundation of China, 81470381, (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action). The funders had no role in study design, data collection and analysis of the manuscript.	Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Alvarez-Guardia D, 2011, BBA-MOL CELL BIOL L, V1811, P59, DOI 10.1016/j.bbalip.2010.11.002; Ayhan M., 2013, ISRN ENDOCRINOL, V2013, DOI DOI 10.1155/2013/858690; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Chen L, 2008, INFLAMM RES, V57, P199, DOI 10.1007/s00011-006-6190-z; Collino M, 2013, BIOCHEM PHARMACOL, V85, P257, DOI 10.1016/j.bcp.2012.10.014; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Gruden G, 2005, J AM SOC NEPHROL, V16, P688, DOI 10.1681/ASN.2004030251; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hong W, 2015, MOL MED REP, V12, P6221, DOI 10.3892/mmr.2015.4145; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Karakikes I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006474; Kim JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062068; Kim SM, 2015, AM J PHYSIOL-RENAL, V308, pF993, DOI 10.1152/ajprenal.00637.2014; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsui T, 2010, BIOCHEM BIOPH RES CO, V398, P326, DOI 10.1016/j.bbrc.2010.06.093; Minutoli Letteria, 2016, Oxid Med Cell Longev, V2016, P2183026, DOI 10.1155/2016/2183026; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sun GD, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5749857; Tan ALY, 2010, AM J PHYSIOL-RENAL, V298, pF763, DOI 10.1152/ajprenal.00591.2009; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Thomas MC, 2011, CONTRIB NEPHROL, V170, P66, DOI 10.1159/000324945; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Watson AMD, 2012, DIABETES, V61, P2105, DOI 10.2337/db11-1546; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Zhang MH, 2014, J ETHNOPHARMACOL, V151, P591, DOI 10.1016/j.jep.2013.11.015; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431	41	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181248	10.1371/journal.pone.0181248	http://dx.doi.org/10.1371/journal.pone.0181248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708885	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800052
J	Anitas, EM; Slyamov, A				Anitas, Eugen Mircea; Slyamov, Azat			Structural characterization of chaos game fractals using small-angle scattering analysis	PLOS ONE			English	Article							FRAUNHOFER-DIFFRACTION; KOCH FRACTALS; FAT FRACTALS; NANOTECHNOLOGY; SYSTEMS	Small-angle scattering (SAS) technique is applied to study the nano and microstructural properties of spatial patterns generated from chaos game representation (CGR). Using a simplified version of Debye formula, we calculate and analyze in momentum space, the monodisperse scattering structure factor from a system of randomly oriented and non-interacting 2D Sierpinski gaskets (SG). We show that within CGR approach, the main geometrical and fractal properties, such as the overall size, scaling factor, minimal distance between scattering units, fractal dimension and the number of units composing the SG, can be recovered. We confirm the numerical results, by developing a theoretical model which describes analytically the structure factor of SG. We apply our findings to scattering from single scale mass fractals, and respectively to a multiscale fractal representing DNA sequences, and for which an analytic description of the structure factor is not known a priori.	[Anitas, Eugen Mircea; Slyamov, Azat] Joint Inst Nucl Res, Dubna, Moscow Region, Russia; [Anitas, Eugen Mircea] Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania; [Slyamov, Azat] Inst Nucl Phys, Alma Ata, Kazakhstan	Joint Institute for Nuclear Research - Russia; Horia Hulubei National Institute of Physics & Nuclear Engineering; Institute of Nuclear Physics - Kazakhstan	Anitas, EM (corresponding author), Joint Inst Nucl Res, Dubna, Moscow Region, Russia.; Anitas, EM (corresponding author), Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania.	anitas@jinr.ru	Anitas, Eugen-Mircea/B-8762-2015; Anitas, Eugen M/G-7260-2011	Anitas, Eugen-Mircea/0000-0003-2693-1383; Anitas, Eugen M/0000-0003-2693-1383				ALLAIN C, 1986, PHYS REV B, V33, P3566, DOI 10.1103/PhysRevB.33.3566; Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Anitas EM, 2016, ROM J PHYS, V61, P457; Anitas EM, 2015, ROM J PHYS, V60, P647; Anitas EM, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41066-9; BALE HD, 1984, PHYS REV LETT, V53, P596, DOI 10.1103/PhysRevLett.53.596; Barnsley M., 2000, FRACTALS EVERYWHERE; Berenschot EJW, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055024; Brumberger H, 1995, MODERN ASPECTS SMALL; Cerofolini GF, 2008, NANOSCALE RES LETT, V3, P381, DOI 10.1007/s11671-008-9170-0; Cherny AY, 2014, J APPL CRYSTALLOGR, V47, P198, DOI 10.1107/S1600576713029956; Cherny AY, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036203; Cherny AY, 2017, PHYS CHEM CHEM PHYS, V19, P2261, DOI 10.1039/c6cp07496k; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Galiceanu M, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/30/305002; Gouyet J. F., 1996, PHYS FRACTAL STRUCTU; Hausdorff F, 1919, MATH ANN, V79, P157; Huang XQ, 2010, METAMATERIALS: THEORY, DESIGN, AND APPLICATIONS, P215, DOI 10.1007/978-1-4419-0573-4_10; HUTCHINSON JE, 1981, INDIANA U MATH J, V30, P713, DOI 10.1512/iumj.1981.30.30055; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Korvin G, 2004, CHAOS SOLITON FRACT, V19, P421, DOI 10.1016/S0960-0779(03)00272-8; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; MARTIN JE, 1987, J APPL CRYSTALLOGR, V20, P61, DOI 10.1107/S0021889887087107; Mayama H, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2336200; Nakayama T., 2003, FRACTAL CONCEPTS CON; Newkome GR, 2006, SCIENCE, V312, P1782, DOI 10.1126/science.1125894; Olivi-Tran N, 2005, CHAOS SOLITON FRACT, V25, P525, DOI 10.1016/j.chaos.2004.12.043; Pantos E, 1996, J MOL STRUCT, V383, P303, DOI 10.1016/S0022-2860(96)09302-7; Roe R. J., 2000, METHODS XRAY NEUTRON; Sandru A, 2012, J MOD OPTIC, V59, P199, DOI 10.1080/09500340.2011.624646; SCHMIDT PW, 1991, J APPL CRYSTALLOGR, V24, P414, DOI 10.1107/S0021889891003400; Sotelo JA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245113; Takeda MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093902; TEIXEIRA J, 1988, J APPL CRYSTALLOGR, V21, P781, DOI 10.1107/S0021889888000263; UOZUMI J, 1991, J MOD OPTIC, V38, P1335, DOI 10.1080/09500349114551501; UOZUMI J, 1990, J MOD OPTIC, V37, P1011, DOI 10.1080/09500349014551081	37	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181385	10.1371/journal.pone.0181385	http://dx.doi.org/10.1371/journal.pone.0181385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704515	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700130
J	Raviv, B; Aghajanyan, L; Granot, G; Makover, V; Frenkel, O; Gutterman, Y; Grafi, G				Raviv, Buzi; Aghajanyan, Lusine; Granot, Gila; Makover, Vardit; Frenkel, Omer; Gutterman, Yitzchak; Grafi, Gideon			The dead seed coat functions as a long-term storage for active hydrolytic enzymes	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; POLYACRYLAMIDE-GEL ELECTROPHORESIS; ANASTATICA-HIEROCHUNTICA L; DEFENSIN-LIKE PEPTIDES; ARABIDOPSIS-THALIANA; PLANT DEFENSINS; ANTIMICROBIAL PEPTIDES; ENHANCED RESISTANCE; FUNGAL PATHOGEN; HOST-DEFENSE	Seed development culminates in programmed cell death (PCD) and hardening of organs enclosing the embryo (e.g., pericarp, seed coat) providing essentially a physical shield for protection during storage in the soil. We examined the proposal that dead organs enclosing embryos are unique entities that store and release upon hydration active proteins that might increase seed persistence in soil, germination and seedling establishment. Proteome analyses of dead seed coats of Brassicaceae species revealed hundreds of proteins being stored in the seed coat and released upon hydration, many are stress-associated proteins such as nucleases, proteases and chitinases. Functional analysis revealed that dead seed coats function as long-term storage for multiple active hydrolytic enzymes (e.g., nucleases) that can persist in active forms for decades. Substances released from the dead seed coat of the annual desert plant Anastatica hierochuntica displayed strong antimicrobial activity. Our data highlighted a previously unrecognized feature of dead organs enclosing embryos ( e.g., seed coat) functioning not only as a physical shield for embryo protection but also as a longterm storage for active proteins and other substances that are released upon hydration to the "seedsphere" and could contribute to seed persistence in the soil, germination and seedling establishment.	[Raviv, Buzi; Aghajanyan, Lusine; Granot, Gila; Gutterman, Yitzchak; Grafi, Gideon] Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Makover, Vardit] Ben Gurion Univ Negev, Inst Desert Res, Zuckerberg Inst Water Res, Midreshet Ben Gurion, Israel; [Frenkel, Omer] ARO, Volcani Ctr, Dept Plant Pathol & Weed Res, Bet Dagan, Israel	Ben Gurion University; Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Grafi, G (corresponding author), Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il		Aghajanyan, Lusine/0000-0003-4486-6095	Harbour Foundation; Margolin foundation	Harbour Foundation; Margolin foundation	This work was supported by the Harbour Foundation to B.R. and by the Margolin foundation to G. Grafi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; Beeckman T, 2000, J PLANT RES, V113, P139, DOI 10.1007/PL00013924; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; Chen F, 2002, J EXP BOT, V53, P215, DOI 10.1093/jexbot/53.367.215; Coca M, 2004, PLANT MOL BIOL, V54, P245, DOI 10.1023/B:PLAN.0000028791.34706.80; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; DEBOLLE MFC, 1995, PLANT MOL BIOL, V28, P713, DOI 10.1007/BF00021195; DeBono AG, 2006, CAN J BOT, V84, P791, DOI 10.1139/B06-034; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FRIEDMAN J, 1981, OECOLOGIA, V51, P400, DOI 10.1007/BF00540912; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Gechev TS, 2014, BIOTECHNOL ADV, V32, P1091, DOI 10.1016/j.biotechadv.2014.03.005; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Givaty-Rapp Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170067; GOLDBERG RB, 1989, CELL, V56, P149, DOI 10.1016/0092-8674(89)90888-X; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Granot G, 2015, BBA-GENE REGUL MECH, V1849, P239, DOI 10.1016/j.bbagrm.2014.12.003; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Gutterman Y, 1997, J ARID ENVIRON, V35, P695, DOI 10.1006/jare.1996.0192; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Hegazy AK, 2007, ACTA OECOL, V31, P332, DOI 10.1016/j.actao.2007.01.006; HENDRY GAF, 1994, FUNCT ECOL, V8, P658, DOI 10.2307/2389929; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Hugot K, 2002, MOL PLANT MICROBE IN, V15, P243, DOI 10.1094/MPMI.2002.15.3.243; Husebye H, 2002, PLANT PHYSIOL, V128, P1180, DOI 10.1104/pp.010925; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Miernyk JA, 2013, J PROTEOMICS, V89, P265, DOI 10.1016/j.jprot.2013.05.013; Mohamed AA, 2010, GRASAS ACEITES, V61, P67, DOI 10.3989/gya.064509; MOHAMEDYASSEEN Y, 1994, BOT REV, V60, P426, DOI 10.1007/BF02857926; Moise JA, 2005, IN VITRO CELL DEV-PL, V41, P620, DOI 10.1079/IVP2005686; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Patton T, 2006, J MICROBIOL METH, V64, P84, DOI 10.1016/j.mimet.2005.04.007; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Radulovic NS, 2013, CURR MED CHEM, V20, P932; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Raviv B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177537; Rose TL, 2006, PLANT SOIL, V286, P181, DOI 10.1007/s11104-006-9036-0; Sanchez-Pons N, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-186; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Shukla P, 2014, FUNCT INTEGR GENOMIC, V14, P307, DOI 10.1007/s10142-014-0367-2; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; Sun Y, 2012, AUST J BOT, V60, P439, DOI 10.1071/BT11314; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Thompson K., 1997, SOIL SEED BANKS OF N; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Voegele A, 2011, J EXP BOT, V62, P5131, DOI 10.1093/jxb/err214; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Western TL, 2012, SEED SCI RES, V22, P1, DOI 10.1017/S0960258511000249; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Windsor JB, 2000, PLANT J, V22, P483, DOI 10.1046/j.1365-313x.2000.00756.x; Yang XJ, 2012, PERSPECT PLANT ECOL, V14, P434, DOI 10.1016/j.ppees.2012.09.002; Yang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024346	75	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181102	10.1371/journal.pone.0181102	http://dx.doi.org/10.1371/journal.pone.0181102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700755	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400030
J	Shimizu, A; Shiratori, I; Horii, K; Waga, I				Shimizu, Akihisa; Shiratori, Ikuo; Horii, Katsunori; Waga, Iwao			Molecular evolution of versatile derivatives from a GFP-like protein in the marine copepod Chiridius poppei	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EXPRESSION; VARIANTS; MUTANTS; BRIGHT	Fluorescent proteins are now indispensable tools in molecular research. They have also been adapted for a wide variety of uses in cases involving creative applications, including textiles, aquarium fish, and ornamental plants. Our colleagues have previously cloned a yellow GFP-like protein derived from the marine copepod Chiridius poppei (YGFP), and moreover, succeeded in generating transgenic flowers with clearly visible fluorescence, without the need for high-sensitivity imaging equipment. However, due to the low Stokes shift of YGFP (10 nm), it is difficult to separate emitted light of a labeled object from the light used for excitation; hence, limitations for various applications remain. In this study, which was aimed at developing YGFP mutants with increased Stokes shifts, we conducted stepwise molecular evolution experiments on YGFP by screening random mutations at three key amino acids, based on their fluorescent characteristics and structural stabilities, followed by optimization of their fluorescence output by DNA shuffling of the entire coding sequence. We successfully identified an eYGFPuv that had an excitation maximum in UV wavelengths and a 24-fold increase in fluorescence intensity compared to the previously reported YGFP mutant (H52D). In addition, eYGFPuv exhibited almost 9-fold higher fluorescence intensity compared to the commercially available GFPuv when expressed in human colon carcinoma HCT116 cells and without any differences in cytotoxicity. Thus, this novel mutant with the desirable characteristics of bright fluorescence, long Stokes shift, and low cytotoxity, may be particularly well suited to a variety of molecular and biological applications.	[Shimizu, Akihisa; Shiratori, Ikuo; Horii, Katsunori; Waga, Iwao] NEC Solut Innovators Ltd, Innovat Labs, Koto Ku, Tokyo, Japan		Shiratori, I (corresponding author), NEC Solut Innovators Ltd, Innovat Labs, Koto Ku, Tokyo, Japan.	iku-shiratori@xc.jp.nec.com		Shiratori, Ikuo/0000-0003-3713-4910				Ansari AM, 2016, STEM CELL REV REP, V12, P553, DOI 10.1007/s12015-016-9670-8; Arpino JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047132; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Bomati EK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05469; BOYD D, 1988, CANCER RES, V48, P3112; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Fradkov AF, 2000, FEBS LETT, V479, P127, DOI 10.1016/S0014-5793(00)01895-0; Gong ZY, 2003, BIOCHEM BIOPH RES CO, V308, P58, DOI 10.1016/S0006-291X(03)01282-8; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365; Ilagan RP, 2010, FEBS J, V277, P1967, DOI 10.1111/j.1742-4658.2010.07618.x; Ito Y, 1999, BIOCHEM BIOPH RES CO, V264, P556, DOI 10.1006/bbrc.1999.1541; Kawasaki M, 2001, BIOCHEM BIOPH RES CO, V280, P842, DOI 10.1006/bbrc.2000.4229; Knight J, 2003, NATURE, V426, P372, DOI 10.1038/426372b; Knop M, 2002, BIOTECHNIQUES, V33, P592, DOI 10.2144/02333rr02_11819a; Laviv T, 2016, NAT METHODS, V13, P989, DOI [10.1038/NMETH.4046, 10.1038/nmeth.4046]; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; ROSE HN, 1975, SCIENCE, V190, P673, DOI 10.1126/science.1188362; Sasaki K, 2014, PLANT BIOTECHNOL-NAR, V31, P309, DOI 10.5511/plantbiotechnology.14.0907a; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171257; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Suto K, 2009, GENES CELLS, V14, P727, DOI 10.1111/j.1365-2443.2009.01305.x; Takai A, 2015, P NATL ACAD SCI USA, V112, P4352, DOI 10.1073/pnas.1418468112; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3	34	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181186	10.1371/journal.pone.0181186	http://dx.doi.org/10.1371/journal.pone.0181186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700734	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649400036
J	Thomasini, RL; Pereira, DS; Pereira, FSM; Mateo, EC; Mota, TN; Guimaraes, GG; Pereira, LSM; Lima, CX; Teixeira, MM; Teixeira, AL				Thomasini, Ronaldo Luis; Pereira, Daniele Sirineu; Maximo Pereira, Fabiana Souza; Mateo, Elvis Cueva; Mota, Thamires Nader; Guimaraes, Gabrielle Gontijo; Maximo Pereira, Leani Souza; Lima, Cristiano Xavier; Teixeira, Mauro Martins; Teixeira Junior, Antonio Lucio			Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; INFECTION; PEOPLE; ADULTS	Immunosenescence is an age-related reduction of immune system activity that can be associated with frailty. This study aimed to compare cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations (based on viremias) between young and elderly women who had a chronic CMV and/or EBV infection (i.e., an IgG(+) serostatus) without an acute infection (i.e., an IgM-serostatus), and among the elderly group categorized according to frailty status. DNA was extracted from plasma using standard protocols and serostatus was determined by enzyme-linked immunosorbent assay. Quantitative real-time polymerase chain reaction analyses for CMV and EBV were carried out and viral loads were determined. Among elderly women (n = 71), 59% were positive for CMV, in contrast to only 8% of young women (n = 73). Elderly women classified as frail, pre-frail, and non-frail presented 82%, 56%, and 48% positivity for CMV, respectively. Frequency and viral load were significantly higher in the elderly group vs. the young group (p < 0.0001 and p = 0.01, respectively) and in elderly with frailty vs. those without frailty (p = 0.007 and p = 0.03, respectively). The frequency of CMV reactivation presented odds ratios of 11.77 for aging and 6.13 for frailty, and relative risks of 5.39 for aging and 1.93 for frailty. EBV was detected in 30% of the elderly women and 15% of the young women (p = 0.04); however, the viral load did not significantly differ between the two age groups. The frequency of EBV reactivation presented odds ratios of 2.36 for aging and 2.90 for frailty, and relative risks of 1.96 for aging and 2.12 for frailty. However, no difference in EBV viral load among the frailty status subgroups was found. In conclusion, the frequency of CMV reactivation was associated with aging and ongoing frailty, whereas the frequency of EBV reactivation was associated only with aging.	[Thomasini, Ronaldo Luis; Maximo Pereira, Fabiana Souza] Univ Fed Vales Jequinhonha & Mucuri, Fac Med Diamantina FAMED, NEPii, Diamantina, MG, Brazil; [Pereira, Daniele Sirineu] Univ Fed Alfenas, Escola Enfermagem, Curso Fisioterapia, Alfenas, MG, Brazil; [Mateo, Elvis Cueva; Mota, Thamires Nader; Guimaraes, Gabrielle Gontijo; Lima, Cristiano Xavier; Teixeira Junior, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Maximo Pereira, Leani Souza] Univ Fed Minas Gerais, Dept Fisioterapia, Belo Horizonte, MG, Brazil; [Maximo Pereira, Leani Souza] Univ Fed Minas Gerais, Programa Ciencias Reabilitacao, Belo Horizonte, MG, Brazil; [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil	Universidade Federal de Alfenas; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Thomasini, RL (corresponding author), Univ Fed Vales Jequinhonha & Mucuri, Fac Med Diamantina FAMED, NEPii, Diamantina, MG, Brazil.	ronaldothomasini@gmail.com	PEREIRA, LSM/L-2541-2014; LIMA, CRISTIANO/AAH-9402-2021; PEREIRA, DANIELE/AAB-9374-2020; Lima, Cristiano/B-1874-2013; Teixeira, Antonio L/N-3315-2014	Teixeira, Antonio L/0000-0002-9621-5422; Thomasini, Ronaldo/0000-0003-4967-0948; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG; Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG and Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue.	[Anonymous], 2006, ENVELHECIMENTO SAU P; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bennett JM, 2012, BRAIN BEHAV IMMUN, V26, P739, DOI 10.1016/j.bbi.2011.11.007; Caruso Calogero, 2009, Immun Ageing, V6, P10, DOI 10.1186/1742-4933-6-10; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Derhovanessian E, 2014, J IMMUNOL, V193, P3624, DOI 10.4049/jimmunol.1303361; El Hayderi L, 2011, MED ORAL PATOL ORAL, V16, pE15, DOI 10.4317/medoral.16.e15; Frantzeskaki F, 2014, J CRIT CARE CRIT CAR, V2; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gardella C., 2009, GLOB LIB WOMENS MED; Gary R, 2012, J CARDIOVASC NURS, V27, P120, DOI 10.1097/JCN.0b013e318239f4a4; Lyndon Helen, 2014, Nurs Older People, V26, P16, DOI [10.7748/nop.26.5.16.s21, 10.7748/nop.26.8.16.s22, 10.7748/nop.26.6.16.s21]; Griffiths SJ, 2013, J IMMUNOL, V190, P5363, DOI 10.4049/jimmunol.1203267; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Hesse J, 2013, J GEN VIROL, V94, P376, DOI 10.1099/vir.0.045682-0; Kekre N, 2013, BIOL BLOOD MARROW TR, V19, P1719, DOI 10.1016/j.bbmt.2013.09.013; King-Kallimanis BL, 2014, J CLIN EPIDEMIOL, V67, P1008, DOI 10.1016/j.jclinepi.2014.05.002; Koch S, 2006, MECH AGEING DEV, V127, P538, DOI 10.1016/j.mad.2006.01.011; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; Nogalski MT, 2014, METHODS MOL BIOL, V1119, P15, DOI 10.1007/978-1-62703-788-4_2; Oliveira DR, 2013, REV LAT-AM ENFERM, V21, P891, DOI 10.1590/S0104-11692013000400009; Pereira DS, 2013, AGE, V35, P2455, DOI 10.1007/s11357-013-9515-1; Razonable RR, 2013, CLIN MICROBIOL REV, V26, P703, DOI 10.1128/CMR.00015-13; Sansoni P, 2014, EXP GERONTOL, V55, P54, DOI 10.1016/j.exger.2014.03.020; Seckert CK, 2012, MED MICROBIOL IMMUN, V201, P551, DOI 10.1007/s00430-012-0273-y; Smeltzer JP, 2014, CASE REP HEMATOL, V2014, DOI 10.1155/2014/641483; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; de Franca TRT, 2012, CLIN ORAL INVEST, V16, P659, DOI 10.1007/s00784-011-0548-5; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Wang GC, 2014, TRANSL MED UNISA, V9, P1; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wolf J, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-1; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	37	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180841	10.1371/journal.pone.0180841	http://dx.doi.org/10.1371/journal.pone.0180841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700679	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800086
J	Wheelock, KM; Cai, J; Looker, HC; Merchant, ML; Nelson, RG; Fufaa, GD; Weil, EJ; Feldman, HI; Vasan, RS; Kimmel, PL; Rovin, BH; Mauer, M; Klein, JB				Wheelock, Kevin M.; Cai, Jian; Looker, Helen C.; Merchant, Michael L.; Nelson, Robert G.; Fufaa, Gudeta D.; Weil, E. Jennifer; Feldman, Harold I.; Vasan, Ramachandran S.; Kimmel, Paul L.; Rovin, Brad H.; Mauer, Michael; Klein, Jon B.		CKD Biomarkers Consortium	Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GLOMERULAR VOLUME; MESSENGER-RNA; B2 RECEPTOR; HUMANS; B1; PROLYLCARBOXYPEPTIDASE; LOSARTAN; THERAPY; KININS	Objective To examine the association of bradykinin and related peptides with the development of diabetic nephropathy lesions in 243 participants with type 1 diabetes (T1D) from the ReninAngiotensin System Study who, at baseline, were normoalbuminuric, normotensive and had normal or increased glomerular filtration rate (GFR). Design Plasma concentrations of bradykinin and related peptides were measured at baseline by quantitative mass spectrometry. All participants were randomly assigned at baseline to receive placebo, enalapril or losartan during the 5 years between kidney biopsies. Kidney morphometric data were available from kidney biopsies at baseline and after 5 years. Relationships of peptides with changes in morphometric variables were assessed using multiple linear regression after adjustment for age, sex, diabetes duration, HbA1c, mean arterial pressure, treatment assignment and, for longitudinal analyses, baseline structure. Results Baseline median albumin excretion rate of study participants was 5.0 mu g/ min, and mean GFR was 128 mL/min/ 1.73 m(2). After multivariable adjustment, higher plasma concentration of bradykinin (1 -8) was associated with greater glomerular volume (partial r = 0.191, P = 0.019) and total filtration surface area (partial r = 0.211, P = 0.010), and higher bradykinin (1 -7) and hyp3-bradykinin (1 -7) were associated with lower cortical interstitial fractional volume (partial r = -0.189, P = 0.011; partial r = -0.164, P = 0.027 respectively). In longitudinal analyses, higher bradykinin was associated with preservation of surface density of the peripheral glomerular basement membrane (partial r = 0.162, P = 0.013), and for participants randomized to losartan, higher hyp3-bradykinin (1 -8) was associated with more limited increase in cortical interstitial fractional volume (partial r = -0.291, P = 0.033). Conclusions Higher plasma bradykinin and related peptide concentrations measured before clinical onset of diabetic nephropathy in persons with T1D were associated with preservation of glomerular structures, suggesting that elevations of these kinin concentrations may reflect adaptive responses to early renal structural changes in diabetic nephropathy.	[Wheelock, Kevin M.; Looker, Helen C.; Nelson, Robert G.; Fufaa, Gudeta D.; Weil, E. Jennifer] NIDDK, Phoenix, AZ 85016 USA; [Cai, Jian; Merchant, Michael L.; Klein, Jon B.] Univ Louisville, Louisville, KY 40292 USA; [Feldman, Harold I.] Univ Penn, Philadelphia, PA 19104 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kimmel, Paul L.] NIDDK, Bethesda, MD 20892 USA; [Rovin, Brad H.] Ohio State Univ, Columbus, OH 43210 USA; [Mauer, Michael] Univ Minnesota, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Louisville; University of Pennsylvania; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Nelson, RG (corresponding author), NIDDK, Phoenix, AZ 85016 USA.	rnelson@nih.gov	Merchant, Michael/F-7109-2013; Mauer, Michael/ABD-5415-2020; Ramachandran, Vasan/Y-2527-2019; Klein, Jon/B-9833-2013; Merchant, Michael/N-7444-2013	Ramachandran, Vasan/0000-0001-7357-5970; Merchant, Michael/0000-0003-4128-4057	Chronic Kidney Disease Biomarker Consortium - National Institute of Diabetes and Digestive and Kidney Diseases [U01DK85649, U01DK085673, U01DK085660, U01DK085688, U01DK085651, U01DK085689]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085689, U01DK085660, ZIADK069062] Funding Source: NIH RePORTER	Chronic Kidney Disease Biomarker Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Chronic Kidney Disease Biomarker Consortium funded by National Institute of Diabetes and Digestive and Kidney Diseases U01DK85649, U01DK085673, U01DK085660, U01DK085688, U01DK085651 and U01DK085689, and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The National Institute of Diabetes and Digestive and Kidney Diseases had no role in study design, data collection and analysis, or decision to publish. The project officer representing the National Institute of Diabetes and Digestive and Kidney Diseases had a role in the preparation of the manuscript.	Ahluwalia A, 1996, J IMMUNOL, V156, P269; BILOUS RW, 1989, DIABETES, V38, P1142, DOI 10.2337/diabetes.38.9.1142; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Campbell DJ, 2005, CIRCULATION, V111, P315, DOI 10.1161/01.CIR.0000153269.07762.3B; Campbell DJ, 1999, HYPERTENSION, V34, P171, DOI 10.1161/01.HYP.34.2.171; CAMPBELL DJ, 1993, HYPERTENSION, V21, P155, DOI 10.1161/01.HYP.21.2.155; Caramori ML, 2013, J AM SOC NEPHROL, V24, P1175, DOI 10.1681/ASN.2012070739; Caramori ML, 2002, DIABETES, V51, P506, DOI 10.2337/diabetes.51.2.506; Chajkowski SM, 2011, BIOCHEM BIOPH RES CO, V405, P338, DOI 10.1016/j.bbrc.2010.12.036; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Duncan AM, 2000, AM J PHYSIOL-REG I, V278, pR897, DOI 10.1152/ajpregu.2000.278.4.R897; FIORETTO P, 1994, DIABETES, V43, P1358, DOI 10.2337/diabetes.43.11.1358; Fufaa GD, 2015, NEPHROL DIAL TRANSPL, V30, P599, DOI 10.1093/ndt/gfv012; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; HONG SL, 1980, THROMB RES, V18, P787, DOI 10.1016/0049-3848(80)90201-7; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Katz A, 2002, KIDNEY INT, V61, P2058, DOI 10.1046/j.1523-1755.2002.00370.x; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Kuoppala A, 2000, AM J PHYSIOL-HEART C, V278, pH1069, DOI 10.1152/ajpheart.2000.278.4.H1069; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mackie FE, 2002, KIDNEY INT, V61, P555, DOI 10.1046/j.1523-1755.2002.00141.x; Mallela J, 2009, INT J BIOCHEM CELL B, V41, P477, DOI 10.1016/j.biocel.2008.02.022; Mauer M, 2002, J RENIN-ANGIO-ALDO S, V3, P262, DOI 10.3317/jraas.2002.048; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Merchant ML, 2013, KIDNEY INT, V83, P1177, DOI 10.1038/ki.2013.8; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Pavkov ME, 2016, KIDNEY INT, V89, P226, DOI 10.1038/ki.2015.278; Paykov ME, 2015, KIDNEY INT, V87, P812, DOI 10.1038/ki.2014.330; REGOLI D, 1991, AGENTS ACTIONS, V34, P138, DOI 10.1007/BF01993260; Spillmann F, 2002, INT IMMUNOPHARMACOL, V2, P1823, DOI 10.1016/S1567-5769(02)00174-1; Sumino H, 1999, AM J HYPERTENS, V12, P1044, DOI 10.1016/S0895-7061(99)00094-1; Tabrizian Tahmineh, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P114, DOI 10.2174/1871525713666150911112916; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; United States Renal Data System, 2015, USRDS ANNUAL DATA RE; Xu SY, 2012, CLIN CHEM, V58, P1110, DOI 10.1373/clinchem.2011.179291; Zeitz CJ, 2003, HYPERTENSION, V41, P482, DOI 10.1161/01.HYP.0000054976.67487.08	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180964	10.1371/journal.pone.0180964	http://dx.doi.org/10.1371/journal.pone.0180964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700653	gold, Green Submitted, Green Published			2022-12-26	WOS:000405544800106
J	Xu, GY; Han, X; Yuan, GX; An, LP; Du, PG				Xu, Guangyu; Han, Xiao; Yuan, Guangxin; An, Liping; Du, Peige			Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury	PLOS ONE			English	Article							NF-KAPPA-B; CANCER SUSCEPTIBILITY; OXIDATIVE STRESS; FIBROSIS; PATHWAY; RATS; INFLAMMATION; ACTIVATION; RESISTANCE; MUTATIONS	Liver injury is a common pathological basis of various liver diseases, and long-term liver injury is often an important initiation factor leading to liver fibrosis and even liver cirrhosis and hepatocellular carcinoma (HCC). It has been reported that deproteinized extract of calf blood (DECB) can inhibit the replication of hepatitis B virus and confers a protective effect on the liver after traumatic liver injury. However, few studies on the regulatory factors and mechanisms of DECB have been reported. In this current study, an acute mouse liver injury model was established with carbon tetrachloride (CCl4\). The differentially expressed genes and related cell signal transduction pathways were screened using mRNA expression microarray. STEM software V1.3.6 was used for clustering gene functions, and the DAVID and KEGG databases were applied for the analysis. A total of 1355 differentially expressed genes were selected, among which nine were validated by RT-qPCR. The results showed that the Fas, IL1b, Pik3r1, Pik3r5, Traf2, Traf2, Csf2rb2, Map3k14, Pik3cd and Ppp3cc genes were involved in the regulation of DECB in an acute mouse liver injury model. Targets of the protective effects of DECB and its related mechanisms were found in mice with acute liver injury induced by carbon tetrachloride, which may provide an important theoretical basis for further DECB research.	[Xu, Guangyu; Han, Xiao; Yuan, Guangxin; An, Liping; Du, Peige] Beihua Univ, Coll Pharm, Jilin, Jilin, Peoples R China	Beihua University	An, LP; Du, PG (corresponding author), Beihua Univ, Coll Pharm, Jilin, Jilin, Peoples R China.	alp960@126.com; dupeige2001@126.com		xu, guangyu/0000-0002-5802-4457	Health Department of Jilin Province [2014Z078]; Sci-tech Department of Jilin Province [20140311084YY]; National and Local United Engineering Research and Development Center	Health Department of Jilin Province; Sci-tech Department of Jilin Province; National and Local United Engineering Research and Development Center	This work was financially supported by project 2014Z078 of the Health Department of Jilin Province, project 20140311084YY Sci-tech Department of Jilin Province and also supported by National and Local United Engineering Research and Development Center for Research on Active Peptides of Medicinal Plants and Animals in Changbai Mountains.	Alsheblak MM, 2016, EUR CYTOKINE NETW, V27, P6, DOI 10.1684/ecn.2016.0372; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Cabal-Hierro L, 2014, CELL SIGNAL, V26, P2658, DOI 10.1016/j.cellsig.2014.08.011; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao Lei, 2016, J Cell Death, V9, P19, DOI 10.4137/JCD.S39824; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chung JY, 2002, J CELL SCI, V115, P679; Craft JM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-15; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; Domitrovic R, 2012, ACTA PHARMACOL SIN, V33, P1260, DOI 10.1038/aps.2012.62; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gimson AES, 1996, BRIT J ANAESTH, V77, P90, DOI 10.1093/bja/77.1.90; Hsieh CW, 2016, ASIAN PAC J TROP MED, V9, P409, DOI 10.1016/j.apjtm.2016.03.029; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088498; Jeong JH, 2017, MOL CELL, V65, P154, DOI 10.1016/j.molcel.2016.11.034; Jung JU, 2016, CURR BIOL, V26, P3288, DOI 10.1016/j.cub.2016.10.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee M, 1985, Nichidai Koko Kagaku, V11, P90; Li CG, 2013, TUMOR BIOL, V34, P3477, DOI 10.1007/s13277-013-0925-6; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Milanovic D, 2016, NEUROTOX RES, V30, P434, DOI 10.1007/s12640-016-9629-1; Mitupatum Thantip, 2015, Asian Pac J Cancer Prev, V16, P1771; Mohammed A, 2016, CLIN EXP PHARMACOL P, V43, P760, DOI 10.1111/1440-1681.12591; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; O'Connell J, 1999, IMMUNOL TODAY, V20, P46, DOI 10.1016/S0167-5699(98)01382-6; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; [任丽萍 REN Li-ping], 2009, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V29, P209; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Shi Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139552; Shu-ping R., 2006, CHINESE J NEUROMEDIC, V5, p767 ; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Weiskirchen R, 2016, DIGEST DIS, V34, P410, DOI 10.1159/000444556; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhong M, 2013, CELL PHYSIOL BIOCHEM, V31, P209, DOI 10.1159/000343362	39	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180899	10.1371/journal.pone.0180899	http://dx.doi.org/10.1371/journal.pone.0180899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700704	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800096
J	Huang, CQ; Xiao, X; Yang, Y; Mishra, A; Liang, YR; Zeng, XM; Yang, XY; Xu, D; Blackburn, MR; Henke, CA; Liu, L				Huang, Chaoqun; Xiao, Xiao; Yang, Ye; Mishra, Amorite; Liang, Yurong; Zeng, Xiangming; Yang, Xiaoyun; Xu, Dao; Blackburn, Michael R.; Henke, Craig A.; Liu, Lin			MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; LUNG FIBROSIS; APOPTOSIS; GROWTH-FACTOR-BETA-1; PATHOGENESIS; EXPRESSION	Aberrant proliferation and activation of lung fibroblasts contribute to the initiation and progression of idiopathic pulmonary fibrosis (IPF). However, the mechanisms responsible for the proliferation and activation of fibroblasts are not fully understood. The objective of this study was to investigate the role of miR-101 in the proliferation and activation of lung fibroblasts. miR-101 expression was determined in lung tissues from patients with IPF and mice with bleomycin-induced pulmonary fibrosis. The regulation of miR-101 and cellular signaling was investigated in pulmonary fibroblasts in vitro. The role of miR-101 in pulmonary fibrosis in vivo was studied using adenovirus-mediated gene transfer in mice. The expression of miR-101 was down-regulated in fibrotic lungs from patients with IPF and bleomycin-treated mice. The down-regulation of miR-101 occurred via the E26 transformation-specific (ETS) transcription factor. miR-101 suppressed the WNT5a-induced proliferation of lung fibroblasts by inhibiting NFATc2 signaling via targeting Frizzled receptor 4/6 and the TGF-beta-induced activation of lung fibroblasts by inhibition of SMAD2/3 signaling via targeting the TGF-beta receptor 1. Adenovirus-mediated miR-101 gene transfer in the mouse lung attenuated bleomycin-induced lung fibrosis and improved lung function. Our data suggest that miR-101 is an anti-fibrotic microRNA and a potential therapeutic target for pulmonary fibrosis.	[Huang, Chaoqun; Xiao, Xiao; Liang, Yurong; Yang, Xiaoyun; Xu, Dao; Liu, Lin] Oklahoma State Univ, Oklahoma Ctr Resp & Infect Dis, Stillwater, OK 74078 USA; [Huang, Chaoqun; Xiao, Xiao; Yang, Ye; Mishra, Amorite; Liang, Yurong; Zeng, Xiangming; Yang, Xiaoyun; Xu, Dao; Liu, Lin] Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA; [Blackburn, Michael R.] Univ Texas Houston, Med Sch, Dept Biochem & Mol Biol, Houston, TX USA; [Henke, Craig A.] Univ Minnesota, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Box 736 UMHC, Minneapolis, MN 55455 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Liang, Yurong/DWV-1204-2022	Huang, Chaoqun/0000-0001-8015-6467	National Institutes of Health [R01HL116876, R03HL95383, P20GM103648, R01HL125227, P01HL 091775]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091775, R01HL116876, R03HL095383, R01HL125227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL116876, R03HL95383, and P20GM103648 (to L. L.) and R01HL125227 and P01HL 091775 (to C. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Baran CP, 2011, AM J RESP CELL MOL, V45, P999, DOI 10.1165/rcmb.2010-0490OC; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bodempudi V, 2014, AM J PHYSIOL-LUNG C, V307, pL283, DOI 10.1152/ajplung.00069.2014; Bruce MC, 1999, AM J RESP CELL MOL, V20, P228, DOI 10.1165/ajrcmb.20.2.3150; Chen ZM, 2007, FREE RADICAL BIO MED, V43, P628, DOI 10.1016/j.freeradbiomed.2007.05.024; Chen ZM, 2005, PHYSIOL GENOMICS, V21, P284, DOI 10.1152/physiolgenomics.00236.2004; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Huang CQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-46; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Kim JH, 2014, ANTIOXID REDOX SIGN, V21, P2469, DOI 10.1089/ars.2014.5856; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Oak SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021253; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Smits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Xia H, 2014, AM J PATHOL, V184, P1369, DOI 10.1016/j.ajpath.2014.01.012; Xiao X, 2015, ARCH BIOCHEM BIOPHYS, V566, P49, DOI 10.1016/j.abb.2014.12.007; Xu YH, 2013, ONCOL REP, V29, P2019, DOI 10.3892/or.2013.2338; Zhao Chunling, 2012, BMC Res Notes, V5, P91, DOI 10.1186/1756-0500-5-91; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	42	76	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16420	16439		10.1074/jbc.M117.805747	http://dx.doi.org/10.1074/jbc.M117.805747			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28726637	hybrid, Green Published			2022-12-26	WOS:000412414800003
J	Kotla, S; Singh, NK; Kirchhofer, D; Rao, GN				Kotla, Sivareddy; Singh, Nikhlesh K.; Kirchhofer, Daniel; Rao, Gadiparthi N.			Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)hydroxyeicosatetraenoic acid-induced monocyte trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; HIGH-RISK PLAQUE; OXIDATIVE STRESS; CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; MESSENGER-RNA; VESSEL WALL; FACTOR GENE; PROTEIN	Tissue factor (TF) is expressed in vascular and nonvascular tissues and functions in several pathways, including embryonic development, inflammation, and cell migration. Many risk factors for atherosclerosis, including hypertension, diabetes, obesity, and smoking, increase TF expression. To better understand the TF-related mechanisms in atherosclerosis, here we investigated the role of 12/15-lipoxygenase (12/15-LOX) in TF expression. 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), the major product of human 15-LOXs 1 and 2, induced TF expression and activity in a time-dependent manner in the human monocytic cell line THP1. Moreover, TF suppression with neutralizing antibodies blocked 15(S)-HETE-induced monocyte migration. We also found that NADPH-and xanthine oxidase-dependent reactive oxygen species (ROS) production, calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation, and interactions between nuclear factor of activated T cells 3 (NFATc3) and FosB proto-oncogene, AP-1 transcription factor subunit (FosB) are involved in 15(S)-HETE-induced TF expression. Interestingly, NFATc3 first induced the expression of its interaction partner FosB before forming the heterodimeric NFATc3-FosB transcription factor complex, which bound the proximal AP-1 site in the TF gene promoter and activated TF expression. We also observed that macrophages from 12/15-LOX-/- mice exhibit diminished migratory response to monocyte chemotactic protein 1 (MCP-1) and lipopolysaccharide compared with WT mouse macrophages. Similarly, compared with WT macrophages, monocytes from 12/15-LOX-/- mice displayed diminished trafficking, which was rescued by prior treatment with 12(S)-HETE, in a peritonitis model. These observations indicate that 15(S)-HETE-induced monocyte/macrophage migration and trafficking require ROS-mediated CaMKIV activation leading to formation of NFATc3 and FosB heterodimer, which binds and activates the TF promoter.	[Kotla, Sivareddy; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	University of Tennessee System; University of Tennessee Health Science Center; Roche Holding; Genentech	Rao, GN (corresponding author), 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020	kotla, sivareddy/0000-0001-7516-7647; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL064165, HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165, R01HL103575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL064165 and HL103575 (to G. N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Celi A, 2010, EXPERT REV CARDIOVAS, V8, P1723, DOI 10.1586/ERC.10.161; Chen J, 2005, DIABETES, V54, P2143, DOI 10.2337/diabetes.54.7.2143; Chu AJ, 2005, ARCH BIOCHEM BIOPHYS, V440, P123, DOI 10.1016/j.abb.2005.06.005; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Fuster V, 2005, J AM COLL CARDIOL, V46, P1209, DOI 10.1016/j.jacc.2005.03.075; Golino P, 1996, NAT MED, V2, P35, DOI 10.1038/nm0196-35; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Kirchhofer D, 2000, THROMB HAEMOSTASIS, V84, P1072; Kotla S, 2017, REDOX BIOL, V11, P350, DOI 10.1016/j.redox.2016.12.005; Kotla S, 2015, J BIOL CHEM, V290, P30306, DOI 10.1074/jbc.M115.686865; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lopez-Pedrera C, 2006, LEUKEMIA, V20, P1331, DOI 10.1038/sj.leu.2404264; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Matetzky S, 2000, CIRCULATION, V102, P602, DOI 10.1161/01.CIR.102.6.602; McGillicuddy FC, 2012, MOL NUTR FOOD RES, V56, P1173, DOI 10.1002/mnfr.201100785; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Nishibe T, 2001, BLOOD, V97, P692, DOI 10.1182/blood.V97.3.692; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; Ott I, 2005, CIRCULATION, V111, P349, DOI 10.1161/01.CIR.0000153333.52294.42; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Palkovits J, 2013, J CROHNS COLITIS, V7, P222, DOI 10.1016/j.crohns.2012.05.016; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parry GCN, 2000, J CLIN INVEST, V105, P1547, DOI 10.1172/JCI9458; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Segal J, 2000, J RHEUMATOL, V27, P2827; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TIPPING PG, 1995, AM J PATHOL, V147, P1736; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Vijil C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088546; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959	57	3	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14885	14901		10.1074/jbc.M117.804344	http://dx.doi.org/10.1074/jbc.M117.804344			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724635	Green Published, hybrid			2022-12-26	WOS:000409902100015
J	Choi, S; Quan, XL; Bang, S; Yoo, H; Kim, J; Park, J; Park, KS; Chung, J				Choi, Sekyu; Quan, Xianglan; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Park, Kyu-Sang; Chung, Jongkyeong			Mitochondrial calcium uniporter in Drosophila transfers calcium between the endoplasmic reticulum and mitochondria in oxidative stress-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RELEASING CELLS; CA2+ UNIPORTER; INOSITOL 1,4,5-TRISPHOSPHATE; ESSENTIAL COMPONENT; HYDROGEN-PEROXIDE; MICE LACKING; MCU; PROTEIN; METABOLISM; MEMBRANE	Mitochondrial calcium plays critical roles in diverse cellular processes ranging from energy metabolism to cell death. Previous studies have demonstrated that mitochondrial calcium uptake is mainly mediated by the mitochondrial calcium uniporter (MCU) complex. However, the roles of the MCU complex in calcium transport, signaling, and dysregulation by oxidative stress still remain unclear. Here, we confirmed that Drosophila MCU contains evolutionarily conserved structures and requires essential MCU regulator (EMRE) for its calcium channel activities. We generated Drosophila MCU loss-of-function mutants, which lacked mitochondrial calcium uptake in response to caffeine stimulation. Basal metabolic activities were not significantly affected in these MCU mutants, as observed in examinations of body weight, food intake, body sugar level, and starvation-induced autophagy. However, oxidative stress-induced increases in mitochondrial calcium, mitochondrial membrane potential depolarization, and cell death were prevented in these mutants. We also found that inositol 1,4,5-trisphosphate receptor genetically interacts with Drosophila MCU and effectively modulates mitochondrial calcium uptake upon oxidative stress. Taken together, these results support the idea that Drosophila MCU is responsible for endoplasmic reticulum-to-mitochondrial calcium transfer and for cell death due to mitochondrial dysfunction under oxidative stress.	[Choi, Sekyu; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 08826, South Korea; [Choi, Sekyu; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Quan, Xianglan; Park, Kyu-Sang] Yonsei Univ, Dept Physiol, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea; [Quan, Xianglan] Yanbian Univ, Dept Oncol, Affiliated Hosp, Yanji 133000, Jilin, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yanbian University	Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea.	qsang@yonsei.ac.kr; jkc@snu.ac.kr		Park, Kyu-Sang/0000-0003-0322-9807; Choi, Sekyu/0000-0003-2928-0942	BK21 Plus Program from the Ministry of Education (MOE), Korea; National Research Foundation of Korea (NRF) Grant [2016R1A2B4014565]	BK21 Plus Program from the Ministry of Education (MOE), Korea; National Research Foundation of Korea (NRF) Grant	Supported by the BK21 Plus Program from the Ministry of Education (MOE), Korea.; Supported by National Research Foundation of Korea (NRF) Grant 2016R1A2B4014565. To whom correspondence may be addressed: Dept. of Physiology, Yonsei University Wonju College of Medicine, 20 Ilsan-Ro, Wonju, Gangwon-Do 26426, Korea. Tel.: 82-33-741-0294; Fax: 82-33-745-6461; E-mail: qsang@yonsei.ac.kr.	Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; Chaudhuri D, 2016, P NATL ACAD SCI USA, V113, pE1872, DOI 10.1073/pnas.1602264113; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Marchi U, 2014, J BIOL CHEM, V289, P20377, DOI 10.1074/jbc.M113.540898; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Dong ZW, 2017, MOL CELL, V65, P1014, DOI 10.1016/j.molcel.2017.01.032; Drago I, 2016, CELL REP, V16, P2763, DOI 10.1016/j.celrep.2016.08.017; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Gouriou Y, 2013, J BIOL CHEM, V288, P12459, DOI 10.1074/jbc.M112.428128; Jhun BS, 2016, AM J PHYSIOL-CELL PH, V311, pC67, DOI 10.1152/ajpcell.00319.2015; Kim W, 2015, J BIOL CHEM, V290, P13591, DOI 10.1074/jbc.M114.607036; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; Lee SK, 2016, CELL CHEM BIOL, V23, P1157, DOI 10.1016/j.chembiol.2016.07.012; Lee Y, 2015, EMBO REP, V16, P1318, DOI 10.15252/embr.201540436; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Liao YJ, 2015, PROTEIN CELL, V6, P434, DOI 10.1007/s13238-015-0144-6; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lye CM, 2014, DEVELOPMENT, V141, P4006, DOI 10.1242/dev.111310; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; Min S, 2016, CURR BIOL, V26, P814, DOI 10.1016/j.cub.2016.01.029; Murphy E, 2014, BIOCHEM BIOPH RES CO, V449, P384, DOI 10.1016/j.bbrc.2014.04.144; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Quan XL, 2015, J BIOL CHEM, V290, P4086, DOI 10.1074/jbc.M114.632547; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; RAGHU P, 1995, DEV BIOL, V171, P564, DOI 10.1006/dbio.1995.1305; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; RENARD DC, 1992, BIOCHEM J, V284, P507, DOI 10.1042/bj2840507; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROVERI A, 1992, ARCH BIOCHEM BIOPHYS, V297, P265, DOI 10.1016/0003-9861(92)90671-I; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai MF, 2016, ELIFE, V5, DOI 10.7554/eLife.15545; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002	58	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14473	14485		10.1074/jbc.M116.765578	http://dx.doi.org/10.1074/jbc.M116.765578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28726639	hybrid, Green Published			2022-12-26	WOS:000408747500014
J	Navarro-Mateu, F; Salmeron, D; Vilagut, G; Tormo, MJ; Ruiz-Merino, G; Escamez, T; Judez, J; Martinez, S; Koenen, KC; Navarro, C; Alonso, J; Kessler, RC				Navarro-Mateu, Fernando; Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Ruiz-Merino, Guadaiupe; Escamez, Teresa; Judez, Javier; Martinez, Salvador; Koenen, Karestan C.; Navarro, Carmen; Alonso, Jordi; Kessler, Ronald C.			Post-Traumatic Stress Disorder and other mental disorders in the general population after Lorca's earthquakes, 2011 (Murcia, Spain): A cross-sectional study	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; DSM-IV DISORDERS; RISK-FACTORS; WENCHUAN EARTHQUAKE; ADULT SURVIVORS; PREVALENCE; DEPRESSION; COMORBIDITY; VERSION; PSYCHOPATHOLOGY	Aims To describe the prevalence and severity of mental disorders and to examine differences in risk among those with and without a lifetime history prior to a moderate magnitude earthquake that took place in Lorca (Murcia, Spain) at roughly the mid-point (on May 11, 2011) of the time interval in which a regional epidemiological survey was already being carried out (June 2010-May 2012). Methods The PEGASUS-Murcia project is a cross-sectional face-to-face interview survey of a representative sample of non-institutionalized adults in Murcia. Main outcome measures are prevalence and severity of anxiety, mood, impulse and substance disorders in the 12 months previous to the survey, assessed using the Composite International Diagnostic Interview (CIDI 3.0). Sociodemographic variables, prior history of any mental disorder and earthquake-related stressors were entered as independent variables in a logistic regression analysis. Findings A total number of 412 participants (response rate: 71%) were interviewed. Significant differences in 12-month prevalence of mental disorders were found in Lorca compared to the rest of Murcia for any (12.8% vs 16.8%), PTSD (3.6% vs 0.5%) and other anxiety disorders (5.3% vs 9.2%) (p <= 0.05 for all). No differences were found for 12-month prevalence of any mood or any substance disorder. The two major predictors for developing a 12-month post-earthquake mental disorder were a prior mental disorder and the level of exposure. Other risk factors included female sex and low-average income. Conclusions PTSD and other mental disorders are commonly associated with earthquake disasters. Prior mental disorders and the level of exposure to the earthquakes are the most important for the development of a consequent mental disorder and this recognition may help to identify those individuals that may most benefit from specific therapeutic intervention.	[Navarro-Mateu, Fernando] Univ Murcia, Dept Psicol Basica & Metodol, UDIF SM, Serv Murciano Salud, Murcia, Spain; [Navarro-Mateu, Fernando; Salmeron, Diego; Jose Tormo, Ma; Ruiz-Merino, Guadaiupe; Escamez, Teresa; Navarro, Carmen] IMIB Arrixaca, Murcia, Spain; [Navarro-Mateu, Fernando; Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Alonso, Jordi] CIBERESP, Madrid, Spain; [Salmeron, Diego; Navarro, Carmen] Serv Epidemiol, Consejeria Salud, Murcia, Spain; [Salmeron, Diego; Vilagut, Gemma; Jose Tormo, Ma; Navarro, Carmen; Alonso, Jordi] Univ Murcia, Dept Ciencias Sociosanitarias, Murcia, Spain; [Vilagut, Gemma] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Ruiz-Merino, Guadaiupe; Escamez, Teresa] Fdn Formac & Invest Sanitarias FFIS Reg Murcia, Murcia, Spain; [Escamez, Teresa] Biobanco HUVA AECC FFIS, IMIB BIOBANC MUR, Murcia, Spain; [Judez, Javier] Fdn Espanola Aparato Digest, Soc Espanola Patol Digest, Madrid, Spain; [Martinez, Salvador] Inst Neurociencias, Alicante, Spain; [Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Alonso, Jordi] Univ Pompeu Fabra, Dept Salud & Ciencias Expt, Barcelona, Spain; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Harvard University; Harvard T.H. Chan School of Public Health; Pompeu Fabra University; Harvard University; Harvard Medical School	Navarro-Mateu, F (corresponding author), Univ Murcia, Dept Psicol Basica & Metodol, UDIF SM, Serv Murciano Salud, Murcia, Spain.; Navarro-Mateu, F (corresponding author), IMIB Arrixaca, Murcia, Spain.; Navarro-Mateu, F (corresponding author), CIBERESP, Madrid, Spain.	fernando.navarro@carm.es	Júdez, Javier/ABG-5828-2020; Alonso, Jordi/A-5514-2010; Serraino, Diego/J-3915-2018; Navarro-Mateu, Fernando/H-9055-2017; Martínez, Diego Salmerón/AAA-3403-2019; Vilagut, Gemma/N-8718-2014	Alonso, Jordi/0000-0001-8627-9636; Serraino, Diego/0000-0003-0565-8920; Navarro-Mateu, Fernando/0000-0002-3228-623X; Martínez, Diego Salmerón/0000-0002-4574-6880; Vilagut, Gemma/0000-0002-3714-226X; Judez, Javier/0000-0001-9724-5191	Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social") [455/2009]; Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia [CM0829 I, FFIDS/EMER09/14]; Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [PI12/00809]; United States National Institute of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; U.S. Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03- TW006481]; Pan American Health Organization; Eli Lilly & Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire	Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social"); Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia; Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly & Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire	The PEGASUS-Murcia Project was supported by the Regional Health Authorities of Murcia ("Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social") (Decreto no 455/2009), the "Fundacion para la Formacion e Investigacion Sanitarias (FFIS) de la Region de Murcia" (No Expedientes: CM0829 I and FFIDS/EMER09/14) and the "Ayudas para proyectos de Investigacion en Salud -ISCIII- del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" (PI12/00809). The PEGASUS-Murcia project is carried out in conjunction with the WHOWMH Survey Initiative. The authors thank the WMH Coordinating Center staff at Harvard and Michigan Universities for their assistance with the instrumentation, fieldwork and data analysis. These activities were supported by the United States National Institute of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the U.S. Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03- TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb and Shire. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. The direct and indirect founders had no role in study design, data collection and analysis, decision to publish,	Anwar J, 2013, J NERV MENT DIS, V201, P1045, DOI 10.1097/NMD.0000000000000060; Abeldano RA, 2014, CAD SAUDE PUBLICA, V30, P2377, DOI 10.1590/0102-311X00141313; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Armenian HK, 2002, J URBAN HEALTH, V79, P373, DOI 10.1093/jurban/79.3.373; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Basoglu M, 2002, J TRAUMA STRESS, V15, P269, DOI 10.1023/A:1016241826589; Beard JR, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-83; Bernstein KT, 2007, J NERV MENT DIS, V195, P41, DOI 10.1097/01.nmd.0000244784.36745.a5; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Bromet EJ, 2016, PSYCHOL MED, P1; Center for Research on the Epidemiology of Disasters-CRED. EM-DAT, 2015, INT DIS DAT; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; Feo P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0270-3; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Galea S, 2008, INT J METH PSYCH RES, V17, pS21, DOI 10.1002/mpr.267; Guo J, 2015, J NERV MENT DIS, V203, P469, DOI 10.1097/NMD.0000000000000310; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hong CL, 2016, TRAUMA VIOLENCE ABUS, V17, P542, DOI 10.1177/1524838015585313; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Lopez-Garcia JJ, 2014, GAC SANIT, V28, P230, DOI 10.1016/j.gaceta.2013.10.009; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2014, WORLD PSYCHIATRY, V13, P265, DOI 10.1002/wps.20150; Kessler RC, 2008, INT J METH PSYCH RES, V17, pS6, DOI 10.1002/mpr.269; Kun P, 2013, PUBLIC HEALTH, V127, P644, DOI 10.1016/j.puhe.2013.04.018; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Martin Julio C, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01691; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Navarro-Mateu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137293; Navarro-Mateu F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004035; Navarro-Mateu F, 2013, GAC SANIT, V27, P325, DOI 10.1016/j.gaceta.2012.06.005; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Priebe S, 2009, SOC PSYCH PSYCH EPID, V44, P393, DOI 10.1007/s00127-008-0441-y; Priebe S, 2011, SOC PSYCH PSYCH EPID, V46, P615, DOI 10.1007/s00127-010-0227-x; Ramirez M, 2005, EPIDEMIOL REV, V27, P47, DOI 10.1093/epirev/mxi005; Rodriguez-Llanes JM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-115; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; StataCorp, 2007, STAT STAT SOFTW REL; Tang BH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-623; Vazquez C., 2001, J ANXIETY DIORD, V19, P313; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wolter K. M., 1985, INTRO VARIANCE ESTIM; Wu ZB, 2016, PSYCHIAT RES, V237, P49, DOI 10.1016/j.psychres.2016.01.041; Wu ZB, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-126; Xu JP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2999-8; Yokoyama Yukari, 2014, PLoS One, V9, pe102497, DOI 10.1371/journal.pone.0102497; Zhang LP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0247-z; Zhang W, 2015, ASIA-PAC J PUBLIC HE, V27, P860, DOI 10.1177/1010539515602089; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhang Z, 2012, STRESS HEALTH, V28, P61, DOI 10.1002/smi.1403; Zhou XB, 2015, PSYCHIAT RES, V228, P468, DOI 10.1016/j.psychres.2015.05.062	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179690	10.1371/journal.pone.0179690	http://dx.doi.org/10.1371/journal.pone.0179690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723949	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800007
J	Sahaboglu, A; Sherif, A; Feng, LL; Secer, E; Zrenner, E; Paquet-Durand, F				Sahaboglu, Ayse; Sherif, Alaa; Feng, Lili; Secer, Enver; Zrenner, Eberhart; Paquet-Durand, Francois			Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34	PLOS ONE			English	Article							RETINAL DEGENERATION; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; RETINITIS-PIGMENTOSA; MICE; DIFFERENTIATION; CONTRIBUTES; SUBUNIT; GENOME	Peripherin (peripherin/rds) is a membrane-associated protein that plays a critical role in the morphogenesis of rod and cone photoreceptor outer segments. Mutations in the corresponding PRPH2 gene cause different types of retinal dystrophies characterized by a loss of photoreceptors. Over activation of poly-ADP-ribose polymerase (PARP) was previously shown to be involved in different animal models for hereditary retinal dystrophies. This includes the rd2 mouse, which suffers from a human homologous mutation in the PRPH2 gene. In the present study, we show that increased retinal PARP activity and poly-ADP-ribosylation of proteins occurs before the peak of rd2 photoreceptor degeneration. Inhibition of PARP activity with the well-characterized PARP inhibitor PJ34 decreased the levels of poly-ADP-ribosylation and photoreceptor cell death. These results suggest a causal involvement of PARP in photoreceptor degeneration caused by peripherin mutations and highlight the possibility to use PARP inhibition for the mutation-independent treatment of hereditary retinal dystrophies.	[Sahaboglu, Ayse; Sherif, Alaa; Feng, Lili; Zrenner, Eberhart; Paquet-Durand, Francois] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Sherif, Alaa] Grad Training Ctr Neurosci, Tubingen, Germany; [Secer, Enver] Erciyes Univ, Dept Med Genet, Kayseri, Turkey; [Zrenner, Eberhart] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Erciyes University; Eberhard Karls University of Tubingen	Sahaboglu, A; Paquet-Durand, F (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.	ayse.sahaboglu-tekgoez@klinikum.uni-tuebingen.de; francois.paquet-durand@klinikum.uni-tuebingen.de	Sherif, Alaa/R-7286-2019; Paquet-Durand, Francois/G-6709-2015	Sahaboglu, Ayse/0000-0003-3241-0672; Paquet-Durand, Francois/0000-0001-7355-5742	European Union (DRUGSFORD) [HEALTH-F2-2012-304963]; Deutsche Forschungsgemeinschaft (DFG) [PA1751/7-1, SA3040/1-1]; Charlotte and Tistou Kerstan Foundation [SAH001/2016]	European Union (DRUGSFORD); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Charlotte and Tistou Kerstan Foundation	This work was supported by the European Union (DRUGSFORD; HEALTH-F2-2012-304963), Deutsche Forschungsgemeinschaft (DFG; PA1751/7-1 and SA3040/1-1), and the Charlotte and Tistou Kerstan Foundation (SAH001/2016).	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buelow B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006339; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; Cardinale A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134482; Chatterjee S, 1999, MOL CELL BIOCHEM, V193, P23, DOI 10.1023/A:1006983304079; Chizzolini M, 2011, CURR GENOMICS, V12, P260, DOI 10.2174/138920211795860071; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Greco R, 2014, EUR J PHARMACOL, P74491; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, FRONT BIOSCI, V2008; Jiao K, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.40; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Ledermann JA, 2016, ANN ONCOL, V27, P40, DOI 10.1093/annonc/mdw094; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Renner AB, 2009, AM J OPHTHALMOL, V147, P518, DOI 10.1016/j.ajo.2008.09.007; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Sahaboglu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39537; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; SANYAL S, 1981, EXP EYE RES, V33, P213, DOI 10.1016/S0014-4835(81)80070-X; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	35	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181374	10.1371/journal.pone.0181374	http://dx.doi.org/10.1371/journal.pone.0181374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723922	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800046
J	Alshahrani, S; Rapoport, RM; Zahediz, K; Jiang, M; Nieman, M; Barone, S; Meredith, AL; Lorenz, JN; Rubinstein, J; Soleimani, M				Alshahrani, Saeed; Rapoport, Robert M.; Zahedi, Kamyar; Jiang, Min; Nieman, Michelle; Barone, Sharon; Meredith, Andrea L.; Lorenz, John N.; Rubinstein, Jack; Soleimani, Manoocher			The non-diuretic hypotensive effects of thiazides are enhanced during volume depletion states	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; NA+-CL-COTRANSPORTER; LARGE-CONDUCTANCE; ESSENTIAL-HYPERTENSION; DOUBLE KNOCKOUT; BLOOD-PRESSURE; THERAPY; METHYCLOTHIAZIDE; VASODILATION; INHIBITION	Thiazide derivatives including Hydrochlorothiazide (HCTZ) represent the most common treatment of mild to moderate hypertension. Thiazides initially enhance diuresis via inhibition of the kidney Na+-Cl- Cotransporter (NCC). However, chronic volume depletion and diuresis are minimal while lowered blood pressure (BP) is maintained on thiazides. Thus, a vasodilator action of thiazides is proposed, likely via Ca2+-activated K+ (BK) channels in vascular smooth muscles. This study ascertains the role of volume depletion induced by salt restriction or salt wasting in NCC KO mice on the non-diuretic hypotensive action of HCTZ. HCTZ (20mg/kg s.c.) lowered BP in 1) NCC KO on a salt restricted diet but not with normal diet; 2) in volume depleted but not in volume resuscitated pendrin/NCC dKO mice; the BP reduction occurs without any enhancement in salt excretion or reduction in cardiac output. HCTZ still lowered BP following treatment of NCC KO on salt restricted diet with paxilline (8 mg/kg, i.p.), a BK channel blocker, and in BK KO and BK/NCC dKO mice on salt restricted diet. In aortic rings from NCC KO mice on normal and low salt diet, HCTZ did not alter and minimally decreased maximal phenylephrine contraction, respectively, while contractile sensitivity remained unchanged. These results demonstrate 1) the non-diuretic hypotensive effects of thiazides are augmented with volume depletion and 2) that the BP reduction is likely the result of HCTZ inhibition of vasoconstriction through a pathway dependent on factors present in vivo, is unrelated to BK channel activation, and involves processes associated with intravascular volume depletion.	[Alshahrani, Saeed; Rapoport, Robert M.; Soleimani, Manoocher] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Div Nephrol, Dept Med, Coll Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Jiang, Min; Rubinstein, Jack] Univ Cincinnati, Div Cardiol, Dept Med, Coll Med, Cincinnati, OH USA; [Nieman, Michelle; Lorenz, John N.] Univ Cincinnati, Dept Physiol, Coll Med, Cincinnati, OH USA; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Maryland; University of Maryland Baltimore	Soleimani, M (corresponding author), Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Univ Cincinnati, Div Nephrol, Dept Med, Coll Med, Cincinnati, OH 45220 USA.; Soleimani, M (corresponding author), Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.	soleimm@ucmail.uc.edu	soleimani, m/U-6889-2017; Alshahrani, Saeed/AAY-8319-2021	soleimani, m/0000-0002-3446-8870; Meredith, Andrea/0000-0003-1061-2302; Soleimani, Manoocher/0000-0003-4909-4469; Rubinstein, Jack/0000-0002-8811-1551	Department of Veterans Affairs [5 I01 BX001000-06]; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI); US Renal Care; NHLBI [R01-HL102758]; Jazan University, Saudi Arabia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001000] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI); US Renal Care; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jazan University, Saudi Arabia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review 5 I01 BX001000-06 award from the Department of Veterans Affairs, funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, and grants from Dialysis Clinic, Inc. (DCI) and US Renal Care (to MS) and NHLBI R01-HL102758 (to AM). S. Alshahrani was supported by a scholarship from Jazan University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alshahrani S, 2017, KIDNEY BLOOD PRESSUR; Alshahrani S, 2017, N-S ARCH PHARMACOL, V390, P321, DOI 10.1007/s00210-017-1340-0; Amlal H, 2013, J MOL MED, V91, P561, DOI 10.1007/s00109-012-0973-1; Barone S, 2012, NEPHROL DIAL TRANSPL, V27, P1368, DOI 10.1093/ndt/gfr505; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; CALDER JA, 1994, J CARDIOVASC PHARM, V24, P158, DOI 10.1097/00005344-199407000-00024; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; CARNEY SL, 1984, CLIN EXP HYPERTENS A, V6, P1095, DOI 10.3109/10641968409039583; Carvalho-De-Souza JL, 2013, AGING DIS, V4, P38; Colas B, 2000, FUNDAM CLIN PHARM, V14, P363, DOI 10.1111/j.1472-8206.2000.tb00417.x; Colas B, 2000, EUR J PHARMACOL, V408, P63, DOI 10.1016/S0014-2999(00)00704-4; CONWAY J, 1960, CIRCULATION, V21, P21, DOI 10.1161/01.CIR.21.1.21; Cox RH, 2002, MICROCIRCULATION, V9, P243, DOI 10.1038/sj.mn.7800140; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; ENGLAND SK, 1993, AM J PHYSIOL, V264, pH1337, DOI 10.1152/ajpheart.1993.264.5.H1337; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Luo JH, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12246; Mastroianni N, 1996, GENOMICS, V35, P486, DOI 10.1006/geno.1996.0388; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; PICKKERS P, 1995, BRIT J PHARMACOL, V114, P703, DOI 10.1111/j.1476-5381.1995.tb17195.x; Pickkers P, 1998, HYPERTENSION, V32, P1071, DOI 10.1161/01.HYP.32.6.1071; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Sinning A, 2016, J AM SOC NEPHROLOGY; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; TARAZI RC, 1970, CIRCULATION, V41, P709, DOI 10.1161/01.CIR.41.4.709; VANBRUMMELEN P, 1980, CLIN PHARMACOL THER, V27, P328, DOI 10.1038/clpt.1980.44; VARDAN S, 1983, JAMA-J AM MED ASSOC, V250, P2807, DOI 10.1001/jama.250.20.2807; VELAZQUEZ H, 1986, AM J PHYSIOL, V250, P1013, DOI 10.1152/ajprenal.1986.250.6.F1013; Wang J, 2015, J CLIN PHARMACOL, V55, P1362, DOI 10.1002/jcph.559; Xu J, 2013, CELL PHYSIOL BIOCHEM, V32, P173, DOI 10.1159/000356637; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Zahedi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079327	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181376	10.1371/journal.pone.0181376	http://dx.doi.org/10.1371/journal.pone.0181376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719636	Green Submitted, gold, Green Published			2022-12-26	WOS:000406061400043
J	Lei, YT; Liu, Q; Hettenhausen, C; Cao, GY; Tan, Q; Zhao, WY; Lin, HH; Wu, JQ				Lei, Yunting; Liu, Qing; Hettenhausen, Christian; Cao, Guoyan; Tan, Qing; Zhao, Weiye; Lin, Honghui; Wu, Jianqiang			Salt-tolerant and - sensitive alfalfa (Medicago sativa) cultivars have large variations in defense responses to the lepidopteran insect Spodoptera litura under normal and salt stress condition	PLOS ONE			English	Article							ABSCISIC-ACID; SALINITY STRESS; NICOTIANA-ATTENUATA; INDUCED RESISTANCE; ABIOTIC STRESSES; GENE-EXPRESSION; PLANTS; HERBIVORES; ARABIDOPSIS; JASMONATE	In nature, plants are often exposed to multiple stress factors at the same time. Yet, little is known about how plants modulate their physiology to counteract simultaneous abiotic and biotic stresses, such as soil salinity and insect herbivory. In this study, insect performance bioassays, phytohormone measurements, quantification of transcripts, and protein determination were employed to study the phenotypic variations of two alfalfa (Medicago sativa) cultivars in response to insect Spodoptera litura feeding under normal and salt stress condition. When being cultivated in normal soil, the salt-tolerant alfalfa cultivar Zhongmu-1 exhibited lower insect resistance than did the salt-sensitive cultivar Xinjiang Daye. Under salinity stress, the defense responses of Xinjiang Daye were repressed, whereas Zhongmu-1 did not show changes in resistance levels. It is likely that salinity influenced the resistance of Xinjiang Daye through suppressing the accumulation of jasmonic acid-isoleucine (JA-Ile), which is the bioactive hormone inducing herbivore defense responses, leading to attenuated trypsin proteinase inhibitor (TPI) activity. Furthermore, exogenous ABA supplementation suppressed the insect herbivory-induced JA/JA-Ile accumulation and levels of JAR1 (jasmonate resistant 1) and TPI, and further decreased the resistance of Xinjiang Daye, whereas Zhongmu-1 showed very little response to the increased ABA level. We propose a mechanism, in which high levels of abscisic acid induced by salt treatment may affect the expression levels of JAR1 and consequently decrease JA-Ile accumulation and thus partly suppress the defense of Xinjiang Daye against insects under salt stress. This study provides new insight into the mechanism by which alfalfa responds to concurrent abiotic and biotic stresses.	[Lei, Yunting; Lin, Honghui] Sichuan Univ, Minist Educ, Coll Life Sci, State Key Lab Hydraul & Mt River Engn,Key Lab Bio, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Liu, Qing] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Liu, Qing] Chinese Acad Sci, Ecol Restorat & Biodivers Conservat Key Lab Sichu, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Lei, Yunting; Hettenhausen, Christian; Cao, Guoyan; Tan, Qing; Zhao, Weiye; Wu, Jianqiang] Chinese Acad Sci, Dept Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming Inst Bot, Kunming, Yunnan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Lin, HH (corresponding author), Sichuan Univ, Minist Educ, Coll Life Sci, State Key Lab Hydraul & Mt River Engn,Key Lab Bio, Chengdu, Sichuan, Peoples R China.; Wu, JQ (corresponding author), Chinese Acad Sci, Dept Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming Inst Bot, Kunming, Yunnan, Peoples R China.	hhlin@scu.edu.cn; wujianqiang@mail.kib.ac.cn	Wu, Jianqiang/A-7169-2019	Wu, Jianqiang/0000-0002-7726-6216	Yunnan Recruitment Program of Experts in Sciences [2012HA016]; Max Planck Partner Group Program	Yunnan Recruitment Program of Experts in Sciences; Max Planck Partner Group Program(Max Planck Society)	This work was supported by a grant from the Yunnan Recruitment Program of Experts in Sciences (No. 2012HA016) and a grant from the Max Planck Partner Group Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28941; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Dombrowski JE, 2003, PLANT PHYSIOL, V132, P2098, DOI 10.1104/pp.102.019927; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Nguyen D, 2016, PLANT CELL ENVIRON, V39, P1485, DOI 10.1111/pce.12708; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Forieri I, 2016, ENVIRON EXP BOT, V122, P68, DOI 10.1016/j.envexpbot.2015.09.007; Foyer CH, 2016, J EXP BOT, V67, P2025, DOI 10.1093/jxb/erw079; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ginzberg I, 1998, PLANT MOL BIOL, V38, P755, DOI 10.1023/A:1006015212391; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Long RC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00424; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Paudel JR, 2015, MOL PLANT MICROBE IN, V28, P569, DOI 10.1094/MPMI-10-14-0348-R; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Postnikova OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123157; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Quan WL, 2016, PLANT CELL TISS ORG, V126, P105, DOI 10.1007/s11240-016-0981-x; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Schile L, 2006, ECOL ENTOMOL, V31, P345, DOI 10.1111/j.1365-2311.2006.00799.x; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Urano K, 2017, PLANT J, V90, P17, DOI 10.1111/tpj.13460; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; VANCE CP, 1979, PLANT PHYSIOL, V64, P1, DOI 10.1104/pp.64.1.1; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129541; Wang XM, 2015, GENES GENET SYST, V90, P175, DOI 10.1266/ggs.90.175; Wu JQ, 2008, PLANT PHYSIOL, V146, P927, DOI 10.1104/pp.107.114785; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00956	42	7	8	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181589	10.1371/journal.pone.0181589	http://dx.doi.org/10.1371/journal.pone.0181589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719628	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400057
J	Liu, PG; Yu, SJ; Cui, Y; He, JF; Yu, C; Wen, ZX; Pan, YY; Yang, K; Song, LL; Yang, X				Liu, Penggang; Yu, Sijiu; Cui, Yan; He, Junfeng; Yu, Chuan; Wen, Zexing; Pan, Yangyang; Yang, Kun; Song, Liangli; Yang, Xue			Cloning of HSP90, expression and localization of HSP70/90 in different tissues including lactating/non-lactating yak (Bos grunniens) breast tissue	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DIFFERENT AGES; CHAPERONE; TRAFFICKING; STRESS; KINASE; INJURY	The aim of this study is to investigate the expression and localization of HSP70/90 in different tissues and explore the regulation effects of HSP70/90 at lactation period of female yaks. HSP90 mRNA was cloned from the heart samples of female yaks, Quantitative real-time (qRT-PCR), Western blotting (WB), immunohistochemistry and immunofluorescence assays were utilized to analyze the expressions of HSP70/90 mRNA and protein in different tissues. Sequence analysis showed that HSP90 is a conserved molecular chaperone of female yaks. The qRT-PCR, WB results showed that the expressions of HSP70/90 mRNA and protein were significantly different in different tissues, and 3-fold higher expression during the lactation period than the non-lactation period of breast tissue (P < 0.01). Immunohistochemistry and immunofluorescence assays results showed that HSP70/90 were located in the cardiac muscle cells, cerebellar medulla, theca cells lining at the reproductive system, and the mammary epithelia of the breasts. In addition, the expression level of HSP70 was higher than those of HSP90 in all examined tissues. Therefore, our results strongly suggest that the expression and localization of HSP70/90 could provide significant evidence to further research in tissue specific expression, and lactation function of female yaks.	[Liu, Penggang; Yu, Sijiu; Cui, Yan; He, Junfeng; Yu, Chuan; Wen, Zexing; Pan, Yangyang; Yang, Kun; Song, Liangli; Yang, Xue] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Cui, Y (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	cuiyan@gsau.edu.cn		Multhoff, Gabriele/0000-0002-2616-3137	Nature Science Foundation of China [31360594, 31572478]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Nature Science Foundation of China (grant No. 31360594, 31572478).	Bombardier E, 2009, J APPL PHYSIOL, V106, P2009, DOI 10.1152/japplphysiol.91573.2008; Cabezon F. A., 2016, Professional Animal Scientist, V32, P333, DOI 10.15232/pas.2015-01495; CARPER SW, 1987, CANCER RES, V47, P5249; CRUM CP, 1990, VIROLOGY, V178, P238, DOI 10.1016/0042-6822(90)90399-C; Cui Y, 1999, VET J, V157, P192, DOI 10.1053/tvjl.1998.0283; Cui Y, 1999, VET J, V157, P197, DOI 10.1053/tvjl.1998.0282; Dangi S.S., 2014, INT J BIOMETEOROL, P1; David JC, 2001, DEV BRAIN RES, V128, P91, DOI 10.1016/S0165-3806(01)00143-2; Driancourt MA, 1999, J REPROD FERTIL, V115, P45, DOI 10.1530/jrf.0.1150045; Duan YX, 2014, ACTA VET ZOOTECHNICA, V41, P1213; Galovic R, 2016, CLIN BIOCHEM, V49, P66, DOI 10.1016/j.clinbiochem.2015.10.006; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Gekle M, 2014, STEROIDS, V81, P103, DOI 10.1016/j.steroids.2013.10.016; Gu Wenwen, 2015, J Immunoassay Immunochem, V36, P487, DOI 10.1080/15321819.2014.996817; He YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157558; Hu H, 2016, ANIM SCI J, V87, P84, DOI 10.1111/asj.12375; Hu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149461; Li WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135251; Manjili MH, 2002, CANCER RES, V62, P1737; McCullagh KJA, 2016, NITRIC OXIDE-BIOL CH, V52, P41, DOI 10.1016/j.niox.2015.11.002; Mead AJ, 2012, NEW ENGL J MED, V366, P967, DOI 10.1056/NEJMc1200349; Meng XueLian, 2006, Veterinary Science in China, V36, P57; Min L, 2015, J ZHEJIANG UNIV-SC B, V16, P541, DOI 10.1631/jzus.B1400341; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Pan YY, 2015, CRYOBIOLOGY, V71, P33, DOI 10.1016/j.cryobiol.2015.06.005; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Scieglinska D, 2011, HISTOCHEM CELL BIOL, V135, P337, DOI 10.1007/s00418-011-0791-5; Secasan CC, 2009, SAUDI J KIDNEY DIS T, V20, P355; Soleilhavoup C, 2016, MOL CELL PROTEOMICS, V15, P93, DOI 10.1074/mcp.M115.052332; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Tan Juan, 2008, Zhongguo Shouyi Kexue, V38, P622; Wang QL, 2014, AQUACULT INT, V22, P1149, DOI 10.1007/s10499-013-9734-6; Wang XX, 2014, INT J ONCOL, V45, P18, DOI 10.3892/ijo.2014.2399; Wells AD, 2000, IMMUNOL TODAY, V21, P129, DOI 10.1016/S0167-5699(99)01558-3; [温泽星 Wen Zexing], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3475; Wiener G, 2003, YAK FAO REGIONAL OFF; Yeyati PL, 2008, CURR OPIN GENET DEV, V18, P264, DOI 10.1016/j.gde.2008.07.004; Yong Yan-Hong, 2005, Acta Zoologica Sinica, V51, P1050; Zhang B, 2011, J DAIRY SCI, V94, P4174, DOI 10.3168/jds.2010-4137; Zhang JX, 2010, DEV COMP IMMUNOL, V34, P1199, DOI 10.1016/j.dci.2010.06.015; Zhao Y, 2007, CELL STRESS CHAPERON, V12, P83, DOI 10.1379/CSC-231R.1; Zugel U, 2001, INFECT IMMUN, V69, P4164, DOI 10.1128/IAI.69.6.4164-4167.2001	46	57	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179321	10.1371/journal.pone.0179321	http://dx.doi.org/10.1371/journal.pone.0179321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3DF	28715410	Green Published, gold, Green Submitted			2022-12-26	WOS:000430382100001
J	Bi, XA; Zhao, JX				Bi, Xia-an; Zhao, Junxia			Hierarchical trie packet classification algorithm based on expectation-maximization clustering	PLOS ONE			English	Article								With the development of computer network bandwidth, packet classification algorithms which are able to deal with large-scale rule sets are in urgent need. Among the existing algorithms, researches on packet classification algorithms based on hierarchical trie have become an important packet classification research branch because of their widely practical use. Although hierarchical trie is beneficial to save large storage space, it has several shortcomings such as the existence of backtracking and empty nodes. This paper proposes a new packet classification algorithm, Hierarchical Trie Algorithm Based on Expectation-Maximization Clustering (HTEMC). Firstly, this paper uses the formalization method to deal with the packet classification problem by means of mapping the rules and data packets into a two-dimensional space. Secondly, this paper uses expectation-maximization algorithm to cluster the rules based on their aggregate characteristics, and thereby diversified clusters are formed. Thirdly, this paper proposes a hierarchical trie based on the results of expectation-maximization clustering. Finally, this paper respectively conducts simulation experiments and real-environment experiments to compare the performances of our algorithm with other typical algorithms, and analyzes the results of the experiments. The hierarchical trie structure in our algorithm not only adopts trie path compression to eliminate backtracking, but also solves the problem of low efficiency of trie updates, which greatly improves the performance of the algorithm.	[Bi, Xia-an; Zhao, Junxia] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Bi, XA (corresponding author), Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China.	bixiaan@hnu.edu.cn			National Science Foundation of China [61502167, 11271121, 11671129]; Hunan Provincial Education Department Scientific Research Fund of PR China [15C0825]; Hunan Provincial Science and Technology Program Project of PR China [2015JC3066]; Scientific Research Foundation for Ph.D Hunan Normal University [Math 120641]; Youth Scientific Research Fund of Hunan Normal University [11301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Education Department Scientific Research Fund of PR China; Hunan Provincial Science and Technology Program Project of PR China; Scientific Research Foundation for Ph.D Hunan Normal University; Youth Scientific Research Fund of Hunan Normal University	This work is supported by the National Science Foundation of China (No. 61502167, 11271121, 11671129); the Hunan Provincial Education Department Scientific Research Fund of PR China (No. 15C0825); Hunan Provincial Science and Technology Program Project of PR China (No. 2015JC3066); Scientific Research Foundation for Ph.D Hunan Normal University (No. Math 120641); Youth Scientific Research Fund of Hunan Normal University (No.11301).	Antichi G, 2014, IEEE INT CONF HIGH, P32, DOI 10.1109/HPSR.2014.6900878; Baboescu F, 2003, IEEE INFOCOM SER, P53; Banerjee T, 2015, IEEE T COMPUT, V64, P1104, DOI 10.1109/TC.2014.2315645; Chang DY, 2016, IEEE ACM T NETWORK, V24, P1125, DOI 10.1109/TNET.2015.2411274; Chang YK, 2013, IEEE ACM T NETWORK, V21, P1201, DOI 10.1109/TNET.2012.2220566; Chen XJ, 2013, IEEE T KNOWL DATA EN, V25, P932, DOI 10.1109/TKDE.2011.262; Cheng YC, 2015, IEEE T COMPUT, V64, P582, DOI 10.1109/TC.2013.227; Erdem O, 2012, IEEE INFOCOM SER, P1898, DOI 10.1109/INFCOM.2012.6195565; Frigui H, 1999, IEEE T PATTERN ANAL, V21, P450, DOI 10.1109/34.765656; Ganegedara T, 2014, IEEE T PARALL DISTR, V25, P1135, DOI 10.1109/TPDS.2013.261; Gupta P, 1999, COMP COMM R, V29, P147, DOI 10.1145/316194.316217; Han WT, 2013, IEEE GLOB COMM CONF, P1342, DOI 10.1109/GLOCOM.2013.6831260; Hanmandlu M, 2013, NEUROCOMPUTING, V120, P235, DOI 10.1016/j.neucom.2012.09.043; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Jiang YZ, 2014, J INTELL FUZZY SYST, V27, P1639, DOI 10.3233/IFS-141130; Lee CL, 2012, IEICE T INF SYST, VE95D, P472, DOI 10.1587/transinf.E95.D.472; Leira R., 2013, SMART COMM NETW TECH, P1; Li W., 2013, THESIS, P1; Lim H, 2015, ELEVENTH 2015 ACM/IEEE SYMPOSIUM ON ARCHITECTURES FOR NETWORKING AND COMMUNICATIONS SYSTEMS, P183, DOI 10.1109/ANCS.2015.7110131; Lim H, 2014, IEEE ACM T NETWORK, V22, P443, DOI 10.1109/TNET.2013.2254124; Lu W, 2014, 2014 28TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P49, DOI 10.1109/WAINA.2014.16; Pak W, 2015, IEEE T DEPENDABLE SE; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Shen RS, 2014, J SUPERCOMPUT, V69, P673, DOI 10.1007/s11227-014-1109-x; Singh S, 2003, ACM SIGCOMM COMP COM, V33, P213; Taylor DE, 2005, IEEE INFOCOM SER, P2068; Trivedi U, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P112, DOI 10.1109/ICACCI.2014.6968202; Wang G, 2013, 2013 IEEE 15TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS & 2013 IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND UBIQUITOUS COMPUTING (HPCC_EUC), P1329, DOI 10.1109/HPCC.and.EUC.2013.189; Wang Jun, 2012, Control and Decision, V27, P321; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Zhou S., 2014, 2014 IEEE HIGH PERFO, P1, DOI 10.1109/HPEC.2014.7041005	31	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181049	10.1371/journal.pone.0181049	http://dx.doi.org/10.1371/journal.pone.0181049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704476	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700082
J	Devos, FC; Pollaris, L; Cremer, J; Seys, S; Hoshino, T; Ceuppens, J; Talavera, K; Nemery, B; Hoet, PHM; Vanoirbeek, JAJ				Devos, Fien C.; Pollaris, Lore; Cremer, Jonathan; Seys, Sven; Hoshino, Tomoaki; Ceuppens, Jan; Talavera, Karel; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.			IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice	PLOS ONE			English	Article							SMOOTH-MUSCLE; TOLUENE DIISOCYANATE; ASTHMA PHENOTYPES; ALLERGIC-ASTHMA; MOUSE MODEL; T-CELLS; INTERLEUKIN-13; PATHOGENESIS; INFLAMMATION; CHALLENGE	Background While the importance of the Th2 cytokine IL-13 as a central mediator of airway hyperreactivity (AHR) has been described in allergic protein-induced asthma, this has never been investigated in chemical-induced asthma. Objective We examined the importance of IL-13 in a mouse model of chemical-induced AHR, using toluene-2,4-diisocyanate (TDI). Methods In a first set-up, wild type (WT) and IL-13 knockout (KO) C57Bl/6 mice were dermally treated on days 1 and 8 with 1% TDI or vehicle (acetone/olive oil) on both ears. On day 15, mice received an intranasal instillation with 0.1% TDI or vehicle. In a second set-up, WT mice sensitized with 1% TDI or vehicle, received i.v. either anti-IL-13 or control antibody prior to the intranasal challenge. Results TDI-sensitized and TDI-challenged WT mice showed AHR to methacholine, in contrast to TDI-sensitized and TDI-challenged IL-13 KO mice, which also showed lower levels of total serum IgE. TDI-sensitized and TDI-challenged IL-13 KO mice had lower numbers of T-cells in the auricular lymph nodes. TDI-treated WT mice, receiving anti-IL-13, showed no AHR, in contrast to those receiving control antibody, despite increased levels of IgE. Anti-IL-13 treatment in TDI-treated WT mice resulted in lower levels of serum IL-13, but did not induce changes in T-and B-cell numbers, and in the cytokine production profile. Conclusion and clinical relevance We conclude that IL-13 plays a critical role in the effector phase of chemical-induced, immune-mediated AHR. This implicates that anti-IL-13 treatment could have a beneficial effect in patients with this asthma phenotype.	[Devos, Fien C.; Pollaris, Lore; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.] Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Environm & Hlth, Leuven, Belgium; [Cremer, Jonathan; Seys, Sven; Ceuppens, Jan] Univ Leuven, Dept Microbiol & Immunol, Lab Clin Immunol, Leuven, Belgium; [Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Med 1, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka, Japan; [Talavera, Karel] Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Leuven, Belgium	KU Leuven; KU Leuven; Kurume University; KU Leuven	Vanoirbeek, JAJ (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Environm & Hlth, Leuven, Belgium.	jeroen.vanoirbeek@kuleuven.be	Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019; Vanoirbeek, Jeroen/D-5183-2016	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689; Vanoirbeek, Jeroen/0000-0001-5508-3518; Seys, Sven/0000-0002-4399-9892; Ceuppens, Jan/0000-0003-4502-2679	Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy [P7/30]; KU Leuven Research Council (PF-TRPLe) [GOA/14/011]; Flemish Research Foundation [1.5.049.12N]	Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven Research Council (PF-TRPLe); Flemish Research Foundation(FWO)	The project was supported by a grant of the Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy (P7/30), by two grants from the KU Leuven Research Council (PF-TRPLe and GOA/14/011) and by a grant of the Flemish Research Foundation (research grant 1.5.049.12N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	De Vooght V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083228; De Vooght V, 2011, TOXICOLOGY, V279, P85, DOI 10.1016/j.tox.2010.09.014; Devos FC, 2016, EUR RESPIR J, V48, P380, DOI 10.1183/13993003.01778-2015; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hacha J, 2012, AM J RESP CELL MOL, V47, P709, DOI 10.1165/rcmb.2012-0031OC; Herrick CA, 2002, J ALLERGY CLIN IMMUN, V109, P873, DOI 10.1067/mai.2002.123533; Herrick CA, 2003, J ALLERGY CLIN IMMUN, V111, P1087, DOI 10.1067/mai.2003.1413; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Ishmael FT, 2011, J AM OSTEOPATH ASSOC, V111, pS11; Jiang HH, 2010, J PHARMACOL EXP THER, V334, P703, DOI 10.1124/jpet.110.168518; Kellner J, 2007, INT ARCH ALLERGY IMM, V142, P199, DOI 10.1159/000097022; Kirstein F, 2010, J ALLERGY CLIN IMMUN, V126, P347, DOI 10.1016/j.jaci.2010.04.028; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Matsumoto H, 2012, CYTOKINE, V57, P19, DOI 10.1016/j.cyto.2011.10.014; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Pollaris L, 2016, ARCH TOXICOL, V90, P1709, DOI 10.1007/s00204-015-1606-6; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Scheerens H, 2014, CLIN EXP ALLERGY, V44, P38, DOI 10.1111/cea.12220; Scheurer S, 2015, CLIN EXP ALLERGY, V45, P1150, DOI 10.1111/cea.12571; Shore SA, 2004, CURR OPIN PHARMACOL, V4, P235, DOI 10.1016/j.coph.2004.01.008; Siddiqui Salman, 2007, Allergy Asthma Clin Immunol, V3, P60, DOI 10.1186/1710-1492-3-2-60; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Singer M, 2002, AM J RESP CELL MOL, V26, P74, DOI 10.1165/ajrcmb.26.1.4618; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wagers S, 1985, J APPL PHYSIOL, V96, P2019; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang GY, 2005, J PHARMACOL EXP THER, V313, P8, DOI 10.1124/jpet.104.076133; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620	41	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180690	10.1371/journal.pone.0180690	http://dx.doi.org/10.1371/journal.pone.0180690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704401	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700047
J	Deyanova, D; Gullstrom, M; Lyimo, LD; Dahl, M; Hamisi, MI; Mtolera, MSP; Bjork, M				Deyanova, Diana; Gullstrom, Martin; Lyimo, Liberatus D.; Dahl, Martin; Hamisi, Mariam I.; Mtolera, Matern S. P.; Bjork, Mats			Contribution of seagrass plants to CO2 capture in a tropical seagrass meadow under experimental disturbance	PLOS ONE			English	Article							SITU LIGHT REDUCTION; THALASSIA-TESTUDINUM; PHYSIOLOGICAL-RESPONSES; POSIDONIA-OCEANICA; LEAF GROWTH; CHWAKA-BAY; PHOTOSYNTHESIS; CARBON; PRODUCTIVITY; HERBIVORY	Coastal vegetative habitats are known to be highly productive environments with a high ability to capture and store carbon. During disturbance this important function could be compromised as plant photosynthetic capacity, biomass, and/or growth are reduced. To evaluate effects of disturbance on CO2 capture in plants we performed a five-month manipulative experiment in a tropical seagrass (Thalassia hemprichii) meadow exposed to two intensity levels of shading and simulated grazing. We assessed CO2 capture potential (as net CO2 fixation) using areal productivity calculated from continuous measurements of diel photosynthetic rates, and estimates of plant morphology, biomass and productivity/respiration (P/R) ratios (from the literature). To better understand the plant capacity to coping with level of disturbance we also measured plant growth and resource allocation. We observed substantial reductions in seagrass areal productivity, biomass, and leaf area that together resulted in a negative daily carbon balance in the two shading treatments as well as in the high-intensity simulated grazing treatment. Additionally, based on the concentrations of soluble carbohydrates and starch in the rhizomes, we found that the main reserve sources for plant growth were reduced in all treatments except for the low-intensity simulated grazing treatment. If permanent, these combined adverse effects will reduce the plants' resilience and capacity to recover after disturbance. This might in turn have long-lasting and devastating effects on important ecosystem functions, including the carbon sequestration capacity of the seagrass system.	[Deyanova, Diana; Gullstrom, Martin; Dahl, Martin; Bjork, Mats] Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Lyimo, Liberatus D.] Univ Dodoma, Sch Biol Sci, Dodoma, Tanzania; [Hamisi, Mariam I.] Univ Dodoma, Coll Nat & Math Sci, Dodoma, Tanzania; [Mtolera, Matern S. P.] Univ Dar Es Salaam, Inst Marine Sci, Zanzibar, Tanzania	Stockholm University; University of Dar es Salaam	Deyanova, D (corresponding author), Stockholm Univ, Seagrass Ecol & Physiol Res Grp, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	diana.deyanova@su.se	Björk, Mats/B-4299-2010	Björk, Mats/0000-0003-0363-110X; Hamisi, Mariam Issa/0000-0002-0144-2930; Deyanova, Diana/0000-0002-6555-2047	Swedish International Development Cooperation Agency (Sida);  [SWE-2010-194]	Swedish International Development Cooperation Agency (Sida); 	The research was funded by the Swedish International Development Cooperation Agency (Sida) through the Bilateral Marine Science Program between Sweden and Tanzania and a three-year research project grant (SWE-2010-194)	Abu Hena MK., 2001, PAKISTAN J BIOL SCI, V4, P1487, DOI 10.3923/pjbs.2001.1487.1489; Agawin NSR, 2001, J EXP MAR BIOL ECOL, V260, P217, DOI 10.1016/S0022-0981(01)00253-2; Alcoverro T, 2004, ECOGRAPHY, V27, P361, DOI 10.1111/j.0906-7590.2004.03736.x; [Anonymous], 1962, CARBOHYDRATE CHEM; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Beer S, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P183, DOI 10.1016/B978-044450891-1/50010-4; Beer S., 2014, PHOTOSYNTHESIS MARIN; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; Bjork M, 2008, IUCN RESILIENCE SCI; Briske D. D., 1995, WILDLAND PLANTS PHYS, P635; BUESA R J, 1977, Aquatic Botany, V3, P203, DOI 10.1016/0304-3770(77)90023-7; Camp DK, 1973, OVERGRAZING SEAGRASS; Carlson PR, 1985, 12TH P ANN C WETL RE, P64; Cayabyab NM, 2007, NEW PHYTOL, V176, P108, DOI 10.1111/j.1469-8137.2007.02147.x; Cebrian J, 1998, J EXP MAR BIOL ECOL, V220, P67, DOI 10.1016/S0022-0981(97)00084-1; Cederlof U, 1995, AMBIO, V24, P458; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Collier CJ, 2010, AQUAT BOT, V93, P47, DOI 10.1016/j.aquabot.2010.03.003; Collier CJ, 2009, J EXP MAR BIOL ECOL, V370, P89, DOI 10.1016/j.jembe.2008.12.003; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CZERNY AB, 1995, ESTUARIES, V18, P418, DOI 10.2307/1352324; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Eklof JS, 2008, ESTUAR COAST SHELF S, V79, P569, DOI 10.1016/j.ecss.2008.05.005; Eklof JS, 2008, AQUAT BOT, V89, P337, DOI 10.1016/j.aquabot.2008.03.009; Ferraro DO, 2002, OIKOS, V98, P125, DOI 10.1034/j.1600-0706.2002.980113.x; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GORDON DM, 1994, AQUAT BOT, V47, P265, DOI 10.1016/0304-3770(94)90057-4; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Harper J. L, 1977, POPULATION BIOL PLAN; Hemminga MA, 1998, J SEA RES, V39, P183, DOI 10.1016/S1385-1101(98)00004-5; Herzka SZ, 1997, MAR ECOL PROG SER, V152, P103, DOI 10.3354/meps152103; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kelkar N, 2013, J ECOL, V101, P1158, DOI 10.1111/1365-2745.12122; Lacey EA, 2014, REV BIOL TROP, V62, P1535, DOI 10.15517/rbt.v62i4.12844; Laffoley D., 2009, MANAGEMENT NATURAL C; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Longstaff BJ, 1999, J EXP MAR BIOL ECOL, V234, P1, DOI 10.1016/S0022-0981(98)00137-3; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 2006, OECOLOGIA, V150, P362, DOI 10.1007/s00442-006-0524-y; MCROY CP, 1977, SEAGRASS ECOSYSTEMS, P53; Mussaka ANN, 1999, 20 ANN C ADV MAR SCI, P569; Nayar S, 2009, J EXP MAR BIOL ECOL, V373, P87, DOI 10.1016/j.jembe.2009.03.010; Olive I, 2016, ESTUAR COAST, V39, P138, DOI 10.1007/s12237-015-9973-z; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pedersen O, 2016, NEW PHYTOL, P1; Peterson BJ, 2002, OIKOS, V97, P361, DOI 10.1034/j.1600-0706.2002.970306.x; QASIM S Z, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P207, DOI 10.1002/iroh.19720570203; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Rose CD, 1999, MAR ECOL PROG SER, V190, P211, DOI 10.3354/meps190211; Ruiz JM, 2003, MAR POLLUT BULL, V46, P1523, DOI 10.1016/j.marpolbul.2003.08.021; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Silva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081058; Suzuki J, 1999, PLANT SPEC BIOL, P11; Thayumanavan B, 1984, PLANT FOOD HUM NUTR, V34, P253; Valentine JF, 1997, OECOLOGIA, V112, P193, DOI 10.1007/s004420050300; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	66	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181386	10.1371/journal.pone.0181386	http://dx.doi.org/10.1371/journal.pone.0181386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704565	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700131
J	Khagayi, S; Amek, N; Bigogo, G; Odhiambo, F; Vounatsou, P				Khagayi, Sammy; Amek, Nyaguara; Bigogo, Godfrey; Odhiambo, Frank; Vounatsou, Penelope			Bayesian spatio-temporal modeling of mortality in relation to malaria incidence in Western Kenya	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE SYSTEM; TRANSMISSION INTENSITY; PLASMODIUM-FALCIPARUM; CHILDHOOD MORTALITY; CIVIL REGISTRATION; HEALTH FACILITY; AFRICA; PATTERNS; DISTANCE; CARE	Introduction The effect of malaria exposure on mortality using health facility incidence data as a measure of transmission has not been well investigated. Health and demographic surveillance systems (HDSS) routinely capture data on mortality, interventions and other household related indicators, offering a unique platform for estimating and monitoring the incidence-mortality relationship in space and time. Methods Mortality data from the HDSS located in Western Kenya collected from 2007 to 2012 and linked to health facility incidence data were analysed using Bayesian spatio-temporal survival models to investigate the relation between mortality (all-cause/malaria-specific) and malaria incidence across all age groups. The analysis adjusted for insecticide-treated net (ITN) ownership, socio-economic status (SES), distance to health facilities and altitude. The estimates obtained were used to quantify excess mortality due to malaria exposure. Results Our models identified a strong positive relationship between slide positivity rate (SPR) and all-cause mortality in young children 1-4 years (HR = 4.29; 95% CI: 2.78-13.29) and all ages combined (HR = 1.55; 1.04-2.80). SPR had a strong positive association with malariaspecific mortality in young children (HR = 9.48; 5.11-37.94), however, in older children (5-14 years), it was associated with a reduction in malaria specific mortality (HR = 0.02; 0.003-0.33). Conclusion SPR as a measure of transmission captures well the association between malaria transmission intensity and all-cause/malaria mortality. This offers a quick and efficient way to monitor malaria burden. Excess mortality estimates indicate that small changes in malaria incidence substantially reduce overall and malaria specific mortality.	[Khagayi, Sammy; Amek, Nyaguara; Bigogo, Godfrey; Odhiambo, Frank] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Khagayi, Sammy; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Khagayi, Sammy; Vounatsou, Penelope] Univ Basel, Basel, Switzerland	Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Vounatsou, P (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Vounatsou, P (corresponding author), Univ Basel, Basel, Switzerland.	penelope.vounatsou@unibas.ch	Bigogo, Godfrey/W-3591-2019	Vounatsou, Penelope/0000-0002-4904-5352	European Research Council (ERC) IMCCA [323180]; Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D) [IZ01Z0-147286]	European Research Council (ERC) IMCCA; Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D)	This work was supported by the European Research Council (ERC) IMCCA grant number 323180 and the Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D) project number IZ01Z0-147286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amek NO, 2013, BAYESIAN SPATIOTEMPO; Amek N, 2015, ACTA TROP, V144, P24, DOI 10.1016/j.actatropica.2015.01.006; Amek NO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25581; [Anonymous], 2012, LANCET, V379, P385, DOI 10.1016/S0140-6736(12)60169-X; [Anonymous], 2013, HOUS SURV IND MAL CO; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bi Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-117; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Boyce RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152410; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; de Savigny D, 2005, MEASURING HLTH EQUIT; Desai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106197; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Division of Malaria Control[Ministry of Public Health and Sanitation] KNB of SIMMD and HS (DHS), 2011, 2010 KEN MAL IND SUR, P2013; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Gething PW, 2016, N ENGL J MED; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; INDEPTH Network, 2000, POP HLTH DEV COUNTR; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Karra M, 2017, INT J EPIDEMIOL, V46, P817, DOI 10.1093/ije/dyw062; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Lo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121763; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Manda S, 2005, J R STAT SOC A STAT, V168, P439, DOI 10.1111/j.1467-985X.2005.00357.x; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Ombok M, 2010, TROP MED INT HEALTH, V15, P423, DOI 10.1111/j.1365-3156.2010.02467.x; Ross A, 2006, AM J TROP MED HYG, V75, P74, DOI 10.4269/ajtmh.2006.75.74; Rumisha SF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-124; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Sedda L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1024-5; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Stanisic DI, 2014, INFECT IMMUN; World Health Organization, 2015, WORLD MAL REP 2015; Ye Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-741	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180516	10.1371/journal.pone.0180516	http://dx.doi.org/10.1371/journal.pone.0180516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704417	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000405649700041
J	Toyomaki, A; Koga, M; Okada, E; Nakai, Y; Miyazaki, A; Tamakoshi, A; Kiso, Y; Kusumi, I				Toyomaki, Atsuhito; Koga, Minori; Okada, Emiko; Nakai, Yukiei; Miyazaki, Akane; Tamakoshi, Akiko; Kiso, Yoshinobu; Kusumi, Ichiro			The relationship between a low grain intake dietary pattern and impulsive behaviors in middle-aged Japanese people	PLOS ONE			English	Article							CLUSTER-ANALYSIS; DEPRESSIVE SYMPTOMS; NUTRITIONAL ADEQUACY; SLEEP QUALITY; CHILD HEALTH; ADULTS; WOMEN; WORKERS; ASSOCIATIONS; COHORT	Several studies indicate that dietary habits are associated with mental health. We are interested in identifying not a specific single nutrient/food group but the population preferring specific food combinations that can be related to mental health. Very few studies have examined relationships between dietary patterns and multifaceted mental states using cluster analysis. The purpose of this study was to investigate population-level dietary patterns associated with mental state using cluster analysis. We focused on depressive state, sleep quality, subjective well-being, and impulsive behaviors using rating scales. Two hundred and seventy-nine Japanese middle-aged people participated in the present study. Dietary pattern was estimated using a brief self-administered diet-history questionnaire (the BDHQ). We conducted K-means cluster analysis using thirteen BDHQ food groups: milk, meat, fish, egg, pulses, potatoes, green and yellow vegetables, other vegetables, mushrooms, seaweed, sweets, fruits, and grain. We identified three clusters characterized as ''vegetable and fruit dominant,'' ''grain dominant,'' and ''low grain tendency'' subgroups. The vegetable and fruit dominant group showed increases in several aspects of subjective wellbeing demonstrated by the SF-8. Differences in mean subject characteristics across clusters were tested using ANOVA. The low frequency intake of grain group showed higher impulsive behavior, demonstrated by BIS-11 deliberation and sum scores. The present study demonstrated that traditional Japanese dietary patterns, such as eating rice, can help with beneficial changes in mental health.	[Toyomaki, Atsuhito; Koga, Minori; Nakai, Yukiei; Miyazaki, Akane; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Okada, Emiko; Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Kiso, Yoshinobu] Hokkaido Univ, Ctr Innovat & Business Promot, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Toyomaki, A (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	toyomaki@med.hokudai.ac.jp	Kiso, Yoshinobu/D-5424-2012		Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	his work was supported by Ministry of Agriculture, Forestry and Fisheries of Japan. This work was supported by Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency SaT, 2005, STAND TABL FOOD COMP, V5th; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Ashby-Mitchell K, 2015, NUTRIENTS, V7, P1052, DOI 10.3390/nu7021052; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Freitas-Vilela AA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12353; Gougeon L, 2015, J NUTR HEALTH AGING, V19, P431, DOI 10.1007/s12603-014-0562-9; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; James DCS, 2009, J AM DIET ASSOC, V109, P255, DOI 10.1016/j.jada.2008.10.052; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Katagiri R, 2014, J OCCUP HEALTH, V56, P359, DOI 10.1539/joh.14-0051-OA; Kim J, 2015, NUTRIENTS, V7, P4154, DOI 10.3390/nu7064154; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kurotani K, 2015, SLEEP MED, V16, P298, DOI 10.1016/j.sleep.2014.09.017; Mimura C, 2011, CLIN PSYCHIATR, V53, P15, DOI [10.11477/mf.1405101760, DOI 10.11477/MF.1405101760]; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Okubo H, 2012, BRIT J NUTR, V107, P1526, DOI 10.1017/S0007114511004636; Okubo H, 2011, PUBLIC HEALTH NUTR, V14, P611, DOI 10.1017/S1368980010002521; Okubo H, 2010, ASIA PAC J CLIN NUTR, V19, P555; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Ruano C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061490; Smith ADAC, 2011, EUR J CLIN NUTR, V65, P1102, DOI 10.1038/ejcn.2011.96; Sugawara N, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-24; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Tanaka E, 2013, J EPIDEMIOL, V23, P132, DOI 10.2188/jea.JE20120101; Tsuruya K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116677; Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0; Wirfalt E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40; Woo HD, 2014, NUTRIENTS, V6, P1539, DOI 10.3390/nu6041539; Yoneyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105198	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181057	10.1371/journal.pone.0181057	http://dx.doi.org/10.1371/journal.pone.0181057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704469	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700085
J	Wang, C; Zhang, X; Li, H; Li, X; Lin, YS				Wang, Chen; Zhang, Xin; Li, Hui; Li, Xin; Lin, Yansong			Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis	PLOS ONE			English	Article							BRAF V600E MUTATION; 30 MU-IU/ML; STIMULATED THYROGLOBULIN; PREABLATIVE THYROGLOBULIN; RADIOIODINE THERAPY; DISTANT METASTASIS; THYROTROPIN LEVEL; PAPILLARY; CARCINOMA; ASSOCIATION	Objective Current diagnosis of radioactive iodine (RAI)-refractory (RAIR) differentiated thyroid cancer (DTC) is based on the imaging technique, which is of a high cost. Serum thyroglobulin (Tg) is a sensitive and easily obtained biomarker. Hence, we aimed to assess the predicting value of quantitative response of Tg in earlier identifying the RAIR-DTC with pulmonary metastasis. Patients and methods Pulmonary metastatic DTC patients who underwent total or near-total thyroidectomy and at least two times of RAI therapy were included in this study. The pre-ablative stimulated Tg at the first and second RAI therapy were defined as pstim-Tg1 and pstim-Tg2, while the suppressed Tg before and after the second RAI therapy were designated sup-Tg1 and supTg2. The predicted value of pstim-Tg2/Tg1 and sup-Tg2/Tg1 ratio were detected using the receiver operating characteristic (ROC) curve and logistic regression analyses. Results Totally 115 patients were involved in this study. ROC curves showed a cut-off value of 0.544 for pstim-Tg2/pstim-Tg1 in detecting RAIR, with a sensitivity of 0.9 and specificity of 0.477, and an area under the curve (AUC) of 0.744. Similarly, the cut-off of sup-Tg2/sup-Tg1 was 0.972, with a sensitivity of 0.733 and specificity of 0.935, and AUC of 0.898. Univariate analysis illustrated that age, tumor size, pstim-Tg2/Tg1, sup-Tg2/sup-Tg1 and BRAF V600E mutation were eligible to predict RAIR. While from multivariate analysis, only age, pstimTg2/Tg1, sup-Tg2/sup-Tg1 and BRAF (V600E) mutation were verified to be the independent predictive factors. Conclusion The quantitative Tg response was encouraging in identifying RAIR-DTC with pulmonary metastasis. Age, BRAF (V600E) mutation and Tg response were independent predictors in predicting RAIR-DTC.	[Wang, Chen; Zhang, Xin; Li, Hui; Lin, Yansong] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China; [Li, Xin] Zhejiang Canc Hosp, Dept Nucl Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang Cancer Hospital	Lin, YS (corresponding author), Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China.	linys@pumch.cn		Wang, Chen/0000-0003-2271-5587	National Natural Science Foundation of China [81571714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No 81571714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Haugen BR, 2015, 2015 AM THYROID ASS; Kim HJ, 2013, WORLD J SURG, V37, P2845, DOI 10.1007/s00268-013-2213-4; Lin YS, 2011, CLIN NUCL MED, V36, P1102, DOI 10.1097/RLU.0b013e3182291c65; Sampson E, 2007, CANCER, V110, P1451, DOI 10.1002/cncr.22956; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schlumberger M, 2014, LANCET DIABETES ENDO, V2, P356, DOI 10.1016/S2213-8587(13)70215-8; Song HJ, 2015, EUR J ENDOCRINOL, V173, P399, DOI 10.1530/EJE-15-0296; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Yang K, 2014, CLIN NUCL MED, V39, P675, DOI 10.1097/RLU.0000000000000498; Yang X, 2016, J CLIN ENDOCR METAB, V101, P1307, DOI 10.1210/jc.2015-4016; Yang X, 2015, CHINESE MED J-PEKING, V128, P1058, DOI 10.4103/0366-6999.155086; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298; Zhao D, 2012, J NUCL MED, V53, P1872, DOI 10.2967/jnumed.112.107821; Zhao T, 2016, ENDOCRINE, V53, P166, DOI 10.1007/s12020-015-0842-0; Zhao T, 2016, CLIN NUCL MED, V41, P454, DOI 10.1097/RLU.0000000000001167; Zhao T, 2016, NUCL MED COMMUN, V37, P632, DOI 10.1097/MNM.0000000000000485	20	10	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179664	10.1371/journal.pone.0179664	http://dx.doi.org/10.1371/journal.pone.0179664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704384	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700013
J	Wei, XL; Schmitt, I; Hodkinson, B; Flakus, A; Kukwa, M; Divakar, PK; Kirika, PM; Otte, J; Meiser, A; Lumbsch, HT				Wei, Xinli; Schmitt, Imke; Hodkinson, Brendan; Flakus, Adam; Kukwa, Martin; Divakar, Pradeep K.; Kirika, Paul M.; Otte, Juergen; Meiser, Anjuli; Lumbsch, H. Thorsten			Circumscription of the genus Lepra, a recently resurrected genus to accommodate the "Variolaria" - group of Pertusaria sensu lato (Pertusariales, Ascomycota)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; LECANOROMYCETES ASCOMYCOTA; LICHENIZED FUNGI; EVOLUTION; INFERENCE; CLASSIFICATION; ALIGNMENTS; DEPSONES; MRBAYES; BLOCKS	Pertusarialean lichens include more than 300 species belonging to several independent phylogenetic lineages. Only some of these phylogenetic clades have been comprehensively sampled for molecular data, and formally described as genera. Here we present a taxonomic treatment of a group of pertusarialean lichens formerly known as "Pertusaria amaragroup", "Monomurata-group", or "Variolaria-group", which includes widespread and well-known taxa such as P. amara, P. albescens, or P. ophthalmiza. We generated a 6-locus data set with 79 OTUs representing 75 species. The distinction of the Variolaria clade is supported and consequently, the resurrection of the genus Lepra is followed. Thirty-five new combinations into Lepra are proposed and the new species Lepra austropacifica is described from mangroves in the South Pacific. Lepra is circumscribed to include species with disciform ascomata, a weakly to non-amyloid hymenial gel, strongly amyloid asci without clear apical amyloid structures, containing 1 or 2, single-layered, thin-walled ascospores. Chlorinated xanthones are not present, but thamnolic and picrolichenic acids occur frequently, as well as orcinol depsides. Seventy-one species are accepted in the genus. Although the distinction of the genus from Pertusaria is strongly supported, the relationships of Lepra remain unresolved and the genus is tentatively placed in Pertusariales incertae sedis.	[Wei, Xinli] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Schmitt, Imke; Meiser, Anjuli] Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany; [Schmitt, Imke] Goethe Univ, Inst Ecol Evolut & Divers, Dept Biol Sci, Frankfurt, Germany; [Hodkinson, Brendan] Squamules Unltd, Henrico, VA USA; [Flakus, Adam] Polish Acad Sci, W Szafer Inst Bot, Lab Lichenol, Lubicz 46, Krakow, Poland; [Kukwa, Martin] Univ Gdansk, Dept Plant Taxon & Nat Conservat, WitaStwosza 59, Gdansk, Poland; [Divakar, Pradeep K.] Univ Complutense, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon & Cajal S-N, Madrid, Spain; [Kirika, Paul M.] Natl Museums Kenya, Bot Dept, Nairobi, Kenya; [Lumbsch, H. Thorsten] Field Museum, Sci & Educ, Chicago, IL USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Polish Academy of Sciences; W. Szafer Institute of Botany of the Polish Academy of Sciences; Fahrenheit Universities; University of Gdansk; Complutense University of Madrid; Field Museum of Natural History (Chicago)	Wei, XL (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	weixl@im.ac.cn	Flakus, Adam/V-4849-2019; Divakar, Pradeep K/E-5603-2014; Kukwa, Martin/X-9510-2019	Flakus, Adam/0000-0002-0712-0529; Divakar, Pradeep K/0000-0002-0300-0124; Kukwa, Martin/0000-0003-1560-909X; Lumbsch, Thorsten/0000-0003-1512-835X; wei, xin li/0000-0001-5470-9590; Calchera, Anjuli/0000-0002-3420-6336	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research; Arts; Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation; Mohamed bin Zayed Species Conservation Fund; Negaunee Foundation; NSF Award [1145898]; National Science Center [2015/17/B/NZ8/02441]	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research; Arts; Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation; Mohamed bin Zayed Species Conservation Fund; Negaunee Foundation; NSF Award(National Science Foundation (NSF)); National Science Center(National Science Centre, Poland)	This study was funded by LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of Hesses Ministry of Higher Education, Research, and the Arts. The field work was financially supported by the Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation, The Mohamed bin Zayed Species Conservation Fund, the Negaunee Foundation and NSF Award No. 1145898 to MVK. AF and MK received support from the National Science Center (project no. 2015/17/B/NZ8/02441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer AW, 2010, A PRELIMINARY WORLD; Buaruang K, 2017, MYCOKEYS, V22; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; ELIX JA, 1994, AUST J CHEM, V47, P1345, DOI 10.1071/CH9941345; ELIX JA, 1991, AUST J CHEM, V44, P1487, DOI 10.1071/CH9911487; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hafellner J., 2016, STAPFIA, V104, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch W. M., 2016, SYLLABUS PLAMT FAMIL, V1/2, P150; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kondratyuk Sergii Y., 2015, Studia Botanica Hungarica, V46, P95, DOI 10.17110/StudBot.2015.46.2.95; Lendemer JC, 2017, BRYOLOGIST, V120, P183, DOI 10.1639/0007-2745-120.2.183; Lucking R, 2016, BRYOLOGIST, V119, P361, DOI 10.1639/0007-2745-119.4.361; LUMBSCH H. T., 2006, FUNGI MULTIFACETED M, P153; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2001, LICHENOLOGIST, V33, P161, DOI 10.1006/lich.2000.0309; Lumbsch HT, 1995, BIBLIOTHECA LICHENOL, V57, P355; LUMBSCH HT, 1994, J HATTORI BOT LAB, V75, P295; Lumbsch HT, 2002, LICHENOLOGY, V1, P37; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Printzen C, 2010, PROG BOT, V71, P233, DOI 10.1007/978-3-642-02167-1_10; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schmitt I., 2010, MYCOLOGY, V1, P75, DOI DOI 10.1080/21501201003631540; Schmitt I, 2006, J HATTORI BOT LAB, P753; Schmitt I, 2012, MYCOKEYS, P23, DOI 10.3897/mycokeys.4.3545; Schmitt I, 2009, MOL PHYLOGENET EVOL, V52, P34, DOI 10.1016/j.ympev.2009.03.017; Schmitz Kerstin E., 1994, Acta Botanica Fennica, V150, P153; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	40	9	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180284	10.1371/journal.pone.0180284	http://dx.doi.org/10.1371/journal.pone.0180284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700682	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400011
J	Yan, MP; Zhang, XH; Chen, A; Gu, W; Liu, J; Ren, XJ; Zhang, JP; Wu, XX; Place, AT; Minshall, RD; Liu, GQ				Yan, Meiping; Zhang, Xinhua; Chen, Ao; Gu, Wei; Liu, Jie; Ren, Xiaojiao; Zhang, Jianping; Wu, Xiaoxiong; Place, Aaron T.; Minshall, Richard D.; Liu, Guoquan			Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction	FASEB JOURNAL			English	Article						inflammation; lung injury; leukocyte; LPS	TYROSINE-PHOSPHATASE SHP2; CADHERIN-CATENIN COMPLEX; VE-CADHERIN; BARRIER FUNCTION; ADHERENS JUNCTIONS; VASCULAR-PERMEABILITY; IN-VIVO; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE EXTRAVASATION; PULMONARY ENDOTHELIUM	Intercellular adhesion molecule-1 (ICAM-1) mediates the firm adhesion of leukocytes to endothelial cells and initiates subsequent signaling that promotes their transendothelial migration (TEM). Vascular endothelial (VE)-cadherin plays a critical role in endothelial cell-cell adhesion, thereby controlling endothelial permeability and leukocyte transmigration. This study aimed to determine the molecular signaling events that originate from the ICAM-1-mediated firm adhesion of neutrophils that regulate VE-cadherin's role as a negative regulator of leukocyte transmigration. We observed that ICAM-1 interacts with Src homology domain 2-containing phosphatase-2 (SHP-2), and SHP-2 down-regulation via silencing of small interfering RNA in endothelial cells enhanced neutrophil adhesion to endothelial cells but inhibited neutrophil transmigration. We also found that VE-cadherin associated with the ICAM-1-SHP-2 complex. Moreover, whereas the activation of ICAM-1 leads to VE-cadherin dissociation from ICAM-1 and VE-cadherin association with actin, SHP-2 down-regulation prevented ICAM-1-VE-cadherin association and promoted VE-cadherin-actin association. Furthermore, SHP-2 down-regulation in vivo promoted LPS-induced neutrophil recruitment in mouse lung but delayed neutrophil extravasation. These results suggest that SHP-2-via association with ICAM-1-mediates ICAM-1-induced Src activation and modulates VE-cadherin switching association with ICAM-1 or actin, thereby negatively regulating neutrophil adhesion to endothelial cells and enhancing their TEM.	[Yan, Meiping; Zhang, Xinhua; Chen, Ao; Gu, Wei; Liu, Jie; Ren, Xiaojiao; Zhang, Jianping; Wu, Xiaoxiong; Liu, Guoquan] Huazhong Agr Univ, Dept Basic Vet Med, Coll Anim Sci & Vet Med, Wuhan, Hubei, Peoples R China; [Place, Aaron T.; Minshall, Richard D.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA	Huazhong Agricultural University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liu, GQ (corresponding author), Huazhong Agr Univ, Anim Sci & Vet Med, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	liuguoquan@mail.hzau.edu.cn		Wei, Gu/0000-0002-4421-2326; yan, meiping/0000-0002-6851-082X	National Natural Science Foundation of China [31372418]; Huazhong Agricultural University Scientific and Technology Self-innovation Foundation [2012RC011]; Fundamental Research Funds for Central University [2662013PY054]; 948 Project of Chinese Ministry of Agriculture [2015-Z33]; U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL71626, P01-HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125356, R01HL071626, P01HL060678] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific and Technology Self-innovation Foundation; Fundamental Research Funds for Central University; 948 Project of Chinese Ministry of Agriculture; U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China (Grant 31372418; to G.L.), the Huazhong Agricultural University Scientific and Technology Self-innovation Foundation (program no. 2012RC011; to G.L.), the Fundamental Research Funds for the Central University (project no. 2662013PY054; to G.L.), the 948 Project of Chinese Ministry of Agriculture (Grant 2015-Z33; to G.L.), and U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants R01-HL71626 and P01-HL60678 (to R.D.M.). The authors thank Maricela Castellon (University of Illinois at Chicago) for excellent technical assistance. The authors declare no conflicts of interest.	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Castillo R L, 2015, Open Respir Med J, V9, P83, DOI 10.2174/1874306401509010083; Chichger H, 2015, AM J RESP CELL MOL, V52, P695, DOI 10.1165/rcmb.2013-0489OC; Chichger H, 2015, FASEB J, V29, P868, DOI 10.1096/fj.14-257212; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Golovkine G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003939; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hamborg M, 2013, PHARM RES-DORDR, V30, P140, DOI 10.1007/s11095-012-0856-8; Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600; HEIMARK RL, 1990, J CELL BIOL, V110, P1745, DOI 10.1083/jcb.110.5.1745; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kustermann S, 2014, TOXICOL SCI, V138, P333, DOI 10.1093/toxsci/kft336; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; Liu GQ, 2011, ARTERIOSCL THROM VAS, V31, P1342, DOI 10.1161/ATVBAHA.110.222208; Ludwig A, 2011, METHODS MOL BIOL, V763, P319, DOI 10.1007/978-1-61779-191-8_22; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miller I, 2002, BLOOD, V99, P2662, DOI 10.1182/blood.V99.8.2662; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Pluskota E, 2000, J BIOL CHEM, V275, P30029, DOI 10.1074/jbc.M000240200; Purswani MU, 2002, J ANTIMICROB CHEMOTH, V50, P51, DOI 10.1093/jac/dkf091; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Su WH, 2002, BLOOD, V100, P3597, DOI 10.1182/blood-2002-01-0303; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang JJ, 2015, CELL MOL LIFE SCI, V72, P4849, DOI 10.1007/s00018-015-1973-4; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	52	11	11	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4759	4769		10.1096/fj.201700280R	http://dx.doi.org/10.1096/fj.201700280R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28701303	Green Published			2022-12-26	WOS:000413398500009
J	Campbell, KT; Hadley, DJ; Kukis, DL; Silva, EA				Campbell, Kevin T.; Hadley, Dustin J.; Kukis, David L.; Silva, Eduardo A.			Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MOLECULAR-WEIGHT DISTRIBUTION; LYMPHATIC VASCULATURE; COVALENT INCORPORATION; MYOCARDIAL-INFARCTION; COLLAGEN MATRICES; TYROSINE KINASES; TUMOR-GROWTH; IN-VIVO; ANGIOGENESIS	Lymphatic dysfunction is associated with the progression of many cardiovascular disorders due to their role in maintaining tissue fluid homeostasis. Promoting new lymphatic vessels (lymphangiogenesis) is a promising strategy to reverse these cardiovascular disorders via restoring lymphatic function. Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are both potent candidates for stimulating lymphangiogenesis, though maintaining spatial and temporal control of these factors represents a challenge to developing efficient therapeutic lymphangiogenic applications. Injectable alginate hydrogels have been useful for the controlled delivery of many angiogenic factors, including VEGF-A, to stimulate new blood vasculature. However, the utility of these tunable hydrogels for delivering lymphangiogenic factors has never been closely examined. Thus, the objective of this study was to utilize ionically cross-linked alginate hydrogels to deliver VEGF-C and VEGF-D for potential lymphangiogenic applications. We demonstrated that lymphatic endothelial cells (LECs) are sensitive to temporal presentation of VEGF-C and VEGF-D but with different responses between the factors. The greatest LEC mitogenic and sprouting response was observed for constant concentrations of VEGF-C and a high initial concentration that gradually decreased over time for VEGF-D. Additionally, alginate hydrogels provided sustained release of radiolabeled VEGF-C and VEGF-D. Finally, VEGF-C and VEGF-D released from these hydrogels promoted a similar number of LEC sprouts as exogenously added growth factors and new vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate hydrogels can provide sustained and bioactive release of VEGF-C and VEGF-D which could have applications for therapeutic lymphangiogenesis.	[Campbell, Kevin T.; Hadley, Dustin J.; Silva, Eduardo A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Kukis, David L.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Silva, EA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	esilva@ucdavis.edu	Silva, Eduardo A./M-2711-2015	Silva, Eduardo A./0000-0003-3173-7622	American Heart Association [15BGIA25730057]; Center for Molecular and Genomic Imaging at UC Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Center for Molecular and Genomic Imaging at UC Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the American Heart Association (15BGIA25730057) and by pilot funding from the Center for Molecular and Genomic Imaging at UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the American Heart Association (15BGIA25730057) and the Center for Molecular and Genomic Imaging at UC Davis for the funding support.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Anderson EM, 2015, J VASC RES, V52, P62, DOI 10.1159/000382129; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cimpean AM, 2010, CLIN EXP MED, V10, P169, DOI 10.1007/s10238-009-0085-6; Cui Yingjie, 2010, Pathophysiology, V17, P307, DOI 10.1016/j.pathophys.2009.07.006; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Hwang JH, 2011, BIOMATERIALS, V32, P4415, DOI 10.1016/j.biomaterials.2011.02.051; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]; Kim IG, 2013, J VASC RES, V50, P124, DOI 10.1159/000343699; Kim S, 2016, BIOMATERIALS, V78, P115, DOI 10.1016/j.biomaterials.2015.11.019; Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x; Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r; Li JY, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.71; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Ludwig LL, 1997, CARDIOVASC RES, V33, P164, DOI 10.1016/S0008-6363(96)00177-0; Madrigal J.L., 2016, ANN BIOMED ENG; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Randolph GJ, 2014, J CLIN INVEST, V124, P929, DOI 10.1172/JCI71610; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Williams PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123437; Wong C, 2003, THROMB HAEMOSTASIS, V89, P573, DOI 10.1055/s-0037-1613389; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	50	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181484	10.1371/journal.pone.0181484	http://dx.doi.org/10.1371/journal.pone.0181484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723974	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800054
J	Perdikis, D; Volhard, J; Muller, V; Kaulard, K; Brick, TR; Wallraven, C; Lindenberger, U				Perdikis, Dionysios; Volhard, Jakob; Mueller, Viktor; Kaulard, Kathrin; Brick, Timothy R.; Wallraven, Christian; Lindenberger, Ulman			Brain synchronization during perception of facial emotional expressions with natural and unnatural dynamics	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PHASE SYNCHRONIZATION; RESPONSES; FACE; RECOGNITION; INFORMATION; HIERARCHY; ALPHA	Research on the perception of facial emotional expressions (FEEs) often uses static images that do not capture the dynamic character of social coordination in natural settings. Recent behavioral and neuroimaging studies suggest that dynamic FEEs (videos or morphs) enhance emotion perception. To identify mechanisms associated with the perception of FEEs with natural dynamics, the present EEG (Electroencephalography) study compared (i) ecologically valid stimuli of angry and happy FEEs with natural dynamics to (ii) FEEs with unnatural dynamics, and to (iii) static FEEs. FEEs with unnatural dynamics showed faces moving in a biologically possible but unpredictable and atypical manner, generally resulting in ambivalent emotional content. Participants were asked to explicitly recognize FEEs. Using whole power (WP) and phase synchrony (Phase Locking Index, PLI), we found that brain responses discriminated between natural and unnatural FEEs (both static and dynamic). Differences were primarily observed in the timing and brain topographies of delta and theta PLI and WP, and in alpha and beta WP. Our results support the view that biologically plausible, albeit atypical, FEEs are processed by the brain by different mechanisms than natural FEEs. We conclude that natural movement dynamics are essential for the perception of FEEs and the associated brain processes.	[Perdikis, Dionysios; Volhard, Jakob; Mueller, Viktor; Brick, Timothy R.; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Kaulard, Kathrin] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Max Planck Society; Korea University	Perdikis, D (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	perdikis@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021; Brick, Timothy/C-9966-2015	Brick, Timothy/0000-0002-3339-9279; Muller, Viktor/0000-0002-3716-5445; Perdikis, Dionysios/0000-0003-0103-7094	Max Planck Society; Max-Planck Network (Maxnet) for Cognition	Max Planck Society(Max Planck Society); Max-Planck Network (Maxnet) for Cognition	This work was supported by the Max Planck Society and the Max-Planck Network (Maxnet) for Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Brick TR, 2012, FACE MODEL GUI VERSI; Brick TR, STAPLES; Cooper NR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00159; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7; De Winter FL, 2015, NEUROIMAGE, V106, P340, DOI 10.1016/j.neuroimage.2014.11.020; Ekman P., 1976, PICTURES FACIAL AFFE; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Fuchs A, 2008, UNDERST COMPLEX SYST, P327, DOI 10.1007/978-3-540-74479-5_16; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Furl N, 2013, CEREB CORTEX, P1; Furl N., 2014, CEREB CORTEX, V1, P1, DOI DOI 10.1093/CERC0R/BHU083; Furl N, 2012, J NEUROSCI, V32, P15952, DOI 10.1523/JNEUROSCI.1992-12.2012; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kleinfeld David, 2014, Cold Spring Harb Protoc, V2014, P248, DOI 10.1101/pdb.top081075; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Matthews I, 2004, INT J COMPUT VISION, V60, P135, DOI 10.1023/B:VISI.0000029666.37597.d3; Maturana, 1998, TREE KNOWLEDGE BIOL; Mayes AK, 2009, BRAIN TOPOGR, V22, P145, DOI 10.1007/s10548-009-0106-5; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Moore A, 2012, BEHAV BRAIN RES, V226, P309, DOI 10.1016/j.bbr.2011.07.048; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Park H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059544; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Saragih J, 2009, PATTERN RECOGN, V42, P2628, DOI 10.1016/j.patcog.2009.04.014; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schultz J, 2013, CEREB CORTEX, V23, P1167, DOI 10.1093/cercor/bhs106; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Trautmann-Lengsfeld SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066997; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Yoshikawa S, 2008, COGN AFFECT BEHAV NE, V8, P25, DOI 10.3758/CABN.8.1.25	63	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181225	10.1371/journal.pone.0181225	http://dx.doi.org/10.1371/journal.pone.0181225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723957	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800039
J	Pitkanen, M; Kallioniemi, E; Julkunen, P				Pitkanen, Minna; Kallioniemi, Elisa; Julkunen, Petro			Effect of inter-train interval on the induction of repetition suppression of motor-evoked potentials using transcranial magnetic stimulation	PLOS ONE			English	Article							CORTEX EXCITABILITY; HABITUATION; INHIBITION; TMS; RESPONSES	Repetition suppression (RS) is evident as a weakened response to repeated stimuli after the initial response. RS has been demonstrated in motor-evoked potentials (MEPs) induced with transcranial magnetic stimulation (TMS). Here, we investigated the effect of inter-train interval (ITI) on the induction of RS of MEPs with the attempt to optimize the investigative protocols. Trains of TMS pulses, targeted to the primary motor cortex by neuronavigation, were applied at a stimulation intensity of 120% of the resting motor threshold. The stimulus trains included either four or twenty pulses with an inter-stimulus interval (ISI) of 1 s. The ITI was here defined as the interval between the last pulse in a train and the first pulse in the next train; the ITIs used here were 1, 3, 4, 6, 7, 12, and 17 s. RS was observed with all ITIs except with the ITI of 1 s, in which the ITI was equal to ISI. RS was more pronounced with longer ITIs. Shorter ITIs may not allow sufficient time for a return to baseline. RS may reflect a startle-like response to the first pulse of a train followed by habituation. Longer ITIs may allow more recovery time and in turn demonstrate greater RS. Our results indicate that RS can be studied with confidence at relatively short ITIs of 6 s and above.	[Pitkanen, Minna; Kallioniemi, Elisa; Julkunen, Petro] Kuopio Univ Hosp, Dept Clin Neurophysiol, Kuopio, Finland; [Pitkanen, Minna] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland; [Kallioniemi, Elisa] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Julkunen, Petro] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Aalto University; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Pitkanen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Neurophysiol, Kuopio, Finland.; Pitkanen, M (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland.	minna.pitk@gmail.com	Julkunen, Petro/AAS-5293-2020; Kallioniemi, Elisa/J-5000-2019	Kallioniemi, Elisa/0000-0001-6706-2837; Julkunen, Petro/0000-0002-0461-1058; Pitkanen, Minna/0000-0003-1716-3909	Finnish Cultural Foundation, Helsinki, Finland; Cancer Society of Finland, Helsinki, Finland; Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland; Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland) [5041726, 5041730, 5041749]	Finnish Cultural Foundation, Helsinki, Finland(Finnish Cultural Foundation); Cancer Society of Finland, Helsinki, Finland; Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland; Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland)	The work was supported by the Finnish Cultural Foundation, Helsinki, Finland, http://skr.fi/en (Received by MP); the Cancer Society of Finland, Helsinki, Finland, https://www.cancersociety.fi/ (Received by EK and PJ); and Paivikki and Sakari Sohlberg Foundation, Helsinki, Finland, http://www.pss-saatio.fi/english.htm (Received by EK). In addition, the authors (EK, PJ) acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (projects 5041726, 5041730 and 5041749, Kuopio, Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, MOTOR THRESHOLD ASSE; BARKER AT, 1985, LANCET, V1, P1106; Cash RFH, 2017, BRAIN STIMUL, P1; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; FRUHSTORFER H, 1971, ELECTROEN CLIN NEURO, V30, P306, DOI 10.1016/0013-4694(71)90113-1; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Giles AC, 2009, NEUROBIOL LEARN MEM, V92, P139, DOI 10.1016/j.nlm.2008.08.004; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hohlefeld FU, 2011, NEUROREPORT, V22, P141, DOI 10.1097/WNR.0b013e3283436d84; Julkunen P, 2012, BRAIN STIMUL, V5, P526, DOI 10.1016/j.brs.2011.07.006; Kallioniemi E, 2015, NEUROSCIENCE, V310, P504, DOI 10.1016/j.neuroscience.2015.09.056; Kim H, 2017, HUM BRAIN MAPP, V38, P1894, DOI 10.1002/hbm.23492; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lofberg O, 2014, NEUROSCIENCE, V274, P403, DOI 10.1016/j.neuroscience.2014.05.060; Lofberg O, 2013, NEUROSCIENCE, V243, P40, DOI 10.1016/j.neuroscience.2013.03.060; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; SCHOENEN J, 1995, EUR J NEUROL, V2, P115, DOI 10.1111/j.1468-1331.1995.tb00103.x; SOININEN HS, 1995, PHYSIOL BEHAV, V57, P927, DOI 10.1016/0031-9384(94)00393-J; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Volz LJ, 2015, CEREB CORTEX, V25, P2346, DOI 10.1093/cercor/bhu032; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181663	10.1371/journal.pone.0181663	http://dx.doi.org/10.1371/journal.pone.0181663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723977	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800065
J	Zhu, QQ; Yu, SG; Chen, GS; Ke, LL; Pan, DR				Zhu, Qiuqiang; Yu, Shuguang; Chen, Guanshui; Ke, Lanlan; Pan, Daren			Analysis of the differential gene and protein expression profile of the rolled leaf mutant of transgenic rice (Oryza sativa L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CELL-DEVELOPMENT; BULLIFORM CELLS; OVEREXPRESSION	The importance of leaf rolling in rice (Oryza sativa L.) has been widely recognized. Although several studies have investigated rice leaf rolling and identified some related genes, knowledge of the molecular mechanism underlying rice leaf rolling, especially outward leaf rolling, is limited. Therefore, in this study, differential proteomics and gene expression profiling were used to analyze rolled leaf mutant of transgenic rice in order to investigate differentially expressed genes and proteins related to rice leaf rolling. To this end, 28 differentially expressed proteins related to rolling leaf traits were isolated and identified. Digital expression profiling detected 10 genes related to rice leaf rolling. Some of the proteins and genes detected are involved in lipid metabolism, which is related to the development of bulliform cells, such as phosphoinositide phospholipase C, Mgll gene, and At4g26790 gene. The "omics"-level techniques were useful for simultaneously isolating several proteins and genes related to rice leaf rolling. In addition, the results of the analysis of differentially expressed proteins and genes were closely consistent with those from a corresponding functional analysis of cellular mechanisms; our study findings might form the basis for further research on the molecular mechanisms underlying rice leaf rolling.	[Zhu, Qiuqiang; Chen, Guanshui; Ke, Lanlan; Pan, Daren] Fujian Agr & Forest Univ, Dept Life Sci, Fuzhou, Fujian, Peoples R China; [Yu, Shuguang] Qingdao Agr Univ, Coll Chem & Pharmaceut Sci, Qingdao, Peoples R China	Fujian Agriculture & Forestry University; Qingdao Agricultural University	Pan, DR (corresponding author), Fujian Agr & Forest Univ, Dept Life Sci, Fuzhou, Fujian, Peoples R China.	qq9884318@163.com	ke, lan/AFP-9825-2022		Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China [2008zx08009-003]	Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China	This work was supported by the Ministry of Agriculture Genetically Modified Organisms Breeding Major Projects of China (2008zx08009-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZhangLiu, 2001, Journal of South China Agricultural University, V22, P88; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Luo ZK, 2007, GENOME, V50, P811, DOI 10.1139/G07-064; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Xu Y, 2014, PLANTA, V239, P803, DOI 10.1007/s00425-013-2009-7; Yan S, 2008, PLANT MOL BIOL, V68, P239, DOI 10.1007/s11103-008-9365-x; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhang JJ, 2015, PLANT BIOLOGY, V17, P437, DOI 10.1111/plb.12255; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	15	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181378	10.1371/journal.pone.0181378	http://dx.doi.org/10.1371/journal.pone.0181378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723953	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800047
J	Chen, ZY; Yao, Y				Chen, Zhen-Yan; Yao, Ying			A synergistic negative effect of gestational smoke-exposure and small litter size on rat placental efficiency, vascularisation and angiogenic factors mRNA expression	PLOS ONE			English	Article							FACTOR-RECEPTOR SYSTEM; CIGARETTE-SMOKE; PREGNANCY; VASCULATURE; MOTHERS; MORPHOLOGY; HYPOXIA; RISK; PIGS	Smoking increases the risk of pregnancy complications such as spontaneous abortion and low birth weight (LBW). By cigarette smoke exposure (gestational day, GD3-17), normal-litter-size pregnancy with low birth weight (NP-LBW) and small-litter-size pregnancy with normal birth weight (SP-NBW) in rats were induced. The placental weight in SP-NBW was twice the weight of the normal in contrast with the smaller placenta in NP-LBW. Compared with the normal, placental efficiency (expressed as fetus-to-placenta weight ratio) and placental vascularisation were significantly decreased in smoke exposed placentas with more obvious decrease in SP-NBW. For NP-LBW, decreased placental vascularisation was due to decreased labyrinth vascularisation which was caused by both decreased number density and diameter of fetal capillary. For SP-NBW, decreased placental vascularisation was due to reduced proportion of labyrinth in placenta and decreased labyrinth vascularisation which was caused by decreased fetal capillary number density. Real time RT-PCR analysis showed a tendency for decreased placental mRNA level of vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang1) and tyrosine kinase receptor-2 (Tie2) in NP-LBW(P<0.1), and the tendency became obvious in SP-NBW(P<0.05). A tendency for decreased placental mRNA level of fms-like tyrosine kinase-1(Flt1) and angiopoietin-2 (Ang2) was also observed in SP-LBW(P<0.1). Our data demonstrated the synergistic negative effect of gestational smoke-exposure and small litter size on placental efficiency, placental vascularisation and placental angiogenic growth factor mRNA expression in rat.	[Chen, Zhen-Yan; Yao, Ying] Huazhong Univ Sci & Technol, Dept Nutr, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	244454698@qq.com			National Natural Science Foundation of China [81300592]; Scientific Research Foundation of Health Department of Hubei Province [WJ2015MB011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Health Department of Hubei Province	This study was supported by the grants funded by National Natural Science Foundation of China (81300592) and general Program in Scientific Research Foundation of Health Department of Hubei Province (WJ2015MB011).nil_	Akpak YK, 2016, J MATERN FETAL NEONA, V1-6; Benedict MD, 2011, HUM REPROD, V26, P2525, DOI 10.1093/humrep/der226; BURTON GJ, 1989, BRIT J OBSTET GYNAEC, V96, P907, DOI 10.1111/j.1471-0528.1989.tb03344.x; Bush PG, 2000, PLACENTA, V21, P247, DOI 10.1053/plac.1999.0470; Chen ZY, 2013, J HUAZHONG U SCI-MED, V33, P293, DOI 10.1007/s11596-013-1114-y; Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Genbacev O, 2003, REPROD TOXICOL, V17, P509, DOI 10.1016/S0890-6238(03)00094-7; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; JAUNIAUX E, 1992, OBSTET GYNECOL, V79, P645; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Kamarainen M, 2009, MOL CELL ENDOCRINOL, V299, P261, DOI 10.1016/j.mce.2008.11.028; Kawashima A, 2014, PLOS ONE, V28; Larsen LG, 2002, AM J OBSTET GYNECOL, V186, P531, DOI 10.1067/mob.2002.120481; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; NAEYE RL, 1978, BRIT J OBSTET GYNAEC, V85, P732, DOI 10.1111/j.1471-0528.1978.tb15593.x; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; Pfarrer C, 1999, LANCET, V354, P303, DOI 10.1016/S0140-6736(99)01676-1; Rizzo G, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.041; Shinjo A, 2014, FETAL DIAGN THER, V35, P289, DOI 10.1159/000357704; TACHI N, 1989, B ENVIRON CONTAM TOX, V43, P467, DOI 10.1007/BF01701884; Talbot P, 2011, BIOL RES, V44, P189, DOI /S0716-97602011000200011; TEASDALE F, 1989, BIOL NEONATE, V55, P251; van Oppenraaij RHF, 2012, PLACENTA, V33, P645, DOI 10.1016/j.placenta.2012.05.007; VANDERVELDE WJ, 1983, PLACENTA, V4, P231, DOI 10.1016/S0143-4004(83)80002-2; Vonnahme KA, 2004, BIOL REPROD, V71, P163, DOI 10.1095/biolreprod.103.026344; Vonnahme KA, 2004, J PHYSIOL-LONDON, V554, P194, DOI 10.1113/jphysiol.2003.055061; Vonnahme KA, 2008, ENDOCRINE, V33, P53, DOI 10.1007/s12020-008-9052-3; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wang N, 2014, PLACENTA, V35, P437, DOI 10.1016/j.placenta.2014.04.006	32	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181348	10.1371/journal.pone.0181348	http://dx.doi.org/10.1371/journal.pone.0181348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719646	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400041
J	Park, S				Park, SangWook			Index extraction for electromagnetic field evaluation of high power wireless charging system	PLOS ONE			English	Article							ELECTRIC-FIELD; BODY	This paper presents the precise dosimetry for highly resonant wireless power transfer (HRWPT) system using an anatomically realistic human voxel model. The dosimetry for the HRWPT system designed to operate at 13.56 MHz frequency, which one of the ISM band frequency band, is conducted in the various distances between the human model and the system, and in the condition of alignment and misalignment between transmitting and receiving circuits. The specific absorption rates in the human body are computed by the two-step approach; in the first step, the field generated by the HR-WPT system is calculated and in the second step the specific absorption rates are computed with the scattered field finite-difference time-domain method regarding the fields obtained in the first step as the incident fields. The safety compliance for non-uniform field exposure from the HR-WPT system is discussed with the international safety guidelines. Furthermore, the coupling factor concept is employed to relax the maximum allowable transmitting power. Coupling factors derived from the dosimetry results are presented. In this calculation, the external magnetic field from the HR-WPT system can be relaxed by approximately four times using coupling factor in the worst exposure scenario.	[Park, SangWook] Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea		Park, S (corresponding author), Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea.	parksw@katech.re.kr			Ministry of Trade, Industry and Energy of Korea [10052912]	Ministry of Trade, Industry and Energy of Korea	This work was supported by a grant Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912) from the Ministry of Trade, Industry and Energy of Korea, http://english.motie.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, IEC62311; [Anonymous], 2006, C9512005 IEEE, V2005; Choi B, 2004, IEEE T IND ELECTRON, V51, P140, DOI 10.1109/TIE.2003.822039; Elliott GAJ, 2006, IEEE T MAGN, V42, P3389, DOI 10.1109/TMAG.2006.879619; Gabriel C, 1996, REPORT NO 21; GREEN AW, 1994, IEE CONF PUBL, P694; Herbertz J, 1998, HEALTH PHYS, V75, P535; Hui SYR, 2005, IEEE T POWER ELECTR, V20, P620, DOI 10.1109/TPEL.2005.846550; HURLEY WG, 1979, IEEE T MAGN, V15, P1174, DOI 10.1109/TMAG.1979.1145874; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Jang YT, 2003, IEEE T IND ELECTRON, V50, P520, DOI 10.1109/TIE.2003.812472; Kunz K. S., 1993, FINITE DIFFERENCE TI; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Laakso I, 2013, PHYS MED BIOL, V58, P7583, DOI 10.1088/0031-9155/58/21/7583; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Park SW, 2013, IEEE T MICROW THEORY, V61, P3461, DOI 10.1109/TMTT.2013.2274053; Park SW, 2013, IEEE T MICROW THEORY, V61, P2153, DOI 10.1109/TMTT.2013.2247211; Park SW, 2015, J ELECTROMAGN ENG SC, V15, P129, DOI 10.5515/JKIEES.2015.15.3.129; Schuder J, 1961, I RADIO ENGRS INT CO	19	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180019	10.1371/journal.pone.0180019	http://dx.doi.org/10.1371/journal.pone.0180019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708840	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800010
J	Pleasants, JM; Zalucki, MP; Oberhauser, KS; Brower, LP; Taylor, OR; Thogmartin, WE				Pleasants, John M.; Zalucki, Myron P.; Oberhauser, Karen S.; Brower, Lincoln P.; Taylor, Orley R.; Thogmartin, Wayne E.			Interpreting surveys to estimate the size of the monarch butterfly population: Pitfalls and prospects	PLOS ONE			English	Article							CYCLE	To assess the change in the size of the eastern North American monarch butterfly summer population, studies have used long-term data sets of counts of adult butterflies or eggs per milkweed stem. Despite the observed decline in the monarch population as measured at overwintering sites in Mexico, these studies found no decline in summer counts in the Midwest, the core of the summer breeding range, leading to a suggestion that the cause of the monarch population decline is not the loss of Midwest agricultural milkweeds but increased mortality during the fall migration. Using these counts to estimate population size, however, does not account for the shift of monarch activity from agricultural fields to non-agricultural sites over the past 20 years, as a result of the loss of agricultural milkweeds due to the nearubiquitous use of glyphosate herbicides. We present the counter-hypotheses that the proportion of the monarch population present in non-agricultural habitats, where counts are made, has increased and that counts reflect both population size and the proportion of the population observed. We use data on the historical change in the proportion of milkweeds, and thus monarch activity, in agricultural fields and non-agricultural habitats to show why using counts can produce misleading conclusions about population size. We then separate out the shifting proportion effect from the counts to estimate the population size and show that these corrected summer monarch counts show a decline over time and are correlated with the size of the overwintering population. In addition, we present evidence against the hypothesis of increased mortality during migration. The milkweed limitation hypothesis for monarch decline remains supported and conservation efforts focusing on adding milkweeds to the landscape in the summer breeding region have a sound scientific basis.	[Pleasants, John M.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Zalucki, Myron P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Oberhauser, Karen S.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Brower, Lincoln P.] Sweet Briar Coll, Sweet Briar, VA 24595 USA; [Taylor, Orley R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Thogmartin, Wayne E.] US Geol Survey, La Crosse, WI USA	Iowa State University; University of Queensland; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; United States Department of the Interior; United States Geological Survey	Pleasants, JM (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jpleasan@iastate.edu	Zalucki, Myron P/G-7983-2012; Thogmartin, Wayne/A-4461-2008	Zalucki, Myron P/0000-0001-9603-7577; Thogmartin, Wayne/0000-0002-2384-4279; Pleasants, John/0000-0003-4076-4710				[Anonymous], 2017, N AM BUTTERFLY MONIT; [Anonymous], 2021, LANG ENV STAT COMP; Davis AK, 2015, ANN ENTOMOL SOC AM, V108, P661, DOI 10.1093/aesa/sav070; Dyer LA, 2016, ANN ENTOMOL SOC AM, V109, P172, DOI 10.1093/aesa/sav160; Flockhart DTT, 2017, GLOBAL CHANGE BIOL, V23, P2565, DOI 10.1111/gcb.13589; Flockhart DTT, 2015, J ANIM ECOL, V84, P155, DOI 10.1111/1365-2656.12253; Hartzler RG, 2000, CROP PROT, V19, P363, DOI 10.1016/S0261-2194(00)00024-7; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; Inamine H, 2016, OIKOS, V125, P1081, DOI 10.1111/oik.03196; Kasten K, 2016, J INSECT CONSERV, V20, P1047, DOI 10.1007/s10841-016-9938-y; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; Nail KR, 2015, ANN ENTOMOL SOC AM, V108, P680, DOI 10.1093/aesa/sav047; Oberhauser K, 2017, ECOL ENTOMOL, V42, P51, DOI 10.1111/een.12351; Pleasants JM., 2015, MONARCHS CHANGING WO, P169; Pleasants J, 2017, INSECT CONSERV DIVER, V10, P42, DOI 10.1111/icad.12198; Pleasants JM, 2016, ANN ENTOMOL SOC AM, V109, P169, DOI 10.1093/aesa/sav115; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Rendon-Salinas E, 2015, FOREST SURFACE OCCUP; Ries L., 2015, MONARCHS CHANGING WO, P268; Ries L, 2015, ANN ENTOMOL SOC AM, V108, P691, DOI 10.1093/aesa/sav055; Saunders SP, 2016, GLOBAL ECOL BIOGEOGR, V25, P1000, DOI 10.1111/geb.12461; Saunders SP, 2017, ECOGRAPHY, V40; Stenoien C., 2016, INSECT SCI; Stenoien C, 2015, ANN ENTOMOL SOC AM, V108, P670, DOI 10.1093/aesa/sav054; Taylor OR., STATUS POPULATION; Thogmartin WE, 2017, PEERJ, V5, DOI 10.7717/peerj.3221; U. S. Department of Agriculture Farm Service Agency, 2014, CONS RES PROGR STAT; U.S. Department of Agriculture (USDA), 2021, PROF STAND DAT; United States Department of Agriculture Economic Research Service, 2012, MAJ LAND US; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Zalucki MP, 2016, AUSTRAL ECOL, V41, P154, DOI 10.1111/aec.12285; ZALUCKI MP, 1982, BEHAVIOUR, V80, P174, DOI 10.1163/156853982X00346; Zalucki MP., 1993, SCI SERIES NATURAL H, V38, P40; ZALUCKI MP, 1985, J LEPID SOC, V38, P209; Zalucki MP, 2010, ECOL ENTOMOL, V35, P84, DOI 10.1111/j.1365-2311.2009.01160.x; Zaya DN, 2017, BIOSCIENCE, V67, P342, DOI 10.1093/biosci/biw186	37	46	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181245	10.1371/journal.pone.0181245	http://dx.doi.org/10.1371/journal.pone.0181245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708851	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649800051
J	Horton, KC; Dueger, EL; Kandeel, A; Abdallat, M; El-Kholy, A; Al-Awaidy, S; Kohlani, AH; Amer, H; El-Khal, AL; Said, M; House, B; Pimentel, G; Talaat, M				Horton, Katherine C.; Dueger, Erica L.; Kandeel, Amr; Abdallat, Mohamed; El-Kholy, Amani; Al-Awaidy, Salah; Kohlani, Abdul Hakim; Amer, Hanaa; El-Khal, Abel Latif; Said, Mayar; House, Brent; Pimentel, Guillermo; Talaat, Maha			Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007-2014	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTIONS; POLYMERASE-CHAIN-REACTION; SYNCYTIAL VIRUS; YOUNG-CHILDREN; EPIDEMIOLOGY; INFANTS; SURVEILLANCE; SYMPTOMS; DISEASE; BURDEN	Introduction Little is known about the role of viral respiratory pathogens in the etiology, seasonality or severity of severe acute respiratory infections (SARI) in the Eastern Mediterranean Region. Methods Sentinel surveillance for SARI was conducted from December 2007 through February 2014 at 20 hospitals in Egypt, Jordan, Oman, Qatar and Yemen. Nasopharyngeal and oropharyngeal swabs were collected from hospitalized patients meeting SARI case definitions and were analyzed for infection with influenza, respiratory syncytial virus (RSV), adenovirus (AdV), human metapneumovirus (hMPV) and human parainfluenza virus types 1-3 (hPIV1-3). We analyzed surveillance data to calculate positivity rates for viral respiratory pathogens, describe the seasonality of those pathogens and determine which pathogens were responsible for more severe outcomes requiring ventilation and/or intensive care and/or resulting in death. Results At least one viral respiratory pathogen was detected in 8,753/28,508 (30.7%) samples tested for at least one pathogen and 3,497/9,315 (37.5%) of samples tested for all pathogens-influenza in 3,345/28,438 (11.8%), RSV in 3,942/24,503 (16.1%), AdV in 923/9,402 (9.8%), hMPV in 617/9,384 (6.6%), hPIV1 in 159/9,402 (1.7%), hPIV2 in 85/9,402 (0.9%) and hPIV3 in 365/9,402 (3.9%). Multiple pathogens were identified in 501/9,316 (5.4%) participants tested for all pathogens. Monthly variation, indicating seasonal differences in levels of infection, was observed for all pathogens. Participants with hMPV infections and participants less than five years of age were significantly less likely than participants not infected with hMPV and those older than five years of age, respectively, to experience a severe outcome, while participants with a pre-existing chronic disease were at increased risk of a severe outcome, compared to those with no reported pre-existing chronic disease. Conclusions Viral respiratory pathogens are common among SARI patients in the Eastern Mediterranean Region. Ongoing surveillance is important to monitor changes in the etiology, seasonality and severity of pathogens of interest.	[Horton, Katherine C.; Dueger, Erica L.; Talaat, Maha] US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt; [Horton, Katherine C.; Dueger, Erica L.; Said, Mayar; House, Brent; Pimentel, Guillermo; Talaat, Maha] US Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt; [Dueger, Erica L.] US Ctr Dis Control & Prevent, Global Dis Detect Branch, Atlanta, GA USA; [Kandeel, Amr] Minist Hlth & Populat, Prevent Sect, Cairo, Egypt; [Abdallat, Mohamed] Minist Hlth, Communicable Dis Dept, Amman, Jordan; [El-Kholy, Amani] Cairo Univ Hosp, Clin Pathol Dept, Cairo, Egypt; [Al-Awaidy, Salah] Minist Hlth, Communicable Dis Dept, Muscat, Oman; [Kohlani, Abdul Hakim] Minist Hlth, Communicable Dis Dept, Sanaa, Yemen; [Amer, Hanaa] Ain Shams Univ, Clin Pathol Dept, Cairo, Egypt; [El-Khal, Abel Latif] Hamad Med Corp, Sect Med, Doha, Qatar	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University; Hamad Medical Corporation	Horton, KC (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt.; Horton, KC (corresponding author), US Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt.	katherinehorton12@gmail.com	Kholy, Amani El/ABA-4759-2020; Awaidy, Salah Al/AAF-5884-2020	Awaidy, Salah Al/0000-0001-5112-3893; El Kholy, Amani/0000-0002-0645-7664; Horton, Katherine/0000-0002-7542-4065	Global Emerging Infections Surveillance Program [GEIS847705.821000.25GB.E0018]; U.S. Centers for Disease Control	Global Emerging Infections Surveillance Program; U.S. Centers for Disease Control	The study was funded through the Global Emerging Infections Surveillance Program (GEIS847705.821000.25GB.E0018) and the U.S. Centers for Disease Control. Authors have no commercial or other associations that might pose a conflict of interest.	Akhter J, 2011, HUMAN RESP SYNCYTIAL; Al-Abdallat M, 2016, INFLUENZA OTHER RESP; Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Al-Awaidy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144186; Al-Thani A, 2010, FUTURE VIROL, V5, P355, DOI 10.2217/FVL.10.13; Al-Toum R., 2009, Jordan Medical Journal, V43, P171; Ali SA, 2010, J MED VIROL, V82, P1012, DOI 10.1002/jmv.21768; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Bezerra P, 2011, PLOS ONE, V6, P1; Breiman RF, 2013, J INFECT DIS, V208, pS167, DOI 10.1093/infdis/jit462; Bruno R, 2009, NEW MICROBIOL, V32, P297; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; Falsey AR, 2006, J CLIN VIROL, V35, P46, DOI 10.1016/j.jcv.2005.04.004; Fattouh AM, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-14; Feikin D, 2012, PLOS ONE, V7, P1; Fry AM, 2006, CLIN INFECT DIS, V43, P1016, DOI 10.1086/507638; Heikkinen T, 2008, EMERG INFECT DIS, V14, P101, DOI 10.3201/eid1401.070251; Henrickson KJ, 2007, PEDIATR INFECT DIS J, V26, pS36, DOI 10.1097/INF.0b013e318157da6f; Hess B, 2012, COMMUNICATIONS, V13, P5; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kandeel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161301; Khamis FA, 2012, J MED VIROL, V84, P1323, DOI 10.1002/jmv.23330; Khuri-Bulos N, 2010, SCAND J INFECT DIS, V42, P368, DOI 10.3109/00365540903496544; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Mameli C, 2013, CURRENT INFECT DIS R; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Mohamed MS Embarek, 2014, INT J MICROBIOLOGY, V2014; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Pan American Health Organization, 2006, PAHOHDMCDV41106; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Sackesen C, 2005, TURKISH J PEDIATR, V47, P227; Sakthivel SK, 2012, J VIROL METHODS, V185, P259, DOI 10.1016/j.jviromet.2012.07.010; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; WHO Initiative for Vaccine Research, 2009, RESP SYNC VIR PAR VI; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; World Health Organization, 2011, WHO GLOB TECHN CONS	45	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180954	10.1371/journal.pone.0180954	http://dx.doi.org/10.1371/journal.pone.0180954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704440	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000405649700065
J	Richards, CD; Warr, CG; Burke, R				Richards, Christopher D.; Warr, Coral G.; Burke, Richard			A role for the Drosophila zinc transporter Zip88E in protecting against dietary zinc toxicity	PLOS ONE			English	Article							MEMBRANE ANDROGEN RECEPTORS; IDENTIFICATION; REVEALS; ZIP9; ABSORPTION; EXPRESSION; DEFICIENCY; PHENOTYPES; MECHANISM; MIDGUT	Zinc absorption in animals is thought to be regulated in a local, cell autonomous manner with intestinal cells responding to dietary zinc content. The Drosophila zinc transporter Zip88E shows strong sequence similarity to Zips 42C. 1, 42C. 2 and 89B as well as mammalian Zips 1, 2 and 3, suggesting that it may act in concert with the apically-localised Drosophila zinc uptake transporters to facilitate dietary zinc absorption by importing ions into the midgut enterocytes. However, the functional characterisation of Zip88E presented here indicates that Zip88E may instead play a role in detecting and responding to zinc toxicity. Larvae homozygous for a null Zip88E allele are viable yet display heightened sensitivity to elevated levels of dietary zinc. This decreased zinc tolerance is accompanied by an overall decrease in Metallothionein B transcription throughout the larval midgut. A Zip88E reporter gene is expressed only in the salivary glands, a handful of enteroendocrine cells at the boundary between the anterior and middle midgut regions, and in two parallel strips of sensory cell projections connecting to the larval ventral ganglion. Zip88E expression solely in this restricted subset of cells is sufficient to rescue the Zip88E mutant phenotype. Together, our data suggest that Zip88E may be functioning in a small subset of cells to detect excessive zinc levels and induce a systemic response to reduce dietary zinc absorption and hence protect against toxicity.	[Richards, Christopher D.; Warr, Coral G.; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Burke, R (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.burke@monash.edu		Warr, Coral/0000-0002-5289-3950; Richards, Christopher/0000-0001-5208-8428; Burke, Richard/0000-0003-0086-0767	National Health and Medical Research Council, Australia [606609]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant (ID# 606609) funding for RB from the National Health and Medical Research Council, Australia.	Afshar N, 2013, FEBS OPEN BIO, V3, P302, DOI 10.1016/j.fob.2013.07.003; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Berg AH, 2014, ENDOCRINOLOGY, V155, P4237, DOI 10.1210/en.2014-1198; Bulldan A, 2016, CELL SIGNAL, V28, P1075, DOI 10.1016/j.cellsig.2016.04.015; Dechen KS, 2015, INT J BIOCHEM CELL B, V60, P23, DOI 10.1016/j.biocel.2014.12.017; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kambe T, 2008, AM J PHYSIOL-REG I, V294, pR1474, DOI 10.1152/ajpregu.00130.2008; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Qin QH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-101; Richards CD, 2015, INT J BIOCHEM CELL B, V69, P11, DOI 10.1016/j.biocel.2015.10.004; Shihan M, 2015, CELL SIGNAL, V27, P2077, DOI 10.1016/j.cellsig.2015.07.013; Thomas P, 2017, MOL CELLULAR ENDOCRI; Thomas P, 2014, ENDOCRINOLOGY, V155, P4250, DOI 10.1210/en.2014-1201; Vanderveken M, 2014, ARCH INSECT BIOCHEM, V85, P76, DOI 10.1002/arch.21144; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wang XX, 2009, FASEB J, V23, P2650, DOI 10.1096/fj.08-126649; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606	24	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181237	10.1371/journal.pone.0181237	http://dx.doi.org/10.1371/journal.pone.0181237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704512	Green Published, gold, Green Accepted			2022-12-26	WOS:000405649700114
J	Wongsuk, T; Pumeesat, P; Luplertlop, N				Wongsuk, Thanwa; Pumeesat, Potjaman; Luplertlop, Natthanej			Genetic variation analysis and relationships among environmental strains of Scedosporium apiospermum sensu stricto in Bangkok, Thailand	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENT; SPECIES COMPLEX; MITOCHONDRIAL-DNA; CYSTIC-FIBROSIS; BRAIN-ABSCESS; EVOLUTIONARY; INFECTIONS; FUNGI; MOLDS; PCR	The Scedosporium apiospermum species complex is an emerging filamentous fungi that has been isolated from environment. It can cause a wide range of infections in both immunocompetent and immunocompromised individuals. We aimed to study the genetic variation and relationships between 48 strains of S. apiospermum sensu stricto isolated from soil in Bangkok, Thailand. For PCR, sequencing and phylogenetic analysis, we used the following genes: actin; calmodulin exons 3 and 4; the second largest subunit of the RNA polymerase II; beta-tubulin exon 2-4; manganese superoxide dismutase; internal transcribed spacer; transcription elongation factor 1 alpha; and beta-tubulin exons 5 and 6. The present study is the first phylogenetic analysis of relationships among S. apiospermum sensu stricto in Thailand and South-east Asia. This result provides useful information for future epidemiological study and may be correlated to clinical manifestation.	[Wongsuk, Thanwa; Pumeesat, Potjaman; Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Wongsuk, Thanwa] Navamindradhiraj Univ, Vajira Hosp, Fac Med, Dept Clin Pathol, Bangkok, Thailand; [Pumeesat, Potjaman] Bansomdejchaopraya Rajabhat Univ, Fac Sci & Technol, Dept Med Technol, Bangkok, Thailand	Mahidol University; Bansomdejchaopraya Rajabhat University	Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	natthanej.lup@mahidol.ac.th	Wongsuk, Thanwa/I-7585-2016; Wongsuk, Thanwa/AAG-5728-2019	Wongsuk, Thanwa/0000-0001-9904-4334; luplertlop, natthanej/0000-0001-7964-5298	Health System Research Institute (HSRI); National Research Council of Thailand (NRCT); Tropical Medicine grant; Faculty of Tropical Medicine, Mahid of University	Health System Research Institute (HSRI); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Tropical Medicine grant; Faculty of Tropical Medicine, Mahid of University	This study was supported by Health System Research Institute (HSRI) 2016, National Research Council of Thailand (NRCT) 2016 and Tropical Medicine grant 2014, Faculty of Tropical Medicine, Mahid of University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007; Bernhardt A, 2015, INT J MED MICROBIOL, V305, P724, DOI 10.1016/j.ijmm.2015.08.024; Borghi E, 2010, MED MYCOL, V48, pS108, DOI 10.3109/13693786.2010.504239; Chen M, 2016, FUNGAL BIOL-UK, V120, P137, DOI 10.1016/j.funbio.2015.09.003; Debourgogne A, 2010, J MICROBIOL METH, V82, P319, DOI 10.1016/j.mimet.2010.07.008; Garzoni C, 2005, EMERG INFECT DIS, V11, P1591, DOI 10.3201/eid1110.050715; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Giraud S, 2014, CURR FUNGAL INFECT R, V8, P211, DOI 10.1007/s12281-014-0192-z; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heath CH, 2009, CLIN MICROBIOL INFEC, V15, P689, DOI 10.1111/j.1469-0691.2009.02802.x; Hoffmann K, 2007, MYCOL RES, V111, P1169, DOI 10.1016/j.mycres.2007.07.002; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larbcharoensub N, 2013, SE ASIAN J TROP MED, V44, P484; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lu QY, 2011, J CLIN MICROBIOL, V49, P960, DOI 10.1128/JCM.01813-10; Luplertlop N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159869; Matray O, 2016, MED MYCOL, V54, P409, DOI 10.1093/mmy/myv080; Pounder JI, 2007, J CLIN MICROBIOL, V45, P568, DOI 10.1128/JCM.01684-06; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Ramsperger M, 2014, CURR CLIN MICROBIOL, V1, P27, DOI 10.1007/s40588-014-0001-z; Rougeron A, 2015, ENVIRON MICROBIOL, V17, P1039, DOI 10.1111/1462-2920.12472; Satirapoj B, 2008, TRANSPL P, V40, P2425, DOI 10.1016/j.transproceed.2008.07.030; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Wang HQ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765985	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181083	10.1371/journal.pone.0181083	http://dx.doi.org/10.1371/journal.pone.0181083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704511	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600058
J	Huang, CM; Chen, HH; Chen, DC; Huang, YC; Liu, SP; Lin, YJ; Chang, YY; Lin, HW; Chen, SY; Tsai, FJ				Huang, Chung-Ming; Chen, Hsin-Han; Chen, Da-Chung; Huang, Yu-Chuen; Liu, Shih-Ping; Lin, Ying-Ju; Chang, Yuan-Yen; Lin, Hui-Wen; Chen, Shih-Yin; Tsai, Fuu-Jen			Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR; DISEASE; BURDEN; GENE; INFLAMMATION; PREVALENCE; RESISTANCE; MORTALITY; ISOFORMS	Objective We have previously described the association of rheumatoid arthritis (RA) prevalence and two epidermal growth factor receptor (EGFR) SNPs (rs17337023 and rs2227983) among the Taiwanese population. This present study aimed to elucidate whether the SNPs can alter the expression of EGFR in the progression of RA. Methods The cohort study included 366 Taiwan's Han Chinese RA patients and 326 age and gender matched healthy controls. Blood samples collected from the participants were analyzed to determine their serum EGFR levels and to identify EGFR SNPs from their genomic DNA. Genotyping for EGFR SNPs was performed by restriction fragment length polymorphism (RFLP) assay. The relationship between EGFR SNP and the clinical manifestations of RA was evaluated. Results Our results showed that a statistically significant difference in genotype frequency distributions at rs17337023 SNP for RA patients and controls (p < 0.05). In addition, compared with the haplotype frequencies between case and control groups, the RA patient with the GT haplotype appeared to be a significant "protective" haplotype compared with other haplotypes (OR: 0.73, 95% CI: 0.59-0.91; p = 0.005). Furthermore, the increased serum level of EGFR was also observed in RA patients (p < 0.001). Conclusion Our study showed that RA is associated with rs17337023 SNP in EGFR gene and increased serum level of the EGFR protein. These findings suggest EGFR is worthy of further investigation as a therapeutic target for RA.	[Huang, Chung-Ming; Huang, Yu-Chuen; Lin, Ying-Ju; Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Huang, Chung-Ming] China Med Univ Hosp, Dept Internal Med, Div Rheumatol & Immunol, Taichung, Taiwan; [Chen, Hsin-Han] China Med Univ Hosp, Div Plast & Reconstruct Surg, Taichung, Taiwan; [Chen, Da-Chung; Chen, Shih-Yin] Taiwan LandSeed Hosp, Taoyuan, Taiwan; [Huang, Yu-Chuen; Lin, Ying-Ju] China Med Univ Hosp, Genet Ctr, Dept Med Res, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Chang, Yuan-Yen] Chung Shan Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Chang, Yuan-Yen] Chung Shan Med Univ, Sch Med, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Hui-Wen] Asia Univ, Dept Optometry, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, SY; Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Chen, SY (corresponding author), Taiwan LandSeed Hosp, Taoyuan, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Pediat, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan.	chenshihy@gmail.com; d0704@mail.cmuh.org.tw		Liu, Shih-Ping/0000-0002-5803-4460; Chang, Yuan-Yen/0000-0001-6395-4280	China Medical University Hospital in Taiwan [DMR-99-015, DMR-100-013, DMR-102-013]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; National Science Council in Taiwan [NSC99-2314-B-039-005-MY3]	China Medical University Hospital in Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by China Medical University Hospital in Taiwan (DMR-99-015, DMR-100-013 and DMR-102-013), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and National Science Council in Taiwan (NSC99-2314-B-039-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; Bai J, 2012, ASIAN PAC J CANCER P, V13, P4879, DOI 10.7314/APJCP.2012.13.10.4879; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; Crowson CS, 2009, J RHEUMATOL, V36, P1606, DOI 10.3899/jrheum.081188; Dabertrand F, 2007, AM J PHYSIOL-CELL PH, V293, pC848, DOI 10.1152/ajpcell.00069.2007; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Guillaudeau A, 2012, INT J ONCOL, V40, P1142, DOI 10.3892/ijo.2011.1287; Hashemi M, 2013, INT J IMMUNOGENET, V40, P299, DOI 10.1111/iji.12038; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120699; Killock David, 2012, Nat Rev Rheumatol, V8, P247, DOI 10.1038/nrrheum.2012.45; Krasinskas A. M., 2011, PATHOLOG RES INT, V2011, P6, DOI DOI 10.4061/2011/932932; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lal P, 2011, ARTHRITIS RHEUM-US, V63, P3681, DOI 10.1002/art.30596; Langley Paul C, 2011, J Med Econ, V14, P709, DOI 10.3111/13696998.2011.611201; Lin YJ, 2014, BIOMEDICINE-TAIWAN, V4, P18, DOI 10.7603/s40681-014-0010-5; Lo SF, 2012, RHEUMATOL INT, V32, P2301, DOI 10.1007/s00296-011-1961-4; Maetzel A, 2004, ANN RHEUM DIS, V63, P395, DOI 10.1136/ard.2003.006031; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orlewska E, 2011, MED SCI MONITOR, V17, pSR1, DOI 10.12659/MSM.881697; Palmer G, 2006, ARTHRITIS RHEUM, V54, P2707, DOI 10.1002/art.22062; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Swanson CD, 2012, J IMMUNOL, V188, P3513, DOI 10.4049/jimmunol.1102693; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Walker F, 2009, HUM PATHOL, V40, P1517, DOI 10.1016/j.humpath.2009.05.010; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YEN JH, 1995, J RHEUMATOL, V22, P1450; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yuan FL, 2013, CLIN RHEUMATOL, V32, P289, DOI 10.1007/s10067-012-2119-9	38	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180604	10.1371/journal.pone.0180604	http://dx.doi.org/10.1371/journal.pone.0180604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700691	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649400015
J	Jung, S; Choi, M; Choi, K; Kwon, EB; Kang, M; Kim, D; Jeong, H; Kim, J; Kim, JH; Kim, MO; Han, SB; Cho, S				Jung, Sunhee; Choi, Miri; Choi, Kwangman; Kwon, Eun Bin; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Kim, Janghwan; Kim, Jong Heon; Kim, Mun Ock; Han, Sang-Bae; Cho, Sungchan			Inactivation of human DGAT2 by oxidative stress on cysteine residues	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE ACTIVITY; GLYCEROL PHOSPHATE ACYLTRANSFERASE; SYNTHESIZED FATTY-ACIDS; TRIACYLGLYCEROL SYNTHESIS; ENDOPLASMIC-RETICULUM; ACYL-COA; TRIGLYCERIDE SYNTHESIS; LIVER; IDENTIFICATION; MITOCHONDRIA	Diacylglycerol acyltransferases (DGATs) have a crucial role in the biosynthesis of triacylglycerol (TG), the major storage form of metabolic energy in eukaryotic organisms. Even though DGAT2, one of two distinct DGATs, has a vital role in TG biosynthesis, little is known about the regulation of DGAT2 activity. In this study, we examined the role of cysteine and its oxidation in the enzymatic activity of human DGAT2 in vitro. Human DGAT2 activity was considerably inhibited not only by thiol-modifying reagents (NEM and IA) but also by ROSrelated chemicals ( H2O2 and beta-lapachone), while human DGAT1 and GPAT1 were little affected. Particularly, ROS-related chemicals concomitantly induced intermolecular disulfide crosslinking of human DGAT2. Both the oxidative inactivation and disulfide crosslinking were almost completely reversed by the treatment with DTT, a disulfide-reducing agent. These results clearly demonstrated the significant role of ROS-induced intermolecular crosslinking in the inactivation of human DGAT2 and also suggested DGAT2 as a redoxsensitive regulator in TG biosynthesis.	[Jung, Sunhee; Choi, Miri; Choi, Kwangman; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea; [Jung, Sunhee; Choi, Miri; Kwon, Eun Bin; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Han, Sang-Bae] Chungbuk Natl Univ, Coll Pharm, 1 Chungdae Ro Seowon Gu, Cheongju, Chungcheongbuk, South Korea; [Kwon, Eun Bin; Kim, Mun Ock] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea; [Kim, Janghwan] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahak Ro, Daejeon, South Korea; [Kim, Jong Heon] Natl Canc Ctr, Res Inst, Canc Cell & Mol Biol Branch, Goyang Si, Gyeonggi Do, South Korea; [Cho, Sungchan] Korea Univ Sci & Technol, Dept Biomol Sci, 217 Gajeong Ro, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC); University of Science & Technology (UST)	Cho, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea.; Cho, S (corresponding author), Korea Univ Sci & Technol, Dept Biomol Sci, 217 Gajeong Ro, Daejeon, South Korea.	sungchan@kribb.re.kr			Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI) - ministry of Health Welfare [HI14C2124]; National Research Foundation of Korea [NRF-2016K1A1A8A01938649, NRF-2015M3A9C7030128]; KRIBB Research Initiative Programs	Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI) - ministry of Health Welfare; National Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative Programs	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI), funded by the ministry of Health & Welfare (HI14C2124), the National Research Foundation of Korea (NRF-2016K1A1A8A01938649 & NRF-2015M3A9C7030128), and the KRIBB Research Initiative Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; BOVERIS A, 1978, BIOCHEM J, V175, P431, DOI 10.1042/bj1750431; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen YI, 2016, AM J TRANSL RES, V8, P1626; Choi K, 2014, FEBS J, V281, P3048, DOI 10.1111/febs.12841; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; KAMISAKA Y, 1993, LIPIDS, V28, P583, DOI 10.1007/BF02536050; Kim H, 2016, DIS MODEL MECH, V9, P839, DOI 10.1242/dmm.025668; Kim MO, 2013, BIOL PHARM BULL, V36, P1167, DOI 10.1248/bpb.b13-00152; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Liu Q, 2010, BIOCHEMISTRY-US, V49, P3237, DOI 10.1021/bi9020499; Lozeman FJ, 2001, COMP BIOCHEM PHYS B, V130, P105, DOI 10.1016/S1096-4959(01)00413-4; Lu XH, 2002, J BIOL CHEM, V277, P711, DOI 10.1074/jbc.M109427200; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; MONROY G, 1972, J BIOL CHEM, V247, P6884; NIMMO HG, 1979, BIOCHEM J, V177, P283, DOI 10.1042/bj1770283; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; RLaA Kuksist, 1996, PROG LIPID RES, V35, P169; Sahebkar A, 2014, PROG LIPID RES, V56, P47, DOI 10.1016/j.plipres.2014.07.002; SAURO VS, 1990, BIOCHEM CELL BIOL, V68, P1393, DOI 10.1139/o90-202; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Wang DQH, 2013, COMPR PHYSIOL, V3, P1493, DOI 10.1002/cphy.c130001; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wurie HR, 2012, FEBS J, V279, P3033, DOI 10.1111/j.1742-4658.2012.08684.x; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181076	10.1371/journal.pone.0181076	http://dx.doi.org/10.1371/journal.pone.0181076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700690	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400029
J	Lund, M; Dahle, MK; Timmerhaus, G; Alarcon, M; Powell, M; Aspehaug, V; Rimstad, E; Jorgensen, SM				Lund, Morten; Dahle, Maria Krudtaa; Timmerhaus, Gerrit; Alarcon, Marta; Powell, Mark; Aspehaug, Vidar; Rimstad, Espen; Jorgensen, Sven Martin			Hypoxia tolerance and responses to hypoxic stress during heart and skeletal muscle inflammation in Atlantic salmon (Salmo salar)	PLOS ONE			English	Article							PISCINE REOVIRUS PRV; ENVIRONMENTAL HYPOXIA; L.; ERYTHROCYTES; PERFORMANCE; METABOLISM; PHYSIOLOGY; ANEMIA; GROWTH; SMOLT	Heart and skeletal muscle inflammation (HSMI) is associated with Piscine orthoreovirus (PRV) infection and is an important disease in Atlantic salmon (Salmo salar) aquaculture. Since PRV infects erythrocytes and farmed salmon frequently experience environmental hypoxia, the current study examined mutual effects of PRV infection and hypoxia on pathogenesis and fish performance. Furthermore, effects of HSMI on hypoxia tolerance, cardiorespiratory performance and blood oxygen transport were studied. A cohabitation trial including PRV-infected post-smolts exposed to periodic hypoxic stress (4 h of 40% O-2; PRV-H) at 4, 7 and 10 weeks post-infection (WPI) and infected fish reared under normoxic conditions (PRV) was conducted. Periodic hypoxic stress did not influence infection levels or histopathological changes in the heart. Individual incipient lethal oxygen saturation (ILOS) was examined using a standardized hypoxia challenge test (HCT). At 7 WPI, i.e. peak level of infection, both PRV and PRV-H groups exhibited reduced hypoxia tolerance compared to non-infected fish. Three weeks later (10 WPI), during peak levels of pathological changes, reduced hypoxia tolerance was still observed for the PRV group while PRV-H performed equal to non-infected fish, implying a positive effect of the repeated exposure to hypoxic stress. This was in line with maximum heart rate (fHmax) measurements, showing equal performance of PRV-H and non-infected groups, but lower fHmax above 19 degrees C as well as lower temperature optimum (T-opt) for aerobic scope for PRV, suggesting reduced cardiac performance and thermal tolerance. In contrast, the PRV-H group had reduced hemoglobinoxygen affinity compared to non-infected fish. In conclusion, Atlantic salmon suffering from HSMI have reduced hypoxia tolerance and cardiac performance, which can be improved by preconditioning fish to transient hypoxic stress episodes.	[Lund, Morten; Dahle, Maria Krudtaa; Alarcon, Marta] Norwegian Vet Inst, Sect Immunol, Oslo, Norway; [Lund, Morten; Dahle, Maria Krudtaa; Alarcon, Marta] Norwegian Vet Inst, Sect Immunol, Harstad, Norway; [Timmerhaus, Gerrit; Jorgensen, Sven Martin] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [Powell, Mark] Univ Bergen, Bergen, Norway; [Powell, Mark] Norwegian Inst Water Res, Bergen, Norway; [Rimstad, Espen] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Aspehaug, Vidar] PatoGen AS, Alesund, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute; Nofima; University of Bergen; Norwegian Institute for Water Research (NIVA); Norwegian University of Life Sciences	Lund, M (corresponding author), Norwegian Vet Inst, Sect Immunol, Oslo, Norway.; Lund, M (corresponding author), Norwegian Vet Inst, Sect Immunol, Harstad, Norway.	Morten.Lund@vetinst.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X	Research Council of Norway [235788/E40, 237315/E40]; Norwegian Seafood Research Fund [901001]; Norwegian Seafood Research Fund	Research Council of Norway(Research Council of Norway); Norwegian Seafood Research Fund; Norwegian Seafood Research Fund	The Research Council of Norway provided support in the form of salary for two authors [ML] (#235788/E40) and [MKD] (#237315/E40), (http://www.forskningsradet.no/en/Home_page/1177315753906) and #901001 of the Norwegian Seafood Research Fund (http://www.fhf.no/om-fhf/about-fhf/). The Research Council of Norway provided support in the form of salary for one author [ML], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Norwegian Seafood Research Fund provided support in the form of funding the challenge trial and the analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The authors employed by NOFIMA AS and PatoGen AS contributed solely with scientific expertise in the study and in the preparation of the manuscript	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Anttila K, 2014, FRONT MAR SCI, P1; Anttila K, 2013, J EXP BIOL, V216, P1183, DOI 10.1242/jeb.080556; AXELSSON M, 1993, AM J PHYSIOL, V264, pR963, DOI 10.1152/ajpregu.1993.264.5.R963; Bjorgen H, 2015, VET RES, V46, DOI 10.1186/s13567-015-0244-6; BOUTILIER RG, 1989, CAN J ZOOL, V67, P2986, DOI 10.1139/z89-421; Burt K, 2012, AQUAC RES, V43, P607, DOI 10.1111/j.1365-2109.2011.02867.x; Claireaux G, 2016, J FISH BIOL, V88, P232, DOI 10.1111/jfb.12833; Claireaux G, 2013, AQUAT TOXICOL, V130, P160, DOI 10.1016/j.aquatox.2013.01.004; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Farrell AP, 2007, J EXP BIOL, V210, P1715, DOI 10.1242/jeb.02781; Farrell AP, 2009, CAN J ZOOL, V87, P835, DOI 10.1139/Z09-092; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; GAMPERL AK, 1995, AM J PHYSIOL-REG I, V269, pR1258, DOI 10.1152/ajpregu.1995.269.5.R1258; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garver KA, 2016, J FISH DIS, V39, P117, DOI 10.1111/jfd.12329; Gattuso A, 2002, DIS AQUAT ORGAN, V52, P11, DOI 10.3354/dao052011; Glover KA, 2013, PLOS ONE, P8; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Johansson D, 2007, AQUACULTURE, V265, P271, DOI 10.1016/j.aquaculture.2006.12.047; Johansson D, 2006, AQUACULTURE, V254, P594, DOI 10.1016/j.aquaculture.2005.10.029; Jopling C, 2012, CIRCULATION, V126, P3017, DOI 10.1161/CIRCULATIONAHA.112.107888; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kocan R, 2006, J FISH DIS, V29, P521, DOI 10.1111/j.1365-2761.2006.00745.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kongtorp RT, 2009, SALMO SALAR L, P253; Krasnov A, 2013, GEN COMP ENDOCR, V192, P181, DOI 10.1016/j.ygcen.2013.04.026; Kvamme BO, 2013, FISH SHELLFISH IMMUN, V34, P55, DOI 10.1016/j.fsi.2012.10.006; Leonard MO, 2016, INDUCTION GLUCOCOR T; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; Lund M, 2016, VET RES IN PRESS; Lund SG, 2000, J EXP BIOL, V203, P2219; Manchenkov T, 2015, G3-GENES GENOM GENET, V5, P1107, DOI 10.1534/g3.115.018010; Markussen T, 2013, PLOS ONE, P8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2012, PLOS ONE, P7; Morera D, 2011, PLOS ONE, P6; Nikinmaa Mikko, 2006, P153; Nilsson GE, 2008, BIOL REV, V83, P173, DOI 10.1111/j.1469-185X.2008.00038.x; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pan Y.K., 2016, J FISH BIOL; Parente V, 2013, PLOS ONE, P8; Phillips MCL, 2000, J EXP BIOL, V203, P1039; Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730; RANDALL D, 1982, J EXP BIOL, V100, P275; Randall DJ, 2014, J EXP BIOL, V217, P1205, DOI 10.1242/jeb.093526; Rehulka J, 2003, DIS AQUAT ORGAN, V56, P185, DOI 10.3354/dao056185; Remen M, 2012, AQUACULTURE, V326, P148, DOI 10.1016/j.aquaculture.2011.11.036; Rimstad E, 2011, AQUAC RES, V42, P86, DOI 10.1111/j.1365-2109.2010.02670.x; Rodger HD, 2014, J FISH DIS, V37, P935, DOI 10.1111/jfd.12186; ROMBOUGH PJ, 1988, CAN J ZOOL, V66, P651, DOI 10.1139/z88-097; Roze T, 2013, J THERM BIOL, V38, P98, DOI 10.1016/j.jtherbio.2012.12.001; Rummer JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139477; Rytkonen KT, 2012, PHYSIOL GENOMICS, V44, P1090, DOI 10.1152/physiolgenomics.00081.2012; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; SCHMIDT W, 1994, BLOOD, V83, P3746; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; SOIVIO A, 1980, J COMP PHYSIOL, V136, P83, DOI 10.1007/BF00688627; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Thorud K, 1988, B EUR ASSOC FISH PAT, P8; Tucker VA, 1967, J APPL PHYSIOL, P23; WEBER RE, 1994, BLOOD, V84, P638; Zhang Y, 2016, AQUACULTURE	71	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181109	10.1371/journal.pone.0181109	http://dx.doi.org/10.1371/journal.pone.0181109			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700748	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000405649400032
J	Sasaki, K; Sasaki, D; Okai, N; Tanaka, K; Nomoto, R; Fukuda, I; Yoshida, K; Kondo, A; Osawa, R				Sasaki, Kengo; Sasaki, Daisuke; Okai, Naoko; Tanaka, Kosei; Nomoto, Ryohei; Fukuda, Itsuko; Yoshida, Ken-ichi; Kondo, Akihiko; Osawa, Ro			Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; DIETARY TAURINE; EXPERIMENTAL-MODELS; ESCHERICHIA-COLI; SUPPLEMENTATION; PROTEIN; IMPACT; MICE	Accumulating evidence suggests that dietary taurine (2-aminoethanesulfonic acid) exerts beneficial anti-inflammatory effects in the large intestine. In this study, we investigated the possible impact of taurine on human colonic microbiota using our single-batch fermentation system (Kobe University Human Intestinal Microbiota Model; KUHIMM). Fecal samples from eight humans were individually cultivated with and without taurine in the KUHIMM. The results showed that taurine remained largely undegraded after 30 h of culturing in the absence of oxygen, although some 83% of the taurine was degraded after 30 h of culturing under aerobic conditions. Diversity in bacterial species in the cultures was analyzed by 16S rRNA gene sequencing, revealing that taurine caused no significant change in the diversity of the microbiota; both operational taxonomic unit and Shannon-Wiener index of the cultures were comparable to those of the respective source fecal samples. In addition, principal coordinate analysis indicated that taurine did not alter the composition of bacterial species, since the 16S rRNA gene profile of bacterial species in the original fecal sample was maintained in each of the cultures with and without taurine. Furthermore, metabolomic analysis revealed that taurine did not affect the composition of short-chain fatty acids produced in the cultures. These results, under these controlled but artificial conditions, suggested that the beneficial anti-inflammatory effects of dietary taurine in the large intestine are independent of the intestinal microbiota. We infer that dietary taurine may act directly in the large intestine to exert anti-inflammatory effects.	[Sasaki, Kengo; Sasaki, Daisuke; Okai, Naoko; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Tanaka, Kosei; Nomoto, Ryohei; Yoshida, Ken-ichi; Osawa, Ro] Kobe Univ, Org Adv Sci & Technol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Fukuda, Itsuko; Yoshida, Ken-ichi; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Fukuda, Itsuko; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Res Ctr Food Safety & Secur, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Kondo, Akihiko] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan	Kobe University; Kobe University; Kobe University; Kobe University; RIKEN	Sasaki, K (corresponding author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan.	sikengo@people.kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015; Sasaki, Kengo/O-6739-2018; Nomoto, Ryohei/AAV-3469-2020; SASAKI, Daisuke/F-9597-2015	Sasaki, Kengo/0000-0002-5764-1429; 	Japan Innovative Bioproduction Kobe	Japan Innovative Bioproduction Kobe	This work was supported by Japan Innovative Bioproduction Kobe (http://www.org.kobe-u.ac.jp/bioproduction/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119137; Anderson CMH, 2009, J PHYSIOL-LONDON, V587, P731, DOI 10.1113/jphysiol.2008.164228; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backus RC, 1994, J NUTR, V124, p2540S; Camargo RL, 2015, AMINO ACIDS, V47, P2419, DOI 10.1007/s00726-015-2035-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen W, 2012, MOL NUTR FOOD RES, V56, P681, DOI 10.1002/mnfr.201100799; Cuttitta CM, 2013, ADV EXP MED BIOL, V775, P299, DOI 10.1007/978-1-4614-6130-2_25; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichhorn E, 2000, J BACTERIOL, V182, P2687, DOI 10.1128/JB.182.10.2687-2695.2000; Farrell B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-78; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Gondo Y, 2012, BIOCHEM BIOPH RES CO, V426, P433, DOI 10.1016/j.bbrc.2012.08.116; Huang CX, 2014, POULTRY SCI, V93, P1475, DOI 10.3382/ps.2013-03533; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ito T, 2015, J PHARMACOL SCI, V129, P59, DOI 10.1016/j.jphs.2015.08.007; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kawaguchi H, 2015, BIORESOURCE TECHNOL, V198, P410, DOI 10.1016/j.biortech.2015.09.024; Kim H, 2006, MOL PHARMACOL, V69, P1405, DOI 10.1124/mol.105.020578; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Maia AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105851; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rosa FT, 2014, EUR J NUTR, V53, P823, DOI 10.1007/s00394-013-0586-7; Rycroft CE, 2001, J APPL MICROBIOL, V91, P878, DOI 10.1046/j.1365-2672.2001.01446.x; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shimizu M, 2009, ADV EXP MED BIOL, V643, P265, DOI 10.1007/978-0-387-75681-3_27; Takagi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160533; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; URIANICKELSEN MR, 1993, J GEN MICROBIOL, V139, P203, DOI 10.1099/00221287-139-2-203; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; Venema K, 2013, BEST PRACT RES CL GA, V27, P115, DOI 10.1016/j.bpg.2013.03.002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; Ward RJ, 2011, BIOCHEM PHARMACOL, V81, P743, DOI 10.1016/j.bcp.2010.12.030; Wu GF, 2009, ADV EXP MED BIOL, V643, P313, DOI 10.1007/978-0-387-75681-3_32; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57; Yu HN, 2016, AMINO ACIDS, V48, P1601, DOI 10.1007/s00726-016-2219-y; Zhao Z, 2008, AMINO ACIDS, V35, P217, DOI 10.1007/s00726-007-0562-8	46	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180991	10.1371/journal.pone.0180991	http://dx.doi.org/10.1371/journal.pone.0180991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700670	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800110
J	Wu, HY; Cottingham, C; Chen, LP; Wang, HX; Che, PL; Liu, KX; Wang, Q				Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Liu, Kexiang; Wang, Qin			Age-dependent differential regulation of anxiety-and depression-related behaviors by neurabin and spinophilin	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; DSM-IV DISORDERS; SUBCELLULAR-DISTRIBUTION; PROTEIN; RECEPTOR; ACTIN; BINDING; PHOSPHATASE-1; MORPHOGENESIS; COMORBIDITY	Affective disorders impact nearly 10% of the adult population in the United States in a given year. Synaptic dysfunction has recently emerged as a key neurobiological mechanism underlying affective disorders such as anxiety and depression. In this study, we investigate the potential role of two synaptic scaffolding proteins, neurabin and spinophilin, in regulating anxiety-and depression-related behaviors at different ages using genetically deficient mice. Loss of the neurabin gene reduces anxiety-like behavior in the elevated zero maze in young adult mice (3-5 months old), but not in middle aged mice (11-13 months old), whereas loss of spinophilin decreases anxiety in middle-aged mice, but not in young adult mice. Neurabin knockout (KO) mice also show reduced immobility in the repeated force swim test (FST) at 3-5 months, but not 11-3 months, of age, compared to age-and strain-matched wild type (WT) controls. Conversely, spinophilin KO mice display a lower level of this behavioral despair than matched WT controls after repeated FST trials at the middle age (11-13 months) but not the young age (3-5 months). Together, these data indicate that, despite their structural similarities and overlapping function in regulating synaptic cytoskeleton, the two homologs neurabin and spinophilin play important yet distinct roles in the regulation of anxietyand depression-like behaviors in an age-dependent manner. Our studies provide new insights into the complex neurobiology of affective disorders.	[Wu, Huiying] Jilin Univ, Hosp 2, Ultrason Diag Dept, Changchun, Jilin, Peoples R China; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Cell, Birmingham, AL 35294 USA; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Mol, Birmingham, AL 35294 USA; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Dev Biol, Birmingham, AL 35294 USA; [Cottingham, Christopher] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA; [Liu, Kexiang] Jilin Univ, Hosp 2, Dept Cardiovasc Surg, Changchun, Jilin, Peoples R China	Jilin University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Morehead State University; Jilin University	Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Cell, Birmingham, AL 35294 USA.; Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Mol, Birmingham, AL 35294 USA.; Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Dev Biol, Birmingham, AL 35294 USA.	qinwang@uab.edu	Wang, Hongxia/G-6655-2018	Wang, Qin/0000-0002-1079-5914	Nationa lInstitute of Mental Health [MH081917]; Brain & Behavior Research Foundation (Independent Investigator Award); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	Nationa lInstitute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain & Behavior Research Foundation (Independent Investigator Award); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study has been supported by the Nationa lInstitute of Mental Health (MH081917 to QW) and the Brain & Behavior Research Foundation (Independent Investigator Award to QW).	Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Boucher AA, 2011, NEUROSCIENCE, V189, P170, DOI 10.1016/j.neuroscience.2011.05.049; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Di Sebastiano AR, 2016, J BIOL CHEM, V291, P17602, DOI 10.1074/jbc.M116.722355; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Evans JC, 2015, J BIOL CHEM, V290, P10295, DOI 10.1074/jbc.M114.605543; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Finn DA, 2003, NEUROGENETICS, V4, P109, DOI 10.1007/s10048-003-0143-2; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; Luscher C, 2009, J PHYSIOL-LONDON, V587, P727, DOI 10.1113/jphysiol.2008.167742; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Mul JD, 2016, CJ MICE ENEURO, V3; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Sweatt JD, 2010, MECHANISMS MEMORY; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180638	10.1371/journal.pone.0180638	http://dx.doi.org/10.1371/journal.pone.0180638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700667	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800060
J	Sakamoto, T; Imai, H				Sakamoto, Taro; Imai, Hirotaka			Hydrogen peroxide produced by superoxide dismutase SOD-2 activates sperm in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMINAL PLASMA; INFERTILE MEN; MULTIGENE FAMILY; AMEBOID MOVEMENT; SEMEN QUALITY; GENE FAMILY; C-ELEGANS; NEMATODE; SPERMATOZOA; PROTEIN	Superoxide dismutase (SOD) is a ubiquitous antioxidant enzyme that catalytically converts the superoxide radical to hydrogen peroxide (H2O2). In mammals, high SOD activity is detectable in sperm and seminal plasma, and loss of SOD activity has been correlated with male infertility; however, the underlying mechanisms of sperm infertility remain to be clarified. Here we report that the deletion of two major SOD genes in Caenorhabditis elegans, sod-1 and sod-2, causes sperm activation defects, leading to a significant reduction in brood size. By examining the reactivity to the sperm activation signals Pronase and triethanolamine, we found that sod-1; sod-2 double mutant sperm cells display defects in pseudopod extension. Neither the content nor oxidative modification of major sperm protein, an essential cytoskeletal component for crawling movement, were significantly affected in sod-1; sod-2 mutant sperm. Surprisingly, H2O2, the dismutation product of SOD, could activate sod-1; sod-2 mutant sperm treated with Pronase. Moreover, the H2O2 scavenger ebselen completely inhibited pseudopod extension in wild-type sperm treated with Pronase, and H2O2 could directly induce pseudopod extension in wild-type sperm. Analysis of Pronase-triggered sperm activation in sod-1 and sod-2 single mutants revealed that sod-2 is required for pseudopod extension. These results suggest that SOD-2 plays an important role in the sperm activation of C. elegans by producing H2O2 as an activator of pseudopod extension.	[Sakamoto, Taro; Imai, Hirotaka] Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shinokane, Tokyo 1088641, Japan	Kitasato University	Sakamoto, T (corresponding author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shinokane, Tokyo 1088641, Japan.	sakamotot@pharm.kitasato-u.ac.jp			National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Fujita, C. Kagami, and Y. Nakagawa for technical assistance; Dr. S. Mitani (Tokyo Women's Medical University School of Medicine) for providing the alleles of sod-1 and sod-5; and Dr. Y. Nakagawa (Iwaki Meisei University) for helpful discussions and comments on this study. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; BARTON MK, 1987, GENETICS, V115, P107; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BRENNER S, 1974, GENETICS, V77, P71; BURKE DJ, 1983, J MOL BIOL, V171, P1, DOI 10.1016/S0022-2836(83)80312-X; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KLASS MR, 1984, MOL CELL BIOL, V4, P529, DOI 10.1128/MCB.4.3.529; LAMUNYON CW, 1995, EXPERIENTIA, V51, P817, DOI 10.1007/BF01922436; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Liau WS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-8; Liu ZY, 2014, BBA-MOL CELL RES, V1843, P299, DOI 10.1016/j.bbamcr.2013.11.001; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; MAZZILLI F, 1994, FERTIL STERIL, V62, P862; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Murawski M, 2007, FOLIA HISTOCHEM CYTO, V45, P123; NELSON GA, 1980, CELL, V19, P457, DOI 10.1016/0092-8674(80)90520-6; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Ochsendorf FR, 1998, HUM REPROD, V13, P353, DOI 10.1093/humrep/13.2.353; Oueslati K, 2016, FOOD CHEM, V209, P43, DOI 10.1016/j.foodchem.2016.04.041; Pearson JK, 2007, J PHYS CHEM A, V111, P3152, DOI 10.1021/jp071499n; Peeker R, 1997, MOL HUM REPROD, V3, P1061, DOI 10.1093/molehr/3.12.1061; ROBERTS TM, 1982, J CELL BIOL, V92, P132, DOI 10.1083/jcb.92.1.132; Said TM, 2004, FERTIL STERIL, V82, P871, DOI 10.1016/j.fertnstert.2004.02.132; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Smith HE, 1998, J MOL BIOL, V279, P605, DOI 10.1006/jmbi.1998.1793; Song GJ, 2006, INT J ANDROL, V29, P569, DOI 10.1111/j.1365-2605.2006.00700.x; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Takada M, 2011, BIOL PHARM BULL, V34, P954, DOI 10.1248/bpb.34.954; Tramer F, 1998, BIOL REPROD, V59, P753, DOI 10.1095/biolreprod59.4.753; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9; Wdowiak A, 2015, ANDROLOGY-US, V3, P748, DOI 10.1111/andr.12061; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; WISPE JR, 1989, BIOCHIM BIOPHYS ACTA, V994, P30, DOI 10.1016/0167-4838(89)90058-7; Yan LF, 2014, J ASSIST REPROD GEN, V31, P549, DOI 10.1007/s10815-014-0215-2; Yang CF, 1999, BIOCHEM PHARMACOL, V57, P273, DOI 10.1016/S0006-2952(98)00299-8; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	51	40	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14804	14813		10.1074/jbc.M117.788901	http://dx.doi.org/10.1074/jbc.M117.788901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724632	Green Published, hybrid			2022-12-26	WOS:000409902100009
J	Rathkey, JK; Benson, BL; Chirieleison, SM; Yang, J; Xiao, TS; Dubyak, GR; Huang, AY; Abbott, DW				Rathkey, Joseph K.; Benson, Bryan L.; Chirieleison, Steven M.; Yang, Jie; Xiao, Tsan S.; Dubyak, George R.; Huang, Alex Y.; Abbott, Derek W.			Live-cell visualization of gasdermin D-driven pyroptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; CASPASE-11; GSDMD; PORE; GREEN	Pyroptosis is a form of cell death important in defenses against pathogens that can also result in a potent and sometimes pathological inflammatory response. During pyroptosis, GSDMD (gasdermin D), the pore-forming effector protein, is cleaved, forms oligomers, and inserts into the membranes of the cell, resulting in rapid cell death. However, the potent cell death induction caused by GSDMD has complicated our ability to understand the biology of this protein. Studies aimed at visualizing GSDMD have relied on expression of GSDMD fragments in epithelial cell lines that naturally lack GSDMD expression and also lack the proteases necessary to cleave GSDMD. In this work, we performed mutagenesis and molecular modeling to strategically place tags and fluorescent proteins within GSDMD that support native pyroptosis and facilitate live-cell imaging of pyroptotic cell death. Here, we demonstrate that these fusion proteins are cleaved by caspases-1 and -11 at Asp-276. Mutations that disrupted the predicted p30-p20 autoinhibitory interface resulted in GSDMD aggregation, supporting the oligomerizing activity of these mutations. Furthermore, we show that these novel GSDMD fusions execute inflammasomedependent pyroptotic cell death in response to multiple stimuli and allow for visualization of the morphological changes associated with pyroptotic cell death in real time. This work therefore provides new tools that not only expand the molecular understanding of pyroptosis but also enable its direct visualization.	[Rathkey, Joseph K.; Benson, Bryan L.; Chirieleison, Steven M.; Yang, Jie; Xiao, Tsan S.; Huang, Alex Y.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Benson, Bryan L.; Huang, Alex Y.] Case Western Reserve Univ, Div Pediat Hematol Oncol, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Yang, Jie; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Abbott, DW (corresponding author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Huang, Alex Y./ABG-8182-2021; Huang, Alex/R-4662-2017; Xiao, Tsan Sam/A-8590-2010	Huang, Alex Y./0000-0002-5701-4521; Huang, Alex/0000-0002-5701-4521; Xiao, Tsan Sam/0000-0001-9688-475X; Abbott, Derek/0000-0003-4387-8094; Benson, Bryan/0000-0003-4318-5693; YANG, JIE/0000-0001-6662-4236; Chirieleison, Steven/0000-0002-3997-5652	National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant [S10ODO16164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441, UL1TR000439, TL1TR002549] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM086550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077888, F31NS096857] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016164] Funding Source: NIH RePORTER	National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Parameswaran Ramakrishnan and Xiaoxia Li for lending helpful comments and expertise. We thank the Abbott, Huang, Dubyak, Xiao, and Ramakrishnan laboratories for insightful discussions and comments on the project and manuscript. We also thank the Case Western Reserve University (CWRU) Imaging Core. Confocal microscopy was supported in part by National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant S10ODO16164 to the CWRU Imaging Facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Chirieleison SM, 2017, J BIOL CHEM, V292, P9666, DOI 10.1074/jbc.M117.781500; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	30	36	36	6	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14649	14658		10.1074/jbc.M117.797217	http://dx.doi.org/10.1074/jbc.M117.797217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28726636	hybrid, Green Published			2022-12-26	WOS:000408747500029
J	Cations, M; Withall, A; Horsfall, R; Denham, N; White, F; Trollor, J; Loy, C; Brodaty, H; Sachdev, P; Gonski, P; Demirkol, A; Cumming, RG; Draper, B				Cations, Monica; Withall, Adrienne; Horsfall, Ruth; Denham, Nicole; White, Fiona; Trollor, Julian; Loy, Clement; Brodaty, Henry; Sachdev, Perminder; Gonski, Peter; Demirkol, Apo; Cumming, Robert G.; Draper, Brian			Why aren't people with young onset dementia and their supporters using formal services? Results from the INSPIRED study	PLOS ONE			English	Article							INFORMAL CARE; EXPERIENCES; CAREGIVERS; BURDEN; ALZHEIMERS; NEEDS; DISABILITY; FAMILIES; PARTNER; VERSION	Background/Aims Despite reporting high levels of burden, supporters of people with young onset dementia (YOD) underuse formal community services. Previous quantitative studies in YOD are of limited utility in guiding service design because they did not consider important contextual barriers to service use. The aim of this study was to identify all relevant barriers and describe the service features considered most important to improving uptake by people with YOD and their supporters. Methods Eighty-six people with consensus-confirmed YOD (mean onset age 55.3 years) and/or their primary supporter participated in quantitative interviews, and 50 also participated in one of seven qualitative focus groups. Interview participants reported levels of community service use and reasons for non-use, functional impairment, behavioural and psychological symptoms, supporter burden, social network, and informal care provision. Focus group participants expanded on reasons for non-use and aspects of an ideal service. Results Although at least one community service was recommended to most participants (96.8%), 66.7% chose not to use one or more of these. Few of the clinical or demographic factors included here were related to service use. Qualitative analyses identified that lack of perceived need, availability, and YOD-specific barriers (including ineligibility, unaffordability, lack of security, lack of childcare) were commonly reported. Five aspects of an ideal service were noted: unique, flexibile, affordable, tailored, and promoting meaningful engagement. Conclusion People with YOD and their families report that formal community services do not meet their personal and psychological needs. Researchers can provide ongoing assessment of program feasibility, suitability, and generalisability.	[Cations, Monica; Withall, Adrienne; Horsfall, Ruth; Gonski, Peter; Demirkol, Apo] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Cations, Monica; Denham, Nicole; White, Fiona; Brodaty, Henry; Sachdev, Perminder; Draper, Brian] UNSW Australia, Sch Psychiat, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia; [Trollor, Julian; Brodaty, Henry; Sachdev, Perminder] UNSW Australia, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Trollor, Julian] UNSW Australia, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Loy, Clement] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW, Australia; [Sachdev, Perminder] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Gonski, Peter] South Eastern Sydney Local Hlth Dist, Sutherland Hosp, Div Aged & Extended Care Southcare, Sydney, NSW, Australia; [Demirkol, Apo] South Eastern Sydney Local Hlth Dist, Langton Ctr, Drug & Alcohol Serv, Surry Hills, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Cations, M (corresponding author), UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.; Cations, M (corresponding author), UNSW Australia, Sch Psychiat, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia.	m.cations@unsw.edu.au	Cumming, Robert G/R-1548-2016; Withall, Adrienne/AAI-3943-2021; Cations, Monica/L-9663-2018; Demirkol, Apo/AAC-4329-2020; Demirkol, Apo/AAI-9933-2020; Sachdev, Perminder/ABC-1137-2020	Cumming, Robert G/0000-0002-0261-6103; Withall, Adrienne/0000-0001-7079-465X; Cations, Monica/0000-0002-9262-0463; Demirkol, Apo/0000-0002-7937-7948; Sachdev, Perminder/0000-0002-9595-3220; Horsfall, Ruth/0000-0002-6230-6940	National Health and Medical Research Council [1008267]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (1008267) (https://www.nhmrc.gov.au/) as received by AW and BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bakker C, 2013, AM J GERIAT PSYCHIAT, V21, P37, DOI 10.1016/j.jagp.2012.10.004; Beattie AM, 2002, AGING MENT HEALTH, V6, P205, DOI 10.1080/13607860220142396; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bender D E, 1994, Health Transit Rev, V4, P63; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brodaty H, 2005, INT J GERIATR PSYCH, V20, P537, DOI 10.1002/gps.1322; Brown A., 2010, DEMENTIA-LONDON, V9, P451, DOI DOI 10.1177/1471301210381778; Castleberry A, 2012, NVIVO 10 SOFTWARE P; Craig D, 2016, AUSTRALAS J AGEING, V35, P48, DOI 10.1111/ajag.12264; Draper B, 2016, INT J GERIATR PSYCH, V31, P1217, DOI 10.1002/gps.4430; Ducharme F, 2016, AM J ALZHEIMERS DIS, V31, P48, DOI 10.1177/1533317515578255; Freyne A, 1999, INT J GERIATR PSYCH, V14, P784, DOI 10.1002/(SICI)1099-1166(199909)14:9<784::AID-GPS16>3.0.CO;2-2; Gaugler JE, 2005, GERONTOLOGIST, V45, P177, DOI 10.1093/geront/45.2.177; Gaugler JE, 2003, INT PSYCHOGERIATR, V15, P37, DOI 10.1017/S1041610203008743; Gibson AK, 2014, AM J ALZHEIMERS DIS, V29, P596, DOI 10.1177/1533317514558160; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Husband HJ, 1999, PSYCHIAT B, V23, P94; IBM Corp, 2013, IBM VERS WIND SOFTW; Jubb Dennis, 2003, Nurs Times, V99, P34; Kaiser Sam, 2006, Am J Alzheimers Dis Other Demen, V21, P398; Kurz A, 2016, INT PSYCHOGERIATR, V28, P2091, DOI 10.1017/S1041610216001186; Laver K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010767; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lockeridge S, 2013, DEMENTIA-LONDON, V12, P635, DOI 10.1177/1471301212440873; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Luciano JV, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-45; Millenaar JK, 2016, INT J GERIATR PSYCH, V31, P1261, DOI 10.1002/gps.4502; NEWENS AJ, 1995, BRIT J PSYCHIAT, V166, P777, DOI 10.1192/bjp.166.6.777; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Prince M., 2016, WORLD ALZHEIMER REPO; Prorok JC, 2013, CAN MED ASSOC J, V185, pE669, DOI 10.1503/cmaj.121795; Roach P, 2016, J AGING STUD, V36, P26, DOI 10.1016/j.jaging.2015.12.001; Roach P, 2008, REV CLIN GERONTOL, V18, P165, DOI 10.1017/S0959259809002779; Robertson J, 2013, DEMENTIA-LONDON, V12, P666, DOI 10.1177/1471301212473881; Rosness TA, 2011, AGING MENT HEALTH, V15, P299, DOI 10.1080/13607861003713224; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; SPERLINGER D, 1994, INT J GERIATR PSYCH, V9, P47, DOI 10.1002/gps.930090110; Sussman T, 2009, HEALTH SOC WORK, V34, P29, DOI 10.1093/hsw/34.1.29; Swaffer K., 2015, REHABILITATION DEMEN; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Wear Helen J., 2008, Dement. neuropsychol., V2, P102, DOI 10.1590/S1980-57642009DN20200005; Westera, 2014, YOUNGER ONSET DEMENT; Williams T., 2001, PSYCHIATR BULL, V25, P384, DOI [https://doi.org/10.1192/pb.25.10.384, DOI 10.1192/PB.25.10.384, 10.1192/pb.25.10.384]; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2003, BRAIN AGING, V3, P47	47	58	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180935	10.1371/journal.pone.0180935	http://dx.doi.org/10.1371/journal.pone.0180935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723931	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800032
J	Gallmetzer, I; Haselmair, A; Tomasovych, A; Stachowitsch, M; Zuschin, M				Gallmetzer, Ivo; Haselmair, Alexandra; Tomasovych, Adam; Stachowitsch, Michael; Zuschin, Martin			Responses of molluscan communities to centuries of human impact in the northern Adriatic Sea	PLOS ONE			English	Article							GULF-OF-TRIESTE; AMPHIURA-FILIFORMIS; INTEGRATED APPROACH; SPECIES COMPOSITION; SEDIMENT TRANSPORT; BENTHIC MACROFAUNA; HYPOXIC TOLERANCE; DEATH ASSEMBLAGES; OXYGEN DEFICIENCY; LEVEL CHANGES	In sediment cores spanning similar to 500 years of history in the Gulf of Trieste, down-core changes in molluscan community structure are characterized by marked shifts in species and functional composition. Between the 16th and 19th century, a strong heavy metal contamination of the sediments, most notably by Hg, together with the effects of natural climatic oscillations (increased sedimentation and organic enrichment) drive community changes. Since the early 20th century up to 2013, the combined impacts of cultural eutrophication, frequent hypoxic events and intensifying bottom trawling replace heavy metal contamination and climatic factors as the main drivers. The pollution-tolerant and opportunistic bivalve Corbula gibba and the scavenging gastropod Nassarius pygmaeus significantly increase in abundance during the 20 th century, while species more sensitive to disturbances and hypoxia such as Turritella communis and Kurtiella bidentata become rare or absent. An infaunal life habit and scavenging emerge as the dominant life strategies during the late 20 th century. Down-core shifts in the proportional abundances of molluscan species and functional groups represent a sensitive proxy for past ecological changes and reveal a century-long anthropogenic impact as the main driver behind these processes in the northern Adriatic Sea, offering also a unique perspective for other shallow marine ecosystems worldwide.	[Gallmetzer, Ivo; Haselmair, Alexandra; Zuschin, Martin] Univ Vienna, Dept Palaeontol, Vienna, Austria; [Tomasovych, Adam] Slovak Acad Sci, Geol Inst, Bratislava, Slovakia; [Stachowitsch, Michael] Univ Vienna, Dept Limnol & Biooceanog, Ctr Ecol, Vienna, Austria	University of Vienna; Slovak Academy of Sciences; University of Vienna	Gallmetzer, I (corresponding author), Univ Vienna, Dept Palaeontol, Vienna, Austria.	ivo.gallmetzer@univie.ac.at	Zuschin, Martin/M-9951-2016; Tomasovych, Adam/C-9623-2010	Zuschin, Martin/0000-0002-5235-0198; Tomasovych, Adam/0000-0002-0471-9480	Austrian Science Fund (FWF) [P24901]; Austrian Science Fund (FWF) [P 24901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), grant number P24901.; The Austrian Science Fund (FWF) supported this study under grant number P24901.	Acquavita A, 2012, ESTUAR COAST SHELF S, V113, P20, DOI 10.1016/j.ecss.2012.02.012; Albano PG, INVASION SUCCESS MAR; Allen AP, 2013, QUAT GEOCHRONOL, V18, P63, DOI 10.1016/j.quageo.2013.06.003; BARMAWIDJAJA DM, 1995, MAR GEOL, V122, P367, DOI 10.1016/0025-3227(94)00121-Z; Bellan-Santini D., 1985, NATO Conference Series I Ecology, V8, P19; Bevilacqua E., 1996, PORTO MONFALCONE STO; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Boldrin A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004837; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BRAMBATI A, 1992, OLSEN INT S, P327; Brambati A, 2013, J GEOPHYS RES-OCEANS, V118, P6183; BRYAN GW, 1992, ENVIRON POLLUT, V76, P89, DOI 10.1016/0269-7491(92)90099-V; Car J., 2005, IDRIJSKI RAZGLEDI, V50, P80; Cibic T, 2008, MAR POLLUT BULL, V56, P1650, DOI 10.1016/j.marpolbul.2008.05.009; Cibic T, 2007, ESTUAR COAST SHELF S, V75, P50, DOI 10.1016/j.ecss.2007.01.020; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Comici C, 2007, B GEOFIS TEOR APPL, V48, P435; Covelli S, 2001, APPL GEOCHEM, V16, P541, DOI 10.1016/S0883-2927(00)00042-1; Covelli S, 2006, MAR GEOL, V230, P29, DOI 10.1016/j.margeo.2006.03.013; Covelli S, 2012, ESTUAR COAST SHELF S, V113, P7, DOI 10.1016/j.ecss.2011.12.038; Cozzi S, 2011, CONT SHELF RES, V31, P1881, DOI 10.1016/j.csr.2011.08.010; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; De Biasi AM, 1999, IMPACT TRAWL FISHING, P61; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Djakovac T, 2015, J MARINE SYST, V141, P179, DOI 10.1016/j.jmarsys.2014.08.001; DUINEVELD GCA, 1986, NETH J SEA RES, V20, P85, DOI 10.1016/0077-7579(86)90064-5; Edgar GJ, 2004, CONSERV BIOL, V18, P1579, DOI 10.1111/j.1523-1739.2004.00191.x; Faber G. L., 1883, FISHERIES ADRIATIC F; FAGANELI J, 1985, MAR POLLUT BULL, V16, P75, DOI 10.1016/0025-326X(85)90127-4; Faivre S, 2013, PALAEOGEOGR PALAEOCL, V369, P163, DOI 10.1016/j.palaeo.2012.10.016; Fonda Umani S., 1989, EPISODI MARE SPORCO; FORTIBUONI T., 2009, THESIS; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; FRANCESCHINI G, 1999, IMPACT TRAWL FISHING, P49; Franzo A, 2016, CONT SHELF RES, V121, P35, DOI 10.1016/j.csr.2015.12.005; Gallmetzer I, 2016, LIMNOL OCEANOGR-METH, V14, P698, DOI 10.1002/lom3.10124; GAMULIN-BRIDA H, 1974, Acta Adriatica, V15, P1; Gelinas M, 2013, J COASTAL RES, V29, P8, DOI 10.2112/JCOASTRES-D-11-00213.1; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gosar M, 2012, ENV INFLUENCES MERCU; Gosar M, 2015, J GEOCHEM EXPLOR, V149, P97, DOI 10.1016/j.gexplo.2014.11.012; Heath E, 2006, WATER AIR SOIL POLL, V6, P241; Holm P, 2012, GLOB ENVIRON, V5, P66; Holmes SP, 2002, J MAR BIOL ASSOC UK, V82, P971, DOI 10.1017/S0025315402006471; Horvat M, 1999, SCI TOTAL ENVIRON, V238, P43, DOI 10.1016/S0048-9697(99)00123-0; ICRAM, 2005, MUC NELL ADR NEL TIR; JOSEFSON AB, 1992, OLSEN INT S, P21; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Justic Dubravko, 1991, Geological Society Special Publication, V58, P95, DOI 10.1144/GSL.SP.1991.058.01.07; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Kidwell SM, 2002, GEOLOGY, V30, P803, DOI 10.1130/0091-7613(2002)030<0803:TAMDAP>2.0.CO;2; Kidwell SM, 2015, P NATL ACAD SCI USA, V112, P4922, DOI 10.1073/pnas.1403660112; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Kowalewski M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2990; Krisch A, 1900, FISCHEREI ADRIATISCH; Langston William J., 1998, Chapman & Hall Ecotoxicology Series, V7, P219; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; MCGREER ER, 1982, MAR ENVIRON RES, V7, P131, DOI 10.1016/0141-1136(82)90038-1; MCGREER ER, 1979, MAR POLLUT BULL, V10, P259, DOI 10.1016/0025-326X(79)90482-X; Miklavcic V, 1999, MERCURY CONTAMINATED, P259; Mlakar L, 1974, IDRIJSKA RAZGLEDI, V3, P1; MURAKAMI SHIRO, 1963, TRANS ROY SOC NEW ZEALAND, V4, P1; Nerlovic V, 2012, FRESEN ENVIRON BULL, V21, P3600; Nerlovic V, 2011, BIOLOGIA, V66, P1114, DOI 10.2478/s11756-011-0121-3; OCKELMANN KW, 1978, OPHELIA, V17, P1; OGORELEC B, 1991, MAR GEOL, V99, P79, DOI 10.1016/0025-3227(91)90084-H; Oldfield F, 2003, QUATERNARY SCI REV, V22, P319, DOI 10.1016/S0277-3791(02)00088-4; Olsgard Frode, 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P25, DOI 10.1023/A:1009967313147; Orel G., 1987, Bulletin d'Ecologie, V18, P229; Orel G, 1969, Pubbl. Staz. Zool. Napoli, V37, P261; Orel G., 1989, BIOCENOSI BENTONICHE, P59; Orel G, 2005, PROPOSTE PIANO PLURI; Perco F, 2006, FOCE ISONZO LISOLA C; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Piva A, 2008, HOLOCENE, V18, P153, DOI 10.1177/0959683607085606; Poulos SE, 2002, GEOL SOC SPEC PUBL, V191, P227, DOI 10.1144/GSL.SP.2002.191.01.16; Pozo K, 2009, MAR POLLUT BULL, V58, P773, DOI 10.1016/j.marpolbul.2009.03.003; Prevedelli D, 2001, J MAR BIOL ASSOC UK, V81, P897, DOI 10.1017/S0025315401004817; Ramakritinan CM, 2012, INDIAN J GEO-MAR SCI, V41, P141; Rampazzo F, 2013, ESTUAR COAST SHELF S, V129, P49, DOI 10.1016/j.ecss.2013.06.001; Riedel B, 2014, BIOGEOSCIENCES, V11, P1491, DOI 10.5194/bg-11-1491-2014; Riedel B, 2012, MAR ECOL PROG SER, V458, P39, DOI 10.3354/meps09724; Rinaldi A., 1992, BIOLOGIA MARINA SUPP, V1, P79; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rueda JL, 2009, J MAR BIOL ASSOC UK, V89, P1319, DOI 10.1017/S0025315409000289; RYGG B, 1985, MAR ECOL PROG SER, V25, P83, DOI 10.3354/meps025083; Sangiorgi F, 2004, ESTUAR COAST SHELF S, V60, P69, DOI 10.1016/j.ecss.2003.12.001; Scarponi D, 2013, GEOLOGY, V41, P239, DOI 10.1130/G33849.1; Singh N, 2009, MAR POLLUT BULL, V58, P559, DOI 10.1016/j.marpolbul.2008.11.014; Smolar-Zvanut N, 2014, HYDROLOG SCI J, V59, P1032, DOI 10.1080/02626667.2013.834339; Solis-Weiss Vivianne, 2007, Annales Series Historia Naturalis, V17, P1; STACHOWITSCH M, 1984, PSZNI MAR ECOL, V5, P243, DOI 10.1111/j.1439-0485.1984.tb00124.x; Stachowitsch Michael, 1991, Geological Society Special Publication, V58, P119, DOI 10.1144/GSL.SP.1991.058.01.09; STEPHENSON RR, 1975, B ENVIRON CONTAM TOX, V14, P304, DOI 10.1007/BF01685641; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thurstan RH, 2013, J NAT CONSERV, V21, P253, DOI 10.1016/j.jnc.2013.01.004; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Tomasovych A, 2017, GEOLOGY; Tsujimoto A, 2006, MAR MICROPALEONTOL, V60, P258, DOI 10.1016/j.marmicro.2006.06.001; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vacchi M, 2016, EARTH-SCI REV, V155, P172, DOI 10.1016/j.earscirev.2016.02.002; Vatova A., 1949, Nova Thalassia Venezia, V1, P1; Vidovic J, 2016, BIOGEOSCIENCES, V13, P5965, DOI 10.5194/bg-13-5965-2016; Vistisen B, 1997, MAR BIOL, V128, P241, DOI 10.1007/s002270050088; Wang XH, 2007, CONT SHELF RES, V27, P613, DOI 10.1016/j.csr.2006.10.008; Wang XH, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001303; Ward TJ, 1996, MAR ECOL PROG SER, V135, P123, DOI 10.3354/meps135123; Wittmer JM, 2014, J GEOL, V122, P649, DOI 10.1086/677901; Zuschin M, 1999, LETHAIA, V32, P299; Zuschin Martin, 1994, Beitraege zur Palaeontologie von Oesterreich, V18, P75; [No title captured]	116	26	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180820	10.1371/journal.pone.0180820	http://dx.doi.org/10.1371/journal.pone.0180820			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723935	Green Published, gold			2022-12-26	WOS:000406067800027
J	Ryser, S; Estelles, A; Tenorio, E; Kauvar, LM; Gishizky, ML				Ryser, Stefan; Estelles, Angeles; Tenorio, Edgar; Kauvar, Lawrence M.; Gishizky, Mikhail L.			High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; IMMUNITY; RECEPTORS; INFECTION; DISCOVERY; BLOCKADE	We report here the cloning of native high affinity anti-TIM-3 and anti-KIR IgG monoclonal antibodies (mAbs) from peripheral blood mononuclear cells (PBMC) of healthy human donors. The cells that express these mAbs are rare, present at a frequency of less than one per 10(5) memory B-cells. Using our proprietary multiplexed screening and cloning technology CellSpot(TM) we assessed the presence of memory B-cells reactive to foreign and endogenous disease-associated antigens within the same individual. When comparing the frequencies of antigen-specific memory B-cells analyzed in over 20 screening campaigns, we found a strong correlation of the presence of anti-TIM-3 memory B-cells with memory B-cells expressing mAbs against three disease-associated antigens: (i) bacterial DNABII proteins that are a marker for Gram negative and Gram positive bacterial infections, (ii) hemagglutinin (HA) of influenza virus and (iii) the extracellular domain of anaplastic lymphoma kinase (ALK). One of the native anti-KIR mAbs has similar characteristics as lirilumab, an anti-KIR mAb derived from immunization of humanized transgenic mice that is in ongoing clinical trials. It is interesting to speculate that these native anti-TIM-3 and anti-KIR antibodies may function as natural regulatory antibodies, analogous to the pharmacological use in cancer treatment of engineered antibodies against the same targets. Further characterization studies are needed to define the mechanisms through which these native antibodies may function in healthy and disease conditions.	[Ryser, Stefan; Estelles, Angeles; Tenorio, Edgar; Kauvar, Lawrence M.; Gishizky, Mikhail L.] Trellis Biosci LLC, Menlo Pk, CA 94025 USA		Ryser, S; Gishizky, ML (corresponding author), Trellis Biosci LLC, Menlo Pk, CA 94025 USA.	sryser@trellisbio.com; mgishizky@trellisbio.com			Trellis Bioscience, LLC	Trellis Bioscience, LLC	This research was funded by Trellis Bioscience, LLC. The funder provided support in the form of salaries for authors [SR, AE, ET, LK, MG], but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beerli RR, 2010, MABS-AUSTIN, V2, P365, DOI 10.4161/mabs.12187; Byun DJ, 2017, NAT REV ENDOCRINOL, V13, P195, DOI 10.1038/nrendo.2016.205; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Ceeraz S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0469-1; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Estelles A, 2016, ANTIMICROB AGENTS CH, V60, P2292, DOI 10.1128/AAC.02588-15; Harriman WD, 2009, J IMMUNOL METHODS, V341, P135, DOI 10.1016/j.jim.2008.11.009; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Kauvar LM, 2015, ANTIMICROB AGENTS CH, V59, P1563, DOI 10.1128/AAC.04295-14; Lee L, 2016, J CLIN PHARMACOL, V56, DOI 10.1002/jcph.591; McCutcheon KM, 2014, MABS-AUSTIN, V6, P460, DOI 10.4161/mabs.27760; Moretta A, 2006, Antibodies binding to receptors KIR2DL1, -2, -3 but not KIR2DS4 and their therapeutic use (2006) PCT/EP 2005/053122, Patent No. 2005053122; Moretta A, 2006, Antibodies binding to receptors KIR2DL1, -2, -3 but not KIR2DS4 and their therapeutic use (2006) WO/2006/003179, Patent No. 2006003179; Murtaza A, 2016, EUR J CANCER, V69, pS102, DOI 10.1016/S0959-8049(16)32903-3; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Vey N, ASCO 2015; Yang DL, 2016, ANAL BIOCHEM, V508, P78, DOI 10.1016/j.ab.2016.06.024; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	22	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181464	10.1371/journal.pone.0181464	http://dx.doi.org/10.1371/journal.pone.0181464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723950	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800051
J	Holman, N; Weinfurter, JT; Harsla, TR; Wiseman, RW; Belli, AJ; Michaels, AJ; Reimann, KA; DeMars, RI; Reynolds, MR				Holman, Nathan; Weinfurter, Jason T.; Harsla, Trevor R.; Wiseman, Roger W.; Belli, Aaron J.; Michaels, Anthony J.; Reimann, Keith A.; DeMars, Robert I.; Reynolds, Matthew R.			Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC T-LYMPHOCYTES; ALLELE DISCOVERY; MOLECULE MAMU-A-ASTERISK-01; FULL-LENGTH; LONG-TERM; HLA; EPITOPES; CHIMERISM; CELLS	Monoclonal antibodies that bind to human leukocyte antigen (HLA) are useful tools for HLAtyping, tracking donor-recipient chimerisms after bone marrow transplants, and characterizing specific major histocompatibility complexes (MHC) on cell surfaces. Unfortunately, equivalent reagents are not available for rhesus macaques, which are commonly used animal as models in organ transplant and infectious disease research. To address this deficiency, we isolated an antibody that recognizes the common Indian rhesus macaque MHC class I molecule, Mamu-A1*001. We induced Mamu-A1*001-binding antibodies by alloimmunizing a female Mamu-A1*001-negative rhesus macaque with peripheral blood mononuclear cells (PBMC) from a male Mamu-A1*001-positive donor. A Fab phage display library was constructed with PBMC from the alloimmunized macaque and panned to isolate an antibody that binds to Mamu-A1*001 but not to other common rhesus macaque MHC class I molecules. The isolated antibody distinguishes PBMC from Mamu-A1*001-positive and -negative macaques. Additionally, the Mamu-A1*001-specific antibody binds the cynomolgus macaque MHC class I ortholog Mafa-A1*001: 01 but not variants Mafa-A1*001: 02/03, indicating a high degree of binding specificity. The Mamu-A1*001-specific antibody will be useful for identifying Mamu-A1*001-positive rhesus macaques, for detecting MamuA1*001-positive cells in populations of Mamu-A1*001-negative cells, and for examining disease processes that alter expression of Mamu-A1*001 on cell surfaces. Moreover, the alloimmunization process we describe will be useful for isolating additional MHC allomorphspecific monoclonal antibodies or antibodies against other polymorphic host proteins which are difficult to isolate with traditional technologies.	[Holman, Nathan; Weinfurter, Jason T.; Harsla, Trevor R.; DeMars, Robert I.; Reynolds, Matthew R.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Wiseman, Roger W.; Reynolds, Matthew R.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Belli, Aaron J.; Michaels, Anthony J.; Reimann, Keith A.] Univ Massachusetts, Med Sch, MassBiol, Boston, MA 02125 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Boston	Reynolds, MR (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; Reynolds, MR (corresponding author), Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.	mrreynol@wisc.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN272201600007C, HHSN272201100013C]; Research Facilities Improvement Program [RR15459-01, RR020141-01]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by contracts HHSN272201600007C and HHSN272201100013C from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and was conducted at a facility constructed with support from the Research Facilities Improvement Program (RR15459-01, RR020141-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Avril Arnaud, 2014, Curr Drug Discov Technol, V11, P20; Barbas C.F., 2004, PHAGE DISPLAY LAB MA; BATTEGAY M, 1995, J VIROL, V69, P2462, DOI 10.1128/JVI.69.4.2462-2470.1995; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Cardarelli F, 2005, TRANSPLANT INT, V18, P532, DOI 10.1111/j.1432-2277.2005.00085.x; Choe W, 2016, ANN CLIN LAB SCI, V46, P161; Choo SY, 2007, YONSEI MED J; de Groot NG, 2012, IMMUNOGENETICS, V64, P615, DOI 10.1007/s00251-012-0617-1; DEVITO LD, 1993, HUM IMMUNOL, V37, P165, DOI 10.1016/0198-8859(93)90182-Z; Drabbels JJM, 2011, BLOOD, V118, pE149, DOI 10.1182/blood-2011-06-362053; Dudley DM, 2014, IMMUNOGENETICS, V66, P15, DOI 10.1007/s00251-013-0744-3; Duquesnoy RJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00469; Duquesnoy RJ, 2012, HUM IMMUNOL, V73, P267, DOI 10.1016/j.humimm.2011.11.011; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; El-Awar NR, 2007, TRANSPLANTATION, V84, P532, DOI 10.1097/01.tp.0000278721.97037.1e; Estep RD, 2013, CURR OPIN VIROL, V3, P245, DOI 10.1016/j.coviro.2013.05.016; Glaze ER, 2015, COMPARATIVE MED, V65, P241; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; Kasuga Kie, 2013, Methods Mol Biol, V1023, P203, DOI 10.1007/978-1-4614-7209-4_14; Kean LS, 2007, AM J TRANSPLANT, V7, P320, DOI 10.1111/j.1600-6143.2006.01622.x; Kean LS, 2012, AM J TRANSPLANT, V12, P812, DOI 10.1111/j.1600-6143.2011.03873.x; Kim BH, 2014, BLOOD, V124; Kling C, 2006, HUM REPROD, V21, P429, DOI 10.1093/humrep/dei316; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Kuwata T, 2011, AIDS RES HUM RETROV, V27, P487, DOI 10.1089/aid.2010.0191; Kwakkenbos MJ, 2016, IMMUNOL REV, V270, P65, DOI 10.1111/imr.12395; Larsen CP, 2010, AM J TRANSPLANT, V10, P2396, DOI 10.1111/j.1600-6143.2010.03272.x; Lau M, 2004, AM J TRANSPLANT, V4, P1543, DOI 10.1111/j.1600-6143.2004.00529.x; Leith JG, 2003, AIDS RES HUM RETROV, V19, P957, DOI 10.1089/088922203322588305; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; MOWBRAY JF, 1987, LANCET, V2, P679; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; PAYNE R, 1957, ARCH INTERN MED, V99, P587, DOI 10.1001/archinte.1957.00260040087010; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; PISTILLO MP, 1988, HUM IMMUNOL, V21, P265, DOI 10.1016/0198-8859(88)90035-3; Pistillo MP, 1997, HUM IMMUNOL, V57, P19, DOI 10.1016/S0198-8859(97)00176-6; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Schmitz JE, 2013, CURR OPIN HIV AIDS, V8, P273, DOI 10.1097/COH.0b013e328361cf5b; Schumm M, 2007, BONE MARROW TRANSPL, V39, P767, DOI 10.1038/sj.bmt.1705676; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; VANROOD JJ, 1958, NATURE, V181, P1735, DOI 10.1038/1811735a0; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Westbrook CJ, 2015, HUM IMMUNOL, V76, P891, DOI 10.1016/j.humimm.2015.03.022; Wiseman RW, 2013, ILAR J, V54, P196, DOI 10.1093/ilar/ilt036; WOLFEL T, 1989, J EXP MED, V170, P797, DOI 10.1084/jem.170.3.797; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179039	10.1371/journal.pone.0179039	http://dx.doi.org/10.1371/journal.pone.0179039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719653	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400003
J	de Villiers, M; Kriticos, DJ; Veldtman, R				de Villiers, Marelize; Kriticos, Darren J.; Veldtman, Ruan			Including irrigation in niche modelling of the invasive wasp Vespula germanica (Fabricius) improves model fit to predict potential for further spread	PLOS ONE			English	Article							YELLOW JACKET WASPS; F HYMENOPTERA; NEW-ZEALAND; EUROPEAN WASP; SOCIAL WASP; VESPIDAE; AUSTRALIA; ABUNDANCE; COLONIES; INSECTS	The European wasp, Vespula germanica (Fabricius) (Hymenoptera: Vespidae), is of Palaearctic origin, being native to Europe, northern Africa and Asia, and introduced into North America, Chile, Argentina, Iceland, Ascension Island, South Africa, Australia and New Zealand. Due to its polyphagous nature and scavenging behaviour, V. germanica threatens agriculture and silviculture, and negatively affects biodiversity, while its aggressive nature and venomous sting pose a health risk to humans. In areas with warmer winters and longer summers, queens and workers can survive the winter months, leading to the build-up of large nests during the following season; thereby increasing the risk posed by this species. To prevent or prepare for such unwanted impacts it is important to know where the wasp may be able to establish, either through natural spread or through introduction as a result of human transport. Distribution data from Argentina and Australia, and seasonal phenology data from Argentina were used to determine the potential distribution of V. germanica using CLIMEX modelling. In contrast to previous models, the influence of irrigation on its distribution was also investigated. Under a natural rainfall scenario, the model showed similarities to previous models. When irrigation is applied, dry stress is alleviated, leading to larger areas modelled climatically suitable compared with previous models, which provided a better fit with the actual distribution of the species. The main areas at risk of invasion by V. germanica include western USA, Mexico, small areas in Central America and in the northwestern region of South America, eastern Brazil, western Russia, north-western China, Japan, the Mediterranean coastal regions of North Africa, and parts of southern and eastern Africa.	[de Villiers, Marelize; Veldtman, Ruan] Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa; [Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Queensland, St Lucia, Qld, Australia; [Veldtman, Ruan] South African Natl Biodivers Inst, Cape Town, South Africa	Stellenbosch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; South African National Biodiversity Institute	de Villiers, M (corresponding author), Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa.	marelizedevilliers@yahoo.co.za	Veldtman, Ruan/I-1131-2019; Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105	South African National Biodiversity Institute (SANBI)	South African National Biodiversity Institute (SANBI)	We would like to thank the South African National Biodiversity Institute (SANBI) for funding this project through the Department of Environmental Affairs, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE RD, 1989, PAN-PAC ENTOMOL, V65, P79; Allsopp MH, 2004, S AFRICAN BEE J, V76, P69; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Austin AD, 2002, REPORT ADELAIDE RES; Bashford Richard, 2001, Australian Entomologist, V28, P1; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; BRAVERMAN Y, 1991, MED VET ENTOMOL, V5, P129, DOI 10.1111/j.1365-2915.1991.tb00530.x; Braverman Y, 1998, J ECON ENTOMOL, V91, P486, DOI 10.1093/jee/91.2.486; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; CLAPPERTON BK, 1989, NEW ZEAL J ZOOL, V16, P325, DOI 10.1080/03014223.1989.10422897; Coelho JR, 1996, J COMP PHYSIOL B, V166, P68, DOI 10.1007/BF00264641; CROSLAND MWJ, 1991, NEW ZEAL J ZOOL, V18, P375, DOI 10.1080/03014223.1991.10422843; Davidson S., 1986, ECOSYSTEMS, V50, P14; DONOVAN BJ, 1992, BEE WORLD, V73, P131, DOI 10.1080/0005772X.1992.11099127; DONOVAN BJ, 1992, NEW ZEAL J ZOOL, V19, P61, DOI 10.1080/03014223.1992.10423252; Farji-Brener Alejandro G., 1998, Ecologia Austral, V8, P237; Fox-Wilson G., 1946, P ROYAL ENTOMOLOGICA, V21, P17; GERBER H S, 1990, Journal of the Entomological Society of British Columbia, V87, P73; GOLLER F, 1990, J EXP BIOL, V150, P221; Goodisman MAD, 2001, J HERED, V92, P346, DOI 10.1093/jhered/92.4.346; Harris RJ, 1996, NEW ZEAL J ZOOL, V23, P11, DOI 10.1080/03014223.1996.9518061; Haupt K., 2015, THESIS; HORWOOD MA, 1993, J AUST ENTOMOL SOC, V32, P241; Hurd CR, 2003, BEHAVIOUR, V140, P827, DOI 10.1163/156853903770238337; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Kasper ML, 2008, AUST J ENTOMOL, V47, P265, DOI 10.1111/j.1440-6055.2008.00658.x; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132807; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; MADDEN JL, 1981, J AUST ENTOMOL SOC, V20, P59; Masciocchi M, 2013, AUSTRAL ECOL, V38, P162, DOI 10.1111/j.1442-9993.2012.02388.x; Miller P. F., 2005, Fifth International Conference on Urban Pests, Singapore, 11-13 July 2005, P387; MOLLER H, 1989, NEW ZEAL J ZOOL, V16, P289, DOI 10.1080/03014223.1989.10422894; Morse RA, 1976, ENVIRON ENTOMOL, V6, P109; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Richards KT, 1985, AGR PROTECTION BOARD; Sackmann P, 2010, INT J PEST MANAGE, V56, P69, DOI 10.1080/09670870903075022; Sackmann Paula, 2000, New Zealand Entomologist, V23, P55; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; SPRADBER.JP, 1971, J ANIM ECOL, V40, P501, DOI 10.2307/3259; SPRADBERY JP, 1992, AUST J ZOOL, V40, P495, DOI 10.1071/ZO9920495; Spradbery P, 2016, INV SPEC COMP; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tezcan Serdar, 2005, Turkiye Entomoloji Dergisi, V29, P101; TRIBE GD, 1994, AFR ENTOMOL, V2, P1; Veldtman R, 2012, IOBC WPRS B, V75; Ward D, 2002, AUST J ENTOMOL, V41, P306, DOI 10.1046/j.1440-6055.2002.00308.x; WHITEHEAD V B, 1975, Journal of the Entomological Society of Southern Africa, V38, P39; Wood GM, 2006, J ECON ENTOMOL, V99, P263, DOI 10.1603/0022-0493-99.2.263; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Yonow T, 2017, J PEST SCI, V90, P459, DOI 10.1007/s10340-016-0801-4	52	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181397	10.1371/journal.pone.0181397	http://dx.doi.org/10.1371/journal.pone.0181397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715452	Green Published, Green Submitted, gold			2022-12-26	WOS:000443975500051
J	Fonseca, AM; Quinto, L; Jimenez, A; Gonzalez, R; Bardaji, A; Maculuve, S; Dobano, C; Ruperez, M; Vala, A; Aponte, JJ; Sevene, E; Macete, E; Menendez, C; Mayor, A				Maria Fonseca, Ana; Quinto, Llorenc; Jimenez, Alfons; Gonzalez, Raquel; Bardaji, Azucena; Maculuve, Sonia; Dobano, Carlota; Ruperez, Maria; Vala, Anifa; Aponte, John J.; Sevene, Esperanza; Macete, Eusebio; Menendez, Clara; Mayor, Alfredo			Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VACCINE CANDIDATE VAR2CSA; INFECTED ERYTHROCYTES; MALARIA TRANSMISSION; PLACENTAL MALARIA; CAMEROONIAN WOMEN; ANTIBODIES; CHILDREN; BINDING; PERSPECTIVES	Background Pregnant women exposed to Plasmodium falciparum generate antibodies against VAR2CSA, the parasite protein that mediates adhesion of infected erythrocytes to the placenta. There is a need of high-throughput tools to determine the fine specificity of these antibodies that can be used to identify immune correlates of protection and exposure. Here we aimed at developing a multiplex-immunoassay to detect antibodies against VAR2CSA antigens. Methods and findings We constructed two multiplex-bead arrays, one composed of 3 VAR2CSA recombinant-domains (DBL3X, DBL5 xi and DBL6 xi) and another composed of 46 new peptides covering VAR2CSA conserved and semi-conserved regions. IgG reactivity was similar in multiplexed and singleplexed determinations (Pearson correlation, protein array: R-2 = 0.99 and peptide array: R-2 = 0.87). IgG recognition of 25 out of 46 peptides and all recombinant-domains was higher in pregnant Mozambican women (n = 106) than in Mozambican men (n = 102) and Spanish individuals (n = 101; p<0.05). Agreement of IgG levels detected in cryopreserved plasma and in elutions from dried blood spots was good after exclusion of inappropriate filter papers. Under heterogeneous levels of exposure to malaria, similar seropositivity cutoffs were obtained using finite mixture models applied to antibodies measured on pregnant Mozambican women and average of antibodies measured on pregnant Spanish women never exposed to malaria. The application of the multiplex-bead array developed here, allowed the assessment of higher IgG levels and seroprevalences against VAR2CSA-derived antigens in women pregnant during 2003-2005 than during 2010-2012, in accordance with the levels of malaria transmission reported for these years in Mozambique. Conclusions The multiplex bead-based immunoassay to detect antibodies against selected 25 VAR2CSA new-peptides and recombinant-domains was successfully implemented. Analysis of field samples showed that responses were specific among pregnant women and dependent on the level of exposure to malaria. This platform provides a high-throughput approach to investigating correlates of protection and identifying serological markers of exposure for malaria in pregnancy.	[Maria Fonseca, Ana; Quinto, Llorenc; Jimenez, Alfons; Gonzalez, Raquel; Bardaji, Azucena; Dobano, Carlota; Ruperez, Maria; Aponte, John J.; Menendez, Clara; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Maria Fonseca, Ana] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, Porto, Portugal; [Jimenez, Alfons] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Gonzalez, Raquel; Bardaji, Azucena; Maculuve, Sonia; Dobano, Carlota; Ruperez, Maria; Vala, Anifa; Aponte, John J.; Sevene, Esperanza; Macete, Eusebio; Menendez, Clara; Mayor, Alfredo] CISM, Maputo, Mozambique; [Sevene, Esperanza] Eduardo Mondlane Univ, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universidade do Porto; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Mayor, A (corresponding author), CISM, Maputo, Mozambique.	alfredo.mayor@isglobal.org	Menéndez, Clara/Q-3446-2016; Dobaño, Carlota/N-4119-2014; Alonso, Azucena Bardají/V-5978-2018; Bardají, Azucena/AAE-9145-2019; JIMENEZ, ALFONS/L-2106-2019; Gonzalez, Raquel/J-3604-2017; Mayor, Alfredo/H-7488-2017; Fonseca, Ana Maria/J-4048-2017	Menéndez, Clara/0000-0002-2641-6907; Dobaño, Carlota/0000-0002-6751-4060; Alonso, Azucena Bardají/0000-0002-5135-0540; JIMENEZ, ALFONS/0000-0003-0301-3344; Gonzalez, Raquel/0000-0001-5487-801X; Mayor, Alfredo/0000-0003-3890-2897; Fonseca, Ana Maria/0000-0001-8051-4850; Quinto, Llorenc/0000-0001-9992-6951; Ruperez, Maria/0000-0001-8322-7881	Malaria Eradication Scientific Alliance (MESA); European and Developing Countries Clinical Trials Partnership (EDCTP); Malaria in Pregnancy (MiP) Consortium; Banco de Bilbao; Argentaria Foundation [BBVA 02-0]; Instituto de Salud Carlos III [PS09/01113, PI13/01478]; Fondo Europeo de Desarrollo Regional [FEDER]; AGAUR/Generalitat de Catalunya [2014 SGR 263]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/51696/2011]; CERCA programme/Generalitat de Catalunya; Bill and Melinda Gates Foundation; Vizcaya; Spanish Agency for International Cooperation and Development;  [CES10/021-I3SNS]	Malaria Eradication Scientific Alliance (MESA); European and Developing Countries Clinical Trials Partnership (EDCTP); Malaria in Pregnancy (MiP) Consortium; Banco de Bilbao; Argentaria Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional [FEDER](European CommissionSpanish Government); AGAUR/Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CERCA programme/Generalitat de Catalunya; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Vizcaya; Spanish Agency for International Cooperation and Development(Spanish Government); 	Supported by the Malaria Eradication Scientific Alliance (MESA), the European and Developing Countries Clinical Trials Partnership (EDCTP), the Malaria in Pregnancy (MiP) Consortium, and grants from Banco de Bilbao, Vizcaya, Argentaria Foundation (BBVA 02-0), Instituto de Salud Carlos III (grants PS09/01113 and PI13/01478 cofounded by the Fondo Europeo de Desarrollo Regional [FEDER], and CES10/021-I3SNS to AM), AGAUR/Generalitat de Catalunya (2014 SGR 263) and The Fundacao para a Ciencia e Tecnologia (SFRH/BD/51696/2011 to AMF). ISGlobal received support from the CERCA programme/Generalitat de Catalunya. The Centro de Investigacao em Saude da Manhica (CISM) receives core support from the Spanish Agency for International Cooperation and Development. The MiP Consortium and MESA are funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine and the Barcelona Institute of Global Health, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alonso PL, 2002, POPULATION HLTH DEV, P189; Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; [Anonymous], 1998, REV SCI TECH OFF INT; Ataide R, 2014, TRENDS PARASITOL, V30, P85, DOI 10.1016/j.pt.2013.12.007; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Babakhanyan A, 2016, AM J TROP MED HYG, V94, P640, DOI 10.4269/ajtmh.15-0521; Babakhanyan A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1023-6; Babakhanyan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088173; Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fodjo BAY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1585-y; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gangnard S, 2013, J MOL BIOL, V425, P1697, DOI 10.1016/j.jmb.2013.02.014; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Irion A, 2002, J IMMUNOL METHODS, V259, P111, DOI 10.1016/S0022-1759(01)00500-2; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459; Mayor A, 2013, J INFECT DIS, V207, P1664, DOI 10.1093/infdis/jit083; Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10; Mazumdar S, 2010, BIOPROC BIOSYST ENG, V33, P719, DOI 10.1007/s00449-009-0394-x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; van Eijk AM, 2015, LANCET GLOB HEALTH, V3, pE617, DOI 10.1016/S2214-109X(15)00049-2; WHO, 2006, MAT IMM TET	56	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181150	10.1371/journal.pone.0181150	http://dx.doi.org/10.1371/journal.pone.0181150			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715465	Green Submitted, gold, Green Published			2022-12-26	WOS:000443975500032
J	Liu, BC; Binaykia, A; Chang, PC; Tiwari, MK; Tsao, CC				Liu, Bing-Chun; Binaykia, Arihant; Chang, Pei-Chann; Tiwari, Manoj Kumar; Tsao, Cheng-Chin			Urban air quality forecasting based on multidimensional collaborative Support Vector Regression (SVR): A case study of BeijingTianjin-Shijiazhuang	PLOS ONE			English	Article							PM10 CONCENTRATIONS; NEURAL-NETWORK; MODEL; PREDICTION; POLLUTION	Today, China is facing a very serious issue of Air Pollution due to its dreadful impact on the human health as well as the environment. The urban cities in China are the most affected due to their rapid industrial and economic growth. Therefore, it is of extreme importance to come up with new, better and more reliable forecasting models to accurately predict the air quality. This paper selected Beijing, Tianjin and Shijiazhuang as three cities from the Jingjinji Region for the study to come up with a new model of collaborative forecasting using Support Vector Regression (SVR) for Urban Air Quality Index (AQI) prediction in China. The present study is aimed to improve the forecasting results by minimizing the prediction error of present machine learning algorithms by taking into account multiple city multi-dimensional air quality information and weather conditions as input. The results show that there is a decrease in MAPE in case of multiple city multi-dimensional regression when there is a strong interaction and correlation of the air quality characteristic attributes with AQI. Also, the geographical location is found to play a significant role in Beijing, Tianjin and Shijiazhuang AQI prediction.	[Liu, Bing-Chun] Tianjin Univ Technol, Res Inst Circular Econ, Tianjin, Peoples R China; [Binaykia, Arihant; Tiwari, Manoj Kumar] Indian Inst Technol, Dept Ind & Syst Engn, Kharagpur, W Bengal, India; [Chang, Pei-Chann; Tsao, Cheng-Chin] Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan; [Chang, Pei-Chann] Beijing Inst Technol, Zhuhai Coll, Off Acad Affairs, Zhuhai, Peoples R China	Tianjin University of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Yuan Ze University; Beijing Institute of Technology	Chang, PC (corresponding author), Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan.; Chang, PC (corresponding author), Beijing Inst Technol, Zhuhai Coll, Off Acad Affairs, Zhuhai, Peoples R China.	iepchang@saturn.yzu.edu.tw	Tiwari, Manoj K./B-3592-2012	Tiwari, M.K/0000-0001-8564-1402	National Natural Science Foundation of China [71503180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding support from the National Natural Science Foundation of China (71503180).	Alhanafy T.E., 2010, J AM SCI, V6, P605; [白鹤鸣 Bai Heming], 2013, [环境科学与技术, Enuivonmental Science and Technology], V36, P186; [陈淳祺 Chen Chunqi], 2013, [环境科学与技术, Enuivonmental Science and Technology], V36, P130; Chen W, 2015, ATMOSPHERE-BASEL, V6, P1243, DOI 10.3390/atmos6081243; Chuang MT, 2011, ATMOS ENVIRON, V45, P6241, DOI 10.1016/j.atmosenv.2011.06.071; Hoi KI, 2008, GLOBAL NEST J, V10, P140; Hu LJ, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080786; Hu YT, 2010, ATMOS POLLUT RES, V1, P280, DOI 10.5094/APR.2010.035; Kassomenos P, 1999, ATMOS ENVIRON, V33, P1861, DOI 10.1016/S1352-2310(98)00355-0; Konar P, 2011, APPL SOFT COMPUT, V11, P4203, DOI 10.1016/j.asoc.2011.03.014; Kumar A, 2011, ATMOS POLLUT RES, V2, P436, DOI 10.5094/APR.2011.050; Li L, 2014, INT J ENV RES PUB HE, V11, P8909, DOI 10.3390/ijerph110908909; Li M, INTECH, V9, P195; Liu DJ, 2015, INT J ENV RES PUB HE, V12, P7085, DOI 10.3390/ijerph120607085; Liu YH, 2015, ATMOSPHERE-BASEL, V6, P891, DOI 10.3390/atmos6070891; McKeen S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011697; MULLER KR, ARTIFICIAL NEURAL NE, P999, DOI DOI 10.1016/J.ASOC.2011.03.014; Perez P, 2006, ATMOS ENVIRON, V40, P2845, DOI 10.1016/j.atmosenv.2006.01.010; Plaia A, 2011, REV ENVIRON SCI BIO, V10, P165, DOI 10.1007/s11157-010-9227-2; Queensland Government, 2017, INFL MET AIR QUAL; R Core Team, 2013, R LANG ENV STAT COMP; Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749; Schwieder M, 2014, REMOTE SENS-BASEL, V6, P3427, DOI 10.3390/rs6043427; Shad R, 2009, COMPUT ENVIRON URBAN, V33, P472, DOI 10.1016/j.compenvurbsys.2009.10.004; Stern R, 2008, ATMOS ENVIRON, V42, P4567, DOI 10.1016/j.atmosenv.2008.01.068; Sun W, 2013, SCI TOTAL ENVIRON, V443, P93, DOI 10.1016/j.scitotenv.2012.10.070; Vapnik V, 1997, ADV NEUR IN, V9, P281; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; XIANG L, 2013, J HUAZHONG U SCI TEC, V41, P63; XIAOFENG XU, 2005, METEOROLOGICAL SCI T, V33, P543, DOI DOI 10.1016/J.ATMOSENV.2011.06.071; ZAHARIM A, 2009, EUR J SCI RES, V27, P308, DOI DOI 10.1016/J.COMPENVURBSYS.2009.10.004	32	79	84	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179763	10.1371/journal.pone.0179763	http://dx.doi.org/10.1371/journal.pone.0179763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708836	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800007
J	Martino, D; Delorme, C; Pelosin, E; Hartmann, A; Worbe, Y; Avanzino, L				Martino, D.; Delorme, C.; Pelosin, E.; Hartmann, A.; Worbe, Y.; Avanzino, L.			Abnormal lateralization of fine motor actions in Tourette syndrome persists into adulthood	PLOS ONE			English	Article							CORPUS-CALLOSUM; INTERHEMISPHERIC-TRANSFER; TIC SEVERITY; CHILDREN; CONNECTIVITY; DEFICITS; BOYS	Youth with Tourette syndrome (TS) exhibit, compared to healthy, abnormal ability to lateralize digital sequential tasks. It is unknown whether this trait is related to inter-hemispheric connections, and whether it is preserved or lost in patients with TS persisting through adult life. We studied 13 adult TS patients and 15 age-matched healthy volunteers. All participants undertook: 1) a finger opposition task, performed with the right hand (RH) only or with both hands, using a sensor-engineered glove in synchrony with a metronome at 2 Hz; we calculated a lateralization index [(single RH-bimanual RH)/single RH X 100) for percentage of correct movements (%CORR); 2) MRI-based diffusion tensor imaging and probabilistic tractography of inter-hemispheric corpus callosum (CC) connections between supplementary motor areas (SMA) and primary motor cortices (M1). We confirmed a significant increase in the %CORR in RH in the bimanual vs. single task in TS patients (p<0.001), coupled to an abnormal ability to lateralize finger movements (significantly lower lateralization index for %CORR in TS patients, p = 0.04). The % CORR lateralization index correlated positively with tic severity measured with the Yale Global Tic Severity Scale (R = 0.55; p = 0.04). We detected a significantly higher fractional anisotropy (FA) in both the M1-M1 (p = 0.036) and the SMA-SMA (p = 0.018) callosal fibre tracts in TS patients. In healthy subjects, the % CORR lateralization index correlated positively with fractional anisotropy of SMA-SMA fibre tracts (R = 0.63, p = 0.02); this correlation was not significant in TS patients. TS patients exhibited an abnormal ability to lateralize finger movements in sequential tasks, which increased in accuracy when the task was performed bimanually. This abnormality persists throughout different age periods and appears dissociated from the transcallosal connectivity of motor cortical regions. The altered interhemispheric transfer of motor abilities in TS may be the result of compensatory processes linked to self-regulation of motor control.	[Martino, D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Delorme, C.; Hartmann, A.; Worbe, Y.] UPMC Univ Paris 06, Sorbonne Univ, ICM, UMR S 975,CNRS,UMR 7225, Paris, France; [Delorme, C.; Hartmann, A.; Worbe, Y.] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, 47-83 Blvd Hop, Paris, France; [Delorme, C.; Hartmann, A.; Worbe, Y.] Grp Hosp Pitie Salpetriere, French Natl Reference Ctr Gilles Tourette Syndrom, Paris, France; [Pelosin, E.] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Worbe, Y.] St Antoine Hosp, Dept Neurophysiol, Paris, France; [Avanzino, L.] Univ Genoa, Sect Human Physiol, Genoa, Italy; [Avanzino, L.] Univ Genoa, Ctr Polifunz Sci Motorie, Dept Expt Med, Genoa, Italy	University of Calgary; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; University of Genoa	Avanzino, L (corresponding author), Univ Genoa, Sect Human Physiol, Genoa, Italy.; Avanzino, L (corresponding author), Univ Genoa, Ctr Polifunz Sci Motorie, Dept Expt Med, Genoa, Italy.	lavanzino76@gmail.com	Avanzino, Laura/K-6623-2016; Pelosin, Elisa/AAA-9637-2019; Worbe, Yulia/GYV-3751-2022	AVANZINO, LAURA/0000-0001-6286-1509; Pelosin, Elisa/0000-0002-9880-2241; Worbe, Yulia/0000-0001-5903-9370				American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Avanzino L, 2011, MOVEMENT DISORD, V26, P2114, DOI 10.1002/mds.23839; Baumer T, 2010, MOVEMENT DISORD, V25, P2828, DOI 10.1002/mds.23418; Bloch MH, 2006, J CHILD PSYCHOL PSYC, V47, P551, DOI 10.1111/j.1469-7610.2005.01561.x; Buse J, 2012, DEV MED CHILD NEUROL, V54, P629, DOI 10.1111/j.1469-8749.2012.04273.x; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Ganos C, 2015, NEUROL CLIN, V33, P115, DOI 10.1016/j.ncl.2014.09.008; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Gooijers J, 2013, HUM BRAIN MAPP, V34, P241, DOI 10.1002/hbm.21429; Grados MA, 2009, J PSYCHOSOM RES, V67, P491, DOI 10.1016/j.jpsychores.2009.07.011; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; Mataix-Cols D, 2015, JAMA PSYCHIAT, V72, P787, DOI 10.1001/jamapsychiatry.2015.0627; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Muetzel RL, 2008, NEUROIMAGE, V39, P1918, DOI 10.1016/j.neuroimage.2007.10.018; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERSON BS, 1994, PSYCHIAT RES-NEUROIM, V55, P85, DOI 10.1016/0925-4927(94)90003-5; Plessen KJ, 2007, NEUROPSYCHOLOGIA, V45, P767, DOI 10.1016/j.neuropsychologia.2006.08.006; Plessen KJ, 2006, J CHILD PSYCHOL PSYC, V47, P1013, DOI 10.1111/j.1469-7610.2006.01639.x; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Roessner V, 2013, J CHILD PSYCHOL PSYC, V54, P273, DOI 10.1111/j.1469-7610.2012.02584.x; Serbruyns L, 2015, BRAIN STRUCT FUNCT, V220, P273, DOI 10.1007/s00429-013-0654-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Wolff N, 2016, PSYCHIAT RES-NEUROIM, V247, P1, DOI 10.1016/j.pscychresns.2015.12.003	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180812	10.1371/journal.pone.0180812	http://dx.doi.org/10.1371/journal.pone.0180812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708864	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649800023
J	Alonso-Dominguez, JM; Casado, LF; Anguita, E; Gomez-Casares, MT; Buno, I; Ferrer-Marin, F; Arenas, A; Del Orbe, R; Ayala, R; Llamas, P; Salgado, RN; Osorio, S; Sanchez-Godoy, P; Burgaleta, C; Mahillo-Fernandez, I; Garcia-Gutierrez, V; Steegmann, JL; Martinez-Lopez, J				Alonso-Dominguez, Juan M.; Felipe Casado, Luis; Anguita, Eduardo; Teresa Gomez-Casares, Maria; Buno, Ismael; Ferrer-Marin, Francisca; Arenas, Alicia; Del Orbe, Rafael; Ayala, Rosa; Llamas, Pilar; Salgado, Rocio N.; Osorio, Santiago; Sanchez-Godoy, Pedro; Burgaleta, Carmen; Mahillo-Fernandez, Ignacio; Garcia-Gutierrez, Valentin; Luis Steegmann, Juan; Martinez-Lopez, Joaquin			PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase	PLOS ONE			English	Article							EUROPEAN-LEUKEMIANET; HEDGEHOG PATHWAY; EXPRESSION; SURVIVAL; REQUIREMENT; CANCER; CML; STANDARDIZATION; RECOMMENDATIONS; PROGRESSION	Patched homolog 1 gene (PTCH1) expression and the ratio of PTCH1 to Smoothened (SMO) expression have been proposed as prognostic markers of the response of chronic myeloid leukemia (CML) patients to imatinib. We compared these measurements in a realistic cohort of 101 patients with CML in chronic phase (CP) using a simplified qPCR method, and confirmed the prognostic power of each in a competing risk analysis. Gene expression levels were measured in peripheral blood samples at diagnosis. The PTCH1/SMO ratio did not improve PTCH1 prognostic power (area under the receiver operating characteristic curve 0.71 vs. 0.72). In order to reduce the number of genes to be analyzed, PTCH1 was the selected measurement. High and low PTCH1 expression groups had significantly different cumulative incidences of imatinib failure (IF), which was defined as discontinuation of imatinib due to lack of efficacy (5% vs. 25% at 4 years, P = 0.013), probabilities of achieving a major molecular response (81% vs. 53% at first year, P = 0.02), and proportions of early molecular failure (14% vs. 43%, P = 0.015). Every progression to an advanced phase (n = 3) and CML-related death (n = 2) occurred in the low PTCH1 group (P<0.001 for both comparisons). PTCH1 was an independent prognostic factor for the prediction of IF. We also validated previously published thresholds for PTCH1 expression. Therefore, we confirmed that PTCH1 expression can predict the imatinib response in CML patients in CP by applying a more rigorous statistical analysis. Thus, PTCH1 expression is a promising molecular marker for predicting the imatinib response in CML patients in CP.	[Alonso-Dominguez, Juan M.; Llamas, Pilar; Salgado, Rocio N.; Mahillo-Fernandez, Ignacio] UAM, Hosp Univ Fdn Jimenez Diaz, IIS FJD, Madrid, Spain; [Felipe Casado, Luis] Hosp Virgen de la Salud, Toledo, Spain; [Anguita, Eduardo] Hosp Univ Clin San Carlos, Madrid, Spain; [Teresa Gomez-Casares, Maria] Hosp Univ Doctor Negrin, Las Palmas Gran Canaria, Spain; [Buno, Ismael; Osorio, Santiago] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Ferrer-Marin, Francisca] UCAM, CIBERER, Hosp Univ Morales Meseguer, Murcia, Spain; [Arenas, Alicia] Hosp Univ 12 Octubre, Fdn Invest Biomed, Madrid, Spain; [Del Orbe, Rafael] Biocruces Hlth Res Inst, Baracaldo, Bilbao, Spain; [Ayala, Rosa; Martinez-Lopez, Joaquin] Hosp Univ 12 Octubre, Madrid, Spain; [Sanchez-Godoy, Pedro] Hosp Univ Severo Ochoa, Leganes, Madrid, Spain; [Burgaleta, Carmen] Hosp Univ Principe Asturias, Alcala De Henares, Madrid, Spain; [Garcia-Gutierrez, Valentin] Hosp Univ Ramon y Cajal, Madrid, Spain; [Luis Steegmann, Juan] Hosp Univ Princesa, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Complejo Hospitalario de Toledo; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Meseguer General University Hospital Morales; Universidad Catolica de Murcia; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Severo Ochoa University Hospital; Prince of Asturias University Hospital; Hospital Universitario Ramon y Cajal; Hospital de La Princesa	Alonso-Dominguez, JM (corresponding author), UAM, Hosp Univ Fdn Jimenez Diaz, IIS FJD, Madrid, Spain.	juan.adominguez@fjd.es	Anguita, Eduardo/G-6050-2017; CASARES, MARIA TERESA GOMEZ/R-6060-2018; Anguita, Eduardo/AAA-2097-2019; osorio, santiago/AAY-4337-2020; martinez, joaquin/AAN-6939-2020; Blanco, Leire/O-5114-2017; Buno, Ismael/G-4524-2013	Anguita, Eduardo/0000-0003-1386-4943; CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Anguita, Eduardo/0000-0003-1386-4943; martinez, joaquin/0000-0001-7908-0063; Buno, Ismael/0000-0003-4931-9170; Garcia, Valentin/0000-0003-4752-0815; Alonso-Dominguez, Juan Manuel/0000-0001-6233-5912; AYALA DIAZ, ROSA MARIA/0000-0002-2699-8353; Del Orbe Barreto, Rafael Andres/0000-0002-1240-1958; Llamas Sillero, Pilar/0000-0002-8552-3219	Fundacion Cris Contra el Cancer	Fundacion Cris Contra el Cancer	This work was supported by the Fundacion Cris Contra el Cancer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Dominguez JM, 2015, AM J HEMATOL, V90, P20, DOI 10.1002/ajh.23857; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Cross NCP, 2015, ANN HEMATOL, V94, pS219, DOI 10.1007/s00277-015-2315-1; Dc W, 2012, BLOOD, V116, P111; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Garcia-Gutierrez V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173532; Gerrard G, 2014, HAEMATOLOGICA; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grinfeld J, 2013, BRIT J HAEMATOL, V163, P631, DOI 10.1111/bjh.12591; Gromicho M, 2011, LEUKEMIA LYMPHOMA, V52, P1980, DOI 10.3109/10428194.2011.584005; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Irvine DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25476; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KAY R, 1984, REV EPIDEMIOL SANTE, V32, P185; Kok CH, 2015, BLOOD, V126, P596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Jorge CE, 2012, ANN HEMATOL, V91, P1245, DOI 10.1007/s00277-012-1468-4; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; O'Brien SG, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50058; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pfirrmann M, 2015, ANN HEMATOL, V94, pS209, DOI 10.1007/s00277-015-2316-0; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Sadarangani A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0453-9; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Su WX, 2012, EXP HEMATOL, V40, P418, DOI 10.1016/j.exphem.2012.01.003; Tang JY, 2016, LANCET ONCOL, V17, P1720, DOI 10.1016/S1470-2045(16)30566-6; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vardiman JW, 2008, WHO CLASSIFICATION T; Vasconcelos FD, 2016, LEUKEMIA RES, V51, P3, DOI 10.1016/j.leukres.2016.10.005; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181366	10.1371/journal.pone.0181366	http://dx.doi.org/10.1371/journal.pone.0181366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704552	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700128
J	Engel, M; Endesfelder, D; Schloter-Hai, B; Kublik, S; Granitsiotis, MS; Boschetto, P; Stendardo, M; Barta, I; Dome, B; Deleuze, JF; Boland, A; Muller-Quernheim, J; Prasse, A; Welte, T; Hohlfeld, J; Subramanian, D; Parr, D; Gut, IG; Greulich, T; Koczulla, AR; Nowinski, A; Gorecka, D; Singh, D; Gupta, S; Brightling, CE; Hoffmann, H; Frankenberger, M; Hofer, TP; Burggraf, D; Heiss-Neumann, M; Ziegler-Heitbrock, L; Schloter, M; zu Castell, W				Engel, Marion; Endesfelder, David; Schloter-Hai, Brigitte; Kublik, Susanne; Granitsiotis, Michael S.; Boschetto, Piera; Stendardo, Mariarita; Barta, Imre; Dome, Balazs; Deleuze, Jean-Francois; Boland, Anne; Mueller-Quernheim, Joachim; Prasse, Antje; Welte, Tobias; Hohlfeld, Jens; Subramanian, Deepak; Parr, David; Gut, Ivo Glynne; Greulich, Timm; Koczulla, Andreas Rembert; Nowinski, Adam; Gorecka, Dorota; Singh, Dave; Gupta, Sumit; Brightling, Christopher E.; Hoffmann, Harald; Frankenberger, Marion; Hofer, Thomas P.; Burggraf, Dorothe; Heiss-Neumann, Marion; Ziegler-Heitbrock, Loems; Schloter, Michael; zu Castell, Wolfgang			Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; ORAL EPITHELIAL-CELLS; FUSOBACTERIUM-NUCLEATUM; PREVOTELLA-INTERMEDIA; BACTERIA; MACROPHAGES; DIVERSITY; SEQUENCE; COAGGREGATION; INFLAMMATION	Background Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited. Methods Bacterial community composition derived from brush samples from lungs of 16 patients suffering from different CT defined subtypes of COPD and 9 healthy subjects was analyzed using a cultivation independent barcoding approach applying 454-pyrosequencing of 16S rRNA gene fragment amplicons. Results We could show that bacterial community composition in patients with changes in CT (either airway or emphysema type changes, designated as severe subtypes) was different from community composition in lungs of patients without visible changes in CT as well as from healthy subjects (designated as mild COPD subtype and control group) (PC1, P-adj = 0.002). Higher abundance of Prevotella in samples from patients with mild COPD subtype and from controls and of Streptococcus in the severe subtype cases mainly contributed to the separation of bacterial communities of subjects. No significant effects of treatment with inhaled glucocorticoids on bacterial community composition were detected within COPD cases with and without abnormalities in CT in PCoA. Co-occurrence analysis suggests the presence of networks of co-occurring bacteria. Four communities of positively correlated bacteria were revealed. The microbial communities can clearly be distinguished by their associations with the CT defined disease phenotype. Conclusion Our findings indicate that CT detectable structural changes in the lung of COPD patients, which we termed severe subtypes, are associated with alterations in bacterial communities, which may induce further changes in the interaction between microbes and host cells. This might result in a changed interplay with the host immune system.	[Engel, Marion; Endesfelder, David; zu Castell, Wolfgang] Helmholtz Zentrum Munchen, Inst Computat Biol, Sci Comp Res Unit, Neuherberg, Germany; [Engel, Marion; Schloter-Hai, Brigitte; Kublik, Susanne; Granitsiotis, Michael S.; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Comparat Microbiome Anal, Neuherberg, Germany; [Boschetto, Piera; Stendardo, Mariarita] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Barta, Imre; Dome, Balazs] Natl Koranyi Inst TB & Pulmonol, Dept Pathophysiol, Budapest, Hungary; [Deleuze, Jean-Francois; Boland, Anne] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Mueller-Quernheim, Joachim] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Prasse, Antje; Welte, Tobias; Hohlfeld, Jens] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Prasse, Antje; Welte, Tobias; Hohlfeld, Jens; Greulich, Timm; Koczulla, Andreas Rembert] Member German Ctr Lung Res DZL, Giessen, Germany; [Hohlfeld, Jens] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Subramanian, Deepak; Parr, David] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Resp Med, Coventry, W Midlands, England; [Subramanian, Deepak; Parr, David] Warwickshire NHS Trust, Coventry, W Midlands, England; [Gut, Ivo Glynne] Barcelona Inst Sci & Technol, Ctr Genom Regulat, CNAG CRG, Barcelona, Spain; [Greulich, Timm; Koczulla, Andreas Rembert] Univ Med Ctr Giessen, Pulm & Crit Care Med, Dept Med, Marburg, Germany; [Greulich, Timm; Koczulla, Andreas Rembert] Univ Philipps Marburg, Marburg, Germany; [Nowinski, Adam; Gorecka, Dorota] Natl TB & Lung Dis Res Inst, Dept Resp Med 2, Warsaw, Poland; [Singh, Dave] Univ Manchester, Medicines Evaluat Unit, Manchester, Lancs, England; [Singh, Dave] Univ Hosp, South Manchester Fdn Trust, Manchester, Lancs, England; [Gupta, Sumit; Brightling, Christopher E.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Hoffmann, Harald] Synlab MVZ Gauting & IML red GmbH, Inst Microbiol, Gauting, Germany; [Hoffmann, Harald] Synlab MVZ Gauting & IML red GmbH, Lab Med, Gauting, Germany; [Frankenberger, Marion] Ludwig Maximilians Univ Munchen, Helmholtz Zentrum Munchen, CPC Comprehens Pneumol Ctr, Munich, Germany; [Frankenberger, Marion] Asklepios Klin Gauting, Munich, Germany; [Hofer, Thomas P.; Burggraf, Dorothe; Heiss-Neumann, Marion; Ziegler-Heitbrock, Loems] Helmholtz Zentrum Muenchen, EvA Study Ctr, Gauting, Germany; [zu Castell, Wolfgang] Tech Univ Munich, Dept Math, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Ferrara; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Hannover Medical School; Fraunhofer Gesellschaft; University of Warwick; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Leicester; SYNLAB Group; SYNLAB Group; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich	Engel, M (corresponding author), Helmholtz Zentrum Munchen, Inst Computat Biol, Sci Comp Res Unit, Neuherberg, Germany.; Engel, M (corresponding author), Helmholtz Zentrum Munchen, Res Unit Comparat Microbiome Anal, Neuherberg, Germany.	marion.engel@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Prasse, Antje/AAY-6279-2020; Gut, Ivo/ABF-3188-2020; Boschetto, Piera/AAM-3247-2020; Prasse, Antje/AAM-7521-2021; Singh, Dave/AAH-4342-2020	Gut, Ivo/0000-0001-7219-632X; Boschetto, Piera/0000-0003-3889-1681; Prasse, Antje/0000-0002-7336-7458; Singh, Dave/0000-0001-8918-7075; brightling, chris/0000-0002-9345-4903; Dome, Balazs/0000-0001-8799-8624; PARR, DAVID/0000-0002-0099-7918	Synlab MVZ Gauting IML red GmbH; National Institute for Health Research [CL-2012-11-002] Funding Source: researchfish	Synlab MVZ Gauting IML red GmbH; National Institute for Health Research(National Institute for Health Research (NIHR))	The funder Synlab MVZ Gauting & IML red GmbH provided support in the form of salaries for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barbosa GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138687; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134209; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BRANDTZAEG P, 1992, J INFECT DIS, V165, pS167, DOI 10.1093/infdis/165-Supplement_1-S167; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dorn BR, 1998, INFECT IMMUN, V66, P6054, DOI 10.1128/IAI.66.12.6054-6057.1998; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Falkow S, PROKARYOTES, V52006, P602; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fouhy F, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0738-z; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOB STRAT DIAGN MAN; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; GREEN GM, 1968, ANNU REV MED, V19, P315, DOI 10.1146/annurev.me.19.020168.001531; Hahn A, 2016, J MICROBIOL METH, V130, P95, DOI 10.1016/j.mimet.2016.09.002; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Johnson M, 2001, CHEST, V120, P258, DOI 10.1378/chest.120.1.258; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kim V, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-52; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Larsen JM, 2015, IMMUNOLOGY, V144, P333, DOI 10.1111/imm.12376; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Lee JH, 2010, RESP MED, V104, P542, DOI 10.1016/j.rmed.2009.10.024; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Mosher JJ, 2014, J MICROBIOL METH, V104, P59, DOI 10.1016/j.mimet.2014.06.012; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Rutten EPA, 2011, PULMONARY MED, V2011, P6; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SCHAFFNER A, 1985, J CLIN INVEST, V76, P1755, DOI 10.1172/JCI112166; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Singh D, 2016, AM J RESP CRIT CARE, V194, P541, DOI 10.1164/rccm.201606-1179PP; Strombeck L, 2007, APMIS, V115, P241, DOI 10.1111/j.1600-0463.2007.apm_512.x; Subramanian DR, 2016, EUR RESPIR J, V48, P92, DOI 10.1183/13993003.01878-2015; Sze MA, 2015, AM J RESP CRITICAL C; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Sze MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006677; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Timmers RA, 2012, APPL MICROBIOL BIOT, V94, P537, DOI 10.1007/s00253-012-3894-6; Tulek B, 2013, CAN RESPIR J, V20, P91, DOI 10.1155/2013/727523; TUOMANEN E, 1988, J EXP MED, V168, P267, DOI 10.1084/jem.168.1.267; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; Wang Z, 2016, EUROPEAN RESP J; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; World Health Organization, CHRON OBSTR PULM DIS; XIE H, 1991, ORAL MICROBIOL IMMUN, V6, P257, DOI 10.1111/j.1399-302X.1991.tb00488.x; Ziegler-Heitbrock L, 2012, EUR RESPIR J, V40, P823, DOI 10.1183/09031936.00142811	73	23	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180859	10.1371/journal.pone.0180859	http://dx.doi.org/10.1371/journal.pone.0180859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704452	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700056
J	Lopes-Ramos, CM; Barros, BP; Koyama, FC; Carpinetti, PA; Pezuk, J; Doimo, NTS; Habr-Gama, A; Perez, RO; Parmigiani, RB				Lopes-Ramos, Camila M.; Barros, Bruna P.; Koyama, Fernanda C.; Carpinetti, Paola A.; Pezuk, Julia; Doimo, Nayara T. S.; Habr-Gama, Angelita; Perez, Rodrigo O.; Parmigiani, Raphael B.			E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; KRAS-VARIANT; MICRORNA; LUNG; POLYMORPHISMS; EXPRESSION; ACTS	Background Genetic studies have largely concentrated on the impact of somatic mutations found in coding regions, and have neglected mutations outside of these. However, 3' untranslated regions (3' UTR) mutations can also disrupt or create miRNA target sites, and trigger oncogene activation or tumor suppressor inactivation. Methods We used next-generation sequencing to widely screen for genetic alterations within predicted miRNA target sites of oncogenes associated with colorectal cancer, and evaluated the functional impact of a new somatic mutation. Target sequencing of 47 genes was performed for 29 primary colorectal tumor samples. For 71 independent samples, Sanger methodology was used to screen for E2F1 mutations in miRNA predicted target sites, and the functional impact of these mutations was evaluated by luciferase reporter assays. Results We identified germline and somatic alterations in E2F1. Of the 100 samples evaluated, 3 had germline alterations at the MIR205-5p target site, while one had a somatic mutation at MIR136-5p target site. E2F1 gene expression was similar between normal and tumor tissues bearing the germline alteration; however, expression was increased 4-fold in tumor tissue that harbored a somatic mutation compared to that in normal tissue. Luciferase reporter assays revealed both germline and somatic alterations increased E2F1 activity relative to wild-type E2F1. Conclusions We demonstrated that somatic mutation within E2F1: MIR136-5p target site impairs miRNAmediated regulation and leads to increased gene activity. We conclude that somatic mutations that disrupt miRNA target sites have the potential to impact gene regulation, highlighting an important mechanism of oncogene activation.	[Lopes-Ramos, Camila M.; Barros, Bruna P.; Koyama, Fernanda C.; Carpinetti, Paola A.; Pezuk, Julia; Doimo, Nayara T. S.; Parmigiani, Raphael B.] Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil; [Koyama, Fernanda C.; Perez, Rodrigo O.] Ludwig Inst Canc Res, Sao Paulo, Brazil; [Habr-Gama, Angelita; Perez, Rodrigo O.] Angelita & Joaquim Gama Inst, Sao Paulo, Brazil; [Habr-Gama, Angelita; Perez, Rodrigo O.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Parmigiani, Raphael B.] Idengene Med Diagnost LTDA, Sao Paulo, SP, Brazil	Hospital Sirio Libanes; Ludwig Institute for Cancer Research; Universidade de Sao Paulo	Parmigiani, RB (corresponding author), Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil.; Parmigiani, RB (corresponding author), Idengene Med Diagnost LTDA, Sao Paulo, SP, Brazil.	raphaparmigiani@gmail.com	Pezuk, Julia Alejandra/H-1727-2014; PARMIGIANI, RAPHAEL B/A-7475-2014; Lopes-Ramos, Camila M/K-3240-2014; Carpinetti, Paola A/K-1763-2016; Perez, Rodrigo Oliva/A-2163-2013; Lopes-Ramos, Camila/ABB-6537-2020	Pezuk, Julia Alejandra/0000-0001-5412-6619; PARMIGIANI, RAPHAEL B/0000-0001-8360-3584; Perez, Rodrigo Oliva/0000-0003-1704-2277; Carpinetti, Paola/0000-0001-8728-6344	Sao Paulo Research Foundation (FAPESP) [13/05304-8]; CAPES [PNPD20132180]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RBP was supported by Sao Paulo Research Foundation (FAPESP) grant 13/05304-8, and CML was supported by CAPES PNPD20132180. The funding agencies had no role in the study design, collection, analysis and interpretation of the data, in writing the article, and in the decision to publish	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya A, 2013, NUCLEIC ACIDS RES, V41, pD977, DOI 10.1093/nar/gks1138; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen LL, 2013, INT J CANCER, V133, P67, DOI 10.1002/ijc.28010; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Gu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102602; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CC, 2014, NUCLEIC ACIDS RES, V42, P9543, DOI 10.1093/nar/gku675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Piletic K, 2017, OMICS, V21, P197, DOI 10.1089/omi.2017.0023; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Real S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016163; Salzman DW, 2013, PHARMACOL THERAPEUT, V137, P55, DOI 10.1016/j.pharmthera.2012.08.016; Suzuki T, 1999, INT J CANCER, V81, P535, DOI 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4; Xiao BX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-172	28	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181153	10.1371/journal.pone.0181153	http://dx.doi.org/10.1371/journal.pone.0181153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704519	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700098
J	Romero-Alvarez, D; Escobar, LE; Varela, S; Larkin, DJ; Phelps, NBD				Romero-Alvarez, Daniel; Escobar, Luis E.; Varela, Sara; Larkin, Daniel J.; Phelps, Nicholas B. D.			Forecasting distributions of an aquatic invasive species (Nitellopsis obtusa) under future climate scenarios	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; MAXIMUM-ENTROPY; COMPLEXITY; CHAROPHYCEAE; CHARACEAE; RANGES; SPACE	Starry stonewort (Nitellopsis obtusa) is an alga that has emerged as an aquatic invasive species of concern in the United States. Where established, starry stonewort can interfere with recreational uses of water bodies and potentially have ecological impacts. Incipient invasion of starry stonewort in Minnesota provides an opportunity to predict future expansion in order to target early detection and strategic management. We used ecological niche models to identify suitable areas for starry stonewort in Minnesota based on global occurrence records and present-day and future climate conditions. We assessed sensitivity of forecasts to different parameters, using four emission scenarios (i.e., RCP 2.6, RCP 4.5, RCP 6, and RCP 8.5) from five future climate models (i.e., CCSM, GISS, IPSL, MIROC, and MRI). From our niche model analyses, we found that (i) occurrences from the entire range, instead of occurrences restricted to the invaded range, provide more informed models; (ii) default settings in Maxent did not provide the best model; (iii) the model calibration area and its background samples impact model performance; (iv) model projections to future climate conditions should be restricted to analogous environments; and (v) forecasts in future climate conditions should include different future climate models and model calibration areas to better capture uncertainty in forecasts. Under present climate, the most suitable areas for starry stonewort are predicted to be found in central and southeastern Minnesota. In the future, suitable areas for starry stonewort are predicted to shift in geographic range under some future climate models and to shrink under others, with most permutations indicating a net decrease of the species' suitable range. Our suitability maps can serve to design shortterm plans for surveillance and education, while future climate models suggest a plausible reduction of starry stonewort spread in the long-term if the trends in climate warming remain.	[Romero-Alvarez, Daniel] Hosp Gen Enrique Garces, Unidad Epidemiol, Quito, Ecuador; [Escobar, Luis E.; Larkin, Daniel J.; Phelps, Nicholas B. D.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Invalidenstr 43, Berlin, Germany	University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Escobar, LE (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	lescobar@umn.edu	Escobar, Luis E./I-2204-2019; Romero-Alvarez, Daniel/K-2270-2019	Escobar, Luis E./0000-0001-5735-2750; Larkin, Daniel/0000-0001-6378-0495; Phelps, Nicholas/0000-0003-3116-860X	Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment; Institute on the Environment Mini Grants program; Natural Resources Trust Fund	Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment; Institute on the Environment Mini Grants program; Natural Resources Trust Fund	Funding for this project was provided through the Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment and Natural Resources Trust Fund. The Institute on the Environment Mini Grants program provided funding for the internship of DRA at the University of Minnesota.	Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; Anderson RP, 2014, 1 S BIOG ACT RET, P11; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Brainard AS, 2016, FRESHW SCI IN PRESS, V36; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; DNR M., 2015, DNR TAK FURTH STEPS; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Escobar L. E., 2014, GEOSPAT HLTH, V11, P221, DOI DOI 10.4081/GH.2014.19; Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29037; Escobar LE, 2015, ACTA TROP, V149, P202, DOI 10.1016/j.actatropica.2015.05.028; Escobar LE, 2013, REV PANAM SALUD PUBL, V34, P135; GEIS JW, 1981, PHYCOLOGIA, V20, P211, DOI 10.2216/i0031-8884-20-2-211.1; Gelviz-Gelvez SM, 2015, ECOL ENG, V74, P302, DOI 10.1016/j.ecoleng.2014.09.082; GISIN, 2015, GLOB INV SPEC INF NE; Golicher D, 2012, INT J GEOGR INF SCI, V26, P2049, DOI 10.1080/13658816.2012.719626; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; HELCOM, 2013, RED LIST NIT OBT, P2012; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Joint Nature Conservation Committee, 2010, UK PRIOR SPEC PAG VE; Kato S, 2014, PHYCOL RES, V62, P222, DOI 10.1111/pre.12057; Kipp RM, NITELLOPSIS OBTUSA N; LIMARIBEIRO MS, 2015, BIODIVERS INFORM, V10, DOI 10.17161/bi.v10i0.4955; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockwood J, 2006, INVASION ECOLOGY; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Midwood JD, 2016, J GREAT LAKES RES, V42, P348, DOI 10.1016/j.jglr.2016.01.005; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Papes M, 2016, FRESHWATER BIOL, V61, P457, DOI 10.1111/fwb.12719; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pullman GD., 2010, LAKELINE, V52, P36; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Sleith RS, 2015, BRITTONIA, V67, P166, DOI 10.1007/s12228-015-9372-6; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; U.S. Fish & Wildlife Service, 2015, NAT WETL INV; Waltari E, 2014, METHODS ECOL EVOL, V5, P1033, DOI 10.1111/2041-210X.12264; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	53	20	21	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180930	10.1371/journal.pone.0180930	http://dx.doi.org/10.1371/journal.pone.0180930			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704433	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700061
J	Wu, WS; Tu, BW; Chen, TT; Hou, SW; Tseng, JT				Wu, Wei-Sheng; Tu, Bor-Wen; Chen, Tsung-Te; Hou, Shang-Wei; Tseng, Joseph T.			CSmiRTar: Condition-Specific microRNA targets database	PLOS ONE			English	Article							IN-VIVO; RESOURCE; MIRNA; EXPRESSION; GENE; GENOMICS; SIRNAS; ATLAS; CERNA; PTEN	MicroRNAs (miRNAs) are functional RNA molecules which play important roles in the post transcriptional regulation. miRNAs regulate their target genes by repressing translation or inducing degradation of the target genes' mRNAs. Many databases have been constructed to provide computationally predicted miRNA targets. However, they cannot provide the miRNA targets expressed in a specific tissue and related to a specific disease at the same time. Moreover, they cannot provide the common targets of multiple miRNAs and the common miRNAs of multiple genes at the same time. To solve these two problems, we construct a database called CSmiRTar (Condition-Specific miRNA Targets). CSmiRTar collects computationally predicted targets of 2588 human miRNAs and 1945 mouse miRNAs from four most widely used miRNA target prediction databases (miRDB, TargetScan, microRNA. org and DIANA-microT) and implements functional filters which allows users to search (i) a miRNA's targets expressed in a specific tissue or/and related to a specific disease, (ii) multiple miRNAs' common targets expressed in a specific tissue or/and related to a specific disease, (iii) a gene's miRNAs related to a specific disease, and (iv) multiple genes' common miRNAs related to a specific disease. We believe that CSmiRTar will be a useful database for biologists to study the molecular mechanisms of post-transcriptional regulation in human or mouse.	[Wu, Wei-Sheng; Tu, Bor-Wen; Chen, Tsung-Te; Hou, Shang-Wei] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan; [Tseng, Joseph T.] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.; Tseng, JT (corresponding author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.	wessonwu@gmail.com; tctseng@mail.ncku.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018; Wu, Wei-Sheng/P-5367-2019	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; 	National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]	National Cheng Kung University and Ministry of Science and Technology of Taiwan	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Deu-Pons J, 2015, DATABASE; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wang DF, 2014, BIOINFORMATICS, V30, P2237, DOI 10.1093/bioinformatics/btu155; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181231	10.1371/journal.pone.0181231	http://dx.doi.org/10.1371/journal.pone.0181231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704505	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700111
J	Yu, Y; Feng, XY; Vieten, G; Dippel, S; Imvised, T; Gueler, F; Ure, BM; Kuebler, JF; Klemann, C				Yu, Yi; Feng, Xiaoyan; Vieten, Gertrud; Dippel, Stephanie; Imvised, Tawan; Gueler, Faikah; Ure, Benno M.; Kuebler, Jochen F.; Klemann, Christian			Conventional alpha beta (alpha beta) T cells do not contribute to acute intestinal ischemiareperfusion injury in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; ISCHEMIA/REPERFUSION INJURY; RESPONSES; LYMPHOCYTES; COMPLEMENT; INNATE	Purpose Ischemia-reperfusion injury (IRI) is associated with significant patient mortality and morbidity. The complex cascade of IRI is incompletely understood, but inflammation is known to be a key mediator. In addition to the predominant innate immune responses, previous research has also indicated that alpha beta T cells contribute to IRI in various organ models. The aim of this study was to clarify the role alpha beta T cells play in IRI to the gut. Methods Adult wild-type (WT) and alpha beta T cell-deficient mice were subjected to acute intestinal IRI with 30min ischemia followed by 4h reperfusion. The gene expression of pro-inflammatory cytokines was measured by qPCR, and the influx of leukocyte subpopulations in the gut was assessed via flow cytometry and histology. Pro-inflammatory cytokines in the serum were measured, and transaminases were assessed as an indicator of distant organ IRI. Results Intestinal IRI led to an increased expression of pro-inflammatory cytokines in the gut tissue and an influx of leukocytes that predominantly consisted of neutrophils and macrophages. Furthermore, intestinal IRI increased serum IL-6, TNF-alpha, and ALT/AST levels. The alpha beta T cell-deficient mice did not exhibit a more significant increase in pro-inflammatory cytokines in the gut or serum following IR than the WT mice. There was also no difference between WT-and alpha beta T cell-deficient mice in terms of neutrophil infiltration or macrophage activation. Furthermore, the increase in transaminases was equal in both groups indicating that the level of distant organ injury was comparable. Conclusion An increasing body of evidence demonstrates that v T cells play a key role in IRI. In the gut, however, alpha beta T cells are not pivotal in the first hours following acute IRI as deficiency does not impact cytokine production, neutrophil recruitment, macrophage activation, or distant organ injury. Thus, alpha beta T cells may be considered innocent bystanders during the acute phase of intestinal IRI.	[Yu, Yi; Feng, Xiaoyan; Vieten, Gertrud; Dippel, Stephanie; Imvised, Tawan; Ure, Benno M.; Kuebler, Jochen F.; Klemann, Christian] Hannover Med Sch, Ctr Surg, Dept Pediat Surg, Hannover, Germany; [Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Klemann, Christian] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Klemann, C (corresponding author), Hannover Med Sch, Ctr Surg, Dept Pediat Surg, Hannover, Germany.; Klemann, C (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany.	Klemann.Christian@mh-hannover.de	Klemann, Christian/AAQ-9301-2020	Klemann, Christian/0000-0002-5639-8690				Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen Y, 2016, J PEDIATR SURG, V51, P1255, DOI 10.1016/j.jpedsurg.2015.12.015; Denecke C, 2014, PROG UROL, V24, pS13, DOI 10.1016/S1166-7087(14)70058-2; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Fleming SD, 2006, AUTOIMMUN REV, V5, P89, DOI 10.1016/j.autrev.2005.09.006; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Hochegger K, 2007, AM J PHYSIOL-RENAL, V293, pF741, DOI 10.1152/ajprenal.00486.2006; Hofmann U, 2016, EUR HEART J, V37, P873, DOI 10.1093/eurheartj/ehv639; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Klemann C, 2016, GASTROENTEROLOGY, V150, P229, DOI 10.1053/j.gastro.2015.09.008; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Lee H, 2010, MOL IMMUNOL, V47, P972, DOI 10.1016/j.molimm.2009.11.022; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P1; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Qiu Y, 2014, J MOL HISTOL, V45, P217, DOI 10.1007/s10735-013-9544-1; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Rong S, 2014, AM J PHYSIOL-RENAL, V307, pF718, DOI 10.1152/ajprenal.00372.2013; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shigematsu T, 2002, MICROCIRCULATION, V9, P99, DOI 10.1038/sj.mn.7800126; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Watson MJ, 2012, SURGERY, V152, P843, DOI 10.1016/j.surg.2012.03.001; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Williams TM, 2016, NEPHROLOGY CARLTON; Winterberg T, 2015, EUR J IMMUNOL, V45, P214, DOI 10.1002/eji.201444468; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562; Yu Y, 2015, EUR J PEDIATR SURG, V25, P46, DOI 10.1055/s-0034-1387945; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022; Zuidema MY, 2010, WORLD J CARDIOL, V2, P325, DOI 10.4330/wjc.v2.i10.325	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181326	10.1371/journal.pone.0181326	http://dx.doi.org/10.1371/journal.pone.0181326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704542	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700123
J	Muscella, A; Vetrugno, C; Cossa, LG; Antonaci, G; Barca, A; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Cossa, Luca Giulio; Antonaci, Giovanna; Barca, Amilcare; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			Apoptosis by [Pt(O, O '-acac)(Y-acac)(DMS)] requires PKC-delta mediated p53 activation in malignant pleural mesothelioma	PLOS ONE			English	Article							KINASE-C-DELTA; BREAST-CANCER CELLS; PROTEIN-KINASE; XENOGRAFT MODEL; PHASE-II; IN-VITRO; CISPLATIN; BCL-2; PT(O,O'-ACAC)(GAMMA-ACAC)(DMS); CARCINOMA	Mesothelioma cancer cells have epithelioid or sarcomatoid morphology. The worst prognosis is associated with sarcomatoid phenotype and resistance to therapy is affected by cells heterogeneity. We recently showed that in ZL55 mesothelioma cell line of epithelioid origin [Pt(O,O '-acac)(Y-acac)(DMS)] (Ptac2S) has an antiproliferative effect in vitro and in vivo. Aim of this work was to extend the study on the effects of Ptac2S on ZL34 cell line, representative of sarcomatoid mesothelioma. ZL34 cells were used to assay the antitumor activity of Ptac2S in a mouse xenograft model in vivo. Then, both ZL34 and ZL55 cells were used in order to assess the involvement of p53 protein in (a) the processes underlying the sensitivity to chemotherapy and (b) the activation of various transduction proteins involved in apoptosis/survival processes. Ptac2S increases ZL34 cell death in vivo compared with cisplatin and, in vitro, Ptac2S was more efficacious than cisplatin in inducing apoptosis. In Ptac2S-treated ZL34 and ZL55 cells, p53 regulated gene products of apoptotic BAX and anti-apoptotic Bcl-2 proteins via transcriptional activation. Ptac2S activated PKC-delta and PKC-epsilon; their inhibition by PKC-siRNA decreased the apoptotic death of cells. PKC-delta was responsible for JNK1/2 activation that has a role in p53 activation. In addition, PKC-e activation provoked phosphorylation of p38MAPK, concurring to apoptosis. In ZL34 cells, Ptac2S also activated PKC-a thus provoking ERK1/2 activation; inhibition of PKC-alpha, or ERK1/ 2, increased Ptac2S cytotoxicity. Results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, giving a substantial starting point for its further validation.	[Muscella, Antonella; Vetrugno, Carla] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy; [Cossa, Luca Giulio; Antonaci, Giovanna; Marsigliante, Santo] Univ Salento, Lab Cell Physiol DiSTeBA, Lecce, Italy; [Barca, Amilcare] Univ Salento, Lab Physiol DiSTeBA, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Univ Salento, DiSTeBA, Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento; University of Salento	Muscella, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy.	antonella.muscella@unisalento.it	Barca, Amilcare/I-1281-2019; Muscella, Antonella/AAE-8075-2019; Fanizzi, Francesco Paolo/K-5766-2012	Barca, Amilcare/0000-0002-3117-2724; Muscella, Antonella/0000-0002-2822-9929; Fanizzi, Francesco Paolo/0000-0003-3073-5772; MARSIGLIANTE, Santo/0000-0001-6535-3286				Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; Bandoh N, 2002, CANCER, V94, P1968, DOI 10.1002/cncr.10388; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Chen LJ, 2010, BLOOD, V115, P61, DOI 10.1182/blood-2009-03-210526; Communal C, 2002, P NATL ACAD SCI USA, V99, P6252, DOI 10.1073/pnas.092022999; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Fan MY, 2001, CANCER RES, V61, P4450; Favoni RE, 2011, TRENDS PHARMACOL SCI, V32, P463, DOI 10.1016/j.tips.2011.03.011; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Hillerdal G, 2008, J THORAC ONCOL, V3, P1325, DOI 10.1097/JTO.0b013e31818b174d; Hopkins-Donaldson S, 2003, INT J CANCER, V106, P160, DOI 10.1002/ijc.11209; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Ko HW, 2000, J NEUROCHEM, V74, P2455, DOI 10.1046/j.1471-4159.2000.0742455.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Mor O, 1997, AM J RESP CELL MOL, V16, P9, DOI 10.1165/ajrcmb.16.1.8998073; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2005, BIOCHEM PHARMACOL, V71, P50, DOI 10.1016/j.bcp.2005.10.022; Muscella A, 2016, BRIT J PHARMACOL, V173, P2633, DOI 10.1111/bph.13543; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165154; Muscella A, 2015, BIOCHEM PHARMACOL, V98, P29, DOI 10.1016/j.bcp.2015.08.103; Muscella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112186; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nilsonne G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-92; Pasello G, 2009, CURR DRUG TARGETS, V10, P1235, DOI 10.2174/138945009789753200; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Powell CT, 1996, CELL GROWTH DIFFER, V7, P419; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Saha MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030215; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Streffer JR, 2002, J NEURO-ONCOL, V56, P43, DOI 10.1023/A:1014448721327; Sun XJ, 2006, CANCER LETT, V232, P161, DOI 10.1016/j.canlet.2005.02.022; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181114	10.1371/journal.pone.0181114	http://dx.doi.org/10.1371/journal.pone.0181114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704484	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600060
J	Yi, XY; Lin, J; Luo, H; Wang, C; Liu, YY				Yi, Xingyang; Lin, Jing; Luo, Hua; Wang, Chun; Liu, Yingying			Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients	PLOS ONE			English	Article							THROMBOXANE A2 RECEPTOR; CEREBRAL INFARCTION; MOLECULAR-MECHANISMS; METABOLITE LEVELS; ATHEROSCLEROSIS; POLYMORPHISM; COX-2; RISK; STENOSIS; EVENTS	Eicosanoids may play a role in ischemic stroke. However, the associations of variants in cyclooxygenase (COX) pathway genes and interaction among these variants with carotid plaque vulnerability are not fully understood. In present study, twelve variants in COX pathway genes were examined using matrix-assisted laser desorption ionization time-of-flight mass spectrometry method in 396 patients with ischemic stroke and 291 controls. Platelet aggregation, platelet-leukocyte aggregates, and urine 11-dehydrothromboxane B2 (11-dTxB2) were also measured. According to the results of carotid high-resolution B-mode ultrasound, the patients were stratified into the following groups [i.e., non-carotid plaque and carotid plaque. The carotid plaque was further classified into subgroups of echolucent plaque (ELP) and echogenic plaque (EGP)]. Additionally, gene-gene interactions were analyzed to assess whether there was any interactive role for assessed variants in affecting carotid plaque vulnerability, platelet activation and 11-dTxB2 levels. There were no significant differences in the frequencies of genotypes of the twelve variants between patients and controls. Among 396 patients, 294 cases (74.2%) had carotid plaques (106 had ELP, 188 had EGP). Frequency of PTGS2 rs20417CC, TXAS1 rs2267679TT, TXAS1 rs41708TT, PTGIS rs5602CC, and TXA2R rs1131882TT genotype was significantly higher in patients with plaque compared with patients without plaque, or in patients with ELP compared with patients with EGP. 11dTxB2 levels, platelet aggregation and platelet-leukocyte aggregates were significantly higher in patients with ELP compared with patients without plaque or with EGP. Multivariate logistic regression analysis revealed that PTGS2 rs20417CC, TXA2R rs1131882TT, and high-risk interaction among variants in PTGS2 rs20417, TXA2R rs1131882 and TXAS1 rs41708 were independently associated with the risk of ELP after adjusting for confounding variables. The variants in COX pathway genes and the high-risk interactions among variants in PTGS2 rs20417, TXA2R rs1131882 and TXAS1 rs41708 were associated with high 11-dTxB2 and platelet activation, and independently associated with the risk of carotid plaque vulnerability. These variants might be potential markers for plaque instability.	[Yi, Xingyang; Wang, Chun; Liu, Yingying] Peoples Hosp Deyang City, Dept Neurol, Deyang, Sichuan, Peoples R China; [Lin, Jing] Wenzhou Med Univ, Affiliated Hosp 3, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Luo, Hua] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China	Wenzhou Medical University; Southwest Medical University	Lin, J (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Neurol, Wenzhou, Zhejiang, Peoples R China.; Luo, H (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China.	22350277@qq.com; lzlh@sina.com	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		Deyang City Science and Technology Research Foundation [2015SZ064]	Deyang City Science and Technology Research Foundation	This study was supported by the Deyang City Science and Technology Research Foundation (Grant No. 2015SZ064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran-Sarmiento E, 2016, AM J CANCER RES, V6, P341; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Borow KM, 2015, ATHEROSCLEROSIS, V242, P357, DOI 10.1016/j.atherosclerosis.2015.07.035; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; de Bray JM, 1998, CEREBROVASC DIS, V8, P273, DOI 10.1159/000015865; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Fritsche E, 2001, J PHARMACOL EXP THER, V299, P468; Gardener H, 2011, STROKE, V42, P889, DOI 10.1161/STROKEAHA.110.591065; Gronholdt MLM, 1997, EUR J VASC ENDOVASC, V14, P439, DOI 10.1016/S1078-5884(97)80121-9; Han SW, 2007, EUR NEUROL, V57, P96, DOI 10.1159/000098059; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165, DOI 10.1177/15910199000060S125; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee C, 2008, CLIN PHARMACOL THER, V83, P52, DOI 10.1038/sj.clpt.6100221; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Mahajan CN, 2015, PEDIATR RES, V77, P455, DOI 10.1038/pr.2014.209; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Nakayama T, 2000, AM J HYPERTENS, V13, P1263, DOI 10.1016/S0895-7061(00)01216-4; Oliveira J, 2015, J STROKE CEREBROVASC, V24, P1817, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.018; Orbe J, 2006, CLIN CHIM ACTA, V368, P138, DOI 10.1016/j.cca.2005.12.019; Park SA, 2009, BMB REP, V42, P200, DOI 10.5483/BMBRep.2009.42.4.200; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Shao JX, 2015, CURR NEUROVASC RES, V12, P15, DOI 10.2174/1567202612666150102125221; Shao MJ, 2015, J FORMOS MED ASSOC, V114, P422, DOI 10.1016/j.jfma.2013.12.004; Wang S, 2003, AM J EPIDEMIOL, V158, P899, DOI 10.1093/aje/kwg233; Yi XY, 2016, J ATHEROSCLER THROMB, V23, P330, DOI 10.5551/jat.31120; Yi XY, 2017, J STROKE CEREBROVASC, V26, P1128, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.032; Yi XY, 2016, J NEUROL, V263, P1612, DOI 10.1007/s00415-016-8181-5; Yi XY, 2016, J ATHEROSCLER THROMB, V23, P621, DOI 10.5551/jat.32714; Yi XY, 2015, J ATHEROSCLER THROMB, V22, P1148, DOI 10.5551/jat.29025; Yi XY, 2014, J STROKE CEREBROVASC, V23, P1975, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.022; Yi XY, 2013, J ATHEROSCLER THROMB, V20, P65, DOI 10.5551/jat.14092; Zhao J, 2013, NEUROL SCI, V34, P1791, DOI 10.1007/s10072-013-1340-x	41	20	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180704	10.1371/journal.pone.0180704	http://dx.doi.org/10.1371/journal.pone.0180704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704403	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600045
J	Meyer, AJ; Patten, C; Fregly, BJ				Meyer, Andrew J.; Patten, Carolynn; Fregly, Benjamin J.			Lower extremity EMG-driven modeling of walking with automated adjustment of musculoskeletal geometry	PLOS ONE			English	Article							KNEE ADDUCTION MOMENT; JOINT MOMENTS; MUSCLE FORCES; LOWER-LIMB; HUMAN GAIT; CONTACT FORCE; PARAMETERS; MECHANICS; REHABILITATION; OSTEOARTHRITIS	Neuromusculoskeletal disorders affecting walking ability are often difficult to manage, in part due to limited understanding of how a patient's lower extremity muscle excitations contribute to the patient's lower extremity joint moments. To assist in the study of these disorders, researchers have developed electromyography (EMG) driven neuromusculoskeletal models utilizing scaled generic musculoskeletal geometry. While these models can predict individual muscle contributions to lower extremity joint moments during walking, the accuracy of the predictions can be hindered by errors in the scaled geometry. This study presents a novel EMG-driven modeling method that automatically adjusts surrogate representations of the patient's musculoskeletal geometry to improve prediction of lower extremity joint moments during walking. In addition to commonly adjusted neuromusculoskeletal model parameters, the proposed method adjusts model parameters defining muscle-tendon lengths, velocities, and moment arms. We evaluated our EMG-driven modeling method using data collected from a high-functioning hemiparetic subject walking on an instrumented treadmill at speeds ranging from 0.4 to 0.8 m/s. EMG-driven model parameter values were calibrated to match inverse dynamic moments for five degrees of freedom in each leg while keeping musculoskeletal geometry close to that of an initial scaled musculoskeletal model. We found that our EMG-driven modeling method incorporating automated adjustment of musculoskeletal geometry predicted net joint moments during walking more accurately than did the same method without geometric adjustments. Geometric adjustments improved moment prediction errors by 25% on average and up to 52%, with the largest improvements occurring at the hip. Predicted adjustments to musculoskeletal geometry were comparable to errors reported in the literature between scaled generic geometric models and measurements made from imaging data. Our results demonstrate that with appropriate experimental data, joint moment predictions for walking generated by an EMG-driven model can be improved significantly when automated adjustment of musculoskeletal geometry is included in the model calibration process.	[Meyer, Andrew J.; Fregly, Benjamin J.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Patten, Carolynn] Univ Florida, Dept Phys Therapy, Gainesville, FL USA; [Patten, Carolynn] Malcom Randall VA Med Ctr, Neural Control Movement Lab, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Fregly, BJ (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	fregly@ufl.edu	Fregly, Benjamin J./AAP-8377-2020; Patten, Carolynn/B-4804-2009	Fregly, Benjamin J./0000-0003-1166-4358; Patten, Carolynn/0000-0002-9948-0045; Meyer, Andrew/0000-0003-4544-1064	Directorate For Engineering [1404767] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Aisen ML, 2011, LANCET NEUROL, V10, P844, DOI 10.1016/S1474-4422(11)70176-4; Amarantini D, 2004, J BIOMECH, V37, P1393, DOI 10.1016/j.jbiomech.2003.12.020; AN KN, 1984, J BIOMECH ENG-T ASME, V106, P280, DOI 10.1115/1.3138494; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Barrios JA, 2010, J BIOMECH, V43, P2208, DOI 10.1016/j.jbiomech.2010.03.040; Bogey RA, 2005, IEEE T NEUR SYS REH, V13, P302, DOI 10.1109/TNSRE.2005.851768; Buchanan TS, 2005, MED SCI SPORT EXER, V37, P1911, DOI 10.1249/01.mss.0000176684.24008.6f; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Cronin NJ, 2015, NEUROSCIENCE, V300, P19, DOI 10.1016/j.neuroscience.2015.05.003; De Groote F, 2012, COMPUT METHOD BIOMEC, V15, P1093, DOI 10.1080/10255842.2011.571679; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Doorenbosch CAM, 2003, CLIN BIOMECH, V18, P142, DOI 10.1016/S0268-0033(02)00183-3; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Fregly BJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-18; Gardinier ES, 2013, GAIT POSTURE, V38, P1051, DOI 10.1016/j.gaitpost.2013.03.014; Gerus P, 2010, ANN BIOMED ENG, V38, P2406, DOI 10.1007/s10439-010-9987-4; Gill P.R., 1981, LEVENBERG MARQUARDT; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; HE JP, 1991, IEEE T AUTOMAT CONTR, V36, P322, DOI 10.1109/9.73565; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Kellis E, 1997, EUR J APPL PHYSIOL O, V76, P253, DOI 10.1007/s004210050244; Kumar D, 2012, J ORTHOP RES, V30, P377, DOI 10.1002/jor.21544; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Manal K, 2003, J BIOMECH, V36, P1197, DOI 10.1016/S0021-9290(03)00152-0; Menegaldo LL, 2004, J BIOMECH, V37, P1447, DOI 10.1016/j.jbiomech.2003.12.017; Meyer AJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00077; Meyer AJ, 2013, J ORTHOP RES, V31, P921, DOI 10.1002/jor.22304; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Mulroy SJ, 2010, PHYS THER, V90, P209, DOI 10.2522/ptj.20090141; OLNEY SJ, 1985, J BIOMECH, V18, P9, DOI 10.1016/0021-9290(85)90041-7; Perotto A, 2005, ANATOMICAL GUIDE FOR; Prieto-Alhambra D., 2013, ANN RHEUM DIS; Racinais S, 2013, J CLIN NEUROPHYSIOL, V30, P415, DOI 10.1097/WNP.0b013e31829ddcf1; Reinbolt JA, 2007, IEEE T BIO-MED ENG, V54, P782, DOI 10.1109/TBME.2006.889187; Sartori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052618; Sartori M, 2012, J BIOMECH, V45, P595, DOI 10.1016/j.jbiomech.2011.10.040; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2008, GAIT POSTURE, V28, P358, DOI 10.1016/j.gaitpost.2008.05.002; Sherman MA, 2013, 9 INT C MULT SYST B, V7B; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Simonsen EB, 2012, EXP BRAIN RES, V219, P163, DOI 10.1007/s00221-012-3075-y; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Tsai LC, 2012, MED SCI SPORT EXER, V44, P305, DOI 10.1249/MSS.0b013e31822dfdb3; WALKER PS, 1988, J BIOMECH, V21, P965, DOI 10.1016/0021-9290(88)90135-2; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	55	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179698	10.1371/journal.pone.0179698	http://dx.doi.org/10.1371/journal.pone.0179698			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700708	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400005
J	Ferreiro, A; Lombardi, R				Ferreiro, Alejandro; Lombardi, Raul			Acute kidney injury after cardiac surgery is associated with mid-term but not long-term mortality: A cohort-based study	PLOS ONE			English	Article							SURGICAL-PATIENTS; RENAL-FUNCTION; RISK-FACTORS; METAANALYSIS; SURVIVAL; OUTCOMES; DISEASE; COSTS; DEATH; AKI	Acute kidney injury (AKI) in cardiac surgery is associated with complications, early and late mortality and increased health care expenditures. The overall dynamic comorbidity-adjusted contributions of an episode of AKI on mortality during long-term follow-up have not been fully explored. A longitudinal cohort of 7075 adult patients admitted for cardiac surgery were enrolled in the study. Follow-up data were obtained through telephonic survey after 1, 5, 10, and 15 years or from the National Mortality Registry. All-cause mortality was assessed at five time intervals: I) 30 days after surgery to 1 year; II) 1 to 3 years; III)3 to 5 years; IV) 5 to 10 years; and V) 10 to 15 years. For the adjustment of mortality for comorbidity and pre-,intra- and postoperative variables, Cox proportional hazard regression models were conducted within each period. The overall incidence of AKI was 36.1%. AKI was an independent predictor of death only during the first five years after surgery ( 30 days to 1 year: HR 1.834, 95% CI 1.459 to 2.306; 1 to 3 years: HR 1.285, 95% CI 1.023 to 1.610; and 3 to five years: HR 1.330, 95% CI 1.123 to 1.750). Only age, diabetes mellitus and CHF were associated with increased risk of death over the entire follow-up period. Our study demonstrates a transient association of AKI with long-term mortality that progressively decreases and vanishes five years after surgery. The knowledge of this dynamic is crucial to understanding this complex association, planning health care and allocating resources.	[Ferreiro, Alejandro; Lombardi, Raul] Univ Republica, Ctr Nefrol, Montevideo, Uruguay; [Ferreiro, Alejandro; Lombardi, Raul] Inst Nacl Cirugia Cardiaca, Montevideo, Uruguay; [Lombardi, Raul] Serv Med Integral, Dept Med Crt, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Lombardi, R (corresponding author), Univ Republica, Ctr Nefrol, Montevideo, Uruguay.; Lombardi, R (corresponding author), Inst Nacl Cirugia Cardiaca, Montevideo, Uruguay.; Lombardi, R (corresponding author), Serv Med Integral, Dept Med Crt, Montevideo, Uruguay.	lombardi.raul2@gmail.com		Lombardi, Raul/0000-0002-2398-794X				Abstract, 2012, KIDNEY INT S; Aronson S, 2007, CIRCULATION, V115, P733, DOI 10.1161/CIRCULATIONAHA.106.623538; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Corredor C, 2016, J CARDIOTHOR VASC AN, V30, P69, DOI 10.1053/j.jvca.2015.07.013; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; Gallaher S, 2014, THORAC CARDIOVASC SU, V147, P989; Haase M, 2007, CONTRIB NEPHROL, V156, P340; Hansen MK, 2015, J CARDIOTHOR VASC AN, V29, P617, DOI 10.1053/j.jvca.2014.08.020; Hansen MK, 2013, CRIT CARE, V17, DOI 10.1186/cc13158; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lombardi R, 2008, RENAL FAILURE, V30, P155, DOI 10.1080/08860220701808129; Lopez-Delgado JC, 2013, CRIT CARE, V17, DOI 10.1186/cc13159; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; O'Neal JB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1352-z; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Sawhney S, AM J KIDNEY DIS; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331	26	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181158	10.1371/journal.pone.0181158	http://dx.doi.org/10.1371/journal.pone.0181158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700753	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800128
J	Funken, D; Ishikawa-Ankerhold, H; Uhl, B; Lerchenberger, M; Rentsch, M; Mayr, D; Massberg, S; Werner, J; Khandoga, A				Funken, Dominik; Ishikawa-Ankerhold, Hellen; Uhl, Bernd; Lerchenberger, Maximilian; Rentsch, Markus; Mayr, Doris; Massberg, Steffen; Werner, Jens; Khandoga, Andrej			In situ targeting of dendritic cells sets tolerogenic environment and ameliorates CD4(+) T-cell response in the postischemic liver	FASEB JOURNAL			English	Article						hepatic ischemia/reperfusion; transplantation; T lymphocytes; immunological tolerance; microvascular injury	HEPATIC STELLATE CELLS; MOUSE-LIVER; INJURY; ACTIVATION; MICE; PARICALCITOL; INFLAMMATION; INDUCTION; PROMOTE	CD4(+) T cells recruited to the liver play a key role in the pathogenesis of ischemia/reperfusion (I/R) injury. The mechanism of their activation during alloantigen-independent I/R is not completely understood. We hypothesized that liver-resident dendritic cells (DCs) interact with CD4(+) T cells in the postischemic liver and that modulation of DCs or T-cell-DC interactions attenuates liver inflammation. In mice, warm hepatic I/R (90/120-240 min) was induced. Tolerogenic DCs were generated in situ by pretreatment of animals with the vitamin D analog paricalcitol. A mAb-CD44 was used for blockade of CD4(+) T-cell-DC interactions. As shown by 2-photon in vivo microscopy as well as confocal microscopy, CD4(+) T cells were closely colocalized with DCs in the postischemic liver. Pretreatment with paricalcitol attenuated I/R-induced maturation of DCs (flow cytometry), CD4(+) T-cell recruitment into the liver (intravital microscopy), and hepatocellular/microvascular damage (intravital microscopy, alanine aminotransferase/aspartate aminotransferase, histology). However, interruption of T-cell-DC interaction increased proinflammatory DC maturation and even enhanced tissue damage. Simultaneous treatment with an anti-CD44mAb completely abolished the beneficial effect of paricalcitol on T-cell migration and tissue injury. Our study demonstrates for the first time that hepatic DCs interact with CD4(+) T cells in the postischemic liver in vivo; modulation of DCs and/or generation of tolerogenic DCs attenuates intrahepatic CD4(+) T-cell recruitment and reduces I/R injury; and interruption of CD44-dependent CD4(+) T-cell-DC interactions enhances tissue injury by preventing the modulatory effect of hepatic DCs on T cells, especially type 1 T helper effector cells. Thus, hepatic DCs are strongly involved in the promotion of CD4(+) T-cell-dependent postischemic liver inflammation.	[Funken, Dominik; Lerchenberger, Maximilian; Rentsch, Markus; Werner, Jens; Khandoga, Andrej] Univ Munich, Dept Gen Visceral & Transplant Surg, Marchioninistr 15, D-81377 Munich, Germany; [Ishikawa-Ankerhold, Hellen; Massberg, Steffen] Univ Munich, Dept Cardiol, Munich, Germany; [Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Ishikawa-Ankerhold, Hellen; Uhl, Bernd] Walter Brendel Ctr Expt Med, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Khandoga, A (corresponding author), Univ Munich, Dept Gen Visceral & Transplant Surg, Marchioninistr 15, D-81377 Munich, Germany.	Andrej.Khandoga@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021		Deutsche Forschungsgemeinschaft [KH92-3/1];  [SFB914]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	The authors thank R. Haas (Max von Pettenkofer Institute, University of Munich) for providing the C57BL/6 CD11c-eYFP mice. This work was supported, in part, by the Deutsche Forschungsgemeinschaft (KH92-3/1), and by the SFB914, Project Z01 (to S.M., A.K., and H.I.-A.). The authors declare no conflicts of interest.	Adorini Luciano, 2002, Curr Opin Investig Drugs, V3, P1458; Bakdash G, 2014, VACCINE, V32, P6294, DOI 10.1016/j.vaccine.2014.08.075; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Castellaneta A, 2014, HEPATOLOGY, V60, P267, DOI 10.1002/hep.27037; Ferreira GB, 2014, J IMMUNOL, V192, P4210, DOI 10.4049/jimmunol.1302350; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gonzalez-Mateo GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108477; Hanschen M, 2008, TRANSPLANTATION, V86, P710, DOI 10.1097/TP.0b013e3181821aa7; Henrickson SE, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.112pt2; Herz J, 2012, MICROSC MICROANAL, V18, P730, DOI 10.1017/S1431927612000281; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Khandoga A, 2006, HEPATOLOGY, V43, P306, DOI 10.1002/hep.21017; Khandoga A, 2002, TRANSPLANTATION, V74, P681, DOI 10.1097/00007890-200209150-00016; Lee JW, 2014, BIOCHEM BIOPH RES CO, V444, P121, DOI 10.1016/j.bbrc.2014.01.005; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Liu Y, 2015, AM J TRANSPLANT, V15, P954, DOI 10.1111/ajt.13067; Martin M, 2010, J GASTROINTEST SURG, V14, P511, DOI 10.1007/s11605-009-1104-3; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Nikolic T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00113; Pommey S, 2013, HEPATOLOGY, V57, P1597, DOI 10.1002/hep.25985; Reifart J, 2015, TRANSPLANTATION, V99, P41, DOI 10.1097/TP.0000000000000461; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Singh-Jasuja H, 2013, IMMUNOBIOLOGY, V218, P28, DOI 10.1016/j.imbio.2012.01.021; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Strauss O, 2015, J HEPATOL, V62, P458, DOI 10.1016/j.jhep.2014.10.006; Suarez-Martinez Edu, 2014, Ther Adv Cardiovasc Dis, V8, P224, DOI 10.1177/1753944714542593; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Termeer C, 2003, IMMUNOLOGY, V109, P32, DOI 10.1046/j.1365-2567.2003.01617.x; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Yang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106892; Zhang M, 2013, HEPATOLOGY, V57, P1585, DOI 10.1002/hep.26129	35	7	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4796	4808		10.1096/fj.201601358R	http://dx.doi.org/10.1096/fj.201601358R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28720647				2022-12-26	WOS:000413398500012
J	Sahu, U; Rajendra, VKH; Kapnoor, SS; Bhagavat, R; Chandra, N; Rangarajan, PN				Sahu, Umakant; Rajendra, Vinod K. H.; Kapnoor, Shankar S.; Bhagavat, Raghu; Chandra, Nagasuma; Rangarajan, Pundi N.			Methionine synthase is localized to the nucleus in Pichia pastoris and Candida albicans and to the cytoplasm in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOL UTILIZATION PATHWAY; REGULATOR 1 MXR1P; METHYLOTROPHIC YEAST; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PROTEIN; EXPRESSION; GENE; IDENTIFICATION; ZINC	Methionine synthase (MS) catalyzes methylation of homocysteine, the last step in the biosynthesis of methionine, which is essential for the regeneration of tetrahydrofolate and biosynthesis of S-adenosylmethionine. Here, we report that MS is localized to the nucleus of Pichia pastoris and Candida albicans but is cytoplasmic in Saccharomyces cerevisiae. The P. pastoris strain carrying a deletion of the MET6 gene encoding MS (Ppmet6) exhibits methionine as well as adenine auxotrophy indicating that MS is required for methionine as well as adenine biosynthesis. Nuclear localization of P. pastoris MS (PpMS) was abrogated by the deletion of 107 C-terminal amino acids or the R742A mutation. In silico analysis of the PpMS structure indicated that PpMS may exist in a dimer-like configuration in which Arg-742 of a monomer forms a salt bridge with Asp-113 of another monomer. Biochemical studies indicate that R742A as well as D113R mutations abrogate nuclear localization of PpMS and its ability to reverse methionine auxotrophy of Ppmet6. Thus, association of two PpMS monomers through the interaction of Arg-742 and Asp-113 is essential for catalytic activity and nuclear localization. When PpMS is targeted to the cytoplasm employing a heterologous nuclear export signal, it is expressed at very low levels and is unable to reverse methionine and adenine auxotrophy of Ppmet6. Thus, nuclear localization is essential for the stability and function of MS in P. pastoris. We conclude that nuclear localization of MS is a unique feature of respiratory yeasts such as P. pastoris and C. albicans, and it may have novel moonlighting functions in the nucleus.	[Sahu, Umakant; Rajendra, Vinod K. H.; Kapnoor, Shankar S.; Bhagavat, Raghu; Chandra, Nagasuma; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in		Chandra, Nagasuma/0000-0002-9939-8439	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India [SB/S2/JCB-025/2015, EMR/2015/000567]; Department of Biotechnology-Indian Institute of Science; Department of Biotechnology, New Delhi, India	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India; Department of Biotechnology-Indian Institute of Science; Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported in part by Research Grant EMR/2015/000567 and J.C. Bose Fellowship Grant SB/S2/JCB-025/2015 from the Science and Engineering Research Board, Department of Science and Technology, New Delhi, India (to P.N.R.), and by the Department of Biotechnology-Indian Institute of Science partnership program. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of post-doctoral fellowship of Department of Biotechnology, New Delhi, India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; GONZALEZ JC, 1992, BIOCHEMISTRY-US, V31, P6045, DOI 10.1021/bi00141a013; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; Huang L, 2005, ACTA BIOCH BIOPH SIN, V37, P371, DOI 10.1111/j.1745-7270.2005.00054.x; IDE GJ, 1981, CURR GENET, V4, P85, DOI 10.1007/BF00365686; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Kacprzak MM, 2003, BIOCHEM J, V376, P517, DOI 10.1042/BJ20030747; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Matthews RG, 2003, HELV CHIM ACTA, V86, P3939, DOI 10.1002/hlca.200390329; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; Prasannan P, 2009, BIOCHEM BIOPH RES CO, V382, P730, DOI 10.1016/j.bbrc.2009.03.098; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Sahu U, 2016, J BIOL CHEM, V291, P20588, DOI 10.1074/jbc.M116.740191; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Mir L, 2012, J BIOL CHEM, V287, P26038, DOI 10.1074/jbc.M112.345611; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shulga N, 1999, J BIOL CHEM, V274, P16501, DOI 10.1074/jbc.274.23.16501; Sohn MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100725; Suliman HS, 2007, ARCH BIOCHEM BIOPHYS, V467, P218, DOI 10.1016/j.abb.2007.09.003; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Ubhi D, 2014, J MOL BIOL, V426, P1839, DOI 10.1016/j.jmb.2014.02.006; Ubhi D, 2011, ARCH BIOCHEM BIOPHYS, V513, P19, DOI 10.1016/j.abb.2011.06.002; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zameitat E, 2006, FEBS J, V273, P3183, DOI 10.1111/j.1742-4658.2006.05327.x	57	3	5	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14730	14746		10.1074/jbc.M117.783019	http://dx.doi.org/10.1074/jbc.M117.783019			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28701466	Green Published, hybrid			2022-12-26	WOS:000409902100002
J	Willy, JA; Young, SK; Mosley, AL; Gawrieh, S; Stevens, JL; Masuoka, HC; Wek, RC				Willy, Jeffrey A.; Young, Sara K.; Mosley, Amber L.; Gawrieh, Samer; Stevens, James L.; Masuoka, Howard C.; Wek, Ronald C.			Function of inhibitor of Bruton's tyrosine kinase isoform (IBTK) in nonalcoholic steatohepatitis links autophagy and the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; eukaryotic initiation factor 2 (eIF2); eukaryotic translation initiation; translation control; unfolded protein response (UPR)	ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; TRANSLATIONAL CONTROL; CELL-DEATH; PHOSPHORYLATION; PATHOGENESIS; BIOGENESIS; APOPTOSIS; PATHWAY; SITES	Nonalcoholic fatty liver disease (steatosis) is the most prevalent liver disease in the Western world. One of the advanced pathologies is nonalcoholic steatohepatitis (NASH), which is associated with induction of the unfolded protein response (UPR) and disruption of autophagic flux. However, the mechanisms by which these processes contribute to the pathogenesis of human diseases are unclear. Herein, we identify the isoform of the inhibitor of Bruton's tyrosine kinase (IBTK) as a member of the UPR, whose expression is preferentially translated during endoplasmic reticulum (ER) stress. We found that IBTK is located in the ER and associates with proteins LC3b, SEC16A, and SEC31A and plays a previously unrecognized role in phagophore initiation from ER exit sites. Depletion of IBTK helps prevent accumulation of autophagosome intermediates stemming from exposure to saturated free fatty acids and rescues hepatocytes from death. Of note, induction of IBTK and the UPR, along with inhibition of autophagic flux, was associated with progression from steatosis to NASH in liver biopsies. These results indicate a function for IBTK in NASH that links autophagy with activation of the UPR.	[Willy, Jeffrey A.; Young, Sara K.; Mosley, Amber L.; Stevens, James L.; Masuoka, Howard C.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Gawrieh, Samer] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu	Gawrieh, Samer/AAS-8904-2020	Young-Baird, Sara/0000-0002-8915-3139	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; Lilly Graduate Research Advanced Degrees program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; Lilly Graduate Research Advanced Degrees program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Lilly Graduate Research Advanced Degrees program.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; CHEN Q, 1990, J BIOL CHEM, V265, P21603; Choi H., 2012, CURR PROTOC BIOINFOR; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gual P, 2017, AM J PHYSIOL-CELL PH, V312, pC263, DOI 10.1152/ajpcell.00295.2016; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Luo M, 2010, CELL RES, V20, P211, DOI 10.1038/cr.2010.9; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Pisano A, 2015, J BIOL CHEM, V290, P13958, DOI 10.1074/jbc.M114.634535; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sanchez-Wandelmer J, 2015, J CELL SCI, V128, P185, DOI 10.1242/jcs.158758; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Tan DY, 2013, P NATL ACAD SCI USA, V110, P19432, DOI 10.1073/pnas.1316356110; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	46	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14050	14065		10.1074/jbc.M117.799304	http://dx.doi.org/10.1074/jbc.M117.799304			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28710282	hybrid, Green Published			2022-12-26	WOS:000408439800013
J	Alcaraz-Castano, M; Alcolea-Gonzalez, J; Kehl, M; Albert, RM; Baena-Preysler, J; de Balbin-Behrmann, R; Cuartero, F; Cuenca-Bescos, G; Jimenez-Barredo, F; Lopez-Saez, JA; Pique, R; Rodriguez-Anton, D; Yravedra, J; Weniger, GC				Alcaraz-Castano, Manuel; Alcolea-Gonzalez, Javier; Kehl, Martin; Albert, Rosa-Maria; Baena-Preysler, Javier; de Balbin-Behrmann, Rodrigo; Cuartero, Felipe; Cuenca-Bescos, Gloria; Jimenez-Barredo, Fernando; Lopez-Saez, Jose-Antonio; Pique, Raquel; Rodriguez-Anton, David; Yravedra, Jose; Weniger, Gerd-Christian			A context for the last Neandertals of interior Iberia: Los Casares cave revisited	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; OLDUVAI GORGE TANZANIA; ISOTOPE MEASUREMENTS; PERCUSSION MARKS; LATE PLEISTOCENE; POLLEN ANALYSIS; MIDDLE; SITE; CHRONOLOGY; HOMINID	Introduction and objectives Although the Iberian Peninsula is a key area for understanding the Middle to Upper Paleolithic transition and the demise of the Neandertals, valuable evidence for these debates remains scarce and problematic in its interior regions. Sparse data supporting a late Neandertal persistence in the Iberian interior have been recently refuted and hence new evidence is needed to build new models on the timing and causes of Neandertal disappearance in inland Iberia and the whole peninsula. In this study we provide new evidence from Los Casares, a cave located in the highlands of the Spanish Meseta, where a Neandertal-associated Middle Paleolithic site was discovered and first excavated in the 1960's. Our main objective is twofold: (1) provide an updated geoarcheological, paleoenvironmental and chronological framework for this site, and (2) discuss obtained results in the context of the time and nature of the last Neandertal presence in Iberia. Methods We conducted new fieldwork in an interior chamber of Los Casares cave named 'Seno A'. Our methods included micromorphology, sedimentology, radiocarbon dating, Uranium/Thorium dating, palinology, microfaunal analysis, anthracology, phytolith analysis, archeo-zoology and lithic technology. Here we present results on site formation processes, paleoenvironment and the chronological setting of the Neandertal occupation at Los Casares cave-Seno A. Results and discussion The sediment sequence reveals a mostly in situ archeological deposit containing evidence of both Neandertal activity and carnivore action in level c, dated to 44,899 +/- 42,175 calendar years ago. This occupation occurred during a warm and humid interval of Marine Isotopic Stage 3, probably correlating with Greenland Interstadial 11, representing one of the latest occurrences of Neandertals in the Iberian interior. However, overlying layer b records a deterioration of local environments, thus providing a plausible explanation for the abandonment of the site, and perhaps for the total disappearance of Neandertals of the highlands of inland Iberia during subsequent Greenland Stadials 11 or 10, or even Heinrich Stadial 4. Since layer b provided very few signs of human activity and no reliable chronometric results, and given the scarce chronostratigrapic evidence recorded so far for this period in interior Iberia, this can only be taken as a working hypothesis to be tested with future research. Meanwhile, 42,000 calendar years ago remains the most plausible date for the abandonment of interior Iberia by Neandertals, possibly due to climate deterioration. Currently, a later survival of this human species in Iberia is limited to the southern coasts.	[Alcaraz-Castano, Manuel; Weniger, Gerd-Christian] Neanderthal Museum, Mettmann, Germany; [Alcaraz-Castano, Manuel; Alcolea-Gonzalez, Javier; de Balbin-Behrmann, Rodrigo] Univ Alcala, Area Prehist, Alcala De Henares, Spain; [Kehl, Martin] Univ Cologne, Inst Geog, Cologne, Germany; [Albert, Rosa-Maria] Univ Barcelona, ERAAUB Dept Hist & Achaeol, Barcelona, Spain; [Albert, Rosa-Maria] ICREA, Barcelona, Spain; [Baena-Preysler, Javier; Cuartero, Felipe] Autonomous Univ Madrid, Dept Prehist & Archeol, Madrid, Spain; [Cuenca-Bescos, Gloria] Univ Zaragoza, Dept Geosci, Aragosaurus IUCA, Zaragoza, Spain; [Jimenez-Barredo, Fernando] CENIEH Natl Res Ctr Human Evolut, Burgos, Spain; [Lopez-Saez, Jose-Antonio] CCHS CSIC, Hist Inst, Archeobiol Res Grp, Madrid, Spain; [Pique, Raquel; Rodriguez-Anton, David] Autonomous Univ Barcelona, Dept Prehist, Barcelona, Spain; [Yravedra, Jose] Univ Complutense Madrid, Dept Prehist, Madrid, Spain	Universidad de Alcala; University of Cologne; University of Barcelona; ICREA; Autonomous University of Madrid; University of Zaragoza; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Historia (IH); Autonomous University of Barcelona; Complutense University of Madrid	Alcaraz-Castano, M (corresponding author), Neanderthal Museum, Mettmann, Germany.; Alcaraz-Castano, M (corresponding author), Univ Alcala, Area Prehist, Alcala De Henares, Spain.	manuel.alcaraz@uah.es	Jimenez, Fernando/W-1462-2019; Alcolea-González, José Javier/ABF-6941-2020; CUARTERO MONTEAGUDO, FELIPE/S-8690-2016; Yravedra, Jose/E-9815-2016; Albert, Rosa Maria/F-2937-2016; David, Rodríguez Antón/ABA-7286-2021; Yravedra, Jose/AAC-2073-2019; Gloria, Cuenca-Bescós/A-3616-2013	Jimenez, Fernando/0000-0002-9794-6489; Alcolea-González, José Javier/0000-0003-0911-5472; CUARTERO MONTEAGUDO, FELIPE/0000-0002-9024-2980; Albert, Rosa Maria/0000-0003-1722-9445; David, Rodríguez Antón/0000-0003-4116-2308; Yravedra, Jose/0000-0002-4323-3379; Gloria, Cuenca-Bescós/0000-0001-5125-9651; Alcaraz-Castano, Manuel/0000-0001-6291-9512; Pique Huerta, Raquel/0000-0002-8253-6874	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme [628179]; German Research Foundation's (DFG) [CRC 806]; Spanish Ministry of Economy, Industry and Competitiveness [HAR2013-48784-C3-3-P, HAR2016-76760-C3-2-P, HAR2013-43701-P, CGL2012-38434-C03-01]; Comunidad de Madrid [2016-T2/HUM-1251]; FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme(European Commission); German Research Foundation's (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission	This research was funded by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (https://ec.europa.euireseamh/fp7/index_en.cfm), under the project 'Testing population hiatuses in the Late Pleistocene of Central Iberia: a geoarchaeological approach' (Grant number 628179) (MAC, GCW). It was also supported by funding of the German Research Foundation's (DFG) project CRC 806 "Our Way to Europe" (http://www.dfg.de/en/) (GCW, MK), and the Spanish Ministry of Economy, Industry and Competitiveness (http://www.minecogob.es/portal/siteimineco/), project numbers HAR2013-48784-C3-3-P (JBP, FC, MAC), HAR2016-76760-C3-2-P (JBP, FC, MAC), HAR2013-43701-P (JALS) and CGL2012-38434-C03-01 (GCB). MAC currently holds a post-doc fellowship (Ayuda para la Atraccion de Talento lnvestigador 2016-T2/HUM-1251) awarded by the Comunidad de Madrid (http://www.madrimasd.org/madrid-ciencia-tecnologia/). Publication fees were funded by the FP7 Post-Grant Open Access Pilot (OpenAIRE) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2006, QUATERN INT, V148, P78, DOI 10.1016/j.quaint.2005.11.026; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Albert RM, 2016, J ARCHAEOL SCI, V68, P98, DOI 10.1016/j.jas.2015.10.014; Alcaraz-Castano M, 2015, 57 ANN M HEID 7 11 A, P14; Alcaraz-Castano M, 2016, P EUR SOC STUD HUM E, P31; Alcaraz-Castano M, VISION GLOBAL CUATER, P42; Alcaraz-Castano M., 2015, ARPI ARQUEOLOGIA PRE, V2, P68; Alcaraz-Castano M, 2015, J ANTHROPOL RES, V71, P565, DOI 10.3998/jar.0521004.0071.406; Alcaraz-Castano M, 2013, TRABAJOS PREHIST, V70, P28, DOI 10.3989/tp.2013.12101; Altuna J, 1973, EXCAVACIONES ARQUEOL, V76, P97; Alvarez-Alonso D, 2017, GEOPH RES ABSTR, V19, P6919; Amick DS, 2014, LITHIC TECHNOL, V39, P64, DOI 10.1179/0197726113Z.00000000025; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; [Anonymous], [No title captured]; [Anonymous], 1982, BAR BRIT SERIES; Lopez-Saez JA, 2015, PHYTOCOENOLOGIA, V45, P107, DOI 10.1127/0340-269X/2014/0044-0572; Antonio Lopez-Saez Jose, 2013, Lazaroa, V34, P191, DOI 10.5209/rev_LAZA.2013.v34.n1.43599; Lopez-Saez JA, 2010, PHYTOCOENOLOGIA, V40, P57, DOI 10.1127/0340-269X/2010/0040-0430; Arnold L, 2013, OSL DATING MIDDLE PA; Arribas Herrera A., 1999, HUE LLA PASADO FOSIL, P327; Arsuaga JL, 2016, P EUR SOC STUD HUM E, V5, P36; Badal E., 2012, SAGVNTUM EXTRA, V13, P13; Preysler JB, 2015, QUATERN INT, V361, P142, DOI 10.1016/j.quaint.2014.07.007; Balbin-Behrmann R, 1992, ANTHROPOLOGIE, V96, P397; Ball TB, 2016, J ARCHAEOL SCI, V68, P106, DOI 10.1016/j.jas.2015.03.023; Baquedano E., 2016, P EUR SOC STUD HUM E, P41; Bar-Yosef O, 2009, CURR ANTHROPOL, V50, P103, DOI 10.1086/592234; Barandiaran I., 1973, EXCAVACIONES ARQUEOL, V76; Barba R, 2005, J TAPHONOMY, V3, P29; Barboni D, 2009, REV PALAEOBOT PALYNO, V158, P29, DOI 10.1016/j.revpalbo.2009.07.002; Basabe J. M, 1973, EXCAVACIONES ARQUEOL, V76, P117; Beckmann T., 1997, MIKROMORPHOLOGISCHE, V40, P89; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Bradtmoller M, 2012, QUATERN INT, V247, P38, DOI 10.1016/j.quaint.2010.10.015; Brain C. K, 1969, SCI PAPERS NAMIBIAN, V32, P1; Bunn H, 1982, MEAT EATING HUMAN EV; Burnett W.C., 1992, URANIUM SERIES DISEQ, P486; Cabre J, 1936, ACT 16 C INT ANTHR B, VI, P402; Cabre J., 1940, AR ESP ARQ, VXIV, P81; Cabre J., 1934, ARCH ESPAN ART, VX, P225; Caceres I., 2002, TAFONOMA YACIMIENTOS, P659; Cacho C, 2010, MONOGRAFIES SERP, VXXI, P115; Carbonell E., 2014, CAZADORES RECOLECTOR, P608; Carnelli AL, 2004, REV PALAEOBOT PALYNO, V129, P39, DOI 10.1016/j.revpalbo.2003.11.002; Carnelli AL, 2001, ANN BOT-LONDON, V87, P425, DOI 10.1006/anbo.2000.1355; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cuenca-Bescos G, 2010, QUATERN INT, V212, P129, DOI 10.1016/j.quaint.2009.06.006; Cuenca-Bescos G., 2003, EXTRA, P95; Cuenca-Bescos G, 2014, INTEGR ZOOL, V9, P481, DOI 10.1111/1749-4877.12053; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; de la Pena P, 2013, P NATL ACAD SCI USA, V110, pE2086, DOI 10.1073/pnas.1303596110; de la Torre I, 2015, J QUATERNARY SCI, V30, P376, DOI 10.1002/jqs.2791; Desprat S, 2015, J BIOGEOGR, V42, P1998, DOI 10.1111/jbi.12566; Diez C, 2008, CUATERN GEOMORFOL, V22, P135; Domingo R, 2017, QUATERN INT, V435, P129, DOI 10.1016/j.quaint.2015.09.088; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo Manuel, 2005, Journal of Taphonomy, V3, P121; Esteban I, 2017, ARCHAEOL ANTHROP SCI, V9, P265, DOI 10.1007/s12520-015-0279-7; Fernandez S, 2007, GEOBIOS-LYON, V40, P75, DOI 10.1016/j.geobios.2006.01.004; Finlayson C, 2008, QUATERN INT, V181, P64, DOI 10.1016/j.quaint.2007.11.016; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Galvan B, 2014, J HUM EVOL, V75, P16, DOI 10.1016/j.jhevol.2014.06.002; Gibert L, 2016, J HUM EVOL, V90, P183, DOI 10.1016/j.jhevol.2015.08.002; Goni MFS, 2010, QUATERNARY SCI REV, V29, P2823, DOI 10.1016/j.quascirev.2009.11.014; Grimm E.C., 1993, TILIA PROGRAM ANAL D; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Guillem P., 1995, CUATERNARIO PAIS VAL, P227; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hodgkins J, 2016, J HUM EVOL, V96, P1, DOI 10.1016/j.jhevol.2016.03.009; Hoffmann DL, 2008, INT J MASS SPECTROM, V275, P75, DOI 10.1016/j.ijms.2008.05.033; Hoffmann DL, 2007, INT J MASS SPECTROM, V264, P97, DOI 10.1016/j.ijms.2007.03.020; Hoffmann DL, 2013, QUATERN INT, V294, P168, DOI 10.1016/j.quaint.2012.05.027; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Inizan ML, 1999, PREHISTORIC PIERRE T, V5; Iturbe G, 1990, RECERQUES MUSEO ALCO, V2, P23; Joris O, 2008, J HUM EVOL, V55, P782, DOI 10.1016/j.jhevol.2008.04.002; Jorda J., 2010, CUATERNARIO ARQUEOLO, P101; Joris O., 2003, TRABAJOS PREHIST, V60, P15, DOI DOI 10.3989/TP.2003.V60.I2.79; Kehl M, 2016, QUAT INT IN PRESS; Kehl M., 2017, GEOPH RES ABSTR, V19, P6402; L6pez Saez J. A., 2003, POLEN, V12, P5; Laplana C, 2013, QUATERNAIRE, V24, P207, DOI 10.4000/quaternaire.6617; Lopez-Garcia JM, 2011, EVOLUION DIVERSIDAD; Lopez-Garcia JM, 2008, J HUM EVOL, V55, P1151, DOI 10.1016/j.jhevol.2008.08.001; Arsuaga JL, 2012, QUATERN INT, V275, P55, DOI 10.1016/j.quaint.2012.04.019; LYMAN RL, 1994, PALAIOS, V9, P288, DOI 10.2307/3515203; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Madella M, 2012, QUATERN INT, V275, P76, DOI 10.1016/j.quaint.2011.09.008; Lopez-Garcia JM, 2014, QUATERN INT, V326, P319, DOI 10.1016/j.quaint.2013.09.010; Lopez-Garcia JM, 2010, QUATERNAIRE, V21, P249; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; Mingo A, 2014, QUAD PREH ARQ CAST, V32, P21; Moore P.D., 1991, BLACKWELL SCI PUBLI; Moure A., 1983, CURR ANTHROPOL, V19, P155; Navazo M., 2005, MUSEO ALTAMIRA MONOG, V20, P151, DOI DOI 10.3406/BSPF.1995.10058; Navazo M, 2014, QUATERN INT, V331, P267, DOI 10.1016/j.quaint.2014.03.032; Nohemi Sala M. T., 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P67; Parsons M. K, 1989, PROCESSES FOSSILIZAT, P22; Perez Ripoll M., 1988, ARCH PREHISTORIA LEV, V18, P83; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Pique R., 2003, RECOGIDA MUESTRAS AR, P11; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Puig, 1894, CAVERNAS SIMAS B COM; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Raposo L, 1998, TRABAJOS PREHIST, V55, P39; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reille M., 1992, POLLEN SPORES DEUROP; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rethemeyer J, 2013, NUCL INSTRUM METH B, V294, P168, DOI 10.1016/j.nimb.2012.02.012; Romanillo A. Moure, 1997, 2 C ARQ PEN, P67; Ruiz-Bustos A, 1997, CUADERNOS PREHISTORI, V2, P7; Yustos PS, 2015, QUATERNARY SCI REV, V121, P75, DOI 10.1016/j.quascirev.2015.05.005; Schmidt I, 2012, QUATERN INT, V274, P179, DOI 10.1016/j.quaint.2012.01.018; Scholz D., 2008, QUATERNARY SCI J, V57, P52; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Sese C, 2011, ESTUD GEOL-MADRID, V67, P471, DOI 10.3989/egeol.40516.203; Silva PG, 2012, ESTUD GEOL-MADRID, V68, P57, DOI 10.3989/egeol.40338.134; Steele TE, 2002, THESIS; Stoops G., 2003, GUIDELINES ANAL DESC; Straus LG, 2005, QUATERN INT, V137, P47, DOI 10.1016/j.quaint.2004.11.019; Straus LG., 1993, PREHISTOIRE EUROPEEN, V3, P11; Svensson A, 2006, QUATERNARY SCI REV, V25, P3258, DOI 10.1016/j.quascirev.2006.08.003; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thompson CEL, 2011, J ARCHAEOL SCI, V38, P784, DOI 10.1016/j.jas.2010.11.001; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; Twiss P.C., 1992, PHYTOLITH SYSTEMATIC, P113, DOI [10.1007/978-1-4899-1155-1_6, DOI 10.1007/978-1-4899-1155-1_6]; Uzquiano P., 2005, MONOGRAFIAS MUSEO AL, V20, P255; Vaquero M., 2006, NEANDERTHALS MODERN, P419; Vaquero Rodriguez M., 2006, PYRENAE, V37, P107; Vega G., 1993, ORIGEN HOMBRE MODERN, P147; Vega-Toscano LG, HOMME DE NEANDERTAL, V2; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Villaverde V, 1990, PALEOLITHIQUE MOYEN, P177; Walker MJ, 2012, QUATERN INT, V259, P7, DOI 10.1016/j.quaint.2011.03.034; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Yravedra J, 2009, J QUATERNARY SCI, V24, P85, DOI 10.1002/jqs.1164; YRAVEDRA J, 2006, TAFONOMIA APLICADA Z; Yravedra J, 2007, ARQUEOWEB, V9; Zilhao J., 1993, ORIGEN HOMBRE MODERN, P127; Zilhao J., 2006, FARMING, V2006, P95; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; Zilhao J, 2013, CULTURAL PERSPECTIVE, V1, P21; Zilhao J, 2016, QUATERNARY SCI REV, V146, P251, DOI 10.1016/j.quascirev.2016.05.038; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	153	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180823	10.1371/journal.pone.0180823	http://dx.doi.org/10.1371/journal.pone.0180823			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723924	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800028
J	Paudel, BR; Shrestha, M; Dyer, AG; Li, QJ				Paudel, Babu Ram; Shrestha, Mani; Dyer, Adrian G.; Li, Qing-Jun			Ginger and the beetle: Evidence of primitive pollination system in a Himalayan endemic alpine ginger (Roscoea alpina, Zingiberaceae)	PLOS ONE			English	Article							SELF-POLLINATION; COLOR-VISION; SOUTH-AFRICA; FLOWER COLOR; EVOLUTION; RED; SENSITIVITY; COLEOPTERA; FLY; ANGIOSPERMS	The Himalayan endemic alpine genus Roscoea, like other members of ginger family, exhibits the combination of floral traits that would fit pollination by long distant foragers such as bees, birds or flies. We studied the pollination biology of Roscoea alpina, observed potential floral visitors and determined their foraging behaviour, visitation frequency and pollination efficiency, to seek evidence in support of the pollination syndrome hypothesis. We also measured the floral spectra of R. alpina flowers to evaluate if signals fit with the currently known framework for observed floral visitors. We found that R. alpina have autonomous selfing and pollinator-mediated crossing, but lack apomixis. We observed that a beetle (Mylabris sp.), and a moth (Macroglossum nycteris) visit the flowers of R. alpina for pollen and nectar feeding respectively. Our field observations, the stigmatic pollen count and fruit set data indicated that the visit by the beetle was legitimate, while that of the moth was illegitimate. Emasculated flowers visited by beetles set as many fruits and seeds/fruit as autoselfed and naturally pollinated flowers, while emasculated flowers excluded from beetle visits did not set fruit and seed; indicating that a single visit of a beetle to the flowers of R. alpina can facilitate pollination. We found that flower spectral signal of R. alpina does not fit typical spectra previously reported for beetle or bee-visited flowers. Our results suggest that, to ensure reproductive success in alpine habitat, R. alpina has evolved autonomous selfing as a predominant mode of reproduction, while beetle pollination would promote genetic diversity of this plant species. The visitation of beetles to the flowers of R. alpina, despite floral signal mismatch with the classically associated beetle vision, suggests that a different visual processing may operate in this plant-pollinator interaction at high altitudes.	[Paudel, Babu Ram] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan, Peoples R China; [Paudel, Babu Ram] Univ Chinese Acad Sci, Beijing, Peoples R China; [Paudel, Babu Ram] Tribhuvan Univ, Dept Bot, Prithvi Narayan Campus, Pokhara, Nepal; [Shrestha, Mani; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Shrestha, Mani] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia; [Li, Qing-Jun] Yunnan Univ, Lab Ecol & Evolutionary Biol, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tribhuvan University; Royal Melbourne Institute of Technology (RMIT); Monash University; Yunnan University	Li, QJ (corresponding author), Yunnan Univ, Lab Ecol & Evolutionary Biol, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China.	Foqingjun.li@ynu.edu.cn	Paudel, Babu Ram/AFN-3769-2022; Shrestha, Mani/P-7045-2015	Garcia, Jair/0000-0001-8456-4759; Paudel, Babu Ram/0000-0002-4556-7794; Shrestha, Mani/0000-0002-6165-8418	National Natural Science Foundation of China [U1202261]; National Basic Research Programme of China (973 Programme) [2007CB411603]; Chinese Academy of Sciences (CAS) 135 Programme [XTBGT01, F01]; Australian Research Council [DP130100015/160100161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China (973 Programme)(National Basic Research Program of China); Chinese Academy of Sciences (CAS) 135 Programme; Australian Research Council(Australian Research Council)	This study was funded by the "National Natural Science Foundation of China (U1202261), the National Basic Research Programme of China (973 Programme No. 2007CB411603), and the Chinese Academy of Sciences (CAS) 135 Programme (XTBGT01, F01) to QJL". AGD acknowledges Australian Research Council Discovery Projects funding scheme DP130100015/160100161 which assisted in support for Mani Shrestha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SEJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2219; Barth FG., 1985, INSECTS FLOWERS BIOL; BEACH JH, 1982, AM J BOT, V69, P1074, DOI 10.1002/j.1537-2197.1982.tb13352.x; Bernhardt P, 2000, PLANT SYST EVOL, V222, P293, DOI 10.1007/BF00984108; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Cowley EJ, 2007, THE GENUS ROSCOEA; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAFNI A, 1990, ISRAEL J BOT, V39, P81; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Darwin C., 1877, VARIOUS CONTRIVANCES; Department of Hydrology and Meteorology Ministry of Science Technology & Environment Government of Nepal, 2016, CLIM DAT PORT; DIERL W, 1968, KHUMBU HIMAL ERGEBN, V3, P76; Doring TF, 2007, ENTOMOL GEN, V29, P81; Doring TF, 2012, PHYSIOL ENTOMOL, V37, DOI 10.1111/j.1365-3032.2012.00850.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Dyer Adrian G., 2015, Proceedings of the Royal Society of Victoria, V127, P66, DOI 10.1071/RS15006; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; ENDRESS PK, 1987, TRENDS ECOL EVOL, V2, P300, DOI 10.1016/0169-5347(87)90082-6; Fan YL, 2012, ANN BOT-LONDON, V110, P969, DOI 10.1093/aob/mcs169; FLETCHER T. BAINBRIGGE, 1931, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V1, P192; Goldblatt P, 2000, ANN MO BOT GARD, V87, P146, DOI 10.2307/2666158; GOTTSBERGER G, 1990, BOT ACTA, V103, P360, DOI 10.1111/j.1438-8677.1990.tb00175.x; KATO M, 1994, NATURE, V368, P195, DOI 10.1038/368195a0; Kato Makoto, 1993, Tropics, V2, P129; Keasar T, 2010, BIOL J LINN SOC, V99, P808, DOI 10.1111/j.1095-8312.2010.01384.x; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Kevan P, 1996, TRENDS PLANT SCI, V1, P280; Kress W. John, 2006, Aliso, V22, P621; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; LALL AB, 1982, J COMP PHYSIOL, V147, P195, DOI 10.1007/BF00609844; Lall AB, 2010, J COMP PHYSIOL A, V196, P629, DOI 10.1007/s00359-010-0549-x; LARSEN K., 1998, FAMILIES GENERA VASC, V4, P474, DOI DOI 10.1007/978-3-662-03531-3_49; Lebesa LN, 2012, INT J PEST MANAGE, V58, P165, DOI 10.1080/09670874.2012.673032; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Martinez-Harms J, 2012, J COMP PHYSIOL A, V198, P451, DOI 10.1007/s00359-012-0722-5; Mkenda P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143530; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Paudel BR, 2016, NEW PHYTOL, V211, P1402, DOI 10.1111/nph.13974; Paudel BR, 2015, ECOL EVOL, V5, P5240, DOI 10.1002/ece3.1784; Raven P. H., 1999, BIOL PLANTS, V6th; RAVEN PH, 1972, EVOLUTION, V26, P674, DOI 10.1111/j.1558-5646.1972.tb01975.x; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Sakai S, 1999, AM J BOT, V86, P646, DOI 10.2307/2656573; Sharkey CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00061-7; Shrestha M, 2016, PLANT BIOLOGY, V18, P842, DOI 10.1111/plb.12456; Shrestha M, 2014, J ECOL, V102, P126, DOI 10.1111/1365-2745.12185; Shrestha Mani, 2013, Commun Integr Biol, V6, pe24000, DOI 10.4161/cib.24000; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Steiner KE, 1998, AM J BOT, V85, P1180, DOI 10.2307/2446351; Steiner KE, 1998, PLANT SYST EVOL, V209, P47, DOI 10.1007/BF00991523; Streinzer M, 2009, J EXP BIOL, V212, P1365, DOI 10.1242/jeb.027482; THIEN LB, 1980, BIOTROPICA, V12, P1, DOI 10.2307/2387768; Waddington K.D., 1983, P213; Wang B, 2003, FRONT PLANT SCI, V4, P1; Wang YQ, 2005, INT J PLANT SCI, V166, P753, DOI 10.1086/431803; WCSP, 2015, WORLD CHECKL SEL PLA; YOUNG HJ, 1986, AM J BOT, V73, P931, DOI 10.2307/2444306; Zhang ZQ, 2008, ANN BOT-LONDON, V102, P531, DOI 10.1093/aob/mcn136; Zhao JL, 2016, GONDWANA RES, V32, P232, DOI 10.1016/j.gr.2015.02.004	62	10	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180460	10.1371/journal.pone.0180460	http://dx.doi.org/10.1371/journal.pone.0180460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723912	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800014
J	Molina-Lopez, RA; Manosa, S; Torres-Riera, A; Pomarol, M; Darwich, L				Angel Molina-Lopez, Rafael; Manosa, Santi; Torres-Riera, Alex; Pomarol, Manel; Darwich, Laila			Morbidity, outcomes and cost-benefit analysis of wildlife rehabilitation in Catalonia (Spain)	PLOS ONE			English	Article							POSTRELEASE SURVIVAL; MORTALITY; TRADE	Background There are few studies of careful examination of wildlife casualties in Wildlife Rehabilitation Centers. These studies are essential for detecting menaces to wild species and providing objective criteria about cost-benefit of treatments in those centers. The release rate is considered the main outcome indicator, but other parameters such as length of stay at the center and a cost-benefit index expressed as number of released animals per euro and day, could be used as reliable estimators of the rehabilitation costs. Methodology A retrospective study based on 54772 admissions recorded from 1995-2013 in the database of the Wildlife Rehabilitation Center of Torreferrussa (Catalonia, NW Spain) assessed the morbidity, outcomes and cost-benefits of the rehabilitation practices. Results Three hundred and two species were included: 232 birds (n = 48633), 37 mammals (n = 3293), 20 reptiles (n = 2705) and 13 amphibians (n = 141). The most frequent causes of admission were: 39.8% confiscation of protected species (89.4% passerines), 31.8% orphaned young animals (35.3% swifts, 21.7% diurnal raptors and owls) and 17.4% trauma casualties (46.7% raptors and owls). The highest proportion of releases was found in the captivity confiscation category [87.4% passerines (median time of stay: 12 days)], followed by the orphaned category [78% owls (66 days), 76.5% diurnal birds of prey (43 days), 75.6% hedgehogs (49 days), 52.7% swifts (19 days) and 52% bats (55 days)]. For the trauma group, 46.8% of releases were hedgehogs (44 days) and 25.6% owls (103 days). As regards the cost-benefit index, the trauma casualties and infectious diseases had the worse values with 1.3 and 1.4 released animals/euro/day respectively, and were particularly low in raptors, waders, marine birds and chiroptera. On the contrary, captivity (4.6) and misplacement (4.1) had the best index, particulary in amphibian, reptiles and passerines. Conclusions/significance Cost-benefit studies including the release rate, the time of stay at the center and the cost-benefit index should be implemented for improving management efficiency of the Wildlife Rehabilitation Centers.	[Angel Molina-Lopez, Rafael; Pomarol, Manel] Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Forestal Catalana, Santa Perpetua, Spain; [Manosa, Santi; Torres-Riera, Alex] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Inst Recerca Biodiversitat IRBio, Fac Biol, Barcelona, Spain; [Darwich, Laila] UAB, Dept Sanitat & Anat Anim, Fac Vet, Cerdanyola Del Valles, Spain; [Darwich, Laila] IRTA, CReSA, Campus UAB, Cerdanyola Del Valles, Spain	University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Molina-Lopez, RA (corresponding author), Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Forestal Catalana, Santa Perpetua, Spain.	rafael.molina@gencat.cat	Darwich, Laila/F-5330-2016; Mañosa, Santiago/R-6693-2018	Darwich, Laila/0000-0001-9027-9452; Manosa, Santi/0000-0003-0681-1552; Molina Lopez, Rafael/0000-0002-9043-2346				Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; BirdLife International, 2011, EUR C ILL KILL BIRDS; Boughner G, 1995, WILDLIFE REHABILITAT, V13, P139; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Burton DL, 1999, P 4 INT S URB WILDL, P171; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; Dubois S, 2003, THESIS; Duerr R, 2007, HAND REARING BIRDS, P3; Estrada J, 2014, PAIS VALENCIA BALEAR; Franco A, 2009, RED ANDALUZA CTR REC; Gosalbez J, 1987, HIST NATURAL DELS PA, V13, P205; Grogan A, 2013, VET REC, V172, P211, DOI 10.1136/vr.101139; Hartup BK, 1996, J WILDLIFE DIS, V32, P109, DOI 10.7589/0090-3558-32.1.109; Kelly Andrew, 2010, Endangered Species Research, V12, P107, DOI 10.3354/esr00299; Kelly TR, 2003, J WILD DIS, V39, P467; Kirkwood James K., 2003, P1; Leighton K, 2008, ANIM WELFARE, V17, P207; Ljubisavljevic K, 2011, NORTH-WEST J ZOOL, V7, P250; Lopez-Jurado L.F, 1979, NATURALIA HISPANICA, V17, P1, DOI [10.5061/dryad.q83bk3jhs, DOI 10.5061/DRYAD.Q83BK3JHS]; Manosa S, 2002, EKV200000637 REGHAB; Martinez Climent Jose Antonio, 2001, Biota (Race), V2, P163; Massey JG, 2005, P INT OIL SPILL C MI P INT OIL SPILL C MI, P463; Memon M, 2009, BIRD POPUL, V9, P76; Miller EA, 2012, MINIMUN STANDARDS WI; Molina-Lopez RA, 2013, PLOS ONE, V17; Molina-Lopez RA, 2015, VET QUART, V35, P9, DOI 10.1080/01652176.2014.985856; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Molony SE, 2007, ANIM WELFARE, V16, P361; Perez I, 2004, BIOL CONSERV, V118, P175, DOI 10.1016/j.biocon.2003.07.019; REDIG PT, 1995, T N AM WILDL NAT RES, P162; Rivera X., 2011, AMFIBIS REPTILS CATA; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Serangeli MT, 2012, ANIM WELFARE, V21, P9, DOI 10.7120/096272812799129510; Sharon Silow-Carroll JackA.Meyer., 2007, HOSP PERFORMANCE IMP; Sleeman JM, 2003, J AVIAN MED SURG, V17, P33, DOI 10.1647/1082-6742(2003)017[0033:CWMANP]2.0.CO;2; Sleeman Jonathan M., 2008, P97; Tribe A, 2014, AUSTR WILDL REH C MA; Tribe Andrew, 2000, Human Dimensions of Wildlife, V5, P69; Turkozan Oguz, 2007, APPLIED HERPETOLOGY, V4, P31, DOI 10.1163/157075407779766679; Vogelnest L, 2008, MED AUSTR MAMMALS, P11; Wendell MD, 2002, J WILDLIFE DIS, V38, P101, DOI 10.7589/0090-3558-38.1.101; Wimberger K, 2010, ANIM WELFARE, V19, P501; Zarate V, 2010, REV MED CHILE, V138, P93	43	24	27	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181331	10.1371/journal.pone.0181331	http://dx.doi.org/10.1371/journal.pone.0181331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719647	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400040
J	Bandyopadhyay, S; Li, J; Traer, E; Tyner, JW; Zhou, A; Oh, ST; Cheng, JX				Bandyopadhyay, Shovik; Li, Junjie; Traer, Elie; Tyner, Jeffrey W.; Zhou, Amy; Oh, Stephen T.; Cheng, Ji-Xin			Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia	PLOS ONE			English	Article							MYELOID-LEUKEMIA; ACYL-COENZYME; CANCER; AVASIMIBE; KINASE; CELLS; PROLIFERATION; VISUALIZATION; METABOLISM; ACTIVATION	Since the advent of tyrosine kinase inhibitors (TKIs) such as imatinib, nilotinib, and dasatinib, chronic myelogenous leukemia (CML) prognosis has improved greatly. However,-3040% of patients develop resistance to imatinib therapy. Although most resistance is caused by mutations in the BCR-ABL kinase domain, 50-85% of these patients develop resistance in the absence of new mutations. In these cases, targeting other pathways may be needed to regain clinical response. Using label-free Raman spectromicroscopy, we evaluated a number of leukemia cell lines and discovered an aberrant accumulation of cholesteryl ester (CE) in CML, which was found to be a result of BCR-ABL kinase activity. CE accumulation in CML was found to be a cancer-specific phenomenon as untransformed cells did not accumulate CE. Blocking cholesterol esterification with avasimibe, a potent inhibitor of acyl-CoA cholesterol acyltransferase 1 (ACAT-1), significantly suppressed CML cell proliferation in Ba/F3 cells with the BCR-ABLT315Imutation and in K562 cells rendered imatinib resistant without mutations in the BCR-ABL kinase domain (K562R cells). Furthermore, the combination of avasimibe and imatinib caused a profound synergistic inhibition of cell proliferation in K562R cells, but not in Ba/F3T3151. This synergistic effect was confirmed in a K562R xenograft mouse model. Analysis of primary cells from a BCR-ABL mutation-independent imatinib resistant patient by mass cytometry suggested that the synergy may be due to downregulation of the MAPK pathway by avasimibe, which sensitized the CML cells to imatinib treatment. Collectively, these data demonstrate a novel strategy for overcoming BCRABL mutation-independent TKI resistance in CML.	[Bandyopadhyay, Shovik] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Li, Junjie; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Traer, Elie; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Zhou, Amy; Oh, Stephen T.] Washington Univ, Sch Med, Div Hematol, St Louis, MO USA; [Cheng, Ji-Xin] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon Health & Science University; Oregon Health & Science University; Washington University (WUSTL); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Oh, ST (corresponding author), Washington Univ, Sch Med, Div Hematol, St Louis, MO USA.; Cheng, JX (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	stoh@dom.wustl.edu; jcheng@purdue.edu	Li, Junjie/B-1424-2017	Li, Junjie/0000-0003-4542-300X; Cheng, Ji-Xin/0000-0002-5607-6683; Bandyopadhyay, Shovik/0000-0003-3919-3914	Walther Cancer Foundation; NIH [K08HL106576, P01CA101937]; NCI Cancer Center Support Grant [P30CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL106576] Funding Source: NIH RePORTER	Walther Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by a grant from Walther Cancer Foundation to JXC. This work was supported by NIH grant K08HL106576 to STO. Support for patient sample collection and processing was provided by NIH grant P01CA101937. Technical support was provided by the Alvin J. Site man Cancer Center Tissue Procurement Core Facility, Flow Cytometry Core, and Immunomonitoring Laboratory, which are supported by NCI Cancer Center Support Grant P30CA91842.	Ai J, 2014, THER ADV HEMATOL, V5, P107, DOI 10.1177/2040620714537865; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Chen YF, 2011, ACTA PHARM SIN B, V1, P197, DOI 10.1016/j.apsb.2011.10.007; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; La Rosee P, 2002, CANCER RES, V62, P7149; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Ma LY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009073; Michallet M, 2010, CURR MED RES OPIN, V26, P307, DOI 10.1185/03007990903479299; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Thielen N, 2013, EUR J CANCER, V49, P3242, DOI 10.1016/j.ejca.2013.06.018; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	26	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179558	10.1371/journal.pone.0179558	http://dx.doi.org/10.1371/journal.pone.0179558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719608	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400006
J	Kim, J; He, HZ; Kim, H				Kim, Joomyeong; He, Hongzhi; Kim, Hana			Inversion of the imprinting control region of the Peg3 domain	PLOS ONE			English	Article							HUMAN-CHROMOSOME 19Q13.4; DNA METHYLATION; GENE; YY1	The imprinting of the mouse Peg3 domain is controlled through a 4-kb genomic region encompassing the bidirectional promoter and 1st exons of Peg3 and Usp29. In the current study, this ICR was inverted to test its orientation dependency for the transcriptional and imprinting control of the Peg3 domain. The inversion resulted in the exchange of promoters and 1st exons between Peg3 and Usp29. Paternal transmission of this inversion caused 10-fold down-regulation of Peg3 and 2-fold up-regulation of Usp29 in neonatal heads, consistent with its original promoter strength in each direction. The paternal transmission also resulted in reduced body size among the animals, which was likely contributed by the dramatic down-regulation of Peg3. Transmission through either allele caused no changes in the DNA methylation and imprinting status of the Peg3 domain except that Zfp264 became bi-allelic through the maternal transmission. Overall, the current study suggests that the orientation of the Peg3-ICR may play no role in its allele-specific DNA methylation, but very critical for the transcriptional regulation of the entire imprinted domain.	[Kim, Joomyeong; He, Hongzhi; Kim, Hana] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526	National Institute of Health [R01-GM066225, R01-GM097074]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institute of Health (R01-GM066225 and R01-GM097074 to J.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow DP, 2014, COLD SPRING HARB PER, V6; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158004; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Keverne EB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0327; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Perera BPU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119493; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Renfree MB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0151; Stewart KR, 2016, EPIGENOMICS-UK, V8, P1399, DOI 10.2217/epi-2016-0056; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181591	10.1371/journal.pone.0181591	http://dx.doi.org/10.1371/journal.pone.0181591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719641	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400058
J	Leiss, H; Salzberger, W; Jacobs, B; Gessl, I; Kozakowski, N; Bluml, S; Puchner, A; Kiss, A; Podesser, BK; Smolen, JS; Stummvoll, GH				Leiss, Harald; Salzberger, Wilhelm; Jacobs, Barbara; Gessl, Irina; Kozakowski, Nicolas; Blueml, Stephan; Puchner, Antonia; Kiss, Attila; Podesser, Bruno K.; Smolen, Josef S.; Stummvoll, Georg H.			MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristaneinduced lupus	PLOS ONE			English	Article							T-CELLS; AUTOIMMUNE INFLAMMATION; BONE HISTOMORPHOMETRY; ERYTHEMATOSUS; INTERFERON; PATHOGENESIS; DISEASE; ARTHRITIS; MECHANISMS; EXPRESSION	Objective We herein examine the role of endogenous miR155 in the development of systemic manifestations in pristane induced lupus. Materials and methods Systemic lupus in miR155-deficient and wild type mice was induced upon injection of pristane and analyzed after 8 months, PBS-injected mice served as controls. Glomerulonephritis and pneumonitis were quantified using the kidney biopsy score and a newly adapted histomorphometric image analysis system; lung tissue was further analyzed by tissue cytometry. Serum levels of anti-dsDNA, anti-histone and anti-chromatin antibodies were measured by ELISA. Frequencies of B cells, activated and regulatory CD4(+) T cells as well as Th1, Th2, Th17 cells were measured by flow cytometry. RT-qPCR was used to measure expression levels of interferon-signature and T-cell subset related as well as miR155-associated genes. Results After induction of lupus, miR155-deficient mice had significant less pulmonary involvement (perivascular inflammatory area in mm2/mm2 lung area 0.00092 +/- 0.00015 vs. 0.0027 +/- 0.00075, p = 0.0347) and renal disease (glomerular activity score 1.95 +/- 0.19 vs 3 +/- 0.26, p = 0.0029) compared to wild types. MiR155-deficient mice had significantly lower serum levels of disease-associated auto-antibodies and decreased frequencies of activated CD4(+)CD25(+) (Foxp3(-)) cells. Upon restimulation, CD4(+) cells showed a less pronounced Th2 and Th17 and a slightly decreased Th1 response in mir155-deficient mice. Pristane-treated wild types showed significantly up-regulated expression of genes related to the INF-signature (MX1, IP10, IRF7, ISG15). Conclusions MiR155-deficient mice had less severe organ involvement, lower serum auto-antibody levels, a less prominent T cell response and lower expressions of genes jointly responsible for disease development. Thus, antagonizing miR155 might be a future approach in treating SLE.	[Leiss, Harald; Salzberger, Wilhelm; Jacobs, Barbara; Gessl, Irina; Blueml, Stephan; Puchner, Antonia; Smolen, Josef S.; Stummvoll, Georg H.] Med Univ Vienna, Dept Rheumatol, Vienna, Austria; [Kozakowski, Nicolas] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Kiss, Attila; Podesser, Bruno K.] Med Univ Vienna, Ctr Biomed Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Leiss, H (corresponding author), Med Univ Vienna, Dept Rheumatol, Vienna, Austria.	harald.leiss@meduniwien.ac.at	Kiss, Attila/ABF-3583-2021; Kozakowski, Nicolas/I-1005-2019	Kiss, Attila/0000-0003-4652-1998; Kozakowski, Nicolas/0000-0001-9180-620X; Podesser, Bruno/0000-0002-4641-7202; Bluml, Stephan/0000-0002-2758-4400	Innovative Medicines Initiative (BTCure) [015142]; European Union's Seventh Framework Programme; EFPIA companies	Innovative Medicines Initiative (BTCure); European Union's Seventh Framework Programme; EFPIA companies	This research has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement 015142 (BTCure), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme and EFPIA companies' in kind contribution. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Chowdhary VR, 2007, RHEUMATOLOGY, V46, P1405, DOI 10.1093/rheumatology/kem117; Dahlgren J, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-8; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hadaschik EN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0538-0; Han SH, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0886-9; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kong KO, 2009, CLIN EXP IMMUNOL, V156, P134, DOI 10.1111/j.1365-2249.2009.03880.x; Leiss H, 2013, LUPUS, V22, P778, DOI 10.1177/0961203313492869; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Leonard JP, 2012, BLOOD; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma XC, 2013, INT J RHEUM DIS, V16, P115, DOI 10.1111/1756-185X.12083; MCKENZIE WN, 1988, AM J PATHOL, V131, P530; Nacionales DC, 2006, AM J PATHOL, V168, P1227, DOI 10.2353/ajpath.2006.050125; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Scheinecker C, 2001, ARTHRITIS RHEUM, V44, P856, DOI 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; Schett Georg, 2007, V135, P269; Stummvoll G, 2017, WIEN KLIN W IN PRESS; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Thai TH, 2013, P NATL ACAD SCI USA, V110, P20194, DOI 10.1073/pnas.1317632110; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Xin Q, 2015, J IMMUNOL, V194, P5437, DOI 10.4049/jimmunol.1403028; Xu Y, 2014, METHODS MOL BIOL, V1134, P103, DOI 10.1007/978-1-4939-0326-9_9; Zhou SY, 2016, ARTHRITIS RHEUMATOL, V68, P953, DOI 10.1002/art.39485	46	22	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181015	10.1371/journal.pone.0181015	http://dx.doi.org/10.1371/journal.pone.0181015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719617	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400027
J	Mehler, DMA; Reichenbach, A; Klein, J; Diedrichsen, J				Mehler, David Marc Anton; Reichenbach, Alexandra; Klein, Julius; Diedrichsen, Jom			Minimizing endpoint variability through reinforcement learning during reaching movements involving shoulder, elbow and wrist	PLOS ONE			English	Article							MOTOR CONTROL; STROKE; COORDINATION; CEREBELLUM; TASK; ADAPTATION; DYNAMICS; RECOVERY; BEHAVIOR; THERAPY	Reaching movements are comprised of the coordinated action across multiple joints. The human skeleton is redundant for this task because different joint configurations can lead to the same endpoint in space. How do people learn to use combinations of joints that maximize success in goal-directed motor tasks? To answer this question, we used a 3-degreeof-freedom manipulandum to measure shoulder, elbow and wrist joint movements during reaching in a plane. We tested whether a shift in the relative contribution of the wrist and elbow joints to a reaching movement could be learned by an implicit reinforcement regime. Unknown to the participants, we decreased the task success for certain joint configurations (wrist flexion or extension, respectively) by adding random variability to the endpoint feedback. In return, the opposite wrist postures were rewarded in the two experimental groups (flexion and extension group). We found that the joint configuration slowly shifted towards movements that provided more control over the endpoint and hence higher task success. While the overall learning was significant, only the group that was guided to extend the wrist joint more during the movement showed substantial learning. Importantly, all changes in movement pattern occurred independent of conscious awareness of the experimental manipulation. These findings suggest that the motor system is generally sensitive to its output variability and can optimize joint-space solutions that minimize task-relevant output variability. We discuss biomechanical biases (e.g. joint's range of movement) that could impose hurdles to the learning process.	[Mehler, David Marc Anton; Reichenbach, Alexandra; Diedrichsen, Jom] UCL, Inst Cognit Neurosci, London, England; [Mehler, David Marc Anton] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Mehler, David Marc Anton] Cardiff Univ, Cardiff Univ Brain Res Imaging Ctr, Sch Psychol, Cardiff, S Glam, Wales; [Reichenbach, Alexandra] Heilbronn Univ, Dept Comp Sci, Heilbronn, Germany; [Klein, Julius] Tecnalia Res & Innovat, Donostia San Sebastian, Spain; [Diedrichsen, Jom] Western Univ, Brain & Mind Inst, London, ON, Canada	University of London; University College London; University of Munster; Cardiff University; Western University (University of Western Ontario)	Diedrichsen, J (corresponding author), UCL, Inst Cognit Neurosci, London, England.; Diedrichsen, J (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.	jdiedric@uwo.ca	Reichenbach, Alexandra/B-1455-2016; Diedrichsen, Jörn/AAQ-2242-2020; Mehler, David/ACO-9611-2022	Reichenbach, Alexandra/0000-0003-4199-3005; Diedrichsen, Jörn/0000-0003-0264-8532; Mehler, David/0000-0001-6587-2617	Biotechnology and Biological Science Research Council (BBSRC) [BB/ J009458/1]; Heinrich Boell Foundation; Deutsche Forschungsgemeinschaft (DFG) [RE 3265/1-1]; Tecnalia Research and Innovation; Heinrich Boll Foundation	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Heinrich Boell Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tecnalia Research and Innovation; Heinrich Boll Foundation	This research was funded by the Biotechnology and Biological Science Research Council (BBSRC; BB/ J009458/1; http://www.bbsrc.ac.uk/), a studentship from Heinrich Boell Foundation to D.M.A.M. (https://www.boell.de/en), and a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft (DFG; RE 3265/1-1; http://www.dfg.de/). Tecnalia Research and Innovation provided support in the form of salaries for J.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.; We thank Etienne Burdet and Nick Roach for their contribution to the development of the robotic interface and the Heinrich Boll Foundation for supporting David Mehler with a studentship. We also thank Harry Manley and Oscar Woolnough for helpful comments on an earlier manuscript of this paper.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Bernstein NA, 1967, COORDINATION MOVEMEN; Campolo D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002978; Cirstea MC, 2003, EXP BRAIN RES, V151, P289, DOI 10.1007/s00221-003-1438-0; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Dam G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055352; Dam G, 2009, COGNITIVE SCI, V33, P530, DOI 10.1111/j.1551-6709.2009.01021.x; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Diedrichsen J, 2007, J NEUROSCI, V27, P6291, DOI 10.1523/JNEUROSCI.0061-07.2007; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; Ganesh G, 2013, ROBOT AUTON SYST, V61, P362, DOI 10.1016/j.robot.2012.09.024; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hasson CJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00459; He K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005023; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kitago T, 2013, MOTOR LEARNING PRINC, P110; Kitago T, 2015, J NEUROPHYSIOL, V114, P1885, DOI 10.1152/jn.00336.2015; Klein J, 2014, IEEE T HAPTICS, V7, P229, DOI 10.1109/TOH.2013.59; Klein J, 2012, IEEE T NEUR SYS REH, V20, P268, DOI 10.1109/TNSRE.2012.2195202; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Levin MF, 2009, NEUROREHABILITATION; Manley H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086580; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Ryu J, 1991, JHS, P409; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schweighofer N, 2009, PHYS THER, V89, P1327, DOI 10.2522/ptj.20080402; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Sketch SM, 2017, BIORXIV; Sternad D, 2014, ADV EXP MED BIOL, V826, P101, DOI 10.1007/978-1-4939-1338-1_8; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Turner DL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00184; Weiler J, 2015, J NEUROPHYSIOL, V114, P3242, DOI 10.1152/jn.00702.2015; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Yarosh CA, 2004, J NEUROPHYSIOL, V92, P3276, DOI 10.1152/jn.00549.2004	50	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180803	10.1371/journal.pone.0180803	http://dx.doi.org/10.1371/journal.pone.0180803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719661	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000406061400018
J	Gao, Q; Yu, M				Gao, Qiong; Yu, Mei			Reforestation-induced changes of landscape composition and configuration modulate freshwater supply and flooding risk of tropical watersheds	PLOS ONE			English	Article							LAND-USE CHANGE; PUERTO-RICO; URBAN SPRAWL; FORESTS; REDISTRIBUTION; FRAGMENTATION; GENERATION; MODEL	Impact of changes in land cover and land use on hydrological service of tropical watersheds is one of the focal research tropics in both hydrology and Land Cover Land Use Changes (LCLUC). Land fragmentation is an important feature of LCLUC, however, its impact on hydrological service of tropical watershed is unclear despite a few theoretical frameworks. In this paper, we described a simulation study of eight tropical watersheds in Puerto Rico using the Soil Water Assessment Tool. Annual average stream discharge was derived according to the simulations with the land cover maps in 1977, 1991, and 2000. Annual big stream discharge with risks of flooding and severe soil erosion was computed as the sum of daily discharge greater than 95 th percentile. The impacts of changes in land cover and fragmentation represented by perimeter-to-area ratio of land patches on annual average and big discharges were further analyzed by means of the linear mixed-effects model. Most mountainous watersheds were characterized by reforestation in 1977-1991 but slight deforestation in 1991-2000. Forest perimeter-to-area ratio was significantly correlated with covers of forest (correlation coefficient of -0.97), pasture (0.94), and urban (0.95). Thus forest fragmentation was reduced by reforestation but increased by deforestation. The annual average and big discharges were significantly reduced by forest cover and forest perimeterto-area ratio. The enhanced edge effect by forest fragmentation may have incurred more effective interception of the subsurface flow by forest root system, and promoted forest transpiration, thus reduced stream flows. Land cover change plays more important roles in regulating the big discharges than altering the annual average discharges. Due to the negative correlation between forest cover and fragmentation, the decreased forest fragmentation accompanied with reforestation offsets the impact of reforestation on lessening freshwater supply and flooding risk.	[Gao, Qiong; Yu, Mei] Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Yu, M (corresponding author), Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA.	meiyu@ites.upr.edu			National Aeronautics and Space Administration Land Cover / Land Use Change Program [NNX12AE98G]; Natural Science Foundation LUQ-LTER program (NSF) [DEB-1546686]	National Aeronautics and Space Administration Land Cover / Land Use Change Program; Natural Science Foundation LUQ-LTER program (NSF)	This study was supported by the grants from the National Aeronautics and Space Administration Land Cover / Land Use Change Program (NNX12AE98G), and the Natural Science Foundation LUQ-LTER program (NSF DEB-1546686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CONTRIBUTION WORKING, P1535; [Anonymous], 2015, SOIL SURV STAFF; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; ARNOLD JG, 1993, J HYDROL, V142, P47, DOI 10.1016/0022-1694(93)90004-S; Arnold JG, 1992, J HYDRAULIC ENG, V121, P171; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Bunyan M., 2012, American Journal of Plant Sciences, V3, P869, DOI 10.4236/ajps.2012.37104; Calder I. R., 2002, LAND USE WATER RESOU, V2, P1; Campbell JD, 2011, INT J CLIMATOL, V31, P1866, DOI 10.1002/joc.2200; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Cashman A, 2013, WATER SECURITY SERVI; Cotler H, 2006, CATENA, V65, P107, DOI 10.1016/j.catena.2005.11.004; DeFries R, 2004, HYDROL PROCESS, V18, P2183, DOI 10.1002/hyp.5584; Demetriou D, 2012, ENVIRON PLANN B, V39, P609, DOI 10.1068/b37075; Demetrious D., 2014, DEV INTEGRATED PLANN; Farrell D., 2010, DROUGHT EARLY WARNIN; Gao Q, 1997, ENVIRON ECOL STAT, V4, P205; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113140; Gao QO, 1997, LANDSCAPE ECOL, V12, P321, DOI 10.1023/A:1007985624887; Heffernan, 2013, NATURE, DOI 10.1038/nature.2013.12570; Helmer EH, 2002, CARIBB J SCI, V38, P165; International Sustainability Unit, 2015, TROP FOR REV; Kennaway T, 2007, GISCI REMOTE SENS, V44, P356, DOI 10.2747/1548-1603.44.4.356; Laursen L., 2012, NATURE; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lopez T.D.M., 1998, CARIBB J SCI, V34, P298; Lugo AE, 2004, FOREST ECOL MANAG, V190, P145, DOI 10.1016/j.foreco.2003.09.012; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; LUGO AE, 1981, AMBIO, V10, P318; Martinuzzi S, 2007, LANDSCAPE URBAN PLAN, V79, P288, DOI 10.1016/j.landurbplan.2006.02.014; Mitchell MGE, 2015, TRENDS ECOL EVOL, V30, P190, DOI 10.1016/j.tree.2015.01.011; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Munoz-Villers LE, 2013, HYDROL EARTH SYST SC, V17, P3543, DOI 10.5194/hess-17-3543-2013; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu JX, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00312.1; R Core Term, 2015, LANG ENV STAT COMP; Recha JW, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000439.1; Ren Y, 2012, J ENVIRON MANAGE, V113, P447, DOI 10.1016/j.jenvman.2012.09.011; Rowland L, 2015, NATURE, V528, P119, DOI 10.1038/nature15539; Sanderson M., 2012, TREE PHYSIOL, V37, P316; SRINIVASAN R, 1994, WATER RESOUR BULL, V30, P453; Srinivasan R, 1995, HYDROLOGICAL SCI TEC, V11, P160; Wu XB, 2000, J ECOL, V88, P790, DOI 10.1046/j.1365-2745.2000.00491.x; Yu M, 2017, SCI REP, V7; Yu M, 2008, ECOL APPL, V18, P1679, DOI 10.1890/07-0640.1; Ziegler AD, 2004, J HYDROL, V287, P124, DOI 10.1016/j.jhydrol.2003.09.027	47	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181315	10.1371/journal.pone.0181315	http://dx.doi.org/10.1371/journal.pone.0181315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708878	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800054
J	Westin, AA; Brekke, M; Molden, E; Skogvoll, E; Spigset, O				Westin, Andreas Austgulen; Brekke, Malin; Molden, Espen; Skogvoll, Eirik; Spigset, Olav			Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition	PLOS ONE			English	Article							PHARMACOKINETIC CHANGES; ANTIDEPRESSANT METABOLISM; PLASMA-CONCENTRATIONS; SERUM CONCENTRATIONS; NORFLUOXETINE; POSTPARTUM; FLUOXETINE; SERTRALINE; CHILDBEARING; ESCITALOPRAM	Background Pregnancy may cause changes in drug disposition. The clinical consequences may be profound and even counterintuitive; in some cases pregnant women may need more than twice their usual drug dose in order to maintain therapeutic drug levels. For antidepressants, evidence on drug disposition in pregnancy is scarce. The aim of this study was to determine the effects of pregnancy on serum levels of selective serotonin reuptake inhibitors (SSRIs) and venlafaxine in a large and naturalistic patient material, in order to provide tentative dose recommendations for pregnant women. Methods Using patient data from two routine therapeutic drug monitoring (TDM) services in Norway with linkage to the national birth registry, dose-adjusted serum drug concentrations of SSRIs and venlafaxine during pregnancy were compared to the women's own baseline (non-pregnant) values, using a linear mixed model. Findings Overall, the TDM databases contained 196,726 serum concentration measurements from 54,393 women. After data linkage and drug selection (SSRIs or venlafaxine only), we identified 367 analyses obtained from a total of 290 pregnancies in 281 women, and 420 baseline observations from the same women. Serum concentrations in the third trimester were significantly lower than baseline for paroxetine (-51%; 95% confidence interval [CI], -66%, -30%; p<0.001), fluvoxamine (-56%; CI, -75%, -23%; p = 0.004) and citalopram (-24%; CI, -38%, -7%; p = 0,007), and higher than baseline for sertraline (+68%; CI, +37%, +106%; p<0.001). For escitalopram, fluoxetine and venlafaxine concentrations did not change significantly. Conclusions For paroxetine and fluvoxamine the pronounced decline in maternal drug serum concentrations in pregnancy may necessitate a dose increase of about 100% during the third trimester in order to maintain stable concentrations. For fluoxetine, venlafaxine, citalopram, escitalopram and sertraline, the present study indicates that dose adjustments are generally not necessary during pregnancy.	[Westin, Andreas Austgulen; Spigset, Olav] St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway; [Brekke, Malin; Molden, Espen] Diakonhjemmet Hosp, Ctr Psychopharmacol, Oslo, Norway; [Molden, Espen] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Skogvoll, Eirik] St Olavs Univ Hosp, Dept Anaesthesiol & Intens Care, Trondheim, Norway; [Skogvoll, Eirik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Spigset, Olav] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Diakonhjemmet Hospital; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Westin, AA (corresponding author), St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway.	andreas.westin@stolav.no		Skogvoll, Eirik/0000-0002-6984-0708				Altshuler LL, 1996, J CLIN PSYCHOPHARM, V16, P78, DOI 10.1097/00004714-199602000-00015; Alwan S, 2016, CNS DRUGS, V30, P499, DOI 10.1007/s40263-016-0338-3; Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001; Briggs GG, 2015, AM J OBSTET GYNECOL, V213, P810, DOI 10.1016/j.ajog.2015.05.047; Brogtrop J, 2007, PHARM WEEKBLAD, V142, P34; Brunton L., 2011, GOODMAN GILMANS PHAR; Caccia S, 2004, IDRUGS, V7, P143; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; Deligiannidis KM, 2014, J CLIN PSYCHOPHARM, V34, P244, DOI 10.1097/JCP.0000000000000087; DeVane C Lindsay, 2006, J Psychopharmacol, V20, P54, DOI 10.1177/1359786806066054; Freeman MP, 2008, J CLIN PSYCHOPHARM, V28, P646, DOI 10.1097/JCP.0b013e31818d2048; Gjestad C, 2015, THER DRUG MONIT, V37, P90, DOI 10.1097/FTD.0000000000000101; Heikkinen T, 2003, CLIN PHARMACOL THER, V73, P330, DOI 10.1016/S0009-9236(02)17634-X; Heikkinen T, 2002, CLIN PHARMACOL THER, V72, P184, DOI 10.1067/mcp.2002.126181; Hermann M, 2015, THER DRUG MONIT, V37, P546, DOI 10.1097/FTD.0000000000000169; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hostetter A, 2000, DEPRESS ANXIETY, V11, P51, DOI 10.1002/(SICI)1520-6394(2000)11:2<51::AID-DA1>3.3.CO;2-I; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kim J, 2006, BRIT J CLIN PHARMACO, V61, P155, DOI 10.1111/j.1365-2125.2005.02538.x; Klier CM, 2007, J CLIN PSYCHOPHARM, V27, P720, DOI 10.1097/JCP.0b013e31815a57d8; Larsen ER, 2015, ACTA PSYCHIAT SCAND, V132, P1, DOI 10.1111/acps.12479; Matsui D., 2012, OBSTET GYNECOL INT, V2012, DOI DOI 10.1155/2012/796590]; Muzik M, 2016, MATERN CHILD HLTH J, V20, P2268, DOI 10.1007/s10995-016-2038-5; O'Brien L, 2010, FORENSIC SCI INT, V196, P93, DOI 10.1016/j.forsciint.2009.12.034; Obach RS, 2005, DRUG METAB DISPOS, V33, P262, DOI 10.1124/dmd.104.002428; Osborne LM, 2014, ARCH WOMEN MENT HLTH, V17, P239, DOI 10.1007/s00737-014-0421-z; Pariente G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002160; Rao N, 2007, CLIN PHARMACOKINET, V46, P281, DOI 10.2165/00003088-200746040-00002; Reis M, 2009, THER DRUG MONIT, V31, P42, DOI 10.1097/FTD.0b013e31819114ea; Scordo MG, 2005, BASIC CLIN PHARMACOL, V97, P296, DOI 10.1111/j.1742-7843.2005.pto_194.x; Sheffield JS, 2014, CLIN INFECT DIS, V59, pS437, DOI 10.1093/cid/ciu709; Sit D, 2010, J CLIN PSYCHOPHARM, V30, P381, DOI 10.1097/JCP.0b013e3181e7be23; Sit DK, 2008, J CLIN PSYCHIAT, V69, P652, DOI 10.4088/JCP.v69n0419; Spigset Olav, 2008, Tidsskr Nor Laegeforen, V128, P2832; Tang SW, 2008, EXPERT OPIN PHARMACO, V9, P787, DOI 10.1517/14656566.9.5.787 ; Tasnif Y, 2016, CLIN PHARMACOL THER, V100, P53, DOI 10.1002/cpt.382; ter Horst PGJ, 2015, EUR J CLIN PHARMACOL, V71, P1493, DOI 10.1007/s00228-015-1944-6; ter Horst PGJ, 2014, J CLIN PHARM THER, V39, P541, DOI 10.1111/jcpt.12188; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; van Heeswijk RPG, 2004, CLIN PHARMACOL THER, V76, P588, DOI 10.1016/j.clpt.2004.08.011; Ververs FFT, 2009, CLIN PHARMACOKINET, V48, P677, DOI 10.2165/11318050-000000000-00000; Voinescu PE, 2015, EXPERT REV NEUROTHER, V15, P1171, DOI 10.1586/14737175.2015.1083422; Westin Andreas Austgulen, 2012, Tidsskr Nor Laegeforen, V132, P2382, DOI 10.4045/tidsskr.12.0383; WISNER KL, 1993, AM J PSYCHIAT, V150, P1541; Wisner KL, 1997, PSYCHOPHARMACOL BULL, V33, P243; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND	46	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181082	10.1371/journal.pone.0181082	http://dx.doi.org/10.1371/journal.pone.0181082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708853	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800039
J	Caballero, D; Li, YW; Fetene, J; Ponsetto, J; Chen, A; Zhu, CL; Braddock, DT; Bergwitz, C				Caballero, Daniel; Li, Yuwen; Fetene, Jonathan; Ponsetto, Julian; Chen, Alyssa; Zhu, Chuanlong; Braddock, Demetrios T.; Bergwitz, Clemens			Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice	PLOS ONE			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; SODIUM-PHOSPHATE COTRANSPORTER; GENERALIZED ARTERIAL CALCIFICATION; INORGANIC PYROPHOSPHATE; MINERALIZATION DISORDERS; ECTOPIC MINERALIZATION; URINARY-EXCRETION; STONE FORMERS; HYPERCALCIURIA; OSTEOPONTIN	Mutations in the proximal tubular sodium-dependent phosphate co-transporters NPT2a and NPT2c have been reported in patients with renal stone disease and nephrocalcinosis, however the relative contribution of genotype, dietary calcium and phosphate, and modifiers of mineralization such as pyrophosphate (PPi) to the formation of renal mineral deposits is unclear. In the present study, we used Npt2a(-/-) mice to model the renal calcifications observed in these disorders. We observed elevated urinary excretion of PPi in Npt2a(-/-) mice when compared to WT mice. Presence of two hypomorphic Extracellular nucleotide pyrophosphatase phosphodiesterase 1 (Enpp1(asj/asj)) alleles decreased urine PPi and worsened renal calcifications in Npt2a(-/-) mice. These studies suggest that PPi is a thus far unrecognized factor protecting Npt2a(-/-) mice from the development of renal mineral deposits. Consistent with this conclusion, we next showed that renal calcifications in these mice can be reduced by intraperitoneal administration of sodium pyrophosphate. If confirmed in humans, urine PPi could therefore be of interest for developing new strategies to prevent the nephrocalcinosis and nephrolithiasis seen in phosphaturic disorders.	[Caballero, Daniel; Fetene, Jonathan; Ponsetto, Julian; Chen, Alyssa; Bergwitz, Clemens] Yale Univ, Sch Med, Dept Med, Sect Endocrinol, New Haven, CT 06510 USA; [Li, Yuwen] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Li, Yuwen; Zhu, Chuanlong] Harvard Med Sch, Boston, MA USA; [Li, Yuwen] Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Chuanlong] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Zhu, Chuanlong] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Braddock, Demetrios T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanjing Medical University; Harvard University; Massachusetts General Hospital; Nanjing Medical University; Yale University	Bergwitz, C (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Endocrinol, New Haven, CT 06510 USA.	clemens.bergwitz@yale.edu	Zhu, Chuanlong/GPF-5191-2022; li, yuwen/HGU-6435-2022; Caballero, Daniel/GXV-3082-2022; Li, yu/HHZ-5236-2022	Caballero, Daniel/0000-0001-9232-8991	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [5K08-DK078361]; Center for Skeletal Research Core NIH [P30 AR066261]; Young Investigator Awards by the National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China [81271713]; Scientific research fund of Anhui Medical University [2011xkj074]; Yale O'Brien Center (Pilot grant); NIH [P30DK079310]; Yale Mouse Metabolic Phenotyping Center NIH [U24 DK-059635]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, P30DK079310, K08DK078361] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core NIH; Young Investigator Awards by the National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific research fund of Anhui Medical University; Yale O'Brien Center (Pilot grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Center NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant 5K08-DK078361 (to C.B.), Center for Skeletal Research Core NIH P30 AR066261, Young Investigator Awards by the National Kidney Foundation, and the American Society for Clinical Investigation (to C.B.), National Natural Science Foundation of China grant 81271713 (to C.Z.) and the Scientific research fund of Anhui Medical University 2011xkj074 (to Y.L.). We are grateful to the Yale OBrien Center (Pilot grant to C.B., NIH P30DK079310), the Yale Mouse Metabolic Phenotyping Center NIH U24 DK-059635 for help with biochemical analysis, the Yale Dept. of Orthopaedics Histology and Histomorphometry Laboratory for help with histological and the Yale Center for Cellular and Molecular Imaging (YCCMI) for electron microscopic analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; ALON U, 1992, J PEDIATR-US, V120, P899, DOI 10.1016/S0022-3476(05)81957-2; Arcidiacono T, 2014, AM J NEPHROL, V40, P499, DOI 10.1159/000369833; Baumann J M, 1977, Z Urol Nephrol, V70, P449; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; BURR RG, 1985, BRIT J UROL, V57, P275, DOI 10.1111/j.1464-410X.1985.tb06342.x; Caballero D, 2016, AM J PHYSL RENAL PHY; Caballero D, 2017, AM J PHYSIOL-RENAL, V312, pF77, DOI 10.1152/ajprenal.00367.2016; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Carr G, 2007, CELL PHYSIOL BIOCHEM, V20, P507, DOI 10.1159/000107534; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Hunter GK, 2013, CALCIFIED TISSUE INT, V93, P348, DOI 10.1007/s00223-013-9698-6; Khan SR, 2011, J UROLOGY, V186, P1107, DOI 10.1016/j.juro.2011.04.109; LAMINSKI NA, 1990, NEPHRON, V56, P379, DOI 10.1159/000186179; Li QL, 2016, J INVEST DERMATOL, V136, P550, DOI 10.1016/j.jid.2015.10.065; Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Li Y, 2017, RESPONSE NPT2A UNPUB; Li YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176232; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; March JG, 2001, CLIN CHIM ACTA, V314, P187, DOI 10.1016/S0009-8981(01)00695-7; Moochhala SH, 2008, EXP PHYSIOL, V93, P43, DOI 10.1113/expphysiol.2007.040790; Moochhala SH, 2012, NEPHRON PHYSIOL, V120, P33, DOI 10.1159/000341597; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Rendenbach C, 2014, CALCIFIED TISSUE INT, V94, P474, DOI 10.1007/s00223-013-9831-6; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; RUSSELL RGG, 1976, ARTHRITIS RHEUM-US, V19, P465, DOI 10.1002/1529-0131(197605/06)19:3+<465::AID-ART1780190722>3.0.CO;2-#; Schlingmann KP, 2015, J AM SOC NEPHROL; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; SHARMA S, 1992, UROL INT, V48, P404, DOI 10.1159/000282364; Tenenhouse HS, 2004, AM J PHYSIOL-RENAL, V286, pF675, DOI 10.1152/ajprenal.00362.2003; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; TIEDER M, 1992, NEPHRON, V62, P176, DOI 10.1159/000187029; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D	48	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180098	10.1371/journal.pone.0180098	http://dx.doi.org/10.1371/journal.pone.0180098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704395	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700028
J	Wu, Q; Fu, XQ; Jiang, LL; Yang, RS; Cun, JP; Zhou, XF; Zhou, YM; Xiang, YB; Gu, WP; Fan, JH; Li, H; Xu, W				Wu, Qiang; Fu, Xiaoqing; Jiang, Lili; Yang, Rusong; Cun, Jianping; Zhou, Xiaofang; Zhou, Yongming; Xiang, Yibing; Gu, Wenpeng; Fan, Jianhua; Li, Hong; Xu, Wen			Prevalence of enteroviruses in healthy populations and excretion of pathogens in patients with hand, foot, and mouth disease in a highly endemic area of southwest China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PACIFIC REGION; RT-PCR; CHILDREN; CIRCULATION; INFECTION; STRAINS; SAMPLES; RISK; VP1	Etiological carriers and the excretion of the pathogens causing hand, foot, and mouth disease (HFMD) in healthy persons, patients, and asymptomatic persons infected with HFMD as ongoing infection sources may play an important role in perpetuating and spreading epidemics of HFMD. The aims of this study were to determine the carrier status of EV-A71 and CV-A16 in healthy populations, as well as the duration of EV-A71 and CV-A16 shedding in the stools of HFMD patients in an epidemic area of southwest China. A cross-sectional study and a follow-up study were conducted in three HFMD endemic counties of Yunnan Province. Six hundred sixty-seven healthy subjects were recruited to participate in the cross-sectional study, and two stool specimens were collected from each subject. Among the healthy subjects, 90 (13.5%) tested positive for viral isolation, but neither EV-A71 nor CV-A16 was detected in healthy individuals. Of the 150 patients with probable HFMD, 55.3% (83/150) tested positive for viral isolation with presented serotypes such as EV-A71 (51.81%, 43/83), CV-A16 (32.53%, 27/83), other EVs (13.25%, 11/83), and mixed EV-A71 and CV-A16 (2.41%, 2/83). The longest duration of EV-A71 and CV-A16 shedding in stool specimens from patients with HFMD was >46 days after onset. The positive rate of EV-A71 in the stool specimens of confirmed patients dropped to 50% by the end of the third week, and the same occurred with CV-A16 by the end of approximately the seventh week after onset. Although carriers of major causative agents of HFMD in healthy populations are fewer in number, the prolonged shedding of pathogens in patients with HFMD may serve as an important factor in perpetuating and spreading HFMD epidemics.	[Wu, Qiang; Yang, Rusong] Yuxi City Ctr Dis Control & Prevent, Yuxi City, Yunnan, Peoples R China; [Fu, Xiaoqing; Jiang, Lili; Cun, Jianping; Zhou, Xiaofang; Zhou, Yongming; Xiang, Yibing; Gu, Wenpeng; Li, Hong; Xu, Wen] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Fan, Jianhua] Xishuang Banna Autonomous Prefecture Ctr Dis Cont, Jinghong City, Yunnan, Peoples R China		Li, H; Xu, W (corresponding author), Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China.	lihongkmyncn@aliyun.com; yncdcxuwen@sohu.com	Gu, Wenpeng/U-5367-2017		academician workstation in Yunnan [2015IC031]	academician workstation in Yunnan	This work was supported by an academician workstation in Yunnan (No. 2015IC031).	Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; Deng Ai-ping, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P189; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Guan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142733; Guo WP, 2015, J CLIN VIROL, V70, P29, DOI 10.1016/j.jcv.2015.06.093; Han J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-178; He SJ, 2013, INT J INFECT DIS, V17, pE1025, DOI 10.1016/j.ijid.2013.04.003; He Yi-lin, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P1073; Honkanen H, 2013, J CLIN VIROL, V56, P348, DOI 10.1016/j.jcv.2012.11.018; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Jiang WenGuo, 2011, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V6, P857; Li J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-31; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Pan Hao, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P339; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Shoja ZO, 2007, J CLIN LAB ANAL, V21, P232, DOI 10.1002/jcla.20171; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Teng Shu, 2013, Zhonghua Er Ke Za Zhi, V51, P787; Wang Zhao-guo, 2011, Chinese Journal of Virology, V27, P438; Wen Hong-mei, 2011, Chinese Journal of Virology, V27, P342; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06; Wu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073920; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yang Zhi-hong, 2005, Zhonghua Er Ke Za Zhi, V43, P648; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao Qi, 2015, Bing Du Xue Bao, V31, P554; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923; Zhuang ZC, 2015, VIRUSES-BASEL, V7, P6400, DOI 10.3390/v7122947	44	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181234	10.1371/journal.pone.0181234	http://dx.doi.org/10.1371/journal.pone.0181234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704524	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700113
J	Ashrafi, S; Helaly, S; Schroers, HJ; Stadler, M; Richert-Poeggeler, KR; Dababat, AA; Maier, W				Ashrafi, Samad; Helaly, Soleiman; Schroers, Hans-Josef; Stadler, Marc; Richert-Poeggeler, Katja R.; Dababat, Abdelfattah A.; Maier, Wolfgang			Ijuhya vitellina sp.nov., a novel source for chaetoglobosin A, is a destructive parasite of the cereal cyst nematode Heterodera filipjevi	PLOS ONE			English	Article							RIBOSOMAL DNA; SECONDARY METABOLITES; NEMATOCIDAL ACTIVITY; NEMATOPHAGOUS FUNGI; CLONOSTACHYS-ROSEA; GEN. NOV; CHAETOMIUM; BIONECTRIACEAE; HYPOCREALES; ASCOMYCOTA	Cyst nematodes are globally important pathogens in agriculture. Their sedentary lifestyle and long-term association with the roots of host plants render cyst nematodes especially good targets for attack by parasitic fungi. In this context fungi were specifically isolated from nematode eggs of the cereal cyst nematode Heterodera filipjevi. Here, Ijuhya vitellina (Ascomycota, Hypocreales, Bionectriaceae), encountered in wheat fields in Turkey, is newly described on the basis of phylogenetic analyses, morphological characters and life-style related inferences. The species destructively parasitises eggs inside cysts of H. filipjevi. The parasitism was reproduced in in vitro studies. Infected eggs were found to harbour microsclerotia produced by I. vitellina that resemble long-term survival structures also known from other ascomycetes. Microsclerotia were also formed by this species in pure cultures obtained from both, solitarily isolated infected eggs obtained from fields and artificially infected eggs. Hyphae penetrating the eggshell colonised the interior of eggs and became transformed into multicellular, chlamydospore-like structures that developed into microsclerotia. When isolated on artificial media, microsclerotia germinated to produce multiple emerging hyphae. The specific nature of morphological structures produced by I. vitellina inside nematode eggs is interpreted as a unique mode of interaction allowing long-term survival of the fungus inside nematode cysts that are known to survive periods of drought or other harsh environmental conditions. Generic classification of the new species is based on molecular phylogenetic inferences using five different gene regions. I. vitellina is the only species of the genus known to parasitise nematodes and produce microsclerotia. Metabolomic analyses revealed that within the Ijuhya species studied here, only I. vitellina produces chaetoglobosin A and its derivate 19-O-acetylchaetoglobosin A. Nematicidal and nematode- inhibiting activities of these compounds have been demonstrated suggesting that the production of these compounds may represent an adaptation to nematode parasitism.	[Ashrafi, Samad; Richert-Poeggeler, Katja R.; Maier, Wolfgang] Fed Res Ctr Cultivated Plants, JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Ashrafi, Samad] Univ Kassel, Fac Organ Agr Sci, Dept Ecol Plant Protect, Witzenhausen, Germany; [Helaly, Soleiman; Stadler, Marc] Helmholtz Ctr Infect Res GmbH HZI, Dept Microbial Drugs, Braunschweig, Germany; [Helaly, Soleiman] Aswan Univ, Fac Sci, Dept Chem, Aswan, Egypt; [Schroers, Hans-Josef] Agr Inst Slovenia, Ljubljana, Slovenia; [Dababat, Abdelfattah A.] Int Maize & Wheat Improvement Ctr, CIMMYT, PK 39, TR-06511 Ankara, Turkey	Julius Kuhn-Institut; Universitat Kassel; Helmholtz Association; Helmholtz-Center for Infection Research; Egyptian Knowledge Bank (EKB); Aswan University; Agricultural Institute Slovenia; Ministry of Food, Agriculture & Livestock - Turkey	Ashrafi, S (corresponding author), Fed Res Ctr Cultivated Plants, JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.; Ashrafi, S (corresponding author), Univ Kassel, Fac Organ Agr Sci, Dept Ecol Plant Protect, Witzenhausen, Germany.	samad.ashrafi@julius-kuehn.de	Stadler, Marc/AHB-7016-2022; Stadler, Marc/P-8882-2014	Stadler, Marc/0000-0002-7284-8671; Stadler, Marc/0000-0002-7284-8671; Helaly, Soleiman/0000-0002-2159-478X; Ashrafi, Samad/0000-0003-0426-7039; DABABAT, Abdelfattah/0000-0002-3172-0452				Ahmed M, 2014, BIOCONTROL SCI TECHN, V24, P389, DOI 10.1080/09583157.2013.863827; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Anke H., 2011, MYCOTA, P151; Baral HO, 2017, MYCOL PROGR; BIRD AF, 1976, PARASITOLOGY, V72, P19, DOI 10.1017/S0031182000043158; Castlebury LA, 2004, MYCOL RES, V108, P864, DOI 10.1017/S0953756204000607; Chaverri P, 2008, STUD MYCOL, P1, DOI 10.3114/sim.2008.60.01; Chaverri P, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.68.03; Chepkirui C, 2016, PHYTOCHEMISTRY, V132, P95, DOI 10.1016/j.phytochem.2016.10.001; Coyne D. L., 2007, Practical plant nematology: a field and laboratory guide; Crous PW, 2016, PERSOONIA, V36, P316, DOI 10.3767/003158516X692185; Curtis RHC, 2011, PROG BIOL CONTROL, V11, P115, DOI 10.1007/978-1-4020-9648-8_5; CUTLER HG, 1980, J AGR FOOD CHEM, V28, P139, DOI 10.1021/jf60227a011; DACKMAN C, 1985, J NEMATOL, V17, P50; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; DIJKSTERHUIS J, 1991, MYCOL RES, V95, P873, DOI 10.1016/S0953-7562(09)80052-X; DIJKSTERHUIS J, 1994, ADV MICROB PHYSIOL, V36, P111, DOI 10.1016/S0065-2911(08)60178-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gams W, 1998, CBS COURSE OF MYCOLO; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghisalberti EL, 2002, STUD NAT PROD CHEM, P425; GOFFART H., 1932, ARB BIOL REICHSANST LAND U FORST WIRTSCH BERLIN DAHLEM, V20, P1; Grum-Grzhimaylo AA, 2013, IMA FUNGUS, V4, P213, DOI 10.5598/imafungus.2013.04.02.07; Helaly SE, 2016, TETRAHEDRON LETT, V57, P5911, DOI 10.1016/j.tetlet.2016.11.075; Herrera CS, 2013, MYCOLOGIA, V105, P1287, DOI 10.3852/12-395; Hirooka Y., 2013, Mycosystema, V32, P485; Hirooka Y, 2012, STUD MYCOL, P1, DOI 10.3114/sim0001; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hirooka Y, 2010, MYCOLOGIA, V102, P418, DOI 10.3852/09-137; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch WM, 2014, PERSOONIA, V33, P182, DOI 10.3767/003158514X685211; Jaklitsch WM, 2011, MYCOLOGIA, V103, P431, DOI 10.3852/10-240; Jansson HB, 1999, MYCOL RES, V103, P249, DOI 10.1017/S0953756298007084; Jansson HB, 2001, MYCOLOGY TRICHOMYCET, P145; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawahara T, 2013, J ANTIBIOT, V66, P727, DOI 10.1038/ja.2013.75; KERRY B R, 1975, Bulletin OEPP, V5, P353, DOI 10.1111/j.1365-2338.1975.tb02485.x; Kerry B. R., 1982, Crop Protection, V1, P99, DOI 10.1016/0261-2194(82)90061-8; KERRY BR, 1974, NEMATOLOGICA, V20, P259, DOI 10.1163/187529274X00230; KERRY BR, 1980, T BRIT MYCOL SOC, V74, P119, DOI 10.1016/S0007-1536(80)80017-9; Khan A, 2006, BIOCONTROL, V51, P643, DOI 10.1007/s10526-005-4241-y; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiyuna T, 2011, MYCOSCIENCE, V52, P1, DOI 10.1007/s10267-010-0063-6; Kornerup A, 1967, METHUEN HANDBOOK OF; Kuhn J, 1877, Z VEREINS RUBENZUCKE, V27, P452; Kuhnert E, 2015, PHYTOCHEMISTRY, V117, P116, DOI 10.1016/j.phytochem.2015.06.002; Kundu A, 2016, J ASIA-PAC ENTOMOL, V19, P631, DOI 10.1016/j.aspen.2016.06.003; Lechat C, 2015, ASCOMYCETE, V7, P101; Lechat C, 2017, ASCOMYCETEORG, V9, P11; Lechat C, 2012, MYCOTAXON, V121, P275, DOI 10.5248/121.275; Lechat C, 2012, MYCOTAXON, V119, P249, DOI 10.5248/119.249; Lechat C, 2010, MYCOTAXON, V113, P443, DOI 10.5248/113.443; Li Guohong, 2007, Recent Pat Biotechnol, V1, P212, DOI 10.2174/187220807782330165; Lopez-Llorcz LV, 2002, MYCOL RES, V106, P499, DOI 10.1017/S0953756202005798; LOW I, 1979, ANAL BIOCHEM, V95, P14, DOI 10.1016/0003-2697(79)90178-7; Luo J, 2010, MYCOTAXON, V113, P243, DOI 10.5248/113.243; Luo J, 2010, MYCOL PROG, V9, P17, DOI 10.1007/s11557-009-0613-5; MARUYAMA K, 1986, BIOCHIM BIOPHYS ACTA, V874, P137, DOI 10.1016/0167-4838(86)90110-X; Meyer SLF, 2004, NEMATOLOGY, V6, P23, DOI 10.1163/156854104323072883; Morton CO, 2004, NEMATOLOGY, V6, P161, DOI 10.1163/1568541041218004; Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1, DOI DOI 10.1002/JPLN.19771400220; Niu XM, 2010, J AGR FOOD CHEM, V58, P828, DOI 10.1021/jf903259n; Nordbring-Hertz B, 2001, ELS, DOI [10.1038/npg.els.0004293, DOI 10.1038/NPG.ELS.0004293]; Nylander JAA., 2004, BIOINFORMATICS; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; PERRY R N, 1986, Revue de Nematologie, V9, P399; Platas G, 2008, FUNGAL PLANET, V24; PROBST A, 1981, HELV CHIM ACTA, V64, P2056, DOI 10.1002/hlca.19810640710; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Richter C, 2016, J NAT PROD, V79, P1684, DOI 10.1021/acs.jnatprod.6b00194; RODRIGUEZKABANA R, 1988, J NEMATOL, V20, P191; Rossman AY, 2001, MYCOLOGIA, V93, P100, DOI 10.2307/3761609; Rossman AY, 1999, STUD MYCOL, P1; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salgado-Salazar C, 2012, MYCOLOGIA, V104, P1325, DOI 10.3852/12-055; SAMUELS G J, 1976, New Zealand Journal of Botany, V14, P231; SAMUELS G J, 1988, Memoirs of the New York Botanical Garden, V48, P1; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; SAMUELS GJ, 1978, NEW ZEAL J BOT, V16, P73, DOI 10.1080/0028825X.1978.10429659; Schroers HJ, 2001, STUD MYCOL, P1; SEKITA S, 1973, TETRAHEDRON LETT, P2109; SEKITA S, 1977, TETRAHEDRON LETT, P2771; SEKITA S, 1976, TETRAHEDRON LETT, P1351, DOI 10.1016/S0040-4039(00)78062-2; SEKITA S, 1982, CHEM PHARM BULL, V30, P1629, DOI 10.1248/cpb.30.1629; Senyu Chen, 2004, P979, DOI 10.1079/9780851996462.0979; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; SILVERTON JV, 1976, TETRAHEDRON LETT, P1349, DOI 10.1016/S0040-4039(00)78061-0; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; SPONDLIN C, 1988, HELV CHIM ACTA, V71, P1881, DOI 10.1002/hlca.19880710806; SPRINGER JP, 1976, TETRAHEDRON LETT, P1355, DOI 10.1016/S0040-4039(00)78063-4; STADLER M, 1993, J ANTIBIOT, V46, P961; STADLER M, 1994, PLANTA MED, V60, P128, DOI 10.1055/s-2006-959433; Stadler M, 2001, MYCOTAXON, V77, P379; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stenroos S, 2010, CLADISTICS, V26, P281, DOI 10.1111/j.1096-0031.2009.00284.x; Stirling GR, 2014, BIOLOGICAL CONTROL O; STLEGER RJ, 1991, J INVERTEBR PATHOL, V57, P299, DOI 10.1016/0022-2011(91)90134-C; Summerbell RC, 2011, STUD MYCOL, P139, DOI 10.3114/sim.2011.68.06; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xue M, 2012, CHIRALITY, V24, P668, DOI 10.1002/chir.22068; Yang EC, 2012, P NATL ACAD SCI USA, V109, P10960, DOI 10.1073/pnas.1120915109; Zhang L, 2008, APPL MICROBIOL BIOT, V78, P983, DOI 10.1007/s00253-008-1392-7; Zheng QC, 2014, FITOTERAPIA, V93, P126, DOI 10.1016/j.fitote.2013.12.022	109	28	29	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180032	10.1371/journal.pone.0180032	http://dx.doi.org/10.1371/journal.pone.0180032			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700638	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600015
J	Suprynowicz, FA; Kamonjoh, CM; Krawczyk, E; Agarwal, S; Wellstein, A; Agboke, FA; Choudhury, S; Liu, XF; Schlegel, R				Suprynowicz, Frank A.; Kamonjoh, Christopher M.; Krawczyk, Ewa; Agarwal, Seema; Wellstein, Anton; Agboke, Fadeke A.; Choudhury, Sujata; Liu, Xuefeng; Schlegel, Richard			Conditional cell reprogramming involves non-canonical beta-catenin activation and mTOR-mediated inactivation of Akt	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; PROTEIN; PHOSPHORYLATION; INHIBITION; SURVIVAL; TARGET; CANCER; SIGNAL; PP2A	The combination of irradiated fibroblast feeder cells and Rho kinase inhibitor, Y-267362, converts primary epithelial cells growing in vitro into an undifferentiated adult stem cell-like state that is characterized by long-term proliferation. This cell culture method also maintains the proliferation of adult epithelial stem cells from various tissues. Both primary and adult stem cells retain their tissue-specific differentiation potential upon removal of the culture conditions. Due to the ability to modulate the proliferation and differentiation of the cells, this method is referred to as conditional reprogramming and it is increasingly being used in studies of tumor heterogeneity, personalized medicine and regenerative medicine. However, little is known about the biology of these conditionally reprogrammed (CR) cells. Previously we showed that beta-catenin activation, a hallmark of stem cells in vivo, occurs in CR human ectocervical cells (HECs). Here we show that beta-catenin-dependent transcription is necessary for the induction of epithelial stem cell markers, and that beta-catenin is activated via a non-canonical pathway that is independent of Wnt and Akt/GSK-3. Active Akt actually decreases due to increased mTOR signaling, with a consequent increase in dephosphorylated, active GSK-3. Despite the increase in active GSK-3, beta-catenin associates with protein phosphatase 2A (PP2A) and is activated. Inhibition of PP2A catalytic activity reduces both the level of active beta-catenin and the acute induction of stem cell markers, suggesting an important role for PP2A in the activation of beta-catenin. Moreover, we demonstrate similar results using human prostate and breast cells, indicating that these changes are not restricted to ectocervical epithelial cells and may represent a more fundamental property of conditional reprogramming.	[Suprynowicz, Frank A.; Kamonjoh, Christopher M.; Krawczyk, Ewa; Agarwal, Seema; Wellstein, Anton; Agboke, Fadeke A.; Choudhury, Sujata; Liu, Xuefeng; Schlegel, Richard] Georgetown Univ, Sch Med, Ctr Cell Reprogramming, Washington, DC 20057 USA	Georgetown University	Suprynowicz, FA (corresponding author), Georgetown Univ, Sch Med, Ctr Cell Reprogramming, Washington, DC 20057 USA.	suprynfa@georgetown.edu			National Cancer Institute [R33CA177466]; Center for Cell Reprogramming (Georgetown)	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cell Reprogramming (Georgetown)	This study was funded in part by a grant from the National Cancer Institute to R.S. (R33CA177466) and internal funds from the Center for Cell Reprogramming (Georgetown). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher LD, 2001, J BIOL CHEM, V276, P21017, DOI 10.1074/jbc.C100136200; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JANICOT M, 1988, BIOCHEM J, V253, P735, DOI 10.1042/bj2530735; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Ji XN, 2014, INT J MOL SCI, V15, P13275, DOI 10.3390/ijms150813275; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7; Kimura M, 2016, STEM CELL REP, V6, P834, DOI 10.1016/j.stemcr.2016.04.012; Krawczyk E, 2010, J VIROL, V84, P1696, DOI 10.1128/JVI.01968-09; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2011, MOL CELL BIOL, V31, P3366, DOI 10.1128/MCB.01403-10; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rosner M, 2012, AMINO ACIDS, V42, P2251, DOI 10.1007/s00726-011-0965-4; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Suprynowicz FA, 2005, VIROLOGY, V332, P102, DOI 10.1016/j.virol.2004.11.011; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Suprynowicz FA, 2010, J VIROL, V84, P10619, DOI 10.1128/JVI.00831-10; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180897	10.1371/journal.pone.0180897	http://dx.doi.org/10.1371/journal.pone.0180897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700668	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800094
J	Wei, JF; Zhang, HF; Zhao, WQ; Zhao, Q				Wei, Jiufeng; Zhang, Hufang; Zhao, Wanqing; Zhao, Qing			Niche shifts and the potential distribution of Phenacoccus solenopsis (Hemiptera: Pseudococcidae) under climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; COTTON; IMPACT; CONSERVATISM; PREDICTION; INVASIONS; PATHWAYS; THREAT; PLANTS; BIRDS	The cotton mealybug, Phenacoccus solenopsis Tinsley (Hemiptera: Pseudococcidae), is a serious invasive species that significantly damages plants of approximately 60 families around the world. It is originally from North America and has also been introduced to other continents. Our goals were to create a current and future potential global distribution map for this pest under climate change with MaxEnt software. We tested the hypothesis of niche conservatism for P. solenopsis by comparing its native niche in North America to its invasive niches on other continents using Principal components analyses (PCA) in R. The potentially suitable habitat for P. solenopsis in its native and non-native ranges is presented in the present paper. The results suggested that the mean temperature of the wettest quarter and the mean temperature of the driest quarter are the most important environmental variables determining the potential distribution of P. solenopsis. We found strong evidence for niche shifts in the realized climatic niche of this pest in South America and Australia due to niche unfilling; however, a niche shift in the realized climatic niche of this pest in Eurasian owing to niche expansion.	[Wei, Jiufeng; Zhao, Wanqing; Zhao, Qing] Shanxi Agr Univ, Dept Entomol, Taigu, Shanxi, Peoples R China; [Zhang, Hufang] Xinzhou Teachers Univ, Xinzhou, Shanxi, Peoples R China	Shanxi Agricultural University; Xinzhou Teachers University	Zhao, Q (corresponding author), Shanxi Agr Univ, Dept Entomol, Taigu, Shanxi, Peoples R China.	zhaoqing86623@163.com	Zhao, Qing/AAW-1409-2021; Zhao, Q./AAO-7751-2021; JIufeng, Wei/ABD-4026-2020		National Science Foundation Project of China [31301899, 31501876]; Natural Science Foundation of Shanxi [201601D021122]; Shanxi Agricultural University of Science and Technology Innovation fund projects [2015YJ03]	National Science Foundation Project of China; Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); Shanxi Agricultural University of Science and Technology Innovation fund projects	This project was supported by the National Science Foundation Project of China (no. 31301899 and no. 31501876), supported by Natural Science Foundation of Shanxi (no. 201601D021122) and Shanxi Agricultural University of Science and Technology Innovation fund projects (2015YJ03).	Abbas Ghulam, 2005, Pakistan Entomologist, V27, P83; Abbas G, 2010, INT J AGRIC BIOL, V12, P421; Almalki M, 2015, APPL ECOL ENV RES, V13, P67; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Charleston K., 2010, AUSTR COTTON GROWER, V31, P18; Dellinger AS, 2016, NEW PHYTOL, V209, P1313, DOI 10.1111/nph.13694; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Ekesi S, 2016, ANNU REV ENTOMOL, V61, P219, DOI 10.1146/annurev-ento-010715-023603; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fand BB, 2014, J ENVIRON BIOL, V35, P973; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Febbraro MD, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0066559; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gallagher RV, 2010, J ECOL, V98, P1126; Gao YL, 2017, PEST MANAG SCI; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Garcia M, 2017, SCALENET A LITERATUR; Granara de Willink MC., 2003, REV SOC ENTOMOLOGICA, V62, P80; Gray DR, 2017, BIOL INVASIONS, V19, P913, DOI 10.1007/s10530-016-1291-2; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Gulik MP, 2005, ZOOTAXA, V964, P1; Hameed A, 2012, PAK J ZOOL, V44, P685; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodgson C, 2008, ZOOTAXA, P1; Hojsgaard D, 2016, NEW PHYTOL, V209, P1; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ibrahim Samah Sayed, 2015, Journal of Plant Protection Research, V55, P48, DOI 10.1515/jppr-2015-0007; Jiang HJ, 2017, PLOS ONE, V11; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Joshi M. D., 2010, Agricultural Reviews, V31, P113; Kolanowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077352; Kumar S, 2015, ECOLOGY AND EVOLUTIO, V5, P4268; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mainka SA, 2010, INTEGR ZOOL, V5, P102, DOI 10.1111/j.1749-4877.2010.00193.x; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mwase ET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002714; Nagrare VS, 2009, B ENTOMOL RES, V99, P537, DOI 10.1017/S0007485308006573; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T, 2011, ECOLOGICAL NICHES GE, DOI 10.23943/princeton/9780691136868.001.0001; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Sarma RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143724; Shabani F, 2015, ECOL INFORM, V29, P57, DOI 10.1016/j.ecoinf.2015.07.006; Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Tingley R, 2016, ECOGRAPHY, V39, P270, DOI 10.1111/ecog.01576; Tinsley J.B., 1898, CAN ENTOMOL, V30, P47, DOI [DOI 10.4039/ENT3047-2, 10.4039/Ent3047-2]; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Walsh JR, 2016, P NATL ACAD SCI USA, V113, P4081, DOI 10.1073/pnas.1600366113; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wise MS, 2008, DIVERSITY AND DISTRI, V14, P129; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Worth JRP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1186, DOI 10.1111/geb.12239; Wu San-An, 2009, Chinese Bulletin of Entomology, V46, P159	71	27	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180913	10.1371/journal.pone.0180913	http://dx.doi.org/10.1371/journal.pone.0180913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700721	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800098
J	Park, SJ; Foote, PK; Krist, DT; Rice, SE; Statsyuk, AV				Park, Sungjin; Foote, Peter K.; Krist, David T.; Rice, Sarah E.; Statsyuk, Alexander V.			UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1-DEPENDENT PHOSPHORYLATION; PATHOGENIC MUTATIONS; AUTOINHIBITED STATE; CATALYTIC-ACTIVITY; SELF-ASSOCIATION; ACTIVATE PARKIN; PINK1; MECHANISM; REVEALS; DISEASE	Ring-between-ring (RBR) E3 ligases have been implicated in autoimmune disorders and neurodegenerative diseases. The functions of many RBR E3s are poorly defined, and their regulation is complex, involving post-translational modifications and allosteric regulation with other protein partners. The functional complexity of RBRs, coupled with the complexity of the native ubiquitination reaction that requires ATP and E1 and E2 enzymes, makes it difficult to study these ligases for basic research and therapeutic purposes. To address this challenge, we developed novel chemical probes, ubiquitin C-terminal fluorescein thioesters UbMES and UbFluor, to qualitatively and quantitatively assess the activity of the RBR E3 ligase PARKIN in a simple experimental setup and in real time using fluorescence polarization. First, we confirmed that PARKIN does not require an E2 enzyme for substrate ubiquitination, lysine selection, and polyubiquitin chain formation. Second, we confirmed that UbFluor quantitatively detects naturally occurring activation states of PARKIN caused by Ser65 phosphorylation (pPARKIN) and phosphorylated ubiquitin (pUb). Third, we showed that both pUb and the ubiquitin-accepting substrate contribute to maximal pPARKIN ubiquitin conjugation turnover. pUb enhances the transthiolation step, whereas the substrate clears the pPARKIN similar to Ub thioester intermediate. Finally, we established that UbFluor can quantify activation or inhibition of PARKIN by structural mutations. These results demonstrate the feasibility of using UbFluor for quantitative studies of the biochemistry of RBR E3s and for high-throughput screening of small-molecule activators or inhibitors of PARKIN and other RBR E3 ligases.	[Park, Sungjin; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Foote, Peter K.; Krist, David T.; Statsyuk, Alexander V.] Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60208 USA; [Statsyuk, Alexander V.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	Northwestern University; Northwestern University; University of Houston System; University of Houston	Statsyuk, AV (corresponding author), Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60208 USA.; Statsyuk, AV (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	avstatsy@central.uh.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Krist, David/0000-0003-2471-4596	National Institutes of Health from NIGMS [R01GM072656, R01GM115632]; Northwestern University; CLP Cornew Innovation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R01GM072656, R01GM115632] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Northwestern University; CLP Cornew Innovation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Awards R01GM072656 (to S. E. R.) and R01GM115632 (to A. V. S.) from NIGMS, Northwestern University, and CLP Cornew Innovation Award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Baumann S, 2010, J AM CHEM SOC, V132, P6973, DOI 10.1021/ja909317n; BENDER ML, 1967, J CHEM EDUC, V44, P84, DOI 10.1021/ed044p84; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birsa N, 2013, BIOCHEM SOC T, V41, P1525, DOI 10.1042/BST20130234; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dove KK, 2017, J MOL BIOL, V429, P3363, DOI 10.1016/j.jmb.2017.08.008; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Fiesel FC, 2015, HUM MUTAT, V36, P774, DOI 10.1002/humu.22808; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Ho SR, 2015, J BIOL CHEM, V290, P23026, DOI 10.1074/jbc.M115.645499; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klosowiak JL, 2013, EMBO REP, V14, P968, DOI 10.1038/embor.2013.151; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Krist David T, 2017, Curr Protoc Chem Biol, V9, P11, DOI 10.1002/cpch.17; Krist DT, 2016, CHEM SCI, V7, P5587, DOI 10.1039/c6sc01167e; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lucking C. B., NEW ENGL J MED, P1560; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park S, 2015, CHEM SCI, V6, P1770, DOI [10.1039/C4SC02340D, 10.1039/c4sc02340d]; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Regnstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066879; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Tang MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14697; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yamano K, 2015, J BIOL CHEM, V290, P25199, DOI 10.1074/jbc.M115.671446; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	70	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16539	16553		10.1074/jbc.M116.773200	http://dx.doi.org/10.1074/jbc.M116.773200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28710279	hybrid, Green Published			2022-12-26	WOS:000412414800016
J	Goodman, JE; Loftus, CT; Liu, XB; Zu, K				Goodman, Julie E.; Loftus, Christine T.; Liu, Xiaobin; Zu, Ke			Impact of respiratory infections, outdoor pollen, and socioeconomic status on associations between air pollutants and pediatric asthma hospital admissions	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; CASE-CROSSOVER ANALYSIS; NEW-YORK-CITY; TIME-SERIES; ENVIRONMENTAL EPIDEMIOLOGY; PARTICULATE MATTER; MEASUREMENT ERROR; NEW-JERSEY; CHILDREN; POLLUTION	Background Epidemiology studies have shown that ambient concentrations of ozone and fine particulate matter (PM2.5) are associated with increased emergency department (ED) visits and hospital admissions (HAs) for asthma. Objective Evaluate the impact of outdoor pollen, respiratory infections, and socioeconomic status (SES) on the associations between ambient ozone and PM2.5 and asthma HAs in New York City. Methods Daily ozone, PM2.5, meteorological factors, pollen, and hospitalization records during 1999 to 2009 were obtained for New York City residents. Daily counts of HAs for asthma and respiratory infections were calculated for all-age and specific age groups, and for high-and low-SES communities. Generalized additive models were used to examine ambient concentrations of ozone and PM2.5 and asthma HAs, potential confounding effects of outdoor pollen and HAs for respiratory infections, and potential effect modification by neighborhood SES. Results Both ozone and PM2.5 were statistically significantly associated with increased asthma HAs in children aged 6-18 years (per 10 ppb increase in ozone: RR = 1.0203, 95% CI: 1.0028-1.0382; per 10 mu g/m(3) increase in PM2.5: RR = 1.0218, 95% CI: 1.0007-1.0434), but not with total asthma HAs, or asthma HAs in other age groups. These associations were stronger for children living in the high-SES areas. Adjustment for respiratory infection HAs at various lags did not result in changes greater than 10% in the risk estimates for either ozone or PM2.5. In contrast, adjustment for outdoor pollen generally attenuated the estimated RRs for both ozone and PM2.5. Conclusions Ambient ozone and PM2.5 are associated with asthma HAs in school-age children, and these associations are not modified by SES. HAs for respiratory infections do not appear to be a confounder for observed ozone- and PM2.5-asthma HAs associations, but pollen may be a weak confounder.	[Goodman, Julie E.; Liu, Xiaobin; Zu, Ke] Gradient, Cambridge, MA 02138 USA; [Loftus, Christine T.] Gradient, Seattle, WA USA; [Loftus, Christine T.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Goodman, JE (corresponding author), Gradient, Cambridge, MA 02138 USA.	jgoodman@gradientcorp.com			Exxonmobil Biomedical Sciences, Inc.	Exxonmobil Biomedical Sciences, Inc.	The work reported in this paper was conducted by the authors during the normal course of their employment, with funding provided by the Exxonmobil Biomedical Sciences, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell ML, 2004, ANNU REV PUBL HEALTH, V25, P247, DOI 10.1146/annurev.publhealth.25.102802.124329; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Canova C, 2013, EUR RESPIR J, V42, P935, DOI 10.1183/09031936.00097412; Dales RE, 2008, INT ARCH ALLERGY IMM, V146, P241, DOI 10.1159/000116360; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; DellaValle CT, 2012, EPIDEMIOLOGY, V23, P55, DOI 10.1097/EDE.0b013e31823b66b8; Dvorin DJ, 2001, ANN ALLERG ASTHMA IM, V87, P394, DOI 10.1016/S1081-1206(10)62921-3; Eggleston PA, 2009, PEDIATRICS, V123, pS160, DOI 10.1542/peds.2008-2233F; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Evans KA, 2014, ENVIRON RES, V129, P11, DOI 10.1016/j.envres.2013.12.001; Forno E, 2012, AM J RESP CRIT CARE, V185, P1033, DOI 10.1164/rccm.201202-0350ED; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Goldman GT, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-61; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Ito K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0057-0; Jalaludin B, 2008, INT ARCH OCC ENV HEA, V81, P967, DOI 10.1007/s00420-007-0290-0; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Kloepfer KM, 2010, IMMUNOL ALLERGY CLIN, V30, P553, DOI 10.1016/j.iac.2010.08.002; Lim Hyungryul, 2016, J Prev Med Public Health, V49, P205, DOI 10.3961/jpmph.16.037; Lumley T, 2000, ENVIRONMETRICS, V11, P705, DOI 10.1002/1099-095X(200011/12)11:6<705::AID-ENV444>3.0.CO;2-H; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; O'Lenick CR, 2016, J EPIDEMIOL COMMUNIT; Rabinovitch N, 2004, J ALLERGY CLIN IMMUN, V114, P1131, DOI 10.1016/j.jaci.2004.08.026; Rhomberg LR, 2011, CRIT REV TOXICOL, V41, P651, DOI 10.3109/10408444.2011.563420; Sheffield PE, 2011, ISRN ALLERGY, V2011; Sheffield PE, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0010-2; Strickland MJ, 2014, EPIDEMIOLOGY, V25, P843, DOI 10.1097/EDE.0000000000000170; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Tolbert PE, 2000, AM J EPIDEMIOL, V151, P798, DOI 10.1093/oxfordjournals.aje.a010280; U.S. Environmental Protection Agency (U.S. EPA), 2013, EPA600R10076F US EPA; US EPA, 2009, EPA600R08139F2 US EP; van der Zee SC, 2000, EUR RESPIR J, V15, P700, DOI 10.1034/j.1399-3003.2000.15d13.x; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002; Yap PS, 2013, AM J PUBLIC HEALTH, V103, P695, DOI 10.2105/AJPH.2012.300945; Zheng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117773	37	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180522	10.1371/journal.pone.0180522	http://dx.doi.org/10.1371/journal.pone.0180522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3RW	28719626	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400014
J	Messaritakis, I; Politaki, E; Kotsakis, A; Dermitzaki, EK; Koinis, F; Lagoudaki, E; Koutsopoulos, A; Kallergi, G; Souglakos, J; Georgoulias, V				Messaritakis, Ippokratis; Politaki, Eleni; Kotsakis, Athanasios; Dermitzaki, Eleftheria-Kleio; Koinis, Filippos; Lagoudaki, Eleni; Koutsopoulos, Anastasios; Kallergi, Galatea; Souglakos, John; Georgoulias, Vassilis			Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer	PLOS ONE			English	Article							RNA-POSITIVE CELLS; MESENCHYMAL TRANSITION MARKERS; EARLY BREAST-CANCER; BONE-MARROW; THORACIC RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; PROGNOSTIC RELEVANCE; EXPRESSION; CARCINOMA; CISPLATIN	Background To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance. Methods CTCs from 108 chemotherapy-naive patients with SCLC were analyzed by double immunofluorescence staining using anti-Ki67, anti-M30, anti-Vimentin along with anti-CKs antibodies. In 83 patients CTCs were also enumerated using the CellSearch. Results Sequential samples were available from 76 and 48 patients after one-treatment cycle and on disease progression (PD), respectively, for immunofluorescence and from 50 and 36 patients after one-cycle and on PD, respectively, for CellSearch. At baseline, 60.2% of the patients had detectable CTCs by either method. Both proliferative (CK67(+)) and non-proliferative (Ki67(-)), apoptotic (M30(+)) and non-apoptotic (M30(-)) as well as EMT (Vim(+)) CTCs were present in the same patient. Among 22 patients without detectable CTCs by CellSearch, CK+/Ki67(+) and CK+/Vim(+) CTCs could be detected in 6 (27.3%) and 6 (27.3%) patients, respectively. One-chemotherapy cycle reduced both the incidence of detection (p<0.001) and the absolute number (p<0.001) of CTCs; conversely, on PD both the incidence of detection and the number of CTCs were significantly increased (p = 0.002 and p = 0.04, respectively). Multivariate analysis revealed that the increased number of Vim(+) CTCs at baseline and of non-apoptotic CTCs on PD could be emerged as independent prognostic factors associated with decreased OS(p = 0.009 and p = 0.023, respectively). Conclusions CK+/Ki67(+), CK+/M30(+) and CK+/Vim(+) CTCs represent distinct subpopulations of CTCs in patients with SCLC, can be detected even in the absence of detectable CTCs by Cell-Search; CK+/Ki67(+) and CK+/Vim(+) CTCs are associated with unfavorable clinical outcome.	[Messaritakis, Ippokratis; Politaki, Eleni; Kotsakis, Athanasios; Kallergi, Galatea; Souglakos, John; Georgoulias, Vassilis] Univ Crete, Lab Tumor Cell Biol, Med Sch, Iraklion, Greece; [Kotsakis, Athanasios; Dermitzaki, Eleftheria-Kleio; Koinis, Filippos; Souglakos, John; Georgoulias, Vassilis] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Lagoudaki, Eleni; Koutsopoulos, Anastasios] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Georgoulias, V (corresponding author), Univ Crete, Lab Tumor Cell Biol, Med Sch, Iraklion, Greece.; Georgoulias, V (corresponding author), Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019; Koutsopoulos, Anastasios/AAO-9498-2020	Koutsopoulos, Anastasios/0000-0002-8430-7565; Messaritakis, Ippokratis/0000-0003-1877-500X; kallergi, Galatea/0000-0001-9825-3871	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO)	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO)	This work was partly supported by research grants from the Cretan Association for Biomedical Research (CABR) and the Hellenic Society of Medical Oncology (HeSMO).	American Cancer Society, 2022, CANC FACTS FIGURES 2; Androulakis N, 2012, BRIT J CANCER, V106, P1917, DOI 10.1038/bjc.2012.202; Ausch C, 2009, J GASTROINTEST SURG, V13, P2020, DOI 10.1007/s11605-009-0992-6; Cabinakova M, 2015, NEOPLASMA, V62, P259, DOI 10.4149/neo_2015_031; Cohen SJ, 2006, CLIN COLORECTAL CANC, V6, P125, DOI 10.3816/CCC.2006.n.029; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Daskalaki A, 2009, BRIT J CANCER, V101, P589, DOI 10.1038/sj.bjc.6605183; Fehm T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1611; Georgoulias V, 2012, ANN ONCOL, V23, P1744, DOI 10.1093/annonc/mds020; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Grobe A, 2014, CLIN CANCER RES, V20, P425, DOI 10.1158/1078-0432.CCR-13-1101; Hartkopf AD, 2014, BREAST CANCER RES TR, V147, P345, DOI 10.1007/s10549-014-3113-5; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Huang CH, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00271; Igawa S, 2014, ONCOL LETT, V7, P1469, DOI 10.3892/ol.2014.1940; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Kallergi G, 2007, MOL MED, V13, P79, DOI 10.2119/2006-00083.Kallergi; Kallergi G, 2013, MOL CANCER THER, V12, P1886, DOI 10.1158/1535-7163.MCT-12-1167; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kruck S, 2012, ADV UROL, V2012, DOI 10.1155/2012/135281; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Lin H, 2011, CRIT REV ONCOL HEMAT, V77, P2, DOI 10.1016/j.critrevonc.2010.04.008; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Normanno N, 2014, LUNG CANCER, V85, P314, DOI 10.1016/j.lungcan.2014.05.002; Okegawa T, 2009, J UROLOGY, V181, P1091, DOI 10.1016/j.juro.2008.11.015; Papadaki MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-651; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saloustros E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2897; Shi WL, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0755-9; Spiliotaki M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0485-8; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Takada M, 2002, J CLIN ONCOL, V20, P3054, DOI 10.1200/JCO.2002.12.071; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Toss A, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.06; Turrisi AT, 1999, NEW ENGL J MED, V340, P265, DOI 10.1056/NEJM199901283400403; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Wimberger P, 2007, GYNECOL ONCOL, V107, P331, DOI 10.1016/j.ygyno.2007.07.073; Xenidis N, 2013, BRIT J CANCER, V108, P549, DOI 10.1038/bjc.2012.597; Xenidis N, 2003, ANN ONCOL, V14, P849, DOI 10.1093/annonc/mdg259; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497	45	24	24	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181211	10.1371/journal.pone.0181211	http://dx.doi.org/10.1371/journal.pone.0181211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719656	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400035
J	Tadege, B; Shimelis, T				Tadege, Bamlaku; Shimelis, Techalew			Infections with Schistosoma mansoni and geohelminths among school children dwelling along the shore of the Lake Hawassa, southern Ethiopia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL TRANSMITTED HELMINTHS; TOWN	Background Infections with Schistosoma mansoni and soil-transmitted helminthes (STHs) are major public health problems in Ethiopia. However, information was scarce on the current status of these infections to guide an intervention in the study area. Therefore, this study was conducted to assess the prevalence of infections with S. mansoni and STHs and associated factors among school children in southern Ethiopia. Methods This cross-sectional study investigated children who were attending the Finchawa and Tullo junior elementary schools and were residing along the shore of the lake Hawassa in January and February, 2015. A total of 374 students were selected using systematic random sampling technique. Data on socio-demography and related factors was collected using structured questionnaires. A single stool sample was collected from each child and processed using formol-ether concentration technique and examined microscopically for parasites' ova/larva. Results The prevalence of parasitic infection with one or more than one helminthiasis was found to be 67.9%. Seven different types of helminths were identified and the most prevalent parasites were Ascaris lumbricoides (44.4%), followed by S. mansoni (31%), Trichuris trichiura (11%), and hookworms (7.7%). The rate of infection with STHs was 52.4%. Single, double, triple and quadruple infections were 42.2, 22.5, 2.4, and 0.8%, respectively. Children who practiced open-field defecation (AOR, 3.6; 95% CI 1.6-8.0; p = 0.001) and had not always washed their hands before eating a meal (AOR, 5.0; 95% CI 2.15-11.7; p < 0.001) were more infected with STHs. Moreover, the rate of S. mansoni infection was significantly higher among children who were attending the Finchawa school (AOR, 2.13; 95% CI 1.31-3.46; p = 0.002), aged 11-15 years ( AOR, 1.97; 95% CI 1.22-3.19; p = 0.006), had swum in the lake Hawassa ( AOR, 2.73; 95% CI 1.20-6.17; p = 0.016), and had involved in irrigation-related activities ( AOR, 1.68; 95% CI 1.04-2.71; p = 0.034). Conclusion The study showed high prevalence of STHs and moderate rate of schisotosomiasis. Mass deworming twice a year for STHs and once every two years for S. mansoni, further to strengthening other prevention measures, is critically needed to reduce these infections to inconsequential level.	[Tadege, Bamlaku] Hawassa Univ, Coll Med & Hlth Sci, Sch Med, Microbiol & Parasitol Unit, Hawassa, Ethiopia; [Shimelis, Techalew] Hawassa Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia	Hawassa University; Hawassa University	Shimelis, T (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia.	techalew03@yahoo.com	Shimelis, Techalew/AFL-2401-2022	Shimelis, Techalew/0000-0003-3531-0482	Hawassa University	Hawassa University	The study was conducted with small grant obtained from Hawassa University.; We would like to thank Hawassa University for financial support of the study. We are so indebted to the Laboratory technicians who analyzed the specimen, and the school directors and health professionals who supported us with data collection. We acknowledge students and their parents/guardians for their willingness and active participation in the study. The Department of Medical Laboratory Science is also much appreciated for allowing us use its laboratory facility.	Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; [Anonymous], 2016, SCHIST CONTR IN SCI; [Anonymous], SCHISTOSOMIASIS CONT; Assefa A, 2013, MOMONA ETHIOP J SCI, V5, P174; Birrie H., 1998, SCHISTOSOMIASIS ETHI, V2, P29; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Dagnew M., 1999, Ethiopian Journal of Health Development, V13, P15; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Erko B, 2003, ETHIOPIAN MED J, V41, P333; Federal Ministry of Health, 2010, GUID ENH OUTR STRAT; Hadidjaja P, 1998, AM J TROP MED HYG, V59, P791, DOI 10.4269/ajtmh.1998.59.791; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; Hotez PJ, 2010, ADV PARASIT, V72, P31, DOI 10.1016/S0065-308X(10)72002-9; Legesse M, 2004, ETHIOP J HEALTH DEV, V18, P116; Ligabaw W, 2014, J PARASITOL; Lo C., 1988, SCHISTOSOMIASIS ECOL; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Mengistu M, 2011, ETHIOP J HEALTH SCI, V21, P111; Rao VG, 2006, PUBLIC HEALTH NUTR, V9, P19, DOI 10.1079/PHN2005761; Samuel F., 2015, AM J HLTH RES, V3, P170, DOI [10.11648/j.ajhr.20150303.21, DOI 10.11648/J.AJHR.20150303.21]; Shamlaye N, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P239; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; STEPHENSON LS, 1993, J NUTR, V123, P1036; Sturrock RF., 1998, T R SOC TROP MED HYG, V92, P470; Tadesse Z, 2008, T ROY SOC TROP MED H, V102, P213, DOI 10.1016/j.trstmh.2007.09.005; Terefe A, 2011, ETHIOP J HEALTH DEV, V25, P46; Wale M., 2014, J PARASITOL VECTOR B, V6, P156, DOI [10.5897/JPVB2014.0159, DOI 10.5897/JPVB2014.0159]; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2002, TECHNICAL SERIES REP, V912; WHO, 2012, EL SOIL TRANSM HELM; World Health Organization, 2001, EX BOARD 107 SESS PR; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P157	34	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181547	10.1371/journal.pone.0181547	http://dx.doi.org/10.1371/journal.pone.0181547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719642	gold, Green Submitted, Green Published			2022-12-26	WOS:000406061400054
J	Chang, CH; Chen, SJ; Liu, CY				Chang, Chun-Hung; Chen, Shaw-Ji; Liu, Chieh-Yu			Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study	PLOS ONE			English	Article							CHILDREN; METAANALYSIS; ASSOCIATION; DISTURBANCES; OVERWEIGHT; CHILDHOOD; BEHAVIOR; OBESITY; DISEASE	Background Studies have shown a higher risk of depressive disorders in children with sleep apnea than in those without sleep apnea. However, the association between sleep apnea and subsequent depressive disorders in the pediatric population remains undetermined. Thus, this study investigated the risk of depressive disorders among pediatric patients with sleep apnea. Methods In this study, the population-based National Health Insurance Research Database of Taiwan was used to identify patients who had first been diagnosed with sleep apnea between 1999 and 2013. Patients with sleep apnea who were younger than 18 years were included in the sleep apnea group. Controls (those without sleep apnea) were matched to patients with sleep apnea at a 1:10 ratio by age, sex, and index year. Patients who had baseline or inherited depressive disorders before the enrollment date were excluded. The two groups were followed up until December 31, 2013. The primary endpoint was the occurrence of one or more depressive disorders. Results At the end of this study, 6,237 children had been enrolled, comprising 567 children with sleep apnea and 5,670 children without sleep apnea. During the mean follow-up period of 5.87 years, a total of 77 children (1.23%) developed one or more depressive disorders; 14 (2.46%) from the sleep apnea group and 63 (1.11%) from the control group. Kaplan-Meier analysis showed that children with sleep apnea had a significantly higher risk of depressive disorders (log-rank test, p = 0.002). After adjusting for covariates, the risk of subsequent depressive disorders among children with sleep apnea was still significantly higher (hazard ratio [HR] = 2.25; 95% confidence interval [CI] = 1.25-4.05; p = 0.006). Moreover, boys with sleep apnea had a significantly higher risk than those without sleep apnea (adjusted HR = 3.77; 95% CI, 1.82-7.54; p < 0.001). Furthermore, in sleep apnea group, children older than 12 years of age had more risk to depression (hazard ratio (HR) = 7.1833, 95% confidence interval (CI), 2.3734 to 21.7411; p = 0.0004). Conclusions This study found a significantly higher subsequent risk of depressive disorders in children with sleep apnea, particularly boys and those older than 12 years of age. The study findings strongly suggest that clinicians should provide psychological evaluation and supportive care for children with sleep apnea, in addition to medical treatment.	[Chang, Chun-Hung] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chang, Chun-Hung] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chang, Chun-Hung] Cardinal Tien Jr Coll Healthcare & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shaw-Ji] Mackay Mem Hosp, Dept Psychiat, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Shaw-Ji] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Midwifery & Women Hlth Care, Taipei, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Nursing & Health Science (NTUNHS)	Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Midwifery & Women Hlth Care, Taipei, Taiwan.; Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan.	chiehyu@ntunhs.edu.tw	Chang, Chun-Hung/AAT-1641-2021; Liu, Chieh-Yu/J-3789-2019; Liu, Chieh-Yu/AAR-9654-2021	Liu, Chieh-Yu/0000-0003-3283-028X				Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974]; Ferini-Strambi L, 2004, Minerva Med, V95, P187; Huang YS, 2007, SLEEP MED, V8, P18, DOI 10.1016/j.sleep.2006.05.016; Kurnatowski P, 2008, J LARYNGOL OTOL, V122, P931, DOI 10.1017/S0022215107001235; Lam RW, 2006, INT CLIN PSYCHOPHARM, V21, pS25, DOI 10.1097/01.yic.0000195658.91524.61; Landau YE, 2012, PEDIATR PULM, V47, P180, DOI 10.1002/ppul.21534; Lin WC, 2012, CURR PSYCHIAT REP, V14, P503, DOI 10.1007/s11920-012-0307-6; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Merikangas AK, 2012, J BEHAV MED, V35, P149, DOI 10.1007/s10865-011-9340-x; Mitchell RB, 2006, INT J PEDIATR OTORHI, V70, P395, DOI 10.1016/j.ijporl.2005.10.020; Nakra N, 2008, PEDIATRICS, V122, pE634, DOI 10.1542/peds.2008-0154; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Reeves Gloria M, 2008, Int J Child Health Hum Dev, V1, P103; Rosen CL, 2004, PEDIATRICS, V114, P1640, DOI 10.1542/peds.2004-0103; Schroder Carmen M, 2005, Ann Gen Psychiatry, V4, P13, DOI 10.1186/1744-859X-4-13; Sedky K, 2014, SLEEP MED REV, V18, P349, DOI 10.1016/j.smrv.2013.12.003; Ting H, 2011, SLEEP BREATH, V15, P91, DOI 10.1007/s11325-010-0329-4; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Yilmaz E, 2013, J CLIN SLEEP MED, V9, P1213, DOI 10.5664/jcsm.3178; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181430	10.1371/journal.pone.0181430	http://dx.doi.org/10.1371/journal.pone.0181430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708880	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800057
J	Panthi, S; Khanal, G; Acharya, KP; Aryal, A; Srivathsa, A				Panthi, Saroj; Khanal, Gopal; Acharya, Krishna Prasad; Aryal, Achyut; Srivathsa, Arjun			Large anthropogenic impacts on a charismatic small carnivore: Insights from distribution surveys of red panda Ailurus fulgens in Nepal	PLOS ONE			English	Article							LANGTANG NATIONAL-PARK; FOOD-HABITS; CONSERVATION; RESERVE; SPACE; AREA; DIVERSITY; LIVESTOCK; ECOLOGY; BAMBOO	Protected areas are key to preserving biodiversity and maintaining ecosystem services. However, their ability to ensure long-term survival of threatened andendangered species varies across countries, regions and landscapes. Distribution surveys can beparticularly important for assessing the value of protected areas, and gauging their efficacy incatering to species-specific requirements. We assessed the conservation value of one such reserve for a charismatic yet globally endangered species, the red panda Ailurus fulgens, in the light of on-going land-use transformation in Nepal. We conducted field surveys forindirect signs of red pandas along forest trails in 25-km(2) sampling grid cells (n = 54) of Dhorpatan Hunting Reserve, and confronted a set of ecological hypotheses to the data using hierarchical occupancy models. We estimated overall occupancy at Psi(SE) = 0.41 (0.007), with relatively high site-level detectability [p = 0.93 (SE = 0.001)]. Our results show that despitebeing a subsistence form of small-scale resource use, extraction of bamboo and livestock grazing negatively affected panda occurrence, albeit at different intensities. The amount of bamboo cover, rather than the overall proportion of forest cover, had greater influence on the panda occurrence. Despite availability of bamboo cover, areas with bamboo extraction and anthropogenic disturbances were less likely to be occupied by pandas. Together, these results suggest that long-term persistence of red pandas in this reserve and elsewhere across the species' range will require preventing commercial extractionof bamboo, coupled with case-specific regulation of anthropogenic exploitation of red panda habitats.	[Panthi, Saroj; Acharya, Krishna Prasad] Minist Forest & Soil Conservat, Dept Forests, Kathmandu, Nepal; [Khanal, Gopal] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Postgrad Programme Wildlife Biol & Conservat, India Program,Wildlife Conservat Soc, Bangalore, Karnataka, India; [Khanal, Gopal] Ctr Ecol Studies, Lalitpur, Nepal; [Aryal, Achyut] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Fac Sci, Sydney, NSW, Australia; [Aryal, Achyut] Toi Ohomai Inst Technol, Dept Forest & Resource Management, Rotorua, New Zealand; [Aryal, Achyut] Federat Univ Australia, Fac Sci & Technol, Gippsland Campus, Churchill, Vic, Australia; [Aryal, Achyut] Massey Univ, Inst Nat & Math Sci, Human Wildlife Interact Res Grp, Auckland, New Zealand; [Srivathsa, Arjun] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Srivathsa, Arjun] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Sydney; Federation University Australia; Massey University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Panthi, S (corresponding author), Minist Forest & Soil Conservat, Dept Forests, Kathmandu, Nepal.	mountsaroj@gmail.com	Khanal, Gopal/N-7765-2017	Khanal, Gopal/0000-0001-6628-0015; Panthi, Saroj/0000-0002-1502-7711; Srivathsa, Arjun/0000-0003-2935-3857	Dhorpatan Hunting Reserve, Nepal; Rufford Small Grants Foundation, UK	Dhorpatan Hunting Reserve, Nepal; Rufford Small Grants Foundation, UK	We acknowledge the Dhorpatan Hunting Reserve, Nepal for financial, logistic and instrument support and the Rufford Small Grants Foundation, UK for funding support for field data collection.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Appel A, 2013, VERTEBR ZOOL, V63, P111; Aryal A, 2015, HYSTRIX, V26, P85, DOI 10.4404/hystrix-26.2-11210; Aryal Achyut, 2009, Journal of Threatened Taxa, V1, P562; Bhatta Manoj, 2014, Open Journal of Ecology, V4, P989; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chakraborty R, 2015, MAMMALIA, V79, P25, DOI 10.1515/mammalia-2013-0105; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; Dendup P, 2016, ORYX, P1; DFRS [Department of Forest Research and Survey], 2015, STAT NEP FOR FOR RES; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; DNPWC, 2011, ANN REP SHRAW 2067 A; Dorji S, 2012, ORYX, V46, P536, DOI 10.1017/S0030605311000780; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Glatston A, 2015, AILURUS FULGENS RED; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE., 2006, PRESENCESOFTWARE EST; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Kandel P, 2016, SMALL-SCALE FOR, V15, P481, DOI 10.1007/s11842-016-9335-0; Kanel KR, 2012, STUDY DEMAND SUPPLY; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Lahoz-Monfort JJ, 2010, J APPL ECOL, V47, P1094, DOI 10.1111/j.1365-2664.2010.01854.x; Lama Sonam Tashi, 2015, Journal of Threatened Taxa, V7, P7460, DOI 10.11609/JoTT.o4208.7460-4; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahato N. K., 2005, NEPAL J FORESTRY, V12, P32; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Muzzini E., 2013, URBAN GROWTH SPATIAL; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Panthi S, 2013, NEPAL OPEN J FOR, V3, P109; Panthi S, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1307-2; Panthi S, 2012, ZOOL STUD, V51, P701; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Ripple WJ, 2016, TRENDS ECOL EVOL, V31, P495, DOI 10.1016/j.tree.2016.03.011; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sharma HP, 2014, HYSTRIX, V25, P47, DOI 10.4404/hystrix-25.1-9033; Sharma HP, 2014, ORYX, V48, P228, DOI 10.1017/S0030605313001403; Sharma Hari Pd., 2010, Human Dimensions of Wildlife, V15, P299, DOI 10.1080/10871200903582634; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106213; Tamang B, 2009, INDIAN J TRADIT KNOW, V8, P89; Thapa A, 2015, INT J CONSERV SCI, V6, P261; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Webb EL, 2011, BIOMASS BIOENERG, V35, P121, DOI 10.1016/j.biombioe.2010.08.023; Wei FW, 1999, J ZOOL, V248, P535, DOI 10.1111/j.1469-7998.1999.tb01053.x; Wei FW, 1999, BIOL CONSERV, V89, P285, DOI 10.1016/S0006-3207(98)00156-6; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; YONZON P, 1991, AMBIO, V20, P285; Yonzon P., 1989, THESIS; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; YONZON PB, 1991, CONSERV BIOL, V5, P196, DOI 10.1111/j.1523-1739.1991.tb00124.x; Zhang JD, 2017, BIOL CONSERV, V209, P119, DOI 10.1016/j.biocon.2017.02.014; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008	71	20	25	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180978	10.1371/journal.pone.0180978	http://dx.doi.org/10.1371/journal.pone.0180978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708881	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649800036
J	Choo, MS; Choi, SR; Han, JH; Lee, SH; Shim, YS				Choo, Min Soo; Choi, Se Rin; Han, Jun Hyun; Lee, Seong Ho; Shim, Young Suk			Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; FEMORAL-NECK STRENGTH; MINERAL DENSITY; CHILDREN; HYPERINSULINEMIA; INDEXES; ADOLESCENTS; CHOLESTEROL; LIPOPROTEIN; POPULATION	Objective This study aimed to evaluate the relationship between insulin resistance and the bone mineral density (BMD) of femur and lumbar spine in Korean adults who are expected to exhibit near peak bone mass. Methods Data from the Korean National Health and Nutrition Examination Survey 2008-2010 were analyzed. A total of 2,750 participants aged 25-35 years were included. Insulin resistance was assessed using a homeostatic model assessment of insulin resistance (HOMA-IR) and serum fasting insulin. Results In a multivariate linear regression analysis, the HOMA-IR was significantly inversely associated with the BMD of the total hip (TH, beta = -0.052, P = 0.002), femoral neck (FN, beta = -0.072, P< 0.001), femoral trochanter (FTr, beta = -0.055, P = 0.003), femoral intertrochanter (FITr, beta = -0.041, P = 0.015), and lumbar spine (LS, beta = -0.063, P = 0.001) among all study subjects after adjustment for gender, age, height, weight, whole body fat mass percentage, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, vitamin D, smoking, alcohol intake, physical activity, education level, and household income in both genders as well as labor, the use of oral contraceptives, and age at menarche in females. The serum fasting insulin was significantly inversely associated with the BMD of the TH (beta = -0.055, P = 0.001), FN (beta= -0.072, P< 0.001), FTr (beta = -0.055, P = 0.003), FITr (beta = -0.045, P = 0.009), and LS (beta = -0.064, P = 0.001) among all subjects in a multivariate linear regression analysis. Conclusion Our results suggest that insulin resistance may be independently and inversely associated with the near peak bone mass of the femur and lumbar spine.	[Choo, Min Soo; Han, Jun Hyun; Lee, Seong Ho] Hallym Univ, Coll Med, Med Ctr, Dept Urol, Seoul, South Korea; [Choi, Se Rin; Shim, Young Suk] Hallym Univ, Coll Med, Dept Pediat, Med Ctr, Seoul, South Korea	Hallym University; Hallym University	Shim, YS (corresponding author), Hallym Univ, Coll Med, Dept Pediat, Med Ctr, Seoul, South Korea.	royjays0217@hallym.or.kr	Shim, Young Suk/AFX-0329-2022	Shim, Young Suk/0000-0002-0850-5279	Hallym University Research Fund [HURF-2016-36]	Hallym University Research Fund	This research was supported by Hallym University Research Fund 2016(HURF-2016-36)	Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; Ahn SH, 2016, CLIN ENDOCRINOL, V84, P185, DOI 10.1111/cen.12958; Arikan S, 2012, J CLIN DENSITOM, V15, P186, DOI 10.1016/j.jocd.2011.11.005; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; BarrettConnor E, 1996, DIABETES CARE, V19, P1388, DOI 10.2337/diacare.19.12.1388; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; de Paula FJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129764; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dennison EM, 2004, DIABETOLOGIA, V47, P1963, DOI 10.1007/s00125-004-1560-y; do Prado WL, 2009, J BONE MINER METAB, V27, P613, DOI 10.1007/s00774-009-0082-6; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hanley DA, 2003, J BONE MINER RES, V18, P784, DOI 10.1359/jbmr.2003.18.4.784; Ishii S, 2012, J CLIN ENDOCR METAB, V97, P190, DOI 10.1210/jc.2011-1883; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Lima JG, 2016, MED HYPOTHESES, V97, P94, DOI 10.1016/j.mehy.2016.10.025; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Makovey J, 2009, BONE, V44, P208, DOI 10.1016/j.bone.2008.09.020; Mather KJ, 2001, J CLIN ENDOCR METAB, V86, P5457, DOI 10.1210/jc.86.11.5457; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Pramojanee SN, 2013, J DENT RES, V92, P560, DOI 10.1177/0022034513485600; REID IR, 1993, AM J PHYSIOL, V265, pE655, DOI 10.1152/ajpendo.1993.265.4.E655; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, pS94, DOI 10.1007/BF01673412; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Shanbhogue VV, 2016, J CLIN ENDOCR METAB, V101, P3114, DOI 10.1210/jc.2016-1726; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shin D, 2014, J CLIN ENDOCR METAB, V99, P988, DOI 10.1210/jc.2013-3338; Stagi S, 2013, CLIN CASES MINER BON, V10, P172, DOI 10.11138/ccmbm/2013.10.3.172; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Stolk RP, 1996, BONE, V18, P545, DOI 10.1016/8756-3282(96)00079-8; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Verroken C, 2016, J CLIN ENDOCR METAB; Wang Xiaoyi, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.CMET.2015.09.010; Wei J, 2012, BMC P, V6, pP74; YANO H, 1994, ENDOCR J, V41, P293, DOI 10.1507/endocrj.41.293; Yi KH, 2014, DIABETES RES CLIN PR, V103, P106, DOI 10.1016/j.diabres.2013.10.021	44	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0177311	10.1371/journal.pone.0177311	http://dx.doi.org/10.1371/journal.pone.0177311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704413	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700003
J	Ghimire, PR; Agho, KE; Renzaho, A; Christou, A; Nisha, MK; Dibley, M; Raynes-Greenow, C				Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre; Christou, Aliki; Nisha, Monjura Khatun; Dibley, Michael; Raynes-Greenow, Camille			Socio-economic predictors of stillbirths in Nepal (2001-2011)	PLOS ONE			English	Article							RISK-FACTORS; MATERNAL AGE; DELAYED CHILDBEARING; INCOME COUNTRIES; RATES; COMPLICATIONS; DETERMINANTS; BANGLADESH; EDUCATION; DELIVERY	Introduction Stillbirth has a long-lasting impact on parents and families. This study examined socio-economic predictors associated with stillbirth in Nepal for the year 2001, 2006 and 2011. Methods The Nepalese Demographic and Health Survey (NDHS) data for the period (2001-2011) were pooled to estimate socio-economic predictors associated with stillbirths in Nepal using binomial logistic regression while taking clustering and sampling weights into account. Results A total of 18,386 pregnancies of at least 28 weeks gestation were identified. Of these pregnancies, 335 stillbirths were reported. Stillbirth increased significantly among women that lived in the hills ecological zones (aRR 1.38, 95% CI 1.02, 1.87) or in the mountains ecological zones (aRR 1.71, 95% CI 1.10, 2.66). Women with no schooling (aRR 1.72, 95% CI 1.10, 2.69), women with primary education (aRR 1.81, 95% CI 1.11, 2.97); open defecation (aRR 1.48, 95% CI 1.00, 2.18), and those whose major occupation was agriculture (aRR 1.80, 95% CI 1.16, 2.78) are more likely to report higher stillbirth. Conclusions Low levels of education, ecological zones and open defecation were found to be strong predictors of stillbirth. Access to antenatal care services and skilled birth attendants for women in the mountainous and hilly ecological zones of Nepal is needed to further reduce stillbirth and improved services should also focus on women with low levels of education.	[Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Christou, Aliki; Nisha, Monjura Khatun; Dibley, Michael; Raynes-Greenow, Camille] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Sydney	Ghimire, PR (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	prameshraj@hotmail.com	Agho, Kingsley/AAW-5622-2021; Renzaho, Andre M.N./AAH-7679-2021; Dangal, Ganesh/O-1989-2017; Christou, Aliki/D-1249-2018; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Dangal, Ganesh/0000-0002-5834-5525; Christou, Aliki/0000-0001-9525-8255; Ghimire, Pramesh/0000-0002-7902-7294; Ghimire, Pramesh Raj/0000-0003-2816-0463; RENZAHO, ANDRE/0000-0002-6844-0833	National Health and Medical Research Council (of Australia) Career Development Fellowship [1087062]; Australian Research Council Future fellowship [FT110100345]; Australian Postgraduate Award funded through the Australian Commonwealth Government; Early Career Researcher Postgraduate Scholarship, Sydney Medical School	National Health and Medical Research Council (of Australia) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future fellowship(Australian Research Council); Australian Postgraduate Award funded through the Australian Commonwealth Government; Early Career Researcher Postgraduate Scholarship, Sydney Medical School	CRG was supported by National Health and Medical Research Council (of Australia) Career Development Fellowship #1087062, AR is supported by an Australian Research Council Future fellowship FT110100345, AC is supported by an Australian Postgraduate Award funded through the Australian Commonwealth Government, and MKN is supported by Early Career Researcher Postgraduate Scholarship, Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; Ashish KC, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0226-9; Ashish KC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0567-3; Auger N, 2012, EPIDEMIOLOGY, V23, P247, DOI 10.1097/EDE.0b013e31824587bc; Biggs J, 1973, OBSTET GYNECOLOGICAL, V28, P710; BOOTH RT, 1964, J OBSTET GYN BR COMM, V71, P249; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Cherry N, 2008, B WORLD HEALTH ORGAN, V86, P172, DOI 10.2471/BLT.07.043083; CNATTINGIUS S, 1992, JAMA-J AM MED ASSOC, V268, P886; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Cripe SM, 2007, J TROP PEDIATRICS, V53, P366, DOI 10.1093/tropej/fmm044; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Dodds L, 2006, ANN EPIDEMIOL, V16, P607, DOI 10.1016/j.annepidem.2005.11.006; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; FORMAN MR, 1984, JAMA-J AM MED ASSOC, V252, P3135, DOI 10.1001/jama.252.22.3135; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gonzales GF, 2008, INT J GYNECOL OBSTET, V100, P221, DOI 10.1016/j.ijgo.2007.08.009; Gordon A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-12; Guillot Michel, 2010, Genus, V66, P43; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; KAJANOJA P, 1978, OBSTET GYNECOL, V51, P47; KUMAR R, 1992, Indian Journal of Pediatrics, V59, P455, DOI 10.1007/BF02751561; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee AC, 2011, INT J GYNECOL OBSTET, V113, P199, DOI 10.1016/j.ijgo.2010.12.015; LEYLAND AH, 1990, NEW ENGL J MED, V323, P413; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; Manandhar S R, 2010, Kathmandu Univ Med J (KUMJ), V8, P62; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mullan Z, 2011, LANCET, V377, P1291, DOI 10.1016/S0140-6736(11)60098-6; NAEYE RL, 1983, OBSTET GYNECOL, V61, P210; NAEYE RL, 1979, EARLY HUM DEV, V3, P229, DOI 10.1016/0378-3782(79)90031-8; Nahar S, 2013, PAEDIATR PERINAT EP, V27, P158, DOI 10.1111/ppe.12026; Olsen O, 1999, SCAND J PUBLIC HEALT, V27, P128, DOI 10.1177/14034948990270021301; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Skrondal A., 2004, GEN LATENT VARIABLE; Suleiman BM, 2015, PEDIATRIC REP, V7, DOI 10.4081/pr.2015.5615; Thind A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-29; Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7; UNICEF, 2004, CHILDH THREAT STAT W; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2015, MAT NEWB CHILD AD HL; World Health Organization, 2015, PROGR SAN DRINK WAT; World Health Organization, 2014, EV NEWB ACT PLAN END	54	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181332	10.1371/journal.pone.0181332	http://dx.doi.org/10.1371/journal.pone.0181332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704548	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700125
J	Ledien, J; Sorn, S; Hem, S; Huy, R; Buchy, P; Tarantola, A; Cappelle, J				Ledien, Julia; Sorn, Sopheak; Hem, Sopheak; Huy, Rekol; Buchy, Philippe; Tarantola, Arnaud; Cappelle, Julien			Assessing the performance of remotelysensed flooding indicators and their potential contribution to early warning for leptospirosis in Cambodia	PLOS ONE			English	Article							WATER INDEX NDWI; INFECTIOUS-DISEASE; SURVEILLANCE; TRANSMISSION; THAILAND; CLIMATE; HEALTH; PONDS	Remote sensing can contribute to early warning for diseases with environmental drivers, such as flooding for leptospirosis. In this study we assessed whether and which remotelysensed flooding indicator could be used in Cambodia to study any disease for which flooding has already been identified as an important driver, using leptospirosis as a case study. The performance of six potential flooding indicators was assessed by ground truthing. The Modified Normalized Difference Water Index (MNDWI) was used to estimate the Risk Ratio (RR) of being infected by leptospirosis when exposed to floods it detected, in particular during the rainy season. Chi- square tests were also calculated. Another variable D the time elapsed since the first flooding of the year D was created using MNDWI values and was also included as explanatory variable in a generalized linear model (GLM) and in a boosted regression tree model (BRT) of leptospirosis infections, along with other explanatory variables. Interestingly, MNDWI thresholds for both detecting water and predicting the risk of leptospirosis seroconversion were independently evaluated at - 0.3. Value of MNDWI greater than - 0.3 was significantly related to leptospirosis infection (RR = 1.61 [ 1.10 - 1.52];x(2) = 5.64, p- value = 0.02, especially during the rainy season (RR = 2.03 [ 1.25 - 3.28];chi(2) = 8.15, p- value = 0.004). Time since the first flooding of the year was a significant risk factor in our GLM model (p- value = 0.042). These results suggest that MNDWI may be useful as a risk indicator in an early warning remote sensing tool for flood- driven diseases like leptospirosis in South East Asia.	[Ledien, Julia; Sorn, Sopheak; Tarantola, Arnaud; Cappelle, Julien] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Hem, Sopheak] Inst Pasteur Cambodge, Med Biol Unit, Phnom Penh, Cambodia; [Huy, Rekol] Ctr Natl Malariol, Phnom Penh, Cambodia; [Buchy, Philippe] GlaxoSmithKline, Vaccines R&D, Singapore, Singapore; [Tarantola, Arnaud] Inst Pasteur Nouvelle Caledonie, Epidemiol Unit, 11 Rue Paul Doumer, Noumea, New Caledonia; [Cappelle, Julien] CIRAD ES, UPR AGIRs, Montpellier, France; [Cappelle, Julien] Univ Lyon, VetAgro Sup, INRA, UMR EPIA, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; GlaxoSmithKline; CIRAD; INRAE; VetAgro Sup	Ledien, J (corresponding author), Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia.	jledien@pasteur-kh.org	Tarantola, Arnaud/D-2149-2015	Tarantola, Arnaud/0000-0002-6946-7958; BUCHY, Philippe/0000-0003-1372-3008; Ledien, Julia/0000-0002-6116-8371; Cappelle, Julien/0000-0001-7668-1971	scholarship from The University of Bordeaux; FidEx International program	scholarship from The University of Bordeaux; FidEx International program	The project was self-funded. Julia Ledien was supported by a scholarship from The University of Bordeaux and the FidEx International program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Berlioz-Arthaud A, 2010, Bull Soc Pathol Exot, V103, P111, DOI 10.1007/s13149-010-0043-2; Bertuzzo E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050723; Bhardwaj Pankaj, 2008, Indian J Med Sci, V62, P431, DOI 10.4103/0019-5359.48454; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boschetti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088741; Chadsuthi S, 2012, ASIAN PAC J TROP MED, V5, P539, DOI 10.1016/S1995-7645(12)60095-9; Clandillon S, 1995, EUROPEAN SYMPOSIUM O, P102, DOI [10.1117/12.227173, DOI 10.1117/12.227173]; Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Dechet AM, 2012, PLOS ONE, P7; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Forbes AE, 2012, QJM-INT J MED, V105, P1151, DOI 10.1093/qjmed/hcs145; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hamm NAS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004164; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hem S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151555; Hijmans Robert J., 2016, DISMO SPECIES DISTRI; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Ivanova S, 2012, AM J TROP MED HYG, V86, P1032, DOI 10.4269/ajtmh.2012.11-0349; Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Kazama S, 2012, SUSTAIN SCI, V7, P45, DOI 10.1007/s11625-011-0141-5; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Lau CL, 2012, PLOS NEGLECT TROP D, P6; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Leal-Castellanos CB, 2003, EPIDEMIOL INFECT, V131, P1149, DOI 10.1017/S0950268803001201; LINTHICUM KJ, 1987, SCIENCE, V235, P1656, DOI 10.1126/science.3823909; Lleo MM, 2008, CURR OPIN BIOTECH, V19, P307, DOI 10.1016/j.copbio.2008.04.001; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; R Core Team, 2014, R A LANGUAGE AND ENV; Remais J, 2008, ENVIRON SCI TECHNOL, V42, P2643, DOI 10.1021/es071052s; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rouse J.W, 1973, P 3 ERTS 1 S, P48; SMITH D. J. W., 1955, JOUR HYG, V53, P436; Soti V, 2010, HYDROL EARTH SYST SC, V14, P1449, DOI 10.5194/hess-14-1449-2010; Soti V, 2009, INT J APPL EARTH OBS, V11, P344, DOI 10.1016/j.jag.2009.05.005; Suwanpakdee S, 2015, EPIDEMIOL INFECT, V143, P2106, DOI 10.1017/S0950268815000205; Thai KTD, 2006, TROP MED INT HEALTH, V11, P738, DOI 10.1111/j.1365-3156.2006.01619.x; Torgerson PR, 2015, PLOS NEGLECT TROP D, P9; Tran A, 2010, INT J APPL EARTH OBS, V12, P1, DOI 10.1016/j.jag.2009.09.014; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; WHITE ME, 1978, PHOTOGRAMM ENG REM S, V44, P1421; WORK EA, 1976, PHOTOGRAMM ENG REM S, V42, P685; World Health Organization. International Leptospirosis Society, 2003, HUMAN LEPTOSPIROSIS; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179	53	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181044	10.1371/journal.pone.0181044	http://dx.doi.org/10.1371/journal.pone.0181044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704461	Green Published, Green Accepted, gold			2022-12-26	WOS:000405649700080
J	Aittomaki, S; Valanne, S; Lehtinen, T; Matikainen, S; Nyman, TA; Ramet, M; Pesu, M				Aittomaki, Saara; Valanne, Susanna; Lehtinen, Tapio; Matikainen, Sampsa; Nyman, Tuula A.; Ramet, Mika; Pesu, Marko			Proprotein convertase Furin1 expression in the Drosophila fat body is essential for a normal antimicrobial peptide response and bacterial host defense	FASEB JOURNAL			English	Article						innate immunity; stress; Toll pathway; IMD pathway; JAK/STAT pathway	PEPTIDOGLYCAN RECOGNITION PROTEIN; TOLL SIGNALING PATHWAY; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; GENE-EXPRESSION; NEGATIVE REGULATOR; PROCESSING ENZYME; IMD PATHWAY; MELANOGASTER; CELLS	Invading pathogens provoke robust innate immune responses in Dipteran insects, such as Drosophila melanogaster. In a systemic bacterial infection, a humoral response is induced in the fat body. Gram-positive bacteria trigger the Toll signaling pathway, whereas gram-negative bacterial infections are signaled via the immune deficiency (IMD) pathway. We show here that the RNA interference-mediated silencing of Furin1-a member of the proprotein convertase enzyme family-specifically in the fat body, results in a reduction in the expression of antimicrobial peptides. This, in turn, compromises the survival of adult fruit flies in systemic infections that are caused by both gram-positive and -negative bacteria. Furin1 plays a nonredundant role in the regulation of immune responses, as silencing of Furin2, the other member of the enzyme family, had no effect on survival or the expression of antimicrobial peptides upon a systemic infection. Furin1 does not directly affect the Toll or IMD signaling pathways, but the reduced expression of Furin1 up-regulates stress response factors in the fat body. We also demonstrate that Furin1 is a negative regulator of the Janus kinase/signal transducer and activator of transcription signaling pathway, which is implicated in stress responses in the fly. In summary, our data identify Furin1 as a novel regulator of humoral immunity and cellular stress responses in Drosophila.	[Aittomaki, Saara; Lehtinen, Tapio; Pesu, Marko] Univ Tampere, Immunoregulat Grp, Tampere, Finland; [Aittomaki, Saara; Valanne, Susanna; Lehtinen, Tapio; Ramet, Mika; Pesu, Marko] Univ Tampere, BioMediTech Inst, Arvo Ylpon Katu 34, FI-33520 Tampere, Finland; [Valanne, Susanna; Ramet, Mika] Univ Tampere, Fac Med & Life Sci, Expt Immunol Grp, Tampere, Finland; [Matikainen, Sampsa] Helsinki Univ Hosp, Dept Rheumatol, Helsinki, Finland; [Nyman, Tuula A.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Ramet, Mika] Univ Oulu, PEDEGO Res Unit, Med Res Ctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Ramet, Mika] Univ Oulu, Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Pesu, Marko] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Nyman, Tuula A.] Univ Oslo, Dept Immunol, Oslo, Norway; [Nyman, Tuula A.] Oslo Univ Hosp, Oslo, Norway	Tampere University; Tampere University; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital; University of Oslo; University of Oslo	Pesu, M (corresponding author), Univ Tampere, BioMediTech Inst, Arvo Ylpon Katu 34, FI-33520 Tampere, Finland.	marko.pesu@uta.fi	Valanne, Susanna/GZK-2381-2022; Pesu, Marko/L-6344-2013; Matikainen, Sampsa/AAH-8654-2021	Valanne, Susanna/0000-0003-0898-8423; Pesu, Marko/0000-0002-7541-3921; 	Sigrid Juselius Foundation; Academy of Finland [295814, 286477]; Finnish Cultural Foundation Pirkanmaa Regional fund; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Cancer Society of Finland; Tampere Tuberculosis Foundation; Cancer Foundation Finland sr [150117] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation Pirkanmaa Regional fund; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Cancer Society of Finland; Tampere Tuberculosis Foundation; Cancer Foundation Finland sr	This work was supported by the Sigrid Juselius Foundation, the Academy of Finland (Grants 295814 and 286477), Finnish Cultural Foundation Pirkanmaa Regional fund, the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, Cancer Society of Finland, and Tampere Tuberculosis Foundation. The authors thank Tuula Myllymaki and Sanna Hamalainen (University of Tampere) for technical assistance and all the members of the Immuno-regulation Group for scientific discussions. Tampere Drosophila Core Facility is acknowledged for providing resources for fly husbandry. The authors declare no conflicts of interest.	Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bhadra R, 2014, J CLIN INVEST, V124, P2441, DOI 10.1172/JCI70522; BRAND AH, 1993, DEVELOPMENT, V118, P401; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Cordova ZM, 2016, ONCOTARGET, V7, P54392, DOI 10.18632/oncotarget.11106; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DEBIE I, 1995, J BIOL CHEM, V270, P1020, DOI 10.1074/jbc.270.3.1020; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Eleftherianos I, 2016, IMMUNOBIOLOGY, V221, P1362, DOI 10.1016/j.imbio.2016.07.011; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; GUNNE H, 1993, EUR J BIOCHEM, V214, P287, DOI 10.1111/j.1432-1033.1993.tb17923.x; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hedengren M, 2000, BIOCHEM BIOPH RES CO, V279, P574, DOI 10.1006/bbrc.2000.3988; Honti V, 2014, DEV COMP IMMUNOL, V42, P47, DOI 10.1016/j.dci.2013.06.005; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hwang SO, 2008, J BIOL CHEM, V283, P13063, DOI 10.1074/jbc.M709656200; Jain A, 2015, J BIOL CHEM, V290, P14945, DOI 10.1074/jbc.M115.656116; Johnson TK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9759; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kunnapuu J, 2009, P NATL ACAD SCI USA, V106, P8501, DOI 10.1073/pnas.0809885106; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lin P, 2015, HISTOCHEM CELL BIOL, V144, P543, DOI 10.1007/s00418-015-1359-6; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Maxton-Kuchenmeister J, 1999, MECH DEVELOP, V83, P107, DOI 10.1016/S0925-4773(99)00041-6; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Ojanen MJT, 2015, INFECT IMMUN, V83, P1431, DOI 10.1128/IAI.03135-14; Oksanen A, 2014, J IMMUNOL, V193, P5470, DOI 10.4049/jimmunol.1401629; Ortutay Z, 2015, J LEUKOCYTE BIOL, V98, P73, DOI 10.1189/jlb.2A0514-257RR; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2012, ACTA PAEDIATR, V101, P900, DOI 10.1111/j.1651-2227.2012.02740.x; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; ROEBROEK AJM, 1991, FEBS LETT, V289, P133, DOI 10.1016/0014-5793(91)81052-A; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; ROEBROEK AJM, 1995, DNA CELL BIOL, V14, P223, DOI 10.1089/dna.1995.14.223; Savijoki K, 2011, J PROTEOME RES, V10, P3460, DOI 10.1021/pr2000896; Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Vanha-aho LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004895; Wharton KA, 1999, GENETICS, V152, P629; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19418; Zhang YC, 2016, INT J FUTUR GENER CO, V9, P1, DOI 10.14257/ijfgcn.2016.9.10.01; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017	75	5	6	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4770	4782		10.1096/fj.201700296R	http://dx.doi.org/10.1096/fj.201700296R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705811				2022-12-26	WOS:000413398500010
J	Pal, D; Boby, N; Kumar, S; Kaur, G; Ali, SA; Reboud, J; Shrivastava, S; Gupta, PK; Cooper, JM; Chaudhuri, P				Pal, Dheeraj; Boby, Nongthombam; Kumar, Satish; Kaur, Gurpreet; Ali, Syed Atif; Reboud, Julien; Shrivastava, Sameer; Gupta, Praveen K.; Cooper, Jonathan M.; Chaudhuri, Pallab			Visual detection of Brucella in bovine biological samples using DNA-activated gold nanoparticles	PLOS ONE			English	Article							REAL-TIME PCR; ASSAY; AMPLIFICATION; LIVESTOCK; MILK; SPP.	Brucellosis is a bacterial disease, which, although affecting cattle primarily, has been associated with human infections, making its detection an important challenge. The existing gold standard diagnosis relies on the culture of bacteria which is a lengthy and costly process, taking up to 45 days. New technologies based on molecular diagnosis have been proposed, either through dip-stick, immunological assays, which have limited specificity, or using nucleic acid tests, which enable to identify the pathogen, but are impractical for use in the field, where most of the reservoir cases are located. Here we demonstrate a new test based on hybridization assays with metal nanoparticles, which, upon detection of a specific pathogen-derived DNA sequence, yield a visual colour change. We characterise the components used in the assay with a range of analytical techniques and show sensitivities down to 1000 cfu/ml for the detection of Brucella. Finally, we demonstrate that the assay works in a range of bovine samples including semen, milk and urine, opening up the potential for its use in the field, in low-resource settings.	[Pal, Dheeraj; Kaur, Gurpreet; Ali, Syed Atif; Chaudhuri, Pallab] Indian Vet Res Inst, Div Bacteriol & Mycol, Izatnagar, Uttar Pradesh, India; [Boby, Nongthombam; Kumar, Satish; Shrivastava, Sameer; Gupta, Praveen K.] Indian Vet Res Inst, Div Anim Biotechnol, Izatnagar, Uttar Pradesh, India; [Reboud, Julien; Cooper, Jonathan M.] Univ Glasgow, Div Biomed Engn, Sch Engn, Glasgow, Lanark, Scotland	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of Glasgow	Chaudhuri, P (corresponding author), Indian Vet Res Inst, Div Bacteriol & Mycol, Izatnagar, Uttar Pradesh, India.; Cooper, JM (corresponding author), Univ Glasgow, Div Biomed Engn, Sch Engn, Glasgow, Lanark, Scotland.	Jon.Cooper@glasgow.ac.uk; pallab.chaudhuri@gmail.com	Cooper, Jonathan/E-9000-2010; Cooper, Jonathan/GLS-9195-2022; Atif Ali, Syed/C-3144-2018; Reboud, Julien/F-1565-2014	Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Atif Ali, Syed/0000-0002-8779-547X; Reboud, Julien/0000-0002-6879-8405	Department of Biotechnology, Ministry of Science & Technology, India [BT/IN/Indo-UK/FADH/43/PC/2013]; Biotechnology and Biological Sciences Research Council, UK [BB/L00464X/1]; BBSRC [BB/L00464X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L00464X/1] Funding Source: researchfish	Department of Biotechnology, Ministry of Science & Technology, India; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Department of Biotechnology, Ministry of Science & Technology, India (PC - BT/IN/Indo-UK/FADH/43/PC/2013) and the Biotechnology and Biological Sciences Research Council, UK (JC - BB/L00464X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk Sascha, 2003, Clin Lab, V49, P577; Amin AS, 2001, VET MICROBIOL, V83, P37, DOI 10.1016/S0378-1135(01)00401-1; Bakthavathsalam P, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-8; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Christopher Supriya, 2010, J Lab Physicians, V2, P55, DOI 10.4103/0974-2727.72149; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Dibbern AG, 2015, GENET MOL RES, V14, P227, DOI 10.4238/2015.January.16.6; Fu ZY, 2013, METHODS, V64, P260, DOI 10.1016/j.ymeth.2013.08.003; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; Mohan Hari, 2014, J INNOV BIOL, V1, P163; Pal N, 2016, BIOSENS BIOELECTRON, V77, P270, DOI 10.1016/j.bios.2015.09.037; Romero C, 1999, APPL ENVIRON MICROB, V65, P3735; Sattarahmady N, 2015, BIOCHEM ENG J, V97, P1, DOI 10.1016/j.bej.2015.01.010; Singh BB, 2015, PREV VET MED, V119, P211, DOI 10.1016/j.prevetmed.2015.03.013; Smirnova EA, 2013, ADV INFECT DIS, V3, P177, DOI DOI 10.4236/AID.2013.33026; Soleimani M, 2013, J APPL MICROBIOL, V115, P828, DOI 10.1111/jam.12290; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282	20	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180919	10.1371/journal.pone.0180919	http://dx.doi.org/10.1371/journal.pone.0180919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719613	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000406061400023
J	Perrone-Bertolotti, M; Tassin, M; Meunier, F				Perrone-Bertolotti, Marcela; Tassin, Maxime; Meunier, Fanny			Speech-in-speech perception and executive function involvement	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; LEXICAL DECISION; EYE-MOVEMENTS; ATTENTION; PRIME; NOISE; TIME; FACILITATION; CAPACITY	This present study investigated the link between speech-in-speech perception capacities and four executive function components: response suppression, inhibitory control, switching and working memory. We constructed a cross-modal semantic priming paradigm using a written target word and a spoken prime word, implemented in one of two concurrent auditory sentences (cocktail party situation). The prime and target were semantically related or unrelated. Participants had to perform a lexical decision task on visual target words and simultaneously listen to only one of two pronounced sentences. The attention of the participant was manipulated: The prime was in the pronounced sentence listened to by the participant or in the ignored one. In addition, we evaluate the executive function abilities of participants (switching cost, inhibitory-control cost and response-suppression cost) and their working memory span. Correlation analyses were performed between the executive and priming measurements. Our results showed a significant interaction effect between attention and semantic priming. We observed a significant priming effect in the attended but not in the ignored condition. Only priming effects obtained in the ignored condition were significantly correlated with some of the executive measurements. However, no correlation between priming effects and working memory capacity was found. Overall, these results confirm, first, the role of attention for semantic priming effect and, second, the implication of executive functions in speech-in-noise understanding capacities.	[Perrone-Bertolotti, Marcela] Univ Grenoble Alpes, CNRS, LPNC, UMR 5105, Grenoble, France; [Tassin, Maxime; Meunier, Fanny] Univ Claude Bernard Lyon 1, CNRS, L2C2, Lyon, France; [Meunier, Fanny] Univ Cote dAzur, CNRS, BCL, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Meunier, F (corresponding author), Univ Claude Bernard Lyon 1, CNRS, L2C2, Lyon, France.; Meunier, F (corresponding author), Univ Cote dAzur, CNRS, BCL, Nice, France.	fanny.meunier@unice.fr		Perrone-Bertolotti, Marcela/0000-0001-9981-7042	Rhone-Alpes Region, France attributed through the ARC2: Qualite de vie et Vieillissement	Rhone-Alpes Region, France attributed through the ARC2: Qualite de vie et Vieillissement	This work was supported by the Rhone-Alpes Region, France attributed through the "ARC2: Qualite de vie et Vieillissement" attributed to MP-B and Michel Hoen and funding MT's salary.	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Andersson U, 2010, MEMORY, V18, P458, DOI 10.1080/09658211003762084; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Boyle W, 2013, LANG LEARN, V63, P211, DOI 10.1111/lang.12003; Carretti B, 2013, INT J GERIATR PSYCH, V28, P539, DOI 10.1002/gps.3859; Carter MD, 2011, APHASIOLOGY, V25, P761, DOI 10.1080/02687038.2010.539697; Cartwright KB, 2012, EARLY EDUC DEV, V23, P24, DOI 10.1080/10409289.2011.615025; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; DEGROOT AMB, 1984, Q J EXP PSYCHOL-A, V36, P253, DOI 10.1080/14640748408402158; Dekerle M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00878; Dupoux E, 2003, J EXP PSYCHOL HUMAN, V29, P172, DOI 10.1037/0096-1523.29.1.172; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Ellis RJ, 2016, EAR HEARING, V37, P73, DOI 10.1097/AUD.0000000000000218; Ferrand L, 2001, ANN PSYCHOL, V101, P683; Fullgrabe C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01268; GREENWALD AG, 1972, J EXP PSYCHOL, V94, P58, DOI 10.1037/h0032760; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Hoedemaker RS, 2014, J EXP PSYCHOL HUMAN, V40, P2179, DOI 10.1037/a0037677; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; HOWARD DV, 1981, J GERONTOL, V36, P707, DOI 10.1093/geronj/36.6.707; Ingvalson EM, 2015, J ACOUST SOC AM, V137, P3477, DOI 10.1121/1.4921601; Keidser G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00597; Kim YSG, 2016, J EXP CHILD PSYCHOL, V141, P101, DOI 10.1016/j.jecp.2015.08.003; Koch I, 2011, J EXP PSYCHOL HUMAN, V37, P1140, DOI 10.1037/a0022189; Koelewijn Thomas, 2012, Int J Otolaryngol, V2012, P865731, DOI 10.1155/2012/865731; Koelewijn T, 2012, EAR HEARING, V33, P291, DOI 10.1097/AUD.0b013e3182310019; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; Meister H, 2013, AM J AUDIOL, V22, P310, DOI 10.1044/1059-0889(2012/12-0067); Melara RD, 2002, J EXP PSYCHOL HUMAN, V28, P279, DOI 10.1037//0096-1523.28.2.279; Meunier F, 2002, BRAIN LANG, V81, P89, DOI 10.1006/brln.2001.2509; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Milliken B, 1998, PSYCHOL REV, V105, P203, DOI 10.1037/0033-295X.105.2.203; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; New B, 2001, ANN PSYCHOL, V101, P447; Ng EHN, 2013, INT J AUDIOL, V52, P433, DOI 10.3109/14992027.2013.776181; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; Osborne J. W., 2002, RES EVALUATION, V8; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reeves C, 2000, J EXP PSYCHOL LEARN, V26, P1638, DOI 10.1037//0278-7393.26.6.1638; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; Rudner M, 2011, J AM ACAD AUDIOL, V22, P156, DOI 10.3766/jaaa.22.3.4; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Schumacher PB, 2012, NEUROSCI LETT, V530, P138, DOI 10.1016/j.neulet.2012.09.057; SHELTON JR, 1992, J EXP PSYCHOL LEARN, V18, P1191, DOI 10.1037/0278-7393.18.6.1191; Silverman MJ, 2007, J MUSIC THER, V44, P415, DOI 10.1093/jmt/44.4.415; Smith SL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01394; Strauss M. E., 2015, J EXPT PSYCHOL GEN; SWINNEY DA, 1979, MEM COGNITION, V7, P159, DOI 10.3758/BF03197534; Tabossi P, 1996, LANG COGNITIVE PROC, V11, P569, DOI 10.1080/016909696386953; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; TREISMAN AM, 1964, AM J PSYCHOL, V77, P533, DOI 10.2307/1420765; Van Zandt T, 2002, STEVENSHANDBOOK EXPT, V4, P461, DOI DOI 10.1002/0471214426.PAS0412; Wechsler D., 2011, MANUEL CHELLE INTELL; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Willoughby MT, 2012, CHILD NEUROPSYCHOL, V18, P79, DOI 10.1080/09297049.2011.578572; Wood NL, 1997, MEM COGNITION, V25, P772, DOI 10.3758/BF03211320; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Xiao KC, 2015, CONSCIOUS COGN, V38, P88, DOI 10.1016/j.concog.2015.09.013	70	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180084	10.1371/journal.pone.0180084	http://dx.doi.org/10.1371/journal.pone.0180084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708830	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800012
J	Hirata, E; Ohya, Y; Suzuki, K				Hirata, Eri; Ohya, Yoshikazu; Suzuki, Kuninori			Atg4 plays an important role in efficient expansion of autophagic isolation membranes by cleaving lipidated Atg8 in Saccharomyces cerevisiae	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; YEAST; PROTEINS; SYSTEM; BIOGENESIS; CYTOPLASM; DECONJUGATION; MECHANISMS; DELIVERY; GENES	Autophagy, an intracellular degradation system, is highly conserved among eukaryotes from yeast to mammalian cells. In the yeast Saccharomyces cerevisiae, most Atg (autophagy-related) proteins, which are essential for autophagosome formation, are recruited to a restricted region close to the vacuole, termed the vacuole-isolation membrane contact site (VICS), upon induction of autophagy. Subsequently, the isolation membrane (IM) expands and sequesters cytoplasmic materials to become a closed autophagosome. In S. cerevisiae, the ubiquitin-like protein Atg8 is C-terminally conjugated to the phospholipid phosphatidylethanolamine (PE) to generate Atg8-PE. During autophagosome formation, Atg8-PE is cleaved by Atg4 to release delipidated Atg8 (Atg8(G116)) and PE. Although delipidation of Atg8-PE is important for autophagosome formation, it remains controversial whether the delipidation reaction is required for targeting of Atg8 to the VICS or for subsequent IM expansion. We used an IM visualization technique to clearly demonstrate that delipidation of Atg8-PE is dispensable for targeting of Atg8 to the VICS, but required for IM expansion. Moreover, by overexpressing Atg8(G116), we showed that the delipidation reaction of Atg8-PE by Atg4 plays an important role in efficient expansion of the IM other than supplying unlipidated Atg8(G116). Finally, we suggested the existence of biological membranes at the Atg8labeled structures in Atg8-PE delipidation-defective cells, but not at those in atg2 Delta cells. Taken together, it is likely that Atg2 is involved in localization of biological membranes to the VICS, where Atg4 is responsible for IM expansion.	[Hirata, Eri; Ohya, Yoshikazu; Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.; Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan.	kuninori@k.u-tokyo.ac.jp	Ohya, Yoshikazu/AAW-2200-2021	Ohya, Yoshikazu/0000-0003-0837-1239				HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; SIKORSKI RS, 1989, GENETICS, V122, P19; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	28	23	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181047	10.1371/journal.pone.0181047	http://dx.doi.org/10.1371/journal.pone.0181047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704456	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700081
J	Gurfein, BT; Hasdemir, B; Milush, JM; Touma, C; Palme, R; Nixon, DF; Darcel, N; Hecht, FM; Bhargava, A				Gurfein, Blake T.; Hasdemir, Burcu; Milush, Jeffrey M.; Touma, Chadi; Palme, Rupert; Nixon, Douglas F.; Darcel, Nicholas; Hecht, Frederick M.; Bhargava, Aditi			Enriched environment and stress exposure influence splenic B lymphocyte composition	PLOS ONE			English	Article							CYTOKINE PRODUCTION; MICE; EXPRESSION; BRAIN; MOUSE; CORTICOSTERONE; TRAFFICKING; METABOLITES; EXCRETION; RESPONSES	Prolonged chronic stress has deleterious effects on immune function and is associated with numerous negative health outcomes. The spleen harbors one-fourth of the body's lymphocytes and mediates both innate and adaptive immune responses. However, the subset of splenic lymphocytes that respond, either adaptively or maladaptively, to various stressors remains largely unknown. Here we investigated the effects of unpredictable chronic mild stress (CMS) exposure on spleen composition in male mice housed in two different caging conditions: standard caging (Cntl) and enriched environment (EE). EE-caged mice exhibited the greatest absolute number of splenocytes and CMS exposure significantly lowered splenocyte numbers in both caging conditions. Glucocorticoid production, measured by mean fecal corticosterone metabolites (FCM), was significantly lower in EE-caged mice vs. Cntlcaged mice. Surprisingly, CMS exposure resulted in an increase in mean FCM in EE-caged mice, but no significant change in Cntl-caged mice. CMS altered the splenic B:T lymphocyte ratio; it reduced the frequency of B cells, but increased the frequency of T cells in EE-caged mice. Splenocyte number and B: T lymphocyte ratio showed a negative relationship with mean FCM. EE-caged mice had a lower frequency of immature and germinal B cells than Cntl-caged mice. CMS markedly increased the frequency of immature and marginal zone B cells, but decreased the frequency of follicular B cells in both caging conditions. Mean FCM correlated positively with frequency of immature, marginal zone and germinal center B cells, but negatively with frequency of follicular B cells. To conclude, splenic immune cells, particularly B lymphocyte composition, are modulated by caging environment and stress and may prime mice differently to respond to immune challenges.	[Gurfein, Blake T.; Hasdemir, Burcu; Hecht, Frederick M.; Bhargava, Aditi] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Gurfein, Blake T.; Milush, Jeffrey M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Touma, Chadi] Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Darcel, Nicholas] Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France; [Bhargava, Aditi] Univ Calif San Francisco, Dept ObGyn, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University Osnabruck; University of Veterinary Medicine Vienna; George Washington University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Francisco	Gurfein, BT; Bhargava, A (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.; Gurfein, BT (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.; Bhargava, A (corresponding author), Univ Calif San Francisco, Dept ObGyn, San Francisco, CA 94143 USA.	Blake.Gurfein@ucsf.edu; Aditi.Bhargava@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Palme, Rupert/A-3499-2008	Nixon, Douglas/0000-0002-2801-1786; Palme, Rupert/0000-0001-9466-3662; Hecht, Frederick/0000-0002-5782-1171; Bhargava, Aditi/0000-0003-1334-0517	National Institutes of Health [K01AT007322]; NCCIH [T32 AT003997, K01 32 AT006153, K24 AT007827, DK080787]; National Center for Complementary & Integrative Health [K24AT007827, T32AT003997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080787, R01DK097518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health K01AT007322 to BG; BH was supported by T32 AT003997 from NCCIH, JMM by K01 32 AT006153, FMH by K24 AT007827 from NCCIH, and AB by DK080787.	CLAMAN HN, 1993, ANN NY ACAD SCI, V685, P288, DOI 10.1111/j.1749-6632.1993.tb35877.x; Cohen S, 1999, PSYCHOSOM MED, V61, P175, DOI 10.1097/00006842-199903000-00009; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gotovac K, 2003, CLIN EXP IMMUNOL, V131, P335, DOI 10.1046/j.1365-2249.2003.02075.x; Goujon E, 1995, BRAIN BEHAV IMMUN, V9, P292, DOI 10.1006/brbi.1995.1028; Gurfein BT, 2014, MOL MED, V20, P179, DOI 10.2119/molmed.2013.00158; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; KIECOLTGLASER JK, 1995, PSYCHOSOM MED, V57, P269, DOI 10.1097/00006842-199505000-00008; Miller GE, 2014, BRAIN BEHAV IMMUN, V41, P191, DOI 10.1016/j.bbi.2014.05.016; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; PERSOONS JHA, 1995, AM J RESP CRIT CARE, V152, P619, DOI 10.1164/ajrccm.152.2.7633716; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180771	10.1371/journal.pone.0180771	http://dx.doi.org/10.1371/journal.pone.0180771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704473	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600049
J	Matusu, R; Senol, B; Yeroglu, C				Matusu, Radek; Senol, Bilal; Yeroglu, Celaleddin			Linear systems with unstructured multiplicative uncertainty: Modeling and robust stability analysis	PLOS ONE			English	Article							PARAMETRIC UNCERTAINTY; PERFORMANCE	This article deals with continuous-time Linear Time-Invariant (LTI) Single-Input Single-Output (SISO) systems affected by unstructured multiplicative uncertainty. More specifically, its aim is to present an approach to the construction of uncertain models based on the appropriate selection of a nominal system and a weight function and to apply the fundamentals of robust stability investigation for considered sort of systems. The initial theoretical parts are followed by three extensive illustrative examples in which the first order time-delay, second order and third order plants with parametric uncertainty are modeled as systems with unstructured multiplicative uncertainty and subsequently, the robust stability of selected feedback loops containing constructed models and chosen controllers is analyzed and obtained results are discussed.	[Matusu, Radek] Tomas Bata Univ Zlin, Fac Appl Informat, CEBIA Tech, Ctr Secur Informat & Adv Technol, Zlin, Czech Republic; [Senol, Bilal; Yeroglu, Celaleddin] Inonu Univ, Fac Engn, Dept Comp Engn, Malatya, Turkey	Tomas Bata University Zlin; Inonu University	Matusu, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, CEBIA Tech, Ctr Secur Informat & Adv Technol, Zlin, Czech Republic.	rmatusu@fai.utb.cz	Matušů, Radek/H-6355-2012; SENOL, Bilal/Y-5328-2018; Yeroglu, Celaleddin/ABG-9572-2020	SENOL, Bilal/0000-0002-3734-8807; Yeroglu, Celaleddin/0000-0002-6106-2374	European Regional Development Fund under the project CEBIA-Tech Instrumentation [CZ.1.05/2.1.00/19.0376]; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project [LO1303, MSMT-7778/2014]	European Regional Development Fund under the project CEBIA-Tech Instrumentation; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project	This work was supported by the European Regional Development Fund under the project CEBIA-Tech Instrumentation No. CZ.1.05/2.1.00/19.0376 and by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project No. LO1303 (MSMT-7778/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann J, 1993, ROBUST CONTROL SYSTE; [Anonymous], 2005, POWER ELECTRONICS P; Barmish BR, 1994, NEW TOOLS ROBUSTNESS; Bhattacharyya SP, 2009, AUTOM CONTROL ENG SE, V33, pXVII; Bhattacharyya SP., 1995, ROBUST CONTROL PARAM; DOYLE J, 1982, IEE PROC-D, V129, P242, DOI 10.1049/ip-d.1982.0053; Doyle JC, 1992, FEEDBACK CONTROL THE; FAN MKH, 1991, IEEE T AUTOMAT CONTR, V36, P25, DOI 10.1109/9.62265; Geromel JC, 2006, SYST CONTROL LETT, V55, P81, DOI 10.1016/j.sysconle.2004.11.016; Gu D. -W., 2005, ADV TK CONT SIGN PRO; Ho MT, 2003, IEEE T AUTOMAT CONTR, V48, P1404, DOI 10.1109/TAC.2003.815028; Kasnakoglu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165017; Keel LH, 1999, AUTOMATICA, V35, P1717, DOI 10.1016/S0005-1098(99)00080-1; Kucera V., 2001, AUTOMA, V7, P43; Kucera V, 2007, INT J ROBUST NONLIN, V17, P682, DOI 10.1002/rnc.1127; KWAKERNAAK H, 1993, AUTOMATICA, V29, P255, DOI 10.1016/0005-1098(93)90122-A; LAUGHLIN DL, 1989, COMPUT VISION GRAPH, V47, P59, DOI 10.1016/0734-189X(89)90054-6; Matus R, 2011, P 13 WSEAS INT C AUT; Matusu R., 2011, INT J MATH MODELS ME, V5, P1011; Matusu R, 2011, T I MEAS CONTROL, V33, P274, DOI 10.1177/0142331210361409; Park P, 2007, AUTOMATICA, V43, P1855, DOI 10.1016/j.automatica.2007.02.022; Patre BM, 2007, ISA T, V46, P343, DOI 10.1016/j.isatra.2006.10.001; Sage HG, 1999, INT J CONTROL, V72, P1498, DOI 10.1080/002071799220137; Skogestad S., 2005, MULTIVARIABLE FEEDBA; Tan N, 2002, P 15 IFAC WORLD C BA; Xie L, 1997, SYST CONTROL LETT, V31, P165, DOI 10.1016/S0167-6911(97)00027-3; Zhong Q. C., 2006, ROBUST CONTROL TIME; Zhou K., 1996, ROBUST OPTIMAL CONTR	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181078	10.1371/journal.pone.0181078	http://dx.doi.org/10.1371/journal.pone.0181078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704471	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600057
J	Pu, CL; Li, HT; Zhu, AJ; Chen, YY; Zhao, Y; Zhan, AB				Pu, Chuanliang; Li, Haitao; Zhu, Aijia; Chen, Yiyong; Zhao, Yan; Zhan, Aibin			Phylogeography in Nassarius mud snails: Complex patterns in congeneric species	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL; DISPERSAL; MOLLUSK; POLYMORPHISM; DIVERGENCE; GASTROPODA; SOFTWARE; BIVALVE	One major goal for phylogeographical studies is to elucidate respective roles of multiple evolutionary and ecological forces that shape the current distribution patterns. In marine and coastal ecosystems, it has been generated a common realization that species with enormous population size and pelagic larval stages can disperse across broad geographical scales, leading to weak or even no phylogeographical structure across large geographical scales. However, the violation of such realization has been frequently reported, and it remains largely unexplored on mechanisms responsible for various phylogeographical patterns observed in different species at varied geographical scales. Here, we used a speciesrich genus Nassarius to assess and compare phylogeographical patterns in congeneric species, and discuss causes and consequences underlying varied phylogeographical patterns. Interestingly, we observed complex phylogeographical patterns both within single species and across multiple species, and multiple analyses showed varied levels of genetic heterogeneity among sites within and across species. Available evidence suggests that related species with similar biological characteristics may not be necessary to result in consistent phylogeographical patterns. Multiple factors, including larval ecology, interactions between dispersal and natural selection, and human activity-mediated dispersal, can partially explain the complex patterns observed in this study. Deep investigations should be performed on these factors, particularly their respective roles in determining evolutionary/ecological processes to form phylogeographical patterns in species with high dispersal capacities in marine and coastal ecosystems.	[Pu, Chuanliang; Chen, Yiyong; Zhao, Yan; Zhan, Aibin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Pu, Chuanliang; Chen, Yiyong; Zhao, Yan; Zhan, Aibin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Haitao; Zhu, Aijia] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State Oceanic Administration	Zhan, AB (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.; Zhan, AB (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhanaibin@hotmail.com	Zhan, Aibin/A-7240-2011		100-Talent Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [41606191]	100-Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the 100-Talent Program of the Chinese Academy of Sciences to AZ and the National Natural Science Foundation of China (41606191) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina N, 2012, MAR BIOL, V159, P1871, DOI 10.1007/s00227-012-1975-9; Armbruster GFJ, 2000, J MOLLUS STUD, V66, P570, DOI 10.1093/mollus/66.4.570; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2006, EVOLUTION, V60, P1825; Barreiro R, 2006, MAR BIOL, V148, P1051, DOI 10.1007/s00227-005-0139-6; CERNOHORSKY W O, 1972, Records of the Auckland Institute and Museum, V9, P125; Cernohorsky W.O., 1984, Bulletin of the Auckland Institute and Museum, P1; Cernohorsky WO, 1984, B AUCKLAND I MUSEUM; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenberg PB, 2014, ECOL EVOL, V4, P3244, DOI 10.1002/ece3.1181; Fernandez R, 2015, MAR ECOL-EVOL PERSP, V36, P701, DOI 10.1111/maec.12178; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Haasl DM, 2000, J PALEONTOL, V74, P839, DOI 10.1666/0022-3360(2000)074<0839:PRANG>2.0.CO;2; Hasselman DJ, 2014, MOL ECOL, V23, P1137, DOI 10.1111/mec.12674; Huang BX, 2000, MAR BIOL, V136, P207, DOI 10.1007/s002270050678; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; KOEHN RK, 1980, P NATL ACAD SCI-BIOL, V77, P5385, DOI 10.1073/pnas.77.9.5385; Kool H.H., 2007, Miscellanea Malacologica, V2, P87; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; Lee HJ, 2007, MOL ECOL, V16, P3084, DOI 10.1111/j.1365-294X.2007.03364.x; Li HT, 2010, CHIN J OCEANOL LIMN, V28, P565, DOI 10.1007/s00343-010-9031-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YP, 2015, REV AQUACULT, V7, P28, DOI 10.1111/raq.12052; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Miller M.A., 2010, P GAT COMP ENV WORKS; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ridgway G, 2001, SARSIA, V86, P157, DOI 10.1080/00364827.2001.10420471; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; Sivasundar A, 2010, MAR BIOL, V157, P1433, DOI 10.1007/s00227-010-1419-3; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TALLMARK B, 1980, MAR ECOL PROG SER, V3, P51, DOI 10.3354/meps003051; van Moorsel CHM, 2000, MALACOLOGIA, V42, P203; Veliz D, 2004, J EVOLUTION BIOL, V17, P953, DOI 10.1111/j.1420-9101.2004.00753.x; Wegner KM, 2012, MOL ECOL, V21, P779, DOI 10.1111/j.1365-294X.2011.05401.x; Wilson AB, 1999, CAN J FISH AQUAT SCI, V56, P2248, DOI 10.1139/cjfas-56-12-2248; Zhan AB, 2015, MAR BIOL, V162, P2449, DOI 10.1007/s00227-015-2734-5; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276	60	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180728	10.1371/journal.pone.0180728	http://dx.doi.org/10.1371/journal.pone.0180728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704536	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600046
J	Loneman, DM; Peddicord, L; Al-Rashid, A; Nikolau, BJ; Lauter, N; Yandeau-Nelson, MD				Loneman, Derek M.; Peddicord, Layton; Al-Rashid, Amani; Nikolau, Basil J.; Lauter, Nick; Yandeau-Nelson, Marna D.			A robust and efficient method for the extraction of plant extracellular surface lipids as applied to the analysis of silks and seedling leaves of maize	PLOS ONE			English	Article							CUTICULAR WAXES; GENOTYPES; MUTANTS; CUTICLE	Aerial plant organs possess a diverse array of extracellular surface lipids, including both non-polar and amphipathic constituents that collectively provide a primary line of defense against environmental stressors. Extracellular surface lipids on the stigmatic silks of maize are composed primarily of saturated and unsaturated linear hydrocarbons, as well as fatty acids, and aldehydes. To efficiently extract lipids of differing polarities from maize silks, five solvent systems (hexanes; hexanes:diethyl ether (95:5); hexanes:diethyl ether (90:10); chloroform:hexanes (1:1) and chloroform) were tested by immersing fresh silks in solvent for different extraction times. Surface lipid recovery and the relative composition of individual constituents were impacted to varying degrees depending on solvent choice and duration of extraction. Analyses were performed using both silks and leaves to demonstrate the utility of the solvent-and time-optimized protocol in comparison to extraction with the commonly used chloroform solvent. Overall, the preferred solvent system was identified as hexanes:diethyl ether (90:10), based on its effectiveness in extracting surface hydrocarbons and fatty acids as well as its reduced propensity to extract presumed internal fatty acids. Metabolite profiling of wildtype and glossy1 seedlings, which are impaired in surface lipid biosynthesis, demonstrated the ability of the preferred solvent to extract extracellular surface lipids rich in amphipathic compounds (aldehydes and alcohols). In addition to the expected deficiencies in dotriacontanal and dotriacontan-1-ol for gl1 seedlings, an unexpected increase in fatty acid recovery was observed in gl1 seedlings extracted in chloroform, suggesting that chloroform extracts lipids from internal tissues of gl1 seedlings. This highlights the importance of extraction method when evaluating mutants that have altered cuticular lipid compositions. Finally, metabolite profiling of silks from maize inbreds B73 and Mo17, exposed to different environments and harvested at different ages, revealed differences in hydrocarbon and fatty acid composition, demonstrating the dynamic nature of surface lipid accumulation on silks.	[Loneman, Derek M.; Al-Rashid, Amani; Yandeau-Nelson, Marna D.] Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Loneman, Derek M.; Nikolau, Basil J.; Yandeau-Nelson, Marna D.] Iowa State Univ, NSF Engn Res Ctr Biorenewable Chem, Ames, IA 50011 USA; [Peddicord, Layton; Lauter, Nick] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Peddicord, Layton; Nikolau, Basil J.; Lauter, Nick; Yandeau-Nelson, Marna D.] Iowa State Univ, Interdept Genet & Genom Grad Program, Ames, IA 50011 USA; [Al-Rashid, Amani] Iowa State Univ, Young Engineers & Scientists Res Program High Sch, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Nikolau, Basil J.; Yandeau-Nelson, Marna D.] Iowa State Univ, Ctr Metab Biol, Ames, IA 50011 USA; [Lauter, Nick] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Loneman, Derek M.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Peddicord, Layton] DuPont Pioneer, Johnston, IA USA; [Al-Rashid, Amani] Perry Community High Sch, Perry, IA USA	Iowa State University; National Science Foundation (NSF); Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Case Western Reserve University; DuPont; Pioneer Hi-Bred International, Inc.	Yandeau-Nelson, MD (corresponding author), Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, NSF Engn Res Ctr Biorenewable Chem, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, Interdept Genet & Genom Grad Program, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, Ctr Metab Biol, Ames, IA 50011 USA.	myn@iastate.edu		Yandeau-Nelson, Marna/0000-0002-2742-7384	National Science Foundation [IOS-1354799]; United States Department of Agriculture National Institute of Food and Agriculture [2011-67003-30342]; Department of Energy Ames Laboratory	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Department of Energy Ames Laboratory	This work was supported by National Science Foundation (www.nsf.gov) grant IOS-1354799 awarded to NL, BJN and MDY-N; United States Department of Agriculture National Institute of Food and Agriculture (nifa.usda.gov) grant 2011-67003-30342 awarded to NL; and a seed grant from the Department of Energy Ames Laboratory (www.ameslab.gov) awarded to BJN and MDY-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVATO P, 1985, PHYTOCHEMISTRY, V24, P1995, DOI 10.1016/S0031-9422(00)83108-8; AVATO P, 1990, PHYTOCHEMISTRY, V29, P1571, DOI 10.1016/0031-9422(90)80124-Y; Axelsson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089643; BIANCHI A, 1985, MAYDICA, V30, P179; BIANCHI G, 1977, MAYDICA, V22, P9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cavonius LR, 2014, ANAL BIOANAL CHEM, V406, P7313, DOI 10.1007/s00216-014-8155-3; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Fernandez-Moreno JP, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0982-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Holloway PJ, 1984, CRC HDB CHROMATOGRAP, P346; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; Jetter R, 2006, ANNU PLANT REV, V23, P145; Kates M., 1986, TECHNIQUES LIPIDOLOG, V2; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Lara I, 2015, J AGR FOOD CHEM, V63, P4005, DOI 10.1021/acs.jafc.5b00013; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; Lee SB, 2015, PLANT CELL REP, V34, P557, DOI 10.1007/s00299-015-1772-2; Miller SS, 2003, J AGR FOOD CHEM, V51, P6702, DOI 10.1021/jf0341363; Perera MADN, 2010, PLANT J, V64, P618, DOI 10.1111/j.1365-313X.2010.04355.x; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ranjan A, 2010, IND ENG CHEM RES, V49, P2979, DOI 10.1021/ie9016557; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; RIEDERER M, 1989, PHYSIOL PLANTARUM, V77, P373, DOI 10.1111/j.1399-3054.1989.tb05656.x; Sathish A, 2015, BIORESOURCE TECHNOL, V193, P15, DOI 10.1016/j.biortech.2015.06.052; SCHNABLE PS, 1994, MAYDICA, V39, P279; Stammitti L, 1996, PHYTOCHEMISTRY, V43, P45, DOI 10.1016/0031-9422(96)00241-5; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Walton T.J, 1990, LIPIDS MEMBRANES ASP, P106; YANG G, 1992, J AGR FOOD CHEM, V40, P1058, DOI 10.1021/jf00018a030; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180850	10.1371/journal.pone.0180850	http://dx.doi.org/10.1371/journal.pone.0180850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700694	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400020
J	Oliver, SV; Brooke, BD				Oliver, Shune V.; Brooke, Basil D.			The effects of ingestion of hormonal host factors on the longevity and insecticide resistance phenotype of the major malaria vector Anopheles arabiensis (Diptera: Culicidae)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; LIFE-SPAN; SIGNALING CASCADE; SOUTH-AFRICA; TGF-BETA; INSULIN; MOSQUITOS; STEPHENSI; TRANSMISSION	Exogenous vertebrate-derived factors circulating in the blood have the capacity to modulate the biology of haematophagous insects. These include insulin, insulin growth factor 1 ( IGF) and transforming growth factor beta 1 ( TGF beta). The effects of the consumption of these three proteins were examined on laboratory strains of Anopheles arabiensis. SENN, an insecticide susceptible strain and SENN DDT, a resistant strain selected from SENN, were fed with host factor-supplemented sucrose. Adult longevity was measured and insecticide resistance phenotype over time was assessed by WHO bioassay. Detoxification and oxidative stress defence enzyme activity was assessed calorimetrically. Insulin supplementation augmented insecticide resistance in young adult mosquitoes. This effect was due to the hormonal nature of the protein, as heat-denatured insulin did not elicit the same response. In contrast, IGF and TGF beta consumption generally reduced the expression of insecticide resistance. Insulin ingestion significantly reduced longevity in the insecticide susceptible strain. IGF elicited the same response in the susceptible strain, while TGF consumption had no effect on either strain. Consumption of all factors significantly decreased Glutathione Stransferase activity and increased cytochrome P450 and superoxide dismutase activity. This suggests that the altered detoxification phenotype is mediated primarily by cytochrome P450 activity, which would result in an increase in oxidative stress. The increased superoxide dismutase activity suggests that this enzyme class alleviates the oxidative stress as opposed to glutathione-based redox systems. Oxidative stress responses play a crucial role in insecticide resistance and longevity. These data show that ingested hormonal factors can affect mosquito longevity and insecticide susceptibility, both of which are important characteristics in terms of malaria transmission and control.	[Oliver, Shune V.; Brooke, Basil D.] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Oliver, Shune V.; Brooke, Basil D.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Oliver, SV (corresponding author), Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.; Oliver, SV (corresponding author), Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	shuneo@nicd.ac.za	Oliver, Shune/AAH-4961-2019	Oliver, Shune/0000-0003-0658-6658; Brooke, Basil/0000-0002-8857-1304	National Health Laboratory Services (NHLS) [2014-2-DEV-31-SOL1]; National Research and Foundation Thuthuka, South African [TTK13070120248]	National Health Laboratory Services (NHLS); National Research and Foundation Thuthuka, South African	This projected was funded by National Health Laboratory Services (NHLS) Research, grant: 2014-2-DEV-31-SOL1 to SVO; Trust grants to both Shune Oliver (Development grant) and Basil Brooke; as well as a National Research and Foundation Thuthuka Grant to Shune Oliver, grant: TTK13070120248. Both granting institutions are South African. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGDON WG, 1990, COMP BIOCHEM PHYS B, V96, P339, DOI 10.1016/0305-0491(90)90385-7; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Brooke B, 2013, SAMJ S AFR MED J, V103, P784, DOI [10.7196/SAMJ.7447, 10.7196/samj.7447]; Brooke BD, 2015, S AFR J SCI, V111, P190; Drexler A, 2013, J EXP BIOL, V216, P208, DOI 10.1242/jeb.078873; Drexler AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004231; Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072; Oliver SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151049; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Oliver SV, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-44; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; Pakpour N, 2014, CURR OPIN INSECT SCI, V3, P1, DOI 10.1016/j.cois.2014.07.001; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Planche T, 2005, CURR TOP MICROBIOL, V295, P105; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; WHITE NJ, 1987, LANCET, V1, P708	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180909	10.1371/journal.pone.0180909	http://dx.doi.org/10.1371/journal.pone.0180909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700639	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400023
J	Wang, RXW; Lee, CS; Haber, JE				Wang, Ruoxi W.; Lee, Cheng-Sheng; Haber, James E.			Position effects influencing intrachromosomal repair of a double-strand break in budding yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; MITOTIC RECOMBINATION; NUCLEAR ARCHITECTURE; ORGANIZATION; CHROMOSOME; REPLICATION; KINETOCHORE; COMPETITION; GENOME	Repair of a double-strand break (DSB) by an ectopic homologous donor sequence is subject to the three-dimensional arrangement of chromosomes in the nucleus of haploid budding yeast. The data for interchromosomal recombination suggest that searching for homology is accomplished by a random collision process, strongly influenced by the contact probability of the donor and recipient sequences. Here we explore how recombination occurs on the same chromosome and whether there are additional constraints imposed on repair. Specifically, we examined how intrachromosomal repair is affected by the location of the donor sequence along the 813-kb chromosome 2 (Chr2), with a site-specific DSB created on the right arm (position 625 kb). Repair correlates well with contact frequencies determined by chromosome conformation capture-based studies (r = 0.85). Moreover, there is a profound constraint imposed by the anchoring of the centromere (CEN2, position 238 kb) to the spindle pole body. Sequences at the same distance on either side of CEN2 are equivalently constrained in recombining with a DSB located more distally on one arm, suggesting that sequences on the opposite arm from the DSB are not otherwise constrained in their interaction with the DSB. The centromere constraint can be partially relieved by inducing transcription through the centromere to inactivate CEN2 tethering. In diploid cells, repair of a DSB via its allelic donor is strongly influenced by the presence and the position of an ectopic intrachromosomal donor.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Wang, Ruoxi W.] MIT, Dept Biol, Cambridge, MA USA; [Lee, Cheng-Sheng] Harvard Med Sch, Dept Genet, Boston, MA USA	Brandeis University; Brandeis University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	National Institutes of Health [GM20056]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant GM20056 to JEH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Avsaroglu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102474; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Chu Angela M., 2008, V416, P205, DOI 10.1007/978-1-59745-321-9_14; Coic E, 2011, GENETICS, V189, P1225, DOI 10.1534/genetics.111.132738; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Hager JE, 2014, GENOME STABILITY: DNA REPAIR AND RECOMBINATION, P1; HILL A, 1989, MOL CELL BIOL, V9, P1368, DOI 10.1128/MCB.9.3.1368; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Jin QW, 2000, J CELL SCI, V113, P1903; Lee CS, 2016, P NATL ACAD SCI USA, V113, pE146, DOI 10.1073/pnas.1523660113; LICHTEN M, 1989, GENETICS, V123, P261; Lorenz A, 2003, EUKARYOT CELL, V2, P856, DOI 10.1128/EC.2.5.856-866.2003; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mehta A, 2017, MOL CELL, V65, P515, DOI 10.1016/j.molcel.2016.12.003; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tsabar M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006021; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	22	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180994	10.1371/journal.pone.0180994	http://dx.doi.org/10.1371/journal.pone.0180994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700723	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400026
J	Podesta, TSV; Rosembach, TV; dos Santos, AA; Martins, ML				Vilela Podesta, Tatiane Souza; Rosembach, Tiago Venzel; dos Santos, Anesia Aparecida; Martins, Marcelo Lobato			Anomalous diffusion and q-Weibull velocity distributions in epithelial cell migration	PLOS ONE			English	Article							LEVY WALKS; MOTILITY; DYNAMICS; MOTION	In multicellular organisms, cell motility is central in all morphogenetic processes, tissue maintenance, wound healing and immune surveillance. Hence, the control of cell motion is a major demand in the creation of artificial tissues and organs. Here, cell migration assays on plastic 2D surfaces involving normal (MDCK) and tumoral (B16F10) epithelial cell lines were performed varying the initial density of plated cells. Through time-lapse microscopy quantities such as speed distributions, velocity autocorrelations and spatial correlations, as well as the scaling of mean-squared displacements were determined. We find that these cells exhibit anomalous diffusion with q-Weibull speed distributions that evolves non-monotonically to a Maxwellian distribution as the initial density of plated cells increases. Although short-ranged spatial velocity correlations mark the formation of small cell clusters, the emergence of collective motion was not observed. Finally, simulational results from a correlated random walk and the Vicsek model of collective dynamics evidence that fluctuations in cell velocity orientations are sufficient to produce q-Weibull speed distributions seen in our migration assays.	[Vilela Podesta, Tatiane Souza; Rosembach, Tiago Venzel; Martins, Marcelo Lobato] Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil; [dos Santos, Anesia Aparecida] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Martins, Marcelo Lobato] Natl Inst Sci & Technol Complex Syst, Vicosa, MG, Brazil; [Rosembach, Tiago Venzel] Univ Fed Minas Gerais, Dept Fis, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais	Martins, ML (corresponding author), Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil.; Martins, ML (corresponding author), Natl Inst Sci & Technol Complex Syst, Vicosa, MG, Brazil.	mmartins@ufv.br	Rosembach, Tiago Venzel/AAV-9443-2021	Venzel Rosembach, Tiago/0000-0001-9805-0951	FAPEMIG [APQ-04232-10, APQ-02710-14]; CNPq [306024/2013-6, 400412/2014-4]; CAPES (Podesta and Venzel graduate fellowships)	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Podesta and Venzel graduate fellowships)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors received funding for this work from FAPEMIG (APQ-04232-10 and APQ-02710-14), CNPq (306024/2013-6 and 400412/2014-4), and CAPES (Podesta and Venzel graduate fellowships).	Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Blitterswijk C.V., 2008, TISSUE ENG; Bray D, 2001, CELL MOVEMENTS MOL M; Carnell MJ, 2011, SEMIN CELL DEV BIOL, V22, P82, DOI 10.1016/j.semcdb.2010.12.003; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; da Silva PCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104253; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Le Bellac M, 2010, EQUILIBRIUM NONEQUIL; Levy P., 1954, THEORIE ADDITION VAR; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peruani F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010602; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Petroff AP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.158102; Picoli S, 2003, PHYSICA A, V324, P678, DOI 10.1016/S0378-4371(03)00071-2; Potdar AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009636; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rabani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083760; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsallis C, 1999, PHYS LETT A, V257, P93, DOI 10.1016/S0375-9601(99)00270-4; Tsallis C, 2009, INTRODUCTION TO NONE; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Viswanathan G. M., 2011, PHYS FORAGING; Wolgemuth CW, 2008, BIOPHYS J, V95, P1564, DOI 10.1529/biophysj.107.118257	33	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180777	10.1371/journal.pone.0180777	http://dx.doi.org/10.1371/journal.pone.0180777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700652	Green Published, gold			2022-12-26	WOS:000405544800074
J	Yuan, Y; Zajicek, J; Qiu, CJ; Chandrahas, V; Lee, SW; Ploplis, VA; Castellino, FJ				Yuan, Yue; Zajicek, Jaroslav; Qiu, Cunjia; Chandrahas, Vishwanatha; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Conformationally organized lysine isosteres in Streptococcus pyogenes M protein mediate direct high-affinity binding to human plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; GROUP-A STREPTOCOCCUS; NMR CHEMICAL-SHIFT; BACTERIAL SURFACE; KRINGLE 2; IMPROVED SENSITIVITY; XPLOR-NIH; SPECTROSCOPY; PAM; RECEPTOR	The binding of human plasminogen (hPg) to the surface of the human pathogen group A Streptococcus pyogenes (GAS) and subsequent hPg activation to the protease plasmin generate a proteolytic surface that GAS employs to circumvent host innate immunity. Direct high-affinity binding of hPg/plasmin to pattern D GAS is fully recapitulated by the hPg kringle 2 domain (K2(hPg)) and a short internal peptide region (a1a2) of a specific subtype of bacterial surface M protein, present in all GAS pattern D strains. To better understand the nature of this binding, critical to the virulence of many GAS skin-tropic strains, we used high-resolutionNMRto define the interaction of recombinant K2(hPg) with recombinant a1a2 (VKK38) of the M protein from GAS isolate NS455. Wefound a 2: 1 (m/m) binding stoichiometry of K2(hPg)/VKK38, with the lysine-binding sites of two K2(hPg) domains anchored to two regions of monomeric VKK38. The K2(hPg)/VKK38 binding altered the VKK38 secondary structure from a helical apo-peptide with a flexible center to an end-to-end K2(hPg)-bound alpha-helix. The K2(hPg) residues occupied opposite faces of this helix, an arrangement that minimized steric clashing of K2(hPg). We conclude that VKK38 provides two conformational lysine isosteres that each interact with the lysine-binding sites in K2(hPg). Further, the adoption of an alpha-helix by VKK38 upon binding to K2(hPg) sterically optimizes the side chains of VKK38 for maximal binding to K2(hPg) and minimizes steric overlap between the K2(hPg) domains. The mechanism for hPg/M protein binding uncovered here may facilitate targeting of GAS virulence factors for disease management.	[Yuan, Yue; Qiu, Cunjia; Chandrahas, Vishwanatha; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Yuan, Yue; Zajicek, Jaroslav; Qiu, Cunjia; Chandrahas, Vishwanatha; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019; Yuan, Yue/S-5884-2017	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Yuan, Yue/0000-0003-1003-379X	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrahari G, 2016, J BIOL CHEM, V291, P9181, DOI 10.1074/jbc.M115.704221; Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Arza B, 1997, THROMB HAEMOSTASIS, V78, P1097; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hawley SB, 2001, J BIOL CHEM, V276, P179, DOI 10.1074/jbc.M004919200; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; LIOTTA LA, 1981, THROMB RES, V21, P663, DOI 10.1016/0049-3848(81)90268-1; LIOTTA LA, 1981, CANCER RES, V41, P4629; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Wang M, 2010, BIOPHYS J, V99, P302, DOI 10.1016/j.bpj.2010.04.019; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	50	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15016	15027		10.1074/jbc.M117.794198	http://dx.doi.org/10.1074/jbc.M117.794198			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724633	Green Published, hybrid			2022-12-26	WOS:000409902100024
J	Campbell, R; Tasevska, N; Jackson, KG; Sagi-Kiss, V; di Paolo, N; Minden, JS; Lister, SJ; Khaw, KT; Kuhnle, GGC				Campbell, Rachel; Tasevska, Natasha; Jackson, Kim G.; Sagi-Kiss, Virag; di Paolo, Nick; Minden, Jennifer S.; Lister, Susan J.; Khaw, Kay-Tee; Kuhnle, Gunter G. C.			Association between urinary biomarkers of total sugars intake and measures of obesity in a cross-sectional study	PLOS ONE			English	Article							SUCROSE INTAKE; FRUCTOSE; DIETARY; CONSUMPTION; HEALTH; INDIVIDUALS; PREVALENCE; NITROGEN; WEIGHT; CANCER	Obesity is an important modifiable risk factor for chronic diseases. While there is increasing focus on the role of dietary sugars, there remains a paucity of data establishing the association between sugar intake and obesity in the general public. The objective of this study was to investigate associations of estimated sugar intake with odds for obesity in a representative sample of English adults. We used data from 434 participants of the 2005 Health Survey of England. Biomarkers for total sugar intake were measured in 24 h urine samples and used to estimate intake. Linear and logistic regression analyses were used to investigate associations between biomarker-based estimated intake and measures of obesity (body mass intake (BMI), waist circumference and waist-to-hip ratio) and obesity risk, respectively. Estimated sugar intake was significantly associated with BMI, waist circumference and waist-to-hip ratio; these associations remained significant after adjustment for estimated protein intake as a marker of non-sugar energy intake. Estimated sugar intake was also associated with increased odds for obesity based on BMI (OR 1.02; 95% CI 1.00-1.04 per 10g), waist-circumference (1.03; 1.01-1.05) and waist-to-hip ratio (1.04; 1.02-1.06); all OR estimates remained significant after adjusting for estimated protein intake. Our results strongly support positive associations between total sugar intake, measures of obesity and likelihood of being obese. It is the first time that such an association has been shown in a nationally-representative sample of the general population using a validated biomarker. This biomarker could be used to monitor the efficacy of public health interventions to reduce sugar intake.	[Campbell, Rachel; Jackson, Kim G.; Sagi-Kiss, Virag; Kuhnle, Gunter G. C.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Tasevska, Natasha; Sagi-Kiss, Virag] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [di Paolo, Nick] NatCen Social Res, London, England; [Minden, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Lister, Susan J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Khaw, Kay-Tee; Kuhnle, Gunter G. C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Reading; Arizona State University; Arizona State University-Downtown Phoenix; University of London; University College London; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Cambridge	Kuhnle, GGC (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.; Kuhnle, GGC (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	g.g.kuhnle@reading.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Kuhnle, Gunter/AAG-5264-2019; Jackson, Kim/G-7356-2016; Mindell, Jennifer/G-2241-2011	Kuhnle, Gunter/0000-0002-8081-8931; Jackson, Kim/0000-0002-0070-3203; Mindell, Jennifer/0000-0002-7604-6131	World Cancer Research Fund (WCRF); Medical Research Council; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; MRC [MR/N003284/1] Funding Source: UKRI	World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by the World Cancer Research Fund (WCRF) and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Becker E, HLTH SURVEY ENGLAND; BINGHAM S, 1983, CLIN SCI, V64, P629, DOI 10.1042/cs0640629; BINGHAM SA, 1985, AM J CLIN NUTR, V42, P1276, DOI 10.1093/ajcn/42.6.1276; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Bingham S, 2007, CANCER EPIDEM BIOMAR, V16, P1651, DOI 10.1158/1055-9965.EPI-06-1050; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; DEANE N, 1955, J CLIN INVEST, V34, P681, DOI 10.1172/JCI103118; Douard Veronique, 2008, Am J Physiol Endocrinol Metab, V295, pE227, DOI 10.1152/ajpendo.90245.2008; England PH, 2015, WHY 5; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, 2006, DIET REF INT ESS GUI, P1; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Joosen AMCP, 2008, INT J OBESITY, V32, P1736, DOI 10.1038/ijo.2008.145; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kuhnle GGC, 2015, PUBLIC HEALTH NUTR, V18, P2815, DOI 10.1017/S1368980015000300; Luceri C, 1996, CANCER EPIDEM BIOMAR, V5, P167; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; NAKAMURA H, 1972, CLIN CHIM ACTA, V39, P397, DOI 10.1016/0009-8981(72)90055-1; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Pryer JA, 1997, INT J EPIDEMIOL, V26, P146, DOI 10.1093/ije/26.1.146; R Core Team, 2021, R LANGUAGE ENV STAT; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827; Tasevska N, 2009, EUR J CLIN NUTR, V63, P653, DOI 10.1038/ejcn.2008.21; Tasevska N, 2011, CANCER EPIDEM BIOMAR, V20, P490, DOI 10.1158/1055-9965.EPI-10-0820; Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255; Whitton C, 2011, BRIT J NUTR, V106, P1899, DOI 10.1017/S0007114511002340; World Health Organisation, 2015, GUID SUG ADULTS CHIL; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	36	14	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179508	10.1371/journal.pone.0179508	http://dx.doi.org/10.1371/journal.pone.0179508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723954	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000406067800004
J	Nakamoto, K; Aizawa, F; Miyagi, K; Yamashita, T; Mankura, M; Koyama, Y; Kasuya, F; Hirasawa, A; Kurihara, T; Miyata, A; Tokuyama, S				Nakamoto, Kazuo; Aizawa, Fuka; Miyagi, Kei; Yamashita, Takuya; Mankura, Mitsumasa; Koyama, Yutaka; Kasuya, Fumiyo; Hirasawa, Akira; Kurihara, Takashi; Miyata, Atsuro; Tokuyama, Shogo			Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice	PLOS ONE			English	Article							ACID RECEPTOR GPR40; NEUROPATHIC PAIN; FATTY-ACIDS; DESCENDING CONTROL; ACTIVATION; MOUSE; SENSITIZATION; INVOLVEMENT; TRANSITION; NEURONS	We previously showed that activation of G protein-coupled receptor 40/free fatty acid receptor 1 (GPR40/FFAR1) signaling modulates descending inhibition of pain. In this study, we investigated the involvement of fatty acid-GPR40/FFAR1 signaling in the transition from acute to chronic pain. We used GPR40/FFAR1-knockout (GPR40KO) mice and wild-type (WT) mice. A plantar incision was performed, and mechanical allodynia and thermal hyperalgesia were evaluated with a von Frey filament test and plantar test, respectively. Immunohistochemistry was used to localize GPR40/FFAR1, and the levels of free fatty acids in the hypothalamus were analyzed with liquid chromatography-tandem mass spectrometry. The repeated administration of GW1100, a GPR40/FFAR1 antagonist, exacerbated the incisioninduced mechanical allodynia and significantly increased the levels of phosphorylated extracellular signal-regulated kinase in the spinal cord after low-threshold touch stimulation in the mice compared to vehicle-treated mice. The levels of long-chain free fatty acids, such as docosahexaenoic acid, oleic acid, and palmitate, which are GPR40/FFAR1 agonists, were significantly increased in the hypothalamus two days after the surgery compared to levels in the sham group. Furthermore, the incision-induced mechanical allodynia was exacerbated in the GPR40KO mice compared to the WT mice, while the response in the plantar test was not changed. These findings suggested that dysfunction of the GPR40/FFAR1 signaling pathway altered the endogenous pain control system and that this dysfunction might be associated with the development of chronic pain.	[Nakamoto, Kazuo; Aizawa, Fuka; Miyagi, Kei; Tokuyama, Shogo] Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan; [Yamashita, Takuya; Kasuya, Fumiyo] Kobe Gakuin Univ, Biochem Toxicol Lab, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan; [Mankura, Mitsumasa] Kurashiki Sakuyo Univ, Fac Food Culture, Kurashiki, Okayama, Japan; [Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, Tondabayashi, Osaka, Japan; [Hirasawa, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto, Japan; [Kurihara, Takashi; Miyata, Atsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pharmacol, Kagoshima, Japan	Kobe Gakuin University; Kobe Gakuin University; Kyoto University; Kagoshima University	Tokuyama, S (corresponding author), Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan.	stoku@pharm.kobegakuin.ac.jp			Takeda Science Foundation; Kobe Gakuin University Joint Research; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [16K15339, 17K08599] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobe Gakuin University Joint Research; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was supported by the Takeda Science Foundation, by Grants-in-Aid and Special Coordination Funds from the Kobe Gakuin University Joint Research (A), and a Grant-in-Aid for Scientific Research (C) (15K10566) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Boneva NB, 2012, HIPPOCAMPUS, V22, P896, DOI 10.1002/hipo.20951; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Campillo A, 2011, EUR J PHARMACOL, V657, P89, DOI 10.1016/j.ejphar.2011.01.059; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; Gao YJ, 2010, J NEUROCHEM, V115, P505, DOI 10.1111/j.1471-4159.2010.06946.x; Gingrich JA, 2000, CURR OPIN NEUROBIOL, V10, P146, DOI 10.1016/S0959-4388(99)00061-6; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Karki P, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0003-8; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Li CS, 2014, J NEUROSCI, V34, P13737, DOI 10.1523/JNEUROSCI.2130-14.2014; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma D, 2007, NEUROSCI RES, V58, P394, DOI 10.1016/j.neures.2007.05.001; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Mifflin KA, 2014, CAN J ANESTH, V61, P112, DOI 10.1007/s12630-013-0087-4; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nakamoto K, 2015, BRIT J PHARMACOL, V172, P1250, DOI 10.1111/bph.13003; Nakamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081563; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Nakamoto K, 2010, BIOL PHARM BULL, V33, P1070, DOI 10.1248/bpb.33.1070; Nishinaka T, 2014, J PHARMACOL SCI, V125, P112, DOI 10.1254/jphs.14001SC; Pereira MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134441; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Taylor Bradley K, 2014, Curr Top Behav Neurosci, V20, P283, DOI 10.1007/7854_2014_351; Thomas T, 1998, PAIN, V75, P177, DOI 10.1016/S0304-3959(97)00218-2; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Walwyn WM, 2016, J NEUROSCI, V36, P204, DOI 10.1523/JNEUROSCI.1751-15.2016; Woolf CJ, 2010, J CLIN INVEST, V120, P3742, DOI 10.1172/JCI45178; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017; Yamashima T, 2015, PROG LIPID RES, V58, P40, DOI 10.1016/j.plipres.2015.01.002; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263	39	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180610	10.1371/journal.pone.0180610	http://dx.doi.org/10.1371/journal.pone.0180610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723961	Green Submitted, gold, Green Published			2022-12-26	WOS:000406067800020
J	Kang, MJ; Lee, JK; Kang, JW				Kang, Min-Joo; Lee, Jung-Kyung; Kang, Je-Won			Combining random forest with multi-block local binary pattern feature selection for multiclass head pose estimation	PLOS ONE			English	Article							FACE RECOGNITION; CLASSIFICATION	A new head pose estimation technique based on Random Forest (RF) and texture features for facial image analysis using a monocular camera is proposed in this paper, especially about how to efficiently combine the random forest and the features. In the proposed technique a randomized tree with useful attributes is trained to improve estimation accuracy and tolerance of occlusions and illumination. Specifically, a number of features Including Multi-scale Block Local Block Pattern (MB-LBP) are extracted from an Image, and random features such as the MB-LBP scale parameters, a block coordinate, and a layer of an Image pyramid in the feature pool are used for training the tree. The randomized tree aims to maximize the Information gain at each node while random samples traverse the nodes in the tree. To this aim, a split function considering the uniform property of the LBP feature is developed to move sample blocks to the left or the right children nodes. The trees are Independently trained with random Inputs, yet they are grouped to form a random forest so that the results collected from the trees are used for make the final decision. Precisely, we use a Maximum-A-Posteriori criterion in the decision. It Is demonstrated with experimental results that the proposed technique provides significantly enhanced classification performance in the head pose estimation In various conditions of Illumination, poses, expressions, and facial occlusions.	[Kang, Min-Joo; Lee, Jung-Kyung; Kang, Je-Won] Ewha W Univ, Dept Elect Engn, Seoul, South Korea	Ewha Womans University	Kang, JW (corresponding author), Ewha W Univ, Dept Elect Engn, Seoul, South Korea.	jewonk@ewha.ac.kr	Kang, Jewon/AAU-9722-2020		Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of Korean government [16CTAP-C114986-01]	Technology Advancement Research Program (TARP) - Ministry of Land, Infrastructure and Transport of Korean government(Ministry of Land, Infrastructure & Transport (MOLIT), Republic of Korea)	This research was supported by a grant (16CTAP-C114986-01) from Technology Advancement Research Program (TARP) funded by Ministry of Land, Infrastructure and Transport of Korean government.	Ahn B, 2014, REAL TIME HEAD ORIEN; Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Balasubramanian NV, COMPUTER VISION PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen L, WORKSH AN MOD FAC GE; Cheng QA, 2011, IEEE T PATTERN ANAL, V33, P1217, DOI 10.1109/TPAMI.2010.195; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; Drouard V, INT C IM PROC ICIP 2; Fanelli G, COMPUTER VISION PATT; Gottumukkal R, 2004, PATTERN RECOGN LETT, V25, P429, DOI 10.1016/j.patrec.2003.11.005; Gourier N, INT WORKSH VIS OBS D; Guo G, 2008, P 19 INT C PATT REC; Guo GD, 2005, IEEE T SYST MAN CY B, V35, P477, DOI 10.1109/TSMCB.2005.846658; Guyon I, 2010, J MACH LEARN RES, V11, P61; Haj M, CVPR 2012; Han B, 2014, PATTERN RECOGN LETT, V45, P145, DOI 10.1016/j.patrec.2014.03.017; Heisele B, 2003, COMPUT VIS IMAGE UND, V91, P6, DOI 10.1016/S1077-3142(03)00073-0; Huang C, INT C PATT REC 2010; Huang D, 2011, IEEE T SYST MAN CY C, V41, P765, DOI 10.1109/TSMCC.2011.2118750; Jain A, 2014, COMPUTER VISION PATT; Kim H, 2014, HUM-CENT COMPUT INFO, V4, DOI 10.1186/s13673-014-0009-7; Koestinger M, IEEE INT WORKSH BENC; Ksander N, 2015, PLOS ONE; Lee D, IEEE INT C COMP VIS; Lee K, COMPUTER VISION PATT; Li Y, 2010, INT C IM PROC ICIP; Ma B, 2006, P INT C PATT REC; Matsumoto Y, 2000, AUT FACE GESTURES RE; Min S, 2012, COMPUTER VISION PATT; Ming Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124640; Moore S, 2011, COMPUT VIS IMAGE UND, V115, P541, DOI 10.1016/j.cviu.2010.12.001; Murphy-Chutorian E, 2009, IEEE T PATTERN ANAL, V31, P607, DOI 10.1109/TPAMI.2008.106; Niese R, 2013, IEEE INT C SYST MAN; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Peng X, 2015, IEEE INT CONF AUTOMA; Saeed A, 2015, INT C IM PROC ICIP; Sagonas C, 2016, 300 FACES WILD CHALL; Storer M, WORKSH SUBSP METH; Taigman Y, COMPUTER VISION PATT; Taigman Y, CVPR 2012; Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645; Valenti R, 2012, IEEE T IMAGE PROCESS, V21, P802, DOI 10.1109/TIP.2011.2162740; Valle R, 2016, HEAD POSE ESTIMATION; Vatahska T, 2007, HUMANOIDS; Wang T, SPIE P 2003; Wang Y, 2015, PLOS ONE; Yang J, INT C PATT REC 2012; Zhu XX, 2012, PROC CVPR IEEE, P2879, DOI 10.1109/CVPR.2012.6248014	51	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180792	10.1371/journal.pone.0180792	http://dx.doi.org/10.1371/journal.pone.0180792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DJ	28715442	Green Published, Green Submitted, gold			2022-12-26	WOS:000413664500001
J	Kim, HS; Kim, JH; Yoon, YC; Choe, BK				Kim, Hyun Su; Kim, Jae-Hun; Yoon, Young Cheol; Choe, Bong Keun			Tumor spatial heterogeneity in myxoid-containing soft tissue using texture analysis of diffusion-weighted MRI	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; FEATURES; CLASSIFICATION; COEFFICIENT; BENIGN; IMAGES	The objective of this study was to examine the tumor spatial heterogeneity in myxoid-containing soft-tissue tumors (STTs) using texture analysis of diffusion-weighted imaging (DWI). A total of 40 patients with myxoid-containing STTs (23 benign and 17 malignant) were included in this study. The region of interest (ROI) was manually drawn on the apparent diffusion coefficient (ADC) map. For texture analysis, the global (mean, standard deviation, skewness, and kurtosis), regional (intensity variability and size-zone variability), and local features (energy, entropy, correlation, contrast, homogeneity, variance, and maximum probability) were extracted from the ADC map. Student's t-test was used to test the difference between group means. Analysis of covariance (ANCOVA) was performed with adjustments for age, sex, and tumor volume. The receiver operating characteristic (ROC) analysis was performed to compare diagnostic performances. Malignant myxoid-containing STTs had significantly higher kurtosis (P = 0.040), energy (P = 0.034), correlation (P<0.001), and homogeneity (P = 0.003), but significantly lower contrast (P<0.001) and variance (P = 0.001) compared with benign myxoid-containing STTs. Contrast showed the highest area under the curve (AUC = 0.923, P<0.001), sensitivity (94.12%), and specificity (86.96%). Our results reveal the potential utility of texture analysis of ADC maps for differentiating benign and malignant myxoid-containing STTs.	[Kim, Hyun Su; Kim, Jae-Hun; Yoon, Young Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 50 Irwon Dong, Seoul, South Korea; [Choe, Bong Keun] Kyung Hee Univ, Dept Prevent Med, Med Coll, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 50 Irwon Dong, Seoul, South Korea.	jaehun.kim78@gmail.com	Yoon, Young Cheol/AAG-4310-2020; Yoon, Young Cheol/AAG-4301-2020; Choe, Bong Keun/AAJ-2060-2020	Yoon, Young Cheol/0000-0002-7822-5344; , Bong Keun/0000-0002-1379-5936; Kim, Jae-Hun/0000-0003-3064-6948; Kim, Hyun Su/0000-0002-0179-9542	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056845]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056845).	Baheti AD, 2015, AM J ROENTGENOL, V204, P374, DOI 10.2214/AJR.14.12888; Brynolfsson P, 2014, MED PHYS, V41, DOI 10.1118/1.4894812; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Du J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001028; Einarsdottir H, 2004, EUR RADIOL, V14, P959, DOI 10.1007/s00330-004-2237-0; Genovese E, 2011, RADIOL MED, V116, P644, DOI 10.1007/s11547-011-0666-9; Georgiadis P, 2009, MAGN RESON IMAGING, V27, P120, DOI 10.1016/j.mri.2008.05.017; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hwang IP, 2015, INVEST RADIOL, V50, P798, DOI 10.1097/RLI.0000000000000186; Juntu J, 2010, J MAGN RESON IMAGING, V31, P680, DOI 10.1002/jmri.22095; Kierans AS, 2013, J MAGN RESON IMAGING, V37, P164, DOI 10.1002/jmri.23794; Ko ES, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002453; Lee SY, 2015, EUR RADIOL; Maeda M, 2007, J MAGN RESON IMAGING, V25, P1199, DOI 10.1002/jmri.20931; Mayerhoefer ME, 2008, MAGN RESON IMAGING, V26, P1316, DOI 10.1016/j.mri.2008.02.013; Nagata S, 2008, RADIAT MED, V26, P287, DOI 10.1007/s11604-008-0229-8; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; Pilavaki M, 2004, EUR J RADIOL, V52, P229, DOI 10.1016/j.ejrad.2003.12.001; Subhawong TK, 2014, AM J ROENTGENOL, V203, P560, DOI 10.2214/AJR.13.12165; SUH JS, 1992, RADIOLOGY, V183, P341, DOI 10.1148/radiology.183.2.1561333; Suo S, 2015, J MAGN RESON IMAGING; Thibault G., 2009, PATTERN RECOGNIT INF, V2009, P140; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tourassi GD, 1999, RADIOLOGY, V213, P317, DOI 10.1148/radiology.213.2.r99nv49317; van Rijswijk CSP, 2002, J MAGN RESON IMAGING, V15, P302, DOI 10.1002/jmri.10061; van Roggen JFG, 1999, HISTOPATHOLOGY, V35, P291; Waugh SA, 2016, EUR RADIOL, V26, P322, DOI 10.1007/s00330-015-3845-6; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	28	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181339	10.1371/journal.pone.0181339	http://dx.doi.org/10.1371/journal.pone.0181339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708850	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800056
J	Barbosa, AD; Gofton, AW; Paparini, A; Codello, A; Greay, T; Gillett, A; Warren, K; Irwin, P; Ryan, U				Barbosa, Amanda D.; Gofton, Alexander W.; Paparini, Andrea; Codello, Annachiara; Greay, Telleasha; Gillett, Amber; Warren, Kristin; Irwin, Peter; Ryan, Una			Increased genetic diversity and prevalence of co-infection with Trypanosoma spp. in koalas (Phascolarctos cinereus) and their ticks identified using next-generation sequencing (NGS)	PLOS ONE			English	Article							BRUSH-TAILED BETTONG; 18S RIBOSOMAL-RNA; COPEMANI; TRANSMISSION; GENOTYPES; REVEALS; MAMMALS; DISEASE; DESIGN; PARVUM	Infections with Trypanosoma spp. have been associated with poor health and decreased survival of koalas (Phascolarctos cinereus), particularly in the presence of concurrent pathogens such as Chlamydia and koala retrovirus. The present study describes the application of a next-generation sequencing (NGS)-based assay to characterise the prevalence and genetic diversity of trypanosome communities in koalas and two native species of ticks (Ixodes holocyclus and I. tasmani) removed from koala hosts. Among 168 koalas tested, 32.2% (95% CI: 25.2-39.8%) were positive for at least one Trypanosoma sp. Previously described Trypanosoma spp. from koalas were identified, including T. irwini (32.1%, 95% CI: 25.2-39.8%), T. gilletti (25%, 95% CI: 18.7-32.3%), T. copemani (27.4%, 95% CI: 20.8-34.8%) and T. vegrandis (10.1%, 95% CI: 6.0-15.7%). Trypanosoma noyesi was detected for the first time in koalas, although at a low prevalence (0.6% 95% CI: 0-3.3%), and a novel species (Trypanosoma sp. AB-2017) was identified at a prevalence of 4.8% (95% CI: 2.1-9.2%). Mixed infections with up to five species were present in 27.4% (95% CI: 21-35%) of the koalas, which was significantly higher than the prevalence of single infections 4.8% (95% CI: 2-9%). Overall, a considerably higher proportion (79.7%) of the Trypanosoma sequences isolated from koala blood samples were identified as T. irwini, suggesting this is the dominant species. Co-infections involving T. gilletti, T. irwini, T. copemani, T. vegrandis and Trypanosoma sp. AB-2017 were also detected in ticks, with T. gilletti and T. copemani being the dominant species within the invertebrate hosts. Direct Sanger sequencing of Trypanosoma 18S rRNA gene amplicons was also performed and results revealed that this method was only able to identify the genotypes with greater amount of reads (according to NGS) within koala samples, which highlights the advantages of NGS in detecting mixed infections. The present study provides new insights on the natural genetic diversity of Trypanosoma communities infecting koalas and constitutes a benchmark for future clinical and epidemiological studies required to quantify the contribution of trypanosome infections on koala survival rates.	[Barbosa, Amanda D.; Gofton, Alexander W.; Paparini, Andrea; Codello, Annachiara; Greay, Telleasha; Warren, Kristin; Irwin, Peter; Ryan, Una] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Barbosa, Amanda D.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Gillett, Amber] Univ Queensland, Sch Vet Sci, St Lucia, Qld, Australia	Murdoch University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Queensland	Barbosa, AD (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.; Barbosa, AD (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	A.DuarteBarbosa@murdoch.edu.au	Gofton, Alexander W/GOJ-8010-2022; Paparini, Andrea/T-8057-2019; Greay, Telleasha/AAZ-4424-2020	Gofton, Alexander W/0000-0002-5039-6117; Greay, Telleasha/0000-0002-0051-2642; Duarte Barbosa, Amanda/0000-0003-3289-1445; Warren, Kristin/0000-0002-9328-2013; Paparini, Andrea/0000-0002-1105-5184; Ryan, Una/0000-0003-2710-9324				Austen JM, 2015, EXP PARASITOL, V153, P105, DOI 10.1016/j.exppara.2015.03.022; Austen JM, 2011, PARASITOLOGY, V138, P866, DOI 10.1017/S0031182011000497; BACKHOUSE TC, 1951, T ROY SOC TROP MED H, V44, P521, DOI 10.1016/0035-9203(51)90032-6; Barbosa A, 2017, VET PARASITOL, V238, P94, DOI 10.1016/j.vetpar.2017.04.007; Barbosa A, 2016, PARASITOL INT, V65, P316, DOI 10.1016/j.parint.2016.03.004; Barbosa AD, 2016, VET PARASITOL, V223, P214, DOI 10.1016/j.vetpar.2016.05.002; Barker SC, 2014, ZOOTAXA, V3816, P1, DOI 10.11646/zootaxa.3816.1.1; Begolo D, 2014, ANTIMICROB AGENTS CH, V58, P6260, DOI 10.1128/AAC.03338-14; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bordbar B, 2014, INFECT GENET EVOL, V25, P81, DOI 10.1016/j.meegid.2014.04.010; Botero A, 2016, PROTIST, V167, P425, DOI 10.1016/j.protis.2016.07.002; Botero Adriana, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P77, DOI 10.1016/j.ijppaw.2013.03.001; Bradley IM, 2016, APPL ENVIRON MICROB, V82, P5878, DOI 10.1128/AEM.01630-16; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlton JM, 2013, ADV PARASIT, V81, P203, DOI 10.1016/B978-0-12-407826-0.00005-9; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Cheng WS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2106-z; Cooper C, 2016, ADV PARASIT IN PRESS; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fantin YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054835; Grinberg A, 2013, INFECT GENET EVOL, V15, P18, DOI 10.1016/j.meegid.2012.08.017; Hamilton PB, 2011, TRENDS PARASITOL, V27, P99, DOI 10.1016/j.pt.2010.11.009; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leprohon P, 2015, INT J PARASITOL-DRUG, V5, P26, DOI 10.1016/j.ijpddr.2014.09.005; MACKERRAS M. JOSEPHINE, 1959, AUSTRALIAN JOUR ZOOL, V7, P105, DOI 10.1071/ZO9590105; Mackie JT, 2017, AUSTR VET J IN PRESS; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McInnes LM, 2011, PARASITOLOGY, V138, P873, DOI 10.1017/S0031182011000369; McInnes LM, 2011, PARASITOLOGY, V138, P59, DOI 10.1017/S0031182010000971; McInnes LM, 2009, PARASITOLOGY, V136, P875, DOI 10.1017/S0031182009006313; Paparini A, 2017, PARASITOLOG IN PRESS; Paparini A, 2015, EXP PARASITOL, V151, P21, DOI 10.1016/j.exppara.2015.02.001; Paparini A, 2012, EXP PARASITOL, V131, P404, DOI 10.1016/j.exppara.2012.05.009; Paparini A, 2011, VET PARASITOL, V183, P21, DOI 10.1016/j.vetpar.2011.07.009; Park JW, 2010, J ENVIRON MONITOR, V12, P985, DOI 10.1039/b924160d; Pickering Jane, 1996, Australian Mammalogy, V19, P19; Pollitt LC, 2011, TRENDS PARASITOL, V27, P197, DOI 10.1016/j.pt.2011.01.004; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR., 2015, S E QUEENSLAND KOALA; Roberts F.H.S., 1970, AUSTR TICKS; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CK, 2015, TRENDS PARASITOL, V31, P553, DOI 10.1016/j.pt.2015.06.011; Thompson CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-169; Vermeulen ET, 2016, J MICROBIOL METH, V124, P1, DOI 10.1016/j.mimet.2016.02.018; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Yang RC, 2013, EXP PARASITOL, V135, P142, DOI 10.1016/j.exppara.2013.06.014; Zahedi A, 2017, INT J PARAS IN PRESS	58	25	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181279	10.1371/journal.pone.0181279	http://dx.doi.org/10.1371/journal.pone.0181279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704541	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700119
J	Bjorkman, F; Edin, F; Mattsson, CM; Larsen, F; Ekblom, B				Bjorkman, Frida; Edin, Fredrik; Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn			Regular moist snuff dipping does not affect endurance exercise performance	PLOS ONE			English	Article							SMOKELESS TOBACCO USE; MIDDLE-AGED MEN; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; BASEBALL PLAYERS; NICOTINE; RISK; MORTALITY; CANCER; COTININE	Physiological and medical effects of snuff have previously been obtained either in cross-sectional studies or after snuff administration to non-tobacco users. The effects of snuff cessation after several years of daily use are unknown. 24 participants with >2 years of daily snuff-use were tested before and after >6 weeks snuff cessation (SCG). A control group (CO) of 11 snuff users kept their normal habits. Resting heart rate (HR) and blood pressure (BP) were significantly lower in SCG after snuff cessation, and body mass was increased by 1.4 +/- 1.7 kg. Total cholesterol increased from 4.12 +/- 0.54 (95% CI 3.89-4.35) to 4.46 +/- 0.70 (95% CI 4.16-4.75) mM L-1 in SCG, due to increased LDL, and this change was significantly different from CO. Resting values of HDL, C-reactive protein, and free fatty acids (FFA) remained unchanged in both groups. In SCG group, both HR and BP were reduced during a four-stage incremental cycling test (from 50 to 80% of VO(2)max) and a prolonged cycling test (60 min at 50% of VO(2)max). Oxygen uptake (VO2), respiratory exchange ratio, blood lactate (bLa) and blood glucose (bGlu) concentration, and rate of perceived exertion (RPE) were unchanged. In CO group, all measurements were unchanged. During the prolonged cycling test, FFA was reduced, but with no significant difference between groups. During the maximal treadmill running test peak values of VO2, pulmonary ventilation (VE), time to exhaustion and bLa were unchanged in both groups. In conclusion, endurance exercise performance (VO(2)dmax and maximal endurance time) does not seem to be affected by prolonged snuff use, while effects on cardiovascular risk factors are contradictory. HR and BP during rest and submaximal exercise are reduced after cessation of regular use of snuff. Evidently, the long-time adrenergic stress on circulation is reversible.	[Bjorkman, Frida; Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden; [Edin, Fredrik] Univ Gothenburg, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Swedish School of Sport & Health Sciences; University of Gothenburg; Karolinska Institutet	Bjorkman, F (corresponding author), Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden.	frida.bjorkman@gih.se		Mattsson, C. Mikael/0000-0002-0642-4838; Bjorkman, Frida/0000-0001-8353-3766	Swedish National Institute of Public Health; Swedish School of Sport and Health Sciences	Swedish National Institute of Public Health; Swedish School of Sport and Health Sciences	The study was supported financially by grants from Swedish National Institute of Public Health (http://www.folkhalsomyndigheten.se) and the Swedish School of Sport and Health Sciences (www.gih.se).	Alaranta A, 2006, INT J SPORTS MED, V27, P581, DOI 10.1055/s-2005-865826; Arefalk G, 2014, CIRCULATION, V130, P325, DOI 10.1161/CIRCULATIONAHA.113.007252; Astrand PO K. R., 1986, TXB WORK PHYSL, P344; BAHRKE MS, 1988, MIL MED, V153, P229; BALDINI F, 1990, Medicine and Science in Sports and Exercise, V22, pS87, DOI 10.1249/00005768-199004000-00519; BALDINI FD, 1992, MIL MED, V157, P51, DOI 10.1093/milmed/157.2.51; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Bolinder G, 1997, ATHEROSCLEROSIS, V132, P95, DOI 10.1016/S0021-9150(97)00075-0; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; Bolinder G, 1997, EUR J CLIN INVEST, V27, P427, DOI 10.1046/j.1365-2362.1997.1290677.x; Borg G., 1962, PHYS PERFORMANCE PER; Cosgrove KP, 2009, ARCH GEN PSYCHIAT, V66, P666, DOI 10.1001/archgenpsychiatry.2009.41; Ebbert JO, 2004, ADDICT BEHAV, V29, P349, DOI 10.1016/j.addbeh.2003.08.046; EKBLOM B, 1971, ACTA PHYSIOL SCAND, V83, P399, DOI 10.1111/j.1748-1716.1971.tb05093.x; ELIASSON M, 1995, ATHEROSCLEROSIS, V113, P41, DOI 10.1016/0021-9150(94)05425-I; ERNSTER VL, 1990, JAMA-J AM MED ASSOC, V264, P218; Henninger S, 2015, INT J ENV RES PUB HE, V12, P7185, DOI 10.3390/ijerph120707185; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; KSIR C, 1986, J SPORT MED PHYS FIT, V26, P384; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Mundel T, 2006, EXP PHYSIOL, V91, P705, DOI 10.1113/expphysiol.2006.033373; PERKINS K A, 1991, Medicine and Science in Sports and Exercise, V23, P1283; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pulcipher J, 1989, MED SCI SPORTS EXERC, V21; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; SIEGEL D, 1992, AM J PUBLIC HEALTH, V82, P417, DOI 10.2105/AJPH.82.3.417; SIMON DL, 1957, JAMA-J AM MED ASSOC, V163, P354, DOI 10.1001/jama.1957.82970400003009a; Sponsiello-Wang Z, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-356; SQUIRES WG, 1984, PREV MED, V13, P195, DOI 10.1016/0091-7435(84)90051-3; TUCKER LA, 1989, AM J PUBLIC HEALTH, V79, P1048, DOI 10.2105/AJPH.79.8.1048; VANDUSER BL, 1992, MED SCI SPORT EXER, V24, P389	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181228	10.1371/journal.pone.0181228	http://dx.doi.org/10.1371/journal.pone.0181228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704507	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700110
J	Crouch, ML; Knowels, G; Stuppard, R; Ericson, NG; Bielas, JH; Marcinek, DJ; Syrjala, KL				Crouch, Marie-Laure; Knowels, Gary; Stuppard, Rudolph; Ericson, Nolan G.; Bielas, Jason H.; Marcinek, David J.; Syrjala, Karen L.			Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BREAST-CANCER SURVIVORS; CHILDHOOD-CANCER; ADULT SURVIVORS; INDUCED HEPATOTOXICITY; GLUTATHIONE DEPLETION; DOXORUBICIN ACTS; BODY-COMPOSITION; DNA DELETIONS; VITAMIN-E	Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7 +/- 10.6 vs. 49.0 +/- 16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 +/- 48.6 vs. 696.2 +/- 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 +/- 0.1 vs. 3.878 +/- 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-B p65 protein 1 day after drug exposure as compared to saline controls (0.091 +/- 0.017 vs. 0.053 +/- 0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.	[Crouch, Marie-Laure; Syrjala, Karen L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Knowels, Gary; Stuppard, Rudolph; Marcinek, David J.] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Bielas, Jason H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Syrjala, Karen L.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Syrjala, KL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Syrjala, KL (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	ksyrjala@fredhutch.org			National Institutes of Health/National Cancer Institute [P30 CA015704, R01 CA112631, R01 CA160684, R01 CA215134]; National Cancer Institute and National Institute on Aging [P20 CA103728]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA215134] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute and National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KLS: Private donation from Robert E. Frey. P30 CA015704, R01 CA112631, R01 CA160684, R01 CA215134, National Institutes of Health/National Cancer Institute; P20 CA103728, National Cancer Institute and National Institute on Aging.	Abraham P, 2011, HUM EXP TOXICOL, V30, P1924, DOI 10.1177/0960327111402240; Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4; al-Majid S, 2001, Biol Res Nurs, V2, P186, DOI 10.1177/109980040100200304; Anton E, 2002, INT J EXP PATHOL, V83, P47, DOI 10.1046/j.1365-2613.2002.00208.x; Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; Banthia R, 2006, J BEHAV MED, V29, P269, DOI 10.1007/s10865-006-9053-8; Bennett Jill A, 2013, Oncol Nurs Forum, V40, pE126, DOI 10.1188/13.ONF.E126-E134; Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067; Bertram LAC, 2011, CANCER CAUSE CONTROL, V22, P427, DOI 10.1007/s10552-010-9714-3; Bjelogrlic SK, 2005, BASIC CLIN PHARMACOL, V97, P311, DOI 10.1111/j.1742-7843.2005.pto_166.x; Bjelogrlic SK, 2013, BASIC CLIN PHARMACOL, V113, P228, DOI 10.1111/bcpt.12086; BLEI ML, 1993, P NATL ACAD SCI USA, V90, P7396, DOI 10.1073/pnas.90.15.7396; BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Bylow K, 2011, UROLOGY, V77, P934, DOI 10.1016/j.urology.2010.11.024; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; CROOK TR, 1986, CANCER RES, V46, P5035; CROOK TR, 1986, CANCER RES, V46, P5029; Cuce G, 2015, CHEM-BIOL INTERACT, V232, P7, DOI 10.1016/j.cbi.2015.02.016; DORR RT, 1994, CHEM-BIOL INTERACT, V93, P117, DOI 10.1016/0009-2797(94)90091-4; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Gilliam LAA, 2011, AM J PHYSIOL-LUNG C, V300, pL225, DOI 10.1152/ajplung.00264.2010; Gilliam LAA, 2011, MUSCLE NERVE, V43, P94, DOI 10.1002/mus.21809; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752; HEINEMAN FW, 1990, MAGNET RESON MED, V13, P490, DOI 10.1002/mrm.1910130316; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Hochman DJ, 2014, ENVIRON TOXICOL, V29, P908, DOI 10.1002/tox.21818; Hoffman MC, 2013, J CLIN ONCOL, V31, P2799, DOI 10.1200/JCO.2012.47.8081; Hoffmeister PA, 2013, BIOL BLOOD MARROW TR, V19, P1081, DOI 10.1016/j.bbmt.2013.04.017; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Kim Sung-Hwan, 2013, Lab Anim Res, V29, P204, DOI 10.5625/lar.2013.29.4.204; Kumari KK, 2012, J BIOENERG BIOMEMBR, V44, P179, DOI 10.1007/s10863-012-9423-6; Kushmerick MJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1739, DOI 10.1152/ajpcell.1997.272.5.C1739; Kwolek-Mirek M, 2015, CELL BIOCHEM BIOPHYS, V71, P1525, DOI 10.1007/s12013-014-0376-8; Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863; Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF; Gomes PRL, 2014, REV BRAS GINECOL OBS, V36, P244, DOI 10.1590/S0100-720320140005004; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003; McDonald C, 2011, CANCER FORUM, V35, P102; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268; Ness KK, 2012, CANCER-AM CANCER SOC, V118, P828, DOI 10.1002/cncr.26337; Nishikawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131394; Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002; Petrick JL, 2014, CANCER CAUSE CONTROL, V25, P1179, DOI 10.1007/s10552-014-0421-3; Rom O, 2013, FREE RADICAL BIO MED, V65, P190, DOI 10.1016/j.freeradbiomed.2013.06.024; Saquib N, 2011, PSYCHO-ONCOLOGY, V20, P252, DOI 10.1002/pon.1742; Sayed-Ahmed MM, 2014, INHI BITION OF GENE; Sehl M, 2013, J CANCER SURVIV, V7, P20, DOI 10.1007/s11764-012-0239-5; Sekeroglu V, 2011, ASIAN PAC J CANCER P, V12, P2925; Sheean PM, 2012, BREAST CANCER RES TR, V135, P663, DOI 10.1007/s10549-012-2200-8; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002; Siegel MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026963; Slater ME, 2015, BIOL BLOOD MARROW TR, V21, P1278, DOI 10.1016/j.bbmt.2015.04.007; Smith LB, 2014, THE ROLE OF IL 1BETA; Sun Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/170309; Syrjala KL, 2010, J CANCER SURVIV, V4, P225, DOI 10.1007/s11764-010-0126-x; Taylor D J, 1983, Mol Biol Med, V1, P77; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012; Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5; Wei C, 2015, PEDIATR BLOOD CANCER, V62, P1992, DOI 10.1002/pbc.25601; Winters-Stone KM, 2011, BREAST CANCER RES TR, V127, P447, DOI 10.1007/s10549-011-1444-z; Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536	87	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181086	10.1371/journal.pone.0181086	http://dx.doi.org/10.1371/journal.pone.0181086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700655	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800119
J	Gulagi, A; Choudhary, P; Bogdanov, D; Breyer, C				Gulagi, Ashish; Choudhary, Piyush; Bogdanov, Dmitrii; Breyer, Christian			Electricity system based on 100% renewable energy for India and SAARC	PLOS ONE			English	Article							SOLAR PV; GENERATION; COST; BENEFITS; COAL	The developing region of SAARC (South Asian Association for Regional Cooperation) is home to a large number of people living below the poverty line. In future, providing affordable, universally accessible, reliable, low to zero carbon electricity in this region will be the main aim. A cost optimal 100% renewable energy system is simulated for SAARC for the year 2030 on an hourly resolved basis. The region was divided into 16 sub-regions and three different scenarios were set up based on the level of high voltage direct current (HVDC) grid connections. The results obtained for a total system levelised cost of electricity (LCOE) showed a decrease from 71.6 sic/MWh in a decentralized to 67.2 sic/MWh for a centralized grid connected scenario. An additional scenario was simulated to show the benefits of integrating industrial gas production and seawater reverse osmosis desalination demand, and showed the system cost decreased by 5% and total electricity generation decreased by 1%. The results show that a 100% renewable energy system could be a reality in the SAARC region with the cost assumptions used in this research and it may be more cost competitive than nuclear and fossil carbon capture and storage (CCS) alternatives. One of the limitations of this study is the cost of land for installation of renewables which is not included in the LCOE calculations, but regarded as a minor contribution.	[Gulagi, Ashish; Bogdanov, Dmitrii; Breyer, Christian] Lappeenranta Univ Technol, Lappeenranta, Finland; [Choudhary, Piyush] Indian Inst Technol BHU, Varanasi, Uttar Pradesh, India	Lappeenranta University of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT BHU) - Varanasi	Gulagi, A (corresponding author), Lappeenranta Univ Technol, Lappeenranta, Finland.	Ashish.Gulagi@lut.fi	Breyer, Christian/W-2106-2018; Gulagi, Ashish/AAF-5016-2020; Choudhary, Piyush/N-9032-2019; Choudhary, Piyush/G-1114-2017	Breyer, Christian/0000-0002-7380-1816; Gulagi, Ashish/0000-0003-3440-1577; Choudhary, Piyush/0000-0002-1563-4554; Choudhary, Piyush/0000-0002-1563-4554; Bogdanov, Dmitrii/0000-0001-7136-4803	Tekes, the Finnish Funding Agency for Innovation [40101/14]; Fortum Foundation	Tekes, the Finnish Funding Agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Fortum Foundation	The authors gratefully acknowledge the public financing of Tekes, the Finnish Funding Agency for Innovation, for the 'Neo-Carbon Energy' project under the number 40101/14. The first author would like to thank Fortum Foundation for the valuable scholarship.	AAPG, 2015, GLOB HEAT FLOW DAT; Abhyankar N., 2015, ASSESSING TECHNICAL; Agora Energiewende, 2015, CURR FUT COST PHOT L; Agora Energiewende, 2014, COMP COST LOW CARB T, P10; [Anonymous], 2016, EXPLORING POTENTIAL, DOI DOI 10.2172/1321487; [Anonymous], 2012, J SUSTAINABLE ENERGY; [Anonymous], 2015, INDIAS ELECT SECTOR; Barnaby F, 2007, SECURE ENERGY CIVIL; Bertheau P., 2012, 5 INT C INT REN EN D; [BNEF]-Bloomberg New Energy Finance, 2015, DISTR SOL STOR ICEF; Bogdanov D, 2016, ENERG CONVERS MANAGE, V112, P176, DOI 10.1016/j.enconman.2016.01.019; Breyer C., 2011, 26 EU PVSEC; Breyer Ch., 2017, PROG PHOTOVOLT RES A; Breyer C, 2013, PROG PHOTOVOLTAICS, V21, P121, DOI 10.1002/pip.1254; British Petroleum, 2015, BP STAT REV WORLD EN, V54th ed.; Buckley T, 2016, MORE EVIDENCE INDIA; Buckley T, 2016, ANCELLATION ULTRA ME; Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/NCLIMATE2771, 10.1038/nclimate2771]; Caldera U, 2016, DESALINATION, V385, P207, DOI 10.1016/j.desal.2016.02.004; [CEA]-Central Electricity Authority, 2016, NAT EL PLAN IN PRESS; [CERC] Central Electricity Regulatory Comission, 2016, DET BENCHM CAP COST; Chakrabarti S., 2013, EN STAT; Chamorro CR, 2014, RENEW ENERG, V66, P1, DOI 10.1016/j.renene.2013.11.065; Chamorro CR, 2014, ENERGY, V65, P250, DOI 10.1016/j.energy.2013.11.078; Coady D., 2015, LARGE ARE GLOBAL ENE; Cochran J., 2013, MARKET EVOLUTION WHO; DBFZ, 2009, REG GLOB RAUML VERT; Denholm P, 2008, ENERG POLICY, V36, P3531, DOI 10.1016/j.enpol.2008.05.035; Dii, 2012, 2050 DES POW PERSP S; Dittmar M, 2012, ENERGY, V37, P35, DOI 10.1016/j.energy.2011.05.040; Duguid B., 2010, ONTARIOS LONG TERM E; Eid C, 2014, ENERG POLICY, V75, P244, DOI 10.1016/j.enpol.2014.09.011; Enerdata, 2014, GLOBAL ENERGY STAT Y; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Ernst & Young, 2012, REN EN COUNTR ATTR I; European Commission, 2014, INT REN EN EUR STUD, p[7, 54]; European Commission, 2014, ETRI 2014 EN TECHN R; Faiman D., 2009, ENERGY DESERT VERY L; Farfan J, 2017, J CLEAN PROD, V141, P370, DOI 10.1016/j.jclepro.2016.09.068; Gerlach A., 2014, 29 EU PVSEC; German Advisory Council on Global Change (WGBU), 2007, CLIMATE CHANGE SECUR, P23; Gol, 2015, REP IND REN EL ROADM; Goswami D., 2014, CAN INDIA ACHIEVE 10; Gulagi A., 2016, 10 INT REN EN STOR C; Hoffmann W., 2014, EU PVSEC; Huenges E, 2012, GEOTHERMAL ENERGY SY; Hummel P, 2017, UBS EVIDENCE LAB ELE; IASPEI, 2015, INT ASS SEISM PHYS E; IEA, 2012, TECHN ROADM BIOEN HE; IEA, 2012, WORLD EN OUTL 2012; IEA, 2013, WORLD EN OUTL 2013; IEA, 2013, EN BAL NONOECD COUNT; IEA International Energy Agency-IEA, 2014, RES PROS DRIV POL OP; [IMF]-International Monetary Fund, 2014, GETT EN PRIC RIGHT P; International Energy Agency (IEA), 2015, IND EN OUTL; IPCC, 2011, SPEC REP REN EN SOUR; [IPCC]-Intergovernmental Panel on Climate Change, 2014, SPEC REP IMP AD VULN; IRENA, 2015, TECHNICAL REPORT; [ISA]-International Solar Alliance, 2015, WORK PAP INT SOL ALL; King E, 2016, CLIMATECHANGENE 0418; KPMG, 2015, RIS SUN DISR HOR; Krewitt W, 2009, ENERG POLICY, V37, P5764, DOI 10.1016/j.enpol.2009.08.042; Lawson R. L., 2008, 21 CENTURY MARSHALL; Luck M., 2015, AQUEDUCT WATER STRES; [MCG]-Mercom Group Capital, 2014, JAW NEHR NAT SOL MIS; Ministry of Finance, 2015, IND PUBL FIN STAT; [MNRE]-Ministry of New and Renewable Energy, 2014, PHYS PROGR ACH REN E; MoEFCC, 2015, IND INT NATL DET CON; Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564; Papaefthymiou G., 2014, FLEXIBILITY OPTIONS; Pillai GG, 2014, ENERGY, V68, P832, DOI 10.1016/j.energy.2014.02.085; Planning Commission, 2011, FAST SUST MOR INCL G; Plessmann G, 2014, ENRGY PROCED, V46, P22, DOI 10.1016/j.egypro.2014.01.154; Powergrid Corporation of India Ltd, 2013, DES POW IND 2050 INT; Pratap A., 2013, POWERING AHEAD RENEW; [PwC]-PricewaterhouseCoopers and Mytrah, 2015, JOINT REP REN EN TRA; Romero S M., 2015, BRINGING VARIABLE RE; Shearer C, 2017, EARTHS FUTURE, V5, P408, DOI 10.1002/2017EF000542; Shrimali G., REACHING INDIAS RENE; Singer S, 2010, ENERGY REPORT 100 RE; Szabo S, 2017, RENEW SUST ENERG REV, V76, P1291, DOI 10.1016/j.rser.2017.03.117; TERI and WWF, 2011, EN REP IND 100 REN E; Teske S., 2012, TECHNICAL REPORT; Teske S., 2008, TECHNICAL REPORT; Teske S., 2015, TECHNICAL REPORT; [UNFCCC] United Nations Framework Convention on Climate Change, 2015, C PARTIES 21 SESS; United Nations, 2015, GOAL; Urban W., 2009, ABSCHLUSSBERICHT BMB; Vartiainen E., 2015, 31 EU PVSEC; WWF]-World Wildlife Fund-India and [WISE]-World Institute of Sustainable Energy, 2013, EN REP KER 100 REN E	90	63	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180611	10.1371/journal.pone.0180611	http://dx.doi.org/10.1371/journal.pone.0180611			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723937	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800021
J	Suarez, CG; Singer, BH; Gebremariam, A; Lee, JM; Singer, K				Suarez, Cecilia Gallego; Singer, Benjamin H.; Gebremariam, Achamyeleh; Lee, Joyce M.; Singer, Kanakadurga			The relationship between adiposity and bone density in US children and adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; FAT MASS; MINERAL DENSITY; OBESITY; CHILDHOOD; FEMALES; FATNESS; WOMEN; AGE	Objective In adults, obesity has been associated with several health outcomes including increased bone density. Our objective was to evaluate the association between percent body fat and fat mass with bone mineral density (BMD) in a nationally representative population of children and adolescents. Study design A total of 8,348 participants 8-18 years of age from the National Health and Nutrition Examination Survey (NHANES) 1999-2006 had whole body DXA scans performed. We conducted linear regressions to examine the relationship between percent body fat and fat mass with outcome variables of total body, pelvic and lumbar spine areal BMD (aBMD), controlling for lean body mass and assessing for gender and race/ethnicity interactions. Results We found evidence of gender and race/ethnicity interactions with percent body fat and total fat mass for the different BMD areas. Generally, there were decreases in total body aBMD (p<0.001) and lumbar spine aBMD (p<0.001) with increasing percent body fat and total fat mass, with less consistent patterns for pelvic aBMD. Conclusion Our findings of regional differences in the relationship of adiposity to aBMD in children and adolescents with significant interactions by gender and race/ethnicity emphasizes the need for further investigations to understand the impact of adiposity on bone health outcomes.	[Suarez, Cecilia Gallego; Lee, Joyce M.; Singer, Kanakadurga] Univ Michigan, Med Sch, Div Pediat Endocrinol & Metab, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Singer, Benjamin H.] Univ Michigan, Med Sch, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Gebremariam, Achamyeleh; Lee, Joyce M.] Univ Michigan, Med Sch, Child Hlth Evaluat & Res Unit CHEAR, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Singer, K (corresponding author), Univ Michigan, Med Sch, Div Pediat Endocrinol & Metab, Dept Pediat & Communicable Dis, Ann Arbor, MI USA.	ksinger@umich.edu	Singer, Benjamin/J-6330-2019	Singer, Benjamin/0000-0002-4721-6920; Singer, Kanakadurga/0000-0001-8278-3800	National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health [K08DK101755]; Department of Pediatrics Woodson Biostatistics Major Award; Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101755, P30DK092926, P30DK020572] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Pediatrics Woodson Biostatistics Major Award; Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Kanakadurga Singer receives support through a National Institute of Diabetes and Digestive and Kidney Diseases / National Institutes of Health Grant (K08DK101755), from the Department of Pediatrics Woodson Biostatistics Major Award and the Edith Briskin/SKS Foundation Taubman Emerging Scholars Program from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Binkovitz LA, 2007, PEDIATR RADIOL, V37, P21, DOI 10.1007/s00247-006-0153-y; Dugas LR, 2011, OBESITY, V19, P2099, DOI 10.1038/oby.2011.52; Freedman DS, 2008, OBESITY, V16, P1105, DOI 10.1038/oby.2008.30; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Freitas IF, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-37; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; GORAN MI, 1995, INT J OBESITY, V19, P638; Gordon CM, 2014, J CLIN DENSITOM, V17, P219, DOI 10.1016/j.jocd.2014.01.007; Gower BA, 2013, J CLIN DENSITOM, V16, P450, DOI 10.1016/j.jocd.2013.08.010; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Johnson CL., 2013, ANAL GUIDELINES 1999; Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lazcano-Ponce E, 2003, OSTEOPOROSIS INT, V14, P539, DOI 10.1007/s00198-002-1363-2; Leonard MB, 2015, BONE, V73, P69, DOI 10.1016/j.bone.2014.12.002; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Lloyd JT, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0175-2; MCCORMICK DP, 1991, J BONE MINER RES, V6, P507; Mosca LN, 2014, NUTRITION, V30, P847, DOI 10.1016/j.nut.2013.12.003; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patsch JM, 2011, METABOLISM, V60, P243, DOI 10.1016/j.metabol.2009.11.023; Pollock NK, 2007, AM J CLIN NUTR, V86, P1530, DOI 10.1093/ajcn/86.5.1530; Sayers A, 2010, J CLIN ENDOCR METAB, V95, P699, DOI 10.1210/jc.2009-1907; Scheller EL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00102; Singer K, 2014, OBESITY, V22, P1332, DOI 10.1002/oby.20710; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Streeter AJ, 2013, PEDIATR OBES, V8, P418, DOI 10.1111/j.2047-6310.2012.00126.x; Taes YEC, 2009, J CLIN ENDOCR METAB, V94, P2325, DOI 10.1210/jc.2008-2501; Van Leeuwen J, 2017, OBES REV; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; Weiler HA, 2000, BONE, V27, P203, DOI 10.1016/S8756-3282(00)00314-8; Wey HE, 2011, J CLIN ENDOCR METAB, V96, P106, DOI 10.1210/jc.2010-0889	34	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181587	10.1371/journal.pone.0181587	http://dx.doi.org/10.1371/journal.pone.0181587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723934	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800060
J	Allevato, M; Bolotin, E; Grossman, M; Mane-Padros, D; Sladek, FM; Martinez, E				Allevato, Michael; Bolotin, Eugene; Grossman, Mark; Mane-Padros, Daniel; Sladek, Frances M.; Martinez, Ernest			Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs	PLOS ONE			English	Article							C-MYC; TRANSCRIPTIONAL CONTROL; MAX; PROTEIN; GENOME; GENE; RECOGNITION; SITES; ACTIVATION; APOPTOSIS	The MYC oncoprotein regulates transcription of a large fraction of the genome as an obligatory heterodimer with the transcription factor MAX. The MYC:MAX heterodimer and MAX: MAX homodimer (hereafter MYC/MAX) bind Enhancer box (E-box) DNA elements (CANNTG) and have the greatest affinity for the canonical MYC E-box (CME) CACGTG. However, MYC:MAX also recognizes E-box variants and was reported to bind DNA in a "non-specific" fashion in vitro and in vivo. Here, in order to identify potential additional non canonical binding sites for MYC/MAX, we employed high throughput in vitro protein-binding microarrays, along with electrophoretic mobility-shift assays and bioinformatic analyses of MYC-bound genomic loci in vivo. We identified all hexameric motifs preferentially bound by MYC/MAX in vitro, which include the low-affinity non-E-box sequence AACGTT, and found that the vast majority (87%) of MYC-bound genomic sites in a human B cell line contain at least one of the top 21 motifs bound by MYC:MAX in vitro. We further show that high MYC/MAX concentrations are needed for specific binding to the low-affinity sequence AACGTT in vitro and that elevated MYC levels in vivo more markedly increase the occupancy of AACGTT sites relative to CME sites, especially at distal intergenic and intragenic loci. Hence, MYC binds diverse DNA motifs with a broad range of affinities in a sequence-specific and dose-dependent manner, suggesting that MYC overexpression has more selective effects on the tumor transcriptome than previously thought.	[Allevato, Michael; Grossman, Mark; Martinez, Ernest] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Bolotin, Eugene; Mane-Padros, Daniel; Sladek, Frances M.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Grossman, Mark] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Martinez, E (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Sladek, FM (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	frances.sladek@ucr.edu; ernest.martinez@ucr.edu		Allevato, Michael/0000-0003-1846-7189	NIH [R01CA158540, R01DK094707]; MARC U-STAR training grant from NIH [T34GM062756]; NATIONAL CANCER INSTITUTE [R01CA158540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MARC U-STAR training grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (R01CA158540 to E.M. and R01DK094707 to F.M.S). M.A. was supported by a MARC U-STAR training grant from NIH (T34GM062756).	AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERBERICH S, 1992, ONCOGENE, V7, P775; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Cowling Victoria H, 2010, Genes Cancer, V1, P576; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; SOLOMON DLC, 1993, NUCLEIC ACIDS RES, V21, P5372, DOI 10.1093/nar/21.23.5372; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tu WB, 2015, BBA-GENE REGUL MECH, V1849, P469, DOI 10.1016/j.bbagrm.2014.06.002; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	40	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180147	10.1371/journal.pone.0180147	http://dx.doi.org/10.1371/journal.pone.0180147			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719624	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400008
J	Kim, EK; Cho, JH; Kim, E; Kim, YJ				Kim, Eun-Kyung; Cho, Jae Hee; Kim, EuiJoo; Kim, Yoon Jae			Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; SUSTAINED ERK PHOSPHORYLATION; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; DEOXYCHOLIC-ACID; CHEMOPREVENTIVE AGENT; ULCERATIVE-COLITIS; CYCLE PROGRESSION; RISK; APOPTOSIS	Introduction The regulation of reactive oxygen species (ROS) exists as a therapeutic target for cancer treatments. Previous studies have shown that ursodeoxycholic acid (UDCA) suppresses the proliferation of colon cancer cells. The aim of this study was to evaluate the effect of UDCA upon the proliferation of colon cancer cells as a direct result of the regulation of ROS. Method Colon cancer cell lines (HT29 and HCT116) were treated with UDCA. The total number of cells and the number of dead cells were determined using cell counters. A fluorescein isothiocyanate-bromodeoxyuridine flow kit was used to analyze cell cycle variations. Upon exposure to UDCA, the protein levels of p27, p21, CDK2, CDK4 and CDK6 were determined using western blotting, and qRT-PCR was used to determine levels of mRNA. We preformed dichlorofluorescindiacetate (DCF-DA) staining to detect alteration of intracellular ROS using fluorescence activated cell sorting (FACS). Colon cancer stem-like cell lines were generated by tumorsphere culture and treated with UDCA for seven days. The total number of tumorspheres was determined using microscopy. Results We found that UDCA reduced the total number of colon cancer cells, but did not increase the number of dead cells. UDCA inhibited the G1/S and G2/M transition phases in colon cancer cells. UDCA induced expression of cell cycle inhibitors such as p27 and p21. However, it was determined that UDCA suppressed levels of CDK2, CDK4, and CDK6. UDCA regulated intracellular ROS generation in colon cancer cells, and induced activation of Erk1/2. Finally, UDCA inhibited formation of colon cancer stem-like cells. Conclusion Our results indicate that UDCA suppresses proliferation through regulation of oxidative stress in colon cancer cells, as well as colon cancer stem-like cells.	[Kim, Eun-Kyung; Cho, Jae Hee; Kim, EuiJoo; Kim, Yoon Jae] Gachon Univ, Div Gastroenterol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea; [Kim, Eun-Kyung] Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Incheon, South Korea	Gachon University; Gachon University	Kim, YJ (corresponding author), Gachon Univ, Div Gastroenterol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea.	yoonmed@gilhospital.com	Cho, Jae Hee/AAL-8192-2020; Kim, Eui Joo/P-8348-2019; Kim, Yoon Jae/G-6633-2015	Cho, Jae Hee/0000-0003-4174-0091; Kim, Eui Joo/0000-0001-5573-7083; Kim, Yoon Jae/0000-0001-8477-6823	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A1A05008202]; Gachon University Gil Medial Cancer [2016-15]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Gachon University Gil Medial Cancer	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A1A05008202) and Gachon University Gil Medial Cancer #2016-15	Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Banerjee B, 2016, CANCER PREV RES, V9, P528, DOI 10.1158/1940-6207.CAPR-15-0276; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Cao AL, 2016, BIOL PHARM BULL, V39, P1300, DOI 10.1248/bpb.b16-00094; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Collins M, 2016, J CROHNS COLITIS; Dozio E, 2010, EUR J PHARMACOL, V641, P29, DOI 10.1016/j.ejphar.2010.05.009; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Grbavac Z, 1989, Neurologija, V38, P95; Hansen JD, 2013, DIGEST DIS SCI, V58, P3079, DOI 10.1007/s10620-013-2772-0; Huang WK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002980; Huang YQ, 2016, WORLD J HEPATOL, V8, P1419, DOI 10.4254/wjh.v8.i33.1419; Ikegami T, 2008, HEPATOL RES, V38, P123, DOI 10.1111/j.1872-034X.2007.00297.x; Kim HY, 2015, INTEST RES, V13, P233, DOI 10.5217/ir.2015.13.3.233; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Kim YH, 2015, INTEST RES, V13, P145, DOI 10.5217/ir.2015.13.2.145; Kohno H, 2007, CLIN CANCER RES, V13, P2519, DOI 10.1158/1078-0432.CCR-06-2727; Kotb MA, 2012, INT J MOL SCI, V13, P8882, DOI 10.3390/ijms13078882; Krishna-Subramanian S, 2012, INT J CANCER, V130, P2771, DOI 10.1002/ijc.26336; Lim SC, 2010, INT J CANCER, V126, P1582, DOI 10.1002/ijc.24853; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miura T, 2001, J BIOL CHEM, V276, P47371, DOI 10.1074/jbc.M107098200; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Patel A, 2016, J CLIN EXP HEPATOL, V6, P311, DOI 10.1016/j.jceh.2016.10.001; Peiro-Jordan R, 2012, EUR J CANCER PREV, V21, P413, DOI 10.1097/CEJ.0b013e32834ef16f; Powell AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-219; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Serfaty L, 2003, HEPATOLOGY, V38, P203, DOI 10.1053/jhep.2003.50311; Shah SA, 2006, INT J CANCER, V118, P532, DOI 10.1002/ijc.21365; Shiraki K, 2005, INT J MOL MED, V16, P729; Singh S, 2013, INFLAMM BOWEL DIS, V19, P1631, DOI 10.1097/MIB.0b013e318286fa61; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Szary N, 2015, BIOMOLECULES, V5, P3295, DOI 10.3390/biom5043295; Tung BY, 2001, ANN INTERN MED, V134, P89, DOI 10.7326/0003-4819-134-2-200101160-00008; Vogt A, 2001, J BIOL CHEM, V276, P20544, DOI 10.1074/jbc.M100078200; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1653; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1316; Wang ZQ, 2003, J BIOL CHEM, V278, P11138, DOI 10.1074/jbc.M209108200; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	42	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181183	10.1371/journal.pone.0181183	http://dx.doi.org/10.1371/journal.pone.0181183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708871	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649800047
J	Zhu, FJ; Yang, ZY; Zhang, YL; Hu, K; Fang, WH				Zhu, Fengjiao; Yang, Zongying; Zhang, Yiliu; Hu, Kun; Fang, Wenhong			Transcriptome differences between enrofloxacin-resistant and enrofloxacinsusceptible strains of Aeromonas hydrophila	PLOS ONE			English	Article							PLASMID; GENES; INFECTION; SEQUENCE; CARP	Enrofloxacin is the most commonly used antibiotic to control diseases in aquatic animals caused by A. hydrophila. This study conducted de novo transcriptome sequencing and compared the global transcriptomes of enrofloxacin-resistant and enrofloxacin-susceptible strains. We got a total of 4,714 unigenes were assembled. Of these, 4,122 were annotated. A total of 3,280 unigenes were assigned to GO, 3,388 unigenes were classified into Cluster of Orthologous Groups of proteins (COG) using BLAST and BLAST2GO software, and 2,568 were mapped onto pathways using the Kyoto Encyclopedia of Gene and Genomes Pathway database. Furthermore, 218 unigenes were deemed to be DEGs. After enrofloxacin treatment, 135 genes were upregulated and 83 genes were downregulated. The GO terms biological process (126 genes) and metabolic process (136 genes) were the most enriched, and the terms for protein folding, response to stress, and SOS response were also significantly enriched. This study identified enrofloxacin treatment affects multiple biological functions of A. hydrophila. Enrofloxacin resistance in A. hydrophila is closely related to the reduction of intracellular drug accumulation caused by ABC transporters and increased expression of topoisomerase IV.	[Zhu, Fengjiao; Yang, Zongying; Zhang, Yiliu; Hu, Kun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China; [Yang, Zongying] Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China; [Fang, Wenhong] East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Shanghai Ocean University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Hu, K (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	khu@shou.edu.cn			Special Fund for Agro-scientific Research in the Public interest [201203085]; 863 Program [2011AA10A216]; Key Project for Developing Agriculture by Science and Technology in Shanghai [2014-3-4]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	Special Fund for Agro-scientific Research in the Public interest; 863 Program(National High Technology Research and Development Program of China); Key Project for Developing Agriculture by Science and Technology in Shanghai; National Natural Resources Platform; Shanghai University Knowledge Service Platform	This research was supported by the Special Fund for Agro-scientific Research in the Public interest (Grant 201203085), the 863 Program (Grant 2011AA10A216), the Key Project for Developing Agriculture by Science and Technology in Shanghai (Grant NO. 2014-3-4), the National Natural Resources Platform, and the Shanghai University Knowledge Service Platform.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cockerill F. R, 2011, CLIN LAB STANDARDS I, P165; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Czesny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031803; del Castillo CS, 2013, ANTIMICROB AGENTS CH, V57, P120, DOI 10.1128/AAC.01239-12; Huang L, 2015, GENE, V565, P275, DOI 10.1016/j.gene.2015.04.031; Khushiramani R, 2008, WORLD J MICROB BIOT, V24, P2263, DOI 10.1007/s11274-008-9740-4; Kregiel D., 2014, BIOMED RES INT, V104; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B., 2011, PLOS ONE, V6, P1159; Liu L, 2015, FISH SHELLFISH IMMUN, V45, P175, DOI 10.1016/j.fsi.2015.03.043; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Martinez M, 2006, VET J, V172, P10, DOI 10.1016/j.tvjl.2005.07.010; Mu XJ, 2013, FISH SHELLFISH IMMUN, V35, P1566, DOI 10.1016/j.fsi.2013.08.027; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Sahoo PK, 2008, FISH SHELLFISH IMMUN, V25, P163, DOI 10.1016/j.fsi.2008.04.003; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Shakir Z, 2012, APPL ENVIRON MICROB, V78, P8137, DOI 10.1128/AEM.02081-12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472	30	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179549	10.1371/journal.pone.0179549	http://dx.doi.org/10.1371/journal.pone.0179549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708867	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800004
J	Suktitipat, B; Sathirareuangchai, S; Roothumnong, E; Thongnoppakhun, W; Wangkiratikant, P; Vorasan, N; Krittayaphong, R; Pithukpakorn, M; Boonyapisit, W				Suktitipat, Bhoom; Sathirareuangchai, Sakda; Roothumnong, Ekkapong; Thongnoppakhun, Wanna; Wangkiratikant, Purin; Vorasan, Nutchavadee; Krittayaphong, Rungroj; Pithukpakorn, Manop; Boonyapisit, Warangkna			Molecular investigation by whole exome sequencing revealed a high proportion of pathogenic variants among Thai victims of sudden unexpected death syndrome	PLOS ONE			English	Article							CHINESE HAN POPULATION; UNEXPLAINED DEATH; CARDIAC DEATH; AUTOPSY; MEN; DISEASES; GENES; SNPS	Introduction Sudden unexpected death syndrome (SUDS) is an important cause of death in young healthy adults with a high incident rate in Southeast Asia; however, there are no molecular autopsy reports about these victims. We performed a combination of both a detailed autopsy and a molecular autopsy by whole exome sequencing (WES) to investigate the cause of SUDS in Thai sudden death victims. Materials and methods A detailed forensic autopsy was performed to identify the cause of death, followed by a molecular autopsy, in 42 sudden death victims who died between January 2015 and August 2015. The coding sequences of 98 SUDS-related genes were sequenced using WES. Potentially causative variants were filtered based on the variant functions annotated in the dbNSFP database. Variants with inconclusive clinical significance evidence in ClinVar were resolved with a variant prediction algorithm, metaSVM, and the frequency data of the variants found in public databases, such as the 1000 Genome Project, ESP6500 project, and the Exome Aggregation Consortium (ExAc) project. Results Combining both autopsy and molecular autopsy enabled the potential identification of cause of death in 81% of the cases. Among the 25 victims with WES data, 72% (18/25) were found to have potentially causative SUDS mutations. The majority of the victims had at a mutation in the TTN gene (8/18 = 44%), and only one victim had an SCN5A mutation. Conclusions WES can help to identify the genetic causes in victims of SUDS and may help to further guide investigations into their relatives to prevent additional SUDS victims.	[Suktitipat, Bhoom] Mahidol Univ, Fac Med, Dept Biochem, Siriraj Hosp, Bangkok, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Integrat Computat BioSci Ctr ICBS, Bangkok, Thailand; [Sathirareuangchai, Sakda] Mahidol Univ, Fac Med, Dept Forens Med, Siriraj Hosp, Bangkok, Thailand; [Roothumnong, Ekkapong; Krittayaphong, Rungroj; Pithukpakorn, Manop; Boonyapisit, Warangkna] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand; [Thongnoppakhun, Wanna] Mahidol Univ, Fac Med, Dept Res & Dev, Siriraj Hosp, Bangkok, Thailand; [Wangkiratikant, Purin; Vorasan, Nutchavadee] Mahidol Univ, Fac Med, Res Div, Siriraj Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Boonyapisit, W (corresponding author), Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand.	waran_byps@yahoo.com	Pithukpakorn, Manop/K-9825-2013; Suktitipat, Bhoom/H-4239-2019	Pithukpakorn, Manop/0000-0003-3611-5718; Suktitipat, Bhoom/0000-0001-8034-7757; Sathirareuangchai, Sakda/0000-0002-0585-6874; Boonyapisit, Warangkna/0000-0002-5278-0091	Mahidol University [R015837002]; Siriraj Core Research Facility (SiCRF); Siriraj Chalermphrakiat; Crown Property Bureau Foundation Grant; Thanapat Fund [D003752]; Faculty of Medicine Siriraj Hospital, Mahidol University [R015734003]	Mahidol University; Siriraj Core Research Facility (SiCRF); Siriraj Chalermphrakiat; Crown Property Bureau Foundation Grant; Thanapat Fund; Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by Mahidol University (Grant R015837002 to WB); Siriraj Core Research Facility (SiCRF) Grant to MP; Siriraj Chalermphrakiat Grant to BS, SS, WT, WB, MP and RK; the Crown Property Bureau Foundation Grant to BS; Thanapat Fund (D003752) to MP, Faculty of Medicine Siriraj Hospital, Mahidol University, Grant Number (IO) R015734003 to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RC, 1983, LANCET, V1, P764; Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Campuzano O, 2015, INT J MOL SCI, V16, P25773, DOI 10.3390/ijms161025773; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Chanavirut R, 2017, INT J CARDIOL, V226, P87, DOI 10.1016/j.ijcard.2016.10.001; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Hertz CL, 2015, EUROPACE, V17, P350, DOI 10.1093/europace/euu210; Huang L, 2014, FORENSIC SCI INT, V235, P14, DOI 10.1016/j.forsciint.2013.12.007; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Liu C, 2014, FORENSIC SCI INT, V236, P38, DOI 10.1016/j.forsciint.2013.12.033; Liu C, 2013, FORENSIC SCI INT, V231, P82, DOI 10.1016/j.forsciint.2013.04.020; Lombardi R, 2013, CURR OPIN CARDIOL, V28, P272, DOI 10.1097/HCO.0b013e32835fb7f3; LUCAS S, 2005, GUIDELINES AUTOPSY P; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; Pithukpakorn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128481; Sanchez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167358; Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581; Tang YY, 2014, CARDIOVASC PATHOL, V23, P1, DOI 10.1016/j.carpath.2013.09.002; TATSANAVIVAT P, 1992, INT J EPIDEMIOL, V21, P904, DOI 10.1093/ije/21.5.904; Torkamani A, 2016, JAMA-J AM MED ASSOC, V316, P1492, DOI 10.1001/jama.2016.11445; TUNGSANGA K, 1993, INT J EPIDEMIOL, V22, P81, DOI 10.1093/ije/22.1.81; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Wang C, 2015, FORENSIC SCI INT, V257, pE20, DOI 10.1016/j.forsciint.2015.08.022; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180056	10.1371/journal.pone.0180056	http://dx.doi.org/10.1371/journal.pone.0180056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704380	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649700024
J	Szafran, AT; Stossi, F; Mancini, MG; Walker, CL; Mancini, MA				Szafran, Adam T.; Stossi, Fabio; Mancini, Maureen G.; Walker, Cheryl L.; Mancini, Michael A.			Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis	PLOS ONE			English	Article							RECEPTOR-ALPHA; CHEMICALS; TRANSCRIPTION; MECHANISMS	Animal studies have linked the estrogenic properties of bisphenol A (BPA) to adverse effects on the endocrine system. Because of concerns for similar effects in humans, there is a desire to replace BPA in consumer products, and a search for BPA replacements that lack endocrine-disrupting bioactivity is ongoing. We used multiple cell-based models, including an established multi-parametric, high throughput microscopy-based platform that incorporates engineered HeLa cell lines with visible ER alpha- or ER beta-regulated transcription loci, to discriminate the estrogen-like and androgen-like properties of previously uncharacterized substituted bisphenol derivatives and hydroquinone. As expected, BPA induced 70-80% of the estrogen-like activity via ER alpha and ER beta compared to E2 in the HeLa prolactin array cell line. 2,2' BPA, Bisguaiacol F, CHDM 4-hydroxybuyl acrylate, hydroquinone, and TM modified variants of BPF showed very limited estrogen-like or androgen-like activity (< 10% of that observed with the control compounds). Interestingly, TM-BFP and CHDM 4-hydroxybuyl acrylate, but not their derivatives, demonstrated evidence of anti-estrogenic and anti-androgenic activity. Our findings indicate that Bisguaiacol F, TM-BFP-ER and TM-BPFDGE demonstrate low potential for affecting estrogenic or androgenic endocrine activity. This suggest that the tested compounds could be suitable commercially viable alternatives to BPA.	[Szafran, Adam T.; Stossi, Fabio; Mancini, Maureen G.; Walker, Cheryl L.; Mancini, Michael A.] Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA; [Mancini, Michael A.] DeepBio Inc, Houston, TX 77046 USA	Baylor College of Medicine	Mancini, MA (corresponding author), Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA.; Mancini, MA (corresponding author), DeepBio Inc, Houston, TX 77046 USA.	mancini@bcm.edu			Integrated Microscopy Core at Baylor College of Medicine; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Dan L. Duncan Cancer Center [NIH P30CA125123]; NIH [HD007495, DK56338, K12DK0083014]; multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded; NIEHS [R01 (1R01ES023206-01), P30 (ES023512-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007495, P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, K12DK083014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES027704, P30ES023512, R01ES023206] Funding Source: NIH RePORTER	Integrated Microscopy Core at Baylor College of Medicine; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Dan L. Duncan Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS grants NIEHS R01 (1R01ES023206-01; Cheryl L. Walker, Bert W. OMalley, M.A.M. and Mark T. Bedford) and NIEHS P30 (ES023512-01; Center of Excellence in Environmental Health, C.L.W.). Further support was provided by the Integrated Microscopy Core at Baylor College of Medicine with funding from the John S. Dunn Gulf Coast Consortium for Chemical Genomics, the Dan L. Duncan Cancer Center (NIH P30CA125123), and the NIH (HD007495, and DK56338). ATS is a K12 Scholar supported by NIH grant K12DK0083014, the multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded to Dr. Dolores J. Lamb. DeepBio, Inc received funds and material support from the Valspar Corporation. Funders do not have scientific or editorial control over the design, conduct, analysis, or interpretation of the data, nor were they involved in the decision to publish or producing this manuscript. DeepBio, Inc provided support in the form of materials and consulting fees for A.T.S., F.S., and M.G.M. and provided salary for M.A.M. The specific roles of these authors are articulated in the author contributions section. M.A.M participated in in study design, data interpretation, and final manuscript review, however, DeepBio, Inc did not have editorial control nor was involved in the decision to publish.	Ashcroft FJ, 2011, GENE, V477, P42, DOI 10.1016/j.gene.2011.01.009; Berno V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002286; Bolt MJ, 2013, NUCLEIC ACIDS RES, V41, P4036, DOI 10.1093/nar/gkt100; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P1239, DOI 10.1289/ehp.1408258; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Colleta SJ, 2015, ENV TOXICOL; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Jiang SM, 2006, MOL ENDOCRINOL, V20, P311, DOI 10.1210/me.2005-0100; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Karmakar S, 2013, J BIOL CHEM, V288, P24020, DOI 10.1074/jbc.M113.473819; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Odian, PRINCIPLES POLYM; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Rehan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138438; Rivas A, 2002, J STEROID BIOCHEM, V82, P45, DOI 10.1016/S0960-0760(02)00146-2; Robertson G.L., 2006, PACKAG TECHNOL SCI; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rosenmai AK, 2014, TOXICOL SCI, V139, P35, DOI 10.1093/toxsci/kfu030; Sharp ZD, 2006, J CELL SCI, V119, P4365, DOI 10.1242/jcs.03264; Soto AM, 2017, ENVIRON SCI TECHNOL, V51, P1718, DOI 10.1021/acs.est.6b04704; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stossi F, 2016, ONCOTARGET; Stossi F, 2014, CHEM BIOL, V21, P743, DOI 10.1016/j.chembiol.2014.03.013; Stoye E, 2014, CHEM WORLD; Szafran AT, 2014, ASSAY DRUG DEV TECHN, V12, P87, DOI 10.1089/adt.2013.532; Weiss B, 2012, NEUROTOXICOLOGY, V33, P1410, DOI 10.1016/j.neuro.2012.05.014; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Wu J, 2015, TOXICOL IND HLTH	31	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180141	10.1371/journal.pone.0180141	http://dx.doi.org/10.1371/journal.pone.0180141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704378	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649700029
J	Horio, Y; Ichiyasu, H; Kojima, K; Saita, N; Migiyama, Y; Iriki, T; Fujii, K; Niki, T; Hirashima, M; Kohrogi, H				Horio, Yuko; Ichiyasu, Hidenori; Kojima, Keisuke; Saita, Naoki; Migiyama, Yohei; Iriki, Toyohisa; Fujii, Kazuhiko; Niki, Toshiro; Hirashima, Mitsuomi; Kohrogi, Hirotsugu			Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; CONNECTIVE-TISSUE BREAKDOWN; SMOKE-INDUCED EMPHYSEMA; NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE; POLYMORPHONUCLEAR NEUTROPHILS; OXIDATIVE STRESS; T-CELLS; MICE	Purpose Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow obstruction and pulmonary emphysema. Persistent inflammation and remodeling of the lungs and airways result in reduced lung function and a lower quality of life. Galectin (Gal)-9 plays a crucial role as an immune modulator in various diseases. However, its role in the pathogenesis of pulmonary emphysema is unknown. This study investigates whether Gal-9 is involved in pulmonary inflammation and changes in emphysema in a porcine pancreatic elastase (PPE)-induced emphysema model. Materials and methods Gal-9 was administered to mice subcutaneously once daily from 1 day before PPE instillation to day 5. During the development of emphysema, lung tissue and bronchoalveolar lavage fluid (BALF) were collected. Histological and cytological findings, concentrations of chemokines and matrix metalloproteinases (MMPs) in the BALF, and the influence of Gal-9 treatment on neutrophils were analyzed. Results Gal-9 suppressed the pathological changes of PPE-induced emphysema. The mean linear intercept (Lm) of Gal-9-treated emphysema mice was significantly lower than that of PBStreated emphysema mice (66.1 +/- 3.3 mu m vs. 118.8 +/- 14.8 ae m, respectively; p < 0.01). Gal-9 decreased the number of neutrophils and levels of MMP-9, MMP-2 and tissue inhibitor of metalloproteinases (TIMP)-1 in the BALF. The number of neutrophils in the BALF correlated significantly with MMPs levels. Interestingly, Gal-9 pretreatment in vitro inhibited the chemotactic activity of neutrophils and MMP-9 production from neutrophils. Furthermore, in Gal-9deficient mice, PPE-induced emphysema progressed significantly compared with that in wild-type (WT) mice (108.7 +/- 6.58 mu m vs. 77.19 +/- 6.97 ae m, respectively; p < 0.01). Conclusions These results suggest that Gal-9 protects PPE-induced inflammation and emphysema by inhibiting the infiltration of neutrophils and decreasing MMPs levels. Exogenous Gal-9 could be a potential therapeutic agent for COPD.	[Horio, Yuko; Ichiyasu, Hidenori; Kojima, Keisuke; Saita, Naoki; Migiyama, Yohei; Iriki, Toyohisa; Fujii, Kazuhiko; Kohrogi, Hirotsugu] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Dept Immunol & Immunopathol, Takamatsu, Kagawa, Japan	Kumamoto University; Kagawa University	Kohrogi, H (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan.	kohrogi@kumamoto-u.ac.jp		Ichiyasu, Hidenori/0000-0003-1773-8485				Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Antunes MA, 2011, AN ACAD BRAS CIENC, V83, P1385, DOI 10.1590/S0001-37652011005000039; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Baila B, 2012, BIOL PHARM BULL, V35, P494, DOI 10.1248/bpb.35.494; BARON EJ, 1982, J IMMUNOL METHODS, V49, P305, DOI 10.1016/0022-1759(82)90130-2; Baseras B, 2012, IMMUNOBIOLOGY, V217, P83, DOI 10.1016/j.imbio.2011.07.031; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Cheng SL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-115; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Dentener MA, 2008, RESPIRATION, V76, P275, DOI 10.1159/000117386; Dhami R, 2000, AM J RESP CELL MOL, V22, P244, DOI 10.1165/ajrcmb.22.2.3809; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Horio Y, 2016, ERS INT C LOND UK; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; John S, 2016, J BIOSCIENCES, V41, P507, DOI 10.1007/s12038-016-9616-y; Kadowaki T, 2013, CRIT CARE, V17, DOI 10.1186/cc13147; KAPLAN PD, 1973, J LAB CLIN MED, V82, P349; Kojima K, 2011, AM J RESP CRIT CARE, V184, P328, DOI 10.1164/rccm.201010-1566OC; Koo HK, 2016, INT J CHRONIC OBSTR, V11, P1129, DOI 10.2147/COPD.S103281; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Leskela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123938; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; Ma DW, 2006, J MED CHEM, V49, P456, DOI 10.1021/jm051101g; Mackarel AJ, 1999, AM J RESP CELL MOL, V20, P1209; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Mikko M, 2013, IMMUNOBIOLOGY, V218, P225, DOI 10.1016/j.imbio.2012.04.012; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Ofulue AF, 1999, AM J PHYSIOL-LUNG C, V277, pL97, DOI 10.1152/ajplung.1999.277.1.L97; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sakao S, 2001, AM J RESP CRIT CARE, V163, P420, DOI 10.1164/ajrccm.163.2.2006031; Seemungal TAR, 2015, AM J RESP CRIT CARE, V192, P1036, DOI 10.1164/rccm.201503-0534UP; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Steichen AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123573; Taguchi L, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0233-3; Tsai WC, 2004, AM J RESP CRIT CARE, V170, P1331, DOI 10.1164/rccm.200402-200OC; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	51	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180742	10.1371/journal.pone.0180742	http://dx.doi.org/10.1371/journal.pone.0180742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704475	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600047
J	Laggner, M; Pollreisz, A; Schmidinger, G; Schmidt-Erfurth, U; Chen, YT				Laggner, Maria; Pollreisz, Andreas; Schmidinger, Gerald; Schmidt-Erfurth, Ursula; Chen, Ying-Ting			Autophagy mediates cell cycle response by regulating nucleocytoplasmic transport of PAX6 in limbal stem cells under ultraviolet-A stress	PLOS ONE			English	Article							EPITHELIAL-CELLS; DOWN-REGULATION; PROLIFERATION; DIFFERENTIATION; APOPTOSIS; GROWTH; MODEL; PREVALENCE; EXPRESSION; PTERYGIUM	Limbal stem cells (LSC) account for homeostasis and regeneration of corneal epithelium. Solar ultraviolet A (UVA) is the major source causing oxidative damage in the ocular surface. Autophagy, a lysosomal degradation mechanism, is essential for physiologic function and stress defense of stem cells. PAX6, a master transcription factor governing corneal homeostasis by regulating cell cycle and cell fate of LSC, responds to oxidative stress by nucleocytoplasmic shuttling. Impaired autophagy and deregulated PAX6 have been reported in oxidative stress-related ocular surface disorders. We hypothesize a functional role for autophagy and PAX6 in LSC's stress response to UVA. Therefore, human LSC colonies were irradiated with a sub-lethal dose of UVA and autophagic activity and intracellular reactive oxygen species (ROS) were measured by CYTO-ID assay and CM-H(2)DCFDA live staining, respectively. Following UVA irradiation, the percentage of autophagic cells significantly increased in LSC colonies while intracellular ROS levels remained unaffected. siRNA-mediated knockdown (KD) of ATG7 abolished UVA-induced autophagy and led to an excessive accumulation of ROS. Upon UVA exposure, LSCs displayed nuclear-to-cytoplasmic translocation of PAX6, while ATG7KD or antioxidant pretreatment largely attenuated the intracellular trafficking event. Immunofluorescence showing downregulation of proliferative marker PCNA and induction of cell cycle regulator p21 indicates cell cycle arrest in UVA-irradiated LSC. Abolishing autophagy, adenoviral-assisted restoration of nuclear PAX6 or antioxidant pretreatment abrogated the UVA-induced cell cycle arrest. Adenoviral expression of an ectopic PAX gene, PAX7, did not affect UVA cell cycle response. Furthermore, knocking down PAX6 attenuated the cell cycle progression of irradiated ATG7KD LSC by de-repressing p21 expression. Collectively, our data suggest a crosstalk between autophagy and PAX6 in regulating cell cycle response of ocular progenitors under UVA stress. Autophagy deficiency leads to impaired intracellular trafficking of PAX6, perturbed redox balance and uncurbed cell cycle progression in UVA-stressed LSCs. The coupling of autophagic machinery and PAX6 in cell cycle regulation represents an attractive therapeutic target for hyperproliferative ocular surface disorders associated with solar radiation.	[Laggner, Maria; Pollreisz, Andreas; Schmidinger, Gerald; Schmidt-Erfurth, Ursula; Chen, Ying-Ting] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Medical University of Vienna	Chen, YT (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	ying-ting.chen@meduniwien.ac.at	Pollreisz, Andreas/AAJ-1538-2021	Schmidt-Erfurth, Ursula/0000-0002-7788-7311; Chen, Ying-Ting/0000-0002-8606-2418	internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien [MUW 2015/2016]	internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien	This study was supported by internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien (MUW 2015/2016). There was no additional external funding received for this study.	Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Bai HQ, 2010, HISTOCHEM CELL BIOL, V134, P527, DOI 10.1007/s00418-010-0751-5; Carmona FD, 2010, J ANAT, V217, P488, DOI 10.1111/j.1469-7580.2010.01299.x; Chan CML, 2002, CORNEA, V21, P38, DOI 10.1097/00003226-200201000-00009; Chen YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077286; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Choi W, 2016, CURR EYE RES, V41, P1143, DOI 10.3109/02713683.2015.1098707; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Garg A, 2007, J AM ACAD DERMATOL, V57, P177, DOI 10.1016/j.jaad.2007.03.037; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Huang SL, 2001, CANCER RES, V61, P3373; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kimura T, 2016, J CELL SCI, V129, P881, DOI 10.1242/jcs.163758; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Korthagen NM, 2015, BRIT J OPHTHALMOL, V99, P700, DOI 10.1136/bjophthalmol-2014-306309; Lesaffre B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-2; Li J, 2016, INVEST OPHTH VIS SCI, V57, P444, DOI 10.1167/iovs.15-17519; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li YW, 2014, DIGEST DIS SCI, V59, P598, DOI 10.1007/s10620-013-2929-x; Liu GY, 2015, ACTA PHARMACOL SIN, V36, P1473, DOI 10.1038/aps.2015.101; McNamara NA, 2014, INVEST OPHTHALMOL VI; Meng YB, 2015, MOL MED REP, V11, P379, DOI 10.3892/mmr.2014.2684; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Parisi I, 2012, INT J DEV BIOL, V56, P341, DOI 10.1387/ijdb.113406ip; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Rasband WS, 2014, IMAGEJ; Sailaja GS, 2013, INT J ONCOL, V42, P188, DOI 10.3892/ijo.2012.1678; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shubham K, 2012, MOL VIS, V18, P951; Tsubota K, 2011, CORNEA, V30, pS1, DOI 10.1097/ICO.0b013e3182284b69; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Willmann G, 2015, HIGH ALT MED BIOL, V16, P277, DOI 10.1089/ham.2015.0109; Wong TY, 2001, AM J OPHTHALMOL, V131, P176, DOI 10.1016/S0002-9394(00)00703-0; Zhang XB, 2015, HUM MUTAT, V36, P1164, DOI 10.1002/humu.22907; Zhao X, 2014, MATH PROBL ENG, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0108020; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26; Zhou WP, 2016, MOL MED REP, V14, P3, DOI 10.3892/mmr.2016.5223	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180868	10.1371/journal.pone.0180868	http://dx.doi.org/10.1371/journal.pone.0180868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700649	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800089
J	Lin, CJ; Adolphs, R; Alvarez, RM				Lin, Chujun; Adolphs, Ralph; Alvarez, R. Michael			Cultural effects on the association between election outcomes and face-based trait inferences	PLOS ONE			English	Article							ELECTORAL SUCCESS; FACIAL APPEARANCE; EMOTIONAL EXPRESSIONS; CANDIDATE APPEARANCE; SOCIAL ATTRIBUTIONS; POLITICAL ELECTIONS; COMPETENCE; IMPRESSIONS; JUDGMENTS; LOOKING	How competent a politician looks, as assessed in the laboratory, is correlated with whether the politician wins in real elections. This finding has led many to investigate whether the association between candidate appearances and election outcomes transcends cultures. However, these studies have largely focused on European countries and Caucasian candidates. To the best of our knowledge, there are only four cross-cultural studies that have directly investigated how face-based trait inferences correlate with election outcomes across Caucasian and Asian cultures. These prior studies have provided some initial evidence regarding cultural differences, but methodological problems and inconsistent findings have complicated our understanding of how culture mediates the effects of candidate appearances on election outcomes. Additionally, these four past studies have focused on positive traits, with a relative neglect of negative traits, resulting in an incomplete picture of how culture may impact a broader range of trait inferences. To study Caucasian-Asian cultural effects with a more balanced experimental design, and to explore a more complete profile of traits, here we compared how Caucasian and Korean participants' inferences of positive and negative traits correlated with U.S. and Korean election outcomes. Contrary to previous reports, we found that inferences of competence (made by participants from both cultures) correlated with both U.S. and Korean election outcomes. Inferences of open-mindedness and threat, two traits neglected in previous cross-cultural studies, were correlated with Korean but not U.S. election outcomes. This differential effect was found in trait judgments made by both Caucasian and Korean participants. Interestingly, the faster the participants made face-based trait inferences, the more strongly those inferences were correlated with real election outcomes. These findings provide new insights into cultural effects and the difficult question of causality underlying the association between facial inferences and election outcomes. We also discuss the implications for political science and cognitive psychology.	[Lin, Chujun; Adolphs, Ralph; Alvarez, R. Michael] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lin, CJ (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	clin7@caltech.edu		Lin, Chujun/0000-0002-7605-6508	Discretionary Caltech research funds; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Discretionary Caltech research funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Discretionary Caltech research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahler DJ, 2016, FACE VALUE EXPT EVID, P1; Albright L, 1997, J PERS SOC PSYCHOL, V72, P558, DOI 10.1037/0022-3514.72.3.558; Alvarez R., 1998, INFORM ELECTIONS; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Atkinson MD, 2009, Q J POLIT SCI, V4, P229, DOI 10.1561/100.00008062; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Banducci SA, 2008, POLIT PSYCHOL, V29, P903, DOI 10.1111/j.1467-9221.2008.00672.x; Bartels LM, 2002, IMPACT CANDIDATE TRA, P44; Berggren N, 2017, J PUBLIC ECON, V146, P79, DOI 10.1016/j.jpubeco.2016.12.008; Berggren N, 2010, J PUBLIC ECON, V94, P8, DOI 10.1016/j.jpubeco.2009.11.002; Buckley Fiona., 2007, POLITICS, V27, P174, DOI [DOI 10.1111/J.1467-9256.2007.00297.X, 10.1111/j.1467-9256.2007.00297.x]; Carpinella CM, 2016, SOC PERSONAL PSYCHOL, V10, P281, DOI 10.1111/spc3.12249; Castelli L, 2009, J EXP SOC PSYCHOL, V45, P1152, DOI 10.1016/j.jesp.2009.06.018; Chen FF, 2014, J EXP SOC PSYCHOL, V51, P27, DOI 10.1016/j.jesp.2013.10.008; Chen FF, 2012, J EXP SOC PSYCHOL, V48, P1350, DOI 10.1016/j.jesp.2012.07.006; Chen FF, 2016, SOCIAL PSYCHOL PERSO, V28; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; Costa P, 2015, WEST EUR POLIT, V38, P1226, DOI 10.1080/01402382.2015.1004231; Ensari N, 2003, ORGAN BEHAV HUM DEC, V92, P52, DOI 10.1016/S0749-5978(03)00066-9; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; GERSTNER CR, 1994, LEADERSHIP QUART, V5, P121, DOI 10.1016/1048-9843(94)90024-8; Glasgow G, 2000, AM POLIT QUART, V28, P26, DOI 10.1177/1532673X00028001002; Guo S., 2006, POLITICAL EC ASIAN T; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Horiuchi Y, 2012, POLIT PSYCHOL, V33, P925, DOI 10.1111/j.1467-9221.2012.00917.x; Kahneman D., 2011, THINKING FAST SLOW; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; King A, 2009, KYKLOS, V62, P579, DOI 10.1111/j.1467-6435.2009.00452.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lau Richard R., 2006, VOTERS DECIDE INFORM; Laustsen L, 2014, POLIT BEHAV, V36, P777, DOI 10.1007/s11109-013-9253-1; Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195; Lenz GS, 2011, AM J POLIT SCI, V55, P574, DOI 10.1111/j.1540-5907.2011.00511.x; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Lutz G, 2010, SWISS POLIT SCI REV, V16, P457, DOI 10.1002/j.1662-6370.2010.tb00437.x; MARTIN DS, 1978, AUST J PSYCHOL, V30, P255, DOI 10.1080/00049537808256378; Mattes K, 2014, ELECT STUD, V34, P177, DOI 10.1016/j.electstud.2013.11.004; Mattes K, 2010, POLIT PSYCHOL, V31, P41, DOI 10.1111/j.1467-9221.2009.00745.x; Miller AH, 1998, LEADER POPULARITY PA; Miller W.E., 1996, NEW AM VOTER; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Na J, 2015, PSYCHOL SCI, V8; Newman B. I., 1999, J MENTAL CHANGES, V5, P7; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Olivola CY, 2014, LEADERSHIP QUART, V25, P817, DOI 10.1016/j.leaqua.2014.06.002; Olivola CY, 2012, SOC PSYCHOL PERS SCI, V3, P605, DOI 10.1177/1948550611432770; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Poutvaara P, 2009, J EXP SOC PSYCHOL, V45, P1132, DOI 10.1016/j.jesp.2009.06.007; Rosar U, 2008, EUR J POLIT RES, V47, P64, DOI 10.1111/j.1475-6765.2007.00720.x; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P1, DOI 10.1037/a0017673; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Spezio ML, 2012, POLIT PSYCHOL, V33, P331, DOI 10.1111/j.1467-9221.2012.00897.x; Spezio ML, 2008, SOC COGN AFFECT NEUR, V3, P344, DOI 10.1093/scan/nsn040; Stockemer D, 2017, BRIT J POLIT INT REL, V8; Sussman AB, 2013, J EXP SOC PSYCHOL, V49, P771, DOI 10.1016/j.jesp.2013.02.003; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tsai JL, 2016, EMOTION, V16, P183, DOI 10.1037/emo0000133; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wong SH, 2016, EVIDENCE CHINA SOCIA; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990	64	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180837	10.1371/journal.pone.0180837	http://dx.doi.org/10.1371/journal.pone.0180837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700647	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800084
J	Moretti, ML; Alarcon-Reverte, R; Pearce, S; Morran, S; Hanson, BD				Moretti, Marcelo L.; Alarcon-Reverte, Rocio; Pearce, Stephen; Morran, Sarah; Hanson, Bradley D.			Transcription of putative tonoplast transporters in response to glyphosate and paraquat stress in Conyza bonariensis and Conyza canadensis and selection of reference genes for qRT-PCR	PLOS ONE			English	Article							REAL-TIME PCR; VACUOLAR SEQUESTRATION; QUANTITATIVE PCR; INTERNAL CONTROL; ABC TRANSPORTER; MIQE GUIDELINES; RT-PCR; RESISTANCE; HORSEWEED; ARABIDOPSIS	Herbicide resistance is a challenge for modern agriculture further complicated by cases of resistance to multiple herbicides. Conyza bonariensis and Conyza canadensis are invasive weeds of field crops, orchards, and non-cropped areas in many parts of the world. In California, USA, Conyza populations resistant to the herbicides glyphosate and paraquat have recently been described. Although the mechanism conferring resistance to glyphosate and paraquat in these species was not elucidated, reduced translocation of these herbicides was observed under experimental conditions in both species. Glyphosate and paraquat resistance associated with reduced translocation are hypothesized to be a result of sequestration of herbicides into the vacuole, with the possible involvement of over-expression of genes encoding tonoplast transporters of ABC-transporter families in cases of glyphosate resistance or cationic amino acid transporters (CAT) in cases of paraquat resistance. However, gene expression in response to herbicide treatment has not been studied in glyphosate and paraquat resistant populations. In the current study, we evaluated the transcript levels of genes possibly involved in resistance using real-time PCR. First, we evaluated eight candidate reference genes following herbicide treatment and selected three genes that exhibited stable expression profiles; ACTIN, HEAT-SHOCK-PROTEIN-70, and CYCLOPHILIN. The reference genes identified here can be used for further studies related to plant-herbicide interactions. We used these reference genes to assay the transcript levels of EPSPS, ABC transporters, and CAT in response to herbicide treatment in susceptible and resistant Conyza spp. lines. No transcription changes were observed in EPSPS or CAT genes after glyphosate or paraquat treatment, suggesting that these genes are not involved in the resistance mechanism. Transcription of the two ABC transporter genes increased following glyphosate treatment in all Conyza spp. lines. Transcription of ABC transporters also increased after paraquat treatment in all three lines of C. bonariensis. However, in C. canadensis, paraquat treatment increased transcription of only one ABC transporter gene in the susceptible line. The increase in transcription of ABC transporters after herbicide treatment is likely a stress response based on similar response observed across all Conyza lines regardless of resistance or sensitivity to glyphosate or paraquat, thus these genes do not appear to be directly involved in the mechanism of resistance in Conyza spp.	[Moretti, Marcelo L.; Alarcon-Reverte, Rocio; Morran, Sarah; Hanson, Bradley D.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Moretti, Marcelo L.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Pearce, Stephen] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Oregon State University; Colorado State University	Moretti, ML (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Moretti, ML (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	marcelo.moretti@oregonstate.edu	Pearce, Stephen/HHS-1613-2022	Hanson, Bradley/0000-0003-4462-5339	USDA-NIFA-AFRI [2010-85320-20415]; Almond Board of California	USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); Almond Board of California	Funding for this research was provided by USDA-NIFA-AFRI Award No. 2010-85320-20415 and by the Almond Board of California.	An J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099940; Benbrook CM, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0070-0; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Faus I, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0378-0; Fujita M, 2014, PLANT CELL PHYSIOL, V55, P855, DOI 10.1093/pcp/pcu032; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Gaines TA, 2014, PLANT J, V78, P865, DOI 10.1111/tpj.12514; Ge X, 2014, PLANT PHYSIOL, V166, P1255, DOI 10.1104/pp.114.247197; Gianessi LP, 2013, PEST MANAG SCI, V69, P1099, DOI 10.1002/ps.3598; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Green JM, 2012, PEST MANAG SCI, V68, P1323, DOI 10.1002/ps.3374; HART JJ, 1992, PLANT PHYSIOL, V99, P1400, DOI 10.1104/pp.99.4.1400; HART JJ, 1994, WEED SCI, V42, P277, DOI 10.1017/S0043174500080395; Hawkes TR, 2014, PEST MANAG SCI, V70, P1316, DOI 10.1002/ps.3699; Heap I, INT SURVEY HERBICIDE; Heap I., 2014, INTEGRATED PEST MANA, DOI [10.1007/978-94-007-7796-5_12, DOI 10.1007/978-94-007-7796-5_12]; Holm L., 1997, WORLD WEEDS NATURAL; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jori B, 2007, PESTIC BIOCHEM PHYS, V88, P57, DOI 10.1016/j.pestbp.2006.08.013; Karlsson LM, 2007, WEED RES, V47, P433, DOI 10.1111/j.1365-3180.2007.00576.x; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kitts PA, 2016, NUCLEIC ACIDS RES, V44, pD73, DOI 10.1093/nar/gkv1226; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lasat MM, 1997, PHYSIOL PLANTARUM, V99, P255, DOI 10.1034/j.1399-3054.1997.990207.x; Li JY, 2013, PLANT PHYSIOL, V162, P470, DOI 10.1104/pp.113.213892; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moretti ML, 2017, WEED RES, V57, P25, DOI 10.1111/wre.12230; Moretti ML, 2016, WEED SCI, V64, P339, DOI 10.1614/WS-D-15-00174.1; Nol N, 2012, WEED RES, V52, P233, DOI 10.1111/j.1365-3180.2012.00911.x; Peng YH, 2014, PLANT PHYSIOL, V166, P1241, DOI 10.1104/pp.114.247668; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Petit Cecile, 2012, BMC Res Notes, V5, P18, DOI 10.1186/1756-0500-5-18; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Saha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106308; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoham J., 2013, Outlooks on Pest Management, V24, P64, DOI 10.1564/v24_apr_05; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Tani E, 2015, PLANT MOL BIOL REP, V33, p1 ; Tani E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040342; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Yang HY, 2014, J PLANT PHYSIOL, V171, P594, DOI 10.1016/j.jplph.2013.11.012; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu Q, 2010, PESTIC BIOCHEM PHYS, V98, P104, DOI 10.1016/j.pestbp.2010.05.007	60	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180794	10.1371/journal.pone.0180794	http://dx.doi.org/10.1371/journal.pone.0180794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700644	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800078
J	Volpato, N; Kobashigawa, J; Yasuda, CL; Kishimoto, ST; Fernandes, PT; Cendes, F				Volpato, Nathalia; Kobashigawa, Juliana; Yasuda, Clarissa Lin; Kishimoto, Simoni Thiemi; Fernandes, Paula Teixeira; Cendes, Fernando			Level of physical activity and aerobic capacity associate with quality of life in patients with temporal lobe epilepsy	PLOS ONE			English	Article							LEISURE-TIME; MOOD DISORDER; EXERCISE; FITNESS; ADULTS; RATS; POPULATION; HABITS	Epilepsy is more than seizures and includes a high risk of comorbidities and psychological disorders, leading to poor quality of life (QOL). Earlier studies have showed a sedentary lifestyle in people with epilepsy (PWE), which could contribute to poorer health and psychological problems. The purpose of the present study was to compare habits of physical activity (PA), aerobic capacity, and QOL between PWE and healthy controls in order to identify the necessity of intervention of habits and information on physical exercise (PE) and to better understand the importance of PE for PWE. The study included 38 patients with temporal lobe epilepsy and 20 normal controls. Both groups answered the WHOQOL-Bref, which assesses the level of QOL, and IPAQ to evaluate the level of PA. In addition, they were submitted to a treadmill maximal cardiopulmonary effort test to identify physical capacity. The continuous variables were compared between groups by t-test and a general linear model, and the frequencies were compared by Chi-Square test through SPSS software. There was no difference in the level of PA between groups by questionnaire evaluation. However, there were significant differences in overall QOL, physical health, and level of PA in relation to work and physical capacity between groups; controls demonstrated better scores than PWE. Controls presented better physical capacity than PWE by cardiopulmonary effort test. According to intra-group analyses, PWE who were physically active had better QOL than inactive PWE. The study concluded that questionnaires about PE may not be the best instrument of evaluation, as demonstrated by the discrepancy of results compared to the validated objective cardiopulmonary evaluation of level of PA and physical capacity in this study.	[Volpato, Nathalia; Yasuda, Clarissa Lin; Cendes, Fernando] Univ Estadual Campinas, UNICAMP, Neuroimaging Lab, Hosp Clin, Rua Vital Brasil, Campinas, SP, Brazil; [Kobashigawa, Juliana; Kishimoto, Simoni Thiemi; Fernandes, Paula Teixeira] Univ Estadual Campinas, UNICAMP, Phys Educ Coll, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cendes, F (corresponding author), Univ Estadual Campinas, UNICAMP, Neuroimaging Lab, Hosp Clin, Rua Vital Brasil, Campinas, SP, Brazil.	fcendes@unicamp.br	Fernandes, Paula Teixeira/D-7714-2013; Cendes, Fernando/C-1301-2012; yasuda, clarissa lin/D-4599-2018; yasuda, clarissa l/B-7934-2013	Fernandes, Paula Teixeira/0000-0002-0492-1670; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa lin/0000-0001-9084-7173; yasuda, clarissa l/0000-0001-9084-7173	Fapesp [2014/05435-8, 2013/07559-3]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fapesp:2014/05435-8, www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the FAPESP for its financial support (grants no. 2014/05435-8 and no. 2013/07559-3).	Arida RM, 2007, PROG NEURO-PSYCHOPH, V31, P814, DOI 10.1016/j.pnpbp.2007.01.021; Arida RM, 2009, ARQ NEURO-PSIQUIAT, V67, P1013, DOI 10.1590/S0004-282X2009000600010; Arida RM, 2004, PHYSIOL BEHAV, V83, P165, DOI 10.1016/j.physbeh.2004.08.008; Arida RM, 2003, EPILEPSY BEHAV, V4, P507, DOI 10.1016/S1525-5050(03)00184-7; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Berg AT, 2008, CURR OPIN NEUROL, V21, P173, DOI 10.1097/WCO.0b013e3282f36ccd; BJORHOLT PG, 1990, EPILEPSIA, V31, P83, DOI 10.1111/j.1528-1157.1990.tb05364.x; Camilo F, 2009, ARQ NEURO-PSIQUIAT, V67, P1007, DOI 10.1590/S0004-282X2009000600009; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cendes F, 2014, ACTA NEUROPATHOL, V128, P21, DOI 10.1007/s00401-014-1292-0; Clarke BM, 2006, EPILEPSY BEHAV, V9, P119, DOI 10.1016/j.yebeh.2006.04.008; de Lima C, 2013, EPILEPSY BEHAV, V28, P47, DOI 10.1016/j.yebeh.2013.03.016; DeToledo JC, 2003, EPILEPSY BEHAV, V4, P553, DOI 10.1016/S1525-5050(03)00155-0; Elliott JO, 2008, EPILEPSY BEHAV, V13, P307, DOI 10.1016/j.yebeh.2008.04.003; ERIKSEN HR, 1994, EPILEPSIA, V35, P1256, DOI 10.1111/j.1528-1157.1994.tb01797.x; FLETCHER GF, 1990, CIRCULATION, V82, P2286, DOI 10.1161/01.CIR.82.6.2286; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Gordon KE, 2010, EPILEPSIA, V51, P2254, DOI 10.1111/j.1528-1167.2010.02709.x; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; HERMANN BP, 1992, J EPILEPSY, V5, P153, DOI 10.1016/S0896-6974(05)80134-3; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Lhatoo SD, 2000, EPILEPSIA, V41, P1592; Liou HH, 2005, EPILEPSY RES, V64, P151, DOI 10.1016/j.eplepsyres.2005.03.006; Marques CM, 2007, EPILEPSY BEHAV, V10, P477, DOI 10.1016/j.yebeh.2007.02.002; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; McAuley JW, 2001, EPILEPSY BEHAV, V2, P592, DOI 10.1006/ebeh.2001.0271; MILLINGTON JT, 1985, JAMA-J AM MED ASSOC, V254, P3182, DOI 10.1001/jama.1985.03360220044021; NAKKEN KO, 1990, EPILEPSIA, V31, P88, DOI 10.1111/j.1528-1157.1990.tb05365.x; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; ROTH DL, 1994, EPILEPSIA, V35, P1248, DOI 10.1111/j.1528-1157.1994.tb01796.x; Steinhoff BJ, 1996, EPILEPSIA, V37, P1221, DOI 10.1111/j.1528-1157.1996.tb00557.x; Sturm JW, 2002, NEUROLOGY, V59, P1246, DOI 10.1212/WNL.59.8.1246; Wasserman K, 2004, PRINCIPLES EXERCISE, V4th; Werz MA, 2005, EPILEPSY BEHAV, V6, P98, DOI 10.1016/j.yebeh.2004.11.008; World Health Organization, 1995, EXP COMM PHYS STAT U	36	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181505	10.1371/journal.pone.0181505	http://dx.doi.org/10.1371/journal.pone.0181505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723919	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800055
J	Mostert, D; Molina, AB; Daniells, J; Fourie, G; Hermanto, C; Chao, CP; Fabregar, E; Sinohin, VG; Masdek, N; Thangavelu, R; Li, CY; Yi, GY; Mostert, L; Viljoen, A				Mostert, Diane; Molina, Agustin B.; Daniells, Jeff; Fourie, Gerda; Hermanto, Catur; Chao, Chih-Ping; Fabregar, Emily; Sinohin, Vida G.; Masdek, Nik; Thangavelu, Raman; Li, Chunyu; Yi, Ganyun; Mostert, Lizel; Viljoen, Altus			The distribution and host range of the banana Fusarium wilt fungus, Fusarium oxysporum f. sp cubense, in Asia	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; TROPICAL RACE 4; GENETIC-VARIATION; PANAMA-DISEASE	Fusarium oxysporum formae specialis cubense (Foc) is a soil-borne fungus that causes Fusarium wilt, which is considered to be the most destructive disease of bananas. The fungus is believed to have evolved with its host in the Indo-Malayan region, and from there it was spread to other banana-growing areas with infected planting material. The diversity and distribution of Foc in Asia was investigated. A total of 594 F. oxysporum isolates collected in ten Asian countries were identified by vegetative compatibility groups (VCGs) analysis. To simplify the identification process, the isolates were first divided into DNA lineages using PCR-RFLP analysis. Six lineages and 14 VCGs, representing three Foc races, were identified in this study. The VCG complex 0124/5 was most common in the Indian subcontinent, Vietnam and Cambodia; whereas the VCG complex 01213/16 dominated in the rest of Asia. Sixty-nine F. oxysporum isolates in this study did not match any of the known VCG tester strains. In this study, Foc VCG diversity in Bangladesh, Cambodia and Sri Lanka was determined for the first time and VCGs 01221 and 01222 were first reported from Cambodia and Vietnam. New associations of Foc VCGs and banana cultivars were recorded in all the countries where the fungus was collected. Information obtained in this study could help Asian countries to develop and implement regulatory measures to prevent the incursion of Foc into areas where it does not yet occur. It could also facilitate the deployment of disease resistant banana varieties in infested areas.	[Mostert, Diane; Mostert, Lizel; Viljoen, Altus] Stellenbosch Univ, Dept Plant Pathol, Stellenbosch, South Africa; [Molina, Agustin B.; Sinohin, Vida G.] Biovers Int Asia Pacific, IRRI Campus, Los Banos, Philippines; [Daniells, Jeff] Dept Agr & Fisheries, South Johnstone, Qld, Australia; [Fourie, Gerda] Univ Pretoria, Dept Microbiol & Plant Pathol, FABI, Pretoria, South Africa; [Hermanto, Catur] Indonesian Agcy Agr Res & Dev, Jakarta, Indonesia; [Chao, Chih-Ping] Taiwan Banana Res Inst, Pingtung, Taiwan; [Fabregar, Emily] Lapanday Foods Corp, Davao, Philippines; [Masdek, Nik] Malaysian Agr Res & Dev Inst, Selangor, Malaysia; [Thangavelu, Raman] ICAR Natl Res Ctr Banana, Tiruchirappalli, Tamil Nadu, India; [Li, Chunyu; Yi, Ganyun] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China	Stellenbosch University; University of Pretoria; Indonesian Agency for Agricultural Research & Development; Institute Penyelidikan Dan Kemajuan Pertanian; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Banana; Guangdong Academy of Agricultural Sciences	Mostert, D (corresponding author), Stellenbosch Univ, Dept Plant Pathol, Stellenbosch, South Africa.	diane@sun.ac.za	Li, Chunyu/AAB-7399-2020		Lapanday Foods Corporation	Lapanday Foods Corporation	I am herewith declaring that the work included in the research article titled "The distribution and host range of Fusarium oxysporum f. sp. cubense vegetative compatibility groups in Asia" were not funded by the Lapanday Foods Corporation. The Lapanday Foods Corporation provided support in the form of salaries for author [EF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author [EF] has been edited in the 'author contributions' section.	Ammar M. I., 2007, Egyptian Journal of Phytopathology, V35, P81; [Anonymous], 2006, BLACKWELL PUB PROF; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; BENTLEY S, 1995, MYCOL RES, V99, P1378, DOI 10.1016/S0953-7562(09)81225-2; Bentley S, 1996, J PHYTOPATHOL, V144, P207, DOI 10.1111/j.1439-0434.1996.tb01516.x; BOEHM EWA, 1994, MOL PLANT MICROBE IN, V7, P196, DOI 10.1094/MPMI-7-0196; Chen HouBin, 2005, Advancing banana and plantain R&D in Asia and the Pacific, Vol.13. Proceedings of the 3rd BAPNET Steering Committee meeting held in Guangzhou, China, 23-26 November, 2004, P165; CORRELL JC, 1991, PHYTOPATHOLOGY, V81, P1061; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; EDEL V, 1995, PHYTOPATHOLOGY, V85, P579, DOI 10.1094/Phyto-85-579; Espino C, 1999, PANAMA DIS; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Groenewald S, 2006, MYCOL RES, V110, P297, DOI 10.1016/j.mycres.2005.10.004; Gulino L, 2007, AUSTR BANANAS, V25, P46; Hermanto C, 2011, ACTA HORTIC, V897, P313; Huang BingZhi, 2005, Advancing banana and plantain R&D in Asia and the Pacific, Vol.13. Proceedings of the 3rd BAPNET Steering Committee meeting held in Guangzhou, China, 23-26 November, 2004, P187; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Jones D. R., 2000, P1; Kangire A., 2001, BANANA FUSARIUM WILT, P152; Katan T, 1999, PHYTOPARASITICA, V27, P51, DOI 10.1007/BF02980727; Koenig RL, 1997, PHYTOPATHOLOGY, V87, P915, DOI 10.1094/PHYTO.1997.87.9.915; Lescot T., 2015, FRUITROP, V231, P98; LESLIE JF, 1990, FUSARIUM WILT OF BANANA, P37; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Li CY, 2013, FUNGAL GENOM BI 1126; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Lodwig EM, 1999, J APPL MICROBIOL, V86, P71, DOI 10.1046/j.1365-2672.1999.00635.x; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Masdek N, 2003, 2 INT S FUS WILT BAN; Molina AB, 2008, PHYTOPATHOLOGY, V98, pS108; Molina AB, 2009, ACTA HORTIC, V828, P109; Molina AB, 2001, P INT WORKSH BAN FUS; Molina AB., 2014, STATUS EPIDEMICS R D; MOORE NY, 1993, AUST J EXP AGR, V33, P797, DOI 10.1071/EA9930797; Nayar NM, 2010, HORTICULTURAL REV, V36, P118; NELSON PE, 1983, FUSARIUM SPECIES AN; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Neill WT, 2011, ACTA HORTIC, V897, P345, DOI 10.17660/ActaHortic.2011.897.47; Pegg K., 1994, IMPROVEMENT TESTING, P70; Ploetz R, 1997, AUSTRALAS PLANT PATH, V26, P239, DOI 10.1071/AP97039; Ploetz R. C., 1992, Plant diseases of international importance. Volume III. Diseases of fruit crops., P270; Ploetz R. C., 2005, Plant Health Progress, P1; Ploetz R. C., 2000, P143; Ploetz RC, 2015, PHYTOPATHOLOGY, V105, P1512, DOI 10.1094/PHYTO-04-15-0101-RVW; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; PLOETZ RC, 1988, PLANT DIS, V72, P325, DOI 10.1094/PD-72-0325; PLOETZ RC, 1990, FUSARIUM WILT OF BANANA, P63; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; PLOETZ RC, 1994, INT J PEST MANAGE, V40, P326, DOI 10.1080/09670879409371908; Ploetz RC, 1997, FRUITS, V51, P387; PUHALLA JE, 1985, CAN J BOT, V63, P179, DOI 10.1139/b85-020; Riska J., 2012, ARPN J AGR BIOL SCI, V4, P244; Rutherford MA, 2001, BANANA FUSARIUM WILT, P86; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soluri John, 2005, BANANA CULTURES AGR; Somrith A., 2011, Kasetsart Journal, Natural Sciences, V45, P451; Stover R.H., 1962, FUSARIAL WILT PANAMA; STOVER RH, 1990, FUSARIUM WILT OF BANANA, P1; Stover RH, 1987, BANANAS, P486; SU HJ, 1986, PLANT DIS, V70, P814, DOI 10.1094/PD-70-814; SU HJ, 1977, TAIWAN BANANA RES I, V2, P22; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Teunissen HAS, 2002, MOL GENET GENOMICS, V268, P298, DOI 10.1007/s00438-002-0747-5; Thangavelu R, 2012, MOL BIOTECHNOL, V51, P203, DOI 10.1007/s12033-011-9457-8; Thangavelu R, 2003, 2 INT S FUS WILT BAN; Thangavelu R., 2001, BANANA FUSARIUM WILT, P58; Valmayor R., 2000, BANANA CULTIVAR NAME; Viljoen A, 2002, S AFR J SCI, V98, P341; WAITE B. H., 1960, Canadian Journal of Botany, V38, P985, DOI 10.1139/b60-087	70	52	59	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181630	10.1371/journal.pone.0181630	http://dx.doi.org/10.1371/journal.pone.0181630			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719631	Green Published, Green Accepted, gold			2022-12-26	WOS:000406061400060
J	Rahman, M; Sadygov, RG				Rahman, Mahbubur; Sadygov, Rovshan G.			Predicting the protein half-life in tissue from its cellular properties	PLOS ONE			English	Article							EXPRESSION	Protein half-life is an important feature of protein homeostasis (proteostasis). The increasing number of in vivo and in vitro studies using high throughput proteomics provide estimates of the protein half-lives in tissues and cells. However, protein half-lives in cells and tissues are different. Due to the resource requirements for researching tissues, more data is available from cellular studies than tissues. We have designed a multivariate linear model for predicting protein half-life in tissue from its cellular properties. Inputs to the model are cellular half-life, abundance, intrinsically disordered sequences, and transcriptional and translational rates. Before the modeling, we determined substructures in the data using the relative distance from the regression line of the protein half-lives in tissues and cells, identifying three separate clusters. The model was trained on and applied to predict protein half-lives from murine liver, brain and heart tissues. In each tissue type we observed similar prediction patterns of protein half-lives. We found that the model provides the best results when there is a strong correlation between tissue and cell culture protein half-lives. Additionally, we clustered the protein half-lives to determine variations in correlation coefficients between the protein half-lives in the tissue versus in cell culture. The clusters identify strongly and weakly correlated protein half-lives, further improves the overall prediction and identifies sub groupings which exhibit specific characteristics. The model described herein, is generalizable to other data sets and has been implemented in a freely available R code.	[Rahman, Mahbubur; Sadygov, Rovshan G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Rahman, M; Sadygov, RG (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Mol Med, Galveston, TX 77555 USA.	mahrahma@utmb.edu; rovshan.sadygov@utmb.edu			NIGMS of NIH [R01GM112044]; NIGMS of National Institutes of Health (US) [R01GM112044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112044] Funding Source: NIH RePORTER	NIGMS of NIH; NIGMS of National Institutes of Health (US); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS of NIH under the award R01GM112044.; This work was supported in part by the NIGMS of National Institutes of Health (US) under the award R01GM112044. The fund was received by RGS.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chiang JH, 2003, IEEE T FUZZY SYST, V11, P518, DOI 10.1109/TFUZZ.2003.814839; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Freedman D.A., 2009, STAT MODELS THEORY P; Fritsch S, 2016, NEURALNET; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guan SH, 2012, ANAL CHEM, V84, P4014, DOI 10.1021/ac203330z; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lau E, 2016, LARGE DATASET PROTEI, P3; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; McCullagh P, 1989, GEN LINEAR MODELS; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyagi M, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0378; Murata T, 1996, COMPUT IND ENG, V30, P957, DOI 10.1016/0360-8352(96)00045-9; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scrucca L, 2013, J STAT SOFTW, V53, P1; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j	23	7	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180428	10.1371/journal.pone.0180428	http://dx.doi.org/10.1371/journal.pone.0180428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719664	gold, Green Submitted, Green Published			2022-12-26	WOS:000406061400013
J	Siqueira, FM; Perez-Wohlfeil, E; Carvalho, FM; Trelles, O; Schrank, IS; Vasconcelos, ATR; Zaha, A				Siqueira, Franciele Maboni; Perez-Wohlfeil, Esteban; Carvalho, Fabiola Marques; Trelles, Oswaldo; Schrank, Irene Silveira; Ribeiro Vasconcelos, Ana Tereza; Zaha, Arnaldo			Microbiome overview in swine lungs	PLOS ONE			English	Article							DISTANCE AIRBORNE TRANSPORT; MYCOPLASMA-HYOPNEUMONIAE; PIGS; PNEUMONIA; TISSUE; DIVERSITY; INFECTION; PATHOGENS; HYORHINIS; DISEASE	Mycoplasma hyopneumoniae is the etiologic agent of swine enzootic pneumonia. However other mycoplasma species and secondary bacteria are found as inhabitants of the swine respiratory tract, which can be also related to disease. In the present study we have performed a total DNA metagenomic analysis from the lungs of pigs kept in a field condition, with suggestive signals of enzootic pneumonia and without any infection signals to evaluate the bacteria variability of the lungs microbiota. Libraries from metagenomic DNA were prepared and sequenced using total DNA shotgun metagenomic pyrosequencing. The metagenomic distribution showed a great abundance of bacteria. The most common microbial families identified from pneumonic swine's lungs were Mycoplasmataceae, Flavobacteriaceae and Pasteurellaceae, whereas in the carrier swine's lungs the most common families were Mycoplasmataceae, Bradyrhizobiaceae and Flavobacteriaceae. Analysis of community composition in both samples confirmed the high prevalence of M. hyopneumoniae. Moreover, the carrier lungs had more diverse family population, which should be related to the lungs normal flora. In summary, we provide a wide view of the bacterial population from lungs with signals of enzootic pneumonia and lungs without signals of enzootic pneumonia in a field situation. These bacteria patterns provide information that may be important for the establishment of disease control measures and to give insights for further studies.	[Siqueira, Franciele Maboni; Schrank, Irene Silveira; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Perez-Wohlfeil, Esteban; Trelles, Oswaldo] Univ Malaga, Dept Comp Architecture, Malaga, Spain; [Carvalho, Fabiola Marques; Ribeiro Vasconcelos, Ana Tereza] Lab Bioinformat, Lab Nacl Comp Cient, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Universidad de Malaga; Laboratorio Nacional de Computacao Cientifica (LNCC)	Zaha, A (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	zaha@cbiot.ufrgs.br	Carvalho, Fabiola M/I-4394-2016; Zaha, Arnaldo/D-3165-2013; Vasconcelos, Ana Tereza R/I-1011-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Siqueira, Franciele M/K-4043-2014	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Siqueira, Franciele M/0000-0001-7282-6117; Zaha, Arnaldo/0000-0001-6336-474X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB [23038.001507/2013-81]; CAPES-Biologia Computacional [23038.010043/2013-02]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB; CAPES-Biologia Computacional	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CAPES-COFECUB - Grant number: 23038.001507/2013-81 and CAPES-Biologia Computacional - Grant number: 23038.010043/2013-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; Charlebois A, 2014, VET MICROBIOL, V168, P348, DOI 10.1016/j.vetmic.2013.11.006; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; FALK K, 1991, ACTA VET SCAND, V32, P67; Fano E, 2007, CAN J VET RES, V71, P195; Neto JCG, 2014, VET MICROBIOL, V174, P163, DOI 10.1016/j.vetmic.2014.08.008; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Lin JH, 2006, VET MICROBIOL, V115, P111, DOI 10.1016/j.vetmic.2006.02.004; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michiels A, 2015, PREV VET MED, V121, P99, DOI 10.1016/j.prevetmed.2015.06.011; Moorkamp L, 2008, VET J, V175, P273, DOI 10.1016/j.tvjl.2007.01.008; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Palzer A, 2008, VET REC, V162, P267, DOI 10.1136/vr.162.9.267; Perez-Wohlfeil E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3063-x; RUBERG SJ, 1991, BIOMETRICS, V47, P1059, DOI 10.2307/2532658; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sibila M, 2007, VET MICROBIOL, V121, P352, DOI 10.1016/j.vetmic.2006.12.028; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Slenker AK, 2012, J CLIN MICROBIOL, V50, P4166, DOI 10.1128/JCM.01761-12; Sorensen V, 2006, DIS SWINE; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Vangroenweghe F, 2015, J VET DIAGN INVEST, V27, P606, DOI 10.1177/1040638715595062; Vela AI, 2007, INT J SYST EVOL MICR, V57, P1291, DOI 10.1099/ijs.0.64537-0; Vranckx K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-24; Yamaguti M, 2015, VET REC, V2, DOI 10.1136/vetreco-2014-000093; Young TF, 2000, VET MICROBIOL, V71, P269, DOI 10.1016/S0378-1135(99)00176-5	36	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181503	10.1371/journal.pone.0181503	http://dx.doi.org/10.1371/journal.pone.0181503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719637	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400052
J	Morud, J; Ashouri, A; Larsson, E; Ericson, M; Soderpalm, B				Morud, Julia; Ashouri, Arghavan; Larsson, Erik; Ericson, Mia; Soderpalm, Bo			Transcriptional profiling of the rat nucleus accumbens after modest or high alcohol exposure	PLOS ONE			English	Article							INTERMITTENT ETHANOL EXPOSURE; GENE-EXPRESSION CHANGES; MOTIVATION; ADDICTION; AMYGDALA	Alcohol use disorder is a chronic relapsing brain disorder and a global health issue. Prolonged high alcohol consumption increases the risk for dependence development, a complex state that includes progressive alterations in brain function. The molecular mechanisms behind these changes remain to be fully disclosed, but several genes show altered expression in various regions of the rat brain even after modest alcohol exposure. The present study utilizes whole-transcriptome sequencing (RNA-seq) to investigate expression changes in the brain nucleus accumbens (NAc), an area of particular interest in addictive disorders, of alcohol consuming rats. The impact on gene expression after eight weeks of moderate voluntary alcohol consumption or voluntary consumption combined with forced excessive exposure was explored in two separate experiments. The results point to a lack of strong and consistent expression alterations in the NAc after alcohol exposure, suggesting that transcriptional effects of alcohol are weak or transient, or occur primarily in brain regions other than NAc.	[Morud, Julia; Ericson, Mia; Soderpalm, Bo] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Addict Biol Unit, Gothenburg, Sweden; [Ashouri, Arghavan; Larsson, Erik] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Soderpalm, Bo] Sahlgrens Univ Hosp, Beroendekliniken, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Morud, J (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Addict Biol Unit, Gothenburg, Sweden.	julia.morud@neuro.gu.se	Ashouri, Arghavan/C-2607-2019; Larsson Lekholm, Erik/HDM-8032-2022; Ericson, Mia/AAI-9992-2021; Larsson Lekholm, Erik/AHE-0932-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; ericson, Mia/0000-0002-7557-7109	Swedish Medical research council [2014-3596, 2014-3887, 2015-02894]; Swedish Brain Foundation; Bror Gadelius Minnesfond; Thurings Stiftelse [2015-00100]; WM Lundgrens Stiftelse [2016-1035]	Swedish Medical research council(Swedish Medical Research Council (SMRC)); Swedish Brain Foundation; Bror Gadelius Minnesfond; Thurings Stiftelse; WM Lundgrens Stiftelse	Financial support was obtained from the Swedish Medical research council (EL, ME, BS. Grant numbers: 2014-3596, 2014-3887, 2015-02894), Swedish Brain Foundation (BS), Bror Gadelius Minnesfond (JM), Thurings Stiftelse (JM: 2015-00100) and WM Lundgrens Stiftelse (JM: 2016-1035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Chang GQ, 2010, ALCOHOL CLIN EXP RES, V34, P761, DOI 10.1111/j.1530-0277.2010.01148.x; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Freeman K, 2013, ALCOHOL CLIN EXP RES, V37, pE88, DOI 10.1111/j.1530-0277.2012.01910.x; Gorini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082656; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Hopf FW, 2014, ALCOHOL, V48, P253, DOI 10.1016/j.alcohol.2014.03.001; Jonsson S, 2014, ALCOHOL CLIN EXP RES, V38, P722, DOI 10.1111/acer.12307; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Linsenbardt DN, 2014, ADDICT BIOL, V19, P812, DOI 10.1111/adb.12052; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; Momeni S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00424; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Oberlin BG, 2015, PSYCHOPHARMACOLOGY, V232, P2207, DOI 10.1007/s00213-014-3850-5; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pickering C, 2015, PHARMACOL BIOCHEM BE, V132, P63, DOI 10.1016/j.pbb.2015.02.021; Ron D, 2013, CURR TOP BEHAV NEURO, V13, P87, DOI 10.1007/7854_2011_161; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Sommer WH, 2005, ADDICT BIOL, V10, P71, DOI 10.1080/13556210412331327821; Sommer WH, 2008, BIOL PSYCHIAT, V63, P139, DOI 10.1016/j.biopsych.2007.01.010; Spoelder M, 2015, ALCOHOL CLIN EXP RES, V39, P2427, DOI 10.1111/acer.12891; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2013, J NEUROSCI, V33, P4527, DOI 10.1523/JNEUROSCI.5261-12.2013; Zahr NM, 2014, PSYCHOPHARMACOLOGY, V231, P429, DOI 10.1007/s00213-013-3253-z	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181084	10.1371/journal.pone.0181084	http://dx.doi.org/10.1371/journal.pone.0181084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715440	Green Submitted, gold, Green Published			2022-12-26	WOS:000443975500025
J	Pan, ML; Chen, LR; Tsao, HM; Chen, KH				Pan, Mei-Lien; Chen, Li-Ru; Tsao, Hsiao-Mei; Chen, Kuo-Hu			Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: A nationwide population-based study	PLOS ONE			English	Article							PREDICTION; DANAZOL; OBESITY; TROPHOBLAST; DIAGNOSIS; CELLS	Objective To investigate the association between preceding endometriosis and gestational hypertension-preeclampsia (GH-PE). Methods In this nationwide population-based longitudinal study, data from 1998-2012 Taiwan National Health Insurance Research Database were used. We used ICD9-CM codes 617.X and 642.X respectively for the diagnoses of endometriosis and GH-PE, which were further confirmed by examining medical records of surgeries, blood pressure and urine protein to ensure the accuracy of the diagnoses. The study excluded women diagnosed with endometriosis at < 15 or > 45 years of age, chronic hypertension, and GH-PE prior to endometriosis. Each pregnant woman with a prior diagnosis of endometriosis was matched to 4 pregnant women without endometriosis by age. Logistic regression analysis was used to calculate odds ratios (ORs) for the risk of GH-PE with adjustment for age, occupation, urbanization, economic status and comorbidities. Results Among 6,300 women with a prior endometriosis diagnosis who were retrieved from a population of 1,000,000 residents, 2,578 (40.92%) had subsequent pregnancies that were eligible for further analysis and were compared with 10,312 pregnant women without previous endometriosis. GH-PE occurred more in women with prior endometriosis as compared to those without endometriosis (3.88% vs. 1.63%, p<0.0001). Further analysis revealed prior endometriosis was associated with GH-PE (adjusted OR = 2.27; 95% CI: 1.76-2.93). For danazol-treated and non-danazol-treated subgroups, the incidences of GH-PE were 3.13% (15/480) and 4.05% (85/2,098), respectively. Although the risk for subsequent GH-PE was lower (adjusted OR = 1.49; 95% CI: 0.86-2.56) after receiving danazol treatment than average (adjusted OR = 2.27; 95% CI:1.76-2.93) for women with preceding endometriosis, the reduction of risk was not statistically remarkable for danazol-treated (adjusted OR = 1.49) vs. non-danazol-treated (adjusted OR = 2.48) subgroups (p heterogeneity = 0.12). Conclusions Preceding endometriosis is an independent and significant risk factor for the occurrence of GH-PE.	[Pan, Mei-Lien; Tsao, Hsiao-Mei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chen, Li-Ru] Mackay Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Li-Ru] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Chen, Kuo-Hu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Kuo-Hu] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Academia Sinica - Taiwan; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Tzu Chi University	Chen, KH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	alexgfctw@yagoo.com.tw			Ministry of Science and Technology, Taiwan; Taipei Tzu-Chi Hospital, Taiwan [TCRDTPE-105-18]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Tzu-Chi Hospital, Taiwan	This work is supported by a grant of the Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx?mp=7) "Multidisciplinary health cloud research program: technology development and application of big health data" for ML Pan, and a grant of Taipei Tzu-Chi Hospital, Taiwan (https://www.tzuchi.com.tw/tzuchi_en/About_TP_Center/Default.htm) (TCRDTPE-105-18) for KH Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2010, J ADOLESCENT HEALTH, V46, P77, DOI 10.1016/j.jadohealth.2009.06.006; Arakaki T, 2015, ULTRASOUND OBST GYN, V45, P539, DOI 10.1002/uog.14633; Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Brosens IA, 2007, HUM REPROD, V22, P1725, DOI 10.1093/humrep/dem072; Cunningham FG, 2010, WILLIAMS OBSTET, p[176, 706 , 964 ]; Farag K, 2004, OBSTET GYNECOL SURV, V59, P464, DOI 10.1097/00006254-200406000-00025; Frederick IO, 2006, EPIDEMIOLOGY, V17, P428, DOI 10.1097/01.ede.0000221028.33245.0b; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Hadfield RM, 2009, HUM REPROD, V24, P2348, DOI 10.1093/humrep/dep123; Hutter S, 2013, J NIPPON MED SCH, V80, P97, DOI 10.1272/jnms.80.97; Jeyabalan A., 2013, NUTR REV S1, V71; Luciano AA, 2006, J MINIM INVAS GYN, V13, P523, DOI 10.1016/j.jmig.2006.06.026; Lynch AM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.035; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Montagnana M, 2008, FERTIL STERIL, V89, P1282, DOI 10.1016/j.fertnstert.2008.02.151; Murakami K, 2006, FERTIL STERIL, V86, P291, DOI 10.1016/j.fertnstert.2005.12.074; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Pan ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140544; Pauli JM, 2015, OBSTET GYN CLIN N AM, V42, P299, DOI 10.1016/j.ogc.2015.01.007; Prefumo F, 2004, HUM REPROD, V19, P206, DOI 10.1093/humrep/deh037; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Selak V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000068.pub2; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Spradley FT, 2015, BIOMOLECULES, V5, P3142, DOI 10.3390/biom5043142; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Telang MA, 2013, PLACENTA, V34, P2, DOI 10.1016/j.placenta.2012.10.017; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; VIGANO P, 1994, GYNECOL ENDOCRINOL, V8, P13, DOI 10.3109/09513599409028452; Visentin S, 2016, AM J HYPERTENS, V29, P273, DOI 10.1093/ajh/hpv103; Visentin S, 2013, J ULTRAS MED, V32, P279; Wallace AE, 2012, HUM REPROD UPDATE, V18, P458, DOI 10.1093/humupd/dms015; WHO, 2005, MAK EV MOTH CHILD CO; Wolf M, 2001, OBSTET GYNECOL, V98, P757, DOI 10.1016/S0029-7844(01)01551-4; Zavalza-Gomez AB, 2011, ARCH GYNECOL OBSTET, V283, P415, DOI 10.1007/s00404-010-1753-1	36	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181261	10.1371/journal.pone.0181261	http://dx.doi.org/10.1371/journal.pone.0181261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715497	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500041
J	Goebel, J; Sulke, M; Lazik-Palm, A; Goebel, T; Dechene, A; Bellendorf, A; Mueller, S; Umutlu, L; Theysohn, J				Goebel, Juliane; Sulke, Maximilian; Lazik-Palm, Andrea; Goebel, Thomas; Dechene, Alexander; Bellendorf, Alexander; Mueller, Stefan; Umutlu, Lale; Theysohn, Jens			Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma	PLOS ONE			English	Article							PORTAL-VEIN EMBOLIZATION; ART BRACHYTHERAPY TREATMENT; INTERNAL RADIATION-THERAPY; (90)YTTRIUM MICROSPHERES; Y-90 RADIOEMBOLIZATION; VOLUMETRIC CHANGES; MALIGNANCIES; CIRRHOSIS; CANCER; CELLS	Introduction Radioembolization for the treatment of hepatocellular carcinoma (HCC) induces liver volume changes referred to as "atrophy-hypertrophy complex". The aim of this study was to investigate lobar liver volume changes after unilateral radioembolization and to search for factors associated with hypertrophy of the untreated lobe. Materials and methods Seventy-five patients were retrospectively evaluated. Inclusion criteria were: (1) right-lobar radioembolization for unresectable unilateral HCC, (2) available liver computed tomography scans before, 1, 3, and at least 6 months after radioembolization. Baseline patient characteristics included clinical features, laboratory results, spleen volume, and liver computed tomography. Absolute and relative (referred to the whole liver volume) liver lobe volumes (LLV) as well as relative LLV (rLLV) change per month were evaluated and compared. Results Absolute and relative contralateral LLV continuously increased after radioembolization (p<0.001). Mean relative contralateral LLV increased from 36 +/- 11.6% before radioembolization to 50 +/- 15.3% 6 months after radioembolization. Median contralateral rLLV increase/month (within first 6 months) was 2.5%. Contralateral rLLV increase/month was significantly lower in patients with ascites (p = 0.017) or platelet count <100/nl (p = 0.009). An inverse correlation of contralateral rLVV increase/month with spleen volume (p = 0.017), patient age (p = 0.024), Child Pugh score (p = 0.001), and tumor burden (p = 0.001) was found. Conclusions Significant contralateral hypertrophy and ipsilateral atrophy were common after unilateral radioembolization. Small spleen volume, low patient age, low Child Pugh score, absence of ascites, platelet count >= 100/nl, and low tumor burden were associated with increased contralateral hypertrophy, indicating that younger patients with compensated cirrhosis might benefit most from radioembolization in a "bridge-to-resection" setting.	[Goebel, Juliane; Sulke, Maximilian; Lazik-Palm, Andrea; Umutlu, Lale; Theysohn, Jens] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany; [Goebel, Thomas] Petrus Hosp, Clin Gastroenterol Hepatol & Diabetol, Wuppertal, Germany; [Bellendorf, Alexander] Univ Hosp Essen, Clin Gastroenterol & Hepatol, Essen, Germany; [Bellendorf, Alexander; Mueller, Stefan] Univ Hosp Essen, Clin Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Goebel, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany.	Juliane.Goebel@uk-essen.de						Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Berzigotti A, 2015, HEPATOLOGY, V61, P526, DOI 10.1002/hep.27431; Bunchorntavakul C, 2016, J VIRAL HEPATITIS, V23, P408, DOI 10.1111/jvh.12534; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Dezarn WA, 2011, MED PHYS, V38, P4824, DOI 10.1118/1.3608909; Edeline J, 2013, ANN SURG ONCOL, V20, P2518, DOI 10.1245/s10434-013-2906-9; Gaba RC, 2009, ANN SURG ONCOL, V16, P1587, DOI 10.1245/s10434-009-0454-0; Gulec SA, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-6; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Jakobs TF, 2008, DIGEST DIS SCI, V53, P2556, DOI 10.1007/s10620-007-0148-z; Kim Robin D, 2008, Semin Intervent Radiol, V25, P92, DOI 10.1055/s-2008-1076679; Kopp JL, 2016, NAT CELL BIOL, V18, P238, DOI 10.1038/ncb3309; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Kubota K, 1997, HEPATOLOGY, V26, P1176; Ladurner R, 2009, HPB SURG, V2009; Liu H, 2009, AM J SURG, V197, P686, DOI [10.1016/j.amjsurg.2008.04.006, 10.1016/j.amjsurg.2008.04.022]; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nadalin S, 2014, Z GASTROENTEROL, V52, P35, DOI 10.1055/s-0033-1356364; Pamecha V, 2009, BRIT J CANCER, V100, P617, DOI 10.1038/sj.bjc.6604872; Salem R, 2006, J VASC INTERV RADIOL, V17, P1571, DOI 10.1097/01.RVI.0000236744.34720.73; Salem R, 2006, J VASC INTERV RADIOL, V17, P1425, DOI 10.1097/01.RVI.0000235779.88652.53; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962; Teo JY, 2014, J DIGEST DIS, V15, P444, DOI 10.1111/1751-2980.12162; Theysohn JM, 2014, CLIN RADIOL, V69, P172, DOI 10.1016/j.crad.2013.09.009; Vouche M, 2013, J HEPATOL, V59, P1029, DOI 10.1016/j.jhep.2013.06.015	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181488	10.1371/journal.pone.0181488	http://dx.doi.org/10.1371/journal.pone.0181488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708902	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800060
J	Murakami, K; Kobayashi, Y; Uehara, S; Suzuki, T; Koide, M; Yamashita, T; Nakamura, M; Takahashi, N; Kato, H; Udagawa, N; Nakamura, Y				Murakami, Kohei; Kobayashi, Yasuhiro; Uehara, Shunsuke; Suzuki, Takako; Koide, Masanori; Yamashita, Teruhito; Nakamura, Midori; Takahashi, Naoyuki; Kato, Hiroyuki; Udagawa, Nobuyuki; Nakamura, Yukio			A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro	PLOS ONE			English	Article							BONE-FORMATION; SIGNALING PATHWAY; TRABECULAR BONE; KNOCKOUT MICE; CELLS; ARTHRITIS; RECEPTOR; DIFFERENTIATION; CYTOKINES; INTERLEUKIN-6	The Janus kinases (Jaks) are hubs in the signaling process of more than 50 cytokine or hormone receptors. However, the function of Jak in bone metabolism remains to be elucidated. Here, we showed that the inhibition of Jak1 and/or Jak2 in osteoblast-lineage cells led to impaired osteoclastogenesis due to the reduced expression of receptor activator of nuclear factor-.B ligand (RANKL). Murine calvaria-derived osteoblasts induced differentiation of bone marrow cells into osteoclasts in the presence of 1,25-dihydroxyvitamin D-3 (1,25D(3)) and prostaglandin E-2 (PGE(2)) in vitro. However, treatment with the Jak1/2 inhibitor, baricitinib, markedly inhibited osteoclastogenesis in the co-culture. On the other hand, baricitinib did not inhibit RANKL-induced osteoclast differentiation of bone marrow macrophages. These results indicated that baricitinib acted on osteoblasts, but not on bone marrow macrophages. Baricitinib suppressed 1,25D(3) and PGE(2)-induced up-regulation of RANKL in osteoblasts, but not macrophage colony-stimulating factor expression. Moreover, the addition of recombinant RANKL to co-cultures completely rescued baricitinib-induced impairment of osteoclastogenesis. shRNA-mediated knockdown of Jak1 or Jak2 also suppressed RANKL expression in osteoblasts and inhibited osteoclastogenesis. Finally, cytokine array revealed that 1,25D(3) and PGE(2) stimulated secretion of interleukin-6 (IL-6), IL-11, and leukemia inhibitory factor in the co-culture. Hence, Jak1 and Jak2 represent novel therapeutic targets for osteoporosis as well as inflammatory bone diseases including rheumatoid arthritis.	[Murakami, Kohei; Suzuki, Takako; Kato, Hiroyuki; Nakamura, Yukio] Shinshu Univ, Dept Orthoped Surg, Sch Med, Matsumoto, Nagano, Japan; [Murakami, Kohei; Kobayashi, Yasuhiro; Koide, Masanori; Yamashita, Teruhito; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Shiojiri, Nagano, Japan; [Murakami, Kohei; Uehara, Shunsuke; Nakamura, Midori; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Shiojiri, Nagano, Japan	Shinshu University; Matsumoto Dental University; Matsumoto Dental University	Nakamura, Y (corresponding author), Shinshu Univ, Dept Orthoped Surg, Sch Med, Matsumoto, Nagano, Japan.	yxn14@aol.jp	Koide, Masanori/ABE-9670-2020; KOBAYASHI, YASUHIRO/AAU-4931-2021	Koide, Masanori/0000-0002-6511-9999; Kobayashi, Yasuhiro/0000-0002-0903-3226; Murakami, Kohei/0000-0001-5458-410X	joint research	joint research	Eli Lilly provided financial support as joint research. However, Eli Lilly did not have any additional role in the study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Cornish J, 1997, BONE, V21, P243, DOI 10.1016/S8756-3282(97)00144-0; Fridman JS, 2010, J IMMUNOL, V184, P5298, DOI 10.4049/jimmunol.0902819; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; LaBranche TP, 2012, ARTHRITIS RHEUM-US, V64, P3531, DOI 10.1002/art.34649; Lee Y, 2011, BIOMOL THER, V19, P141, DOI 10.4062/biomolther.2011.19.2.141; Li C., 2013, J MAT, V2013, P1, DOI DOI 10.5402/2013/629807; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; MALAVAL L, 1995, ENDOCRINOLOGY, V136, P1411, DOI 10.1210/en.136.4.1411; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; METCALF D, 1989, P NATL ACAD SCI USA, V86, P5948, DOI 10.1073/pnas.86.15.5948; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Park JS, 2014, J IMMUNOL, V192, P4417, DOI 10.4049/jimmunol.1300514; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sims NA, 2014, ARCH BIOCHEM BIOPHYS, V561, P22, DOI 10.1016/j.abb.2014.05.015; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeda S, 1999, ENDOCRINOLOGY, V140, P1005, DOI 10.1210/en.140.2.1005; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	36	58	63	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181126	10.1371/journal.pone.0181126	http://dx.doi.org/10.1371/journal.pone.0181126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708884	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800043
J	Riau, AK; Liu, YC; Lim, CHL; Lwin, NC; Teo, EP; Yam, GH; Tan, DT; Mehta, JS				Riau, Andri K.; Liu, Yu-Chi; Lim, Chris H. L.; Lwin, Nyein C.; Teo, Ericia P.; Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.			Retreatment strategies following Small Incision Lenticule Extraction (SMILE): In vivo tissue responses	PLOS ONE			English	Article							FEMTOSECOND LASER; PHOTOREFRACTIVE KERATECTOMY; SITU KERATOMILEUSIS; KERATOCYTE APOPTOSIS; CIRCLE PATTERNS; FLAP CREATION; LASIK; ORGANIZATION; ENHANCEMENT; ASTIGMATISM	With any refractive correction, including Small Incision Lenticule Extraction (SMILE), there may be a residual refractive error that requires a retreatment. Here, we investigated the tissue responses following various retreatment procedures in a rabbit model of SMILE. All rabbits underwent a -6.00D correction with SMILE. Two weeks later, they underwent -1.00D enhancement by: (i) VisuMax Circle, followed by excimer ablation (S+C); (ii) secondary SMILE anterior to the primary procedure (S+SE); or (iii) surface ablation (S+P), and were examined for 28 days. S+P induced corneal edema and haze, and more CD11b- (23 +/- 6 cells) and TUNEL-positive (36 +/- 4 cells) cells in the central stromal superficial layers early post-operatively (p<0.001 compared to other procedures). The corneas appeared normal on day 28 after S+P, but had a lower number of keratocytes near the laser ablated plane compared to other procedures. S+SE and S+C did not induce corneal haze and resulted similar level of fibronectin. However, S+C resulted in more inflammatory (10 +/- 2 cells; p = 0.001) and apoptotic cells (25 +/- 2 cells; p<0.001) compared to S+SE (7 +/- 1 inflammatory cells and 21 +/- 3 apoptotic cells) early post-operatively. In conclusion, each SMILE retreatment method resulted in unique tissue responses. S+SE offers advantages, such as minimal inflammation and cell death, as well as maintaining a 'flap-less' surgery, over other procedures. However, depending on the degree of enhancement, the lenticule may become too thin to be extracted and the procedure becomes more difficult to perform than S+C and S+P. S+P can maintain corneal integrity by avoiding flap creation and is technically more simple to perform than the others, but the surgery needs to be supplemented with mitomycin-C in order to reduce inflammation and modulate better wound healing.	[Riau, Andri K.; Liu, Yu-Chi; Lim, Chris H. L.; Lwin, Nyein C.; Teo, Ericia P.; Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Liu, Yu-Chi; Lim, Chris H. L.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Lim, Chris H. L.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lim, Chris H. L.] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Yam, Gary H.; Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Royal Melbourne Hospital; National University of Singapore; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.	jodmehta@gmail.com	Yam, Gary Hin-Fai/ABE-1710-2020; Lim, Chris/ABH-2772-2021; Riau, Andri/P-9693-2019; Liu, Yu Chi/AAM-7010-2020; Lim, Chris/ABE-1727-2021	Lim, Chris/0000-0003-2219-3184; Riau, Andri/0000-0002-5105-0484; Liu, Yu Chi/0000-0001-5408-0382; 	National Research Foundation of Singapore [NMRC/TCR/002-SERI/2008]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This study was supported by National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR/002-SERI/2008). The funding was received by JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2008, AM J OPHTHALMOL, V145, P55, DOI 10.1016/j.ajo.2007.08.035; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Chansue E, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0031-5; Davis EA, 2002, OPHTHALMOLOGY, V109, P2308, DOI 10.1016/S0161-6420(02)01245-9; Donate D, 2015, J REFRACT SURG, V31, P708, DOI 10.3928/1081597X-20150928-04; Durrie DS, 1999, J REFRACT SURG, V15, P150; Febbraro JL, 2000, J CATARACT REFR SURG, V26, P41, DOI 10.1016/S0886-3350(99)00263-1; FUJIKAWA LS, 1984, J CELL BIOL, V98, P128, DOI 10.1083/jcb.98.1.128; Hall RC, 2011, J CATARACT REFR SURG, V37, P544, DOI 10.1016/j.jcrs.2010.10.037; HANNA KD, 1992, ARCH OPHTHALMOL-CHIC, V110, P1286, DOI 10.1001/archopht.1992.01080210104035; Hersh PS, 2003, OPHTHALMOLOGY, V110, P748, DOI 10.1016/S0161-6420(02)01981-4; Hong JW, 2001, INVEST OPHTH VIS SCI, V42, P2795; Ivarsen A, 2014, J REFRACT SURG, V30, P429, DOI 10.3928/1081597X-20140508-02; LATVALA T, 1995, BRIT J OPHTHALMOL, V79, P65, DOI 10.1136/bjo.79.1.65; Li MY, 2014, J REFRACT SURG, V30, P94, DOI 10.3928/1081597X-20140120-04; Meltendorf C, 2007, INVEST OPHTH VIS SCI, V48, P2068, DOI 10.1167/iovs.06-1150; Miyamoto T, 2003, J CATARACT REFR SURG, V29, P153, DOI 10.1016/S0886-3350(02)01450-5; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Netto MV, 2007, J REFRACT SURG, V23, P667; Netto MV, 2004, OPHTHALMOLOGY, V111, P1362, DOI 10.1016/j.ophtha.2003.11.009; Reinstein DZ, 2014, J REFRACT SURG, V30, P813, DOI 10.3928/1081597X-20141113-07; Ren HW, 1996, INVEST OPHTH VIS SCI, V37, P1017; Riau AK, 2013, J REFRACT SURG, V29, P236, DOI 10.3928/1081597X-20130318-02; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Roberts C, 2000, J REFRACT SURG, V16, P407; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Tay E, 2012, J CATARACT REFR SURG, V38, P1544, DOI 10.1016/j.jcrs.2012.05.030; Vestergaard A, 2013, ACTA OPHTHALMOL, V91, P355, DOI 10.1111/j.1755-3768.2012.02406.x; Vrana NE, 2007, BIOMATERIALS, V28, P4303, DOI 10.1016/j.biomaterials.2007.06.013; Wilson SE, 1998, INVEST OPHTH VIS SCI, V39, P220; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038	37	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180941	10.1371/journal.pone.0180941	http://dx.doi.org/10.1371/journal.pone.0180941			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708898	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800032
J	Puolakkainen, T; Rummukainen, P; Lehto, J; Ritvos, O; Hiltunen, A; Saamanen, AM; Kiviranta, R				Puolakkainen, Tero; Rummukainen, Petri; Lehto, Jemina; Ritvos, Olli; Hiltunen, Ari; Saamanen, Anna-Marja; Kiviranta, Riku			Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFLAMMATORY RESPONSE; GROWTH-FACTORS; BONE; BISPHOSPHONATES; MYOSTATIN; PROTEIN; REGENERATION; OSTEOPOROSIS; FOLLISTATIN	Fractures still present a significant burden to patients due to pain and periods of unproductivity. Numerous growth factors have been identified to regulate bone remodeling. However, to date, only the bone morphogenetic proteins (BMPs) are used to enhance fracture healing in clinical settings. Activins are pleiotropic growth factors belonging to the TGF-beta superfamily. We and others have recently shown that treatment with recombinant fusion proteins of activin receptors greatly increases bone mass in different animal models by trapping activins and other ligands thus inhibiting their signaling pathways. However, their effects on fracture healing are less known. Twelve-week old male C57Bl mice were subjected to a standardized, closed tibial fracture model. Animals were divided into control and treatment groups and were administered either PBS control or a soluble activin type IIB receptor (ActRIIB-Fc) intraperitoneally once a week for a duration of two or four weeks. There were no significant differences between the groups at two weeks but we observed a significant increase in callus mineralization in ActRIIB-Fc-treated animals by microcomputed tomography imaging at four weeks. Bone volume per tissue volume was 60%, trabecular number 55% and bone mineral density 60% higher in the 4-week calluses of the ActRIIB-Fc-treated mice (p< 0.05 in all). Biomechanical strength of 4-week calluses was also significantly improved by ActRIIBFc treatment as stiffness increased by 64% and maximum force by 45% (p< 0.05) compared to the PBS-injected controls. These results demonstrate that ActRIIB-Fc treatment significantly improves healing of closed long bone fractures. Our findings support the previous reports of activin receptors increasing bone mass but also demonstrate a novel approach for using ActRIIB-Fc to enhance fracture healing.	[Puolakkainen, Tero; Rummukainen, Petri; Lehto, Jemina; Saamanen, Anna-Marja; Kiviranta, Riku] Univ Turku, Inst Biomed, Turku, Finland; [Ritvos, Olli] Univ Helsinki, Dept Physiol, Helsinki, Finland; [Hiltunen, Ari] Terveystalo Pulssi, Turku, Finland; [Kiviranta, Riku] Turku Univ Hosp, Div Endocrinol, Turku, Finland	University of Turku; University of Helsinki; University of Turku	Kiviranta, R (corresponding author), Univ Turku, Inst Biomed, Turku, Finland.; Kiviranta, R (corresponding author), Turku Univ Hosp, Div Endocrinol, Turku, Finland.	Riku.kiviranta@utu.fi	Ritvos, Olli/GWC-2442-2022	Lehto, Jemina/0000-0002-2827-5749; Saamanen, Anna-Marja/0000-0003-3963-6324; Ritvos, Olli/0000-0001-7017-6931	Academy of Finland [132962, 139165, 298535]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation; Terveystalo Pulssi	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Terveystalo Pulssi	The work was supported by the following: RK: Academy of Finland-Grants 132962, 139165, 298535, http://webfocus.aka.fi/ibi_apps/WFServlet?IBIF_ex=x_HakKuvaus & Sigrid Juselius Foundation; Emil Aaltonen Foundation; and Finnish Cultural Foundation. Regarding the employer of Dr. Ari Hiltunen, the funder, Terveystalo Pulssi, provided support in the form of salaries for author AH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the "author contributions" section.	Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Bray N, 2015, NAT REV DRUG DISCOV, V14, P677, DOI 10.1038/nrd4745; Canalis E, 2010, J CLIN ENDOCR METAB, V95, P1496, DOI 10.1210/jc.2009-2677; Chen YG, 2006, EXP BIOL MED, V231, P534; Crawford Charles H 3rd, 2009, Am J Orthop (Belle Mead NJ), V38, P567; DiGirolamo DJ, 2015, BONE RES, V3, DOI 10.1038/boneres.2014.42; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fisher DM, 2013, CURR STEM CELL RES T, V8, P260; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Goldhahn J, 2012, CALCIFIED TISSUE INT, V90, P343, DOI 10.1007/s00223-012-9587-4; Hardy CL, 2015, CLIN EXP ALLERGY, V45, P1510, DOI 10.1111/cea.12561; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Khojasteh A, 2013, OR SURG OR MED OR PA, V116, pE405, DOI 10.1016/j.oooo.2012.01.044; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Kuklo TR, 2008, J BONE JOINT SURG BR, V90B, P1068, DOI 10.1302/0301-620X.90B8.20349; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Li YT, 2015, OSTEOPOROSIS INT, V26, P431, DOI 10.1007/s00198-014-2903-2; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Lowery JW, 2015, J CELL SCI, V128, P1308, DOI 10.1242/jcs.156737; Marino FE, 2014, MOL HUM REPROD, V20, P1223, DOI 10.1093/molehr/gau074; Morse A, 2015, J ORTHOPAEDIC RES OF; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nagamine T, 1998, J ORTHOPAED RES, V16, P314, DOI 10.1002/jor.1100160307; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Sattui SE, 2014, NAT REV ENDOCRINOL, V10, P592, DOI 10.1038/nrendo.2014.125; Shintaku Y, 2011, CELLS TISSUES ORGANS, V194, P38, DOI 10.1159/000322557; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tanko LB, 2016, CALCIFIED TISSUE INT, V99, P310, DOI 10.1007/s00223-016-0148-0; Williamson RD, 2015, CYTOKINE, V71, P360, DOI 10.1016/j.cyto.2014.11.017	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180593	10.1371/journal.pone.0180593	http://dx.doi.org/10.1371/journal.pone.0180593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704409	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700043
J	Simino, J; Wang, ZY; Bressler, J; Chouraki, V; Yang, Q; Younkin, SG; Seshadri, S; Fornage, M; Boerwinkle, E; Mosley, TH				Simino, Jeannette; Wang, Zhiying; Bressler, Jan; Chouraki, Vincent; Yang, Qiong; Younkin, Steven G.; Seshadri, Sudha; Fornage, Myriam; Boerwinkle, Eric; Mosley, Thomas H., Jr.			Whole exome sequence-based association analyses of plasma amyloid-beta in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-AGE INTERACTIONS; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DECLINE; PRECURSOR PROTEIN; BLOOD-PRESSURE; ABNORMAL-BEHAVIOR; THP-1 MACROPHAGES; CONTACT SYSTEM	Objective We performed single-variant and gene-based association analyses of plasma amyloid-beta (a beta) concentrations using whole exome sequence from 1,414 African and European Americans. Our goal was to identify genes that influence plasma a beta(42) concentrations and a beta(42): a beta(40) ratios in late middle age (mean = 59 years), old age (mean = 77 years), or change over time (mean = 18 years). Methods Plasma a beta measures were linearly regressed onto age, gender, APOE epsilon 4 carrier status, and time elapsed between visits (fold-changes only) separately by race. Following inverse normal transformation of the residuals, seqMeta was used to conduct race-specific single-variant and gene-based association tests while adjusting for population structure. Linear regression models were fit on autosomal variants with minor allele frequencies (MAF)>= 1%. T5 burden and Sequence Kernel Association (SKAT) gene-based tests assessed functional variants with MAF <= 5%. Cross-race fixed effects meta-analyses were Bonferroni-corrected for the number of variants or genes tested. Results Seven genes were associated with a beta in late middle age or change over time; no associations were identified in old age. Single variants in KLKB1 (rs3733402; p = 4.33x10(-10)) and F12 (rs1801020; p = 3.89x10(-8)) were significantly associated with midlife a beta(42) levels through cross-race meta-analysis; the KLKB1 variant replicated internally using 1,014 additional participants with exome chip. ITPRIP, PLIN2, and TSPAN18 were associated with the midlife a beta(42): a beta(40) ratio via the T5 test; TSPAN18 was significant via the cross-race meta-analysis, whereas ITPRIP and PLIN2 were European American-specific. NCOA1 and NT5C3B were associated with the midlife a beta(42): a beta(40) ratio and the fold-change in a beta(42), respectively, via SKAT in African Americans. No associations replicated externally (N = 725). Conclusion We discovered age-dependent genetic effects, established associations between vascularrelated genes (KLKB1, F12, PLIN2) and midlife plasma a beta levels, and identified a plausible Alzheimer's Disease candidate gene (ITPRIP) influencing cell death. Plasma a beta concentrations may have dynamic biological determinants across the lifespan; plasma a beta study designs or analyses must consider age.	[Simino, Jeannette; Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Gertrude C Ford MIND Ctr, Jackson, MS 39216 USA; [Simino, Jeannette] Univ Mississippi, Med Ctr, Dept Data Sci, John D Bower Sch Populat Hlth, Jackson, MS 39216 USA; [Wang, Zhiying; Bressler, Jan; Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Chouraki, Vincent] Lille Univ, Inst Pasteur Lille, CHU Lille, Inserm,U1167,RID AGE Risk Factors & Mol Determina, Lille, France; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Yang, Qiong; Seshadri, Sudha] NHLBI, Framingham Heart Study, Framingham, MA USA; [Younkin, Steven G.] Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Res Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MA USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Boston University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Mississippi; University of Mississippi Medical Center	Simino, J (corresponding author), Univ Mississippi, Med Ctr, Gertrude C Ford MIND Ctr, Jackson, MS 39216 USA.; Simino, J (corresponding author), Univ Mississippi, Med Ctr, Dept Data Sci, John D Bower Sch Populat Hlth, Jackson, MS 39216 USA.	jsimino@umc.edu		Chouraki, Vincent/0000-0002-4698-1794; Seshadri, Sudha/0000-0001-6135-2622	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01 HL70825]; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Deafness and Other Communication Disorders [U01 HL096812, HL096814, HL096899, HL096902, HL096917]; Framingham Heart Study (NHLBI/NIH) [HHSN268201500001I]; National Institute on Aging [R01 AG008122, R01 AG054076, R01 AG049607, R01 AG033193, U01 AG049505, U01 AG052409]; National Institute of Neurological Disorders and Stroke [NS017950, UH2 NS100605]; National Institutes of Health through American Recovery and Reinvestment Act (ARRA) [5RC2HL102419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096899, U01HL096812, U01HL096814, U01HL096917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Framingham Heart Study (NHLBI/NIH); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health through American Recovery and Reinvestment Act (ARRA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). ARIC Neurocognitive data was collected through the joint support of the National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute on Aging; and the National Institute on Deafness and Other Communication Disorders (U01 HL096812, HL096814, HL096899, HL096902, HL096917), with previous brain MRI examinations funded by R01 HL70825 from the National Heart, Lung, and Blood Institute. This work was supported by the Framingham Heart Study (NHLBI/NIH contract HHSN268201500001I to the Boston University School of Medicine) and by grants from the National Institute on Aging (R01 AG008122, R01 AG054076, R01 AG049607, R01 AG033193, U01 AG049505, U01 AG052409) and the National Institute of Neurological Disorders and Stroke (NS017950 and UH2 NS100605). Funding support for Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium was provided by the National Institutes of Health through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Sequencing for both studies was carried out at the Baylor College of Medicine Human Genome Sequencing Center (U54 HG003273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Ashby EL, 2012, NEUROBIOL AGING, V33, P1345, DOI 10.1016/j.neurobiolaging.2010.09.024; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002093-199806000-00008; Bergamaschini L, 2001, NEUROBIOL AGING, V22, P63, DOI 10.1016/S0197-4580(00)00174-3; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Biswas N, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0283-5; Calero M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00138; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chen FL, 2010, MOL CELL BIOCHEM, V337, P193, DOI 10.1007/s11010-009-0299-7; Cho SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20185; Chou CT, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0222-x; Chouraki V, 2014, MOL PSYCHIATR, V19, P1326, DOI 10.1038/mp.2013.185; Chouraki V, 2015, ALZHEIMERS DEMENT, V11, P249, DOI 10.1016/j.jalz.2014.07.001; Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001; De Meyer GRY, 2002, CIRC RES, V90, P1197, DOI 10.1161/01.RES.0000020017.84398.61; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Glahn DC, 2014, AM J MED GENET B, V165, P122, DOI 10.1002/ajmg.b.32221; Gomez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Gronewold J, 2016, MOL NEUROBIOL, V53, P3136, DOI 10.1007/s12035-015-9218-y; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Guella I, 2011, THROMB HAEMOSTASIS, V106, P655, DOI 10.1160/TH11-04-0247; Gupta A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00115; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Huang HM, 1998, LIFE SCI, V63, P195, DOI 10.1016/S0024-3205(98)00260-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jakobsdottir J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006327; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Jawaid A, 2015, J AM GERIATR SOC, V63, P419, DOI 10.1111/jgs.13262; Jensen LE, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00036; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Kanaji T, 1998, BLOOD, V91, P2010, DOI 10.1182/blood.V91.6.2010.2010_2010_2014; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Katsuda I, 2007, EUR J HAEMATOL, V79, P59, DOI 10.1111/j.1600-0609.2007.00871.x; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Knopman David S, 2016, Alzheimers Dement (Amst), V2, P1; Koyama A, 2012, ARCH NEUROL-CHICAGO, V69, P824, DOI 10.1001/archneurol.2011.1841; Kunkle BW, 2015, ALZHEIMERS DEMENTIA; Kyratzi E, 2014, NEUROBIOL AGING, V35, P2053, DOI 10.1016/j.neurobiolaging.2014.03.019; Lachno DR, 2012, J ALZHEIMERS DIS, V32, P905, DOI 10.3233/JAD-2012-121075; Lai AY, 2012, FUTUR NEUROL, V7, P165, DOI 10.2217/FNL.12.6; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018536; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lord J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00369; Lu XF, 2007, HUM GENET, V121, P327, DOI 10.1007/s00439-007-0340-4; Magne J, 2013, FASEB J OFFICIAL PUB, P27; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; Musani SK, 2015, CIRC-CARDIOVASC GENE, V8, P122, DOI 10.1161/CIRCGENETICS.114.000900; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Najt CP, 2014, BIOCHEMISTRY-US, V53, P7051, DOI 10.1021/bi500918m; Nitsch RM, 1998, NEUROCHEM RES, V23, P807, DOI 10.1023/A:1022423813362; Oien DB, 2008, FREE RADICAL BIO MED, V45, P193, DOI 10.1016/j.freeradbiomed.2008.04.003; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Poljak A, 2017, EXPERT REV NEUROTHER, V17, P3, DOI 10.1080/14737175.2016.1217156; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramirez A, 2014, HUM MOL GENET, V23, P6644, DOI 10.1093/hmg/ddu372; Reitz C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.005; Rembach A, 2014, ALZHEIMERS DEMENT, V10, P53, DOI 10.1016/j.jalz.2012.12.006; Santamaria A, 2004, STROKE, V35, P1795, DOI 10.1161/01.STR.0000133127.68041.a3; Scholz CJ, 2010, AM J MED GENET B, V153B, P967, DOI 10.1002/ajmg.b.31057; Schupf N, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.020; Seipold L, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2016.00149, 10.3389/fnmol.2015.00013]; Shen C, 2015, J MOL NEUROSCI, V56, P89, DOI 10.1007/s12031-014-0470-9; Shi G, 2009, HYPERTENSION, V53, P35, DOI 10.1161/HYPERTENSIONAHA.108.120071; Shibayama Y, 1999, CLIN IMMUNOL, V90, P89, DOI 10.1006/clim.1998.4621; Shie FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134531; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Siegerink B, 2014, J THROMB HAEMOST, V12, P606, DOI 10.1111/jth.12531; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Simino J, 2014, ATHEROSCLEROSIS, V235, P84, DOI 10.1016/j.atherosclerosis.2014.04.008; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Swaminathan Shanker, 2014, Alzheimers Dement, V10, pe9, DOI 10.1016/j.jalz.2013.01.007; The ARIC Investigators, 1989, AM J EPIDEMIOL, V129, P687; Toledo JB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt162; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Tzen KY, 2014, ACS CHEM NEUROSCI, V5, P830, DOI 10.1021/cn500101j; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Verweij N, 2013, HYPERTENSION, V61, P602, DOI 10.1161/HYPERTENSIONAHA.111.203117; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QB, 2002, CHINESE MED J-PEKING, V115, P884; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995; YASUHARA O, 1994, BRAIN RES, V654, P234, DOI 10.1016/0006-8993(94)90484-7; Yuan JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058785; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zamolodchikov D, 2015, P NATL ACAD SCI USA, V112, P4068, DOI 10.1073/pnas.1423764112; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762; Zinser EG, 2007, BBA-BIOMEMBRANES, V1768, P1991, DOI 10.1016/j.bbamem.2007.02.014; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	104	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180046	10.1371/journal.pone.0180046	http://dx.doi.org/10.1371/journal.pone.0180046			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704393	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700023
J	Mulu, W; Abera, B; Mekonnen, Z; Adem, Y; Yimer, M; Zenebe, Y; Amuamuta, A; Gebeyehu, W				Mulu, Wondemagegn; Abera, Bayeh; Mekonnen, Zewdie; Adem, Yesuf; Yimer, Mulat; Zenebe, Yohannes; Amuamuta, Asmare; Gebeyehu, Wondimu			Haematological and CD4(+) T cells reference ranges in healthy adult populations in Gojjam zones in Amhara region, Ethiopia	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; REFERENCE INTERVALS; REFERENCE VALUES; COUNT	Introduction Establishing national population haematological and immunological reference ranges are essential for clinical management of patients. However, there is scarcity of information on community based haematological reference ranges established from Ethiopian population. Therefore, this study aimed at determining haematological and CD4(+) T cells reference ranges in healthy adults from East and West Gojjam zones, Ethiopia. Methods Community based cross-sectional study was conducted from May 2015 to December 2015 in healthy adult residents of Gojjam zone. A total of 481(246 females and 235 males) healthy adults enrolled in the study. Healthy adults were defined by medical history, physical examination and laboratory screening for HIV, HBV, HCV and intestinal parasitosis. Haematological parameters were measured using haematology analyzer MindrayBC320 (Mindray Biomedical electronic Corporation, China). CD4(+) T cells were enumerated using FACS count (Becton Dickinson). Results The median age of the participants was 25 years. The overall median and 95th percentile of CD4+ T cells count were 869 cells/mm(3) and 396-1598 cells/mm(3), respectively. Females had a significantly higher CD4+ T cell counts compared to males (P = 0.002). The 95th percentile range for red blood cells (RBCs) was 3.93-6.1 x 10(6) cells/mm(3) and for hematocrit (Hct) was 40-58% while for hemoglobin (Hb) was 15.69-17.84g/dl. Males had significantly higher values of RBC and Hct than females (P < 0.001). Females (120-379 x 10(6) cells/mm(3)) had significantly higher platelet counts than males (106-352 x 10(6) cells/mm(3)) (P < 0.001). The overall median of WBC was 6.78 x 10(3)/mm(3) and its 95 th percentile range was 3.5-11.5 x 10(3)/ mm(3). The overall 95 th percentile range of MCV, MCH and MCHC were 89.5-107.5 fl, 28-34pg and 30-33.2g/dl, respectively. The higher mean absolute count of RBCs was found in the youngest age groups (P = 0.03). The mean count of RBCs and Hct were significantly higher in highschool completed and above than other participants ( P < 0.001). The lower and upper limit of platelet counts was significantly higher in highland (118-383x10(6) cells/ mm3) compared to lowland residents (107-352x10(6) cells/ mm3) ( P < 0.001). Moreover, it was significantly higher in residents with better monthly income (124-383x10(6) cells/ mm3) compared to the counters (115-368x10(6) cells/mm(3)) (P = 0.02). Conclusions Some of the haematological and CD4(+) T cells reference ranges of the healthy adults in this study showed variations with the reference ranges used and reported so far in Ethiopia, Africa and Western countries. We recommend further study considering gender, altitude, and residency in other parts of Ethiopia to establish national reference ranges for Ethiopian population.	[Mulu, Wondemagegn; Abera, Bayeh; Adem, Yesuf; Yimer, Mulat; Zenebe, Yohannes] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia; [Mekonnen, Zewdie; Amuamuta, Asmare] Bahir Dar Univ, Biotechnol Res Inst, Biomed Res Dept, Bahir Dar, Ethiopia; [Mekonnen, Zewdie; Amuamuta, Asmare] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Biochem, Bahir Dar, Ethiopia; [Gebeyehu, Wondimu] Amhara Reg Hlth Res Lab Ctr, Bahir Dar, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Mulu, W (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia.	Wondem_32@yahoo.com	/AAD-8608-2020; Limeneh, Asmare Amuamuta/AAB-5229-2021; Abera, Bayeh/AAU-8754-2020; Mulu, Wondemagegn/X-3190-2019	/0000-0001-8016-6817; Limeneh, Asmare Amuamuta/0000-0002-9047-2962; chekol, yohannes zenebe/0000-0003-4522-4481; Mulu, Wondemagegn/0000-0002-5966-9388	Biotechnology Research Institute of Bahir Dar University [2.1/9407/1.11.10]; Biotechnology Research Institute of Bahir Dar University	Biotechnology Research Institute of Bahir Dar University; Biotechnology Research Institute of Bahir Dar University	The research project was funded by Biotechnology Research Institute of Bahir Dar University for the financial support on grant number 2.1/9407/1.11.10. The fund was utilized for purchasing reagents, data collection, analysis and interpretation.; This research was financed by Biotechnology Research Institute of Bahir Dar University. We would like to acknowledge DebreMarkos Referral Hospital for their permission to analyze the haemato immunological parameters in their setting. We also acknowledge the technical support of the staff of DebreMarkos Referral Hospital Laboratory. We also acknowledge Amhara Regional Health Bureau for their permission and support to conduct the study in the region.	Abera B, 2012, ETHIOP J HEALTH DEV, V26, P152; Ambayya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091968; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Federal Ministry of Health (FMOH), 2007, GUID LIN HIV CAR ART; Haileamlak A, 2012, ETHIOP J HEALTH SCI, V22, P39; Ittermann T, 2010, CLIN LAB, V56, P9; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Miri-dashe T, 2014, PLOS ONE; Mugisha Joseph O, 2016, BMC Res Notes, V9, P433, DOI 10.1186/s13104-016-2217-x; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; Osei-Bimpong A, 2012, INT J LAB HEMATOL, V34, P91, DOI 10.1111/j.1751-553X.2011.01365.x; Ramezani A., 2014, IRAN J PATHOL, V9, P50; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Samaneka WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165821; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Wintrobe MM, 1999, WINTROBES CLIN HEMAT; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Yaman A, REFERENCE RANGES LYM; Zeh CE, LAB REFERENCE INTERV; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181268	10.1371/journal.pone.0181268	http://dx.doi.org/10.1371/journal.pone.0181268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723945	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800042
J	Ershova, AI; Meshkov, AN; Bazhan, SS; Storozhok, MA; Efanov, AY; Medvedeva, IV; Indukaeva, EV; Danilchenko, YV; Kuzmina, OK; Barbarash, OL; Deev, AD; Shalnova, SA; Boytsov, SA				Ershova, Alexandra I.; Meshkov, Alexey N.; Bazhan, Stepan S.; Storozhok, Marina A.; Efanov, Alexey Y.; Medvedeva, Irina V.; Indukaeva, Elena V.; Danilchenko, Yana V.; Kuzmina, Olga K.; Barbarash, Olga L.; Deev, Alexander D.; Shalnova, Svetlana A.; Boytsov, Sergey A.			The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; COMMUNITY	Background The prevalence of familial hypercholesterolemia (FH) in Russia has not previously been evaluated. The aim of our study was to investigate the prevalence of FH in the population of the West Siberian region of Russia, and then estimate the frequency of coronary artery disease (CAD) and treatment with cholesterol-lowering medication in FH patients. Methods The sample of our study consisted of participants from the population-based cohort of The Epidemiology of Cardiovascular Risk Factors and Diseases in Regions of the Russian Federation Study (ESSE-RF), conducted in the Tyumen and Kemerovo regions (1,630 and 1,622 people, respectively, aged 25-64). All participants who had LDL-cholesterol higher than 4.9 mmol/l and who had LDL-cholesterol less than or equal to 4.9 mmol/l but had statin therapy were examined and interviewed by experts in FH. Results The prevalence of patients with definite FH was 0.24% (one in 407) (95% confidence interval [CI]: 0.06%-0.42%), with probable FH was 0.68% (one in 148) (95% CI: 0.38%-0.98%), and with definite or probable FH combined was 0.92% (one in 108) (95% CI: 0.58%-1.26%). 40% (95% CI: 20.8%-59.2%) of patients with definite or probable FH had CAD. However, only 23% (95% CI: 6.3%-39.7%) of patients with definite or probable FH were on statins. The odds ratios for CAD and myocardial infarction (MI), adjusted for age, gender, region, smoking, hypertension, and diabetes mellitus, were 3.71 (95% CI: 1.58-8.72) (p = 0.003) and 4.06 (95% CI: 0.89-18.55) (p = 0.070) respectively for individuals with definite or probable FH relative to those who were unlikely to have FH. Conclusions The prevalence of FH in Russia may be significantly higher than previously estimated. There is underdiagnosis and undertreatment of FH in Russia.	[Ershova, Alexandra I.; Meshkov, Alexey N.; Deev, Alexander D.; Shalnova, Svetlana A.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Moscow, Russia; [Bazhan, Stepan S.] Inst Internal & Prevent Med, Novosibirsk, Russia; [Storozhok, Marina A.; Efanov, Alexey Y.; Medvedeva, Irina V.] Tyumen State Med Acad, Tyumen, Russia; [Indukaeva, Elena V.; Danilchenko, Yana V.; Kuzmina, Olga K.; Barbarash, Olga L.] Res Inst Complex Issues Cardiovasc Dis, Kemerovo, Russia	National Medical Research Center for Therapy & Preventive Medicine; Tyumen State Medical University; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases	Ershova, AI (corresponding author), Natl Res Ctr Prevent Med, Moscow, Russia.	alersh@mail.ru	Ershova, Alexandra I/J-8772-2017; Indukaeva, Elena/I-2340-2017; Meshkov, Alexey N/K-1056-2017; Shalnova, Svetlana/D-3824-2016; Boytsov, Sergey A/M-4486-2014; Danilchenko, Yana/H-6780-2017; Efanov, Alexei/N-8887-2016; Boytsov, Sergey/AAK-5354-2021; Storozhok, Marina/AAH-2523-2019; deev, alexander/M-7754-2014; Barbarash, Olga/A-4834-2017	Ershova, Alexandra I/0000-0001-7989-0760; Indukaeva, Elena/0000-0002-6911-6568; Meshkov, Alexey N/0000-0001-5989-6233; Boytsov, Sergey A/0000-0001-6998-8406; Danilchenko, Yana/0000-0001-8308-8308; Boytsov, Sergey/0000-0001-6998-8406; Barbarash, Olga/0000-0002-4642-3610; Efanov, Alexey/0000-0002-3770-3725				[Anonymous], 2014, J CLIN ENDOCRINOL ME, V99, P4758; BASS EB, 1989, J CLIN EPIDEMIOL, V42, P385, DOI 10.1016/0895-4356(89)90126-1; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Boitsov S.A., 2013, PREVENT MED, V6, P25, DOI DOI 10.20333/25000136-2014-4-82-85; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Goldstein JL, 1995, METABOLIC BASIS INHE, P1215; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Kish L, 1965, SURVEY SAMPLING; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; Meshkov AN, 2009, TERAPEVT ARKH, V81, P23; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; SLACK J, 1969, LANCET, V2, P1380; Steyn K, 1996, HUM GENET, V98, P479, DOI 10.1007/s004390050243; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Watts GF, 2015, INT J CARDIOL, V185, P69, DOI 10.1016/j.ijcard.2015.03.027	20	13	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181148	10.1371/journal.pone.0181148	http://dx.doi.org/10.1371/journal.pone.0181148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719663	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400033
J	Queiroz, FR; Silva, LM; Jeremias, WD; Baba, EH; Caldeira, RL; Coelho, PMZ; Gomes, MD				Queiroz, Fabio Ribeiro; Silva, Luciana Maria; Jeremias, Wander de Jesus; Baba, Elio Hideo; Caldeira, Roberta Lima; Zech Coelho, Paulo Marcos; Gomes, Matheus de Souza			Differential expression of small RNA pathway genes associated with the Biomphalaria glabrata/Schistosoma mansoni interaction	PLOS ONE			English	Article							INTERMEDIATE SNAIL HOST; STEM-CELL MAINTENANCE; SCHISTOSOMA-MANSONI; MICRORNA MATURATION; NUCLEAR EXPORT; AUSTRALORBIS-GLABRATUS; TARGET RECOGNITION; STRUCTURAL BASIS; PIWI PROTEINS; PIRNA PATHWAY	The World Health Organization (WHO) estimates that approximately 240 million people in 78 countries require treatment for schistosomiasis, an endemic disease caused by trematodes of the genus Schistosoma. In Brazil, Schistosoma mansoni is the only species representative of the genus whose passage through an invertebrate host, snails of the genus Biomphalaria, is obligatory before infecting a mammalian host, including humans. The availability of the genome and transcriptome of B. glabrata makes studying the regulation of gene expression, particularly the regulation of miRNA and piRNA processing pathway genes, possible. This might assist in better understanding the biology of B. glabrata as well as its relationship to the parasite S. mansoni. Some aspects of this interaction are still poorly explored, including the participation of non-coding small RNAs, such as miRNAs and piRNAs, with lengths varying from 18 to 30 nucleotides in mature form, which are potent regulators of gene expression. Using bioinformatics tools and quantitative PCR, we characterized and validated the miRNA and piRNA processing pathway genes in B. glabrata. In silico analyses showed that genes involved in miRNA and piRNA pathways were highly conserved in protein domain distribution, catalytic site residue conservation and phylogenetic analysis. Our study showed differential expression of putative Argonaute, Drosha, Piwi, Exportin-5 and Tudor genes at different snail developmental stages and during infection with S. mansoni, suggesting that the machinery is required for miRNA and piRNA processing in B. glabrata at all stages. These data suggested that the silencing pathway mediated by miRNAs and piRNAs can interfere in snail biology throughout the life cycle of the snail, thereby influencing the B. glabrata/S. mansoni interaction. Further studies are needed to confirm the participation of the small RNA processing pathway proteins in the parasite/host relationship, mainly the effective participation of small RNAs in regulating their target genes.	[Queiroz, Fabio Ribeiro; Jeremias, Wander de Jesus; Baba, Elio Hideo; Zech Coelho, Paulo Marcos] Fundacao Oswaldo Cruz, Grp Pesquisa Biol Schistosoma Mansoni & Sua Inter, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Queiroz, Fabio Ribeiro; Silva, Luciana Maria] Fundacao Ezequiel Dias, Serv Biol Celular, Dept Pesquisas & Desenvolvimento, Belo Horizonte, MG, Brazil; [Caldeira, Roberta Lima] Fundacao Oswaldo Cruz, Grp Pesquisa Helmintol & Malacol Med, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Gomes, Matheus de Souza] Univ Fed Uberlandia, Lab Bioinformat & Anal Mol, Inst Genet & Bioquim, Campus Patos Minas, Patos De Minas, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Uberlandia	Silva, LM (corresponding author), Fundacao Ezequiel Dias, Serv Biol Celular, Dept Pesquisas & Desenvolvimento, Belo Horizonte, MG, Brazil.	luciana.silva@funed.mg.gov.br	Silva, Luciana M/I-4353-2014; Coelho, Paulo Marcos Zech/ABE-6169-2021; Silva, Luciana M/R-6340-2018; Caldeira, Roberta/AAZ-3858-2020; de Souza Gomes, Matheus/G-3480-2012	Silva, Luciana M/0000-0002-2038-0405; Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Silva, Luciana M/0000-0002-2038-0405; Caldeira, Roberta/0000-0003-4706-0732; Jeremias, Wander/0000-0001-8204-6712; de Souza Gomes, Matheus/0000-0001-7352-3089	FAPEMIG [APQ-00467-13]; CNPq [479890/2013-7]; CAPES; Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED	This work was supported by FAPEMIG, through project number APQ-00467-13 and CNPq - project number 479890/2013-7; CAPES, Rene Rachou Research Center/CPqRR - The Oswaldo Cruz Foundation and Ezequiel Dias Foundation FUNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15451; de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldeira RL, 2009, ACTA TROP, V111, P1, DOI 10.1016/j.actatropica.2009.02.004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; clinicaltrials. gov, 2020, RNA; Costa MC, 2012, INT J MOL SCI, V13, P10268, DOI 10.3390/ijms130810268; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flor TB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040538; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hale BJ, 2014, MOL REPROD DEV, V81, P148, DOI 10.1002/mrd.22272; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanington PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001591; Hesse M, 2014, METHODS MOL BIOL, V1095, P11, DOI 10.1007/978-1-62703-703-7_2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jannot G, 2008, RNA, V14, P829, DOI 10.1261/rna.901908; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, MOL CELLS, V19, P1; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu HP, 2010, GENE DEV, V24, P1876, DOI 10.1101/gad.1956010; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09999; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maldonado Jose F., 1947, PUERTO RICO JOUR PUBL HEALTH AND TROP MED, V22, P331; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109745; Negrao-Correa D, 2012, J Parasitol Res, V2012, P743920, DOI 10.1155/2012/743920; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; PAN CT, 1965, AM J TROP MED HYG, V14, P931, DOI 10.4269/ajtmh.1965.14.931; PAN CT, 1963, ANN NY ACAD SCI, V113, P475, DOI 10.1111/j.1749-6632.1963.tb40684.x; Paraense WL, 2001, MEM I OSWALDO CRUZ, V96, P7, DOI 10.1590/S0074-02762001000900002; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; PIMENTEL D, 1957, ECOLOGY, V38, P576, DOI 10.2307/1943122; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOSHINO TP, 1983, PARASITE IMMUNOL, V5, P317, DOI 10.1111/j.1365-3024.1983.tb00747.x; Coelho PMZ, 2008, ACTA TROP, V108, P245, DOI 10.1016/j.actatropica.2008.05.028; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.4, 10.1038/cr.2015.14]	99	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181483	10.1371/journal.pone.0181483	http://dx.doi.org/10.1371/journal.pone.0181483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719649	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400049
J	Tani, H; Okuda, S; Nakamura, K; Aoki, M; Umemura, T				Tani, Hidenori; Okuda, Sayaka; Nakamura, Kaoru; Aoki, Motohide; Umemura, Tomonari			Short-lived long non-coding RNAs as surrogate indicators for chemical exposure and LINC00152 and MALAT1 modulate their neighboring genes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; PROMOTES PROLIFERATION; EXPRESSION; TRANSCRIPTS; PATHWAY; DECAY; IDENTIFICATION; TRANSLATION	Whole transcriptome analyses have revealed a large number of novel long non-coding RNAs (lncRNAs). Although accumulating evidence demonstrates that lncRNAs play important roles in regulating gene expression, the detailed mechanisms of action of most lncRNAs remain unclear. We previously reported that a novel class of lncRNAs with a short half-life (t(1/2) < 4 h) in HeLa cells, termed short-lived non-coding transcripts (SLiTs), are closely associated with physiological and pathological functions. In this study, we focused on 26 SLiTs and nuclear-enriched abundant lncRNA, MALAT1(t(1/2) of 7.6 h in HeLa cells) in neural stem cells (NSCs) derived from human induced pluripotent stem cells, and identified four SLiTs (TUG1, GAS5, FAM222-AS1, and SNHG15) that were affected by the following typical chemical stresses (oxidative stress, heavy metal stress and protein synthesis stress). We also found the expression levels of LINC00152 (t(1/2) of 2.1 h in NSCs), MALAT1 (t(1/2) of 1.8 h in NSCs), and their neighboring genes were elevated proportionally to the chemical doses. Moreover, we confirmed that the overexpression of LINC00152 or MALAT1 upregulated the expressions of their neighboring genes even in the absence of chemical stress. These results reveal that LINC00152 and MALAT1 modulate their neighboring genes, and thus provide a deeper understanding of the functions of lncRNAs.	[Tani, Hidenori; Okuda, Sayaka; Nakamura, Kaoru] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, 16-1 Onogawa, Tsukuba, Ibaraki, Japan; [Okuda, Sayaka; Aoki, Motohide; Umemura, Tomonari] Tokyo Univ Pharm & Life Sci, Dept Mol Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Pharmacy & Life Sciences	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, 16-1 Onogawa, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp	Tani, Hidenori/F-2042-2010	Tani, Hidenori/0000-0001-6390-4136	JSPS [26810100]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B), grant number 26810100.; We thank Dr. Yuzuru Ito (AIST) and Dr. Yasuko Onuma (AIST) for their technical help, and Dr. Tetsuro Hirose (Hokkaido University) for providing the plasmid expressing MALAT1. The human iPSC line 201B7 was provided by the RIKEN BRC through the Project for Realization of Regenerative Medicine and the National Bio Resource Project of MEXT, Japan. This work was supported by a JSPS Grant-in-Aid for Young Scientists (B), grant number 26810100.	Abe K, 2012, BIOCHEM BIOPH RES CO, V428, P44, DOI 10.1016/j.bbrc.2012.09.144; Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; Hirose T, 2014, EMBO REP, V15, P489, DOI 10.1002/embr.201338390; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Ji J, 2015, ONCOTARGET, V6, P42813, DOI 10.18632/oncotarget.5970; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Li J, 2015, CELL PHYSIOL BIOCHEM, V37, P687, DOI 10.1159/000430387; Lin R, 2011, FEBS LETT, V585, P671, DOI 10.1016/j.febslet.2011.01.030; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Meola N, 2016, MOL CELL, V64, P520, DOI 10.1016/j.molcel.2016.09.025; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Pang QQ, 2014, TUMOR BIOL, V35, P5441, DOI 10.1007/s13277-014-1709-3; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tani H, 2016, J BIOSCI BIOENG, V122, P329, DOI 10.1016/j.jbiosc.2016.02.007; Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36045; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034; Zhou JP, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0250-6	36	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181628	10.1371/journal.pone.0181628	http://dx.doi.org/10.1371/journal.pone.0181628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719640	Green Submitted, gold, Green Published			2022-12-26	WOS:000406061400059
J	Ferreira, SJ; Senning, M; Fischer-Stettler, M; Streb, S; Ast, M; Neuhaus, HE; Zeeman, SC; Sonnewald, S; Sonnewald, U				Ferreira, Stephanus J.; Senning, Melanie; Fischer-Stettler, Michaela; Streb, Sebastian; Ast, Michelle; Neuhaus, H. Ekkehard; Zeeman, Samuel C.; Sonnewald, Sophia; Sonnewald, Uwe			Simultaneous silencing of isoamylases ISA1, ISA2 and ISA3 by multi-target RNAi in potato tubers leads to decreased starch content and an early sprouting phenotype	PLOS ONE			English	Article							DEBRANCHING ENZYMES; ARABIDOPSIS LACKING; GRANULE INITIATION; BRANCHING ENZYMES; CHAIN-LENGTH; PROTEIN; GROWTH; AMYLOPECTIN; BREAKDOWN; MUTANTS	Isoamylases hydrolyse (1-6)-alpha-D-glucosidic linkages in starch and are involved in both starch granule formation and starch degradation. In plants, three isoamylase isoforms with distinct functions in starch synthesis (ISA1 and ISA2) and degradation (ISA3) have been described. Here, we created transgenic potato plants with simultaneously decreased expression of all three isoamylases using a chimeric RNAi construct targeting all three isoforms. Constitutive expression of the hairpin RNA using the 35S CaMV promoter resulted in efficient silencing of all three isoforms in leaves, growing tubers, and sprouting tubers. Neither plant growth nor tuber yield was effected in isoamylase- deficient potato lines. Interestingly, starch metabolism was found to be impaired in a tissue- specific manner. While leaf starch content was unaffected, tuber starch was significantly reduced. The reduction in tuber starch content in the transgenic plants was accompanied by a decrease in starch granules size, an increased sucrose content and decreased hexose levels. Despite the effects on granule size, only little changes in chain length composition of soluble and insoluble glucose polymers were detected. The transgenic tubers displayed an early sprouting phenotype that was accompanied by an increased level of sucrose in parenchyma cells below the outgrowing bud. Since high sucrose levels promote sprouting, we propose that the increased number of small starch granules may cause an accelerated turnover of glucan chains and hence a more rapid synthesis of sucrose. This observation links alterations in starch structure/degradation with developmental processes like meristem activation and sprout outgrowth in potato tubers.	[Ferreira, Stephanus J.; Senning, Melanie; Sonnewald, Sophia; Sonnewald, Uwe] Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Erlangen, Germany; [Fischer-Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Zurich, Switzerland; [Ast, Michelle; Neuhaus, H. Ekkehard] Tech Univ Kaiserslautern, Dept Biol, Div Plant Physiol, Kaiserslautern, Germany; [Ferreira, Stephanus J.] Westcape Biotech Pty Ltd, Stellenbosch, South Africa	University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kaiserslautern	Sonnewald, U (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Erlangen, Germany.	uwe.sonnewald@fau.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Streb, Sebastian/0000-0002-9095-6596; Zeeman, Samuel/0000-0002-2791-0915	EU-SOL [FOOD-CT-2006-016214]; Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative [SO300/20-1, SO1002/3-1]	EU-SOL; Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative	The project was funded by EU-SOL (FOOD-CT-2006-016214 (https://www.eu-sol.wur.nl/about.jsp) and by grants from the Deutsche Forschungsgemeinschaft (DFG) within the ERA-CAPS initiative (https://www.eu-sol.wur.nl/about.jsp) to US and SSo (SO300/20-1 and SO1002/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, J BIOTECHNOL, V123, P137, DOI 10.1016/j.jbiotec.2005.11.001; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Hartmann A, 2011, PLANT PHYSIOL, V155, P776, DOI 10.1104/pp.110.168252; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Lu KJ, 2015, PLANT PHYSIOL, V169, P1638, DOI 10.1104/pp.15.00792; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; MULLERROBER B, 1992, EMBO J, V11, P1229, DOI 10.1002/j.1460-2075.1992.tb05167.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister B, 2016, CELL MOL LIFE SCI, V73, P2781, DOI 10.1007/s00018-016-2250-x; Pfister B, 2014, PLANT PHYSIOL, V165, P1457, DOI 10.1104/pp.114.241455; Rahman S, 2003, GENOME, V46, P496, DOI 10.1139/g02-130; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Sonnewald S, 2014, PLANTA, V239, P27, DOI 10.1007/s00425-013-1968-z; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Van Harsselaar JK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3381-z; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	37	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181444	10.1371/journal.pone.0181444	http://dx.doi.org/10.1371/journal.pone.0181444			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708852	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800058
J	Wagner, FH; Herault, B; Rossi, V; Hilker, T; Maeda, EE; Sanchez, A; Lyapustin, AI; Galvao, LS; Wang, YJ; Aragao, LEOC				Wagner, Fabien Hubert; Herault, Bruno; Rossi, Vivien; Hilker, Thomas; Maeda, Eduardo Eiji; Sanchez, Alber; Lyapustin, Alexei I.; Galvao, Lenio Soares; Wang, Yujie; Aragao, Luiz E. O. C.			Climate drivers of the Amazon forest greening	PLOS ONE			English	Article							TROPICAL DRY FOREST; SEASONAL-VARIATIONS; CANOPY STRUCTURE; WOOD PRODUCTION; RAIN-FOREST; LEAF; PHENOLOGY; DROUGHT; SENSITIVITY; GROWTH	Our limited understanding of the climate controls on tropical forest seasonality is one of the biggest sources of uncertainty in modeling climate change impacts on terrestrial ecosystems. Combining leaf production, litterfall and climate observations from satellite and ground data in the Amazon forest, we show that seasonal variation in leaf production is largely triggered by climate signals, specifically, insolation increase (70.4% of the total area) and precipitation increase (29.6%). Increase of insolation drives leaf growth in the absence of water limitation. For these non-water-limited forests, the simultaneous leaf flush occurs in a sufficient proportion of the trees to be observed from space. While tropical cycles are generally defined in terms of dry or wet season, we show that for a large part of Amazonia the increase in insolation triggers the visible progress of leaf growth, just like during spring in temperate forests. The dependence of leaf growth initiation on climate seasonality may result in a higher sensitivity of these ecosystems to changes in climate than previously thought.	[Wagner, Fabien Hubert; Galvao, Lenio Soares; Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Herault, Bruno] CIRAD, UMR Ecol Forets Guyane, F-97379 Kourou, France; [Rossi, Vivien] CIRAD, UR B&SEF Biens & Serv Ecosyst Forestiers Tropicau, BP 2572, Yaounde, Cameroon; [Hilker, Thomas] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Maeda, Eduardo Eiji] Univ Helsinki, Dept Environm Sci, FI-00014 Helsinki, Finland; [Sanchez, Alber] Natl Inst Space Res INPE, Earth Syst Sci Ctr, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Lyapustin, Alexei I.; Wang, Yujie] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England	Instituto Nacional de Pesquisas Espaciais (INPE); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; University of Southampton; University of Helsinki; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Exeter	Wagner, FH (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, BR-12227010 Sao Jose Dos Campos, SP, Brazil.	wagner.h.fabien@gmail.com	aragao, luiz eoc/G-8387-2012; Lyapustin, Alexei/H-9924-2014; Sanchez, Alber/AAQ-4055-2021; Hérault, Bruno/B-2765-2011; Wagner, Fabien FW/B-8364-2013; Maeda, Eduardo/E-7327-2011	aragao, luiz eoc/0000-0002-4134-6708; Lyapustin, Alexei/0000-0003-1105-5739; Sanchez, Alber/0000-0001-7966-2880; Hérault, Bruno/0000-0002-6950-7286; Wagner, Fabien FW/0000-0002-9623-1182; Maeda, Eduardo/0000-0001-7932-1824; Galvao, Lenio/0000-0002-8313-0497	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [processo 13/14520-6, processo 15/50484-0, processo 16/17652-9, processo 2016/03397-7]; FAPESP [50533-5]; CNPQ [304425/2013-3]; Academy of Finland [266393]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PVE 401025/2014-4]; NASA Program "Science from Terra and Aqua"	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Finland(Academy of Finland); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NASA Program "Science from Terra and Aqua"	This project and F.H.W. have been funded by the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 13/14520-6, processo 15/50484-0 and processo 16/17652-9). L.E.O.C.A. is thankful for the support of FAPESP (grant 50533-5) and CNPQ (grant 304425/2013-3). E.E.M. was funded by the Academy of Finland (project: 266393). A.S. has been funded by the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 2016/03397-7). T.H. was supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number PVE 401025/2014-4. The work of Dr. Lyapustin was funded by the NASA Program "Science from Terra and Aqua". The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064014; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Borchert R, 2015, NEW PHYTOL, V205, P7, DOI 10.1111/nph.12981; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Brazilian Institute of Geography and Statistics ( IBGE), 2004, MAPA DE VEGETACO DO; Caldararu S, 2014, BIOGEOSCIENCES, V11, P763, DOI 10.5194/bg-11-763-2014; Chavana-Bryant C, 2017, NEW PHYTOL, V214, P1049, DOI 10.1111/nph.13853; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Elliott S, 2006, GLOBAL ECOL BIOGEOGR, V15, P248, DOI 10.1111/j.1466-822x.2006.00213.x; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Free CM, 2014, FOREST ECOL MANAG, V330, P46, DOI 10.1016/j.foreco.2014.05.057; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Girardin CAJ, 2016, GLOBAL BIOGEOCHEM CY, V30, P700, DOI 10.1002/2015GB005270; Grogan J, 2012, BIOTROPICA, V44, P331, DOI 10.1111/j.1744-7429.2011.00825.x; Guan KY, 2015, NAT GEOSCI, V8, P284, DOI 10.1038/NGEO2382; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2008, AGR FOREST METEOROL, V148, P748, DOI 10.1016/j.agrformet.2008.01.012; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Jarvis A, 2008, HOLE FILLED SEAMLESS; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Lopes AP, 2016, REMOTE SENS ENVIRON, V182, P90, DOI 10.1016/j.rse.2016.05.009; Lyapustin AI, 2012, REMOTE SENS ENVIRON, V127, P385, DOI 10.1016/j.rse.2012.09.002; Maeda EE, 2016, INT J APPL EARTH OBS, V52, P42, DOI 10.1016/j.jag.2016.05.005; Marechaux I, 2015, FUNCT ECOL, V29, P1268, DOI 10.1111/1365-2435.12452; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morel H, 2015, DENDROMETER AND LITT, V29, P973; Morel H, 2015, TREES-STRUCT FUNCT, V29, P973, DOI 10.1007/s00468-015-1177-4; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; R. Core Team, 2015, R A LANGUAGE AND ENV; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; Rivera G, 2002, TREES-STRUCT FUNCT, V16, P445, DOI 10.1007/s00468-002-0185-3; Rowland L, 2014, OECOLOGIA, V174, P295, DOI 10.1007/s00442-013-2766-9; Saleska S.R, 2003, SITZBER HEIDELBER MN, V302, P1554; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Saleska SR, 2016, NATURE, V531, pE4, DOI 10.1038/nature16457; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Tang H, 2017, P NATL ACAD SCI USA, V114, P2640, DOI 10.1073/pnas.1616943114; Wagner F, 2013, BIOGEOSCIENCES, V10, P7307, DOI 10.5194/bg-10-7307-2013; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; WRIGHT SJ, 1990, ECOLOGY, V71, P1165, DOI 10.2307/1937384; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	59	44	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180932	10.1371/journal.pone.0180932	http://dx.doi.org/10.1371/journal.pone.0180932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708897	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800031
J	Chen, RJ; Gifford, DK				Chen, Rujian; Gifford, David K.			Differential chromatin profiles partially determine transcription factor binding	PLOS ONE			English	Article							IN-VIVO	We characterize how genomic variants that alter chromatin accessibility influence regulatory factor binding with a new method called DeltaBind that predicts condition specific factor binding more accurately than other methods based on DNase-seq data. Using DeltaBind and DNase-seq experiments we predicted the differential binding of 18 factors in K562 and GM12878 cells with an average precision of 28% at 10% recall, with the prediction of individual factors ranging from 5% to 65% precision. We further found that genome variants that alter chromatin accessibility are not necessarily predictive of altering proximal factor binding. Taken together these findings suggest that DNase-seq or ATAC-seq Quantitative Trait Loci (dsQTLs), while important, must be considered in a broader context to establish causality for phenotypic changes.	[Chen, Rujian; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institute of Health [U01HG007037]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health under grant U01HG007037 to D.G.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; MacQuarrie KL, 2013, MOL CELL BIOL, V33, P773, DOI 10.1128/MCB.00916-12; Mahony S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003501; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Teif VB, 2014, GENOME RES, V24, P1285, DOI 10.1101/gr.164418.113	11	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179411	10.1371/journal.pone.0179411	http://dx.doi.org/10.1371/journal.pone.0179411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704389	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700010
J	Gleason, RJ; Vora, M; Li, Y; Kane, NS; Liao, K; Padgett, RW				Gleason, Ryan J.; Vora, Mehul; Li, Ying; Kane, Nanci S.; Liao, Kelvin; Padgett, Richard W.			C-elegans SMA-10 regulates BMP receptor trafficking	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; TGF-BETA; I RECEPTOR; SIGNALING PATHWAY; TRANSGENIC LINES; FAMILY; GENOME; LRIG1; UBIQUITINATION; ACTIVATION	Signal transduction of the conserved transforming growth factor-beta(TGF beta) family signaling pathway functions through two distinct serine/ threonine transmembrane receptors, the type I and type II receptors. Endocytosis orchestrates the assembly of signaling complexes by coordinating the entry of receptors with their downstream signaling mediators. Recently, we showed that the C. elegans type I bone morphogenetic protein (BMP) receptor SMA-6, part of the TGF beta family, is recycled through the retromer complex while the type II receptor, DAF-4 is recycled in a retromer-independent, ARF-6 dependent manner. From genetic screens in C. elegans aimed at identifying new modifiers of BMP signaling, we reported on SMA-10, a conserved LRIG (leucine-rich and immunoglobulin-like domains) transmembrane protein. It is a positive regulator of BMP signaling that binds to the SMA-6 receptor. Here we show that the loss of sma-10 leads to aberrant endocytic trafficking of SMA-6, resulting in its accumulation in distinct intracellular endosomes including the early endosome, multivesicular bodies (MVB), and the late endosome with a reduction in signaling strength. Our studies show that trafficking defects caused by the loss of sma-10 are not universal, but affect only a limited set of receptors. Likewise, in Drosophila, we find that the fly homolog of sma-10, lambik (lbk), reduces signaling strength of the BMP pathway, consistent with its function in C. elegans and suggesting evolutionary conservation of function. Loss of sma-10 results in reduced ubiquitination of the type I receptor SMA-6, suggesting a possible mechanism for its regulation of BMP signaling.	[Gleason, Ryan J.; Vora, Mehul; Li, Ying; Kane, Nanci S.; Liao, Kelvin; Padgett, Richard W.] Rutgers State Univ, Canc Inst New Jersey, Dept Mol Biol & Biochem, Waksman Inst, Piscataway, NJ 08854 USA; [Gleason, Ryan J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Li, Ying] Chongqing Med Univ, Life Sci Inst, Chongqing, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Johns Hopkins University; Chongqing Medical University	Padgett, RW (corresponding author), Rutgers State Univ, Canc Inst New Jersey, Dept Mol Biol & Biochem, Waksman Inst, Piscataway, NJ 08854 USA.	padgett@waksman.rutgers.edu	Vora, Mehul/P-4848-2016	Vora, Mehul/0000-0002-1239-6458; Padgett, Richard/0000-0002-5740-3324	 [GM103995]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by GM103995 (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; BRENNER S, 1974, GENETICS, V77, P71; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cendrowski J, 2016, CYTOKINE GROWTH F R, V32, P63, DOI 10.1016/j.cytogfr.2016.07.002; Chen CL, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0229-4; de Leon N, 2016, CURR GENET, V62, P765, DOI 10.1007/s00294-016-0605-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Elderbroom JL, 2014, MOL BIOL CELL, V25, P2320, DOI 10.1091/mbc.E13-09-0524; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gleason RJ, 2014, P NATL ACAD SCI US; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gudey SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004207; Gumienny TL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000963; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gupta Bhagwati P, 2012, WormBook, P1, DOI 10.1895/wormbook.1.152.1; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Heldin C. H., 2016, COLD SPRING HARB PER, V8; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herhaus L, 2014, CELL SIGNAL, V26, P2186, DOI 10.1016/j.cellsig.2014.06.012; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Liu ZY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005221; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McLean S, 2010, BIOCHEM J, V429, P137, DOI 10.1042/BJ20091598; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; O'Brien CE, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0065-0; Padgett RW, 1999, CANCER METAST REV, V18, P247, DOI 10.1023/A:1006325408261; Padgett RW, 2008, TGFBETA SIGNALING NE, P527; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Praitis V, 2001, GENETICS, V157, P1217; Praitis Vida, 2006, V351, P93; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sato Ken, 2014, WormBook, P1, DOI 10.1895/wormbook.1.77.2; Savage-Dunn C, 2017, COLD SPRING HARB PER; Savage-Dunn C., 2005, TGF BETA SIGNALING; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; Schweinsberg Peter J, 2013, WormBook, P1, DOI 10.1895/wormbook.1.166.1; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Simion C, 2014, ENDOCR-RELAT CANCER, V21, pR431, DOI 10.1530/ERC-14-0179; Skorobogata O, 2016, MOL BIOL CELL; Skorobogata O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036489; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tian CX, 2010, DEVELOPMENT, V137, P2375, DOI 10.1242/dev.051615; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Upadhyay A, 2017, COLD SPRING HARB PER; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Wang L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006568; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xu P, 2016, COLD SPRING HARB PER; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Zhang Jing, 2012, Cell Logist, V2, P161	78	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180681	10.1371/journal.pone.0180681	http://dx.doi.org/10.1371/journal.pone.0180681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704415	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700046
J	Paulone, S; Ardizzoni, A; Tavanti, A; Piccinelli, S; Rizzato, C; Lupetti, A; Colombari, B; Pericolini, E; Polonelli, L; Magliani, W; Conti, S; Posteraro, B; Cermelli, C; Blasi, E; Peppoloni, S				Paulone, Simona; Ardizzoni, Andrea; Tavanti, Arianna; Piccinelli, Serena; Rizzato, Cosmeri; Lupetti, Antonella; Colombari, Bruna; Pericolini, Eva; Polonelli, Luciano; Magliani, Walter; Conti, Stefania; Posteraro, Brunella; Cermelli, Claudio; Blasi, Elisabetta; Peppoloni, Samuele			The synthetic killer peptide KP impairs Candida albicans biofilm in vitro	PLOS ONE			English	Article							ANTIFUNGAL SUSCEPTIBILITY; AMPHOTERICIN-B; RESISTANCE; FUNGAL; INFECTIONS; MECHANISMS	Candida albicans is a commensal organism, commonly inhabiting mucosal surfaces of healthy individuals, as a part of the resident microbiota. However, in susceptible hosts, especially hospitalized and/or immunocompromised patients, it may cause a wide range of infections. The presence of abiotic substrates, such as central venous or urinary catheters, provides an additional niche for Candida attachment and persistence, particularly via biofilm development. Furthermore, Candida biofilm is poorly susceptible to most antifungals, including azoles. Here we investigated the effects of a synthetic killer peptide (KP), known to be active in vitro, ex vivo and/or in vivo against different pathogens, on C. albicans biofilm. Together with a scrambled peptide used as a negative control, KP was tested against Candida biofilm at different stages of development. A reference strain, two fluconazole-resistant and two fluconazole-susceptible C. albicans clinical isolates were used. KP-induced C. albicans oxidative stress response and membrane permeability were also analysed. Moreover, the effect of KP on transcriptional profiles of C. albicans genes involved in different stages of biofilm development, such as cell adhesion, hyphal development and extracellular matrix production, was evaluated. Our results clearly show that the treatment with KP strongly affected the capacity of C. albicans to form biofilm and significantly impairs preformed mature biofilm. KP treatment resulted in an increase in C. albicans oxidative stress response and membrane permeability; also, biofilm-related genes expression was significantly reduced. Comparable inhibitory effects were observed in all the strains employed, irrespective of their resistance or susceptibility to fluconazole. Finally, KP-mediated inhibitory effects were observed also against a catheter-associated C. albicans biofilm. This study provides the first evidence on the KP effectiveness against C. albicans biofilm, suggesting that KP may be considered as a potential novel tool for treatment and prevention of biofilm-related C. albicans infections.	[Paulone, Simona; Ardizzoni, Andrea; Piccinelli, Serena; Colombari, Bruna; Pericolini, Eva; Cermelli, Claudio; Blasi, Elisabetta; Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Tavanti, Arianna] Univ Pisa, Dept Biol, Pisa, Italy; [Rizzato, Cosmeri; Lupetti, Antonella] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Polonelli, Luciano; Magliani, Walter; Conti, Stefania] Univ Parma, Dept Med & Surg, Parma, Italy; [Posteraro, Brunella] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Publ Hlth, Rome, Italy	Universita di Modena e Reggio Emilia; University of Pisa; University of Pisa; University of Parma; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Blasi, E (corresponding author), Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy.	elisabetta.blasi@unimore.it	Rizzato, Cosmeri/AAI-1261-2020; Posteraro, Brunella/K-8499-2018; Pericolini, Eva/AAZ-5848-2021; ardizzoni, andrea/AAC-4337-2021; Blasi, Elisabetta/F-5870-2015; Cermelli, Claudio/L-1501-2016; Conti, Stefania/N-3558-2015; Ardizzoni, Andrea/G-2976-2015	Posteraro, Brunella/0000-0002-1663-7546; ardizzoni, andrea/0000-0003-2678-0714; Blasi, Elisabetta/0000-0002-4202-8293; Cermelli, Claudio/0000-0003-3396-0000; Conti, Stefania/0000-0001-9973-8352; Ardizzoni, Andrea/0000-0001-9845-7399; Tavanti, Arianna/0000-0001-5791-686X; Pericolini, Eva/0000-0002-5299-8197				Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414; Mesa-Arango AC, 2014, ANTIMICROB AGENTS CH, V58, P6627, DOI 10.1128/AAC.03570-14; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; De Brucker K, 2014, ANTIMICROB AGENTS CH, V58, P5395, DOI 10.1128/AAC.03045-14; Delattin N, 2017, CURR TOP MED CHEM, V17, P604, DOI 10.2174/1568026616666160713142228; Deorukhkar SC, 2016, INTERDISCIPLINARY PE, V2016, P5; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Gulati M, 2016, MICROBES INFECT, V18, P310, DOI 10.1016/j.micinf.2016.01.002; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Hirota K, 2017, J APPL MICROBIOL, V122, P321, DOI 10.1111/jam.13330; Hua J, 2010, MOL ORAL MICROBIOL, V25, P418, DOI 10.1111/j.2041-1014.2010.00590.x; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kucharikova S, 2015, JOVE-J VIS EXP, DOI 10.3791/52239; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lupetti A, 2002, ANTIMICROB AGENTS CH, V46, P1634, DOI 10.1128/AAC.46.6.1634-1639.2002; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Magliani W, 2011, FUTURE MED CHEM, V3, P1209, DOI [10.4155/fmc.11.71, 10.4155/FMC.11.71]; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Mazaheritehrani E, 2014, VIRUS RES, V179, P153, DOI 10.1016/j.virusres.2013.10.018; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Moreno MG, 2017, CURR TOP MED CHEM; Morici P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167470; Niimi K, 2010, J ANTIMICROB CHEMOTH, V65, P842, DOI 10.1093/jac/dkq073; Pierce Christopher G, 2010, J Vis Exp, DOI 10.3791/2287; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35018; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramirez-Zavala B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003696; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2016, ANTIMICROB AGENTS CH, V60, P229, DOI 10.1128/AAC.02157-15; Scorzoni L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00036; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Vriens K, 2016, PEPTIDES, V75, P71, DOI 10.1016/j.peptides.2015.11.001; Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117; Zhao L-P, 2013, PLOS ONE, V8	47	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181278	10.1371/journal.pone.0181278	http://dx.doi.org/10.1371/journal.pone.0181278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704490	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700118
J	Rosenberg, M; Steele, KM				Rosenberg, Michael; Steele, Katherine M.			Simulated impacts of ankle foot orthoses on muscle demand and recruitment in typically-developing children and children with cerebral palsy and crouch gait	PLOS ONE			English	Article							SINGLE-LIMB STANCE; FLEXED-KNEE STANCE; HUMAN WALKING; ENERGY-COST; AUTONOMOUS EXOSKELETON; DYNAMIC SIMULATIONS; LOWER-EXTREMITY; METABOLIC COST; FORCE; MODEL	Passive ankle foot orthoses (AFOs) are often prescribed for children with cerebral palsy (CP) to assist locomotion, but predicting how specific device designs will impact energetic demand during gait remains challenging. Powered AFOs have been shown to reduce energy costs of walking in unimpaired adults more than passive AFOs, but have not been tested in children with CP. The goal of this study was to investigate the potential impact of powered and passive AFOs on muscle demand and recruitment in children with CP and crouch gait. We simulated gait for nine children with crouch gait and three typically-developing children with powered and passive AFOs. For each AFO design, we computed reductions in muscle demand compared to unassisted gait. Powered AFOs reduced muscle demand 15-44% compared to unassisted walking, 1-14% more than passive AFOs. A slower walking speed was associated with smaller reductions in absolute muscle demand for all AFOs (r(2) = 0.60-0.70). However, reductions in muscle demand were only moderately correlated with crouch severity (r(2) = 0.40-0.43). The ankle plantarflexor muscles were most heavily impacted by the AFOs, with gastrocnemius recruitment decreasing 13-73% and correlating with increasing knee flexor moments (r(2) = 0.29-0.91). These findings support the potential use of powered AFOs for children with crouch gait, and highlight how subject-specific kinematics and kinetics may influence muscle demand and recruitment to inform AFO design.	[Rosenberg, Michael; Steele, Katherine M.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rosenberg, M (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	mcrosenb@uw.edu	Steele, Katherine/GYE-0887-2022; Rosenberg, Michael/AAD-6682-2020	Steele, Katherine/0000-0002-4128-9387; 	National Science Foundation [CBET-1452646]; Institute for Translational Health Sciences, National Institutes of Health - National Center for Advancing Translational Sciences [TL1TR000422]; Directorate For Engineering [1452646] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Translational Health Sciences, National Institutes of Health - National Center for Advancing Translational Sciences; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding was provided to KMS by the National Science Foundation (https://www.nsf.gov/) grant CBET-1452646 and to MR by the Institute for Translational Health Sciences (https://www.iths.org/) as part of National Institutes of Health - National Center for Advancing Translational Sciences (https://ncats.nih.gov/) grant number TL1TR000422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Arnold AS, 2006, J BIOMECH, V39, P1498, DOI 10.1016/j.jbiomech.2005.03.026; Arnold EM, 2013, J EXP BIOL, V216, P2150, DOI 10.1242/jeb.075697; Bregman DJJ, 2009, GAIT POSTURE, V30, P144, DOI 10.1016/j.gaitpost.2009.05.012; Brehm MA, 2008, J REHABIL MED, V40, P529, DOI 10.2340/16501977-0209; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Fowler EG, 2010, DEV MED CHILD NEUROL, V52, P264, DOI 10.1111/j.1469-8749.2009.03586.x; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Harlaar J, 2010, PROSTHET ORTHOT INT, V34, P327, DOI 10.3109/03093646.2010.504977; HARRINGTON ED, 1983, ORTHOTICS PROSTHET, V37, P34; Hegarty AK, 2016, J BIOMECHANICAL ENG; Hicks J, 2006, GAIT POSTURE, V24, pS99; Hicks JL, 2008, J BIOMECH, V41, P960, DOI 10.1016/j.jbiomech.2008.01.002; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Hoang HX, 2012, GAIT POSTURE, V36, P405, DOI 10.1016/j.gaitpost.2012.03.020; HOF AL, 1996, GAIT POSTURE, V4, P222; HSU AT, 1993, CLIN ORTHOP RELAT R, P254; Kerkum YL, 2016, GAIT POSTURE, V46, P104, DOI 10.1016/j.gaitpost.2016.03.001; Kerkum YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142878; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Maltais D, 2001, MED SCI SPORT EXER, V33, P320; Meyns P, 2017, FRONT HUM NEUROSCI, P11; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; PERRY J, 1975, J BONE JOINT SURG AM, V57, P961, DOI 10.2106/00004623-197557070-00014; Ries AJ, 2015, PM&R, V7, P922, DOI 10.1016/j.pmrj.2015.03.005; Ries AJ, 2014, GAIT POSTURE, V40, P539, DOI 10.1016/j.gaitpost.2014.06.011; ROSE J, 1989, J PEDIATR ORTHOPED, V9, P276; Royer TD, 2005, MED SCI SPORT EXER, V37, P649, DOI 10.1249/01.MSS.0000159007.56083.96; Sawicki GS, 2016, IEEE T BIO-MED ENG, V63, P914, DOI 10.1109/TBME.2015.2491224; Schwartz MH, 2004, J PEDIATR ORTHOPED, V24, P45, DOI 10.1097/01241398-200401000-00009; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Steele KM, 2013, GAIT POSTURE, V38, P86, DOI 10.1016/j.gaitpost.2012.10.019; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Summa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151792; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; TURNER DL, 1991, J EXP BIOL, V160, P309; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018; Wren TAL, 2015, PEDIATR PHYS THER, V27, P218, DOI 10.1097/PEP.0000000000000153	54	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180219	10.1371/journal.pone.0180219	http://dx.doi.org/10.1371/journal.pone.0180219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704464	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700032
J	Vassiliou, VS; Flynn, PD; Raphael, CE; Newsome, S; Khan, T; Ali, A; Halliday, B; Bruengger, AS; Malley, T; Sharma, P; Selvendran, S; Aggarwal, N; Sri, A; Berry, H; Donovan, J; Lam, W; Auger, D; Cook, SA; Pennell, DJ; Prasad, SK				Vassiliou, Vassilios S.; Flynn, Paul D.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Berry, Helen; Donovan, Jackie; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.			Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance	PLOS ONE			English	Article							MYOCARDIAL FIBROSIS; VALVE STENOSIS; ELEVATED LIPOPROTEIN(A); PROGNOSTIC-SIGNIFICANCE; RAISED LIPOPROTEIN(A); PLASMINOGEN-ACTIVATOR; REFRACTORY ANGINA; MIDWALL FIBROSIS; DISEASE; CARDIOMYOPATHY	Background Aortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patients with aortic stenosis. Although mechanistic pathways could link Lipoprotein(a) with myocardial fibrosis, whether the two are related has not been previously explored. In this study, we investigated whether elevated Lipoprotein(a) was associated with the presence of myocardial replacement fibrosis. Methods A total of 110 patients with mild, moderate and severe aortic stenosis were assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance to identify fibrosis. Mann Whitney U tests were used to assess for evidence of an association between Lp(a) and the presence or absence of myocardial fibrosis and aortic stenosis severity and compared to controls. Univariable and multivariable linear regression analysis were undertaken to identify possible predictors of Lp(a). Results Thirty-six patients (32.7%) had no LGE enhancement, 38 (34.6%) had midwall enhancement suggestive of midwall fibrosis and 36 (32.7%) patients had subendocardial myocardial fibrosis, typical of infarction. The aortic stenosis patients had higher Lp(a) values than controls, however, there was no significant difference between the Lp(a) level in mild, moderate or severe aortic stenosis. No association was observed between midwall or infarction pattern fibrosis and Lipoprotein(a), in the mild/moderate stenosis (p = 0.91) or severe stenosis patients (p = 0.42). Conclusion There is no evidence to suggest that higher Lipoprotein(a) leads to increased myocardial midwall or infarction pattern fibrosis in patients with aortic stenosis.	[Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, CMR Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, NIHR Biomed Res Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Harefield Hosp, NIHR Biomed Res Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Imperial Coll London, London, England; [Vassiliou, Vassilios S.] Univ East Anglia, Norwich Med Sch, Bob Champion Res & Educ Bldg, Norwich, Norfolk, England; [Flynn, Paul D.] UK & Univ Cambridge, Cambridge Univ Fdn NHS Trust, Addenbrookes Hosp, Lipid Clin, Cambridge, England; [Newsome, Simon] London Sch Hyg & Trop Med, Dept Stat, London, England; [Bruengger, Annina Studer] Stadtspital Triemli, Clin Cardiol, Zurich, Switzerland; [Berry, Helen; Donovan, Jackie] Royal Brompton & Harefield NHS Trust, Dept Biochem, London, England; [Cook, Stuart A.] Duke Natl Univ Hosp, Singapore, Singapore; [Cook, Stuart A.] Imperial Coll London, MRC London Inst Med Sci, Cardiovasc Magnet Resonance Imaging & Genet, Hammersmith Hosp Campus, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; University of East Anglia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Triemli Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Vassiliou, VS (corresponding author), Royal Brompton Hosp, CMR Unit, London, England.; Vassiliou, VS (corresponding author), Royal Brompton Hosp, NIHR Biomed Res Unit, London, England.; Vassiliou, VS (corresponding author), Harefield Hosp, NIHR Biomed Res Unit, London, England.; Vassiliou, VS (corresponding author), Imperial Coll London, London, England.; Vassiliou, VS (corresponding author), Univ East Anglia, Norwich Med Sch, Bob Champion Res & Educ Bldg, Norwich, Norfolk, England.	v.vassiliou@rbht.nhs.uk; b.halliday@rbht.nhs.uk	Halliday, Brian/R-5634-2019; Vassiliou, Vass/AAZ-7358-2020; Auger, Dominique/AAG-3819-2020	Vassiliou, Vass/0000-0002-4005-7752; Halliday, Brian/0000-0002-5876-1748; Pennell, Dudley/0000-0001-5523-1314	Rosetrees Charity Trust, London, UK; NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK; British Heart Foundation Clinical Research Training fellowship [FS/14/13/30619, FS/15/29/31492]; Medical Research Council, UK; MRC [MR/M003191/1, MC_U120085815] Funding Source: UKRI; British Heart Foundation [FS/15/29/31492, FS/14/13/30619] Funding Source: researchfish; Medical Research Council [MC_U120085815, MR/M003191/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10089] Funding Source: researchfish; Rosetrees Trust [M189-F1] Funding Source: researchfish	Rosetrees Charity Trust, London, UK; NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK; British Heart Foundation Clinical Research Training fellowship; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	The authors would like to acknowledge financial support from Rosetrees Charity Trust (VSV, SKP), London, UK, and the NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK (TK, DJP, SKP). CR and BH were supported by a British Heart Foundation Clinical Research Training fellowship (FS/14/13/30619 and FS/15/29/31492). SAC was supported by the Medical Research Council, UK.	Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P369, DOI 10.1016/0009-3084(94)90159-7; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Barone-Rochette G, 2014, J AM COLL CARDIOL, V64, P144, DOI 10.1016/j.jacc.2014.02.612; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Bouchareb R, 2015, CIRCULATION, V132, P677, DOI 10.1161/CIRCULATIONAHA.115.016757; BROWN MS, 1987, NATURE, V330, P113, DOI 10.1038/330113a0; Capoulade R, 2015, J AM COLL CARDIOL, V66, P1236, DOI 10.1016/j.jacc.2015.07.020; Chin CW, 2014, EXPERT REV CARDIOVAS, V12, P901, DOI 10.1586/14779072.2014.923307; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Dube JB, 2012, CURR OPIN LIPIDOL, V23, P133, DOI 10.1097/MOL.0b013e32835111d8; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hung MY, 2014, CURR OPIN LIPIDOL, V25, P423, DOI 10.1097/MOL.0000000000000131; Kamstrup PR, 2014, J AM COLL CARDIOL, V63, P470, DOI 10.1016/j.jacc.2013.09.038; Khan TZ, 2017, EUR HEART J, V38, P1561, DOI 10.1093/eurheartj/ehx178; Khan TZ, 2015, ATHEROSCLEROSIS SUPP, V18, P103, DOI 10.1016/j.atherosclerosissup.2015.02.019; Kostner KM, 2013, EUR HEART J, V34, P3268, DOI 10.1093/eurheartj/eht053; Kotar K, 2015, EARLY AORTIC VALVE L; Lee SP, 2015, RADIOLOGY, V274, P359, DOI 10.1148/radiol.14141120; Lippi G, 2012, J CLIN PHARM THER, V37, P1, DOI 10.1111/j.1365-2710.2011.01244.x; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Nordestgaard BG, 2015, J AM COLL CARDIOL, V66, P1247, DOI 10.1016/j.jacc.2015.07.045; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sabatine MS, 2015, NEW ENGL J MED, V372; SIMON DI, 1991, BIOCHEMISTRY-US, V30, P6671, DOI 10.1021/bi00241a006; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Vassiliou V, 2017, MAGMA IN PRESS; Vassiliou VS, 2017, J AM COLL CARDIOL, V69, P1755, DOI 10.1016/j.jacc.2017.01.034; Vassiliou VS, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0275-9; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181077	10.1371/journal.pone.0181077	http://dx.doi.org/10.1371/journal.pone.0181077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704465	Green Accepted, Green Published, gold			2022-12-26	WOS:000405649700089
J	Wang, J; Fan, H; Xiong, KC; Liu, YH				Wang, Jia; Fan, Huan; Xiong, Ke-Cai; Liu, Ying-Hong			Transcriptomic and metabolomic profiles of Chinese citrus fly, Bactrocera minax (Diptera: Tephritidae), along with pupal development provide insight into diapause program	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; INSECT DIAPAUSE; GENE-EXPRESSION; SARCOPHAGA-CRASSIPALPIS; COLD-HARDINESS; GC-MS; TREHALOSE; STRESS; TERMINATION; CALCIUM	The Chinese citrus fly, Bactrocera minax (Enderlein), is a devastating citrus pest in Asia. This univoltine insect enters obligatory pupal diapause in each generation, while little is known about the course and the molecular mechanisms of diapause. In this study, the course of diapause was determined by measuring the respiratory rate throughout the pupal stage. In addition, the variation of transcriptomic and metabolomic profiles of pupae at five developmental stages (pre-, early-, middle-, late-, and post-diapause) were evaluated by next-generation sequencing technology and H-1 nuclear magnetic resonance spectroscopy (NMR), respectively. A total of 4,808 genes were significantly altered in ten pairwise comparisons, representing major shifts in metabolism and signal transduction as well as endocrine system and digestive system. Gene expression profiles were validated by qRT-PCR analysis. In addition, 48 metabolites were identified and quantified by H-1 NMR. Nine of which significantly contributed to the variation in the metabolomic profiles, especially proline and trehalose. Moreover, the samples collected within diapause maintenance (early-, middle-, and late- diapause) only exhibited marginal transcriptomic and metabolomic variation with each other. These findings greatly improve our understanding of B. minax diapause and lay the foundation for further pertinent studies.	[Wang, Jia; Fan, Huan; Xiong, Ke-Cai; Liu, Ying-Hong] Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China	Southwest University - China	Wang, J (corresponding author), Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China.	aimarjia@126.com	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022	Wang, Jia/0000-0002-5803-5113	National Natural Science Foundation of China [31401742]; China Postdoctoral Science Foundation [2014M552307]; Chongqing Research program of Basic Research and Frontier Technology [cstc2016jcyjA0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Research program of Basic Research and Frontier Technology	This study was financially supported by the National Natural Science Foundation of China (31401742), the China Postdoctoral Science Foundation (2014M552307), and the Chongqing Research program of Basic Research and Frontier Technology (cstc2016jcyjA0203). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bi ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090435; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Bround MJ, 2013, J BIOL CHEM, V288, P18975, DOI 10.1074/jbc.M112.427062; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen EH, 2012, FLA ENTOMOL, V95, P593, DOI 10.1653/024.095.0309; CHURCHILL TA, 1989, J INSECT PHYSIOL, V35, P579, DOI 10.1016/0022-1910(89)90147-9; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Dong YC, 2014, J PEST SCI, V87, P647, DOI 10.1007/s10340-014-0605-3; Dong YC, 2014, INT J BIOL SCI, V10, P1051, DOI 10.7150/ijbs.9438; Dorji C, 2006, B ENTOMOL RES, V96, P531, DOI 10.1079/BER2006455; Drew RAI, 2006, J ECON ENTOMOL, V99, P1651, DOI 10.1603/0022-0493-99.5.1651; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Farag MA, 2012, PHYTOCHEMISTRY, V76, P60, DOI 10.1016/j.phytochem.2011.12.010; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gao Li-zhi, 2013, Scientia Agricultura Sinica, V46, P3285; Guo Q, 2015, GENE, V565, P106, DOI 10.1016/j.gene.2015.03.070; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Han P, 2011, J PEST SCI, V84, P289, DOI 10.1007/s10340-011-0363-4; Hounoum BM, 2015, ANAL BIOANAL CHEM, V407, P8861, DOI 10.1007/s00216-015-9047-x; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020; Kankofer M, 2001, PLACENTA, V22, P466, DOI 10.1053/plac.2001.0650; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Li YP, 2001, J INSECT PHYSIOL, V47, P1181, DOI 10.1016/S0022-1910(01)00099-3; Lu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099948; Lv J.X., 2010, J HUAZHONG AGR U SOC, V6, P46; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ragland GJ, 2011, J EXP BIOL, V214, P3948, DOI 10.1242/jeb.061085; Ragland GJ, 2009, J INSECT PHYSIOL, V55, P344, DOI 10.1016/j.jinsphys.2008.12.013; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santulli G, 2015, CURR MOL PHARMACOL, V8, P206, DOI 10.2174/1874467208666150507105105; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Tredwell GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016286; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157656; Wang Jia, 2014, Acta Entomologica Sinica, V57, P1375; Wang J, 2014, J ECON ENTOMOL, V107, P1519, DOI 10.1603/EC13539; Wang J, 2014, ARCH INSECT BIOCHEM, V85, P216, DOI 10.1002/arch.21155; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100558; Zhang Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-751; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d; Zhang Y., 2005, B AGR SCI TECH, V2, P22	75	12	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181033	10.1371/journal.pone.0181033	http://dx.doi.org/10.1371/journal.pone.0181033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704500	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600054
J	Yoshida, K; Shimizu, Y; Yoshimoto, J; Takamura, M; Okada, G; Okamoto, Y; Yamawaki, S; Doya, K				Yoshida, Kosuke; Shimizu, Yu; Yoshimoto, Junichiro; Takamura, Masahiro; Okada, Go; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Prediction of clinical depression scores and detection of changes in whole-brain using resting-state functional MRI data with partial least squares regression	PLOS ONE			English	Article							MAJOR DEPRESSION; REGIONAL HOMOGENEITY; HEAD MOTION; CONNECTIVITY; METAANALYSIS; CEREBELLUM; ACTIVATION; DISORDER; PATTERN; ENDOPHENOTYPES	In diagnostic applications of statistical machine learning methods to brain imaging data, common problems include data high-dimensionality and co-linearity, which often cause over-fitting and instability. To overcome these problems, we applied partial least squares (PLS) regression to resting-state functional magnetic resonance imaging (rs-fMRI) data, creating a low-dimensional representation that relates symptoms to brain activity and that predicts clinical measures. Our experimental results, based upon data from clinically depressed patients and healthy controls, demonstrated that PLS and its kernel variants provided significantly better prediction of clinical measures than ordinary linear regression. Subsequent classification using predicted clinical scores distinguished depressed patients from healthy controls with 80% accuracy. Moreover, loading vectors for latent variables enabled us to identify brain regions relevant to depression, including the default mode network, the right superior frontal gyrus, and the superior motor area.	[Yoshida, Kosuke] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Yoshida, Kosuke; Doya, Kenji] Okinawa Inst Sci & Technol Grad Univ, Neural Computat Unit, Onna, Okinawa, Japan; [Shimizu, Yu] Okinawa Inst Sci & Technol Grad Univ, Integrated Open Syst Unit, Onna, Okinawa, Japan; [Yoshimoto, Junichiro] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara, Japan; [Takamura, Masahiro; Okada, Go; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University; Nara Institute of Science & Technology; Hiroshima University	Yoshida, K (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.; Yoshida, K (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Neural Computat Unit, Onna, Okinawa, Japan.	kosuke.yoshida@oist.jp; yamawaki@hiroshima-u.ac.jp	Takamura, Masahiro/AEJ-6059-2022; Yoshimoto, Junichiro/B-5884-2015; Yoshimoto, Junichiro/ABI-8028-2020	Takamura, Masahiro/0000-0001-9742-152X; Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimoto, Junichiro/0000-0001-7995-0321	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This research is supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED (http://www.amed.go.jp/en). All authors of this study are supported by this program. This program does not have a grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Chen KW, 2009, NEUROIMAGE, V47, P602, DOI 10.1016/j.neuroimage.2009.04.053; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Embrechts M.J., 2003, NATO SCI SER SUBSER, V190, P227; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Giessing C, 2007, J COGNITIVE NEUROSCI, V19, P658, DOI 10.1162/jocn.2007.19.4.658; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haldane M, 2008, J PSYCHOPHARMACOLOGY; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Iwabuchi SJ, 2015, NEUROSCI BIOBEHAV R, V51, P77, DOI 10.1016/j.neubiorev.2015.01.006; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Katona CLE, 1995, REV CLIN GERONTOLOGY, V5, P427, DOI DOI 10.1017/S095925980000486X; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; MANNE R, 1987, CHEMOMETR INTELL LAB, V2, P187, DOI 10.1016/0169-7439(87)80096-5; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nestor PG, 2002, SCHIZOPHR RES, V53, P57, DOI 10.1016/S0920-9964(00)00171-7; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price JC, 2004, IEEE NUCL SCI CONF R, P3161; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Rosipal R, 2002, J MACH LEARN RES, V2, P97, DOI 10.1162/15324430260185556; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Shimizu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123524; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wold H., 1975, PERSPECTIVES PROBABI, P520; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yahata N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11254; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yoshida K, 2015, IEEE INT C BIOINFORM, P1078, DOI 10.1109/BIBM.2015.7359831; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	51	34	34	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179638	10.1371/journal.pone.0179638	http://dx.doi.org/10.1371/journal.pone.0179638			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700672	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600010
J	Naumann, P; Liermann, J; Fortunato, F; Schmid, TE; Weber, KJ; Debus, J; Combs, SE				Naumann, Patrick; Liermann, Jakob; Fortunato, Franco; Schmid, Thomas E.; Weber, Klaus-Josef; Debus, Juergen; Combs, Stephanie E.			Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; OXIDATIVE STRESS; NEOADJUVANT CHEMORADIATION; GAMMA-H2AX; ARREST; CHEMOTHERAPY; RADIATION; APOPTOSIS; PATHWAYS; PHASE	Background Sulforaphane (SFN), an herbal isothiocyanate enriched in cruciferous vegetables like broccoli and cauliflower, has gained popularity for its antitumor effects in cell lines such as pancreatic cancer. Antiproliferative as well as radiosensitizing properties were reported for head and neck cancer but little is known about its effects in pancreatic cancer cells in combination with irradiation (RT). Methods In four established pancreatic cancer cell lines we investigated clonogenic survival, analyzed cell cycle distribution and compared DNA damage via flow cytometry and western blot after treatment with SFN and RT. Results Both SFN and RT show a strong and dose dependent survival reduction in clonogenic assays, an induction of a G2/M cell cycle arrest and an increase in.H2AX protein level indicating DNA damage. Effects were more pronounced in combined treatment and both cell cycle perturbation and DNA damage persisted for a longer period than after SFN or RT alone. Moreover, SFN induced a loss of DNA repair proteins Ku 70, Ku 80 and XRCC4. Conclusion Our results suggest that combination of SFN and RT exerts a more distinct DNA damage and growth inhibition than each treatment alone. SFN seems to be a viable option to improve treatment efficacy of chemoradiation with hopefully higher rates of secondary resectability after neoadjuvant treatment for pancreatic cancer.	[Naumann, Patrick; Liermann, Jakob; Weber, Klaus-Josef; Debus, Juergen] Univ Clin Heidelberg, Dept Radiat Oncol, Heidelberg, Germany; [Fortunato, Franco] Univ Clin Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Schmid, Thomas E.; Combs, Stephanie E.] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany; [Combs, Stephanie E.] Helmholtz Zentrum Munchen, DRS, Inst Innovat Radiotherapy iRT, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Naumann, P (corresponding author), Univ Clin Heidelberg, Dept Radiat Oncol, Heidelberg, Germany.	patrick.naumann@med.uni-heidelberg.de		Schmid, Thomas/0000-0002-8894-8087				Adiseshaiah PP, 2016, NAT REV CLIN ONCOL, V13, P750, DOI 10.1038/nrclinonc.2016.119; Akasaka H, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0729-0; Appari M, 2014, INT J ONCOL, V45, P1391, DOI 10.3892/ijo.2014.2539; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brunner T, 2012, STRAHLENTHER ONKOL, V188, P366, DOI 10.1007/s00066-012-0079-2; Brunner TB, 2016, BEST PRACT RES CL GA, V30, P617, DOI 10.1016/j.bpg.2016.08.001; Chang CC, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-41; Forster T, 2014, ONCOTARGET, V5, P1621, DOI 10.18632/oncotarget.1764; Ganai SA, 2016, ANTICANCER AGENTS ME; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Habermehl D, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-28; Harrabi SB, 2016, J RADIAT RES, V57, P110, DOI 10.1093/jrr/rrv097; Kotowski U, 2011, STRAHLENTHER ONKOL, V187, P575, DOI 10.1007/s00066-011-2218-6; Kuo LJ, 2008, IN VIVO, V22, P305; Li YY, 2012, J NUTR BIOCHEM, V23, P1617, DOI 10.1016/j.jnutbio.2011.11.004; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lozanovski VJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-204; Naumann P, 2013, STRAHLENTHER ONKOL, V189, P745, DOI 10.1007/s00066-013-0393-3; Naumann P, 2011, INT J ONCOL, V39, P101, DOI 10.3892/ijo.2011.1025; Pham NA, 2004, MOL CANCER THER, V3, P1239; RADFORD IR, 1985, INT J RADIAT BIOL, V48, P45, DOI 10.1080/09553008514551051; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sawai Y, 2013, ONCOL REP, V29, P941, DOI 10.3892/or.2012.2195; Schlaich F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-260; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Song JY, 2003, J BIOL CHEM, V278, P36676, DOI 10.1074/jbc.M303692200; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Stewart FA, 2009, INT J RADIAT BIOL, V85, P574, DOI 10.1080/09553000902985136	34	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180940	10.1371/journal.pone.0180940	http://dx.doi.org/10.1371/journal.pone.0180940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700650	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800102
J	Yasuga, H; Inoue, K; Kawano, R; Takinoue, M; Osaki, T; Kamiya, K; Miki, N; Takeuchi, S				Yasuga, Hiroki; Inoue, Kosuke; Kawano, Ryuji; Takinoue, Masahiro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji			Serial DNA relay in DNA logic gates by electrical fusion and mechanical splitting of droplets	PLOS ONE			English	Article							MICROFLUIDIC MIXER; BILAYER FORMATION; NANOPORE; ACID; DISCRIMINATION; OPERATIONS; MOLECULES; CIRCUITS; PLATFORM	DNA logic circuits utilizing DNA hybridization and/or enzymatic reactions have drawn increasing attention for their potential applications in the diagnosis and treatment of cellular diseases. The compartmentalization of such a system into a microdroplet considerably helps to precisely regulate local interactions and reactions between molecules. In this study, we introduced a relay approach for enabling the transfer of DNA from one droplet to another to implement multi-step sequential logic operations. We proposed electrical fusion and mechanical splitting of droplets to facilitate the DNA flow at the inputs, logic operation, output, and serial connection between two logic gates. We developed Negative-OR operations integrated by a serial connection of the OR gate and NOT gate incorporated in a series of droplets. The four types of input defined by the presence/absence of DNA in the input droplet pair were correctly reflected in the readout at the Negative-OR gate. The proposed approach potentially allows for serial and parallel logic operations that could be used for complex diagnostic applications.	[Yasuga, Hiroki; Inoue, Kosuke; Kawano, Ryuji; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji] Kanagawa Inst Ind Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan; [Yasuga, Hiroki; Inoue, Kosuke; Miki, Norihisa] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa, Japan; [Kawano, Ryuji] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa, Japan	Kanagawa Academy Science & Technology; Keio University; Tokyo University of Agriculture & Technology; Tokyo Institute of Technology; University of Tokyo; Keio University	Takeuchi, S (corresponding author), Kanagawa Inst Ind Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takinoue, Masahiro/AAI-6179-2020; Takeuchi, Shoji/J-5349-2019; Takinoue, Masahiro/A-1490-2014; Kawano, Ryuji/A-3177-2011; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Kamiya, Koki/F-9889-2018; Kamiya, Koki/AAL-6950-2020; Yasuga, Hiroki/AGZ-6419-2022	Takinoue, Masahiro/0000-0002-3874-2670; Takinoue, Masahiro/0000-0002-3874-2670; Kawano, Ryuji/0000-0001-6523-0649; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Yasuga, Hiroki/0000-0003-2040-9017; Takeuchi, Shoji/0000-0001-6946-0409	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25246017];  [24104002];  [15H00803];  [16H06043]	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (No. 24104002, 15H00803 and 16H06043) to MT and RK; the Regional Innovation Strategy Support Program to ST and TO; a Grant- in-Aid for Scientific Research (A) (No. 25246017) to ST of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Ayukawa S, 2011, ACCOUNTS CHEM RES, V44, P1369, DOI 10.1021/ar200128b; Barlow NE, 2016, LAB CHIP, V16, P4653, DOI 10.1039/c6lc01011c; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Feng LY, 2015, ANGEW CHEM INT EDIT, V54, P7693, DOI 10.1002/anie.201502315; Frezza BM, 2007, J AM CHEM SOC, V129, P14875, DOI 10.1021/ja0710149; Fu LM, 2005, ELECTROPHORESIS, V26, P1814, DOI 10.1002/elps.200410222; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Hiratani M, 2017, ANAL CHEM, V89, P2312, DOI 10.1021/acs.analchem.6b03830; Huang YY, 2015, ANAL CHIM ACTA, V870, P92, DOI 10.1016/j.aca.2015.02.026; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Kawano R, 2009, LANGMUIR, V25, P1233, DOI 10.1021/la803556p; Kim J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100099; Li Y, 2014, ANAL CHEM, V86, P4333, DOI 10.1021/ac500112d; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Nishimura T, 2012, MICROFLUID NANOFLUID, V13, P1, DOI 10.1007/s10404-012-0934-6; Ohara M, 2017, ACS SYNTH BIOL; Osaki T, 2017, ANAL CHEM, V89, P216, DOI 10.1021/acs.analchem.6b04744; Paik P, 2003, LAB CHIP, V3, P253, DOI 10.1039/b307628h; Park KS, 2012, SMALL, V8, P2203, DOI 10.1002/smll.201102758; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Yasuga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149667; You MX, 2015, J AM CHEM SOC, V137, P667, DOI 10.1021/ja509263k; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2010, NUCLEIC ACIDS RES, V38, P4182, DOI 10.1093/nar/gkq088	37	4	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180876	10.1371/journal.pone.0180876	http://dx.doi.org/10.1371/journal.pone.0180876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700641	gold, Green Published			2022-12-26	WOS:000405544800090
J	Li, Y; Wang, L; Liu, J; Zhang, P; An, M; Han, C; Li, Y; Guan, X; Zhang, K				Li, Y.; Wang, L.; Liu, J.; Zhang, P.; An, M.; Han, C.; Li, Y.; Guan, X.; Zhang, K.			O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer	ONCOGENE			English	Article							GLCNAC TRANSFERASE; CHROMATIN-ASSOCIATION; STEM-CELLS; C-MYC; PHOSPHORYLATION; OGT; IDENTIFICATION; TARGET; GROWTH; DOMAIN	The Polycomb group transcriptional repressor Bmi-1 often overexpressed and participated in stem cells self-renewal and tumorigenesis initiating of prostate cancer. In this progression, Bmi-1 protein was regulated by transcription and post-translational modifications (PTMs). Nobly, the underlying PTMs regulation of Bmi-1 is poorly known. Here we use co-immunoprecipitation show that in C4-2 cell line, Bmi-1 directly interacted with OGT which is the only known enzyme catalyzed the O-GlcNAcylation in human. Furthermore, we identified that Ser255 is the site for Bmi-1 O-GlcNAcylation, and O-GlcNAcylation promoted Bmi-1 protein stability and its oncogenic activity. Finally, microarray analysis has characterized potential oncogenes associated pathway subject to repression via the OGT-Bmi-1 axis. Taken together, these results indicate that OGT-mediated O-GlcNAcylation at Ser255 stabilizes Bmi-1 and hence inhibits the TP53, PTEN and CDKN1A/CDKN2A pathway. The study not only uncovers a novel functional PTMs of Bmi-1 but also reveals a unique oncogenic role of O-GlcNAcylation in prostate cancer.	[Li, Y.; Wang, L.; Liu, J.; An, M.; Han, C.; Li, Y.; Guan, X.] Dalian Med Univ, Affiliated Hosp 1, Sino UK Regenerat Med Ctr, 222 Zhongshan Rd, Dalian 116011, Peoples R China; [Zhang, P.] Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian, Peoples R China; [Zhang, K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Dalian Medical University; Dalian Medical University; University of California System; University of California San Diego	Liu, J (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Sino UK Regenerat Med Ctr, 222 Zhongshan Rd, Dalian 116011, Peoples R China.	liujing@dmu.edu.cn	Wang, Liang/O-8394-2019	Wang, Liang/0000-0003-1952-3525; Wang, Liang/0000-0003-2244-7535; Liu, Jing/0000-0002-0493-296X				Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bansal N, 2016, CLIN CANCER RES, V22, P6176, DOI 10.1158/1078-0432.CCR-15-3107; Barlow Lamont J, 2013, Cancer Cell, V24, DOI 10.1016/j.ccr.2013.08.033; Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Dardenne E, 2016, CANCER CELL, V30, P563, DOI 10.1016/j.ccell.2016.09.005; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu L, 2015, NAT GENET, V47, P22, DOI 10.1038/ng.3165; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wu J, 2011, J CELL BIOCHEM, V112, P1938, DOI 10.1002/jcb.23114; Xie X, 2014, ONCOGENE, V33, P2040, DOI 10.1038/onc.2013.173; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yoo YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12943; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	37	28	28	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6293	6305		10.1038/onc.2017.223	http://dx.doi.org/10.1038/onc.2017.223			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28714959				2022-12-26	WOS:000414774800008
J	Njemanze, PC; Kranz, M; Amend, M; Hauser, J; Wehrl, H; Brust, P				Njemanze, Philip C.; Kranz, Mathias; Amend, Mario; Hauser, Jens; Wehrl, Hans; Brust, Peter			Gender differences in cerebral metabolism for color processing in mice: A PET/MRI Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; OCULAR DOMINANCE PLASTICITY; RECEPTIVE-FIELD STRUCTURE; PRIMARY VISUAL-CORTEX; BLOOD-FLOW VELOCITY; SEX-DIFFERENCES; BRAIN ACTIVITY; MONOCULAR DEPRIVATION; GENERAL INTELLIGENCE; GLUCOSE-UTILIZATION	Introduction Color processing is a central component of mammalian vision. Gender-related differences of color processing revealed by non-invasive functional transcranial Doppler ultrasound suggested right hemisphere pattern for blue/yellow chromatic opponency by men, and a left hemisphere pattern by women. Materials and Methods The present study measured the accumulation of [F-18] fluorodeoxyglucose ([F-18]FDG) in mouse brain using small animal positron emission tomography and magnetic resonance imaging (PET/MRI) with statistical parametric mapping (SPM) during light stimulation with blue and yellow filters compared to darkness condition. Results PET revealed a reverse pattern relative to dark condition compared to previous human studies: Male mice presented with left visual cortex dominance for blue through the right eye, while female mice presented with right visual cortex dominance for blue through the left eye. We applied statistical parametric mapping (SPM) to examine gender differences in activated architectonic areas within the orbital and medial prefrontal cortex and related cortical and sub-cortical areas that lead to the striatum, medial thalamus and other brain areas. The metabolic connectivity of the orbital and medial prefrontal cortex evoked by blue stimulation spread through a wide range of brain structures implicated in viscerosensory and visceromotor systems in the left intra-hemispheric regions in male, but in the right-to-left inter-hemispheric regions in female mice. Color functional ocular dominance plasticity was noted in the right eye in male mice but in the left eye in female mice. Conclusions This study of color processing in an animal model could be applied in the study of the role of gender differences in brain disease.	[Njemanze, Philip C.] Int Inst Adv Res Training, Neurocybernet Flow Lab, Chidicon Med Ctr, Owerri, Imo State, Nigeria; [Kranz, Mathias; Brust, Peter] Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Helmholtz Zent Dresden Rossendorf, Leipzig, Germany; [Amend, Mario; Wehrl, Hans] Eberhard Karls Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Hauser, Jens] Dept Mech Engn Dresden, Helmholtz Zent Dresden Rossendorf, Dresden, Germany	Eberhard Karls University of Tubingen; Siemens AG; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Brust, P (corresponding author), Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Helmholtz Zent Dresden Rossendorf, Leipzig, Germany.	p.brust@hzdr.de		Kranz, Mathias/0000-0002-5641-7396	DFG [WE 5795/2-1]; University of Tubingen [2209-0-0]; BMBF [DLR 01GQ1415]; Werner Siemens Foundation; Chidicon Medical Research Foundation	DFG(German Research Foundation (DFG)); University of Tubingen; BMBF(Federal Ministry of Education & Research (BMBF)); Werner Siemens Foundation; Chidicon Medical Research Foundation	M. A. and H.F.W. acknowledge the funding by DFG (WE 5795/2-1), University of Tubingen, fortuene: 2209-0-0, BMBF DLR 01GQ1415 and the Werner Siemens Foundation. P.C.N. was funded by Chidicon Medical Research Foundation.	Armstrong RA, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/908306; Bandi P, 2012, IEEE ENG MED BIO, P5351, DOI 10.1109/EMBC.2012.6347203; BARON M, 1977, ARCH GEN PSYCHIAT, V34, P721; Delpero WT, 2005, AVIAT SPACE ENVIR MD, V76, P127; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Ducker G., 1964, J BOMBAY NATURAL HIS, V61, P572; Eastman Kodak Company, 1990, KOD PHOT FILT HDB E, P161; Endo S, 1997, IEEE T MED IMAGING, V16, P252, DOI 10.1109/42.585759; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; FRACKOWIAK RSJ, 1994, J ANAT, V184, P211; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Gerstl F, 2008, NEUROIMAGE, V41, P204, DOI 10.1016/j.neuroimage.2008.02.044; Ghanavati S, 2014, J NEUROSCI METH, V221, P70, DOI 10.1016/j.jneumeth.2013.09.002; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gouras P., 1991, PERCEPTION COLOR VIS, P179; Gray H., 1984, GRAYS ANATOMY HUMAN, V30; Haak KV, 2014, CORTEX, V56, P14, DOI 10.1016/j.cortex.2012.12.005; HAWRYSHYN CW, 1982, CAN J ZOOL, V60, P2968, DOI 10.1139/z82-378; Helmholtz HV, 1867, HDB PHYSL OPTIK; Hering E., 1878, ZH LEHRE LICHTSINNE, P107; Hering E., 1878, ZH LEHRE LICHTSINNE, P141; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1985, VISION RES, V25, P141, DOI 10.1016/0042-6989(85)90088-4; Jacobs GH, 1981, COMP COLOR VISION; Jung RE, 2005, NEUROIMAGE, V26, P965, DOI 10.1016/j.neuroimage.2005.02.039; Kitahara Kenji, 2007, Nippon Ganka Gakkai Zasshi, V111, P160; Kollias SS, 2004, EUR J RADIOL, V49, P64, DOI 10.1016/j.ejrad.2003.09.005; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Marshak DW, 2014, VISUAL NEUROSCI, V31, P165, DOI 10.1017/S095252381300031X; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neumeyer C., 1991, EVOLUTION EYE VISUAL, V2; NJEMANZE PC, 1992, CORTEX, V28, P69, DOI 10.1016/S0010-9452(13)80166-9; Njemanze PC, 2005, BRAIN LANG, V92, P234, DOI 10.1016/j.bandl.2004.06.104; Njemanze PC, 2004, AVIAT SPACE ENVIR MD, V75, P800; Njemanze PC., 2008, J GRAVIT PHYSL, V15, P49; Njemanze PC, 2007, LATERALITY, V12, P31, DOI 10.1080/13576500600886796; Njemanze Philip C, 2011, Exp Transl Stroke Med, V3, P1, DOI 10.1186/2040-7378-3-1; Njemanze Philip C, 2010, Exp Transl Stroke Med, V2, P21, DOI 10.1186/2040-7378-2-21; NUBOER JFW, 1986, NETH J ZOOL, V36, P344; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102392; Pache M, 2003, AGE AGEING, V32, P422, DOI 10.1093/ageing/32.4.422; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Purves D., 2009, VISION, P224; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Siikanen J, 2015, AM J NUCL MED MOLEC, V5, P270; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; STONE J, 1974, J COMP NEUROL, V155, P377, DOI 10.1002/cne.901550402; Takechi H, 1997, NEUROSCI LETT, V230, P17, DOI 10.1016/S0304-3940(97)00461-8; Thie JA, 2004, J NUCL MED, V45, P1431; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Turner RS., 2014, EYES MIND VISION HEL; Urban A, 2015, NAT METHODS, V12, P873, DOI [10.1038/nmeth.3482, 10.1038/NMETH.3482]; Villien M, 2014, NEUROIMAGE, V100, P192, DOI 10.1016/j.neuroimage.2014.06.025; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Walls GL, 1942, VERTEBRATE EYE ITS A, P810; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wehrl HF, 2014, NEUROIMAGE, V89, P271, DOI 10.1016/j.neuroimage.2013.11.044; Wehrl HF, 2013, NAT MED, V19, P1184, DOI 10.1038/nm.3290; Westheimer G, 2007, PROG RETIN EYE RES, V26, P636, DOI 10.1016/j.preteyeres.2007.07.003; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Woo SK, 2008, NUCL MED BIOL, V35, P143, DOI 10.1016/j.nucmedbio.2007.10.003; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104	86	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179919	10.1371/journal.pone.0179919	http://dx.doi.org/10.1371/journal.pone.0179919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723938	gold, Green Submitted, Green Published			2022-12-26	WOS:000406067800009
J	Onuma, T; Penwannakul, Y; Fuchimoto, J; Sakai, N				Onuma, Takuya; Penwannakul, Yuwadee; Fuchimoto, Jun; Sakai, Nobuyuki			The effect of order of dwells on the first dwell gaze bias for eventually chosen items	PLOS ONE			English	Article							DECISION-MAKING; EYE-MOVEMENTS; ATTENTION; CHOICE; PREFERENCE; FIXATION; OSCILLATIONS; EXPOSURE; FEATURES; CASCADE	The relationship between choice and eye movement has gained marked interest. The gaze bias effect, i.e., the tendency to look longer at items that are eventually chosen, has been shown to occur in the first dwell (initial cohesion of fixations for an item). In the two-alternative forced-choice (2AFC) paradigm, participants would look at one of the items first (defined as first look; FL), and they would then move and look at another item (second look; SL). This study investigated how the order in which the chosen items were looked at modulates the first dwell gaze bias effect. Participants were asked to assert their preferences and perceptual 2AFC decisions about human faces (Experiment 1) and daily consumer products (Experiment 2), while their eye movements were recorded. The results showed that the first dwell gaze bias was found only when the eventually chosen item was looked at after another one; the chosen item was looked at for longer as compared to the not-chosen item in the SL, but not in the FL. These results indicate that participants actively allocate more time to looking at a subsequently chosen item only after they perceive both items in the SL. Therefore, the selective encoding seems to occur in the early comparison stage of visual decision making, and not in the initial encoding stage. These findings provide insight into the relationship between choice and eye movement.	[Onuma, Takuya; Penwannakul, Yuwadee; Fuchimoto, Jun; Sakai, Nobuyuki] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi, Japan; [Onuma, Takuya] Tohoku Univ, Div Interdisciplinary Adv Res & Educ, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Sakai, N (corresponding author), Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi, Japan.	nob_sakai@m.tohoku.ac.jp	Sakai, Nobuyuki/AAE-8840-2019	Sakai, Nobuyuki/0000-0002-4647-8435	JSPS KAKENHI [26350088]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (no. 26350088 to NS, https://www.jsps.go.jp/english/egrants/), and there was no additional external funding received for this study.	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bialkova S, 2011, FOOD QUAL PREFER, V22, P592, DOI 10.1016/j.foodqual.2011.03.010; Bialkova S, 2010, FOOD QUAL PREFER, V21, P1042, DOI 10.1016/j.foodqual.2010.07.001; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Glaholt M. G., 2011, J NEUROSCI PSYCHOL E, V4, P125, DOI DOI 10.1037/A0020692; Glaholt MG, 2009, VIS COGN, V17, P1228, DOI 10.1080/13506280802362962; Glaholt MG, 2009, ATTEN PERCEPT PSYCHO, V71, P445, DOI 10.3758/APP.71.3.445; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lindsen JP, 2011, CONSCIOUS COGN, V20, P1781, DOI 10.1016/j.concog.2011.01.008; Lindsen JP, 2010, NEUROIMAGE, V50, P1626, DOI 10.1016/j.neuroimage.2010.01.079; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Nuthmann A, 2015, ANN NY ACAD SCI, V1339, P82, DOI 10.1111/nyas.12705; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Park J, 2010, P NATL ACAD SCI USA, V104, P18253; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RUSSO JE, 1994, J CONSUM RES, V21, P274, DOI 10.1086/209397; Schotter ER, 2012, VIS COGN, V20, P1110, DOI 10.1080/13506285.2012.735719; Schotter ER, 2010, VIS COGN, V18, P1113, DOI 10.1080/13506281003668900; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simion C, 2007, PERCEPT PSYCHOPHYS, V69, P591, DOI 10.3758/BF03193916; Simion C, 2006, VISION RES, V46, P3331, DOI 10.1016/j.visres.2006.04.019; Stoll J, 2015, VISION RES, V107, P36, DOI 10.1016/j.visres.2014.11.006; van der Laan LN, 2015, FOOD QUAL PREFER, V39, P46, DOI 10.1016/j.foodqual.2014.06.015; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zhang BY, 2015, FOOD QUAL PREFER, V41, P172, DOI 10.1016/j.foodqual.2014.12.004	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181641	10.1371/journal.pone.0181641	http://dx.doi.org/10.1371/journal.pone.0181641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723947	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800063
J	Alam, U; Jeziorska, M; Petropoulos, LN; Asghar, O; Fadavi, H; Ponirakis, G; Marshall, A; Tavakoli, M; Boulton, AJM; Efron, N; Malik, RA				Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Ponirakis, Georgios; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Efron, Nathan; Malik, Rayaz A.			Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy	PLOS ONE			English	Article							SKIN BIOPSY; CONDUCTION; REGENERATION; SENSATION; SURROGATE; SEVERITY; SYMPTOMS; PANCREAS; DAMAGE; SIGNS	Objectives Corneal confocal microscopy (CCM) is a rapid, non-invasive, reproducible technique that quantifies small nerve fibres. We have compared the diagnostic capability of CCM against a range of established measures of nerve damage in patients with diabetic neuropathy. Methods In this cross sectional study, thirty subjects with Type 1 diabetes without neuropathy (T1DM), thirty one T1DM subjects with neuropathy (DSPN) and twenty seven non-diabetic healthy control subjects underwent detailed assessment of neuropathic symptoms and neurologic deficits, quantitative sensory testing (QST), electrophysiology, skin biopsy and corneal confocal microscopy (CCM). Results Subjects with DSPN were older (C vs T1DM vs DSPN: 41.0 +/- 14.9 vs 38.8 +/- 12.5 vs 53.3 +/- 11.9, P = 0.0002), had a longer duration of diabetes (P<0.0001), lower eGFR (P = 0.006) and higher albumin-creatinine ratio (P = 0.03) with no significant difference for HbA1c, BMI, lipids and blood pressure. Patients with DSPN were representative of subjects with diabetic neuropathy with clinical signs and symptoms of neuropathy and greater neuropathy deficits quantified by QST, electrophysiology, intra-epidermal nerve fibre density and CCM. Corneal nerve fibre density (CNFD) (Spearman's Rho = 0.60 P<0.0001) and IENFD (Spearman's Rho = 0.56 P<0.0001) were comparable when correlated with peroneal nerve conduction velocity. For the diagnosis of diabetic neuropathy the sensitivity for CNFD was 0.77 and specificity was 0.79 with an area under the ROC curve of 0.81. IENFD had a diagnostic sensitivity of 0.61, specificity of 0.80 and area under the ROC curve of 0.73. Conclusions CCM is a valid accurate non-invasive method to identify small nerve fibre pathology and is able to diagnose DPN.	[Alam, Uazman] Univ Liverpool, Inst Ageing & Chron Dis, Diabet & Endocrinol Res, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Alam, Uazman] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Malik, Rayaz A.] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Inst Human Dev, Manchester, Lancs, England; [Alam, Uazman; Jeziorska, Maria; Petropoulos, Loannis N.; Asghar, Omar; Fadavi, Hassan; Marshall, Andrew; Tavakoli, Mitra; Boulton, Andrew J. M.; Malik, Rayaz A.] Cent Manchester Hosp Fdn Trust, Manchester Royal Infirm, Manchester, Lancs, England; [Ponirakis, Georgios; Malik, Rayaz A.] Weill Cornell Med Qatar, Doha, Qatar; [Tavakoli, Mitra] Univ Exeter, Exeter, Devon, England; [Efron, Nathan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia	University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Manchester; University of Manchester; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Exeter; Queensland University of Technology (QUT)	Malik, RA (corresponding author), Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Inst Human Dev, Manchester, Lancs, England.; Malik, RA (corresponding author), Cent Manchester Hosp Fdn Trust, Manchester Royal Infirm, Manchester, Lancs, England.; Malik, RA (corresponding author), Weill Cornell Med Qatar, Doha, Qatar.	ram2045@qatar-med.cornell.edu	Efron, Nathan/I-9766-2012; Alam, Uazman/I-9173-2019; Ponirakis, Georgios/T-7207-2019; Jeziorska, Maria/P-1731-2015; Marshall, Andrew/AAE-5203-2019; Malik, Rayaz/H-9231-2019; TAVAKOLI, MITRA/N-1402-2016	Efron, Nathan/0000-0002-7037-779X; Alam, Uazman/0000-0002-3190-1122; Ponirakis, Georgios/0000-0002-6936-1248; Jeziorska, Maria/0000-0002-3492-0177; Malik, Rayaz/0000-0002-7188-8903; TAVAKOLI, MITRA/0000-0003-2319-1543	Juvenile Diabetes Research Foundation [8-2008-362]; NIHR/Wellcome Trust Clinical Research Facility (Manchester)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIHR/Wellcome Trust Clinical Research Facility (Manchester)	This work was funded by the Juvenile Diabetes Research Foundation (Grant No.: 8-2008-362) and the NIHR/Wellcome Trust Clinical Research Facility (Manchester) for their facilitation of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Carrington AL, 2002, DIABETES CARE, V25, P2010, DOI 10.2337/diacare.25.11.2010; Chen X, 2015, DIABETES CARE, V38, P1138, DOI 10.2337/dc14-2422; Chien HF, 2001, ACTA NEUROPATHOL, V102, P455; Dyck PJ, 2007, DIABETES CARE, V30, P2619, DOI 10.2337/dc06-2479; Dyck PJ, 2014, MUSCLE NERVE, V49, P645, DOI 10.1002/mus.23982; Dyck PJ, 2013, DIABETES, V62, P3677, DOI 10.2337/db13-0352; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2007, NAT CLIN PRACT NEURO, V3, P546, DOI 10.1038/ncpneuro0630; Lauria G, 2012, CURR DIABETES REP, V12, P384, DOI 10.1007/s11892-012-0280-9; Loseth S, 2006, EUR J NEUROL, V13, P105, DOI 10.1111/j.1468-1331.2006.01232.x; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; Mehra S, 2007, DIABETES CARE, V30, P2608, DOI 10.2337/dc07-0870; Nebuchennykh M, 2009, J NEUROL, V256, P1067, DOI 10.1007/s00415-009-5065-y; Petropoulos IN, 2013, DIABETES CARE, V36, P3646, DOI 10.2337/dc13-0193; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Pham M, 2011, DIABETES CARE, V34, P721, DOI 10.2337/dc10-1491; Pop-Busui R, 2009, CIRCULATION, V119, P2886, DOI 10.1161/CIRCULATIONAHA.108.837369; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Scherens A, 2009, EUR J PAIN, V13, P711, DOI 10.1016/j.ejpain.2008.07.014; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Sivaskandarajah GA, 2013, DIABETES CARE, V36, P2748, DOI 10.2337/dc12-2075; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2011, DIABETIC MED, V28, P1261, DOI 10.1111/j.1464-5491.2011.03372.x; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2013, DIABETES, V62, P254, DOI 10.2337/db12-0574; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Thakkar RS, 2012, AM J ROENTGENOL, V199, P407, DOI 10.2214/AJR.11.7893; Tobin K, 1999, CLIN NEUROPHYSIOL, V110, P1909, DOI 10.1016/S1388-2457(99)00164-9; Umapathi T, 2006, MUSCLE NERVE, V33, P742, DOI 10.1002/mus.20528; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889	40	93	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180175	10.1371/journal.pone.0180175	http://dx.doi.org/10.1371/journal.pone.0180175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719619	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400009
J	Ryu, YS; Chandran, SP; Kim, K; Lee, SK				Ryu, Young Shin; Chandran, Sathesh-Prabu; Kim, Kyungchul; Lee, Sung Kuk			Oligo- and dsDNA-mediated genome editing using a tetA dual selection system in Escherichia coli	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; GENE REPLACEMENT; EFFICIENT; SCARLESS; RECOMBINATION; TRANSCRIPTION; SEQUENCE; PATHWAY; DESIGN; CELLS	The ability to precisely and seamlessly modify a target genome is needed for metabolic engineering and synthetic biology techniques aimed at creating potent biosystems. Herein, we report on a promising method in Escherichia coli that relies on the insertion of an optimized tetA dual selection cassette followed by replacement of the same cassette with short, single-stranded DNA (oligos) or long, double-stranded DNA and the isolation of recombinant strains by negative selection using NiCl2. This method could be rapidly and successfully used for genome engineering, including deletions, insertions, replacements, and point mutations, without inactivation of the methyl-directed mismatch repair (MMR) system and plasmid cloning. The method we describe here facilitates positive genome-edited recombinants with selection efficiencies ranging from 57 to 92%. Using our method, we increased lycopene production (3.4-fold) by replacing the ribosome binding site (RBS) of the rate-limiting gene (dxs) in the 1-deoxy-D-xylulose-5-phosphate (DXP) biosynthesis pathway with a strong RBS. Thus, this method could be used to achieve scarless, proficient, and targeted genome editing for engineering E. coli strains.	[Ryu, Young Shin; Chandran, Sathesh-Prabu; Lee, Sung Kuk] UNIST, Sch Energy & Chem Engn, Ulsan, South Korea; [Kim, Kyungchul; Lee, Sung Kuk] UNIST, Sch Life Sci, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Lee, SK (corresponding author), UNIST, Sch Energy & Chem Engn, Ulsan, South Korea.; Lee, SK (corresponding author), UNIST, Sch Life Sci, Ulsan, South Korea.	sklee@unist.ac.kr	Lee, Sung K/E-6525-2010; Lee, Sung K/HGC-6832-2022		National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2058667]; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ011181]	National Research Foundation of Korea (NRF) - Ministry of Education; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) through grants funded by the Ministry of Education (2013R1A1A2058667) and by a grant from the Next-Generation Bio Green 21 Program (SSAC, PJ011181), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; GRIFFITH JK, 1982, PLASMID, V8, P86, DOI 10.1016/0147-619X(82)90044-0; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeong J, 2013, BIOTECHNOL ADV, V31, P804, DOI 10.1016/j.biotechadv.2013.04.003; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Kim J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-84; Kim SM, 2015, METAB ENG, V30, P141, DOI 10.1016/j.ymben.2015.05.002; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Madyagol M, 2011, FOLIA MICROBIOL, V56, P253, DOI 10.1007/s12223-011-0035-z; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Nomura Y, 2007, BIOSYSTEMS, V90, P115, DOI 10.1016/j.biosystems.2006.07.006; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Vinuselvi P, 2012, ENZYME MICROB TECH, V50, P1, DOI 10.1016/j.enzmictec.2011.10.001; Vinuselvi P, 2011, BIOFUELS-UK, V2, P153, DOI [10.4155/bfs.11.4, 10.4155/BFS.11.4]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	47	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181501	10.1371/journal.pone.0181501	http://dx.doi.org/10.1371/journal.pone.0181501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719630	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400051
J	Bhattacharjee, D; Dev, NN; Gupta, S; Sau, S; Sarkar, R; Biswas, A; Banerjee, A; Babu, D; Mehta, D; Bhadra, A				Bhattacharjee, Debottam; Dev, Nikhil N.; Gupta, Shreya; Sau, Shubhra; Sarkar, Rohan; Biswas, Arpita; Banerjee, Arunita; Babu, Daisy; Mehta, Diksha; Bhadra, Anindita			Free-ranging dogs show age related plasticity in their ability to follow human pointing	PLOS ONE			English	Article							CANIS-LUPUS-FAMILIARIS; OBJECT CHOICE TASK; DOMESTIC DOGS; SOCIAL CUES; HIDDEN FOOD; COGNITION; ONTOGENY; WOLVES; GESTURES; OWNER	Differences in pet dogs' and captive wolves' ability to follow human communicative intents have led to the proposition of several hypotheses regarding the possession and development of social cognitive skills in dogs. It is possible that the social cognitive abilities of pet dogs are induced by indirect conditioning through living with humans, and studying free-ranging dogs can provide deeper insights into differentiating between innate abilities and conditioning in dogs. Free-ranging dogs are mostly scavengers, indirectly depending on humans for their sustenance. Humans can act both as food providers and as threats to these dogs, and thus understanding human gestures can be a survival need for the free-ranging dogs. We tested the responsiveness of such dogs in urban areas toward simple human pointing cues using dynamic proximal points. Our experiment showed that pups readily follow proximal pointing and exhibit weaker avoidance to humans, but stop doing so at the later stages of development. While juveniles showed frequent and prolonged gaze alternations, only adults adjusted their behaviour based on the reliability of the human experimenter after being rewarded. Thus free-ranging dogs show a tendency to respond to human pointing gestures, with a certain level of behavioural plasticity that allows learning from ontogenic experience.	[Bhattacharjee, Debottam; Dev, Nikhil N.; Gupta, Shreya; Sau, Shubhra; Sarkar, Rohan; Biswas, Arpita; Banerjee, Arunita; Babu, Daisy; Mehta, Diksha; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India; [Dev, Nikhil N.] Indian Inst Sci Educ & Res Thiruvannathapuram, Thiruvannathapuram, Kerala, India; [Gupta, Shreya] Indian Inst Sci Educ & Res Bhopal, Bhopal, Madhya Pradesh, India; [Mehta, Diksha] Univ Delhi, Shivaji Coll, Delhi, India	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Indian Institute of Science Education & Research (IISER) - Bhopal; University of Delhi	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia, W Bengal, India.	abhadra@iiserkol.ac.in	Bhadra, Anindita/H-6899-2019; Bhattacharjee, Debottam/AAN-5412-2020	Bhadra, Anindita/0000-0002-3717-9732; Bhattacharjee, Debottam/0000-0002-4555-7983; Babu, Daisy/0000-0003-4957-1720; Narendradev, Nikhil Dev/0000-0002-5641-3571	INSPIRE fellowship of the Department of Science and Technology, India; IAS; INSA; NASI; DST [SB/WEA-005/2013]; IISER Kolkata PBIP fellowship; DST, IISER Kolkata; IISER Kolkata Summer Research Fellowship	INSPIRE fellowship of the Department of Science and Technology, India; IAS; INSA; NASI; DST(Department of Science & Technology (India)); IISER Kolkata PBIP fellowship; DST, IISER Kolkata; IISER Kolkata Summer Research Fellowship	Debottam Bhattacharjee is supported by the INSPIRE fellowship of the Department of Science and Technology, India. Nikhil Dev N received the Summer Research Fellowship jointly funded by IAS, INSA and NASI, the three science academies of India. Shreya Gupta, Daisy Babu, Arpita Biswas and Diksha Mehta were supported by the IISER Kolkata Summer Research Fellowship during this experiment. Shubhra Sau was supported by a fellowship from the DST funded project SB/WEA-005/2013. Arunita Banerjee received the IISER Kolkata PBIP fellowship. IISER Kolkata provided the infrastructure support, but the project itself was not funded by any specific project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank DST, IISER Kolkata for their support. The authors would also like to thank Dr. Monique Udell, Oregon State University and Dr. Brian Hare, Duke University for their inputs on earlier versions of this manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7; Bhadra A, 2015, ETHOL ECOL EVOL, P9370; Bhadra A, 2014, J ETHOL, V32, P15, DOI 10.1007/s10164-013-0388-7; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Clutton-Brock Juliet, 1995, P7; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; Dorey NR, 2010, ANIM BEHAV, V79, P37, DOI 10.1016/j.anbehav.2009.09.032; Duranton C, 2016, J VET BEHAV, V14, P20, DOI [10.1016/j.jveb.2016.06.011, 10.1016/j.jveb.2016]; FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298; FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x; Marshall-Pescini S, 2014, THE SOCIAL DOG, P3; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Nawroth C, 2014, ANIM COGN, V17, P701, DOI 10.1007/s10071-013-0702-3; Paul M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170590; Paul M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150580; Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641; Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Sen Majumder S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32014; Serpell JA, 1996, APPL ANIM BEHAV SCI, V47, P49, DOI 10.1016/0168-1591(95)01010-6; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Takaoka A, 2015, ANIM COGN, V18, P475, DOI 10.1007/s10071-014-0816-2; Thapar Romila, 1990, HIST INDIA; Udell MAR, 2008, J COMP PSYCHOL, V122, P84, DOI 10.1037/0735-7036.122.1.84; Udell MAR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0489; Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1; Zaine I, 2015, BEHAV PROCESS, V119, P76, DOI 10.1016/j.beproc.2015.07.004	61	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180643	10.1371/journal.pone.0180643	http://dx.doi.org/10.1371/journal.pone.0180643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS8PU	28715475	Green Published, Green Submitted, gold			2022-12-26	WOS:000443975500014
J	Renard, M; Muino-Mosquera, L; Manalo, EC; Tufa, S; Carlson, EJ; Keene, DR; De Backer, J; Sakai, LY				Renard, Marjolijn; Muino-Mosquera, Laura; Manalo, Elise C.; Tufa, Sara; Carlson, Eric J.; Keene, Douglas R.; De Backer, Julie; Sakai, Lynn Y.			Sex, pregnancy and aortic disease in Marfan syndrome	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; TGFBR2 MUTATIONS; IN-VIVO; ANEURYSM; FIBRILLIN-1; WOMEN; COMPLICATIONS; MICE; ESTROGEN; GROWTH	Background Sex-related differences as well as the adverse effect of pregnancy on aortic disease outcome are well-established phenomena in humans with Marfan syndrome (MFS). The underlying mechanisms of these observations are largely unknown. Objectives In an initial (pilot) step we aimed to confirm the differences between male and female MFS patients as well as between females with and without previous pregnancy. We then sought to evaluate whether these findings are recapitulated in a pre-clinical model and performed in-depth cardiovascular phenotyping of mutant male and both nulliparous and multiparous female Marfan mice. The effect of 17 beta-estradiol on fibrillin-1 protein synthesis was compared in vitro using human aortic smooth muscle cells and fibroblasts. Results Our small retrospective study of aortic dimensions in a cohort of 10 men and 20 women with MFS (10 pregnant and 10 non-pregnant) confirmed that aortic root growth was significantly increased in the pregnant group compared to the non-pregnant group (0.64mm/year vs. 0.12mm/year, p = 0.018). Male MFS patients had significantly larger aortic root diameters compared to the non-pregnant and pregnant females at baseline and follow-up (p = 0.002 and p = 0.007, respectively), but no significant increase in aortic root growth was observed compared to the females after follow-up (p = 0.559 and p = 0.352). In the GT-8/+ MFS mouse model, multiparous female Marfan mice showed increased aortic diameters when compared to nulliparous females. Aortic dilatation in multiparous females was comparable to Marfan male mice. Moreover, increased aortic diameters were associated with more severe fragmentation of the elastic lamellae. In addition, 17 beta-estradiol was found to promote fibrillin-1 production by human aortic smooth muscle cells. Conclusions Pregnancy-related changes influence aortic disease severity in otherwise protected female MFS mice and patients. There may be a role for estrogen in the female sex protective effect.	[Renard, Marjolijn; Muino-Mosquera, Laura; De Backer, Julie] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium; [Manalo, Elise C.; Carlson, Eric J.; Sakai, Lynn Y.] Shriners Hosp Children, Dept Mol & Med Genet & Biochem & Mol Biol, Portland, OR 97201 USA; [Tufa, Sara; Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97201 USA	Ghent University	Renard, M (corresponding author), Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium.	marjolijn.renard@ugent.be	De Backer, Julie/B-2897-2014; Muino Mosquera, Laura/ABD-5010-2020	De Backer, Julie/0000-0001-8878-1507; Muino Mosquera, Laura/0000-0002-3094-7807; Manalo, Elise/0000-0003-2752-5280; Tufa, Sara/0000-0002-6447-8041; Renard, Marjolijn/0000-0003-1105-8948	Flemishg overnment; Ghent University [BOF15/ MET-V/011]; NIH [P01AR049698]; Shriners Hospitals for Children; Special Research Fund from the Ghent University [BOFB/13474/01]	Flemishg overnment(European Commission); Ghent University(Ghent University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; Special Research Fund from the Ghent University	This study was supported by a Methusalem grant from the Flemishg overnment and the Ghent University to A. DePaepe (BOF15/ MET-V/011; www.ugent.be) and by grants from the NIH (P01AR049698; www.nig.gov) and from the Shriners Hospitals for Children (to LYS and DRK; http://www.shrinershospitalsforchildren.org). MR is a postdoctoral fellow and JDB is a senior clinical investigator of the Research Foundation - Flanders www.fwo.be). LMM is supported by a Special Research Fund from the Ghent University (BOFB/ 13474/01; www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2004, ARTERIOSCL THROM VAS, V24, P2116, DOI 10.1161/01.ATV.0000143386.26399.84; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Campens L, 2015, PEDIATR RES, V78, P256, DOI 10.1038/pr.2015.110; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; Cho BS, 2010, SURGERY, V147, P258, DOI 10.1016/j.surg.2009.06.047; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; De Backer JF, 2006, INT J CARDIOL, V112, P353, DOI 10.1016/j.ijcard.2005.10.010; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; Dietz H. C., 1996, AM J MED GENET, V26, P10; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Donnelly RT, 2012, J AM COLL CARDIOL, V60, P224, DOI 10.1016/j.jacc.2012.03.051; EASTERLING TR, 1991, OBSTET GYNECOL, V78, P1073; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; FINKBOHNER R, 1995, CIRCULATION, V91, P728, DOI 10.1161/01.CIR.91.3.728; Franken R, 2016, EUR HEART J, V37, P3285, DOI 10.1093/eurheartj/ehv739; HUNTER S, 1992, BRIT HEART J, V68, P540; Johnston WF, 2015, J VASC SURG, V61, P1565, DOI 10.1016/j.jvs.2014.01.032; Jondeau G, 2016, CIRC-CARDIOVASC GENE, V9, P548, DOI 10.1161/CIRCGENETICS.116.001485; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kissin EY, 2002, ARTHRITIS RHEUM, V46, P3000, DOI 10.1002/art.10621; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lind J, 2001, EUR J OBSTET GYN R B, V98, P28, DOI 10.1016/S0301-2115(01)00314-1; Lipscomb KJ, 1997, BRIT J OBSTET GYNAEC, V104, P201, DOI 10.1111/j.1471-0528.1997.tb11045.x; Marshall LM, 2013, CIRC RES, V113, P1159, DOI 10.1161/CIRCRESAHA.113.301498; Martin-McNulty B, 2003, ARTERIOSCL THROM VAS, V23, P1627, DOI 10.1161/01.ATV.0000085842.20866.6A; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; Meijboom LJ, 2006, INT J CARDIOL, V110, P53, DOI 10.1016/j.ijcard.2005.07.017; Meijboom LJ, 2005, EUR HEART J, V26, P914, DOI 10.1093/eurheartj/ehi103; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Natoli AK, 2005, HYPERTENSION, V46, P1129, DOI 10.1161/01.HYP.0000187016.06549.96; Omnes S, 2013, INT J GYNECOL OBSTET, V122, P219, DOI 10.1016/j.ijgo.2013.04.013; Pacini L, 2009, INT J CARDIOL, V136, P156, DOI 10.1016/j.ijcard.2008.04.035; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PYERITZ RE, 1981, AM J MED, V71, P784, DOI 10.1016/0002-9343(81)90365-X; Rahman J, 2003, J REPROD MED, V48, P723; ROBSON SC, 1987, BRIT MED J, V294, P1065, DOI 10.1136/bmj.294.6579.1065; Roman MJ., 2016, J AM HEART ASSOC, V5, P8, DOI DOI 10.1161/JAHA.116.004052; ROSSITER JP, 1995, AM J OBSTET GYNECOL, V173, P1599, DOI 10.1016/0002-9378(95)90655-X; Rybczynski M, 2007, CLIN CARDIOL, V30, P19, DOI 10.1002/clc.3; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SAVOLAINEN A, 1994, EUR HEART J, V15, P625, DOI 10.1093/oxfordjournals.eurheartj.a060558; Schmit BM, 2015, AM J PHYSIOL-HEART C, V308, pH115, DOI 10.1152/ajpheart.00521.2014; Schoenhoff FS, 2013, CIRCULATION, V127, P1569, DOI 10.1161/CIRCULATIONAHA.113.001457; Sinha I, 2006, ANN NY ACAD SCI, V1085, P367, DOI 10.1196/annals.1383.027; Tran-Fadulu V, 2009, J MED GENET, V46, P607, DOI 10.1136/jmg.2008.062844; Wu XF, 2009, AM J SURG, V197, P49, DOI 10.1016/j.amjsurg.2007.11.022; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181166	10.1371/journal.pone.0181166	http://dx.doi.org/10.1371/journal.pone.0181166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708846	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800044
J	Azizi, H; Romao, TP; Charret, KS; Padmanabhan, PK; Neto, OPD; Muller-McNicoll, M; Papadopoulou, B				Azizi, Hiva; Romao, Tatiany P.; Charret, Karen Santos; Padmanabhan, Prasad K.; de Melo Neto, Osvaldo P.; Mueller-McNicoll, Michaela; Papadopoulou, Barbara			RNA secondary structure and nucleotide composition of the conserved hallmark sequence of Leishmania SIDER2 retroposons are essential for endonucleolytic cleavage and mRNA degradation	PLOS ONE			English	Article							GENE-EXPRESSION; DEVELOPMENTAL REGULATION; DECAY; RECOGNITION; ELEMENTS; REGION; TRYPANOSOMATIDS; DEADENYLATION; AMASTIGOTES; TRANSLATION	We have reported previously that Short Interspersed Degenerate Retroposons of the SIDER2 subfamily, largely located within 3'UTRs of Leishmania transcripts, promote rapid turnover of mRNAs through endonucleolytic cleavage within the highly conserved second tandem 79-nt hallmark sequence (79-nt SII). Here, we used site-directed mutagenesis and in silico RNA structural studies to delineate the cis-acting requirements within 79-nt SII for cleavage and mRNA degradation. The putative cleavage site(s) and other nucleotides predicted to alter the RNA secondary structure of 79-nt SII were either deleted or mutated and their effect on mRNA turnover was monitored using a gene reporter system. We found that short deletions of 8-nt spanning the two predicted cleavage sites block degradation of SIDER2-containing transcripts, leading to mRNA accumulation. Furthermore, single or double substitutions of the dinucleotides targeted for cleavage as well as mutations altering the predicted RNA secondary structure encompassing both cleavage sites also prevent mRNA degradation, confirming that these dinucleotides are the bona fide cleavage sites. In line with these results, we show that stage-regulated SIDER2 inactivation correlates with the absence of endonucleolytic cleavage. Overall, these data demonstrate that both cleavage sites within the conserved 79-nt SII as well as RNA folding in this region are essential for SIDER2-mediated mRNA decay, and further support that SIDER2-harboring transcripts are targeted for degradation by endonucleolytic cleavage.	[Azizi, Hiva; Padmanabhan, Prasad K.; Papadopoulou, Barbara] Univ Laval, CHU Quebec, Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada; [Azizi, Hiva; Padmanabhan, Prasad K.; Papadopoulou, Barbara] Univ Laval, Fac Med, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada; [Romao, Tatiany P.; de Melo Neto, Osvaldo P.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil; [Charret, Karen Santos] Fundacao Oswaldo Cruz, FIOCRUZ, Rio De Janeiro, Brazil; [Mueller-McNicoll, Michaela] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Cluster Excellence Macromol Complexes, RNA Regulat Grp, Frankfurt, Germany	Laval University; Laval University; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Goethe University Frankfurt	Papadopoulou, B (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada.; Papadopoulou, B (corresponding author), Univ Laval, Fac Med, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada.	barbara.papadopoulou@crchul.ulaval.ca	Müller-McNicoll, Michaela/AAC-6125-2019; Romão, Tatiany Patrícia/F-6957-2015; de Melo Neto, Osvaldo P/B-1366-2015	Müller-McNicoll, Michaela/0000-0002-7174-8310; Romão, Tatiany Patrícia/0000-0002-5296-0543; de Melo Neto, Osvaldo P/0000-0001-5402-7346	Canadian Institutes of Health Research (CIHR) Strategic Training Program [STP-53924]; Centre for Host-Parasite Interactions (CHPI); National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil; German Research Counsel [CEF-MC, SFB902]; Canadian Institutes of Health Research [MOP-12182]	Canadian Institutes of Health Research (CIHR) Strategic Training Program(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions (CHPI); National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil; German Research Counsel; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	HA was supported by a PhD studentship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program STP-53924 and the Centre for Host-Parasite Interactions (CHPI). TPR and KSC were supported by fellowships from the National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil, respectively. MMM was supported by the German Research Counsel (CEF-MC and SFB902). This work was supported by the Canadian Institutes of Health Research operating grant MOP-12182 awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi H, 2017, INT J PARASITOL, V47, P305, DOI 10.1016/j.ijpara.2017.02.001; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2008, MICROBES INFECT, V10, P575, DOI 10.1016/j.micinf.2008.02.009; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dupe A, 2014, MOL MICROBIOL, V91, P548, DOI 10.1111/mmi.12478; Geraldo MV, 2005, FEMS MICROBIOL LETT, V242, P275, DOI 10.1016/j.femsle.2004.11.030; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haile S, 2008, NUCLEIC ACIDS RES, V36, P1634, DOI 10.1093/nar/gkn019; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Sanchez-Luque FJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-340; Kligun E, 2015, RNA BIOL, V12, P720, DOI 10.1080/15476286.2015.1040977; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Muller M, 2010, NUCLEIC ACIDS RES, V38, P5867, DOI 10.1093/nar/gkq349; Muller M, 2010, MOL MICROBIOL, V77, P471, DOI 10.1111/j.1365-2958.2010.07226.x; Muller M, 2010, MOL BIOCHEM PARASIT, V170, P17, DOI 10.1016/j.molbiopara.2009.11.009; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; Smith M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-240; SOGIN ML, 1993, NATURE, V362, P795, DOI 10.1038/362795a0; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180678	10.1371/journal.pone.0180678	http://dx.doi.org/10.1371/journal.pone.0180678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704426	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700045
J	Beninca, E; van Boven, M; Hagenaars, T; van der Hoek, W				Beninca, Elisa; van Boven, Michiel; Hagenaars, Thomas; van der Hoek, Wim			Space-time analysis of pneumonia hospitalisations in the Netherlands	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; WAVELET ANALYSIS; RESPIRATORY SYMPTOMS; PRIMARY-CARE; SERIES; EPIDEMICS; MORTALITY; DYNAMICS; CLUSTERS; FARMS	Community acquired pneumonia is a major global public health problem. In the Netherlands there are 40,000-50,000 hospital admissions for pneumonia per year. In the large majority of these hospital admissions the etiologic agent is not determined and a real-time surveillance system is lacking. Localised and temporal increases in hospital admissions for pneumonia are therefore only detected retrospectively and the etiologic agents remain unknown. Here, we perform spatio-temporal analyses of pneumonia hospital admission data in the Netherlands. To this end, we scanned for spatial clusters on yearly and seasonal basis, and applied wavelet cluster analysis on the time series of five main regions. The pneumonia hospital admissions show strong clustering in space and time superimposed on a regular yearly cycle with high incidence in winter and low incidence in summer. Cluster analysis reveals a heterogeneous pattern, with most significant clusters occurring in the western, highly urbanised, and in the eastern, intensively farmed, part of the Netherlands. Quantitatively, the relative risk (RR) of the significant clusters for the age-standardised incidence varies from a minimum of 1.2 to a maximum of 2.2. We discuss possible underlying causes for the patterns observed, such as variations in air pollution.	[Beninca, Elisa; van Boven, Michiel; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Beninca, Elisa; Hagenaars, Thomas] Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Beninca, E (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.; Beninca, E (corresponding author), Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.	elisa.beninca@rivm.nl			ZonMw [522001001]; Netherlands Organization for Scientific Research (NWO)	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of E.B., W.v.d.H., T.H. and M.v.B. is supported by a ZonMw grant (project number 522001001) from the Netherlands Organization for Scientific Research (NWO)	Ben-Ari T, 2012, P NATL ACAD SCI USA, V109, P8196, DOI 10.1073/pnas.1110585109; Beninca E, 2015, P NATL ACAD SCI USA, V112, P6389, DOI 10.1073/pnas.1421968112; Beninca E, 2009, ECOL LETT, V12, P1367, DOI 10.1111/j.1461-0248.2009.01391.x; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Crighton EJ, 2008, GEOSPATIAL HEALTH, V2, P191, DOI 10.4081/gh.2008.243; Curtin L.R., 2000, HLTH PEOPLE 2000 STA, V1995, P1; Freidl GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174796; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Maassen K, 2016, 20160058 RIVM; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755; Malcolm BL, 2014, SPAT SPATIO-TEMPORAL, V8, P35, DOI 10.1016/j.sste.2014.01.001; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Quan TP, 2016, THORAX, V71, P535, DOI 10.1136/thoraxjnl-2015-207688; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Schenker MB, 1998, AM J RESP CRITICAL C, V158; Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Smit LAM, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0027-0; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Snijders BEP, 2013, PRIM CARE RESP J, V22, P400, DOI 10.4104/pcrj.2013.00085; Teirlinck AC vAL, 2015, 20150042 RIVM; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van Gageldonk-Lafeber AB, 2009, EPIDEMIOL INFECT, V137, P1472, DOI 10.1017/S0950268809002258	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180797	10.1371/journal.pone.0180797	http://dx.doi.org/10.1371/journal.pone.0180797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704495	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700051
J	Evangelista, KV; Lourdault, K; Matsunaga, J; Haake, DA				Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.			Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis	PLOS ONE			English	Article							BORGPETERSENII SEROVAR HARDJO; OUTER-MEMBRANE PROTEINS; IMMUNOGLOBULIN-LIKE; PROTECTIVE IMMUNITY; PATHOGENIC LEPTOSPIRA; RENAL COLONIZATION; CONSERVED REGION; LETHAL INFECTION; BOVIS INFECTION; DNA VACCINE	Leptospirosis is the most widespread zoonosis and is considered a major public health problem worldwide. Currently, there is no widely available vaccine against leptospirosis for use in humans. A purified, recombinant subunit vaccine that includes the last six immunoglobulin-like (Ig-like) domains of the leptospiral protein LigA (LigA7'-13) protects against lethal infection but not renal colonization after challenge by Leptospira interrogans. In this study, we examined whether the addition of the first seven Ig-like domains of LigB (LigB0-7) to LigA7'-13, can enhance immune protection and confer sterilizing immunity in the Golden Syrian hamster model of acute leptospirosis. Hamsters were subcutaneously immunized with soluble, recombinant LigA7'-13, LigB0-7, or a combination of LigA7'-13 and LigB0-7 in Freund's adjuvant. Immunization with Lig proteins generated a strong humoral immune response with high titers of IgG that recognized homologous protein, and cross-reacted with the heterologous protein as assessed by ELISA. LigA7'-13 alone, or in combination with LigB0-7, protected all hamsters from intraperitoneal challenge with a lethal dose of L. interrogans serovar Copenhageni strain Fiocruz L1-130. However, bacteria were recovered from the kidneys of all animals. Of eight animals immunized with LigB0-7, only three survived Leptospira challenge, one of which lacked renal colonization and had antibodies to native LigB by immuno-blot. In addition, sera from two of the three LigB0-7 immunized survivors cross-reacted with LigA11-13, a region of LigA that is sufficient for protection. In summary, we confirmed that LigA7'-13 protects hamsters from death but not infection, and immunization with LigB0-7, either alone or in combination with LigA7'-13, did not confer sterilizing immunity.	[Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Haake, David A.] UCLA, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Haake, David A.] UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Evangelista, KV (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.; Evangelista, KV (corresponding author), UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	karen.evangelista@gmail.com		lourdault, kristel/0000-0003-2875-5918	Veterans Affairs Merit Award; National Institutes of Health [R01 AI 034431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI128560, R01AI034431] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Veterans Affairs Merit Award to DAH, and National Institutes of Health grant R01 AI 034431 to DAH.	ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977; Adler B., 2014, LEPTOSPIRA LEPTOSPIR; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002; BOLIN CA, 1991, AM J VET RES, V52, P1639; BOLIN CA, 1989, AM J VET RES, V50, P2004; Bolin CA, 2001, AM J VET RES, V62, P995, DOI 10.2460/ajvr.2001.62.995; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Breda LCD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004192; Brown RA, 2003, VACCINE, V21, P4448, DOI 10.1016/S0264-410X(03)00439-0; Cao YG, 2011, VACCINE, V29, P7379, DOI 10.1016/j.vaccine.2011.07.070; Castiblanco-Valencia MM, 2016, IMMUNOL LETT, V173, P61, DOI 10.1016/j.imlet.2016.03.005; Castiblanco-Valencia MM, 2016, IMMUNOBIOLOGY, V221, P679, DOI 10.1016/j.imbio.2016.01.001; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Choy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041566; Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879; Conrad NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005441; Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307; Coutinho ML, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001422; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Forster KM, 2015, MEM I OSWALDO CRUZ, V110, P989, DOI 10.1590/0074-02760150222; Forster KM, 2013, CLIN VACCINE IMMUNOL, V20, P725, DOI 10.1128/CVI.00601-12; Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Goris MGA., 2005, LEPTOSPIROSIS SERODI; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 2006, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc12-02s02, DOI 10.1002/9780471729259.MC12-02S02]; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hartwig DD, 2014, CURR MICROBIOL, V68, P524, DOI 10.1007/s00284-013-0505-4; Hsieh CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004974; Humphryes PC, 2014, CLIN VACCINE IMMUNOL, V21, P546, DOI 10.1128/CVI.00719-13; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2005, J Postgrad Med, V51, P210; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin XA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-21; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2011, MOL MICROBIOL, V79, P1063, DOI 10.1111/j.1365-2958.2010.07510.x; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Martinez Sanchez R, 1998, Rev Cubana Med Trop, V50, P159; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2012, APPL ENVIRON MICROB, V78, P5699, DOI 10.1128/AEM.00713-12; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Monaris D, 2015, CLIN VACCINE IMMUNOL, V22, P965, DOI 10.1128/CVI.00285-15; Murray GL, 2013, VACCINE, V31, P495, DOI 10.1016/j.vaccine.2012.11.028; Naiman BM, 2001, INFECT IMMUN, V69, P7550, DOI 10.1128/IAI.69.12.7550-7558.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P7888, DOI 10.1128/AEM.02202-15; Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127; Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17; Truccolo J, 2002, ANTIMICROB AGENTS CH, V46, P848, DOI 10.1128/AAC.46.3.848-853.2002; Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618	69	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180004	10.1371/journal.pone.0180004	http://dx.doi.org/10.1371/journal.pone.0180004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704385	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700022
J	Mameli, C; Krakauer, JC; Krakauer, NY; Bosetti, A; Ferrari, CM; Schneider, L; Borsani, B; Arrigoni, S; Pendezza, E; Zuccotti, GV				Mameli, Chiara; Krakauer, Jesse C.; Krakauer, Nir Y.; Bosetti, Alessandra; Ferrari, Chiara Matilde; Schneider, Laura; Borsani, Barbara; Arrigoni, Sara; Pendezza, Erica; Zuccotti, Gian Vincenzo			Effects of a multidisciplinary weight loss intervention in overweight and obese children and adolescents: 11 years of experience	PLOS ONE			English	Article							PEDIATRIC OBESITY; CHILDHOOD OBESITY; PREVENTION; MANAGEMENT	Aims To evaluate the effects of an outpatient multidisciplinary weight loss intervention in reducing body mass index (BMI) in children and adolescents suffering overweight and obesity, changes in A Body Shape Index (ABSI, waist circumference normalized to height and weight) and Hip Index (HI, normalized hip circumference) during treatment and correlation between the ABSI and HI with change in BMI z score. Methods We analyze anthropometric data from pediatric patients affected by overweight and obesity aged 2 to 18 years old who entered our multidisciplinary weight loss intervention, which included medical, psychological and nutritional sessions, from January 1(st) 2006 to December 31(st) 2016. Lifestyle modification counselling was delivered. Follow-up visits were planned every month for 3 months and subsequently every 2-4 months. BMI, ABSI, and HI were converted to z scores using age and sex specific population normals. Results 864 patients entered our intervention. 453 patients (208 males), mean age 11.2 +/- 3.1 years, 392 with obesity (86%, z-BMI 2.90 +/- 0.80 SD) and 61 patients with overweight (z-BMI 1.73 +/- 0.21 SD) attended at least 1 follow-up visit. The mean number of visits was 3.5 (+/- 1.8 SD) in overweight subjects and 3.9 (+/- 2.2 SD) in ones with obesity. At the last attended follow-up visit (at 16 +/- 12 months SD) we observed a reduction in mean z-BMI in patients with obesity (to 2.52 +/- 0.71 SD) and patients with overweight (to 1.46 +/- 0.5 SD). Most patients (80.8%) reduced their BMI z scores. Mean ABSI and HI z scores showed no significant change. 78/ 392 patients (19.8%) recovered from obese to overweight, 5/392 (1.2%) from obese to normal weight. The recovery rate from overweight to normal weight was 13.1%. In a multivariate model, initial BMI z score and number of follow-up visits were significant predictors of weight change, while age, sex, ABSI, and HI were not significant predictors. Conclusions Patients affected by overweight and obesity involved in a multidisciplinary weight loss intervention reduced their mean BMI z score, while ABSI and HI were stable. Weight loss was not predicted by initial ABSI or HI. More visits predict more weight loss, but dropout rates are high. The great majority of patients leave the weight management program before having normalized their BMI.	[Mameli, Chiara; Bosetti, Alessandra; Ferrari, Chiara Matilde; Schneider, Laura; Borsani, Barbara; Arrigoni, Sara; Pendezza, Erica; Zuccotti, Gian Vincenzo] Univ Milan, V Buzzi Childrens Hosp, Dept Pediat, Milan, Italy; [Krakauer, Jesse C.] Metro Detroit Diabet & Endocrinol, Southfield, MI USA; [Krakauer, Nir Y.] CUNY City Coll, Dept Civil Engn, New York, NY 10031 USA	University of Milan; City University of New York (CUNY) System; City College of New York (CUNY)	Mameli, C (corresponding author), Univ Milan, V Buzzi Childrens Hosp, Dept Pediat, Milan, Italy.	chiara.mameli@unimi.it	Krakauer, Jesse/AAV-2692-2021	Pendezza, Erica/0000-0002-4966-7389				Aschbrenner KA, 2015, TRANSL BEHAV MED, V5, P277, DOI 10.1007/s13142-015-0313-4; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Danielsson P, 2016, ACTA PAEDIATR, V105, P1181, DOI 10.1111/apa.13360; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Kirk S, 2005, OBES RES, V13, P876, DOI 10.1038/oby.2005.101; Krakauer NY, 2016, J OBES, V2016, DOI 10.1155/2016/8094275; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Mameli C, 2016, PEDIAT OBES; Mameli C, 2017, PHARMACOL RES, V119, P99, DOI 10.1016/j.phrs.2017.01.017; Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838; McGovern L, 2008, J CLIN ENDOCR METAB, V93, P4600, DOI 10.1210/jc.2006-2409; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Resnicow K, 2006, J AM DIET ASSOC, V106, P2024, DOI 10.1016/j.jada.2006.09.015; Styne DM, 2017, J CLIN ENDOCR METAB, V102, P709, DOI 10.1210/jc.2016-2573; Tate EB, 2013, TRANSL BEHAV MED, V3, P406, DOI 10.1007/s13142-013-0222-3; Woolford SJ, 2011, CLIN PEDIATR, V50, P187, DOI 10.1177/0009922810384845; World Health Organization Expert Committee on Physical Status, 1995, TECHNICAL REPORT SER, V854; Xu Y, 2015, ANN HUM BIOL, V42, P70, DOI 10.3109/03014460.2014.903998	22	28	30	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181095	10.1371/journal.pone.0181095	http://dx.doi.org/10.1371/journal.pone.0181095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704494	Green Published, gold			2022-12-26	WOS:000405649700090
J	Sprenger, M; Mettler, T; Osma, J				Sprenger, Michaela; Mettler, Tobias; Osma, Jorge			Health professionals' perspective on the promotion of e-mental health apps in the context of maternal depression	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; WEB-BASED INTERVENTION; POSTNATAL DEPRESSION; POSTPARTUM DEPRESSION; POSITIVE PSYCHOLOGY; PLANNED BEHAVIOR; PRIMARY-CARE; SELF-HELP; WOMEN; IMPLEMENTATION	Objective Our study focuses on exploring (1) the intention of health professionals to use and recommend e-mental health applications, (2) how this intention of health professionals might be influenced, (3) which group of health professionals might be most accessible to promote emental health applications for maternal depression, and (4) for which tasks they rate them to be most useful. Materials and methods Based on a questionnaire informed by the theory of planned behavior, we collected 131 responses of U.S., Spanish, and Swiss health professionals in the field of pregnancy and maternal care (including psychologists, psychiatrists, midwives, and doctors) by means of an online survey. We analyzed the gathered data applying a structured equation model. Results Our study reveals that health professionals would in general intend to recommend and use e-mental health applications. However, their attitude towards e-mental health applications varies regarding the respective use cases and also differs among health professions. Conclusion We offer three alternative propositions for private or public organizations, associations, or any other entity whose purpose is service to the community for introducing e-mental health applications into practice.	[Sprenger, Michaela] Univ St Gallen, Inst Informat Management, St Gallen, Switzerland; [Mettler, Tobias] Univ Lausanne, Swiss Grad Sch Publ Adm, Lausanne, Switzerland; [Osma, Jorge] Univ Zaragoza, Dept Psychol & Sociol, Teruel, Spain	University of St Gallen; University of Lausanne; University of Zaragoza	Mettler, T (corresponding author), Univ Lausanne, Swiss Grad Sch Publ Adm, Lausanne, Switzerland.	tobias.mettler@unil.ch	Osma Lopez, Jorge Javier/F-9221-2011; Mettler, Tobias/A-9581-2015	Osma Lopez, Jorge Javier/0000-0002-7293-318X; Mettler, Tobias/0000-0002-7895-7545	Universidad de Zaragoza; Gobiernode Aragon; Fondo Social Europeo; Fundacion Bancaria Ibercaja; Fundacion CAI- [CH-21/16]; Swiss National Science Foundation [IZK0Z1_171209]	Universidad de Zaragoza; Gobiernode Aragon(Gobierno de Aragon); Fondo Social Europeo(European Social Fund (ESF)European Commission); Fundacion Bancaria Ibercaja; Fundacion CAI-; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partially supported by the Universidad de Zaragoza, Gobiernode Aragon, Fondo Social Europeo, Fundacion Bancaria Ibercaja, and Fundacion CAI- (CH-21/16) and the Swiss National Science Foundation (grant no. IZK0Z1_171209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2005, PERINATAL DEPRESSION; Austin M-P, 2004, Arch Womens Ment Health, V7, P1, DOI 10.1007/s00737-003-0034-4; Barlow DH, 2013, ANNU REV CLIN PSYCHO, V9, P1, DOI 10.1146/annurev-clinpsy-050212-185629; Barrera Alinne Z, 2015, Internet Interv, V2, P257, DOI 10.1016/j.invent.2015.06.002; Berg M, 2003, METHOD INFORM MED, V42, P297; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Byatt N, 2012, J REPROD INFANT PSYC, V30, P436, DOI 10.1080/02646838.2012.743000; Bygholm A, 2012, STUD HEALTH TECHNOL, V180, P934, DOI 10.3233/978-1-61499-101-4-934; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Chau PYK, 2002, INFORM MANAGE-AMSTER, V39, P297, DOI 10.1016/S0378-7206(01)00098-2; Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7; Chin W.W., 2010, HDB PARTIAL LEAST SQ, DOI DOI 10.1007/978-3-540-32827-8_29; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; Christensen Helen, 2003, Evid Based Ment Health, V6, P66; Christensen LarsRune., 2021, INFRAHEALTH 2021 P 8; Conner M., 2005, PREDICTING HLTH BEHA, P1; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Danaher BG, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2329; Emmelkamp PMG, 2005, PSYCHOTHER PSYCHOSOM, V74, P336, DOI 10.1159/000087780; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Fleming ML, 2014, RES SOC ADMIN PHARM, V10, P285, DOI 10.1016/j.sapharm.2013.05.009; Gefen D, 2011, MIS QUART, V35, pIII; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Haga SM, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2659; Hagger MS, 2015, HEALTH PSYCHOL REV, V9, P125, DOI 10.1080/17437199.2015.1034470; Hair J. F., 2017, ADV ISSUES PARTIAL L; Heneghan AM, 2007, CHILD CARE HLTH DEV, V33, P333, DOI 10.1111/j.1365-2214.2006.00648.x; Hewitt CE, 2009, BJOG-INT J OBSTET GY, V116, P1019, DOI 10.1111/j.1471-0528.2009.02148.x; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; Lal S, 2014, PSYCHIAT SERV, V65, P24, DOI 10.1176/appi.ps.201300009; Mair FS, 2012, B WORLD HEALTH ORGAN, V90, P357, DOI 10.2471/BLT.11.099424; Maloni JA, 2013, ARCH PSYCHIAT NURS, V27, P90, DOI 10.1016/j.apnu.2012.12.001; Meinel C, 2011, UNDERST INNOV, pXIII; Mettler T, 2011, INFORM HEALTH SOC CA, V36, P220, DOI 10.3109/17538157.2011.554931; Meurk C, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4827; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Munoz RF, 2012, AM PSYCHOL, V67, P285, DOI 10.1037/a0027666; Murray E, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-6; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; O'Mahen HA, 2013, J AFFECT DISORDERS, V150, P814, DOI 10.1016/j.jad.2013.03.005; Osma J, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P547, DOI 10.1109/BHI.2014.6864423; Osma J, 2016, CYBERPSYCH BEH SOC N, V19, P412, DOI 10.1089/cyber.2015.0549; Penate W, 2012, INT J CLIN HLTH PSYC, V12, P475; Petrou S, 2002, BRIT J PSYCHIAT, V181, P505, DOI 10.1192/bjp.181.6.505; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Ragaban Nouran, 2012, Stud Health Technol Inform, V178, P186; Reynolds J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4200; Santoro, 2010, IDENTIFYING TREATING; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Sockol LE, 2015, J AFFECT DISORDERS, V177, P7, DOI 10.1016/j.jad.2015.01.052; Staemmler M, 2011, STUD HEALTH TECHNOL, V169, P537, DOI 10.3233/978-1-60750-806-9-537; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Venkatesh V., 2012, EUR C INF SYST ECIS; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Vis Christiaan, 2015, Internet Interventions, V2, P399, DOI 10.1016/j.invent.2015.10.002; Warmerdam L, 2012, STUD HEALTH TECHNOL, V181, P339, DOI 10.3233/978-1-61499-121-2-339; Wykes T, 2016, J MENT HEALTH, V25, P1, DOI 10.3109/09638237.2015.1124406; [No title captured]	67	28	28	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180867	10.1371/journal.pone.0180867	http://dx.doi.org/10.1371/journal.pone.0180867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28704442	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649600051
J	Haupt-Jorgensen, M; Nielsen, E; Engkilde, K; Lerche, M; Larsen, J; Buschard, K				Haupt-Jorgensen, Martin; Nielsen, Erik; Engkilde, Kare; Lerche, Mia; Larsen, Jesper; Buschard, Karsten			Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study	PLOS ONE			English	Article							GLUTEN-FREE; NOD MICE; INSULIN; DIET; MELLITUS	Intranasal administration of gliadin prevents autoimmune diabetes in non-obese diabetic mice. The current study was designed to investigate if bakers are intranasally exposed to gluten during work and whether occupation as baker is inversely associated with type 1 diabetes. Gliadin was measured in nasal swabs from eight bakers and butchers. The odds ratio of type 1 diabetes in selected profession groups was analysed in a registry-based case-control study with data from 1980 to 2010 derived from Statistics Denmark. The cohort included 1,210,017 Danish individuals, thereof 15,451 with type 1 diabetes (1.28%). Average nasal gliadin swab content after full working days was 6.3 mu g (confidence interval (CI): 2.8 to 9.7) among bakers, while no nasal gliadin was detected among butchers. The odds ratio of type 1 diabetes was lower among bakers (OR = 0.57; CI: 0.52 to 0.62) and agriculture workers occupied with production of grains (OR = 0.65; CI: 0.56 to 0.75). Bakers had a lower odds ratio of type 1 diabetes, which potentially could be attributed to exposure of nasal mucosal gluten during work, as observed in this study. If other studies confirm the present observations, intranasal gliadin administration could possibly be an easy and safe approach for the prevention of type 1 diabetes in high-risk individuals or prediabetic subjects.	[Haupt-Jorgensen, Martin; Nielsen, Erik; Engkilde, Kare; Lerche, Mia; Larsen, Jesper; Buschard, Karsten] Rigshosp, Bartholin Inst, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Haupt-Jorgensen, M (corresponding author), Rigshosp, Bartholin Inst, Copenhagen, Denmark.	martin.haupt-joergensen@regionh.dk	Haupt-Jorgensen, Martin/K-7424-2019	Haupt-Jorgensen, Martin/0000-0003-4088-5862; Buschard, Karsten/0000-0002-0126-7423	Kirsten and Freddy Johannsen Foundation	Kirsten and Freddy Johannsen Foundation	This study was supported by Kirsten and Freddy Johannsen Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094530; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Hansen D, 2001, ACTA PAEDIATR, V90, P1238, DOI 10.1080/080352501317130254; Harrison LC, 2013, CURR DIABETES REP, V13, P616, DOI 10.1007/s11892-013-0415-7; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; Ostman J, 2008, J INTERN MED, V263, P386, DOI 10.1111/j.1365-2796.2007.01896.x; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Sildorf S. M., 2012, BMJ CASE REP, V2012; Svensson J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2641-3; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	16	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e.0181143	10.1371/journal.pone.0181143	http://dx.doi.org/10.1371/journal.pone.0181143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700675	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400034
J	Grellet, S; Tzelepi, K; Roskamp, M; Williams, P; Sharif, A; Slade-Carter, R; Goldie, P; Whilde, N; Smialek, MA; Mason, NJ; Golding, JP				Grellet, Sophie; Tzelepi, Konstantina; Roskamp, Meike; Williams, Phil; Sharif, Aquila; Slade-Carter, Richard; Goldie, Peter; Whilde, Nicky; Smialek, Malgorzata A.; Mason, Nigel J.; Golding, Jon P.			Cancer-selective, single agent chemoradiosensitising gold nanoparticles	PLOS ONE			English	Article							RADIATION-THERAPY; CELLS; RADIOSENSITIZATION; ENHANCEMENT; RESONANCE; SIZE	Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50: 50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics.	[Grellet, Sophie; Tzelepi, Konstantina; Golding, Jon P.] Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England; [Roskamp, Meike; Williams, Phil] Midatech Pharma, Milton Pk, Abingdon, Oxon, England; [Sharif, Aquila; Slade-Carter, Richard] Milton Keynes Med Ctr, GenesisCare, Milton Keynes, Bucks, England; [Goldie, Peter; Whilde, Nicky] Northampton Gen Hosp NHS Trust, Radiotherapy Dept, Northampton, England; [Smialek, Malgorzata A.] Gdansk Univ Technol, Fac Ocean Engn & Ship Technol, Dept Control & Power Engn, Gdansk, Poland; [Smialek, Malgorzata A.; Mason, Nigel J.] Open Univ, Sch Phys Sci, Walton Hall, Milton Keynes, Bucks, England	Open University - UK; Fahrenheit Universities; Gdansk University of Technology; Open University - UK	Golding, JP (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England.	Jon.Golding@open.ac.uk	Golding, Jon/L-2700-2017; Smialek, Malgorzata A./G-1577-2011; Śmiałek-Telega, Małgorzata/GYJ-5849-2022	Golding, Jon/0000-0002-7910-7382; Smialek, Malgorzata A./0000-0003-2624-3716; 				Alric C, 2013, NANOSCALE, V5, P5930, DOI 10.1039/c3nr00012e; Beddoes CM, 2015, ADV COLLOID INTERFAC, V218, P48, DOI 10.1016/j.cis.2015.01.007; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Butterworth KT, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/29/295101; Chhour P, 2017, BIOCONJUGATE CHEM, V28, P260, DOI 10.1021/acs.bioconjchem.6b00566; Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; COLLINS AK, 1994, MED PHYS, V21, P1741, DOI 10.1118/1.597275; Fratoddi I, 2015, NANO RES, V8, P1771, DOI 10.1007/s12274-014-0697-3; Geng F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285101; Gilles M, 2014, COLLOID SURFACE B, V123, P770, DOI 10.1016/j.colsurfb.2014.10.028; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hau H, 2016, BIOENG TRANSL MED, V1, P94, DOI 10.1002/btm2.10007; Haume Kaspar, 2016, Cancer Nanotechnol, V7, P8, DOI 10.1186/s12645-016-0021-x; Hong R, 2006, GLUTATHIONE MEDIATED; Hostetler MJ, 1998, ALKANETHIOLATE GOLD; Irure A, 2013, BIOMATER SCI-UK, V1, P658, DOI 10.1039/c3bm60032g; Jain S, 2011, INT J RADIAT ONCOL, V79, P531, DOI 10.1016/j.ijrobp.2010.08.044; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Kelts JL, 2015, ALTERED CYTOTOXICITY, V4, P269; Khoshgard K, 2014, PHYS MED BIOL, V59, P2249, DOI 10.1088/0031-9155/59/9/2249; Kwatra D, 2013, TRANSL CANCER RES, V2, P330, DOI 10.3978/j.issn.2218-676X.2013.08.06; Lee K, 2011, BIOMATERIALS, V32, P2556, DOI 10.1016/j.biomaterials.2010.11.072; Liu CJ, 2010, PHYS MED BIOL, V55, P931, DOI 10.1088/0031-9155/55/4/002; Liu CJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295104; Luchette M, 2014, NANOMED-NANOTECHNOL, V10, P1751, DOI 10.1016/j.nano.2014.06.004; Lund T, 2011, BIOMATERIALS, V32, P9776, DOI 10.1016/j.biomaterials.2011.09.018; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; McMahon SJ, 2016, NANOSCALE, V8, P581, DOI 10.1039/c5nr07089a; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Page P, 2010, ANTICANCER RES, V30, P3675; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pottier A, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150171; Qian HF, 2012, P NATL ACAD SCI USA, V109, P696, DOI 10.1073/pnas.1115307109; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; Sancey L, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140134; Schaaff GT, 2001, PROPERTIES UBIQUITOU; Xiao FX, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/46/465101; Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047; Zhang XJ, 2008, CLIN INVEST MED, V31, pE160, DOI 10.25011/cim.v31i3.3473; Zhu CD, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0129-x	43	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0181103	http://dx.doi.org/10.1371/journal.pone.0181103			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700660	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000405544800121
J	Lee, LW; Lin, CM; Li, HC; Hsiao, PL; Chung, AC; Hsieh, CJ; Wu, PC; Hsu, SF				Lee, Li-Wen; Lin, Chieh-Mo; Li, Hung-Chou; Hsiao, Pei-Lin; Chung, An-Chi; Hsieh, Chu-Jung; Wu, Pi-Chi; Hsu, Shu-Feng			Body composition changes in male patients with chronic obstructive pulmonary disease: Aging or disease process?	PLOS ONE			English	Article							YOUNG-ADULTS; COPD; AGE; CACHEXIA; PREVALENCE; MECHANISMS; SAMPLE; COHORT; MASS; DXA	Background Chronic obstructive pulmonary disease (COPD) mainly affects middle-age and elderly adults. It is unclear if the presence of muscle wasting and fat accumulation in patients with COPD is age or disease-related. This study investigated the effect of age and COPD disease severity on body composition with the aim of identifying a biomarker(s) for COPD. Methods Healthy subjects and patients with COPD of different severity were recruited. Dual-energy X-ray absorptiometry was used to analyze total and segmental body composition. Subjects included in the analysis were classified into four groups: healthy young (aged 20-45 years) (n = 35), healthy old (aged >= 60 years) (n = 37), moderate COPD (n = 40), and severe COPD (n = 14). Results In healthy old adults, leg and limb lean masses were lower by 10.6% and 8.5%, respectively, compared with healthy young adults (P < 0.05). Appendicular lean outcomes were significantly lower in the moderate COPD compared to the healthy old group and were significant lower in subjects with severe COPD compared to those with moderate COPD. All fat depots were similar for both young and old healthy subjects and subjects with moderate COPD, but significantly decreased in patients with severe COPD. Conclusions This study examined the changes in total and segmental body composition with aging and COPD severity. It found that aging and COPD altered the body composition differently, and the effect was most pronounced in leg lean mass. Remarkably, differences in appendicular lean masses were seen in mild COPD although no changes in body weight or BMI were apparent compared with healthy young adults. In contrast, fat depot changes were only observed in severe COPD. Aging and COPD processes are multifactorial and additional longitudinal studies are required to explore both the quantitative and qualitative changes in body composition with aging and disease process.	[Lee, Li-Wen; Li, Hung-Chou; Hsiao, Pei-Lin; Hsieh, Chu-Jung] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Lee, Li-Wen; Lin, Chieh-Mo] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Lin, Chieh-Mo] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Chieh-Mo] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chung, An-Chi] Chang Gung Mem Hosp, Dept Resp Therapy, Chiayi, Taiwan; [Wu, Pi-Chi; Hsu, Shu-Feng] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsu, SF (corresponding author), Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan.	koala7138@cgmh.org.tw	Lee, Li-Wen/AAY-3542-2021	Lee, Li-Wen/0000-0001-8019-1772	Chang Gung Medical Foundation (Chang Gung Memorial Hospital) [CMRPG6D0262, CMRPG6D0271]	Chang Gung Medical Foundation (Chang Gung Memorial Hospital)	This study was funded by the Chang Gung Medical Foundation (Chang Gung Memorial Hospital), grant number CMRPG6D0262 to SFH and CMRPG6D0271 (https://www.cgmh.org.tw/) to HCL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazmi M, 2007, CAN RESPIR J, V14, P221, DOI 10.1155/2007/987249; Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; [Anonymous], 2004, PRACT GUID BON DENS; Atlantis E, 2008, AM J CLIN NUTR, V88, P95; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Cerveri I, 2001, EUR RESPIR J, V18, P85, DOI 10.1183/09031936.01.00087101; Charlier R, 2015, ARCH GERONTOL GERIAT, V61, P161, DOI 10.1016/j.archger.2015.06.009; Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Ding JZ, 2007, AM J CLIN NUTR, V85, P405; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Franssen FME, 2002, MED SCI SPORT EXER, V34, P1570, DOI 10.1097/00005768-200210000-00007; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOBAL STRATEGY DIAG; Hart NH, 2015, J SPORT SCI MED, V14, P620; Heymsfield SB, 2000, EUR J CLIN NUTR, V54, pS26, DOI 10.1038/sj.ejcn.1601022; HIMES JH, 1979, MONOGR SOC RES CHILD, V44, P28, DOI 10.2307/1165884; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Joppa P, 2016, J AM MED DIR ASSOC, V17, P712, DOI 10.1016/j.jamda.2016.03.020; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; National health and nutrition examination survey (NHANES), 2013, BOD COMP PROC MAN; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Polkey MI, 2002, CHEST, V121, p131S, DOI 10.1378/chest.121.5_suppl.131S; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Romme EAPM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0192-8; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Sanders KJC, 2016, J CACHEXIA SARCOPENI, V7, P5, DOI 10.1002/jcsm.12062; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Sun SMS, 2012, AM J HUM BIOL, V24, P506, DOI 10.1002/ajhb.22256; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180928	10.1371/journal.pone.0180928	http://dx.doi.org/10.1371/journal.pone.0180928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700654	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800101
J	Sundberg, JP; Dadras, SS; Silva, KA; Kennedy, VE; Garland, G; Murray, SA; Sundberg, BA; Schofield, PN; Pratt, CH				Sundberg, John P.; Dadras, Soheil S.; Silva, Kathleen A.; Kennedy, Victoria E.; Garland, Gaven; Murray, Stephen A.; Sundberg, Beth A.; Schofield, Paul N.; Pratt, C. Herbert			Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program	PLOS ONE			English	Article							GENE-FUNCTION; GENOME-WIDE; AKR/J MICE; HISTOPATHOLOGY; DISEASE; EXPRESSION; GENERATION; PHENOTYPES; MUTATIONS; PATHOLOGY	The International Knockout Mouse Consortium was formed in 2007 to inactivate ("knockout") all protein-coding genes in the mouse genome in embryonic stem cells. Production and characterization of these mice, now underway, has generated and phenotyped 3,100 strains with knockout alleles. Skin and adnexa diseases are best defined at the gross clinical level and by histopathology. Representative retired breeders had skin collected from the back, abdomen, eyelids, muzzle, ears, tail, and lower limbs including the nails. To date, 169 novel mutant lines were reviewed and of these, only one was found to have a relatively minor sebaceous gland abnormality associated with follicular dystrophy. The B6N(Cg)Far2 (tm2b(KOMP) Wtsi)/2J strain, had lesions affecting sebaceous glands with what appeared to be a secondary follicular dystrophy. A second line, B6N(Cg)-Ppp1r9b(tm1.1(KOMP)Vlcg)/J, had follicular dystrophy limited to many but not all mystacial vibrissae in heterozygous but not homozygous mutant mice, suggesting that this was a nonspecific background lesion. We discuss potential reasons for the low frequency of skin and adnexal phenotypes in mice from this project in comparison to those seen in human Mendelian diseases, and suggest alternative approaches to identification of human disease-relevant models.	[Sundberg, John P.; Silva, Kathleen A.; Kennedy, Victoria E.; Garland, Gaven; Murray, Stephen A.; Sundberg, Beth A.; Schofield, Paul N.; Pratt, C. Herbert] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Dadras, Soheil S.] Univ Connecticut, Dept Dermatol, Farmington, CT USA; [Dadras, Soheil S.] Univ Connecticut, Dept Pathol, Farmington, CT USA; [Schofield, Paul N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Jackson Laboratory; University of Connecticut; University of Connecticut; University of Cambridge	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org		Schofield, Paul/0000-0002-5111-7263	National Institutes of Health [R21-AR063781, U42-OD011185]; National Cancer Institute Core Grant [P30-CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UM1OD023222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (R21-AR063781 and U42-OD011185). Shared services at The Jackson Laboratory are subsidized by a National Cancer Institute Core Grant (P30-CA034196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Adissu HA, 2014, DIS MODEL MECH, V7, P515, DOI 10.1242/dmm.015263; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Carroll JM, 2002, J INVEST DERMATOL, V119, P392, DOI 10.1046/j.1523-1747.2002.01811.x; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DiTommaso T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004705; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Giehl KA, 2009, CLIN EXP DERMATOL, V34, P509, DOI 10.1111/j.1365-2230.2008.03135.x; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Qin Wenning, 2016, Curr Protoc Mouse Biol, V6, P39, DOI 10.1002/9780470942390.mo150178; Schofield PN, 2012, DIS MODEL MECH, V5, P19, DOI 10.1242/dmm.008334; Schofield PN, 2011, TOXICOL PATHOL, V39, P559, DOI 10.1177/0192623311399789; Silva K, 2012, LAB MOUSE, P779; Simon MM, 2015, MAMM GENOME, V26, P486, DOI 10.1007/s00335-015-9603-x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stenn KS, 1999, ARCH DERMATOL, V135, P973, DOI 10.1001/archderm.135.8.973; Sundberg JP, 2011, VET PATHOL, V48, P513, DOI 10.1177/0300985810379431; Sundberg J. P., 2012, COMP ANATOMY HISTOLO, P433; Sundberg JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113582; Taylor DK, 2012, VET PATHOL, V49, P146, DOI 10.1177/0300985811430511; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vogel P, 2015, VET PATHOL, V52, P224, DOI 10.1177/0300985814528218; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Ward JM, 2017, LAB ANIMAL, V46, P146, DOI 10.1038/laban.1214; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wolf JC, 2017, ENVIRON TOXICOL CHEM, V36, P601, DOI 10.1002/etc.3695; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180682	10.1371/journal.pone.0180682	http://dx.doi.org/10.1371/journal.pone.0180682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700664	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800065
J	Matzaraki, V; Gresnigt, MS; Jaeger, M; Ricano-Ponce, I; Johnson, MD; Oosting, M; Franke, L; Withoff, S; Perfect, JR; Joosten, LAB; Kullberg, BJ; van de Veerdonk, FL; Jonkers, I; Li, Y; Wijmenga, C; Netea, MG; Kumar, V				Matzaraki, Vasiliki; Gresnigt, Mark S.; Jaeger, Martin; Ricano-Ponce, Isis; Johnson, Melissa D.; Oosting, Marije; Franke, Lude; Withoff, Sebo; Perfect, John R.; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Jonkers, Iris; Li, Yang; Wijmenga, Cisca; Netea, Mihai G.; Kumar, Vinod			An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOST-DEFENSE; ALBICANS; INFLAMMATION; RECOGNITION; ASSOCIATION; INDUCTION; CYTOKINES; RESPONSES; SEPSIS	Candidaemia is a bloodstream infection caused by Candida species that primarily affects specific groups of at-risk patients. Because only small candidaemia patient cohorts are available, classical genome wide association cannot be used to identify Candida susceptibility genes. Therefore, we have applied an integrative genomics approach to identify novel susceptibility genes and pathways for candidaemia. Candida-induced transcriptome changes in human primary leukocytes were assessed by RNA sequencing. Genetic susceptibility to candidaemia was assessed using the Illumina immunochip platform for genotyping of a cohort of 217 patients. We then integrated genetics data with gene-expression profiles, Candidainduced cytokine production capacity, and circulating concentrations of cytokines. Based on the intersection of transcriptome pathways and genomic data, we prioritized 31 candidate genes for candidaemia susceptibility. This group of genes was enriched with genes involved in inflammation, innate immunity, complement, and hemostasis. We then validated the role of MAP3K8 in cytokine regulation in response to Candida stimulation. Here, we present a new framework for the identification of susceptibility genes for infectious diseases that uses an unbiased, hypothesis-free, systems genetics approach. By applying this approach to candidaemia, we identified novel susceptibility genes and pathways for candidaemia, and future studies should assess their potential as therapeutic targets.	[Matzaraki, Vasiliki; Ricano-Ponce, Isis; Franke, Lude; Withoff, Sebo; Jonkers, Iris; Li, Yang; Wijmenga, Cisca; Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Gresnigt, Mark S.; Jaeger, Martin; Oosting, Marije; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Gresnigt, Mark S.; Jaeger, Martin; Oosting, Marije; Joosten, Leo A. B.; Kullberg, Bart Jan; van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Johnson, Melissa D.; Perfect, John R.] Duke Univ, Med Ctr, Durham, NC USA; [Wijmenga, Cisca] Univ Oslo, Dept Immunol, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Netea, Mihai G.] Craiova Univ Med & Pharm, Human Genom Lab, Craiova, Romania	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Duke University; University of Oslo; University of Medicine & Pharmacy of Craiova	Kumar, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	v.kumar@umcg.nl	Matzaraki, Vasiliki/V-7081-2018; van de Veerdonk, Frank L/C-7256-2008; Gresnigt, Mark/H-3530-2015; Johnson, Melissa D/AAT-2078-2020; Ricaño-Ponce, Isis/ABC-5454-2020; Matzaraki, Vasiliki/AAK-7880-2020; Joosten, Leo AB/H-3138-2015; Jaeger, Martin/H-3359-2015; Wijmenga, Cisca/AAE-7719-2019; Kullberg, BJ/C-8520-2013; Kumar, Vinod/ABC-4866-2020; Netea, Mihai/N-5155-2014; Li, Yang/HGT-8446-2022; Matzaraki, Vasiliki/GZB-0509-2022; Oosting, Marije/H-7437-2015	Matzaraki, Vasiliki/0000-0002-5852-6801; van de Veerdonk, Frank L/0000-0002-1121-4894; Gresnigt, Mark/0000-0002-9514-4634; Johnson, Melissa D/0000-0002-6606-9460; Ricaño-Ponce, Isis/0000-0002-7530-9526; Matzaraki, Vasiliki/0000-0002-5852-6801; Joosten, Leo AB/0000-0001-6166-9830; Jaeger, Martin/0000-0001-6994-493X; Wijmenga, Cisca/0000-0002-5635-1614; Kullberg, BJ/0000-0002-6813-8167; Kumar, Vinod/0000-0002-2775-6049; Li, Yang/0000-0003-4022-7341; Matzaraki, Vasiliki/0000-0002-5852-6801; 	ERC [FP/ERC] [2012-310372, 2012-322698]; Spinoza prize grant [NWO SPI 92-266]; European Union Seventh Framework Programme grant (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; NWO VENI grant [863.13.011]; Graduate School of Medical Sciences, University of Groningen, the Netherlands	ERC [FP/ERC]; Spinoza prize grant; European Union Seventh Framework Programme grant (EU FP7) TANDEM project; NWO VENI grant; Graduate School of Medical Sciences, University of Groningen, the Netherlands	This work was supported by an ERC Consolidator Grant [FP/2007-2013/ERC grant 2012-310372 to M.G.N.], an ERC Advanced grant [FP/2007-2013/ERC grant 2012-322698 to C.W.], a Spinoza prize grant [NWO SPI 92-266 to C.W.], a European Union Seventh Framework Programme grant (EU FP7) TANDEM project [HEALTH-F3-2012-305279 to C.W. and V.K.] and an NWO VENI grant [863.13.011 to Y.L.]. V.M. is supported by a PhD scholarship from Graduate School of Medical Sciences, University of Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2005, CRIT CARE CLIN, V21, P417, DOI 10.1016/j.ccc.2005.04.004; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Griese M, 2007, EUR RESPIR J, V29, P240, DOI 10.1183/09031936.00047306; Hu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102767; Jaeger M, 2015, EUR J CLIN MICROBIOL, V34, P963, DOI 10.1007/s10096-014-2309-2; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kaner Z, 2015, J INFECT DIS, V211, P1489, DOI 10.1093/infdis/jiu620; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kidane YH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-224; Krueger KE, 2004, MICROBIOL-SGM, V150, P229, DOI 10.1099/mic.0.26792-0; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Kuriakose T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005038; LEHRER RI, 1969, J BACTERIOL, V98, P996, DOI 10.1128/JB.98.3.996-1004.1969; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Newport MJ, 2011, BRIEF FUNCT GENOMICS, V10, P98, DOI 10.1093/bfgp/elq037; Obel N, 2010, AM J EPIDEMIOL, V171, P1007, DOI 10.1093/aje/kwq037; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Speth C, 2014, THROMB HAEMOSTASIS, V112, P632, DOI 10.1160/TH14-01-0074; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van de Veerdonk FL, 2012, CLIN MICROBIOL INFEC, V18, P112, DOI 10.1111/j.1469-0691.2011.03676.x; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Vani J, 2010, NEW ENGL J MED, V363, P1676, DOI 10.1056/NEJMc1007642; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wisplinghoff H, 2006, CLIN MICROBIOL INFEC, V12, P170, DOI 10.1111/j.1469-0691.2005.01318.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Zipfel PF, 2012, EUR J IMMUNOL, V42, P822, DOI 10.1002/eji.201242466	52	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180824	10.1371/journal.pone.0180824	http://dx.doi.org/10.1371/journal.pone.0180824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727728	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500030
J	Duarte, S; Cassio, F; Pascoal, C; Barlocher, F				Duarte, Sofia; Cassio, Fernanda; Pascoal, Claudia; Barlocher, Felix			Taxa-area relationship of aquatic fungi on deciduous leaves	PLOS ONE			English	Article							DECOMPOSER COMMUNITIES; SPECIES ACCUMULATION; LITTER DECOMPOSITION; ISLAND SIZE; DIVERSITY; MICROBES; COLONIZATION; EVOLUTIONARY; DISPERSAL; PATTERNS	One of the fundamental patterns in macroecology is the increase in the number of observed taxa with size of sampled area. For microbes, the shape of this relationship remains less clear. The current study assessed the diversity of aquatic fungi, by the traditional approach based on conidial morphology (captures reproducing aquatic hyphomycetes) and next generation sequencing (NGS; captures other fungi as well), on graded sizes of alder leaves (0.6 to 13.6 cm(2)). Leaves were submerged in two streams in geographically distant locations: the Oliveira Stream in Portugal and the Boss Brook in Canada. Decay rates of alder leaves and fungal sporulation rates did not differ between streams. Fungal biomass was higher in Boss Brook than in Oliveira Stream, and in both streams almost 100% of the reads belonged to active fungal taxa. In general, larger leaf areas tended to harbour more fungi, but these findings were not consistent between techniques. Morphospecies-based diversity increased with leaf area in Boss Brook, but not in Oliveira Stream; metabarcoding data showed an opposite trend. The higher resolution of metabarcoding resulted in steeper taxa-accumulation curves than morphospecies-based assessments (fungal conidia morphology). Fungal communities assessed by metabarcoding were spatially structured by leaf area in both streams. Metabarcoding promises greater resolution to assess biodiversity patterns in aquatic fungi and may be more accurate for assessing taxa-area relationships and local to global diversity ratios.	[Duarte, Sofia; Cassio, Fernanda; Pascoal, Claudia] Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal; [Cassio, Fernanda; Pascoal, Claudia] Univ Minho, Inst Sci & Innovat Biosustainabil IB S, Braga, Portugal; [Barlocher, Felix] Mt Allison Univ, Dept Biol, New Brunswick, NJ USA	Universidade do Minho; Universidade do Minho	Duarte, S (corresponding author), Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal.	sduarte@bio.uminho.pt	Duarte, Sofia/H-3323-2013; Baerlocher, Felix/C-1307-2011; Duarte, Sofia/ABD-8278-2021; Pascoal, Claudia/C-4072-2009; Cassio, Fernanda/A-6653-2011	Duarte, Sofia/0000-0002-0181-0676; Baerlocher, Felix/0000-0003-2404-625X; Duarte, Sofia/0000-0002-0181-0676; Pascoal, Claudia/0000-0002-2018-4201; Cassio, Fernanda/0000-0003-3924-3280	Portuguese Foundation for Science and Technology (FCT) [UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569)]; ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT [PTDC/AAC-AMB/117068/2010, SFRH/BPD/47574/2008, SFRH/BPD/109842/2015]; European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE); NSERC Discovery grant program; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/117068/2010] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE); NSERC Discovery grant program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fundação para a Ciência e a Tecnologia	This work was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569), funded by national funds through the Portuguese Foundation for Science and Technology (FCT) I.P. (http://www.fct.pt/) and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) and by the project PTDC/AAC-AMB/117068/2010, funded by national funds through FCT I.P. and the European Regional Development Funds through the Operational Competitiveness Program (FEDER-COMPETE). Support from FCT to SD (SFRH/BPD/47574/2008 and SFRH/BPD/109842/2015) and from NSERC Discovery grant program (http://www.nserc-crsng.gc.ca/index_eng.asp) to FB is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], ISME J; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Barlocher F, 2016, FUNGAL ECOL, V19, P14, DOI 10.1016/j.funeco.2015.05.005; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; Baerlocher Felix, 2011, Czech Mycology, V63, P113; Barlocher F, 2010, J N AM BENTHOL SOC, V29, P1027, DOI 10.1899/09-081.1; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; BARLOCHER F, 1980, OECOLOGIA, V47, P303, DOI 10.1007/BF00398521; BARLOCHER F, 1983, OIKOS, V41, P205, DOI 10.2307/3544265; BARLOCHER F, 1981, T BRIT MYCOL SOC, V76, P479; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardoso P, 2009, DIVERS DISTRIB, V15, P1081, DOI 10.1111/j.1472-4642.2009.00607.x; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y; Duarte S, 2017, LIMNETICA IN PRESS; Duarte S, 2016, FUNGAL ECOL, V19, P169, DOI 10.1016/j.funeco.2015.06.002; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; Dunck B, 2015, ENVIRON POLLUT, V202, P32, DOI 10.1016/j.envpol.2015.03.014; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Fernandes I, 2015, FUNGAL ECOL, V18, P130, DOI 10.1016/j.funeco.2015.08.005; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gessner Mark O., 2005, P189, DOI 10.1007/1-4020-3466-0_25; Gray JS, 2004, GLOBAL ECOL BIOGEOGR, V13, P567, DOI 10.1111/j.1466-822X.2004.00138.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Grimmett IJ, 2013, FUNGAL ECOL, V6, P493, DOI 10.1016/j.funeco.2013.08.002; Grimmett IJ, 2012, FRESHW SCI, V31, P1088, DOI 10.1899/12-034.1; Gulis Vladislav, 2005, P153, DOI 10.1007/1-4020-3466-0_21; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Lima-Fernandes E, 2015, FRESHW SCI, V34, P31, DOI 10.1086/679223; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Matthews TJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P607, DOI 10.1111/geb.12439; Meiser A, 2014, NEW PHYTOL, V201, P623, DOI 10.1111/nph.12532; Motulsky Harvey J., 2004, P1; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SANDERS PF, 1979, T BRIT MYCOL SOC, V73, P103, DOI 10.1016/S0007-1536(79)80079-0; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Suberkropp K, 1998, MICROORGANISMS ORGAN; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; van der Gast CJ, 2005, ENVIRON MICROBIOL, V7, P1220, DOI 10.1111/j.1462-2920.2005.00802.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; WOODEGGENSCHWILER S, 1983, T BRIT MYCOL SOC, V81, P371, DOI 10.1016/S0007-1536(83)80089-8; Wurzbacher Christian, 2015, F1000Res, V4, P1378, DOI 10.12688/f1000research.7359.1; Zar J.H., 1996, BIOSTAT ANAL	66	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181545	10.1371/journal.pone.0181545	http://dx.doi.org/10.1371/journal.pone.0181545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719634	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400053
J	te Beest, DE; de Bruin, E; Imholz, S; Koopmans, M; van Boven, M				te Beest, Dennis E.; de Bruin, Erwin; Imholz, Sandra; Koopmans, Marion; van Boven, Michiel			Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; MEMORY B-CELLS; VIRUS HEMAGGLUTININ; PROTEIN MICROARRAY; VACCINE; INFECTION; RESPONSES; EPITOPE; TRANSMISSION; RECOGNITION	Epidemics of influenza A vary greatly in size and age distribution of cases, and this variation is attributed to varying levels of pre-existing immunity. Recent studies have shown that anti-body-mediated immune responses are more cross-reactive than previously believed, and shape patterns of humoral immunity to influenza A viruses over long periods. Here we quantify antibody responses to the hemagglutinin subunit 1 (HA1) across a range of subtypes using protein microarray analysis of cross-sectional serological surveys carried out in the Netherlands before and after the A/2009 (H1N1) pandemic. We find significant associations of responses, both within and between subtypes. Interestingly, substantial overall reactivity is observed to HA1 of avian H7N7 and H9N2 viruses. Seroprevalence of H7N7 correlates with antibody titers to A/1968 (H3N2), and is highest in persons born between 1954 and 1969. Seroprevalence of H9N2 is high across all ages, and correlates strongly with A/1957 (H2N2). This correlation is most pronounced in A/2009 (H1N1) infected persons born after 1968 who have never encountered A/1957 (H2N2)-like viruses. We conclude that heterosubtypic antibody cross-reactivity, both between human subtypes and between human and nonhuman subtypes, is common in the human population.	[te Beest, Dennis E.; de Bruin, Erwin; Koopmans, Marion; van Boven, Michiel] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [te Beest, Dennis E.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [de Bruin, Erwin; Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Imholz, Sandra] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; te Beest, Dennis E./0000-0001-5265-9008	National Institute for Public Health and the Environment project [S/210096]	National Institute for Public Health and the Environment project	This work was supported by the National Institute for Public Health and the Environment project S/210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas DC, 2013, J MED VIROL, V85, P899, DOI 10.1002/jmv.23535; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Chiu C, 2013, ANN NY ACAD SCI, V1283, P13, DOI 10.1111/nyas.12012; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Huijskens EGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054890; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; Kucharski AJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002741; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Lee PS, 2015, CURR TOP MICROBIOL, V386, P323, DOI 10.1007/82_2014_413; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Miller MS, 2014, CELL, V157, P294, DOI 10.1016/j.cell.2014.03.023; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Nachbagauer R, 2017, NAT IMMUNOL, V18, P464, DOI 10.1038/ni.3684; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; te Beest D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113021; te Beest DE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1244; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang W, 2015, P NATL ACAD SCI USA, V112, P2723, DOI 10.1073/pnas.1415012112	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181093	10.1371/journal.pone.0181093	http://dx.doi.org/10.1371/journal.pone.0181093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715468	Green Published, Green Submitted, gold			2022-12-26	WOS:000443975500027
J	Yin, WX; Zhang, C; Zhu, HY; Zhao, YR; He, Y				Yin, Wenxin; Zhang, Chu; Zhu, Hongyan; Zhao, Yanru; He, Yong			Application of near-infrared hyperspectral imaging to discriminate different geographical origins of Chinese wolfberries	PLOS ONE			English	Article							SPECTROSCOPY; CLASSIFICATION; WAVELENGTHS; TECHNOLOGY; FEATURES; SPECTRA	Near-infrared (874-1734 nm) hyperspectral imaging (NIR-HSI) technique combined with chemometric methods was used to trace origins of 1200 Chinese wolfberry samples, which from Ningxia, Inner Mongolia, Sinkiang and Qinghai in China. Two approaches, named pixel-wise and object-wise, were investigated to discriminative the origin of these Chinese wolfberries. The pixel-wise classification assigned a class to each pixel from individual Chinese wolfberries, and with this approach, the differences in the Chinese wolfberries from four origins were reflected intuitively. Object-wise classification was performed using mean spectra. The average spectral information of all pixels of each sample in the hyperspectral image was extracted as the representative spectrum of a sample, and then discriminant analysis models of the origins of Chinese wolfberries were established based on these average spectra. Specifically, the spectral curves of all samples were collected, and after removal of obvious noise, the spectra of 972-1609 nm were viewed as the spectra of wolfberry. Then, the spectral curves were pretreated with moving average smoothing (MA), and discriminant analysis models including support vector machine (SVM), neural network with radial basis function (NN-RBF) and extreme learning machine (ELM) were established based on the full-band spectra, the extracted characteristic wavelengths from loadings of principal component analysis (PCA) and 2nd derivative spectra, respectively. Among these models, the recognition accuracies of the calibration set and prediction set of the ELM model based on extracted characteristic wavelengths from loadings of PCA were higher than 90%. The model not only ensured a high recognition rate but also simplified the model and was conducive to future rapid on-line testing. The results revealed that NIR-HSI combined with PCA loadings-ELM could rapidly trace the origins of Chinese wolfberries.	[Yin, Wenxin; Zhang, Chu; Zhu, Hongyan; Zhao, Yanru; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010; Zhang, Chu/J-7191-2017	He, Yong/0000-0001-6752-1757; Zhang, Chu/0000-0001-6760-3154	Key Projects in the National Science & Technology Pillar Program [2015BAD19B03]	Key Projects in the National Science & Technology Pillar Program	This study was supported by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (Project No. 2015BAD19B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello F, 2015, INT J REMOTE SENS, V36, P645, DOI 10.1080/01431161.2014.999882; Bagnasco L, 2015, TALANTA, V144, P1225, DOI 10.1016/j.talanta.2015.07.071; Boyaci IH, 2014, FOOD CHEM, V148, P37, DOI 10.1016/j.foodchem.2013.10.006; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Chen J, 2013, J CEREAL SCI, V58, P241, DOI 10.1016/j.jcs.2013.07.002; Cynkar W, 2009, FOOD RES INT, V42, P653, DOI 10.1016/j.foodres.2009.02.002; Delwiche SR, 2013, BIOSYST ENG, V115, P260, DOI 10.1016/j.biosystemseng.2013.03.015; Devos O, 2009, CHEMOMETR INTELL LAB, V96, P27, DOI 10.1016/j.chemolab.2008.11.005; Feng YZ, 2013, FOOD CHEM, V138, P1829, DOI 10.1016/j.foodchem.2012.11.040; Gao JF, 2013, COMPUT ELECTRON AGR, V99, P186, DOI 10.1016/j.compag.2013.09.011; Hajati S, 2014, J IND ENG CHEM, V20, P2421, DOI 10.1016/j.jiec.2013.10.022; He NW, 2012, FOOD CHEM, V133, P978, DOI 10.1016/j.foodchem.2012.02.018; Huang M, 2013, J FOOD ENG, V116, P45, DOI 10.1016/j.jfoodeng.2012.11.014; Ishii K., 2014, OPTICS PHOTONICS J, V4, P271, DOI DOI 10.4236/OPJ.2014.410026; Kafle GK, 2016, POSTHARVEST BIOL TEC, V120, P188, DOI 10.1016/j.postharvbio.2016.06.013; Langeron Y, 2007, ENG APPL ARTIF INTEL, V20, P415, DOI 10.1016/j.engappai.2006.07.001; Li H, 2007, ANAL BIOANAL CHEM, V389, P2313, DOI 10.1007/s00216-007-1624-1; Li Q, 2017, INT J FOOD IN PRESS; Li SX, 2014, LASER PHYS LETT, V11, DOI 10.1088/1612-2011/11/6/065603; Li XT, 2012, MODERN FOOD SCI TECH, V9; Li YH, 2017, FOOD ANAL METHOD, V10, P1034, DOI 10.1007/s12161-016-0666-4; Li Z, 2016, SPECTROSC SPECT ANAL, V36, P720, DOI 10.3964/j.issn.1000-0593(2016)03-0720-04; Lu WY, 2014, J AGR FOOD CHEM, V62, P9073, DOI 10.1021/jf502156n; Ma J, 2016, FOOD CHEM, V197, P848, DOI 10.1016/j.foodchem.2015.11.023; Manley M, 2012, TALANTA, V89, P223, DOI 10.1016/j.talanta.2011.11.086; Nagao R, 2015, ADV BIOMED ENG, V4, P158, DOI 10.14326/abe.4.158; Nagao R, 2015, OPT REV, V22, P329, DOI 10.1007/s10043-015-0035-3; Qiao J, 2007, J FOOD ENG, V83, P10, DOI 10.1016/j.jfoodeng.2007.02.038; Santos AAP, 2014, MARIT ECON LOGIST, V16, P72, DOI 10.1057/mel.2013.20; Shen TT, 2016, FOOD ANAL METHOD, V9, P68, DOI 10.1007/s12161-015-0175-x; Tabasi SH, 2009, INT J PHARMACEUT, V382, P1, DOI 10.1016/j.ijpharm.2009.07.029; van der Meijde M, 2013, INT J APPL EARTH OBS, V23, P384, DOI 10.1016/j.jag.2012.11.001; Wang J, 2011, LWT-FOOD SCI TECHNOL, V44, P1119, DOI 10.1016/j.lwt.2010.11.012; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Wang YG, 2016, FOOD ANAL METHOD, V9, P131, DOI 10.1007/s12161-015-0178-7; Williams PJ, 2016, FOOD CHEM, V209, P131, DOI 10.1016/j.foodchem.2016.04.044; Wu D, 2008, ANAL CHIM ACTA, V610, P232, DOI 10.1016/j.aca.2008.01.056; Yan Y.L., 2005, BASICS APPL NEAR INF; Yu KQ, 2014, FOOD BIOPROCESS TECH, V7, P3077, DOI 10.1007/s11947-014-1357-z; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234; Zhao LQ, 2013, IND CROP PROD, V47, P51, DOI 10.1016/j.indcrop.2013.02.008	41	46	47	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180534	10.1371/journal.pone.0180534	http://dx.doi.org/10.1371/journal.pone.0180534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704423	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700042
J	Nejdl, L; Kudr, J; Moulick, A; Hegerova, D; Ruttkay-Nedecky, B; Gumulec, J; Cihalova, K; Smerkova, K; Dostalova, S; Krizkova, S; Novotna, M; Kopel, P; Adam, V				Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Gumulec, Jaromir; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech			Platinum nanoparticles induce damage to DNA and inhibit DNA replication	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; CANCER-CELLS; SUPEROXIDE ANION; BACTERIAL GHOSTS; POLYMERASE-BETA; SILVER(I) IONS; CROSS-LINKS; COMPLEXES; RESISTANCE; CISPLATIN	Sparsely tested group of platinum nanoparticles (PtNPs) may have a comparable effect as complex platinum compounds. The aim of this study was to observe the effect of PtNPs in in vitro amplification of DNA fragment of phage., on the bacterial cultures (Staphylococcus aureus), human foreskin fibroblasts and erythrocytes. In vitro synthesized PtNPs were characterized by dynamic light scattering (PtNPs size range 4.8-11.7 nm), zeta potential measurements (-15 mV at pH 7.4), X-ray fluorescence, UV/vis spectrophotometry and atomic absorption spectrometry. The PtNPs inhibited the DNA replication and affected the secondary structure of DNA at higher concentrations, which was confirmed by polymerase chain reaction, DNA sequencing and DNA denaturation experiments. Further, cisplatin (CisPt), as traditional chemotherapy agent, was used in all parallel experiments. Moreover, the encapsulation of PtNPs in liposomes (LipoPtNPs) caused an approximately 2.4x higher of DNA damage in comparison with CisPt, LipoCisPt and PtNPs. The encapsulation of PtNPs in liposomes also increased their antibacterial, cytostatic and cytotoxic effect, which was determined by the method of growth curves on S. aureus and HFF cells. In addition, both the bare and encapsulated PtNPs caused lower oxidative stress (determined by GSH/GSSG ratio) in the human erythrocytes compared to the bare and encapsulated CisPt. CisPt was used in all parallel experiments as traditional chemotherapy agent.	[Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Gumulec, Jaromir; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Gumulec, Jaromir] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic	Mendel University in Brno; Brno University of Technology; Masaryk University Brno	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.	vojtech.adam@mendelu.cz	Chudobová, Dagmar/J-7030-2012; Adam, Vojtech/D-7686-2012; Nejdl, Lukas/E-8438-2012; Kudr, Jiri/D-1921-2013; Kopel, Pavel/E-5711-2012; Rex, Simona/D-4951-2013; Moulick, Amitava/I-9677-2016; Gumulec, Jaromir/D-7638-2012; Smerkova, Kristyna/F-3892-2012; Dolezelikova, Kristyna/H-4517-2018; Krizkova, Sona/E-9617-2012	Chudobová, Dagmar/0000-0003-0826-234X; Adam, Vojtech/0000-0002-8527-286X; Nejdl, Lukas/0000-0001-6332-8917; Kudr, Jiri/0000-0002-2058-4563; Kopel, Pavel/0000-0003-4216-9544; Rex, Simona/0000-0003-0737-3144; Moulick, Amitava/0000-0001-5769-6748; Gumulec, Jaromir/0000-0002-9658-3444; Smerkova, Kristyna/0000-0002-1667-7660; Dolezelikova, Kristyna/0000-0001-8661-0763; Krizkova, Sona/0000-0002-0479-8369	Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II [CEITEC 2020 (LQ1601)]; AZV [15-28334A]; CIISB research infrastructure - MEYS CR [LM2015043]	Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II; AZV; CIISB research infrastructure - MEYS CR	This research was carried out under the project CEITEC 2020 (LQ1601) with financial support from the Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II. The financial support from AZV project no. 15-28334A is also highly acknowledged. Moreover, authors acknowledge the CF CEITEC - Cryo-electron Microscopy and Tomography supported by the CIISB research infrastructure (LM2015043 funded by MEYS CR) for their support with obtaining scientific data presented in this paper.	Ali I, 2013, ANTI-CANCER AGENT ME, V13, P296, DOI 10.2174/1871520611313020016; Asharani PV, 2010, NANOMEDICINE-UK, V5, P51, DOI [10.2217/nnm.09.85, 10.2217/NNM.09.85]; Barabas R, 2013, CHEM PAP, V67, P1414, DOI 10.2478/s11696-013-0409-6; Bednarski PJ, 2013, PHILOS T R SOC A, V371, P1; Boulikas T, 2004, ONCOL REP, V12, P3; Boulikas T, 2003, ONCOL REP, V10, P1663; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Brabec V, 2002, DRUG RESIST UPDATE, V5, P147, DOI 10.1016/S1368-7646(02)00047-X; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chang CL, 2012, BIOPOLYMERS, V97, P807, DOI 10.1002/bip.22077; Chudobova D, 2015, MICROBIOL RES, V170, P147, DOI 10.1016/j.micres.2014.08.003; Chudobova D, 2014, INT J ENV RES PUB HE, V11, P3233, DOI 10.3390/ijerph110303233; Chudobova D, 2013, INT J MOL SCI, V14, P13592, DOI 10.3390/ijms140713592; Chudobova D, 2013, INT J ELECTROCHEM SC, V8, P4422; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Conlin AK, 2010, CLIN BREAST CANCER, V10, P281, DOI 10.3816/CBC.2010.n.036; Edwards KA, 2012, CURR OPIN CHEM BIOL, V16, P444, DOI 10.1016/j.cbpa.2012.05.182; Fan J, 2011, BIOMATERIALS, V32, P1611, DOI 10.1016/j.biomaterials.2010.11.004; Fenske AE, 2012, CANCER LETT, V324, P171, DOI 10.1016/j.canlet.2012.05.009; Fikrova P, 2013, NEOPLASMA, V60, P413, DOI 10.4149/neo_2013_053; Gao JH, 2007, J AM CHEM SOC, V129, P1428, DOI 10.1021/ja067785e; Gehrke H, 2011, ARCH TOXICOL, V85, P799, DOI 10.1007/s00204-010-0636-3; Gopal J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01260; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Ho YP, 2003, MED RES REV, V23, P633, DOI 10.1002/med.10038; Hrabeta J, 2016, ANTI-CANCER AGENT ME, V16, P686, DOI 10.2174/1871520616666151120122611; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679; Kim WK, 2012, EXP MOL MED, V44, P432, DOI 10.3858/emm.2012.44.7.048; Konieczny P, 2013, INT J NANOMED, V8, P3963, DOI 10.2147/IJN.S49612; Kosmider B, 2004, MUTAT RES-GEN TOX EN, V558, P93, DOI 10.1016/j.mrgentox.2003.11.006; Kunjachan S, 2012, EUR J PHARM SCI, V45, P421, DOI 10.1016/j.ejps.2011.08.028; Li Y, 2012, MUTAT RES-GEN TOX EN, V745, P4, DOI 10.1016/j.mrgentox.2011.11.010; Manikandan M, 2013, BIOMATERIALS, V34, P5833, DOI 10.1016/j.biomaterials.2013.03.077; Mayr UB, 2005, ADV DRUG DELIVER REV, V57, P1381, DOI 10.1016/j.addr.2005.01.027; Melnik M, 2013, MAIN GROUP MET CHEM, V36, P1, DOI 10.1515/mgmc-2012-0062; Mitchell C, 2007, MOL PHARMACOL, V72, P704, DOI 10.1124/mol.107.038406; Mouron SA, 2001, MUTAT RES-GEN TOX EN, V498, P47, DOI 10.1016/S1383-5718(01)00266-2; Nejdl L, 2014, ELECTROPHORESIS, V35, P393, DOI 10.1002/elps.201300197; Oehlsen ME, 2005, J BIOL INORG CHEM, V10, P433, DOI 10.1007/s00775-005-0009-1; Oh JG, 2013, CURR APPL PHYS, V13, P130, DOI 10.1016/j.cap.2012.06.025; Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015; Palchoudhury S, 2013, IEEE T MAGN, V49, P373, DOI 10.1109/TMAG.2012.2223660; Paraskar A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075103; Paraskar A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265101; Paraskar AS, 2010, P NATL ACAD SCI USA, V107, P12435, DOI 10.1073/pnas.1007026107; Park EJ, 2010, ARCH PHARM RES, V33, P727, DOI 10.1007/s12272-010-0512-y; Paukner S, 2003, J DRUG TARGET, V11, P151, DOI 10.1080/10611860310001593366; Pekarik V, 2013, CURR MED CHEM, V20, P534; Pelka J, 2009, CHEM RES TOXICOL, V22, P649, DOI 10.1021/tx800354g; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; POPENOE EA, 1979, ARCH BIOCHEM BIOPHYS, V196, P109, DOI 10.1016/0003-9861(79)90557-5; Rehman MU, 2012, INFLAMM RES, V61, P1177, DOI 10.1007/s00011-012-0512-0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; Sgarbossa P, 2012, ORGANOMETALLICS, V31, P1257, DOI 10.1021/om200953z; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Skladanka J, 2012, INT J ENV RES PUB HE, V9, P3789, DOI 10.3390/ijerph9113789; Smerkova K, 2013, CHROMATOGRAPHIA, V76, P329, DOI 10.1007/s10337-012-2326-1; Stathopoulos GP, 2006, ANTICANCER RES, V26, P1489; Summa N, 2007, INORG CHEM, V46, P2094, DOI 10.1021/ic061990d; Takamiya M, 2012, NEUROSCIENCE, V221, P47, DOI 10.1016/j.neuroscience.2012.06.060; Takamiya M, 2011, J NEUROSCI RES, V89, P1125, DOI 10.1002/jnr.22622; Theile D, 2012, J PHARMACOL EXP THER, V341, P51, DOI 10.1124/jpet.111.189621; Vavrova M, 2003, RADIAT ONCOL, P1; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Williams JW, 2007, INORG CHEM, V46, P5820, DOI 10.1021/ic700410y; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Zhang LB, 2010, NANO LETT, V10, P219, DOI 10.1021/nl903313r; ZOLOTOV YA, 1983, ANAL CHIM ACTA, V148, P135, DOI 10.1016/S0003-2670(00)85160-0	73	43	44	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180798	10.1371/journal.pone.0180798	http://dx.doi.org/10.1371/journal.pone.0180798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704436	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600050
J	Cui, YB; Zhu, CC; Ming, Z; Cao, JM; Yan, YL; Zhao, P; Pang, GC; Deng, ZX; Yao, Y; Chen, QS				Cui, Yongbo; Zhu, Chenchen; Ming, Zhu; Cao, Jiangming; Yan, Yali; Zhao, Pei; Pang, Guangchang; Deng, Zixin; Yao, Yi; Chen, Qingsen			Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; BOVINE GLYCOMACROPEPTIDE; TGF-BETA; HUMAN MONOCYTES; CROHNS-DISEASE; COLONIC-MUCOSA; EXPRESSION; PATHOGENESIS; TGF-BETA-1	Objectives The aim of this study was to elucidate the molecular mechanisms by which food-derived casein glycomacropeptide (CGMP) maintains internal homeostasis in the intestinal mucosa and to investigate the effects of CGMP on the intestinal mucosal immunological barrier and related signal transduction pathways. Methods In this study, a famoxadone (OXZ)-induced mouse experimental ulcerative colitis (UC) model was built. The experimental UC mice were intragastrically administered milk-derived CGMP for four consecutive days. The molecular mechanisms by which milk-derived CGMP improved and restored the inflammatory status in UC symptoms were elucidated by H&E staining, immunohistochemical staining and western blotting. Results The results indicated that CGMP (50 mg/(kg bw center dot d)) could significantly improve morphological injury to intestinal mucosa in OXZ-induced UC mice to the same extent that did sulfasalazine (SASP, 40 mg/(kg bw center dot d)), a medicine used to treat UC, in the control group. The study found that CGMP could significantly reduce the expression of Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1), Cluster of differentiation 4 (CD4) and Cluster of differentiation 8 (CD8) in the lamina propria of the intestinal mucosa and significantly stimulate the secretion of sIgA to increase intestinal immunity. Furthermore, CGMP was found to be directly involved in inhibiting the MAPK pathway and activating the TGF-beta 1/Smad signal transduction cascade, which could maintain immunological regulation of the intestinal mucosa and protect the functions of the intestinal mucosal barrier. Conclusions This study elucidated the molecular mechanisms by which CGMP maintained homeostasis of the intestinal mucosa and further confirmed its pharmaceutical value as a food-derived functional component with promising potential for further exploration/utilization.	[Cui, Yongbo; Deng, Zixin] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China; [Zhu, Chenchen; Ming, Zhu; Cao, Jiangming; Yan, Yali; Zhao, Pei; Pang, Guangchang; Chen, Qingsen] Tianjin Univ Commerce, Tianjin Key Lab Food Biotechnol, Coll Biotechnol & Food Sci, Tianjin, Peoples R China; [Yao, Yi] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Wuhan University; Tianjin University of Commerce; Yale University	Deng, ZX (corresponding author), Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China.; Chen, QS (corresponding author), Tianjin Univ Commerce, Tianjin Key Lab Food Biotechnol, Coll Biotechnol & Food Sci, Tianjin, Peoples R China.; Yao, Y (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	zxdeng@sjtu.edu.cn; yi.yao@yale.edu; chqsen@tjcu.edu.cn	Ming, Zhu/ABD-8589-2021		National Natural Science Foundation of China [31071522]; National Natural Fund Training Project of Tianjin University of Commerce [160120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Fund Training Project of Tianjin University of Commerce	This work was supported by the National Natural Science Foundation of China [No. 31071522] and National Natural Fund Training Project of Tianjin University of Commerce [No. 160120]. Prof Qingsen Chen had the main role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Balmus IM, 2016, SAUDI J GASTROENTERO, V22, P3, DOI 10.4103/1319-3767.173753; Biasi F, 2007, GENES NUTR, V2, P233, DOI 10.1007/s12263-007-0053-2; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Brandhorst G, 2013, CLIN CHIM ACTA, V421, P31, DOI 10.1016/j.cca.2013.02.016; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; Daddaoua A, 2005, J NUTR, V135, P1164, DOI 10.1093/jn/135.5.1164; Dolan K.T., 2016, MOL NUTR FOOD RES; Dosani T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.32; Ekstrom GM, 1998, SCAND J GASTROENTERO, V33, P174, DOI 10.1080/00365529850166914; ElSalam MHA, 1996, INT DAIRY J, V6, P327, DOI 10.1016/0958-6946(95)00026-7; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Fujimori H, 2002, GASTROENTEROLOGY, V122, P734, DOI 10.1053/gast.2002.31899; Ghosh S, 2000, BMJ-BRIT MED J, V320, P1119, DOI 10.1136/bmj.320.7242.1119; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; HARPAZ N, 1994, HUM PATHOL, V25, P1069, DOI 10.1016/0046-8177(94)90067-1; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hozumi H, 2013, INT J COLORECTAL DIS, V28, P1049, DOI 10.1007/s00384-013-1654-4; Hvas CL, 2016, EUR J CLIN INVEST, V46, P555, DOI 10.1111/eci.12634; Kaetzel CS, 2014, IMMUNOL LETT, V162, P10, DOI 10.1016/j.imlet.2014.05.008; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Leal MC, 2015, INFLAMM BOWEL DIS, V21, P2936, DOI 10.1097/MIB.0000000000000511; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li Fang, 2010, Chinese Journal of Pathology, V39, P19, DOI 10.3760/cma.j.issn.0529-5807.2010.01.006; Li Guohua, 2012, Gastroenterol Res Pract, V2012, P404752, DOI 10.1155/2012/404752; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Marion-Letellier R, 2016, J CROHNS COLITIS, V10, P1351, DOI 10.1093/ecco-jcc/jjw106; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Ming Z, 2015, FOOD AGR IMMUNOL, V26, P1; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Neurath Markus F., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P81; Ortega-Gonzalez M, 2014, BRIT J NUTR, V111, P1202, DOI 10.1017/S0007114513003590; Pang G., 2014, FOOD SCI HUM WELL, V3, P51, DOI [10.1016/j.fshw.2014.04.001, DOI 10.1016/J.FSHW.2014.04.001]; Pang G., 2012, FOOD SCI HUM WELL, V1, P26, DOI DOI 10.1016/J.FSHW.2012.10.001; Requena P, 2008, BRIT J PHARMACOL, V154, P825, DOI 10.1038/bjp.2008.138; Requena P, 2009, BRIT J PHARMACOL, V157, P1232, DOI 10.1111/j.1476-5381.2009.00195.x; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Rong YL, 2015, ANIM NUTR, V1, P54, DOI 10.1016/j.aninu.2015.05.006; Sales-Campos H, 2015, BRAZ J MED BIOL RES, V48, P96, DOI [10.1590/1414-431X20143774, 10.1590/1414-431x20143774]; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Ueno E, 2011, HISTOL HISTOPATHOL, V26, P1317, DOI 10.14670/HH-26.1317; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; WOLF HM, 1994, BLOOD, V83, P1278; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yu CG, 2013, J DIGEST DIS, V14, P513, DOI 10.1111/1751-2980.12087; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	54	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181075	10.1371/journal.pone.0181075	http://dx.doi.org/10.1371/journal.pone.0181075			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700735	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800118
J	Magee, MJ; Sun, YV; Brust, JCM; Shah, NS; Ning, YM; Allana, S; Campbell, A; Hui, Q; Mlisana, K; Moodley, P; Gandhi, NR				Magee, Matthew J.; Sun, Yan V.; Brust, James C. M.; Shah, N. Sarita; Ning, Yuming; Allana, Salim; Campbell, Angela; Hui, Qin; Mlisana, Koleka; Moodley, Pravi; Gandhi, Neel R.			Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrugresistant tuberculosis patients in South Africa	PLOS ONE			English	Article							HIGH-DOSE VITAMIN-D-3; PULMONARY TUBERCULOSIS; DOUBLE-BLIND; SUPPLEMENTATION	Background Vitamin D modulates the inflammatory and immune response to tuberculosis (TB) and also mediates the induction of the antimicrobial peptide cathelicidin. Deficiency of 25-hydroxyvitamin D and single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene may increase the risk of TB disease and decrease culture conversion rates in drug susceptible TB. Whether these VDR SNPs are found in African populations or impact multidrugresistant (MDR) TB treatment has not been established. We aimed to determine if SNPs in the VDR gene were associated with sputum culture conversion among a cohort of MDR TB patients in South Africa. Methods We conducted a prospective cohort study of adult MDR TB patients receiving second-line TB treatment in KwaZulu-Natal province. Subjects had monthly sputum cultures performed. In a subset of participants, whole blood samples were obtained for genomic analyses. Genomic DNA was extracted and genotyped with Affymetrix Axiom Pan-African Array. Cox proportional models were used to determine the association between VDR SNPs and rate of culture conversion. Results Genomic analyses were performed on 91 MDR TB subjects enrolled in the sub-study; 60% were female and median age was 35 years (interquartile range [IQR] 29-42). Smoking was reported by 21% of subjects and most subjects had HIV (80%), were smear negative (57%), and had cavitary disease (55%). Overall, 87 (96%) subjects initially converted cultures to negative, with median time to culture conversion of 57 days (IQR 17-114). Of 121 VDR SNPs examined, 10 were significantly associated (p<0.01) with rate of sputum conversion in multivariable analyses. Each additional risk allele on SNP rs74085240 delayed culture conversion significantly (adjusted hazard ratio 0.30, 95% confidence interval 0.14-0.67). Conclusions Polymorphisms in the VDR gene were associated with rate of sputum culture conversion in MDR TB patients in this high HIV prevalence setting in South Africa.	[Magee, Matthew J.] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA; [Sun, Yan V.; Allana, Salim; Campbell, Angela; Hui, Qin; Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Brust, James C. M.; Ning, Yuming] Albert Einstein Coll Med, Div Gen Internal Med & Infect Dis, Bronx, NY 10467 USA; [Shah, N. Sarita] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Mlisana, Koleka; Moodley, Pravi] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Gandhi, Neel R.] Emory Univ, Emory Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; Yeshiva University; Albert Einstein College of Medicine; Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; Emory University; Emory University; Rollins School Public Health	Magee, MJ (corresponding author), Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA.	mjmagee@gsu.edu	Magee, Matthew/W-1169-2019; Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268; Campbell, Angela/0000-0003-3990-3656; Moodley, Pravi/0000-0002-9946-8783	US National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [R01AI087465, R01AI089349]; NIH/NIAID [K23AI083088, K24AI114444]; Emory Center for AIDS Research (CFAR) [P30AI050409]; Einstein CFAR [P30AI051519]; Einstein/Montefiore Institute for Clinical and Translational Research (ICTR) [UL1TR001073]; Atlanta Clinical Translational Science Institute (ACTSI) [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI114444, R01AI087465, P30AI050409] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory Center for AIDS Research (CFAR); Einstein CFAR; Einstein/Montefiore Institute for Clinical and Translational Research (ICTR); Atlanta Clinical Translational Science Institute (ACTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH www.nih.gov): R01AI087465 and R01AI089349 (both to NRG). It was also supported in part by NIH/NIAID grants: K23AI083088 (to JCMB), K24AI114444 (to NRG), Emory Center for AIDS Research (CFAR www.cfar.emory.edu) P30AI050409, Einstein CFAR (www.einstein.yu.edu/centers/erc-center-for-aids-research) P30AI051519, Einstein/Montefiore Institute for Clinical and Translational Research (ICTR http://www.einstein.yu.edu/centers/ictr) UL1TR001073 and the Atlanta Clinical Translational Science Institute (ACTSI www.actsi.org) UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb C, 2007, TUBERCULOSIS, V87, P295, DOI 10.1016/j.tube.2007.03.001; Bruns H, 2014, FUTURE MICROBIOL, V9, P327, DOI 10.2217/fmb.13.164; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Cegielski P, 2015, LANCET INFECT DIS, V15, P489, DOI 10.1016/S1473-3099(15)70163-5; Coussens AK, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/903680; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Daley P, 2015, LANCET INFECT DIS, V15, P528, DOI 10.1016/S1473-3099(15)70053-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Ndjecka N, 2014, MULTIDRUG RESISTANT; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Rathored J, 2012, INT J TUBERC LUNG D, V16, P1522, DOI 10.5588/ijtld.12.0122; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Scientific ATF, AX GEN WID POP OPT H; Shisana O., 2012, INCIDENCE BEHAV SURV INCIDENCE BEHAV SURV; Sutaria N, 2014, J CLIN TRANSL ENDOCR, V1, P151, DOI 10.1016/j.jcte.2014.08.001; Tukvadze N, 2015, AM J CLIN NUTR, V102, P1059, DOI 10.3945/ajcn.115.113886; WHO, 2016, GLOB TUB REP; World Health Organization, 2015, GLOB TUB REP 2015	25	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180916	10.1371/journal.pone.0180916	http://dx.doi.org/10.1371/journal.pone.0180916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700743	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800099
J	Marco-Jimenez, F; Vicente, JS				Marco-Jimenez, Francisco; Salvador Vicente, Jose			Overweight in young males reduce fertility in rabbit model	PLOS ONE			English	Article							BODY-MASS INDEX; REPRODUCTIVE HORMONE-LEVELS; DIET-INDUCED OBESITY; SEMEN QUALITY; WAIST CIRCUMFERENCE; MALE PARTNERS; PARAMETERS; ASSOCIATION; IMPACT; CHOLESTEROL	Semen quality has certainly declined over the past few decades, possibly owing to modern lifestyle factors. In this sense, the role of overweight and obesity in the development of subfertility in males has generated a considerable amount of interest in recent years. However, there is no consensus on whether overweight or obesity impaired sperm quality. Thus, based on the ongoing debate about risk factors for subfertility associated with overweight and obesity in men, this study was designed to investigate the effect of overweight on sperm quality parameters and fertility success in randomized controlled trial in a rabbit model. Fourteen male rabbits were randomly assigned to a control group in which nutritional requirements were satisfied or a group fed to satiety from 12 to 32 weeks of age. At 24 weeks of age, semen samples were analysed weekly by conventional semen analysis for 8 weeks. In addition, during the trial female rabbits were artificially inseminated by each male to assess the fertility success and the number of offspring. Young males fed to satiety were associated with a significant increase in body weight (13.6% overweight) and perirenal fat thickness (5%). Male overweight presented a significant decrease in sperm concentration. There were no differences in the remaining sperm parameters. However, male overweight showed a clear and significant decrease in fertility success (control group, 64 +/- 8.9% versus fed to satiety group, 35 +/- 9.2%), but not in the number of offspring. Taken together, our findings provide new evidence on the loss of fertility induced by overweight in males.	[Marco-Jimenez, Francisco; Salvador Vicente, Jose] Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012	Jiménez, Francisco Marco/0000-0002-5226-4118	Spanish Research project Comision Interministerial de Ciencia y Tecnologia [AGL2014-5 3405-C2-1-P]	Spanish Research project Comision Interministerial de Ciencia y Tecnologia	This research was supported by the projects: Spanish Research project AGL2014-5 3405-C2-1-P Comision Interministerial de Ciencia y Tecnologia (FMJ, JSV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Mormandi EA, 2013, ENDOCRINOL NUTR, V60, P303, DOI 10.1016/j.endonu.2013.01.006; Alshahrani S, 2016, ANDROLOGIA, V48, P1125, DOI 10.1111/and.12549; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bataineh HN, 2005, SAUDI MED J, V26, P398; Belloc S, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1212; Bieniek Jared M, 2016, F1000Res, V5, P2756; Bjorndahl L, 2011, HUM FERTIL, V14, P179, DOI 10.3109/14647273.2011.580823; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Duits FH, 2010, FERTIL STERIL, V94, P1356, DOI 10.1016/j.fertnstert.2009.05.075; Ehala-Aleksejev K, 2015, ANDROLOGY-US, V3, P225, DOI 10.1111/andr.12002; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; ESTANY J, 1992, GENET SEL EVOL, V24, P527, DOI 10.1051/gse:19920604; Ewuola EO, 2010, REPRODUCTION, V139, P439, DOI 10.1530/REP-09-0077; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; GARNER DL, 1994, J ANDROL, V15, P620; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Guney AI, 2012, GENET MOL RES, V11, P1039, DOI 10.4238/2012.April.27.2; Guo D, 2017, ONCOTARGET IN PRESS; GUPTA RS, 1988, Z ERNAHRUNGSWISS, V27, P236, DOI 10.1007/BF02019512; Gurunath S, 2011, HUM REPROD UPDATE, V17, P575, DOI 10.1093/humupd/dmr015; Gutorova NV, 2014, B EXP BIOL MED+, V157, P95, DOI 10.1007/s10517-014-2500-6; Hajshafiha M, 2013, INT J GEN MED, V6, P447, DOI 10.2147/IJGM.S41341; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Kumar Naina, 2015, J Hum Reprod Sci, V8, P191, DOI 10.4103/0974-1208.170370; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lancellotti TES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052386; Leisegang K, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-34; Littell RC, 1998, J ANIM SCI, V76, P1216; Lu JC, 2015, ANDROLOGIA, V47, P1047, DOI 10.1111/and.12376; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; McPherson NO, 2015, ASIAN J ANDROL, V17, P450, DOI 10.4103/1008-682X.148076; Mendiola J, 2009, FERTIL STERIL, V91, P812, DOI 10.1016/j.fertnstert.2008.01.020; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43475; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Pascual JJ, 2000, ANIM SCI, V70, P435, DOI 10.1017/S135772980005178X; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Petersen GL, 2013, FERTIL STERIL, V99, P1654, DOI 10.1016/j.fertnstert.2013.01.092; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Rato L, 2014, OBES REV, V15, P996, DOI 10.1111/obr.12226; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Soubry A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0217-2; Thomsen L, 2014, ASIAN J ANDROL, V16, P749, DOI 10.4103/1008-682X.125398; Tsao CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119458; Virtanen HE, 2017, NAT REV UROL, V14, P120, DOI 10.1038/nrurol.2016.261; Wang EY, 2017, ASIAN J ANDROL, V19, P234, DOI 10.4103/1008-682X.169996; WHO, 2016, OBESITY SITUATION AN; Xiccato G, 2010, NUTRITION OF THE RABBIT, 2ND EDITION, P83, DOI 10.1079/9781845936693.0083; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516	62	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180679	10.1371/journal.pone.0180679	http://dx.doi.org/10.1371/journal.pone.0180679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700645	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800064
J	Pagel, R; Bar, F; Schroder, T; Sunderhauf, A; Kunstner, A; Ibrahim, SM; Autenrieth, SE; Kalies, K; Konig, P; Tsang, AH; Bettenworth, D; Divanovic, S; Lehnert, H; Fellermann, K; Oster, H; Derer, S; Sina, C				Pagel, Rene; Baer, Florian; Schroeder, Torsten; Suenderhauf, Annika; Kuenstner, Axel; Ibrahim, Saleh M.; Autenrieth, Stella E.; Kalies, Kathrin; Koenig, Peter; Tsang, Anthony H.; Bettenworth, Dominik; Divanovic, Senad; Lehnert, Hendrik; Fellermann, Klaus; Oster, Henrik; Derer, Stefanie; Sina, Christian			Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine	FASEB JOURNAL			English	Article						epithelial cells; necroptosis; inflammatory bowel disease	BOWEL-DISEASE; CELL-DIFFERENTIATION; SLEEP DISTURBANCES; CROHNS-DISEASE; CLOCK; GENES; MPER2; MICE; RISK; PROLIFERATION	Endogenous circadian clocks regulate 24-h rhythms of physiology and behavior. Circadian rhythm disruption (CRD) is suggested as a risk factor for inflammatory bowel disease. However, the underlying molecular mechanisms remain unknown. Intestinal biopsies from Per1/2 mutant and wild-type (WT) mice were investigated by electron microscopy, immunohistochemistry, and bromodeoxyuridine pulse-chase experiments. TNF-alpha was injected intraperitoneally, with or without necrostatin-1, into Per1/2 mice or rhythmic and externally desynchronized WT mice to study intestinal epithelial cell death. Experimental chronic colitis was induced by oral administration of dextran sodium sulfate. In vitro, caspase activity was assayed in Per1/2-specific small interfering RNA-transfected cells. Wee1 was overexpressed to study antiapoptosis and the cell cycle. Genetic ablation of circadian clock function or environmental CRD in mice increased susceptibility to severe intestinal inflammation and epithelial dysregulation, accompanied by excessive necroptotic cell death and a reduced number of secretory epithelial cells. Receptor-interacting serine/threonine-protein kinase (RIP)-3-mediated intestinal necroptosis was linked to increased mitotic cell cycle arrest via Per1/2-controlled Wee1, resulting in increased antiapoptosis via cellular inhibitor of apoptosis-2. Together, our data suggest that circadian rhythm stability is pivotal for the maintenance of mucosal barrier function. CRD increases intestinal necroptosis, thus rendering the gut epithelium more susceptible to inflammatory processes.	[Pagel, Rene; Baer, Florian; Schroeder, Torsten; Tsang, Anthony H.; Lehnert, Hendrik; Fellermann, Klaus; Oster, Henrik; Sina, Christian] Univ Hosp Schleswig Holstein, Dept Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany; [Schroeder, Torsten; Suenderhauf, Annika; Derer, Stefanie; Sina, Christian] Univ Hosp Schleswig Holstein, Inst Nutr Med, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany; [Schroeder, Torsten] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Kuenstner, Axel; Ibrahim, Saleh M.] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany; [Kalies, Kathrin; Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Kuenstner, Axel] Max Planck Inst Evolutionary Biol, Guest Grp Evolutionary Genom, Plon, Germany; [Autenrieth, Stella E.] Univ Tubingen, Dept Internal Med 2, Tubingen, Germany; [Bettenworth, Dominik] Univ Hosp Munster, Dept Med B, Munster, Germany; [Divanovic, Senad] Univ Cincinnati, Div Immunobiol, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Lubeck; University of Lubeck; Max Planck Society; Eberhard Karls University of Tubingen; University of Munster; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Sina, C (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.; Sina, C (corresponding author), Univ Hosp Schleswig Holstein, Inst Nutr Med, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	christian.sina@uksh.de	Oster, Henrik/O-4426-2019; Autenrieth, Stella/GOG-8744-2022; König, Peter/AAK-2021-2020; Derer, Stefanie/B-9300-2017; Ibrahim, Saleh/AAO-9541-2020	Oster, Henrik/0000-0002-1414-7068; Sunderhauf, Annika/0000-0003-0591-8809; Kunstner, Axel/0000-0003-0692-2105; Kalies, Kathrin/0000-0002-8929-4249; Ibrahim, Saleh/0000-0001-7827-2290; Tsang, Anthony/0000-0002-3673-6365	Section of Medicine, University of Lubeck [E15-2013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Section of Medicine, University of Lubeck; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Petra Langenstrassen, Ann-Kathrin Brethack, and Heidi Schlichting (all from the Institute of Nutritional Medicine, University Hospital Schleswig-Holstein), and Lidija Gutjahr, Harry Manfeldt, and Christo Orun, (all from the Institute of Anatomy, University of Lubeck) for excellent technical support. This work was supported by Grant E15-2013 from the Section of Medicine, University of Lubeck (to F.B.). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. S.D. and C.S. shared senior authorship of this project. The authors declare no conflicts of interest.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ali T, 2013, INFLAMM BOWEL DIS, V19, P2440, DOI 10.1097/MIB.0b013e3182a0ea54; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P965, DOI 10.1016/j.cgh.2013.01.021; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; BUCHI KN, 1991, GASTROENTEROLOGY, V101, P410, DOI 10.1016/0016-5085(91)90019-H; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Froy O, 2005, FASEB J, V19, P1920, DOI 10.1096/fj.05-4216fje; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Graff LA, 2011, INFLAMM BOWEL DIS, V17, P1882, DOI 10.1002/ibd.21580; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V299, pG549, DOI 10.1152/ajpgi.00147.2010; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Jin HS, 2006, BIOCHEM J, V399, P335, DOI 10.1042/BJ20060612; Karpowicz P, 2013, CELL REP, V3, P996, DOI 10.1016/j.celrep.2013.03.016; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Keefer L, 2006, J CLIN SLEEP MED, V2, P409; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102495; MARRA G, 1994, GASTROENTEROLOGY, V106, P982, DOI 10.1016/0016-5085(94)90757-9; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P994, DOI 10.3109/07420528.2012.705935; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; NARDUCCI F, 1987, GUT, V28, P17, DOI 10.1136/gut.28.1.17; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Pacha J, 2013, ACTA PHYSIOL, V208, P11, DOI 10.1111/apha.12090; Palmieri O, 2015, CHRONOBIOL INT, V32, P903, DOI 10.3109/07420528.2015.1050726; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Ranjbaran Z, 2007, J GASTROEN HEPATOL, V22, P1748, DOI 10.1111/j.1440-1746.2006.04820.x; Rogler G, 2015, INFLAMM BOWEL DIS, V21, P400, DOI 10.1097/MIB.0000000000000229; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Saito H, 2008, AM J PHYSIOL-GASTR L, V295, pG395, DOI 10.1152/ajpgi.90317.2008; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwerk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072700; Seidelin JB, 2007, VIRCHOWS ARCH, V451, P1031, DOI 10.1007/s00428-007-0517-1; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; STEVENSON NR, 1980, AM J PHYSIOL, V238, pG203, DOI 10.1152/ajpgi.1980.238.3.G203; STEVENSON NR, 1975, BIOCHIM BIOPHYS ACTA, V406, P131, DOI 10.1016/0005-2736(75)90048-6; Swanson GR, 2011, EXPERT REV CLIN IMMU, V7, P29, DOI [10.1586/eci.10.83, 10.1586/ECI.10.83]; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Watson AJM, 2012, ANN NY ACAD SCI, V1258, P1, DOI 10.1111/j.1749-6632.2012.06523.x; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	66	47	48	1	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4707	4719		10.1096/fj.201700141RR	http://dx.doi.org/10.1096/fj.201700141RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28710114	Green Published			2022-12-26	WOS:000413398500005
J	Philip, K; Mills, TW; Davies, J; Chen, NY; Karmouty-Quintana, H; Luo, FY; Molina, JG; Amione-Guerra, J; Sinha, N; Guha, A; Eltzschig, HK; Blackburn, MR				Philip, Kemly; Mills, Tingting Weng; Davies, Jonathan; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Luo, Fayong; Molina, Jose G.; Amione-Guerra, Javier; Sinha, Neeraj; Guha, Ashrith; Eltzschig, Holger K.; Blackburn, Michael R.			HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; hypoxia; adenosine receptors	IDIOPATHIC INTERSTITIAL PNEUMONIA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; A(2B) ADENOSINE RECEPTOR; A2B RECEPTOR; LUNG INJURY; HYPERTENSION; DISEASE; INFLAMMATION; CELLS; MICE	Idiopathic pulmonary fibrosis (IPF) is a deadly chronic lung disease. Extracellular accumulation of adenosine and subsequent activation of the ADORA2B receptor play important roles in regulating inflammation and fibrosis in IPF. Additionally, alternatively activated macrophages (AAMs) expressing ADORA2B have been implicated in mediating adenosine's effects in IPF. Although hypoxic conditions are present in IPF, hypoxia's role as a direct modulator of macrophage phenotype and identification of factors that regulate ADORA2B expression on AAMs in IPF is not well understood. In this study, an experimental mouse model of pulmonary fibrosis and lung samples from patients with IPF were used to examine the effects and interactions of macrophage differentiation and hypoxia on fibrosis. We demonstrate that hypoxia-inducible factor 1-alpha (HIF1A) inhibition in late stages of bleomycin-induced injury attenuates pulmonary fibrosis in association, with reductions in ADORA2B expression in AAMs. Additionally, ADORA2B deletion or pharmacological antagonism along with HIF1A inhibition disrupts AAM differentiation and subsequent IL-6 production in cultured macrophages. These findings suggest that hypoxia, through HIF1A, contributes to the development and progression of pulmonary fibrosis through its regulation of ADORA2B expression on AAMs, cell differentiation, and production of profibrotic mediators. These studies support a potential role for HIF1A or ADORA2B antagonists in the treatment of IPF.	[Philip, Kemly; Mills, Tingting Weng; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Luo, Fayong; Molina, Jose G.; Blackburn, Michael R.] UTHealth, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA; [Eltzschig, Holger K.] UTHealth, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA; [Philip, Kemly; Blackburn, Michael R.] Univ Texas MD Anderson Canc Ctr, UTHealth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Davies, Jonathan] Baylor Coll Med, Dept Pediat, Div Neonatal Perinatal Med, Houston, TX 77030 USA; [Amione-Guerra, Javier; Sinha, Neeraj; Guha, Ashrith] Houston Methodist Hosp, JC Walter Jr Transplant Ctr, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Blackburn, MR (corresponding author), UTHealth, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.	Michael.R.Blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020; Amione, Javier/AAM-3106-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Philip, Kemly/0000-0002-7749-9781	U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program [1P01HL114457]; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kelly A. Volcik (UTHealth) for assisting in manuscript revisions. This work was supported by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program Project Grant 1P01HL114457 (to M. R. Blackburn) and the Schissler Foundation Fellowship for Translational Studies of Common Human Diseases (to K. Philip).	Bryant AJ, 2016, AM J PHYSIOL-LUNG C, V310, pL249, DOI 10.1152/ajplung.00258.2015; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Jakubzick C, 2004, J CLIN PATHOL, V57, P477, DOI 10.1136/jcp.2003.012799; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Karmouty-Quintana H, 2013, AM J RESP CELL MOL, V49, P1038, DOI 10.1165/rcmb.2013-0089OC; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Malli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053658; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Rafii R, 2013, J THORAC DIS, V5, P48, DOI 10.3978/j.issn.2072-1439.2012.12.07; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Rottoli P, 2005, PROTEOMICS, V5, P1423, DOI 10.1002/pmic.200301007; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Takeda K, 1996, J IMMUNOL, V157, P3220; Tanaka T, 2010, J ANESTH, V24, P54, DOI 10.1007/s00540-009-0829-1; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Wada H, 1997, SURG TODAY, V27, P1131, DOI 10.1007/BF02385681; Weng TT, 2014, AM J RESP CRIT CARE, V190, P1402, DOI 10.1164/rccm.201404-0744OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhou QY, 2016, AM J RESP CELL MOL, V54, P728, DOI 10.1165/rcmb.2015-0111OC; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	45	38	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4745	4758		10.1096/fj.201700219R	http://dx.doi.org/10.1096/fj.201700219R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28701304	Green Published			2022-12-26	WOS:000413398500008
J	Myrach, T; Zhu, AT; Witte, CP				Myrach, Till; Zhu, Anting; Witte, Claus-Peter			The assembly of the plant urease activation complex and the essential role of the urease accessory protein G (UreG) in delivery of nickel to urease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI; FUNCTIONAL-ANALYSIS; IN-VIVO; IDENTIFICATION; BINDING; METALLOCHAPERONE; APOPROTEIN; PURIFICATION; ARABIDOPSIS; CHAPERONE	Urease is a ubiquitous nickel metalloenzyme. In plants, its activation requires three urease accessory proteins (UAPs), UreD, UreF, and UreG. In bacteria, the UAPs interact with urease and facilitate activation, which involves the channeling of two nickel ions into the active site. So far this process has not been investigated in eukaryotes. Using affinity pulldowns of Strep-tagged UAPs from Arabidopsis and rice transiently expressed in planta, we demonstrate that a urease-UreD-UreF-UreG complex exists in plants and show its stepwise assembly. UreG is crucial for nickel delivery because UreG-dependent urease activation in vitro was observed only with UreG obtained from nickel-sufficient plants. This activation competence could not be generated in vitro by incubation of UreG with nickel, bicarbonate, and GTP. Compared with their bacterial orthologs, plant UreGs possess an N-terminal extension containing a His-and Asp/Glu-rich hypervariable region followed by a highly conserved sequence comprising two potential HXH metal-binding sites. Complementing the ureG-1 mutant of Arabidopsis with N-terminal deletion variants of UreG demonstrated that the hypervariable region has a minor impact on activation efficiency, whereas the conserved region up to the first HXH motif is highly beneficial and up to the second HXH motif strictly required for activation. We also show that urease reaches its full activity several days after nickel becomes available in the leaves, indicating that urease activation is limited by nickel accessibility in vivo. Our data uncover the crucial role of UreG for nickel delivery during eukaryotic urease activation, inciting further investigations of the details of this process.	[Myrach, Till] Free Univ Berlin, Dahlem Ctr Plant Sci, Dept Plant Biochem, Konigin Luise Str 12-16, D-14195 Berlin, Germany; [Zhu, Anting; Witte, Claus-Peter] Leibniz Univ Hannover, Inst Plant Nutr Mol Nutr & Biochem Plants, Herrenhauser Str 2, D-30419 Hannover, Germany	Free University of Berlin; Leibniz University Hannover	Witte, CP (corresponding author), Leibniz Univ Hannover, Inst Plant Nutr Mol Nutr & Biochem Plants, Herrenhauser Str 2, D-30419 Hannover, Germany.	cpwitte@pflern.uni-hannover.de	Witte, Claus-Peter/L-1676-2017	Witte, Claus-Peter/0000-0002-3617-7807	German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups [57041752]	German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups	This work was supported by the German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups (Grant ID 57041752). The authors declare that they have no conflicts of interest with the contents of this article.	Bacanamwo M, 2002, MOL GENET GENOMICS, V268, P525, DOI 10.1007/s00438-002-0769-z; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Boer JL, 2012, BIOCHEMISTRY-US, V51, P2298, DOI 10.1021/bi3000897; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; Cao FQ, 2010, PLANT PHYSIOL, V154, P98, DOI 10.1104/pp.110.160929; Carter EL, 2011, BIOCHEMISTRY-US, V50, P9296, DOI 10.1021/bi2011064; Colpas GJ, 1999, BIOCHEMISTRY-US, V38, P4078, DOI 10.1021/bi982435t; Colpas GJ, 2000, J BIOL CHEM, V275, P10731, DOI 10.1074/jbc.275.15.10731; D'Urzo A, 2014, J BIOL INORG CHEM, V19, P1341, DOI 10.1007/s00775-014-1191-9; Dahncke K, 2013, PLANT CELL, V25, P4101, DOI 10.1105/tpc.113.117184; Farrugia MA, 2015, BIOCHEMISTRY-US, V54, P6392, DOI 10.1021/acs.biochem.5b00942; Farrugia MA, 2013, J AM SOC MASS SPECTR, V24, P1328, DOI 10.1007/s13361-013-0677-y; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Freyermuth SK, 2000, PLANT J, V21, P53, DOI 10.1046/j.1365-313x.2000.00655.x; Glinski M, 2003, RAPID COMMUN MASS SP, V17, P1579, DOI 10.1002/rcm.1093; Goldraij A, 1999, PLANT PHYSIOL, V119, P297, DOI 10.1104/pp.119.1.297; Hauck OK, 2014, PLANT CELL, V26, P3090, DOI 10.1105/tpc.114.124008; LEE MH, 1992, J BACTERIOL, V174, P4324, DOI 10.1128/JB.174.13.4324-4330.1992; Liu GW, 2015, PLANTA, V241, P861, DOI 10.1007/s00425-014-2219-7; Liu LH, 2003, PLANT CELL, V15, P790, DOI 10.1105/tpc.007120; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Soriano A, 2000, BIOCHEMISTRY-US, V39, P12435, DOI 10.1021/bi001296o; Wang WH, 2012, NEW PHYTOL, V193, P432, DOI 10.1111/j.1469-8137.2011.03929.x; Werner AK, 2008, PLANT PHYSIOL, V146, P418, DOI 10.1104/pp.107.110809; Witte CP, 2005, PLANT PHYSIOL, V139, P1155, DOI 10.1104/pp.105.070292; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Witte CP, 2001, PLANT MOL BIOL, V45, P169, DOI 10.1023/A:1006429315851; Witte CP, 2001, ANAL BIOCHEM, V290, P102, DOI 10.1006/abio.2000.4933; Yang XM, 2015, J BIOL CHEM, V290, P12474, DOI 10.1074/jbc.M114.632364; Yang XM, 2014, METALLOMICS, V6, P1731, DOI 10.1039/c4mt00134f; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zambelli B, 2013, J BIOL INORG CHEM, V18, P1005, DOI 10.1007/s00775-013-1049-6; Zanin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0222-6	43	21	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14556	14565		10.1074/jbc.M117.780403	http://dx.doi.org/10.1074/jbc.M117.780403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710280	Green Published, hybrid			2022-12-26	WOS:000408747500021
J	Klyczek, KK; Bonilla, JA; Jacobs-Sere, D; Adair, TL; Afram, P; Allen, KG; Archambault, ML; Aziz, RM; Bagnasco, FG; Ball, SL; Barrette, NA; Benjamin, RC; Blasi, CJ; Borst, K; Braun, MA; Broomell, H; Browns, CB; Brynell, ZS; Bue, AB; Burke, SO; Casazza, W; Cautele, JA; Chen, K; Chimalakonda, NS; Chudoff, D; Connor, JA; Cross, TS; Curtis, KN; Dahlke, JA; Deaton, BM; Degroote, SJ; DeNigris, DM; DeRuff, KC; Dolan, M; Dunbar, D; Egan, MS; Evans, DR; Fahnestock, AK; Farooq, A; Finn, G; Fratus, CR; Gaffney, BL; Garlena, RA; Garrigan, KE; Gibbon, BC; Goedde, MA; Bustamante, CAG; Harrison, M; Hartwell, MC; Heckman, EL; Huang, J; Hughes, LE; Hyduchak, KM; Jacob, AE; Kaku, M; Karstens, AW; Kenna, MA; Khetarpal, S; King, RA; Kobokovich, AL; Kolev, H; Konde, SA; Kriese, E; Lamey, ME; Lantz, CN; Lapin, JS; Lawson, TO; Lee, IY; Lee, SM; Lee-Soety, JY; Lehmann, EM; London, SC; Lopez, AJ; Lynch, KC; Mageeney, CM; Martynyuk, T; Mathew, KJ; Mavrich, TN; McDaniel, CM; McDonald, H; McManus, CJ; Medrano, JE; Melee, FE; Menninger, JE; Miller, SN; Minick, JE; Nabua, CT; Napoli, CK; Nkangabwa, M; Oates, EA; Ott, CT; Pellerino, SK; Pinamont, WJ; Pirnie, RT; Pizzorno, MC; Plautz, EJ; Pope, WH; Pruett, KM; Rickstrew, G; Rimple, PA; Rinehart, CA; Robinson, KM; Rose, VA; Russell, DA; Schick, AM; Schlossman, J; Schneider, VM; Sells, CA; Sieker, JW; Silvan, MP; Silvi, MM; Simons, SE; Staples, AK; Steed, IL; Stowe, EL; Stueven, NA; Swartz, PT; Sweet, EA; Sweetman, AT; Tender, C; Terry, K; Thomas, C; Thomas, DS; Thompson, AR; Vanderveen, L; Varma, R; Vaught, HL; Vo, QD; Vonberg, ZT; Ware, VC; Warrad, YM; Wathen, KE; Weinstein, JL; Wyper, JF; Yankauskas, JR; Zhang, C; Hatfull, GF				Klyczek, Karen K.; Bonilla, J. Alfred; Jacobs-Sere, Deborah; Adair, Tamarah L.; Afram, Patricia; Allen, Katherine G.; Archambault, Megan L.; Aziz, Rahat M.; Bagnasco, Filippa G.; Ball, Sarah L.; Barrette, Natalie A.; Benjamin, Robert C.; Blasi, Christopher J.; Borst, Katherine; Braun, Mary A.; Broomell, Haley; Browns, Conner B.; Brynell, Zachary S.; Bue, Ashley B.; Burke, Sydney O.; Casazza, William; Cautele, Julia A.; Chen, Kevin; Chimalakonda, Nitish S.; Chudoff, Dylan; Connor, Jade A.; Cross, Trevor S.; Curtis, Kyra N.; Dahlke, Jessica A.; Deaton, Bethany M.; Degroote, Sarah J.; DeNigris, Danielle M.; DeRuff, Katherine C.; Dolan, Milan; Dunbar, David; Egan, Marisa S.; Evans, Daniel R.; Fahnestock, Abby K.; Farooq, Amal; Finn, Garrett; Fratus, Christopher R.; Gaffney, Bobby L.; Garlena, Rebecca A.; Garrigan, Kelly E.; Gibbon, Bryan C.; Goedde, Michael A.; Bustamante, Carlos A. Guerrero; Harrison, Melinda; Hartwell, Megan C.; Heckman, Emily L.; Huang, Jennifer; Hughes, Lee E.; Hyduchak, Kathryn M.; Jacob, Aswathi E.; Kaku, Machika; Karstens, Allen W.; Kenna, Margaret A.; Khetarpal, Susheel; King, Rodney A.; Kobokovich, Amanda L.; Kolev, Hannah; Konde, Sai A.; Kriese, Elizabeth; Lamey, Morgan E.; Lantz, Carter N.; Lapin, Jonathan S.; Lawson, Temiloluwa O.; Lee, In Young; Lee, Scott M.; Lee-Soety, Julia Y.; Lehmann, Emily M.; London, Shawn C.; Lopez, A. Javier; Lynch, Kelly C.; Mageeney, Catherine M.; Martynyuk, Tetyana; Mathew, Kevin J.; Mavrich, Travis N.; McDaniel, Christopher M.; McDonald, Hannah; McManus, C. Joel; Medrano, Jessica E.; Melee, Francis E.; Menninger, Jennifer E.; Miller, Sierra N.; Minick, Josephine E.; Nabua, Courtney T.; Napoli, Caroline K.; Nkangabwa, Martha; Oates, Elizabeth A.; Ott, Cassandra T.; Pellerino, Sarah K.; Pinamont, William J.; Pirnie, Ross T.; Pizzorno, Marie C.; Plautz, Emilee J.; Pope, Welkin H.; Pruett, Katelyn M.; Rickstrew, Gabbi; Rimple, Patrick A.; Rinehart, Claire A.; Robinson, Kayla M.; Rose, Victoria A.; Russell, Daniel A.; Schick, Amelia M.; Schlossman, Julia; Schneider, Victoria M.; Sells, Chloe A.; Sieker, Jeremy W.; Silvan, Morgan P.; Silvi, Marissa M.; Simons, Stephanie E.; Staples, Amanda K.; Steed, Isabelle L.; Stowe, Emily L.; Stueven, Noah A.; Swartz, Porter T.; Sweet, Emma A.; Sweetman, Abigail T.; Tender, Corrina; Terry, Katrina; Thomas, Chrystal; Thomas, Daniel S.; Thompson, Allison R.; Vanderveen, Lorianna; Varma, Rohan; Vaught, Hannah L.; Vo, Quynh D.; Vonberg, Zachary T.; Ware, Vassie C.; Warrad, Yasmene M.; Wathen, Kaitlyn E.; Weinstein, Jonathan L.; Wyper, Jacqueline F.; Yankauskas, Jakob R.; Zhang, Christine; Hatfull, Graham F.			Tales of diversity: Genomic and morphological characteristics of forty-six Arthrobacter phages	PLOS ONE			English	Article							BACTERIOPHAGES; SOIL; ACTINOMYCETE; EVOLUTION; HOST	The vast bacteriophage population harbors an immense reservoir of genetic information. Almost 2000 phage genomes have been sequenced from phages infecting hosts in the phylum Actinobacteria, and analysis of these genomes reveals substantial diversity, pervasive mosaicism, and novel mechanisms for phage replication and lysogeny. Here, we describe the isolation and genomic characterization of 46 phages from environmental samples at various geographic locations in the U.S. infecting a single Arthrobacter sp. strain. These phages include representatives of all three virion morphologies, and Jasmine is the first sequenced podovirus of an actinobacterial host. The phages also span considerable sequence diversity, and can be grouped into 10 clusters according to their nucleotide diversity, and two singletons each with no close relatives. However, the clusters/singletons appear to be genomically well separated from each other, and relatively few genes are shared between clusters. Genome size varies from among the smallest of siphoviral phages (15,319 bp) to over 70 kbp, and G+C contents range from 45-68%, compared to 63.4% for the host genome. Although temperate phages are common among other actinobacterial hosts, these Arthrobacter phages are primarily lytic, and only the singleton Galaxy is likely temperate.	[Klyczek, Karen K.; Bonilla, J. Alfred; Archambault, Megan L.; Bue, Ashley B.; Dahlke, Jessica A.; Degroote, Sarah J.; Finn, Garrett; Kriese, Elizabeth; Lawson, Temiloluwa O.; Lehmann, Emily M.; Pellerino, Sarah K.; Plautz, Emilee J.; Steed, Isabelle L.; Stueven, Noah A.; Swartz, Porter T.; Sweet, Emma A.; Vaught, Hannah L.; Vonberg, Zachary T.] Univ Wisconsin, Biol Dept, River Falls, WI 54022 USA; [Jacobs-Sere, Deborah; Garlena, Rebecca A.; Bustamante, Carlos A. Guerrero; Lapin, Jonathan S.; Lee, In Young; Mavrich, Travis N.; Ott, Cassandra T.; Pope, Welkin H.; Rimple, Patrick A.; Russell, Daniel A.; Schneider, Victoria M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Adair, Tamarah L.; Bagnasco, Filippa G.; Brynell, Zachary S.; Burke, Sydney O.; Chimalakonda, Nitish S.; Connor, Jade A.; Curtis, Kyra N.; Deaton, Bethany M.; Fahnestock, Abby K.; Fratus, Christopher R.; Gibbon, Bryan C.; Karstens, Allen W.; Konde, Sai A.; Lantz, Carter N.; Lee, Scott M.; Miller, Sierra N.; Minick, Josephine E.; Pruett, Katelyn M.; Rose, Victoria A.; Schick, Amelia M.; Sells, Chloe A.; Sieker, Jeremy W.; Thomas, Daniel S.; Warrad, Yasmene M.; Wyper, Jacqueline F.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Afram, Patricia; Broomell, Haley; Chudoff, Dylan; Cross, Trevor S.; Dunbar, David; Harrison, Melinda; Terry, Katrina] Cabrini Univ, Dept Sci, Radnor, PA USA; [Allen, Katherine G.; Browns, Conner B.; Dolan, Milan; Gaffney, Bobby L.; Goedde, Michael A.; King, Rodney A.; Lynch, Kelly C.; McDaniel, Christopher M.; Oates, Elizabeth A.; Rinehart, Claire A.; Staples, Amanda K.; Thompson, Allison R.; Wathen, Kaitlyn E.] Western Kentucky Univ, Biol Dept, Bowling Green, KY 42101 USA; [Aziz, Rahat M.; Benjamin, Robert C.; Farooq, Amal; Hughes, Lee E.; Mathew, Kevin J.; Robinson, Kayla M.; Silvan, Morgan P.; Simons, Stephanie E.; Vo, Quynh D.] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Ball, Sarah L.] Ohio State Univ, Ctr Life Sci Educ, Columbus, OH 43210 USA; [Barrette, Natalie A.; Cautele, Julia A.; DeNigris, Danielle M.; Egan, Marisa S.; Garrigan, Kelly E.; Hartwell, Megan C.; Hyduchak, Kathryn M.; Jacob, Aswathi E.; Lamey, Morgan E.; Lee-Soety, Julia Y.; London, Shawn C.; Martynyuk, Tetyana; Melee, Francis E.; Menninger, Jennifer E.; Nabua, Courtney T.; Napoli, Caroline K.; Sweetman, Abigail T.; Weinstein, Jonathan L.] St Josephs Univ, Biol Dept, Philadelphia, PA 19131 USA; [Blasi, Christopher J.; DeRuff, Katherine C.; Kobokovich, Amanda L.; Medrano, Jessica E.; Pinamont, William J.; Pirnie, Ross T.; Pizzorno, Marie C.; Silvi, Marissa M.; Stowe, Emily L.; Yankauskas, Jakob R.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Borst, Katherine; Braun, Mary A.; Casazza, William; Chen, Kevin; Evans, Daniel R.; Huang, Jennifer; Kaku, Machika; Khetarpal, Susheel; Kolev, Hannah; Lopez, A. Javier; McDonald, Hannah; McManus, C. Joel; Nkangabwa, Martha; Rickstrew, Gabbi; Schlossman, Julia; Tender, Corrina; Thomas, Chrystal; Vanderveen, Lorianna; Varma, Rohan; Zhang, Christine] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Heckman, Emily L.; Kenna, Margaret A.; Mageeney, Catherine M.; Ware, Vassie C.] Lehigh Univ, Biol Sci, Bethlehem, PA 18015 USA	University of Wisconsin System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Western Kentucky University; University of North Texas System; University of North Texas Denton; University System of Ohio; Ohio State University; Saint Joseph's University; Bucknell University; Carnegie Mellon University; Lehigh University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Evans, Daniel/AAM-3103-2020	Thomas, Chrystal/0000-0001-7926-8293; DeRuff, Katherine/0000-0001-6011-4323; Lee, In Young/0000-0001-8406-1801; Evans, Daniel/0000-0002-3553-9263; Guerrero, Carlos/0000-0002-7256-5188; Barrett, Natalie/0000-0001-6732-418X; Egan, Marisa/0000-0001-6191-5552; Klyczek, Karen/0000-0001-7882-0429; Miller, Sierra/0000-0002-9490-9041; Cross, Trevor/0000-0002-6102-2532; Pizzorno, Marie/0000-0003-3502-6289; Sells, Chloe/0000-0002-9895-0949; Mavrich, Travis/0000-0001-9252-5020; Kaku, Machika/0000-0002-9921-0678	National Institutes of Health [GM116884, P20GM103436]; Howard Hughes Medical Institute [54308198]; National Science Foundation [1247842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116884, P20GM103436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM116884 to GFH, Howard Hughes Medical Institute 54308198 to GFH, National Science Foundation 1247842 to TNM, and National Institutes of Health P20GM103436 to RAK and CAR.	ACHBERGER EC, 1978, J BACTERIOL, V135, P595, DOI 10.1128/JB.135.2.595-602.1978; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; BROWN DR, 1978, APPL ENVIRON MICROB, V35, P185, DOI 10.1128/AEM.35.1.185-191.1978; Camargo FAO, 2004, BIOL TRACE ELEM RES, V97, P183, DOI 10.1385/BTER:97:2:183; CASIDA LE, 1974, APPL MICROBIOL, V28, P951, DOI 10.1128/AEM.28.6.951-959.1974; Cresawn SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118725; Dyson ZA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134512; EINCK KH, 1973, J VIROL, V12, P1031, DOI 10.1128/JVI.12.5.1031-1033.1973; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Gregory AC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3286-x; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix R., 2006, BACTERIOPHAGES; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Jordan TC, 2014, MBIO, V5, DOI 10.1128/mBio.01051-13; Kaliniene L, 2017, J VIROL, V91, DOI [10.1128/JVI.00023-17, 10.1128/jvi.00023-17]; Khairnar Krishna, 2014, Biotechnol Res Int, V2014, P151952, DOI 10.1155/2014/151952; Kloepper TH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-22; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13754; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; O'Loughlin EJ, 1999, BIODEGRADATION, V10, P93, DOI 10.1023/A:1008309026751; OSTLE AG, 1979, APPL ENVIRON MICROB, V38, P59, DOI 10.1128/AEM.38.1.59-65.1979; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2013, ARCH VIROL, V158, P601, DOI 10.1007/s00705-012-1530-5; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Salifu SP, 2013, ENV MICROBIOL REP, V5, P170, DOI 10.1111/1758-2229.12028; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sarkis GJ, 1998, METH MOL B, V101, P145, DOI 10.1385/0-89603-471-2:145; Simoliunas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111230; Smith MCM, 2013, J BACTERIOL, V195, P4924, DOI 10.1128/JB.00618-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; TO CM, 1966, J ULTRA MOL STRUCT R, V14, P441, DOI 10.1016/S0022-5320(66)80074-6; Veesler D, 2014, STRUCTURE, V22, P230, DOI 10.1016/j.str.2013.11.007; Verma M, 2013, RES MICROBIOL, V164, P718, DOI 10.1016/j.resmic.2013.04.002; WARD CM, 1973, J BACTERIOL, V114, P378, DOI 10.1128/JB.114.1.378-389.1973; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083	52	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180517	10.1371/journal.pone.0180517	http://dx.doi.org/10.1371/journal.pone.0180517			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715480	Green Submitted, gold, Green Published			2022-12-26	WOS:000443975500010
J	vanEngelsdorp, D; Traynor, KS; Andree, M; Lichtenberg, EM; Chen, YP; Saegerman, C; Cox-Foster, DL				vanEngelsdorp, Dennis; Traynor, Kirsten S.; Andree, Michael; Lichtenberg, Elinor M.; Chen, Yanping; Saegerman, Claude; Cox-Foster, Diana L.			Colony Collapse Disorder (CCD) and bee age impact honey bee pathophysiology	PLOS ONE			English	Article							MALPIGHIAN TUBULES; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; NATIONAL-SURVEY; LOSSES; HYMENOPTERA; SENSITIVITY; HOMEOSTASIS; MICROFLORA; NODULATION	Honey bee (Apis mellifera) colonies continue to experience high annual losses that remain poorly explained. Numerous interacting factors have been linked to colony declines. Understanding the pathways linking pathophysiology with symptoms is an important step in understanding the mechanisms of disease. In this study we examined the specific pathologies associated with honey bees collected from colonies suffering from Colony Collapse Disorder (CCD) and compared these with bees collected from apparently healthy colonies. We identified a set of pathological physical characteristics that occurred at different rates in CCD diagnosed colonies prior to their collapse: rectum distension, Malpighian tubule iridescence, fecal matter consistency, rectal enteroliths (hard concretions), and venom sac color. The multiple differences in rectum symptomology in bees from CCD apiaries and colonies suggest effected bees had trouble regulating water. To ensure that pathologies we found associated with CCD were indeed pathologies and not due to normal changes in physical appearances that occur as an adult bee ages (CCD colonies are assumed to be composed mostly of young bees), we documented the changes in bees of different ages taken from healthy colonies. We found that young bees had much greater incidences of white nodules than older cohorts. Prevalent in newly-emerged bees, these white nodules or cellular encapsulations indicate an active immune response. Comparing the two sets of characteristics, we determined a subset of pathologies that reliably predict CCD status rather than bee age (fecal matter consistency, rectal distension size, rectal enteroliths and Malpighian tubule iridescence) and that may serve as biomarkers for colony health. In addition, these pathologies suggest that CCD bees are experiencing disrupted excretory physiology. Our identification of these symptoms is an important first step in understanding the physiological pathways that underlie CCD and factors impacting bee health.	[vanEngelsdorp, Dennis; Traynor, Kirsten S.; Lichtenberg, Elinor M.] Univ Maryland, Dept Entomol, Plant Sci Bldg, College Pk, MD 20742 USA; [Andree, Michael] Univ Calif Cooperat Extens, Cooperat Extens Butte Cty, Oroville, CA USA; [Lichtenberg, Elinor M.] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; [Chen, Yanping] USDA ARS, Bee Res Lab, Beltsville, MD USA; [Saegerman, Claude] Univ Liege, Fac Vet Med, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Sart Tilman Par Liege, Belgium; [Cox-Foster, Diana L.] USDA ARS PWA, Pollinating Insect Biol, Mgmt Syst Res Unit, Logan, UT USA; [Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University System of Maryland; University of Maryland College Park; University of California System; University of Arizona; United States Department of Agriculture (USDA); University of Liege; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	vanEngelsdorp, D (corresponding author), Univ Maryland, Dept Entomol, Plant Sci Bldg, College Pk, MD 20742 USA.	dvane@umd.edu	Traynor, Kirsten/GWC-1553-2022; Lichtenberg, Elinor M./I-4126-2012; vanEngelsdorp, Dennis/E-7934-2010; Lichtenberg, Elinor M./AAG-6251-2020	Saegerman, Claude/0000-0001-9087-7436; Traynor, Kirsten/0000-0002-0848-4607; Lichtenberg, Elinor/0000-0002-2729-4534	Pennsylvania Department of Agriculture; US National Honey Board; Pennsylvania State University, Department of Entomology	Pennsylvania Department of Agriculture; US National Honey Board; Pennsylvania State University, Department of Entomology	The following provided funding for this study: Pennsylvania Department of Agriculture (DVE, DCF), US National Honey Board (DVE, DCF), and the Pennsylvania State University, Department of Entomology (DCF, DVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], 2014, R LANG ENV STAT COMP; Barron AB, 2015, CURR OPIN INSECT SCI, V10, P45, DOI 10.1016/j.cois.2015.04.004; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; Breiman L., 1984, CLASSIFICATION REGRE; CALDERONE NW, 1988, BEHAV ECOL SOCIOBIOL, V22, P17, DOI 10.1007/BF00395694; Carreck NL, 2015, J APICULT RES, V52, P1; Christensen R., 2013, R PACKAGE VERSION 20, P08; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dade H.A., 1994, ANATOMY DISSECTION H; Dow J. A. T., 1987, ADV INSECT PHYSIOL, V19, P187, DOI [DOI 10.1016/S0065-2806(08)60102-2, 10.1016/S0065-2806(08)60102-2]; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Engel P, 2015, MBIO, V6, DOI 10.1128/mBio.00193-15; Erickson E, 1997, J INVERTEBR PATHOL, V70, P27, DOI 10.1006/jipa.1997.4663; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; FYG W, 1964, ANNU REV ENTOMOL, V9, P207, DOI 10.1146/annurev.en.09.010164.001231; Fyg W, 1960, Z BIENENFORSCH, V5, P93; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Graham JM, 1992, HIVE HONEY BEE, Vxxv; Gramigni E, 2011, X-RAY SPECTROM, V40, P186, DOI 10.1002/xrs.1308; Gurvits GE, 2014, WORLD J GASTROENTERO, V20, P17819, DOI 10.3748/wjg.v20.i47.17819; Hertig M., 1923, Journal of Parasitology Urbana, V9, P109; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Hothorn T, 2015, SIMULTANEOUS INFEREN; Isidori AM, 2014, EUR UROL, V65, P99, DOI 10.1016/j.eururo.2013.08.048; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; KUMMEL G, 1974, CYTOBIOLOGIE, V9, P432; Lacey Lawrence A., 1997, P1, DOI 10.1016/B978-012432555-5/50004-X; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; LIU TP, 1985, J INVERTEBR PATHOL, V46, P125, DOI 10.1016/0022-2011(85)90140-5; Lothmar R, 1946, FLAGELLATEN BAKTERIE, P49; Maiolino P., 2014, VET MED ANIM SCI, V2, P4, DOI [10.7243/2054-3425-2-4, DOI 10.7243/2054-3425-2-4]; MARTIGNONI ME, 1964, ANNU REV ENTOMOL, V9, P179, DOI 10.1146/annurev.en.09.010164.001143; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Miller J, 2013, J UROLOGY, V190, P1648, DOI 10.1016/j.juro.2013.03.010; Nation J, 2005, ENCY ENTOMOLOGY, P65; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; Page RE, 1995, ANIM BEHAV, V50, P1617, DOI 10.1016/0003-3472(95)80015-8; PAGE RE, 1991, ADV INSECT PHYSIOL, V23, P117, DOI 10.1016/S0065-2806(08)60093-4; Peng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10565; Pennsylvania State University College of Agricultural Sciences Mid-Atlantic Apiculture Research and Extension Consortium United_ States_ Department_ of_ Agriculture, 2011, FIELD GUIDE HONEY BE; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Porter RS, 2011, TRANSBOUND EMERG DIS, V58, P197, DOI 10.1111/j.1865-1682.2010.01196.x; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rennich K., 2012, 2011 2012 NATL HONEY; Ritter W., 2006, HONEY BEE DIS PESTS; Saegerman C, 2015, TRANSBOUND EMERG DIS, V62, P46, DOI 10.1111/tbed.12070; Saegerman C, 2011, REV SCI TECH OIE, V30, P555; Saegerman C, 2014, CLIN SENTINEL SURVEI; Sammataro D, 2015, J APICULT RES, V52, P1; Sammataro D, 2006, INT J ACAROL, V32, P339, DOI 10.1080/01647950608684479; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Seeley TD, 1995, WISDOM HIVE SOCIAL P, VXIV; Seitz N, 2016, J APICULT RES, P1; Shimanuki H., 2000, DIAGNOSIS HONEY BEE; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snow JW, 2016, J INVERTEBR PATHOL, V135, P10, DOI 10.1016/j.jip.2016.01.007; SOHAL RS, 1976, TISSUE CELL, V8, P447, DOI 10.1016/0040-8166(76)90005-7; Spivak M., 2006, HONEY BEE DIS PESTS; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; The National Bee Unit, 2015, COMM PESTS DIS DIS A, P20; Trappmann W., 1923, Archiv fuer Bienenkunde, V5, P190; Tursi A, 2015, ALIMENT PHARM THER, V42, P664, DOI 10.1111/apt.13322; VanEngelsdorp D, 2007, FALL DWINDLE DIS INV; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; WEIL ERNEST, 1935, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V30, P438, DOI 10.1007/BF00410842; White G. F., 1919, Bulletin United States Department of Agriculture, V780; World Organization for Animal Health (OIE), 2016, NOS HON BEES MAN DIA; Zanella G, 2013, TRANSBOUND EMERG DIS, V60, P231, DOI 10.1111/j.1865-1682.2012.01334.x	88	42	45	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179535	10.1371/journal.pone.0179535	http://dx.doi.org/10.1371/journal.pone.0179535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715431	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500003
J	Jamei, M; Nisnevich, A; Wetchler, E; Sudat, S; Liu, E				Jamei, Mehdi; Nisnevich, Aleksandr; Wetchler, Everett; Sudat, Sylvia; Liu, Eric			Predicting all-cause risk of 30-day hospital readmission using artificial neural networks	PLOS ONE			English	Article							HEART-FAILURE; MODELS	Avoidable hospital readmissions not only contribute to the high costs of healthcare in the US, but also have an impact on the quality of care for patients. Large scale adoption of Electronic Health Records (EHR) has created the opportunity to proactively identify patients with high risk of hospital readmission, and apply effective interventions to mitigate that risk. To that end, in the past, numerous machine-learning models have been employed to predict the risk of 30-day hospital readmission. However, the need for an accurate and real-time predictive model, suitable for hospital setting applications still exists. Here, using data from more than 300,000 hospital stays in California from Sutter Health's EHR system, we built and tested an artificial neural network (NN) model based on Google's TensorFlow library. Through comparison with other traditional and non-traditional models, we demonstrated that neural networks are great candidates to capture the complexity and interdependency of various data fields in EHRs. LACE, the current industry standard, showed a precision (PPV) of 0.20 in identifying high-risk patients in our database. In contrast, our NN model yielded a PPV of 0.24, which is a 20% improvement over LACE. Additionally, we discussed the predictive power of Social Determinants of Health (SDoH) data, and presented a simple cost analysis to assist hospitalists in implementing helpful and cost-effective post-discharge interventions.	[Jamei, Mehdi; Nisnevich, Aleksandr; Wetchler, Everett; Liu, Eric] Bayes Impact, Technol 501 c3 Nonprofit, San Francisco, CA 94103 USA; [Sudat, Sylvia] Sutter Hlth, Res Dev & Disseminat, Walnut Creek, CA USA		Jamei, M (corresponding author), Bayes Impact, Technol 501 c3 Nonprofit, San Francisco, CA 94103 USA.	mehdi@bayesimpact.org; keuters@sutterhealth.org		Upadhyaya, Kirtan/0000-0002-0708-0141; Jamei, Mehdi/0000-0003-0658-9621	Robert Wood Johnson Foundation;  [33676]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); 	Robert Wood Johnson Foundation (www.rwjf.org) funded this study through a grant. Eric Liu was awarded grant #33676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi  M., 2016, ARXIV160304467; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2015, SOCIAL EXPLORER TABL; Bayati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109264; Chollet F., 2015, KERAS DEEP LEARNING; Commission MPA, 2007, REP C PROM GREAT EFF; Futoma J, 2015, J BIOMED INFORM, V56, P229, DOI 10.1016/j.jbi.2015.05.016; Gerhardt G, 2012, MED MED RES REV, V2013, P3; Goodman D, 2013, REVOLVING DOOR REPOR; Hao SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140271; He DN, 2014, J AM MED INFORM ASSN, V21, P272, DOI 10.1136/amiajnl-2013-002151; Ho TK, 1995, P 3 INT C DOC AN REC; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; McKinney W., 2010, P 9 PYTH SCI C, DOI DOI 10.25080/MAJORA-92BF1922-00A; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P3; Navathe A., 2016, AC HLTH ANN RES M BO; QGIS A., 2015, FREE OP SOURC GEOGR; Rockville M., 2015, HOSP GUIDE REDUCING; Shams I, 2015, HEALTH CARE MANAG SC, V18, P19, DOI 10.1007/s10729-014-9278-y; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117	22	61	62	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181173	10.1371/journal.pone.0181173	http://dx.doi.org/10.1371/journal.pone.0181173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708848	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800045
J	Zhang, YX; Yu, CS; Lin, JZ; Liu, J; Liu, B; Wang, J; Huang, AB; Li, HY; Zhao, T				Zhang, Yongxing; Yu, Chunsheng; Lin, Jianzhong; Liu, Jun; Liu, Bin; Wang, Jian; Huang, Aobo; Li, Hongyu; Zhao, Tao			OsMPH1 regulates plant height and improves grain yield in rice	PLOS ONE			English	Article							SECONDARY WALL BIOSYNTHESIS; 2ND GREEN-REVOLUTION; MYB TRANSCRIPTION FACTORS; KINASE GENE FAMILY; CELL-SURFACE; ARABIDOPSIS; EXPRESSION; NAC; DNA	Plant height is a major trait affecting yield potential in rice. Using a large-scale hybrid transcription factor approach, we identified the novel MYB-like transcription factor OsMPH1 (MYB-like gene of Plant Height 1), which is involved in the regulation of plant height in rice. Overexpression of OsMPH1 leads to increases of plant height and grain yield in rice, while knockdown of OsMPH1 leads to the opposite phenotypes. Microscopy of longitudinal stem sections indicated that a change in internode cell length resulted in the change in plant height. RNA sequencing (RNA-seq) analysis of transgenic rice lines showed that multiple genes related to cell elongation and cell wall synthesis, which are associated with plant height and yield phenotypes, exhibited an altered expression profile. These results imply that OsMPH1 might be involved in specific recognition and signal transduction processes related to plant height and yield formation, providing further insights into the mechanisms underlying the regulation of plant height and providing a candidate gene for the efficient improvement of rice yield.	[Zhang, Yongxing; Yu, Chunsheng; Liu, Jun; Liu, Bin; Huang, Aobo; Li, Hongyu; Zhao, Tao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Lin, Jianzhong] Hunan Univ, Coll Biol, Hunan Prov Key Lab Plant Funct Genom & Dev Regula, Changsha, Hunan, Peoples R China; [Wang, Jian] Ningxia Acad Agr & Forestry Sci, Crop Res Inst, Ningxia, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hunan University	Li, HY; Zhao, T (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	lihongyu@caas.cn; zhaotao02@caas.cn		Zhao, Tao/0000-0002-5641-8161	Ministry of Agriculture Transgenic Research Grant [2010ZX08010-002]; National Natural Science Foundation of China [3157101834]; CAAS Innovation Program	Ministry of Agriculture Transgenic Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program	This study design, data collection and analysis, decision to publish, or preparation of the manuscripThis work is supported in part by Ministry of Agriculture Transgenic Research Grant 2010ZX08010-002 awarded to the Institute of Crop Science Chinese Academy of Agricultural Sciences and by the National Natural Science Foundation of China (3157101834 to T.Z) and the CAAS Innovation Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassan-Wang H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00189; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kim WC, 2013, PLANT J, V73, P26, DOI 10.1111/j.1365-313x.2012.05124.x; Ko JH, 2012, MOL PLANT, V5, P961, DOI 10.1093/mp/sss076; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Meng YY, 2013, PLANT CELL, V25, P4405, DOI 10.1105/tpc.113.116590; Mooney BP, 2009, BIOCHEM J, V418, P219, DOI 10.1042/BJ20081769; Palme K, 2014, J GENET GENOMICS, V41, P315, DOI 10.1016/j.jgg.2014.05.003; Steffen A, 1994, PLANT J, V5, P421; de Oliveira LFV, 2014, PLANT SCI, V229, P181, DOI 10.1016/j.plantsci.2014.09.007; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Ye YF, 2015, PLANT MOL BIOL, V89, P385, DOI 10.1007/s11103-015-0376-0; Zhao T, 2015, SCI CHINA LIFE SCI, V58, P1160, DOI 10.1007/s11427-015-4937-x; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	26	23	26	16	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180825	10.1371/journal.pone.0180825	http://dx.doi.org/10.1371/journal.pone.0180825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708834	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800024
J	Wang, HP; Ba, HJ; Yang, C; Zhang, JQ; Tai, YC				Wang, Huipin; Ba, Huajie; Yang, Chun; Zhang, Jianqiu; Tai, Yunchun			Inner and inter population structure construction of Chinese Jiangsu Han population based on Y23 STR system	PLOS ONE			English	Article							MODERN HUMAN-ORIGIN; Y-CHROMOSOME; DEVELOPMENTAL VALIDATION; MINORITY POPULATION; SEQUENCE VARIATION; GENETIC-ANALYSIS; HAPLOTYPE DATA; PLUS KIT; LOCI; MULTIPLEX	In this study, we analyzed the genetic polymorphisms of 23 Y-STR loci from PowerPlex (R) Y23 system in 916 unrelated healthy male individuals from Chinese Jiangsu Han, and observed 912 different haplotypes including 908 unique haplotypes and 4 duplicate haplotypes. The haplotype diversity reached 0.99999 and the discrimination capacity and match probability were 0.9956 and 0.0011, respectively. The gene diversity values ranged from 0.3942 at DYS438 to 0.9607 at DYS385a/b. Population differentiation within 10 Jiangsu Han subpopulations were evaluated by RST values and visualized in Neighbor-Joining trees and Multi-Dimensional Scaling plots as well as population relationships between the Jiangsu Han population and other 18 Eastern Asian populations. Such results indicated that the 23 Y-STR loci were highly polymorphic in Jiangsu Han population and played crucial roles in forensic application as well as population genetics. For the first time, we reported the genetic diversity of male lineages in Jiangsu Han population at a high-resolution level of 23 Y-STR set and consequently contributed to familial searching, offender tracking, and anthropology analysis of Jiangsu Han population.	[Wang, Huipin] Zhongshan City Peoples Hosp, Zhongshan, Guangdong, Peoples R China; [Ba, Huajie] Publ Secur Bur Changzhou, DNA Lab, Changzhou, Jiangsu, Peoples R China; [Yang, Chun] 102 Hosp Peoples Liberat Army, Psychiat Ctr Chinese Peoples Liberat Army, Dept Psychiat, Changzhou, Jiangsu, Peoples R China; [Zhang, Jianqiu] Publ Secur Bur Yangzhou, DNA Lab, Yangzhou, Jiangsu, Peoples R China; [Tai, Yunchun] Southern Med Univ, Sch Forens Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Tai, YC (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou, Guangdong, Peoples R China.	yunchun_tai@163.com			Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province) [2015A030310080]	Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province)	This project was supported by the Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province, No. 2015A030310080).	Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Cann R L, 1982, Prog Clin Biol Res, V103 Pt A, P157; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coble MD, 2013, FORENSIC SCI INT-GEN, V7, pE66, DOI 10.1016/j.fsigen.2013.03.006; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fulmer PM, PROMEGA APPL NOTES; Gao TZ, 2016, INT J LEGAL MED, V130, P1509, DOI 10.1007/s00414-016-1433-1; Gao TZ, 2015, FORENSIC SCI INT-GEN, V19, P130, DOI 10.1016/j.fsigen.2015.07.006; Gopinath S, 2016, FORENSIC SCI INT-GEN, V24, P164, DOI 10.1016/j.fsigen.2016.07.006; Hasan MM, 2016, INT J LEGAL MED, V130, P1493, DOI 10.1007/s00414-016-1367-7; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; Jiang WB, 2017, INT J LEGAL MED, V131, P115, DOI 10.1007/s00414-016-1411-7; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Jung JY, 2016, LEGAL MED-TOKYO, V23, P17, DOI 10.1016/j.legalmed.2016.09.001; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kwon SY, 2016, FORENSIC SCI INT-GEN, V25, P132, DOI 10.1016/j.fsigen.2016.08.010; Lacerenza D, 2017, FORENSIC SCI INT-GEN, V27, P172, DOI 10.1016/j.fsigen.2016.12.009; Li LM, 2016, FORENSIC SCI INT-GEN, V20, P101, DOI 10.1016/j.fsigen.2015.10.007; Luo HB, 2015, INT J LEGAL MED, V129, P737, DOI 10.1007/s00414-015-1175-5; Meng ZY, 2012, SCI GEOGRAPHICA SINI, V32, P8; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Olofsson JK, 2015, FORENSIC SCI INT-GEN, V16, P232, DOI 10.1016/j.fsigen.2015.02.006; Ottaviani E, 2015, INT J LEGAL MED, V129, P729, DOI 10.1007/s00414-014-1078-x; Petit E, 2002, TRENDS ECOL EVOL, V17, P28, DOI 10.1016/S0169-5347(01)02356-4; Provine WB, 2004, GENETICS, V167, P1041; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Rapone C, 2016, FORENSIC SCI INT-GEN, V21, pE1, DOI 10.1016/j.fsigen.2015.11.006; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schneider PM, 2007, FORENSIC SCI INT, V165, P238, DOI 10.1016/j.forsciint.2006.06.067; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Siegert S, 2015, FORENSIC SCI INT-GEN, V16, P216, DOI 10.1016/j.fsigen.2015.02.001; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JM, 2013, FORENSIC SCI INT-GEN, V7, P240, DOI 10.1016/j.fsigen.2012.10.013; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Toscanini U, 2016, FORENSIC SCI INT-GEN, V20, P1, DOI 10.1016/j.fsigen.2015.09.002; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang H, 2016, INT J LEGAL MED; Wang Y, 2016, INT J LEGAL MED, V130, P689, DOI 10.1007/s00414-015-1301-4; Yang M, 2016, INT J LEGAL MED, V130, P1195, DOI 10.1007/s00414-016-1332-5; Yao J, 2016, FORENSIC SCI INT-GEN, V24, P112, DOI 10.1016/j.fsigen.2016.06.015; Yao J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160415; Yin CY, 2015, FORENSIC SCI INT-GEN, V14, P108, DOI 10.1016/j.fsigen.2014.09.015; Zeng ZS, 2014, FORENSIC SCI INT-GEN, V12, P100, DOI 10.1016/j.fsigen.2014.05.004; Zhang XF, 2017, FORENSIC SCI INT-GEN, V28, pE30, DOI 10.1016/j.fsigen.2017.02.006	56	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180921	10.1371/journal.pone.0180921	http://dx.doi.org/10.1371/journal.pone.0180921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704439	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649700060
J	Kuribayashi, T; Abe, T; Montani, S				Kuribayashi, Takanori; Abe, Tsuyoshi; Montani, Shigeru			Historical delta(15) N records of Saccharina specimens from oligotrophic waters of Japan Sea (Hokkaido)	PLOS ONE			English	Article							NITROGEN ISOTOPE RATIO; N-15 NATURAL-ABUNDANCE; FOOD-CHAINS; DELTA-N-15; PACIFIC; MARINE; CARBON; INDICATORS; ENRICHMENT; SALMON	Historically Saccharina spp. beds occurred along the west coast of Hokkaido, an oligotrophic area, and were commercially exploited. Currently extensive commercial Saccharina spp. beds do not form due to nutrient limitations. Here, we postulate that nutrients assimilated by paleo-Saccharina spp. beds may have been derived from spawning herrings (Clupea pallasii) acting as organisms that formed a vector from their feeding grounds (Okhotsk Sea and Pacific Ocean) to their spawning area (west coast of Hokkaido, Japan Sea). To test this hypothesis we examined stable nitrogen isotope ratios (delta N-15) of 100-to 135-year-old Saccharina specimens preserved at the Herbarium (Hokkaido University Museum). delta(15) N values of the paleo-Saccharina specimens collected from this region were in the range of 10%, which is significantly higher than the current 3-7% in freshly sampled Saccharina spp. This high delta(15) N indicates that spawning herring (Clupea pallasii) had potentially been a significant source of dissolved inorganic nitrogen (DIN) absorbed by Saccharina, acting as an organism forming a vector for transporting nutrients from eutrophic to oligotrophic coastal ecosystems. Our findings support the hypothesis of so-called "herring-derived nutrients."	[Kuribayashi, Takanori; Montani, Shigeru] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan; [Kuribayashi, Takanori] Hokkaido Nucl Energy Environm Res Ctr, Sect Fisheries Res, Iwanai, Hokkaido, Japan; [Abe, Tsuyoshi] Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Abe, Tsuyoshi] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan; [Montani, Shigeru] Hokkaido Univ, Grad Sch Fisheries Sci, Div Marine Bioresource & Environm Sci, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Kuribayashi, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.; Kuribayashi, T (corresponding author), Hokkaido Nucl Energy Environm Res Ctr, Sect Fisheries Res, Iwanai, Hokkaido, Japan.	kuribayashi-takanori@hro.or.jp	Kuribayashi, Takanori/AAK-6924-2020	Kuribayashi, Takanori/0000-0001-8885-4219	Hokkaido Research Organization; Hokkaido Government; Hokkaido University	Hokkaido Research Organization; Hokkaido Government; Hokkaido University	This work was funded by the Hokkaido Research Organization, Hokkaido Government, and Hokkaido University. The funders had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agatsuma Y, 2014, J APPL PHYCOL, V26, P1845, DOI 10.1007/s10811-013-0196-z; Akaike S., 1998, AQUAC SCI, V46, P57; Akaike Shoichi, 2002, Scientific Reports of Hokkaido Fisheries Experimental Station, V63, P41; Baker DM, 2010, GLOBAL CHANGE BIOL, V16, P2701, DOI 10.1111/j.1365-2486.2010.02167.x; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; BROWDER RG, 1994, T AM FISH SOC, V123, P993, DOI 10.1577/1548-8659(1994)123<0993:IACIAT>2.3.CO;2; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Cole ML, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003269; Costanzo SD, 2001, MAR POLLUT BULL, V42, P149, DOI 10.1016/S0025-326X(00)00125-9; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dotsu K, 1999, NIPPON SUISAN GAKK, V65, P216; DURBIN AG, 1979, ECOLOGY, V60, P8, DOI 10.2307/1936461; Fong P, 1998, J EXP MAR BIOL ECOL, V231, P63, DOI 10.1016/S0022-0981(98)00085-9; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; HAY DE, 1983, CAN J FISH AQUAT SCI, V40, P109, DOI 10.1139/f83-019; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hokkaido Prefectural Government, 1960, HOKK SUIS GENS; Ishida T, 1952, FISHERIES SCIS SERIE; Jones AB, 2001, ESTUAR COAST SHELF S, V52, P91, DOI 10.1006/ecss.2000.0729; KLINE TC, 1990, CAN J FISH AQUAT SCI, V47, P136, DOI 10.1139/f90-014; Kobayashi Tokimasa, 2002, Scientific Reports of Hokkaido Fisheries Experimental Station, V62, P1; Kobayashi Tokimasa, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P1; Kondo H., 1965, SCI REPORTS HOKKAIDO, V3, P1; Kuribayashi T, 2014, B COASTAL OCEANOGRAP, V52, P75; Kuribayashi T, 2014, FISHEREIS ENG, V51, P47; Kuribayashi T, 2016, ALGAL RESOURCES, V9, P1; MacAvoy SE, 2000, OECOLOGIA, V122, P568, DOI 10.1007/s004420050980; MacAvoy SE, 2009, FISH B-NOAA, V107, P165; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; McClelland JW, 1998, MAR ECOL PROG SER, V168, P259, DOI 10.3354/meps168259; McClelland JW, 1997, LIMNOL OCEANOGR, V42, P930, DOI 10.4319/lo.1997.42.5.0930; McKinney RA, 1999, HYDROBIOLOGIA, V412, P17, DOI 10.1023/A:1003887913402; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minagawa M, 2001, J OCEANOGR, V57, P285, DOI DOI 10.1023/A:1012430512137; MIYAKE Y, 1967, Records of Oceanographic Works in Japan, V9, P37; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; Nagasawa K, 2001, PROG OCEANOGR, V49, P551, DOI 10.1016/S0079-6611(01)00040-4; Nakano S, 1999, ECOLOGY, V80, P2435; North W. J., 1982, SYNTHETIC DEGRADATIV, P247; Oba T, 1991, PALEOCEANOGRAPHY, V6, P499, DOI 10.1029/91PA00560; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; SAINO T, 1980, NATURE, V283, P752, DOI 10.1038/283752a0; SAINO T, 1987, DEEP-SEA RES, V34, P807, DOI 10.1016/0198-0149(87)90038-0; Seto M, 2001, P CIV ENG OC, V17, P123; SEUNG YH, 1995, J OCEANOGR, V51, P421; SUDO H, 1986, PROG OCEANOGR, V17, P313, DOI 10.1016/0079-6611(86)90052-2; Torii S, 1987, J HOKKAIDO FISHERIES, V44, P275; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; Wiley AE, 2013, P NATL ACAD SCI USA, V110, P8972, DOI 10.1073/pnas.1300213110	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180760	10.1371/journal.pone.0180760	http://dx.doi.org/10.1371/journal.pone.0180760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704453	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649600048
J	Tosetti, V; Sassone, J; Ferri, ALM; Taiana, M; Bedini, G; Nava, S; Brenna, G; Di Resta, C; Pareyson, D; Di Giulio, AM; Carelli, S; Parati, EA; Gorio, A				Tosetti, Valentina; Sassone, Jenny; Ferri, Anna L. M.; Taiana, Michela; Bedini, Gloria; Nava, Sara; Brenna, Greta; Di Resta, Chiara; Pareyson, Davide; Di Giulio, Anna Maria; Carelli, Stephana; Parati, Eugenio A.; Gorio, Alfredo			Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis	PLOS ONE			English	Article							MESSENGER-RNA; ACTIVE CHROMATIN; GENE-EXPRESSION; ENHANCER RNAS; NEURONS ARISE; STEM-CELLS; BICALUTAMIDE; TESTOSTERONE; BINDING; REVEALS	The complex architecture of adult brain derives from tightly regulated migration and differentiation of precursor cells generated during embryonic neurogenesis. Changes at transcriptional level of genes that regulate migration and differentiation may lead to neurodevelopmental disorders. Androgen receptor (AR) is a transcription factor that is already expressed during early embryonic days. However, AR role in the regulation of gene expression at early embryonic stage is yet to be determinate. Long non-coding RNA (lncRNA) Sox2 overlapping transcript (Sox2OT) plays a crucial role in gene expression control during development but its transcriptional regulation is still to be clearly defined. Here, using Bicalutamide in order to pharmacologically inactivated AR, we investigated whether AR participates in the regulation of the transcription of the lncRNASox2OTat early embryonic stage. We identified a new DNA binding region upstream of Sox2 locus containing three androgen response elements (ARE), and found that AR binds such a sequence in embryonic neural stem cells and in mouse embryonic brain. Our data suggest that through this binding, AR can promote the RNA polymerase II dependent transcription of Sox2OT. Our findings also suggest that AR participates in embryonic neurogenesis through transcriptional control of the long non-coding RNA Sox2OT.	[Tosetti, Valentina; Ferri, Anna L. M.; Bedini, Gloria; Parati, Eugenio A.] Fdn IRCCS Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy; [Tosetti, Valentina; Di Giulio, Anna Maria; Carelli, Stephana; Gorio, Alfredo] Univ Milan, Dept Hlth Sci, Lab Pharmacol, Milan, Italy; [Sassone, Jenny] Vita Salute Univ & San Raffaele Sci Inst, Div Neurosci, Milan, Italy; [Taiana, Michela] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy; [Nava, Sara] Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit, Cerebrovasc Unit, Lab Cellular Neurobiol, Milan, Italy; [Nava, Sara] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurooncol, Milan, Italy; [Brenna, Greta] Fdn IRCCS Ist Neurol Carlo Besta, Biostatistician Serv Clin Res, Sci Dept, Milan, Italy; [Di Resta, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Di Resta, Chiara] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Pareyson, Davide] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Neurol Rare Dis Adulthood Unit, Milan, Italy; [Di Giulio, Anna Maria] Univ Milan, Pediat Clin Res Ctr Fdn Romeo & Enrica Invernizzi, Milan, Italy	IRCCS Istituto Neurologico Besta; University of Milan; Vita-Salute San Raffaele University; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; University of Milan	Tosetti, V (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy.; Tosetti, V (corresponding author), Univ Milan, Dept Hlth Sci, Lab Pharmacol, Milan, Italy.	tosettivalentina@gmail.com	Taiana, Michela/AAB-8846-2019; Parati, Eugenio Agostino/AAN-5893-2021; Nava, Sara/J-8740-2016; Carelli, Stephana/AAB-2365-2021; Ferri, Luca Angelo/AAC-5890-2022; Di Resta, Chiara/J-3627-2018; Pareyson, Davide/K-5890-2016	Parati, Eugenio Agostino/0000-0001-5020-6523; Nava, Sara/0000-0001-9912-8255; Carelli, Stephana/0000-0003-4603-396X; Ferri, Luca Angelo/0000-0001-9031-6284; Pareyson, Davide/0000-0001-6854-765X; DI RESTA, Chiara/0000-0003-2880-6631				Altwein JE, 2013, MOL BIOL PROSTATE CA; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Askarian-Amiri ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102140; AYUB M, 1989, J STEROID BIOCHEM, V33, P251, DOI 10.1016/0022-4731(89)90301-4; Chuang HC, AUTISMRES, V20158, P412; CLAESSENS F, 1993, ANN NY ACAD SCI, V684, P199, DOI 10.1111/j.1749-6632.1993.tb32283.x; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P1256, DOI 10.1210/me.11.9.1256; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Cockshott ID, 2004, CLIN PHARMACOKINET, V43, P855, DOI 10.2165/00003088-200443130-00003; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FELDMAN SC, 1978, ENDOCRINOLOGY, V102, P999, DOI 10.1210/endo-102-4-999; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Furr BJA, 1996, EUR UROL, V29, P83; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Giorgetti E, 2015, HUM MOL GENET, V24, P64, DOI 10.1093/hmg/ddu419; Godsave SF, 2002, J COMP NEUROL, V453, P57, DOI 10.1002/cne.10391; Gorelick DA, 2008, DEV DYNAM, V237, P2987, DOI 10.1002/dvdy.21700; Gravina GL, 2009, UROLOGY, V74, P452, DOI 10.1016/j.urology.2009.01.018; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; HEINLEIN CA, 2002, ENDOCR REV, V23, P175, DOI DOI 10.1210/ER.23.2.175; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Lee DK, 2003, J STEROID BIOCHEM, V84, P41, DOI 10.1016/S0960-0760(03)00005-0; Ling Guoyu, 2013, Methods Mol Biol, V977, P21, DOI 10.1007/978-1-62703-284-1_3; Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4; Luo SQ, 1997, UROLOGY, V50, P913, DOI 10.1016/S0090-4295(97)00393-2; MacLean HE, 2008, PHYSIOL GENOMICS, V33, P133, DOI 10.1152/physiolgenomics.00260.2007; Malkowicz SB, 1996, UROLOGY, V47, P29, DOI 10.1016/S0090-4295(96)80005-7; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001; Mora GR, 1999, STEROIDS, V64, P587, DOI 10.1016/S0039-128X(99)00037-9; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOUMURA T, 1966, ENDOCRINOLOGY, V78, P245, DOI 10.1210/endo-78-2-245; Orom UA, 2013, CELL, V143, P46; PARKER MG, 1977, CELL, V12, P401, DOI 10.1016/0092-8674(77)90116-7; Perets R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046467; Prensner JR, 2014, ONCOTARGET, V5, P1434, DOI 10.18632/oncotarget.1846; Rangasamy S, 2013, NEUROTHERAPEUTICS, V10, P742, DOI 10.1007/s13311-013-0227-0; Ransome Mark I, 2015, Front Cell Neurosci, V9, P253, DOI 10.3389/fncel.2015.00253; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Ronen D, 2014, CELL REP, V8, P923, DOI 10.1016/j.celrep.2014.07.013; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Sheflin LG, 2004, BIOCHEM BIOPH RES CO, V322, P644, DOI 10.1016/j.bbrc.2004.07.173; Sheppard KM, 2011, J NEUROENDOCRINOL, V23, P401, DOI 10.1111/j.1365-2826.2011.02126.x; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; SRIDARAN R, 1983, ENDOCRINOLOGY, V112, P1770, DOI 10.1210/endo-112-5-1770; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; TEUTSCH G, 1994, J STEROID BIOCHEM, V48, P111, DOI 10.1016/0960-0760(94)90257-7; TOOLE JJ, 1979, CELL, V17, P441, DOI 10.1016/0092-8674(79)90170-3; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WARREN DW, 1973, BIOL REPROD, V8, P560, DOI 10.1093/biolreprod/8.5.560; WATSON G, 1990, MOL CELL ENDOCRINOL, V68, P67, DOI 10.1016/0303-7207(90)90171-4; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wood CE, 2008, NEUROSCI LETT, V439, P153, DOI 10.1016/j.neulet.2008.05.008; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yu IC, 2013, DIABETES, V62, P411, DOI 10.2337/db12-0135; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhao Y, 2016, CELL REP, V15, P599, DOI 10.1016/j.celrep.2016.03.038	87	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180579	10.1371/journal.pone.0180579	http://dx.doi.org/10.1371/journal.pone.0180579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704421	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600036
J	Wang, HL; Zhang, J; Sun, QL; Lian, C; Sun, L				Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Lian, Chao; Sun, Li			A comparative study revealed first insights into the diversity and metabolisms of the microbial communities in the sediments of Pacmanus and Desmos hydrothermal fields	PLOS ONE			English	Article							BACK-ARC BASIN; COMPLETE GENOME SEQUENCE; EASTERN MANUS BASIN; DEEP-SEA SEDIMENTS; PHYLOGENETIC DIVERSITY; VENT FIELD; EPSILON-PROTEOBACTERIA; SULFUR OXIDATION; IHEYA NORTH; GEN. NOV.	Currently, little is known about the microbial diversity in the sediments of Pacmanus and Desmos hydrothermal fields in Manus Basin. In this study, Illumina-based sequencing of 16S rRNA gene amplicons and metagenomic analysis were conducted to investigate the microbial populations and metabolic profiles in the sediments from four different regions in Pacmanus and Desmos hydrothermal fields. It was found that Gammaproteobacteria and Thaumarchaeota were the most abundant bacterial and archaeal populations, respectively. The autotrophic prokaryotes in the four communities probably fixed CO2 via four major pathways, i.e. Calvin-Benson-Bassham cycle, reductive acetyl-CoA cycle, rTCA cycle, and 3-hydroxypropionate/ 4-hydroxybutyrate cycle. Ammonia- oxidizing Thaumarchaeota, nitrifiers, denitrifiers, and sulfur oxidizers belonging to the subgroups of Proteobacteria (e.g., alpha, beta, gamma, and epsilon), Nitrospira, and Nitrospina, and sulfate-reducing Desulfobacterales likely played critical roles in nitrogen and sulfur cycling, in which ammonia, sulfur compounds, and hydrogen could be utilized as potential energy sources. These findings revealed new insights into the operational mechanism of the microbial communities associated with Pacmanus and Desmos hydrothermal fields.	[Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Hai-liang; Zhang, Jian; Sun, Qing-lei; Sun, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Wang, Hai-liang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lian, Chao] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Sun, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences [ZSSD-005]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11030401]; Scientific & Technological Innovation Projects - Qingdao National Laboratory for Marine Science and Technology [2016ASKJ14, 2016ASKJ05]; Taishan Scholar Program of Shandong Province	Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific & Technological Innovation Projects - Qingdao National Laboratory for Marine Science and Technology; Taishan Scholar Program of Shandong Province	This work was supported by the grants from the Strategic Biological Resources Service Network Plan of Chinese Academy of Sciences (ZSSD-005), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11030401), the Scientific & Technological Innovation Projects supported by Qingdao National Laboratory for Marine Science and Technology (No. 2016ASKJ14 and No. 2016ASKJ05), and the Taishan Scholar Program of Shandong Province. We thank there search vessel KEXUE of the Chinese Academy of Sciences for collecting samples and WPOS sample center for providing samples	Anantharaman K, 2016, ISME J, V10, P225, DOI 10.1038/ismej.2015.81; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Binns R.A., 2007, PAP NEW GUIN P OC DR, P1, DOI DOI 10.2973/ODP.PROC.SR.193.201.2007; Bock E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P457, DOI 10.1007/0-387-30742-7_16; Bothe H, 2000, FEMS MICROBIOL REV, V24, P673, DOI 10.1111/j.1574-6976.2000.tb00566.x; Burow LC, 2014, GEOBIOLOGY, V12, P221, DOI 10.1111/gbi.12080; Cao HL, 2014, MBIO, V5, DOI 10.1128/mBio.00980-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerqueira T, 2015, MAR GENOM, V24, P343, DOI 10.1016/j.margen.2015.09.001; Cheng TW, 2014, MICROBES ENVIRON, V29, P377, DOI 10.1264/jsme2.ME14086; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Feng WW, 2011, INT BIODETER BIODEGR, V65, P1081, DOI 10.1016/j.ibiod.2011.05.009; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GAMO T, 1993, DEEP-SEA RES PT I, V40, P2335, DOI 10.1016/0967-0637(93)90108-F; Gamo T, 1997, GEOLOGY, V25, P139, DOI 10.1130/0091-7613(1997)025<0139:AASRHF>2.3.CO;2; Gena K, 2001, RESOUR GEOL, V51, P31, DOI 10.1111/j.1751-3928.2001.tb00079.x; Gena KR, 2006, RESOUR GEOL, V56, P183, DOI 10.1111/j.1751-3928.2006.tb00278.x; Guo JH, 2016, ENVIRON MICROBIOL, V18, P2979, DOI 10.1111/1462-2920.13132; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Hug LA, 2016, ENVIRON MICROBIOL, V18, P159, DOI 10.1111/1462-2920.12930; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khelifi N, 2014, ISME J, V8, P2153, DOI 10.1038/ismej.2014.58; Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Lee CS, 2006, SCI TOTAL ENVIRON, V356, P45, DOI 10.1016/j.scitotenv.2005.03.024; Lenk S, 2012, ISME J, V6, P2178, DOI 10.1038/ismej.2012.66; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maugeri TL, 2013, ATTI ACCAD PELORIT, V91, DOI 10.1478/AAPP.912A1; McDermott JM, 2015, GEOCHIM COSMOCHIM AC, V160, P169, DOI 10.1016/j.gca.2015.02.016; Mino S, 2014, INT J SYST EVOL MICR, V64, P3195, DOI 10.1099/ijs.0.065094-0; Monecke T, 2007, J VOLCANOL GEOTH RES, V160, P23, DOI 10.1016/j.jvolgeores.2006.08.007; Moss R, 2001, CAN MINERAL, V39, P957, DOI 10.2113/gscanmin.39.4.957; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa T, 2004, FEMS MICROBIOL LETT, V232, P145, DOI 10.1016/S0378-1097(04)00044-8; Nercessian O, 2005, ENVIRON MICROBIOL, V7, P698, DOI 10.1111/j.1462-2920.2005.00744.x; Nilsen RK, 1996, INT J SYST BACTERIOL, V46, P397, DOI 10.1099/00207713-46-2-397; Ontiveros-Valencia A, 2013, FEMS MICROBIOL ECOL, V85, P158, DOI 10.1111/1574-6941.12107; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Plugge CM, 2012, STAND GENOMIC SCI, V7, P91, DOI 10.4056/sigs.2996379; Reed AJ, 2009, DEEP-SEA RES PT II, V56, P1665, DOI 10.1016/j.dsr2.2009.05.012; Reeves EP, 2011, GEOCHIM COSMOCHIM AC, V75, P1088, DOI 10.1016/j.gca.2010.11.008; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Seitz KW, 2016, ISME J, V10, P1696, DOI 10.1038/ismej.2015.233; Sikorski J, 2010, STAND GENOMIC SCI, V3, P194, DOI 10.4056/sigs.1173118; Sun QL, 2015, WORLD J MICROB BIOT, V31, P2025, DOI 10.1007/s11274-015-1953-8; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka N, 2011, INT J SYST EVOL MICR, V61, P412, DOI 10.1099/ijs.0.020263-0; Taubner Ruth-Sophie, 2015, Life-Basel, V5, P1652, DOI 10.3390/life5041652; Thal J, 2014, MAR GEOL, V355, P98, DOI 10.1016/j.margeo.2014.05.011; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trubitsyn IV, 2013, MICROBIOLOGY+, V82, P15, DOI 10.1134/S0026261713010153; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wang L, 2015, J BASIC MICROB, V55, P1308, DOI 10.1002/jobm.201400811; Wang XY, 2014, APPL MICROBIOL BIOT, V98, P1883, DOI 10.1007/s00253-013-5174-5; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Winkel M, 2014, ENVIRON MICROBIOL, V16, P1612, DOI 10.1111/1462-2920.12316; Wu YH, 2014, ACTA OCEANOL SIN, V33, P94, DOI 10.1007/s13131-014-0544-0; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Yanagawa K, 2014, APPL ENVIRON MICROB, V80, P6126, DOI 10.1128/AEM.01741-14; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang J, 2015, MICROBIOL RES, V177, P43, DOI 10.1016/j.micres.2015.05.006; Zhou JZ, 2011, NAT REV MICROBIOL, V9, P452, DOI 10.1038/nrmicro2575; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	87	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181048	10.1371/journal.pone.0181048	http://dx.doi.org/10.1371/journal.pone.0181048			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704556	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600055
J	Chen, X; Li, SJ; Ojcius, DM; Sun, AH; Hu, WL; Lin, X; Yan, J				Chen, Xu; Li, Shi-Jun; Ojcius, David M.; Sun, Ai-Hua; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie			Mononuclear-macrophages but not neutrophils act as major infiltrating antileptospiral phagocytes during leptospirosis	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; PHAGOSOME MATURATION; ESCHERICHIA-COLI; DENDRITIC CELLS; MICE; INTERROGANS; DISEASE; INFECTION; MODEL; LIPOPOLYSACCHARIDE	Objective To identify the major infiltrating phagocytes during leptospirosis and examine the killing mechanism used by the host to eliminate Leptospira interrogans. Methods Major infiltrating phagocytes in Leptospira-infected C3H/HeJ mice were detected by immunohistochemistry. Chemokines and vascular endothelial cell adhesion molecules (VECAMs) of Leptospira-infected mice and leptospirosis patients were detected by microarray and immunohistochemistry. Leptospira-phagocytosing and -killing abilities of human or mouse macrophages and neutrophils, and the roles of intracellular ROS, NO and [Ca2+]i in Leptospira-killing process were evaluated by confocal microscopy and spectrofluorimetry. Results Peripheral blood mononuclear-macrophages rather than neutrophils were the main infiltrating phagocytes in the lungs, liver and kidneys of infected mice. Levels of macrophage-but not neutrophil-specific chemokines and VECAMs were significantly increased in the samples from infected mice and patients. All macrophages tested had a higher ability than neutrophils to phagocytose and kill leptospires. Higher ROS and NO levels and [Ca2+] i in the macrophages were involved in killing leptospires. Human macrophages displayed more phagolysosome formation and a stronger leptospire-killing ability to than mouse macrophages. Conclusions Mononuclear-macrophages but not neutrophils represent the main infiltrating and anti-leptospiral phagocytes during leptospirosis. A lower level of phagosome-lysosome fusion may be responsible for the lower Leptospira-killing ability of human macrophages.	[Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou, Zhejiang, Peoples R China; [Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Div Basic Med Microbiol,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, Shi-Jun] Guizhou Prov Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Ojcius, David M.] Univ Pacific, Dept Biomed Sci, Arthur Dugoni Sch Dent, San Francisco, CA USA; [Sun, Ai-Hua] Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University; University of the Pacific; Hangzhou Medical College	Lin, X; Yan, J (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Lin, X; Yan, J (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou, Zhejiang, Peoples R China.; Lin, X; Yan, J (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Div Basic Med Microbiol,Sch Med, Hangzhou, Zhejiang, Peoples R China.	lxai122@163.com; Med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81471907, 81671974, 81260250]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [J20111845/2013-032]; National Natural Science Foundation of Zhejiang Province, China [LQ14H190001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China; National Natural Science Foundation of Zhejiang Province, China	This work was supported by grants from the National Natural Science Foundation of China (81471907, 81671974 and 81260250), the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China (J20111845/2013-032) and the National Natural Science Foundation of Zhejiang Province, China (LQ14H190001).	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; AREAN VM, 1962, AM J PATHOL, V40, P393; Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; da Silva JB, 2009, MICROB PATHOGENESIS, V47, P87, DOI 10.1016/j.micpath.2009.05.002; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Eisele NA, 2011, AM J PATHOL, V178, P1190, DOI 10.1016/j.ajpath.2010.11.067; Forbes AE, 2012, QJM-INT J MED, V105, P1151, DOI 10.1093/qjmed/hcs145; Ghanem ENB, 2015, J IMMUNOL, V194, P1090, DOI 10.4049/jimmunol.1402401; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Goswami RP, 2014, T ROY SOC TROP MED H, V108, P791, DOI 10.1093/trstmh/tru144; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Harding MG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004379; Hu WL, 2014, CURR OPIN INFECT DIS, V27, P432, DOI 10.1097/QCO.0000000000000097; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Kassegne K, 2014, J INFECT DIS, V209, P1105, DOI 10.1093/infdis/jit659; Kaufmann SHE, 2016, IMMUNITY, V44, P476, DOI 10.1016/j.immuni.2016.02.014; Kern B, 2015, CELL MICROBIOL, V17, P1811, DOI 10.1111/cmi.12474; Kolonko M, 2014, CELL MICROBIOL, V16, P232, DOI 10.1111/cmi.12217; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Komi KK, 2015, MICROBES INFECT, V17, P34, DOI 10.1016/j.micinf.2014.10.010; Landes MB, 2015, J LEUKOCYTE BIOL, V97, P1111, DOI 10.1189/jlb.3A1114-557R; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Lau CL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0982-0; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Luz RA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/102160; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McGuinness WA, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010032; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miraglia F, 2013, DIAGN MICR INFEC DIS, V77, P195, DOI 10.1016/j.diagmicrobio.2013.08.003; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nakashima K, 2002, NITRIC OXIDE-BIOL CH, V6, P61, DOI 10.1006/niox.2001.0384; Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005; Nizet V, 2010, J INNATE IMMUN, V2, P505, DOI 10.1159/000320473; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3; Podgorny PJ, 2016, BIOL BLOOD MARROW TR, V22, P37, DOI 10.1016/j.bbmt.2015.09.003; Popova TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129860; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; Scharrig E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003927; SITPRIJA V, 1980, KIDNEY INT, V17, P827, DOI 10.1038/ki.1980.95; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Toma C, 2011, CELL MICROBIOL, V13, P1783, DOI 10.1111/j.1462-5822.2011.01660.x; Traxler RM, 2014, EMERG INFECT DIS, V20, P1273, DOI 10.3201/eid2008.130450; Vadia S, 2014, INFECT IMMUN, V82, P1084, DOI 10.1128/IAI.01067-13; Vedel-Krogh S, 2017, CLIN CHEM, V63, P823, DOI 10.1373/clinchem.2016.267450; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Visvalingam J, 2013, FOOD MICROBIOL, V34, P95, DOI 10.1016/j.fm.2012.11.021; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042266; Wang SH, 2015, MOL NEUROBIOL, V51, P718, DOI 10.1007/s12035-014-8755-0; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Xu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28802; Zeng QO, 2010, BIOMATERIALS, V31, P5772, DOI 10.1016/j.biomaterials.2010.04.022; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang L, 2012, MOL MICROBIOL, V83, P1006, DOI 10.1111/j.1365-2958.2012.07985.x; Zhao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075652; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhu XW, 2012, CIRC RES, V111, P1398, DOI 10.1161/CIRCRESAHA.112.269043	72	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181014	10.1371/journal.pone.0181014	http://dx.doi.org/10.1371/journal.pone.0181014			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700741	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649400028
J	Nagayoshi, Y; Miyazaki, T; Shimamura, S; Nakayama, H; Minematsu, A; Yamauchi, S; Takazono, T; Nakamura, S; Yanagihara, K; Kohno, S; Mukae, H; Izumikawa, K				Nagayoshi, Yohsuke; Miyazaki, Taiga; Shimamura, Shintaro; Nakayama, Hironobu; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Yanagihara, Katsunori; Kohno, Shigeru; Mukae, Hiroshi; Izumikawa, Koichi			Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species	PLOS ONE			English	Article							FLUCONAZOLE RESISTANCE; ECHINOCANDIN SUSCEPTIBILITY; OPPORTUNISTIC YEAST; MONOAMINE-OXIDASE; DRUG-RESISTANCE; ALBICANS; EFFLUX; GENE; SPHINGOLIPIDS; CASPOFUNGIN	The pathogenic fungus Candida glabrata is often resistant to azole antifungal agents. Drug efflux through azole transporters, such as Cdr1 and Cdr2, is a key mechanism of azole resistance and these genes are under the control of the transcription factor Pdr1. Recently, the monoamine oxidase A (MAO-A) inhibitor clorgyline was shown to inhibit the azole efflux pumps, leading to increased azole susceptibility in C. glabrata. In the present study, we have evaluated the effects of clorgyline on susceptibility of C. glabrata to not only azoles, but also to micafungin and amphotericin B, using wild-type and several mutant strains. The addition of clorgyline to the culture media increased fluconazole susceptibility of a C. glabrata wild-type strain, whereas micafungin and amphotericin B susceptibilities were markedly decreased. These phenomena were also observed in other medically important Candida species, including Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida krusei. Expression levels of CDR1, CDR2 and PDR1 mRNAs and an amount of Cdr1 protein in the C. glabrata wild-type strain were highly increased in response to the treatment with clorgyline. However, loss of Cdr1, Cdr2, Pdr1, and a putative clorgyline target (Fms1), which is an ortholog of human MAO-A, or overexpression of CDR1 did not affect the decreased susceptibility to micafungin and amphotericin B in the presence of clorgyline. The presence of other azole efflux pump inhibitors including milbemycin A4 oxime and carbonyl cyanide 3chlorophenylhydrazone also decreased micafungin susceptibility in C. glabrata wild-type,.cdr1,.cdr2, and.pdr1 strains. These findings suggest that azole efflux pump inhibitors increase azole susceptibility but concurrently induce decreased susceptibility to other classes of antifungals independent of azole transporter functions.	[Nagayoshi, Yohsuke; Miyazaki, Taiga; Takazono, Takahiro; Izumikawa, Koichi] Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan; [Nagayoshi, Yohsuke; Miyazaki, Taiga; Shimamura, Shintaro; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Kohno, Shigeru; Mukae, Hiroshi] Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan; [Nakayama, Hironobu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Minematsu, Asuka; Mukae, Hiroshi] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan; [Yamauchi, Shunsuke; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Nakamura, Shigeki] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; National Institute of Infectious Diseases (NIID)	Miyazaki, T (corresponding author), Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan.; Miyazaki, T (corresponding author), Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan.	taiga-m@nagasaki-u.ac.jp		Takazono, Takahiro/0000-0002-0696-5386	Japanese Ministry of Education, Culture, Sports, Science and Technology [24791027, 21390305]; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15K09573] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Grant-in-Aid for Scientific Research (no. 24791027 to TM and no. 21390305 to SK) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann SP, 2002, J CLIN MICROBIOL, V40, P2228, DOI 10.1128/JCM.40.6.2228-2230.2002; Basso LR, 2010, EUKARYOT CELL, V9, P960, DOI 10.1128/EC.00355-09; Bennett JE, 2004, ANTIMICROB AGENTS CH, V48, P1773, DOI 10.1128/AAC.48.5.1773-1777.2004; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cormack BP, 1999, GENETICS, V151, P979; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Flamand V, 2010, J CANCER RES CLIN, V136, P1761, DOI 10.1007/s00432-010-0835-6; Guinea J, 2006, MED MYCOL, V44, P575, DOI 10.1080/13693780600561544; Healey KR, 2015, ANTIMICROB AGENTS CH, V59, P3377, DOI 10.1128/AAC.04667-14; Healey KR, 2012, MOL MICROBIOL, V86, P303, DOI 10.1111/j.1365-2958.2012.08194.x; Holmes AR, 2012, ANTIMICROB AGENTS CH, V56, P1508, DOI 10.1128/AAC.05706-11; Joets J, 1996, CURR GENET, V30, P115, DOI 10.1007/s002940050109; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; KAISER C, 1994, LAB COURSE MANUAL ME; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; MALLOY PJ, 1993, P NATL ACAD SCI USA, V90, P1902, DOI 10.1073/pnas.90.5.1902; Miyazaki H, 1998, ANTIMICROB AGENTS CH, V42, P1695, DOI 10.1128/AAC.42.7.1695; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Miyazaki T, 2010, ANTIMICROB AGENTS CH, V54, P1639, DOI 10.1128/AAC.01364-09; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Niimi K, 2006, ANTIMICROB AGENTS CH, V50, P1148, DOI 10.1128/AAC.50.4.1148-1155.2006; Mario DAN, 2012, MEM I OSWALDO CRUZ, V107, P433, DOI 10.1590/S0074-02762012000300022; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Silva ATPE, 2009, FEMS YEAST RES, V9, P626, DOI 10.1111/j.1567-1364.2009.00508.x; Posteraro B, 2006, J ANTIMICROB CHEMOTH, V58, P458, DOI 10.1093/jac/dkl237; Pudencio C, 2000, CYTOMETRY, V39, P26, DOI 10.1002/(SICI)1097-0320(20000101)39:1<26::AID-CYTO5>3.0.CO;2-C; Richards TS, 2008, J ANTIMICROB CHEMOTH, V62, P349, DOI 10.1093/jac/dkn156; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Schuetzer-Muehlbauer M, 2003, MOL MICROBIOL, V48, P225, DOI 10.1046/j.1365-2958.2003.03430.x; Silva LV, 2013, ANTIMICROB AGENTS CH, V57, P873, DOI 10.1128/AAC.02040-12; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06	41	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7								10.1371/journal.pone.0180990	http://dx.doi.org/10.1371/journal.pone.0180990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700656	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400025
J	Dierck, F; Kuhn, C; Rohr, C; Hiile, S; Braune, J; Sossalla, S; Molt, S; van der Ven, PFM; Furst, DO; Frey, N				Dierck, Franziska; Kuhn, Christian; Rohr, Claudia; Hiile, Susanne; Braune, Julia; Sossalla, Samuel; Molt, Sibylle; van der Ven, Peter F. M.; Fuerst, Dieter O.; Frey, Norbert			The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE LIM PROTEIN; DILATED CARDIOMYOPATHY; HUMAN HEART; FILAMIN C; IN-VIVO; FHL2; MICE; MAINTENANCE; CALSARCIN-1; INTERACTS	The z-disc is a structural component at the lateral borders of the sarcomere and is important for mechanical stability and contractility of both cardiac and skeletal muscles. Of note, the sarcomeric z-disc also represents a nodal point in cardiomyocyte function and signaling. Mutations of numerous z-disc proteins are associated with cardiomyopathies and muscle diseases. To identify additional z-disc proteins that might contribute to cardiac disease, we employed an in silico screen for cardiac-enriched cDNAs. This screen yielded a previously uncharacterized protein named cardiac-enriched FHL2-interacting protein (CEFIP), which exhibited a heart-and skeletal muscle-specific expression profile. Importantly, CEFIP was located at the z-disc and was up-regulated in several models of cardiomyopathy. We also found that CEFIP overexpression induced the fetal gene program and cardiomyocyte hypertrophy. Yeast two-hybrid screens revealed that CEFIP interacts with the calcineurin-binding protein four and a half LIM domains 2 (FHL2). Because FHL2 binds calcineurin, a phosphatase controlling hypertrophic signaling, we examined the effects of CEFIP on the calcineurin/ nuclear factor of activated T-cell (NFAT) pathway. These experiments revealed that CEFIP overexpression further enhances calcineurin-dependent hypertrophic signal transduction, and its knockdown repressed hypertrophy and calcineurin/ NFAT activity. In summary, we report on a previously uncharacterized protein CEFIP that modulates calcineurin/ NFAT signaling in cardiomyocytes, a finding with possible implications for the pathogenesis of cardiomyopathy.	[Dierck, Franziska; Kuhn, Christian; Hiile, Susanne; Sossalla, Samuel; Frey, Norbert] Univ Med Ctr Schleswig Holstein, Dept Internal Med 3, Campus Kiel, D-24105 Kiel, Germany; [Dierck, Franziska; Kuhn, Christian; Hiile, Susanne; Sossalla, Samuel; Frey, Norbert] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, D-24105 Kiel, Germany; [Rohr, Claudia] Heidelberg Univ, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Braune, Julia; Molt, Sibylle; van der Ven, Peter F. M.; Fuerst, Dieter O.] Univ Bonn, Inst Cell Biol, Dept Mol Cell Biol, D-53121 Bonn, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; University of Bonn	Frey, N (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Internal Med 3, Campus Kiel, D-24105 Kiel, Germany.	norbert.frey@uksh.de	Fürst, Dieter O./H-8561-2013; Frey, Norbert/M-7749-2019; Frey, Norbert/A-9695-2010; Sossalla, Samuel/AAF-3611-2020	Fürst, Dieter O./0000-0001-8805-6444; Frey, Norbert/0000-0001-7611-378X; Hille, Susanne/0000-0002-9809-4636; van der Ven, Peter/0000-0002-9750-8913; Sossalla, Samuel/0000-0001-8034-2673	Deutsche Forschungsgemeinschaft (German Research Foundation) [Forschergruppe 1352]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (German Research Foundation) Forschergruppe 1352: "Structure, Function and Regulation of the Myofibrillar z-disc Interactome." The authors declare that they have no conflicts of interest with the contents of this article.	Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Arimura T, 2007, BIOCHEM BIOPH RES CO, V357, P162, DOI 10.1016/j.bbrc.2007.03.128; Bovill E, 2009, J THORAC CARDIOV SUR, V137, P853, DOI 10.1016/j.jtcvs.2008.09.006; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Friedrich FW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0451-8; Heineke J, 2012, J MOL CELL CARDIOL, V52, P62, DOI 10.1016/j.yjmcc.2011.10.018; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; Knoll Ralph, 2002, Exp Clin Cardiol, V7, P104; Kong YF, 2001, CIRCULATION, V103, P2731; Kuhn C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0262-8; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopes KD, 2011, J CELL BIOL, V193, P785, DOI 10.1083/jcb.201010099; Luedde M, 2009, J MOL MED, V87, P411, DOI 10.1007/s00109-008-0436-x; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molt S, 2014, J CELL SCI, V127, P3578, DOI 10.1242/jcs.152157; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Ritter O, 2002, CIRCULATION, V105, P2265, DOI 10.1161/01.CIR.0000016044.19527.96; Schoensiegel F, 2007, COMPARATIVE MED, V57, P546; Spaich S, 2012, CIRC RES, V111, P1504, DOI 10.1161/CIRCRESAHA.112.271007; Tran MK, 2016, BBA-MOL CELL RES, V1863, P219, DOI 10.1016/j.bbamcr.2015.11.002; Wang J, 2011, CYTOSKELETON, V68, P661, DOI 10.1002/cm.20542; Will RD, 2010, CIRC RES, V107, P1253, DOI 10.1161/CIRCRESAHA.110.222372	35	7	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15180	15191		10.1074/jbc.M117.786764	http://dx.doi.org/10.1074/jbc.M117.786764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717008	Green Published, hybrid			2022-12-26	WOS:000410809800002
J	Astegno, A; Bonza, MC; Vallone, R; La Verde, V; D'Onofrio, M; Luoni, L; Molesini, B; Dominici, P				Astegno, Alessandra; Bonza, Maria Cristina; Vallone, Rosario; La Verde, Valentina; D'Onofrio, Mariapina; Luoni, Laura; Molesini, Barbara; Dominici, Paola			Arabidopsis calmodulin-like protein CML36 is a calcium (Ca2+) sensor that interacts with the plasma membrane Ca2+-ATPase isoform ACA8 and stimulates its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT GLUTAMATE-DECARBOXYLASE; ION-BINDING-PROPERTIES; N-TERMINUS; SACCHAROMYCES-CEREVISIAE; REFERENCE GENES; THALIANA; EXPRESSION; MECHANISM; NMR; MAGNESIUM	Calmodulin-like (CML) proteins are major EF-hand-containing, calcium (Ca2+)-binding proteins with crucial roles in plant development and in coordinating plant stress tolerance. Given their abundance in plants, the properties of Ca2+ sensors and identification of novel target proteins of CMLs deserve special attention. To this end, we recombinantly produced and biochemically characterized CML36 from Arabidopsis thaliana. We analyzed Ca2+ and Mg2+ binding to the individual EF-hands, observed metal-induced conformational changes, and identified a physiologically relevant target. CML36 possesses two high-affinity Ca2+/Mg2+ mixed binding sites and two low-affinity Ca2+-specific sites. Binding of Ca2+ induced an increase in the alpha-helical content and a conformational change that lead to the exposure of hydrophobic regions responsible for target protein recognition. Cation binding, either Ca2+ or Mg2+, stabilized the secondary and tertiary structures of CML36, guiding a large structural transition from a molten globule apo-state to a compact holoconformation. Importantly, through in vitro binding and activity assays, we showed that CML36 interacts directly with the regulative N terminus of the Arabidopsis plasma membrane Ca2+-ATPase isoform 8 (ACA8) and that this interaction stimulates ACA8 activity. Gene expression analysis revealed that CML36 and ACA8 are co-expressed mainly in inflorescences. Collectively, our results support a role for CML36 as a Ca2+ sensor that binds to and modulates ACA8, uncovering a possible involvement of the CML protein family in the modulation of plant-autoinhibited Ca2+ pumps.	[Astegno, Alessandra; Vallone, Rosario; La Verde, Valentina; D'Onofrio, Mariapina; Molesini, Barbara; Dominici, Paola] Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy; [Bonza, Maria Cristina; Luoni, Laura] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Verona; University of Milan	Astegno, A (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	alessandra.astegno@univr.it	Bonza, Maria Cristina/B-1351-2017	Bonza, Maria Cristina/0000-0001-7096-2967; Luoni, Laura/0000-0002-6485-5417; MOLESINI, Barbara/0000-0002-4324-4908; Astegno, Alessandra/0000-0002-7341-0970	Grant FUR from the University of Verona	Grant FUR from the University of Verona	This study was supported in part by Grant FUR2014 from the University of Verona (to A.A. and P.D.). The authors declare that they have no conflicts of interest with the contents of this article.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Astegno A, 2016, BBA-PROTEINS PROTEOM, V1864, P297, DOI 10.1016/j.bbapap.2015.12.003; Astegno A, 2015, BBA-PROTEINS PROTEOM, V1854, P1229, DOI 10.1016/j.bbapap.2015.01.001; Astegno A, 2014, NANOSCALE, V6, P15037, DOI 10.1039/c4nr04368e; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bonza MC, 2011, PLANT BIOLOGY, V13, P421, DOI 10.1111/j.1438-8677.2010.00405.x; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; Bonza MC, 2000, PLANT PHYSIOL, V123, P1495, DOI 10.1104/pp.123.4.1495; Bonza MC, 2004, PLANTA, V218, P814, DOI 10.1007/s00425-003-1160-y; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Cali T, 2017, BBA-MOL BASIS DIS, V1863, P165, DOI 10.1016/j.bbadis.2016.09.007; Cerana M, 2006, PLANT BIOLOGY, V8, P572, DOI 10.1055/s-2006-924111; Costa A, 2017, J EXP BOT, V68, P3215, DOI 10.1093/jxb/erx162; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dobney S, 2009, J BIOL CHEM, V284, P31647, DOI 10.1074/jbc.M109.056770; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; Favretto F, 2015, FEBS J, V282, P1271, DOI 10.1111/febs.13218; Frey NFD, 2012, PLANT PHYSIOL, V159, P798, DOI 10.1104/pp.111.192575; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GARRIGOS M, 1991, ANAL BIOCHEM, V194, P82, DOI 10.1016/0003-2697(91)90154-L; Giacometti S, 2012, J EXP BOT, V63, P1215, DOI 10.1093/jxb/err346; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2013, PLANT CELL, V25, P4512, DOI 10.1105/tpc.113.113183; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Gut H, 2009, J MOL BIOL, V392, P334, DOI 10.1016/j.jmb.2009.06.080; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luoni L, 2006, PHYSIOL PLANTARUM, V126, P175, DOI 10.1111/j.1399-3054.2006.00588.x; Luoni L, 2004, FEBS LETT, V574, P20, DOI 10.1016/j.febslet.2004.08.003; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Marino V, 2014, NANOSCALE, V6, P412, DOI 10.1039/c3nr04978g; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Permyakov E. A., 2010, CALCIUM BINDING PROT, P567; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Ranty B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00327; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schiott M, 2005, PHYSIOL PLANTARUM, V124, P278, DOI 10.1111/j.1399-3054.2005.00512.x; Sorensen BR, 1996, BIOPHYS J, V71, P3407, DOI 10.1016/S0006-3495(96)79535-8; Sorensen BR, 2001, BIOCHEMISTRY-US, V40, P896, DOI 10.1021/bi0023091; Steinhorst L, 2013, PLANT PHYSIOL, V163, P471, DOI 10.1104/pp.113.222950; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Vallone R, 2016, PROTEIN SCI, V25, P1461, DOI 10.1002/pro.2942; VANELDIK LJ, 1980, P NATL ACAD SCI-BIOL, V77, P1912, DOI 10.1073/pnas.77.4.1912; Waters BM, 2011, NEW PHYTOL, V190, P510, DOI 10.1111/j.1469-8137.2011.03724.x; Webb AAR, 1996, ADV BOT RES, V22, P45; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600	65	37	40	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15049	15061		10.1074/jbc.M117.787796	http://dx.doi.org/10.1074/jbc.M117.787796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726644	hybrid, Green Published			2022-12-26	WOS:000409902100027
J	Johnson, KM; Phan, TTN; Albertolle, ME; Guengerich, FP				Johnson, Kevin M.; Phan, Thanh T. N.; Albertolle, Matthew E.; Guengerich, F. Peter			Human mitochondrial cytochrome P450 27C1 is localized in skin and preferentially desaturates trans-retinol to 3,4-dehydroretinol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN-CLEAVAGE; RATE-LIMITING STEPS; ADRENODOXIN REDUCTASE; HUMAN KERATINOCYTES; ELECTRON-TRANSFER; DRUG-METABOLISM; VITAMIN-A; SUBSTRATE; CHOLESTEROL; ENZYMES	Recently, zebrafish and human cytochrome P450 (P450) 27C1 enzymes have been shown to be retinoid 3,4-desaturases. The enzyme is unusual among mammalian P450s in that the predominant oxidation is a desaturation and in that hydroxylation represents only a minor pathway. We show by proteomic analysis that P450 27C1 is localized to human skin, with two proteins of different sizes present, one being a cleavage product of the full-length form. P450 27C1 oxidized all-trans-retinol to 3,4-dehydroretinol, 4-hydroxy (OH) retinol, and 3-OH retinol in a 100:3:2 ratio. Neither 3-OH nor 4-OH retinol was an intermediate in desaturation. No kinetic burst was observed in the steady state; neither the rate of substrate binding nor product release was rate-limiting. Ferric P450 27C1 reduction by adrenodoxin was 3-fold faster in the presence of the substrate and was similar to 5-fold faster than the overall turnover. Kinetic isotope effects of 1.5-2.3 (on k(cat)/K-m) were observed with 3,3-, 4,4-, and 3,3,4,4-deuterated retinol. Deuteration at C-4 produced a 4-fold increase in 3-hydroxylation due to metabolic switching, with no observable effect on 4-hydroxylation. Deuteration at C-3 produced a strong kinetic isotope effect for 3-hydroxylation but not 4-hydroxylation. Analysis of the products of deuterated retinol showed a lack of scrambling of a putative allylic radical at C-3 and C-4. We conclude that the most likely catalytic mechanism begins with abstraction of a hydrogen atom from C-4 (or possibly C-3) initiating the desaturation pathway, followed by a sequential abstraction of a hydrogen atom or proton-coupled electron transfer. Adrenodoxin reduction and hydrogen abstraction both contribute to rate limitation.	[Johnson, Kevin M.; Phan, Thanh T. N.; Albertolle, Matthew E.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Albertolle, Matthew E./0000-0003-4195-4006; , Thanh Thanh/0000-0002-2727-6133	National Institutes of Health [P30 CA068485]; NATIONAL CANCER INSTITUTE [T32CA009582, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the mass spectrometry and proteomic work was supported in part by National Institutes of Health Grant P30 CA068485 (Vanderbilt-Ingram Cancer Center Support Grant).	Acimovic J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28462; ANDERSSON E, 1994, BBA-MOL CELL RES, V1224, P349, DOI 10.1016/0167-4889(94)90267-4; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Arnqvist L, 2008, PLANTA, V227, P309, DOI 10.1007/s00425-007-0618-8; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Bell SG, 2012, CHEM-EUR J, V18, P16677, DOI 10.1002/chem.201202776; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Cooper HLR, 2012, J AM CHEM SOC, V134, P20365, DOI 10.1021/ja3059149; Daniels F., 1966, PHYS CHEM, P330; Distlerath L. M., 1987, MAMMALIAN CYTOCHROME, V1, P133; Du LP, 2004, TOXICOL APPL PHARM, V195, P278, DOI 10.1016/j.taap.2003.09.020; Enright JM, 2015, CURR BIOL, V25, P3048, DOI 10.1016/j.cub.2015.10.018; FASCO MJ, 1978, J MED CHEM, V21, P1054, DOI 10.1021/jm00208a009; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guan XM, 1998, CHEM-BIOL INTERACT, V110, P103, DOI 10.1016/S0009-2797(97)00145-2; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2013, J LABELLED COMPD RAD, V56, P428, DOI 10.1002/jlcr.3031; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P413, DOI 10.1021/tx00022a003; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; HUME R, 1984, EUR J BIOCHEM, V140, P583, DOI 10.1111/j.1432-1033.1984.tb08142.x; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; Ji L, 2015, CHEM-EUR J, V21, P9083, DOI 10.1002/chem.201500329; Johnson Kenneth A., 2003, P1; KATAGIRI M, 1977, BIOCHEM BIOPH RES CO, V77, P804, DOI 10.1016/S0006-291X(77)80049-1; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kramlinger VM, 2016, FEBS LETT, V590, P1304, DOI 10.1002/1873-3468.12167; Kumar D, 2004, J AM CHEM SOC, V126, P5072, DOI 10.1021/ja0318737; LAMBETH JD, 1980, J BIOL CHEM, V255, P4667; LAMBETH JD, 1979, J BIOL CHEM, V254, P7255; LAMBETH JD, 1977, J BIOL CHEM, V252, P2908; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MASSEY V, 1977, J BIOL CHEM, V252, P5612; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Nelson David R., 2009, Human Genomics, V4, P59; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Oesch F, 2007, DRUG METAB REV, V39, P659, DOI 10.1080/03602530701690366; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Palfey Bruce A., 2003, P203; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Popa C, 1999, BRIT J DERMATOL, V141, P460; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; RETTIE AE, 1988, J BIOL CHEM, V263, P13733; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; Rishavy MA, 2013, J BIOL CHEM, V288, P31556, DOI 10.1074/jbc.M113.497297; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Schiffler B, 2004, J BIOL CHEM, V279, P34269, DOI 10.1074/jbc.M402798200; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; SEYBERT DW, 1978, J BIOL CHEM, V253, P8355; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Skaggs BA, 1996, GENE, V169, P105, DOI 10.1016/0378-1119(95)00770-9; STEVENS VL, 1984, J BIOL CHEM, V259, P1174; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Swanson HI, 2004, CHEM-BIOL INTERACT, V149, P69, DOI 10.1016/j.cbi.2004.08.006; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tafrova JI, 2012, MOL CELL BIOCHEM, V364, P351, DOI 10.1007/s11010-012-1237-7; THOMAS PE, 1979, ARCH BIOCHEM BIOPHYS, V192, P524, DOI 10.1016/0003-9861(79)90122-X; TORMA H, 1994, J INVEST DERMATOL, V102, P49, DOI 10.1111/1523-1747.ep12371731; TORMA H, 1985, J INVEST DERMATOL, V85, P498, DOI 10.1111/1523-1747.ep12277290; Tuckey RC, 1997, EUR J BIOCHEM, V244, P835, DOI 10.1111/j.1432-1033.1997.00835.x; TUCKEY RC, 1982, J BIOL CHEM, V257, P9309; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VAHLQUIST A, 1982, J INVEST DERMATOL, V79, P94, DOI 10.1111/1523-1747.ep12500033; Vahlquist A, 1996, J INVEST DERMATOL, V106, P1070, DOI 10.1111/1523-1747.ep12339284; VAHLQUIST A, 1980, EXPERIENTIA, V36, P317, DOI 10.1007/BF01952299; Wang B, 2016, J AM CHEM SOC, V138, P2426, DOI 10.1021/jacs.5b13500; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; Whitehouse CJC, 2008, CHEM-EUR J, V14, P10905, DOI 10.1002/chem.200801927; Wu ZL, 2006, ARCH BIOCHEM BIOPHYS, V445, P138, DOI 10.1016/j.abb.2005.11.002; Yengi LG, 2003, ANAL BIOCHEM, V316, P103, DOI 10.1016/S0003-2697(03)00042-3; Yoshimoto FK, 2016, J AM CHEM SOC, V138, P12124, DOI 10.1021/jacs.6b04437; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200	95	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13672	13687		10.1074/jbc.M116.773937	http://dx.doi.org/10.1074/jbc.M116.773937			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28701464	hybrid, Green Published			2022-12-26	WOS:000407942400011
J	Connor, DO; Danckert, L; Hoppe, S; Bier, FF; von Nickisch-Rosenegk, M				Connor, Daniel O.; Danckert, Lena; Hoppe, Sebastian; Bier, Frank F.; von Nickisch-Rosenegk, Markus			Epitope determination of immunogenic proteins of Neisseria gonorrhoeae	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MODEL QUALITY; I-TASSER; RECOGNITION; PEPTIDE; IDENTIFICATION; LOCALIZATION; FLEXIBILITY; SPECIFICITY; PREVALENCE	Neisseria gonorrhoeae is the causative organism of gonorrhoea, a sexually transmitted disease that globally accounts for an estimated 80 to 100 million new infections per year. Increasing resistances to all common antibiotics used for N. gonorrhoeae treatment pose the risk of an untreatable disease. Further knowledge of ways of infection and host immune response are needed to understand the pathogen-host interaction and to discover new treatment alternatives against this disease. Therefore, detailed information about immunogenic proteins and their properties like epitope sites could advance further research in this area. In this work, we investigated immunogenic proteins of N. gonorrhoeae for linear epitopes by microarrays. Dominant linear epitopes were identified for eleven of the nineteen investigated proteins with three polyclonal rabbit antibodies from different immunisations. Identified linear epitopes were further examined for non-specific binding with antibodies to Escherichia coli and the closely related pathogen Neisseria meningitidis. On top of that, amino acids crucial for the antibody epitope binding were detected by microarray based alanine scans.	[Connor, Daniel O.; Danckert, Lena; Hoppe, Sebastian; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, Dept Mol & Cellular Bioanalyt, Potsdam, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol, Dept Automat, Branch Bioanalyt & Bioproc, Potsdam, Germany	Fraunhofer Gesellschaft; University of Potsdam; Fraunhofer Gesellschaft	Connor, DO (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, Dept Mol & Cellular Bioanalyt, Potsdam, Germany.	Daniel.Connor@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832	German Federal Ministry of Education and Research [03I52201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03I52201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bennett JE, 2015, MANDELL DOUGLAS BENN; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; CDC, 2014, REP STDS US; CDC, 2015, GONOCOCCAL INFECT 20; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Connor DO, 2016, PLOS ONE, P11; Cordeiro AT, 2007, J MOL BIOL, V372, P1215, DOI 10.1016/j.jmb.2007.07.021; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gaseitsiwe S, 2010, CLIN VACCINE IMMUNOL, V17, P168, DOI 10.1128/CVI.00208-09; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Hoppe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110703; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; HORSFALL AC, 1991, IMMUNOL TODAY, V12, P211, DOI 10.1016/0167-5699(91)90029-S; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jw T, 1994, SEX TRANSM DIS, V22, P310; KAWULA TH, 1987, MOL MICROBIOL, V1, P179, DOI 10.1111/j.1365-2958.1987.tb00510.x; Kim DH, 2014, ACTA CRYSTALLOGR D, V70, P3273, DOI 10.1107/S1399004714023931; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; Nisemblat S, 2015, P NATL ACAD SCI USA, V112, P6044, DOI 10.1073/pnas.1411718112; Pariser H, 1976, Cutis, V17, P723; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shigematsu H, 2000, HEPATOLOGY, V32, P901, DOI 10.1053/jhep.2000.18714; Song KY, 2013, J GEN VIROL, V94, P1510, DOI 10.1099/vir.0.052084-0; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tanaka M, 2000, J CLIN MICROBIOL, V38, P521, DOI 10.1128/JCM.38.2.521-525.2000; Tapsall JW, 2009, CURR OPIN INFECT DIS, V22, P87, DOI 10.1097/QCO.0b013e328320a836; Unemo M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0009-2015; VIRJI M, 1989, J GEN MICROBIOL, V135, P1895; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; World Health Organization, 2015, SEX TRANSM INF STIS; Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180962	10.1371/journal.pone.0180962	http://dx.doi.org/10.1371/journal.pone.0180962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723967	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800034
J	Tien, SH; Crabtree, JN; Gray, HL; Peterson, EJ				Tien, Shelly H.; Crabtree, Juliet N.; Gray, Heather L.; Peterson, Erik J.			Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INFLUENZA VACCINE; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; VIRUS ILLNESS; T-CELLS; WOMEN; IMMUNIZATION; MONOVALENT; PROFILES	Objectives Influenza infection is a significant cause of respiratory morbidity among pregnant women. Seasonal influenza vaccination engages innate immune receptors to promote protective immunity. A coding polymorphism (R620W) in PTPN22 imparts elevated risk for human infection and autoimmune disease, predisposes to diminished innate immune responses, and associates with reduced immunization responses. We sought to quantify the effects of PTPN22-R620W on humoral and cell-mediated immune responses to the inactivated influenza vaccine among healthy pregnant women. Study Design Immune responses were measured in healthy pregnant R620W carrier (n = 17) and non-carrier (n = 33) women receiving the 2013 quadrivalent inactivated influenza vaccine (Fluzone). Hemagglutination inhibition assays were performed to quantify neutralizing antibodies; functional influenza-reactive CD4 T cells were quantified by flow cytometry, and influenza-specific CD8 T cells were enumerated with MHC Class I tetramers. Antibody seroconversion data were evaluated by Chi-square analysis, and the Mann-Whitney or Wilcoxon signed-rank tests were applied to T cell response data. Results PTPN22 R620W carrier (n = 17) and non-carrier (n = 33) groups did not differ in age, parity, BMI, gestational age at time of vaccine, or history of prior influenza vaccination. After Fluzone exposure, 51.5% of non-carriers met criteria for antibody seroconversion to H1N1 influenza, compared with 23.5% of R620W carriers (p = 0.06). Influenza-reactive CD4 T cells showed modest increase at days 9-15 after vaccination in both R620W carriers and non-carriers (p = 0.02 and p = 0.04, respectively). However, there was no difference inoverall response between the two groups (p = 0.6). The vaccine did not result in significant induction of influenza-specific CD8 T cells in either group. Conclusions There was no significant difference among healthy pregnant R620W carriers and non-carriers in H1N1 antibody seroconversion rates after influenza vaccination. Studies of larger cohorts will be needed to define the effect of PTPN22 risk allele carriage on antibody and T cell responses to influenza vaccination during pregnancy.	[Tien, Shelly H.; Gray, Heather L.] Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Div Maternal Fetal Med, Minneapolis, MN 55455 USA; [Crabtree, Juliet N.; Peterson, Erik J.] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Crabtree, Juliet N.; Peterson, Erik J.] Univ Minnesota, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA; [Tien, Shelly H.] Northshore Univ Hlth Syst, Ctr Maternal & Fetal Hlth, Evanston, IL 60201 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; NorthShore University Health System	Tien, SH (corresponding author), Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Div Maternal Fetal Med, Minneapolis, MN 55455 USA.; Tien, SH (corresponding author), Northshore Univ Hlth Syst, Ctr Maternal & Fetal Hlth, Evanston, IL 60201 USA.	shtien@gmail.com		Crabtree, Juliet/0000-0003-4921-0087	National Center for Advancing Translational Sciences of National Institutes of Health [UL1TR000114]; University of Minnesota Center for Health Equity from National Institute on Minority Health and Health Disparities [1P6OMD003433]; Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of National Institutes of Health; University of Minnesota Center for Health Equity from National Institute on Minority Health and Health Disparities; Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. http://www. ctsi.umn.edu/about-ctsa-award. The University of Minnesota Center for Health Equity, 1P6OMD003433 from the National Institute on Minority Health and Health Disparities. http://www.umnche.umn.edu/. The Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal-Fetal Medicine fellowship research stipend. http://www.obgyn.umn.edu/educational-opportunities/maternal-fetel-medicinefellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; [Anonymous], 2014, Obstet Gynecol, V124, P648, DOI 10.1097/01.AOG.0000453599.11566.11; [Anonymous], COMPELLING NEED GAME; [Anonymous], 2013, MMWR RECOMM REP; [Anonymous], PLOS ONE; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Berger CT, 2015, HUM VACC IMMUNOTHER, V11, P391, DOI 10.1080/21645515.2015.1008930; Bottini N, 2014, ANNU REV IMMUNOL, V32, P83, DOI 10.1146/annurev-immunol-032713-120249; BUGAWAN TL, 1994, TISSUE ANTIGENS, V44, P137, DOI 10.1111/j.1399-0039.1994.tb02371.x; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Couch R B, 2003, Dev Biol (Basel), V115, P25; Crabtree JN, 2016, J INFECT DIS, V214, P248, DOI 10.1093/infdis/jiw126; Dolfi DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077164; Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438; Faucette AN, 2015, HUM REPROD UPDATE, V21, P119, DOI 10.1093/humupd/dmu041; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Heer AK, 2007, J IMMUNOL, P178; Hegewald MJ, 2011, CLIN CHEST MED, V32, P1, DOI 10.1016/j.ccm.2010.11.001; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, pS17, DOI 10.1016/j.ajog.2012.06.070; Jegaskanda S, 2013, J VIROL, V87, P13706, DOI 10.1128/JVI.01666-13; Kay AW, 2014, P NATL ACAD SCI USA, V111, P14506, DOI 10.1073/pnas.1416569111; Kourtis AP, 2014, NEW ENGL J MED, P371; Krnic EK, 2008, SCAND J IMMUNOL, V67, P86, DOI 10.1111/j.1365-3083.2007.02042.x; Lobermann M, 2012, AUTOIMMUN REV, V11, P212, DOI 10.1016/j.autrev.2011.05.015; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; Nasr R, 2012, CURR OPIN RHEUMATOL, V24, P609, DOI 10.1097/BOR.0b013e3283585731; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Thompson MG, 2014, CLIN INFECT DIS, V58, P449, DOI 10.1093/cid/cit750; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Tsatsaris V, 2011, ANN INTERN MED, V155, P733, DOI 10.7326/0003-4819-155-11-201112060-00005; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181338	10.1371/journal.pone.0181338	http://dx.doi.org/10.1371/journal.pone.0181338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723925	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800044
J	Imohl, M; Fitzner, C; Perniciaro, S; van der Linden, M				Imoehl, Matthias; Fitzner, Christina; Perniciaro, Stephanie; van der Linden, Mark			Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014	PLOS ONE			English	Article							INFECTIONS; PROFILE; EUROPE	A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 719) were obtained between 2009 and 2014. Most isolates were obtained from blood (92.1%). The proportions of isolates from cerebrospinal fluid, pleural fluid, synovial fluid and peritoneal fluid were 3.9%, 1.8%, 1.7% and 0.6%, respectively. The most common emm types were emm 1 (31.8%), emm 28 (15.4%) and emm 89 (14.5%). The most common superantigen genes (speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa) identified from S. pyogenes were speG (92.1%), speJ (50.9%), and speC (42.0%). Significant associations of superantigen genes with underlying conditions or risks were observed in speG, speH, speJ, and speK. Significant associations between emm types or superantigen genes with clinical complications were observed in emm type 3 and in superantigen gene speA 1-3. Most frequent clinical manifestations included sepsis 59.4%, STSS 6.3%, meningitis 5.4%, and necrotizing fasciitis 5.0% (significantly associated with emm1).	[Imoehl, Matthias; Perniciaro, Stephanie; van der Linden, Mark] Univ Hosp RWTH, Inst Med Microbiol, Aachen, Germany; [Imoehl, Matthias; Perniciaro, Stephanie; van der Linden, Mark] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Aachen, Germany; [Fitzner, Christina] Univ Hosp RWTH, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Imohl, M (corresponding author), Univ Hosp RWTH, Inst Med Microbiol, Aachen, Germany.; Imohl, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Aachen, Germany.	mimoehl@ukaachen.de	Imöhl, Matthias/P-5014-2014; van der Linden, Mark/B-9305-2009; Perniciaro, Stephanie R/J-3669-2017; Fitzner, Christina/H-6431-2013	Imöhl, Matthias/0000-0002-8372-0251; van der Linden, Mark/0000-0002-6574-4313; Perniciaro, Stephanie R/0000-0002-3146-2182; 				BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Commons RJ, 2014, TRENDS MOL MED, V20, P48, DOI 10.1016/j.molmed.2013.10.004; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ekelund K, 2005, J CLIN MICROBIOL, V43, P1789, DOI 10.1128/JCM.43.4.1789-1796.2005; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Ikebe T, 2007, EPIDEMIOL INFECT, V135, P1227, DOI 10.1017/S0950268807007984; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Lamagni T L, 2005, Euro Surveill, V10, P179; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lintges M, 2007, INT J MED MICROBIOL, V297, P471, DOI 10.1016/j.ijmm.2007.03.015; Lintges M, 2010, J INFECT DIS, V202, P20, DOI 10.1086/653082; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Martin J, 2011, EURO SURVEILL, V16; Meehan M, 2013, EUROSURVEILLANCE, P18; O'Grady KAF, 2007, MED J AUSTRALIA, V186, P565, DOI 10.5694/j.1326-5377.2007.tb01054.x; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; Schmitz FJ, 2003, J INFECT DIS, V188, P1578, DOI 10.1086/379230; Siljander T, 2010, EUR J CLIN MICROBIOL, V29, P1229, DOI 10.1007/s10096-010-0989-9; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vlaminckx BJM, 2003, J CLIN MICROBIOL, V41, P4941, DOI 10.1128/JCM.41.11.4941-4949.2003; Wahl RU, 2007, CLIN MICROBIOL INFEC, V13, P1173, DOI 10.1111/j.1469-0691.2007.01821.x; Zakikhany K, 2011, EUROSURVEILLANCE, P16	30	24	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180757	10.1371/journal.pone.0180757	http://dx.doi.org/10.1371/journal.pone.0180757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719668	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400016
J	Steinborn, C; Klemd, AM; Sanchez-Campillo, AS; Rieger, S; Scheffen, M; Sauer, B; Garcia-Kaufer, M; Urech, K; Follo, M; Ucker, A; Kienle, GS; Huber, R; Grundemann, C				Steinborn, Carmen; Klemd, Amy Marisa; Sanchez-Campillo, Ann-Sophie; Rieger, Sophie; Scheffen, Marieke; Sauer, Barbara; Garcia-Kaeufer, Manuel; Urech, Konrad; Follo, Marie; Uecker, Annekathrin; Kienle, Gunver Sophia; Huber, Roman; Gruendemann, Carsten			Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN DENDRITIC CELLS; PANCREATIC-CANCER; MISTLETOE; MATURATION; ACTIVATION; THERAPY; LECTINS; STIMULATION; INHIBITION	Tumor cells have the capacity to secrete immunosuppressive substances in order to diminish dendritic cell (DC) activity and thereby escape from immune responses. The impact of mistletoe (Viscum album) extracts (VAE), which are frequently used as an additive anti-cancer therapy to stimulate the immune response, is still unknown. Using a human cellular system, the impact of two different VAE (VAEA + VAEI) on the maturation of human dendritic cells and on T cell function has been investigated using flow cytometry, automated fluorescence microscopy and cytokine bead array assays. Furthermore, we examined whether VAEI was able to counteract tumor-induced immunosuppression within this cellular system using a renal cancer cell model. The role of mistletoe lectin (ML) was analyzed using ML-specific antibodies and ML-depleted VAEI. VAEI and VAEA augmented the maturation of dendritic cells. VAEI abrogated tumor-induced immunosuppression of dendritic cells and both processes were partially mediated by ML since ML-depleted VAEI and ML-specific antibodies almost neutralized the rehabilitative effects of VAEI on DC maturation. Using these settings, co-culture experiments with purified CD4(+) T cells had no influence on T cell proliferation and activation but did have an impact on IFN-Upsilon secretion. The study provides a potential mode-of-action of VAE as an additive cancer therapy based on immunomodulatory effects. However, the impact on the in vivo situation has to be evaluated in further studies.	[Steinborn, Carmen; Klemd, Amy Marisa; Sanchez-Campillo, Ann-Sophie; Rieger, Sophie; Scheffen, Marieke; Sauer, Barbara; Garcia-Kaeufer, Manuel; Uecker, Annekathrin; Kienle, Gunver Sophia; Huber, Roman; Gruendemann, Carsten] Univ Freiburg, Ctr Complementary Med, Inst Infect Prevent & Hosp Epidemiol, Fac Med, Freiburg, Germany; [Urech, Konrad] Verein Krebsforsch, Arlesheim, Switzerland; [Follo, Marie] Univ Freiburg, Lighthouse Core Facil, Dept Med 1, Med Ctr,Fac Med, Freiburg, Germany	University of Freiburg; University of Freiburg	Grundemann, C (corresponding author), Univ Freiburg, Ctr Complementary Med, Inst Infect Prevent & Hosp Epidemiol, Fac Med, Freiburg, Germany.	carsten.gruendemann@uniklinik-freiburg.de	Garcia-Käufer, Manuel/AAF-8340-2020	Follo, Marie/0000-0002-3090-7442	Software AG foundation; DAMUSDONATA e.V.; Iscador AG; ABNOBA GmbH; Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V.	Software AG foundation; DAMUSDONATA e.V.; Iscador AG; ABNOBA GmbH; Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V.	CG and CS have been financed by the Software AG foundation and DAMUSDONATA e.V.. The study was kindly financially supported by the Iscador AG, ABNOBA GmbH and the Verein zur Forderung der Naturheilkunde am Universitatsklinikum Freiburg e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bantel H, 1999, CANCER RES, V59, P2083; Chen X, 2017, ONCOTARGET, P5; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Frantz M, 2000, ARZNEIMITTEL-FORSCH, V50, P471; FRANZ H, 1986, ONCOLOGY, V43, P23, DOI 10.1159/000226417; Fricke I, 2006, IMMUNOL INVEST, V35, P459, DOI 10.1080/08820130600803429; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Horneber MA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003297.pub2; Huber R, 2005, EUR J MED RES, V10, P411; Huber Roman, 2006, J Soc Integr Oncol, V4, P3; Huber R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-116; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; Kelter G, 2007, ANTICANCER RES, V27, P223; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Lechmann M, 2002, INT ARCH ALLERGY IMM, V129, P113, DOI 10.1159/000065883; Oosterhoff D, 2012, ONCOIMMUNOLOGY, V1, P649, DOI 10.4161/onci.20365; Podlech O, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/501796; Rostock M, 2005, ANTICANCER RES, V25, P1969; Saha C, 2016, MOLECULES, V21, DOI 10.3390/molecules21070912; Schad F, 2014, INTEGR CANCER THER, V13, P332, DOI 10.1177/1534735413513637; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Sombroek CC, 2002, J IMMUNOL, V168, P4333, DOI 10.4049/jimmunol.168.9.4333; Stein GM, 2002, ANTICANCER RES, V22, P4215; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Takahashi A, 2004, CANCER IMMUNOL IMMUN, V53, P543, DOI 10.1007/s00262-003-0466-8; Troger W, 2013, EUR J CANCER, V49, P3788, DOI 10.1016/j.ejca.2013.06.043; Troy AJ, 1998, CLIN CANCER RES, V4, P585; Urech K, 2006, ARZNEIMITTEL-FORSCH, V56, P428; Valentiner U, 2002, TOXICOLOGY, V171, P187, DOI 10.1016/S0300-483X(01)00581-9; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Webster R, 2014, NAT REV DRUG DISCOV, V13, P883, DOI 10.1038/nrd4476	35	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181553	10.1371/journal.pone.0181553	http://dx.doi.org/10.1371/journal.pone.0181553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719632	gold, Green Published			2022-12-26	WOS:000406061400055
J	Bonjack-Shterengartz, M; Avnir, D				Bonjack-Shterengartz, Maayan; Avnir, David			The enigma of the near-symmetry of proteins: Domain swapping	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SH3 DOMAIN; STEFIN-B; DIMER; EVOLUTION; MECHANISM; BINDING; OLIGOMERIZATION; RESOLUTION; REVEALS	The majority of proteins form oligomers which have rotational symmetry. Literature has suggested many functional advantages that the symmetric packing offers. Yet, despite these advantages, the vast majority of protein oligomers are only nearly symmetric. A key question in the field of proteins structure is therefore, if symmetry is so advantageous, why do oligomers settle for aggregates that do not maximize that structural property? The answer to that question is apparently multi-parametric, and involves distortions at the interaction zones of the monomer units of the oligomer in order to minimize the free energy, the dynamics of the protein, the effects of surroundings parameters, and the mechanism of oligomerization. The study of this problem is in its infancy: Only the first parameter has been explored so far. Here we focus on the last parameter-the mechanism of formation. To test this effect we have selected to focus on the domain swapping mechanism of oligomerization, by which oligomers form in a mechanism that swaps identical portions of monomeric units, resulting in an interwoven oligomer. We are using continuous symmetry measures to analyze in detail the oligomer formed by this mechanism, and found, that without exception, in all analyzed cases, perfect symmetry is given away, and we are able to identify that the main burden of distortion lies in the hinge regions that connect the swapped portions. We show that the continuous symmetry analysis method clearly identifies the hinge region of swapped domain proteins-considered to be a non-trivial task. We corroborate our conclusion about the central role of the hinge region in affecting the symmetry of the oligomers, by a special probability analysis developed particularly for that purpose.	[Avnir, David] Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel; Hebrew Univ Jerusalem, Lise Meitner Minerva Ctr Computat Quantum Chem, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Avnir, D (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel.	david.avnir@mail.huji.ac.il	Avnir, David/AAK-4189-2021		Israel Science Foundation Grant [411/15]	Israel Science Foundation Grant(Israel Science Foundation)	The study was supported by the Israel Science Foundation Grant (grant #411/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Bonjack-Shterengartz M, 2015, PROTEINS, V83, P722, DOI 10.1002/prot.24706; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Camara-Artigas A, 2016, ARCH BIOCHEM BIOPHYS, V602, P116, DOI 10.1016/j.abb.2016.02.024; Canals A, 2001, STRUCTURE, V9, P967, DOI 10.1016/S0969-2126(01)00659-1; Chagot B, 2005, PROTEINS, V59, P380, DOI 10.1002/prot.20425; Chu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013361; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; D'Alessio G, 1999, PROG BIOPHYS MOL BIO, V72, P271, DOI 10.1016/S0079-6107(99)00009-7; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Dryzun C, 2009, PHYS CHEM CHEM PHYS, V11, P9653, DOI 10.1039/b911179d; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Fushinobu S, 2003, BIOCHEMISTRY-US, V42, P11707, DOI 10.1021/bi034220b; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kojic-Prodic B, 2010, SYMMETRY-BASEL, V2, P884, DOI 10.3390/sym2020884; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Levy Y, 2005, P NATL ACAD SCI USA, V102, P2373, DOI 10.1073/pnas.0409572102; Lin YW, 2015, ANGEW CHEM INT EDIT, V54, P511, DOI 10.1002/anie.201409267; Linhananta A, 2002, PROTEIN SCI, V11, P1695, DOI 10.1110/ps.0205002; Lipinski PFJ, 2014, RSC ADV, V4, P47047, DOI 10.1039/c4ra08434a; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu SJ, 2015, INT J PRECIS ENG MAN, V16, P2731, DOI 10.1007/s12541-015-0349-x; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Mezey PG, 2014, ACCOUNTS CHEM RES, V47, P2821, DOI 10.1021/ar5001154; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Mura C, 2003, J MOL BIOL, V326, P1559, DOI 10.1016/S0022-2836(03)00056-1; Murray AJ, 1998, NAT STRUCT BIOL, V5, P778, DOI 10.1038/1816; MURRAY AJ, 1995, P NATL ACAD SCI USA, V92, P7337, DOI 10.1073/pnas.92.16.7337; NALINI V, 1994, J MOL BIOL, V236, P1250, DOI 10.1016/0022-2836(94)90025-6; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Ohlendorf DH, 1998, J MOL BIOL, V280, P129, DOI 10.1006/jmbi.1998.1849; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Pinsky M, 1998, INORG CHEM, V37, P5575, DOI 10.1021/ic9804925; Pinsky M, 2008, J COMPUT CHEM, V29, P2712, DOI 10.1002/jcc.20990; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Radaev S, 2003, STRUCTURE, V11, P1527, DOI 10.1016/j.str.2003.11.001; Ridderstrom M, 1998, J BIOL CHEM, V273, P21623, DOI 10.1074/jbc.273.34.21623; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Salomon Y, 1999, J MATH CHEM, V25, P295, DOI 10.1023/A:1019144702913; Schiering N, 2000, BIOCHEMISTRY-US, V39, P13376, DOI 10.1021/bi0012336; Shameer K, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar042; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; Taylor WR, 2004, SERIES IN BIOPHYSICS; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Xu D, 1998, PROTEIN SCI, V7, P533; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; Zerovnik E, 1997, EUR J BIOCHEM, V245, P364, DOI 10.1111/j.1432-1033.1997.t01-1-00364.x; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	77	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180030	10.1371/journal.pone.0180030	http://dx.doi.org/10.1371/journal.pone.0180030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708874	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800011
J	Powell, AC; Mirhadi, AJ; Loy, BA; Happe, LE; Long, JW; Kren, EM; Gupta, AK				Powell, Adam C.; Mirhadi, Amin J.; Loy, Bryan A.; Happe, Laura E.; Long, James W.; Kren, Erin M.; Gupta, Amit K.			Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer	PLOS ONE			English	Article								Background As Medicare expands the use of computed tomography (CT) for diagnosing lung cancer, there is increased opportunity to diagnose lung cancer in asymptomatic patients. This descriptive study characterizes the disease-specific diagnostic and treatment services that patients with a positive diagnosis following CT received, stratified by presentation at CT. Methods Patients who were diagnosed with lung cancer following CT in 2013, had no history of lung cancer, survived at least 1 year, were aged 55-80 years, and had Medicare Advantage insurance were included. Patients were grouped based upon presentation at CT: morbidities unrelated to lung cancer, classic lung cancer symptoms, and cancer syndromes. Patients with none of these factors were categorized into a no diagnoses/symptoms group. The type and intensity of services used in the year following the CT was reported for each group. Results 1,261 patients were included. Early treatment services were most common in the group with morbidities unrelated to lung cancer (13.7%) and least common in the cancer syndromes group (6.6%). Advanced treatment services were used by 47.3% of the cancer syndromes group versus 23.5% of the no diagnoses/symptoms group. Conclusions The intensity of disease-specific diagnostic and treatment services varied by presentation at CT. Patients with no symptoms or morbidities at the time of CT less frequently received advanced interventions. Learning about the utilization patterns of others with a similar presentation at CT may help patients with positive lung cancer diagnoses engage in shared decision making and in norming their experiences against those of other similarly-situated patients.	[Powell, Adam C.; Mirhadi, Amin J.; Kren, Erin M.; Gupta, Amit K.] HealthHelp, Houston, TX 77060 USA; [Loy, Bryan A.; Happe, Laura E.; Long, James W.] Humana Inc, Louisville, KY USA	Humana Inc.	Powell, AC (corresponding author), HealthHelp, Houston, TX 77060 USA.	powellad@healthhelp.com		Powell, Adam/0000-0001-6519-3120	Health Help and Humana Inc.	Health Help and Humana Inc.	The authors received no specific funding for this work. This study was completed by Humana, Inc. and Health Help, and authors worked on it as a part of their duties for their respective organization. Health Help and Humana Inc. provided support in the form of paid employment or consulting fees for all the authors. (Humana: BL, LH, and JL. Health Help: AP, AM, EK, and AG.). The specific roles of these authors are articulated in the 'author contributions' section. This research represents the findings of a quality improvement project conducted by the funding organizations, which were both actively involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. URL of Health Help :www.healthhelp.com; URL of Humana: www.humana.com.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Centers for Medicare & Medicaid Services, 2010, BEN POL OP GUID REG; Centers for Medicare & Medicaid Services (CMS), 2015, DECISION MEMO SCREEN; Coyle N, 2006, J PAIN SYMPTOM MANAG, V32, P266, DOI 10.1016/j.jpainsymman.2006.04.003; Dismuke CE, 2005, MED CARE, V43, P713, DOI 10.1097/01.mlr.0000167175.72130.a7; Gould MK, 2014, NEW ENGL J MED, V371, P1813, DOI 10.1056/NEJMcp1404071; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Medicare.gov, 2017, MED ADV PLANS COV AL; MURRAY N, 1993, J CLIN ONCOL, V11, P336, DOI 10.1200/JCO.1993.11.2.336; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Powell A, 2012, M&SOM-MANUF SERV OP, V14, P512, DOI 10.1287/msom.1120.0384; Powell RC., 2014, DEATH IS NOT THEORET; Quest Diagnostics, 2017, LUNG CANC MUT PAN; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; U.S. Food and Drug Administration, 2016, HEM ONC CANC APPR SA; U. S. Preventive Services Task Force (USPSTF) Recommendations, 2013, US PREVENTIVE SERVIC; United States Securities and Exchange Commission, 2016, FORM 10 K YEAR END D; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181319	10.1371/journal.pone.0181319	http://dx.doi.org/10.1371/journal.pone.0181319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708876	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800055
J	Singh, M; Khan, MMA; Uddin, M; Naeem, M; Qureshi, MI				Singh, Minu; Khan, M. Masroor A.; Uddin, Moin; Naeem, M.; Qureshi, M. Irfan			Proliferating effect of radiolytically depolymerized carrageenan on physiological attributes, plant water relation parameters, essential oil production and active constituents of Cymbopogon flexuosus Steud. under drought stress	PLOS ONE			English	Article							IRRADIATED SODIUM ALGINATE; NITRATE REDUCTASE; SALICYLIC-ACID; ANTIOXIDANT ACTIVITY; BIOCHEMICAL-CHANGES; OSMOTIC-STRESS; RICE SEEDLINGS; GROWTH; TOLERANCE; MODULATION	Carrageenan has been proved as potent growth promoting substance in its depolymerized form. However, relatively little is known about its role in counteracting the adverse effects of drought stress on plants. In a pot experiment, lemongrass (Cymbopogon flexuosus Steud.), grown under different water stress regimes [(100% field capacity (FC), 80% FC and 60% FC)], was sprayed with 40, 80 and 120 mg L-1 of gamma irradiated carrageenan (ICA). Foliar application of ICA mitigated the harmful effects of drought stress to various extents and improved the biochemical characteristics, quality attributes and active constituents (citral and geraniol) of lemongrass significantly. Among the applied treatments, ICA-80 mg L(-)1 proved the best in alleviating detrimental effects of drought. However, drought stress (80 and 60% FC), irrespective of the growth stages, had an adverse impact on most of the studied attributes. Generally, 60% FC proved more deleterious than 80% FC. At 80% FC, application of ICA-80 mg L-1 elevated the essential oil (EO) content by 18.9 and 25%, citral content by 7.33 and 8.19% and geraniol content by 9.2 and 8.9% at 90 and 120 days after planting (DAP), respectively, as compared to the deionized-water (DW) spray treatment (80% FC+DW). Whereas, at 60% FC, foliar application of 80 mg L-1 ICA significantly augmented the EO content by 15.4 and 17.8% and active constituents viz. citral and geraniol, by 5.01 and 5.62% and by 6.06 and 5.61% at 90 and 120 DAP, respectively, as compared to the control (water-spray treatment).	[Singh, Minu; Khan, M. Masroor A.; Uddin, Moin; Naeem, M.] Aligarh Muslim Univ, Dept Bot, Plant Physiol Sect, Aligarh, Uttar Pradesh, India; [Singh, Minu; Qureshi, M. Irfan] Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India	Aligarh Muslim University; Jamia Millia Islamia	Singh, M (corresponding author), Aligarh Muslim Univ, Dept Bot, Plant Physiol Sect, Aligarh, Uttar Pradesh, India.; Singh, M (corresponding author), Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India.	minusingh5@gmail.com	Qureshi, M Irfan/CAF-0824-2022; Naeem, M/ABE-5239-2020	Qureshi, M Irfan/0000-0001-9625-0036; Naeem, M/0000-0002-2487-1228; A Khan, M Masroor/0000-0002-4530-9082	University Grant Commission, New Delhi, India; Post Doctoral Fellowship [F.15/17/12]	University Grant Commission, New Delhi, India(University Grants Commission, India); Post Doctoral Fellowship	Financial support by the University Grant Commission, New Delhi, India for the award of Women Scientist, Post Doctoral Fellowship (Project No. F.15/17/12) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LV, 2009, CARBOHYD POLYM, V78, P100, DOI 10.1016/j.carbpol.2009.04.009; Abad LV, 2016, RADIAT PHYS CHEM, V118, P75, DOI 10.1016/j.radphyschem.2015.03.001; Abad LV, 2014, NUCL INSTRUM METH B, V336, P167, DOI 10.1016/j.nimb.2014.07.005; Abad LV, 2004, INT J BIOL MACROMOL, V34, P81, DOI 10.1016/j.ijbiomac.2004.03.012; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Aftab T, 2013, IND CROP PROD, V50, P874, DOI 10.1016/j.indcrop.2013.08.026; AHMADIMIRABAD A, 2014, ELECTRON J BIOL, V10, P79; Ali A, 2014, CARBOHYD POLYM, V112, P134, DOI 10.1016/j.carbpol.2014.05.070; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 1992, J ESSEN OIL RES, DOI DOI 10.1080/10412905.1992.9698013; [Anonymous], 1972, ESSENTIAL OILS HIST; Bandurska H, 2001, ACTA PHYSIOL PLANT, V23, P483, DOI 10.1007/s11738-001-0059-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bi F, 2011, J SAUDI CHEM SOC, V15, P269, DOI 10.1016/j.jscs.2010.10.003; Birhanu K., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2139; Campbell Wilbur H., 2002, Physiology and Molecular Biology of Plants, V8, P31; Castro J, 2012, J PLANT GROWTH REGUL, V31, P173, DOI 10.1007/s00344-011-9229-5; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; CHARLES DJ, 1990, PHYTOCHEMISTRY, V29, P2837, DOI 10.1016/0031-9422(90)87087-B; Dalal VK, 2012, PLANT CELL ENVIRON, V35, P1685, DOI 10.1111/j.1365-3040.2012.02520.x; Dash S, 2001, J PLANT PHYSIOL, V158, P1153, DOI 10.1078/0176-1617-00243; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; DWIVEDI RS, 1974, PLANT SOIL, V40, P445, DOI 10.1007/BF00011531; Farahani HA, 2009, J MED PLANTS RES, V3, P329; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Farooqi A. H. A., 2000, Journal of Plant Biology, V27, P277; FERRARIO S, 1995, PLANTA, V196, P288, DOI 10.1007/BF00201387; Gonzalez A, 2013, J PLANT GROWTH REGUL, V32, P443, DOI 10.1007/s00344-012-9309-1; Grzesiak MT, 2006, PHOTOSYNTHETICA, V44, P561, DOI 10.1007/s11099-006-0072-z; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hashmi N, 2012, CARBOHYD POLYM, V90, P407, DOI 10.1016/j.carbpol.2012.05.058; Hayat S, 2008, J PLANT INTERACT, V3, P297, DOI 10.1080/17429140802320797; Hien NQ, 2000, RADIAT PHYS CHEM, V59, P97, DOI 10.1016/S0969-806X(99)00522-8; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Hristova, 2003, BULG J PLANT PHYSL, V133, P152; Hura T, 2007, ANN BOT-LONDON, V100, P767, DOI 10.1093/aob/mcm162; Hussein M. M., 2012, Agricultural Sciences, V3, P241, DOI 10.4236/as.2012.32028; Idrees M, 2012, IND CROP PROD, V40, P62, DOI 10.1016/j.indcrop.2012.02.024; Idrees M, 2010, J PLANT INTERACT, V5, P293, DOI 10.1080/17429145.2010.508566; JAWORSKI EG, 1971, BIOCHEM BIOPH RES CO, V43, P1274, DOI 10.1016/S0006-291X(71)80010-4; Jones HG, 1998, J EXP BOT, V49, P387, DOI 10.1093/jexbot/49.suppl_1.387; Kalaji M.H., 2010, CHLOROPHYLL FLUORESC, P116; Khalid K. A., 2006, International Agrophysics, V20, P289; Khanna-Chopra R, 2007, ENVIRON EXP BOT, V60, P276, DOI 10.1016/j.envexpbot.2006.11.004; Kume T, 2002, RADIAT PHYS CHEM, V63, P625, DOI 10.1016/S0969-806X(01)00558-8; Kusvuran S., 2012, African Journal of Agricultural Research, V7, P775; Lejay L, 1997, PLANT PHYSIOL, V115, P623, DOI 10.1104/pp.115.2.623; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Luan L. Q., 2006, RADIOISOTOPES TOKYO, V55, P23; Ma LJ, 2010, PLANT GROWTH REGUL, V62, P71, DOI 10.1007/s10725-010-9489-2; Maningas JAC, 2016, PNRI NEWSLETTER, V12, P5; Marcinska I, 2013, INT J MOL SCI, V14, P13171, DOI 10.3390/ijms140713171; Matysik J, 2002, CURR SCI INDIA, V82, P525; Moinuddin, 2007, J PLANT NUTR, V30, P517, DOI 10.1080/01904160701209196; Moinuddin, 2004, CROP SCI, V44, P449; Naeem M, 2017, J ESSENT OIL RES, V29, P179, DOI 10.1080/10412905.2016.1213188; Naeem M, ADV BOT; Ozturk A, 2004, J AGRON CROP SCI, V190, P93, DOI 10.1046/j.1439-037X.2003.00080.x; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Pereira GJG, 2002, PLANT SOIL, V239, P123, DOI 10.1023/A:1014951524286; Potin P, 1999, CURR OPIN MICROBIOL, V2, P276, DOI 10.1016/S1369-5274(99)80048-4; Qazi Fariduddin, 2014, Journal of Stress Physiology & Biochemistry, V10, P181; Relleve L, 2005, POLYM DEGRAD STABIL, V87, P403, DOI 10.1016/j.polymdegradstab.2004.09.003; Sabharwal S, 2004, IAEATECDOC1422; Sangwan, 2006, PHYSIOL MOL BIOL PLA, V11, P153; SANGWAN RS, 1993, J PLANT PHYSIOL, V142, P618, DOI 10.1016/S0176-1617(11)80408-6; Sara K., 2012, Journal of Stress Physiology & Biochemistry, V8, P160; Sarfaraz A, 2011, J MED PLANTS RES, V5, P15; Scandalios JO, 1997, COLD SPRING HARBOR M, V34, P343, DOI DOI 10.1101/087969502.34.343; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; SINGHSANGWAN N, 1994, NEW PHYTOL, V128, P173, DOI 10.1111/j.1469-8137.1994.tb04000.x; Siriwardhana N, 2003, FOOD SCI TECHNOL INT, V9, P339, DOI 10.1177/1082013203039014; Srivalli B, 2003, PHYSIOL PLANTARUM, V119, P503, DOI 10.1046/j.1399-3054.2003.00125.x; SUMITHRA K, 2004, J PLANT BIOL, V31, P201; Taiz L., 2015, PLANT PHYSL DEV; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Tiwari A, 2005, PHOTOSYNTHETICA, V43, P1, DOI 10.1007/s11099-005-1011-0; Tsiapali E, 2001, FREE RADICAL BIO MED, V30, P393, DOI 10.1016/S0891-5849(00)00485-8	80	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180129	10.1371/journal.pone.0180129	http://dx.doi.org/10.1371/journal.pone.0180129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708833	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800013
J	Blanc-Durand, P; Van Der Gucht, A; Guedj, E; Abulizi, M; Aoun-Sebaiti, M; Lerman, L; Verger, A; Authier, FJ; Itti, E				Blanc-Durand, Paul; Van Der Gucht, Axel; Guedj, Eric; Abulizi, Mukedaisi; Aoun-Sebaiti, Mehdi; Lerman, Lionel; Verger, Antoine; Authier, Francois-Jerome; Itti, Emmanuel			Cerebral F-18-FDG PET in macrophagic myofasciitis: An individual SVM-based approach	PLOS ONE			English	Article							ALUMINUM-HYDROXIDE; FIBROMYALGIA; ABNORMALITIES; DIAGNOSIS	Introduction Macrophagic myofasciitis (MMF) is an emerging condition with highly specific myopathological alterations. A peculiar spatial pattern of a cerebral glucose hypometabolism involving occipito-temporal cortex and cerebellum have been reported in patients with MMF; however, the full pattern is not systematically present in routine interpretation of scans, and with varying degrees of severity depending on the cognitive profile of patients. Aim was to generate and evaluate a support vector machine (SVM) procedure to classify patients between healthy or MMF (18) F-FDG brain profiles. Methods F-18-FDG PET brain images of 119 patients with MMF and 64 healthy subjects were retrospectively analyzed. The whole-population was divided into two groups; a training set (100 MMF, 44 healthy subjects) and a testing set (19 MMF, 20 healthy subjects). Dimensionality reduction was performed using a t-map from statistical parametric mapping (SPM) and a SVM with a linear kernel was trained on the training set. To evaluate the performance of the SVM classifier, values of sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) and accuracy (Acc) were calculated. Results The SPM12 analysis on the training set exhibited the already reported hypometabolism pattern involving occipito-temporal and fronto-parietal cortices, limbic system and cerebellum. The SVM procedure, based on the t-test mask generated from the training set, correctly classified MMF patients of the testing set with following Se, Sp, PPV, NPV and Acc: 89%, 85%, 85%, 89%, and 87%. Conclusion We developed an original and individual approach including a SVM to classify patients between healthy or MMF metabolic brain profiles using (18) F-FDG-PET. Machine learning algorithms are promising for computer-aided diagnosis but will need further validation in prospective cohorts.	[Blanc-Durand, Paul; Van Der Gucht, Axel; Abulizi, Mukedaisi; Lerman, Lionel; Itti, Emmanuel] Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, Creteil, France; [Guedj, Eric] La Timone Hosp, AP HM, Dept Nucl Med, Marseille, France; [Guedj, Eric] Aix Marseille Univ, INT, CNRS UMR 7289, Marseille, France; [Guedj, Eric] Aix Marseille Univ, CERIMED, Marseille, France; [Aoun-Sebaiti, Mehdi; Authier, Francois-Jerome] INSERM U955, Team 10, Creteil, France; [Aoun-Sebaiti, Mehdi] Paris Est Univ, H Mondor Hosp, AP HP, Dept Neurol, Creteil, France; [Verger, Antoine] CHU Nancy, Nucl Med & Nancyclotep Expt Imaging Platform, Nancy, France; [Authier, Francois-Jerome] Paris Est Univ, H Mondor Hosp, AP HP, Dept Pathol, Creteil, France; [Authier, Francois-Jerome] H Mondor Hosp, AP HP, Reference Ctr Neuromuscular Disorders, Creteil, France; [Itti, Emmanuel] INSERM U955, GRC Amyloid Res Inst, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Van Der Gucht, A (corresponding author), Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, Creteil, France.	axel.vandergucht@gmail.com	Guedj, Eric/AAK-1589-2020; Verger, Antoine/AAA-2066-2022; Guedj, Eric/AAF-8682-2019	AUTHIER, Francois Jerome/0000-0002-0182-2052; Itti, Emmanuel/0000-0003-1578-4058	Region Ile-de-France; Association Francaise contre les Myopathies though Translamuscle program; A*MIDEX project - ''Investissements d'Avenir'' French Government program [ANR-11-IDEX-0001-02]; patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs)	Region Ile-de-France(Region Ile-de-France); Association Francaise contre les Myopathies though Translamuscle program; A*MIDEX project - ''Investissements d'Avenir'' French Government program(French National Research Agency (ANR)); patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs)	This work was supported by grants from Region Ile-de-France and patients association E3M through "Partenariats institutions-citoyens pour la recherche et l'innovation" (PICRI programs 2010 and 2014), and from the Association Francaise contre les Myopathies though Translamuscle program. This work has been carried out thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02) funded by the ''Investissements dAvenir'' French Government program, managed by the French National Research Agency (ANR).	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Authier FJ, 2003, ARTHRITIS RHEUM-US, V48, P569, DOI 10.1002/art.10740; Bao Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1353-6; Blanc-Durand P, 2017, J NUCL MED; Couette M, 2009, J INORG BIOCHEM, V103, P1571, DOI 10.1016/j.jinorgbio.2009.08.005; Gherardi RK, 1998, LANCET, V352, P347, DOI 10.1016/S0140-6736(98)02326-5; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Kuncheva LI, 2010, IEEE T MED IMAGING, V29, P531, DOI 10.1109/TMI.2009.2037756; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu JK, 2017, J MED SYST, V41, DOI 10.1007/s10916-016-0669-0; Long ZQ, 2016, NEUROSCIENCE, V331, P169, DOI 10.1016/j.neuroscience.2016.06.025; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Passeri E, 2011, J INORG BIOCHEM, V105, P1457, DOI 10.1016/j.jinorgbio.2011.08.006; Pouliakis A, 2016, BIOMED ENG COMPUT BI, V7, P1, DOI 10.4137/BECB.S31601; Rigolet M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00230; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Van der Gucht A, 2017, J NUCL MED, V58, P492, DOI 10.2967/jnumed.114.151878; Van Der Gucht A, 2016, NUCL MED MOLEC IMAG, V50, P80, DOI 10.1007/s13139-015-0371-z; Van Der Gucht A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128353; Van Weehaeghe D, 2016, J NUCL MED, V57, P1238, DOI 10.2967/jnumed.115.166272; Vapnik V., 1998, STAT LEARNING THEORY; Wik G, 2003, NEUROREPORT, V14, P619, DOI 10.1097/00001756-200303240-00019; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Xu R, 2014, ANN NUCL MED, V28, P926, DOI 10.1007/s12149-014-0895-9; Yoshida H, 2001, IEEE T MED IMAGING, V20, P1261, DOI 10.1109/42.974921; Yunus MB, 2004, ARTHRIT RHEUM-ARTHR, V51, P513, DOI 10.1002/art.20544	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181152	10.1371/journal.pone.0181152	http://dx.doi.org/10.1371/journal.pone.0181152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704562	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649700097
J	Klose, D; Woitok, M; Niesen, J; Beerli, RR; Grawunder, U; Fischer, R; Barth, S; Fendel, R; Nachreiner, T				Klose, Diana; Woitok, Mira; Niesen, Judith; Beerli, Roger R.; Grawunder, Ulf; Fischer, Rainer; Barth, Stefan; Fendel, Rolf; Nachreiner, Thomas			Generation of an artificial human B cell line test system using Transpo-mAb (TM) technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins	PLOS ONE			English	Article							HUMAN GRANZYME-B; PIGGYBAC TRANSPOSON SYSTEM; PHASE-I TRIAL; LYMPHOMA-CELLS; GENE-TRANSFER; LUPUS; IMMUNOTOXIN; VITRO; ANTIBODIES; LEUKEMIA	The antigen-specific targeting of autoreactive B cells via their unique B cell receptors (BCRs) is a novel and promising alternative to the systemic suppression of humoral immunity. We generated and characterized cytolytic fusion proteins based on an existing immunotoxin comprising tetanus toxoid fragment C (TTC) as the targeting component and the modified Pseudomonas aeruginosa exotoxin A (ETA') as the cytotoxic component. The immunotoxin was reconfigured to replace ETA' with either the granzyme B mutant R201K or MAPTau as human effector domains. The novel cytolytic fusion proteins were characterized with a recombinant human lymphocytic cell line developed using Transpo-mAb (TM) technology. Genes encoding a chimeric TTC-reactive immunoglobulin G were successfully integrated into the genome of the precursor B cell line REH so that the cells could present TTC-reactive BCRs on their surface. These cells were used to investigate the specific cytotoxicity of GrB(R201K)-TTC and TTC-MAPTau, revealing that the serpin proteinase inhibitor 9-resistant granzyme B R201K mutant induced apoptosis specifically in the lymphocytic cell line. Our data confirm that antigen-based fusion proteins containing granzyme B (R201K) are suitable candidates for the depletion of autoreactive B cells.	[Klose, Diana; Woitok, Mira; Niesen, Judith; Fischer, Rainer; Fendel, Rolf] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Klose, Diana; Barth, Stefan; Nachreiner, Thomas] Univ Hosp RWTH Aachen, Inst Appl Med Engn, Dept Expt Med & Immunotherapy, Aachen, Germany; [Woitok, Mira; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol Biol 7, Aachen, Germany; [Beerli, Roger R.; Grawunder, Ulf] NBE Therapeut AG, Basel, Switzerland; [Barth, Stefan] Univ Cape Town, Inst Infect Dis & Mol Med IDM, South African Res Chair Canc Biotechnol, Dept Integrat Biomed Sci,Fac Hlth Sci, Cape Town, South Africa	Fraunhofer Gesellschaft; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; University of Cape Town	Fendel, R (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	rolf.fendel@ime.fraunhofer.de	Barth, Stefan/F-7301-2012; Fendel, Rolf/K-3985-2013	Barth, Stefan/0000-0001-9589-653X; Fendel, Rolf/0000-0003-4716-0311	NBE-Therapeutics AG	NBE-Therapeutics AG	The company NBE-Therapeutics AG provided support in the form of salaries for authors RRB and UG as well as study material (cell line REH, expression vectors pPB-EGFP-LC-Ac10/pPB-EGFP-HC-Ac10 and pcDNA3.1-hy-mPB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijon Lana M, 2014, DRUGS TARGETING B CE, P65; Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062; Bialon Magdalena, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P369, DOI 10.1089/mab.2014.0044; Brehm H, 2015, CANCER LETT, V365, P149, DOI 10.1016/j.canlet.2015.04.004; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Cremer C, 2015, J IMMUNOTHER, V38, P85, DOI 10.1097/CJI.0000000000000053; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Di Matteo M, 2014, MOL THER, V22, P1614, DOI 10.1038/mt.2014.131; Dorner T, 2015, AUTOIMMUN REV, V14, P1079, DOI 10.1016/j.autrev.2015.07.013; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel P, 2011, PHARMACOL REV, V63, P127, DOI 10.1124/pr.109.002006; Fitzsimmons SP, 2000, VACCINE, V19, P114, DOI 10.1016/S0264-410X(00)00115-8; GODING JW, 1980, J IMMUNOL METHODS, V39, P285, DOI 10.1016/0022-1759(80)90230-6; Grawunder U, 2014, TRANSPOSITION MEDIAT; Hampe CS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/215308; Hehmann-Titt G, 2013, ANTIBODIES, V2, P19, DOI 10.3390/antib2010019; Horlick RA, 2013, J BIOL CHEM, V288, P19861, DOI 10.1074/jbc.M113.452482; Hostmann A, 2008, LUPUS, V17, P1064, DOI 10.1177/0961203308095138; Hoyer BF, 2015, Z RHEUMATOL, V74, P206, DOI 10.1007/s00393-014-1458-0; Hristodorov D, 2013, BRIT J CANCER, V109, P1570, DOI 10.1038/bjc.2013.457; Hristodorov D, 2014, MOL CANCER THER, V13, P2194, DOI 10.1158/1535-7163.MCT-13-0781; Hristodorov D, 2014, BRIT J HAEMATOL, V164, P251, DOI 10.1111/bjh.12626; Jabulowsky RA, 2012, BIOCONJUGATE CHEM, V23, P1567, DOI 10.1021/bc3000657; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Kamen DL, 2016, RHEUM DIS CLIN N AM, V42, P63, DOI 10.1016/j.rdc.2015.08.008; Kampmeier F, 2009, BIOCONJUGATE CHEM, V20, P1010, DOI 10.1021/bc9000257; Kapelski S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0577-7; Kapelski S, 2015, ANTIMICROB AGENTS CH, V59, P669, DOI 10.1128/AAC.04190-14; Klose D, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0249-x; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kreitman RJ, 2009, J CLIN ONCOL, V27, P2983, DOI 10.1200/JCO.2008.20.2630; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Losasso V, 2012, PROTEINS, V80, P2514, DOI 10.1002/prot.24133; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Mathew M, 2009, CANCER SCI, V100, P1359, DOI 10.1111/j.1349-7006.2009.01192.x; Mirabelli G, 2015, CLIN EXP RHEUMATOL, V33, P414; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nachreiner T, 2008, J NEUROIMMUNOL, V195, P28, DOI 10.1016/j.jneuroim.2008.01.001; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Niesen J, 2015, J CANCER RES CLIN, V141, P2079, DOI 10.1007/s00432-015-1975-5; Niesen J, 2015, J CANCER RES CLIN, V141, P1049, DOI 10.1007/s00432-014-1884-z; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Saha S, 2015, NUCLEIC ACIDS RES, V43, P1770, DOI 10.1093/nar/gkv017; Saha S, 2012, JOVE-J VIS EXP, DOI 10.3791/4235; Schiffer S, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.4; Schiffer S, 2014, INT J CANCER, V135, P1497, DOI 10.1002/ijc.28786; Schiffer S, 2013, CANCER LETT, V341, P178, DOI 10.1016/j.canlet.2013.08.005; Sciascia S, 2015, INT IMMUNOPHARMACOL, V27, P189, DOI 10.1016/j.intimp.2015.04.049; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Skipper KA, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-92; Stahnke B, 2008, MOL CANCER THER, V7, P2924, DOI 10.1158/1535-7163.MCT-08-0554; Stepanov A, 2016, BIOTECHNOL LETT; Stocker M, 2003, PROTEIN EXPRES PURIF, V28, P211, DOI 10.1016/S1046-5928(02)00709-X; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Tarlinton DM, 2015, NAT IMMUNOL, V16, P685, DOI 10.1038/ni.3209; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Waldmeier L, 2016, MABS-AUSTIN, V8, P726, DOI 10.1080/19420862.2016.1160990; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Wayne AS, 2014, BLOOD, V123, P2470, DOI 10.1182/blood-2014-01-492256; Weidle UH, 2012, CANCER GENOM PROTEOM, V9, P119; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Yildirim-Toruner C, 2011, J ALLERGY CLIN IMMUN, V127, P303, DOI 10.1016/j.jaci.2010.12.1087; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	77	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180305	10.1371/journal.pone.0180305	http://dx.doi.org/10.1371/journal.pone.0180305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704435	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700036
J	Maiga, S; Allain, G; Hauet, T; Roumy, J; Baulier, E; Scepi, M; Dierick, M; Van Hoorebeke, L; Hannaert, P; Guy, F; Favreau, F				Maiga, Souleymane; Allain, Geraldine; Hauet, Thierry; Roumy, Jerome; Baulier, Edouard; Scepi, Michel; Dierick, Manuel; Van Hoorebeke, Luc; Hannaert, Patrick; Guy, Franck; Favreau, Frederic			Renal auto-transplantation promotes cortical microvascular network remodeling in a preclinical porcine model	PLOS ONE			English	Article							LONG-TERM; COLD ISCHEMIA/REPERFUSION; ENDOTHELIAL INJURY; KIDNEY; DYSFUNCTION; MICROCIRCULATION; MECHANISMS; REJECTION; ISCHEMIA; DAMAGE	The vascular network is a major target of ischemia-reperfusion, but has been poorly investigated in renal transplantation. The aim of this study was to characterize the remodeling of the renal vascular network that follows ischemia-reperfusion along with the most highly affected cortex section in a preclinical renal transplantation model. There were two experimental groups. The first was a grafted kidney group consisting of large white pigs for which the left kidney was harvested, cold flushed, preserved for 24 h in the University of Wisconsin's preservation solution, and then auto-transplanted (n = 5); the right kidney was removed to mimic the situation of human kidney transplantation. The second group (uni-nephrectomized kidney group) consisted of animals that underwent only right nephrectomy, but not left renal transplantation (n = 5). Three months after autotransplantation, the kidneys were studied by X-ray microcomputed tomography. Vessel morphology and density and tortuosity of the network were analyzed using a 3D image analysis method. Cortical blood flow was determined by laser doppler analysis and renal function and tissue injury assessed by plasma creatinine levels and histological analysis. Renal ischemia-reperfusion led to decreased vascular segment volume associated with fewer vessels of less than 30 mu m, particularly in the inner cortex: 0.79 +/- 0.54% in grafted kidneys vs. 7.06 +/- 1.44% in uni-nephrectomized kidneys, p < 0.05. Vessels showed higher connectivity throughout the cortex (the arborescence factor of the whole cortex was less in grafted than uni-nephrectomized kidneys 0.90 +/- 0.04 vs. 1.07 +/- 0.05, p < 0.05, with an increase in the number of bifurcations). Furthermore, cortical blood flow decreased early in kidney grafts and remained low three months after autotransplantation. The decrease in microvasculature correlated with a deterioration of renal function, proteinuria, and tubular dysfunction, and was associated with the development of fibrous tissue. This work provides new evidence concerning the impact of ischemia-reperfusion injuries on the spectrum of renal vascular diseases and could potentially guide future therapy to preserve microvessels in transplantation ischemia-reperfusion injury.	[Maiga, Souleymane; Allain, Geraldine; Hauet, Thierry; Roumy, Jerome; Baulier, Edouard; Scepi, Michel; Hannaert, Patrick; Favreau, Frederic] INSERM, U1082, Poitiers, France; [Maiga, Souleymane; Hauet, Thierry; Scepi, Michel; Favreau, Frederic] Univ Poitiers, Fac Med & Pharm, Poitiers, France; [Maiga, Souleymane] Ctr Hosp Univ Bordeaux, Grp Hosp Pellegrin, Serv Imagerie Diagnost & Intervent Adulte, Bordeaux, France; [Allain, Geraldine] CHU Poitiers, Serv Chirurg Cardiothorac, Poitiers, France; [Hauet, Thierry; Favreau, Frederic] CHU Poitiers, Lab Biochim, Poitiers, France; [Hauet, Thierry] INRA, GenESI UE1372, Plateforme IBISA, Surgeres, France; [Hauet, Thierry] CHU La Miletrie, Federat Hosp Univ Transplantat, SUrvival oPtimizat ORgan Transplantat SUPORT, Poitiers, France; [Dierick, Manuel; Van Hoorebeke, Luc] Univ Ghent, UGCT Dept Phys & Astron, Fac Sci, Proeftuinstr 86, Ghent, Belgium; [Guy, Franck] CNRS, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, INEE,UMR 7262, Poitiers, France; [Guy, Franck] Univ Poitiers, Fac Sci, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Bordeaux; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; INRAE; CHU Poitiers; Universite de Poitiers; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Universite de Poitiers	Hauet, T (corresponding author), INSERM, U1082, Poitiers, France.; Hauet, T (corresponding author), Univ Poitiers, Fac Med & Pharm, Poitiers, France.; Hauet, T (corresponding author), CHU Poitiers, Lab Biochim, Poitiers, France.; Hauet, T (corresponding author), INRA, GenESI UE1372, Plateforme IBISA, Surgeres, France.; Hauet, T (corresponding author), CHU La Miletrie, Federat Hosp Univ Transplantat, SUrvival oPtimizat ORgan Transplantat SUPORT, Poitiers, France.	thierry.hauet@gmail.com	Hauet, Thierry/AAC-9277-2021; raphael, thuillier/P-5709-2016	Hauet, Thierry/0000-0002-0117-071X; GUY, Franck/0000-0001-7032-7963; raphael, thuillier/0000-0002-7482-0031	Inserm; University of Poitiers	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Poitiers	This study was supported by funding from Inserm (http://www.inserm.fr) and University of Poitiers (http://www.univ-poitiers.fr). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Professor T Hauet and F Favreau received a salary from University of Poitiers, but they worked independently from University of Poitiers in this research study.	Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bentley MD, 2002, KIDNEY INT, V61, P1056, DOI 10.1046/j.1523-1755.2002.00211.x; Bentley MD, 2002, AM J PHYSIOL-REG I, V282, pR1267, DOI 10.1152/ajpregu.00560.2001; BISHOP GA, 1989, TRANSPLANTATION, V48, P408, DOI 10.1097/00007890-198909000-00011; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Brenner BM, 1999, BRENNER RECTORS KIDN; Chade AR, 2004, AM J PHYSIOL-RENAL, V286, pF1079, DOI 10.1152/ajprenal.00385.2003; Chade AR, 2003, ARTERIOSCL THROM VAS, V23, P1295, DOI 10.1161/01.ATV.0000077477.40824.52; Cicco G, 2005, ADV EXP MED BIOL, V566, P363; CLARK RL, 1977, INVEST RADIOL, V12, P62, DOI 10.1097/00004424-197701000-00014; Eirin A, 2011, AM J PHYSIOL-RENAL, V300, pF1394, DOI 10.1152/ajprenal.00697.2010; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Hauet T, 2002, KIDNEY INT, V62, P654, DOI 10.1046/j.1523-1755.2002.00473.x; Hauet T, 2000, J AM SOC NEPHROL, V11, P138, DOI 10.1681/ASN.V111138; Jochmans I, 2011, ANN SURG, V254, P784, DOI 10.1097/SLA.0b013e3182368fa7; Kline TL, 2010, ANN BIOMED ENG, V38, P2851, DOI 10.1007/s10439-010-0058-7; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; MCNAY JL, 1970, CIRC RES, V27, P571, DOI 10.1161/01.RES.27.4.571; Menger MD, 2000, MICROCIRCULATION, V7, P291, DOI 10.1038/sj.mn.7300117; Mikhalski D, 2008, TRANSPLANTATION, V85, pS3, DOI 10.1097/TP.0b013e318169c29e; Minnich B, 2000, SCANNING, V22, P173, DOI 10.1002/sca.4950220305; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Nankivell BJ, 2001, TRANSPLANTATION, V71, P515, DOI 10.1097/00007890-200102270-00006; Navar LG, 1996, PHYSIOL REV, V76, P425, DOI 10.1152/physrev.1996.76.2.425; Pereira-Sampaio MA, 2004, J UROLOGY, V172, P2077, DOI 10.1097/01.ju.0000138085.19352.b5; Persy V, 2006, ARTERIOSCL THROM VAS, V26, P2110, DOI 10.1161/01.ATV.0000236200.02726.f7; Pober J, 1998, TRANSPLANTATION P; Reffelmann T, 2003, CIRCULATION, V108, P2911, DOI 10.1161/01.CIR.0000101917.80668.E1; Reinders MEJ, 2006, J AM SOC NEPHROL, V17, P932, DOI 10.1681/ASN.2005121250; Ren Y, 2007, KIDNEY INT, V71, P1116, DOI 10.1038/sj.ki.5002190; Sato M, 2000, COMP GRAPH APPL 2000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skov K, 1999, KIDNEY INT, V55, P1462, DOI 10.1046/j.1523-1755.1999.00398.x; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Vodenicharov A, 1998, ANAT HISTOL EMBRYOL, V27, P257, DOI 10.1111/j.1439-0264.1998.tb00190.x; WARE RW, 1975, INT REV CYTOL, V40, P325, DOI 10.1016/S0074-7696(08)60956-0; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhu XY, 2004, ARTERIOSCL THROM VAS, V24, P1854, DOI 10.1161/01.ATV.0000142443.52606.81	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181067	10.1371/journal.pone.0181067	http://dx.doi.org/10.1371/journal.pone.0181067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704481	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700086
J	Priya, GB; Nagaleekar, VK; Milton, AAP; Saminathan, M; Kumar, A; Sahoo, AR; Wani, SA; Kumar, A; Gupta, SK; Sahoo, AP; Tiwari, AK; Agarwal, RK; Gandham, RK				Priya, G. Bhuvana; Nagaleekar, Viswas Konasagara; Milton, A. Arun Prince; Saminathan, M.; Kumar, Amod; Sahoo, Amit Ranjan; Wani, Sajad Ahmad; Kumar, Amit; Gupta, S. K.; Sahoo, Aditya P.; Tiwari, A. K.; Agarwal, R. K.; Gandham, Ravi Kumar			Genome wide host gene expression analysis in mice experimentally infected with Pasteurella multocida	PLOS ONE			English	Article							BACTERIAL PEPTIDOGLYCAN; DEFICIENT MICE; APOPTOSIS; SEPSIS; INNATE; PATHOGENESIS; INFLAMMATION; RECOGNITION; ENVIRONMENT; RECEPTORS	Pasteurella multocida causes acute septicemic and respiratory diseases, including haemorrhagic septicaemia, in cattle and buffalo with case fatality of 100%. In the present study, mice were infected with P. multocida (1.6 x 10 (3) cfu, intraperitoneal) to evaluate host gene expression profile at early and late stages of infection using high throughput microarray transcriptome analyses. Several differentially expressed genes (DEGs) at both the time points were identified in P. multocida infected spleen, liver and lungs. Functional annotation of these DEGs showed enrichment of key pathways such as TLR, NF-.B, MAPK, TNF, JAKSTAT and NOD like receptor signaling pathways. Several DEGs overlapped across different KEGG pathways indicating a crosstalk between them. The predicted protein D protein interaction among these DEGs suggested, that the recognition of P. multocida LPS or outer membrane components by TLR4 and CD14, results in intracellular signaling via MyD88, IRAKs and/or TRAF6 leading to activation of NF kappa B and MAPK pathways and associated cytokines.	[Priya, G. Bhuvana; Nagaleekar, Viswas Konasagara; Agarwal, R. K.] ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India; [Milton, A. Arun Prince] ICAR Indian Vet Res Inst, Div Vet Publ Hlth, Bareilly, Uttar Pradesh, India; [Saminathan, M.] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India; [Kumar, Amod] ICAR Indian Vet Res Inst, Div Anim Genet, Bareilly, Uttar Pradesh, India; [Sahoo, Amit Ranjan; Wani, Sajad Ahmad; Kumar, Amit; Sahoo, Aditya P.; Gandham, Ravi Kumar] ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India; [Gupta, S. K.] ICAR RCER, Div Livestock & Fishery Management, Patna, Bihar, India; [Tiwari, A. K.] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for Eastern Region; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Nagaleekar, VK; Agarwal, RK (corresponding author), ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India.; Gandham, RK (corresponding author), ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.	vkn111@gmail.com; grace_bly@yahoo.com; gandham71@gmail.com	MILTON, AROCKIASAMY ARUN PRINCE/M-5350-2019; Kumar, Amod/AAB-3464-2019	MILTON, AROCKIASAMY ARUN PRINCE/0000-0002-0436-6582; M, Saminathan/0000-0003-0557-7194; Kumar, Amod/0000-0002-7531-574X; WANI, SAJAD/0000-0002-7593-1825; Nagaleekar, Viswas K./0000-0003-4873-0857; KUMAR, AMIT/0000-0002-4423-7881	Network projecton Hemorrhagic Septicemia [AS/8/1/2014/ASR-IV]	Network projecton Hemorrhagic Septicemia	Funded by Network projecton Hemorrhagic Septicemia- F.No. AS/8/1/2014/ASR-IV, dated November 2014.	Boyce JD, 2006, CURR OPIN MICROBIOL, V9, P117, DOI 10.1016/j.mib.2005.12.005; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brogaard L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1557-6; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Horadagoda NU, 2001, MICROB PATHOGENESIS, V30, P171, DOI 10.1006/mpat.2000.0423; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Jaeger A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0178-z; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; OKERMAN L, 1979, J COMP PATHOL, V89, P51, DOI 10.1016/0021-9975(79)90008-2; Peschon JJ, 1998, J IMMUNOL, V160, P943; Praveena PE, 2010, RES VET SCI, V89, P332, DOI 10.1016/j.rvsc.2010.04.012; Quinn PJ, 2011, VET MICROBIOLOGY MIC, V27, P300; RAMDANI, 1990, IMMUNOL CELL BIOL, V68, P57, DOI 10.1038/icb.1990.8; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Saminathan M, 2016, J EXP BIOL AGRIC SCI, V4, P338, DOI 10.18006/2016.4(3S).338.367; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; VOGEL SN, 1990, IMMUNOPHYSIOLOGY ROL, P238; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Xie F, 2010, AM J REPROD IMMUNOL, V63, P7, DOI 10.1111/j.1600-0897.2009.00745.x	43	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179420	10.1371/journal.pone.0179420	http://dx.doi.org/10.1371/journal.pone.0179420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704394	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700011
J	Mihoubi, W; Sahli, E; Gargouri, A; Amiel, C				Mihoubi, Wafa; Sahli, Emna; Gargouri, Ali; Amiel, Caroline			FTIR spectroscopy of whole cells for the monitoring of yeast apoptosis mediated by p53 over-expression and its suppression by Nigella sativa extracts	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; RADIATION-INDUCED APOPTOSIS; SACCHAROMYCES-CEREVISIAE; IR SPECTROSCOPY; FATTY-ACID; HL60 CELLS; MICROSPECTROSCOPY; DEATH; STRESS; IDENTIFICATION	p53 over expression in yeast results in cell death with typical markers of apoptosis such as DNA fragmentation and phosphatidylserine externalization. We aimed to substitute/ supplement classical fluorescent techniques (TUNEL, Annexin V, ROS detection) usually used to detect biochemical changes occurring during yeast apoptosis mediated by p53 over expression and the effect of anti-apoptotic purified molecules from Nigel (Nigella sativa) extracts on these same yeasts by the label free technique of FTIR spectroscopy. The comparison of the entire IR spectra highlighted clear modifications between apoptotic p53-expressing yeasts and normal ones. More precisely, DNA damage was detected by the decrease of band intensities at 1079 and 1048 cm(-1). While phosphatidylserine exposure was followed by the increase of.sCH(2) and.asCH(2) bands of unsaturated fatty acids that were exhibited at 2855 and 2926 cm(-1), and the appearance of the C = O ester functional group band at 1740 cm(-1). In a second step, this FTIR approach was used to estimate the effect of a purified fraction of the Nigel extract. The modulation of band intensities specific to DNA and membrane status was in agreement with apoptosis supression in presence of the Nigel extracts. FTIR spectroscopy is thus proven to be a very reliable technique to monitor the apoptotic cell death in yeast and to be used as a means of evaluating the biomolecules effect on yeast survival.	[Mihoubi, Wafa; Sahli, Emna; Gargouri, Ali] Ctr Biotechnol Sfax, Lab Biotechnol Mol Eucaryotes, Sfax, Tunisia; [Amiel, Caroline] Univ Caen Normandie, Unite Rech Aliments Bioproc Toxicol Environm, EA 4651, Blvd Marechal Juin, Caen, France	Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Caen Normandie	Mihoubi, W (corresponding author), Ctr Biotechnol Sfax, Lab Biotechnol Mol Eucaryotes, Sfax, Tunisia.	fafani.mihoubi@yahoo.fr						Abbott GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049070; Amiel C, 2000, LAIT, V80, P445, DOI 10.1051/lait:2000137; Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Bellisola G, 2012, AM J CANCER RES, V2, P1; BENEDETTI E, 1986, APPL SPECTROSC, V40, P39, DOI 10.1366/0003702864815565; BENEDETTI E, 1990, APPL SPECTROSC, V44, P1276, DOI 10.1366/000370290789619621; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Cheung HY, 1999, MICROBIOL-SGM, V145, P1043, DOI 10.1099/13500872-145-5-1043; CHOO LP, 1993, BIOCHIM BIOPHYS ACTA, V1182, P333, DOI 10.1016/0925-4439(93)90078-F; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; CULLIN C, 1988, GENE, V65, P203, DOI 10.1016/0378-1119(88)90457-X; Diem M, 1999, APPL SPECTROSC, V53, p148A, DOI 10.1366/0003702991946712; Dixit VM, 1996, ADV EXP MED BIOL, V406, P113; Dogan A, 2007, APPL SPECTROSC, V61, P199, DOI 10.1366/000370207779947459; Erukhimovitch V, 2009, BIOPOLYMERS, V91, P61, DOI 10.1002/bip.21082; Ferreira P, 2014, FEMS YEAST RES, V14, P1006, DOI 10.1111/1567-1364.12189; Gao YF, 2015, MOL MED REP, V11, P2585, DOI 10.3892/mmr.2014.3088; Gasparri F, 2003, BIOCHEM J, V369, P239, DOI 10.1042/BJ20021021; Gaudenzi AS, 2004, CELL APOPTOSIS SPECI, V18, P415; Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1; Gautam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045521; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Griffiths P., 1986, FOURIER TRANSFORM IN; Guibet M, 2006, CARBOHYD RES, V341, P1859, DOI 10.1016/j.carres.2006.04.018; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kamnev AA, 2005, J TRACE ELEM MED BIO, V19, P91, DOI 10.1016/j.jtemb.2005.03.002; Kendall C, 2009, ANALYST, V134, P1029, DOI 10.1039/b822130h; Lasch P, 2008, BIOMEDICAL VIBRATION, P79; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Liu KZ, 2007, BRIT J HAEMATOL, V136, P713, DOI 10.1111/j.1365-2141.2006.06474.x; Liu KZ, 2005, BLOOD CELL MOL DIS, V35, P404, DOI 10.1016/j.bcmd.2005.06.009; Liu KZ, 2001, J MOL STRUCT, V565, P299, DOI 10.1016/S0022-2860(00)00817-6; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mahmood MS, 2003, PHYTOTHER RES, V17, P921, DOI 10.1002/ptr.1251; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Mantsch HH, 2002, VIB SPECTROSC, V30, P31, DOI 10.1016/S0924-2031(02)00036-X; Mecozzi M, 2007, VIB SPECTROSC, V44, P228, DOI 10.1016/j.vibspec.2006.11.006; Melin AM, 2001, ARCH BIOCHEM BIOPHYS, V394, P265, DOI 10.1006/abbi.2001.2533; Moen B, 2005, APPL ENVIRON MICROB, V71, P2086, DOI 10.1128/AEM.71.4.2086-2094.2005; Mokdad-Gargouri R, 2001, NUCLEIC ACIDS RES, V29, P1222, DOI 10.1093/nar/29.5.1222; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Perromat A, 2003, BIOPOLYMERS, V72, P207, DOI 10.1002/bip.10381; Portenier I, 2005, J ENDODONT, V31, P380, DOI 10.1097/01.don.0000145421.84121.c8; Pozzi D, 2007, RADIAT RES, V168, P698, DOI 10.1667/RR0991.1; Ryser S, 1999, CURR GENET, V36, P21, DOI 10.1007/s002940050468; Saharan RK, 2011, VIB SPECTROSC, V55, P85, DOI 10.1016/j.vibspec.2010.08.003; Sajbidor J, 1995, FOLIA MICROBIOL, V40, P508, DOI 10.1007/BF02814733; Sambrook J., MOL CLONING LAB MANU; Saulou C, 2010, ANAL BIOANAL CHEM, V396, P1441, DOI 10.1007/s00216-009-3316-5; Schultz CP, 1998, ONCOL RES, V10, P277; Scott CE, 1999, J CELL PHYSIOL, V181, P147, DOI 10.1002/(SICI)1097-4652(199910)181:1<147::AID-JCP15>3.0.CO;2-M; Singh JK, 1996, BBA-LIPID LIPID MET, V1304, P171, DOI 10.1016/S0005-2760(96)00134-8; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toyran N, 2005, INT J RADIAT BIOL, V81, P911, DOI 10.1080/09553000600571022; van den Driesche S, 2013, SENSOR ACTUAT B-CHEM, V179, P150, DOI 10.1016/j.snb.2012.10.139; Wu B., 2015, DISCRETE DYN NAT SOC, V2015, P1, DOI DOI 10.1186/S12967-015-0468-2; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yacoubi-Hadj Amor I, 2008, FEMS YEAST RES, V8, P1, DOI DOI 10.1111/J.1567-1364.2008.00445; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026; ZEROUAL W, 1995, PATHOL BIOL, V43, P300; Zhou JB, 2001, BIOTECHNOL APPL BIOC, V33, P127, DOI 10.1042/BA20000074	73	43	44	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180680	10.1371/journal.pone.0180680	http://dx.doi.org/10.1371/journal.pone.0180680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704406	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600042
J	Tang, JJ; He, HM; Chen, C; Fu, S; Xue, FS				Tang, Jianjun; He, Haimin; Chen, Chao; Fu, Shu; Xue, Fangsen			Latitudinal cogradient variation of development time and growth rate and a negative latitudinal body weight cline in a widely distributed cabbage beetle	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; STRIDER AQUARIUS-REMIGIS; LIFE-HISTORY RESPONSES; COLAPHELLUS-BOWRINGI; PHENOTYPIC PLASTICITY; GEOGRAPHIC-VARIATION; COUNTERGRADIENT VARIATION; EVOLUTIONARY SIGNIFICANCE; DIAPAUSE INCIDENCE; TEMPERATURE-CHANGE	The evolutionary and phenotypic responses to environmental gradients are often assumed to be the same, a phenomenon known as "cogradientvariation" .However, only a few insect species display cogradient variation in physiological traits along a latitudinal gradient. We found evidence for such a response in the examination of the life history traits of the cabbage beetle Colaphellus bowringi from 6 different geographical populations at 16, 19, 22, 24, 26 and 28 degrees C. Our results showed that larval and pupal development times significantly decreased as rearing temperature increased, and that growth rates were positively correlated with temperature. Body weight tended to decrease with increasing temperature, consistent with the general pattern in ectothermic animals. Larval development time was positively correlated with latitude, whereas the growth rate decreased as latitude increased, showing an example of latitudinal cogradient variation. Body weight significantly decreased with increasing latitude in a stepwise manner, showing a negative latitudinal body weight cline. Females were significantly larger than males, consistent with the female biased sex dimorphism in insects. Body weight tended to decrease with increasing rearing temperature, whereas the differences in sexual size dimorphism (SSD) tended to decrease with increasing body weight, which biased our results toward acceptance of Rensch's rule. We found that weight loss was an important regulator of SSD, and because male pupae lost significantly more weight at metamorphosis than female pupae, SSD was greater in adults than in pupae. Overall, our data provide a new example that a latitudinal cogradient variation in physiological traits is associated with a negative latitudinal body weight cline.	[Tang, Jianjun] Jiangxi Agr Univ, Coll Comp & Informat Engn, Nanchang, Jiangxi, Peoples R China; [He, Haimin; Fu, Shu; Xue, Fangsen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Chen, Chao] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Jiangxi Agricultural University; Jiangxi Agricultural University; State University System of Florida; University of Florida	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com		Xue, Fangsen/0000-0002-7609-7414	National Natural Science Foundation of the People's Republic of China [31260430]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	The research was supported by a grant from National Natural Science Foundation of the People's Republic of China to FSX (31260430). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Arendt JD, 1999, ECOLOGY, V80, P2793, DOI 10.1890/0012-9658(1999)080[2793:CSFRGI]2.0.CO;2; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Barton M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095258; Bidau CJ, 2007, B ENTOMOL RES, V97, P69, DOI 10.1017/S0007485307004749; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; BLANCKENHORN WU, 1995, J EVOLUTION BIOL, V8, P21, DOI 10.1046/j.1420-9101.1995.8010021.x; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; De Block M, 2008, ECOGRAPHY, V31, P115, DOI 10.1111/j.2007.0906-7590.05313.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fischer K, 2000, OIKOS, V90, P372, DOI 10.1034/j.1600-0706.2000.900218.x; Fu DM, 2016, J THERM BIOL, V61, P115, DOI 10.1016/j.jtherbio.2016.09.006; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hirst AG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2475; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Kivela SM, 2012, J EVOLUTION BIOL, V25, P881, DOI 10.1111/j.1420-9101.2012.02478.x; Kivela SM, 2011, J ANIM ECOL, V80, P1184, DOI 10.1111/j.1365-2656.2011.01864.x; Lai XT, 2008, ENTOMOL EXP APPL, V129, P117, DOI 10.1111/j.1570-7458.2008.00749.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; PARK O, 1949, PHYSIOL ZOOL, V22, P359, DOI 10.1086/physzool.22.4.30152061; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; Poykko H, 2010, J EVOLUTION BIOL, V23, P1278, DOI 10.1111/j.1420-9101.2010.01990.x; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Schutze MK, 2008, GLOBAL ECOL BIOGEOGR, V17, P424, DOI 10.1111/j.1466-8238.2007.00374.x; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Stillwell RC, 2009, OIKOS, V118, P703, DOI 10.1111/j.1600-0706.2008.17327.x; Tang JJ, 2016, ENTOMOL RES, V46, P337, DOI 10.1111/1748-5967.12184; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Valimaki P, 2013, J EVOLUTION BIOL, V26, P118, DOI 10.1111/jeb.12033; Winterhalter Wade E., 2008, Journal of Orthoptera Research, V17, P347, DOI 10.1665/1082-6467-17.2.347; Xiao L, 2016, ECOL EVOL, V6, P5129, DOI 10.1002/ece3.2275; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; Yang D, 2007, J INSECT PHYSIOL, V53, P900, DOI 10.1016/j.jinsphys.2007.02.015	51	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181030	10.1371/journal.pone.0181030	http://dx.doi.org/10.1371/journal.pone.0181030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704496	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600053
J	Bin Naser, I; Hoque, MM; Abdullah, A; Bari, SMN; Ghosh, AN; Faruque, SM				Bin Naser, Iftekhar; Hoque, M. Mozammel; Abdullah, Ahmed; Bari, S. M. Nayeemul; Ghosh, Amar N.; Faruque, Shah M.			Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: Potential relevance in cholera epidemiology	PLOS ONE			English	Article							PHAGE; BACTERIA; INFECTIVITY; RESISTANCE; ENHANCE; WATER	In cholera-endemic areas, toxigenic Vibrio cholerae persist in the aquatic ecosystem mostly in a biofilm-associated state in which the bacteria remain embedded in an exopolysaccharide matrix. The biofilm-associated cells often enter into a dormant form referred to as conditionally viable environmental cells (CVEC), which resist cultivation on routine bacteriological media. However, these cells can naturally resuscitate into the active planktonic form through various mechanisms, multiply, and cause epidemics of cholera. This study was conducted to study possible effects of environmental bacteriophages on the prevalence and distribution of the pathogen between the biofilm associated state, and the planktonic form.	[Bin Naser, Iftekhar; Hoque, M. Mozammel; Abdullah, Ahmed; Bari, S. M. Nayeemul; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh; [Ghosh, Amar N.] Natl Inst Cholera & Enter Dis, Kolkata, W Bengal, India	International Centre for Diarrhoeal Disease Research (ICDDR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Faruque, SM (corresponding author), Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh.	faruque@icddrb.org		Hoque, Md Mozammel/0000-0002-6014-6955; Faruque, Shah/0000-0002-7006-622X	Wellcome Trust through a senior investigator [WT-105927/Z/14/Z]; Swedish International Development Cooperation Agency (Sida) under International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb); Governments of Bangladesh, Canada, Sweden; UK	Wellcome Trust through a senior investigator; Swedish International Development Cooperation Agency (Sida) under International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb); Governments of Bangladesh, Canada, Sweden; UK	This research was funded by the Wellcome Trust through a senior investigator award WT-105927/Z/14/Z to Shah Faruque, and the Swedish International Development Cooperation Agency (Sida) under an agreement with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb). The icddreb receives core support from the Governments of Bangladesh, Canada, Sweden and the UK. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ACKERMANN HW, 1987, MICROBIOL SCI, V4, P214; Albert MJ, 1996, J CLIN MICROBIOL, V34, P1843, DOI 10.1128/JCM.34.7.1843-1845.1996; Bari SMN, 2013, P NATL ACAD SCI USA, V110, P9926, DOI 10.1073/pnas.1307697110; Colwell Rita R., 1994, P117; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Faruque SM, 2012, VIRULENCE, V3, P556, DOI 10.4161/viru.22351; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Faruque SM, 2003, EMERG INFECT DIS, V9, P1116; Faruque SM, 2000, INFECT IMMUN, V68, P4795, DOI 10.1128/IAI.68.8.4795-4801.2000; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoque MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37956; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107; KHAN MU, 1984, TROP GEOGR MED, V36, P335; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Maniatis T., 1982, MOL CLONING; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Seed KD, 2011, MBIO, V2, DOI 10.1128/mBio.00334-10; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	30	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180838	10.1371/journal.pone.0180838	http://dx.doi.org/10.1371/journal.pone.0180838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700707	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800085
J	Liu, PF; Hu, YC; Kang, BH; Tseng, YK; Wu, PC; Liang, CC; Hou, YY; Fu, TY; Liou, HH; Hsieh, IC; Ger, LP; Shu, CW				Liu, Pei-Feng; Hu, Yu-Chang; Kang, Bor-Hwang; Tseng, Yu-Kai; Wu, Pi-Chuang; Liang, Chi-Chuang; Hou, Yu-Yi; Fu, Ting-Ying; Liou, Huei-Han; Hsieh, I-Chien; Ger, Luo-Ping; Shu, Chih-Wen			Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma	PLOS ONE			English	Article							CANCER-CELLS; PROTEIN EXPRESSION; BLADDER-CANCER; APOPTOSIS; ACTIVATION; REPOPULATION; INSTABILITY; RECURRENCE; PATHWAYS; DISEASE	Apoptosis plays a dual role in cancer development and malignancy. The role of apoptosisrelated caspases in cancer remains controversial, particularly in oral tongue squamous cell carcinoma (OTSCC). In this study, we examined the protein levels of cleaved caspase-3, caspase-3, caspase-8, and caspase-9 on tissue microarrays consisting of samples from 246 OTSCC patients by immunohistochemistry. Wilcoxon signed-rank test indicated that the protein levels of cleaved caspase-3, caspase-3, caspase-8, and caspase-9 in tumor tissues were significantly higher compared to those in adjacent normal tissues (all p<0.001). The expression level of caspase-8 in tumors was elevated in patients with lymph node invasion. Moreover, positive expression of cleaved caspase-3 was associated with shorter disease-free survival (DFS) in OTSCC patients with moderate differentiation and lymph node invasion. Combination of either positive cleaved caspase-3 or higher caspase-3 expression or both was associated with poor DFS. Interestingly, stratification analysis showed that coexpression levels of positive cleaved caspase-3 or/and higher caspase-3 were associated with better disease-specific survival in patients with advanced stages of the disease, such as large tumor size and lymph node invasion, whereas it was associated with poor DFS in OTSCC patients with moderate cell differentiation and small tumor size. Taken together, cleaved caspase-3 and caspase-3/8/9 could be biomarkers for tumorigenesis in OTSCC patients. The co-expression level of cleaved caspase-3 and caspase-3 might be a prognostic biomarker for OTSCC patients, particular in those patients with certain tumor stages and cell differentiation status.	[Liu, Pei-Feng; Liou, Huei-Han; Ger, Luo-Ping; Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Hu, Yu-Chang] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Kang, Bor-Hwang; Hou, Yu-Yi] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Kang, Bor-Hwang] Natl Def Med Ctr, Sch Med, Dept Otorhinolaryngol, Taipei, Taiwan; [Tseng, Yu-Kai] Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan; [Tseng, Yu-Kai] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Wu, Pi-Chuang; Liang, Chi-Chuang] Kaohsiung Vet Gen Hosp, Dept Nutr, Kaohsiung, Taiwan; [Fu, Ting-Ying; Hsieh, I-Chien] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Ger, Luo-Ping] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; Show Chwan Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University	Ger, LP; Shu, CW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.; Ger, LP (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.	lpger@vghks.gov.tw; cwshu@vghks.gov.tw	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002; Liu, Pei-Feng/0000-0002-7849-8940	Kaohsiung Veterans General Hospital in Taiwan, ROC [VGHKS 102-037, VGHKS102-080, VGHKS105-024, VGHKS106-154, VGHKS106-020]	Kaohsiung Veterans General Hospital in Taiwan, ROC	This study was supported by a research grant from the Kaohsiung Veterans General Hospital (VGHKS 102-037, VGHKS102-080, VGHKS105-024, VGHKS106-154, and VGHKS106-020) in Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andressakis D, 2008, J LARYNGOL OTOL, V122, P1213, DOI 10.1017/S0022215108002636; Coutinho-Camillo CM, 2011, HEAD NECK-J SCI SPEC, V33, P1191, DOI 10.1002/hed.21602; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; de Heer P, 2007, CLIN CANCER RES, V13, P5810, DOI 10.1158/1078-0432.CCR-07-0343; Fan CF, 2011, FOLIA HISTOCHEM CYTO, V49, P231, DOI 10.5603/FHC.2011.0032; Fujikawa K, 2000, ANTICANCER RES, V20, P1927; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Fulda S, 2009, CANCER LETT, V281, P128, DOI 10.1016/j.canlet.2008.11.023; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Jakubowska K, 2016, ONCOL LETT, V11, P1879, DOI 10.3892/ol.2016.4125; Kumar S, 1999, CLIN EXP PHARMACOL P, V26, P295, DOI 10.1046/j.1440-1681.1999.03031.x; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Li S, 2014, J CLIN ENDOCR METAB, V99, pE2298, DOI 10.1210/jc.2014-1779; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Loro LL, 2005, ORAL DIS, V11, P274, DOI 10.1111/j.1601-0825.2005.01117.x; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mukai M, 2005, CANCER RES, V65, P9121, DOI 10.1158/0008-5472.CAN-04-4344; Nagaraj NS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-38; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Noble P, 2013, BRIT J CANCER, V108, P2097, DOI 10.1038/bjc.2013.166; O'Donovan N, 2003, CLIN CANCER RES, V9, P738; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Satoh K, 2000, PANCREAS, V21, P352, DOI 10.1097/00006676-200011000-00005; Tormanen-Napankangas U, 2001, INT J CANCER, V93, P192, DOI 10.1002/ijc.1315; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; Wang JW, 2014, WORLD J UROL, V32, P1477, DOI 10.1007/s00345-014-1246-0; Winter RN, 2001, CANCER RES, V61, P1227; Xia B, 2005, WORLD J GASTROENTERO, V11, P415, DOI 10.3748/wjg.v11.i3.415; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	35	48	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180620	10.1371/journal.pone.0180620	http://dx.doi.org/10.1371/journal.pone.0180620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700659	gold, Green Submitted, Green Published			2022-12-26	WOS:000405544800058
J	Tuitert, I; Bootsma, RJ; Schoemaker, MM; Otten, E; Mouton, LJ; Bongers, RM				Tuitert, Inge; Bootsma, Reinoud J.; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.			Does practicing a wide range of joint angle configurations lead to higher flexibility in a manual obstacle-avoidance target-pointing task?	PLOS ONE			English	Article							UNCONTROLLED MANIFOLD ANALYSIS; MOTOR ABUNDANCE; EFFECT SIZE; VARIABILITY; COORDINATION; ADAPTATION; STATISTICS; REDUNDANCY; MOVEMENTS; ELBOW	Flexibility in motor actions can be defined as variability in the use of degrees of freedom (e.g., joint angles in the arm) over repetitions while keeping performance (e.g., fingertip position) stabilized. We examined whether flexibility can be increased through enlarging the joint angle range during practice in a manual obstacle-avoidance target-pointing task. To establish differences in flexibility we partitioned the variability in joint angles over repetitions in variability within (GEV) and variability outside the solution space (NGEV). More GEV than NGEV reflects flexibility; when the ratio of the GEV and NGEV is higher, flexibility is higher. The pretest and posttest consisted of 30 repetitions of manual pointing to a target while moving over a 10 cm high obstacle. To enlarge the joint angle range during practice participants performed 600 target-pointing movements while moving over obstacles of different heights (5-9 cm, 11-15 cm). The results indicated that practicing movements over obstacles of different heights led participants to use enlarged range of joint angles compared to the range of joint angles used in movements over the 10 cm obstacle in the pretest. However, for each individual obstacle neither joint angle variance nor flexibility were higher during practice. We also did not find more flexibility after practice. In the posttest, joint angle variance was in fact smaller than before practice, primarily in GEV. The potential influences of learning effects and the task used that could underlie the results obtained are discussed. We conclude that with this specific type of practice in this specific task, enlarging the range of joint angles does not lead to more flexibility.	[Tuitert, Inge; Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Tuitert, Inge; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Groningen	Tuitert, I (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France.; Tuitert, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	i.tuitert@umcg.nl	Bootsma, Reinoud/B-1254-2008; Bongers, Raoul/C-1094-2012	Bootsma, Reinoud/0000-0002-3719-7586; Mouton, Leonora/0000-0001-8389-2013; Bongers, Raoul/0000-0002-3518-7464	Excellence Initiative of Aix-Marseille University - A*MIDEX, a French "Investissements d'Avenir" programme	Excellence Initiative of Aix-Marseille University - A*MIDEX, a French "Investissements d'Avenir" programme(French National Research Agency (ANR))	The project leading to this publication has received funding from Excellence Initiative of Aix-Marseille University - A*MIDEX, a French Investissements dAvenir programme.	Alberts JL, 2002, EXP BRAIN RES, V143, P417, DOI 10.1007/s00221-002-1005-0; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bernstein N, 1967, COORDINATION REGULAT; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Borbely BJ, 2014, EXP BRAIN RES, V232, P889, DOI 10.1007/s00221-013-3801-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Freitas SMSF, 2007, NEUROSCI LETT, V417, P66, DOI 10.1016/j.neulet.2007.02.037; Domkin D, 2005, EXP BRAIN RES, V163, P44, DOI 10.1007/s00221-004-2137-1; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gelfand I M, 1998, Motor Control, V2, P306; Gera G, 2010, MOTOR CONTROL, V14, P83, DOI 10.1123/mcj.14.1.83; Greve C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127017; Jacquier-Bret J, 2009, MOTOR CONTROL, V13, P342, DOI 10.1123/mcj.13.3.342; Klous M, 2010, EXP BRAIN RES, V202, P457, DOI 10.1007/s00221-009-2153-2; Kruger M, 2012, HUM MOVEMENT SCI, V31, P1071, DOI 10.1016/j.humov.2011.12.002; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Latash ML, 2002, EXP BRAIN RES, V146, P345, DOI 10.1007/s00221-002-1189-3; Mattos DJS, 2011, J NEUROPHYSIOL, V106, P1424, DOI 10.1152/jn.00163.2011; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Park J, 2013, CLIN NEUROPHYSIOL, V124, P991, DOI 10.1016/j.clinph.2012.10.021; Park J, 2012, J NEUROPHYSIOL, V108, P915, DOI 10.1152/jn.00043.2012; Saling M, 1998, EXP BRAIN RES, V118, P251, DOI 10.1007/s002210050279; Scholz JP, 2003, EXP BRAIN RES, V153, P45, DOI 10.1007/s00221-003-1580-8; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tuitert I, 2014, EXP BRAIN RES, V232, P3211, DOI 10.1007/s00221-014-4009-7; Valk TA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00826; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; Verrel J, 2010, J NEUROSCI METH, V191, P166, DOI 10.1016/j.jneumeth.2010.06.016; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/454021; Wu YH, 2013, EXP BRAIN RES, V226, P273, DOI 10.1007/s00221-013-3433-4; Wu YH, 2012, J MOTOR BEHAV, V44, P471, DOI 10.1080/00222895.2012.740101; Yang JF, 2007, EXP BRAIN RES, V176, P54, DOI 10.1007/s00221-006-0602-8; Yang JF, 2005, EXP BRAIN RES, V163, P137, DOI 10.1007/s00221-004-2149-x; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007; Zhang W, 2009, MOTOR CONTROL, V13, P251, DOI 10.1123/mcj.13.3.251	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181041	10.1371/journal.pone.0181041	http://dx.doi.org/10.1371/journal.pone.0181041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700695	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800116
J	Rodriguez-Blanco, J; Pednekar, L; Penas, C; Li, B; Martin, V; Long, J; Lee, E; Weiss, WA; Rodriguez, C; Mehrdad, N; Nguyen, DM; Ayad, NG; Rai, P; Capobianco, AJ; Robbins, DJ				Rodriguez-Blanco, J.; Pednekar, L.; Penas, C.; Li, B.; Martin, V.; Long, J.; Lee, E.; Weiss, W. A.; Rodriguez, C.; Mehrdad, N.; Nguyen, D. M.; Ayad, N. G.; Rai, P.; Capobianco, A. J.; Robbins, D. J.			Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma	ONCOGENE			English	Article							BASAL-CELL CARCINOMA; HEDGEHOG PATHWAY INHIBITOR; SMALL-MOLECULE INHIBITORS; TUMOR-INITIATING CELLS; CANCER STEM-CELLS; NEVUS SYNDROME; MOUSE; IDENTIFICATION; VISMODEGIB; RESISTANCE	The SMOOTHENED inhibitor vismodegib is FDA approved for advanced basal cell carcinoma (BCC), and shows promise in clinical trials for SONIC HEDGEHOG (SHH)-subgroup medulloblastoma (MB) patients. Clinical experience with BCC patients shows that continuous exposure to vismodegib is necessary to prevent tumor recurrence, suggesting the existence of a vismodegib-resistant reservoir of tumor-propagating cells. We isolated such tumor-propagating cells from a mouse model of SHH-subgroup MB and grew them as sphere cultures. These cultures were enriched for the MB progenitor marker SOX2 and formed tumors in vivo. Moreover, while their ability to self-renew was resistant to SHH inhibitors, as has been previously suggested, this self-renewal was instead WNT-dependent. We show here that loss of Trp53 activates canonical WNT signaling in these SOX2-enriched cultures. Importantly, a small molecule WNT inhibitor was able to reduce the propagation and growth of SHH-subgroup MB in vivo, in an ontarget manner, leading to increased survival. Our results imply that the tumor-propagating cells driving the growth of bulk SHH-dependent MB are themselves WNT dependent. Further, our data suggest combination therapy with WNT and SHH inhibitors as a therapeutic strategy in patients with SHH-subgroup MB, in order to decrease the tumor recurrence commonly observed in patients treated with vismodegib.	[Rodriguez-Blanco, J.; Pednekar, L.; Li, B.; Long, J.; Capobianco, A. J.; Robbins, D. J.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Mol Oncol Program, 1600 NW 10th Ave, Miami, FL 33136 USA; [Penas, C.; Ayad, N. G.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA; [Martin, V.; Rodriguez, C.] Univ Oviedo, Morphol & Cell Biol Dept, Asturias, Spain; [Lee, E.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Weiss, W. A.] Univ Calif San Francisco, Dept Neurobiol, San Francisco, CA 94143 USA; [Mehrdad, N.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Nguyen, D. M.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Div Cardiothorac Surg, Miami, FL 33136 USA; [Nguyen, D. M.; Ayad, N. G.; Rai, P.; Capobianco, A. J.; Robbins, D. J.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Rai, P.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Oviedo; Vanderbilt University; University of California System; University of California San Francisco; University of Miami; University of Miami; University of Miami; University of Miami	Robbins, DJ (corresponding author), Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Mol Oncol Program, 1600 NW 10th Ave, Miami, FL 33136 USA.	drobbins@miami.edu	MARTIN, VANESA/A-7312-2012; Long, Jun/S-2382-2019; Rodriguez, Jezabel/B-7613-2019; Rodríguez, Carmen/R-9541-2019; penas, clara/K-3480-2017	MARTIN, VANESA/0000-0001-6923-2529; Long, Jun/0000-0002-8229-9653; Rodriguez, Jezabel/0000-0003-1839-6181; Rodríguez, Carmen/0000-0002-3203-4753; penas, clara/0000-0003-0554-3832; Rai, Priyamvada/0000-0001-7822-7553; Weiss, William/0000-0003-2230-9132; Capobianco, Anthony/0000-0002-3706-6797	Alex Lemonade Stand Foundation [M1201547]; University of Miami Women's Cancer Association; B*Cured; Childhood Brain Tumor Foundation; FICYT [POST10-27]; Sylvester Cancer Center; NIH [R01GM081635, R01GM103926];  [1R21NS096502-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103926, R35GM122516, R01GM081635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096502] Funding Source: NIH RePORTER	Alex Lemonade Stand Foundation; University of Miami Women's Cancer Association; B*Cured; Childhood Brain Tumor Foundation; FICYT; Sylvester Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Alex Lemonade Stand Foundation M1201547 (DJR), 1R21NS096502-01 (DJR), The University of Miami Women's Cancer Association (DJR), B*Cured 2016 (DJR), Childhood Brain Tumor Foundation (JR-B), FICYT POST10-27 (JR-B), funds from the Sylvester Cancer Center (DJR), NIH R01GM081635 (EL), and R01GM103926 (EL).	Ahlfeld J, 2013, CANCER RES, V73, P3796, DOI 10.1158/0008-5472.CAN-13-0238; Anne SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081769; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Atwood SX, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013581; Azad N, 2011, CELL J, V13, P39; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Cha YH, 2012, CELL CYCLE, V11, P1273, DOI 10.4161/cc.19618; Corno D, 2012, CANCER DISCOV, V2, P554, DOI 10.1158/2159-8290.CD-11-0199; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Fei DL, 2010, CANCER RES, V70, P1981, DOI 10.1158/0008-5472.CAN-09-2898; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritti A, 1996, J NEUROSCI, V16, P1091; HEPPNER GH, 1984, CANCER RES, V44, P2259; Huang X, 2010, J VIS EXP, P2086; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kennedy MWL, 2011, BIOCHEM J, V435, P247, DOI 10.1042/BJ20101801; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lange C, 2006, NEURODEGENER DIS, V3, P76, DOI 10.1159/000092097; Lee Hae Young, 2009, J Vis Exp, DOI 10.3791/990; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meani RE, 2014, AUSTRALAS J DERMATOL, V55, P218, DOI 10.1111/ajd.12196; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Northcott PA, 2012, EXPERT REV NEUROTHER, V12, P871, DOI [10.1586/ERN.12.66, 10.1586/ern.12.66]; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olson JM, 2014, CANCER CELL, V25, P267, DOI 10.1016/j.ccr.2014.03.003; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Poschl J, 2014, ACTA NEUROPATHOL, V127, P605, DOI 10.1007/s00401-014-1258-2; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Remke M, 2013, CURR OPIN ONCOL, V25, P674, DOI 10.1097/CCO.0000000000000008; Robinson GW, 2015, J CLIN ONCOL, V33, P2646, DOI 10.1200/JCO.2014.60.1591; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Tam WL, 2014, CANCER CELL, V26, P3, DOI 10.1016/j.ccr.2014.06.024; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Voorneveld PW, 2015, BRIT J CANCER, V112, P122, DOI 10.1038/bjc.2014.560; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Wetmore C, 2001, CANCER RES, V61, P513; Wolfe CM, 2012, DERMATOL SURG, V38, P1863, DOI 10.1111/j.1524-4725.2012.02513.x; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Zhao XS, 2015, CANCER RES, V75, P3623, DOI 10.1158/0008-5472.CAN-14-2999-T; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052; Zinke J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0294-4	67	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6306	6314		10.1038/onc.2017.232	http://dx.doi.org/10.1038/onc.2017.232			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28714964	Green Accepted			2022-12-26	WOS:000414774800009
J	Nguyen, K; Li, J; Puthenveetil, R; Lin, XC; Poe, MM; Hsiao, CHC; Vinogradova, O; Wiemer, AJ				Nguyen, Khiem; Li, Jin; Puthenveetil, Robbins; Lin, Xiaochen; Poe, Michael M.; Hsiao, Chia-Hung Christine; Vinogradova, Olga; Wiemer, Andrew J.			The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region	FASEB JOURNAL			English	Article						phosphoantigen; CD277; B7 family coreceptor; gamma delta T cell; bisphosphonate	DELTA T-CELLS; SMALL-ANGLE SCATTERING; ISOPRENOID METABOLISM; NONPEPTIDE ANTIGENS; CANCER-IMMUNOTHERAPY; BTN3A1 CONTROLS; IN-VIVO; ACTIVATION; RECOGNITION; NMR	Small isoprenoid diphosphates, such as (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), are ligands of the internal domain of BTN3A1. Ligand binding in target cells promotes activation of V gamma 9V delta 2 T cells. We demonstrate by small-angle X-ray scattering (SAXS) that HMBPP binding to the internal domain of BTN3A1 induces a conformational change in the position of the B30.2 domain relative to the juxtamembrane (JM) region. To better understand the molecular details of this conformational rearrangement, NMR spectroscopy was used to discover that the JM region interacts with HMBPP, specifically at the diphosphate. The spectral location of the affected amide peaks, partial NMR assignments, and JM mutants (ST(296)AA or T(304)A) investigated, confirm that the backbone amide of at least one Thr (Thr(304)), adjacent to conserved Ser, comes close to the HMBPP diphosphate, whereas double mutation of nonconserved residues (Ser/Thr(296/297)) may perturb the local fold. Cellular mutation of either of the identified Thr residues reduces the activation of V gamma 9V delta 2 T cells by HMBPP, zoledronate, and POM2-C-HMBP, but not by a partial agonist BTN3 antibody. Taken together, our results show that ligand binding to BTN3A1 induces a conformational change within the intracellular domain that involves the JM region and is required for full activation.	[Nguyen, Khiem; Li, Jin; Lin, Xiaochen; Poe, Michael M.; Hsiao, Chia-Hung Christine; Vinogradova, Olga; Wiemer, Andrew J.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA; [Puthenveetil, Robbins] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Wiemer, Andrew J.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Wiemer, AJ (corresponding author), Univ Connecticut, 69 N Eagleville Rd,Unit 3092, Storrs Mansfield, CT 06269 USA.	andrew.wiemer@uconn.edu	Wiemer, Andrew J/C-2257-2009; Vinogradova, Olga/ABE-8367-2020	Wiemer, Andrew J/0000-0002-3029-1780; Vinogradova, Olga/0000-0001-5101-7361; Hsiao, Chia-Hung Christine/0000-0002-9037-027X; Li, Jin/0000-0002-6764-3743; Poe, Michael/0000-0002-8054-2947	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) [R01CA186935]; NATIONAL CANCER INSTITUTE [R01CA186935] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant R01CA186935 (to A.J.W. and P.I.). A.J.W. owns shares in Terpenoid Therapeutics, Coralville, IA, USA. The current work did not involve Terpenoid Therapeutics. The remaining authors have no conflicts of interest.	Adams EJ, 2015, CELL IMMUNOL, V296, P31, DOI 10.1016/j.cellimm.2015.04.008; Ali Z, 2009, J IMMUNOL, V183, P5407, DOI 10.4049/jimmunol.0901760; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; Boedec A, 2008, J MED CHEM, V51, P1747, DOI 10.1021/jm701101g; BORN WK, 1991, FASEB J, V5, P2699, DOI 10.1096/fasebj.5.12.1717333; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hsiao CHC, 2014, CHEM BIOL, V21, P945, DOI 10.1016/j.chembiol.2014.06.006; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; Kilcollins AM, 2016, J IMMUNOL, V197, P419, DOI 10.4049/jimmunol.1501833; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Nada MH, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0209-6; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Peigne CM, 2017, J IMMUNOL, V198, P4228, DOI 10.4049/jimmunol.1601910; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Puthenveetil R, 2017, NANOTECHNOL REV, V6, P111, DOI 10.1515/ntrev-2016-0076; Puthenveetil R, 2013, PROTEINS, V81, P1222, DOI 10.1002/prot.24271; Reichenberg A, 2003, BIOORG MED CHEM LETT, V13, P1257, DOI 10.1016/S0960-894X(03)00138-0; Rhodes DA, 2015, J IMMUNOL, V194, P2390, DOI 10.4049/jimmunol.1401064; Riano F, 2014, EUR J IMMUNOL, V44, P2571, DOI 10.1002/eji.201444712; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Santolaria T, 2013, J IMMUNOL, V191, P1993, DOI 10.4049/jimmunol.1300255; Sebestyen Z, 2016, CELL REP, V15, P1973, DOI 10.1016/j.celrep.2016.04.081; Seo M, 2016, P NATL ACAD SCI USA, V113, P14390, DOI 10.1073/pnas.1615287113; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shippy RR, 2017, J MED CHEM, V60, P2373, DOI 10.1021/acs.jmedchem.6b00965; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang H, 2015, J IMMUNOL, V195, P4583, DOI 10.4049/jimmunol.1500314; Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697; Wiemer AJ, 2010, CURR TOP MED CHEM, V10, P1858; Wiemer AJ, 2009, ANTI-CANCER AGENT ME, V9, P526, DOI 10.2174/187152009788451860; Wiemer DF, 2014, BIOCHEM PHARMACOL, V89, P301, DOI 10.1016/j.bcp.2014.03.009; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	47	33	34	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4697	4706		10.1096/fj.201601370RR	http://dx.doi.org/10.1096/fj.201601370RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705810	Green Published			2022-12-26	WOS:000413398500004
J	Chen, JF; Wu, QS; Xie, YX; Si, BL; Yang, PP; Wang, WY; Hua, Q; He, Q				Chen, Jun-Feng; Wu, Qi-Shun; Xie, Yu-Xian; Si, Bo-Lin; Yang, Ping-Ping; Wang, Wen-Yan; Hua, Qin; He, Qing			TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria	FASEB JOURNAL			English	Article						apoptosis; extracellular matrix; mitochondrial DNA; mitofilin; reactive oxygen species	COLORECTAL-CARCINOMA; METABOLIC SWITCH; OXIDATIVE STRESS; CHAPERONE TRAP1; APOPTOSIS; MITOFILIN; INJURY; PROTEIN; OVEREXPRESSION; CARDIOMYOCYTES	Mitochondrial dysfunction causes renal tubular epithelial cell injury and promotes cell apoptosis and renal tubulointerstitial fibrosis (TIF) progression. TNF receptor-associated protein 1 (TRAP1) is a molecular chaperone protein that is localized in mitochondria. It plays an important role in cell apoptosis; however, its functional mechanism in TIF remains unclear. In this study, we observed the effects of TRAP1 in renal tubular epithelial cell mitochondria in mice with unilateral ureteral obstruction and its function in cell apoptosis and TIF. Results show that TRAP1 could protect the mitochondrial structure in renal tubular epithelial cells; maintain the levels of mitochondrial membrane potential, ATP, and mitochondrial DNA copy number; inhibit reactive oxygen species production; stabilize the expression of the mitochondrial inner membrane protein mitofilin; reduce renal tubular epithelial cell apoptosis; and inhibit TIF. These results provide new theoretical foundations for additional understanding of the antifibrotic mechanism of TRAP1 in the kidney.-Chen, J.-F., Wu, Q.-S., Xie, Y.-X., Si, B.-L., Yang, P.-P., Wang, W.-Y., Hua, Q., He, Q. TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria.	[Chen, Jun-Feng; He, Qing] Nanjing Med Univ, Nanjing Hosp 1, Div Hemodialysis, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China; [Wu, Qi-Shun; Si, Bo-Lin; Yang, Ping-Ping; Wang, Wen-Yan; Hua, Qin] Jiangsu Univ, Affiliated Hosp, Div Nephrol, Zhenjiang, Peoples R China; [Xie, Yu-Xian] Jiangsu Univ, Peoples Hosp Suzhou High Tech Dist, Div Nephrol, Suzhou, Peoples R China	Nanjing Medical University; Jiangsu University; Jiangsu University	Chen, JF (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Div Hemodialysis, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	njchenjf@sina.com			National Natural Science Foundation of China [81400743]; Medical Science and Technology Development Foundation (Nanjing Department of Health) [JQX16027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Foundation (Nanjing Department of Health)	This study was supported by grants from the National Natural Science Foundation of China (81400743) and the Medical Science and Technology Development Foundation (Nanjing Department of Health; JQX16027). The authors declare no conflicts of interest.	Agorreta J, 2014, MOL CANCER RES, V12, P660, DOI 10.1158/1541-7786.MCR-13-0481; Bhreathnach U, 2017, BBA-MOL BASIS DIS, V1863, P896, DOI 10.1016/j.bbadis.2017.01.015; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Condelli V, 2015, ONCOTARGET, V6, P22298, DOI 10.18632/oncotarget.4263; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Im CN, 2016, CELL STRESS CHAPERON, V21, P553, DOI 10.1007/s12192-016-0687-3; Ix JH, 2015, J AM SOC NEPHROL, V26, P2494, DOI 10.1681/ASN.2014070696; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kadye R, 2014, IUBMB LIFE, V66, P42, DOI 10.1002/iub.1234; Kramer S, 2009, AM J PHYSIOL-RENAL, V297, pF218, DOI 10.1152/ajprenal.90617.2008; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lettini G, 2016, CELL DEATH DIFFER, V23, P1792, DOI 10.1038/cdd.2016.67; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Masgras I, 2017, CELL REP, V18, P659, DOI 10.1016/j.celrep.2016.12.056; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Noh YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.341; Palladino G, 2016, ENDOCR-RELAT CANCER, V23, P699, DOI 10.1530/ERC-16-0063; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Romanov V, 2011, APOPTOSIS, V16, P1217, DOI 10.1007/s10495-011-0646-5; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Suzuki T, 2016, J AM SOC NEPHROL, V27, P1925, DOI 10.1681/ASN.2015060623; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Thapa D, 2015, J MOL CELL CARDIOL, V79, P212, DOI 10.1016/j.yjmcc.2014.11.008; Tian X, 2014, FEBS J, V281, P2805, DOI 10.1111/febs.12822; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Wang C, 2013, FREE RADICAL BIO MED, V65, P1417, DOI 10.1016/j.freeradbiomed.2013.10.005; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Yang RF, 2012, BIOCHEM BIOPH RES CO, V428, P93, DOI 10.1016/j.bbrc.2012.10.012; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang P, 2015, CELL PHYSIOL BIOCHEM, V36, P2072, DOI 10.1159/000430174	39	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4503	4514		10.1096/fj.201700283R	http://dx.doi.org/10.1096/fj.201700283R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28710113				2022-12-26	WOS:000413397400027
J	Schubert, LF; Kruger, S; Moritz, GB; Schubert, V				Schubert, Lea F.; Krueger, Stephanie; Moritz, Gerald B.; Schubert, Veit			Male reproductive system and spermatogenesis of Limodromus assimilis (Paykull 1790)	PLOS ONE			English	Article							SPERM-BUNDLES; COLEOPTERA CARABIDAE; ACCESSORY-GLANDS; ULTRASTRUCTURE; MORPHOLOGY; SPERMATOZOON; DIVERSITY; EVOLUTION; ORGANS	Based on advanced light and electron microscopy, we describe the male reproductive system and sperm development of Limodromus assimilis. The genital tract consists of pairs of uni-follicular testes, spermatic ducts with diverticula regions, seminal vesicles, accessory glands, an unpaired ejaculatory duct and an aedeagus containing an internal sac equipped with sclerotic scales. Based on their morphology, we draw conclusions about their functions. After spermatogenesis within the follicle, the spermatozoa become released from the sperm cysts. The single spermatozoa move into the diverticula of the vasa deferentia I. Here, they become attached to central rods (spermatostyles), forming secondary conjugates (spermiozeugmata). The coordinated flagella movement of the conjugates possibly improves sperm velocity. Using super-resolution microscopy, we identified highly condensed reticulate chromatin in the lancet-shaped spermatozoa heads and the mitochondrial derivates of the flagella, likely formed by genomic and mitochondrial DNA, respectively. The results show, for the first time, sperm bundle formation in a Platynini species mainly corresponding to that found in Pterostichini species.	[Schubert, Lea F.; Krueger, Stephanie; Moritz, Gerald B.] Martin Luther Univ Halle Wittenberg, Halle, Germany; [Schubert, Veit] Leibniz Inst Plant Genet & Crop Plant Res IPK, Seeland, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schubert, V (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Seeland, Germany.	schubertv@ipk-gatersleben.de		Schubert, Veit/0000-0002-3072-0485; Kruger, Stephanie/0000-0002-7159-8316				ANDERSON JM, 1950, BIOL BULL, V99, P49, DOI 10.2307/1538751; Ballowitz E, 1916, BIOL ZBL, V36, P209; BAWA SR, 1975, EXPERIENTIA, V31, P684, DOI 10.1007/BF01944627; Bock C, 1987, BEITR ELEKTRONENMIKR, V20, P209; BRELAND O P, 1970, Entomological News, V81, P101; Cadeddu B., 2008, STRATEGIE MONITORAGG; Carcupino M, 2002, PROCEEDING OF 9TH INTERNATIONAL SYMPOSIUM ON SPERMATOLOGY, P31; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P257, DOI 10.1016/j.asd.2014.04.002; DELOOF A, 1972, Z ZELLFORSCH MIK ANA, V130, P545; Dettner K, 2010, LEHRBUCH ENTOMOLOGIE; Dias G, 2015, MICRON, V73, P21, DOI 10.1016/j.micron.2015.03.003; Ferenz H.-J., 1986, P147; Ferraguti M, 2006, TISSUE CELL, V38, P1, DOI 10.1016/j.tice.2005.05.001; FREUDE H., 1976, KAFER MITTELEUROPAS, V2; Fritzsch D, 2013, THESIS, P23; Gilbert O., 1956, N WALES, V7, P22; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gilson G., 1884, CELLULE, VI, P84; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HAPP GM, 1992, ANNU REV ENTOMOL, V37, P303, DOI 10.1146/annurev.en.37.010192.001511; Hayashi F, 1998, FUNCT ECOL, V12, P347, DOI 10.1046/j.1365-2435.1998.00205.x; Hayashi F, 1997, INT J INSECT MORPHOL, V26, P63, DOI 10.1016/S0020-7322(96)00023-2; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Hodgson AN, 2013, INVERTEBR REPROD DEV, V57, P120, DOI 10.1080/07924259.2012.695295; ISHIKAWA R, 1973, Bulletin of the National Science Museum (Tokyo), V16, P191; Jamieson B.G., 1987, ULTRASTRUCTURE PHYLO; Kaulenas MS, 1992, INSECT ACCESSORY REP, p[3, 123]; Koch D., 1986, P267; Kruger S, 2014, INVERTEBR REPROD DEV, V58, P75, DOI 10.1080/07924259.2013.822835; Lawrence J.F., 1991, P543; Loser S, 1973, VERHANDLUNGEN DTSCH, V66, P83; MACKIE JB, 1974, CELL TISSUE RES, V148, P505; Opitz W, 2003, COLEOPTS BULL, V57, P167, DOI 10.1649/0010-065X(2003)057[0167:SSPIOO]2.0.CO;2; Paoli F, 2014, TISSUE CELL, V46, P274, DOI 10.1016/j.tice.2014.06.003; PHILLIPS DM, 1970, J CELL BIOL, V44, P243, DOI 10.1083/jcb.44.2.243; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; PRATT SA, 1968, J MORPHOL, V126, P31, DOI 10.1002/jmor.1051260104; Romeis B, 2010, MIKROSKOPISCHE TECHN, P214; Sasakawa K, 2008, ENTOMOL SCI, V11, P415, DOI 10.1111/j.1479-8298.2008.00289.x; Sasakawa K, 2007, NATURWISSENSCHAFTEN, V94, P384, DOI 10.1007/s00114-006-0200-4; SHARP D, 1912, T ROYAL ENTOMOLOGICA, V60, P477, DOI DOI 10.1111/J.1365-2311.1912.TB03107.X; Skinner BM, 2017, CHROMOSOMA, V126, P195, DOI 10.1007/s00412-016-0614-5; Snodgrass RE, 1993, PRINCIPLES INSECT MO, DOI DOI 10.7591/J.CTV1NHM1J; SPICER S. S., 1960, TECH BULL REG MED TECHNOL, V30, P53; Takami Y, 2002, ZOOL SCI, V19, P1067, DOI 10.2108/zsj.19.1067; Takami Y, 2007, NATURWISSENSCHAFTEN, V94, P543, DOI 10.1007/s00114-007-0225-3; Temkin MH, 2004, BIOL BULL-US, V206, P35, DOI 10.2307/1543196; Viscuso R, 1998, TISSUE CELL, V30, P453, DOI 10.1016/S0040-8166(98)80059-1; Weisshart K.D., 2016, BIOPROTOC, V6, pe1725, DOI [10.21769/BioProtoc.1725, DOI 10.21769/BIOPROTOC.1725, DOI 10.21769/BioProtoc.1725]; WERNER G, 1965, Z ZELLFORSCH MIK ANA, V66, P255, DOI 10.1007/BF00344339; Will KW, 2005, J MORPHOL, V264, P75, DOI 10.1002/jmor.10319; WITZ BW, 1990, INVERTEBR REPROD DEV, V18, P197, DOI 10.1080/07924259.1990.9672144; Wolfer M., 2010, THESIS, P31; Wu YF, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew116	56	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180492	10.1371/journal.pone.0180492	http://dx.doi.org/10.1371/journal.pone.0180492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723911	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800016
J	Jesus, TF; Moreno, JM; Repolho, T; Athanasiadis, A; Rosa, R; Almeida-Val, VMF; Coelho, MM				Jesus, Tiago F.; Moreno, Joao M.; Repolho, Tiago; Athanasiadis, Alekos; Rosa, Rui; Almeida-Val, Vera M. F.; Coelho, Maria M.			Protein analysis and gene expression indicate differential vulnerability of Iberian fish species under a climate change scenario	PLOS ONE			English	Article							GUANYLATE-BINDING PROTEIN-1; FRESH-WATER; TEMPERATURE; ACIDIFICATION; EVOLUTIONARY; RESPONSES; IMPACTS; BIODIVERSITY; TORGALENSIS; PHYSIOLOGY	Current knowledge on the biological responses of freshwater fish under projected scenarios of climate change remains limited. Here, we examine differences in the protein configuration of two endemic Iberian freshwater fish species, Squalius carolitertii and the critically endangered S. torgalensis that inhabit in the Atlantic-type northern and in the Mediterranean-type southwestern regions, respectively. We performed protein structure modeling of fourteen genes linked to protein folding, energy metabolism, circadian rhythms and immune responses. Structural differences in proteins between the two species were found for HSC70, FKBP52, HIF1 alpha and GPB1. For S. torgalensis, besides structural differences, we found higher thermostability for two proteins (HSP90 and GBP1), which can be advantageous in a warmer environment. Additionally, we investigated how these species might respond to projected scenarios of 3 degrees climate change warming, acidification (Delta pH = -0.4), and their combined effects. Significant changes in gene expression were observed in response to all treatments, particularly under the combined warming and acidification. While S. carolitertii presented changes in gene expression for multiple proteins related to folding (hsp90aa1, hsc70, fkbp4 and stip1), only one such gene was altered in S. torgalensis (stip1). However, S. torgalensis showed a greater capacity for energy production under both the acidification and combined scenarios by increasing cs gene expression and maintaining ldha gene expression in muscle. Overall, these findings suggest that S. torgalensis is better prepared to cope with projected climate change. Worryingly, under the simulated scenarios, disturbances to circadian rhythm and immune system genes (cry1aa, per1a and gbp1) raise concerns for the persistence of both species, highlighting the need to consider multi-stressor effects when evaluating climate change impacts upon fish. This work also highlights that assessments of the potential of endangered freshwater species to cope with environmental change are crucial to help decision-makers adopt future conservation strategies.	[Jesus, Tiago F.; Moreno, Joao M.; Coelho, Maria M.] Univ Lisbon, Ctr Ecol Evolucao & Alteracaes Ambientais, Fac Ciencias, Lisbon, Portugal; [Repolho, Tiago; Rosa, Rui] Univ Lisbon, Lab Maritimo Guia, MARE Ctr Ciencias Mar & Ambiente, Fac Ciencias, Ave Nossa Senhora Cabo, Cascais, Portugal; [Athanasiadis, Alekos] Inst Gulbenkian Ciencias, Rua Quinta Grande, Oeiras, Portugal; [Almeida-Val, Vera M. F.] INPA, Lab Ecofisiol & Evolucao Mol, Manaus, AM, Brazil	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Institute Nacional de Pesquisas da Amazonia	Jesus, TF (corresponding author), Univ Lisbon, Ctr Ecol Evolucao & Alteracaes Ambientais, Fac Ciencias, Lisbon, Portugal.	tfjesus@fc.ul.pt	Moreno, João M/M-1651-2017; Athanasiadis, Alekos/F-2038-2011; Rosa, Rui/A-4580-2009; Coelho, Maria M/B-8672-2009; Repolho, Tiago/C-8975-2009; de Jesus, Tiago Filipe Salgueiro/J-1765-2019; Almeida-Val, Vera/J-5818-2014	Moreno, João M/0000-0002-2004-7442; Athanasiadis, Alekos/0000-0003-1526-0000; Rosa, Rui/0000-0003-2801-5178; Coelho, Maria M/0000-0003-3288-1693; Repolho, Tiago/0000-0002-1048-8009; de Jesus, Tiago Filipe Salgueiro/0000-0001-8054-4136; Almeida-Val, Vera/0000-0001-7038-5266	Fundacao para a Ciencia e Tecnologia [SFRH/BD/73801/2010]; FCT fellowship [SFRH/BD/73801/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT fellowship(Portuguese Foundation for Science and Technology)	The experimental procedures of this study were financially supported by the PhD fellowship SFRH/BD/73801/2010 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt).; We thank Isa Matos, Miguel Machado, Miguel Santos and Joana Pinho for their help in fieldwork. We thank two anonymous reviewers, Vitor Sousa and Margarida Matos for their helpful comments and suggestions on the manuscript. We also acknowledge ICNF (Instituto da Conservacao da Natureza e Florestas) for issuing the fishing licenses. This work was supported by the FCT fellowship SFRH/BD/73801/2010 to Tiago F. Jesus.	Almeida-Val VMF, 2015, MOL ECOL RESOUR, V15, P1256, DOI 10.1111/1755-0998.12439; Alvarez P, 2015, MOL ECOL RESOUR, V15, P1510, DOI 10.1111/1755-0998.12454; Amaral IPG, 2012, AM J PHYSIOL-REG I, V302, pR193, DOI 10.1152/ajpregu.00367.2011; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aurelio M, 2013, MAR BIOL, V160, P2663, DOI 10.1007/s00227-013-2259-8; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Boersma M, 2016, ECOL LETT, V19, P45, DOI 10.1111/ele.12541; Buxbaum E., 2007, PROTEIN STRUCTURE FU, P15; Campos DF, 2017, HYDROBIOLOGIA, V789, P133, DOI 10.1007/s10750-016-2649-2; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; Coelho MM, 1998, J FISH BIOL, V52, P937, DOI 10.1006/jfbi.1998.0642; Cornish -Bowden A., 2013, FUNDAMENTALS ENZYME; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Doadrio I., 1988, Senckenbergiana Biologica, V68, P301; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Field C.B., 2014, CLIMATE CHANGE 2014, P1132; Fussel H-M, 2012, EEA REPORT; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hartmann DL, 2013, WORKING GROUP CONTRI; Henriques R, 2010, CONSERV GENET, V11, P1859, DOI 10.1007/s10592-010-0078-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Idda ML, 2012, PROG BRAIN RES, V199, P41, DOI 10.1016/B978-0-444-59427-3.00003-4; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Jesus TF, 2013, GENET MOL BIOL, V36, P61, DOI 10.1590/S1415-47572013000100009; Jesus TF, 2016, J THERM BIOL, V55, P54, DOI 10.1016/j.jtherbio.2015.11.009; Cisneros BEJ, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P229; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Lake PS, 2000, BIOSCIENCE, V50, P1099, DOI 10.1641/0006-3568(2000)050[1099:GCATBO]2.0.CO;2; Leduc AOHC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0447; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lu Yin-ping, 2007, Virologica Sinica, V22, P193, DOI 10.1007/s12250-007-0021-4; Magalhaes MF, 2003, J FISH BIOL, V63, P300, DOI 10.1046/j.1095-8649.2003.00148.x; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McCairns RJS, 2016, EVOL APPL, V9, P531, DOI 10.1111/eva.12363; Mesquita N, 2007, J FISH BIOL, V71, P45, DOI 10.1111/j.1095-8649.2007.01518.x; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munoz NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1082; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ou M, 2015, NAT CLIM CHANGE, V5, P950, DOI 10.1038/NCLIMATE2694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pimentel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134082; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Prado-Lima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152366; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Rosa R, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2840-z; Rosa R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1738; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scammell JG, 2003, GENOMICS, V81, P640, DOI 10.1016/S0888-7543(03)00090-9; Schunter C, 2016, NAT CLIM CHANGE, V6, P1014, DOI 10.1038/NCLIMATE3087; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero GN, 2011, AM J PHYSIOL-REG I, V301, pR1, DOI 10.1152/ajpregu.00719.2010; Sorensen JG, 2009, J THERM BIOL, V34, P49, DOI 10.1016/j.jtherbio.2008.10.004; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Trifonov EN, 2003, CURR OPIN STRUC BIOL, V13, P110, DOI 10.1016/S0959-440X(03)00005-8; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Vinagre C, 2013, REG ENVIRON CHANGE, V13, P853, DOI 10.1007/s10113-012-0376-4; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1	78	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181325	10.1371/journal.pone.0181325	http://dx.doi.org/10.1371/journal.pone.0181325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719655	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400039
J	Luciano, CS; Newell, SJ				Luciano, Carl S.; Newell, Sandra J.			Effects of prey, pitcher age, and microbes on acid phosphatase activity in fluid from pitchers of Sarracenia purpurea (Sarraceniaceae)	PLOS ONE			English	Article							BACTERIAL DIVERSITY; CARNIVOROUS PLANTS; WONDERFUL PLANTS; NEPENTHES; STOICHIOMETRY; EXPRESSION; MUTUALISM; COMMUNITY; DISTINCT; ENZYMES	Carnivory in pitcher plants generally involves digestion of prey, by the plant itself, by symbionts, or both. While symbionts appear to be important in the digestion of prey in Sarracenia purpurea, the importance of pitcher-derived enzymes is less well documented. Our goal was to reduce microbial numbers in pitcher fluid in order to measure the acid phosphatase activity attributable to the pitchers themselves. Preliminary experiments indicated that various antibiotics were minimally effective at reducing microbial populations and that antibioticresistant microbes were easily cultured from pitcher fluid. Consequently, we measured the abundance of culturable microbes in every sample taken for the measurement of acid phosphatase activity. Pitchers fed with one sterilized ant had higher levels of acid phosphatase activity than unfed pitchers. Older pitchers were more responsive to feeding than young pitchers. Pitchers with high levels of microbes (on Day 5) had higher acid phosphatase activity than pitchers with low levels of microbes. However, fed pitchers were not more likely to have higher microbe levels and microbe levels were not related to pitcher age. When fluid samples from inside the pitcher were compared to appropriate controls incubated outside the pitcher, acid phosphatase activity was higher inside the pitcher. Results from the feeding experiments are consistent with a primary role of microbes in the digestion of prey in pitchers of S. purpurea. However, the relationship between pitcher age and enzyme activity is not a function of microbes in the pitcher fluid and may depend on enzymes produced by the plant. Our methods would not detect microbes embedded on the inner surface of the pitcher; and if they survived the alcohol rinse and antibiotics, we cannot rule out microbes as the source of the relationship between pitcher age and acid phosphatase activity.	[Luciano, Carl S.; Newell, Sandra J.] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA	Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Luciano, CS (corresponding author), Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA.	luciano@iup.edu			IUP Senate; IUP School of Graduate Studies	IUP Senate; IUP School of Graduate Studies	The authors CSL and SJN received funding from the IUP Senate (http://www.iup.edu/senate/committees/research/) and the IUP School of Graduate Studies (http://www.iup.edu/graduatestudies/) to support this work but no specific grant numbers were associated with the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adamec L, 2011, CELL ORIG LIFE EXTRE, V16, P457; ADAMS RM, 1977, AM J BOT, V64, P265, DOI 10.2307/2441969; Adlassnig W, 2011, ANN BOT-LONDON, V107, P181, DOI 10.1093/aob/mcq238; Anderson B, 2003, OIKOS, V102, P221, DOI 10.1034/j.1600-0706.2003.12478.x; Buch F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118853; Buch F, 2013, ANN BOT-LONDON, V111, P375, DOI 10.1093/aob/mcs287; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CHAPIN CT, 1995, CAN J BOT, V73, P728, DOI 10.1139/b95-079; Chase MW, 2009, BOT J LINN SOC, V161, P329, DOI 10.1111/j.1095-8339.2009.01014.x; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Deubel A, 2005, SOIL BIOL, V3, P177; Ellison AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039291; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Fukushima K, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0059; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Givnish TJ, 2015, P NATL ACAD SCI USA, V112, P10, DOI 10.1073/pnas.1422278112; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gray SM, 2012, AQUAT ECOL, V46, P487, DOI 10.1007/s10452-012-9417-9; Harvey E, 1996, OECOLOGIA, V108, P562, DOI 10.1007/BF00333734; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hepburn JS, 1927, T WAGNER FREE I SCI, V11, P75; HEPBURN JS, 1927, T WAGNER FREE I SCI, V11, P49; HIGASHI S, 1993, J PLANT RES, V106, P47, DOI 10.1007/BF02344372; Hoekman D, 2011, OECOLOGIA, V165, P1073, DOI 10.1007/s00442-010-1802-2; JAFFE K, 1992, NEW PHYTOL, V122, P733; JENTSCH J, 1972, FEBS LETT, V21, P273, DOI 10.1016/0014-5793(72)80181-9; Joel D.M., 1986, P219; Kneitel JM, 2007, J ANIM ECOL, V76, P651, DOI 10.1111/j.1365-2656.2007.01250.x; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; Krol E, 2012, ANN BOT-LONDON, V109, P47, DOI 10.1093/aob/mcr249; Miller TE, 2002, COMMUNITY ECOL, V3, P109, DOI 10.1556/ComEc.3.2002.1.13; Mouquet N, 2008, FUNCT ECOL, V22, P728, DOI 10.1111/j.1365-2435.2008.01421.x; Peeples CR, 2013, EC SOC AM 98 ANN M A; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Plachno BJ, 2006, PLANT BIOLOGY, V8, P813, DOI 10.1055/s-2006-924177; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Robinson W.J., 1908, TORREYA, V8, P181; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Stauffer RE, 1987, P ROCHESTER ACAD SCI, V15, P181; Strojsova A, 2003, EUR J PHYCOL, V38, P295, DOI 10.1080/09670260310001612628; TOKES ZA, 1974, PLANTA, V119, P39, DOI 10.1007/BF00390820; Tran MPT., 2015, THESIS; Trzcinski MK, 2003, ECOL ENTOMOL, V28, P482, DOI 10.1046/j.1365-2311.2003.00530.x; Wakefield AE, 2005, ECOLOGY, V86, P1737, DOI 10.1890/04-1673	51	11	11	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181252	10.1371/journal.pone.0181252	http://dx.doi.org/10.1371/journal.pone.0181252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719666	gold, Green Published, Green Submitted			2022-12-26	WOS:000406061400036
J	Dou, LL; Jia, XY; Wei, HL; Fan, SL; Wang, HT; Guo, YN; Duan, S; Pang, CY; Yu, SX				Dou, Lingling; Jia, Xiaoyun; Wei, Hengling; Fan, Shuli; Wang, Hantao; Guo, Yaning; Duan, Shan; Pang, Chaoyou; Yu, Shuxun			Global analysis of DNA methylation in young (J1) and senescent (J2) Gossypium hirsutum L. cotyledons by MeDIP-Seq	PLOS ONE			English	Article							PLANT SENESCENCE; LEAF SENESCENCE; CPG-ISLANDS; GENOME; GENE; TRANSCRIPTOME; EXPRESSION; RNA; DEMETHYLATION; PATTERNS	DNA methylation is an important epigenetic modification regulating gene expression, genomic imprinting, transposon silencing and chromatin structure in plants and plays an important role in leaf senescence. However, the DNA methylation pattern during Gossypium hirsutum L. cotyledon senescence is poorly understood. In this study, global DNA methylation patterns were compared between two cotyledon development stages, young (J1) and senescence (J2), using methylated DNA immunoprecipitation (MeDIP-Seq). Methylated cytosine occurred mostly in repeat elements, especially LTR/Gypsy in both J1 and J2. When comparing J1 against J2, there were 1222 down-methylated genes and 623 up-methylated genes. Methylated genes were significantly enriched in carbohydrate metabolism, biosynthesis of other secondary metabolites and amino acid metabolism pathways. The global DNA methylation level decreased from J1 to J2, especially in gene promoters, transcriptional termination regions and regions around CpG islands. We further investigated the expression patterns of 9 DNA methyltransferase-associated genes and 2 DNA demethyl-transferase-associated genes from young to senescent cotyledons, which were down-regulated during cotyledon development. In this paper, we first reported that senescent cotton cotyledons exhibited lower DNA methylation levels, primarily due to decreased DNA methyltransferase activity and which also play important role in regulating secondary metabolite process.	[Dou, Lingling; Jia, Xiaoyun; Wei, Hengling; Fan, Shuli; Wang, Hantao; Guo, Yaning; Duan, Shan; Pang, Chaoyou; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Dou, Lingling] Weinan Inst Agr Sci, Weinan, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Pang, CY; Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	chypang@163.com; ysx195311@163.com	Wang, Han/GPW-9809-2022		earmarked fund for China Agriculture Research System [CARS-18]	earmarked fund for China Agriculture Research System	We appreciate and thank the earmarked fund for China Agriculture Research System (CARS-18) for the financial support.; We appreciate and thank the earmarked fund for China Agriculture Research System (CARS-18) for the financial support.	Ay N, 2014, J EXP BOT, V65, P3875, DOI 10.1093/jxb/eru132; Baurens FC, 2004, TREE PHYSIOL, V24, P401, DOI 10.1093/treephys/24.4.401; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Diaz-Mendoza M, 2016, GENET MOL BIOL, V39, P329, DOI 10.1590/1678-4685-GMB-2016-0015; Dou LL, 2014, MOL GENET GENOMICS, V289, P1103, DOI 10.1007/s00438-014-0872-y; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Gim JA, 2015, MOL CELLS, V38, P210, DOI 10.14348/molcells.2015.2138; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Jin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060547; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0433-5; Lin MH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/798631; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mankessi F, 2011, PHYSIOL PLANTARUM, V143, P178, DOI 10.1111/j.1399-3054.2011.01491.x; Michalak M, 2015, ANN BOT-LONDON, V116, P369, DOI 10.1093/aob/mcv104; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Osabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086049; Ouyang B, 2012, PLANT MOL BIOL, V79, P315, DOI 10.1007/s11103-012-9914-1; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Permar V, 2014, PHYSIOL MOL PLANT P, V88, P77, DOI 10.1016/j.pmpp.2014.09.004; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Schippers JHM, 2015, CURR OPIN PLANT BIOL, V27, P77, DOI 10.1016/j.pbi.2015.06.018; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shah ST, 2014, PLANT CELL TISS ORG, V117, P167, DOI 10.1007/s11240-014-0430-7; Shakeel A, 2012, J ANIM PLANT SCI, V22, P722; Shi J, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00803; Song QX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005724; Su JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-12; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Wang K, 2016, SCI CHINA LIFE SCI, V59, P112, DOI 10.1007/s11427-015-4928-y; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Watson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105338; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yan HX, 2015, RICE, V8, P1, DOI 10.1186/s12284-015-0047-4; Yang HX, 2015, PLANT J, V81, P268, DOI 10.1111/tpj.12726; Yuan JL, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036126; Zhu MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep07693	53	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0179141	10.1371/journal.pone.0179141	http://dx.doi.org/10.1371/journal.pone.0179141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM3TT	28715427	Green Published, gold, Green Submitted			2022-12-26	WOS:000414932400001
J	von der Beck, D; Seeger, W; Herold, S; Gunther, A; Loh, B				von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin			Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data	PLOS ONE			English	Article							A H1N1 VIRUS; INFECTION; A(H1N1); PREGNANCY; ILLNESS; DEATH; 1ST	Rationale From June of 2009 to August of 2010 the influenza subtype H1N1pdm09 caused a worldwide pandemic. The impact on populations and health care systems around the globe evolved differently. Substantial data come from the German national surveillance network in an outpatient and private practice setting, while information on hospitalized patients in Germany is rather limited. Methods Data from the Federal Statistics Office comprising health insurance claims of the entire nationwide inpatient sample from 2005 to 2012 were used to identify patients who were hospitalized for laboratory-confirmed influenza and to analyse demographical aspects, comorbidities, hospitalization duration, outcomes and ventilator use during the pandemic and seasonal waves of influenza. Measurements and main results A number of 34,493 admissions for laboratory-confirmed influenza occurred during waves between 2005 and 2012. During the pandemic seasonal waves, the number of hospitalizations vastly surpassed the level that was seen in any of the seasonal waves. A major demographic shift was seen with respect to patient age, as younger patients (< 60 years old) were more frequently hospitalized. Mean length of stay was shorter (149 vs. 193 hours), mean time on ventilation tended to be shorter (261 vs. 305 hours) in young children (< 4 years old) and longer (393 vs. 339 hours) in the elderly (> 60 years old). Time to ventilation was shorter in non-fatal cases (328 vs. 349 hours) and longer in fatal cases (419 vs. 358 hours). Logistic regression was used to show the impact of comorbidities and co-diagnoses on mortality and the need for ventilation, as well as differences between pandemic and seasonal influenza. Conclusions Inpatient data suggest differences in patient populations during pandemic and seasonal influenza. Younger patients were more frequently hospitalized. Differences with respect to the presence of certain comorbidities and co-diagnoses, length of stay, time to ventilation and ventilation time could be identified.	[von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin] Univ Giessen, Giessen, Germany; [von der Beck, Daniel; Seeger, Werner; Herold, Susanne; Guenther, Andreas; Loeh, Benjamin] German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Giessen, Germany; [Guenther, Andreas; Loeh, Benjamin] Agaples Lung Clin Waldhof Elgershausen, Greifensstein, Germany	Justus Liebig University Giessen	von der Beck, D (corresponding author), Univ Giessen, Giessen, Germany.; von der Beck, D (corresponding author), German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Giessen, Germany.	daniel.vdbeck@outlook.de		Herold, Susanne/0000-0001-6343-0911; Seeger, Werner/0000-0003-1946-0894				Adlhoch C, 2012, INFLUENZA OTHER RESP, V6, pe162, DOI 10.1111/j.1750-2659.2012.00404.x; Balanzat AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033670; Becker A, 2007, MDK AUTWANDSPAUSCHAL, V76, P508; Buda S, 2010, BUNDESGESUNDHEITSBLA, V53, P1223, DOI 10.1007/s00103-010-1158-0; Buda S, 2010, BERICHT EPIDEMIOLOGI; Chen CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024440; Chowell G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/914196; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; CULLEN G, 2009, EURO SURVEILL, V14; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Hansen C, 2012, J INFECT DIS, V206, P1260, DOI 10.1093/infdis/jis488; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Louie JK, 2010, NEW ENGL J MED, V65, P227, DOI DOI 10.1097/01.0GX.0000371713.49382.2F; Pebody RG, 2010, EUROSURVEILLANCE, V15; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; VAILLANT L, 2009, EURO SURVEILL, V14; van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI DOI 10.1111/IRV.12074; Widgren K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013939; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2015, MAN EST DIS BURD ASS; World Health Organization, 2009, WHO GUID DOC; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125447; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180920	10.1371/journal.pone.0180920	http://dx.doi.org/10.1371/journal.pone.0180920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708896	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800029
J	An, XP; Song, YX; Hou, JX; Zhang, Y; Chen, KW; Ma, HD; Zhao, XY; Li, G; Gao, KX; Wang, S; Cao, BY; Bai, YY				An, Xiaopeng; Song, Yuxuan; Hou, Jinxing; Zhang, Yue; Chen, Kaiwen; Ma, Haidong; Zhao, Xinyan; Li, Guang; Gao, Kexin; Wang, Shan; Cao, Binyun; Bai, Yueyu			Chi-miR-4110 promotes granulosa cell apoptosis by targeting Sma- and Mad-related protein 2 (Smad2) in the caprine ovary	PLOS ONE			English	Article							EXPRESSION; MICRORNA; PROLIFERATION; LOCALIZATION; ATRESIA; GROWTH	Follicular atresia mainly results from the apoptosis of granulosa cells (GCs). Whilst our previous investigations examined the role of chi-miR-4110 in regulating ovarian function, the present study detected the role of chi-miR-4110 in GC development. We transfected caprine GCs cultured in vitro with chi-miR-4110 mimics. Results revealed that chi-miR-4110 decreased mRNA and protein levels of Smad2 by targeting its 3'-untranslated region (3'UTR). FoxC1 and Sp1 mRNA and protein levels markedly increased, whereas those of bHLHe22 significantly decreased (P< 0.01 or 0.05) in GCs transfected with the chi-miR-4110 mimics. Further studies revealed a significantly higher number of apoptotic cells in GCs transfected with the chi-miR-4110 mimics (P< 0.05) than in GCs transfected with mimics negative control. GCs transfected with the chi-miR-4110 mimics exhibited significantly increased mRNA and protein levels of the pro-apoptotic gene Bax (P< 0.01) and significantly decreased expression levels of the anti-apoptotic gene BCL-2 (P< 0.01). Smad2 interference (Si-1282) results were consistent with those of the chi-miR-4110 mimics. Previous reports and our results showed that chi-miR-4110 increases Sp1 expression by repressing Smad2. The increase in Sp1 induces p53-upregulated modulator of apoptosis, which increases the relative abundance of Bax and causes caprine GC apoptosis. Our findings may provide relevant data for the investigation of miRNA-mediated regulation of ovarian functions.	[An, Xiaopeng; Song, Yuxuan; Zhang, Yue; Chen, Kaiwen; Ma, Haidong; Li, Guang; Gao, Kexin; Wang, Shan; Cao, Binyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Hou, Jinxing] Yangling Vocat & Tech Coll, Anim Engn Branch, Yangling, Shaanxi, Peoples R China; [Zhao, Xinyan] Northwest A&F Univ, Northwest A&F Univ Hosp, Yangling, Shaanxi, Peoples R China; [Bai, Yueyu] Anim Hlth Supervis Inst Henan Prov, Zhengzhou, Henan, Peoples R China	Northwest A&F University - China; Yangling Vocational & Technical College; Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Bai, YY (corresponding author), Anim Hlth Supervis Inst Henan Prov, Zhengzhou, Henan, Peoples R China.	caobinyun@126.com; baiyueyu_56@163.com		Zhang, Yue/0000-0003-3568-0395	National Natural Science Foundation of China [31601925]; China Postdoctoral Science Foundation [2016T90954, 2014M552498]; Nature Science Foundation of Shaanxi Provincial [2015JM3087]; Shaanxi Science and Technology Innovation Project Plan [2015KTCQ03-08]; PhD Research Funding of Northwest AF University [2013BSJJ003]; Basic Research Funds of Northwest AF University [2452015029]; Shaanxi Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Shaanxi Provincial; Shaanxi Science and Technology Innovation Project Plan; PhD Research Funding of Northwest AF University; Basic Research Funds of Northwest AF University; Shaanxi Postdoctoral Science Foundation	This study was supported by the National Natural Science Foundation of China (31601925), China Postdoctoral Science Foundation (2016T90954 and 2014M552498), Nature Science Foundation of Shaanxi Provincial (2015JM3087), Shaanxi Science and Technology Innovation Project Plan (2015KTCQ03-08), PhD Research Funding of Northwest A&F University (2013BSJJ003), Basic Research Funds of Northwest A&F University (2452015029), and Shaanxi Postdoctoral Science Foundation.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; An XP, 2016, THERIOGENOLOGY, V85, P769, DOI 10.1016/j.theriogenology.2015.09.056; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bradford AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135163; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng JC, 2014, PLOS ONE, V10; Christenson L. K., 2010, Animal Reproduction, V7, P129; Fenwick MA, 2013, ENDOCRINOLOGY, V154, P3423, DOI 10.1210/en.2012-2251; Gebremedhn S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137539; Gebremedhn S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125912; Grossman H, 2015, FASEB J, V29, P3206, DOI 10.1096/fj.14-269449; Hopkins A, 2016, J CELL BIOCHEM, V117, P1707, DOI 10.1002/jcb.25464; Iwamune M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108997; Jiang LL, 2015, J CLIN ENDOCR METAB, V100, pE729, DOI 10.1210/jc.2014-3827; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liu JY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122788; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602; Maalouf SW, 2016, CELL TISSUE RES, V363, P7, DOI 10.1007/s00441-015-2307-4; Maeda A, 2007, J REPROD DEVELOP, V53, P481, DOI 10.1262/jrd.18149; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peng JY, 2016, DOMEST ANIM ENDOCRIN, V57, P108, DOI 10.1016/j.domaniend.2016.05.006; Peng JY, 2015, MOL CELL ENDOCRINOL, V412, P104, DOI 10.1016/j.mce.2015.06.001; Perdas E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060909; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Tian X, 2010, GENE EXPR PATTERNS, V10, P105, DOI 10.1016/j.gep.2010.02.003; Toms D, 2015, MOL CELL ENDOCRINOL, V399, P95, DOI 10.1016/j.mce.2014.07.022; Troppmann B, 2014, MOL CELL ENDOCRINOL, V390, P65, DOI 10.1016/j.mce.2014.04.003; Xing N, 2014, ACTA HISTOCHEM, V116, P1301, DOI 10.1016/j.acthis.2014.07.014; Yin MM, 2014, J BIOL CHEM, V289, P18239, DOI 10.1074/jbc.M113.546044; Zhao L, 2011, ACTA HISTOCHEM, V113, P771, DOI 10.1016/j.acthis.2010.11.005; Zhou JL, 2015, MOL CELL ENDOCRINOL, V409, P103, DOI 10.1016/j.mce.2015.03.012	41	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181162	10.1371/journal.pone.0181162	http://dx.doi.org/10.1371/journal.pone.0181162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704526	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700100
J	Sano, H; Goto, R; Hamashima, C				Sano, Hiroshi; Goto, Rei; Hamashima, Chisato			Does lack of resources impair access to breast and cervical cancer screening in Japan?	PLOS ONE			English	Article							TAILORED INTERVENTIONS; SOCIOECONOMIC-STATUS; COST-EFFECTIVENESS; COLLECTED SAMPLES; GEOGRAPHIC ACCESS; HEALTH-EDUCATION; CLINICAL-TRIAL; OLDER WOMEN; MAMMOGRAPHY; METAANALYSIS	Objectives To assess the impact of the quantity of resources for breast and cervical cancer screening on the participation rates in screening in clinical settings in municipalities, as well as to clarify whether lack of resources impairs access to cancer screening in Japan. Methods Of the 1,746 municipalities in 2010, 1,443 (82.6%) and 1,469 (84.1%) were included in the analyses for breast and cervical cancer screening, respectively. In order to estimate the effects of the number of mammography units and of gynecologists on the participation rates in breast and cervical cancer screening in clinical settings, multiple regression analyses were performed using the interaction term for urban municipalities. Results The average participation rate in screening in clinical settings was 6.01% for breast cancer, and was 8.93% for cervical cancer. The marginal effect of the number of mammography units per 1,000 women was significantly positive in urban municipalities (8.20 percent point). The marginal effect of the number of gynecologists per 1,000 women was significantly positive in all municipalities (2.54 percent point) and rural municipalities (3.68 percent point). Conclusions Lack of mammography units in urban areas and of gynecologists particularly in rural areas impaired access to breast and cervical cancer screening. Strategies are required that quickly improve access for the residents and increase their participation rates in cancer screening.	[Sano, Hiroshi] Shiga Univ, Fac Econ, Hikone, Shiga, Japan; [Goto, Rei] Keio Univ, Grad Sch Business Adm, Yokohama, Kanagawa, Japan; [Hamashima, Chisato] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Canc Screening Assessment & Management, Chuo Ku, Tokyo, Japan	Shiga University; Keio University; National Cancer Center - Japan	Sano, H (corresponding author), Shiga Univ, Fac Econ, Hikone, Shiga, Japan.	hi-sano@biwako.shiga-u.ac.jp	Hamashima, Chisato/AAI-3061-2021		Ministry of Health, Labour and Welfare of Japan [008]; Center for Risk Research, Faculty of Economics, Shiga University, Japan [1304]; Grants-in-Aid for Scientific Research [17H03589] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Center for Risk Research, Faculty of Economics, Shiga University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for H26-Research for Promotion of Cancer Control from the Ministry of Health, Labour and Welfare of Japan (Grant number: general study-008; URL: http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo/09.html), and the Center for Risk Research, Faculty of Economics, Shiga University, Japan (Grant number: 1304; URL: http://www.econ.shiga-u.ac.jp/main.cgi?c=10/2/6:28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Autier P, 2008, BRIT J CANCER, V99, P1185, DOI 10.1038/sj.bjc.6604657; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Baron RC, 2008, AM J PREV MED, V35, pS56, DOI 10.1016/j.amepre.2008.04.001; Blumenthal DS, 2010, CANCER-AM CANCER SOC, V116, P922, DOI 10.1002/cncr.24842; Champion V, 2003, PREV MED, V36, P150, DOI 10.1016/S0091-7435(02)00038-5; Crosby RA, 2015, SEX TRANSM DIS, V42, P607, DOI 10.1097/OLQ.0000000000000365; Dolan NC, 1999, ARCH INTERN MED, V159, P393, DOI 10.1001/archinte.159.4.393; Duport N, 2012, REV EPIDEMIOL SANTE, V60, P421, DOI 10.1016/j.respe.2012.05.006; Eguchi N, 2014, 331 JAP MED ASS RES, P331; Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb; Elting LS, 2009, AM J PREV MED, V37, P102, DOI 10.1016/j.amepre.2009.03.017; Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x; Fukuda Y, 2005, PUBLIC HEALTH, V119, P875, DOI 10.1016/j.puhe.2005.03.013; Fukuda Yoshiharu, 2007, Environmental Health and Preventive Medicine, V12, P90, DOI 10.1007/BF02898155; Giordano L, 2012, EUR J PUBLIC HEALTH, V22, P413, DOI 10.1093/eurpub/ckr090; Greene WH, 2000, ECONOMETRIC ANAL, P652; Hamashima C, 2010, JPN J CLIN ONCOL, V40, P485, DOI 10.1093/jjco/hyq036; Hashimoto S, 2008, CALCULATION METHODS; Ho SSM, 2014, PUBLIC HEALTH, V128, P1009, DOI 10.1016/j.puhe.2014.09.001; Kuroki H, 2012, J OBSTET GYNAECOL RE, V38, P35, DOI 10.1111/j.1447-0756.2011.01672.x; Lee FH, 2011, CANCER NURS, V34, P464, DOI 10.1097/NCC.0b013e31820b7866; Leung J, 2014, RURAL REMOTE HEALTH, V14; Maddala GS, 1983, LTD DEPENDENT QUALIT, P149; Ministry of Health Labour and Welfare, 2014, RES SURV REG IMPL CA; Ministry of Health Labour and Welfare, 2015, REP REG PUBL HLTH SE; National Cancer Center, 2014, JAP GUID BREAST CANC; National Cancer Center, 2009, JAP GUID CERV CANC S; New Medicine in Japan (Monthly), 2012, DAT BOOK MED DEV SYS; OECD, 2013, GYN OBST MIDW HLTH G; Okamoto N, 2014, J HLTH WELF STAT, V61, P13; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Racey CS, 2016, J WOMENS HEALTH, V25, P1; Reuben DB, 2002, AM J ROENTGENOL, V179, P1509, DOI 10.2214/ajr.179.6.1791509; RIMER BK, 1992, PUBLIC HEALTH REP, V107, P369; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009; Sano H, 2014, ASIAN PAC J CANCER P, V15, P2607, DOI 10.7314/APJCP.2014.15.6.2607; Saywell RM, 2003, AM J MANAG CARE, V9, P33; Saywell RM, 2004, J WOMENS HEALTH, V13, P909, DOI 10.1089/jwh.2004.13.909; Shariff-Marco S, 2013, AM J MANAG CARE, V19, P205; Shimada T, 2010, J GASTROENTEROLOGICA, V48, P655; Soneji S, 2013, REV PANAM SALUD PUBL, V33, P174, DOI 10.1590/S1020-49892013000300003; St-Jacques S, 2013, J EPIDEMIOL COMMUN H, V67, P861, DOI 10.1136/jech-2013-202614; Tabuchi T, 2013, INT J CANCER, V133, P972, DOI 10.1002/ijc.28095; Takaku R, 2011, J HLTH CARE MED COMM, V21, P121; Teo A, 2007, MED EDUC, V41, P302, DOI 10.1111/j.1365-2929.2007.02691.x; Tsunematsu M, 2013, ASIAN PAC J CANCER P, V14, P6041, DOI 10.7314/APJCP.2013.14.10.6041; Watanabe R., 2003, MED SOC, V13, P113, DOI [10.4091/iken.13.2_113, DOI 10.4091/IKEN.13.2_113]; Yoshida M, 2012, J MED INVESTIG, V59, P127, DOI 10.2152/jmi.59.127	49	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180819	10.1371/journal.pone.0180819	http://dx.doi.org/10.1371/journal.pone.0180819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704430	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700052
J	Wie, JH; Park, IY; Namkung, J; Seo, HW; Jeong, MJ; Kwon, JY				Wie, Jeong Ha; Park, In Yang; Namkung, Jeong; Seo, Hae Won; Jeong, Min Jin; Kwon, Ji Young			Is it appropriate for Korean women to adopt the 2009 Institute of Medicine recommendations for gestational weight gain?	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANCY OUTCOMES; RISK; OVERWEIGHT; OBESITY; IMPACT	Background The 2009 Institute of Medicine (IOM) guidelines for gestational weight gain (GWG) are intended for use among women in the United States. Little data are available on whether the 2009 IOM recommendations can be applied to Asian women. This study aimed to evaluate whether the recommendations are related to adverse pregnancy outcomes in Korean pregnant women. Methods and findings A retrospective cohort study was conducted for all singleton-pregnant women at a university hospital in Korea. After classifying the enrolled women into four Korean pre-pregnancy body mass index (BMI) categories, the risk of adverse pregnancy outcomes were analyzed for women who gained inadequate or excessive GWG based on 2009 IOM recommendations. Of 7,843 pregnancies, 64.0% of women had normal pre-pregnancy BMI and 42.7% achieved optimal GWG. Across all BMI categories, adverse pregnancies outcomes such as small for gestational age (SGA), large for gestational age (LGA), preterm birth, preeclampsia, and cesarean due to dystocia were significantly associated with GWG (all P <= 0.001). Women with normal BMI who gained inadequate weight were more likely to develop SGA and preterm birth and less likely to develop LGA (adjusted odds ratio (aOR) 2.21, 1.33, and 0.54, respectively). Whereas, women with normal BMI who gained excessive weight were more likely to develop LGA, preterm birth, preeclampsia, and cesarean section due to dystocia (aOR 2.10, 1.33, 1.37, and 1.37, respectively) and less likely to develop SGA (aOR 0.60). Conclusions It is tolerable for Korean women to follow recommended GWG from the 2009 IOM guidelines to decrease adverse pregnancy outcomes. This will be helpful for antenatal care on GWG not only for Korean pregnant women, but also other Asian women who have lower BMI criteria than Caucasian women.	[Wie, Jeong Ha; Park, In Yang; Namkung, Jeong; Seo, Hae Won; Jeong, Min Jin; Kwon, Ji Young] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea	Kwon, JY (corresponding author), Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jiyoungk@catholic.ac.kr		Wie, Jeong Ha/0000-0001-7897-5148				Anderson JE, 2012, PRIMARY CARE, V39, P135, DOI 10.1016/j.pop.2011.12.002; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauer CMC, 2016, J PERINATOL, V36, P278, DOI 10.1038/jp.2015.202; Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677; Challis JRG, 2004, AM J OBSTET GYNECOL, V191, P1059, DOI 10.1016/j.ajog.2004.06.071; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Enomoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157081; Fouelifack Florent Ymele, 2015, BMC Res Notes, V8, P806, DOI 10.1186/s13104-015-1765-9; Hannaford KE, 2017, AM J PERINAT, V34, P147, DOI 10.1055/s-0036-1584583; Headen I, 2017, OBES REV, V18, P350, DOI 10.1111/obr.12486; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Jeffs E, 2014, NEW ZEAL MED J, V127, P17; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; Mandujano A, 2012, J MATERN-FETAL NEO M, V25, P1395, DOI 10.3109/14767058.2011.636099; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Sharples H, 2012, NEW ZEAL MED J, V125, P60; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Tanaka T, 2014, J OBSTET GYNAECOL RE, V40, P1296, DOI 10.1111/jog.12353; Triunfo S, 2015, J ENDOCRINOL INVEST, V38, P31, DOI 10.1007/s40618-014-0168-4; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Vesco KK, 2009, OBSTET GYNECOL, V114, P1069, DOI 10.1097/AOG.0b013e3181baeacf; Waldenstrom U, 2014, OBSTET GYNECOL, V123, P104, DOI 10.1097/AOG.0000000000000062; Wong W, 2000, J AM DIET ASSOC, V100, P791, DOI 10.1016/S0002-8223(00)00230-3; 이정주, 2007, Clinical and Experimental Pediatrics, V50, P732	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181164	10.1371/journal.pone.0181164	http://dx.doi.org/10.1371/journal.pone.0181164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704550	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700101
J	Kaufmann, B; Wang, BC; Zhong, SY; Laschinger, M; Patil, P; Lu, M; Assfalg, V; Cheng, ZJ; Friess, H; Huser, N; von Figura, G; Hartmann, D				Kaufmann, Benedikt; Wang, Baocai; Zhong, Suyang; Laschinger, Melanie; Patil, Pranali; Lu, Miao; Assfalg, Volker; Cheng, Zhangjun; Friess, Helmut; Hueser, Norbert; von Figura, Guido; Hartmann, Daniel			BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness	PLOS ONE			English	Article							CELL-CYCLE; HEPATOCELLULAR-CARCINOMA; RETINOBLASTOMA PROTEIN; MUTATIONAL LANDSCAPE; SWI/SNF COMPLEX; EXPRESSION; COMPONENT	The chromatin remodeler complex SWI/SNF plays an important role in physiological and pathological processes. Brahma related gene 1(BRG1), a catalytic subunit of the SWI/SNF complex, is known to be mutated in hepatocellular carcinoma (HCC). However, its role in HCC remains unclear. Here, we investigate the role of BRG1 on cell growth and invasiveness as well as its effect on the expression of putative target genes. Expression of BRG1 was examined in human liver tissue samples and in HCC cell lines. In addition, BRG1 was silenced in human HCC cell lines to analyse cell growth and invasiveness by growth curves, colony formation assay, invasion assay and the expression of putative target genes. BRG1 was found to be significantly increased in HCC samples compared to non-HCC samples. In addition, a declined proliferation rate of BRG1-silenced human HCC cell lines was associated with a decrease of expression of cyclin family members. In line with a decreased invasiveness of BRG1-siRNA-treated human HCC cell lines, down-regulation of MMP7 was detected. These results support the hypothesis that overexpression of BRG1 increases cell growth and invasiveness in HCC. Furthermore, the data highlight cyclin B, E and MMP7 to be associated with BRG1 during hepatocarcinogenesis.	[Kaufmann, Benedikt; Wang, Baocai; Laschinger, Melanie; Patil, Pranali; Assfalg, Volker; Friess, Helmut; Hueser, Norbert; Hartmann, Daniel] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Zhong, Suyang; von Figura, Guido] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany; [Lu, Miao; Cheng, Zhangjun] Southeast Univ, Zhongda Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Southeast University - China	Hartmann, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany.; von Figura, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany.	gvfigura@tum.de; daniel.hartmann@tum.de						Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059772; Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Endo M, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12005; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Karnezis AN, 2016, J PATHOL, V238, P389, DOI 10.1002/path.4633; Lee JS, 2015, CLIN MOL HEPATOL, V21, P220, DOI 10.3350/cmh.2015.21.3.220; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; REMMELE W, 1987, PATHOLOGE, V8, P138; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shanahan F., 2013, PLOS ONE, V8; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Torkamandi S, 2014, IRAN J BASIC MED SCI, V17, P912; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong AKC, 2000, CANCER RES, V60, P6171; Wu Q, 2015, J CELL PHYSIOL, V230, P2683, DOI 10.1002/jcp.24991; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608	35	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180225	10.1371/journal.pone.0180225	http://dx.doi.org/10.1371/journal.pone.0180225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700662	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600023
J	Kuhnen, VV; Romero, GQ; Linhares, AX; Vizentin-Bugoni, J; Porto, EAC; Setz, EZF				Kuhnen, Vanessa Villanova; Romero, Gustavo Quevedo; Linhares, Aricio Xavier; Vizentin-Bugoni, Jeferson; Correa Porto, Erica Aline; Freire Setz, Eleonore Zulnara			Diet overlap and spatial segregation between two neotropical marsupials revealed by multiple analytical approaches	PLOS ONE			English	Article							OPOSSUM DIDELPHIS-AURITA; STABLE-ISOTOPE ANALYSIS; ATLANTIC FOREST; FOOD-HABITS; METACHIRUS-NUDICAUDATUS; SOUTHEASTERN BRAZIL; SOUTHERN BRAZIL; SMALL MAMMALS; RESOURCE USE; NICHE	Species co-existence depends on how organisms utilize their environment and resources. When two sympatric species are similar in some ecological requirements, their coexistence may arise from differences in resource use over time and/ or space. Interactions among coexisting marsupials remain poorly understood, especially in the Neotropics. Here we combine spatial niche measurements, individual-resource networks, and isotopic niche approaches, to investigate the ecological strategies used by the Neotropical marsupials Didelphis aurita and Metachirus nudicaudatus to co-occur in an area of Serra do Mar State Park (southeast of Brazil). Both individual-resource networks and isotopic niche approaches indicate similar patterns of omnivory for both species. Isotopic analysis showed the species' trophic niche to be similar, with 52% of overlap, and no differences between proportional contributions of each resource to their diets. Moreover, individual-resource network analysis found no evidence of diet nestedness or segregation. The trophic niche overlap observed was associated with spatial segregation between species. Despite using the same area over the year, D. aurita and M. nudicaudatus exhibited spatial segregation among seasons. These results illustrate that the detection of spatial segregation is scale-dependent and must be carefully considered. In conclusion, our findings provide a new perspective on the ecology of these two Neotropical marsupials by illustrating how the association of distinct but complementary methods can be applied to reach a more complete understanding of resource partitioning and species coexistence.	[Kuhnen, Vanessa Villanova; Vizentin-Bugoni, Jeferson] Univ Estadual Campinas, Inst Biol, Posgrad Ecol, Campinas, SP, Brazil; [Romero, Gustavo Quevedo; Linhares, Aricio Xavier; Freire Setz, Eleonore Zulnara] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Correa Porto, Erica Aline] Univ Estadual Campinas, Inst Biol, Grad Ciencias Biol, Campinas, SP, Brazil; [Kuhnen, Vanessa Villanova] Inst Pesca, Lab Piscicultura Marinha Nucleo Pesquisa & Desenv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Kuhnen, VV (corresponding author), Univ Estadual Campinas, Inst Biol, Posgrad Ecol, Campinas, SP, Brazil.; Kuhnen, VV (corresponding author), Inst Pesca, Lab Piscicultura Marinha Nucleo Pesquisa & Desenv, Sao Paulo, Brazil.	vanessavk3@gmail.com	Vizentin-Bugoni, Jeferson/J-9342-2016; Romero, Gustavo Q/N-1896-2019; Kuhnen, Vanessa Villanova/F-8360-2016; Romero, Gustavo Q/H-8974-2012; Setz, Eleonore Z F/C-1050-2012	Vizentin-Bugoni, Jeferson/0000-0002-6343-3650; Romero, Gustavo Q/0000-0003-3736-4759; Kuhnen, Vanessa Villanova/0000-0001-7087-1395; Romero, Gustavo Q/0000-0003-3736-4759; Setz, Eleonore Z F/0000-0001-7638-7086	Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq) [142137/20120]; Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES); Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP)	Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP)	V.V. Kuhnen PhD scholarship was funded by Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (CNPq, 142137/20120). J. Vizentin-Bugoni PhD scholarship was funded by Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior (CAPES). Isotopic analyses were funded by Fundac Eaode Amparo Pesquisado Estadode Sao Paulo (FAPESP) project coordinated by GQ Romero. GQ Romero received a CNPq-Brazil research grant. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Astua de Moraes D., 2000, Hystrix, V11, P115; Astua Diego, 2006, Boletim do Museu de Biologia Mello Leitao Nova Serie, V19, P31; Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Benadi G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0117; Breviglieri CPB, 2016, FOLIA ZOOL, V65, P243, DOI 10.25225/fozo.v65.i3.a11.2016; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Browning NE, 2014, J EXP MAR BIOL ECOL, V457, P15, DOI 10.1016/j.jembe.2014.03.016; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Caceres NC, 2001, STUD NEOTROP FAUNA E, V36, P85, DOI 10.1076/snfe.36.2.85.2138; Caceres Nilton C., 2013, Open Ecology Journal, V6, P10; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Ceotto Paula, 2009, Mastozool. neotrop., V16, P49; CIIAGRO (Centro Integrado de Informacoes Agrometeorologicas), 2015, CIIAGRO DAT BAS; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Correa SB, 2014, ECOLOGY, V95, P210, DOI 10.1890/13-0393.1; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cunha AA, 2002, J ZOOL, V258, P419, DOI 10.1017/S0952836902001565; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; DIETZ J M, 1984, Smithsonian Contributions to Zoology, P1; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Eisenlohr PV, 2013, BIODIVERS CONSERV, V22, P2767, DOI 10.1007/s10531-013-0553-x; Freitas Simone R., 1997, Revista Brasileira de Biologia, V57, P93; Gause G. F., 1934, STRUGGLE EXISTENCE; Gonzalez AMM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1212, DOI 10.1111/geb.12355; Graipel ME, 2003, MAMMALIA, V67, P551, DOI 10.1515/mamm-2003-0409; Grelle CEV, 2003, STUD NEOTROP FAUNA E, V38, P81, DOI 10.1076/snfe.38.2.81.15926; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Helder-Jose H., 2012, MARSUPIAIS BRASIL BI, P185; HELDERJOSE, 1995, ACTA ANAT, V153, P31; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jansa SA, 2014, EVOLUTION, V68, P684, DOI 10.1111/evo.12290; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kronfeld-Schor N, 1999, OECOLOGIA, V121, P123, DOI 10.1007/s004420050913; Kuhnen VV, 2017, BIOTROPICA IN PRESS; Kuhnen VV, 2016, B SOC BRAS MASTOZOOL, V75, P1; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lessa LG, 2014, STUD NEOTROP FAUNA E, V49, P75, DOI 10.1080/01650521.2014.924805; Lessa LG, 2010, MAMM BIOL, V75, P10, DOI 10.1016/j.mambio.2008.11.002; Logan Kenneth A., 2010, P105; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; MACDONALD SM, 1980, ACTA THERIOL, V25, P245, DOI 10.4098/AT.arch.80-19; Maitz WE, 2001, OECOLOGIA, V128, P526, DOI 10.1007/s004420100689; Svendsen GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126182; Melo GL, 2012, MARSUPIAIS BRASIL BI, P385; Mohd-Azlan J, 2014, BIOTROPICA, V46, P331, DOI 10.1111/btp.12108; Moura MC, 2009, AUSTRAL ECOL, V34, P481, DOI 10.1111/j.1442-9993.2009.01948.x; MUNHOZ COG, 1967, ACTA ANAT, V68, P258; Nakano S, 1999, J ANIM ECOL, V68, P1079, DOI 10.1046/j.1365-2656.1999.00355.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V6, P1, DOI DOI 10.1646/0006-3606(2000)032[; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Passamani Marcelo, 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P215; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Reid REB, 2013, J MAMMAL, V94, P1248, DOI 10.1644/13-MAMM-A-104.1; Remonti L, 2012, POPUL ECOL, V54, P521, DOI 10.1007/s10144-012-0326-5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Righetti J, 2000, AUST J ZOOL, V48, P561, DOI 10.1071/ZO00023; Rossi RV, 2012, MARSUPIAIS BRASIL BI, P385; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Santori RT, 1995, MAMMALIA, V59, P511, DOI 10.1515/mamm.1995.59.4.511; Santori RT, 2012, MARSUPIAIS BRASIL BI, P383; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; THOMSON J. A., 1962, VICTORIAN NAT, V78, P306; TYNDALEBISCOE CH, 1976, J MAMMAL, V57, P249, DOI 10.2307/1379686; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Vieira EM, 2006, PREDATORS POUCHES BI, P271; Vilar de Carvalho Fabio Martins, 1999, Zoociencias, V1, P91	86	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181188	10.1371/journal.pone.0181188	http://dx.doi.org/10.1371/journal.pone.0181188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704561	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600065
J	Zheng, BQ; Zou, LH; Li, K; Wan, X; Wang, Y				Zheng, Bao-Qiang; Zou, Long-Hai; Li, Kui; Wan, Xiao; Wang, Yan			Photosynthetic, morphological, and reproductive variations in Cypripedium tibeticum in relation to different light regimes in a subalpine forest	PLOS ONE			English	Article							UV-B RADIATION; LEAF TRAITS; GROWTH; IRRADIANCE; PLASTICITY; FLAVUM; PAPHIOPEDILUM; UNDERSTOREY; POPULATIONS; PERFORMANCE	Cypripedium tibeticum, a subalpine orchid species, inhabits various habitats of subalpine forests, mainly including the forest edge (FE), forest gap (FG), and understory (UST), which have significantly different light intensities (FE > FG > UST). However, the ecological and physiological influences caused by different light regimes in this species are still poorly understood. In the present study, photosynthetic, morphological, and reproductive characteristics were comprehensively studied in plants of C. tibeticum grown in three types of habitats. The photosynthetic capacities, such as the net photosynthetic rate, light-saturated photosynthesis (P-max), and dry mass per unit leaf area (LMA), were higher in FE and FG than in UST according to light availability. Compared with FG, the populations in FE and UST suffer from excessively strong and inadequate radiation, respectively, which was further corroborated by the low Fv/Fm in FE and high apparent quantum yield (AQY) in FG. The leaves of the orchids had various proportions of constituents, such as the leaf area, thickness and (or) epidermal hair, to reduce damage from high radiation (including ultraviolet-b radiation) in FE and capture more light in FG and UST. Although the flower rate (FR) was positively correlated to both P-max and the daily mean PAR, fruit-set only occurred in the populations in FG. The failures in FE and UST might be ascribed to changes in the floral functional structure and low biomass accumulation, respectively. Moreover, analysis of the demographic statistics showed that FG was an advantageous habitat for the orchid. Thus, C. tibeticum reacted to photosynthetic and morphological changes to adapt to different subalpine forest habitats, and neither full (under FE) nor low (UST) illumination was favorable for population expansion. These findings could serve as a guide for the protection and reintroduction of C. tibeticum and emphasize the importance of specific habitats for Cypripedium spp.	[Wang, Yan] State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF	Wang, Y (corresponding author), State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	chwy8915@sina.com			Basic Research Fund of RIF [RIF2014-05]	Basic Research Fund of RIF	This work was supported by the Basic Research Fund of RIF (grant No. RIF2014-05) to Bao-Qiang Zheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroniya SS, 2013, ACTA PHYSIOL PLANT, V35, P1521, DOI 10.1007/s11738-012-1193-6; Cai ZQ, 2011, IND CROP PROD, V34, P1235, DOI 10.1016/j.indcrop.2011.03.021; Chang W, 2011, PHYSIOL PLANTARUM, V141, P30, DOI 10.1111/j.1399-3054.2010.01418.x; Chen JW, 2011, PHYSIOL PLANTARUM, V141, P84, DOI 10.1111/j.1399-3054.2010.01414.x; Chen SC, 1997, FLORAE REIPUBLICAE P, P20; Costa R, 2008, GENETIC DIVERSITY UN; Cribb P, 1997, GENUS CYPRIPEDIUM; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Evans JR, 1999, NEW PHYTOL, V143, P93, DOI 10.1046/j.1469-8137.1999.00440.x; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gaafar ARZ, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0109-4; Gratani L., 2014, ADV IN BOT, V2014, DOI [10.1155/2014/208747, DOI 10.1155/2014/208747]; Greenberg BM, 1997, PLANTS ENV STUDIES; Gregoriou K, 2007, PHOTOSYNTHETICA, V45, P172, DOI 10.1007/s11099-007-0029-x; Guan ZJ, 2011, J PLANT RES, V124, P289, DOI 10.1007/s10265-010-0372-z; Jin LI, 2011, FOR RESOUR MANAG, V40, P30; Jonson G., 2007, HDB PLANT SCI, V2, P1206; Kull T, 1999, J ECOL, V87, P913, DOI 10.1046/j.1365-2745.1999.00407.x; Kull T, 1998, BOT J LINN SOC, V126, P27, DOI 10.1111/j.1095-8339.1998.tb02513.x; Li P, 2006, PLANT SYST EVOL, V262, P53, DOI 10.1007/s00606-006-0456-3; Li ZR, 2008, J PLANT RES, V121, P559, DOI 10.1007/s10265-008-0186-4; MADRONICH S, 1995, AMBIO, V24, P143; MARLER TE, 1994, J AM SOC HORTIC SCI, V119, P711, DOI 10.21273/JASHS.119.4.711; Muraoka H, 2003, OECOLOGIA, V135, P500, DOI 10.1007/s00442-003-1227-2; [李鹏 Peng Li], 2009, [生物多样性, Biodiversity Science], V17, P406; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; RANKOU H, 2014, IUCN RED LIST THREAT; Richardson AD, 2002, AM J BOT, V89, P88, DOI 10.3732/ajb.89.1.88; Rocas G, 2001, BOT J LINN SOC, V136, P231, DOI 10.1111/j.1095-8339.2001.tb00568.x; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; SALLEO S, 1990, ANN BOT-LONDON, V65, P259, DOI 10.1093/oxfordjournals.aob.a087932; Shi S, 1999, ACTA PHYTOECOL SIN, P64; TERAMURA AH, 1994, PHOTOSYNTH RES, V39, P463, DOI 10.1007/BF00014599; Urban O, 2006, PHOTOSYNTHETICA, V44, P215, DOI 10.1007/s11099-006-0009-6; Valladares F, 2002, TREES-STRUCT FUNCT, V16, P395, DOI 10.1007/s00468.002.0184.4; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Vats SK, 2002, PHOTOSYNTHETICA, V40, P625, DOI 10.1023/A:1024372623650; VOGELMANN TC, 1993, PLANT CELL ENVIRON, V16, P65, DOI 10.1111/j.1365-3040.1993.tb00845.x; Xiong FSS, 2002, GLOBAL CHANGE BIOL, V8, P1146, DOI 10.1046/j.1365-2486.2002.00539.x; Xu D, 2005, HDB PHOTOSYNTH, V2, P287; Xu D-Q, 2012, SCI PHOTOSYNTHESIS; Yang SJ, 2014, J EUR CERAM SOC, V34, P3329; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; YOUNG DR, 1983, ECOLOGY, V64, P681, DOI 10.2307/1937189; Yuan L, 2010, MYCORRHIZA, V20, P559, DOI 10.1007/s00572-010-0307-5; Zhang JinFeng, 2012, Journal of West China Forestry Science, V41, P34; Zhang SB, 2008, ACTA PHYSIOL PLANT, V30, P381, DOI 10.1007/s11738-008-0135-9; Zhang SB, 2006, PHOTOSYNTHETICA, V44, P425, DOI 10.1007/s11099-006-0046-1; Zhang SB, 2005, ANN BOT-LONDON, V96, P43, DOI 10.1093/aob/mci146; Zhang SB, 2007, J PLANT PHYSIOL, V164, P611, DOI 10.1016/j.jplph.2006.02.012; Zunzunegui M, 2011, PLANT ECOL, V212, P127, DOI 10.1007/s11258-010-9809-7	52	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181274	10.1371/journal.pone.0181274	http://dx.doi.org/10.1371/journal.pone.0181274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704518	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649600070
J	Stervbo, U; Pohlmann, D; Baron, U; Bozzetti, C; Jurchott, K; Malzer, JN; Nienen, M; Olek, S; Roch, T; Schulz, AR; Warth, S; Neumann, A; Thiel, A; Grutzkau, A; Babel, N				Stervbo, Ulrik; Pohlmann, Dominika; Baron, Udo; Bozzetti, Cecilia; Juerchott, Karsten; Maelzer, Julia Nora; Nienen, Mikalai; Olek, Sven; Roch, Toralf; Schulz, Axel Ronald; Warth, Sarah; Neumann, Avidan; Thiel, Andreas; Gruetzkau, Andreas; Babel, Nina			Age dependent differences in the kinetics of Y delta T cells after influenza vaccination	PLOS ONE			English	Article							PROFESSIONAL ANTIGEN-PRESENTATION; B-CELLS; A VIRUSES; ACTIVATION; INFECTION; RESPONSES; CYTOMEGALOVIRUS; NEUTRALIZATION; CYTOTOXICITY; LYMPHOCYTES	Immunosenescence is a hallmark of the aging immune system and is considered the main cause of a reduced vaccine efficacy in the elderly. Although Y delta T cells can become activated by recombinant influenza hemagglutinin, their age-related immunocompetence during a virus-induced immune response has so far not been investigated. In this study we evaluate the kinetics of Y delta T cells after vaccination with the trivalent 2011/2012 northern hemisphere seasonal influenza vaccine. We applied multi-parametric flow cytometry to a cohort of 21 young (19-30 years) and 23 elderly (53-67 years) healthy individuals. Activated and proliferating Y delta T cells, as identified by CD38 and Ki67 expression, were quantified on the days 0, 3, 7, 10, 14, 17, and 21. We observed a significantly lower number of activated and proliferating Y delta T cells at baseline and following vaccination in elderly as compared to young individuals. The kinetics changes of activated Upsilon delta T cells were much stronger in the young, while corresponding changes in the elderly occurred slower. In addition, we observed an association between day 21 HAI titers of influenza A and the frequencies of Ki67(+) Y delta T cells at day 7 in the young. In conclusion, aging induces alterations of the Upsilon delta T cell response that might have negative implications for vaccination efficacy.	[Stervbo, Ulrik; Pohlmann, Dominika; Bozzetti, Cecilia; Juerchott, Karsten; Maelzer, Julia Nora; Schulz, Axel Ronald; Warth, Sarah; Neumann, Avidan; Thiel, Andreas; Babel, Nina] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, Berlin, Germany; [Stervbo, Ulrik; Nienen, Mikalai; Babel, Nina] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Clin 1,Ctr Translat Med, Holkeskampring 40, Herne, Germany; [Baron, Udo; Olek, Sven] Epiontis GmbH, Rudower Chaussee 29, Berlin, Germany; [Roch, Toralf] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Inst Biomat Sci, Kantstr 55, Teltow, Germany; [Roch, Toralf] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Berlin Brandenburg Ctr Regenerat Therapies, Kantstr 55, Teltow, Germany; [Schulz, Axel Ronald; Gruetzkau, Andreas] Deutsch Rheuma Forschungszentrum Berlin, Leibniz Inst, Charitepl 1, Berlin, Germany; [Pohlmann, Dominika] Charite, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany; [Neumann, Avidan] Helmholtz Ctr Munich, Chair & Inst Environm Med, UNIKA T, Neusaesser Str 47, Augsburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; St. Marien Hospital; Epiontis GmbH; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stervbo, U (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, Berlin, Germany.; Stervbo, U (corresponding author), Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Clin 1,Ctr Translat Med, Holkeskampring 40, Herne, Germany.	ulrik.stervbo-kristensen@charite.de	Thiel, Andreas/F-1539-2013; Babel, Nina/AAK-2034-2021; Stervbo, Ulrik/AAV-1561-2020; Roch, Toralf/AAQ-7480-2021	Stervbo, Ulrik/0000-0002-2831-8868; Jurchott, Karsten/0000-0003-1589-0037; Roch, Toralf/0000-0003-2948-8700; Nienen, Mikalai/0000-0002-5678-1956; Babel, Nina/0000-0003-3673-712X; Baron, Udo/0000-0001-7432-3601; Schulz, Axel Ronald/0000-0002-5106-0148; Thiel, Andreas/0000-0002-5515-4002; Pohlmann, Dominika/0000-0002-9866-0431	Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE	Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE	This work was supported by the following Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. Epiontis GmbH provided support in the form of salaries for authors (UB, SO), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Bauvois B, 1999, J INTERF CYTOK RES, V19, P1059, DOI 10.1089/107999099313299; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bissel SJ, 2014, J VIROL, V88, P3077, DOI 10.1128/JVI.01840-13; Born WK, 2011, CELL MOL LIFE SCI, V68, P2335, DOI 10.1007/s00018-011-0697-3; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P1, DOI 10.1038/cmi.2012.73; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Ernst IMA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00259; Fisher JPH, 2014, CLIN CANCER RES, V20, P5720, DOI 10.1158/1078-0432.CCR-13-3464; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Fujishima N, 2007, CLIN EXP IMMUNOL, V149, P70, DOI 10.1111/j.1365-2249.2007.03388.x; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Himoudi N, 2012, J IMMUNOL, V188, P1708, DOI 10.4049/jimmunol.1102654; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; Hou LF, 2015, INT IMMUNOPHARMACOL, V28, P887, DOI 10.1016/j.intimp.2015.03.038; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Iwasaki M, 2011, EUR J IMMUNOL, V41, P345, DOI 10.1002/eji.201040959; Jurchott K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150812; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Lafont V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00622; Langer JC, 2006, J GERONTOL A-BIOL, V61, P568, DOI 10.1093/gerona/61.6.568; Lee N, 2012, J GERONTOL A-BIOL, V67, P254, DOI 10.1093/gerona/glr237; Li H, 2013, CELL MOL IMMUNOL, V10, P159, DOI 10.1038/cmi.2012.70; Lu YL, 2013, CELL MOL IMMUNOL, V10, P463, DOI 10.1038/cmi.2013.26; Meuter S, 2010, P NATL ACAD SCI USA, V107, P8730, DOI 10.1073/pnas.1002769107; Motamedi M, 2016, J IMMUNOL METHODS, V437, P43, DOI 10.1016/j.jim.2016.08.002; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Petrasca A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00650; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; R Core Team, 2012, R LANG ENV STAT COMP; Rambal V, 2014, MED MICROBIOL IMMUN, V203, P35, DOI 10.1007/s00430-013-0312-3; Roux A, 2013, J IMMUNOL, V191, P1300, DOI 10.4049/jimmunol.1202940; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Tseng CTK, 2001, HEPATOLOGY, V33, P1312, DOI 10.1053/jhep.2001.24269; Tuero I, 2016, J IMMUNOL, V197, P4686, DOI 10.4049/jimmunol.1600579; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; WHO, 2011, RELEVE EPIDEMIOLOGIQ, V86, P86; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wistuba-Hamprecht K, 2014, CYTOM PART A, V85A, P522, DOI 10.1002/cyto.a.22470; Wistuba-Hamprecht K, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-26; Wu YL, 2014, INT J BIOL SCI, V10, P119, DOI 10.7150/ijbs.7823; Yin WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26296	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181161	10.1371/journal.pone.0181161	http://dx.doi.org/10.1371/journal.pone.0181161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700738	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400035
J	Minges, A; Groth, G				Minges, Alexander; Groth, Georg			Small-molecule inhibition of pyruvate phosphate dikinase targeting the nucleotide binding site	PLOS ONE			English	Article							PROTEIN-KINASE-C; SWIVELING-DOMAIN MECHANISM; BUNDLE SHEATH-CELLS; ORTHOPHOSPHATE DIKINASE; C-4 PHOTOSYNTHESIS; REVERSIBLE PHOSPHORYLATION; INACTIVATION; ACTIVATION; DESIGN; CANCER	Pyruvate phosphate dikinase (PPDK) is an essential enzyme of C4 photosynthesis in plants, catalyzing the ATP-driven conversion of pyruvate to phosphoenolpyruvate ( PEP). It is further used by some bacteria and unicellular protists in the reverse, ATP-forming direction. Many weed species use C4 photosynthesis in contrast to world's major crops, which are C3 plants. Hence inhibitors of PPDK may be used as C4-specific herbicides. By screening a library of 80 commercially available kinase inhibitors, we identified compounds derived from bisindolylmaleimide (bisindolylmaleimide IV, IC50 = 0.76 +/- 0.13 mu M) and indirubin (indirubin3'- monoxime, IC50 = 4.2 +/- 0.9 mu M) that showed high inhibitory potency towards PPDK and are among the most effective PPDK inhibitors described today. Physiological studies on leaf tissues of a C4 model plant confirmed in vivo inhibition of C4-driven photosynthesis by these substances. Moreover, comparative docking studies of non-inhibitory bisindolylmaleimide derivatives suggest that the selectivity towards PPDK may be increased by addition of functional groups to the core structure.	[Minges, Alexander; Groth, Georg] Heinrich Heine Univ, Inst Biochem Plant Physiol, Cluster Excellence Plant Sci CEPLAS, D-40204 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Cologne	Groth, G (corresponding author), Heinrich Heine Univ, Inst Biochem Plant Physiol, Cluster Excellence Plant Sci CEPLAS, D-40204 Dusseldorf, Germany.	georg.groth@hhu.de		Minges, Alexander/0000-0001-7760-2753	Heinrich Heine University Dusseldorf within iGRASPseed-Graduate Cluster	Heinrich Heine University Dusseldorf within iGRASPseed-Graduate Cluster	This work was supported by Heinrich Heine University Dusseldorf (scholarships within the iGRASPseed-Graduate Cluster for AM) (http://igrasp.hhu.de/).	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert DH, 2006, MOL CANCER THER, V5, P995, DOI 10.1158/1535-7163.MCT-05-0410; [Anonymous], 2016, RDKIT OPEN SOURCE CH; Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO;2-0; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ASHTON AR, 1984, ARCH BIOCHEM BIOPHYS, V230, P492, DOI 10.1016/0003-9861(84)90429-6; Astley HM, 2011, PLANT J, V68, P1070, DOI 10.1111/j.1365-313X.2011.04759.x; BURNELL JN, 1988, ARCH BIOCHEM BIOPHYS, V260, P177, DOI 10.1016/0003-9861(88)90439-0; CHAPMAN KSR, 1981, ARCH BIOCHEM BIOPHYS, V210, P82, DOI 10.1016/0003-9861(81)90166-1; Chastain CJ, 2011, J EXP BOT, V62, P3083, DOI 10.1093/jxb/err058; Chastain CJ, 2003, PLANT PHYSIOL BIOCH, V41, P523, DOI 10.1016/S0981-9428(03)00065-2; Chen YB, 2014, PLANT PHYSIOL, V165, P534, DOI 10.1104/pp.113.231993; Cosenza LW, 2002, J MOL BIOL, V318, P1417, DOI 10.1016/S0022-2836(02)00113-4; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; Doyle JR, 2005, J BIOMOL SCREEN, V10, P67, DOI 10.1177/1087057104269978; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Ghannoum O, 2011, ADV PHOTOSYNTH RESP, V32, P129; Greaves B, 1996, US Patent, Patent No. [5,587,109, 5587109]; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Haines DS, 2005, J AGR FOOD CHEM, V53, P3856, DOI 10.1021/jf048010x; Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Holm LG, 1977, THE WORLDS WORST WEE; Jiang L, 2016, PLANT PHYSIOL, V170, P732, DOI 10.1104/pp.15.01709; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Kopriva S, 2011, ADV PHOTOSYNTH RESP, V32, P109; LAWYER AL, 1987, Z NATURFORSCH C, V42, P834; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lim K, 2007, BIOCHEMISTRY-US, V46, P14845, DOI 10.1021/bi701848w; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Minges A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45389; MOORE R, 1979, PLANT PHYSIOL, V64, P309, DOI 10.1104/pp.64.2.309; Motti CA, 2007, MOLECULES, V12, P1376, DOI 10.3390/12071376; Motti CA, 2007, APPL ENVIRON MICROB, V73, P1921, DOI 10.1128/AEM.02479-06; Nakanishi T, 2005, BIOCHEMISTRY-US, V44, P1136, DOI 10.1021/bi0484522; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2004, R FOUNDATION FOR STA; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; SALAHAS G, 1990, PHOTOSYNTH RES, V24, P183, DOI 10.1007/BF00032598; Schrodinger LLC, 2015, THE PYMOL MOLECULAR; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Tanaka M, 2004, BIOORG MED CHEM LETT, V14, P5171, DOI 10.1016/j.bmcl.2004.07.061; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu C, 2013, J ORG CHEM, V78, P1910, DOI 10.1021/jo3018473; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	51	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181139	10.1371/journal.pone.0181139	http://dx.doi.org/10.1371/journal.pone.0181139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700696	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800126
J	Yang, LS; Craviso, GL; Vernier, PT; Chatterjee, I; Leblanc, N				Yang, Lisha; Craviso, Gale L.; Vernier, P. Thomas; Chatterjee, Indira; Leblanc, Normand			Nanosecond electric pulses differentially affect inward and outward currents in patch clamped adrenal chromaffin cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PERMEABILIZATION; GATED SODIUM-CHANNELS; INTRACELLULAR CA2+; ION CHANNELS; PHOSPHATIDYLSERINE TRANSLOCATION; CALCIUM-CHANNELS; SALT-BRIDGE; FIELD NSPEF; IN-VITRO; INHIBITION	This study examined the effect of 5 ns electric pulses on macroscopic ionic currents in whole-cell voltage-clamped adrenal chromaffin cells. Current-voltage (I-V) relationships first established that the early peak inward current was primarily composed of a fast voltage-dependent Na+ current (I-Na), whereas the late outward current was composed of at least three ionic currents: a voltage-gated Ca2+ current (I-Ca), a Ca2+-activated K+ current (I-K(Ca)), and a sustained voltage-dependent delayed rectifier K+ current (I-KV). A constant-voltage step protocol was next used to monitor peak inward and late outward currents before and after cell exposure to a 5 ns pulse. A single pulse applied at an electric (E)-field amplitude of 5 MV/m resulted in an instantaneous decrease of similar to 4% in peak INa that then declined exponentially to a level that was similar to 85% of the initial level after 10 min. Increasing the E-field amplitude to 8 or 10 MV/m caused a twofold greater inhibitory effect on peak INa. The decrease in INa was not due to a change in either the steady-state inactivation or activation of the Na+ channel but instead was associated with a decrease in maximal Na+ conductance. Late outward current was not affected by a pulse applied at 5 MV/m. However, for a pulse applied at the higher E-field amplitudes of 8 and 10 MV/m, late outward current in some cells underwent a progressive similar to 22% decline over the course of the first 20 s following pulse exposure, with no further decline. The effect was most likely concentrated on ICa and IK(Ca) as IKV was not affected. The results of this study indicate that in whole-cell patch clamped adrenal chromaffin cells, a 5 ns pulse differentially inhibits specific voltage-gated ionic currents in a manner that can be manipulated by tuning E-field amplitude.	[Yang, Lisha; Craviso, Gale L.; Leblanc, Normand] Univ Nevada, Dept Pharmacol, Reno Sch Med, Reno, NV 89557 USA; [Vernier, P. Thomas] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Chatterjee, Indira] Univ Nevada, Dept Elect & Biomed Engn, Coll Engn, Reno, NV 89557 USA; [Leblanc, Normand] Univ Nevada, Ctr Cardiovasc Res, Reno Sch Med, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Old Dominion University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Leblanc, N (corresponding author), Univ Nevada, Dept Pharmacol, Reno Sch Med, Reno, NV 89557 USA.; Leblanc, N (corresponding author), Univ Nevada, Ctr Cardiovasc Res, Reno Sch Med, Reno, NV 89557 USA.	nleblanc@unr.edu	YANG, LISHA/AAA-1663-2019; Vernier, P. Thomas/D-7926-2016	YANG, LISHA/0000-0001-6318-4298; Vernier, P. Thomas/0000-0003-2335-1500; Leblanc, Normand/0000-0002-1090-9432	Air Force Office of Scientific Research [FA9550-14-1-0018, FA9550-14-1-0123]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by grants FA9550-14-1-0018 (GLC) and FA9550-14-1-0123 (PTV) from the Air Force Office of Scientific Research (http://www.afosr.af.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Barry PH, 2013, EUR BIOPHYS J BIOPHY, V42, P631, DOI 10.1007/s00249-013-0911-3; Blanchard MG, 2012, BRIT J PHARMACOL, V165, P2167, DOI 10.1111/j.1476-5381.2011.01674.x; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Cain SM, 2012, JASPER S BASIC MECH, P1; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Catterall WA, 2014, EXP PHYSIOL, V99, P1; Chen W, 2004, BIOELECTROCHEMISTRY, V62, P47, DOI 10.1016/j.bioelechem.2003.10.006; Chen W, 2006, BURNS, V32, P52, DOI 10.1016/j.burns.2005.08.008; Craviso GL, 2015, BIOELECTROCHEMISTRY, V103, P98, DOI 10.1016/j.bioelechem.2014.08.006; Craviso GL, 2012, BIOELECTROCHEMISTRY, V87, P244, DOI 10.1016/j.bioelechem.2011.11.016; Craviso GL, 2010, CELL MOL NEUROBIOL, V30, P1259, DOI 10.1007/s10571-010-9573-1; Craviso GL, 2009, IEEE T DIELECT EL IN, V16, P1294, DOI 10.1109/TDEI.2009.5293941; Craviso GL, 2004, J NEUROSCI METH, V137, P275, DOI 10.1016/j.jneumeth.2004.02.031; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Dworakowska B, 2000, ACTA BIOCHIM POL, V47, P685, DOI 10.18388/abp.2000_3989; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; GRIMES JA, 1995, FEBS LETT, V369, P290, DOI 10.1016/0014-5793(95)00772-2; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; ISLASSUAREZ L, 1994, J NEUROPHYSIOL, V72, P1938, DOI 10.1152/jn.1994.72.4.1938; Jiang N, 2011, BIOELECTROMAGNETICS, V32, P148, DOI 10.1002/bem.20620; Lee S, 2013, CURR NEUROPHARMACOL, V11, P606, DOI 10.2174/1570159X11311060005; MALECOT CO, 1988, PFLUG ARCH EUR J PHY, V411, P235, DOI 10.1007/BF00585109; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MEECH RW, 1975, J PHYSIOL-LONDON, V249, P211, DOI 10.1113/jphysiol.1975.sp011012; Muratori C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36835; Neely A, 1992, THE JOURNAL OF PHYSI; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P443, DOI 10.1002/bem.21703; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; Romeo S, 2013, BBA-BIOMEMBRANES, V1828, P1715, DOI 10.1016/j.bbamem.2013.03.007; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; Semenov I, 2013, CELL CALCIUM, V54, P145, DOI 10.1016/j.ceca.2013.05.008; Semenov I, 2013, BBA-BIOMEMBRANES, V1828, P981, DOI 10.1016/j.bbamem.2012.11.032; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Shao XM, 2007, J NEUROSCI METH, V159, P108, DOI 10.1016/j.jneumeth.2006.07.001; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tolstykh GP, 2013, BIOELECTROCHEMISTRY, V94, P23, DOI 10.1016/j.bioelechem.2013.05.002; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Wada A, 2008, ACTA PHYSIOL, V192, P221, DOI 10.1111/j.1748-1716.2007.01810.x; Wu YH, 2012, BIOPHYS J, V102, p190A, DOI 10.1016/j.bpj.2011.11.1035; Yoon J, 2016, J MEMBRANE BIOL, V249, P633, DOI 10.1007/s00232-016-9902-5	57	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181002	10.1371/journal.pone.0181002	http://dx.doi.org/10.1371/journal.pone.0181002			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700658	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800114
J	Adane, M; Mengistie, B; Medhin, G; Kloos, H; Mulat, W				Adane, Metadel; Mengistie, Bezatu; Medhin, Girmay; Kloos, Helmut; Mulat, Worku			Piped water supply interruptions and acute diarrhea among under-five children in Addis Ababa slums, Ethiopia: A matched case-control study	PLOS ONE			English	Article							GLOBAL ENTERIC MULTICENTER; HOUSEHOLD DRINKING-WATER; DEVELOPING-COUNTRIES; MICROBIOLOGICAL CONTAMINATION; FECAL CONTAMINATION; REDUCE DIARRHEA; QUALITY; STORAGE; HOME; SANITATION	Background The problem of intermittent piped water supplies that exists in low-and middle-income countries is particularly severe in the slums of sub-Saharan Africa. However, little is known about whether there is deterioration of the microbiological quality of the intermittent piped water supply at a household level and whether it is a factor in reducing or increasing the occurrence of acute diarrhea among under-five children in slums of Addis Ababa. This study aimed to determine the association of intermittent piped water supplies and point-of-use (POU) contamination of household stored water by Escherichia coli (E. coli) with acute diarrhea among under-five children in slums of Addis Ababa. Methods A community-based matched case-control study was conducted from November to December, 2014. Cases were defined as under-five children with acute diarrhea during the two weeks before the survey. Controls were matched by age and neighborhood with cases by individual matching. Data were collected using a pre-tested structured questionnaire and E. coli analysis of water from piped water supplies and household stored water. A five-tube method of Most Probable Number (MPN)/100 ml standard procedure was used for E. coli analysis. Multivariable conditional logistic regression with 95% confidence interval (CI) was used for data analysis by controlling potential confounding effects of selected socio-demographic characteristics. Main findings During the two weeks before the survey, 87.9% of case households and 51.0% of control households had an intermittent piped water supply for an average of 4.3 days and 3.9 days, respectively. POU contamination of household stored water by E. coli was found in 83.3% of the case households, and 52.1% of the control households. In a fully adjusted model, a periodically intermittent piped water supply (adjusted matched odds ratio (adjusted mOR) = 4.8; 95% CI: 1.3-17.8), POU water contamination in household stored water by E. coli (adjusted mOR = 3.3; 95% CI: 1.1-10.1), water retrieved from water storage containers using handleless vessels (adjusted mOR = 16.3; 95% CI: 4.4-60.1), and water retrieved by interchangeably using vessels both with and without handle (adjusted mOR = 5.4; 95% CI: 1.1-29.1) were independently associated with acute diarrhea. Conclusion We conclude that provision of continuously available piped water supplies and education of caregivers about proper water retrieval methods of household stored water can effectively reduce POU contamination of water at the household level and thereby reduce acute diarrhea among under-five children in slums of Addis Ababa. Promotion of household water treatment is also highly encouraged until the City's water authority is able to deliver continuously available piped water supplies.	[Adane, Metadel] Addis Ababa Univ, EIWR, Addis Ababa, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Coll Hlth & Med Sci, Haramaya, Ethiopia; [Medhin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mulat, Worku] Univ Connecticut, Dept Civil & Environm Engn, Storrs, CT USA	Addis Ababa University; Haramaya University; Addis Ababa University; University of California System; University of California San Francisco; University of Connecticut	Adane, M (corresponding author), Addis Ababa Univ, EIWR, Addis Ababa, Ethiopia.	metadel.adane2@gmail.com	Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768; Medhin, Girmay/0000-0003-2146-4261	Ethiopian Institute of Water Resources of Addis Ababa University; Wollo University; Addis Ababa Water and Sewerage Authority	Ethiopian Institute of Water Resources of Addis Ababa University; Wollo University; Addis Ababa Water and Sewerage Authority	Ethiopian Institute of Water Resources of Addis Ababa University and Wollo University funded this research project. Addis Ababa Water and Sewerage Authority also supported the research by making available free of charge all the necessary reagents and chemicals for bacteriological analysis of water. The funders had no role in study design, data collection and analysis, decision to publish, interpretation of the data or preparation of the manuscript for publication.; We would like to thank the Addis Ababa Water and Sewerage Authority for their support by allowing us the use of their bacteriological laboratory for two months. We are also very grateful to the caregivers of the studied children for their dedication and commitment to providing information. We also strongly acknowledge the support of Shirley Lewis, Linda A. Willis and Adrienne Cruise for our project. Lisa Penttila and Linda M. Weller are highly acknowledged for the language editing of the manuscript.	Adane M, 2017, J HEALTH POPUL NUTR, V36, P1, DOI 10.1186/s41043-017-0085-1; Alam MJ, 2007, BRAC U J, V4, P103; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Baker KK, 2013, AM J TROP MED HYG, V89, P214, DOI 10.4269/ajtmh.12-0256; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Baum R, 2014, AM J TROP MED HYG, V90, P121, DOI 10.4269/ajtmh.13-0380; Breurec S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004283; Brick T, 2004, INT J HYG ENVIR HEAL, V207, P473, DOI 10.1078/1438-4639-00318; Brocklehurst C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001894; City Government of Addis Ababa Addis Ababa Water and Sewerage Authority (AAWSA), 2011, BUS PLAN 2011 2020 F; Clasen TF, 2006, INT J ENVIRON HEAL R, V16, P231, DOI 10.1080/09603120600641474; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Copeland CC, 2009, J WATER HEALTH, V7, P324, DOI 10.2166/wh.2009.081; Council for International Organizations of Medical Sciences, 2002, Bull Med Ethics, P17; Ercumen A, 2017, TROP MED INT HEALTH, V22, P2, DOI 10.1111/tmi.12803; Ercumen A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001892; Ercumen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121907; Erickson JJ, 2017, WATER RES, V114, P338, DOI 10.1016/j.watres.2017.02.009; Fadel ME, 2014, ENVIRON MONIT ASSESS, V186, P665, DOI DOI 10.1007/S10661-013-3406-X; Farthing M, 2012, ACUTE DIARRHEA ADULT, P1; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gruber JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107429; HACH, 2003, WAT WAST QUAL PROC; Herbst S, 2008, INT J ENVIRON HEAL R, V18, P305, DOI 10.1080/09603120701834507; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; Jeandron A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001893; Johnson K.M., 2010, ECOL ENVIRON CONSERV, V16, P277; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973; Luby SP, 2004, AM J TROP MED HYG, V71, P420, DOI 10.4269/ajtmh.2004.71.420; Luby SP, 2015, AM J TROP MED HYG, V93, P904, DOI 10.4269/ajtmh.15-0274; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; MIETTINEN OS, 1969, BIOMETRICS, V25, P339, DOI 10.2307/2528794; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; MoH, 2011, NAT DRINK WAT QUAL M; Oswald WE, 2007, AM J TROP MED HYG, V77, P699, DOI 10.4269/ajtmh.2007.77.699; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Tadesse D, 2010, RAPID ASSESSMENT DRI; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; Tumwine JK, 2002, TROP MED INT HEALTH, V7, P750, DOI 10.1046/j.1365-3156.2002.00927.x; UN-HABITAT, 2010, ETH CAS COND HOUS IN; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Vedachalam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176272; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; WHO, 2011, GUID DRINK WAT QUAL; WHO UNICEF, 2015, PR3GR SAN DR2N5 WAT; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; WHO(WorldHealthOrganization), 1997, GUID DRINK WAT QUAL; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2000, GLOB WAT SUPPL SAN A; World Health Organization, 2005, TREATM DIARRH MAN PH; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	62	47	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181516	10.1371/journal.pone.0181516	http://dx.doi.org/10.1371/journal.pone.0181516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723927	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800056
J	Xi, L; Belyaev, A; Spurgeon, S; Wang, XH; Gong, HB; Aboukhalil, R; Fekete, R				Xi, Larry; Belyaev, Alexander; Spurgeon, Sandra; Wang, Xiaohui; Gong, Haibiao; Aboukhalil, Robert; Fekete, Richard			New library construction method for single-cell genomes	PLOS ONE			English	Article							COPY-NUMBER VARIATIONS; CANCER; AMPLIFICATION; EVOLUTION; PCR	A central challenge in sequencing single-cell genomes is the accurate determination of point mutations, phasing of these mutations, and identifying copy number variations with few assumptions. Ideally, this is accomplished under as low sequencing coverage as possible. Here we report our attempt to meet these goals with a novel library construction and library amplification methodology. In our approach, single-cell genomic DNA is first fragmented with saturated transposition to make a primary library that uniformly covers the whole genome by short fragments. The library is then amplified by a carefully optimized PCR protocol in a uniform and synchronized fashion for next-generation sequencing. Each step of the protocol can be quantitatively characterized. Our shallow sequencing data show that the library is tightly distributed and is useful for the determination of copy number variations.	[Xi, Larry; Belyaev, Alexander; Spurgeon, Sandra; Wang, Xiaohui; Gong, Haibiao; Aboukhalil, Robert; Fekete, Richard] Fluidigm Corp, San Francisco, CA 94080 USA; [Xi, Larry] Digenomix Corp, San Francisco, CA USA		Xi, L (corresponding author), Fluidigm Corp, San Francisco, CA 94080 USA.	lxi@digenomix.net			Fluidigm	Fluidigm	Fluidigm provided financial support in the form of authors' salaries and research materials for the authors, LX, AB, SS, XW, HG, RA, and RF. Fluidigm did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Arneson N, 2008, CSH PROTOC; Babayan A., 2016, ONCOTARGET; Baslan T, 2014, CURR OPIN GENET DEV, V26, P59, DOI 10.1016/j.gde.2014.06.004; Bronner I.F., 2014, CURR PROTOC HUM GENE, V80, P2, DOI DOI 10.1002/0471142905.HG1802S80; Chen CY, 2017, SCIENCE, V356, P189, DOI 10.1126/science.aak9787; Dai ZM, 2007, J BIOTECHNOL, V128, P435, DOI 10.1016/j.jbiotec.2006.10.018; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Green B, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-3; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linnarsson S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0960-x; Mamaeva SE, 1998, INT REV CYTOL, V178, P1; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; MUTTER GL, 1991, NUCLEIC ACIDS RES, V19, P4203, DOI 10.1093/nar/19.15.4203; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Navin NE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8319; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin H, 2001, Dev Biol (Basel), V106, P61; Szulwach KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135007; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zahn H, 2017, NAT METHODS, V14, P167, DOI [10.1038/NMETH.4140, 10.1038/nmeth.4140]; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	34	14	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181163	10.1371/journal.pone.0181163	http://dx.doi.org/10.1371/journal.pone.0181163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723968	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800037
J	Li, CJ; Shi, X; Mohamad, OA; Gaol, J; Xu, XW; Xie, YJ				Li, Congjuan; Shi, Xiang; Mohamad, Osama Abdalla; Gaol, Jie; Xu, Xinwen; Xie, Yijun			Moderate irrigation intervals facilitate establishment of two desert shrubs in the Taklimakan Desert Highway Shelterbelt in China	PLOS ONE			English	Article							SALINE WATER; HALOXYLON-AMMODENDRON; CARBON ASSIMILATION; PRECIPITATION; CLIMATE; CLASSIFICATION; RESPONSES; STRATEGY; DROUGHT	Background Water influences various physiological and ecological processes of plants in different ecosystems, especially in desert ecosystems. The purpose of this study is to investigate the response of physiological and morphological acclimation of two shrubs Haloxylon ammo-dendron and Calligonum mongolicunl to variations in irrigation intervals. Methodology/Principal findings The irrigation frequency was set as 1-, 2-, 4-, 8- and 12-week intervals respectively from March to October during 2012-2014 to investigate the response of physiological and morphological acclimation of two desert shrubs Haloxylon ammo-dendron and Calligonum mongolicunl to variations in the irrigation system. The irrigation interval significantly affected the individual-scale carbon acquisition and biomass allocation pattern of both species. Under good water conditions (1- and 2-week intervals), carbon assimilation was significantly higher than other treatments; while, under water shortage conditions (8- and 12-week intervals), there was much defoliation; and under moderate irrigation intervals (4 weeks), the assimilative organs grew gently with almost no defoliation occurring. Conclusion/Significance Both studied species maintained similar ecophysiologically adaptive strategies, while C. mongolicunl was more sensitive to drought stress because of its shallow root system and preferential belowground allocation of resources. A moderate irrigation interval of 4 weeks was a suitable pattern for both plants since it not only saved water but also met the water demands of the plants.	[Li, Congjuan; Gaol, Jie; Xu, Xinwen] Chinese Acad Sci, Dept Natl Engn Technol Res Ctr Desert Oasis Ecol, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Shi, Xiang] Shihezi Univ, Dept Agr Coll, Shihezi, Xinjiang, Peoples R China; [Mohamad, Osama Abdalla] Chinese Acad Sci, Dept Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Xie, Yijun] Urumqi Forestry Bur, Dept Midong Municipal Bur Pk, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Shihezi University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Shi, X (corresponding author), Shihezi Univ, Dept Agr Coll, Shihezi, Xinjiang, Peoples R China.	2000wwww@163.com	Li, Congjuan/ABH-8523-2020; Abdalla Abdelshafy Mohamad, Osama/GGS-3886-2022	Abdalla Abdelshafy Mohamad, Osama/0000-0002-2234-8273	Youth Innovation Promotion Association of CAS [2017476]; Xinjiang Youth Science and Technology Innovation Leader Project [QN2016BS0162]; National Natural Science Foundation of China [31300449, 31660061, 31200417, 41301038]; Western Light Project of CAS [XBBS201205]; Urumqi Science and Technology Support [G151310005]	Youth Innovation Promotion Association of CAS; Xinjiang Youth Science and Technology Innovation Leader Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Western Light Project of CAS; Urumqi Science and Technology Support	This study was supported by grants from the Youth Innovation Promotion Association of CAS (2017476), Xinjiang Youth Science and Technology Innovation Leader Project (QN2016BS0162), the National Natural Science Foundation of China (31300449, 31660061, 31200417, 41301038), the Western Light Project of CAS (XBBS201205), and Urumqi Science and Technology Support (G151310005).	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; [李向义 Li Xiangyi], 2004, [生态学报, Acta Ecologica Sinica], V24, P1164; Beltran JM, 1999, AGR WATER MANAGE, V40, P183, DOI 10.1016/S0378-3774(98)00120-6; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; COHEN Y, 1983, J EXP BOT, V34, P451, DOI 10.1093/jxb/34.4.451; Dai Y, 2015, PLANT SOIL, V389, P73, DOI 10.1007/s11104-014-2342-z; Dai Yue, 2014, Chinese Journal of Plant Ecology, V38, P1214, DOI 10.3724/SP.J.1258.2014.00117; Day P. R., 1965, METHODS SOIL ANAL 2, V9, P548; DONOVAN LA, 1994, FUNCT ECOL, V8, P289, DOI 10.2307/2389821; Feikema PM, 2010, PLANT SOIL, V332, P429, DOI 10.1007/s11104-010-0309-2; GIBSON AC, 1996, STRUCTURE FUNCTION R, P45; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; Horton JL, 2001, TREE PHYSIOL, V21, P233, DOI 10.1093/treephys/21.4.233; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lei JQ, 2008, CHINESE SCI BULL, V53, P1, DOI 10.1007/s11434-008-6023-2; Li BW, 2008, CHINESE SCI BULL, V53, P31, DOI 10.1007/s11434-008-6003-6; Li C.J., 2012, 2 INT C REM SENS ENV, P2522, DOI [10.1109/rsete.2012.6260734, DOI 10.1109/RSETE.2012.6260734]; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li CJ, 2011, ECOL RES, V26, P385, DOI 10.1007/s11284-010-0793-0; Li XY, 2002, ACTA PHYTOECOLOGIC S, V27, P516; Li Y, 2005, PLANT CELL ENVIRON, V28, P492, DOI 10.1111/j.1365-3040.2005.01291.x; Lombardini L, 2006, DRYLAND ECOHYDROLOGY, P47, DOI 10.1007/1-4020-4260-4_4; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; SMITH SD, 1997, PHYSL ECOLOGY N AM D, P27; Su PeiXi, 2005, Acta Phytoecologica Sinica, V29, P1; [苏培垒 SU PeiXi], 2006, [生态学报, Acta Ecologica Sinica], V26, P75; Su PX, 2004, SCI CHINA SER D, V47, P39, DOI 10.1360/04zd0005; Tedeschi A, 2005, AGR WATER MANAGE, V77, P308, DOI 10.1016/j.agwat.2004.09.036; Verma AK, 2012, AGR WATER MANAGE, V115, P186, DOI 10.1016/j.agwat.2012.09.005; Wang HF, 2008, CHINESE SCI BULL, V53, P41, DOI 10.1007/s11434-008-6004-5; Wang RS, 2011, AGR WATER MANAGE, V100, P58, DOI 10.1016/j.agwat.2011.08.005; Weltzin JF, 2000, ECOLOGY, V81, P1902, DOI 10.1890/0012-9658(2000)081[1902:IOPRFS]2.0.CO;2; Xu GQ, 2008, FUNCT PLANT BIOL, V35, P1234, DOI 10.1071/FP08175; Xu GQ, 2016, J PLANT PHYSIOL, V194, P35, DOI 10.1016/j.jplph.2016.02.014; Xu GQ, 2014, J ARID LAND, V6, P581, DOI 10.1007/s40333-014-0029-1; Xu H, 2007, PLANT CELL ENVIRON, V30, P399, DOI 10.1111/j.1365-3040.2006.001626.x; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Xu Hao, 2010, Chinese Journal of Plant Ecology, V34, P375, DOI 10.3773/j.issn.1005-264x.2010.04.003; Yang Xiao-Lin, 2008, Zhiwu Shengtai Xuebao, V32, P1268, DOI 10.3773/j.issn.1005-264x.2008.06.007; [杨小林 Yang Xiaolin], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P145; Zhang JG, 2008, CHINESE SCI BULL, V53, P63, DOI 10.1007/s11434-008-6006-3; Zou T, 2010, ECOL RES, V25, P185, DOI 10.1007/s11284-009-0642-1	45	10	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180875	10.1371/journal.pone.0180875	http://dx.doi.org/10.1371/journal.pone.0180875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719623	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400022
J	Xu, MJ; Kitaura, Y; Ishikawa, T; Kadota, Y; Terai, C; Shindo, D; Morioka, T; Ota, M; Morishita, Y; Ishihara, K; Shimomura, Y				Xu, Minjun; Kitaura, Yasuyuki; Ishikawa, Takuya; Kadota, Yoshihiro; Terai, Chihaya; Shindo, Daichi; Morioka, Takashi; Ota, Miki; Morishita, Yukako; Ishihara, Kengo; Shimomura, Yoshiharu			Endurance performance and energy metabolism during exercise in mice with a muscle-specific defect in the control of branched-chain amino acid catabolism	PLOS ONE			English	Article							KETOACID DEHYDROGENASE KINASE; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; SWIMMING POOL; ACTIVATION; COMPLEX; PROTEIN; SUPPLEMENTATION; EXPRESSION; CAPACITY	It is known that the catabolism of branched-chain amino acids (BCAAs) in skeletal muscle is suppressed under normal and sedentary conditions but is promoted by exercise. BCAA catabolism in muscle tissues is regulated by the branched-chain a-keto acid (BCKA) dehydrogenase complex, which is inactivated by phosphorylation by BCKA dehydrogenase kinase (BDK). In the present study, we used muscle-specific BDK deficient mice (BDK-mKO mice) to examine the effect of uncontrolled BCAA catabolism on endurance exercise performance and skeletal muscle energy metabolism. Untrained control and BDK-mKO mice showed the same performance; however, the endurance performance enhanced by 2 weeks of running training was somewhat, but significantly less in BDK-mKO mice than in control mice. Skeletal muscle of BDK-mKO mice had low levels of glycogen. Metabolome analysis showed that BCAA catabolism was greatly enhanced in the muscle of BDK-mKO mice and produced branched-chain acyl-carnitine, which induced perturbation of energy metabolism in the muscle. These results suggest that the tight regulation of BCAA catabolism in muscles is important for homeostasis of muscle energy metabolism and, at least in part, for adaptation to exercise training.	[Xu, Minjun; Kitaura, Yasuyuki; Ishikawa, Takuya; Kadota, Yoshihiro; Terai, Chihaya; Shindo, Daichi; Morioka, Takashi; Ota, Miki; Morishita, Yukako; Shimomura, Yoshiharu] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Ishihara, Kengo] Ryukoku Univ, Fac Agr, Fushimi Ku, Kyoto, Japan	Nagoya University; Ryukoku University	Shimomura, Y (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	shimo@agr.nagoya-u.ac.jp	Ishihara, Kengo/J-7913-2019	Ishihara, Kengo/0000-0001-9374-5033	JSPS KAKENHI [26292068, 17H03817, 25504005, 22650152]; Uehara Memorial Foundation; Food Science Institute Foundation; Grants-in-Aid for Scientific Research [17H03817] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Food Science Institute Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 26292068 and 17H03817 from Grant-in-Aid for Scientific Research (B) (to YS), No. 25504005 from Grant-in-Aid for Scientific Research (C) (to YKitaura), No. 22650152 from Grant-in-Aid for Challenging Exploratory Research (to YS)), The Uehara Memorial Foundation (to YKitaura), and The Food Science Institute Foundation (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antweiler RC, 2008, ENVIRON SCI TECHNOL, V42, P3732, DOI 10.1021/es071301c; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Ishihara K, 2009, J NUTR SCI VITAMINOL, V55, P301, DOI 10.3177/jnsv.55.301; Ishikawa T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39825; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; Kobayashi R, 1999, J NUTR SCI VITAMINOL, V45, P303, DOI 10.3177/jnsv.45.303; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; POPOV KM, 1992, J BIOL CHEM, V267, P13127; Schadewaldt P, 2000, METHOD ENZYMOL, V324, P23; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; SHIMOMURA Y, 1990, J APPL PHYSIOL, V68, P161, DOI 10.1152/jappl.1990.68.1.161; Shimomura Y, 2006, J NUTR, V136, p250S, DOI 10.1093/jn/136.1.250S; SHIMOMURA Y, 1990, ARCH BIOCHEM BIOPHYS, V283, P293, DOI 10.1016/0003-9861(90)90645-F; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Uchida MC, 2008, REV BRAS MED ESPORTE, V14, P42, DOI 10.1590/S1517-86922008000100008; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; WAGENMAKERS AJM, 1989, EUR J APPL PHYSIOL, V59, P159, DOI 10.1007/BF02386181; Watson P, 2004, EUR J APPL PHYSIOL, V93, P306, DOI 10.1007/s00421-004-1206-2; Wharton DC., 1967, METHOD ENZYMOL, P245; Xu M, 2001, BIOCHEM BIOPH RES CO, V287, P752, DOI 10.1006/bbrc.2001.5647	32	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180989	10.1371/journal.pone.0180989	http://dx.doi.org/10.1371/journal.pone.0180989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719620	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400026
J	Barr, KA; Reinitz, J				Barr, Kenneth A.; Reinitz, John			A sequence level model of an intact locus predicts the location and function of nonadditive enhancers	PLOS ONE			English	Article							SEGMENTATION GENE-EXPRESSION; TRANSCRIPTION FACTOR-BINDING; CIS-REGULATORY MODULES; MULTIPLE ENHANCERS; SHADOW ENHANCERS; COMMON SET; DROSOPHILA; STRIPE; ELEMENTS; PATTERNS	Metazoan gene expression is controlled through the action of long stretches of noncoding DNA that contain enhancers-shorter sequences responsible for controlling a single aspect of a gene's expression pattern. Models built on thermodynamics have shown how enhancers interpret protein concentration in order to determine specific levels of gene expression, but the emergent regulatory logic of a complete regulatory locus shows qualitative and quantitative differences from isolated enhancers. Such differences may arise from steric competition limiting the quantity of DNA that can simultaneously influence the transcription machinery. We incorporated this competition into a mechanistic model of gene regulation, generated efficient algorithms for this computation, and applied it to the regulation of Drosophila even-skipped (eve). This model finds the location of enhancers and identifies which factors control the boundaries of eve expression. This model predicts a new enhancer that, when assayed in vivo, drives expression in a non-eve pattern. Incorporation of chromatin accessibility eliminates this inconsistency.	[Barr, Kenneth A.; Reinitz, John] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Barr, KA (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	barr@uchicago.edu		Barr, Kenneth/0000-0002-0769-7053	National Institute of Health [R01 OD010936]; University of Chicago; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010936] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago(University of Chicago); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health R01 OD010936 (KB JR) and the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bertolino E, 2016, DEV BIOL, V413, P128, DOI 10.1016/j.ydbio.2016.02.030; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Gibson D., 2009, PROTOCOL EXCHANGE; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janssens H, 2005, DEV GENES EVOL, V215, P374, DOI 10.1007/s00427-005-0484-y; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Jiang P, 2015, DEV BIOL, V123, p106 ; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kazemian M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000456; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kozlov Konstantin, 2002, In Silico Biology, V2, P125; Kozlov KN, 2009, FLY, V3, P151, DOI 10.4161/fly.8599; Lam J., 1988, EFFICIENT SIMULATED, P8816; Lam J., 1988, EFFICIENT SIMULATED; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Martinez C, 2014, MOL BIOL EVOL, V31, P903, DOI 10.1093/molbev/msu042; Martinez CA, 2013, METHODS, V62, P91, DOI 10.1016/j.ymeth.2013.05.014; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noyes MB, 2008, NUCLEIC ACIDS RES, P1; Ogawa N, 2012, METHODS MOL BIOL, V786, P51, DOI 10.1007/978-1-61779-292-2_3; Pagans S, 2002, NUCLEIC ACIDS RES, V30, P4406, DOI 10.1093/nar/gkf570; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Sackerson C, 1999, DEV BIOL, V211, P39, DOI 10.1006/dbio.1999.9301; Samee MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003467; Samee MA, 2013, METHODS, V62, P79, DOI 10.1016/j.ymeth.2013.03.005; Satija R, 2012, GENOME RES, V22, P656, DOI 10.1101/gr.130682.111; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Teif VB, 2013, METHODS, V62, P26, DOI 10.1016/j.ymeth.2013.03.011; Tsurumi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002086; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050	79	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180861	10.1371/journal.pone.0180861	http://dx.doi.org/10.1371/journal.pone.0180861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715438	gold, Green Submitted, Green Published			2022-12-26	WOS:000443975500019
J	Ogunola, OF; Hawkins, LK; Mylroie, E; Kolomiets, MV; Borrego, E; Tang, JD; Williams, WP; Warburton, ML				Ogunola, Oluwaseun F.; Hawkins, Leigh K.; Mylroie, Erik; Kolomiets, Michael, V; Borrego, Eli; Tang, Juliet D.; Williams, W. Paul; Warburton, Marilyn L.			Characterization of the maize lipoxygenase gene family in relation to aflatoxin accumulation resistance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FUSARIUM-VERTICILLIOIDES; CONTRIBUTING RESISTANCE; ASPERGILLUS-FLAVUS; JASMONIC ACID; DEFENSE; IDENTIFICATION; EXPRESSION; DISRUPTION; INFECTION	Maize (Zea mays L.) is a globally important staple food crop prone to contamination by aflatoxin, a carcinogenic secondary metabolite produced by the fungus Aspergillus flavus. An efficient approach to reduce accumulation of aflatoxin is the development of germplasm resistant to colonization and toxin production by A. flavus. Lipoxygenases (LOXs) are a group of non-heme iron containing dioxygenase enzymes that catalyze oxygenation of polyunsaturated fatty acids (PUFAs). LOX derived oxylipins play critical roles in plant defense against pathogens including A. flavus. The objectives of this study were to summarize sequence diversity and expression patterns for all LOX genes in the maize genome, and map their effect on aflatoxin accumulation via linkage and association mapping. In total, 13 LOX genes were identified, characterized, and mapped. The sequence of one gene, ZmLOX10, is reported from 5 inbred lines. Genes ZmLOX1/2, 5, 8, 9, 10 and 12 (GRMZM2G156861, or V4 numbers ZM00001D042541 and Zm00001D042540, GRMZM2G102760, GRMZM2G104843, GRMZM2G017616, GRMZM2G015419, and GRMZM2G106748, respectively) fell under previously published QTL in one or more mapping populations and are linked to a measurable reduction of aflatoxin in maize grains. Association mapping results found 28 of the 726 SNPs tested were associated with reduced aflatoxin levels at p <= 9.71 x 10(-4) according to association statistics. These fell within or near nine of the ZmLOX genes. This work confirms the importance of some lipoxygenases for resistance to aflatoxin accumulation and may be used to direct future genetic selection in maize.	[Ogunola, Oluwaseun F.] Mississippi State Univ, Dept Plant & Soil Sci, Starkville, MS USA; [Hawkins, Leigh K.; Mylroie, Erik; Williams, W. Paul; Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS 39759 USA; [Kolomiets, Michael, V; Borrego, Eli] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Tang, Juliet D.] USDA FS, Forest Prod Lab, Durabil & Wood Protect, Starkville, MS USA	Mississippi State University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service	Warburton, ML (corresponding author), USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS 39759 USA.	marilyn.warburton@ars.usda.gov	Borrego, Eli/G-9867-2011; Warburton, Marilyn/J-2250-2017	Borrego, Eli/0000-0002-3538-3203; Warburton, Marilyn/0000-0002-9542-9912	United States Department of Agriculture; United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize" [58-0210-3-012]	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize"(United States Agency for International Development (USAID))	This work was supported entirely by the United States Department of Agriculture and the United States Agency for International Development joint Feed the Future program, project "Genetic resistance to Aspergillus flavus and aflatoxin in maize", agreement 58-0210-3-012. There was no additional external funding received for this study.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Anders S, 2014, BIOINFORMATICS, V25; Andorf CM, 2016, NUCLEIC ACIDS RES, V44, pD1195, DOI 10.1093/nar/gkv1007; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blount WP, 1961, TURKEYS, V52, P55; Borrego EJ, 2012, BIOCOMMUNICATION FUN, P249; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brooks TD, 2005, CROP SCI, V45, P171; Castegnaro M, 1998, REV MED VET-TOULOUSE, V149, P671; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Christensen SA, 2014, MOL PLANT MICROBE IN, V27, P1263, DOI 10.1094/MPMI-06-13-0184-R; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; De La Fuente GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053973; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2013, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, DOI 10.1093/NAR/GKH121]; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Goldblatt L., 2012, AFLATOXIN SCI BACKGR; Isakeit T, 2007, J PHYTOPATHOL, V155, P758, DOI 10.1111/j.1439-0434.2007.01301.x; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Kim ES, 2003, PLANT MOL BIOL, V52, P1203, DOI 10.1023/B:PLAN.0000004331.94803.b0; Lawrence Carolyn J, 2008, Int J Plant Genomics, V2008, P496957, DOI 10.1155/2008/496957; MARSH SF, 1984, PHYTOPATHOLOGY, V74, P1284, DOI 10.1094/Phyto-74-1284; Maschietto V, 2015, J PLANT PHYSIOL, V188, P9, DOI 10.1016/j.jplph.2015.09.003; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Monaco MK, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.09.0025; Moreno OJ, 1999, PLANT BREEDING, V118, P1, DOI 10.1046/j.1439-0523.1999.118001001.x; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; Park Yoon Joo, 2011, THESIS; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Stelpflug SC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0025; Tang JD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1874-9; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Warburton ML, 2015, CROP SCI, V55, P1857, DOI 10.2135/cropsci2014.06.0424; Warburton ML, 2013, CROP SCI, V53, P2374, DOI 10.2135/cropsci2012.10.0616; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Warburton ML, 2009, CROP SCI, V49, P1403, DOI 10.2135/cropsci2008.12.0696; Warburton ML, 2014, ADV BOT, V2014, P10, DOI [10.1155/2014/352831, DOI 10.1155/2014/352831]; Wessler S, 2009, MAIZE TRANSPOSABLE E; Willcox MC, 2013, MOL BREEDING, V32, P15, DOI 10.1007/s11032-012-9821-9; Williams WP, 2015, WORLD MYCOTOXIN J, V8, P193, DOI 10.3920/WMJ2014.1751; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151	49	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181265	10.1371/journal.pone.0181265	http://dx.doi.org/10.1371/journal.pone.0181265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715485	Green Submitted, Green Published, gold			2022-12-26	WOS:000443975500042
J	Idh, J; Andersson, B; Lerm, M; Raffetseder, J; Eklund, D; Woksepp, H; Werngren, J; Mansjo, M; Sundqvist, T; Stendahl, O; Schon, T				Idh, Jonna; Andersson, Blanka; Lerm, Maria; Raffetseder, Johanna; Eklund, Daniel; Woksepp, Hanna; Werngren, Jim; Mansjo, Mikael; Sundqvist, Tommy; Stendahl, Olle; Schon, Thomas			Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISONIAZID ACTIVATION; IN-VITRO; RESISTANCE; HOMEOSTASIS; INFECTION; REDUCTASE; DONORS; OXYGEN; KATG	Background Drugs such as isoniazid (INH) and pretomanid (PRT), used against Mycobacterium tuberculosis are active partly through generation of reactive nitrogen species (RNS). The aim of this study was to explore variability in intracellular susceptibility to nitric oxide (NO) in clinical strains of M. tuberculosis. Method Luciferase-expressing clinical M. tuberculosis strains with or without INH resistance were exposed to RNS donors (DETA/NO and SIN-1) in broth cultures and bacterial survival was analysed by luminometry. NO-dependent intracellular killing in a selection of strains was assessed in interferon gamma/lipopolysaccharide-activated murine macrophages using the NO inhibitor L-NMMA. Results When M. tuberculosis H37Rv was compared to six clinical isolates and CDC1551, three isolates with inhA mediated INH resistance showed significantly reduced NO-susceptibility in broth culture. All strains showed a variable but dose-dependent susceptibility to RNS donors. Two clinical isolates with increased susceptibility to NO exposure in broth compared to H37Rv were significantly inhibited by activated macrophages whereas there was no effect on growth inhibition when activated macrophages were infected by clinical strains with higher survival to NO exposure in broth. Furthermore, the most NO-tolerant clinical isolate showed increased resistance to PRT both in broth culture and the macrophage model compared to H37Rv in the absence of mutational resistance in genes associated to reduced susceptibility against PRT or NO. Conclusion In a limited number of clinical M. tuberculosis isolates we found a significant difference in susceptibility to NO between clinical isolates, both in broth cultures and in macrophages. Our results indicate that mycobacterial susceptibility to cellular host defence mechanisms such as NO need to be taken into consideration when designing new therapeutic strategies.	[Idh, Jonna; Andersson, Blanka; Lerm, Maria; Raffetseder, Johanna; Eklund, Daniel; Sundqvist, Tommy; Stendahl, Olle; Schon, Thomas] Linkoping Univ, Dept Clin & Expt Med, Div Microbiol & Mol Med, Linkoping, Sweden; [Lerm, Maria] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Woksepp, Hanna; Schon, Thomas] Linneaus Univ, Dept Optometry & Med, Kalmar, Sweden; [Woksepp, Hanna; Schon, Thomas] Kalmar Cty Hosp, Dept Infect Dis & Clin Microbiol, Kalmar, Sweden; [Werngren, Jim; Mansjo, Mikael] Publ Hlth Agcy Sweden, Dept Microbiol, Unit Lab Surveillance Bacterial Pathogens, Solna, Sweden	Linkoping University; Karolinska Institutet; Linnaeus University; Public Health Agency of Sweden	Schon, T (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Microbiol & Mol Med, Linkoping, Sweden.; Schon, T (corresponding author), Linneaus Univ, Dept Optometry & Med, Kalmar, Sweden.; Schon, T (corresponding author), Kalmar Cty Hosp, Dept Infect Dis & Clin Microbiol, Kalmar, Sweden.	tschon@hotmail.com	Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Woksepp, Hanna/0000-0002-1707-2655; Eklund, Daniel/0000-0002-6045-4800; Raffetseder, Johanna/0000-0001-8871-2560	Research Council of South East of Sweden; Swedish Heart and Lung Foundation; Swedish Research Council	Research Council of South East of Sweden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was financially supported by the Research Council of South East of Sweden (TSc; FORSS, http://www.fou.nu/is/forss), the Swedish Heart and Lung Foundation (OS, TSc; https://www3.hjart-lungfonden.se, (Oscar II Jubilee Foundation) and the Swedish Research Council (TSc, OS; http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Attarian R, 2009, FEBS LETT, V583, P3215, DOI 10.1016/j.febslet.2009.09.007; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Firmani MA, 2002, INFECT IMMUN, V70, P3965, DOI 10.1128/IAI.70.7.3965-3968.2002; Flynn JL, 1998, J IMMUNOL, V160, P1796; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; Idh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039891; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Liu YC, 2016, J EXP MED, V213, P809, DOI 10.1084/jem.20151248; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Martin-Romero FJ, 2004, J FLUORESC, V14, P17, DOI 10.1023/B:JOFL.0000014655.89256.bd; Miranda KM EM, 2010, NITRIC OXIDE; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2008, SCIENCE, V322, P1337, DOI 10.1126/science.1167452; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Schon T, 2004, INT J TUBERC LUNG D, V8, P1134; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shi SP, 2006, INFECT IMMUN, V74, P56, DOI 10.1128/IAI.74.1.56-63.2006; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timmins GS, 2004, J BACTERIOL, V186, P5427, DOI 10.1128/JB.186.16.5427-5431.2004; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181221	10.1371/journal.pone.0181221	http://dx.doi.org/10.1371/journal.pone.0181221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704501	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700109
J	Lim, YC; Li, J; Ni, YY; Liang, Q; Zhang, JJ; Yeo, GSH; Lyu, JX; Jin, SN; Ding, CM				Lim, Yen Ching; Li, Jie; Ni, Yiyun; Liang, Qi; Zhang, Junjiao; Yeo, George S. H.; Lyu, Jianxin; Jin, Shengnan; Ding, Chunming			A complex association between DNA methylation and gene expression in human placenta at first and third trimesters	PLOS ONE			English	Article							IMPRINTED GENES; GROWTH; METHYLOME; PATTERNS; CHILDREN	The human placenta is a maternal-fetal organ essential for normal fetal development and maternal health. During pregnancy, the placenta undergoes many structural and functional changes in response to fetal needs and environmental exposures. Previous studies have demonstrated widespread epigenetic and gene expression changes from early to late pregnancy. However, on the global level, how DNA methylation changes impact on gene expression in human placenta is not yet well understood. We performed DNA methylome analysis by reduced representation bisulfite sequencing (RRBS)and gene expression analysis by RNA-Seq for both first and third trimester human placenta tissues. From first to third trimester, 199 promoters (corresponding to 189 genes) and 2,297 gene bodies were differentially methylated, with a clear dominance of hypermethylation (96.8% and 93.0% for promoters and gene bodies, respectively). A total of 2,447 genes were differentially expressed, of which 77.2% were down-regulated. Gene ontology analysis using differentially expressed genes were enriched for cell cycle and immune response functions. The correlation between DNA methylation and gene expression was non-linear and complex, depending on the genomic context (promoter or gene body) and gene expression levels. A wide range of DNA methylation and gene expression changes were observed at different gestational ages. The non-linear association between DNA methylation and gene expression indicates that epigenetic regulation of placenta development is more complex than previously envisioned.	[Lim, Yen Ching; Li, Jie; Ni, Yiyun; Liang, Qi; Zhang, Junjiao; Lyu, Jianxin; Jin, Shengnan; Ding, Chunming] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou, Zhejiang, Peoples R China; [Yeo, George S. H.] KK Womens & Childrens Hosp, Singapore, Singapore	Ministry of Education, China; Wenzhou Medical University; KK Women's & Children's Hospital	Lyu, JX; Jin, SN; Ding, CM (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou, Zhejiang, Peoples R China.	ljxwzmc@aliyun.com; snjin1997@qq.com; cmding@gmail.com	Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594	National Health and Family Planning Commission of Zhejiang Province; Wenzhou Medical University Startup fund	National Health and Family Planning Commission of Zhejiang Province; Wenzhou Medical University Startup fund	This work is supported by National Health and Family Planning Commission of Zhejiang Province (CD) and the Wenzhou Medical University Startup fund (CD and SJ). The funder provided support in the form of salaries for authors [JL, SJ, CD, YCL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barbaux S, 2012, EPIGENETICS-US, V7, P1079, DOI 10.4161/epi.21495; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Buckberry S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051210; Chu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107318; Comas M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.044; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Das R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-685; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fattal-Valevski A, 2009, J CHILD NEUROL, V24, P846, DOI 10.1177/0883073808331082; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hamada H, 2016, AM J HUM GENET, V99, P1045, DOI 10.1016/j.ajhg.2016.08.021; HECHER K, 1995, CIRCULATION, V91, P129, DOI 10.1161/01.CIR.91.1.129; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; John R, 2012, REPROD BIOMED ONLINE, V25, P5, DOI 10.1016/j.rbmo.2012.03.018; Lambertini L, 2012, PLACENTA, V33, P480, DOI 10.1016/j.placenta.2012.03.001; Lambertini L, 2011, REPROD SCI, V18, P1111, DOI 10.1177/1933719111404611; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee YK, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-1; Lim YC, 2016, MOL METAB, V5, P1033, DOI 10.1016/j.molmet.2016.08.006; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Magalhaes HR, 2013, BRAZ J MED BIOL RES, V46, P916, DOI 10.1590/1414-431X20133035; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Roifman M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0238-x; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spence D, 2012, PUBLIC HEALTH, V126, P561, DOI 10.1016/j.puhe.2012.03.010; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Teeninga N, 2008, NEPHROL DIAL TRANSPL, V23, P1615, DOI 10.1093/ndt/gfm829; Tycko B, 2006, CYTOGENET GENOME RES, V113, P271, DOI 10.1159/000090842; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yeung KR, 2016, AM J PHYSIOL-HEART C, V310, pH1295, DOI 10.1152/ajpheart.00958.2015; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	46	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181155	10.1371/journal.pone.0181155	http://dx.doi.org/10.1371/journal.pone.0181155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704530	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700099
J	Matthews, GJ; Thiruvathukal, GK; Luetkemeier, MP; Brophy, JK				Matthews, Gregory J.; Thiruvathukal, George K.; Luetkemeier, Maxwell P.; Brophy, Juliet K.			Examining the use of Amazon's Mechanical Turk for edge extraction of the occlusal surface of fossilized bovid teeth	PLOS ONE			English	Article							GAUTENG PROVINCE; PLOVERS LAKE	In order to reconstruct environments associated with Plio-Pleistocene hominins in southern Africa, researchers frequently rely upon the animals associated with the hominins, in particular, animals in the Family Bovidae. Bovids in southern Africa are typically identified by their teeth. However, identifying the taxon of a bovid tooth is challenging due to various biasing factors. Furthermore, inaccurate identification of fossil bovids can have significant consequences on the reconstructed paleoenvironment. Recent research on the classification of bovid fossil teeth has relied on using elliptical Fourier analysis to summarize the shape of the outline of the occlusal surface of the tooth and the resulting harmonic amplitudes. Currently, an expert in the field must manually place landmarks around the edges of each tooth which is slow and time consuming. This study tests whether it is possible to crowdsource this task, while maintaining the necessary level of quality needed to perform a statistical analysis on each tooth. Amazon Mechanical Turk workers place landmarks on the edge of the tooth which is compared to the performance of an expert in the field. The results suggest that crowdsourcing the digitization process is reliable and replicable. With the technical aspects of digitization managed, researchers can concentrate on analyzing and interpreting the data.	[Matthews, Gregory J.; Luetkemeier, Maxwell P.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Thiruvathukal, George K.] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA; [Brophy, Juliet K.] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA	Loyola University Chicago; Loyola University Chicago; Louisiana State University System; Louisiana State University	Matthews, GJ (corresponding author), Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA.	gmatthews1@luc.edu						Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bright JA, 2014, J PALEONTOL, V88, P760, DOI 10.1666/13-090; Brophy JK, 2011, RECONSTRUCTING HABIT; Brophy JK, 2014, J ARCHAEOL SCI, V41, P376, DOI 10.1016/j.jas.2013.08.005; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cooke HBS, 1956, FOSSIL BOVIDAE LIMEW; de Ruiter DJ, 2008, J HUM EVOL, V55, P1102, DOI 10.1016/j.jhevol.2008.07.011; Drake AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08299; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Kendall DG, 1982, B LOND MATH SOC, V16, P81; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LESTREL P E, 1989, American Journal of Human Biology, V1, P149, DOI 10.1002/ajhb.1310010204; Lindeberg T, 1998, INT J COMPUT VISION, V30, P117, DOI 10.1023/A:1008097225773; Matthews GJ, 2016, COMP MACHINE LEARNIN; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Polly PD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111225; R Core Team, 2021, R LANGUAGE ENV STAT; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Rouse SV, 2015, COMPUT HUM BEHAV, V43, P304, DOI 10.1016/j.chb.2014.11.004; Sorokin A., 2008, P 1 IEEE WORKSH INT, V08, P1, DOI DOI 10.1109/CVPRW.2008.4562953; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; The GIMP Development Team, 2016, GMU IM MAN PROGR GIM; Vittayakorn S, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.109; Vrba ES, 1995, FOSSIL RECORD AFRICA; Wolfe CA, 1999, EFF23 2 D 3 D ELLIPT	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179757	10.1371/journal.pone.0179757	http://dx.doi.org/10.1371/journal.pone.0179757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704414	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700017
J	Zhao, J; Bi, HY; Coltheart, M				Zhao, Jing; Bi, Hong-Yan; Coltheart, Max			Different relationship of magnocellular-dorsal function and reading-related skills between Chinese developing and skilled readers	PLOS ONE			English	Article							PHONOLOGICAL AWARENESS; DEVELOPMENTAL DYSLEXIA; FMRI EVIDENCE; CHILDREN; DEFICITS; PATHWAY; ATTENTION; DYSFUNCTION; STREAM; SENSITIVITY	Previous studies have indicated that the relationship between magnocellular-dorsal (M-D) function and reading-related skills may vary with reading development in readers of alphabetic languages. Since this relationship could be affected by the orthographic depth of writing systems, the present study explored the relationship between M-D function and readingrelated skills in Chinese, a writing system with a deeper orthography than alphabetic languages. Thirty-seven primary school students and fifty-one undergraduate students participated. Orthographic and phonological awareness tests were adopted as reading-related skill measurements. A steady-pedestal paradigm was used to assess the low-spatial-frequency contrast thresholds of M-D function. Results showed that M-D function was only correlated with orthographic awareness for adults, revealing an enhancement with reading development; while being related to phonological awareness only for children revealing a developmental decrement. It suggested that the mechanism responsible for the relationship between M-D activity and reading-related skills was affected by the characteristics of literacy development in Chinese.	[Zhao, Jing; Bi, Hong-Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Ctr Brain Sci & Learning Difficulties, Beijing, Peoples R China; [Zhao, Jing; Bi, Hong-Yan] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Coltheart, Max] Macquarie Univ, Ctr Cognit & Its Disorders, Sydney, NSW, Australia	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Macquarie University	Bi, HY (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Ctr Brain Sci & Learning Difficulties, Beijing, Peoples R China.; Bi, HY (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.	bihy@psych.ac.cn	zhao, jing/B-3868-2019	Coltheart, Max/0000-0002-6580-0047	National Natural Science Foundation of China [31371044, 31671155, 31500903]; Beijing Advanced Innovation Center for Imaging Technology [BAICIT-2016018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Advanced Innovation Center for Imaging Technology	This research is supported by National Natural Science Foundation of China (grant numbers: 31371044, 31671155, 31500903), and Beijing Advanced Innovation Center for Imaging Technology (grant numbers: BAICIT-2016018). The website for National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The funders had a role in data collection of the manuscript.	Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar-Kochva I, 2013, READ WRIT, V26, P1417, DOI 10.1007/s11145-012-9414-3; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Boden C, 2009, BRAIN COGNITION, V69, P580, DOI 10.1016/j.bandc.2008.12.002; Boden C, 2007, PSYCHOL BULL, V133, P346, DOI 10.1037/0033-2909.133.2.346; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Cao F, 2011, NEUROIMAGE, V57, P750, DOI 10.1016/j.neuroimage.2010.09.047; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chung KKH, 2008, ANN DYSLEXIA, V58, P15, DOI 10.1007/s11881-008-0015-4; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Danelli L, 2013, HUM BRAIN MAPP, V34, P2669, DOI 10.1002/hbm.22098; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Giraldo-Chica M, 2015, NEUROIMAGE-CLIN, V7, P830, DOI 10.1016/j.nicl.2015.03.011; Goodbourn PT, 2012, P ROY SOC B-BIOL SCI, V279, P4263, DOI 10.1098/rspb.2012.1430; Gori S, 2016, CEREB CORTEX, V26, P4356, DOI 10.1093/cercor/bhv206; Gori S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00460; Gori S, 2014, VISION RES, V99, P78, DOI 10.1016/j.visres.2013.11.011; Grainger J, 2012, COGNITION, V123, P280, DOI 10.1016/j.cognition.2012.01.003; Heim S, 2014, BRAIN STRUCT FUNCT, V219, P461, DOI 10.1007/s00429-013-0509-7; Heim S, 2010, DYSLEXIA, V16, P258, DOI 10.1002/dys.409; Horie S, 2012, NEUROIMAGE, V63, P979, DOI 10.1016/j.neuroimage.2012.03.046; HUANG HS, 1995, COGNITION, V54, P73, DOI 10.1016/0010-0277(94)00641-W; Jednorog K, 2011, DEVELOPMENTAL SCI, V14, P873, DOI 10.1111/j.1467-7687.2011.01037.x; Kevan A, 2008, NEUROREPORT, V19, P467, DOI 10.1097/WNR.0b013e3282f5f7ad; Kevan A, 2009, NEUROPSYCHOLOGIA, V47, P3174, DOI 10.1016/j.neuropsychologia.2009.07.016; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1494, DOI 10.1016/j.neubiorev.2008.06.002; Levy T, 2010, VISION RES, V50, P883, DOI 10.1016/j.visres.2010.02.019; Luo YC, 2013, SCI STUD READ, V17, P22, DOI 10.1080/10888438.2012.689790; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; McBride-Chang C, 2011, J CHILD PSYCHOL PSYC, V52, P204, DOI 10.1111/j.1469-7610.2010.02299.x; McLean GMT, 2011, J EXP PSYCHOL HUMAN, V37, P1957, DOI 10.1037/a0024668; Meng XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108274; Meng XZ, 2011, ANN DYSLEXIA, V61, P161, DOI 10.1007/s11881-010-0049-2; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Olulade OA, 2013, NEURON, V79, P180, DOI 10.1016/j.neuron.2013.05.002; Pammer K, 2007, SCI STUD READ, V11, P33; Peng DS, 2004, COGNITIVE BRAIN RES, V20, P156, DOI 10.1016/j.cogbrainres.2004.02.006; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Pokorny J, 2011, J VISION, V11, DOI 10.1167/11.5.7; Qian Y, 2016, BRAIN LANG, V160, P42, DOI 10.1016/j.bandl.2016.07.007; Qian Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01529; Qian Y, 2015, NEUROPSYCHOLOGIA, V71, P84, DOI 10.1016/j.neuropsychologia.2015.03.024; Qian Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00692; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Ruffino M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00331; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Stein J., 2012, VISUAL ASPECTS DYSLE, P405; Stein John, 2014, Curr Dev Disord Rep, V1, P267; Tholen N, 2011, DYSLEXIA, V17, P268, DOI 10.1002/dys.434; Wang JJ, 2010, NEUROPSYCHOLOGIA, V48, P3627, DOI 10.1016/j.neuropsychologia.2010.08.015; Wang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044848; Wang ZK, 2014, DYSLEXIA, V20, P280, DOI 10.1002/dys.1475; Wei TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096240; X C Guo, 2000, PSYCHOL SCI, V23, P576; Xu GF, 2012, NEUROPSYCHOLOGIA, V50, P862, DOI 10.1016/j.neuropsychologia.2012.01.026; Zhao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07068; Zhao J, 2013, PROG BIOCHEM BIOPHYS, V40, P141, DOI 10.3724/SP.J.1206.2012.00262; Zhou W, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00495	67	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179712	10.1371/journal.pone.0179712	http://dx.doi.org/10.1371/journal.pone.0179712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704422	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700014
J	Chou, CL; Lin, H; Chen, JS; Fang, TC				Chou, Chu-Lin; Lin, Heng; Chen, Jin-Shuen; Fang, Te-Chao			Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; HYPERINSULINEMIA-INDUCED HYPERTENSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; TYPE-1 RECEPTOR; BLOOD-PRESSURE; CARDIOVASCULAR CHANGES; VASCULAR DYSFUNCTION; ALISKIREN; EXPRESSION	Renin-angiotensin system in visceral fat plays a crucial role in the pathogenesis of metabolic syndrome in fructose-fed rats. However, the effects of renin inhibition on visceral adiposity in metabolic syndrome are not fully investigated. We investigated the effects of renin inhibition on visceral adiposity in fructose-fed rats. Male Wistar-Kyoto rats were divided into 4 groups for 8-week experiments: Group Con (standard chow diet), Group Fru (high-fructose diet; 60% fructose), Group FruA (high-fructose diet and concurrent aliskiren treatment; 100 mg/kg body weight [BW] per day), and Group FruB (high-fructose diet and subsequent, i.e. 4 weeks after initiating high-fructose feeding, aliskiren treatment; 100 mg/kg BW per day). The high-fructose diet induced metabolic syndrome, increased visceral fat weights and adipocyte sizes, and augmented angiotensin II (Ang II), NADPH oxidase (NOX) isoforms expressions, oxidative stress, and dysregulated production of adipocytokines from visceral adipose tissues. Concurrent and subsequent aliskiren administration ameliorated metabolic syndrome, dysregulated adipocytokines, and visceral adiposity in high fructose-fed hypertensive rats, and was associated with reducing Ang II levels, NOX isoforms expressions and oxidative stress in visceral fat tissues. Therefore, this study demonstrates renin inhibition could improve metabolic syndrome, and reduce Ang II levels and oxidative stress in visceral fat tissue in fructose-fed rats, and suggests that visceral adipose Ang II plays a crucial role in the pathogenesis of metabolic syndrome in fructose-fed rats.	[Chou, Chu-Lin; Chen, Jin-Shuen] Natl Def Med Ctr, Div Nephrol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan; [Chou, Chu-Lin; Fang, Te-Chao] Taipei Med Univ, Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chou, Chu-Lin; Fang, Te-Chao] Taipei Med Univ, Sch Med, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Lin, Heng] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Fang, TC (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Fang, TC (corresponding author), Taipei Med Univ, Sch Med, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	fangtechao@yahoo.com.tw	Fang, Te-Chao/V-7731-2017	Fang, Te-Chao/0000-0002-5577-9280; Chou, Chu-Lin/0000-0002-9695-1067	Ministry of Science and Technology, Taiwan [MOST101-2314-B-303-013-MY3]; Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan [WFH104-11]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan (https://www. most.gov.tw; MOST101-2314-B-303-013-MY3; Funds for Te-Chao Fang) and Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan (http:// wfh.tmu.edu.tw; WFH104-11; Funds for Te-Chao Fang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamendi A, 2009, ENDOCRINE, V35, P227, DOI 10.1007/s12020-008-9143-1; Buczko W, 2008, PHARMACOL REP, V60, P623; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; Caminhotto Rde O, 2016, BRAZ J MED BIOL RES, V49; Castro MC, 2015, LIFE SCI, V137, P1, DOI 10.1016/j.lfs.2015.07.010; Chang L, 2012, AM J MED SCI, V343, P220, DOI 10.1097/MAJ.0b013e31822993ff; Chou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119843; Chou CL, 2013, HYPERTENS RES, V36, P123, DOI 10.1038/hr.2012.124; Chou CL, 2011, ARCH MED SCI, V7, P882, DOI 10.5114/aoms.2011.25566; Fang TC, 1998, HYPERTENSION, V32, P235, DOI 10.1161/01.HYP.32.2.235; Fang TC, 1998, J HYPERTENS, V16, P1767, DOI 10.1097/00004872-199816120-00009; Ferder L, 2010, CURR HYPERTENS REP, V12, P105, DOI 10.1007/s11906-010-0097-3; Fukui T, 1997, CIRC RES, V80, P45, DOI 10.1161/01.RES.80.1.45; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Galinier A, 2006, J BIOL CHEM, V281, P12682, DOI 10.1074/jbc.M506949200; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Guo Q, 2012, HYPERTENS RES, V35, P48, DOI 10.1038/hr.2011.140; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Habibi J, 2008, ENDOCRINOLOGY, V149, P5643, DOI 10.1210/en.2008-0070; Hayashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116163; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Iwai M, 2010, J HYPERTENS, V28, P1471, DOI 10.1097/HJH.0b013e32833bc420; Kalupahana NS, 2012, OBESITY, V20, P48, DOI 10.1038/oby.2011.299; Kubota Y, 2006, BIOL PHARM BULL, V29, P1756, DOI 10.1248/bpb.29.1756; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lastra G, 2009, ENDOCRINOLOGY, V150, P2561, DOI 10.1210/en.2008-1391; Lee KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18899; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miatello R, 2005, AM J HYPERTENS, V18, P864, DOI 10.1016/j.amjhyper.2004.12.012; Miatello R, 2003, CELL MOL BIOL, V49, P945; Miatello R, 2002, AM J HYPERTENS, V15, P872, DOI 10.1016/S0895-7061(02)02983-7; Miatello Roberto, 2004, Current Vascular Pharmacology, V2, P371, DOI 10.2174/1570161043385510; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Nagai Y, 2009, EXP PHYSIOL, V94, P1016, DOI 10.1113/expphysiol.2009.048108; Nyby MD, 2007, HYPERTENS RES, V30, P451, DOI 10.1291/hypres.30.451; Oudot C, 2013, KIDNEY INT, V83, P674, DOI 10.1038/ki.2012.478; Farina JP, 2013, CLIN SCI, V125, P87, DOI 10.1042/CS20120470; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Rabie EM, 2015, EUR J PHARMACOL, V760, P145, DOI 10.1016/j.ejphar.2015.04.019; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rashikh A, 2011, HUM EXP TOXICOL, V30, P102, DOI 10.1177/0960327110369819; Rebolledo A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-65; Risler NR, 2005, THESCIENTIFICWORLDJO, V5, P959, DOI 10.1100/tsw.2005.122; Shinozaki K, 2004, HYPERTENSION, V43, P255, DOI 10.1161/01.HYP.0000111136.86976.26; Stucchi P, 2009, BRIT J PHARMACOL, V158, P771, DOI 10.1111/j.1476-5381.2009.00355.x; Sugimoto M, 2009, ATHEROSCLEROSIS, V204, P388, DOI 10.1016/j.atherosclerosis.2008.10.021; Tamura Y, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.34; Umeda M, 2003, HYPERTENS RES, V26, P485, DOI 10.1291/hypres.26.485; Vazquez-Prieto MA, 2011, AM J HYPERTENS, V24, P234, DOI 10.1038/ajh.2010.214; Wood JM, 2005, J HYPERTENS, V23, P417, DOI 10.1097/00004872-200502000-00025; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yarows SA, 2008, ADV THER, V25, P1288, DOI 10.1007/s12325-008-0123-x	54	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180712	10.1371/journal.pone.0180712	http://dx.doi.org/10.1371/journal.pone.0180712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700686	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800068
J	Sun, Q; Zhu, JJ; Cao, FW; Chen, FJ				Sun, Qi; Zhu, Jiajin; Cao, Feiwei; Chen, Fengjia			Anti-inflammatory properties of extracts from Chimonanthus nitens Oliv. leaf	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BIOACTIVE COMPOUNDS; PHENOLIC-COMPOUNDS; COMPREHENSIVE CHARACTERIZATION; ANTIOXIDANT ACTIVITY; IMMUNE-RESPONSES; ZEBRAFISH LARVAE; INFLAMMATION; MODEL; IDENTIFICATION	Chimonanthus nitens Oliv. (CN) is a species in the family Calycanthaceae. Its leaf is widely used to make traditional herbal tea in southern China and has a wide range of therapeutic effects. The profile of the ethanol extracts from CN leaves was identified by UPLC-QTOFMS/ MS. Forty seven compounds were determined including organic acids, phenolic acids and derivatives, flavonoids, coumarins, fatty acids and other compounds. The effect of the CN extracts on the inflammatory damage in zebrafish and in RAW 264.7 cells was investigated. The extracts demonstrated a strong ability to inhibit the recruitment of neutrophils in LPS-stimulated zebrafish, but macrophage migration was not significantly affected. Proinflammatory cytokines (i.e., TNF-alpha, IL-6 and IL-1 beta) were also determined by q-PCR. The extracts strongly reduced mRNA expression of TNF-alpha, IL-6 but not IL-1 beta in zebrafish model, while significantly inhibited the production of the factors in the RAW 264.7 cells. Therefore, our results suggest that the ethanol extracts of CN leaves may serve as a source of nutraceutical compounds with anti-inflammatory properties.	[Sun, Qi; Zhu, Jiajin; Cao, Feiwei; Chen, Fengjia] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang Engn Ctr Food Technol & Equipment, Fuli Inst Food Sci,Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhu, JJ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang Engn Ctr Food Technol & Equipment, Fuli Inst Food Sci,Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.	jjzhu@zju.edu.cn	朱, 加进/HHS-3257-2022		National High-tech Research and Development Program of China (863 Program) [2011AA100804]; Research Fund of Fuli Institute of Food Science Zhejiang University [KY201403]	National High-tech Research and Development Program of China (863 Program); Research Fund of Fuli Institute of Food Science Zhejiang University	This research was funded by National High-tech Research and Development Program of China (863 Program) (No. 2011AA100804) (http://program.most.gov.cn/) and Research Fund of Fuli Institute of Food Science Zhejiang University (No. KY201403) (http://fifs.zju.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Chen H, 2016, PLOS ONE, V11, P14; Chen L, 2014, MODERN FOOD SCI TECH, V30, P13; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; Chyau CC, 2015, J FUNCT FOODS, V18, P159, DOI 10.1016/j.jff.2015.06.025; [Commission CP. Pharmacopoeia of the People's Republic of China. Health PCoMo], 1977, PHARMACOPOEIA OF THE; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Cruz FF, 2017, COMP BIOCHEM PHYS C, V194, P28, DOI 10.1016/j.cbpc.2017.01.007; Cadiz-Gurrea MD, 2014, INT J MOL SCI, V15, P20382, DOI 10.3390/ijms151120382; Cadiz-Gurrea MD, 2013, FOOD RES INT, V50, P197, DOI 10.1016/j.foodres.2012.09.038; Debnath T, 2013, MOLECULES, V18, P7253, DOI 10.3390/molecules18067253; Ding ZQ, 2008, PHARM BIOL, V46, P854, DOI 10.1080/13880200802367155; DuPont MS, 2000, J AGR FOOD CHEM, V48, P3957, DOI 10.1021/jf0002387; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Farag MA, 2013, PHYTOCHEM ANALYSIS, V24, P277, DOI 10.1002/pca.2408; FINGER A, 1991, PHYTOCHEMISTRY, V30, P2057, DOI 10.1016/0031-9422(91)85066-9; Fylaktakidou KC, 2004, CURR PHARM DESIGN, V10, P3813, DOI 10.2174/1381612043382710; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Hall JE, 2011, GUYTON AND HALL TEXT; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang J, 2016, IND CROP PROD, V91, P302, DOI 10.1016/j.indcrop.2016.07.033; Iswaldi I, 2013, FOOD RES INT, V50, P77, DOI 10.1016/j.foodres.2012.09.030; Kawabata K, 2015, FOOD FUNCT, V6, P1399, DOI [10.1039/C4FO01178C, 10.1039/c4fo01178c]; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim SM, 2012, BIOMED CHROMATOGR, V26, P199, DOI 10.1002/bmc.1646; Kitajima M, 2006, TETRAHEDRON LETT, V47, P3199, DOI 10.1016/j.tetlet.2006.03.047; Kupeli E, 2007, J ETHNOPHARMACOL, V114, P234, DOI 10.1016/j.jep.2007.08.005; Kwon JH, 2011, ARCH PHARM RES, V34, P1459, DOI 10.1007/s12272-011-0907-4; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li CQ, 2007, J ETHNOPHARMACOL, V114, P212, DOI 10.1016/j.jep.2007.08.002; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Li Z, 2010, J AGR FOOD CHEM, V58, P6503, DOI 10.1021/jf1006962; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lim D, 2015, J DERMATOL SCI, V79, P288, DOI 10.1016/j.jdermsci.2015.06.012; Lima A, 2014, ZEBRAFISH, V11, P434, DOI 10.1089/zeb.2014.1001; Liu ZZ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789263; Lv HP, 2015, J FUNCT FOODS, V19, P194, DOI 10.1016/j.jff.2015.09.047; Marcon M, 2016, PSYCHOPHARMACOLOGY, V233, P3815, DOI 10.1007/s00213-016-4408-5; Meier SM, 2015, PLOS ONE, V10, P16; Mena P, 2014, IUBMB LIFE, V66, P745, DOI 10.1002/iub.1332; Mullen W, 2004, J CHROMATOGR A, V1058, P163, DOI 10.1016/j.chroma.2004.08.117; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Ni SM, 2010, J CHROMATOGR B, V878, P2741, DOI 10.1016/j.jchromb.2010.08.014; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Qing LS, 2012, J CHROMATOGR A, V1249, P130, DOI 10.1016/j.chroma.2012.06.013; Riveiro ME, 2010, CURR MED CHEM, V17, P1325, DOI 10.2174/092986710790936284; Ryu HW, 2015, J FUNCT FOODS, V17, P774, DOI 10.1016/j.jff.2015.06.036; Sanz M, 2010, J AGR FOOD CHEM, V58, P9631, DOI 10.1021/jf102718t; Shelembe JS, 2012, INT J FOOD SCI TECH, V47, P648, DOI 10.1111/j.1365-2621.2011.02889.x; Stankovic MS, 2017, IND CROP PROD, V95, P493, DOI 10.1016/j.indcrop.2016.09.070; Sun Y, 2015, J FUNCT FOODS, V18, P300, DOI 10.1016/j.jff.2015.07.009; Uddin MN, 2016, INT J FOOD PROP, V19, P911, DOI 10.1080/10942912.2015.1048355; [王凌云 Wang Lingyun], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P3103; Wang WX, 2011, PHYTOCHEM LETT, V4, P271, DOI 10.1016/j.phytol.2011.04.012; Wang XJ, 2005, BIOL PHARM BULL, V28, P1106, DOI 10.1248/bpb.28.1106; Xu W, 2016, J ZHEJIANG UNIV-SC B, V17, P425, DOI 10.1631/jzus.B1500213; Yan B, 2014, J IMMUNOL, V192, P5998, DOI 10.4049/jimmunol.1301645; Yang LL, 2014, MOLECULES, V19, P2390, DOI 10.3390/molecules19022390; Yen CT, 2009, CHEM PHARM BULL, V57, P280, DOI 10.1248/cpb.57.280; Zhang CN, 2017, ECOTOX ENVIRON SAFE, V138, P1, DOI 10.1016/j.ecoenv.2016.12.016; Zhao J, 2013, J CHROMATOGR A, V1313, P2, DOI 10.1016/j.chroma.2013.07.039; Zhou L, 2008, J PHARMACEUT BIOMED, V47, P39, DOI 10.1016/j.jpba.2007.12.009; Zhou Y, 2010, J SEP SCI, V33, P3675, DOI 10.1002/jssc.201000452; Zhu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096576; Zon LI, 1999, GENOME RES, V9, P99	71	27	32	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181094	10.1371/journal.pone.0181094	http://dx.doi.org/10.1371/journal.pone.0181094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700722	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800120
J	Wang, WW; Li, Z; Lv, ZP; Zhang, BB; Lv, H; Guo, YM				Wang, Weiwei; Li, Zhui; Lv, Zengpeng; Zhang, Beibei; Lv, Hong; Guo, Yuming			Effects of Kluyveromyces marxianus supplementation on immune responses, intestinal structure and microbiota in broiler chickens	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST CULTURE; IN-VITRO; PERFORMANCE; GROWTH; PROTEIN; DIETS; PARAMETERS; EXPRESSION; BOULARDII	To investigate the effects of Kluyveromyces marxianus on immune responses, intestinal structure and microbiota in broilers, 840 1-d-old broiler chicks were randomly divided into seven groups (eight replicates) and were fed basal diets without or with 0.25, 0.50, 1.0, 1.5, 2.0, and 2.5 g/kg of K. marxianus (2.0x10(10) CFU/g). Serum and intestine samples were collected at 21 d of age. The results showed that increasing K. marxianus addition linearly reduced feed conversion ratio but linearly elevated relative thymus weight, as well as quadratically increased serum lysozyme and IgG levels, with the medium dose (1.0 g/kg) being the most effective. The ratio of villus height to crypt depth of jejunum and ileum, ileal villus height and sucrase activity, as well as the mRNA expression of ileal mucin-2, claudin-1 and sodium glucose cotransporter 1 linearly responded to the increasing K. marxianus addition. Supplemental K. marxianus at low (0.5 g/kg), medium (1.5 g/kg) and high (2.5 g/kg) dose all decreased the abundance of phylum Cyanobacteria, increased the abundance of phylum Firmicutes and genus Lactobacillus in ileum. The high dose of K. marxianus addition also reduced the abundance of order Rickettsiales and Pseudomonadales along with species Acinetobacter junii. Ileal bacterial communities between K. marxianus-treated and untreated groups formed distinctly different clusters. In summary, K. marxianus supplementation benefits feed efficiency and immune function, as well as intestinal structure in broilers, which might be attributed to the improved ileal microbial structure. Supplemental K. marxianus at high dose (2.5 g/kg) was more effective for feed efficiency and intestinal health of broilers, while the innate immunity was optimized at a medium dose (1.0 g/kg).	[Wang, Weiwei; Li, Zhui; Lv, Zengpeng; Zhang, Beibei; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Lv, Hong] Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, Shanghai, Peoples R China	China Agricultural University; Fudan University	Guo, YM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	guoyum@cau.edu.cn		Wang, Weiwei/0000-0002-1886-6748	Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China); China Agricultural Research System program [CARS-42]	Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China); China Agricultural Research System program	This work was financially supported by Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China) and China Agricultural Research System program (CARS-42). The authors received nos pecific funding for this work.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; BALLARD ST, 1995, ANNU REV NUTR, V15, P35, DOI 10.1146/annurev.nu.15.070195.000343; Bolla PA, 2013, ANAEROBE, V21, P28, DOI 10.1016/j.anaerobe.2013.03.010; Bontempo V, 2006, ANIM FEED SCI TECH, V129, P224, DOI 10.1016/j.anifeedsci.2005.12.015; Breves G, 2000, J ANIM PHYSIOL AN N, V84, P9, DOI 10.1046/j.1439-0396.2000.00277.x; Broniek G, 2014, INFECTION, V42, P1051, DOI 10.1007/s15010-014-0647-8; De Maesschalck C, 2015, APPL ENVIRON MICROB, V81, P5880, DOI 10.1128/AEM.01616-15; Fasina YO, 2004, POULTRY SCI, V83, P1559, DOI 10.1093/ps/83.9.1559; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Funari E, 2008, CRIT REV TOXICOL, V38, P97, DOI 10.1080/10408440701749454; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Gao J, 2009, POULTRY SCI, V88, P2141, DOI 10.3382/ps.2009-00151; Goyer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149159; Greig SL, 2016, DRUGS, V76, P1467, DOI 10.1007/s40265-016-0636-6; Haldar S, 2011, ANIM FEED SCI TECH, V168, P61, DOI 10.1016/j.anifeedsci.2011.03.007; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Heckert RA, 2002, POULTRY SCI, V81, P451, DOI 10.1093/ps/81.4.451; Jahromi MF, 2016, INT J BIOMETEOROL, V60, P1099, DOI 10.1007/s00484-015-1103-x; Jang YD, 2013, LIVEST SCI, V152, P167, DOI 10.1016/j.livsci.2012.12.022; Kourelis A, 2010, J APPL MICROBIOL, V109, P260, DOI 10.1111/j.1365-2672.2009.04651.x; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Lane MM, 2011, ANTON LEEUW INT J G, V100, P507, DOI 10.1007/s10482-011-9606-x; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Milewski S, 2013, ACTA VET BRNO, V82, P147, DOI 10.2754/avb201382020147; Moran AW, 2010, BRIT J NUTR, V104, P647, DOI 10.1017/S0007114510000954; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Prakash UNS, 2010, BRIT J NUTR, V104, P31, DOI 10.1017/S0007114510000334; Rajput IR, 2013, POULTRY SCI, V92, P956, DOI 10.3382/ps.2012-02845; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; Romanin D, 2010, INT J FOOD MICROBIOL, V140, P102, DOI 10.1016/j.ijfoodmicro.2010.04.014; Rymuszka A, 2010, ENVIRON TOXICOL CHEM, V29, P569, DOI 10.1002/etc.87; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Sugiharto S., 2016, Journal of the Saudi Society of Agricultural Sciences, V15, P99, DOI 10.1016/j.jssas.2014.06.001; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Tripathi MK, 2011, LIVEST SCI, V135, P17, DOI 10.1016/j.livsci.2010.06.007; Tripathi MK, 2010, ANIM FEED SCI TECH, V155, P163, DOI 10.1016/j.anifeedsci.2009.11.007; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valbuena G, 2009, THROMB HAEMOSTASIS, V102, P1071, DOI 10.1160/TH09-03-0186; van Heugten E, 2003, J ANIM SCI, V81, P1004; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078507; Zanello G, 2013, VET IMMUNOL IMMUNOP, V152, P20, DOI 10.1016/j.vetimm.2012.09.023; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	56	13	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180884	10.1371/journal.pone.0180884	http://dx.doi.org/10.1371/journal.pone.0180884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700666	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800092
J	Sample, A; Zhao, BZ; Qiang, L; He, YY				Sample, Ashley; Zhao, Baozhong; Qiang, Lei; He, Yu-Ying			Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; CYCLOOXYGENASE-2 EXPRESSION; CARCINOMA-CELLS; HAIRLESS MICE; AUTOPHAGY; TUMORIGENESIS; TFEB; P62/SQSTM1; ACTIVATION; INHIBITION	Skin cancer is the most common cancer, and exposure to ultraviolet (UV) radiation, namely UVA and UVB, is the major risk factor for skin cancer development. UVAis significantly less effective in causing direct DNA damage than UVB, but UVA has been shown to increase skin cancer risk. The mechanism by which UVA contributes to skin cancer remains unclear. Here, using RNA-Seq, we show that UVA induces autophagy and lysosomal gene expression, including the autophagy receptor and substrate p62. We found that UVA activates transcription factor EB (TFEB), a known regulator of autophagy and lysosomal gene expression, which, in turn, induces p62 transcription. Next, we identified a novel relationship between p62 and cyclooxygenase-2 (COX-2), a prostaglandin synthase critical for skin cancer development. COX-2 expression was up-regulated by UVA-induced p62, suggesting that p62 plays a role in UVA-induced skin cancer. Moreover, we found that p62 stabilizes COX-2 protein through the p62 ubiquitin-associated domain and that p62 regulates prostaglandin E-2 production in vitro. In a syngeneic squamous cell carcinoma mouse model, p62 knockdown inhibited tumor growth and metastasis. Furthermore, p62-deficient tumors exhibited reduced immune cell infiltration and increased cell differentiation. Because prostaglandin E-2 is known to promote pro-tumorigenic immune cell infiltration, increase proliferation, and inhibit keratinocyte differentiation in vivo, this work suggests that UVA-induced p62 acts through COX-2 to promote skin tumor growth and progression. These findings expand our understanding of UVA-induced skin tumorigenesis and tumor progression and suggest that targeting p62 can help prevent or treat UVA-associated skin cancer.	[Sample, Ashley; Zhao, Baozhong; Qiang, Lei; He, Yu-Ying] Univ Chicago, Dept Med, Sect Dermatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Sample, Ashley; He, Yu-Ying] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Qiang, Lei] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing 210008, Jiangsu, Peoples R China	University of Chicago; University of Chicago; China Pharmaceutical University	He, YY (corresponding author), Univ Chicago, Dept Med, Sect Dermatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012	Qiang, Lei/0000-0002-7164-3164	NIEHS, National Institutes of Health (NIH) [ES024373, ES016936]; American Cancer Society [RSG-13-078-01]; NCI, NIH [P30 CA014599]; NIH (CTSA) [UL1 TR000430]; University of Chicago; NATIONAL CANCER INSTITUTE [T32CA009594, P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024373, P30ES027792, R01ES016936] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health (NIH); American Cancer Society(American Cancer Society); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health (NIH), Grants ES024373 and ES016936 (to Y. Y. H.), American Cancer Society Grant RSG-13-078-01 (to Y. Y. H.), NCI, NIH, Grant P30 CA014599 (University of Chicago Cancer Research Center), NIH Clinical and Translational Science Award (CTSA) UL1 TR000430, and the University of Chicago Friends of Dermatology Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Bachelor MA, 2002, ONCOGENE, V21, P7092, DOI 10.1038/sj.onc.1205855; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Ellis RA, 2014, J INVEST DERMATOL, V134, P1476, DOI 10.1038/jid.2013.497; Elmets CA, 2010, JNCI-J NATL CANCER I, V102, P1835, DOI 10.1093/jnci/djq442; Higashi Y, 2000, INT J CANCER, V86, P667, DOI 10.1002/(SICI)1097-0215(20000601)86:5<667::AID-IJC10>3.3.CO;2-P; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; KELFKENS G, 1991, CARCINOGENESIS, V12, P1377, DOI 10.1093/carcin/12.8.1377; Klein K, 2016, INT J ONCOL, V49, P164, DOI 10.3892/ijo.2016.3505; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Singh B, 2005, INT J ONCOL, V26, P1393; STERENBORG HJCM, 1990, PHOTOCHEM PHOTOBIOL, V51, P325, DOI 10.1111/j.1751-1097.1990.tb01718.x; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tiano HF, 2002, CANCER RES, V62, P3395; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VANWEELDEN H, 1988, ARCH DERMATOL RES, V280, P300, DOI 10.1007/BF00440604; White AL, 2004, PHOTOCHEM PHOTOBIOL, V80, P340, DOI 10.1562/2003-12-31-RA-040.1; Wischermann K, 2008, ONCOGENE, V27, P4269, DOI 10.1038/onc.2008.70; Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang MF, 2012, J CLIN ONCOL, V30, P1588, DOI 10.1200/JCO.2011.39.3652; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26	51	18	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14786	14795		10.1074/jbc.M117.786160	http://dx.doi.org/10.1074/jbc.M117.786160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724634	Green Published, hybrid			2022-12-26	WOS:000409902100007
J	Chen, XG; Lu, XK; Shu, N; Wang, DL; Wang, S; Wang, JJ; Guo, LX; Guo, XN; Fan, WL; Lin, ZX; Ye, WW				Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Delong; Wang, Shuai; Wang, Junjuan; Guo, Lixue; Guo, Xiaoning; Fan, Weili; Lin, Zhongxu; Ye, Wuwei			GhSOS1, a plasma membrane Na+/H+ antiporter gene from upland cotton, enhances salt tolerance in transgenic Arabidopsis thaliana	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; ION HOMEOSTASIS; PROTEIN-KINASE; SOS1; TRANSPORT; CONSERVATION; EXPRESSION; HALOPHYTE	Upland cotton (Gossypium hirsutum L.), an important source of natural fiber, can tolerate relatively high salinity and drought stresses. In the present study, a plasma membrane Na+/H+ antiporter gene, GhSOS1, was cloned from a salt-tolerant genotype of G. hirsutum, Zhong 9807. The expression level of GhSOS1 in cotton roots was significantly upregulated in the presence of high concentrations of NaCl (200 mM), while its transcript abundance was increased when exposed to low temperature and drought stresses. Localization analysis using onion epidermal cells showed that the GhSOS1 protein was localized to the plasma membrane. The overexpression of GhSOS1 in Arabidopsis enhanced tolerance to salt stress, as indicated by a lower MDA content and decreased Na+/K+ ratio in transgenic plants. Moreover, the transcript levels of stress-related genes were significantly higher in GhSOS1 overexpression lines than in wild-type plants under salt treatment. Hence, GhSOS1 may be a potential target gene for enhancing salt tolerance in transgenic plants.	[Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Delong; Wang, Shuai; Wang, Junjuan; Guo, Lixue; Guo, Xiaoning; Fan, Weili; Ye, Wuwei] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Chen, Xiugui; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Huazhong Agricultural University	Ye, WW (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yew158@163.com			National key research and development program [2016YFD0101400]; National Key Program of Research and Development in China [2016YFD0101400]	National key research and development program; National Key Program of Research and Development in China	This work was supported by grants from National key research and development program (2016YFD0101400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Key Program of Research and Development in China (2016YFD0101400).	An J, 2014, MOL BIOL REP, V41, P4155, DOI 10.1007/s11033-014-3287-2; Ashraf M, 2000, FIELD CROP RES, V66, P115, DOI 10.1016/S0378-4290(00)00064-2; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chung JS, 2008, PLANT J, V53, P554, DOI 10.1111/j.1365-313X.2007.03364.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Iqbal K, 2011, INT J AGRIC BIOL, V13, P61; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jain M, 2001, PLANT CELL REP, V20, P463, DOI 10.1007/s002990100353; Kant S, 2006, PLANT CELL ENVIRON, V29, P1220, DOI 10.1111/j.1365-3040.2006.01502.x; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li Q, 2014, MOL BIOL REP, V41, P5097, DOI 10.1007/s11033-014-3375-3; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Maathuis FJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00467; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Olias R, 2009, PLANT CELL ENVIRON, V32, P904, DOI 10.1111/j.1365-3040.2009.01971.x; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Zhou L, 2015, PLANT PHYSIOL BIOCH, V96, P311, DOI 10.1016/j.plaphy.2015.08.016; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	38	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181450	10.1371/journal.pone.0181450	http://dx.doi.org/10.1371/journal.pone.0181450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723926	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800050
J	Dean, CL; Eggleston, BA; Gibney, KD; Aligbe, E; Blackwell, M; Kwakye, LD				Dean, Cassandra L.; Eggleston, Brady A.; Gibney, Kyla David; Aligbe, Enimielen; Blackwell, Marissa; Kwakye, Leslie Dowell			Auditory and visual distractors disrupt multisensory temporal acuity in the crossmodal temporal order judgment task	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; SUPERIOR COLLICULUS NEURONS; AUTISM SPECTRUM DISORDERS; SPATIAL ATTENTION; PRIOR ENTRY; SENSORY MODALITIES; DEVELOPMENTAL DYSLEXIA; PSYCHOMETRIC FUNCTION; SELECTIVE ATTENTION; TIME-WINDOW	The ability to synthesize information across multiple senses is known as multisensory integration and is essential to our understanding of the world around us. Sensory stimuli that occur close in time are likely to be integrated, and the accuracy of this integration is dependent on our ability to precisely discriminate the relative timing of unisensory stimuli (crossmodal temporal acuity). Previous research has shown that multisensory integration is modulated by both bottom-up stimulus features, such as the temporal structure of unisensory stimuli, and top-down processes such as attention. However, it is currently uncertain how attention alters crossmodal temporal acuity. The present study investigated whether increasing attentional load would decrease crossmodal temporal acuity by utilizing a dual-task paradigm. In this study, participants were asked to judge the temporal order of a flash and beep presented at various temporal offsets (crossmodal temporal order judgment (CTOJ) task) while also directing their attention to a secondary distractor task in which they detected a target stimulus within a stream visual or auditory distractors. We found decreased performance on the CTOJ task as well as increases in both the positive and negative just noticeable difference with increasing load for both the auditory and visual distractor tasks. This strongly suggests that attention promotes greater crossmodal temporal acuity and that reducing the attentional capacity to process multisensory stimuli results in detriments to multisensory temporal processing. Our study is the first to demonstrate changes in multisensory temporal processing with decreased attentional capacity using a dual task paradigm and has strong implications for developmental disorders such as autism spectrum disorders and developmental dyslexia which are associated with alterations in both multisensory temporal processing and attention.	[Dean, Cassandra L.; Eggleston, Brady A.; Gibney, Kyla David; Aligbe, Enimielen; Blackwell, Marissa; Kwakye, Leslie Dowell] Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA	Oberlin College	Kwakye, LD (corresponding author), Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA.	LKwakye@oberlin.edu		Gibney, Kyla/0000-0003-4319-9200	Oberlin College Research Fellowship; Oberlin College Office of Foundation, Government, and Corporate Grants	Oberlin College Research Fellowship; Oberlin College Office of Foundation, Government, and Corporate Grants	We would like to thank the Oberlin College Research Fellowship and the Oberlin College Office of Foundation, Government, and Corporate Grants for their support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the contributions of Susan Russ to some of the data collection and analysis for this study. We would also like to thank the Oberlin College Research Fellowship and the Oberlin College Office of Foundation, Government, and Corporate Grants for their support of this study.	Alain C, 2003, J COGNITIVE NEUROSCI, V15, P1063, DOI 10.1162/089892903770007443; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Alsius A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00727; Asanowicz D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00452; Barrett DJK, 2012, EXP BRAIN RES, V222, P11, DOI 10.1007/s00221-012-3191-8; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bonato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136719; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Diederich A, 2015, PSYCHOL REV, V122, P232, DOI 10.1037/a0038696; Donohue SE, 2015, FRONT INTEGR NEUROSC, V9, DOI [10.3389/fnint.2015.00032, 10.3389/fnint.2015.0003]; Donohue SE, 2011, J NEUROSCI, V31, P7982, DOI 10.1523/JNEUROSCI.5298-10.2011; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Gibney KD, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00001; Greenaway R, 2005, PSYCHOL SCI, V16, P987, DOI 10.1111/j.1467-9280.2005.01648.x; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; Hillock-Dunn A., 2016, NEUROPSYCHOLOGIA; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Jacoby O, 2012, NEUROIMAGE, V61, P1050, DOI 10.1016/j.neuroimage.2012.03.040; Klemen J, 2009, EUR J NEUROSCI, V29, P2426, DOI 10.1111/j.1460-9568.2009.06774.x; Kostaki M, 2016, VISION RES, V127, P165, DOI 10.1016/j.visres.2016.08.004; Krause MB, 2015, DYSLEXIA, V21, P285, DOI 10.1002/dys.1505; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Marchant JL, 2012, HUM BRAIN MAPP, V33, P1212, DOI 10.1002/hbm.21278; Mazza V, 2007, NEUROPSYCHOLOGIA, V45, P514, DOI 10.1016/j.neuropsychologia.2006.02.010; Megevand P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071608; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Molholm S, 2007, EUR J NEUROSCI, V26, P499, DOI 10.1111/j.1460-9568.2007.05668.x; Molloy K, 2015, J NEUROSCI, V35, P16046, DOI 10.1523/JNEUROSCI.2931-15.2015; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Murata A, 2017, APPL ERGON, V60, P58, DOI 10.1016/j.apergo.2016.11.002; Noel JP, 2016, NEUROPSYCHOLOGIA, V82, P84, DOI 10.1016/j.neuropsychologia.2016.01.005; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pierno AC, 2005, APPL ERGON, V36, P335, DOI 10.1016/j.apergo.2004.11.002; Powers AR, 2012, J NEUROSCI, V32, P6263, DOI 10.1523/JNEUROSCI.6138-11.2012; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; Santangelo V, 2008, CONSCIOUS COGN, V17, P989, DOI 10.1016/j.concog.2008.02.006; Santangelo V, 2008, PSYCHON B REV, V15, P398, DOI 10.3758/PBR.15.2.398; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stevenson RA, 2014, BRAIN TOPOGR, V27, P707, DOI 10.1007/s10548-014-0365-7; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Stevenson RA, 2013, EXP BRAIN RES, V225, P479, DOI 10.1007/s00221-012-3387-y; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Stolte M, 2014, J VISION, V14, DOI 10.1167/14.3.9; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Talsma D, 2009, EXP BRAIN RES, V198, P313, DOI 10.1007/s00221-009-1858-6; Tang XY, 2016, NEUROSCI BIOBEHAV R, V61, P208, DOI 10.1016/j.neubiorev.2015.11.002; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05098; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; Vatakis A, 2006, NEUROSCI LETT, V408, P5, DOI 10.1016/j.neulet.2006.06.017; Venezia JH, 2016, ATTEN PERCEPT PSYCHO, V78, P583, DOI 10.3758/s13414-015-1026-y; Vibell J, 2007, J COGNITIVE NEUROSCI, V19, P109, DOI 10.1162/jocn.2007.19.1.109; Vroomen J, 2001, PERCEPT PSYCHOPHYS, V63, P651, DOI 10.3758/BF03194427; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Woynaroski TG, 2013, J AUTISM DEV DISORD, V43, P2891, DOI 10.1007/s10803-013-1836-5; Yates MJ, 2011, ATTEN PERCEPT PSYCHO, V73, P1586, DOI 10.3758/s13414-011-0117-7; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2007, NEUROSCI LETT, V414, P75, DOI 10.1016/j.neulet.2006.12.006; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	85	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179564	10.1371/journal.pone.0179564	http://dx.doi.org/10.1371/journal.pone.0179564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB3UH	28723907	Green Submitted, Green Published, gold			2022-12-26	WOS:000406067800006
J	Alanagreh, L; Pegg, C; Harikumar, A; Buchheim, M				Alanagreh, Lo'ai; Pegg, Caitlin; Harikumar, Amritha; Buchheim, Mark			Assessing intragenomic variation of the internal transcribed spacer two: Adapting the Illumina metagenomics protocol	PLOS ONE			English	Article							HAEMATOCOCCUS CHLOROPHYCEAE; CONCERTED EVOLUTION; FUNGAL COMMUNITIES; PROFILE DISTANCES; GENE CONVERSION; RIBOSOMAL DNA; RDNA REGION; ITS2 RDNA; PHYLOGENY; DIVERSITY	Primary and secondary structural data from the internal transcribed spacer two (ITS2) have been used extensively for diversity studies of many different eukaryotic organisms, including the green algae. Ease of amplification is due, at least in part, to the fact that ITS2 is part of the tandemly-repeated rRNA array. The potential confounding influence of intragenomic variability has yet to be addressed except in a few organisms. Moreover, few of the assessments of intragenomic variation have taken advantage of the deep sequencing capacity of sequence-by-synthesis protocols. We present results from our adaptation of the 16S Meta-genomics Sequencing Library Preparation/Illumina protocol for deep sequencing of the ITS2 genes in selected isolates of the green algal genus, Haematococcus. Deep sequencing yielded from just under 20,000 to more than 500,000 merged reads, outpacing results from recent pyrosequencing efforts. Furthermore, a conservative evaluation of these data revealed a range of three to six ITS2 sequence haplotypes (defined as unique sets of nucleotide polymorphisms) across the taxon sampling. The frequency of the dominant haplotype ranged from 0.35 to 0.98. In all but two cases, the haplotype with the greatest frequency corresponded to a sequence obtained by the Sanger method using PCR templates. Our data also show that results from the sequencing-by-synthesis approach are reproducible. In addition to advancing our understanding of ribosomal RNA variation, the results of this investigation will allow us to begin testing hypotheses regarding the maintenance of homogeneity across multi-copy genes.	[Alanagreh, Lo'ai; Pegg, Caitlin; Harikumar, Amritha; Buchheim, Mark] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Pegg, Caitlin] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Harikumar, Amritha] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	University of Tulsa; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University	Buchheim, M (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	mark-buchheim@utulsa.edu		Harikumar, Amritha/0000-0002-6681-7756; Alanagreh, loai/0000-0001-5759-4581	Office of Research at the University of Tulsa; Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa; Oklahoma Center for the Advancement of Science and Technology [PS 16-02]	Office of Research at the University of Tulsa; Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa; Oklahoma Center for the Advancement of Science and Technology	This project was supported by grants from the Office of Research at the University of Tulsa (to MB, LS and CP), the Mervin Bovaird Institute for Molecular Biology and Biotechnology at the University of Tulsa (to MB), and the Oklahoma Center for the Advancement of Science and Technology (PS 16-02 to MB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allewaert CC, 2015, PHYCOLOGIA, V54, P583, DOI 10.2216/15-55.1; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; [Anonymous], PAUP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Arnheim N., 1983, P38; Bao Y, 2010, MOL PHYLOGENET EVOL, V55, P136, DOI 10.1016/j.ympev.2009.10.023; Bart A, 2008, J CLIN MICROBIOL, V46, P3270, DOI 10.1128/JCM.00680-08; Batovska J, 2017, G3-GENES GENOM GENET, V7, P19, DOI 10.1534/g3.116.036145; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Buchheim MA, 2012, ANN BOT-LONDON, V109, P109, DOI 10.1093/aob/mcr275; Buchheim MA, 2010, J PHYCOL, V46, P1038, DOI 10.1111/j.1529-8817.2010.00886.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Harder CB, 2013, FUNGAL BIOL-UK, V117, P764, DOI 10.1016/j.funbio.2013.09.004; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; Karlep L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066601; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Maddison W.P., MESQUITE MODULAR SYS; Mark K, 2016, GENOME, V59, P685, DOI 10.1139/gen-2015-0189; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; NAGYLAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P3796, DOI 10.1073/pnas.81.12.3796; Pegg C, 2015, PHYCOLOGIA, V54, P385, DOI 10.2216/15-015.1; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Pocock M. A., 1960, Transactions of the Royal Society of South Africa, V36, P5; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rahmann S, 2006, ADV DATA MINING TECH, P104; Richardson R. T, 2015, APPL PLANT SCI, V3; Rybalka N, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-39; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Triki A, 1997, PHYCOLOGIA, V36, P190, DOI 10.2216/i0031-8884-36-3-190.1; Vaz ABM, 2017, PHYTOTAXA, V295, P1, DOI 10.11646/phytotaxa.295.1.1; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Xiao LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117971; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039; Zimmer EA, 1980, P NATL ACAD SCI USA, V77, P2518	58	12	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181491	10.1371/journal.pone.0181491	http://dx.doi.org/10.1371/journal.pone.0181491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719667	Green Submitted, gold, Green Published			2022-12-26	WOS:000406061400050
J	Matoba, R; Morizane, Y; Shiode, Y; Hirano, M; Doi, S; Toshima, S; Araki, R; Hosogi, M; Yonezawa, T; Shiraga, F				Matoba, Ryo; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Yonezawa, Tomoko; Shiraga, Fumio			Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; MATRIX METALLOPROTEINASES; THERAPEUTIC TARGET; RPE CELLS; INHIBITION; EXPRESSION; CYTOKINES	The epithelial-mesenchymal transition (EMT) in retinal pigment epithelial (RPE) cells plays a central role in the development of proliferative vitreoretinopathy (PVR). The purpose of this study was to investigate the effect of AMP-activated protein kinase (AMPK), a key regulator of energy homeostasis, on the EMT in RPE cells. In this study, EMT-associated formation of cellular aggregates was induced by co-stimulation of cultured ARPE-19 cells with tumor necrosis factor (TNF)-alpha (10 ng/ml) and transforming growth factor (TGF)-beta(2) (5 ng/ml). 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), a potent activator of AMPK, significantly suppressed TNF-alpha and TGF-beta(2)-induced cellular aggregate formation (p < 0.01). Dipyridamole almost completely reversed the suppressive effect of AICAR, whereas 5'-amino-5'-deoxyadenosine restored aggregate formation by approximately 50%. AICAR suppressed the downregulation of E-cadherin and the upregulation of fibronectin and alpha-smooth muscle actin by TNF-alpha and TGF-beta(2). The levels of matrix metalloproteinase (MMP)-2, MMP-9, interleukin-6, and vascular endothelial growth factor were significantly decreased by AICAR. Activation of the mitogen-activated protein kinase and mammalian target of rapamycin pathways, but not the Smad pathway, was inhibited by AICAR. These findings indicate that AICAR suppresses the EMT in RPE cells at least partially via activation of AMPK. AMPK is a potential target molecule for the prevention and treatment of PVR, so AICAR may be a promising candidate for PVR therapy.	[Matoba, Ryo; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yonezawa, Tomoko] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University	Morizane, Y (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	moriza-y@okayama-u.ac.jp		YONEZAWA, Tomoko/0000-0002-3380-8298; Matoba, Ryo/0000-0003-0440-1103				Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chan CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056819, 10.1371/journal.pone.0068504]; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044937; Eichler W, 2002, INVEST OPHTH VIS SCI, V43, P2767; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HUNT RC, 1993, INVEST OPHTH VIS SCI, V34, P3179; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LEAVER PK, 1995, BRIT J OPHTHALMOL, V79, P871, DOI 10.1136/bjo.79.10.871; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin H, 2015, MOL PHARMACOL, V88, P1062, DOI 10.1124/mol.115.099549; Liou G, 2002, MOL VIS, V8, P494; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Moysidis SN, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/815937; NEWSOME DA, 1981, ARCH OPHTHALMOL-CHIC, V99, P873, DOI 10.1001/archopht.1981.03930010873017; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Pennock S, 2013, AM J PATHOL, V182, P1659, DOI 10.1016/j.ajpath.2013.01.052; Qin SF, 2008, INVEST OPHTH VIS SCI, V49, P1274, DOI 10.1167/iovs.07-1109; Qiu SL, 2015, J PATHOL, V237, P330, DOI 10.1002/path.4579; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Shibata T, 2013, J PHARMACOL SCI, V122, P93, DOI 10.1254/jphs.12270FP; Symeonidis C, 2007, GRAEF ARCH CLIN EXP, V245, P560, DOI 10.1007/s00417-006-0386-3; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Wang Q, 2012, INVEST OPHTH VIS SCI, V53, P2395, DOI 10.1167/iovs.11-8982; Xiao W, 2014, J CELL MOL MED, V18, P646, DOI 10.1111/jcmm.12212; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yang S, 2015, DISCOV MED, V20, P207; Zhao ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095884	44	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181481	10.1371/journal.pone.0181481	http://dx.doi.org/10.1371/journal.pone.0181481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719670	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400048
J	Huang, CN; Wang, CJ; Lee, YJ; Peng, CH				Huang, Chien-Ning; Wang, Chau-Jong; Lee, Yi-Ju; Peng, Chiung-Huei			Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced beta cell apoptosis via inhibiting dipeptidyl peptidase-4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; PROTEIN-KINASE; HIGH GLUCOSE; AMPK; SURVIVAL; PROLIFERATION; LIPOTOXICITY; LIPOGENESIS; ACTIVATION	Lipotoxicity plays an important role in exacerbating type 2 diabetes mellitus (T2DM) and leads to apoptosis of beta cells. Recently dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as a useful tool in the treatment of T2DM. DPP-4 degrades type 1 glucagon-like peptide (GLP-1), and GLP-1 receptor (GLP-1R) signaling has been shown to protect beta cells by modulating AMPK/mTOR, PI3K, and Bax. The anti-hyperglycemic effect of Abelmoschus esculentus (AE) is well known, however its mucilage makes it difficult to further examine this effect. In our recent report, a sequence of extraction steps was used to obtain a series of subfractions from AE, each with its own composition and property. Among them F1 (rich in quercetin glucosides and pentacyclic triterpene ester) and F2 (containing large amounts of carbohydrates and polysaccharides) were found to be especially effective in attenuating DPP-4 signaling, and to have the potential to counter diabetic nephropathy. Hence, the aim of the present study was to investigate whether AE subfractions can prevent the palmitate-induced apoptosis of beta cells, and the putative signals involved. We demonstrated that AE, and especially 1 mu g/mL of F2, decreased palmitate-induced apoptosis analyzed by flow cytometry. The result of western blot revealed that palmitate-induced decrease in GLP-1R and increase in DPP-4 were restored by F1 and F2. The DPP-4 inhibitor linagliptin decreased the expression of caspase 3, suggesting that DPP-4 is critically involved in apoptotic signaling. Analysis of enzyme activity revealed that palmitate increased the activity of DPP4 nearly 2 folds, while F2 especially inhibited the activation. In addition, AMPK/mTOR, PI3K and mitochondrial pathways were regulated by AE, and this attenuated the palmitate-induced signaling cascades. In conclusion, AE is useful to prevent the exacerbation of beta cell apoptosis, and it could potentially be used as adjuvant or nutraceutical therapy for diabetes.	[Huang, Chien-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Chien-Ning] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Lee, Yi-Ju] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Peng, Chiung-Huei] Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Hungkuang University	Peng, CH (corresponding author), Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan.	a222907@sunrise.hk.edu.tw		Peng, Chiung-Huei/0000-0003-1833-5522	Ministry of Science and Techonology, Taiwan [MOST 105-2320-B-241 -004 -MY2]	Ministry of Science and Techonology, Taiwan	This work was supported by the grant MOST 105-2320-B-241 -004 -MY2 of Ministry of Science and Techonology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu N, 1995, ILLUSTRATED MED PLAN, VI.; Choi YJ, 2005, J NUTR, V135, P707, DOI 10.1093/jn/135.4.707; Council NR, 2006, LOST CROPS AFR; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Hocher B, 2012, KIDNEY BLOOD PRESS R, V36, P65, DOI 10.1159/000339028; Hwang HJ, 2014, MOL CELL ENDOCRINOL, V392, P1, DOI 10.1016/j.mce.2014.04.017; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; Miao XY, 2013, PEPTIDES, V39, P71, DOI 10.1016/j.peptides.2012.10.006; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Peng CH, 2016, FOOD FUNCT, V7, P728, DOI [10.1039/C5FO01214G, 10.1039/c5fo01214g]; Peterszegi G, 2003, BIOMED PHARMACOTHER, V57, P187, DOI 10.1016/S0753-3322(03)00031-3; Puljak L, 2008, EXP CELL RES, V314, P2100, DOI 10.1016/j.yexcr.2008.03.002; Shirakawa J, 2011, J BIOL CHEM, V286, P25467, DOI 10.1074/jbc.M110.217216; Tseng HL, 2012, TOXICOL APPL PHARM, V264, P104, DOI 10.1016/j.taap.2012.07.022; Wang XM, 2015, CELL PHYSIOL BIOCHEM, V37, P1914, DOI 10.1159/000438552; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Yang MY, 2010, J AGR FOOD CHEM, V58, P850, DOI 10.1021/jf903209w; Yang TY, 2016, TOXICOL APPL PHARM, V294, P54, DOI 10.1016/j.taap.2016.01.013; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5	24	23	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180285	10.1371/journal.pone.0180285	http://dx.doi.org/10.1371/journal.pone.0180285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715446	gold, Green Published, Green Submitted			2022-12-26	WOS:000443975500005
J	Seliger, C; Meier, CR; Becker, C; Jick, SS; Proescholdt, M; Bogdahn, U; Hau, P; Leitzmann, MF				Seliger, Corinna; Meier, Christoph R.; Becker, Claudia; Jick, Susan S.; Proescholdt, Martin; Bogdahn, Ulrich; Hau, Peter; Leitzmann, Michael F.			Diabetes, use of metformin, and the risk of meningioma	PLOS ONE			English	Article							BRAIN-TUMORS; GLIOMA; ASSOCIATION; THERAPY; HISTORY; CANCER; WOMEN	Background Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. Methods We conducted a matched case-control analysis using data from the U. K.-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of diabetes, glycemic control, and use of metformin, sulfonylureas, and insulin in relation to the risk of meningioma. We conducted conditional logistic regression analyses to determine relative risks, estimated as odds ratios (ORs) with 95% confidence intervals (CIs) and adjusted for body mass index, smoking, history of arterial hypertension, myocardial infarction, and use of estrogens (among women). Results We identified 2,027 meningioma cases and 20,269 controls. For diabetes there was the suggestion of an inverse association with meningioma (OR = 0.89; 95% CI = 0.74 - 1.07), which was driven by an inverse relation among women (OR = 0.78; 95% CI = 0.62 - 0.98), in whom we also noted a suggestive inverse association with duration of diabetes (p-value for trend = 0.071). For metformin there was a suggestive positive relation, particularly after matching on duration of diabetes and HbA1c level (OR = 1.64; 95% CI = 0.89 - 3.04). Sulfonylureas showed no clear association (OR = 0.91; 95% CI = 0.46 - 1.80). For insulin there was the suggestion of an inverse relation, in particular when comparing a high vs. low number of prescriptions (OR = 0.58; 95% CI = 0.18 - 1.83). Conclusion Further studies are needed to solidify a possible inverse association between diabetes and meningioma risk and to clarify the role of antidiabetics in this context.	[Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Meier, Christoph R.; Becker, Claudia] Univ Basel, Div Clin Pharm & Epidemiol, Dept Pharmaceut Sci, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Meier, Christoph R.; Jick, Susan S.] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Boston, MA USA; [Meier, Christoph R.] Univ Hosp Basel, Hosp Pharm, Basel, Switzerland; [Proescholdt, Martin] Regensburg Univ Hosp, Dept Neurosurg, Regensburg, Germany; [Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Basel; Boston University; University of Basel; University of Regensburg; University of Regensburg	Seliger, C (corresponding author), Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany.; Seliger, C (corresponding author), Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany.	corinna.seliger@klinik.uni-regensburg.de	Seliger, Corinna/GSE-3989-2022	Jick, Susan/0000-0002-2215-1067; Hau, Peter/0000-0003-3894-5053	German Research Foundation [KFO262-P10]	German Research Foundation(German Research Foundation (DFG))	This work was founded by the German Research Foundation (KFO262-P10 to C.S. and M. F.L.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Benson VS, 2015, INT J CANCER, V136, P2369, DOI 10.1002/ijc.29274; Bernardo BM, 2016, BRIT J CANCER, V115, P108, DOI 10.1038/bjc.2016.157; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Edlinger M, 2012, J HYPERTENS, V30, P290, DOI 10.1097/HJH.0b013e32834e9176; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Labuzek K, 2010, PHARMACOL REP, V62, P956; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Niedermaier T, 2015, NEUROLOGY, V85, P1342, DOI 10.1212/WNL.0000000000002020; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pachow D, 2013, CLIN CANCER RES, V19, P1180, DOI 10.1158/1078-0432.CCR-12-1904; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; SCHEEN AJ, 1993, DIABETES METAB, V19, P547; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Schneider B, 2005, CANCER DETECT PREV, V29, P440, DOI 10.1016/j.cdp.2005.07.002; Schwartzbaum J, 2005, CANCER EPIDEM BIOMAR, V14, P643, DOI 10.1158/1055-9965.EPI-04-0119; Seliger C, 2016, ONCOTARGET; Stamataki KE, 1996, CLIN ENDOCRINOL, V45, P615, DOI 10.1046/j.1365-2265.1996.00795.x; Surace EI, 2004, ANN NEUROL, V56, P295, DOI 10.1002/ana.20201; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wilisch-Neumann A, 2014, J CANCER RES CLIN, V140, P1343, DOI 10.1007/s00432-014-1683-6; Zahra M, 2016, HORMONE AND METABOLI	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181089	10.1371/journal.pone.0181089	http://dx.doi.org/10.1371/journal.pone.0181089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708856	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800041
J	Newell-Fugate, AE; Lenz, K; Skenandore, C; Nowak, RA; White, BA; Braundmeier-Fleming, A				Newell-Fugate, Annie E.; Lenz, Katherine; Skenandore, Cassandra; Nowak, Romana A.; White, Bryan A.; Braundmeier-Fleming, Andrea			Effects of coconut oil on glycemia, inflammation, and urogenital microbial parameters in female Ossabaw mini-pigs	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TRANS-FATTY-ACIDS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MINIATURE SWINE; GUT MICROBIOTA; RISK-FACTORS; OBESITY; LIPIDS; RATS	Forty percent of American women are obese and at risk for type II diabetes, impaired immune function, and altered microbiome diversity, thus impacting overall health. We investigated whether obesity induced by an excess calorie, high fat diet containing hydrogenated fats, fructose, and coconut oil (HFD) altered glucose homeostasis, peripheral immunity, and urogenital microbial dynamics. We hypothesized that HFD would cause hyperglycemia, increase peripheral inflammation, and alter urogenital microbiota to favor bacterial taxonomy associated with inflammation. We utilized female Ossabaw mini-pigs to model a ` thrifty' metabolic phenotype associated with increased white adipose tissue mass. Pigs were fed HFD (similar to 4570 kcal/pig/day) or lean (similar to 2000 kcal/pig/day) diet for a total of 9 estrous cycles (similar to 6 months). To determine the effect of cycle stage on cytokines and the microbiome, animals had samples collected during cycles 7 and 9 on certain days of the cycle: D1, 4, 8, 12, 16, 18. Vaginal swabs or cervical flushes assessed urogenital microbiota. Systemic fatty acids, insulin, glucose, and cytokines were analyzed. Pig weights and morphometric measurements were taken weekly. Obese pigs had increased body weight, length, heart and belly girth but similar glucose concentrations. Obese pigs had decreased cytokine levels (IL-1 beta, TNF-alpha, IL-4, IL-10), arachidonic acid and plasma insulin, but increased levels of vaccenic acid. Obese pigs had greater urogenital bacterial diversity, including several taxa known for anti-inflammatory properties. Overall, induction of obesity did not induce inflammation but shifted the microbial communities within the urogenital tract to an anti-inflammatory phenotype. We postulate that the coconut oil in the HFD oil may have supported normal glucose homeostasis and modulated the immune response, possibly through regulation of microbial community dynamics and fatty acid metabolism. This animal model holds promise for the study of how different types of obesity and high fat diets may affect metabolism, immune phenotype, and microbial dynamics.	[Newell-Fugate, Annie E.; Skenandore, Cassandra] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Newell-Fugate, Annie E.; Nowak, Romana A.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Lenz, Katherine; Braundmeier-Fleming, Andrea] Southern Illinois Univ, Sch Med, Dept Med Microbiol & Immunol, Springfield, IL 62702 USA; [White, Bryan A.; Braundmeier-Fleming, Andrea] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Braundmeier-Fleming, Andrea] Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University; University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University	Newell-Fugate, AE (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.; Newell-Fugate, AE (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Braundmeier-Fleming, A (corresponding author), Southern Illinois Univ, Sch Med, Dept Med Microbiol & Immunol, Springfield, IL 62702 USA.; Braundmeier-Fleming, A (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Braundmeier-Fleming, A (corresponding author), Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA.	ANewell-Fugate@cvm.tamu.edu; abraundmeier88@siumed.edu	Newell-Fugate, Anne/AAD-5499-2019; Skenandore, Cassandra S/B-7251-2017; Braundmeier-Fleming, Andrea/AAQ-4014-2020	Newell-Fugate, Anne/0000-0002-1878-5892; Skenandore, Cassandra S/0000-0002-9337-7602; Braundmeier-Fleming, Andrea/0000-0001-7136-9567	NIH [NIH K01 RR031274-01A21]; USDA ILLU [USDA ILLU 538-370]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ILLU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: 1) NIH K01 RR031274-01A21 (ANF); http://dpcpsi.nih.gov/orip/index; 2) USDA ILLU 538-370 (RAN); https://nifa.usda.gov/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Archibeque SL, 2005, J ANIM SCI, V83, P1153; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Deol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132672; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; HALL JA, 1993, DOMEST ANIM ENDOCRIN, V10, P141, DOI 10.1016/0739-7240(93)90019-8; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Intahphuak S, 2010, PHARM BIOL, V48, P151, DOI 10.3109/13880200903062614; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kongmun P, 2010, LIVEST SCI, V127, P38, DOI 10.1016/j.livsci.2009.08.008; Kotzampassi Katerina, 2014, ISRN Obes, V2014, P651895, DOI 10.1155/2014/651895; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Machmuller A, 1999, CAN J ANIM SCI, V79, P65, DOI 10.4141/A98-079; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Moreno JJ., 2016, EUR J PHARM; MORRISON WR, 1964, J LIPID RES, V5, P600; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Narayanankutty A, 2016, J FOOD SCI TECH MYS, V53, P895, DOI 10.1007/s13197-015-2040-8; Naziroglu M, 2004, CLIN CHIM ACTA, V344, P63, DOI 10.1016/j.cccn.2004.01.031; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Newell-Fugate AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128749; Newell-Fugate AE, 2014, COMPARATIVE MED, V64, P44; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; PANEPINTO LM, 1983, LAB ANIM SCI, V33, P95; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sadeghi S, 1999, IMMUNOLOGY, V96, P404, DOI 10.1046/j.1365-2567.1999.00701.x; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; TUOMANEN E, 1985, J INFECT DIS, V151, P535, DOI 10.1093/infdis/151.3.535; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; Vickers SP, 2011, BRIT J PHARMACOL, V164, P1248, DOI 10.1111/j.1476-5381.2011.01245.x; WANG LL, 1992, APPL ENVIRON MICROB, V58, P624, DOI 10.1128/AEM.58.2.624-629.1992; Wang Y, 2008, J NUTR, V138, P2117, DOI 10.3945/jn.108.091009; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; Xu X, 2003, GRAEF ARCH CLIN EXP, V241, P56, DOI 10.1007/s00417-002-0575-7	62	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179542	10.1371/journal.pone.0179542	http://dx.doi.org/10.1371/journal.pone.0179542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704429	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649700012
J	Payr, S; Tichy, B; Atteneder, C; Michel, M; Tiefenboeck, T; Lang, N; Nuernberger, S; Hajdu, S; Rosado-Balmayor, E; Marlovits, S; Albrecht, C				Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Rosado-Balmayor, Elizabeth; Marlovits, Stefan; Albrecht, Christian			Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; CHONDROGENIC DIFFERENTIATION; CARTILAGE REPAIR; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; IN-VITRO; ALGINATE; CULTURES; MARKERS	Melanoma inhibitory activity (MIA) affects the differentiation to hyaline cartilage and can inhibit the osteogenic potential of bone morphogenetic protein (BMP)-2 in mesenchymal stem cells (MSC). The aim of this study was to investigate if MIA also inhibits the osteogenic potential of BMP-2 in human articular chondrocytes during redifferentiation, which may lead to a higher grade of differentiation without calcification. HAC of four female patients (mean age: 73.75 +/- 6.98) were seeded into 3D culture for 28 days; after adding the recombinant proteins, four groups were formed (Control, BMP-2, MIA, BMP-2+ MIA). Samples were analysed for gene expression, glycosaminoglycan (GAG) content and histology on day 0, 14 and 28. Collagen type 2 (COL2A1) was significantly increased in the BMP-2 containing groups on day 28; BMP-2 (100-fold, p = 0.001), BMP-2+ MIA (65-fold, p = 0.009) and similar to the level of native cartilage. Higher aggrecan (Agg) levels were present in the BMP-2 (3fold, p = 0.007) and BMP-2+ MIA (4-fold, p = 0.002) group after 14 days and in the BMP-2 (9fold, p = 0.001) group after 28 days. Collagen type 10 (COL10A1) was increased in the BMP-2 containing groups (6-fold, p = 0.006) but these levels were significantly below native cartilage. Alkaline phosphatase (ALP), collagen type 1 (COL1A1) and the glycosaminoglycan (GAG) content did not reveal any relevant differences between groups. BMP-2 is a potent inducer for differentiation of HAC. A significant enhancement of this effect in combination with MIA could not be observed. Furthermore no significant reduction of osteogenic markers during re-differentiation of chondrocytes was present combining BMP-2 and MIA.	[Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Marlovits, Stefan; Albrecht, Christian] Med Univ Vienna, Gen Hosp, Dept Trauma Surg, Vienna, Austria; [Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Marlovits, Stefan; Albrecht, Christian] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Rosado-Balmayor, Elizabeth] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, Munich, Germany	Medical University of Vienna; Technical University of Munich	Payr, S (corresponding author), Med Univ Vienna, Gen Hosp, Dept Trauma Surg, Vienna, Austria.; Payr, S (corresponding author), Austrian Cluster Tissue Regenerat, Vienna, Austria.	stephan.payr@meduniwien.ac.at	Balmayor, E. R./N-9283-2015	Balmayor, E. R./0000-0002-0484-4847; Nurnberger, Sylvia/0000-0002-5175-5118; Albrecht, Christian/0000-0001-8022-1417; Tiefenboeck, Thomas/0000-0002-8698-8341	medical scientific fund of the mayor of the city of Vienna [15002]	medical scientific fund of the mayor of the city of Vienna	Study was funded by the medical scientific fund of the mayor of the city of Vienna (C.A.); project number 15002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, J TISSUE ENG REGEN M, V4, P233, DOI 10.1002/term.235; Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Albrecht C, 2014, AM J SPORT MED, V42, P59, DOI 10.1177/0363546513507543; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Ashraf S, 2015, OSTEOARTHRITIS CARTI; Ashraf S., 2016, J TISSUE ENG REGEN M; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015; Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Claus S, 2010, J CELL BIOCHEM, V111, P1642, DOI 10.1002/jcb.22897; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Krawczak DA, 2009, TISSUE ENG PT A, V15, P1247, DOI 10.1089/ten.tea.2008.0249; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; Marlovits S, 2004, INT J MOL MED, V13, P281; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Martin I, 2000, BIORHEOLOGY, V37, P141; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701; O'Connell G.D., 2015, J TISSUE ENG REGEN M; Rackwitz L, 2014, OSTEOARTHR CARTILAGE, V22, P1148, DOI 10.1016/j.joca.2014.05.019; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Schubert T, 2010, EXP MOL MED, V42, P166, DOI 10.3858/emm.2010.42.3.017; Steinert A, 2003, J ORTHOP RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179729	10.1371/journal.pone.0179729	http://dx.doi.org/10.1371/journal.pone.0179729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704392	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700015
J	Yu, D; Lin, QY; Chiu, APY; He, DH				Yu, Duo; Lin, Qianying; Chiu, Alice P. Y.; He, Daihai			Effects of reactive social distancing on the 1918 influenza pandemic	PLOS ONE			English	Article							PUBLIC-HEALTH MEASURES; TIME-SERIES; DYNAMICS; TRANSMISSION; IMMUNITY; DISEASE; MODELS; MORTALITY; INFERENCE; EPIDEMIC	The 1918 influenza pandemic was characterized by multiple epidemic waves. We investigated reactive social distancing, a form of behavioral response where individuals avoid potentially infectious contacts in response to available information on an ongoing epidemic or pandemic. We modelled its effects on the three influenza waves in the United Kingdom. In previous studies, human behavioral response was modelled by a Power function of the proportion of recent influenza mortality in a population, and by a Hill function, which is a function of the number of recent influenza mortality. Using a simple epidemic model with a Power function and one common set of parameters, we provided a good model fit for the observed multiple epidemic waves in London boroughs, Birmingham and Liverpool. We further applied the model parameters from these three cities to all 334 administrative units in England and Wales and including the population sizes of individual administrative units. We computed the Pearson's correlation between the observed and simulated for each administrative unit. We found a median correlation of 0.636, indicating that our model predictions are performing reasonably well. Our modelling approach is an improvement from previous studies where separate models are fitted to each city. With the reduced number of model parameters used, we achieved computational efficiency gain without over-fitting the model. We also showed the importance of reactive behavioral distancing as a potential non-pharmaceutical intervention during an influenza pandemic. Our work has both scientific and public health significance.	[Yu, Duo; Lin, Qianying; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China; [Yu, Duo] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA	Hong Kong Polytechnic University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	Lin, Qianying/ABD-8415-2021; He, Daihai/AAT-8735-2021	He, Daihai/0000-0003-3253-654X	General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council [PolyU 251001/14M]; Hong Kong Polytechnic University	General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	DH was supported by General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council (PolyU 251001/14M) and Start-up Fund for New Recruits from Hong Kong Polytechnic University.	Barry John M, 2004, J Transl Med, V2, P3, DOI 10.1186/1479-5876-2-3; Bhadra A, 2010, J R STAT SOC B, V72, P314, DOI [DOI 10.1111/J.1467-9868.2009.00736.X, 10.1111/j.1467-9868.2009.00736.x]; Bhadra A, 2011, J AM STAT ASSOC, V106, P440, DOI 10.1198/jasa.2011.ap10323; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P9595, DOI 10.1073/pnas.1220908110; Blake IM, 2014, P NATL ACAD SCI USA, V111, P10604, DOI 10.1073/pnas.1323688111; Bolton KJ, 2014, EPIDEMICS-NETH, V8, P18, DOI 10.1016/j.epidem.2014.07.004; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Breto C, 2014, STAT PROBABIL LETT, V91, P20, DOI 10.1016/j.spl.2014.04.003; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Camacho A, 2011, P ROY SOC B-BIOL SCI, V278, P3635, DOI 10.1098/rspb.2011.0300; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Gani R, 2005, EMERG INFECT DIS, V11, P1355; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886; Ionides EL, 2011, STAT SCI, V26, P49, DOI 10.1214/11-STS345C; Johnson N, 2011, SN4350 UK DAT SERV; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Lavine JS, 2012, EXPERT REV VACCINES, V11, P1319, DOI [10.1586/ERV.12.109, 10.1586/erv.12.109]; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Zhou J, 2013, STAT PROBABIL LETT, V83, P1448, DOI 10.1016/j.spl.2013.01.032	42	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180545	10.1371/journal.pone.0180545	http://dx.doi.org/10.1371/journal.pone.0180545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704460	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649600033
J	Holmes, MJ; Robertson, FC; Little, F; Randall, SR; Cotton, MF; van der Kouwe, AJW; Laughton, B; Meintjes, EM				Holmes, Martha J.; Robertson, Frances C.; Little, Francesca; Randall, Steven R.; Cotton, Mark F.; van der Kouwe, Andre J. W.; Laughton, Barbara; Meintjes, Ernesta M.			Longitudinal increases of brain metabolite levels in 5-10 year old children	PLOS ONE			English	Article							ABSOLUTE QUANTITATION; SOCIOECONOMIC-STATUS; SYNAPSE ELIMINATION; MR SPECTROSCOPY; BASAL GANGLIA; WHITE-MATTER; PROTON; CHILDHOOD; CORTEX; MATURATION	Longitudinal magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) studies reveal significant changes in brain structure and structural networks that occur together with cognitive and behavioral maturation in childhood. However, the underlying cellular changes accompanying brain maturation are less understood. Examining regional agerelated changes in metabolite levels provides insight into the physiology of neurodevelopment. Magnetic resonance spectroscopy (MRS) measures localize brain metabolism. The majority of neuroimaging studies of healthy development are from the developed world. In a longitudinal MRS study of 64 South African children aged 5 to 10 years old (29 female; 29 HIV exposed, uninfected), we examined the age-related trajectories of creatine (Cr +PCr), N-acetyl-aspartate (NAA), the combined NAA+N-acetyl-aspartyl-glutamate (NAAG), choline (GPC+PCh), glutamate (Glu) and the combined Glu+glutamine (Glu +Gln) in voxels within gray and white matter, as well as subcortically in the basal ganglia (BG). In frontal gray matter, we found age-related increases in Cr+PCr, NAA, NAA+NAAG and Glu+Gln levels pointing to synaptic activity likely related to learning. In the BG we observed increased levels of Glu, Glu+Gln and NAA+NAAG with age that point to subcortical synaptic reorganization. In white matter, we found increased levels of Cr+PCr, NAA, NAA+NAAG, Glu and Glu+Gln with age, implicating these metabolites in ongoing myelination. We observed no sex-age or HIV exposure-age interactions, indicating that physiological changes are independent of sex during this time period. The metabolite trajectories presented, therefore, provide a critical benchmark of normal cellular growth for a low socioeconomic pediatric population in the developing world against which pathology and abnormal development may be compared.	[Holmes, Martha J.; Robertson, Frances C.; Meintjes, Ernesta M.] Univ Cape Town, Fac Hlth Sci, Div Biomed Engn, MRC UCT Med Imaging Res Unit, Cape Town, South Africa; [Holmes, Martha J.; Robertson, Frances C.; Randall, Steven R.; Meintjes, Ernesta M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Cape Town, South Africa; [Little, Francesca] Univ Cape Town, Fac Sci, Dept Stat Sci, Cape Town, South Africa; [Cotton, Mark F.; Laughton, Barbara] Stellenbosch Univ, Childrens Infect Dis Clin Res Unit, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [van der Kouwe, Andre J. W.] Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [van der Kouwe, Andre J. W.] Harvard Med Sch, Dept Radiol, Boston, MA USA	University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Holmes, MJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Biomed Engn, MRC UCT Med Imaging Res Unit, Cape Town, South Africa.; Holmes, MJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Cape Town, South Africa.	martha.j.holmes@gmail.com	Laughton, Barbara/AAR-5427-2020; Meintjes, Ernesta/ABD-8771-2020; Cotton, Mark/AAQ-9936-2020	Laughton, Barbara/0000-0001-7260-7723; Meintjes, Ernesta/0000-0002-0781-3632; Cotton, Mark/0000-0003-2559-6034; Holmes, Martha/0000-0001-5873-2405; Little, Francesca/0000-0002-5917-9928; Randall, Steven Ronald/0000-0002-5029-2174	National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network [U19 AI53217]; National Institutes of Health (NIH) [R01HD071664, R21MH096559, R21MH108346]; NRF [CPR20110614000019421]; Medical Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH108346] Funding Source: NIH RePORTER	National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRF; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study was provided by the National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network, Grant U19 AI53217; National Institutes of Health (NIH) grants R01HD071664 (PIs: AJWvdK, EMM, BL; https://www.fic.nih.gov/Grants/Search/Pages/brain-R01HD071664.aspx), R21MH096559 (PIs: AJWvdK, EMM, BL) and R21MH108346 (PI: EMM; https://www.fic.nih.gov/Grants/Search/Pages/brain-R21MH108346.aspx); NRF grant CPR20110614000019421 (PI Ernesta Meintjes), and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agarwal N, 2012, AM J NEURORADIOL, V33, P595, DOI 10.3174/ajnr.A2587; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Ben Bashat D, 2005, J MAGN RESON IMAGING, V21, P503, DOI 10.1002/jmri.20281; Benarroch EE, 2005, BASIC NEUROSCIENCES; Benjamini Y, 2001, ANN STAT, V29, P1165; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Graybiel AM, 2004, PARKINSONISM RELAT D, V10, P293, DOI 10.1016/j.parkreldis.2004.03.007; HASHIMOTO T, 1995, DEV MED CHILD NEUROL, V37, P398; Hess AT, 2011, MAGN RESON MED, V66, P314, DOI 10.1002/mrm.22805; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Keller MA, 2004, NEUROLOGY, V62, P1810, DOI 10.1212/01.WNL.0000125492.57419.25; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; R-Core-Team, 2015, LANG ENV STAT COMP; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; UNAIDS, 2014, UND FAST TRACK ACC A; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072	46	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180973	10.1371/journal.pone.0180973	http://dx.doi.org/10.1371/journal.pone.0180973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700727	gold, Green Published			2022-12-26	WOS:000405649400024
J	Lv, M; Li, Y; Kou, B; Zhou, ZL				Lv, Ming; Li, Yi; Kou, Bo; Zhou, Zhili			Integer programming for improving radiotherapy treatment efficiency	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; WAITING TIME; MODEL; OPTIMIZATION	Background and purpose Patients received by radiotherapy departments are diverse and may be diagnosed with different cancers. Therefore, they need different radiotherapy treatment plans and thus have different needs for medical resources. This research aims to explore the best method of scheduling the admission of patients receiving radiotherapy so as to reduce patient loss and maximize the usage efficiency of service resources. Materials and methods A mix integer programming (MIP) model integrated with special features of radiotherapy is constructed. The data used here is based on the historical data collected and we propose an exact method to solve the MIP model. Results Compared with the traditional First Come First Served (FCFS) method, the new method has boosted patient admission as well as the usage of linear accelerators (LINAC) and beds. Conclusions The integer programming model can be used to describe the complex problem of scheduling radio-receiving patients, to identify the bottleneck resources that hinder patient admission, and to obtain the optimal LINAC-bed radio under the current data conditions. Different management strategies can be implemented by adjusting the settings of the MIP model. The computational results can serve as a reference for the policy-makers in decision making.	[Lv, Ming; Zhou, Zhili] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China; [Li, Yi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China; [Kou, Bo] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiac Surg, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, Y (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China.	flinglee@sina.com						Buchanan R., 2002, ROYAL COLL RADIOLOGI, P1; Ceschia S, 2011, COMPUT OPER RES, V38, P1452, DOI 10.1016/j.cor.2011.01.007; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Claudio D., 2014, IIE T HEALTHC SYST E, V4, P16, DOI [10.1080/19488300.2013.879459, DOI 10.1080/19488300.2013.879459]; Conforti D, 2008, 4OR-Q J OPER RES, V6, P263, DOI 10.1007/S10288-007-0050-8; Conforti D, 2010, EUR J OPER RES, V201, P289, DOI 10.1016/j.ejor.2009.02.016; D'Souza DP, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-3; Danjoux C, 2006, SUPPORT CARE CANCER, V14, P38, DOI 10.1007/s00520-005-0822-7; Delaney G, 2002, CLIN ONCOL-UK, V14, P406, DOI 10.1053/clon.2002.0141; Faria SL, 2006, AM J CLIN ONCOL-CANC, V29, P463, DOI 10.1097/01.coc.0000225919.35003.88; Garg L, 2010, HEALTH CARE MANAG SC, V13, P155, DOI 10.1007/s10729-009-9120-0; Gemmel P, 1999, INT J OPER PROD MAN, V19, P863, DOI 10.1108/01443579910280188; Hahn-Goldberg S, 2014, HEALTH CARE MANAG SC, V17, P379, DOI 10.1007/s10729-014-9268-0; Han Y, 2005, JPN J CLIN ONCOL, V35, P470, DOI 10.1093/jjco/hyi129; Herbert C E, 2000, Australas Radiol, V44, P444, DOI 10.1046/j.1440-1673.2000.00851.x; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; KOLESAR P, 1970, MANAGE SCI B-APPL, V16, pB384; Mackillop WJ, 2007, RADIOTHER ONCOL, V84, P1, DOI 10.1016/j.radonc.2007.05.006; MACKILLOP WJ, 1994, INT J RADIAT ONCOL, V30, P221, DOI 10.1016/0360-3016(94)90538-X; Matta Marie E, 2007, Health Care Manag Sci, V10, P173, DOI 10.1007/s10729-007-9010-2; Sadki A, 2013, DECIS SUPPORT SYST, V55, P640, DOI 10.1016/j.dss.2012.10.020; Saure A, 2012, EUR J OPER RES, V223, P573, DOI 10.1016/j.ejor.2012.06.046; Schafer C, 2005, STRAHLENTHER ONKOL, V181, P9, DOI 10.1007/s00066-005-1252-7; Seel Matthew, 2002, Australas Radiol, V46, P275, DOI 10.1046/j.1440-1673.2002.01059.x; Turkcan Ayten, 2012, IIE Transactions on Healthcare Systems Engineering, V2, P31, DOI 10.1080/19488300.2012.665155; Verellen D, 2002, RADIOTHER ONCOL, V63, P27, DOI 10.1016/S0167-8140(02)00030-0; Winston WL, 2004, OPERATIONS RES APPL	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180564	10.1371/journal.pone.0180564	http://dx.doi.org/10.1371/journal.pone.0180564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700726	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800054
J	Sjogren, V; Bystrom, B; Renlund, H; Svensson, PJ; Oldgren, J; Norrving, B; Sjalander, A				Sjogren, Vilhelm; Bystrom, Bjorn; Renlund, Henrik; Svensson, Peter J.; Oldgren, Jonas; Norrving, Bo; Sjalander, Anders			Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study	PLOS ONE			English	Article							NORMALIZED RATIO CONTROL; ATRIAL-FIBRILLATION; EFFICACY; SAFETY; QUALITY; METAANALYSIS; VALIDATION; DABIGATRAN; INPATIENT; APIXABAN	Background For patients with atrial fibrillation, non-vitamin K oral anticoagulants, or NOACs (dabigatran, rivaroxaban, edoxaban, and apixaban) have been proven non-inferior or superior to warfarin in preventing stroke and systemic embolism, and in risk of haemorrhage. In the pivotal NOAC studies, quality of warfarin treatment was poor with mean time in therapeutic range (TTR) 55-65%, compared with >= 70% in Swedish clinical practice. Methods We compared NOACs (as a group) to warfarin in non-valvular atrial fibrillation, studying all 12,694 patients starting NOAC treatment within the Swedish clinical register and dosing system Auricula, from July 1, 2011 to December 31, 2014, and matching them to 36,317 patients starting warfarin using propensity scoring. Endpoints were thromboembolic events and major bleedings that were fatal or required hospital care. Outcome data were collected from validated Swedish hospital administrative and clinical registers. Results Mean age was 72.2 vs 72.3 years, proportion of males 58.2% vs 57.0%, and mean follow-up time 299 vs 283 days for NOACs and warfarin. Distribution of NOACs was: dabigatran 40.3%, rivaroxaban 31.2%, and apixaban 28.5%. Mean TTR was 70%. There were no significant differences in rates of thromboembolic/thrombotic events or gastrointestinal bleeding. NOAC treated patients had lower rates of major bleeding overall, hazard ratio 0.78 (95% confidence interval 0.67-0.92), intracranial bleeding 0.59 (0.40-0.87), haemorrhagic stroke 0.49 (0.28-0.86), and other major bleeding 0.71 (0.57-0.89). Conclusion For patients with atrial fibrillation, NOACs are as effective for stroke prevention as well-managed warfarin but cause fewer major bleedings.	[Sjogren, Vilhelm; Bystrom, Bjorn; Sjalander, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Renlund, Henrik] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Svensson, Peter J.] Lund Univ, Dept Translat Med, Clin Coagulat Res Unit, Skane Univ Hosp, Malmo, Sweden; [Oldgren, Jonas] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Oldgren, Jonas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Norrving, Bo] Lund Hosp, Dept Clin Sci Lund, Neurol, Skane Univ Hosp, Lund, Sweden	Umea University; Uppsala University; Lund University; Skane University Hospital; Uppsala University; Uppsala University; Lund University; Skane University Hospital	Sjogren, V (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	vilhelm.sjogren.md@gmail.com	Sjögren, Vilhelm/N-5150-2016	Sjögren, Vilhelm/0000-0003-0282-8648; Renlund, Henrik/0000-0002-2141-6086	Swedish Heart-Lung Foundation [20150435]; Swedish Association of Local Authorities and Regions; Northern Swedish Stroke fund	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association of Local Authorities and Regions; Northern Swedish Stroke fund	This work was supported by The Swedish Heart-Lung Foundation, grant number 20150435, https://www3.hjart-lungfonden.se/ViewPublicReport.aspx (AS); The Swedish Association of Local Authorities and Regions, http://kvalitetsregister.se/englishpages/findaregistry/registerarkivenglish/nationalqualityregistryforatrialfibrillationandanticoagulationauricula.2145.html; and The Northern Swedish Stroke fund, http://www.umu.se/om-universitetet/aktuellt/nyheter/nyhetsvisning//bidrag-ska-framja-strokeforskning.cid258571 (AS).	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Austin PC, 2015, STAT MED, V34, P3949, DOI 10.1002/sim.6602; Bjorck F, 2016, JAMA CARDIOL, V1, P172, DOI 10.1001/jamacardio.2016.0199; Bjorck F, 2015, THROMB RES, V136, P216, DOI 10.1016/j.thromres.2015.04.016; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Kirchhof P., 2016, EUR HEART J; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ming KW, 2000, BIOMETRICS, V56, P118, DOI 10.1111/j.0006-341X.2000.00118.x; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sjogren V, 2015, THROMB HAEMOSTASIS, V113, P1370, DOI 10.1160/TH14-10-0859; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Therneau TM, 2000, GRAMBSCH PM MODELING, Vxiii; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725	26	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181000	10.1371/journal.pone.0181000	http://dx.doi.org/10.1371/journal.pone.0181000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700711	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800113
J	Szostak, N; Synak, J; Borowski, M; Wasik, S; Blazewicz, J				Szostak, Natalia; Synak, Jaroslaw; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek			Simulating the origins of life: The dual role of RNA replicases as an obstacle to evolution	PLOS ONE			English	Article							SYSTEMS BIOLOGY; GROUP SELECTION; HYPERCYCLES; POLYMERIZATION; PARASITES; RIBOZYME; COMPLEX; MODEL	Despite years of study, it is still not clear how life emerged from inanimate matter and evolved into the complex forms that we observe today. One of the most recognized hypotheses for the origins of life, the RNA World hypothesis, assumes that life was sparked by prebiotic replicating RNA chains. In this paper, we address the problems caused by the interplay between hypothetical prebiotic RNA replicases and RNA parasitic species. We consider the coexistence of parasite RNAs and RNA replicases as well as the impact of parasites on the further evolution of replicases. For these purposes, we used multi-agent modeling techniques that allow for realistic assumptions regarding the movement and spatial interactions of modeled species. The general model used in this study is based on work by Takeuchi and Hogeweg. Our results confirm that the coexistence of parasite RNAs and replicases is possible in a spatially extended system, even if we take into consideration more realistic assumptions than Takeuchi and Hogeweg. However, we also showed that the presence of trade-off that takes into the account an RNA folding process could still pose a serious obstacle to the evolution of replication. We conclude that this might be a cause for one of the greatest transitions in life that took place early in evolution-the separation of the function between DNA templates and protein enzymes, with a central role for RNA species.	[Szostak, Natalia; Synak, Jaroslaw; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Szostak, Natalia; Wasik, Szymon; Blazewicz, Jacek] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Szostak, Natalia; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek] European Ctr Bioinformat & Genom, Poznan, Poland	Poznan University of Technology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Wasik, S (corresponding author), Poznan Univ Tech, Inst Comp Sci, Poznan, Poland.; Wasik, S (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.; Wasik, S (corresponding author), European Ctr Bioinformat & Genom, Poznan, Poland.	szymon.wasik@cs.put.poznan.pl	Borowski, Marcin/F-9278-2013; Szostak, Natalia/H-1331-2015; Wasik, Szymon/F-7677-2014; Synak, Jaroslaw/AAI-3858-2021; Szostak, Natalia/GPX-0551-2022; Blazewicz, Jacek/L-5597-2014	Borowski, Marcin/0000-0003-2116-8761; Szostak, Natalia/0000-0001-9933-0496; Wasik, Szymon/0000-0002-2753-2862; Szostak, Natalia/0000-0001-9933-0496; Blazewicz, Jacek/0000-0001-8326-1094	Poznan University of Technology [09/91/DSPB/0600]; Etiuda grant from National Science Center, Poland [2016/20/T/ST6/00395]	Poznan University of Technology; Etiuda grant from National Science Center, Poland	This work was supported by Poznan University of Technology (www.put.edu.pl) grant [09/91/DSPB/0600]. Additionally NS was supported by Etiuda grant from National Science Center (www.ncn.gov.pl), Poland [2016/20/T/ST6/00395]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber MS, 2003, IMA VOL MATH APPL, V134, P1; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bartel DP., 1999, COLD SPRING HARBOR M, V37, P143; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; BOERLIJST MC, 1991, SFI STUD SCI COMPLEX, P255; BRESCH C, 1980, J THEOR BIOL, V85, P399, DOI 10.1016/0022-5193(80)90314-8; Colizzi ES, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004902; Costanzo G, 2009, J BIOL CHEM, V284, P33206, DOI 10.1074/jbc.M109.041905; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRONHJORT MB, 1995, ORIGINS LIFE EVOL B, V25, P227, DOI 10.1007/BF01581586; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; DAMUTH J, 1988, BIOL PHILOS, V3, P407, DOI 10.1007/BF00647962; Domingo E, 2015, CURRENT TOPICS IN MI, P1; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1982, DISEQUILIBRIUM SELF, P169; Eigen M., 1979, THE HYPERCYCLE A PRI; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Gesteland R. F., 2005, RNA WORLD; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Horning DP, 2016, P NATL ACAD SCI USA, V113, P9786, DOI 10.1073/pnas.1610103113; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Klann M, 2012, INT J MOL SCI, V13, P7798, DOI 10.3390/ijms13067798; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Knuth DE., 1981, THE ART OF COMPUTER, V2, P133; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Leigh E. G., 1995, EVOLUTION, V49, P1302; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035454; MAY RM, 1991, NATURE, V353, P607, DOI 10.1038/353607a0; McCaskill JS, 2001, BIOL CHEM, V382, P1343, DOI 10.1515/BC.2001.167; Merelli E, 2007, BRIEF BIOINFORM, V8, P45, DOI 10.1093/bib/bbl014; NUNNEY L, 1985, AM NAT, V126, P212, DOI 10.1086/284410; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Prejzendanc T, 2016, CURR BIOINFORM, V11, P551, DOI 10.2174/1574893610666150928193510; Rybarczyk A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0718-6; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Scheuring I., 2001, AVOIDING CATCH 22 OF, V1, P135; Sczepanski JT, 2014, NATURE, V515, P440, DOI 10.1038/nature13900; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2015, P NATL ACAD SCI USA, V112, P10104, DOI 10.1073/pnas.1421398112; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Szostak N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004853; Szostak N, 2014, RNA BIOL, V11, P836, DOI 10.4161/rna.29305; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Takeuchi N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002024; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vodovotz Y, 2015, TRANSLATIONAL SYSTEM, P111, DOI [10.1016/b978-0-12-397884-4.00014-8, DOI 10.1016/B978-0-12-397884-4.00014-8]; von Kiedrowski G., 2001, SELECTION, V1, P173, DOI DOI 10.1556/SELECT.1.2000.1-3.17; Wasik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145557; Wasik S, 2014, ARTIF INTELL MED, V60, P123, DOI 10.1016/j.artmed.2013.11.001; Wasik S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/320715; Wasik S, 2010, COMPUT MATH METHOD M, V11, P185, DOI 10.1080/17486700903170712; WEIMAR JR, 1994, PHYS REV E, V49, P1749, DOI 10.1103/PhysRevE.49.1749; Woese C., 1967, THE GENETIC CODE THE; Wojciechowski P, 2016, FOUND COMPUT DECIS S, V41, P123, DOI 10.1515/fcds-2016-0007	73	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180827	10.1371/journal.pone.0180827	http://dx.doi.org/10.1371/journal.pone.0180827			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700697	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800083
J	Scoville, DK; Botta, D; Galdanes, K; Schmuck, SC; White, CC; Stapleton, PL; Bammler, TK; MacDonald, JW; Altemeier, WA; Hernandez, M; Kleeberger, SR; Chen, LC; Gordon, T; Kavanagh, TJ				Scoville, David K.; Botta, Dianne; Galdanes, Karen; Schmuck, Stefanie C.; White, Collin C.; Stapleton, Patricia L.; Bammler, Theo K.; MacDonald, James W.; Altemeier, William A.; Hernandez, Michelle; Kleeberger, Steven R.; Chen, Lung-Chi; Gordon, Terry; Kavanagh, Terrance J.			Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice	FASEB JOURNAL			English	Article						genome-wide association; nanosilver; Nedd4l; Ano6; Rnf220	GENOME-WIDE ASSOCIATION; COLLABORATIVE CROSS; INTRATRACHEAL INSTILLATION; RAT LUNG; OROPHARYNGEAL ASPIRATION; ALVEOLAR MACROPHAGES; CARBON NANOTUBES; PARTICLE-SIZE; ANOCTAMIN 6; MOUSE	Silver nanoparticles (AgNPs) are employed in a variety of consumer products; however, in vivo rodent studies indicate that AgNPs can cause lung inflammation and toxicity in a strain- and particle type-dependent manner, but mechanisms of susceptibility remain unclear. The aim of this study was to assess the variation in AgNP-induced lung inflammation and toxicity across multiple inbred mouse strains and to use genome-wide association (GWA) mapping to identify potential candidate susceptibility genes. Mice received doses of 0.25 mg/kg of either 20-nm citrate-coated AgNPs or citrate buffer using oropharyngeal aspiration. Neutrophils in bronchoalveolar lavage fluid (BALF) served as markers of inflammation. We found significant strain- and treatment-dependent variation in neutrophils in BALF. GWA mapping identified 10 significant single-nucleotide polymorphisms (false discovery rate, 15%) in 4 quantitative trait loci on mouse chromosomes 1, 4, 15, and 18, and Nedd4l (neural precursor cell expressed developmentally downregulated gene 4-like; chromosome 18), Ano6 (anocatmin 6; chromosome 15), and Rnf220 (Ring finger protein 220; chromosome 4) were considered candidate genes. Quantitative RT-PCR revealed significant inverse associations between mRNA levels of these genes and neutrophil influx. Nedd4l, Ano6, and Rnf220 are candidate susceptibility genes for AgNP-induced lung inflammation that warrant additional exploration in future studies.-Scoville, D. K., Botta, D., Galdanes, K., Schmuck, S. C., White, C. C., Stapleton, P. L., Bammler, T. K., MacDonald, J. W., Altemeier, W. A., Hernandez, M., Kleeberger, S. R., Chen, L.-C., Gordon, T., Kavanagh, T. J. Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice.	[Scoville, David K.; Botta, Dianne; Schmuck, Stefanie C.; White, Collin C.; Stapleton, Patricia L.; Bammler, Theo K.; MacDonald, James W.; Kavanagh, Terrance J.] Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE Suite 100,Box 354695, Seattle, WA 98195 USA; [Altemeier, William A.] Univ Washington, Dept Med, Seattle, WA USA; [Galdanes, Karen; Hernandez, Michelle; Chen, Lung-Chi] NYU, Dept Environm Med, Tuxedo Pk, NY USA; [Kleeberger, Steven R.] NIEHS, Immun Inflammat & Dis Lab, POB 12233, Res Triangle Pk, NC 27709 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kavanagh, TJ (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE Suite 100,Box 354695, Seattle, WA 98195 USA.	tjkav@uw.edu	Kleeberger, Steven R/F-1807-2019	Kleeberger, Steven R/0000-0003-2948-8452; Altemeier, William/0000-0001-8860-405X	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) [U01-ES019545, U01-ES0200126, T32-ES015459, P30-ES007033, P30-ES000260]; NIH NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, U19ES019545, P30ES000260, ZIAES100512, ZIAES100557, T32ES015459] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Grants U01-ES019545, U01-ES0200126, T32-ES015459, P30-ES007033, and P30-ES000260. S.R.K. was supported by the NIH NIEHS Intramural Research Program. The silver nanomaterials used in these studies were procured, characterized, and provided by NIEHS Centers for Nanotechnology Health Implications Research Consortium.	Almasy L, 2010, COLD SPRING HARB PRO, V2010; Anderson DS, 2015, NANOTOXICOLOGY, V9, P591, DOI 10.3109/17435390.2014.958116; Anderson DS, 2015, TOXICOL SCI, V144, P366, DOI 10.1093/toxsci/kfv005; [Anonymous], 2014, R LANG ENV STAT COMP; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Botelho DJ, 2016, NANOTOXICOLOGY, V10, P118, DOI 10.3109/17435390.2015.1038330; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; Church RJ, 2014, TOXICOL SCI, V140, P481, DOI 10.1093/toxsci/kfu094; Cohen J., 1988, J AM STAT ASSOC, V2nd, DOI [10.1016/B978-0-12-179060-8.50007-4, DOI 10.1016/B978-0-12-179060-8.50007-4, DOI 10.2307/2290095]; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Cui L., 2013, THESIS; Deepayan S., 2008, LATTICE MULTIVARIATE; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Guo YJ, 2015, BLOOD, V126, P2220, DOI 10.1182/blood-2015-02-622233; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kinaret P, 2017, ACS NANO, V11, P291, DOI 10.1021/acsnano.6b05652; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Labots M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0411-4; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lee JS, 2015, NANOTOXICOLOGY, V9, P802, DOI 10.3109/17435390.2014.978404; Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021; Li B, 2015, ENDOCRINOLOGY, V156, P203, DOI 10.1210/en.2014-1539; Liao HY, 2014, NANOTOXICOLOGY, V8, P100, DOI 10.3109/17435390.2013.858793; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mares CA, 2011, IMMUNOL CELL BIOL, V89, P167, DOI 10.1038/icb.2010.81; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; McConnachie LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064165; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morimoto K, 2012, RESP MED, V106, P1800, DOI 10.1016/j.rmed.2012.08.020; Nichols JL, 2014, FASEB J, V28, P2538, DOI 10.1096/fj.13-247221; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pang CF, 2016, NANOTOXICOLOGY, V10, P129, DOI 10.3109/17435390.2015.1024295; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pinheiro JBD, 2020, R CORE TEAM NLME LIN; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Rutledge H, 2014, GENETICS, V198, P735, DOI 10.1534/genetics.114.168138; Rysavy Noel M, 2014, Bioarchitecture, V4, P127, DOI 10.1080/19490992.2014.995516; Scoville DK, 2015, TOXICOL APPL PHARM, V289, P240, DOI 10.1016/j.taap.2015.09.019; Seiffert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119726; Shannahan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074001; Silva RM, 2016, TOXICOL PATHOL, V44, P673, DOI 10.1177/0192623316629804; Silva RM, 2015, TOXICOL SCI, V144, P151, DOI 10.1093/toxsci/kfu265; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki OT, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00272; The Jackson Laboratory, 2011, STEARNS1 LUNG GEN EX; The National Institute for Occupational Safety and Health, 1994, IMM DANG LIF HLTH; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; Turner S.D., 2014, QQMAN R PACKAGE VISU, V7, pe1002043, DOI [DOI 10.21105/JOSS.00731, 10.1101/005165, DOI 10.1101/005165]; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; Weldon BA, 2016, NANOTOXICOLOGY, V10, P945, DOI 10.3109/17435390.2016.1148793; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	73	24	24	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4600	4611		10.1096/fj.201700187R	http://dx.doi.org/10.1096/fj.201700187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28716969	Green Published			2022-12-26	WOS:000413397400035
J	Anaker, A; von Koch, L; Sjostrand, C; Bernhardt, J; Elf, M				Anaker, Anna; von Koch, Lena; Sjostrand, Christina; Bernhardt, Julie; Elf, Marie			A comparative study of patients' activities and interactions in a stroke unit before and after reconstruction-The significance of the built environment	PLOS ONE			English	Article							ENRICHED ENVIRONMENT; PHYSICAL-ACTIVITY; REHABILITATION; CARE; ROOMS; EMERGENCY	Early mobilization and rehabilitation, multidisciplinary stroke expertise and comprehensive therapies are fundamental in a stroke unit. To achieve effective and safe stroke care, the physical environment in modern stroke units should facilitate the delivery of evidence-based care. Therefore, the purpose of this study was to explore patients' activities and interactions in a stroke unit before the reconstruction of the physical environment, while in a temporary location and after reconstruction. This case study examined a stroke unit as an integrated whole. The data were collected using a behavioral mapping technique at three different time points: in the original unit, in the temporary unit and in the new unit. A total of 59 patients were included. The analysis included field notes from observations of the physical environment and examples from planning and design documents. The findings indicated that in the new unit, the patients spent more time in their rooms, were less active, and had fewer interactions with staff and family than the patients in the original unit. The reconstruction involved a change from a primarily multi-bed room design to single-room accommodations. In the new unit, the patients' lounge was located in a far corner of the unit with a smaller entrance than the patients' lounge in the old unit, which was located at the end of a corridor with a noticeable entrance. Changes in the design of the stroke unit may have influenced the patients' activities and interactions. This study raises the question of how the physical environment should be designed in the future to facilitate the delivery of health care and improve outcomes for stroke patients. This research is based on a case study, and although the results should be interpreted with caution, we strongly recommend that environmental considerations be included in future stroke guidelines.	[Anaker, Anna; von Koch, Lena; Elf, Marie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Anaker, Anna; Elf, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [von Koch, Lena; Sjostrand, Christina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bernhardt, Julie] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Elf, Marie] Chalmers Univ Technol, Sch Architecture, Gothenburg, Sweden	Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Florey Institute of Neuroscience & Mental Health; Chalmers University of Technology	Anaker, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.; Anaker, A (corresponding author), Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden.	anna.anaker@ki.se	von Koch, Lena/P-2310-2018; Bernhardt, Julie/F-9538-2015	von Koch, Lena/0000-0002-8560-3016; Bernhardt, Julie/0000-0002-2787-8484	Swedish Research Council Formas; Swedish Stroke Association; Doctoral School in Health Care Sciences at Karolinska Institutet	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Stroke Association; Doctoral School in Health Care Sciences at Karolinska Institutet	Financial support was provided through the Swedish Research Council Formas, the Swedish Stroke Association and the Doctoral School in Health Care Sciences at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided through the Swedish Research Council Formas, the Swedish Stroke Association and the Doctoral School in Health Care Sciences at Karolinska Institutet. We would like to thank Christina Nylen and Olivia Ortlund, who both worked as research assistants in the study, and Jan Chamberlain for support with data processing.	Astrand A, 2016, J STROKE CEREBROVASC, V25, P938, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.046; Barlas D, 2001, ANN EMERG MED, V38, P135, DOI 10.1067/mem.2001.115441; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; Devlin AS, 2016, HERD-HEALTH ENV RES, V9, P190, DOI 10.1177/1937586715607052; Elf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161942; Elf M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0782-7; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Hamilton D.K., 2003, HEALTHCARE DESIGN, V3, P18; Hendrich AL, 2004, AM J CRIT CARE, V13, P35, DOI 10.4037/ajcc2004.13.1.35; Hokstad A, 2015, J STROKE CEREBROVASC, V24, P1333, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.009; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; Keysor JJ, 2006, ARCH PHYS MED REHAB, V87, P1566, DOI 10.1016/j.apmr.2006.08.347; Kramer SF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460482; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lincoln N B, 1989, Int Disabil Stud, V11, P149; Maben J, 2015, ONE SIZE FITS ALL MI; Malenbaum S, 2008, PAIN, V134, P241, DOI 10.1016/j.pain.2007.12.002; McDonald S., 2005, QUAL RES, V5, P455, DOI 10.1177/1468794105056923; Persson E, 2015, SCAND J CARING SCI, V29, P340, DOI 10.1111/scs.12168; Rapoport A., 1990, MEANING BUILT ENV NO; RIKS Stroke, 2014, STROK TIA; Ringelstein EB, 2013, STROKE, V44, P828, DOI 10.1161/STROKEAHA.112.670430; Sadler BL, 2011, HASTINGS CENT REP, V41, P13; Salonen H, 2013, INTELL BUILD INT, V5, P26, DOI 10.1080/17508975.2013.764839; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Singh I, 2016, GERONTOLOGY GEARIATR, V2; Spradley J. P., 2016, PARTICIPANT OBSERVAT; Steinke C, 2009, HERD, V3, P63; Steinke C, 2015, HERD-HEALTH ENV RES, V8, P31, DOI 10.1177/1937586714565611; SUTC, 2013, COCHRANE DATABASE SY; Teasell R. W., 2015, TOP STROKE REHABIL; Tinson D J, 1989, Int Disabil Stud, V11, P45; Ulrich RS, 2010, HERD-HEALTH ENV RES, V4, P95, DOI 10.1177/193758671000400107; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; West T, 2011, STROKE RES TREATMENT; White JH, 2014, DISABIL REHABIL, V36, P1783, DOI 10.3109/09638288.2013.872200; World Health Organization (WHO), 2015, INT CLASS FUNCT DIS, V1st; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]	41	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0177477	10.1371/journal.pone.0177477	http://dx.doi.org/10.1371/journal.pone.0177477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727727	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500001
J	Abernathy, J; Brezas, A; Snekvik, KR; Hardy, RW; Overturf, K				Abernathy, Jason; Brezas, Andreas; Snekvik, Kevin R.; Hardy, Ronald W.; Overturf, Ken			Integrative functional analyses using rainbow trout selected for tolerance to plant diets reveal nutrigenomic signatures for soy utilization without the concurrence of enteritis	PLOS ONE			English	Article							SALMON SALMO-SALAR; ONCORHYNCHUS-MYKISS WALBAUM; FISH-MEAL REPLACEMENT; ATLANTIC SALMON; SOYBEAN-MEAL; GENE-EXPRESSION; GROWTH-PERFORMANCE; DISTAL INTESTINE; PROTEIN-SOURCES; GRADED-LEVELS	Finding suitable alternative protein sources for diets of carnivorous fish species remains a major concern for sustainable aquaculture. Through genetic selection, we created a strain of rainbow trout that outperforms parental lines in utilizing an all-plant protein diet and does not develop enteritis in the distal intestine, as is typical with salmonids on long-term plant protein-based feeds. By incorporating this strain into functional analyses, we set out to determine which genes are critical to plant protein utilization in the absence of gut inflammation. After a 12-week feeding trial with our selected strain and a control trout strain fed either a fishmeal-based diet or an all-plant protein diet, high-throughput RNA sequencing was completed on both liver and muscle tissues. Differential gene expression analyses, weighted correlation network analyses and further functional characterization were performed. A strain-by-diet design revealed differential expression ranging from a few dozen to over one thousand genes among the various comparisons and tissues. Major gene ontology groups identified between comparisons included those encompassing central, intermediary and foreign molecule metabolism, associated biosynthetic pathways as well as immunity. A systems approach indicated that genes involved in purine metabolism were highly perturbed. Systems analysis among the tissues tested further suggests the interplay between selection for growth, dietary utilization and protein tolerance may also have implications for nonspecific immunity. By combining data from differential gene expression and co-expression networks using selected trout, along with ontology and pathway analyses, a set of 63 candidate genes for plant diet tolerance was found. Risk loci in human inflammatory bowel diseases were also found in our datasets, indicating rainbow trout selected for plant-diet tolerance may have added utility as a potential biomedical model.	[Abernathy, Jason; Overturf, Ken] USDA ARS, Hagerman Fish Culture Expt Stn, Hagerman, ID 83332 USA; [Brezas, Andreas; Hardy, Ronald W.] Univ Idaho, Aquaculture Res Inst, Hagerman, ID USA; [Snekvik, Kevin R.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Abernathy, Jason] USDA ARS, Harry K Dupree Stuttgart Natl Aquaculture Res Ctr, Stuttgart, AR USA	United States Department of Agriculture (USDA); Idaho; University of Idaho; Washington State University; United States Department of Agriculture (USDA)	Abernathy, J; Overturf, K (corresponding author), USDA ARS, Hagerman Fish Culture Expt Stn, Hagerman, ID 83332 USA.	Jason.Abernathy@ars.usda.gov; Ken.Overturf@ars.usda.gov	Hardy, Ronald/AAK-4878-2021	Hardy, Ronald/0000-0002-4521-864X; Abernathy, Jason/0000-0001-6084-8239	Soy Aquaculture Alliance [UI/2013T01, U1/2013T02]; USDA Agricultural Research Service [2050-21310-005-00D]	Soy Aquaculture Alliance; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by grants to RWH and KO from the Soy Aquaculture Alliance (awards #UI/2013T01 and #U1/2013T02) and by the USDA Agricultural Research Service under the Trout Grains Project (project #2050-21310-005-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy J, 2016, ANIM BIOTECHNOL, V27, P60, DOI 10.1080/10495398.2015.1086365; Alami-Durante H, 2010, AQUACULTURE, V303, P50, DOI 10.1016/j.aquaculture.2010.03.012; Andersen O, 2006, FEBS J, V273, P2839, DOI 10.1111/j.1742-4658.2006.05288.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Caruso G., 2015, FISH AQUAC J, V6, pe123, DOI DOI 10.4172/2150-3508.1000E123; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Cronstein BN, 1999, OSTEOARTHR CARTILAGE, V7, P361, DOI 10.1053/joca.1998.0236; Davies SJ, 1997, AQUAC RES, V28, P65, DOI 10.1111/j.1365-2109.1997.tb01316.x; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Ding Y, 2016, FISH SHELLFISH IMMUN; Dupont-Nivet M, 2009, AQUACULTURE, V295, P15, DOI 10.1016/j.aquaculture.2009.06.031; Fonseca-Camarillo G, 2011, INFLAMM BOWEL DIS, V17, pE135, DOI 10.1002/ibd.21816; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hasler R, 2011, EUR J CELL BIOL, V90, P603, DOI 10.1016/j.ejcb.2010.11.010; Han QF, 2015, J IMMUNOL, V195, P5440, DOI 10.4049/jimmunol.1500892; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Heath A.G., 1995, WATER POLLUTION FISH; Hixson S. M., 2014, Journal of Aquaculture Research and Development, V5, P234; Jenke AC, 2012, CURR OPIN GASTROEN, V28, P577, DOI 10.1097/MOG.0b013e328357336b; Jonas E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00049; Kaneko K, 2008, NUCLEOS NUCLEOT NUCL, V27, P628, DOI 10.1080/15257770802138681; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Lee KJ, 2015, AQUAC RES, V46, P1590, DOI 10.1111/are.12313; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Martin SAM, 2003, BBA-PROTEINS PROTEOM, V1651, P17, DOI 10.1016/S1570-9639(03)00231-0; Mirza AH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0162-2; Montes CL, 2007, J LEUKOCYTE BIOL, V82, P1027, DOI 10.1189/jlb.0407214; Morais S, 2012, BMC GENOMICS, V13, P1; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murdoch BM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00182; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Refstie S, 2000, AQUACULTURE, V190, P49, DOI 10.1016/S0044-8486(00)00382-3; Renna M, 2006, INT J BIOCHEM CELL B, V38, P2040, DOI 10.1016/j.biocel.2006.05.016; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Santigosa E, 2008, AQUACULTURE, V282, P68, DOI 10.1016/j.aquaculture.2008.06.007; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Sasaki MM, 2016, INFLAMM BOWEL DIS, V22, P20, DOI 10.1097/MIB.0000000000000610; Sealey WM, 2013, J WORLD AQUACULT SOC, V44, P655, DOI 10.1111/jwas.12074; Skugor S, 2011, AQUACULT NUTR, V17, P505, DOI 10.1111/j.1365-2095.2010.00832.x; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Ulloa PE, 2015, MAR BIOTECHNOL, V17, P353, DOI 10.1007/s10126-015-9624-1; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Vilhelmsson OT, 2004, BRIT J NUTR, V92, P71, DOI 10.1079/BJN20041176; Wu BJ, 2011, IMMUNOGENETICS, V63, P835, DOI 10.1007/s00251-011-0554-4; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yendrek Craig R, 2012, BMC Res Notes, V5, P506, DOI 10.1186/1756-0500-5-506; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020	77	15	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180972	10.1371/journal.pone.0180972	http://dx.doi.org/10.1371/journal.pone.0180972			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723948	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800035
J	Alvarado, D; Ligon, GF; Lillquist, JS; Seibel, SB; Wallweber, G; Neumeister, VM; Rimm, DL; McMahon, G; LaVallee, TM				Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; Seibel, Scott B.; Wallweber, Gerald; Neumeister, Veronique M.; Rimm, David L.; McMahon, Gerald; LaVallee, Theresa M.			ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; BREAST-CANCER; UP-REGULATION; PHASE-II; CETUXIMAB; HER3; HEAD; NECK; INHIBITION	Head and neck squamous cell carcinoma (HNSCC) accounts for 3-5% of all tumor types and remains an unmet medical need with only two targeted therapies approved to date. ErbB3 (HER3), the kinase-impaired member of the EGFR/ErbB family, has been implicated as a disease driver in a number of solid tumors, including a subset of HNSCC. Here we show that the molecular components required for ErbB3 activation, including its ligand neuregulin-1 (NRG1), are highly prevalent in HNSCC and that HER2, but not EGFR, is the major activating ErbB3 kinase partner. We demonstrate that cetuximab treatment primarily inhibits the ERK signaling pathway and KTN3379, an anti-ErbB3 monoclonal antibody, inhibits the AKT signaling pathway, and that dual ErbB receptor inhibition results in enhanced antitumor activity in HNSCC models. Surprisingly, we found that while NRG1 is required for ErbB3 activation, it was not sufficient to fully predict for KTN3379 activity. An evaluation of HNSCC patient samples demonstrated that NRG1 expression was significantly associated with expression of the EGFR ligands amphiregulin (AREG) and transforming growth factor a (TGF alpha). Furthermore, NRG1-positive HNSCC cell lines that secreted high levels of AREG and TGFa or contained high levels of EGFR homodimers (H11D) demonstrated a better response to KTN3379. Although ErbB3 and EGFR activation are uncoupled at the receptor level, their respective signaling pathways are linked through co-expression of their respective ligands. We propose that NRG1 expression and EGFR activation signatures may enrich for improved efficacy of anti-ErbB3 therapeutic mAb approaches when combined with EGFR-targeting therapies in HNSCC.	[Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; Seibel, Scott B.; McMahon, Gerald; LaVallee, Theresa M.] Kolltan Pharmaceut, New Haven, CT 06511 USA; [Wallweber, Gerald] Lab Corp Amer Holdings, Monogram Biosci, San Francisco, CA USA; [Neumeister, Veronique M.; Rimm, David L.] Yale Univ, Yale Pathol Tissue Serv, New Haven, CT USA; [Alvarado, Diego; Ligon, Gwenda F.; Lillquist, Jay S.; LaVallee, Theresa M.] Celldex Therapeut Inc, New Haven, CT 06511 USA; [McMahon, Gerald] Harpoon Therapeut, San Francisco, CA USA	Yale University	Alvarado, D (corresponding author), Kolltan Pharmaceut, New Haven, CT 06511 USA.; Alvarado, D (corresponding author), Celldex Therapeut Inc, New Haven, CT 06511 USA.	dalvarado@celldex.com	Garzon-Alvarado, Diego/AAD-6607-2019	Rimm, David/0000-0001-5820-4397; Alvarado, Diego/0000-0002-5878-1730	Kolltan Pharmaceuticals; Monogram Biosciences	Kolltan Pharmaceuticals; Monogram Biosciences	Kolltan Pharmaceuticals provided support in the form of salaries for authors DA, GFL, JSL, SBS, GM and TML but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GW, VMN and DLR were contracted by Kolltan Pharmaceuticals to carry out specific assays described in the manuscript. Monogram Biosciences provided support in the form of salaries for author GW. The specific roles of these authors are articulated in the 'author contributions' section.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Awasthi S, 2014, J CELL PHYSIOL, V229, P1831, DOI 10.1002/jcp.24637; Baselga J, 2014, J CLIN ONCOL, V32, P3753, DOI 10.1200/JCO.2013.54.5384; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Capparelli C, 2015, J BIOL CHEM, V290, P24267, DOI 10.1074/jbc.M115.657270; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chen RC, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.18_suppl.LBA10033; Cheng H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-326; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gianni L, 2010, J CLIN ONCOL, V28, P1131, DOI 10.1200/JCO.2009.24.1661; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hughes B, 2014, ONCOLOGIST, V19, P175, DOI 10.1634/theoncologist.2013-0026; Janjigian YY, 2014, CANCER DISCOV, V4, P1036, DOI 10.1158/2159-8290.CD-14-0326; Jiang N, 2014, MOL CANCER THER, V13, P1826, DOI 10.1158/1535-7163.MCT-13-1093; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee S, 2015, P NATL ACAD SCI USA, V112, P13225, DOI 10.1073/pnas.1518361112; Lipton A, 2013, BREAST CANCER RES TR, V141, P43, DOI 10.1007/s10549-013-2665-0; Liu JF, 2016, J CLIN ONCOL, V34, P4345, DOI 10.1200/JCO.2016.67.1891; Ma J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-105; MacBeath G, 2014, ANN ONCOL, V25, piv58; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Mandic R, 2006, FEBS LETT, V580, P4793, DOI 10.1016/j.febslet.2006.07.064; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Pollock NI, 2015, CLIN CANCER RES, V21, P4597, DOI 10.1158/1078-0432.CCR-14-3338; Qian GQ, 2015, CANCER-AM CANCER SOC, V121, P3600, DOI 10.1002/cncr.29549; Rubinson DA, 2014, INVEST NEW DRUG, V32, P113, DOI 10.1007/s10637-013-9956-5; Sacco AG, 2015, J CLIN ONCOL, V33, P3305, DOI 10.1200/JCO.2015.62.0963; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shames DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056765; Shames DS, 2012, ASCO M, V30, P5575; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Von Pawel J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8045; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Xiao Z, 2016, MOL CANCER THER, V15, P689, DOI 10.1158/1535-7163.MCT-15-0555; Yoshida T, 2008, INT J CANCER, V122, P1530, DOI 10.1002/ijc.23253; Zhang L, 2014, MOL CANCER THER, V13, P1345, DOI 10.1158/1535-7163.MCT-13-1033	50	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181356	10.1371/journal.pone.0181356	http://dx.doi.org/10.1371/journal.pone.0181356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723928	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800045
J	Mollazade, M; Tabarin, T; Nicovich, PR; Soeriyadi, A; Nieves, DJ; Gooding, JJ; Gaus, K				Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Soeriyadi, Alexander; Nieves, Daniel J.; Gooding, J. Justin; Gaus, Katharina			Can single molecule localization microscopy be used to map closely spaced RGD nanodomains?	PLOS ONE			English	Article							STEM-CELL ADHESION; SUPERRESOLUTION MICROSCOPY; FLUORESCENT-PROBES; INTEGRIN LIGANDS; FOCAL ADHESIONS; SURFACE; NANOLITHOGRAPHY; MORPHOLOGY; INTERFACES; DYNAMICS	Cells sense and respond to nanoscale variations in the distribution of ligands to adhesion receptors. This makes single molecule localization microscopy (SMLM) an attractive tool to map the distribution of ligands on nanopatterned surfaces. We explore the use of SMLM spatial cluster analysis to detect nanodomains of the cell adhesion-stimulating tripeptide arginine-glycine-aspartic acid (RGD). These domains were formed by the phase separation of block copolymers with controllable spacing on the scale of tens of nanometers. We first determined the topology of the block copolymer with atomic force microscopy (AFM) and then imaged the localization of individual RGD peptides with direct stochastic optical reconstruction microscopy (dSTORM). To compare the data, we analyzed the dSTORM data with DBSCAN (density-based spatial clustering application with noise). The ligand distribution and polymer topology are not necessary identical since peptides may attach to the polymer outside the nanodomains and/or coupling and detection of peptides within the nanodomains is incomplete. We therefore performed simulations to explore the extent to which nanodomains could be mapped with dSTORM. We found that successful detection of nanodomains by dSTORM was influenced by the inter-domain spacing and the localization precision of individual fluorophores, and less by non-specific absorption of ligands to the substratum. For example, under our imaging conditions, DBSCAN identification of nanodomains spaced further than 50 nm apart was largely independent of background localisations, while nanodomains spaced closer than 50 nm required a localization precision of similar to 11 nm to correctly estimate the modal nearest neighbor distance (NDD) between nanodomains. We therefore conclude that SMLM is a promising technique to directly map the distribution and nanoscale organization of ligands and would benefit from an improved localization precision.	[Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Nieves, Daniel J.; Gaus, Katharina] Univ New South Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia; [Mollazade, Mahdie; Tabarin, Thibault; Nicovich, Philip R.; Nieves, Daniel J.; Gaus, Katharina] Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [Soeriyadi, Alexander; Gooding, J. Justin] Univ New South Wales, Sch Chem, Australian Ctr NanoMed, Sydney, NSW, Australia; [Soeriyadi, Alexander; Gooding, J. Justin] Univ New South Wales, ARC Ctr Excellence Convergent Bionano Sci & Techn, Sydney, NSW, Australia; [Nicovich, Philip R.] Allen Inst Brain Sci, Seattle, WA USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Allen Institute for Brain Science	Gaus, K (corresponding author), Univ New South Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia.; Gaus, K (corresponding author), Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia.	k.gaus@unsw.edu.au	tabarin, thibault P/M-7212-2018; Nieves, Daniel/I-5906-2014	Gooding, John Justin/0000-0002-5398-0597; Gaus, Katharina/0000-0002-8009-9658; Nieves, Daniel/0000-0002-0873-4418; Soeriyadi, Alexander/0000-0003-2876-2384; Mollazade, Mahdie/0000-0001-8648-5413; Nicovich, Philip/0000-0002-8517-4469	Australian Research Council [LP140100967, DP130100269]; ARC Centre of Excellence in Advanced Molecular Imaging [CE140100011]; National Health and Medical Research Council of Australia [1059278, 1037320]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; ARC Laureate Fellowship [FL150100060]	Australian Research Council(Australian Research Council); ARC Centre of Excellence in Advanced Molecular Imaging(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); ARC Laureate Fellowship(Australian Research Council)	This work was supported by the Australian Research Council; grant numbers LP140100967 (to KG and PRN) and DP130100269 (to KG). KG also acknowledges funding from the ARC Centre of Excellence in Advanced Molecular Imaging (CE140100011) and National Health and Medical Research Council of Australia (1059278, 1037320). JJB acknowledges funding from the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CE140100036) and the ARC Laureate Fellowship (FL150100060) program. The authors declare no competing interests.	Andronov L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24084; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Bang J, 2009, ADV MATER, V21, P4769, DOI 10.1002/adma.200803302; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bifano TG, 2016, P SPIE; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bretschneider S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218103; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chao J, 2009, OPT EXPRESS, V17, P24377, DOI 10.1364/OE.17.024377; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Clerget E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063722; Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r; Ester M, 1996, COMPR CHEMOM, V2, P635, DOI DOI 10.1016/8978-044452701-1.00067-3; George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039; George PA, 2009, EUR POLYM J, V45, P1065, DOI 10.1016/j.eurpolymj.2008.11.039; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Glass R, 2003, ADV FUNCT MATER, V13, P569, DOI 10.1002/adfm.200304331; Gooding JJ, 2016, ANGEW CHEM INT EDIT, V55, P11354, DOI 10.1002/anie.201600495; Gramlich MW, 2014, OPT EXPRESS, V22, P8438, DOI 10.1364/OE.22.008438; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hennig S, 2015, ACS NANO, V9, P8122, DOI 10.1021/acsnano.5b02220; Henriques R, 2011, BIOPOLYMERS, V95, P322, DOI 10.1002/bip.21586; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Kimura T, 2012, LANGMUIR, V28, P12901, DOI 10.1021/la302695q; Klein T, 2014, HISTOCHEM CELL BIOL, V141, P561, DOI 10.1007/s00418-014-1184-3; Le Saux G, 2011, BIOPHYS J, V101, P764, DOI 10.1016/j.bpj.2011.06.064; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lei Y, 2011, CHEM SOC REV, V40, P1247, DOI 10.1039/b924854b; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; Lew MD, 2011, P NATL ACAD SCI USA, V108, pE1102, DOI 10.1073/pnas.1114444108; Li H, 2014, BIOMATER SCI-UK, V2, P1693, DOI 10.1039/c4bm00109e; Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562; Lin ZQ, 2002, ADV MATER, V14, P1373, DOI 10.1002/1521-4095(20021002)14:19<1373::AID-ADMA1373>3.0.CO;2-F; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maheshwari G, 2000, J CELL SCI, V113, P1677; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rubin-Delanchy P, 2015, NAT METHODS, V12, P1072, DOI [10.1038/nmeth.3612, 10.1038/NMETH.3612]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Smith JR, 2011, T I MET FINISH, V89, P18, DOI 10.1179/174591910X12922367327388; Tehrani KF, 2015, PROC SPIE, V9335, DOI 10.1117/12.2077269; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Zamir E, 2001, J CELL SCI, V114, P3583	57	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180871	10.1371/journal.pone.0180871	http://dx.doi.org/10.1371/journal.pone.0180871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723958	Green Published, gold			2022-12-26	WOS:000406067800029
J	Balazsfi, DG; Zelena, D; Farkas, L; Demeter, K; Barna, I; Cserep, C; Takacs, VT; Nyiri, G; Goloncser, F; Sperlagh, B; Freund, TF; Haller, J				Balazsfi, Diana G.; Zelena, Dora; Farkas, Livia; Demeter, Komel; Barna, Istvan; Cserep, Csaba; Takacs, Virag T.; Nyiri, Gabor; Goloncser, Flora; Sperlagh, Beata; Freund, Tamas F.; Haller, Jozsef			Median raphe region stimulation alone generates remote, but not recent fear memory traces	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; CONDITIONED FEAR; HIPPOCAMPAL; NUCLEUS; RAT; ACTIVATION; EXPRESSION; RECEPTORS; BEHAVIOR; NEURONS	The median raphe region (MRR) is believed to control the fear circuitry indirectly, by influencing the encoding and retrieval of fear memories by amygdala, hippocampus and prefrontal cortex. Here we show that in addition to this established role, MRR stimulation may alone elicit the emergence of remote but not recent fear memories. We substituted electric shocks with optic stimulation of MRR in C57BL/6N male mice in an optogenetic conditioning paradigm and found that stimulations produced agitation, but not fear, during the conditioning trial. Contextual fear, reflected by freezing was not present the next day, but appeared after a 7 days incubation. The optogenetic silencing of MRR during electric shocks ameliorated conditioned fear also seven, but not one day after conditioning. The optogenetic stimulation patterns (50Hz theta burst and 20Hz) used in our tests elicited serotonin release in vitro and lead to activation primarily in the periaqueductal gray examined by c-Fos immunohistochemistry. Earlier studies demonstrated that fear can be induced acutely by stimulation of several subcortical centers, which, however, do not generate persistent fear memories. Here we show that the MRR also elicits fear, but this develops slowly over time, likely by plastic changes induced by the area and its connections. These findings assign a specific role to the MRR in fear learning. Particularly, we suggest that this area is responsible for the durable sensitization of fear circuits towards aversive contexts, and by this, it contributes to the persistence of fear memories. This suggests the existence a bottom-up control of fear circuits by the MRR, which complements the top-down control exerted by the medial prefrontal cortex.	[Balazsfi, Diana G.; Zelena, Dora; Farkas, Livia; Demeter, Komel; Barna, Istvan; Haller, Jozsef] Inst Expt Med, Dept Behav Neurobiol, Budapest, Hungary; [Balazsfi, Diana G.] Semmelweis Univ, Janos Szentagothai Sch Neurosci, Budapest, Hungary; [Cserep, Csaba; Takacs, Virag T.; Nyiri, Gabor; Freund, Tamas F.] Inst Expt Med, Dept Cellular & Network Neurobiol, Budapest, Hungary; [Goloncser, Flora; Sperlagh, Beata] Inst Expt Med, Dept Pharmacol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Balazsfi, DG (corresponding author), Inst Expt Med, Dept Behav Neurobiol, Budapest, Hungary.; Balazsfi, DG (corresponding author), Semmelweis Univ, Janos Szentagothai Sch Neurosci, Budapest, Hungary.	balazsfi.diana@koki.mta.hu	Zelena, Dóra/AAO-5418-2020; Demeter, Kornel/GRF-0289-2022	Demeter, Kornel/0000-0002-5497-6493; Haller, Jozsef/0000-0003-4315-3026	European Research Council Advanced Research grant (SERRACO) [ERC-2011-ADG-294313]; NKFIH [112907, 120311]	European Research Council Advanced Research grant (SERRACO); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary)	This study was supported by European Research Council Advanced Research grant ERC-2011-ADG-294313 (SERRACO) to Tamas Freund (https://erc.europa.eu/projects-figures/erc-funded-projects/results?search_api_views_fulltext=SERRACO), NKFIH 120311 to Dora Zelena (www.otka.hu); NKFIH 112907 to Jozsef Haller (www.otka.hu).	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; Aliczki M, 2015, COMPREHENSIVE GUIDE; Amo R, 2014, NEURON, V84, P1034, DOI 10.1016/j.neuron.2014.10.035; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Avanzi V, 1998, BRAIN RES, V790, P178, DOI 10.1016/S0006-8993(97)01538-2; BANDLER R, 1991, NATO ADV SCI I A-LIF, V213, P175; Berg BA, 2014, EUR J NEUROSCI, V40, P3096, DOI 10.1111/ejn.12676; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Haller J, 2014, PSYCHOPHARMACOLOGY, V231, P593, DOI 10.1007/s00213-013-3273-8; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayes DJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00049; Horvath G, 2014, NEUROBIOL DIS, V70, P162, DOI 10.1016/j.nbd.2014.06.011; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Liu Y, 2015, NEUROSCIENCE, V298, P436, DOI 10.1016/j.neuroscience.2015.04.032; Paxinos G., 2001, THE MOUSE BRAIN IN S, V2; PECK BK, 1991, BRAIN RES, V568, P244, DOI 10.1016/0006-8993(91)91404-O; Poulos AM, 2016, LEARN MEMORY, V23, P379, DOI 10.1101/lm.041400.115; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Schenberg LC, 2005, NEUROSCI BIOBEHAV R, V29, P1279, DOI 10.1016/j.neubiorev.2005.05.006; Silva RCB, 2004, BEHAV BRAIN RES, V151, P93, DOI 10.1016/j.bbr.2003.08.015; Stanton PK, 1996, HIPPOCAMPUS, V6, P35, DOI 10.1002/(SICI)1098-1063(1996)6:1<35::AID-HIPO7>3.0.CO;2-6; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; Szonyi A, 2016, BRAIN STRUCT FUNCT, V221, P735, DOI 10.1007/s00429-014-0935-1; Takase LF, 2004, BEHAV BRAIN RES, V153, P233, DOI 10.1016/j.bbr.2003.12.020; Tulogdi A, 2012, BRAIN RES BULL, V88, P359, DOI 10.1016/j.brainresbull.2012.04.001; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Wang DV, 2015, NAT NEUROSCI, V18, P728, DOI 10.1038/nn.3998; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zelena D, 2016, PSYCHOPHARMACOLOGY, V233, P2065, DOI 10.1007/s00213-016-4255-4	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181264	10.1371/journal.pone.0181264	http://dx.doi.org/10.1371/journal.pone.0181264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708877	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000405649800053
J	Couderc, E; Morel, F; Levillain, P; Buffiere-Morgado, A; Camus, M; Paquier, C; Bodet, C; Jegou, JF; Pohin, M; Favot, L; Garcia, M; Huguier, V; Mcheik, J; Lacombe, C; Yssel, H; Guillet, G; Bernard, FX; Lecron, JC				Couderc, Elodie; Morel, Franck; Levillain, Pierre; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Bodet, Charles; Jegou, Jean-Francois; Pohin, Mathilde; Favot, Laure; Garcia, Martine; Huguier, Vincent; Mcheik, Jiad; Lacombe, Corinne; Yssel, Hans; Guillet, Gerard; Bernard, Francois-Xavier; Lecron, Jean-Claude			Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SKIN INFLAMMATION; KAPPA-B; RHEUMATOID-ARTHRITIS; ONCOSTATIN-M; EXPRESSION; BINDING; CD36; DIFFERENTIATION; SECRETION	Background Acute-serum Amyloid A (A-SAA), one of the major acute-phase proteins, is mainly produced in the liver but extra-hepatic synthesis involving the skin has been reported. Its expression is regulated by the transcription factors NF-kappa B, C/EBP beta, STAT3 activated by proinflammatory cytokines. Objectives We investigated A-SAA synthesis by resting and cytokine-activated Normal Human Epidermal Keratinocytes (NHEK), and their inflammatory response to A-SAA stimulation. A-SAA expression was also studied in mouse skin and liver in a model mimicking psoriasis and in the skin and sera of psoriatic and atopic dermatitis (AD) patients. Methods NHEK were stimulated by A-SAA or the cytokines IL-1 alpha, IL-17A, IL-22, OSM, TNF-alpha alone or in combination, previously reported to reproduce features of psoriasis. Murine skins were treated by imiquimod cream. Human skins and sera were obtained from patients with psoriasis and AD. A-SAA mRNA was quantified by RT qPCR. A-SAA proteins were dosed by ELISA or immunonephelemetry assay. Results IL-1 alpha, TNF-alpha and mainly IL-17A induced A-SAA expression by NHEK. A-SAA induced its own production and the synthesis of hBD2 and CCL20, both ligands for CCR6, a chemokine receptor involved in the trafficking of Th17 lymphocytes. A-SAA expression was increased in skins and livers from imiquimod-treated mice and in patient skins with psoriasis, but not significantly in those with AD. Correlations between A-SAA and psoriasis severity and duration were observed. Conclusion Keratinocytes could contribute to psoriasis pathogenesis via A-SAA production, maintaining a cutaneous inflammatory environment, activating innate immunity and Th17 lymphocyte recruitment.	[Couderc, Elodie; Morel, Franck; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Bodet, Charles; Jegou, Jean-Francois; Pohin, Mathilde; Favot, Laure; Garcia, Martine; Huguier, Vincent; Mcheik, Jiad; Guillet, Gerard; Lecron, Jean-Claude] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, UPRES EA4331, Pole Biol Sante,TSA, Poitiers, France; [Couderc, Elodie; Buffiere-Morgado, Amandine; Camus, Magalie; Paquier, Camille; Huguier, Vincent; Mcheik, Jiad; Guillet, Gerard] CHU Poitiers, Serv Dermatol, Poitiers, France; [Levillain, Pierre; Huguier, Vincent; Mcheik, Jiad; Lacombe, Corinne] CHU Poitiers, Serv Anatomopathol, Poitiers, France; [Huguier, Vincent; Mcheik, Jiad] CHU Poitiers, Serv Chirurg Plast, Poitiers, France; [Mcheik, Jiad] CHU Poitiers, Serv Chirurg Pediat, Poitiers, France; [Lacombe, Corinne; Lecron, Jean-Claude] CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France; [Yssel, Hans] Hop La Pitie Salpetriere, Ctr Immunol & Malad Infect, INSERM, U1135, Paris, France; [Bernard, Francois-Xavier] Lab BIOalternat, Gencay, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lecron, JC (corresponding author), Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, UPRES EA4331, Pole Biol Sante,TSA, Poitiers, France.; Lecron, JC (corresponding author), CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France.	Jean-Claude.Lecron@univ-poitiers.fr	Morel, Franck/AAI-4274-2021; Yssel, Hans/C-6406-2009; Yssel, Hans/AFV-2907-2022; Laforge, Laure Favot/AGW-2729-2022; Bodet, Charles/Z-4585-2019	Morel, Franck/0000-0003-3812-9304; Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; Bodet, Charles/0000-0002-8016-0324; Jegou, Jean-Francois/0000-0002-9703-5976; POHIN, Mathilde/0000-0003-2809-9498; LECRON, Jean-Claude/0000-0003-3990-5213				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Armstrong AW, 2011, BRIT J DERMATOL, V165, P1162, DOI 10.1111/j.1365-2133.2011.10526.x; Balci DD, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2008.02936.x; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Bergis M, 2003, ANN DERMATOL VENER, V130, P1039; Beygi S, 2014, J EUR ACAD DERMATOL, V28, P700, DOI 10.1111/jdv.12257; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Dogan S, 2010, BRIT J DERMATOL, V163, P895, DOI 10.1111/j.1365-2133.2010.09907.x; Dzhndoian Z T, 2011, Georgian Med News, P48; Fujimoto E, 2010, J INVEST DERMATOL, V130, P405, DOI 10.1038/jid.2009.269; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; Jung SY, 2007, YONSEI MED J, V48, P218, DOI 10.3349/ymj.2007.48.2.218; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee HY, 2013, BIOCHEM BIOPH RES CO, V433, P255, DOI 10.1016/j.bbrc.2013.03.002; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Morizane S, 2017, J INVEST DERMATOL, V137, P757, DOI 10.1016/j.jid.2016.10.016; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Ortiz A, 2012, INT J DERMATOL, V51, P250, DOI 10.1111/j.1365-4632.2011.05205.x; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; Rabeony H, 2015, EUR J IMMUNOL, V45, P2847, DOI 10.1002/eji.201445215; Rabeony H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101937; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yu N, 2015, CLIN EXP IMMUNOL, V179, P344, DOI 10.1111/cei.12458; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320	51	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181486	10.1371/journal.pone.0181486	http://dx.doi.org/10.1371/journal.pone.0181486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708859	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649800059
J	Wang, JX; Gronalt, M; Sun, Y				Wang, Jiaxi; Gronalt, Manfred; Sun, Yan			A two-stage approach to the depot shunting driver assignment problem with workload balance considerations	PLOS ONE			English	Article							PASSENGER TRAIN UNITS; MODEL; OPTIMIZATION; VEHICLE; ALGORITHM	Due to its environmentally sustainable and energy-saving characteristics, railway transportation nowadays plays a fundamental role in delivering passengers and goods. Emerged in the area of transportation planning, the crew (workforce) sizing problem and the crew scheduling problem have been attached great importance by the railway industry and the scientific community. In this paper, we aim to solve the two problems by proposing a novel two-stage optimization approach in the context of the electric multiple units (EMU) depot shunting driver assignment problem. Given a predefined depot shunting schedule, the first stage of the approach focuses on determining an optimal size of shunting drivers. While the second stage is formulated as a bi-objective optimization model, in which we comprehensively consider the objectives of minimizing the total walking distance and maximizing the workload balance. Then we combine the normalized normal constraint method with a modified Pareto filter algorithm to obtain Pareto solutions for the bi-objective optimization problem. Furthermore, we conduct a series of numerical experiments to demonstrate the proposed approach. Based on the computational results, the regression analysis yield a driver size predictor and the sensitivity analysis give some interesting insights that are useful for decision makers.	[Wang, Jiaxi] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Gronalt, Manfred] Univ Nat Resources & Life Sci, Vienna BOKU, Inst Prod & Logist, Vienna, Austria; [Sun, Yan] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China	Beijing Jiaotong University; University of Natural Resources & Life Sciences, Vienna; Shandong University of Finance & Economics	Wang, JX (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	wangjiaxi@bjtu.edu.cn			Austrian Federal Ministry of Science, Research and Economy within the EURASIA PACIFIC UNINET scholarship framework [ICM-2016-04321]	Austrian Federal Ministry of Science, Research and Economy within the EURASIA PACIFIC UNINET scholarship framework	This work is partially financed by the Austrian Federal Ministry of Science, Research and Economy (http://www.en.bmwfw.gv.at/Seiten/default.aspx) within the EURASIA PACIFIC UNINET scholarship framework (Reference No.: ICM-2016-04321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RK, 2005, TRANSPORT SCI, V39, P503, DOI 10.1287/trsc.1050.0115; [Anonymous], 1986, MANAGING HUMAN RESOU; Azadeh A, 2013, APPL SOFT COMPUT, V13, P158, DOI 10.1016/j.asoc.2012.08.012; Bai Q, 2015, COMPUT-AIDED CIV INF, V30, P163, DOI 10.1111/mice.12079; Beasley JE, 1996, EUR J OPER RES, V94, P517, DOI 10.1016/0377-2217(95)00093-3; BEAUJON GJ, 1991, TRANSPORT SCI, V25, P19, DOI 10.1287/trsc.25.1.19; Borndorfer R, 2011, OASICS OPENACCESS SE; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; Engels B, 2015, NETWORKS, V66, P33, DOI 10.1002/net.21603; Florian M., 1976, INFOR. Canadian Journal of Operational Research and Information Processing, V14, P121; Freling R, 2005, TRANSPORT SCI, V39, P261, DOI 10.1287/trsc.1030.0076; Freling R, 2004, ANN OPER RES, V127, P203, DOI 10.1023/B:ANOR.0000019090.39650.32; Giacco GL, 2014, J INTELL TRANSPORT S, V18, P95, DOI 10.1080/15472450.2013.801712; Haase K, 2001, TRANSPORT SCI, V35, P286, DOI 10.1287/trsc.35.3.286.10153; Hanafi R, 2014, COMPUT IND ENG, V70, P11, DOI 10.1016/j.cie.2014.01.002; Huisman D, 2005, TRANSPORT SCI, V39, P491, DOI 10.1287/trsc.1040.0104; Ighravwe DE, 2014, INT J PROD ECON, V150, P204, DOI 10.1016/j.ijpe.2014.01.004; Jacobsen PM, 2011, FLEX SERV MANUF J, V23, P156, DOI 10.1007/s10696-011-9096-1; JORDAN WC, 1983, TRANSPORT SCI, V17, P123, DOI 10.1287/trsc.17.2.123; Jutte S, 2012, EUR J OPER RES, V219, P214, DOI 10.1016/j.ejor.2011.12.038; Jutte S, 2011, INTERFACES, V41, P109, DOI 10.1287/inte.1100.0549; Kroon LG, 2008, TRANSPORT SCI, V42, P436, DOI 10.1287/trsc.1080.0243; Lai YC, 2015, COMPUT IND ENG, V85, P284, DOI 10.1016/j.cie.2015.03.016; Li YJ, 2007, ANN OPER RES, V155, P361, DOI 10.1007/s10479-007-0215-z; Mansouri SA, 2015, TRANSPORT RES E-LOG, V78, P3, DOI 10.1016/j.tre.2015.01.012; Messac A, 2003, STRUCT MULTIDISCIP O, V25, P86, DOI 10.1007/s00158-002-0276-1; Milenkovic M, 2013, TRANSPORT RES C-EMER, V33, P107, DOI 10.1016/j.trc.2013.05.003; Narisetty AK, 2008, INTERFACES, V38, P89, DOI 10.1287/inte.1070.0330; Piu F, 2015, TRANSPORT RES E-LOG, V82, P217, DOI 10.1016/j.tre.2015.07.003; Shiftan Y, 1995, COMPUTER AIDED SCHED, P248; Sun Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080762; VERBEEK PJ, 1991, EUR J OPER RES, V55, P368, DOI 10.1016/0377-2217(91)90206-B; Wang JX, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/5804626; Zak J, 2008, J ADV TRANSPORT, V42, P379, DOI 10.1002/atr.5670420402; Zak J, 2011, J ADV TRANSPORT, V45, P1, DOI 10.1002/atr.108	35	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181165	10.1371/journal.pone.0181165	http://dx.doi.org/10.1371/journal.pone.0181165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704489	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700102
J	Carmona-Antonanzas, G; Bekaert, M; Humble, JL; Boyd, S; Roy, W; Bassett, DI; Houston, RD; Gharbi, K; Bron, JE; Sturm, A				Carmona-Antonanzas, Greta; Bekaert, Michael; Humble, Joseph L.; Boyd, Sally; Roy, William; Bassett, David I.; Houston, Ross D.; Gharbi, Karim; Bron, James E.; Sturm, Armin			Maternal inheritance of deltamethrin resistance in the salmon louse Lepeophtheirus salmonis (Kroyer) is associated with unique mtDNA haplotypes	PLOS ONE			English	Article							INSECT SODIUM-CHANNELS; SEA LICE; EMAMECTIN BENZOATE; PYRETHROID RESISTANCE; MOLECULAR-BIOLOGY; CALIGUS-ROGERCRESSEYI; DRUG-RESISTANCE; P-GLYCOPROTEIN; COMPLEX I; GENE	Parasitic infections by the salmon louse, Lepeophtheirus salmonis (Kroyer), cause huge economic damage in salmon farming in the northern hemisphere, with combined treatment costs and production losses in 2014 having been estimated at US$ 350 million for Norway (annual production 1.25 million tonnes). The control of L. salmonis relies significantly on medicinal treatments, supplemented by non-pharmacological approaches. However, efficacy losses have been reported for several delousing agents, including the pyrethroid deltamethrin. The aim of the present study was to analyse the genetic basis of deltamethrin resistance in L. salmonis. Deltamethrin median effective concentrations (EC50) were 0.28 mu g L (-1) in the drug susceptible L. salmonis strain IoA-00 and 40.1 mu g L (-1) in the pyrethroid resistant strain IoA-02. IoA-00 and IoA-02 were crossed to produce families spanning one parental and three filial generations (P0, F1-F3). In three families derived from P0 crosses between an IoA-00 sire and an IoA-02 dam, 98.8% of F2 parasites (n = 173) were resistant, i.e. remained unaffected after exposure to 2.0 mu g L (-1) deltamethrin. F3 parasites from these crosses showed a deltamethrin EC50 of 9.66 mu g L (-1).(.) In two families of the inverse orientation at P0 (IoA-02 sire x IoA-00 dam), 16.7% of F2 parasites were resistant (n = 84), while the deltamethrin EC50 in F3 animals was 0.26 mu g L (-1). The results revealed a predominantly maternal inheritance of deltamethrin resistance. The 15,947-nt mitochondrial genome was sequenced and compared among six unrelated L. salmonis strains and parasites sampled from wild salmon in 2010. IoA-02 and three further deltamethrin resistant strains, established from isolates originating from different regions of Scotland, showed almost identical mitochondrial haplotypes. In contrast, the mitochondrial genome was variable among susceptible strains and L. salmonis from wild hosts. Deltamethrin caused toxicity and depletion of whole body ATP levels in IoA-00 but not IoA-02 parasites. The maternal inheritance of deltamethrin resistance and its association with mitochondrial haplotypes suggests that pyrethroid toxicity in L. salmonis may involve molecular targets encoded by mitochondrial genes.	[Carmona-Antonanzas, Greta; Bekaert, Michael; Humble, Joseph L.; Boyd, Sally; Roy, William; Bassett, David I.; Bron, James E.; Sturm, Armin] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Houston, Ross D.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Houston, Ross D.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Gharbi, Karim] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Stirling; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Sturm, A (corresponding author), Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland.	armin.sturm@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Roy, William/0000-0001-9493-5795; Sturm, Armin/0000-0003-2632-1999; Bassett, David/0000-0002-7529-0829; Bekaert, Michael/0000-0002-1206-7654; Houston, Ross/0000-0003-1805-0762	Biotechnology and Biological Sciences Research Council [BB/L022923/1, BBS/E/D/20002173, BB/L024004/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211553] Funding Source: Medline; BBSRC [BB/L024004/1, BB/L022923/1, BBS/E/D/20211553, BBS/E/D/20002173] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Anand SS, 2006, TOXICOL APPL PHARM, V212, P156, DOI 10.1016/j.taap.2005.07.021; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Blanquer A., 1990, PHYLOGEOGRAPHIE INTR; Braguini WL, 2004, TOXICOL LETT, V152, P191, DOI 10.1016/j.toxlet.2004.03.017; Brooker R.J., 2012, GENETICS ANAL PRINCI; Carmichael SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077832; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Carmona-Antonanzas G, 2016, AQUACULTURE, V464, P570, DOI 10.1016/j.aquaculture.2016.08.007; CASIDA JE, 1980, ENVIRON HEALTH PERSP, V34, P189, DOI 10.2307/3428960; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Chen D, 2007, J APPL TOXICOL, V27, P368, DOI 10.1002/jat.1215; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; ELLIOTT M, 1974, NATURE, V248, P710, DOI 10.1038/248710a0; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Fast MD, 2007, LEPEOPHTHEIRUS SALMO, V5000, P179; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gassner B, 1997, J PHARMACOL EXP THER, V281, P855; Godin SJ, 2006, DRUG METAB DISPOS, V34, P1764, DOI 10.1124/dmd.106.010058; Gong MQ, 2005, ARCH BIOCHEM BIOPHYS, V438, P53, DOI 10.1016/j.abb.2005.03.021; Carcamo JG, 2011, AQUACULTURE, V321, P207, DOI 10.1016/j.aquaculture.2011.09.012; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Helgesen KO, 2015, MONITORING DRUG RESI; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Heumann J, 2014, AQUACULTURE, V424, P207, DOI 10.1016/j.aquaculture.2013.12.015; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Igboeli OO, 2012, AQUACULTURE, V344, P40, DOI 10.1016/j.aquaculture.2012.03.026; ISHAAYA I, 1993, ARCH INSECT BIOCHEM, V22, P263, DOI 10.1002/arch.940220119; Iversen A., 2015, KOSTNADSDRIVERE LAKS; Jackson D, 2012, AQUACULTURE, V364, P118, DOI 10.1016/j.aquaculture.2012.08.003; Johnson SC, 2004, ZOOL STUD, V43, P229; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nardini L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-229; Nilsen F, 2015, Method for detection of pyrethroid resistance in crustaceans and oligonucleotide sequences useful in detection of pyrethroid resistance. Can Pat Appl, Patent No. [CA 2920588: A1, 2920588]; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Perlman SJ, 2015, P NATL ACAD SCI USA, V112, P10162, DOI 10.1073/pnas.1421391112; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Salama NKG, 2013, J FISH DIS, V36, P323, DOI 10.1111/jfd.12065; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2005, AQUACULTURE, V244, P19, DOI 10.1016/j.aquaculture.2004.11.009; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skern-Mauritzen R, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-44; Soderlund DM, 2015, PEST MANAG SCI, V71, P801, DOI 10.1002/ps.3881; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014; Stien LH, 2016, AQUACULTURE, V458, P29, DOI 10.1016/j.aquaculture.2016.02.014; Sutherland BJG, 2015, EVOL APPL, V8, P133, DOI 10.1111/eva.12237; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Tjensvoll K, 2006, DIS AQUAT ORGAN, V68, P251, DOI 10.3354/dao068251; Tjensvoll K, 2005, GENE, V353, P218, DOI 10.1016/j.gene.2005.04.033; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Valenzuela-Miranda D, 2016, AQUACULTURE, V465, P65, DOI 10.1016/j.aquaculture.2016.08.027; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2006, INSECT BIOCHEM MOLEC, V36, P869, DOI 10.1016/j.ibmb.2006.08.005; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Westcott JD, 2008, DIS AQUAT ORGAN, V79, P119, DOI 10.3354/dao01887; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Zhang SY, 2007, ENDOCRINOLOGY, V148, P3941, DOI 10.1210/en.2006-1497; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	76	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180625	10.1371/journal.pone.0180625	http://dx.doi.org/10.1371/journal.pone.0180625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704444	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600037
J	Pradhan, S; Kant, C; Verma, S; Bhatia, S				Pradhan, Seema; Kant, Chandra; Verma, Subodh; Bhatia, Sabhyata			Genome-wide analysis of the CCCH zinc finger family identifies tissue specific and stress responsive candidates in chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							RNA-BINDING PROTEINS; AU-RICH ELEMENTS; MESSENGER-RNA; GENE FAMILY; ABSCISIC-ACID; ARABIDOPSIS; SEED; EVOLUTION; SEQUENCE; TRISTETRAPROLIN	The CCCH zinc finger is a group of proteins characterised by a typical motif consisting of three cysteine residues and one histidine residue. These proteins have been reported to play important roles in regulation of plant growth, developmental processes and environmental responses. In the present study, genome wide analysis of the CCCH zinc finger gene family was carried out in the available chickpea genome. Various bioinformatics tools were employed to predict 58 CCCH zinc finger genes in chickpea (designated CarC3H158), which were analysed for their physio-chemical properties. Phylogenetic analysis classified the proteins into 12 groups in which members of a particular group had similar structural organization. Further, the numbers as well as the types of CCCH motifs present in the CarC3H proteins were compared with those from Arabidopsis and Medicago truncatula. Synteny analysis revealed valuable information regarding the evolution of this gene family. Tandem and segmental duplication events were identified and their Ka/Ks values revealed that the CarC3H gene family in chickpea had undergone purifying selection. Digital, as well as real time qRT-PCR expression analysis was performed which helped in identification of several CarC3H members that expressed preferentially in specific chickpea tissues as well as during abiotic stresses (desiccation, cold, salinity). Moreover, molecular characterization of an important member CarC3H45 was carried out. This study provides comprehensive genomic information about the important CCCH zinc finger gene family in chickpea. The identified tissue specific and abiotic stress specific CCCH genes could be potential candidates for further characterization to delineate their functional roles in development and stress.	[Pradhan, Seema; Kant, Chandra; Verma, Subodh; Bhatia, Sabhyata] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	sabhyatabhatia@nipgr.ac.in	Verma, Subodh/X-3993-2019	Verma, Subodh/0000-0001-9071-037X; Bhatia, Sabhyata/0000-0003-0811-219X	Department of Biotechnology (DBT), Ministry of Science and Technology, India [BT/AGR/CG-Phase II/01/2014]; Department of Biotechnology (DBT); Council for Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT), Ministry of Science and Technology, India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by grant (BT/AGR/CG-Phase II/01/2014) from the Department of Biotechnology (DBT), Ministry of Science and Technology, India (http://www.dbtindia.nic.in). SP and SV acknowledge the award of research fellowship from the Department of Biotechnology (DBT) and CK acknowledges the award of research fellowship from Council for Scientific and Industrial Research (CSIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bogamuwa SP, 2014, PLANT AND CELL PHYSI; Bogamuwa S, 2013, PLANT CELL ENVIRON, V36, P1507, DOI 10.1111/pce.12084; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Carranco RT, 2004, PLANT MOL BIOL, V55, P221, DOI 10.1007/s11103-004-0512-8; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Doyle J. J., 1987, PHYTOCHEM B, P11; Duran Chris, 2009, V513, P41, DOI 10.1007/978-1-59745-427-8_3; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Garg R, 2014, PLANT MOL BIOL REP; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kim DH, 2008, PLANT CELL, V20, P1260, DOI 10.1105/tpc.108.058859; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Koornneef M, 1994, COLD SPRING HARB MON, V27, P313; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; LI WH, 1983, MOL BIOL EVOL, V1, P94; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Liu SR, 2014, MOL GENET GENOMICS, V289, P855, DOI 10.1007/s00438-014-0858-9; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; MCCARTY DR, 1995, ANNU REV PLANT PHYS, V46, P71, DOI 10.1146/annurev.pp.46.060195.000443; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Nandi S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-116; Ouwerkerk P B, 2001, CURR PROTOC MOL BIOL, P12; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Pradhan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00698; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Soderman EM, 2000, PLANT PHYSIOL, V124, P1752, DOI 10.1104/pp.124.4.1752; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wagner A, 2002, GENOME BIOL, V3; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003521; Wang XL, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0019; Zhang CQ, 2013, PLANT CELL REP, V32, P1543, DOI 10.1007/s00299-013-1466-6	70	22	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180469	10.1371/journal.pone.0180469	http://dx.doi.org/10.1371/journal.pone.0180469			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704400	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600032
J	Roy, D; Farabaugh, KT; Wu, J; Charrier, A; Smas, C; Hatzoglou, M; Thirumurugan, K; Buchner, DA				Roy, Debasish; Farabaugh, Kenneth T.; Wu, Jing; Charrier, Alyssa; Smas, Cynthia; Hatzoglou, Maria; Thirumurugan, Kavitha; Buchner, David A.			Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor gamma (PPAR gamma) during adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; LEUCINE-ZIPPER; GENOME-WIDE; TNF-ALPHA; LIPOLYSIS; CELLS; BINDING; OBESITY	The breakdown of stored fat deposits into its components is a highly regulated process that maintains plasma levels of free fatty acids to supply energy to cells. Insulin-mediated transcription of Atgl, the enzyme that mediates the rate-limiting step in lipolysis, is a key point of this regulation. Under conditions such as obesity or insulin resistance, Atgl transcription is often misregulated, which can contribute to overall disease progression. The mechanisms by which Atgl is induced during adipogenesis are not fully understood. Weutilized computational approaches to identify putative transcriptional regulatory elements in Atgl and then tested the effect of these elements and the transcription factors that bind to them in cultured preadipocytes and mature adipocytes. Here we report that Atgl is down-regulated by the basal transcription factor Sp1 in preadipocytes and that the magnitude of down-regulation depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPAR gamma). In mature adipocytes, when PPAR gamma is abundant, PPAR gamma abrogated transcriptional repression by Sp1 at the Atgl promoter and up-regulated Atgl mRNA expression. Targeting the PPAR gamma Sp1 interaction could be a potential therapeutic strategy to restore insulin sensitivity by modulating Atgl levels in adipocytes.	[Roy, Debasish; Thirumurugan, Kavitha] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Farabaugh, Kenneth T.; Wu, Jing; Charrier, Alyssa; Hatzoglou, Maria; Buchner, David A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Smas, Cynthia] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43614 USA	Vellore Institute of Technology; Case Western Reserve University; University System of Ohio; University of Toledo	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, 2109 Adelbert Rd, Cleveland, OH 44106 USA.; Thirumurugan, K (corresponding author), VIT Univ, Ctr Biomed Res, Sch Biosci & Technol, 213B, Vellore 632014, Tamil Nadu, India.	mxh8@case.edu; m.kavitha@vit.ac.in		Thirumurugan, Kavitha/0000-0002-4673-4099; Buchner, David/0000-0003-3920-4871; Roy, Debasish/0000-0001-7516-8615	National Institutes of Health [R01DK53307, R37DK060596, R03DK099533]; American Diabetes Association; United StatesIndia Educational Foundation; Fulbright Commission; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099533, R37DK060596, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); United StatesIndia Educational Foundation; Fulbright Commission; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK53307 and R37DK060596 (to M. H.) and R03DK099533 (to D. B.), an American Diabetes Association postdoctoral fellowship (to A. C.), and the United StatesIndia Educational Foundation and the Fulbright Commission (Fulbright-Nehru Doctoral Research fellowship) (to D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; BURNS TW, 1968, J LAB CLIN MED, V72, P813; BURNS TW, 1979, DIABETES, V28, P957, DOI 10.2337/diabetes.28.11.957; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Canaff L, 2008, J BIOL CHEM, V283, P13586, DOI 10.1074/jbc.M708087200; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; FAIN JN, 1966, ENDOCRINOLOGY, V78, P773, DOI 10.1210/endo-78-4-773; Glass CK, 2000, GENE DEV, V14, P121; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; Lei N, 2002, BIOL REPROD, V66, P675, DOI 10.1095/biolreprod66.3.675; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Opitz OG, 2000, CANCER RES, V60, P2825; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pan XL, 2001, ENDOCRINOLOGY, V142, P1635, DOI 10.1210/en.142.4.1635; Parisi F, 2007, NUCLEIC ACIDS RES, V35, P1098, DOI 10.1093/nar/gkl1157; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	52	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14827	14835		10.1074/jbc.M117.783043	http://dx.doi.org/10.1074/jbc.M117.783043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726642	Green Published, hybrid			2022-12-26	WOS:000409902100011
J	Ben El Haj, R; Salmi, A; Regragui, W; Moussa, A; Bouslam, N; Tiber, H; Benomar, A; Yahyaoui, M; Bouhouche, A				Ben El Haj, Rafiqua; Salmi, Ayyoub; Regragui, Wafa; Moussa, Ahmed; Bouslam, Naima; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed			Evidence for prehistoric origins of the G2019S mutation in the North African Berber population	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; Y-CHROMOSOME; LRRK2 G2019S; PATERNAL LINEAGES; GENE; PHYLOGEOGRAPHY; IDENTIFICATION; HAPLOGROUPS; FOOTPRINTS; COUNTRIES	The most common cause of the monogenic form of Parkinson's disease known so far is the G2019S mutation of the leucine-rich repeat kinase 2 (LRRK2) gene. Its frequency varies greatly among ethnic groups and geographic regions ranging from less than 0.1% in Asia to 40% in North Africa. This mutation has three distinct haplotypes; haplotype 1 being the oldest and most common. Recent studies have dated haplotype 1 of the G2019S mutation to about 4000 years ago, but it remains controversial whether the mutation has a Near-Eastern or Moroccan-Berber ancestral origin. To decipher this evolutionary history, we genotyped 10 microsatellite markers spanning a region of 11.27 Mb in a total of 57 unrelated Moroccan PD patients carrying the G2019S mutation for which the Berber or Arab origin was established over 3 generations based on spoken language. We estimated the age of the most recent common ancestor for the 36 Arab-speaking and the 15 Berber-speaking G2019S carriers using the likelihood-based method with a mutation rate of 10(-4). Data analysis suggests that the shortest haplotype originated in a patient of Berber ethnicity. The common founder was estimated to have lived 159 generations ago (95% CI 116-224) for Arab patients, and 200 generations ago (95% CI 123-348) for Berber patients. Then, 29 native North African males carrying the mutation were assessed for specific uniparental markers by sequencing the Y-chromosome (E-M81, E-M78, and M-267) and mitochondrial DNA (mtDNA) hypervariable regions (HV1 and HV2) to examine paternal and maternal contributions, respectively. Results showed that the autochthonous genetic component reached 76% for mtDNA (Eurasian and north African haplogroups) and 59% for the Y-chromosome (E-M81 and E-M78), suggesting that the G2019S mutation may have arisen in an autochthonous DNA pool. Therefore, we conclude that LRRK2 G2019S mutation most likely originated in a Berber founder who lived at least 5000 years ago (95% CI 3075-8700).	[Ben El Haj, Rafiqua; Regragui, Wafa; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed] Mohammed V Univ, Med Sch & Pharm, Genom Ctr Human Pathol, Res Team Neurol & Neurogenet, Rabat, Morocco; [Salmi, Ayyoub; Moussa, Ahmed] Abdelmalek Essaadi Univ, Natl Sch Appl Sci, Lab Informat & Commun Technol, Tanger, Morocco; [Regragui, Wafa; Bouslam, Naima; Tiber, Houyam; Benomar, Ali; Yahyaoui, Mohamed; Bouhouche, Ahmed] IBN Sina Univ, Specialties Hosp, Hosp Ctr, Dept Neurol & Neurogenet, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Abdelmalek Essaadi University of Tetouan; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Bouhouche, A (corresponding author), Mohammed V Univ, Med Sch & Pharm, Genom Ctr Human Pathol, Res Team Neurol & Neurogenet, Rabat, Morocco.; Bouhouche, A (corresponding author), IBN Sina Univ, Specialties Hosp, Hosp Ctr, Dept Neurol & Neurogenet, Rabat, Morocco.	a.bouhouche@um5s.net.ma	Moussa, Ahmed/AAI-1351-2020	Moussa, Ahmed/0000-0003-1628-8179; Salmi, Ayyoub/0000-0003-1332-8534; Bouhouche, Ahmed/0000-0001-5279-8649	"Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC); Mohammed V University in Rabat, Morocco [UM5R]	"Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC); Mohammed V University in Rabat, Morocco	This work was supported by the "Centre National de Recherche Scientifique et Technique" (CNRST) of "Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Formation des Cadres" (MESRSFC) and the Mohammed V University in Rabat (UM5R), Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhalid R, 2013, INT J LEGAL MED, V127, P757, DOI 10.1007/s00414-012-0813-4; Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; Al-Mubarak BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135950; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alamri Y, 2015, EUR NEUROL, V74, P222, DOI 10.1159/000442283; Allouche-Benayoun J, 1989, JUIFS ALGERIE MEMOIR; Ayoun R, 1982, JIFS ALGERIE DEUX MI, P27; Bar-Shira A, 2009, NEUROGENETICS, V10, P355, DOI 10.1007/s10048-009-0186-0; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; Benamer HTS, 2010, EUR NEUROL, V63, P321, DOI 10.1159/000279653; Bokbot Y, 2008, ETUDES ANTIQUITES AF, V1, P21; Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Bouhouche A, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/2412486; Campbell CL, 2012, P NATL ACAD SCI USA, V109, P13865, DOI 10.1073/pnas.1204840109; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Change N, 2008, GENET TEST, V12, P333, DOI 10.1089/gte.2007.0098; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Dieterlen F, 2010, INT J MOD ANTHROP, V3, P81; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; El-Desoky E. S., 2015, British Journal of Medicine and Medical Research, V5, P404, DOI 10.9734/BJMMR/2015/10458; Fadhlaoui-Zid K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080293; Falk R, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00462; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Hashad DI, 2011, GENET TEST MOL BIOMA, V15, P861, DOI 10.1089/gtmb.2011.0016; Healy D G, 2008, Pract Neurol, V8, P381, DOI 10.1136/jnnp.2008.162420; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Ibn Khaldoun, 1978, HIST BERBERES DYNAST; Kefi R, 2005, ANTHROPOL-INT J HUM, V43, P1; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Lesage S, 2010, HUM MOL GENET, V19, P1998, DOI 10.1093/hmg/ddq081; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Lucotte G., 2012, INT J MOD ANTHR, V1, P11, DOI [10.4314/ijma.v1i5.1, DOI 10.4314/IJMA.V1I5.1]; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Nebot D, 2004, TRIBUS OUBLIEES ISRA; Nebot D., LA KAHENA; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Pirkevi C, 2009, NEUROGENETICS, V10, P271, DOI 10.1007/s10048-009-0173-5; Reguig A, 2014, HUM BIOL, V86, P105, DOI 10.3378/027.086.0204; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Schulte C, 2011, APPL CLIN GENET, V4, P67, DOI 10.2147/TACG.S11639; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sierra M, 2011, MOVEMENT DISORD, V26, P2343, DOI 10.1002/mds.23965; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tomiyama H, 2006, MOVEMENT DISORD, V21, P1102, DOI 10.1002/mds.20886; Triki-Fendri S, 2016, AM J HUM BIOL, V28, P203, DOI 10.1002/ajhb.22773; Triki-Fendri S, 2015, AM J PHYS ANTHROPOL, V157, P242, DOI 10.1002/ajpa.22705; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Warren L, 2008, PARKINSONISM RELAT D, V14, P77, DOI 10.1016/j.parkreldis.2007.02.001; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Zabetian CP, 2006, NEUROLOGY, V67, P697, DOI 10.1212/01.wnl.0000227732.37801.d4; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181335	10.1371/journal.pone.0181335	http://dx.doi.org/10.1371/journal.pone.0181335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723952	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800043
J	Tanos, T; Saibene, AM; Pipolo, C; Battaglia, P; Felisati, G; Rubio, A				Tanos, Tamara; Saibene, Alberto Maria; Pipolo, Carlotta; Battaglia, Paolo; Felisati, Giovanni; Rubio, Alicia			Isolation of putative stem cells present in human adult olfactory mucosa	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; HORIZONTAL BASAL-CELLS; MEMBRANE GLYCOPROTEIN; SELF-RENEWAL; IN-VITRO; EPITHELIUM; REGENERATION; EXPRESSION; BRAIN; NICHE	The olfactory mucosa (OM) has the unique characteristic of performing an almost continuous and lifelong neurogenesis in response to external injuries, due to the presence of olfactory stem cells that guarantee the maintenance of the olfactory function. The easy accessibility of the OM in humans makes these stem cells feasible candidates for the development of regenerative therapies. In this report we present a detailed characterization of a patient-derived OM, together with a description of cell cultures obtained from the OM. In addition, we present a method for the enrichment and isolation of OM stem cells that might be used for future translational studies dealing with neuronal plasticity, neuro-regeneration or disease modeling.	[Tanos, Tamara; Rubio, Alicia] Ist Europeo Oncol, Milan, Italy; [Saibene, Alberto Maria; Pipolo, Carlotta; Felisati, Giovanni] Univ Milan, Otolaryngol Unit, ASST Santi Paolo & Carlo, Dept Hlth Sci, Milan, Italy; [Battaglia, Paolo] Univ Insubria, Otolaryngol Unit, Varese, Italy; [Tanos, Tamara] InSphero AG, Wagistr 27, Zurich, Switzerland; [Rubio, Alicia] Ist Sci San Raffaele, Stem Cells & Neurogenesis Res Unit, Div Neurosci, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan; University of Insubria; InSphero AG; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Rubio, A (corresponding author), Ist Europeo Oncol, Milan, Italy.; Felisati, G (corresponding author), Univ Milan, Otolaryngol Unit, ASST Santi Paolo & Carlo, Dept Hlth Sci, Milan, Italy.; Rubio, A (corresponding author), Ist Sci San Raffaele, Stem Cells & Neurogenesis Res Unit, Div Neurosci, Milan, Italy.	giovanni.felisati@unimi.it; rubiogarrido.alicia@hsr.it	felisati, giovanni/AAW-2724-2021; rubio, alicia/I-7487-2018; Battaglia, Paolo/AAT-7742-2020; Pipolo, Carlotta/AAA-3425-2022; Saibene, Alberto Maria/H-7702-2019	felisati, giovanni/0000-0001-6763-4305; rubio, alicia/0000-0003-0897-4806; Saibene, Alberto Maria/0000-0003-1457-6871; Tanos, Tamara/0000-0002-3217-3104; PIPOLO, GIORGIA CARLOTTA/0000-0001-6628-2117	"Instituto de Salud Carlos III"	"Instituto de Salud Carlos III"(Instituto de Salud Carlos III)	The authors received no specific funding for this work. A.R. had a postdoctoral fellowship Sara Borrell from the "Instituto de Salud Carlos III."	Borgmann-Winter K, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.141; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; COSTANZO RM, 1984, BRAIN RES, V307, P295, DOI 10.1016/0006-8993(84)90483-9; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Fletcher RB, 2011, NEURON, V72, P748, DOI 10.1016/j.neuron.2011.09.009; Fuchsova B, 2015, NEUROSCIENCE, V299, P1, DOI 10.1016/j.neuroscience.2015.04.057; Garcia-Escudero V, 2015, J CELL MOL MED, V19, P1284, DOI 10.1111/jcmm.12488; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; HAAN EA, 1982, P NATL ACAD SCI-BIOL, V79, P7585, DOI 10.1073/pnas.79.23.7585; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Iwai N, 2008, STEM CELLS, V26, P1298, DOI 10.1634/stemcells.2007-0891; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Krolewski RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051737; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lindsay SL, 2016, NEUROCHEMISTRY INT; Lindsay SL, 2013, GLIA, V61, P368, DOI 10.1002/glia.22440; Mackay-Sim A, 2010, ARCH ITAL BIOL, V148, P47; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MORRISON EE, 1990, J COMP NEUROL, V297, P1, DOI 10.1002/cne.902970102; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Murrell W, 2009, SPINE J, V9, P585, DOI 10.1016/j.spinee.2009.02.011; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; PAIK SI, 1992, ARCH OTOLARYNGOL, V118, P731; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Qin FX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14430; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Tome M, 2009, STEM CELLS, V27, P2196, DOI 10.1002/stem.130; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; VINORES SA, 1984, CANCER RES, V44, P2595; Whitlock KE, 2004, BRAIN BEHAV EVOLUT, V64, P126, DOI 10.1159/000079742; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; YAMAGISHI M, 1989, ANN OTO RHINOL LARYN, V98, P384, DOI 10.1177/000348948909800514; Yee KK, 2010, AM J RHINOL ALLERGY, V24, P110, DOI 10.2500/ajra.2010.24.3435	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181151	10.1371/journal.pone.0181151	http://dx.doi.org/10.1371/journal.pone.0181151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719644	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400034
J	Welsch, N; Lyon, LA				Welsch, Nicole; Lyon, L. Andrew			Oligo(ethylene glycol)-sidechain microgels prepared in absence of cross-linking agent: Polymerization, characterization and variation of particle deformability	PLOS ONE			English	Article							FREE-RADICAL POLYMERIZATION; N-ISOPROPYLACRYLAMIDE; POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES; RESPONSIVE MICROGELS; PORE SENSOR; POLYMERS; NANOPARTICLES; BIOMATERIALS; SUSPENSIONS	We present a systematic study of self-cross-linked microgels formed by precipitation polymerization of oligo ethylene glycol methacrylates. The cross-linking density of these microgels and, thus, the network flexibility can be easily tuned through the modulation of the reaction temperature during polymerization. Microgels prepared in absence of any difunctional monomer, i.e. cross-linker, show enhanced deformability and particle spreading on solid surfaces as compared to microgels cross-linked with varying amounts of poly(ethylene glycol diacrylate) (PEG-DA) in addition to self-crosslinking. Particles prepared at low reaction temperatures exhibit the highest degree of spreading due to the lightly cross-linked and flexible polymer network. Moreover, AFM force spectroscopy studies suggest that cross-linker-free microgels constitute of a more homogeneous polymer network than PEG-DA cross-linked particles and have elastic moduli at the particle apex that are similar to 5 times smaller than the moduli of 5 mol-% PEG-DA cross-linked microgels. Resistive pulse sensing experiments demonstrate that microgels prepared at 75 and 80 degrees C without PEG-DA are able to deform significantly to pass through nanopores that are smaller than the microgel size. Additionally, we found that polymer network flexibility of microgels is a useful tool to control the formation of particle dewetting patterns. This offers a promising new avenue for build-up of 2D self-assembled particle structures with patterned chemical and mechanical properties.	[Welsch, Nicole; Lyon, L. Andrew] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Lyon, L. Andrew] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lyon, L. Andrew] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Chapman University System; Chapman University	Lyon, LA (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Lyon, LA (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Lyon, LA (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	lyon@chapman.edu	Lyon, Andrew/A-4082-2009	Lyon, Andrew/0000-0001-7828-7345	German Research Foundation (DFG) [WE 5485/1-1]; National Institute of Health [R01HL130918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130918] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work received support from the National Institute of Health (R01HL130918); URL: https://www.nih.gov/ and the German Research Foundation (DFG, WE 5485/1-1); URL:http://www. dfg.de/.; Viscometry experiments were performed in the laboratories of A. Fernandez-Nieves, to whom we are extremely grateful for his assistance. We thank Dr. Molla Islam for helpful discussions regarding this work. Financial support from the German Research Foundation (DFG, WE 5485/1-1) and the National Institute of Health (R01HL130918) is gratefully acknowledged.	Bachman H, 2015, SOFT MATTER, V11, P2018, DOI 10.1039/c5sm00047e; Bakaic E, 2015, RSC ADV, V5, P35469, DOI 10.1039/c4ra13581d; Balaceanu A, 2011, MACROMOLECULES, V44, P2161, DOI 10.1021/ma200103y; Barth J, 2010, MACROMOLECULES, V43, P4023, DOI 10.1021/ma1006039; BATCHELOR GK, 1977, J FLUID MECH, V83, P97, DOI 10.1017/S0022112077001062; Brown AC, 2014, NAT MATER, V13, P1108, DOI [10.1038/nmat4066, 10.1038/NMAT4066]; Burmistrova A, 2011, COLLOID POLYM SCI, V289, P613, DOI 10.1007/s00396-011-2383-2; Carlsson L, 2010, SOFT MATTER, V6, P3619, DOI 10.1039/c0sm00009d; Chua GBH, 2012, MACROMOLECULES, V45, P1362, DOI 10.1021/ma202700y; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dong HC, 2010, MACROMOLECULES, V43, P4623, DOI 10.1021/ma100570s; Gao J, 2003, LANGMUIR, V19, P5217, DOI 10.1021/la034207s; Gao J, 2003, LANGMUIR, V19, P5212, DOI 10.1021/la0269762; Gaulding JC, 2013, POLYM CHEM-UK, V4, P4890, DOI 10.1039/c3py00173c; Gawlitza K, 2014, POLYMER, V55, P6717, DOI 10.1016/j.polymer.2014.10.069; Gawlitza K, 2012, Z PHYS CHEM, V226, P749, DOI 10.1524/zpch.2012.0271; Geoghegan M, 2003, PROG POLYM SCI, V28, P261, DOI 10.1016/S0079-6700(02)00080-1; Gu LM, 2001, MACROMOL RAPID COMM, V22, P212, DOI 10.1002/1521-3927(200102)22:3<212::AID-MARC212>3.0.CO;2-B; Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hashmi SM, 2009, SOFT MATTER, V5, P3682, DOI 10.1039/b906051k; Higgins MJ, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2162455; Hu ZB, 2010, SOFT MATTER, V6, P2115, DOI 10.1039/b921150k; Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956; Junkers T, 2008, J POLYM SCI POL CHEM, V46, P7585, DOI 10.1002/pola.23071; Kozak D, 2012, CHEM LETT, V41, P1134, DOI 10.1246/cl.2012.1134; Kozak D, 2012, ACS NANO, V6, P6990, DOI 10.1021/nn3020322; Lapeyre V, 2006, BIOMACROMOLECULES, V7, P3356, DOI 10.1021/bm060588n; Lee TY, 2004, POLYMER, V45, P6155, DOI 10.1016/j.polymer.2004.06.060; Liu RX, 2012, SOFT MATTER, V8, P10932, DOI 10.1039/c2sm26522b; Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706; Lutz JF, 2007, MACROMOLECULES, V40, P8540, DOI 10.1021/ma7021474; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; Lyon LA, 2012, ANNU REV PHYS CHEM, V63, P25, DOI 10.1146/annurev-physchem-032511-143735; Martin CP, 2004, NANO LETT, V4, P2389, DOI 10.1021/nl048536w; MCPHEE W, 1993, J COLLOID INTERF SCI, V156, P24, DOI 10.1006/jcis.1993.1075; Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108; Moad G, 2008, ACCOUNTS CHEM RES, V41, P1133, DOI 10.1021/ar800075n; Nayak S, 2005, ANGEW CHEM INT EDIT, V44, P7686, DOI 10.1002/anie.200501321; Qiao ZY, 2010, MACROMOLECULES, V43, P6485, DOI 10.1021/ma101090g; Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008; Saxena S, 2014, ACCOUNTS CHEM RES, V47, P2426, DOI 10.1021/ar500131v; Saxena S, 2014, SOFT MATTER, V10, P1356, DOI 10.1039/c3sm52518j; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730; Senff H, 2000, COLLOID POLYM SCI, V278, P830, DOI 10.1007/s003960000329; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Smith MH, 2011, J PHYS CHEM B, V115, P3761, DOI 10.1021/jp111634k; South AB, 2010, CHEM MATER, V22, P3300, DOI 10.1021/cm100702p; South AB, 2009, ACS APPL MATER INTER, V1, P2747, DOI 10.1021/am9005435; Stieger M, 2004, J CHEM PHYS, V120, P6197, DOI 10.1063/1.1665752; Tsutsui M, 2012, ACS NANO, V6, P3499, DOI 10.1021/nn300530b; Vancoillie G, 2014, PROG POLYM SCI, V39, P1074, DOI 10.1016/j.progpolymsci.2014.02.005; Virtanen OLJ, 2016, SOFT MATTER, V12, P3919, DOI 10.1039/c6sm00140h; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Voudouris P, 2013, SOFT MATTER, V9, P7158, DOI 10.1039/c3sm50917f; Wang W, 2010, CHEM ENG TECHNOL, V33, P1745, DOI 10.1002/ceat.201000234; Wang Y, 2013, BIOMACROMOLECULES, V14, P3034, DOI 10.1021/bm401131w; Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8; Welsch N, 2009, J PHYS CHEM B, V113, P16039, DOI 10.1021/jp907508w; Wiedemair J, 2007, LANGMUIR, V23, P130, DOI 10.1021/la061288u; Wu WT, 2010, ACS NANO, V4, P4831, DOI 10.1021/nn1008319; WU X, 1994, COLLOID POLYM SCI, V272, P467, DOI 10.1007/BF00659460; Xu YH, 2008, J CHROMATOGR A, V1191, P40, DOI 10.1016/j.chroma.2008.01.051; Yao ZL, 2013, SOFT MATTER, V9, P5319, DOI 10.1039/c3sm50374g	65	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181369	10.1371/journal.pone.0181369	http://dx.doi.org/10.1371/journal.pone.0181369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719648	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400042
J	Xie, DL; Zheng, MM; Zheng, Y; Gao, H; Zhang, J; Zhang, T; Guo, JC; Yang, XF; Zhong, XP; Lou, YL				Xie, Dan-Li; Zheng, Meng-Meng; Zheng, Yi; Gao, Hui; Zhang, Jie; Zhang, Ting; Guo, Jian-Chun; Yang, X. Frank; Zhong, Xiao-Ping; Lou, Yong-Liang			Vibrio vulnificus induces mTOR activation and inflammatory responses in macrophages	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; SCLEROSIS COMPLEX 1; KAPPA-B PATHWAY; PATHOGEN RECOGNITION; MAMMALIAN TARGET; INNATE IMMUNITY; MARINE VIBRIO; DISEASE; INFECTION; LIVER	Vibrio vulnificus (V. vulnificus), a Gram-negative marine bacterium, can cause life-threatening primary septicemia, especially in patients with liver diseases. How V. vulnificus affects the liver and how it acts on macrophages are not well understood. In this report, we demonstrated that V. vulnificus infection causes a strong inflammatory response, marked expansion of liver-resident macrophages, and liver damage in mice. We demonstrated further that V. vulnificus activates mTOR in macrophages and inhibition of mTOR differentially regulates V. vulnificus induced inflammatory responses, suggesting the possibility of targeting mTOR as a strategy to modulate V. vulnificus induced inflammatory responses.	[Xie, Dan-Li; Zheng, Meng-Meng; Zheng, Yi; Gao, Hui; Guo, Jian-Chun; Zhong, Xiao-Ping; Lou, Yong-Liang] Wenzhou Med Univ, Dept Microbiol & Immunol, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Xie, Dan-Li; Zheng, Yi; Zhong, Xiao-Ping; Lou, Yong-Liang] China Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Jie] Sichuan Prov Peoples Hosp, Dept Clin Lab Med, Chengdu, Sichuan, Peoples R China; [Zhang, Ting] Fudan Univ, Dept Lab Med, Jinshan Hosp, Shanghai, Peoples R China; [Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA	Wenzhou Medical University; Sichuan Provincial People's Hospital; Fudan University; Indiana University System; Indiana University Bloomington; Duke University	Zhong, XP; Lou, YL (corresponding author), Wenzhou Med Univ, Dept Microbiol & Immunol, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China.; Zhong, XP; Lou, YL (corresponding author), China Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China.; Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	xiaoping.zhong@duke.edu; lyl@wmu.edu.cn			National Natural Science Foundation Grant [31400763]; Zhejiang Provincial Natural Science Foundation [LY13H190007]; Zhejiang Provincial Medical Science Foundation [2015KYB238]; Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine); National Institute of Allergy and Infectious Diseases [R01 (AI101206)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101206] Funding Source: NIH RePORTER	National Natural Science Foundation Grant(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical Science Foundation; Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by Chinese National Natural Science Foundation Grant (31400763 to DLX, https://urldefense.proofpoint.com/v2/url?u=http-3A www.nsfc.gov.cn-&d=DwIFAw&c=imBPVzF250nBgGmVOIcsiEgHoG1i6 YHLR0Sj_gZ4adc&r=S_JYpfDmLaCC5h9z1VA JNIjLauCLn5g6DAXa1EehYb0&m=XIUXuJN_RGRbtSLmM33ECqPzzDZGaLjTSBWV1zNYk&s=Ofe0f_WYMDZFIQCqNwlc9XPFZHx2ZqWbfK-vMyYrbDag&e=), Zhejiang Provincial Natural Science Foundation Grant (LY13H190007 to DLX, https://urldefense.proofpoint.com/v2/url?u=http-3A_www.zinsf.gov.cn_&d=DwIFAw&c= imBPVzF250nBgGmV0IcsiEgHoG1i6YHLR0Sj_ gZ4adc&r=S_JYpfDmLaCC5h9z1VAJNljLauCLn5 g6DAXa1EehYb0&m=,X1UXuJN_RGJRbtSLmM3 3ECqPzzZvZGaLjTSBWV1zNYk&s=K2ZgERc PVNiUyndwY4LhAspigWjqM5RyMwy_scnu 4bU&e=), Zhejiang Provincial Medical Science Foundation Grant (2015KYB238 to YZ, https://urldefense.proofpoint.com/v2/url?=http-3A_kj.zjwst.gov.cn_&d=DwIFAw&c=imBPVzF250nBgGmVOIcsIEgHoG1i6yHLR0Sj_gZ4adc&r=S_jypfDmLaCEgHoG1i6YHLROSi_gZ4adc&r=S_JYpfDmLaCC5h9z1VAJNILauCLn5g6DAXa1EehYn0&m=XIUXuJN_RGJBbtSLmM33ECqPzzZvZGaLjTSBWV1zNYk&s=WB6AuX6_w2TICh2hnlf24l30E1HSGfAGSdWd7RhEH1k&e=) and Open Fund of Zhejiang Provincial Top Key Discipline of Clinical Medicine (Laboratory Medicine,toXFY,https://urldefense.proofpoint.com/v2/ur1?u=http-3A_www.wmu.edu.cn_view.php-3Fid-3077e70089-2D5da6-2D11e5-2D11e5-2Dbc3f-2Ddd6031fe976&d=,DwlFAw&c=imBPVzF250nBgGMVOlcsiEgHoG!,v&c=imBPV7F250nE3gGmVOIcsiEgHoG1i6YHLR0Si_gZ4adc&r=G_JYpfDmLaCC5b9z1VAJ NljLauCLn5g6DAXal EehYb08,m,X1UXuJ RGJRbtSLmM33ECqpzzZvZGaLjTSBWV1zNYk&s= 6-arDcNi5NqGgPiXmJmMElAc45P0zwrK9BLP7u FI-DY&e=,), and The National Institute of Allergy and Infectious Diseases-R01 (AI101206 to XPZ, https://urldefense.proofpoint.com/v2/url?u-https-3A_projectreporter.nih.gov_project-5Finfo-5Fdetails.cfm=3Faid=3D9062374=26icde=3D34992657&d=DwlFAw&c=imBPVzF250nBgGmVOIcsiEgH0G1I6YHLR0Sj_gZ4adc&r=S_JYPfDmLaCC5h9z1VAJNIjLauCLn5g6DAXa1EehYb0&m=XIUXuJN_RGJRbtSLmM33ECqPzzaZvZGaLjTSBWV1zNYk&s=r9ZA99LrG01jRVyy7Sk6UwMXa7gVQa0zENQuubK4QGE&e=). Thefunders did not play a role in experimental design.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ali S, 2004, CELL BIOCHEM FUNCT, V22, P67, DOI 10.1002/cbf.1082; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chapman NM, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00686; Deng WH, 2017, J IMMUNOL, V198, P492, DOI 10.4049/jimmunol.1501845; ELLINGTON EP, 1982, NEW ENGL J MED, V307, P1642; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gulig PA, 2005, J MICROBIOL, V43, P118; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jiang Q, 2011, CANCER RES, V71, P4074, DOI 10.1158/0008-5472.CAN-10-3968; Kashimoto T, 2003, INFECT IMMUN, V71, P533, DOI 10.1128/IAI.71.1.533-535.2003; Kim K, 2015, INFECT IMMUN, V83, P1150, DOI 10.1128/IAI.02878-14; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee BC, 2010, INT J MOL MED, V25, P581, DOI 10.3892/ijmm_00000380; Lee SJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.19; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Lee SJ, 2015, J IMMUNOL, V195, P2282, DOI 10.4049/jimmunol.1500951; Liu XF, 2015, INFLAMMATION, V38, P1864, DOI 10.1007/s10753-015-0166-5; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Nazir Salik, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214772; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Brien TF, 2012, ARCH IMMUNOL THER EX, V60, P173, DOI 10.1007/s00005-012-0171-4; Pan HJ, 2013, J IMMUNOL, V191, P699, DOI 10.4049/jimmunol.1201443; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Wang YY, 2013, P NATL ACAD SCI USA, V110, pE4894, DOI 10.1073/pnas.1308905110; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wu JH, 2014, J IMMUNOL, V192, P2643, DOI 10.4049/jimmunol.1302076; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	44	9	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181454	10.1371/journal.pone.0181454	http://dx.doi.org/10.1371/journal.pone.0181454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719654	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400047
J	Beamish, JA; Chen, E; Putnam, AJ				Beamish, Jeffrey A.; Chen, Evan; Putnam, Andrew J.			Engineered extracellular matrices with controlled mechanics modulate renal proximal tubular cell epithelialization	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; POLY(ETHYLENE GLYCOL) HYDROGELS; FOCAL ADHESION; DIACRYLATE HYDROGELS; MC3T3-E1 CELLS; PROLIFERATION; STIFFNESS; RIGIDITY; FIBROSIS; GROWTH	Acute kidney injury (AKI) is common and associated with significant morbidity and mortality. Recovery from many forms of AKI involves the proliferation of renal proximal tubular epithelial cells (RPTECs), but the influence of the microenvironment in which this recovery occurs remains poorly understood. Here we report the development of a poly(ethylene glycol) (PEG) hydrogel platform to study the influence of substrate mechanical properties on the proliferation of human RPTECs as a model for recovery from AKI. PEG diacrylate based hydrogels were generated with orthogonal control of mechanics and cell-substrate interactions. Using this platform, we found that increased substrate stiffness promotes RPTEC spreading and proliferation. RPTECs showed similar degrees of apoptosis and Yes-associated protein (YAP) nuclear localization regardless of stiffness, suggesting these were not key mediators of the effect. However, focal adhesion formation, cytoskeletal organization, focal adhesion kinase (FAK) activation, and extracellular signal-regulated kinase (ERK) activation were all enhanced with increasing substrate stiffness. Inhibition of ERK activation substantially attenuated the effect of stiffness on proliferation. In long-term culture, hydrogel stiffness promoted the formation of more complete epithelial monolayers with tight junctions, cell polarity, and an organized basement membrane. These data suggest that increased stiffness potentially may have beneficial consequences for the renal tubular epithelium during recovery from AKI.	[Beamish, Jeffrey A.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Chen, Evan; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beamish, JA (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA.; Putnam, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jebeamish@med.umich.edu; putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377	University of Michigan O'Brien Kidney Center [DK-P30-081943]; NIH/NHLBI [R01-HL085339]; NIH [T32-DK007378]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, T32DK007378] Funding Source: NIH RePORTER	University of Michigan O'Brien Kidney Center; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided in part by the University of Michigan O'Brien Kidney Center (DK-P30-081943) and the NIH/NHLBI (R01-HL085339 to AJP). JAB was also supported by NIH T32-DK007378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Anvari A, 2015, ABDOM IMAGING, V40, P709, DOI 10.1007/s00261-015-0383-2; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Beamish JA, 2010, J BIOMED MATER RES A, V92A, P441, DOI 10.1002/jbm.a.32353; Berger K, 2014, P NATL ACAD SCI USA, V111, P1533, DOI 10.1073/pnas.1316177111; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brito PL, 1998, KIDNEY INT, V53, P754, DOI 10.1046/j.1523-1755.1998.00809.x; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chen WC, 2015, AM J PATHOL, V185, P2468, DOI 10.1016/j.ajpath.2015.05.019; Chen WC, 2014, AM J PHYSIOL-RENAL, V307, pF695, DOI 10.1152/ajprenal.00684.2013; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2010, CURR OPIN NEPHROL HY, V19, P266, DOI 10.1097/MNH.0b013e3283375538; Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031; Cummings BS, 2001, MEASUREMENT CELL DEA, DOI [10.1002/0471141755.ph1208s56, DOI 10.1002/0471141755.PH1208S56]; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kohn JC, 2016, J BIOMECH, V49, P1447, DOI 10.1016/j.jbiomech.2016.03.016; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Lin L, 2014, ACTA BIOMATER, V10, P5106, DOI 10.1016/j.actbio.2014.08.025; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Morikawa H, 2011, J GASTROENTEROL, V46, P350, DOI 10.1007/s00535-010-0301-x; Orlacchio A, 2014, ULTRASOUND MED BIOL, V40, P2564, DOI 10.1016/j.ultrasmedbio.2014.06.002; Oxburgh L, 2017, J AM SOC NEPHROL, V28, P1370, DOI 10.1681/ASN.2016101077; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Qin Y, 2011, AM J PATHOL, V179, P2766, DOI 10.1016/j.ajpath.2011.08.025; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Samir AE, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0120-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh RK, 2013, BIOMATERIALS, V34, P9331, DOI 10.1016/j.biomaterials.2013.08.016; Wang YH, 2007, J BIOL CHEM, V282, P752, DOI 10.1074/jbc.M604801200; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; West MB, 2010, ARCH BIOCHEM BIOPHYS, V504, P177, DOI 10.1016/j.abb.2010.08.019; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181085	10.1371/journal.pone.0181085	http://dx.doi.org/10.1371/journal.pone.0181085			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715434	Green Submitted, Green Published, gold			2022-12-26	WOS:000443975500026
J	Casillas-Espinosa, PM; Powell, KL; Zhu, MF; Campbell, CR; Maia, JM; Ren, Z; Jones, NC; O'Brien, TJ; Petrovski, S				Casillas-Espinosa, Pablo M.; Powell, Kim L.; Zhu, Mingfu; Campbell, C. Ryan; Maia, Jessica M.; Ren, Zhong; Jones, Nigel C.; O'Brien, Terence J.; Petrovski, Slave			Evaluating whole genome sequence data from the Genetic Absence Epilepsy Rat from Strasbourg and its related non-epileptic strain	PLOS ONE			English	Article							GENERALIZED EPILEPSY; SEIZURE EXPRESSION; MODEL; EPILEPTOGENESIS; MECHANISMS; PHENOTYPES; DISORDERS; CHILDREN; BEHAVIOR; STRESS	Objective The Genetic Absence Epilepsy Rats from Strasbourg (GAERS) are an inbreed Wistar rat strain widely used as a model of genetic generalised epilepsy with absence seizures. As in humans, the genetic architecture that results in genetic generalized epilepsy in GAERS is poorly understood. Here we present the strain-specific variants found among the epileptic GAERS and their related Non-Epileptic Control (NEC) strain. The GAERS and NEC represent a powerful opportunity to identify neurobiological factors that are associated with the genetic generalised epilepsy phenotype. Methods We performed whole genome sequencing on adult epileptic GAERS and adult NEC rats, a strain derived from the same original Wistar colony. We also generated whole genome sequencing on four double-crossed (GAERS with NEC) F-2 selected for high-seizing (n = 2) and non-seizing (n = 2) phenotypes. Results Specific to the GAERS genome, we identified 1.12 million single nucleotide variants, 296.5K short insertion-deletions, and 354 putative copy number variants that result in complete or partial loss/duplication of 41 genes. Of the GAERS-specific variants that met high quality criteria, 25 are annotated as stop codon gain/loss, 56 as putative essential splice sites, and 56 indels are predicted to result in a frameshift. Subsequent screening against the two F-2 progeny sequenced for having the highest and two F-2 progeny for having the lowest seizure burden identified only the selected Cacna1h GAERS-private protein-coding variant as exclusively co-segregating with the two high-seizing F-2 rats. Significance This study highlights an approach for using whole genome sequencing to narrow down to a manageable candidate list of genetic variants in a complex genetic epilepsy animal model, and suggests utility of this sequencing design to investigate other spontaneously occurring animal models of human disease.	[Casillas-Espinosa, Pablo M.; Powell, Kim L.; Jones, Nigel C.; O'Brien, Terence J.; Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Zhu, Mingfu; Campbell, C. Ryan] Duke Univ, Sch Med, Durham, NC USA; [Maia, Jessica M.] BD Technol, Durham, NC USA; [Ren, Zhong; Petrovski, Slave] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10027 USA	Royal Melbourne Hospital; University of Melbourne; Duke University; Columbia University	Petrovski, S (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.; Petrovski, S (corresponding author), Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10027 USA.	slavep@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; Powell, Kim/0000-0002-9007-4614; Jones, Nigel/0000-0002-1080-8439	Melbourne Research Scholarship; NHMRC Project	Melbourne Research Scholarship; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	Pablo M. Casillas-Espinosa was funded by a Melbourne Research Scholarship. Work for this project was supported in part by a NH&MRC Project Grant to Terence OBrien and Kim Powell and a R.D Wright Career Development Fellowship (1126877) to SP. The current affiliation of JMM, BD technologies, provides support in the form of salaries for JMM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Depaulis A, 2016, J NEUROSCI METH, V260, P159, DOI 10.1016/j.jneumeth.2015.05.022; Dezsi G, 2013, EPILEPSIA, V54, P635, DOI 10.1111/epi.12118; DOOSE H, 1994, EUR J PEDIATR, V153, P372, DOI 10.1007/s004310050157; DOOSE H, 1973, EPILEPSIA, V14, P57, DOI 10.1111/j.1528-1157.1973.tb03942.x; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Edwards HE, 2002, EXP NEUROL, V175, P182, DOI 10.1006/exnr.2002.7874; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gardiner M, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00310.x; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goltvanitsa GA, 2012, ZH NEVROL PSIKHIATR, V112, P25; Hermsen R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1594-1; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Kaminski RM, 2011, NEUROPHARMACOLOGY, V61, P133, DOI 10.1016/j.neuropharm.2011.03.019; Koe AS, 2014, PSYCHONEUROENDOCRINO, V42, P124, DOI 10.1016/j.psyneuen.2014.01.009; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LG, 2006, J PHARMACOL EXP THER, V319, P790, DOI 10.1124/jpet.106.104968; LOISEAU P, 1995, EPILEPSIA, V36, P1182, DOI 10.1111/j.1528-1157.1995.tb01060.x; Maggio N, 2012, EXP NEUROL, V234, P200, DOI 10.1016/j.expneurol.2011.12.035; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; MARESCAUX M, 1984, REV NEUROL-FRANCE, V140, P63; MICHELETTI G, 1987, EUR J PHARMACOL, V135, P397, DOI 10.1016/0014-2999(87)90690-X; MICHELETTI G, 1985, ARZNEIMITTELFORSCH, V35, P483; Ott D, 2003, EPILEPSIA, V44, P591, DOI 10.1046/j.1528-1157.2003.25002.x; Ott D, 2001, J AM ACAD CHILD PSY, V40, P907, DOI 10.1097/00004583-200108000-00012; Ottman R, 1997, EPIDEMIOL REV, V19, P120, DOI 10.1093/oxfordjournals.epirev.a017934; PORTER RJ, 1993, EPILEPSIA, V34, pS42; Powell KL, 2014, EPILEPSIA, V55, P1959, DOI 10.1111/epi.12840; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; Racine RJ, 1999, EPILEPSY RES, V35, P183, DOI 10.1016/S0920-1211(99)00013-3; Rudolf G, 2004, EPILEPSIA, V45, P301, DOI 10.1111/j.0013-9580.2004.50303.x; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Zheng T, 2009, EPILEPSIA, V50, P83, DOI 10.1111/j.1528-1167.2008.01759.x; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179924	10.1371/journal.pone.0179924	http://dx.doi.org/10.1371/journal.pone.0179924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708842	Green Published, gold			2022-12-26	WOS:000405649800009
J	Kadison, E; Brandt, M; Nemeth, R; Martens, J; Blondeau, J; Smith, T				Kadison, Elizabeth; Brandt, Marilyn; Nemeth, Richard; Martens, Justin; Blondeau, Jeremiah; Smith, Tyler			Abundance of commercially important reef fish indicates different levels of over-exploitation across shelves of the US Virgin Islands	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PROTECTED AREAS; GROUPERS PISCES; FLORIDA; RETENTION; FISHERIES; RECRUITMENT; POPULATION; SERRANIDAE; DENSITY	The United States Virgin Islands are comprised of two separate insular platforms separated by the deep water Anegada Passage. Although managed by the same regulations, as one fishery, several physical and spatial differences exist between the two northern shelf islands, St. Thomas and St. John, and isolated St. Croix. Based on two long-term fisheries independent datasets, collected by the U.S. Virgin Islands Territorial Coral Reef Monitoring Program and the National Oceanographic and Atmospheric Administration Center for Coastal Monitoring and Assessment, there were significant differences between the northern USVI and St. Croix in both the occurrence and size of several species of large and commercially important reef fishes. These fishes are primarily apex piscivores and generally the first species over-exploited in small-scale fisheries. The disparities between the fish communities on the two island shelves cannot be explained solely by differences in habitat (coral cover, rugosity) or fisheries management, such as relative amount of marine protected area in local waters. They are instead probably caused by a combination of several other interrelated factors including water depth, fishing methodology, fishable area, and the presence or absence of viable fish spawning areas. This study considers those aspects, and illustrates the need for management of island artisanal fisheries that is tailored to the physical and spatial constraints imposed by insular platforms.	[Kadison, Elizabeth; Brandt, Marilyn; Nemeth, Richard; Smith, Tyler] Univ Virgin Isl, Ctr Marine & Environm Studies, USVI, St Thomas, VI 00802 USA; [Martens, Justin] US Fish & Wildlife Serv, Alpine, AZ USA; [Blondeau, Jeremiah] NOAA, Southwest Fisheries Sci Ctr, 75 Virginia Beach Dr, Miami, FL USA	University of the Virgin Islands; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA	Kadison, E (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, USVI, St Thomas, VI 00802 USA.	ekadiso@live.uvi.edu			Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration [233041]	Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration	This work was supported by the Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration, coralreef.noaa.gov, Award Number 233041, Recipient: TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DAT USVI TRIP TICK A; [Anonymous], 2006, TITL 50 WILDL FISH P, P216; Appeldoorn R, 1992, 304 NOAA NMFSSEFSC; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Ault JS, 2005, B MAR SCI, V76, P595; Ault JS, 2005, ICES J MAR SCI, V62, P417, DOI 10.1016/j.icesjms.2004.12.001; Beets J, 1999, ENVIRON BIOL FISH, V55, P91, DOI 10.1023/A:1007404421518; Beets J, 1996, 5 VINP; BROCK RE, 1982, B MAR SCI, V32, P269; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; CLARO R, 1991, Tropical Ecology, V32, P36; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Friedlander A.M., 2008, 70 NOAA NOS NCCOS; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garrison VH, 1998, REV BIOL TROP, V46, P41; Gillett R, 2006, FAO FISHCODE REV; Gladfelter EH, 1977, ENV STUDIES BUCK ISL; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Kadison Elizabeth, 2006, Rev. biol. trop, V54, P69; Kendall MS, 2001, METHODS USED MAP BEN; KIMMEL JJ, 1985, ENVIRON BIOL FISH, V12, P23, DOI 10.1007/BF00007707; Kojis BL, 2006, P 10 INT COR REEF S, V1326, P1334; KOSLOW JA, 1988, MAR ECOL PROG SER, V43, P201, DOI 10.3354/meps043201; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; MCCLANAHAN TR, 1988, HYDROBIOLOGIA, V166, P269, DOI 10.1007/BF00008136; Mohammed E., 2003, MEXICO BRAZIL CENTRA, P11; Monaco M.E., 2008, 71 NOAA NOS NCCOS; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Munro JL, 1983, CARIBBEAN CORAL REEF; Nemeth R. S., 2006, P GULF CARIBBEAN FIS, V57, P543; Nemeth RS, 2008, 3349 CAR FISH MAN CO; Nevill J, 2006, IMPACTS SPEARFISHING; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Oakley SG, 1984, P S COR REEF ENV RED, P341; Olsen D. A., 1979, P GULF CARIB FISH I, V31, P130; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Quinn NJ, 2011, P 64 GULF CAR FISH I, P135; Randall J.E., 1962, P GULF CARIBBEAN FIS, V14, P201; RANDALL JOHN E., 1963, CARIBBEAN J SCI, V3, P31; Richards WJ, 1990, LARGE MARINE ECOSYST; Rogers C.S., 1985, P 5 INT COR REEF C T, V6, P491; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; Rogers CS, 1982, MARINE ENV BREWERS B; Ruttenberg BI, 2001, CONSERV BIOL, V15, P1691, DOI 10.1046/j.1523-1739.2001.99556.x; Sadovy Y, 2001, J FISH BIOL, V59, P90, DOI 10.1006/jfbi.2001.1760; Sluka R, 1996, NATURE CONSERVANCY; Sluka RD, 1998, FISH B-NOAA, V96, P388; Smith TB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00107.1; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Tobias W, 1988, 26 BIOSPH RES; Tobias W, 2000, US VIRGIN ISLANDS NA; Tyler EHM, 2009, BIOL CONSERV, V142, P652, DOI 10.1016/j.biocon.2008.11.017; Warner RR, 2002, B MAR SCI, V70, P245; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; [No title captured]	70	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180063	10.1371/journal.pone.0180063	http://dx.doi.org/10.1371/journal.pone.0180063			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704387	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700025
J	Pinsof, D; Haselton, MG				Pinsof, David; Haselton, Martie G.			The effect of the promiscuity stereotype on opposition to gay rights	PLOS ONE			English	Article							MATING STRATEGIES; SEX; RELIGIOSITY; ATTITUDES; MARRIAGE; STATES; ORIENTATION; IDEOLOGY; VALUES	Opposition to gay rights is prevalent in countries around the world. Recent correlational research suggests that opposition to gay rights may be driven by an interaction between one's own short-term mating orientation (i.e. willingness to engage in casual sex) and representations of gay people as sexually promiscuous. Here, we experimentally manipulated representations of gay men by randomly assigning participants to read one of two versions of a fictitious newspaper article, one of which contained faux scientific evidence confirming the stereotype that gay men are promiscuous, and the other containing faux scientific evidence refuting the stereotype. We found that the manipulation interacted with short-term mating orientation (STMO) to predict opposition to gay rights, such that low-STMO individuals (i.e. more averse to casual sex) exhibited more support for gay rights when assigned to read the stereotype-refuting article compared to the stereotype-confirming article, whereas high-STMO individuals (i.e. less averse to casual sex) were not significantly influenced by the manipulation. We discuss the implications of these findings for the study of antigay attitudes, as well as for recent societal changes in acceptance of homosexuality.	[Pinsof, David; Haselton, Martie G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Pinsof, D (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	david.pinsof@gmail.com						Al-Shawaf L, 2015, EVOL HUM BEHAV, V36, P199, DOI 10.1016/j.evolhumbehav.2014.11.003; Apostolou M, 2016, ADAPT HUM BEHAV PHYS, V3, P1; Atunji BO, 2008, J RES PERS, V42, P1364, DOI 10.1016/j.jrp.2008.04.001; Brody S, 1996, J PSYCHOL, V130, P615, DOI 10.1080/00223980.1996.9915035; Brumbaugh SM, 2008, J MARRIAGE FAM, V70, P345, DOI 10.1111/j.1741-3737.2008.00486.x; Cahn Naomi R., 2010, RED FAMILIES BLUE FA; Chambers JR, 2013, PSYCHOL SCI, V24, P140, DOI 10.1177/0956797612447820; Cosmides L., 2006, HEURISTICS LAW, P182; Craig SC, 2005, POLIT RES QUART, V58, P5, DOI 10.1177/106591290505800101; Doherty Carroll, 2015, NEGATIVE VIEWS SUPRE; Francis AM, 2013, ARCH SEX BEHAV, V42, P5, DOI 10.1007/s10508-012-0018-4; Gates G, 2011, MANY PEOPLE ARE LESB; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hayford SR, 2008, SOC FORCES, V86, P1163, DOI 10.1353/sof.0.0000; Hodson G, 2009, EUR J SOC PSYCHOL, V39, P509, DOI 10.1002/ejsp.558; Jackson JJ, 2007, EVOL HUM BEHAV, V28, P382, DOI 10.1016/j.evolhumbehav.2007.04.005; Kurzban R, 2010, P ROY SOC B-BIOL SCI, V277, P3501, DOI 10.1098/rspb.2010.0608; McVeigh R, 2009, AM SOCIOL REV, V74, P891, DOI 10.1177/000312240907400603; Monson RA, 2011, SOCIOL QUART, V52, P244, DOI 10.1111/j.1533-8525.2011.01203.x; Moss JH, 2016, PERS SOC PSYCHOL B, V42, P72, DOI 10.1177/0146167215612744; Pedersen F A, 1991, Hum Nat, V2, P271, DOI 10.1007/BF02692189; Pinsof D, 2016, PSYCHOL SCI, V27, P435, DOI 10.1177/0956797615621719; Price ME, 2014, ARCH SEX BEHAV, V43, P1289, DOI 10.1007/s10508-014-0320-4; Reyna C, 2014, J APPL SOC PSYCHOL, V44, P289, DOI 10.1111/jasp.12226; Rowatt WC, 2003, J SCI STUD RELIG, V42, P455, DOI 10.1111/1468-5906.00194; Smith TW, 2008, 53 GSS NAT OP RES CT; Smith TW, 1994, SEXUALITY LIFE COURS, P63; Stewart N, 2015, JUDGM DECIS MAK, V10, P479; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099; Swift A, 2015, MOST AMERICANS SAY S; Tybur JM, 2015, EVOL HUM BEHAV, V36, P489, DOI 10.1016/j.evolhumbehav.2015.01.006; Weeden J., 2014, HIDDEN AGENDA POLITI, DOI 10.1515/9781400851966; Weeden J, 2003, THESIS; Weeden J, 2008, EVOL HUM BEHAV, V29, P327, DOI 10.1016/j.evolhumbehav.2008.03.004; Weeden J, 2013, EVOL HUM BEHAV, V34, P440, DOI 10.1016/j.evolhumbehav.2013.08.006; Whitley BE, 2009, INT J PSYCHOL RELIG, V19, P21, DOI 10.1080/10508610802471104	37	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0178534	10.1371/journal.pone.0178534	http://dx.doi.org/10.1371/journal.pone.0178534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704375	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700008
J	Staron, R; Lipinski, P; Lenartowicz, M; Bednarz, A; Gajowiak, A; Smuda, E; Krzeptowski, W; Pieszka, M; Korolonek, T; Hamza, I; Swinkels, DW; Van Swelm, RPL; Starzynski, RR				Staron, Robert; Lipinski, Pawel; Lenartowicz, Malgorzata; Bednarz, Aleksandra; Gajowiak, Anna; Smuda, Ewa; Krzeptowski, Wojciech; Pieszka, Marek; Korolonek, Tamara; Hamza, Iqbal; Swinkels, Dorine W.; Van Swelm, Rachel P. L.; Starzynski, Rafal R.			Dietary hemoglobin rescues young piglets from severe iron deficiency anemia: Duodenal expression profile of genes involved in heme iron absorption	PLOS ONE			English	Article							INTESTINAL BRUSH-BORDER; REGULATORY PROTEINS; METABOLISM; TRANSPORTER; IDENTIFICATION; HOMEOSTASIS; RECEPTOR; MICE; SUPPLEMENTATION; FERROPORTIN	Heme is an efficient source of iron in the diet, and heme preparations are used to prevent and cure iron deficiency anemia in humans and animals. However, the molecular mechanisms responsible for heme absorption remain only partially characterized. Here, we employed young iron-deficient piglets as a convenient animal model to determine the efficacy of oral heme iron supplementation and investigate the pathways of heme iron absorption. The use of bovine hemoglobin as a dietary source of heme iron was found to efficiently counteract the development of iron deficiency anemia in piglets, although it did not fully rebalance their iron status. Our results revealed a concerted increase in the expression of genes responsible for apical and basolateral heme transport in the duodenum of piglets fed a heme-enriched diet. In these animals the catalytic activity of heme oxygenase 1 contributed to the release of elemental iron from the protoporphyrin ring of heme within enterocytes, which may then be transported by the strongly expressed ferroportin across the basolateral membrane to the circulation. We hypothesize that the well-recognized high bioavailability of heme iron may depend on a split pathway mediating the transport of heme derived elemental iron and intact heme from the interior of duodenal enterocytes to the bloodstream.	[Staron, Robert; Lipinski, Pawel; Gajowiak, Anna; Smuda, Ewa; Starzynski, Rafal R.] Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland; [Lenartowicz, Malgorzata; Bednarz, Aleksandra; Krzeptowski, Wojciech] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, Krakow, Poland; [Pieszka, Marek] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Krakow, Poland; [Korolonek, Tamara; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Korolonek, Tamara; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Swinkels, Dorine W.; Van Swelm, Rachel P. L.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med LGEM 830, Nijmegen, Netherlands	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University; National Research Institute of Animal Production; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Radboud University Nijmegen	Lipinski, P; Starzynski, RR (corresponding author), Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl; r.starzynski@ighz.pl	van Swelm, Rachel PL/P-6063-2015	, Rafal/0000-0002-7470-0507; Hamza, Iqbal/0000-0003-0045-0610; Bednarz, Aleksandra/0000-0003-2256-2998	National Science Centre [2012/05/E/NZ5/02126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085035] Funding Source: NIH RePORTER	National Science Centre(National Science Centre, Poland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Science Centre, grant no. 2012/05/E/NZ5/02126 (https://ncn.gov.pl/). RRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2005, BIOMETALS, V18, P339, DOI 10.1007/s10534-005-3708-8; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Blachier F, 2007, CAN J PHYSIOL PHARM, V85, P185, DOI 10.1139/Y07-007; BONI RE, 1993, PHARMACOLOGY, V47, P318, DOI 10.1159/000139113; Canonne-Hergaux F, 2000, BLOOD, V96, P3964; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Delaby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042199; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Egeli AK, 1998, ACTA VET SCAND, V39, P381; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Fiorito V, 2015, ANTIOXID REDOX SIGN, V23, P1410, DOI 10.1089/ars.2014.6216; Fiorito V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068146; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gonzalez-Rosendo G, 2010, J FOOD SCI, V75, pH73, DOI 10.1111/j.1750-3841.2010.01523.x; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; GRASBECK R, 1979, SCAND J HAEMATOL, V23, P5; GRASBECK R, 1982, BIOCHIM BIOPHYS ACTA, V700, P137, DOI 10.1016/0167-4838(82)90089-9; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Khan AA, 2013, MOL ASPECTS MED, V34, P669, DOI 10.1016/j.mam.2012.07.013; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Laftah AH, 2009, BRIT J NUTR, V101, P1150, DOI 10.1017/S0007114508066762; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Le Blanc S, 2012, AM J PHYSIOL-CELL PH, V302, pC1780, DOI 10.1152/ajpcell.00080.2012; Lin YW, 2013, J INORG BIOCHEM, V129, P162, DOI 10.1016/j.jinorgbio.2013.07.023; Lipinski P, 2010, AM J PATHOL, V177, P1233, DOI 10.2353/ajpath.2010.091020; Maes D, 2011, VET REC, V168, P188, DOI 10.1136/vr.c7033; Moretti D, 2015, BLOOD, V126, P1981, DOI 10.1182/blood-2015-05-642223; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Quintero-Gutierrez AG, 2008, INT J BIOL SCI, V4, P58; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rincker MJ, 2005, J ANIM SCI, V83, P2137; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Staron R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136695; Starzynski RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064022; Starzynski RR, 2013, BIOCHEM J, V449, P69, DOI 10.1042/BJ20121139; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; Svoboda M., 2005, Folia Veterinaria, V49, P104; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Vinchi F, 2014, GASTROENTEROLOGY, V146, P1325, DOI 10.1053/j.gastro.2014.01.053; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; WALSH R J, 1955, Australas Ann Med, V4, P272; WEINTRAUB LR, 1968, J CLIN INVEST, V47, P531, DOI 10.1172/JCI105749; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; West AR, 2008, J GASTROEN HEPATOL, V23, P150, DOI 10.1111/j.1440-1746.2007.05047.x; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Young MF, 2010, J NUTR, V140, P2162, DOI 10.3945/jn.110.127209	62	30	30	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181117	10.1371/journal.pone.0181117	http://dx.doi.org/10.1371/journal.pone.0181117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704474	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649700092
J	Wu, MC; Xu, X; Chen, SM; Tyan, YS; Chiou, JY; Wang, YH; Lin, LC; Chen, CM; Wei, JCC				Wu, Ming-Chi; Xu, Xun; Chen, Shan-Ming; Tyan, Yeu-Sheng; Chiou, Jeng-Yuan; Wang, Yu-Hsun; Lin, Li-Chi; Chen, Chyong-Mei; Wei, James Cheng-Chung			Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INCREASED RISK; MANIFESTATION; GENDER; COHORT; AGE	Objective To investigate whether Sjogren's syndrome would have an influence on the development of Parkinson's disease. Methods A population-based case-control study was conducted. Participants consisted of 7716 subjects with newly diagnosed Parkinson's disease and a population of 75129 matched control subjects between 2000 and 2010. We measured the risk of Parkinson's disease in association with Sjogren's syndrome by using adjusted odds ratios. Results A total of 143 Parkinson's disease subjects (1.9%) and 893 control subjects (1.2%) suffered from Sjogren's syndrome (p < 0.001). The crude odds ratio for Parkinson's disease among subjects with Sjogren's syndrome was 1.56 (95% CI 1.30- 1.86; p < 0.01). After adjustment for potential confounders which have been proposed that would increase the risk of development of Parkinson's disease, Sjogren's syndrome was found to be significantly associated with the risk of Parkinson's disease with an odds ratio of 1.37 (95% CI 1.15-1.65; p < 0.01). Conclusion This study preliminarily proposed that Sjogren's syndrome was significant associated with an increased risk of Parkinson's disease.	[Wu, Ming-Chi; Chen, Shan-Ming; Tyan, Yeu-Sheng; Wei, James Cheng-Chung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Chi; Xu, Xun; Tyan, Yeu-Sheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Wu, Ming-Chi] Chung Shan Med Univ, Dept Med Informat, Taichung, Taiwan; [Xu, Xun] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Chen, Shan-Ming] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Chiou, Jeng-Yuan] Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan; [Wang, Yu-Hsun] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Li-Chi; Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Li-Chi] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Chen, Chyong-Mei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Chyong-Mei] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Nanjing Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Oklahoma State University System; Oklahoma State University - Stillwater; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University	Wei, JCC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	jccwei@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679				ALEXANDER EL, 1993, RHEUM DIS CLIN N AM, V19, P869; Brocks DR, 1999, J PHARM PHARM SCI, V2, P39; Chambers Mark S, 2004, ORL Head Neck Nurs, V22, P22; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Fabiani G, 2002, MOVEMENT DISORD, V17, P601, DOI 10.1002/mds.10029; Garcia-Carrasco M, 2006, ARCH MED RES, V37, P921, DOI 10.1016/j.arcmed.2006.08.002; Garcia-Moreno JM, 2002, MOVEMENT DISORD, V17, P1329, DOI 10.1002/mds.10288; Hassin-Baer S, 2007, CLIN RHEUMATOL, V26, P743, DOI 10.1007/s10067-006-0398-8; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kchaou M, 2015, CASE REP MED, V2015, P1; Kogure T, 2008, JCR-J CLIN RHEUMATOL, V14, P192, DOI 10.1097/RHU.0B013E318178825f; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Mavragani CP, 2007, CLIN REV ALLERG IMMU, V32, P284, DOI 10.1007/s12016-007-8008-3; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; MIYOSHI Y, 1993, LUPUS, V2, P199, DOI 10.1177/096120339300200314; Mochizuki H, 1997, Rinsho Shinkeigaku, V37, P57; MOLL JWB, 1993, NEUROLOGY, V43, P2574, DOI 10.1212/WNL.43.12.2574; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Rugbjerg K, 2009, NEUROLOGY, V73, P1462, DOI 10.1212/WNL.0b013e3181c06635; Rugbjerg K, 2010, MOVEMENT DISORD, V25, P2355, DOI 10.1002/mds.23274; Shahar E, 1998, PEDIATR NEUROL, V18, P456, DOI 10.1016/S0887-8994(97)00229-4; Sheu JJ, 2013, J AM ACAD DERMATOL, V68, P992, DOI 10.1016/j.jaad.2012.12.961; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van der Hooft CS, 2004, J AM COLL CARDIOL, V44, P2117, DOI 10.1016/j.jacc.2004.08.053; Walker RH, 1999, MOVEMENT DISORD, V14, P262, DOI 10.1002/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6; Wang IK, 2014, NEUROEPIDEMIOLOGY, V42, P204, DOI 10.1159/000358921; Zhang P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/729194	32	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0175836	10.1371/journal.pone.0175836	http://dx.doi.org/10.1371/journal.pone.0175836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704397	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700002
J	Gomez-Gonzalez, S; Paula, S; Cavieres, LA; Pausas, JG				Gomez-Gonzalez, Susana; Paula, Susana; Cavieres, Lohengrin A.; Pausas, Juli G.			Postfire responses of the woody flora of Central Chile: Insights from a germination experiment	PLOS ONE			English	Article							SEED-GERMINATION; EVOLUTIONARY ECOLOGY; FIRE REGIMES; SMOKE; HEAT; LIGNOTUBERS; VEGETATION; EMERGENCE; INVASIONS; DYNAMICS	Fire is a selective agent shaping plant traits and community assembly in fire-prone ecosystems. However, in ecosystems with no fire history, it can be a cause of land degradation when it is suddenly introduced by humans, as plant species may not be able to respond to such novel disturbance. Unlike other Mediterranean-type ecosystems (MTE) of the world, natural fires have not been frequent during the Quaternary in the matorral of Central Chile, and thus, plant adaptive responses are expected to be uncommon. We evaluated the effect of heat shock on seed survival and germination of 21 native woody plants of the Chilean matorral and compiled information on smoke-stimulation and resprouting, to evaluate the importance of fire-adaptive responses in the context of the other MTE. We found that in the Chilean woody flora negative seed responses to fire cues were more frequent than positive responses. Although resprouting is a relatively widespread trait, fire-stimulated germination is not as common in the Chilean matorral as in other MTE. The seeds of seven endemic species were strongly damaged by fire cues and this should be considered in post-fire restoration planning. However, our results also showed that many species were resistant to elevated doses of heat shock and in some, germination was even stimulated. Thus, future research should focus on the evolutionary causes of these responses. These findings could help to develop strategies for fire management in the Chilean matorral. In addition, they will improve our understanding of the evolutionary forces that shaped this plant community and to better frame this region among the other MTE worldwide.	[Gomez-Gonzalez, Susana] Univ Cadiz, IVAGRO, Dept Biol, Puerto Real, Spain; [Gomez-Gonzalez, Susana] Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile; [Paula, Susana] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Cavieres, Lohengrin A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, ECOBIOSIS, Dept Bot, Concepcion, Chile; [Cavieres, Lohengrin A.] IEB, Santiago, Chile; [Pausas, Juli G.] CSIC, Ctr Invest Desertificac CIDE, Valencia, Spain	Universidad de Cadiz; Universidad de Chile; Universidad Austral de Chile; Universidad de Concepcion; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Gomez-Gonzalez, S (corresponding author), Univ Cadiz, IVAGRO, Dept Biol, Puerto Real, Spain.; Gomez-Gonzalez, S (corresponding author), Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile.	susana.gomez@uca.es	Gómez-González, Susana/AAL-2631-2021; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Pausas, Juli/C-5794-2008	Gómez-González, Susana/0000-0002-3779-8701; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Pausas, Juli/0000-0003-3533-5786; Paula, Susana/0000-0001-5405-6155	Comision Nacional de Investigacion Cientifica y Tecnologica (Chile) [CONICYT/FONDECYT-INICIACION 11121264, CONICYT/FONDAP 1511009]	Comision Nacional de Investigacion Cientifica y Tecnologica (Chile)	SGG was funded by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT-INICIACION 11121264 and CONICYT/FONDAP 1511009, Chile); SGG, SP, LAC and JGP were funded by Consejo Superior de Investigaciones Cientificas (ilink0556, Spain); and JGP was funded by Generalitat Valenciana (PROMETEO/2016/021, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua AM, 2016, PALAEOGEOGR PALAEOCL, V459, P76, DOI 10.1016/j.palaeo.2016.06.036; ACEITUNO P, 1988, MON WEATHER REV, V116, P505, DOI 10.1175/1520-0493(1988)116<0505:OTFOTS>2.0.CO;2; Aravena JC, 2003, ECOL STU AN, V160, P343; Armesto J., 2009, FIRE EFFECTS SOILS R, P537; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BROWN NAC, 1993, NEW PHYTOL, V123, P575, DOI 10.1111/j.1469-8137.1993.tb03770.x; BUSTAMANTE RO, 1993, ACTA OECOL, V14, P739; D'Antonio C.M., 2000, INVASIVE SPECIES CHA, P65; Daniau AL, 2007, QUATERNARY SCI REV, V26, P1369, DOI 10.1016/j.quascirev.2007.02.005; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; DUBAR M, 1995, CR ACAD SCI II, V320, P873; Figueroa JA, 2004, REV CHIL HIST NAT, V77, P201; Figueroa JA, 2012, REV CHIL HIST NAT, V85, P101, DOI 10.4067/S0716-078X2012000100008; Figueroa JA, 2009, ACTA OECOL, V35, P335, DOI 10.1016/j.actao.2008.12.004; Fuentes N., 2014, PLANTAS INVASORAS CT; Garcia RA, 2010, REV CHIL HIST NAT, V83, P443; Gomez-Gonzalez S, 2008, FOREST ECOL MANAG, V255, P1510, DOI 10.1016/j.foreco.2007.11.006; Gomez-Gonzalez S, 2017, OPEN SCIENCE FR 0214; Gomez-Gonzalez S., 2008, THESIS; Gomez-Gonzalez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159655; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, GAYANA BOT, V68, P86, DOI 10.4067/S0717-66432011000100007; Gomez-Gonzalez S, 2009, INT J WILDLAND FIRE, V18, P213, DOI 10.1071/WF07074; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hart SC, 2005, FOREST ECOL MANAG, V220, P166, DOI 10.1016/j.foreco.2005.08.012; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; Keeley J. E., 2000, Seeds: the ecology of regeneration in plant communities, P311, DOI 10.1079/9780851994321.0311; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 1998, ECOLOGY, V79, P2320, DOI 10.1890/0012-9658(1998)079[2320:SISGIC]2.0.CO;2; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; KEELEY SC, 1977, AM MIDL NAT, V97, P120, DOI 10.2307/2424690; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; Lamont BB, 2011, PLANT ECOL, V212, P1945, DOI 10.1007/s11258-011-9982-3; Lloret F, 1998, J VEG SCI, V9, P417, DOI 10.2307/3237106; Montenegro G, 2004, REV CHIL HIST NAT, V77, P455, DOI 10.4067/S0716-078X2004000300005; MONTENEGRO G, 1983, CAN J BOT, V61, P1804, DOI 10.1139/b83-189; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Moreira B, 2016, S AFRICAN J BOT; MUNOZ MR, 1989, OIKOS, V56, P177, DOI 10.2307/3565333; Ojeda F, 2010, OECOLOGIA, V163, P729, DOI 10.1007/s00442-009-1550-3; Pauchard A, 2008, BIOL INVASIONS, V10, P547, DOI 10.1007/s10530-007-9151-8; Paula S, 2008, J ECOL, V96, P543, DOI 10.1111/j.1365-2745.2008.01359.x; Paula S, 2016, PLANT ECOL, V217, P661, DOI 10.1007/s11258-015-0538-9; Pausas JG, 2006, J ECOL, V94, P31, DOI 10.1111/j.1365-2745.2005.01092.x; Pausas JG, 2015, FUNCT ECOL, V29, P315, DOI 10.1111/1365-2435.12372; Pausas JG, 2014, NEW PHYTOL, V204, P55, DOI 10.1111/nph.12921; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; PLISCOFF P., 2006, SINOPSIS BIOCLIMATIC; Quintanilla P?rez V., 1998, SERIE GEOGRAFICA, V7, P147; Quintanilla Perez Victor, 1996, Pirineos, V147-148, P97; Segura AM, 1998, PLANT ECOL, V139, P259, DOI 10.1023/A:1009715328868; Taylor KT, 2017, ECOLOGY, V98, P678, DOI 10.1002/ecy.1673; Trabaud L., 1991, Biogeography of mediterranean invasions., P179, DOI 10.1017/CBO9780511525544.017; van Staden Johannes, 2000, Plant Species Biology, V15, P167, DOI 10.1046/j.1442-1984.2000.00037.x; Venier P, 2012, S AFR J BOT, V79, P19, DOI 10.1016/j.sajb.2011.11.005; Villa-Martinez R, 2003, QUATERNARY RES, V60, P284, DOI 10.1016/j.yqres.2003.07.007; WICKLOW DT, 1988, P ROY SOC EDINB B, V94, P87, DOI 10.1017/S0269727000007168; Williams R. J., 2003, FIRE TROPICAL SAVANN; Zouhar K, 2008, RMRSGTR42 DEP AGR FO, V6; Zuloaga FO., 2008, MONOGR SYST BOT MISS, V107, P136; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1111/J.1472-4642.2010.00728.X	69	17	20	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180661	10.1371/journal.pone.0180661	http://dx.doi.org/10.1371/journal.pone.0180661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704449	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600040
J	Tangri, N; Ferguson, TW; Whitlock, RH; Rigatto, C; Jassal, DS; Kass, M; Toleva, O; Komenda, P				Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Jassal, Davinder S.; Kass, Malek; Toleva, Olga; Komenda, Paul			Long term health outcomes in patients with a history of myocardial infarction: A population based cohort study	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; POSTMYOCARDIAL INFARCTION; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; CORONARY; RISK; GUIDELINE; DISEASE; METAANALYSIS; OUTPATIENTS	Background Myocardial infarction (MI) is associated with high morbidity and mortality, particularly in the first 12 months post-event. Interventions such as dual antiplatelet therapy can reduce the risk of major adverse cardiovascular events (MACE), but the duration of the high-risk time interval and the optimal prescription time frame for these interventions remains unknown. Design, setting, participants, and measurements We performed a retrospective cohort study using data from medical services and hospitalizations in Manitoba, Canada for patients admitted with a MI between April 2006 and March 2010, and followed until Nov 30, 2014. We used survival analysis to determine the cumulative incidence of death, subsequent MI, or stroke, and used Cox proportional hazards models to assess factors associated with these endpoints. Results There were 8,493 patients in Manitoba admitted to hospital for a MI during the study period. Of those, 6,749 (79.5%) survived for at least 1 year without a recurrent MI or stroke. In the following year, this population remained at high risk, with 372 (5.5%) of the remaining patients dying in the next twelve months (48.1% cardiovascular deaths), 244 (3.6%) having a recurrent MI, and 74 (1.1%) having a stroke. Older age, male sex, diabetes, prior stroke, prior heart failure, prior unstable angina, and absence of revascularization were associated with worse long-term prognosis. Conclusions The risk of MACE remains elevated among post-MI patients after the first year. Interventions to more intensively monitor, evaluate, and treat these patients should be considered beyond the first year following myocardial infarction.	[Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Jassal, Davinder S.; Kass, Malek; Toleva, Olga; Komenda, Paul] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Komenda, Paul] Univ Manitoba, Seven Oaks Hosp Chron Dis Innovat Ctr, Winnipeg, MB, Canada; [Jassal, Davinder S.; Kass, Malek; Toleva, Olga] St Boniface Gen Hosp, Dept Cardiac Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Tangri, N (corresponding author), Univ Manitoba, Dept Med, Winnipeg, MB, Canada.; Tangri, N (corresponding author), Univ Manitoba, Seven Oaks Hosp Chron Dis Innovat Ctr, Winnipeg, MB, Canada.	ntangri@sogh.mb.ca		Jassal, Davinder/0000-0002-3639-9047				Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Rapsomaniki E, 2014, EUR HEART J, V35, P844, DOI 10.1093/eurheartj/eht533; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Yang E, 2016, CARDIOVASC THER; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003	17	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180010	10.1371/journal.pone.0180010	http://dx.doi.org/10.1371/journal.pone.0180010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700669	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600013
J	Cho, JH				Cho, Jun Ho			The association between electronic-cigarette use and self-reported oral symptoms including cracked or broken teeth and tongue and/or inside-cheek pain among adolescents: A cross-sectional study	PLOS ONE			English	Article							NICOTINE DELIVERY; SMOKING; NICKEL; HEALTH; CANCER; AREAS	Background Little is known about oral health related to electronic-cigarette (EC) use, even though EC use is increasing rapidly. The aim of this study is to assess the relationship between EC use and oral health, including 'gingival pain and/or bleeding', 'tongue and/or inside-cheek pain', and 'cracked or broken teeth' among adolescents. Methods A total of 65,528 students in 2016 were included in this cross-sectional study. Results For EC use, 0.5% (n = 297) students were daily users, 1.9% (n = 1259) were '1 to 29 days past month users', and 5.9% (n = 3848) were former users. Overall, 18.5% students reported they had experienced 'gingival pain and/or bleeding', 11.0% reported 'tongue and/or inside-cheek pain', and 11.4% reported a 'cracked or broken tooth' within the past 12 months. When comparing 'daily EC users', '1 to 29 days past month EC users', and 'former EC users' with 'never EC users', the adjusted ORs for 'cracked or broken tooth' were 1.65 (95% CI: 1.19-2.27), 1.26 (95% CI: 1.06-1.51), and 1.16 (95% CI: 1.04-1.30), respectively. Comparing 'daily EC users' with ` never EC users', the adjusted OR for 'tongue and/or inside-cheek pain' was 1.54 (1.05-2.26). However, EC use among adolescents was not associated with 'gingival pain and/or bleeding' when adjusted for the potential confounders. Conclusions Based on the results, the odds of cracked or broken teeth among daily, '1 to 29 days past month', and former EC users were significantly higher than those among never EC users. The odds of tongue and/or inside-cheek pain among daily EC users were significantly higher than those among never EC users. In conclusion, the results suggest that daily EC use among adolescents may be a risk factor for cracked or broken teeth and tongue and/or inside-cheek pain.	[Cho, Jun Ho] Hanyang Womens Univ, Dept Publ Hlth Adm, Seoul, South Korea		Cho, JH (corresponding author), Hanyang Womens Univ, Dept Publ Hlth Adm, Seoul, South Korea.	cjhjunho@hanmail.net		CHO, JUN HO/0000-0002-6936-9055	2016-2nd semester Hanyang Women's University Research Fund [2016-2-034]	2016-2nd semester Hanyang Women's University Research Fund	The study was supported by the 2016-2nd semester Hanyang Women's University Research Fund (2016-2-034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avezov K, 2014, TOXICOL IN VITRO, V28, P485, DOI 10.1016/j.tiv.2014.01.004; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Cho JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151022; Cooper Maria, 2016, Tob Regul Sci, V2, P278; Dawkins LE, 2016, PSYCHOPHARMACOLOGY, V233, P2933, DOI 10.1007/s00213-016-4338-2; Do D, 2013, BIOMATERIALS, V34, P8650, DOI 10.1016/j.biomaterials.2013.07.090; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084; Giroud C, 2015, INT J ENV RES PUB HE, V12, P9988, DOI 10.3390/ijerph120809988; Goniewicz ML, 2014, J ADOLESCENT HEALTH, V55, P713, DOI 10.1016/j.jadohealth.2014.07.015; Huang LL, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150564; Huang RJ, 2012, EUR J ORAL SCI, V120, P319, DOI 10.1111/j.1600-0722.2012.00971.x; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Javed F, 2017, ORAL DIS; Ji EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154447; Jin LJ, 2016, ORAL DIS, V22, P609, DOI 10.1111/odi.12428; Kahler B, 2003, J BIOMECH, V36, P229, DOI 10.1016/S0021-9290(02)00327-5; Khlystov A, 2016, ENVIRON SCI TECHNOL, V50, P13080, DOI 10.1021/acs.est.6b05145; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; Korea Centers for Disease Control and Prevention, STAT AD HLTH REL BEH; Krause MJ, 2015, WASTE MANAGE, V39, P57, DOI 10.1016/j.wasman.2015.02.005; Lee CP, 2016, J CANCER, V7, P1724, DOI 10.7150/jca.15441; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee Sungkyu, 2011, J Prev Med Public Health, V44, P235, DOI 10.3961/jpmph.2011.44.6.235; Lopez AA, 2016, NICOTINE TOB RES, V18, P720, DOI 10.1093/ntr/ntv182; Maida CA, 2015, QUAL LIFE RES, V24, P2739, DOI 10.1007/s11136-015-1015-6; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; Manuela R, 2015, LIFE SCI, V135, P49, DOI 10.1016/j.lfs.2015.04.027; Meo SA, 2014, EUR REV MED PHARMACO, V18, P3315; Miech R, 2016, TOB CONTROL; Moran-Martinez J, 2013, GENET MOL RES, V12, P3178, DOI 10.4238/2013.August.29.1; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Ogunwale MA, 2017, ACS OMEGA, V2, P1207, DOI 10.1021/acsomega.6b00489; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; PERCIVAL RS, 1994, J DENT RES, V73, P1416, DOI 10.1177/00220345940730080401; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Soares TR, 2016, DENT TRAUMATOL; Su CC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-67; Sundar IK, 2016, ONCOTARGET, V7, P77196, DOI 10.18632/oncotarget.12857; The Network for Public Health Law, IMPR OR HLTH CAR ACA; Tomar SL, 2015, J AM DENT ASSOC, V146, P651, DOI 10.1016/j.adaj.2015.07.002; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; U.S. Department of Health and Human Services, 2014, REP SURG GEN; Varlet V, 2015, INT J ENV RES PUB HE, V12, P4796, DOI 10.3390/ijerph120504796; Vasiliou A, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0284-y; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Yahyazadehfar M, 2014, APPL MECH REV, V66, DOI 10.1115/1.4027431; Yanagita M, 2008, J ENDODONT, V34, P1061, DOI 10.1016/j.joen.2008.06.005; Yu V, 2016, ORAL ONCOL, V52, P58, DOI 10.1016/j.oraloncology.2015.10.018	53	27	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180506	10.1371/journal.pone.0180506	http://dx.doi.org/10.1371/journal.pone.0180506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700729	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400014
J	Teodoro, GR; Gontijo, AVL; Borges, AC; Tanaka, MH; Lima, GDG; Salvador, MJ; Koga-Ito, CY				Teodoro, Guilherme Rodrigues; Lacerda Gontijo, Aline Vidal; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Salvador, Marcos Jose; Koga-Ito, Cristiane Yumi			Gallicacid/hydroxypropyl-beta-cyclodextrin complex: Improving solubility for application on in vitro/in vivo Candida albicans biofilms	PLOS ONE			English	Article							GALLIC ACID; ANTIFUNGAL ACTIVITY; INCLUSION COMPLEX; ORAL CANDIDIASIS; GROWTH; MODEL; FORMULATIONS; ANTIOXIDANT; INFECTION; EXTRACTS	The aim of this study was to increase the solubility of gallic acid (GA) for the treatment of Candida albicans biofilm, which is very difficult to treat and requires high drug concentrations. Cyclodextrins (CDs) were used for this purpose. Complexes were evaluated by phase-solubility studies, prepared by spray drying and characterized by drug loading, scanning electron microscopy (SEM) and differential scanning calorimetry (DSC). The complexes were tested on C. albicans biofilm using in vitro and in vivo models. HP beta CD formed soluble inclusion complexes with GA. The percentage of GA in GA/HP beta CD was 10.8 +/- 0.01%. The SEM and DSC analyses confirmed the formation of inclusion complexes. GA/HP beta CD maintained the antimicrobial activity of the pure GA. GA/HP beta CD was effective on C. albicans biofilms of 24 and 48h. The in vivo results showed an anti-inflammatory activity of GA/HP beta CD with no difference in invading hypha counting among the groups. This study encourages the development of new antifungal agents.	[Teodoro, Guilherme Rodrigues; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Oral Biopathol Grad Program, Sao Jose Dos Campos, SP, Brazil; [Lacerda Gontijo, Aline Vidal; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Dept Environm Engn, Sao Jose Dos Campos, SP, Brazil; [Lacerda Gontijo, Aline Vidal; Salvador, Marcos Jose] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Koga-Ito, CY (corresponding author), Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Oral Biopathol Grad Program, Sao Jose Dos Campos, SP, Brazil.; Koga-Ito, CY (corresponding author), Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Dept Environm Engn, Sao Jose Dos Campos, SP, Brazil.	cristiane@ict.unesp.br	Salvador, Marcos/V-3129-2019; Tanaka, Marcia Hiromi/J-7804-2012; Koga-Ito, Cristiane/ABC-6537-2020; Koga-Ito, Cristiane Y/D-7999-2012; Borges, Aline/AAH-7429-2021; Lima, Gabriela M G/I-5491-2012; Gontijo, Aline/G-9909-2013	Salvador, Marcos/0000-0002-3839-5445; Tanaka, Marcia Hiromi/0000-0002-6594-2301; Koga-Ito, Cristiane Y/0000-0002-2416-2173; Gontijo, Aline/0000-0002-4122-7610	Sao Paulo Research Foundation (FAPESP) [2013/00037-1]; GR Teodoro [2012/16805-5]; AVL Gontijo [2014/09666-4]; AC Borges [2014/02354-7]; MH Tanaka [2014/13469-0]; GMG Lima [2015/03470-3]; FAPESP	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); GR Teodoro; AVL Gontijo; AC Borges; MH Tanaka; GMG Lima; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grant #2013/00037-1, Sao Paulo Research Foundation (FAPESP). GR Teodoro (#2012/16805-5), AVL Gontijo (#2014/09666-4), AC Borges, (#2014/02354-7), MH Tanaka (#2014/13469-0) and GMG Lima (#2015/03470-3) are supported by FAPESP. The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the article for publication.	Alnuaimi AD, 2013, FEMS YEAST RES, V13, P689, DOI 10.1111/1567-1364.12068; Alves CT, 2014, FUTURE MICROBIOL, V9, P139, DOI 10.2217/fmb.13.147; Aytac Z, 2016, MAT SCI ENG C-MATER, V63, P231, DOI 10.1016/j.msec.2016.02.063; Boniface PK, 2016, J ETHNOPHARMACOLOGY; Bouzidi A, 2016, PAK J PHARM SCI, V29, P1299; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Cheng L, 2011, CARIES RES, V45, P87, DOI 10.1159/000324084; Crastechini E, 2009, 21 C IN CIENT UNESP; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Ge X, 2012, CARBOHYD POLYM, V89, P208, DOI 10.1016/j.carbpol.2012.02.072; Girardot M, 2016, FUTURE MICROBIOL, V11, P69, DOI 10.2217/fmb.15.118; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Jug M, 2011, J PHARMACEUT BIOMED, V54, P1030, DOI 10.1016/j.jpba.2010.12.009; Junqueira JC, 2005, MICROBIOL IMMUNOL, V49, P199, DOI 10.1111/j.1348-0421.2005.tb03721.x; Loftsson T, 2005, INT J PHARMACEUT, V302, P18, DOI 10.1016/j.ijpharm.2005.05.042; Loftsson T, 2007, J INCL PHENOM MACRO, V57, P545, DOI 10.1007/s10847-006-9247-2; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Lyu X, 2016, DRUG DES DEV THER, V10, P1161, DOI 10.2147/DDDT.S100795; Macaev F, 2013, CURR TOP MED CHEM, V13, P2677, DOI 10.2174/15680266113136660194; Vila TVM, 2015, ANTIMICROB AGENTS CH, V59, P7611, DOI 10.1128/AAC.01890-15; National Committee for Clinical Laboratory Standards, 2008, M27A3 NCCLS; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Okada M, 2013, ARCH ORAL BIOL, V58, P444, DOI 10.1016/j.archoralbio.2012.09.014; Olga G, 2015, FOOD CHEM, V185, P33, DOI 10.1016/j.foodchem.2015.03.058; Petronilho S, 2012, IND CROP PROD, V40, P1, DOI 10.1016/j.indcrop.2012.02.041; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rosales P, 2012, PLOS ONE, V7; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Spampinato C., 2013, BIOMED RES INT, V2013; Srinivas K, 2010, J CHEM ENG DATA, V55, P3101, DOI 10.1021/je901097n; Tang PX, 2016, CARBOHYD POLYM, V142, P16, DOI 10.1016/j.carbpol.2016.01.042; Teodoro GR, 2015, FUTURE MICROBIOL, V10, P917, DOI [10.2217/FMB.15.20, 10.2217/fmb.15.20]; Tewes F, 2008, J CONTROL RELEASE, V129, P93, DOI 10.1016/j.jconrel.2008.04.007; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Veiga MD, 2005, J INCL PHENOM MACRO, V53, P77, DOI 10.1007/s10847-005-1047-6; Veiga MD, 2002, J THERM ANAL CALORIM, V68, P511, DOI 10.1023/A:1016091803317; Williams DW, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22434; Yao YS, 2014, CARBOHYD POLYM, V110, P329, DOI 10.1016/j.carbpol.2014.04.006	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181199	10.1371/journal.pone.0181199	http://dx.doi.org/10.1371/journal.pone.0181199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700692	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649400038
J	McDonnell, C; Leanez, S; Pol, O				McDonnell, Christina; Leanez, Sergi; Pol, Olga			The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice	PLOS ONE			English	Article							MEDIATES MECHANICAL ALLODYNIA; IMPROVES INSULIN SENSITIVITY; SPINAL NITRIC-OXIDE; HEME OXYGENASE 1; NEUROPATHIC PAIN; MOUSE MODEL; KEAP1-NRF2 SYSTEM; RATS; ACTIVATION; MELLITUS	The involvement of heme oxygenase 1 (HO-1) in the modulation of the antinociceptive effects of opioids in type 1 diabetes has been demonstrated but the role played by the transcription factor Nrf2 in the regulation of painful neuropathy and in the effects and expression of d-opioid receptors (DOR) in type 2 diabetes, has not been studied. In male BKS. Cg-m+/+Leprdb/J (db/db) mice, the anti-allodynic effects produced by a Nrf2 transcription factor activator, sulforaphane (SFN) administered alone and combined with two DOR agonists, [dPen( 2), d-Pen(5)]-Enkephalin (DPDPE) and (+)-4-[(aR)-a-((2S, 5R)-4-Allyl-2,5-dimethyl-1piperazinyl)-3-methoxybenzyl]-N, N diethylbenzamide (SNC-80), were evaluated. The effects of SFN on glucose levels and body weight as well as on the proteins levels of Nrf2, HO-1, NAD(P) H: quinone oxidoreductase 1 (NQO1), MAPKs (JNK) and DOR in sciatic nerve from db/db mice were also assessed. This study showed that the administration of SFN dose dependently reversed mechanical allodynia, reduced hyperglycemia and body weight gain associated to type 2 diabetes and significantly increased the anti-allodynic effects of DPDPE and SNC-80 in db/db mice. This treatment normalized the down regulation of Nrf2 and NQO1 and enhanced the protein levels of HO-1 in db/db mice. Moreover, the administration of SFN also inhibited the JNK phosphorylation and DOR down-regulation in the sciatic nerve of diabetic mice. Our data indicated that SFN treatment is effective in reversing mechanical allodynia and enhancing DOR antinociceptive effects in db/db mice which effects might be mediated by activating Nrf2 signaling, reducing hyperglycemia, inhibiting JNK phosphorylation and avoiding DOR down-regulation in the sciatic nerve of these animals. These results propose SFN, alone and/or combined with DOR agonists, as interesting approaches for the treatment of painful diabetic neuropathy associated to type 2 diabetes in mice.	[McDonnell, Christina; Leanez, Sergi; Pol, Olga] Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, Barcelona, Spain; [McDonnell, Christina; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain	Autonomous University of Barcelona	Pol, O (corresponding author), Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, Barcelona, Spain.; Pol, O (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain.	opol@santpau.es	Pol, Olga/O-2146-2019	Pol, Olga/0000-0002-4621-8457	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER); Union Europea [PI1400927]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER); Union Europea	This work was supported by Ministerio de Economia y Competitividad, Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Union Europea [Grant: PI1400927]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine T, 2015, J PHARMACOL EXP THER, V354, P65, DOI 10.1124/jpet.115.223891; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Carcole M, 2014, J PHARMACOL EXP THER, V351, P224, DOI 10.1124/jpet.114.215681; Castany S, 2016, NEUROSCI LETT, V614, P49, DOI 10.1016/j.neulet.2015.12.059; Castany S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146427; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2003, ANESTHESIOLOGY, V98, P217, DOI 10.1097/00000542-200301000-00033; Cheng HT, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-28; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Courteix C, 1998, J PHARMACOL EXP THER, V285, P63; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Gou G, 2014, EUR J PHARMACOL, V737, P41, DOI 10.1016/j.ejphar.2014.05.004; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; KAMEI J, 1992, BRAIN RES, V571, P199, DOI 10.1016/0006-8993(92)90655-S; Khan GM, 2002, J PHARMACOL EXP THER, V303, P1021, DOI 10.1124/jpet.102.040865; Kiguchi N, 2017, BBA-MOL BASIS DIS, V1863, P274, DOI 10.1016/j.bbadis.2016.10.007; Kong Q, 2012, NEURAL REGEN RES, V7, P2305, DOI 10.3969/j.issn.1673-5374.2012.29.010; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Li M, 2007, CELL CYCLE, V6, P567, DOI 10.4161/cc.6.5.3917; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; Ndisang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087936; Negi G, 2011, CURR NEUROVASC RES, V8, P294, DOI 10.2174/156720211798120972; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohsawa M, 2000, EUR J PHARMACOL, V401, P55, DOI 10.1016/S0014-2999(00)00408-8; Patrick BA, 2012, FREE RADICAL BIO MED, V53, P1886, DOI 10.1016/j.freeradbiomed.2012.08.584; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Saito T, 2015, ANESTHESIOLOGY, V123, P1420, DOI 10.1097/ALN.0000000000000892; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Shen Y, 2015, NEUROBIOL DIS, V79, P100, DOI 10.1016/j.nbd.2015.04.012; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Tian RF, 2016, EUR J PHARMACOL, V771, P84, DOI 10.1016/j.ejphar.2015.12.021; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Xu X, 2014, NEUROSCI BULL, V30, P53, DOI 10.1007/s12264-013-1387-y; Yeo SH, 2013, TOXICOL LETT, V219, P35, DOI 10.1016/j.toxlet.2013.02.013; Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005; Zhou JY, 2014, MOL NEUROBIOL, V49, P536, DOI 10.1007/s12035-013-8537-0	42	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180998	10.1371/journal.pone.0180998	http://dx.doi.org/10.1371/journal.pone.0180998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700700	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800111
J	Peng, XY; Jiang, LP; Chen, C; Qin, Y; Yuan, T; Wang, O; Xing, XP; Li, XM; Nie, M; Chen, LM				Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Yuan, Tao; Wang, Ou; Xing, Xiaoping; Li, Xuemei; Nie, Min; Chen, Limeng			Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome	PLOS ONE			English	Article							CYCLOOXYGENASE-2; PATHOPHYSIOLOGY; INHIBITION; PHENOTYPE	Background Gitelman syndrome (GS), an inherited autosomal recessive salt-losing renal tubulopathy caused by mutations in SLC12A3 gene, has been associated with normal prostaglandin E2 (PGE2) levels since 1995 by a study involving 11 clinically diagnosed patients. However, it is difficult to explain why cyclooxygenase-2 (COX2) inhibitors, which pharmacologically reduce PGE2 synthesis, are helpful to patients with GS, and few studies performed in the last 20 years have measured PGE2 levels. The relationships between the clinical manifestations and PGE2 levels were never thoroughly analyzed. Methods This study involved 39 GS patients diagnosed by SLC12A3 gene sequencing. Plasma and 24-h urine samples as well as the clinical data were collected at admission. PGE2 and PGEM levels were detected in plasma and urine samples by enzyme immunoassays. The in vivo function of the sodium-chloride co-transporter (NCC) in GS patients was evaluated using a modified thiazide test. The association among PGE2 levels, clinical manifestations and the function of NCC in GS patients were analyzed. Results Significantly higher levels of urinary and plasma PGEM were observed in GS patients than in the healthy volunteers. Higher urinary PGEM levels indicated more severe clinical manifestations and NCC dysfunction estimated by the increase of Cl- clearance. A higher PGEM level was found in male GS patients, who showed earlier onset age and more severe hypokalemia, hypochloremia and metabolic alkalosis than female GS patients. No relationship between renin angiotensin aldosterone system activation and PGEM level was observed. Conclusions Higher urinary PGEM levels indicated more severe clinical manifestations and NCC dysfunction in GS patients. COX2 inhibition might be a potential therapeutic target in GS patients with elevated PGEM levels.	[Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Li, Xuemei; Chen, Limeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China; [Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Yuan, Tao; Wang, Ou; Xing, Xiaoping; Li, Xuemei; Nie, Min; Chen, Limeng] Peking Union Med Coll, Beijing, Peoples R China; [Chen, Chen] Cent South Univ, Xiangya Hosp, Dept Pediat, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Yuan, Tao; Wang, Ou; Xing, Xiaoping; Nie, Min] Chinese Acad Med Sci, Peking Union Med Coll, Natl Hlth & Family Planning Commiss, Dept Endocrinol, Beijing, Peoples R China; [Yuan, Tao; Wang, Ou; Xing, Xiaoping; Nie, Min] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Key Lab Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, LM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China.; Chen, LM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	chenlimeng@pumch.cn			Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2016-I2M-2-004]; Xiehe Scholar Professor grant of Peking Union Medical College; National Natural Scientific Foundation, China [81470937, 81641024]; Capital Specialized Clinical Application Project [Z121107001012139]	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; Xiehe Scholar Professor grant of Peking Union Medical College; National Natural Scientific Foundation, China(National Natural Science Foundation of China (NSFC)); Capital Specialized Clinical Application Project	This work was partly supported by (1) Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-2-004 to CL), URL: http://english.cams.cn/index.html; (2) Xiehe Scholar Professor grant of Peking Union Medical College (to CL), URL: http://english.cams.cn/index.html; (3) National Natural Scientific Foundation, China (81470937, 81641024 to CL), URL: http://www.nsfc.gov.cn/publish/portal1/; (4) the Capital Specialized Clinical Application Project (Z121107001012139 to CL), URL: http://www.bjkw.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Shibli Amar, 2015, World J Methodol, V5, P55, DOI 10.5662/wjm.v5.i2.55; Arai Y, 2014, INFLAMM BOWEL DIS, V20, P1208, DOI 10.1097/MIB.0000000000000062; Blanchard A, 2017, KIDNEY INT, V91, P24, DOI 10.1016/j.kint.2016.09.046; Blanchard A, 2015, J AM SOC NEPHROL, V26, P468, DOI 10.1681/ASN.2014030293; Deschenes G, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/396209; DUNN MJ, 1981, KIDNEY INT, V19, P86, DOI 10.1038/ki.1981.12; Grill A, 2016, ACTA PHYSL; Jeck N, 2005, AM J PHYSIOL-REG I, V288, pR782, DOI 10.1152/ajpregu.00600.2004; Jiang LP, 2015, ENDOCR PRACT, V21, P1017, DOI 10.4158/EP14432.OR; Jiang LP, 2014, AM J NEPHROL, V39, P357, DOI 10.1159/000360773; Kammerl MC, 2001, KIDNEY INT, V60, P1684, DOI 10.1046/j.1523-1755.2001.00988.x; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Komhoff M, 2004, PEDIATR RES, V55, P261, DOI 10.1203/01.PDR.0000101747.09626.6B; Larkins N, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu029; Lauridsen TG, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-28; Liaw LCT, 1999, ARCH DIS CHILD, V81, P508, DOI 10.1136/adc.81.6.508; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; LUTHY C, 1995, AM J KIDNEY DIS, V25, P824, DOI 10.1016/0272-6386(95)90563-4; Martin-Miguel V, 2014, Semergen, V40, pe95, DOI 10.1016/j.semerg.2013.03.003; Nasrallah R, 2015, LAB INVEST, V95, P1044, DOI 10.1038/labinvest.2015.79; NIVET H, 1978, LANCET, V1, P333; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Onem Y, 2008, RENAL FAILURE, V30, P691, DOI 10.1080/08860220802212718; Peng Xiao-yan, 2016, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V38, P275, DOI 10.3881/j.issn.1000-503X.2016.03.006; Peters M, 2002, AM J MED, V112, P183, DOI 10.1016/S0002-9343(01)01086-5; Peti-Peterdi J, 2013, PFLUG ARCH EUR J PHY, V465, P53, DOI 10.1007/s00424-012-1130-y; Qu Ling, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P432; Seyberth HW, 2016, PEDIATR NEPHROL, V31, P407, DOI 10.1007/s00467-015-3143-1; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Seys E, 2017, J AM SOC NEPHROL; Soleimani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159804; Tseng MH, 2012, J CLIN ENDOCR METAB, V97, pE1478, DOI 10.1210/jc.2012-1707; Tuhta GA, 2010, J NEPHROL, V23, P617; Wang F, 2016, CLIN EXP NEPHROL; Yang Guo-qing, 2006, Zhonghua Nei Ke Za Zhi, V45, P650; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118004	36	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180811	10.1371/journal.pone.0180811	http://dx.doi.org/10.1371/journal.pone.0180811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700713	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800081
J	Hormaechea-Agulla, D; Jimenez-Vacas, JM; Gomez-Gomez, E; Lopez, FL; Carrasco-Valiente, J; Valero-Rosa, J; Moreno, MM; Sanchez-Sanchez, R; Ortega-Salas, R; Gracia-Navarro, F; Culler, MD; Ibanez-Costa, A; Gahete, MD; Requena, MJ; Castano, JP; Luque, RM				Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Culler, Michael D.; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.			The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer	FASEB JOURNAL			English	Article						splicing; biomarker; aggressiveness; metastasis; xenograft models	GROWTH-FACTOR-I; ANALOG LANREOTIDE; SUBTYPE 5; CELL-GROWTH; PATHWAY; NEUROENDOCRINE; INCREASES; PROTEIN; AGGRESSIVENESS; IDENTIFICATION	sst5TMD4, a splice variant of the sst5 gene, is overexpressed and associated with aggressiveness in various endocrine-related tumors, but its presence, functional role, and mechanisms of actions in prostate cancer (PCa)the most common cancer type in malesis completely unexplored. In this study, formalin-fixed, paraffin-embedded prostate pieces from patients with localized PCa, which included tumoral and nontumoral adjacent regions (n = 45), fresh biopsies from patients with high-risk PCa (n = 52), and healthy fresh prostates from cystoprostatectomies (n = 14) were examined. In addition, PCa cell lines and xenograft models were used to determine the presence and functional role of sst5TMD4. Results demonstrated that sst5TMD4 is overexpressed (mRNA/protein) in PCa samples, and this is especially drastic in metastatic and/or high Gleason score tumor samples. Remarkably, sst5TMD4 expression was associated with an altered frequency of 2 single-nucleotide polymorphisms: rs197055 and rs12599155. In addition, PCa cell lines and xenograft models were used to demonstrate that sst5TMD4 overexpression increases cell proliferation and migration in PCa cells and induces larger tumors in nude mice, whereas its silencing decreased proliferation and migration. Remarkably, sst5TMD4 overexpression activated multiple intracellular pathways (ERK/JNK, MYC/MAX, WNT, retinoblastoma), altered oncogenes and tumor suppressor gene expression, and disrupted the normal response to somatostatin analogs in PCa cells. Altogether, we demonstrate that sst5TMD4 is overexpressed in PCa, especially in those patients with a worse prognosis, and plays an important pathophysiologic role in PCa, which suggesting its potential as a biomarker and/or therapeutic target.	[Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.] Hosp Univ Reina Sofia, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Campus Excelencia Int Agroalimentario CEIA3, Cordoba, Spain; [Gomez-Gomez, Enrique; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Requena, Maria J.] Hosp Univ Reina Sofia, Urol Serv, IMIBIC, Cordoba, Spain; [Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa] Hosp Univ Reina Sofia, Serv Anat Pathol, Cordoba, Spain; [Culler, Michael D.] Ipsen Biosci, Cambridge, MA USA	Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Castano, JP; Luque, RM (corresponding author), Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba, Edificio Maimonides Inst Biomed Res Cordoba, Cordoba 14004, Spain.	justo@uco.es; raul.luque@uco.es	Gahete, Manuel D./C-4969-2009; Raul, Luque Huertas/M-6948-2018; Ibáñez-Costa, Alejandro/L-5323-2013; Gomez, Enrique Gomez/ABI-6063-2020; Castaño, Justo P/A-7124-2010	Gahete, Manuel D./0000-0002-4578-2179; Ibáñez-Costa, Alejandro/0000-0003-4649-0095; Castaño, Justo P/0000-0002-3145-7287; Carrasco Valiente, Julia/0000-0002-3974-3990; Gracia Navarro, Francisco/0000-0003-2128-4228; Culler, Michael D./0000-0001-5168-8739; Jimenez-Vacas, Juan/0000-0003-4391-3726; Moreno, Maria M/0000-0001-6846-8601; Luque, Raul M./0000-0002-7585-1913; Lopez, Fernando/0000-0002-0534-2304; Sanchez-Sanchez, Rafael/0000-0002-9821-0211; Gomez Gomez, Enrique/0000-0002-8753-3306	Instituto de Salud Carlos III; European Union [ERDF/ESF] [PI13-00651, PI16/00264]; Rio Hortega Grant [CM16/00180]; Miguel Servet Grant [CP15/00156]; MINECO [BFU2016-80360-R]; Junta de Andalucia [BIO-0139, CTS-1406, PI-0541-2013]; CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III; Ministerio de Sanidad, Servicios Sociales e Igualdad	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union [ERDF/ESF]; Rio Hortega Grant; Miguel Servet Grant; MINECO(Spanish Government); Junta de Andalucia(Junta de Andalucia); CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III; Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government)	This study was supported by Instituto de Salud Carlos III, cofunded by the European Union [ERDF/ESF, Investing in your future; PI13-00651 and PI16/00264 to R.M.L., Rio Hortega Grant (CM16/00180) to E.G.-G., Miguel Servet Grant (CP15/00156) to M.D.G.], MINECO (BFU2016-80360-R; to J.P.C.), Junta de Andalucia (BIO-0139, CTS-1406, PI-0541-2013; to R.M.L., J.P.C., and M.D.G.), and CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad. The authors declare no conflicts of interest.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Berruti A, 2001, PROSTATE, V47, P205, DOI 10.1002/pros.1064; Cakir M, 2010, J CELL MOL MED, V14, P2570, DOI 10.1111/j.1582-4934.2010.01125.x; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; D'Angelillo RM, 2014, TUMORI, V100, P249, DOI 10.1700/1578.17192; Duran-Prado M, 2012, ONCOGENE, V31, P2049, DOI 10.1038/onc.2011.389; Duran-Prado M, 2010, J CLIN ENDOCR METAB, V95, P2497, DOI 10.1210/jc.2009-2247; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Fotouhi O, 2016, J CLIN ENDOCR METAB, V101, P3616, DOI 10.1210/jc.2016-2028; Friedlander TW, 2012, UROL ONCOL-SEMIN ORI, V30, P408, DOI 10.1016/j.urolonc.2010.06.014; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ibanez-Costa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08714; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Ladomery Michael, 2013, Int J Cell Biol, V2013, P463786, DOI 10.1155/2013/463786; Lapierre M, 2014, J CLIN INVEST, V124, P1899, DOI 10.1172/JCI65178; Lo Nigro C, 2008, BJU INT, V102, P622, DOI 10.1111/j.1464-410X.2008.07706.x; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Luque RM, 2015, CANCER LETT, V359, P299, DOI 10.1016/j.canlet.2015.01.037; Martin-Rodriguez JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16298; MAULARD C, 1995, CANCER CHEMOTH PHARM, V36, P259; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mole D, 2015, ENDOCRINE, V50, P442, DOI 10.1007/s12020-015-0594-x; Ogata A, 1997, J IMMUNOL, V159, P2212; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Puig-Domingo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085527; Rai U, 2015, PHARMACOL THERAPEUT, V152, P98, DOI 10.1016/j.pharmthera.2015.05.007; Rajan P, 2009, NAT REV UROL, V6, P454, DOI 10.1038/nrurol.2009.125; REUBI JC, 1995, J CLIN ENDOCR METAB, V80, P2806, DOI 10.1210/jc.80.9.2806; Ruscica M, 2014, MOL CELL ENDOCRINOL, V382, P860, DOI 10.1016/j.mce.2013.10.027; Sampedro-Nunez M, 2016, ONCOTARGET, V7, P6593, DOI 10.18632/oncotarget.6565; Sciarra A, 2008, EUR UROL, V53, P652, DOI 10.1016/j.eururo.2007.02.010; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sternberg Cora N, 2014, Am Soc Clin Oncol Educ Book, P117, DOI 10.14694/EdBook_AM.2014.34.117; Sun LC, 2016, CURR DRUG TARGETS, V17, P529, DOI 10.2174/1389450116666141205163548; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Uphoff Cord C, 2013, Methods Mol Biol, V946, P1, DOI 10.1007/978-1-62703-128-8_1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu GJ, 2007, CANCER RES, V67, P4123, DOI 10.1158/0008-5472.CAN-07-0012; Wyatt AW, 2015, EMBO MOL MED, V7, P878, DOI 10.15252/emmm.201303701; Zhang JS, 2007, ONCOGENE, V26, P111, DOI 10.1038/sj.onc.1209769; Zhu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091817	45	31	31	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4682	4696		10.1096/fj.201601264RRR	http://dx.doi.org/10.1096/fj.201601264RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705809				2022-12-26	WOS:000413398500003
J	Tortosa, C; Cabrera-Marante, O; Serrano, M; Martinez-Flores, JA; Perez, D; Lora, D; Morillas, L; Paz-Artal, E; Morales, JM; Pleguezuelo, D; Serrano, A				Tortosa, Carlos; Cabrera-Marante, Oscar; Serrano, Manuel; Martinez-Flores, Jose A.; Perez, Dolores; Lora, David; Morillas, Luis; Paz-Artal, Estela; Morales, Jose M.; Pleguezuelo, Daniel; Serrano, Antonio			Incidence of thromboembolic events in asymptomatic carriers of IgA anti beta 2 glycoprotein-I antibodies	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; 14TH INTERNATIONAL-CONGRESS; ANTI-BETA-2 GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; RISK-FACTORS; CLINICAL-SIGNIFICANCE; THROMBOTIC RECURRENCES; PIEDMONT COHORT; ANTICARDIOLIPIN; DIAGNOSIS	Background The antiphospholipid syndrome (APS) is defined by simultaneous presence of vascular clinical events and antiphospholipid antibodies (aPL). The aPL considered as diagnostics are lupus anticoagulant and antibodies anticardiolipin (aCL) and anti-beta 2 glycoprotein-I (aB2GP1). During recent years, IgA aB2GP1 antibodies have been associated with thrombotic events both in patients positive, and mainly negative for other aPL, however its value as a pro-thrombotic risk-factor in asymptomatic patients has not been well defined. Objective To test the role of IgA anti B2GP1 as a risk factor for the development of APS-events (thrombosis or pregnancy morbidity) in asymptomatic population with a 5-year follow-up. Methods 244 patients isolated positive for anti-beta2-glycoprotein I IgA (Group-1 study) and 221 negative patients (Group-2 control) were studied. All the patients were negative for IgG and IgM aCL. Results During the follow-up, 45 patients (9.7%) had APS-events, 38 positive for IgA-aB2GP1 and 7 negative (15.6% vs 3.2%, p<0.001). The incidence rate of APS-events was 3.1% per year in IgA-aB2GP1 positive patients and 0.6% per year in the control group. Arterial thrombosis were the most frequent APS-events (N = 25, 55%) and were mainly observed in Group-1 patients (21 vs 4, p = 0.001). Multivariate analysis were shown as independent risk-factors for the development of APS-events, age, sex (men) and presence of IgA-aB2GP1 (odds ratio 5.25, 95% CI 2.24 to 12.32). Conclusion The presence of IgA-aB2GP1 in people with no history of APS-events is the main independent risk factor for the development of these types of events, mainly arterial thrombosis.	[Tortosa, Carlos; Cabrera-Marante, Oscar; Serrano, Manuel; Martinez-Flores, Jose A.; Perez, Dolores; Paz-Artal, Estela; Morales, Jose M.; Pleguezuelo, Daniel; Serrano, Antonio] Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid, Spain; [Lora, David] Hosp Univ 12 Octubre, Inst Invest, Dept Epidemiol, Madrid, Spain; [Morillas, Luis] Hosp Univ 12 Octubre, Inst Invest, Dept Rheumatol, Madrid, Spain	Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre	Serrano, A (corresponding author), Hosp Univ 12 Octubre, Inst Invest, Dept Immunol, Madrid, Spain.	aserrano@h12o.es		Serrano, Antonio/0000-0003-1993-640X	Fondo de Investigaciones Sanitarias; EU FEDER funds [PI14-00360]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); EU FEDER funds(European Commission)	This work was supported by grants from Fondo de Investigaciones Sanitarias and cofunded by EU FEDER funds (Grant: PI14-00360).	Amengual O, 2015, LUPUS, V24, P1135, DOI 10.1177/0961203315578765; Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; ANNESI I, 1989, STAT MED, V8, P1515, DOI 10.1002/sim.4780081211; Arnaud L, 2015, AUTOIMMUN REV, V14, P192, DOI 10.1016/j.autrev.2014.10.019; Artenjak A, 2012, AUTOIMMUN REV, V11, P873, DOI 10.1016/j.autrev.2012.03.002; Audrain MAP, 2002, RHEUMATOLOGY, V41, P550, DOI 10.1093/rheumatology/41.5.550; Barbhaiya M, 2011, CURR RHEUMATOL REP, V13, P59, DOI 10.1007/s11926-010-0149-3; Bazzan M, 2016, LUPUS, V25, P479, DOI 10.1177/0961203315617538; Bazzan M, 2013, AUTOIMMUN REV, V12, P826, DOI 10.1016/j.autrev.2012.11.007; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Brusch A, 2016, ANTIBODIES, V5, DOI 10.3390/antib5020016; Cervera R, 2015, ANN RHEUM DIS, V74, P1011, DOI 10.1136/annrheumdis-2013-204838; Cervera R, 2012, AUTOIMMUN REV, V11, P581, DOI 10.1016/j.autrev.2011.10.017; Cervera R, 2009, J AUTOIMMUN, V32, P240, DOI 10.1016/j.jaut.2009.02.008; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Despierres L, 2014, RHEUMATOLOGY, V53, P1215, DOI 10.1093/rheumatology/keu003; Douketis JD, 2016, INTERN EMERG MED; Erkan D, 2002, RHEUMATOLOGY, V41, P924, DOI 10.1093/rheumatology/41.8.924; Forastiero R, 2005, J THROMB HAEMOST, V3, P1231, DOI 10.1111/j.1538-7836.2005.01295.x; Garcia D, 2013, BLOOD, V122, P817, DOI 10.1182/blood-2013-04-496257; Gerosa M, 2016, CURR OPIN RHEUMATOL, V28, P51, DOI 10.1097/BOR.0000000000000240; Hood DB, 2015, EUR J RHEUMATOL, V2, P135, DOI 10.5152/eurjrheum.2015.0012; Hughes GRV, 2014, LUPUS, V23, P400, DOI 10.1177/0961203314522341; Keswani SC, 2002, J ROY SOC MED, V95, P336, DOI 10.1258/jrsm.95.7.336; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Martinez-Flores JA, 2016, J ATHEROSCLER THROMB, V23, P1242, DOI 10.5551/jat.34488; Martinez-Flores JA, 2013, ANAL CHEM, V85, P12093, DOI 10.1021/ac403194t; Mehrani T, 2011, J RHEUMATOL, V38, P64, DOI 10.3899/jrheum.100568; Meijide H, 2013, AUTOIMMUN REV, V12, P421, DOI 10.1016/j.autrev.2012.08.002; Metjian Ara, 2009, Hematology Am Soc Hematol Educ Program, P247, DOI 10.1182/asheducation-2009.1.247; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Morales JM, 2016, TRANSPLANTATION; Morales JM, 2015, J AM SOC NEPHROL, V26, P735, DOI 10.1681/ASN.2014030228; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Mustonen P, 2014, LUPUS, V23, P1468, DOI 10.1177/0961203314545410; Pengo V, 2011, BLOOD, V118, P4714, DOI 10.1182/blood-2011-03-340232; Perez D, 2016, INT J LAB HEMATOL, V38, P560, DOI 10.1111/ijlh.12543; Pericleous C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156407; Pierangeli SS, 2005, CLIN CHIM ACTA, V357, P17, DOI 10.1016/j.cccn.2005.02.002; Previtali E, 2011, BLOOD TRANSFUS-ITALY, V9, P120, DOI 10.2450/2010.0066-10; Rodriguez-Garcia V, 2015, RHEUMATOLOGY, V54, P2042, DOI 10.1093/rheumatology/kev226; Ruffatti A, 2011, ANN RHEUM DIS, V70, P1083, DOI 10.1136/ard.2010.142042; Ruiz-Garcia R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/704395; Samarkos M, 2006, CLIN RHEUMATOL, V25, P199, DOI 10.1007/s10067-005-1156-z; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Serrano A, 2012, KIDNEY INT, V81, P1239, DOI 10.1038/ki.2011.477; Tebo AE, 2016, CLIN CHIM ACTA, V460, P107, DOI 10.1016/j.cca.2016.06.025; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Yamada H, 1999, ARTHRITIS RHEUM, V42, P2727, DOI 10.1002/1529-0131(199912)42:12<2727::AID-ANR33>3.0.CO;2-Q	50	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178889	10.1371/journal.pone.0178889	http://dx.doi.org/10.1371/journal.pone.0178889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727732	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500004
J	Dargham, SR; Ahmed, L; Kilpatrick, ES; Atkin, SL				Dargham, Soha R.; Ahmed, Lina; Kilpatrick, Eric S.; Atkin, Stephen L.			The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; DIAGNOSTIC-CRITERIA; RISK-FACTORS; WOMEN; FEATURES; PCOS	Objective The prevalence of polycystic ovary syndrome (PCOS) in the Qatari population is unknown and hence the estimated impact on the local population cannot be determined. The purpose of this study was to estimate the prevalence and metabolic features of PCOS among Qatari women. Design Cross sectional analysis. Patients 3,017 Qatari subjects volunteered to be phenotyped and genotyped for the Qatar Biobank from which all women between the ages of 18-40 years were identified (750). Measurements 720 women had testosterone and sex hormone binding globulin (SHBG) measurements. PCOS was diagnosed according the National Institute of Health (NIH) Guidelines of a raised androgen level (free androgen index >4.5 or a raised total testosterone) and menstrual irregularity after the exclusion of other conditions. Results All results are reported as mean value of PCOS versus control. 87 of 720 women fulfilled the NIH guidelines (12.1%) for PCOS specifically using a free androgen index greater than 4.5 or a total testosterone greater than 2.7nmol/l and menstrual irregularity. Subjects were heavier with a more metabolic profile of a greater systolic and diastolic blood pressure, higher levels of C reactive protein, insulin (p<0.01) and HbA1c (P<0.02), and decreased HDL levels (p<0.01). Pulse wave velocity as a marker of arterial stiffness was also increased (p<0.05) Conclusions By NIH guidelines the prevalence of PCOS in this Qatari cohort was 12.1% that would likely reflect 20% by Rotterdam criteria, with a markedly more metabolic phenotype than Qatari controls.	[Dargham, Soha R.] Weill Cornell Med, Infect Dis Epidemiol Grp, Doha, Qatar; [Ahmed, Lina; Atkin, Stephen L.] Weill Cornell Med, Res Fac, Doha, Qatar; [Kilpatrick, Eric S.] Sidra Med & Res Ctr, Dept Pathol, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center	Atkin, SL (corresponding author), Weill Cornell Med, Res Fac, Doha, Qatar.	sla2002@qatar-med.cornell.edu	Atkin, stephen/ABE-7047-2020; Atkin, Stephen/D-7400-2014	Atkin, Stephen/0000-0002-5887-7257; Dargham, Soha/0000-0003-2695-6564; Hasabelgawi, Lina/0000-0001-9512-8231	Qatar Foundation; Qatar Biobank	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Qatar Biobank(Qatar Foundation (QF))	This work was supported by the Qatar Foundation and the Qatar Biobank. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for the support for this work from the Qatar Biobank and the Qatar Foundation.	Al-Ruhaily AD, 2008, ANN SAUDI MED, V28, P28; Boardman H, 2017, J HYPERTENS, V35, P513, DOI 10.1097/HJH.0000000000001192; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Casarini L, 2014, J CLIN ENDOCR METAB, V99, pE2412, DOI 10.1210/jc.2014-2703; Dumesic DA, 2016, J CLIN ENDOCR METAB, V101, P4178, DOI 10.1210/jc.2016-2586; Dunaif A, 2016, J CLIN ENDOCR METAB, V101, P759, DOI 10.1210/jc.2015-3780; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Glintborg D, 2010, CLIN ENDOCRINOL, V73, P732, DOI 10.1111/j.1365-2265.2010.03873.x; Kahal H, 2013, CLIN ENDOCRINOL, V79, P252, DOI 10.1111/cen.12137; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Rosenfield RL, 2016, ENDOCR REV; Sathyapalan T, 2011, EUROPEAN J ENDOCRINO; Sharif E, 2017, INT J WOMENS HEALTH, V9, P1, DOI 10.2147/IJWH.S120027; Teede HJ, 2013, OBESITY, V21, P1526, DOI 10.1002/oby.20213; van Wissen S, 2002, ATHEROSCLEROSIS, V165, P361, DOI 10.1016/S0021-9150(02)00280-0; Vishram JKK, 2015, J HYPERTENS, V33, P2422, DOI 10.1097/HJH.0000000000000739; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yildiz BO, 2012, HUM REPROD, V27, P3067, DOI 10.1093/humrep/des232	21	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181467	10.1371/journal.pone.0181467	http://dx.doi.org/10.1371/journal.pone.0181467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723965	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800052
J	Marioni, J; Bresoli-Obach, R; Agut, M; Comini, LR; Cabrera, JL; Paraje, MG; Nonell, S; Montoya, SC				Marioni, Juliana; Bresoli-Obach, Roger; Agut, Montserrat; Comini, Laura R.; Cabrera, Jose L.; Paraje, Maria G.; Nonell, Santi; Nunez Montoya, Susana C.			On the mechanism of Candida tropicalis biofilm reduction by the combined action of naturally-occurring anthraquinones and blue light	PLOS ONE			English	Article							SINGLET OXYGEN; PHOTODYNAMIC THERAPY; ESCHERICHIA-COLI; INACTIVATION; HYPERICIN	The photoprocesses involved in the photo-induced Candida tropicalis biofilm reduction by two natural anthraquinones (AQs), rubiadin (1) and rubiadin-1-methyl ether (2), were examined. Production of singlet oxygen (O-1(2)) and of superoxide radical anion (O-2(center dot-)) was studied. Although it was not possible to detect the triplet state absorption of any AQs in biofilms, observation of O-1(2) phosphorescence incubated with deuterated Phosphate Buffer Solution, indicated that this species is actually formed in biofilms. 2 was accumulated in the biofilm to a greater extent than 1 and produced measurable amounts of O-2(center dot-) after 3h incubation in biofilms. The effect of reactive oxygen species scavengers on the photo-induced biofilm reduction showed that Tiron (a specific O-2(center dot-) scavenger) is most effective than sodium azide (a specific O-1(2) quencher). This suggests that O-2(center dot-) formed by electron transfer quenching of the AQs excited states, is the main photosensitizing mechanism involved in the photoinduced antibiofilm activity, whereas O-1(2) participation seems of lesser importance.	[Marioni, Juliana; Comini, Laura R.; Cabrera, Jose L.; Paraje, Maria G.; Nunez Montoya, Susana C.] Univ Nacl Cordoba, CONICET, IMBIV, Cordoba, Argentina; [Marioni, Juliana; Comini, Laura R.; Cabrera, Jose L.; Nunez Montoya, Susana C.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Ciencias Farmaceut, Cordoba, Argentina; [Bresoli-Obach, Roger; Agut, Montserrat; Nonell, Santi] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain; [Paraje, Maria G.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Microbiol, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Universitat Ramon Llull; Institut Quimic de Sarria; National University of Cordoba	Montoya, SC (corresponding author), Univ Nacl Cordoba, CONICET, IMBIV, Cordoba, Argentina.; Montoya, SC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Ciencias Farmaceut, Cordoba, Argentina.; Nonell, S (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain.	santi.nonell@iqs.url.edu; sununez@fcq.unc.edu.ar	Comini, Laura Raquel/AAP-3720-2021; Agut, Montserrat/L-5905-2013; Obach, Roger Bresoli/ABG-5022-2020	Agut, Montserrat/0000-0001-9173-9684; MARIONI, JULIANA/0000-0002-4404-0800; Bresoli-Obach, Roger/0000-0002-7819-7750	Fondo para investigacion Cientifica y Tecnologica [2204]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [GI 4316/2013]; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria [203/14]; Ministerio de Economia y Competitividad [CTQ2013-48767-C3-1-R]; European Social Funds; SUR del DEC de la Generalitat de Catalunya [2016 FI_B1 00021]	Fondo para investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria; Ministerio de Economia y Competitividad(Spanish Government); European Social Funds(European Social Fund (ESF)); SUR del DEC de la Generalitat de Catalunya	This study was funded by Fondo para investigacion Cientifica y Tecnologica. Plan Argentina Innovadora 2020, tipo A, PICT 2014 no 2204, http://www.agencia.mincyt.gob.ar/frontend/ agencia/fondo/foncyt JLC; Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP 2013-2015, s/ res. GI 4316/2013, http://www.conicet. gov.ar/ JLC; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba, Categoria A, s/ res. no 203/14, http:http://www.unc.edu.ar/investigacion/finarciamiento/subsidios-e-incentivos SCNM; Ministerio de Economia y Competitividad, CTQ2013-48767-C3-1-R, http://ww.mineco.gob.es/portal/site/mineco/idi SN.; J. Marioni is a research fellow of CONICET. L.R. Comini, M.G. Paraje, J.L. Cabrera and S.C. Nunez Montoya are members of the Research Career of CONICET. R.B.-O. thanks the European Social Funds and the SUR del DEC de la Generalitat de Catalunya for his predoctoral fellowship (2016 FI_B1 00021).	Allevato MA., 2006, ACT TERAP DERMATOL, V29, P302; Peralta MA, 2015, PHYTOMEDICINE, V22, P975, DOI 10.1016/j.phymed.2015.07.003; Villegas NA, 2015, TOXICOL IN VITRO, V29, P1692, DOI 10.1016/j.tiv.2015.06.025; Bacigalupo NM., 1993, FLORA PROVINCIA JUJU, P375; Berry D, 2015, P NATL ACAD SCI USA, V112, pE194, DOI 10.1073/pnas.1420406112; Bizerra FC, 2008, FEMS YEAST RES, V8, P442, DOI 10.1111/j.1567-1364.2007.00347.x; BORS W, 1979, BIOCHIM BIOPHYS ACTA, V582, P537, DOI 10.1016/0304-4165(79)90145-4; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Cieplik F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00405; Clinical and Laboratory Standards Institute (CLSI), 2002, M27A2 CLSI; Comini LR, 2007, J PHOTOCH PHOTOBIO A, V188, P185, DOI 10.1016/j.jphotochem.2006.12.011; Davids LM, 2008, J PHOTOCH PHOTOBIO B, V91, P67, DOI 10.1016/j.jphotobiol.2008.01.011; Dijkstra AT, 2001, J EUR ACAD DERMATOL, V15, P550, DOI 10.1046/j.1468-3083.2001.00333.x; Eisfeld A, 2006, CHEM PHYS, V324, P376, DOI 10.1016/j.chemphys.2005.11.015; Goldani LZ, 2003, J INFECTION, V46, P155, DOI 10.1053/jinf.2002.1067; Gonzalez F Pereira, 2011, FUNGAL BIOL, V116, P1; Gouloumis A, 2006, J AM CHEM SOC, V128, P12674, DOI 10.1021/ja055344+; Jimenez-Banzo A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1003, DOI 10.1039/b804333g; Kahler C P, 2000, Blood Cells Mol Dis, V26, P626, DOI 10.1006/bcmd.2000.0340; Khan MSA, 2010, COMBATING FUNGAL INFECTIONS: PROBLEMS AND REMEDY, P21, DOI 10.1007/978-3-642-12173-9_2; Konigheim BS, 2012, LAT AM J PHARM, V31, P51; Lopez-Chicon P, 2012, PHOTOCH PHOTOBIO SCI, V11, P1099, DOI 10.1039/c2pp25105a; Marioni J, 2016, PHARM BIOL, V54, P2791, DOI 10.1080/13880209.2016.1183683; Marioni J, 2016, PHYTOMEDICINE, V23, P1321, DOI 10.1016/j.phymed.2016.07.008; Marti C, 1996, J PHOTOCH PHOTOBIO A, V97, P11, DOI 10.1016/1010-6030(96)04321-3; Montoya SC, 2006, ACTA FARM BONAER, V25, P252; Montoya SCN, 2005, J PHOTOCH PHOTOBIO B, V78, P77, DOI 10.1016/j.jphotobiol.2004.09.009; Montoya SCN, 2003, PHYTOMEDICINE, V10, P569, DOI 10.1078/094471103322331854; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Montoya SCN, 2006, J NAT PROD, V69, P801, DOI 10.1021/np050181o; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Paz-Cristobal MP, 2014, MYCOSES, V57, P35, DOI 10.1111/myc.12099; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Ragas X, 2010, FREE RADICAL BIO MED, V49, P770, DOI 10.1016/j.freeradbiomed.2010.05.027; Rajendran M, 2016, PHOTODIAGN PHOTODYN, V13, P175, DOI 10.1016/j.pdpdt.2015.07.177; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; SCHMIDT R, 1994, J PHOTOCH PHOTOBIO A, V79, P11, DOI 10.1016/1010-6030(93)03746-4; Shida T., 1988, PHYS SCI DATA, V34; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Snyder JW, 2006, PHYS CHEM CHEM PHYS, V8, P4280, DOI 10.1039/b609070m; Zhang YS, 2016, VIRULENCE, V7, P536, DOI 10.1080/21505594.2016.1155015	42	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181517	10.1371/journal.pone.0181517	http://dx.doi.org/10.1371/journal.pone.0181517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723923	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800057
J	Yu, MY; Lee, SW; Baek, SH; Na, KY; Chae, DW; Chin, HJ; Kim, S				Yu, Mi-yeon; Lee, Sung Woo; Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong			Hypoalbuminemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; NITRIC-OXIDE; SERUM-ALBUMIN; RISK-FACTOR; SURVIVAL; RESUSCITATION; METAANALYSIS; OUTCOMES; SURGERY	Background Development of acute kidney injury (AKI) is common and is associated with poor outcomes. We aimed to determine whether hypoalbuminemia (HA) at admission could be a risk factor for the development of AKI and mortality in hospitalized patients. Methods We enrolled patients who were admitted to Seoul National University Bundang Hospital from January 2013 to December 2013. HA at admission was defined as a serum albumin level < 3.4 mg/dL measured within two days after admission. AKI was defined as an increase in the serum creatinine level by >= 0.3 mg/dL or >= 1.5 times of the baseline value during the hospital stay. Results A total of 19,472 patients were enrolled and divided into HA and normoalbuminemia (NA) groups at admission. The incidence of AKI was 10.7% (340/3179) in the HA group and 4.1% (662/16293) in the NA group (adjusted odds ratio [OR], 1.243; 95% confidence interval [CI], 1.069 +/- 1.445; P = 0.005). The hazard ratios for the 30-day, 90-day, and 1-year mortality were 1.873 (95% CI, 1.383 +/- 2.537; P < 0.001), 1.710 (95% CI, 1.410 +/- 2.072; P < 0.001), and 1.372 (95% CI, 1.214 +/- 1.551; P < 0.001), compared to the NA group. In patients with AKI, albumin replacement improved renal recovery (OR, 2.605; 95% CI, 1.450 +/- 4.681; P = 0.001). The mortality rate was not different according to albumin replacement. Conclusions HA is associated with the development of AKI and high mortality in hospitalized patients. Replacement of albumin after the development of AKI may contribute to renal recovery. Further clinical trials are warranted.	[Yu, Mi-yeon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Sung Woo] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha] Hallym Univ, Dept Internal Med, Dongtan Sacred Heart Hosp, Gyeonggi Do, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Eulji University; Hallym University; Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	sejoong2@snu.ac.kr	Yu, Mi-Yeon/ABB-7937-2021; Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2221]; National Research Foundation of Korea [2017R1A2B4005251]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the a grand of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C2221), and a grant No. 2017R1A2B4005251 from the National Research Foundation of Korea.	Asher V, 2012, MED ONCOL, V29, P2005, DOI 10.1007/s12032-011-0019-5; Baek SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156444; Berbel MN, 2011, REV ASSOC MED BRAS, V57, P600, DOI 10.1590/S0104-42302011000500022; Brown JR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4278579; BURLESON RL, 1978, ARCH SURG-CHICAGO, V113, P688; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Chawla LS, 2005, KIDNEY INT, V68, P2274, DOI 10.1111/j.1523-1755.2005.00686.x; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; CONTRERAS AM, 1994, REV INVEST CLIN, V46, P37; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207; Duly EB, 2003, J CLIN PATHOL, V56, P780, DOI 10.1136/jcp.56.10.780; Frenette AJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0602-1; GERKENS JF, 1990, EUR J PHARMACOL, V177, P119, DOI 10.1016/0014-2999(90)90261-4; Hollenberg SM, 1997, AM J PHYSIOL-REG I, V272, pR969, DOI 10.1152/ajpregu.1997.272.3.R969; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jellinge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105983; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Lee SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162990; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Lyons O, 2010, EUR J INTERN MED, V21, P17, DOI 10.1016/j.ejim.2009.10.010; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Pulimood TB, 2000, CRIT CARE, V4, P151, DOI 10.1186/cc688; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; Sang BH, 2015, CRIT CARE MED, V43, P2552, DOI 10.1097/CCM.0000000000001279; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Sung J, 2004, AM SURGEON, V70, P1099; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Tsai HS, 2014, ACTA CARDIOL SIN, V30, P93; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Zamlauski-Tucker M, 1988, Ren Physiol, V10, P352	42	28	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180750	10.1371/journal.pone.0180750	http://dx.doi.org/10.1371/journal.pone.0180750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723973	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800022
J	Sevrin, T; Alexandre-Gouabau, MC; Darmaun, D; Palvadeau, A; Andre, A; Nguyen, P; Ouguerram, K; Boquien, CY				Sevrin, Thomas; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique; Palvadeau, Antoine; Andre, Agnes; Nguyen, Patrick; Ouguerram, Khadija; Boquien, Clair-Yves			Use of water turnover method to measure mother's milk flow in a rat model: Application to dams receiving a low protein diet during gestation and lactation	PLOS ONE			English	Article							TOTAL-BODY WATER; DEUTERIUM-OXIDE; RESTRICTION; GROWTH; METABOLISM; INSULIN; YIELD; O-18; LIFE; H-2	Assessment of milk production is of utmost relevance for pediatricians and scientists interested in early life nutrition. The weight-suckle-weight (WSW) method, which consists of weighing babies before and after they suckle their mother, uses the difference in body weight as an estimate of milk intake. However, this is prone to many sources of error. In the current study, we used for the first time the water turnover method and compartmental analysis with deuterated water (D2O) as a non-toxic tracer to quantify in vivo milk production in a rat model. We assessed the effect of a nutritional intervention presumed to affect milk production, a maternal dietary protein restriction during gestation and lactation, which results in the birth of pups with intrauterine growth restriction. The specific aim of this study was to determine milk production with the body water turnover method in rat dams receiving during gestation and lactation, either a control diet (NP) or an iso-caloric low-protein diet (LP). In NP dams, mass of dam's total body water, output flow constant from dam to litter (K21) and median milk flow, calculated between days 11 to 14 after pup birth, were 282.1 g, 0.0122 h(-1) and 3.30 g/h for NP dams, respectively. Maternal dietary protein restriction (-59%) during perinatal period led to a 34% reduction in milk flow (NP versus LP). With the WSW method, milk flow varied from 1.96 g/h to 2.37 g/h between days 11 to 14 for NP dams. The main advantage of the D(2)0 method compared to the WSW method stems from its higher precision, as attested by the narrowest range of measured values of milk flow ([2.90; 3.75] and [0.98; 6.85] g/h, respectively) for NP group. This method could be suitable for testing the effectiveness of candidate galactologue molecules presumed to enhance milk production in the lactating rat model.	[Sevrin, Thomas; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique; Palvadeau, Antoine; Ouguerram, Khadija; Boquien, Clair-Yves] Univ Nantes, UMR PhAN, INRA, CRNH Ouest, Nantes, France; [Darmaun, Dominique] CHU Hotel Dieu, Nantes Hosp, CRNH Ouest, IMAD,DHU2020, Nantes, France; [Andre, Agnes; Nguyen, Patrick] Nantes Atlantic Natl Coll Vet Med, ONIRIS, UNE, Nantes, France	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Boquien, CY (corresponding author), Univ Nantes, UMR PhAN, INRA, CRNH Ouest, Nantes, France.	clair-yves.boquien@univ-nantes.fr	Darmaun, Dominique/X-8453-2018; Boquien, Clair-Yves/AAP-5275-2020	Darmaun, Dominique/0000-0002-0366-3227; Boquien, Clair-Yves/0000-0001-6944-5372; Alexandre-Gouabau, Marie-Cecile/0000-0002-9966-9593; Sevrin, Thomas/0000-0003-2596-6998	AlimH Department of INRA (AlimH - ANSSD 2015); AlimH Department of INRA (AlimH-ANSSD 2015)	AlimH Department of INRA (AlimH - ANSSD 2015); AlimH Department of INRA (AlimH-ANSSD 2015)	The study was supported, in part, by a grant from the AlimH Department of INRA (AlimH - ANSSD 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported, in part, by a grant from the AlimH Department of INRA (AlimH-ANSSD 2015). The authors would like to thank specifically Guillaume POUPEAU and Thomas MOYON (PhAN, INRA, Nantes, France) for animal care and for statistical analysis supervision, respectively. The authors also acknowledge Prof. Jean-Francois HUNEAU (Agro-ParisTech) for his invaluable advice in setting up the deuterated water dilution method.	Agnoux AM, 2015, J NUTR BIOCHEM, V26, P784, DOI 10.1016/j.jnutbio.2015.02.012; Agnoux AM, 2014, AM J PHYSIOL-REG I, V307, pR184, DOI 10.1152/ajpregu.00015.2014; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Berman ESF, 2015, EUR J CLIN NUTR, V69, P1091, DOI 10.1038/ejcn.2015.10; BUTTE NF, 1988, AM J CLIN NUTR, V47, P815, DOI 10.1093/ajcn/47.5.815; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; FOY JM, 1960, J PHYSIOL-LONDON, V154, P169, DOI 10.1113/jphysiol.1960.sp006571; Haisma H, 2003, BREAST MILK ENERGY I; Hauck YL, 2011, MATERN CHILD HLTH J, V15, P260, DOI 10.1007/s10995-009-0554-2; Houdebine L- M, 2007, BIOL LACTATION; KANTO U, 1980, J NUTR, V110, P1840, DOI 10.1093/jn/110.9.1840; KLAVER J, 1981, J ANIM SCI, V52, P1091, DOI 10.2527/jas1981.5251091x; Maugeais C, 1998, CLIN CHEM LAB MED, V36, P739, DOI 10.1515/CCLM.1998.131; Morag M, 1975, Lab Anim, V9, P43, DOI 10.1258/002367775780994844; Moretto VL, 2011, ISRN OBSTET GYNECOL, V2011, DOI [10.5402/2011/876502, DOI 10.5402/2011/876502]; Salanave B., 2014, Bulletin Epidemiologique Hebdomadaire, P450; SAMPSON DA, 1984, J PEDIATR GASTR NUTR, V3, P613, DOI 10.1097/00005176-198409000-00023; Savenije OEM, 2006, ARCH DIS CHILD-FETAL, V91, P330, DOI 10.1136/adc.2005.091876; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; Siret V, 2008, ARCH PEDIATRIE, V15, P1167, DOI 10.1016/j.arcped.2008.04.014; Theil PK, 2002, ACTA AGR SCAND A-AN, V52, P221, DOI 10.1080/090647002762381104; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180550	10.1371/journal.pone.0180550	http://dx.doi.org/10.1371/journal.pone.0180550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715436	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500011
J	Ateia, M; Koch, C; Jelavic, S; Hirt, A; Quinson, J; Yoshimura, C; Johnson, M				Ateia, Mohamed; Koch, Christian; Jelavic, Stanislav; Hirt, Ann; Quinson, Jonathan; Yoshimura, Chihiro; Johnson, Matthew			Green and facile approach for enhancing the inherent magnetic properties of carbon nanotubes for water treatment applications	PLOS ONE			English	Article							ACTIVATED CARBON; AQUEOUS-SOLUTION; ARSENIC REMOVAL; ONE-POT; ADSORPTION; CATALYST; NANOPARTICLES; PURIFICATION; PARTICLES; GRAPHENE	Current methods for preparing magnetic composites with carbon nanotubes (MCNT) commonly include extensive use of treatment with strong acids and result in massive losses of carbon nanotubes (CNTs). In this study we explore the potential of taking advantage of the inherent magnetic properties associated with the metal (alloy or oxide) incorporated in CNTs during their production. The as-received CNTs are refined by applying a permanent magnet to a suspension of CNTs to separate the high-magnetic fraction; the low-magnetic fraction is discarded with the solvent. The collected MCNTs were characterized by a suite of 10 diffraction and spectroscopic techniques. A key discovery is that metallic nano-clusters of Fe and/or Ni located in the interior cavities of the nanotubes give MCNTs their ferromagnetic character. After refinement using our method, the MCNTs show saturation magnetizations up to 10 times that of the as-received materials. In addition, we demonstrate the ability of these MCNTs to repeatedly remove atrazine from water in a cycle of dispersion into a water sample, adsorption of the atrazine onto the MCNTs, collection by magnetic attraction and regeneration by ethanol. The resulting MCNTs show high adsorption capacities (>40 mg-atrazine/g), high magnetic response, and straightforward regeneration. The method presented here is simpler, faster, and substantially reduces chemical waste relative to current techniques and the resulting MCNTs are promising adsorbents for organic/chemical contaminants in environmental waters.	[Ateia, Mohamed; Yoshimura, Chihiro] Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo, Japan; [Koch, Christian; Johnson, Matthew] Univ Copenhagen, Dept Chem, Univ Pk 5, Copenhagen O, Denmark; [Jelavic, Stanislav; Quinson, Jonathan] Univ Copenhagen, Dept Chem, Nanosci Ctr, Univ Pk 5, Copenhagen O, Denmark; [Hirt, Ann] ETH, Inst Geophys, Sonneggstr 5, Zurich, Switzerland	Tokyo Institute of Technology; University of Copenhagen; University of Copenhagen; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ateia, M (corresponding author), Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo, Japan.	mohamedateia1@gmail.com	Johnson, Matthew Stanley/AAS-7100-2021; Quinson, Jonathan/AAG-8243-2021; Ateia, Mohamed/AAF-8299-2020; Ateia, Mohamed/S-3512-2017; Quinson, Jonathan/I-8780-2016; Hirt, Ann M/M-5540-2016; Koch, Christian Bender/C-7070-2013	Johnson, Matthew Stanley/0000-0002-3645-3955; Quinson, Jonathan/0000-0002-9374-9330; Ateia, Mohamed/0000-0002-3524-5513; Ateia, Mohamed/0000-0002-3524-5513; Quinson, Jonathan/0000-0002-9374-9330; Hirt, Ann M/0000-0002-2193-0472; Koch, Christian Bender/0000-0002-7496-297X	Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology; JSPS Core-to-Core Program	Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology; JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Program for Leading Graduate School "Academy for Co creative Education of Environment and Energy Science," MEXT, Japan, Tokyo Institute of Technology and the JSPS Core-to-Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khabouri S, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0971-7; Alig I, 2012, POLYMER, V53, P4, DOI 10.1016/j.polymer.2011.10.063; Antunes EF, 2011, APPL SURF SCI, V257, P8038, DOI 10.1016/j.apsusc.2011.04.090; Ateia M, 2017, INT J ENVIRON SCI TE, V14, P867, DOI 10.1007/s13762-016-1214-x; Ateia M, 2017, ENV SCI TECHNOLOGY; Bhattacharjee K, 2013, COLLOID POLYM SCI, V291, P2589, DOI 10.1007/s00396-013-3002-1; Bilgili MS, 2006, J HAZARD MATER, V137, P157, DOI 10.1016/j.jhazmat.2006.01.005; Chen B, 2014, J COLLOID INTERF SCI, V434, P9, DOI 10.1016/j.jcis.2014.07.046; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Dong XL, 1998, J MATER SCI, V33, P1915, DOI 10.1023/A:1004369708540; Edwards ER, 2011, APPL SURF SCI, V258, P641, DOI 10.1016/j.apsusc.2011.07.032; Engel M, 2016, WATER RES, V106, P146, DOI 10.1016/j.watres.2016.09.051; Feng JT, 2008, MATER SCI ENG B-ADV, V150, P208, DOI 10.1016/j.mseb.2008.05.017; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Gao C, 2006, J PHYS CHEM B, V110, P7213, DOI 10.1021/jp0602474; Ghosh S, 2014, J PHYS CHEM C, V118, P4489, DOI 10.1021/jp411941k; Hartmann NB, 2015, J TOXICOL ENV HEAL B, V18, P299, DOI 10.1080/10937404.2015.1074969; Ho YS, 2002, WATER AIR SOIL POLL, V141, P1, DOI 10.1023/A:1021304828010; Hosseini SJ, 2011, FRESEN ENVIRON BULL, V20, P219; Hu WC, 2016, MATERIALS, V9, DOI 10.3390/ma9110939; John AR, 2014, CHEM ENG J, V243, P436, DOI 10.1016/j.cej.2013.12.087; Jordanova D, 2016, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00090; Koh B, 2014, LANGMUIR, V30, P10899, DOI 10.1021/la5014279; Kolodiazhnyi T, 2008, SMALL, V4, P1476, DOI 10.1002/smll.200800125; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Liu RJ, 2016, J ALLOY COMPD, V657, P138, DOI 10.1016/j.jallcom.2015.10.099; Lottermoser W, 2006, J PHYS CHEM B, V110, P9768, DOI 10.1021/jp061803x; Ma J, 2008, CHEM MATER, V20, P2895, DOI 10.1021/cm8001699; Ma J, 2013, J MATER CHEM A, V1, P4662, DOI 10.1039/c3ta10329c; Mahmood A, 2014, FOOD CHEM TOXICOLOGY; Masotti A, 2013, INT J MOL SCI, V14, P24619, DOI 10.3390/ijms141224619; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Nakanishi R, 2017, MATERIALS, V10, DOI 10.3390/ma10010007; Pacakova B, 2015, J MATER SCI, V50, P2544, DOI 10.1007/s10853-014-8813-z; Pardasani D, 2011, TALANTA, V86, P248, DOI 10.1016/j.talanta.2011.08.067; Pastrana-Martinez LM, 2010, WATER RES, V44, P879, DOI 10.1016/j.watres.2009.09.053; Pike C, 1999, J APPL PHYS, V85, P6668, DOI 10.1063/1.370177; Pike CR, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104424; Pumera M, 2007, LANGMUIR, V23, P6453, DOI 10.1021/la070088v; Qu S, 2008, J HAZARD MATER, V160, P643, DOI 10.1016/j.jhazmat.2008.03.037; Rambabu N, 2012, CHEM ENG TECHNOL, V35, P272, DOI 10.1002/ceat.201100376; Ruskov T, 2004, J APPL PHYS, V96, P7514, DOI 10.1063/1.1811781; Salam MA, 2012, SYNTHETIC MET, V161, P2651, DOI 10.1016/j.synthmet.2011.09.038; Scrimshire A, 2015, CROAT CHEM ACTA, V88, DOI 10.5562/cca2782; Shan Y, 2010, APPL SURF SCI, V257, P362, DOI 10.1016/j.apsusc.2010.06.078; Smith SWJ, 1912, P PHYS SOC LOND, V24, P62; Sui ZY, 2012, J MATER CHEM, V22, P8767, DOI 10.1039/c2jm00055e; Sun ZY, 2005, J MATER CHEM, V15, P4497, DOI 10.1039/b509968d; Tang WW, 2012, CHEM ENG J, V211, P470, DOI 10.1016/j.cej.2012.09.102; Uzun I, 2004, J COLLOID INTERF SCI, V274, P398, DOI 10.1016/j.jcis.2004.02.022; Vejpravova J, 2016, ANALYST, V141, P2639, DOI 10.1039/c6an00248j; Wang Q, 2011, CHEM ENG J, V174, P126, DOI 10.1016/j.cej.2011.08.059; Weissker U, 2010, MATERIALS, V3, P4387, DOI 10.3390/ma3084387; Winklhofer M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2176598; Xiao D., 2012, J NANOPART RES, V14, P1; Yan XM, 2008, J COLLOID INTERF SCI, V321, P30, DOI 10.1016/j.jcis.2008.01.047; Yang D, 2009, CHEM COMMUN, P4447, DOI 10.1039/b908012k; Zhang M, 2016, CATAL COMMUN, V78, P26, DOI 10.1016/j.catcom.2016.02.004; Zhao X, 2009, J MATER CHEM, V19, P8755, DOI 10.1039/b909779a; Zhao YR, 2015, RSC ADV, V5, P70309, DOI 10.1039/c5ra13183a; Zhong W, 2012, IND ENG CHEM RES, V51, P12017, DOI 10.1021/ie300891h; Zhou LX, 2014, CHEM ENG J, V257, P10, DOI 10.1016/j.cej.2014.07.060	62	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180636	10.1371/journal.pone.0180636	http://dx.doi.org/10.1371/journal.pone.0180636			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708835	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800017
J	Amissah, NA; van Dam, L; Ablordey, A; Ampomah, OW; Prah, I; Tetteh, CS; van der Werf, TS; Friedrich, AW; Rossen, JW; van Dijl, JM; Stienstra, Y				Amissah, Nana Ama; van Dam, Lieke; Ablordey, Anthony; Ampomah, Opoku-Ware; Prah, Isaac; Tetteh, Caitlin S.; van der Werf, Tjip S.; Friedrich, Alexander W.; Rossen, John W.; van Dijl, Jan Maarten; Stienstra, Ymkje			Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana	PLOS ONE			English	Article							HAND HYGIENE PRACTICES; METHICILLIN-RESISTANT; ANTIBIOTIC CONSUMPTION; TRANSMISSION; COLONIZATION; PROBABILITY; ACQUISITION; PREVALENCE; RESOURCES; MORTALITY	Background In developing countries, hospitalized burn victims are at high risk of nosocomial infections caused by Staphylococcus aureus. Risk factors include poor infection control practices, prolonged hospitalisation and limited capacity for laboratory microbiological analyses. These problems are compounded by widespread use of antibiotics that drives the spread of multidrug resistant bacteria. Methods During the study period (November 2014-June 2015), nasal and invasive S. aureus isolates were collected consecutively from patients and healthcare workers (HCWs) within the burn unit of the Reconstructive Plastic Surgery and Burn Center of Korle Bu Teaching Hospital in Ghana. Antibiotic prescription, antibiotic susceptibility and bacterial typing were used to assess antibiotic pressure, antibiotic resistance, and possible transmission events among patients and HCWs. Results Eighty S. aureus isolates were obtained from 37 of the 62 included burn patients and 13 of the 29 HCWs. At admission, 50% of patients carried or were infected with S. aureus including methicillin resistant S. aureus (MRSA). Antibiotic use per 100 days of hospitalization was high (91.2 days), indicating high selective pressure for resistant pathogens. MRSA isolates obtained from 11 patients and one HCW belonged to the same spa-type t928 and multi-locus sequence type 250, implying possible transmission events. A mortality rate of 24% was recorded over the time of admission in the burn unit. Conclusion This study revealed a high potential for MRSA outbreaks and emergence of resistant pathogens amongst burn patients due to lack of patient screening and extended empirical use of antibiotics. Our observations underscore the need to implement a system of antibiotic stewardship and infection prevention where microbiological diagnostics results are made available to physicians for timely and appropriate patient treatment.	[Amissah, Nana Ama; van der Werf, Tjip S.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands; [Amissah, Nana Ama; Ablordey, Anthony; Prah, Isaac; Tetteh, Caitlin S.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana; [van Dam, Lieke; Friedrich, Alexander W.; Rossen, John W.; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Ampomah, Opoku-Ware] Korle Bu Teaching Hosp, Reconstruct Plast Surg & Burn Ctr, Korle Bu, Ghana	University of Groningen; University of Ghana; University of Groningen	Amissah, NA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.; Amissah, NA (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Legon, Ghana.	namissah@noguchi.ug.edu.gh	Rossen, John W/G-7564-2011; Friedrich, Alex/ABG-9823-2020; Ablordey, Anthony/AAY-4016-2021	Rossen, John W/0000-0002-7167-8623; van der Werf, Tjip/0000-0002-4824-1642; Amissah, Nana Ama/0000-0003-1373-8330; Ablordey, Anthony/0000-0002-4486-0286	Graduate School for Medical Sciences of the University of Groningen NAA	Graduate School for Medical Sciences of the University of Groningen NAA	This work was supported by the Fellowship from the Graduate School for Medical Sciences of the University of Groningen NAA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenorku P, 2010, BURNS, V36, P1309, DOI 10.1016/j.burns.2010.03.017; Agbenorku P, 2011, BURNS, V37, P1259, DOI 10.1016/j.burns.2011.04.014; Ahuja RB, 2004, BRIT MED J, V329, P447, DOI 10.1136/bmj.329.7463.447; Amissah NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003421; Asare A, 2009, J INFECT DEV COUNTR, V3, P352; Atiyeh B, 2009, Ann Burns Fire Disasters, V22, P189; Bahemia IA, 2015, BURNS, V41, P1536, DOI 10.1016/j.burns.2015.05.007; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; COURTRIGHT P, 1993, J EPIDEMIOL COMMUN H, V47, P19, DOI 10.1136/jech.47.1.19; Dokter J, 2016, BURNS, V42, P421, DOI 10.1016/j.burns.2015.08.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096119; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; FORJUOH SN, 1995, BURNS, V21, P24, DOI 10.1016/0305-4179(95)90776-V; Fournier A, 2016, BURNS, V42, P564, DOI 10.1016/j.burns.2015.10.030; Gupta S, 2014, INT J SURG, V12, P1070, DOI 10.1016/j.ijsu.2014.08.353; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hassen AF, 2014, BURNS, V40, P1040, DOI 10.1016/j.burns.2013.10.020; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Jeschke MG, 2016, BURNS, V42, P276, DOI 10.1016/j.burns.2015.12.008; Khashaba HA, 2012, ANN BURNS FIRE DISAS, V25, P178; Khosravi AD, 2012, BURNS, V38, P247, DOI 10.1016/j.burns.2011.08.002; Kpeli G., 2016, New Microbes and New Infections, V13, P92, DOI 10.1016/j.nmni.2016.07.001; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lancashire JF, 2013, PATHOLOGY, V45, P492, DOI 10.1097/PAT.0b013e3283632667; Leseva M, 2013, Ann Burns Fire Disasters, V26, P5; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Meshulam-Derazon S, 2006, PLAST RECONSTR SURG, V118, P116, DOI 10.1097/01.prs.0000221111.89812.ad; Mir MA, 2017, INT WOUND J, V14, P194, DOI 10.1111/iwj.12588; Murray CK, 2009, BURNS, V35, P1112, DOI 10.1016/j.burns.2009.02.013; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Nthumba PM, 2016, BURNS, V42, P258, DOI 10.1016/j.burns.2015.04.006; Oncul O, 2014, BURNS, V40, P835, DOI 10.1016/j.burns.2013.11.003; Owusu-Ofori A, 2010, INFECT CONT HOSP EP, V31, P802, DOI 10.1086/654005; Patel M, 2013, J HOSP INFECT, V84, P319, DOI 10.1016/j.jhin.2013.04.013; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; References World Health Organization, 2008, A WHO PLAN FOR BURN; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Scholten-Jaegers SMHJ, 2017, J BURN CARE RES, V38, pE432, DOI 10.1097/BCR.0000000000000448; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Tagoe D N A, 2011, Ghana Med J, V45, P22; Vandendriessche S, 2017, EUR J CLIN MICROBIOL; Yawson AE, 2013, J INFECT DEV COUNTR, V7, P338, DOI 10.3855/jidc.2422	50	14	16	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181072	10.1371/journal.pone.0181072	http://dx.doi.org/10.1371/journal.pone.0181072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704546	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700088
J	Das, G; Patra, JK; Lee, SY; Kim, C; Park, JG; Baek, KH				Das, Gitishree; Patra, Jayanta Kumar; Lee, Sun-Young; Kim, Changgeon; Park, Jae Gyu; Baek, Kwang-Hyun			Analysis of metabolomic profile of fermented Orostachys japonicus A. Berger by capillary electrophoresis time of flight mass spectrometry	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM STRAINS; ACID; NICOTINAMIDE; PATHWAY; GROWTH; IDENTIFICATION; HISTAMINE; FOODS; TOOL; NAD	Microbial cell performance in food biotechnological processes has become an important concern for improving human health worldwide. Lactobacillus plantarum, which is widely distributed in nature, is a lactic acid bacterium with many industrial applications for fermented foods or functional foods (e.g., probiotics). In the present study, using capillary electrophoresis time of flight mass spectrometry, the metabolomic profile of dried Orostachys japonicus A. Berger, a perennial medicinal herb with L. plantarum was compared with that of O. japonicus fermented with L. plantarum to elucidate the metabolomic changes induced by the fermentation process. The levels of several metabolites were changed by the fermentation process, indicating their involvement in microbial performance. For example, glycolysis, the pentose phosphate pathway, the TCA cycle, the urea cycle-related metabolism, nucleotide metabolism, and lipid and amino acid metabolism were altered significantly by the fermentation process. Although the fermented metabolites were not tested using in vivo studies to increase human health benefits, our findings provide an insight into the alteration of metabolites induced by fermentation, and indicated that the metabolomic analysis for the process should be accompanied by fermenting strains and conditions.	[Das, Gitishree; Patra, Jayanta Kumar] Dongguk Univ Seoul, Res Inst Biotechnol & Med Converged Sci, Gyeonggi Do, South Korea; [Lee, Sun-Young] Chung Ang Univ, Dept Food Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kim, Changgeon; Park, Jae Gyu] Pohang Technopk Fdn, Pohang Ctr Evaluat Biomat POCEB, Pohang, Gyeongbuk, South Korea; [Baek, Kwang-Hyun] Yeungnam Univ, Dept Biotechnol, Gyongsan, Gyeongbuk, South Korea	Dongguk University; Chung Ang University; Yeungnam University	Park, JG (corresponding author), Pohang Technopk Fdn, Pohang Ctr Evaluat Biomat POCEB, Pohang, Gyeongbuk, South Korea.; Baek, KH (corresponding author), Yeungnam Univ, Dept Biotechnol, Gyongsan, Gyeongbuk, South Korea.	jaepark@pohangtp.org; khbaek@ynu.ac.kr	PATRA, JAYANTA KUMAR/AEM-6689-2022	PATRA, JAYANTA KUMAR/0000-0003-4118-4355; BAEK, KWANG-HYUN/0000-0002-6719-9187	industrial infrastructure program for fundamental technologies [N0000885]; Ministry of Trade, Industry & Energy (MOTIE, Korea)	industrial infrastructure program for fundamental technologies; Ministry of Trade, Industry & Energy (MOTIE, Korea)	This research was conducted under the industrial infrastructure program for fundamental technologies (N0000885), which was funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumourad I. M. K., 2013, Journal of Applied Sciences Research, V9, P572; Akdis CA, 2003, J ALLERGY CLIN IMMUN, V112, P15, DOI 10.1067/mai.2003.1585; Arasu MV, 2013, J APPL MICROBIOL, V115, P1172, DOI 10.1111/jam.12319; Benavente CA, 2009, CURR PHARM DESIGN, V15, P29, DOI 10.2174/138161209787185760; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Bull MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07202; Dhanasekaran AR, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0462-y; Di Cagno R, 2013, FOOD MICROBIOL, V33, P1, DOI 10.1016/j.fm.2012.09.003; Dickinson JR, 1998, J BIOL CHEM, V273, P25751, DOI 10.1074/jbc.273.40.25751; Elli M, 2000, J APPL MICROBIOL, V88, P695, DOI 10.1046/j.1365-2672.2000.01013.x; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Huang CC, 2014, ASIAN J COMPLEMENT A, V2, P12; Huang PX, 2015, ONCOTARGET, V6, P10812, DOI 10.18632/oncotarget.3580; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Kandler O., 1986, BERGEYS MANUAL SYSTE, P1208; Karthikeyan K, 2002, INT J DERMATOL, V41, P476, DOI 10.1046/j.1365-4362.2002.01551.x; KILARA A, 1978, J DAIRY SCI, V61, P1793, DOI 10.3168/jds.S0022-0302(78)83805-3; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lee Won Sup, 2015, Asian Pac J Cancer Prev, V16, P465; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Mozzi F, 2013, FOOD RES INT, V54, P1152, DOI 10.1016/j.foodres.2012.11.010; Murray MF, 2003, CLIN INFECT DIS, V36, P453, DOI 10.1086/367544; Murray MF, 1999, MED HYPOTHESES, V53, P375, DOI 10.1054/mehy.1999.0908; Okano K, 2009, APPL ENVIRON MICROB, V75, P5175, DOI 10.1128/AEM.00573-09; Park HJ, 2015, J ETHNOPHARMACOL, V170, P210, DOI 10.1016/j.jep.2015.04.012; Plumed-Ferrer C, 2008, APPL ENVIRON MICROB, V74, P5349, DOI 10.1128/AEM.00324-08; Romeo T, 2005, ECOSAL PLUS, P1; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schachter M, 2005, CARDIOVASC DRUG THER, V19, P415, DOI 10.1007/s10557-005-5685-0; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Siragusa S, 2014, J PROTEOMICS, V96, P366, DOI 10.1016/j.jprot.2013.11.003; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soudijn W, 2007, MED RES REV, V27, P417, DOI 10.1002/med.20102; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Tomaszewska E, 2012, J PHYSIOL PHARMACOL, V63, P547; Tsuji A, 2013, ENZYME MICROB TECH, V53, P97, DOI 10.1016/j.enzmictec.2013.04.008; Wolfe AJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0014-2014; [No title captured]	50	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181280	10.1371/journal.pone.0181280	http://dx.doi.org/10.1371/journal.pone.0181280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704842	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700120
J	Lau, JK; Chow, V; Brown, A; Kritharides, L; Ng, ACC				Lau, Jerrett K.; Chow, Vincent; Brown, Alex; Kritharides, Leonard; Ng, Austin C. C.			Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; HYPONATREMIA; INDEX; EPIDEMIOLOGY; METAANALYSIS; DIAGNOSIS; SEVERITY; OUTCOMES	Background Pulmonary embolism continues to be a significant cause of death. The aim was to derive and validate a risk prediction model for in-hospital death after acute pulmonary embolism to identify low risk patients suitable for outpatient management. Methods A confirmed acute pulmonary embolism database of 1,426 consecutive patients admitted to a tertiary-center (2000-2012) was analyzed, with odd and even years as derivation and validation cohorts respectively. Risk stratification for in-hospital death was performed using multivariable logistic-regression modelling. Models were compared using receiver-operating characteristic-curve and decision curve analyses. Results In-hospital mortality was 3.6% in the derivation cohort (n = 693). Adding day-1 sodium and bicarbonate to simplified Pulmonary Embolism Severity Index (sPESI) significantly increased the C-statistic for predicting in-hospital death (0.71 to 0.86, P = 0.001). The validation cohort yielded similar results (n = 733, C-statistic 0.85). The new model was associated with a net reclassification improvement of 0.613, and an integrated discrimination improvement of 0.067. The new model also increased the C-statistic for predicting 30-day mortality compared to sPESI alone (0.74 to 0.83, P = 0.002). Decision curve analysis demonstrated superior clinical benefit with the use of the new model to guide admission for pulmonary embolism, resulting in 43 fewer admissions per 100 presentations based on a risk threshold for admission of 2%. Conclusions A risk model incorporating sodium, bicarbonate, and the sPESI provides accurate risk prediction of acute in-hospital mortality after pulmonary embolism. Our novel model identifies patients with pulmonary embolism who are at low risk and who may be suitable for outpatient management.	[Lau, Jerrett K.; Chow, Vincent; Kritharides, Leonard; Ng, Austin C. C.] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia; [Brown, Alex] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Concord Repatriation General Hospital; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Ng, ACC (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia.	chin.ng@sydney.edu.au	Ng, Austin Chin Chwan/AAQ-3192-2021; Kritharides, Leonard/AAQ-2720-2020	Brown, Alex/0000-0003-2112-3918	NHMRC/National Heart Foundation of Australia Postgraduate Scholarship [1094384]; Viertel Senior Medical Research Fellowship; NHMRC Program grant [1037903]	NHMRC/National Heart Foundation of Australia Postgraduate Scholarship; Viertel Senior Medical Research Fellowship; NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia)	Dr J.K. Lau is supported by a NHMRC/National Heart Foundation of Australia Postgraduate Scholarship (1094384). Professor A. Brown is supported by a Viertel Senior Medical Research Fellowship. Professor L. Kritharides is supported by NHMRC Program grant (1037903). No sponsors had a role in the study design, data collection, data analysis, data interpretation, or writing of the report. There was no additional external funding received for this study.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Ng ACC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061966; Becattini C, 2001, THROMB RES, V103, pV239, DOI 10.1016/S0049-3848(01)00291-2; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Berend K, 2014, NEW ENGL J MED, V371, P1434, DOI 10.1056/NEJMra1003327; Binder L, 2005, CIRCULATION, V112, P1573, DOI 10.1161/CIRCULATIONAHA.105.552216; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forfia PR, 2008, AM J RESP CRIT CARE, V177, P1364, DOI 10.1164/rccm.200712-1876OC; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Haley H, 2010, AM J MED SCI, V340, P42, DOI 10.1097/MAJ.0b013e3181e5939e; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2008, AM J RESP CRIT CARE, V178, P425, DOI 10.1164/rccm.200803-459OC; Marini C, 2010, INTERN EMERG MED, V5, P235, DOI 10.1007/s11739-010-0354-0; Moutzouris JP, 2014, J AM GERIATR SOC, V62, P2004, DOI 10.1111/jgs.13063; Murin S, 2002, THROMB HAEMOSTASIS, V88, P407; National Research Council, 2008, INSTR CLASS UND CAUS, P20001; Ng ACC, 2011, CIRC-CARDIOVASC QUAL, V4, P122, DOI 10.1161/CIRCOUTCOMES.110.958397; Scherz N, 2010, AM J RESP CRIT CARE, V182, P1178, DOI 10.1164/rccm.201003-0481OC; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	25	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179755	10.1371/journal.pone.0179755	http://dx.doi.org/10.1371/journal.pone.0179755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704383	Green Published, gold			2022-12-26	WOS:000405649700016
J	Sausville, LN; Jones, CC; Aldrich, MC; Blot, WJ; Pozzi, A; Williams, SM				Sausville, Lindsay N.; Jones, Carissa C.; Aldrich, Melinda C.; Blot, William J.; Pozzi, Ambra; Williams, Scott M.			Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival	PLOS ONE			English	Article							SOUTHERN COMMUNITY COHORT; ACTIVATED RECEPTOR-ALPHA; PROGNOSTIC-SIGNIFICANCE; FEMALE GENDER; GROWTH-FACTOR; EXPRESSION; 15-LIPOXYGENASE-2; OVEREXPRESSION; INHIBITION; CLONING	Globally, lung cancer results in more deaths worldwide than any other cancer, indicating a need for better treatments. Members of the eicosanoid metabolism pathway represent promising therapeutic targets, as several enzymes involved in the generation of these lipids are dysregulated in many cancers and their inhibition reduces lung cancer growth in mouse models. However, genetic variation of enzymes involved in eicosanoid metabolism has not been adequately examined for association with lung cancer. The goal of this study was to determine whether germline genetic variation altering eicosanoid producing enzyme function and/or expression are associated with differences in lung cancer survival. We examined the association of genetic variation with mortality within eicosanoid metabolism genes in 395 non-small-cell lung cancer (NSCLC) cases from the Southern Community Cohort Study (SCCS). A total of 108 SNPs, both common and rare, in 19 genes, were examined for association. No common or rare variants were associated with lung cancer survival across the entire study population. However, rare variants in ALOX15B (arachidonate 15-lipoxygenase, type B) and the common variant rs12529 in AKR1C3 (prostaglandin F synthase) were associated with NSCLC mortality in women and African Americans, respectively. Rare variants in ALOX15B were associated with greater mortality in women (HR = 2.10, 95% CI = 1.25-3.54, p-value = 0.005). The major allele of rs12529 in AKCR1C3 associated with improved survival in African Americans (HR = 0.74, 95% CI = 0.59-0.92, p-value = 0.008). The lack of genetic associations among all NSCLC cases and the association among women only for rare variants in ALOX15B may, in part, explain the better NSCLC survival observed among women. These results raise the possibility that some subgroups within the NSCLC population may benefit from drugs targeting eicosanoid metabolism.	[Sausville, Lindsay N.; Williams, Scott M.] Dartmouth Coll, Dept Genet, Geisel Sch Med, Hanover, NH 03755 USA; [Sausville, Lindsay N.; Williams, Scott M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Jones, Carissa C.; Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Jones, Carissa C.; Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.; Blot, William J.] Vanderbilt Univ, Sch Med, Div Epidemiol, Nashville, TN 37212 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Pozzi, Ambra] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Pozzi, Ambra] Vet Affairs Hosp, Dept Med, Nashville, TN 37212 USA	Dartmouth College; Case Western Reserve University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Williams, SM (corresponding author), Dartmouth Coll, Dept Genet, Geisel Sch Med, Hanover, NH 03755 USA.; Williams, SM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.; Pozzi, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.; Pozzi, A (corresponding author), Vet Affairs Hosp, Dept Med, Nashville, TN 37212 USA.	ambra.pozzi@vanderbilt.edu; smw154@case.edu	Williams, Scott/Q-4812-2019	Williams, Scott/0000-0002-4835-9544	National Cancer Institute of the National Institutes of Health, USDA [R01CA092447, R01CA162433]; NATIONAL CANCER INSTITUTE [R01CA162433, K07CA172294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health, USDA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Cancer Institute of the National Institutes of Health, USDA numbers R01CA092447 and R01CA162433 (https://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript	ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632; Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Aldrich MC, 2013, J THORAC ONCOL, V8, P1248, DOI 10.1097/JTO.0b013e3182a406f6; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Araujo JM, 2016, ONCOTARGET; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batevik R, 2005, LUNG CANCER, V47, P173, DOI 10.1016/j.lungcan.2004.08.014; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Brabender J, 2002, ANN SURG, V235, P440, DOI 10.1097/00000658-200203000-00017; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Chang J, 2015, PLOS ONE, V10; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howlader N, 2013, SEER CANC STAT REV 1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Keightley MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-488; Keightley MC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-8; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MY, 2012, CURR CANCER DRUG TAR, V12, P597; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Nakamura H, 2011, ANN THORAC CARDIOVAS, V17, P469, DOI 10.5761/atcs.oa.10.01637; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Sales KJ, 2005, CANCER RES, V65, P7707, DOI 10.1158/0008-5472.CAN-05-0101; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Skrypnyk N, 2014, CANCER RES, V74, P621, DOI 10.1158/0008-5472.CAN-13-1928; Society AC, 2013, CANC FACTS FIG 2015; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Soumya SJ, 2013, BIOCHEM CELL BIOL, V91, P498, DOI 10.1139/bcb-2013-0037; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Wallace AE, 2011, MOL CELL ENDOCRINOL, V331, P129, DOI 10.1016/j.mce.2010.08.018; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wheatley-Price P, 2010, ANN ONCOL, V21, P2023, DOI 10.1093/annonc/mdq067; Yarla NS, 2016, SEMINARS CANC BIOL; Yuan HL, 2010, THORAX, V65, P321, DOI 10.1136/thx.2009.122747; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	62	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180471	10.1371/journal.pone.0180471	http://dx.doi.org/10.1371/journal.pone.0180471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704416	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700040
J	Gamell, A; Luwanda, LB; Kalinjuma, AV; Samson, L; Ntamatungiro, AJ; Weisser, M; Gingo, W; Tanner, M; Hatz, C; Letang, E; Battegay, M				Gamell, Anna; Luwanda, Lameck Bonaventure; Kalinjuma, Aneth Vedastus; Samson, Leila; Ntamatungiro, Alex John; Weisser, Maja; Gingo, Winfrid; Tanner, Marcel; Hatz, Christoph; Letang, Emilio; Battegay, Manuel		KIULARCO Study Grp	Prevention of mother-to-child transmission of HIV Option B plus cascade in rural Tanzania: The One Stop Clinic model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; PREGNANCY; RETENTION	Background Strategies to improve the uptake of Prevention of Mother-To-Child Transmission of HIV (PMTCT) are needed. We integrated HIV and maternal, newborn and child health services in a One Stop Clinic to improve the PMTCT cascade in a rural Tanzanian setting. Methods The One Stop Clinic of Ifakara offers integral care to HIV-infected pregnant women and their families at one single place and time. All pregnant women and HIV-exposed infants attended during the first year of Option B+ implementation (04/2014-03/2015) were included. PMTCT was assessed at the antenatal clinic (ANC), HIV care and labour ward, and compared with the pre-B+ period. We also characterised HIV-infected pregnant women and evaluated the MTCT rate. Results 1,579 women attended the ANC. Seven (0.4%) were known to be HIV-infected. Of the remainder, 98.5% (1,548/1,572) were offered an HIV test, 94% (1,456/1,548) accepted and 38 (2.6%) tested HIV-positive. 51 were re-screened for HIV during late pregnancy and one had seroconverted. The HIV prevalence at the ANC was 3.1% (46/1,463). Of the 39 newly diagnosed women, 35 (90%) were linked to care. HIV test was offered to >98% of ANC clients during both the pre-and post-B+ periods. During the post-B+ period, test acceptance (94% versus 90.5%, p<0.0001) and linkage to care (90% versus 26%, p<0.0001) increased. Ten additional women diagnosed outside the ANC were linked to care. 82% (37/ 45) of these newly-enrolled women started antiretroviral treatment (ART). After a median time of 17 months, 27% (12/45) were lost to follow-up. 79 women under HIV care became pregnant and all received ART. After a median follow-up time of 19 months, 6% (5/79) had been lost. 5,727 women delivered at the hospital, 20% (1,155/5,727) had unknown HIV serostatus. Of these, 30% (345/1,155) were tested for HIV, and 18/345 (5.2%) were HIV-positive. Compared to the pre-B+ period more women were tested during labour (30% versus 2.4%, p<0.0001). During the study, the MTCT rate was 2.2%. Conclusions The implementation of Option B+through an integrated service delivery model resulted in universal HIV testing in the ANC, high rates of linkage to care, and MTCT below the elimination threshold. However, HIV testing in late pregnancy and labour, and retention during early ART need to be improved.	[Gamell, Anna; Luwanda, Lameck Bonaventure; Kalinjuma, Aneth Vedastus; Samson, Leila; Ntamatungiro, Alex John; Weisser, Maja; Letang, Emilio] United Republ Tanzania, Ifakara Hlth Inst, Ifakara, Tanzania; [Gamell, Anna; Weisser, Maja; Tanner, Marcel; Hatz, Christoph; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gamell, Anna; Weisser, Maja; Tanner, Marcel; Hatz, Christoph; Letang, Emilio; Battegay, Manuel] Univ Basel, Basel, Switzerland; [Gingo, Winfrid] St Francis Referral Hosp, Ifakara, Tanzania; [Letang, Emilio] Hosp Clin Univ Barcelona, ISGlobal, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Basel	Gamell, A (corresponding author), United Republ Tanzania, Ifakara Hlth Inst, Ifakara, Tanzania.; Gamell, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Gamell, A (corresponding author), Univ Basel, Basel, Switzerland.	anna.gamell@unibas.ch		Ntamatungiro, Alex/0000-0002-3134-3992; Weisser, Maja/0000-0002-0134-1929; Kalinjuma, Aneth Vedastus/0000-0001-5862-9264	Ministry of Health and Social Welfare of Tanzania; Swiss Tropical and Public Health Institute; Ifakara Health Institute; Government of the Canton of Basel; USAID through the local implementer TUNAJALI-Deloitte; Merck for Mothers Global Giving Program [10937]	Ministry of Health and Social Welfare of Tanzania; Swiss Tropical and Public Health Institute; Ifakara Health Institute; Government of the Canton of Basel; USAID through the local implementer TUNAJALI-Deloitte(United States Agency for International Development (USAID)); Merck for Mothers Global Giving Program	The funders of our clinic are: the Ministry of Health and Social Welfare of Tanzania, the Swiss Tropical and Public Health Institute, the Ifakara Health Institute, the Government of the Canton of Basel, USAID through the local implementer TUNAJALI-Deloitte, and the Merck for Mothers Global Giving Program (grant number 10937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, AIDS, V27, pS235, DOI 10.1097/QAD.0000000000000099; Aliyu MH, 2016, LANCET HIV, V3, pE202, DOI 10.1016/S2352-3018(16)00018-7; [Anonymous], 2016, CHILDR HIV FACTSH JU; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Chan AK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20672; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Gamell A, 2016, JAIDS-J ACQ IMM DEF, V73, pE67, DOI 10.1097/QAI.0000000000001178; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123275; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Letang E, 2017, SWISS MED W IN PRESS; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Ministry of Health and Social Welfare (MoHSW), 2013, NAT GUID COMPR CAR S; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Muri L, 2016, AIDS LOND ENGL; Ramirez-Mena A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw162; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; Tanzanian MoHSW, 2015, NAT GUID MAN HIV AID; Tanzanian NBS, 2012, POP HOUS CENS 2012 M; Tenthani L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-140; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2016, CONGUID UANT DRU; WHO, 2004, US ANT DRUGS TREAT P; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Health Organization, 2014, GLOB GUID CRIT PROC; Wudineh F, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/3262746	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181096	10.1371/journal.pone.0181096	http://dx.doi.org/10.1371/journal.pone.0181096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704472	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000405649600059
J	Goto, A; Tanaka, M; Yoshida, M; Umakoshi, M; Nanjo, H; Shiraishi, K; Saito, M; Kohno, T; Kuriyama, S; Konno, H; Imai, K; Saito, H; Minamiya, Y; Maeda, D				Goto, Akiteru; Tanaka, Masamitsu; Yoshida, Makoto; Umakoshi, Michinobu; Nanjo, Hiroshi; Shiraishi, Kouya; Saito, Motonobu; Kohno, Takashi; Kuriyama, Sei; Konno, Hayato; Imai, Kazuhiro; Saito, Hajime; Minamiya, Yoshihiro; Maeda, Daichi			The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; MICRORNA-451 INCREASES; UP-REGULATION; STEM-CELLS; ADENOCARCINOMA; CARCINOMA; CHEMORESISTANCE; PROLIFERATION; SENSITIVITY; APOPTOSIS	Purpose miR-451 is a tumor suppressive microRNA with several target genes, including Macrophage migration inhibitory factor (MIF). As little is known about the expression and clinicopathological significance of mir-451 in NSCLC, we performed a clinicopathological study of 370 NSCLC cases to clarify them. Cell biological experiments were also performed on NSCLC cell lines to confirm the tumor-suppressive role of miR-451 and whether or not MIF is targeted by miR-451. Methods We analyzed 370 NSCLC cases for the miR-451 expression by quantitative real-time polymerase chain reaction and the MIF expression by immunohistochemistry. Eighty-four background lung tissue samples were also evaluated for the miR-451 expression. The clinicopathological and genetic factors surveyed were the disease-free survival, smoking status, histological type, disease stage, EGFR gene mutations and ALK rearrangements. In 286 adenocarcinoma cases, the invasive status (adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma) was also evaluated. Five NSCLC cell lines (H23, H441, H522, H1703, and H1975) were cultured and evaluated for their miR-451 and MIF expression. The cell lines with lower miR-451 and higher MIF expressions were then selected and transfected with miR-451-mimic to observe its effects on MIF expression, Akt and Erk status, cell proliferation, and cell migration. Results The miR-451 expression was down-regulated in cancer tissues compared with background lung tissues (P<0.0001). Factors such as advanced disease stage, positive pleural invasion and nodal status and being a smoker were significantly correlated with a lower expression of miR-451 (P<0.05 each), while EGFR gene mutations and ALK rearrangements were not. In adenocarcinoma, invasive and minimally invasive adenocarcinoma showed lower expression of miR-451 than adenocarcinoma in situ (P<0.0005, respectively). A survival analysis showed that a lower expression of miR-451 was an independent predictor of a poor prognosis for NSCLC (P<0.05). The MIF expression was inversely correlated with the miR-451 expression. Out of 5 NSCLC cell lines examined, H441 and H1975 showed higher MIF and lower miR-451 expressions. After the transfection of miR-451-mimic, the MIF expression and phosphorylated Akt expression of these cell lines was suppressed, as were cell proliferation and cell migration. Conclusion This clinicopathological study of 370 NSCLC cases and the cell biological studies of NSCLC cell lines clarified the tumor-suppressive role of miR-451 and its prognostic value. We also validated MIF as a target of miR-451 in NSCLC.	[Goto, Akiteru; Yoshida, Makoto; Umakoshi, Michinobu; Maeda, Daichi] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita, Japan; [Tanaka, Masamitsu; Kuriyama, Sei] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita, Japan; [Nanjo, Hiroshi] Akita Univ Hosp, Dept Clin Pathol, Akita, Japan; [Shiraishi, Kouya; Saito, Motonobu; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Tokyo, Japan; [Konno, Hayato; Imai, Kazuhiro; Saito, Hajime; Minamiya, Yoshihiro] Akita Univ Hosp, Dept Thorac Surg, Akita, Japan	Akita University; Akita University; Akita University; National Cancer Center - Japan; Akita University	Goto, A (corresponding author), Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita, Japan.	akigoto@med.akita-u.ac.jp	Goto, Akiteru/P-5775-2014; Kuriyama, Sei/AAV-2368-2020; Saito, Motonobu/AAQ-3633-2021	Kuriyama, Sei/0000-0002-5502-7177; Saito, Motonobu/0000-0001-5072-3520; Goto, Akiteru/0000-0001-8776-9004	Japan Society for the Promotion of Science [C25460431]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [17K19579] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science C25460431 (http://www.jsps.go.jp/english/) and the Smoking Research Foundation (http://www.srf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen DQ, 2014, EUR J CANCER, V50, P3050, DOI 10.1016/j.ejca.2014.09.008; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Goto A, 2016, HUM PATHOL, V56, P1, DOI 10.1016/j.humpath.2016.04.011; Huang JY, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.82; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Liu N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-123; Liu W, 2017, BIOMED PHARMACOTHER, V87, P621, DOI 10.1016/j.biopha.2016.12.121; Nakaoku T, 2014, CLIN CANCER RES, V20, P3087, DOI 10.1158/1078-0432.CCR-14-0107; Nobre CC, 2016, PATHOL ONCOL RES; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; The Japan Lung Cancer Society, 2017, GEN RUL CLIN PATH RE, V8th; Tian F, 2016, THORAC CANCER, V7, P226, DOI 10.1111/1759-7714.12318; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; von der Thusen JH, 2013, J THORAC ONCOL, V8, P37, DOI 10.1097/JTO.0b013e318276274e; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Warth A, 2015, AM J SURG PATHOL, V39, P793, DOI 10.1097/PAS.0000000000000409; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; White ES, 2003, CLIN CANCER RES, V9, P853; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yokouchi H, 2016, ONCOTARGET; Zhao JW, 2016, J BIOL CHEM, V291, P27343, DOI 10.1074/jbc.M116.740084	32	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181270	10.1371/journal.pone.0181270	http://dx.doi.org/10.1371/journal.pone.0181270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704499	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600069
J	Song, YS; Ha, S; Hsu, H; Ting, LH; Liu, CK				Song, Yun Seong; Ha, Sehoon; Hsu, Hsiang; Ting, Lena H.; Liu, C. Karen			Stair negotiation made easier using novel interactive energy-recycling assistive stairs	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; GENERATING ELECTRICITY; HUMAN WALKING; DESCENT; ASCENT; ADULTS; FORCE; WORK; TASK; GAIT	Here we show that novel, energy-recycling stairs reduce the amount of work required for humans to both ascend and descend stairs. Our low-power, interactive, and modular steps can be placed on existing staircases, storing energy during stair descent and returning that energy to the user during stair ascent. Energy is recycled through event-triggered latching and unlatching of passive springs without the use of powered actuators. When ascending the energy-recycling stairs, naive users generated 17.4 +/- 6.9% less positive work with their leading legs compared to conventional stairs, with the knee joint positive work reduced by 37.7 +/- 10.5%. Users also generated 21.9 +/- 17.8% less negative work with their trailing legs during stair descent, with ankle joint negative work reduced by 26.0 +/- 15.9%. Our low-power energy-recycling stairs have the potential to assist people with mobility impairments during stair negotiation on existing staircases.	[Song, Yun Seong] Missouri Univ Sci & Technol, Dept Mech Engn, Rolla, MO USA; [Ha, Sehoon] Disney Res, Pittsburgh, PA USA; [Hsu, Hsiang] Georgia Inst Technol, Dept Mech Engn, Atlanta, GA 30332 USA; [Ting, Lena H.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Ting, Lena H.] Emory Univ, Atlanta, GA 30322 USA; [Ting, Lena H.] Emory Univ, Div Phys Therapy, Dept Rehabil Med, Atlanta, GA 30322 USA; [Liu, C. Karen] Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA	University of Missouri System; Missouri University of Science & Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Liu, CK (corresponding author), Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA.	karenliu@cc.gatech.edu		Song, Yun Seong/0000-0003-1826-586X	National Science Foundation (NSF) [EFRI-1137229]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR016151] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Science Foundation (NSF), Grant EFRI-1137229.	[Anonymous], 2011, US ENERGY INFORM ADM; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Dolbow DR, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0826; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Firth S, 2008, ENERG BUILDINGS, V40, P926, DOI 10.1016/j.enbuild.2007.07.005; Granstrom J, 2007, SMART MATER STRUCT, V16, P1810, DOI 10.1088/0964-1726/16/5/036; Hall M, 2016, HIP BIOMECHANICS STA; Hayashida J. Y., 2000, UNOBTRUSIVE INTEGRAT; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; LaStayo PC, 2003, J ORTHOP SPORT PHYS, V33, P557, DOI 10.2519/jospt.2003.33.10.557; LaStayo PC, 2003, J GERONTOL A-BIOL, V58, P419, DOI 10.1093/gerona/58.5.M419; Liu C. Karen, 2012, GITGVU15011 SCH INT; MCFADYEN BJ, 1988, J BIOMECH, V21, P733, DOI 10.1016/0021-9290(88)90282-5; McLaughlin P, 2013, CLIN BIOMECH, V28, P672, DOI 10.1016/j.clinbiomech.2013.05.008; Morlock M, 2001, J BIOMECH, V34, P873, DOI 10.1016/S0021-9290(01)00035-5; Nadeau S, 2003, CLIN BIOMECH, V18, P950, DOI 10.1016/S0268-0033(03)00179-7; Niu P, 2004, IEEE POWER ELECTRON, P2100, DOI 10.1109/PESC.2004.1355442; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Preece SJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1209-2; Pynoos J, 2009, GENERATIONS, V33, P26; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Riemer R, 2010, 1 INT C APPL BION BI, P14; Riemer R, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-22; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Routson RL, 2010, EFFECTS VARYING SPEE; Schertzer E, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0023-7; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Startzell J, 2000, J AM GERIATRICS SOC, V48; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Williamson JD, 1996, J AM GERIATR SOC, V44, P1429, DOI 10.1111/j.1532-5415.1996.tb04066.x	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179637	10.1371/journal.pone.0179637	http://dx.doi.org/10.1371/journal.pone.0179637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700719	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600009
J	Mikami, K; Shiraishi, M; Kawasaki, T; Kamo, T				Mikami, Kyohei; Shiraishi, Makoto; Kawasaki, Tsubasa; Kamo, Tsutomu			Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position	PLOS ONE			English	Article							PROGRESSION; IMPAIRMENT; POSTURE	Purpose No method has been established to evaluate the dissociation between subjective and objective vertical positions with respect to the self-awareness of postural deformity in patients with Parkinson's disease (PD). The purpose of this study was to demonstrate, from the relationship between an assessment of the dissociation of subjective and objective vertical positions of PD patients and an assessment based on established PD clinical evaluation scales, that the dissociation regarding vertical position is a factor in the severity of the forward flexion of trunk (FFT). Methods Subjects were 39 PD patients and 15 age-matched healthy individuals (control group). Posture was evaluated with measurement of FFT angle during static standing and the subjective vertical position (SV) of the patient. For evaluation of motor function, the Modified Hoehn & Yahr scale, Unified Parkinson's Disease Rating Scale (UPDRS), 3-m Timed Up and Go Test ( TUG), and Functional Reach Test (FRT) were used. Results In PD patients, FFT angle in the 3rd tertile of patients was 13.8 +/- 9.7 E, significantly greater than those in the control group and the 1st and 2nd tertiles of PD patients ( control group vs 3rd tertile, p = 0.008; 1st tertile vs 3rd tertile, p< 0.001; 2nd vs 3rd tertile, p = 0.008). In multiple regression analysis for factors in the FFT angle, significant factors were SV, disease duration, and the standard deviation of each SV angle measurement. Conclusion The dissociation between SV and objective vertical position affects the FFT of PD patients, suggesting an involvement of non-basal ganglia pathologies.	[Mikami, Kyohei] Noborito Neurol Clin, Dept Rehabil, Kawasaki, Kanagawa, Japan; [Shiraishi, Makoto] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kawasaki, Tsubasa] Ryotokuji Univ, Fac Hlth Sci, Dept Phys Therapy, 5-8-1 Akemi, Urayasu, Chiba, Japan; [Kamo, Tsutomu] Noborito Neurol Clin, Dept Neurol, Kawasaki, Kanagawa, Japan; [Mikami, Kyohei] Noborito Neurol Clin, Tama Ku, 434 Nobotitoshinmachi, Kawasaki, Kanagawa, Japan; [Shiraishi, Makoto] St Marianna Univ, Sch Med, Div Neurol, Miyamae Ku, 2-16-1Sugao, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Mikami, K (corresponding author), Noborito Neurol Clin, Dept Rehabil, Kawasaki, Kanagawa, Japan.; Mikami, K (corresponding author), Noborito Neurol Clin, Tama Ku, 434 Nobotitoshinmachi, Kawasaki, Kanagawa, Japan.	kyo.mikami@gmail.com						[Anonymous], 1995, JPN J REHABIL MED, V32, P208; Azher SN, 2005, NEUROLOGY, V65, P355, DOI 10.1212/01.wnl.0000171857.09079.9f; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Benninger F, 2015, GAIT POSTURE, V42, P263, DOI 10.1016/j.gaitpost.2015.05.015; Bergmann J, 2015, ATTEN PERCEPT PSYCHO, V77, P953, DOI 10.3758/s13414-014-0815-z; BONNET AM, 1987, NEUROLOGY, V37, P1539, DOI 10.1212/WNL.37.9.1539; Broussolle E, 2007, MOVEMENT DISORD, V22, P909, DOI 10.1002/mds.21484; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; DIETZ V, 1988, ANN NEUROL, V24, P660, DOI 10.1002/ana.410240511; Djaldetti R, 2004, MOVEMENT DISORD, V19, P1325, DOI 10.1002/mds.20187; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; DUVOISIN RC, 1975, J NEUROL NEUROSUR PS, V38, P787, DOI 10.1136/jnnp.38.8.787; EKBOM K, 1972, Z NEUROL, V202, P94, DOI 10.1007/BF00316159; GOETZ CG, 1987, NEUROLOGY, V37, P695, DOI 10.1212/WNL.37.4.695; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; HUBER SJ, 1988, J NEUROL NEUROSUR PS, V51, P855, DOI 10.1136/jnnp.51.6.855; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Karnath HO, 2000, NEUROLOGY, V55, P1298, DOI 10.1212/WNL.55.9.1298; Khlebtovsky A, 2017, J NEUROL, V264, P675, DOI 10.1007/s00415-017-8402-6; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Ninomiya S, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/462143; Poewe WH, 1998, ANN NEUROL, V44, pS1, DOI 10.1002/ana.410440703; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; Shiraishi M., 2016, ADV PARKINSONS DIS, V5, P7, DOI [10.4236/apd.2016.52002, DOI 10.4236/APD.2016.52002]; Tagliabue M, 2009, NEUROSCIENCE, V158, P1206, DOI 10.1016/j.neuroscience.2008.12.007; Umapathi T, 2003, J NEUROL NEUROSUR PS, V74, P692; Uzawa A, 2009, MOVEMENT DISORD, V24, P2408, DOI 10.1002/mds.22779; Vaugoyeau M, 2010, J NEUROL SCI, V289, P66, DOI 10.1016/j.jns.2009.08.019	28	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181210	10.1371/journal.pone.0181210	http://dx.doi.org/10.1371/journal.pone.0181210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700731	gold, Green Submitted, Green Published			2022-12-26	WOS:000405544800130
J	Pita, S; Panzera, F; Mora, P; Vela, J; Cuadrado, A; Sanchez, A; Palomeque, T; Lorite, P				Pita, Sebastian; Panzera, Francisco; Mora, Pablo; Vela, Jesus; Cuadrado, Angeles; Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro			Comparative repeatome analysis on Triatoma infestans Andean and Non-Andean lineages, main vector of Chagas disease	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; REPETITIVE DNA; SATELLITE DNA; SEX-CHROMOSOMES; SOUTH-AMERICA; SEQUENCES; EVOLUTIONARY; ORGANIZATION; HETEROPTERA; VARIABILITY	Triatoma infestans is the most important Chagas disease vector in South America. Two main evolutionary lineages, named Andean and non-Andean, have been recognized by geographical distribution, phenetic and genetic characteristics. One of the main differences is the genomic size, varying over 30% in their haploid DNA content. Here we realize a genome wide analysis to compare the repetitive genome fraction (repeatome) between both lineages in order to identify the main repetitive DNA changes occurred during T. infestans differentiation process. RepeatExplorer analysis using Illumina reads showed that both lineages exhibit the same amount of non-repeat sequences, and that satellite DNA is by far the major component of repetitive DNA and the main responsible for the genome size differentiation between both lineages. We characterize 42 satellite DNA families, which are virtually all present in both lineages but with different amount in each lineage. Furthermore, chromosomal location of satellite DNA by fluorescence in situ hybridization showed that genomic variations in T. infestans are mainly due to satellite DNA families located on the heterochromatic regions. The results also show that many satDNA families are located on the euchromatic regions of the chromosomes.	[Pita, Sebastian; Panzera, Francisco] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Mora, Pablo; Vela, Jesus; Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro] Univ Jaen, Area Genet, Dept Biol Expt, Jaen, Spain; [Cuadrado, Angeles] Univ Alcala de Henares, Dept Cell Biol & Genet, Madrid, Spain	Universidad de la Republica, Uruguay; Universidad de Jaen; Universidad de Alcala	Pita, S (corresponding author), Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	spita@fcien.edu.uy	Mora, Pablo/S-5300-2016; Panzera, Francisco/M-9884-2015; Palomeque, Teresa/H-6365-2015; Pita, Sebastián/Z-6090-2019; Cuadrado, Angeles/H-3470-2015; Sanchez, Antonio/N-4174-2015; Martínez, Pedro Lorite/K-6806-2012; Mora-Ruiz, Pablo/U-7587-2019; Vela, Jesus/A-7534-2017	Mora, Pablo/0000-0001-7967-3379; Panzera, Francisco/0000-0001-5148-957X; Palomeque, Teresa/0000-0002-7144-4931; Pita, Sebastián/0000-0002-4102-5808; Cuadrado, Angeles/0000-0003-0089-5249; Sanchez, Antonio/0000-0002-6715-8158; Martínez, Pedro Lorite/0000-0002-9692-5870; Mora-Ruiz, Pablo/0000-0001-7967-3379; Vela, Jesus/0000-0003-2699-3031	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia" - Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association); Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion" [610220]; University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela"	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia" - Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association); Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion"; University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela"	This work was funded by the project grant from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar, Uruguay), Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay), Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) and by the "Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia", sponsor of Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association) for SP and FP. This work was also supported by the Spanish Junta de Andalucia, through the program "Ayudas a Grupos de Investigacion," Group 610220, assigned to PL and TP. This paper is included in the Ph.D. Thesis of Sebastian Pita (Udelar-University of Jaen), partially funded by a grant from the University of Jaen through the program "Ayudas para la realizacion de tesis doctoral en regimen de cotutela."	Altemose N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003628; Bardella VB, 2014, INFECT GENET EVOL, V23, P106, DOI 10.1016/j.meegid.2014.01.035; Bargues MD, 2006, INFECT GENET EVOL, V6, P46, DOI 10.1016/j.meegid.2005.01.006; Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Calderon-Fernandez GM, 2012, MED VET ENTOMOL, V26, P201, DOI 10.1111/j.1365-2915.2011.00978.x; Depickere S, 2012, MEM I OSWALDO CRUZ, V107, P1042, DOI 10.1590/S0074-02762012000800013; Fernandez-Medina RD, 2016, INSECT BIOCHEM MOLEC, V69, P14, DOI 10.1016/j.ibmb.2015.09.003; FRY K, 1977, CELL, V12, P1069, DOI 10.1016/0092-8674(77)90170-2; Heckmann S, 2013, PLANT J, V73, P555, DOI 10.1111/tpj.12054; Hernandez L, 2008, ACTA TROP, V106, P60, DOI 10.1016/j.actatropica.2008.01.006; Hughes SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000233; JONES KW, 1981, HUM GENET, V58, P46; Kumar RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2872; Maumus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094101; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; MIKLOS GLG, 1989, CHROMOSOMA, V98, P194, DOI 10.1007/BF00329683; Monteiro FA, 1999, MEM I OSWALDO CRUZ, V94, P229, DOI 10.1590/S0074-02761999000700037; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Palomeque T, 2005, CHROMOSOME RES, V13, P795, DOI 10.1007/s10577-005-1013-6; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2007, AM J TROP MED HYG, V76, P516, DOI 10.4269/ajtmh.2007.76.516; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Pavlek M, 2015, DNA RES, V22, P387, DOI 10.1093/dnares/dsv021; Pita S, 2017, J MED ENTOMOL, V54, P44, DOI 10.1093/jme/tjw146; Pita S, 2016, COMP CYTOGENET, V10, P427, DOI 10.3897/CompCytogen.v10i3.9960; Pita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114298; Ribeiro T, 2016, CHROMOSOMA, P1; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rovatsos M, 2015, CYTOGENET GENOME RES, V147, P48, DOI 10.1159/000441646; Ruiz-Ruano FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28333; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003; SINGH L, 1982, CELL, V28, P205, DOI 10.1016/0092-8674(82)90338-5; Subramanian S, 2003, BIOINFORMATICS, V19, P681, DOI 10.1093/bioinformatics/btg067; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0	40	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181635	10.1371/journal.pone.0181635	http://dx.doi.org/10.1371/journal.pone.0181635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723933	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800062
J	Richardson, S; Seekaew, P; Koblin, B; Vazquez, T; Nandi, V; Tieu, HV				Richardson, Sharise; Seekaew, Pich; Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van			Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City	PLOS ONE			English	Article							TRANSGENDER WOMEN; TRIALS; WILLINGNESS; RISK; MEN; SEX; ENROLLMENT; INFECTION	Background Black men who have sex with men (MSM), and Transwomen (TW) shoulder disproportionate burden of HIV. However, they are unrepresented in HIV vaccine trials. We investigated the perceptions of that factors associated with HIV vaccine trials participation among Black MSM and TW in New York. Methods Self-administered online questionnaires were administered to 18-29 years of NYC residents who identified as Black MSM and TW, assessing demographics, awareness and willingness to participate in HIV vaccine trials, barriers and facilitators associated with willingness, and sexual behaviors. Frequency summation was performed to determine barriers and facilitators, and logistic regression analysis was performed to determine factors association with expressed willingness. Results Black MSM and TW who reported engaging in risk behaviors had a 61% lower likelihood of participating in HIV vaccine trials when compared to those who did not report engaging in any risk behavior. Facilitators associated with trial participation were: cash compensation, confidentiality regarding participation, public transportation vouchers, gift cards, and food or grocery vouchers as potential facilitators for trial participation. Conversely, fear of side effects from the vaccine, concerns about testing positive on routine HIV testing due to an HIV vaccine, limited knowledge of research trials, and fear of being judged as HIV-positive were perceived as barriers. Conclusions These findings provided insights into the considerations and perceptions of Black MSM and TW towards HIV vaccine trials. However, further studies are needed to delineate the complex mechanisms underlying the decision-making process and establish approaches to increase study participation in this population.	[Richardson, Sharise] Univ Miami, Sch Med, Miami, FL 33146 USA; [Seekaew, Pich] Thai Red Cross AIDS Res Ctr, Dept Prevent, Bangkok, Thailand; [Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Koblin, Beryl; Vazquez, Tasha; Nandi, Vijay; Tieu, Hong-Van] New York Blood Ctr, New York, NY 10021 USA	University of Miami; Thai Red Cross Society; New York Blood Center; New York Blood Center	Seekaew, P (corresponding author), Thai Red Cross AIDS Res Ctr, Dept Prevent, Bangkok, Thailand.	pich@trcarc.org	Seekaew, Pich/GPJ-9576-2022		National Institutes of Mental Health (NIMH); National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service, HVTN Research and Mentorship Program (RAMP) [UM1 A1068614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069470, UM1AI068614] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service, HVTN Research and Mentorship Program (RAMP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Mental Health (NIMH) and the National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service Grant UM1 A1068614 [LOC: HIV Vaccine Trials Network (HVTN)] as part of the HVTN Research and Mentorship Program (RAMP) Scholar Program (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Castillo-Mancilla JR, 2014, HIV CLIN TRIALS, V15, P14, DOI 10.1310/hct1501-14; Centers for Disease Control and Prevention, 2016, HIV SURV REP 2016, V17, P4; Chu Z, 2013, BIOMED RES INT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dhalla S, 2011, VACCINE, V29, P5850, DOI 10.1016/j.vaccine.2011.06.055; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Jenkins RA, 2000, SEX TRANSM INFECT, V76, P386, DOI 10.1136/sti.76.5.386; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; Mbunda T, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22853; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Newman PA, 2004, JAIDS-J ACQ IMM DEF, V37, P1393, DOI 10.1097/01.qai.0000127064.84325.ad; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saunders KO, 2012, AIDS, V26, P1293, DOI 10.1097/QAD.0b013e32835474d2; Strauss RP, 2001, J ACQ IMMUN DEF SYND, V26, P63, DOI 10.1097/00126334-200101010-00010; Voronin Y, 2015, VACCINE, V33, P1243, DOI 10.1016/j.vaccine.2014.10.040; Wansom T, 2016, J VIRUS ERAD, V2, P87; Wheeler DP, CROI 2016	26	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181702	10.1371/journal.pone.0181702	http://dx.doi.org/10.1371/journal.pone.0181702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723970	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800066
J	Ukibe, NR; Ukibe, SN; Emelumadu, OF; Onyenekwe, CC; Ahaneku, JE; Igwegbe, AO; Monago, IN; Ilika, AL				Ukibe, Nkiruka Rose; Ukibe, Solomon Nwabueze; Emelumadu, Obiageli Fidelia; Onyenekwe, Chinedum Charles; Ahaneku, Joseph Eberendu; Igwegbe, Anthony Osita; Monago, Ifeoma Nwamaka; Ilika, Amobi Linus			Impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in premenopausal HIV infected females at NAUTH, Nnewi, Nigeria	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; SUBCLINICAL HYPOTHYROIDISM; WOMEN; DYSFUNCTION; LEVOTHYROXINE; PREVALENCE; DISORDERS; PATIENT; MEN	Background This was a prospective study designed to evaluate the impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in HIV infected females at Nnamdi Azikiwe University Teaching Hospital Nnewi, South-East Nigeria. Methods The study randomly recruited 35 Symptomatic HIV infected females and 35 Symptomatic HIV infected females on antiretroviral therapy (HAART) for not less than six weeks from an HIV clinic and 40 apparently healthy control females among the hospital staff of NAUTH Nnewi. They were all premenopausal females with regular menstrual cycle and aged between 15-45 years. Blood samples were collected at follicular and luteal phases of their menstrual cycle for assay of Thyroid indices (FT3, FT4 and TSH) and Reproductive indices (FSH, LH, Estrogen, Progesterone, Prolactin and Testosterone) using ELISA method. Results The result showed significantly higher FSH and LH but significantly lower progesterone (prog) and estrogen (E2) in the test females compared to control females at both phases of menstrual cycle (P<0.05). There was significantly lower FT3 but significantly higher TSH value in Symptomatic HIV females (P<0.05). FSH, LH and TSH values were significantly lowered while prog and FT3 were significantly higher in Symptomatic HIV on ART compared to Symptomatic HIV females ( P<0.05). FT3, FT4, Prog and E2 were inversely correlated while FSH and LH were positively correlated with duration of HIV infection in HIV females ( P<0.05 respectively). There was a direct correlation between CD4+ count and FT3 while inverse correlation was found between CD4+ count and TSH levels ( P<0.05). Discussion The present study demonstrated hypothyroidism with a significant degree of primary hypogonadism in Symptomatic HIV infected females at both follicular and luteal phases of menstrual cycle which tends to normalize on treatments.	[Ukibe, Nkiruka Rose; Onyenekwe, Chinedum Charles] Nnamdi Azikiwe Univ, Coll Hlth Sci, Dept Med Lab Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Ukibe, Solomon Nwabueze] Fed Univ Technol Owerri, Dept Prosthesis & Orthot, Sch Hlth Technol, Akure, Imo State, Nigeria; [Emelumadu, Obiageli Fidelia; Ilika, Amobi Linus] Nnamdi Azikiwe Univ, Depatment Community Med, Coll Hlth Sci, Nnewi, Anambra State, Nigeria; [Ahaneku, Joseph Eberendu] Nnamdi Azikiwe Univ, Dept Chem Pathol, Coll Hlth Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Igwegbe, Anthony Osita] Nnamdi Azikiwe Univ, Dept Obstet & Gynecol, Coll Hlth Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria; [Monago, Ifeoma Nwamaka] Fed Polytech, Dept Med Serv, Oko, Anambra State, Nigeria		Ukibe, NR (corresponding author), Nnamdi Azikiwe Univ, Coll Hlth Sci, Dept Med Lab Sci, Nnewi Campus, Nnewi, Anambra State, Nigeria.	ezinne4real2007@yahoo.com		Ahaneku, Joseph/0000-0003-0393-3984; Onyenekwe, Chinedum Charles/0000-0001-6181-9835	TETFUND through Nnamdi Azikiwe University, Awka, Nigeria [ETF/ES/NAUNIV/AWKA/VOL.1]	TETFUND through Nnamdi Azikiwe University, Awka, Nigeria	This work was funded by TETFUND through Nnamdi Azikiwe University, Awka, Nigeria. ETF/ES/NAUNIV/AWKA/VOL.1.	Aghajanova L, 2009, REPROD BIOMED ONLINE, V18, P337, DOI 10.1016/S1472-6483(10)60091-0; Ajayi AF, 2013, W INDIAN MED J, V62, P835, DOI 10.7727/wimj.2013.038; Atis G, 2010, J SEX MED, V7, P2583, DOI 10.1111/j.1743-6109.2010.01815.x; Hapon MB, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-14; Beltran S, 2003, CLIN INFECT DIS, V37, P579, DOI 10.1086/376626; Binita G, 2009, J REPROD INFERTIL, V10, P207; Bongiovanni M, 2006, J ANTIMICROB CHEMOTH, V58, P1086, DOI 10.1093/jac/dkl360; Brent GA, 2011, WILLIAMS TXB ENDOCRI, P412; Brockmeyer NH, 2000, HORM RES, V54, P294, DOI 10.1159/000053274; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cedikova M, 2012, Ceska Gynekol, V77, P471; Chirgwin KD, 1996, J ACQ IMMUN DEF SYND, V12, P489, DOI 10.1097/00042560-199608150-00008; Croxson TS, 1990, CRIT CARE MED, V18, P440; DOBS AS, 1988, AM J MED, V84, P611, DOI 10.1016/0002-9343(88)90144-1; Friedman TC, 2012, THYROID MENSTRUATION; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P1332, DOI 10.1210/jc.82.5.1332; Grinspoon SK., 2011, WILLIAM TXB ENDOCRIN, P1675; GRUNFELD C, 1993, METABOLISM, V42, P1270, DOI 10.1016/0026-0495(93)90124-7; Hampl R, 2003, THYROID, V13, P755, DOI 10.1089/105072503768499644; Henrik N., 1999, LANCET, V6, P56; Hoffmann CJ, 2007, CLIN INFECT DIS, V45, P488, DOI 10.1086/519978; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hutchinson A, 2000, LANCET, V356, P1003, DOI 10.1016/S0140-6736(00)02697-0; Karim R, 2013, J CLIN ENDOCR METAB, V98, pE610, DOI 10.1210/jc.2012-3195; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Krassas GE, 2013, WERNER INGBARS THYRO, P585; Krassas GE, 2008, THYROID, V18, P1255, DOI 10.1089/thy.2008.0257; Lanzafame M, 2002, INFECTION, V30, P54, DOI 10.1007/s15010-002-2092-3; Madeddu G, 2006, NAT CLIN PRACT ENDOC, V2, P602; Mandal SK, 2013, INT RES J PHARM, V4, P220; Meena L P, 2011, J Assoc Physicians India, V59, P365; Mylonakis E, 2001, CLIN INFECT DIS, V33, P857, DOI 10.1086/322695; Neema A, 2011, J OBSTET GYN INDIA, V61, P550, DOI 10.1007/s13224-011-0079-7; Norman J., 2001, JEFFCOATES PRINCIPLE, P60; Redmond GP, 2004, THYROID, V14, pS5, DOI 10.1089/105072504323024543; RicartEngel W, 1996, CLIN ENDOCRINOL, V44, P53, DOI 10.1046/j.1365-2265.1996.623445.x; da Silva GAR, 2015, ARCH ENDOCRIN METAB, V59, P116, DOI 10.1590/2359-3997000000023; Rosenfeld C R, 1999, AIDS Read, V9, P393; Salim YS, 1998, ACTA PATHOL MIC SC, V96, P889; San Francisco AIDS foundation, 2014, HIV AND HORMONES; Saran Sanjay, 2016, Indian J Endocrinol Metab, V20, P108, DOI 10.4103/2230-8210.172245; Shomon M., 2012, MENSTRUAL PROBLEMS T; Shujing J, 2016, BIOMED RES INT; Stern L, 2009, CLIN ADVISOR FORUM; Touzot M, 2006, AIDS, V20, P1210, DOI 10.1097/01.aids.0000226969.96880.3c; TRACEY KJ, 1990, ANN NY ACAD SCI, V587, P325, DOI 10.1111/j.1749-6632.1990.tb00173.x; Ukibe NR, 2013, S E NIGERIA ASIAN J, V3, P29; Ukibe NR, 2015, EUR SCI J, V11, P134; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Zhang SS, 1997, MOL HUM REPROD, V3, P555, DOI 10.1093/molehr/3.7.555; Zheng KZ, 2015, REPROD BIOL, V15, P27, DOI 10.1016/j.repbio.2014.11.002	53	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0176361	10.1371/journal.pone.0176361	http://dx.doi.org/10.1371/journal.pone.0176361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723963	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800002
J	Alba, A; Morrison, RE; Cheerer, A; Rovira, A; Alvarez, J; Perez, AM				Alba, Anna; Morrison, Robert E.; Cheerer, Ann; Rovira, Albert; Alvarez, Julio; Perez, Andres M.			Optisample (TM): Open web-based application to optimize sampling strategies for active surveillance activities at the herd level illustrated using Porcine Respiratory Reproductive Syndrome (PRRS)	PLOS ONE			English	Article							SYNDROME VIRUS; DISEASE FREEDOM; SENSITIVITY; ELIMINATION; CHALLENGES	Porcine reproductive and respiratory syndrome virus (PRRSv) infection causes a devastating economic impact to the swine industry. Active surveillance is routinely conducted in many swine herds to demonstrate freedom from PRRSv infection. The design of efficient active surveillance sampling schemes is challenging because optimum surveillance strategies may differ depending on infection status, herd structure, management, or resources for conducting sampling. Here, we present an open web-based application, named 'Optisample (TM)', designed to optimize herd sampling strategies to substantiate freedom of infection considering also costs of testing. In addition to herd size, expected prevalence, test sensitivity, and desired level of confidence, the model takes into account the presumed risk of pathogen introduction between samples, the structure of the herd, and the process to select the samples over time. We illustrate the functionality and capacity of 'Optisample (TM)' through its application to active surveillance of PRRSv in hypothetical swine herds under disparate epidemiological situations. Diverse sampling schemes were simulated and compared for each herd to identify effective strategies at low costs. The model results show that to demonstrate freedom from disease, it is important to consider both the epidemiological situation of the herd and the sample selected.	[Alba, Anna; Morrison, Robert E.; Cheerer, Ann; Alvarez, Julio; Perez, Andres M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Rovira, Albert] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Alba, A (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	aalbacas@umn.edu	Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 	University of Minnesota MnDrive program; US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA)	University of Minnesota MnDrive program; US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA)	This study was funded in part by grants of the University of Minnesota MnDrive program and the US Center of Excellence in Emergingand Zoonotic Animal Diseases (CEEZAD/KBA).	Amezcua R, 2013, CAN VET J, V54, P775; [Anonymous], 2002, 27 SAS US GROUP INT; [Anonymous], 2014, R LANG ENV STAT COMP; Cameron A., 2002, MONOGRAPHS; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; Chang W, 2015, SHINY WEB APPL FRAME; Collins J, 1996, LAB DIAGNOSIS PORCIN; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dean A, 2014, OPENEPI OPEN SOURCE; Dee SA, 2004, J SWINE HEALTH PROD, V12, P129; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Forbes C., 2011, STAT DISTRIBUTIONS; Frossling J, 2009, PREV VET MED, V91, P137, DOI 10.1016/j.prevetmed.2009.05.012; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Holtkamp DJ, 2010, PREV VET MED, V96, P186, DOI 10.1016/j.prevetmed.2010.06.016; Lambert ME, 2012, PREV VET MED, V104, P74, DOI 10.1016/j.prevetmed.2011.12.004; Linhares DCL, 2014, PREV VET MED, V116, P111, DOI 10.1016/j.prevetmed.2014.05.010; Martin PAJ, 2008, PREV VET MED, V84, P291, DOI 10.1016/j.prevetmed.2007.12.002; Martin PAJ, 2007, PREV VET MED, V79, P98, DOI 10.1016/j.prevetmed.2006.09.007; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Pouillot R, 2016, PACKAGE MC2D HIST, V1100, P17; Rovira A, 2007, J VET DIAGN INVEST, V19, P502, DOI 10.1177/104063870701900507; Rowland RRR, 2012, TRANSBOUND EMERG DIS, V59, P55, DOI 10.1111/j.1865-1682.2011.01306.x; Seo BJ, 2016, J VET MED SCI, V78, P133, DOI 10.1292/jvms.15-0126; Sergeant E, 2014, RSURVEILLANCE DESIGN; Stark KDC, 2015, PREV VET MED, V122, P229, DOI 10.1016/j.prevetmed.2015.05.002; Team R, 2015, RSTUDIO INT DEV R; Zimmerman JJ, 1997, VET MICROBIOL, V55, P187, DOI 10.1016/S0378-1135(96)01330-2	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0176863	10.1371/journal.pone.0176863	http://dx.doi.org/10.1371/journal.pone.0176863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719658	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400001
J	Herbomel, GG; Rojas, RE; Tran, DT; Ajinkya, M; Beck, L; Tabak, LA				Herbomel, Gaetan G.; Rojas, Raul E.; Tran, Duy T.; Ajinkya, Monica; Beck, Lauren; Tabak, Lawrence A.			The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucintype O-glycosylation	PLOS ONE			English	Article							BREAST-CANCER; BIOLOGICAL MICROSCOPY; TRANSFERASE FAMILY; EXPRESSION; COLOCALIZATION; GROWTH; SECRETION; ANTIGENS; ADHESION; MEMBERS	Mucin-type O-glycosylation is initiated by the UDP-GalNAc polypeptide: N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. Their activity results in the GalNAc a1-OThr/ Ser structure, termed the Tn antigen, which is further decorated with additional sugars. In neoplastic cells, the Tn antigen is often overexpressed. Because O-glycosylation is controlled by the activity of GalNAc-Ts, their regulation is of great interest. Previous reports suggest that growth factors, EGF or PDGF, induce Golgi complex-to-endoplasmic reticulum (ER) relocation of both GalNAc-Ts and Tn antigen in HeLa cells, offering a mechanism for Tn antigen overexpression termed "GALA". However, we were unable to reproduce these findings. Upon treatment of HeLa cells with either EGF or PDGF we observed no change in the co-localization of endogenous GalNAc-T1, GalNAc-T2 or Tn antigen with the Golgi complex marker TGN46. There was also no enhancement of localization with the ER marker calnexin. We conclude that growth factors do not cause redistribution of GalNAc-Ts from the Golgi complex to the ER in HeLa cells.	[Herbomel, Gaetan G.; Rojas, Raul E.; Tran, Duy T.; Ajinkya, Monica; Beck, Lauren; Tabak, Lawrence A.] Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Tabak, LA (corresponding author), Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA.	Lawrence.Tabak@nih.gov		Tabak, Lawrence/0000-0002-4261-7856	Intramural Research Program of the National Institutes of Health, NICDR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NICDR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the National Institutes of Health, NICDR.; We thank Kanishka Patel for help with experiments, Dr. George Patterson for advice on quantification of confocal microscopy data and providing reagents, and Dr. Kenneth Yamada for critical reading of earlier versions of the manuscript. We thank Dr. Ulla Mendel for providing antibodies to endogenous Ga1NAc-T1 and -T2, and for her review of the manuscript. We thank Drs. Kelly Ten Hagen and George Patterson for reviewing multiple versions of the manuscript. We thank Dr. Frederic Bard for providing us with additional details of his work and a sample of HeLa cells from his lab. This work was supported by the Intramural Research Program of the National Institutes of Health, NICDR.	Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brockhausen I, 2009, BBA-GEN SUBJECTS, V1790, P1244, DOI 10.1016/j.bbagen.2009.05.020; Dam TK, 2007, J BIOL CHEM, V282, P28256, DOI 10.1074/jbc.M704677200; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Gao JX, 2005, ACTA BIOCH BIOPH SIN, V37, P525, DOI 10.1111/j.1745-7270.2005.00076.x; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Kato K, 2008, BIOCHEM BIOPH RES CO, V371, P698, DOI 10.1016/j.bbrc.2008.04.120; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Konno A, 2002, CLIN EXP METASTAS, V19, P61, DOI 10.1023/A:1013879702702; Konska G, 2006, ONCOL REP, V15, P305; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ostuni MA, 2014, BIOL OPEN, V3, P1173, DOI 10.1242/bio.20149845; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Spang A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013391; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179241	10.1371/journal.pone.0179241	http://dx.doi.org/10.1371/journal.pone.0179241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719662	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400004
J	Kamato, D; Bhaskarala, VV; Mantri, N; Oh, TG; Ling, D; Janke, R; Zheng, WH; Little, PJ; Osman, N				Kamato, Danielle; Bhaskarala, Venkata Vijayanand; Mantri, Nitin; Oh, Tae Gyu; Ling, Dora; Janke, Reearna; Zheng, Wenhua; Little, Peter J.; Osman, Narin			RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-BETA RECEPTOR; TGF-BETA; ANGIOTENSIN-II; PROTEOGLYCAN SYNTHESIS; GENE-EXPRESSION; CANCER CELLS; EGF RECEPTOR; CARDIOMYOCYTE HYPERTROPHY; COLORECTAL-CANCER	G protein coupled receptor (GPCR) signalling covers three major mechanisms. GPCR agonist engagement allows for the G proteins to bind to the receptor leading to a classical downstream signalling cascade. The second mechanism is via the utilization of the beta-arrestin signalling molecule and thirdly via transactivation dependent signalling. GPCRs can transactivate protein tyrosine kinase receptors (PTKR) to activate respective downstream signalling intermediates. In the past decade GPCR transactivation dependent signalling was expanded to show transactivation of serine/threonine kinase receptors (S/TKR). Kinase receptor transactivation enormously broadens the GPCR signalling paradigm. This work utilizes next generation RNA-sequencing to study the contribution of transactivation dependent signalling to total protease activated receptor (PAR)-1 signalling. Transactivation, assessed as gene expression, accounted for 50 percent of the total genes regulated by thrombin acting through PAR-1 in human coronary artery smooth muscle cells. GPCR transactivation of PTKRs is approximately equally important as the transactivation of the S/TKR with 209 and 177 genes regulated respectively, via either signalling pathway. This work shows that genome wide studies can provide powerful insights into GPCR mediated signalling pathways.	[Kamato, Danielle; Ling, Dora; Janke, Reearna; Little, Peter J.; Osman, Narin] Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, Woolloongabba, Qld, Australia; [Bhaskarala, Venkata Vijayanand; Mantri, Nitin] RMIT Univ, Sch Appl Sci, Dept Biotechnol & Environm Biol, Bundoora, Vic, Australia; [Oh, Tae Gyu] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Zheng, Wenhua] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China; [Little, Peter J.] Sun Yat Sen Univ, Xinhua Coll, Guangzhou, Guangdong, Peoples R China; [Osman, Narin] RMIT Univ, Sch Hlth & Biomed Sci, Diabet Complicat Grp, Bundoora, Vic, Australia; [Osman, Narin] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Osman, Narin] Monash Univ, Dept Immunol, Cent & Eastern Clin Sch, Alfred Hlth, Melbourne, Vic, Australia	University of Queensland; Royal Melbourne Institute of Technology (RMIT); University of Queensland; University of Macau; Sun Yat Sen University; Royal Melbourne Institute of Technology (RMIT); Monash University; Monash University	Kamato, D (corresponding author), Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, Woolloongabba, Qld, Australia.	d.kamato@uq.edu.au	Little, Peter J./F-9865-2015; Kamato, Danielle/B-5894-2018	Little, Peter J./0000-0002-0335-3835; Kamato, Danielle/0000-0002-1089-2829; Mantri, Nitin/0000-0002-7621-035X; Bhaskarla, Vijay/0000-0002-2514-1171	RMIT University Research and Innovation Strategic Initiative grant; University of Queensland new head of school strategic Fund; Australian Postgraduate Award	RMIT University Research and Innovation Strategic Initiative grant; University of Queensland new head of school strategic Fund; Australian Postgraduate Award(Australian Government)	This work was supported by a RMIT University Research and Innovation 2014 Strategic Initiative grant and the University of Queensland new head of school strategic Fund. DK was supported by an Australian Postgraduate Award.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Burch ML, 2013, J BIOL CHEM, V288, P7410, DOI 10.1074/jbc.M112.400259; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Burch ML, 2010, CELL MOL LIFE SCI, V67, P2077, DOI 10.1007/s00018-010-0315-9; Catanzaro DF, 2010, SOUTH MED J, V103, P669, DOI 10.1097/SMJ.0b013e3181e1e2da; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen H, 2013, MOL THER, V21, P167, DOI [10.1038/mt.2012.225, 10.1038/mt.2013.197]; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Fang Y, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00295; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; George AJ, 2013, J CELL SCI, V126, P5377, DOI 10.1242/jcs.128280; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Ghiselli G, 2016, DRUG DISCOV TODAY, V21, P1162, DOI 10.1016/j.drudis.2016.05.010; Giannopoulou EG, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0677-3; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Hong ZG, 2014, J MOL MED, V92, P995, DOI 10.1007/s00109-014-1162-1; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kamato D, 2016, CELL SIGNAL, V28, P110, DOI 10.1016/j.cellsig.2015.11.003; Kanai H, 2001, CIRC RES, V88, P30, DOI 10.1161/01.RES.88.1.30; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang Y, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00037; Little PJ, 2008, CURR VASC PHARMACOL, V6, P195, DOI 10.2174/157016108784911966; Little PJ, 2010, J CARDIOVASC PHARM, V56, P360, DOI 10.1097/FJC.0b013e3181ee6811; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Moore-Smith L, 2011, J MAMMARY GLAND BIOL, V16, P89, DOI 10.1007/s10911-011-9216-2; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Osman N, 2011, GROWTH FACTORS, V29, P203, DOI 10.3109/08977194.2011.615747; PACKER M, 2001, AM J MED, V110, P81; Pasche Boris, 2014, Trans Am Clin Climatol Assoc, V125, P300; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; RCore Team, 2020, R LANG ENV STAT COMP; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosano L, 2007, CANCER RES, V67, P6351, DOI 10.1158/0008-5472.CAN-07-0883; Rostam MA, 2016, CELLULAR SIGNALLING; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Smiljanic K, 2014, MOL CELL BIOCHEM, V396, P147, DOI 10.1007/s11010-014-2151-y; Song Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/254976; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Spinella F, 2013, J MOL MED, V91, P395, DOI 10.1007/s00109-012-0956-2; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Stockert JA, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00100; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Suzuki R, 2015, J CROHNS COLITIS, V9, P565, DOI 10.1093/ecco-jcc/jjv073; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang XL, 2012, ACTA PHARMACOL SIN, V33, P363, DOI 10.1038/aps.2011.210; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tuteja N, 2009, PLANT SIGNAL BEHAV, V4, P942, DOI 10.4161/psb.4.10.9530; Vacca F, 2000, CANCER RES, V60, P5310; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Xu JZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S2; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yu GL, 2002, CHINESE MED J-PEKING, V115, P1287; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Zhou ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122064; Zhu XJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00085	98	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180842	10.1371/journal.pone.0180842	http://dx.doi.org/10.1371/journal.pone.0180842			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719611	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400019
J	Ota, T; Nishida, Y; Ikuta, K; Kato, R; Kozawa, E; Hamada, S; Sakai, T; Ishiguro, N				Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kato, Ryuji; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki			Heat-stimuli-enhanced osteogenesis using clinically available biomaterials	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CELLULAR-RESPONSES; BONE; HYPERTHERMIA; SHOCK; STRESS; TISSUE; INDUCTION	A recent study reported that heat stress stimulates osteogenesis in an in vivo rat model using alginate gel and magnetite cationic liposomes. However, for clinical use, the efficacy for promoting osteogenesis needs to be investigated using clinically approved materials, and preferably with animals larger than rats. The aim of this study was to evaluate multiple heat stimuli-triggered osteogenesis in rat tibial defect models using already clinically applicable materials (Resovist (R) and REGENOS (R)) and determine the efficacy also in the rabbit. Fifty-eight rats and 10 rabbits were divided into two groups, respectively, with or without hyperthermia treatment at 45 degrees C for 15 min. (hyperthermia; 20 rats once a week, 8 rats three times a week, 5 rabbits once a week, control; 30 rats and 5 rabbits). Micro-CT assessment at 4 weeks revealed that a significantly stimulated osteogenesis was observed in the once a week group of both rats and rabbits as compared to the control group (p = 0.018 and 0.036, respectively). In contrast, the three times a week group did not show enhanced osteogenesis. Histological examination and image analysis showed consistent results in which the area of mineralized bone formation in the once a week hyperthermia group was significantly increased compared with that in the control group at four weeks (rat; p = 0.026, rabbit; p = 0.031). Newly formed bone was observed in the grafted materials from the periphery toward the center, and more osteoclasts were found in the once a week group. Heat stress also induced enhanced alkaline phosphatase expression in cultured osteoblastic cells, MC3T3, in vitro (p = 0.03). On the other hand, heat stress had no obvious effects on chondrogenic differentiation using ATDC5 cells. Our study demonstrates that heat-stimuli with clinically applicable novel heating materials can promote significant osteogenesis, and may thus be a promising treatment option for diseases associated with bone defects.	[Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi, Japan; [Ota, Takehiro; Nishida, Yoshihiro; Ikuta, Kunihiro; Kozawa, Eiji; Hamada, Shunsuke; Sakai, Tomohisa; Ishiguro, Naoki] Sch Med, Nagoya, Aichi, Japan; [Kato, Ryuji] Nagoya Univ, Dept Basic Med Sci, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Kozawa, Eiji] Aichi Canc Ctr Hosp, Unit Orthopaed Surg, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Aichi Cancer Center	Nishida, Y (corresponding author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Nagoya, Aichi, Japan.; Nishida, Y (corresponding author), Sch Med, Nagoya, Aichi, Japan.	ynishida@med.nagoya-u.ac.jp	Kato, Ryuji/I-6952-2014	Nishida, Yoshihiro/0000-0002-7511-6388	Ministry of Education, Culture, Sports, Science and Technology of Japan [26670659]; Nagoya University Hospital	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagoya University Hospital	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Challenging Exploratory Research 26670659], and Nagoya University Hospital Funding for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champagne M-J, 1999, HYPERTENSION, V33; Chen EM, 2015, FEBS LETT, V589, P4088, DOI 10.1016/j.febslet.2015.11.021; Chen J, 2013, TISSUE ENG PT A, V19, P716, DOI [10.1089/ten.tea.2012.0070, 10.1089/ten.TEA.2012.0070]; de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; DOYLE JR, 1963, J BONE JT SURG, V45; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Hilger I, 2013, INT J HYPERTHER, V29, P828, DOI 10.3109/02656736.2013.832815; Ikuta K, 2015, INT J HYPERTHER, V31, P58, DOI 10.3109/02656736.2014.988662; Iwasashi M, 2013, KEY ENG MATER, V529-530, P313, DOI 10.4028/www.scientific.net/KEM.529-530.313; Kajiya H, 2015, INT J HYPERTHER, V31, P635, DOI 10.3109/02656736.2015.1041430; Kobayashi T, 2011, BIOTECHNOL J, V6, P1342, DOI 10.1002/biot.201100045; Lange U, 2016, CLIN RHEUMATOL, V35, P2783, DOI 10.1007/s10067-016-3236-7; Lawaczeck R, 1997, ACTA RADIOL, V38, P584, DOI 10.1080/02841859709174391; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li M, 2014, TISSUE ENG PART C-ME, V20, P328, DOI [10.1089/ten.tec.2013.0087, 10.1089/ten.TEC.2013.0087]; Li S, 1999, J ORTHOP RES, V17, P891, DOI 10.1002/jor.1100170614; Matsumine A, 2011, INT J CLIN ONCOL, V16, P101, DOI 10.1007/s10147-011-0217-3; McDonald MM, 2012, J ORTHOP RES, V30, P1541, DOI 10.1002/jor.22109; Motomura T, 2010, ONCOL REP, V24, P591, DOI 10.3892/or_00000896; Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063; O'Loughlin PF, 2008, J BONE JT SURG, V90; Olkku A, 2010, BONE, V47, P320, DOI 10.1016/j.bone.2010.04.604; Patil S, 2014, CELLS TISSUES ORGANS, V199, P81, DOI 10.1159/000362226; Petryk AA, 2013, INT J HYPERTHER, V29, P845, DOI 10.3109/02656736.2013.825014; RICHARDS V, 1959, SURGERY, V46, P84; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Samali A, 1999, FEBS LETT, V461, P306, DOI 10.1016/S0014-5793(99)01486-6; Sato I, 2014, J PHYSIOL SCI, V64, P177, DOI 10.1007/s12576-014-0309-8; Serrat MA, 2015, J ORTHOP RES; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Shido Y, 2010, J BONE JOINT SURG BR, V92B, P580, DOI 10.1302/0301-620X.92B4.22814; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P235, DOI 10.1109/TBME.1984.325334; STORM FK, 1979, CANCER RES, V39, P2245; Sukenik S, 1999, RHEUM DIS CLIN N AM, V25, P883, DOI 10.1016/S0889-857X(05)70108-3; Takahashi KA, 2009, INT J HYPERTHER, V25, P661, DOI 10.3109/02656730903107519; Uemura K, 2014, J MATER SCI-MATER M, V25, P2541, DOI 10.1007/s10856-014-5266-5; Wang XD, 2003, ARCH BIOCHEM BIOPHYS, V415, P6, DOI 10.1016/S0003-9861(03)00213-3; Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x	43	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181404	10.1371/journal.pone.0181404	http://dx.doi.org/10.1371/journal.pone.0181404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719650	Green Published, gold, Green Submitted			2022-12-26	WOS:000406061400046
J	Pallavali, RR; Degati, VL; Lomada, D; Reddy, MC; Durbaka, VRP				Pallavali, Roja Rani; Degati, Vijaya Lakshmi; Lomada, Dakshayani; Reddy, Madhava C.; Durbaka, Vijaya Raghava Prasad			Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections	PLOS ONE			English	Article							PHAGE THERAPY; ANTIMICROBIAL RESISTANCE; PATHOGENS; PROFILE; SKIN	Multi-drug resistance has become a major problem for the treatment of pathogenic bacterial infections. The use of bacteriophages is an attractive approach to overcome the problem of drug resistance in several pathogens that cause fatal diseases. Our study aimed to isolate multi drug resistant bacteria from patients with septic wounds and then isolate and apply bacteriophages in vitro as alternative therapeutic agents. Pus samples were aseptically collected from Rajiv Gandhi Institute of Medical Science (RIMS), Kadapa, A.P., and samples were analyzed by gram staining, evaluating morphological characteristics, and biochemical methods. MDR-bacterial strains were collected using the Kirby-Bauer disk diffusion method against a variety of antibiotics. Bacteriophages were collected and tested in vitro for lytic activity against MDR-bacterial isolates. Analysis of the pus swab samples revealed that the most of the isolates detected had Pseudomonas aeruginosa as the predominant bacterium, followed by Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli. Our results suggested that gram-negative bacteria were more predominant than gram-positive bacteria in septic wounds; most of these isolates were resistant to ampicillin, amoxicillin, penicillin, vancomycin and tetracycline. All the gram-positive isolates (100%) were multi-drug resistant, whereas 86% of the gram-negative isolates had a drug resistant nature. Further bacteriophages isolated from sewage demonstrated perfect lytic activity against the multi-drug resistant bacteria causing septic wounds. In vitro analysis of the isolated bacteriophages demonstrated perfect lysis against the corresponding MDR-bacteria, and these isolated phages may be promising as a first choice for prophylaxis against wound sepsis, Moreover, phage therapy does not enhance multi-drug resistance in bacteria and could work simultaneously on a wide variety of MDR-bacteria when used in a bacteriophage cocktail. Hence, our results suggest that these bacteriophages could be potential therapeutic options for treating septic wounds caused by P. aeruginosa, S. aureus, K. pneumoniae and E. coli.	[Pallavali, Roja Rani; Degati, Vijaya Lakshmi; Durbaka, Vijaya Raghava Prasad] Yogi Vemana Univ, Dept Microbiol, Kadapa, AP, India; [Lomada, Dakshayani; Reddy, Madhava C.] Yogi Vemana Univ, Dept Genet & Genom, Kadapa, AP, India; [Lomada, Dakshayani; Reddy, Madhava C.] Yogi Vemana Univ, Dept Biotechnol & Bioinformat, Kadapa, AP, India	Yogi Vemana University; Yogi Vemana University; Yogi Vemana University	Durbaka, VRP (corresponding author), Yogi Vemana Univ, Dept Microbiol, Kadapa, AP, India.	dvrp@yogvemanauniversity.ac.n	D, Vijayalakshmi/ABH-5397-2020	Reddy, Madhava/0000-0003-4885-0437; PALLAVALI, ROJARANI/0000-0001-5865-2974; Pallavali, Roja Rani/0000-0001-8729-3528	UGC	UGC(University Grants Commission, India)	The author (PRR) gratefully acknowledges UGC for financial support in the form of JRF and SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoran O, 2013, RATES RISK FACTORS A; Anguzu J., 2007, AFRICAN HLTH SCI, V7; [Anonymous], 2009, KIRBY BAUER DISK DIF; ARMON R, 1993, J APPL BACTERIOL, V74, P490, DOI 10.1111/j.1365-2672.1993.tb05159.x; Ayub M, 2015, ANN CLIN LAB RES; Beyene BA, 2011, TANZANIA J HLTH RES, V13; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bourdin G, 2014, APPL ENVIRON MICROB, V80, P1469, DOI 10.1128/AEM.03357-13; Buteera A, 2009, PRINCIPLES MANAGEMEN; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124; Deep A, 2012, INDIAN J CLIN PRACT, V22, P519; Esebelahie N. O., 2013, African Journal of Clinical and Experimental Microbiology, V14, P155; Golkar Z, 2013, J ANTIVIRALS ANTIRET; Goswami NN, 2011, J PHARMACOL PHARMACO, V2, P158, DOI 10.4103/0976-500X.83279; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Hout B, 2015, TROPICAL DIS TRAVEL, V1, P1; Hsueh PR, 2010, J MICROBIOL IMMUNOL, V43, P452, DOI 10.1016/S1684-1182(10)60070-9; Iregbu K, AFRICAN J CLIN EXPT, V14, P160; Janda JM, 1997, EUR J CLIN MICROBIOL, V16, P189, DOI 10.1007/BF01709581; Kaftandzieva A., 2012, Macedonian Journal of Medical Sciences, V5, P72, DOI 10.3889/MJMS.1857-5773.2012.0201; Kotz P, 2009, INT WOUND J, V6, P186, DOI 10.1111/j.1742-481X.2009.00608.x; Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Mama M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-14; Mathur M D, 2003, J Assoc Physicians India, V51, P593; Mehta M, 2007, INDIAN J PLAST SURG, V40, P25, DOI 10.4103/0970-0358.32659; Mehta PA, 2000, PEDIATR INFECT DIS J, V19, P1000, DOI 10.1097/00006454-200010000-00012; Mirnejad R., 2008, Journal of Biological Sciences, V8, P478; Mulu W, 2012, ETHIOP J HEALTH SCI, V22, P7; Ndip RN, 2007, AFRICAN HLTH SCI, V7; Nkang O, 2009, J MICROBIOLOGY ANTIM, V1; Nouraldin AAM, 2016, ALEX J MED, V52, P99, DOI 10.1016/j.ajme.2015.05.002; Ohalete C, 2012, WORLD J PHARM PHARM, V1, P1155; Organization WH, 2014, ANT RES GLOB REP SUR; Perim MC, 2015, REV SOC BRAS MED TRO, V48, P546, DOI 10.1590/0037-8682-0146-2015; Sambrook J., 2001, MOL CLONING LAB MANU; Sankaran SV, 2016, J ACAD CLIN MICROBIO, V18, P12; Santos SB, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-148; Shahi SK, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01464; Sheridan Robert L, 2005, Pediatr Crit Care Med, V6, pS112, DOI 10.1097/01.PCC.0000161577.27849.BE; Shittu A., 2002, NIGERIA AFR J BIOMED, DOI [10.4314/ajbr.v5i3.53994, DOI 10.4314/AJBR.V5I3.53994]; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tayfour MA, 2005, SAUDI MED J, V26, P1305; Thanni LOA, 2003, J NATL MED ASSOC, V95, P1189; Upadhyay A. K., 2012, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V3, P797; Valerie EJ, 2003, BURNS, V29, P15, DOI 10.1016/S0305-4179(02)00203-6; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Wang ZF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00934; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE	56	49	50	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0179245	10.1371/journal.pone.0179245	http://dx.doi.org/10.1371/journal.pone.0179245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719657	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400005
J	Chonmaitree, T; Jennings, K; Golovko, G; Khanipov, K; Pimenova, M; Patel, JA; McCormick, DP; Loeffelholz, MJ; Fofanov, Y				Chonmaitree, Tasnee; Jennings, Kristofer; Golovko, Georgiy; Khanipov, Kamil; Pimenova, Maria; Patel, Janak A.; McCormick, David P.; Loeffelholz, Michael J.; Fofanov, Yuriy			Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS COLONIZATION; ALPHA-HEMOLYTIC STREPTOCOCCI; HAEMOPHILUS-INFLUENZAE; IN-VITRO; PNEUMONIAE; HEALTHY; COMMUNITIES; PROBIOTICS; PATHOGENS; CHILDREN	Background Interferences between pathogenic bacteria and specific commensals are known. We determined the interactions between nasopharyngeal microbial pathogens and commensals during viral upper respiratory tract infection (URI) and acute otitis media (AOM) in infants. Methods We analyzed 971 specimens collected monthly and during URI and AOM episodes from 139 infants. The 16S rRNA V4 gene regions were sequenced on the Illumina MiSeq platform. Results Among the high abundant genus-level nasopharyngeal microbiota were Moraxella, Haemophilus, and Streptococcus (3 otopathogen genera), Corynebacterium, Dolosigranulum, Staphylococcus, Acinetobacter, Pseudomonas, and Bifidobacterium. Bacterial diversity was lower in culture-positive samples for Streptococcus pneumoniae, and Haemophilus influenzae, compared to cultured-negative samples. URI frequencies were positively associated with increasing trend in otopathogen colonization. AOM frequencies were associated with decreasing trend in Micrococcus colonization. During URI and AOM, there were increases in abundance of otopathogen genera and decreases in Pseudomonas, Myroides, Yersinia, and Sphingomonas. Otopathogen abundance was increased during symptomatic viral infection, but not during asymptomatic infection. The risk for AOM complicating URI was reduced by increased abundance of Staphylococcus and Sphingobium. Conclusion Otopathogen genera played the key roles in URI and AOM occurrences. Staphylococcus counteracts otopathogens thus Staphylococcal colonization may be beneficial, rather than harmful. While Sphingobium may play a role in preventing AOM complicating URI, the commonly used probiotic Bifidobacterium did not play a significant role during URI or AOM. The role of less common commensals in counteracting the deleterious effects of otopathogens requires further studies.	[Chonmaitree, Tasnee; Patel, Janak A.; McCormick, David P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Chonmaitree, Tasnee; Loeffelholz, Michael J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Golovko, Georgiy; Khanipov, Kamil; Pimenova, Maria; Fofanov, Yuriy] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Chonmaitree, T (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.; Chonmaitree, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	tchonmai@utmb.edu	Khanipov, Kamil/Y-6486-2019	Khanipov, Kamil/0000-0002-3881-737X; Golovko, George/0000-0003-4609-2767; Jennings, Kristofer/0000-0002-5442-9326	National Institutes of Health [K18DC13564, R01DC005841]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health research grants K18DC13564 and R01DC005841. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Bakaletz LO, 2010, J LEUKOCYTE BIOL, V87, P213, DOI 10.1189/jlb.0709518; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bosch AATM, 2016, EBIOMEDICINE, V9, P336, DOI 10.1016/j.ebiom.2016.05.031; Chatzakis E, 2011, EUR J CLIN MICROBIOL, V30, P1111, DOI 10.1007/s10096-011-1199-9; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Chonmaitree T, 2006, CLIN INFECT DIS, V43, P1423, DOI 10.1086/509329; Chonmaitree T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3555; Chonmaitree T, 2015, CLIN INFECT DIS, V60, P1, DOI 10.1093/cid/ciu714; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FUJIMORI I, 1995, INT J PEDIATR OTORHI, V33, P249, DOI 10.1016/0165-5876(95)01220-6; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lehtoranta L, 2014, EUR J CLIN MICROBIOL, V33, P1289, DOI 10.1007/s10096-014-2086-y; Lewnard JA, 2016, J INFECT DIS, V213, P1596, DOI 10.1093/infdis/jiv761; Marom T, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002695; Mika M, 2015, J ALLERGY CLIN IMMUN, V135, P905, DOI 10.1016/j.jaci.2014.12.1909; Nagalingam NA, 2013, TRENDS MICROBIOL, V21, P485, DOI 10.1016/j.tim.2013.04.008; Niittynen L, 2012, INT J PEDIATR OTORHI, V76, P465, DOI 10.1016/j.ijporl.2012.01.011; Nokso-Koivisto J, 2015, CURR OPIN PEDIATR, V27, P110, DOI 10.1097/MOP.0000000000000184; Patel JA, 2015, PEDIATR INFECT DIS J, V34, P826, DOI 10.1097/INF.0000000000000744; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rodrigues F, 2013, PEDIATR INFECT DIS J, V32, P227, DOI 10.1097/INF.0b013e31827687fc; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483; Tano K, 2002, ACTA OTO-LARYNGOL, V122, P745, DOI 10.1080/00016480260349827; Tano K, 1999, INT J PEDIATR OTORHI, V47, P49, DOI 10.1016/S0165-5876(98)00174-8; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008	34	54	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180630	10.1371/journal.pone.0180630	http://dx.doi.org/10.1371/journal.pone.0180630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708872	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800016
J	Marshall, AT; Liu, AT; Murphy, NP; Maidment, NT; Ostlund, SB				Marshall, Andrew T.; Liu, Angela T.; Murphy, Niall P.; Maidment, Nigel T.; Ostlund, Sean B.			Sex-specific enhancement of palatability-driven feeding in adolescent rats	PLOS ONE			English	Article							DOPAMINE-RECEPTOR OVERPRODUCTION; MU-OPIOID RECEPTOR; NUCLEUS-ACCUMBENS; RISK-TAKING; FOOD REWARD; INGESTIVE BEHAVIOR; GENDER-DIFFERENCES; PREFRONTAL CORTEX; NEGATIVE FEEDBACK; LICKING BEHAVIOR	It has been hypothesized that brain development during adolescence perturbs reward processing in a way that may ultimately contribute to the risky decision making associated with this stage of life, particularly in young males. To investigate potential reward dysfunction during adolescence, Experiment 1 examined palatable fluid intake in rats as a function of age and sex. During a series of twice-weekly test sessions, non-food-deprived rats were given the opportunity to voluntarily consume a highly palatable sweetened condensed milk (SCM) solution. We found that adolescent male, but not female, rats exhibited a pronounced, transient increase in SCM intake (normalized by body weight) that was centered around puberty. Additionally, adult females consumed more SCM than adult males and adolescent females. Using a well-established analytical framework to parse the influences of reward palatability and satiety on the temporal structure of feeding behavior, we found that palatability-driven intake at the outset of the meal was significantly elevated in adolescent males, relative to the other groups. Furthermore, although we found that there were some group differences in the onset of satiety, they were unlikely to contribute to differences in intake. Experiment 2 confirmed that adolescent male rats exhibit elevated palatable fluid consumption, relative to adult males, even when a non-caloric saccharin solution was used as the taste stimulus, demonstrating that these results were unlikely to be related to age-related differences in metabolic need. These findings suggest that elevated palatable food intake during adolescence is sex specific and driven by a fundamental change in reward processing. As adolescent risk taking has been hypothesized as a potential result of hypersensitivity to and overvaluation of appetitive stimuli, individual differences in reward palatability may factor into individual differences in adolescent risky decision making.	[Marshall, Andrew T.; Liu, Angela T.; Ostlund, Sean B.] Univ Calif Irvine, Ctr Addict Neurosci, Dept Anesthesiol & Perioperat Care, Irvine, CA 92697 USA; [Murphy, Niall P.; Maidment, Nigel T.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Hatos Ctr, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Irvine; University of California System; University of California Los Angeles	Marshall, AT; Ostlund, SB (corresponding author), Univ Calif Irvine, Ctr Addict Neurosci, Dept Anesthesiol & Perioperat Care, Irvine, CA 92697 USA.	marshaa1@uci.edu; sostlund@uci.edu		Marshall, Andrew/0000-0002-0068-8138; Liu, Angela/0000-0002-2839-7092	National Institutes of Health [AG045380, DK098709, DA029035, MH106972]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants AG045380 (SBO, NTM and NPM), DK098709 (SBO, NTM and NPM), DA029035 (SBO), and MH106972 (SBO).The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	ALLISON J, 1971, J COMP PHYSIOL PSYCH, V76, P408, DOI 10.1037/h0031388; ALLISON J, 1970, J COMP PHYSIOL PSYCH, V70, P116, DOI 10.1037/h0028402; Andersen SL, 1997, NEUROREPORT, V8, P1495, DOI 10.1097/00001756-199704140-00034; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2002, PSYCHONEUROENDOCRINO, V27, P683, DOI 10.1016/S0306-4530(01)00069-5; Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Angelopoulos T, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000013; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breslin PAS, 1996, PHYSIOL BEHAV, V60, P411, DOI 10.1016/S0031-9384(96)80012-6; Burnham K. P., 1998, MODEL SELECTION INFE; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carretero J, 2004, NEUROPEPTIDES, V38, P63, DOI 10.1016/j.npep.2004.01.004; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; CORBIT JD, 1969, J COMP PHYSIOL PSYCH, V69, P119, DOI 10.1037/h0027943; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; DAVIS JD, 1977, PSYCHOL REV, V84, P379, DOI 10.1037/0033-295X.84.4.379; DAVIS JD, 1995, PHYSIOL BEHAV, V57, P1081, DOI 10.1016/0031-9384(95)00008-7; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106; DAVIS JD, 1973, PHYSIOL BEHAV, V11, P39, DOI 10.1016/0031-9384(73)90120-0; DAVIS JD, 1988, APPETITE, V11, P229, DOI 10.1016/S0195-6663(88)80005-9; Davis JD, 1999, NUTRITION, V15, P32, DOI 10.1016/S0899-9007(98)00109-9; DAVIS JD, 1993, AM J PHYSIOL, V264, pR97, DOI 10.1152/ajpregu.1993.264.1.R97; Davis JD, 2000, PHYSIOL BEHAV, V69, P477, DOI 10.1016/S0031-9384(99)00265-6; Doremus-Fitzwater TL, 2016, NEUROSCI BIOBEHAV R, V70, P121, DOI 10.1016/j.neubiorev.2016.08.015; Doremus-Fitzwater TL, 2012, BEHAV NEUROSCI, V126, P735, DOI 10.1037/a0029697; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; DUPONT A, 1981, LIFE SCI, V29, P2317, DOI 10.1016/0024-3205(81)90565-8; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Friemel CM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00039; Frutos MGS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.006; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hay-Jahans C., 2012, R COMPANION LINEAR S; Higgs S, 2003, PSYCHOPHARMACOLOGY, V165, P370, DOI 10.1007/s00213-002-1263-3; Hodgson SR, 2009, LIFE SCI, V84, P52, DOI 10.1016/j.lfs.2008.11.002; Hoffman L, 2015, MULTIVAR APPL SER, P1; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Holland PC, 2005, PHYSIOL BEHAV, V86, P747, DOI 10.1016/j.physbeh.2005.08.062; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Johnson AW, 2013, TRENDS NEUROSCI, V36, P101, DOI 10.1016/j.tins.2013.01.002; Johnson AW, 2011, P ROY SOC B-BIOL SCI, V278, P1450, DOI 10.1098/rspb.2010.1581; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kral JG, 2001, INT J OBESITY, V25, P258, DOI 10.1038/sj.ijo.0801469; KREFT IGG, 1995, MULTIVAR BEHAV RES, V30, P1, DOI 10.1207/s15327906mbr3001_1; MCCLEERY RH, 1977, ANIM BEHAV, V25, P1005, DOI 10.1016/0003-3472(77)90052-5; Meyer HC, 2016, PHYSIOL BEHAV, V167, P354, DOI 10.1016/j.physbeh.2016.10.004; Naneix F, 2012, J NEUROSCI, V32, P16223, DOI 10.1523/JNEUROSCI.3080-12.2012; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Overduin J, 2012, AM J PHYSIOL-REG I, V303, pR259, DOI 10.1152/ajpregu.00488.2011; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Piers LS, 1998, J APPL PHYSIOL, V85, P2196, DOI 10.1152/jappl.1998.85.6.2196; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro J., NLME LINEAR NONLINEA; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Reichelt AC, 2016, PHYSIOL BEHAV, V157, P13, DOI 10.1016/j.physbeh.2016.01.038; REIDELBERGER R, 1982, PHYSIOL BEHAV, V29, P173, DOI 10.1016/0031-9384(82)90385-7; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P241, DOI 10.1016/S0149-7634(87)80032-5; Shaffer H J, 1996, J Gambl Stud, V12, P193, DOI 10.1007/BF01539174; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Smith JC, 2002, APPETITE, V38, P155, DOI 10.1006/appe.2001.0467; SMITH JC, 1980, PHYSIOL BEHAV, V24, P173, DOI 10.1016/0031-9384(80)90031-1; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; STELLAR E, 1952, J COMP PHYSIOL PSYCH, V45, P96, DOI 10.1037/h0062150; Stolyarova A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00115; Styne DM, 2001, PEDIATR CLIN N AM, V48, P823, DOI 10.1016/S0031-3955(05)70344-8; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; UENO E, 1988, NEUROBIOL AGING, V9, P279, DOI 10.1016/S0197-4580(88)80066-6; Vaidya JG, 2004, ANN NY ACAD SCI, V1021, P395, DOI 10.1196/annals.1308.051; VALENSTE.ES, 1967, SCIENCE, V156, P942, DOI 10.1126/science.156.3777.942; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wassum KM, 2009, P NATL ACAD SCI USA, V106, P12512, DOI 10.1073/pnas.0905874106; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Wassum KM, 2011, J NEUROSCI, V31, P1591, DOI 10.1523/JNEUROSCI.3102-10.2011; WEIJNEN JAWM, 1984, BRAIN BEHAV EVOLUT, V25, P117, DOI 10.1159/000118857; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286; Wilmouth CE, 2009, PHARMACOL BIOCHEM BE, V92, P566, DOI 10.1016/j.pbb.2009.02.009; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Young ME, 2016, BEHAV PROCESS, V123, P43, DOI 10.1016/j.beproc.2015.09.009	99	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180907	10.1371/journal.pone.0180907	http://dx.doi.org/10.1371/journal.pone.0180907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708901	Green Published, gold			2022-12-26	WOS:000405649800028
J	Stalter, RM; Tharaldson, J; Owen, DH; Okumu, E; Moench, T; Mack, N; Tolley, EE; MacQueen, KM				Stalter, Randy M.; Tharaldson, Jenae; Owen, Derek H.; Okumu, Eunice; Moench, Thomas; Mack, Natasha; Tolley, Elizabeth E.; MacQueen, Kathleen M.			Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; TENOFOVIR GEL; HIV-INFECTION; BREATH TEST; ADHERENCE; HAIR; DISCLOSURE; TRIAL	Results of recent microbicide and pre-exposure prophylaxis clinical trials have shown adherence to be a significant challenge with new HIV prevention technologies. As the vaginal ring containing dapivirine moves into two open label follow-on studies (HOPE/MTN-025 and DREAM) and other antiretroviral-based and multi-purpose prevention technology ring products advance through the development pipeline, there is a need for more accurate and reliable measures of adherence to microbicide ring products. We previously conducted a comprehensive landscape analysis to identify new technologies that could be applied to adherence measurement of vaginal rings containing antiretrovirals. To explore attitudes and perceptions towards the approaches that we identified, we conducted a survey of stakeholders with experience and expertise in microbicide and HIV prevention clinical trials. From May to July 2015 an electronic survey was distributed via email to 894 stakeholders; a total of 206 eligible individuals responded to at least one question and were included in the data analysis. Survey respondents were presented with various objective measures and asked about their perceived acceptability to trial participants, feasibility of implementation by study staff, usefulness for measuring adherence and ethical concerns. Methods that require no additional input from the participant and require no modifications to the existing ring product (i.e., measurement of residual drug or excipient, or a vaginal analyte that enters the ring) were viewed as being more acceptable to trial participants and more feasible to implement in the field. Respondents saw value in using objective measures to provide real-time feedback on adherence. However, approaches that involve unannounced home visits for sample collection or spot checks of ring use, which could provide significant value to adherence feedback efforts, were met with skepticism. Additional research on the acceptability of these methods to potential trial participants and trial staff is recommended.	[Stalter, Randy M.; Owen, Derek H.] Contracept Technol Innovat Dept, FHI 360, Durham, NC 27701 USA; [Tharaldson, Jenae; Okumu, Eunice; Mack, Natasha; Tolley, Elizabeth E.; MacQueen, Kathleen M.] Global Hlth Res Dept, FHI 360, Durham, NC USA; [Moench, Thomas] ReProtect Inc, Baltimore, MD USA	FHI 360; FHI 360	Stalter, RM (corresponding author), Contracept Technol Innovat Dept, FHI 360, Durham, NC 27701 USA.	rstalter@fhi360.org			USAID [AID-OAA-A-14-00003]	USAID(United States Agency for International Development (USAID))	Financial assistance was provided by USAID to FHI 360 under the terms of the Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Ring Agreement, AID-OAA-A-14-00003. The contents are the responsibility of FHI 360 and do not necessarily reflect the views of USAID or the United States Government. USAID had no role in the study's design, data collection or data analysis. USAID was involved in discussions about publication of the results and reviewed and approved the manuscript prior to submission for publication. ReProtect, Inc. provided support in the form of salary for author TRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	[Anonymous], 2016, IPMS DAPIVIRINE RING; [Anonymous], 2016, HOPE OPEN LABEL STUD; Baeten JM, 2016, NEW ENGLAND J MED; Baxi SM, 2015, JAIDS-J ACQ IMM DEF, V68, P13, DOI 10.1097/QAI.0000000000000386; Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702; Coetzee B, 2012, FUTURE VIROL, V7, P1135, DOI 10.2217/FVL.12.100; Fernandez-Romero JA, 2015, TRENDS MICROBIOL, V23, P429, DOI 10.1016/j.tim.2015.02.006; Gandhi M, 2015, J INFECT DIS, V212, P1402, DOI 10.1093/infdis/jiv239; Gandhi M, 2014, AIDS RES HUM RETROV, V30, P25, DOI [10.1089/aid.2013.0239, 10.1089/AID.2013.0239]; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kalichman SC, 2010, HIV CLIN TRIALS, V11, P325, DOI 10.1310/hct1106-325; Keller MJ, 2015, AIDS LONDON ENGLAND; Liu AY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083736, 10.1371/journal.pone.0095291]; MacQueen KM, 2016, AIDS BEHAV, V20, P2682, DOI 10.1007/s10461-016-1339-4; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Morey TE, 2013, J CLIN PHARMACOL, V53, P103, DOI 10.1177/0091270011434157; Nanda K, 2015, WOMENS HEALTH, V11, P729, DOI 10.2217/whe.15.84; Nel A, 2015, C RETR OPP INF; Nel A, 2016, 23 C RETR OPP INF CR; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Rees H, 2015, C RETR OPP INF CROI; Rosen EP, 2015, ANAL CHEM; Stalter RM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20746; Succop SM, 2014, AIDS CARE, V26, P1521, DOI 10.1080/09540121.2014.938014; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2013, AIDS BEHAV, V17, P2211, DOI 10.1007/s10461-012-0390-z; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180963	10.1371/journal.pone.0180963	http://dx.doi.org/10.1371/journal.pone.0180963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TM	28708847	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649800034
J	Jimenez, E; Arroyo, R; Cardenas, N; Marin, M; Serrano, P; Fernandez, L; Rodriguez, JM				Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia; Marin, Maria; Serrano, Pilar; Fernandez, Leonides; Rodriguez, Juan M.			Mammary candidiasis: A medical condition without scientific evidence?	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; BREAST-FEEDING WOMEN; INFECTIOUS MASTITIS; BACTERIAL DIVERSITY; LACTATION MASTITIS; CLINICAL SYMPTOMS; HUMAN-MILK; ALBICANS; PAIN; IDENTIFICATION	Many physicians, midwives and lactation consultants still believe that yeasts (particularly Candida spp.) play an important role as an agent of nipple and breast pain despite the absolute absence of scientific proofs to establish such association. In this context, the objective of this study was to investigate the microorganisms involved in sore nipples and/or painful ''shooting'' breastfeeding by using a variety of microscopy techniques, as well as culturedependent and-independent identification methods. Initially, 60 women (30 diagnosed as suffering ''mammary candidiasis'' and 30 with no painful breastfeeding) were recruited to elucidate the role of their pumps on the milk microbial profiles. After realizing the bias introduced by using such devices, manual expression was selected as the collection method for the microbiological analysis of milk samples provided by 529 women with symptoms compatible with ''mammary candidiasis''. Nipple swabs and nipple biopsy samples were also collected from the participating women. Results showed that the role played by yeasts in breast and nipple pain is, if any, marginal. In contrast, our results strongly support that coagulasenegative staphylococci and streptococci (mainly from the mitis and salivarius groups) are the agents responsible for such cases. As a consequence, and following the recommendations of the US Library of Medicine for the nomenclature of infectious diseases, the term ''mammary candidiasis'' or ''nipple thrush'' should be avoided when referring to such condition and replaced by ''subacute mastitis''.	[Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia; Marin, Maria; Fernandez, Leonides; Rodriguez, Juan M.] Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain; [Serrano, Pilar] Hosp Virgen del Rocio, Unidadde Endocrinol & Nutr, Seville, Spain; [Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia] Probisearch, Madrid, Spain	Complutense University of Madrid; Virgen del Rocio University Hospital	Rodriguez, JM (corresponding author), Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain.	jmrodrig@ucm.es	Rodriguez, Juan Miguel/ABB-6650-2020; Fernández, Leonides/N-7521-2019	Rodriguez, Juan Miguel/0000-0002-1285-9686; Fernández, Leonides/0000-0003-2380-0767	Ministerio de Economia y Competitividad (Spain) [AGL2016-75476-R]	Ministerio de Economia y Competitividad (Spain)	This work was supported by project AGL2016-75476-R from the Ministerio de Economia y Competitividad (Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir L H, 1991, J Hum Lact, V7, P177, DOI 10.1177/089033449100700414; Amir LH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002351; Andrews JI, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.053; Arroyo R, 2011, ACTA PEDIATR ESP, V69, P276; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Barrett ME, 2013, DERMATOL THER, V26, P331, DOI 10.1111/dth.12071; Beaussart A, 2013, NANOSCALE, V5, P10894, DOI 10.1039/c3nr03272h; Betzold CM, 2012, J MIDWIFERY WOM HEAL, V57, P353, DOI 10.1111/j.1542-2011.2011.00136.x; Brent NB, 2001, CLIN PEDIATR, V40, P503, DOI 10.1177/000992280104000905; Brown SL, 2005, J HUM LACT, V21, P169, DOI 10.1177/0890334405275445; Carmichael AR, 2002, BREAST, V11, P88, DOI 10.1054/brst.2001.0313; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delgado S, 2015, PROCEDURES IN CLINIC, V54; Delgado S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-51; Dixon JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d396; Eglash A, 2006, J HUM LACT, V22, P429, DOI 10.1177/0890334406293431; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Fernandez L, 2016, CLIN INFECT DIS, V62, P568, DOI 10.1093/cid/civ974; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Francis-Morrill J, 2004, J HUM LACT, V20, P288, DOI 10.1177/0890334404267226; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Graves Stephen, 2003, Aust Fam Physician, V32, P570; Hale TW, 2009, BREASTFEED MED, V4, P57, DOI 10.1089/bfm.2008.0144; Heinig M J, 1999, J Hum Lact, V15, P281; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jarvinen KM, 2002, PEDIAT ALLERG IMM-UK, V13, P243, DOI 10.1034/j.1399-3038.2002.00087.x; Jimenez E, 2008, APPL ENVIRON MICROB, V74, P4650, DOI 10.1128/AEM.02599-07; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Johnstone H A, 1990, J Obstet Gynecol Neonatal Nurs, V19, P171, DOI 10.1111/j.1552-6909.1990.tb01636.x; Marin ML, 2009, J PEDIATR GASTR NUTR, V49, P343, DOI 10.1097/MPG.0b013e31818cf53d; MATHESON I, 1988, ACTA OBSTET GYN SCAN, V67, P723, DOI 10.3109/00016349809004296; Mediano P, 2017, J HUM LACT, V33, P309, DOI 10.1177/0890334417692968; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Morrill JF, 2003, J CLIN MICROBIOL, V41, P475, DOI 10.1128/JCM.41.1.475-478.2003; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Park JY, 2011, VET MICROBIOL, V147, P149, DOI 10.1016/j.vetmic.2010.06.021; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Renfrew M, 2012, PREVENTING DIS SAVIN; Schoenfelder SMK, 2010, INT J MED MICROBIOL, V300, P380, DOI 10.1016/j.ijmm.2010.04.011; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shin JH, 1997, J CLIN MICROBIOL, V35, P1454, DOI 10.1128/JCM.35.6.1454-1459.1997; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Thomassen P, 1998, GYNECOL OBSTET INVES, V46, P73, DOI 10.1159/000010004; THOMSEN AC, 1985, ACTA OBSTET GYN SCAN, V64, P163, DOI 10.3109/00016348509154711; Thorberg BM, 2009, J DAIRY SCI, V92, P4962, DOI 10.3168/jds.2009-2184; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACT SU; Walker M, 2008, J PERINAT NEONAT NUR, V22, P267, DOI 10.1097/01.JPN.0000341356.45446.23; Witt A, 2014, BREASTFEED MED, V9, P29, DOI 10.1089/bfm.2013.0012; Zhang SL, 2000, INFECT IMMUN, V68, P1102, DOI 10.1128/IAI.68.3.1102-1108.2000	50	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181071	10.1371/journal.pone.0181071	http://dx.doi.org/10.1371/journal.pone.0181071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704470	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700087
J	Song, YK; Kilburn, D; Song, JH; Cheng, YL; Saeui, CT; Cheung, DG; Croce, CM; Yarema, KJ; Meltzer, SJ; Liu, KJ; Wang, TH				Song, Yunke; Kilburn, Duncan; Song, Jee Hoon; Cheng, Yulan; Saeui, Christopher T.; Cheung, Douglas G.; Croce, Carlo M.; Yarema, Kevin J.; Meltzer, Stephen J.; Liu, Kelvin J.; Wang, Tza-Huei			Determination of absolute expression profiles using multiplexed miRNA analysis	PLOS ONE			English	Article							DROPLET DIGITAL PCR; DOWN-REGULATION; CELL-CYCLE; RT-PCR; CANCER; QUANTIFICATION; MICRORNAS; GENERATION; MIR-15A; IDENTIFICATION	Accurate measurement of miRNA expression is critical to understanding their role in gene expression as well as their application as disease biomarkers. Correct identification of changes in miRNA expression rests on reliable normalization to account for biological and technological variance between samples. Ligo-miR is a multiplex assay designed to rapidly measure absolute miRNA copy numbers, thus reducing dependence on biological controls. It uses a simple 2-step ligation process to generate length coded products that can be quantified using a variety of DNA sizing methods. We demonstrate Ligo-miR's ability to quantify miRNA expression down to 20 copies per cell sensitivity, accurately discriminate between closely related miRNA, and reliably measure differential changes as small as 1.2-fold. Then, benchmarking studies were performed to show the high correlation between Ligo-miR, microarray, and TaqMan qRT-PCR. Finally, Ligo-miR was used to determine copy number profiles in a number of breast, esophageal, and pancreatic cell lines and to demonstrate the utility of copy number analysis for providing layered insight into expression profile changes.	[Song, Yunke; Saeui, Christopher T.; Yarema, Kevin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Kilburn, Duncan; Liu, Kelvin J.] Circulomics Inc, Baltimore, MD 21202 USA; [Song, Jee Hoon; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA; [Song, Jee Hoon; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Cheung, Douglas G.; Croce, Carlo M.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Liu, Kelvin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Wang, Tza-Huei] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Wang, Tza-Huei] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Wang, TH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Kilburn, D (corresponding author), Circulomics Inc, Baltimore, MD 21202 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA.	dkilburn@circulomics.com; thwang@jhu.edu	Young, Richard A/F-6495-2012; Liu, Kelvin/F-5432-2010	Young, Richard A/0000-0001-8855-8647; Liu, Kelvin/0000-0002-1164-582X; Wang, Tza-Huei/0000-0002-3540-9354	National Institute of Health [1R43GM103360, 2R44GM103360, F31CA192767, 5R21CA191715, T32-GM086252, P30 CA006973, CA190040, CA211457, R21CA173390, R21CA186809]; Johns Hopkins University[JHU Synergy Award]; OSU/HHMI Medin to Grad Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM103360, T32GM086252, R43GM103360] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021567] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University[JHU Synergy Award]; OSU/HHMI Medin to Grad Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health [grant numbers 1R43GM103360, 2R44GM103360, F31CA192767, 5R21CA191715, T32-GM086252 to DGC, P30 CA006973, CA190040, CA211457, R21CA173390, R21CA186809]; Johns Hopkins University[JHU Synergy Award]; OSU/HHMI	Amin M, 2015, EXP MOL PATHOL, V98, P411, DOI 10.1016/j.yexmp.2015.03.002; Ayers D, 2015, COMPUT STRUCT BIOTEC, V13, P307, DOI 10.1016/j.csbj.2015.04.003; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cappella P, 2001, INT J CANCER, V93, P401, DOI 10.1002/ijc.1351.abs; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; HUANG P, 1995, SEMIN ONCOL, V22, P19; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kestens C, 2016, WORLD J GASTROENTERO, V22, P1, DOI 10.3748/wjg.v22.i1.1; Kilburn D, 2017, METHODS MOL BIOL, V1509, P185, DOI 10.1007/978-1-4939-6524-3_17; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu KJ, 2011, J AM CHEM SOC, V133, P6898, DOI 10.1021/ja200279y; Lohman GJS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv898; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; Luo QF, 2013, INT J ONCOL, V43, P1212, DOI 10.3892/ijo.2013.2034; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Roberts TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089237; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shinden Y, 2015, ANTICANCER RES, V35, P123; Showalter AK, 2006, CHEM REV, V106, P340, DOI 10.1021/cr040487k; Song Y, 2015, NAT PUBL GR, V5, P1; Song YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089725; Sorbara L, 2014, CANC RES, V69; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Veigaard C, 2014, GENOMICS, V104, P271, DOI 10.1016/j.ygeno.2014.08.002; Vigneron N, 2016, MOL ONCOL, V10, P981, DOI 10.1016/j.molonc.2016.03.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Wu HL, 2009, EXPERT OPIN THER TAR, V13, P1439, DOI 10.1517/14728220903338777; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199	59	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180988	10.1371/journal.pone.0180988	http://dx.doi.org/10.1371/journal.pone.0180988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704432	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700070
J	Tapio, I; Fischer, D; Blasco, L; Tapio, M; Wallace, RJ; Bayat, AR; Ventto, L; Kahala, M; Negussie, E; Shingfield, KJ; Vilkki, J				Tapio, Ilma; Fischer, Daniel; Blasco, Lucia; Tapio, Miika; Wallace, R. John; Bayat, Ali R.; Ventto, Laura; Kahala, Minna; Negussie, Enyew; Shingfield, Kevin J.; Vilkki, Johanna			Taxon abundance, diversity, co-occurrence and network analysis of the ruminal microbiota in response to dietary changes in dairy cows	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RUMEN BACTERIAL; PHYLUM NEOCALLIMASTIGOMYCOTA; CELLULOLYTIC BACTERIA; METHANOGENIC ARCHAEA; FUNGAL DIVERSITY; COMMUNITY; OIL; DEGRADATION; POPULATIONS	The ruminal microbiome, comprising large numbers of bacteria, ciliate protozoa, archaea and fungi, responds to diet and dietary additives in a complex way. The aim of this study was to investigate the benefits of increasing the depth of the community analysis in describing and explaining responses to dietary changes. Quantitative PCR, ssu rRNA amplicon based taxa composition, diversity and co-occurrence network analyses were applied to ruminal digesta samples obtained from four multiparous Nordic Red dairy cows fitted with rumen cannulae. The cows received diets with forage: concentrate ratio either 35: 65 (diet H) or 65: 35 (L), supplemented or not with sunflower oil (SO) (0 or 50 g/kg diet dry matter), supplied in a 4 x 4 Latin square design with a 2 x 2 factorial arrangement of treatments and four 35-day periods. Digesta samples were collected on days 22 and 24 and combined. QPCR provided a broad picture in which a large fall in the abundance of fungi was seen with SO in the H but not the L diet. Amplicon sequencing showed higher community diversity indices in L as compared to H diets and revealed diet specific taxa abundance changes, highlighting large differences in protozoal and fungal composition. Methanobrevibacter ruminantium and Mbb. gottschalkii dominated archaeal communities, and their abundance correlated negatively with each other. Co-occurrence network analysis provided evidence that no microbial domain played a more central role in network formation, that some minor-abundance taxa were at nodes of highest centrality, and that microbial interactions were diet specific. Networks added new dimensions to our understanding of the diet effect on rumen microbial community interactions.	[Tapio, Ilma; Fischer, Daniel; Tapio, Miika; Bayat, Ali R.; Ventto, Laura; Negussie, Enyew; Shingfield, Kevin J.; Vilkki, Johanna] Nat Resources Inst Finland, Green Technol, Jokioinen, Finland; [Blasco, Lucia; Kahala, Minna] Nat Resources Inst Finland, Biobased Business & Ind, Jokioinen, Finland; [Wallace, R. John] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Shingfield, Kevin J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Aberdeen; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Tapio, I (corresponding author), Nat Resources Inst Finland, Green Technol, Jokioinen, Finland.	ilma.tapio@luke.fi	Tapio, Miika/AAA-7043-2020; Kahala, Minna/AAQ-1743-2020; Fischer, Daniel/C-8791-2017; Bayat, Ali-Reza/O-5769-2016	Fischer, Daniel/0000-0002-7513-683X; Bayat, Ali-Reza/0000-0002-4894-0662; Tapio, Ilma/0000-0002-0752-9551; Kahala, Minna/0000-0003-0679-3729; Negussie, Enyew/0000-0003-4892-9938	Finnish Ministry of Agriculture and Forestry, GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production) [2908234]; BBSRC [BB/J016608/1] Funding Source: UKRI	Finnish Ministry of Agriculture and Forestry, GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Study was funded by the Finnish Ministry of Agriculture and Forestry as part of the GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production; Project No. 2908234). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldassano SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26087; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bates D., 2016, MATRIX SPARSE DENSE; Bayat AR, 2015, J DAIRY SCI, V98, P3166, DOI 10.3168/jds.2014-7976; Belanche A, 2012, J ANIM SCI, V90, P4495, DOI 10.2527/jas.2012-5118; Belanche A, 2012, J NUTR, V142, P1684, DOI 10.3945/jn.112.159574; Belenguer A, 2010, J DAIRY SCI, V93, P3275, DOI 10.3168/jds.2010-3101; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Boots B, 2013, J APPL MICROBIOL, V114, P626, DOI 10.1111/jam.12067; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DEMEYER DI, 1981, AGR ENVIRON, V6, P295, DOI 10.1016/0304-1131(81)90020-5; Denman SE, 2008, LETT APPL MICROBIOL, V47, P492, DOI 10.1111/j.1472-765X.2008.02449.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Forsberg Cecil W., 1997, P319; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Hristov AN, 2012, J ANIM SCI, V90, P4449, DOI 10.2527/jas.2011-4624; Huhtanen P, 2013, AGR FOOD SCI, V22, P35, DOI 10.23986/afsci.6632; Huws SA, 2015, MICROB BIOTECHNOL, V8, P331, DOI 10.1111/1751-7915.12164; Ivan M, 2001, SMALL RUMINANT RES, V41, P215, DOI 10.1016/S0921-4488(01)00220-6; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Joblin KN, 2002, CURR MICROBIOL, V45, P46, DOI 10.1007/s00284-001-0078-5; Kim M, 2011, FOLIA MICROBIOL, V56, P453, DOI 10.1007/s12223-011-0066-5; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kittelmann Sandra, 2013, PLoS One, V8, pe47879, DOI 10.1371/journal.pone.0047879; Koetschan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091928; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oksanen J., **DATA OBJECT**; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Popova M, 2011, ANIM FEED SCI TECH, V166-67, P113, DOI 10.1016/j.anifeedsci.2011.04.060; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2016, R LANG ENV STAT COMP; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Shingfield KJ, 2013, ANIMAL, V7, P132, DOI 10.1017/S1751731112001681; Tapio I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151220; Taxis TM, 2015, NUCLEIC ACIDS RES, V43, P9600, DOI 10.1093/nar/gkv973; Ventto L, 2017, BRIT J NUTR, V117, P364, DOI [10.1017/S0007114517000010, 10.1017/s0007114517000010]; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	57	51	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180260	10.1371/journal.pone.0180260	http://dx.doi.org/10.1371/journal.pone.0180260			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704445	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649700033
J	Morettini, M; Palumbo, MC; Sacchetti, M; Castiglione, F; Mazza, C				Morettini, Micaela; Palumbo, Maria Concetta; Sacchetti, Massimo; Castiglione, Filippo; Mazza, Claudia			A system model of the effects of exercise on plasma Interleukin-6 dynamics in healthy individuals: Role of skeletal muscle and adipose tissue	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; MATHEMATICAL-MODEL; INSULIN-SECRETION; RECEPTOR AGONISTS; FUEL HOMEOSTASIS; GLYCOGEN-CONTENT; OXYGEN-UPTAKE; HUMANS; IL-6; INFLAMMATION	Interleukin-6 (IL-6) has been recently shown to play a central role in glucose homeostasis, since it stimulates the production and secretion of Glucagon-like Peptide-1 (GLP-1) from intestinal L-cells and pancreas, leading to an enhanced insulin response. In resting conditions, IL-6 is mainly produced by the adipose tissue whereas, during exercise, skeletal muscle contractions stimulate a marked IL-6 secretion as well. Available mathematical models describing the effects of exercise on glucose homeostasis, however, do not account for this IL-6 contribution. This study aimed at developing and validating a system model of exercise's effects on plasma IL-6 dynamics in healthy humans, combining the contributions of both adipose tissue and skeletal muscle. A two-compartment description was adopted to model plasma IL-6 changes in response to oxygen uptake's variation during an exercise bout. The free parameters of the model were estimated by means of a cross-validation procedure performed on four different datasets. A low coefficient of variation (< 10%) was found for each parameter and the physiologically meaningful parameters were all consistent with literature data. Moreover, plasma IL-6 dynamics during exercise and post-exercise were consistent with literature data from exercise protocols differing in intensity, duration and modality. The model successfully emulated the physiological effects of exercise on plasma IL-6 levels and provided a reliable description of the role of skeletal muscle and adipose tissue on the dynamics of plasma IL-6. The system model here proposed is suitable to simulate IL-6 response to different exercise modalities. Its future integration with existing models of GLP-1-induced insulin secretion might provide a more reliable description of exercise's effects on glucose homeostasis and hence support the definition of more tailored interventions for the treatment of type 2 diabetes.	[Morettini, Micaela] Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy; [Morettini, Micaela; Palumbo, Maria Concetta; Castiglione, Filippo] Natl Res Council Italy, Inst Appl Calculus Mauro Picone, Rome, Italy; [Sacchetti, Massimo] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Mazza, Claudia] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	Foro Italico University of Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Foro Italico University of Rome; University of Sheffield; University of Sheffield	Morettini, M (corresponding author), Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy.; Morettini, M (corresponding author), Natl Res Council Italy, Inst Appl Calculus Mauro Picone, Rome, Italy.	m.morettini@iac.cnr.it	Morettini, Micaela/K-3097-2018; Palumbo, Maria Concetta/GVY-6861-2022; Castiglione, Filippo/B-1366-2010	Morettini, Micaela/0000-0002-8327-8379; Palumbo, Maria Concetta/0000-0001-8559-4749; Castiglione, Filippo/0000-0002-1442-3552; Mazza, Claudia/0000-0002-5215-1746; Sacchetti, Massimo/0000-0002-5365-5161	European Commission under the 7th Framework Programme [600803]	European Commission under the 7th Framework Programme	This study was funded by the European Commission under the 7th Framework Programme (https://ec.europa.eu/research/fp7 MISSION-T2D project, contract No.600803). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adamu II, 2012, OZEAN J APPL SCI, V5, P229; Allen TL, 2012, CELL METAB, V15, P8, DOI 10.1016/j.cmet.2011.12.004; ARTS FJP, 1994, INT J SPORTS MED, V15, P228, DOI 10.1055/s-2007-1021051; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bell C, 2001, EXP PHYSIOL, V86, P667, DOI 10.1113/eph8602150; Brubaker PL, 2007, ANN BIOMED ENG, V35, P1286, DOI 10.1007/s10439-007-9274-1; Burattini R, 2012, COMPUT METH PROG BIO, V107, P248, DOI 10.1016/j.cmpb.2011.07.002; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; CARSON ER, 1983, MATH MODELING METABO; Dalla Man C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1115, DOI 10.1152/ajpendo.00705.2009; Derouich M, 2002, J BIOMECH, V35, P911, DOI 10.1016/S0021-9290(02)00055-6; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Febbraio MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE397, DOI 10.1152/ajpendo.00134.2003; FELIG P, 1975, NEW ENGL J MED, V293, P1078; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Hiscock N, 2005, AM J PHYSIOL-ENDOC M, V289, pE2, DOI 10.1152/ajpendo.00274.2004; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Leicht CA, 2016, MED SCI SPORT EXER, V48, P1161, DOI 10.1249/MSS.0000000000000874; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P373, DOI 10.1113/jphysiol.2002.019380; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; Man Chiara Dalla, 2009, J Diabetes Sci Technol, V3, P56; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morettini Micaela, 2015, Prev Med Rep, V2, P538, DOI 10.1016/j.pmedr.2015.06.012; Morettini M, 2015, IFMBE PROC, V45, P431, DOI 10.1007/978-3-319-11128-5_108; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Roy Anirban, 2007, J Diabetes Sci Technol, V1, P338; Salinari S, 2011, AM J PHYSIOL-ENDOC M, V300, pE955, DOI 10.1152/ajpendo.00451.2010; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Singh S, 2016, COMPUTATIONAL MATH B, V5, P5; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Svitra D, 2010, NONLINEAR ANAL-MODEL, V15, P213, DOI 10.15388/NA.2010.15.2.14355; Toft AD, 2011, EUR J APPL PHYSIOL, V111, P1351, DOI 10.1007/s00421-010-1755-5; Tura A, 2014, DIABETOLOGIA, V57, P1199, DOI 10.1007/s00125-014-3219-7; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	49	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181224	10.1371/journal.pone.0181224	http://dx.doi.org/10.1371/journal.pone.0181224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704555	Green Accepted, Green Published, gold			2022-12-26	WOS:000405649600067
J	Zhao, WQ; Gong, CX; Ouyang, ZH; Wang, PF; Wang, J; Zhou, PP; Zheng, NG; Gong, ZF				Zhao, Weiqiao; Gong, Caixia; Ouyang, Zhenhuan; Wang, Pengfei; Wang, Jie; Zhou, Peipei; Zheng, Nenggan; Gong, Zhefeng			Turns with multiple and single head cast mediate Drosophila larval light avoidance	PLOS ONE			English	Article							GENETIC-ANALYSIS; DECISION-MAKING; NEURONS; PHOTOBEHAVIOR; THERMOTAXIS; LOCOMOTION; DISSECTION; PREFERENCE; PHOTOTAXIS; BEHAVIOR	Drosophila larvae exhibit klinotaxis when placed in a gradient of temperature, chemicals, or light. The larva samples environmental stimuli by casting its head from side to side. By comparing the results of two consecutive samples, it decides the direction of movement, appearing as a turn proceeded by one or more head casts. Here by analyzing larval behavior in a light-spot-based phototaxis assay, we showed that, in addition to turns with a single cast (1cast), turns with multiple head casts (n-cast) helped to improve the success of light avoidance. Upon entering the light spot, the probability of escape from light after the first head cast was only similar to 30%. As the number of head casts increased, the chance of successful light avoidance increased and the overall chance of escaping from light increased to >70%. The amplitudes of first head casts that failed in light avoidance were significantly smaller in n cast turns than those in 1-cast events, indicating that n-cast turns might be planned before completion of the first head cast. In n-casts, the amplitude of the second head cast was generally larger than that of the first head cast, suggesting that larvae tried harder in later attempts to improve the efficacy of light avoidance. We propose that both 1-cast turns and n-cast turns contribute to successful larval light avoidance, and both can be initiated at the first head cast.	[Zhao, Weiqiao; Gong, Caixia; Wang, Jie; Zhou, Peipei; Gong, Zhefeng] Zhejiang Univ, Sch Med, Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou, Zhejiang, Peoples R China; [Ouyang, Zhenhuan; Wang, Pengfei; Zheng, Nenggan] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gong, ZF (corresponding author), Zhejiang Univ, Sch Med, Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou, Zhejiang, Peoples R China.; Zheng, NG (corresponding author), Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China.	zng@cs.zju.edu.cn; zfgong@zju.edu.cn		ZHOU, Peipei/0000-0002-1798-3344	National Basic Research Program of China (973 Program) [2013CB945603]; National Natural Science Foundation of China [31070944, 31271147, 31471063, 31671074, 61572433]; Natural Science Foundation of Zhejiang Province [LR13C090001, LZ14F020002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Basic Research Program of China (973 Program 2013CB945603), the National Natural Science Foundation of China (31070944, 31271147, 31471063, 31671074, and 61572433), and the Natural Science Foundation of Zhejiang Province (LR13C090001 and LZ14F020002).	Busto M, 1999, J NEUROSCI, V19, P3337; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Davies A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004606; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gong ZF, 2010, SCIENCE, V330, P499, DOI 10.1126/science.1195993; Gong ZF, 2009, BIOCHEM BIOPH RES CO, V382, P395, DOI 10.1016/j.bbrc.2009.03.033; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Hernandez-Nunez L, 2015, ELIFE, V4, DOI 10.7554/eLife.06225; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; Klein M, 2015, P NATL ACAD SCI USA, V112, pE220, DOI 10.1073/pnas.1416212112; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schulze A, 2015, ELIFE, V4, DOI 10.7554/eLife.06694; Tastekin I, 2015, CURR BIOL, V25, P1448, DOI 10.1016/j.cub.2015.04.016; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210	24	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181193	10.1371/journal.pone.0181193	http://dx.doi.org/10.1371/journal.pone.0181193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700684	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649400037
J	Salters, K; Loutfy, M; de Pokomandy, A; Money, D; Pick, N; Wang, L; Jabbari, S; Carter, A; Webster, K; Conway, T; Dubuc, D; O'Brien, N; Proulx-Boucher, K; Kaida, A				Salters, Kate; Loutfy, Mona; de Pokomandy, Alexandra; Money, Deborah; Pick, Neora; Wang, Lu; Jabbari, Shahab; Carter, Allison; Webster, Kath; Conway, Tracey; Dubuc, Daniele; O'Brien, Nadia; Proulx-Boucher, Karene; Kaida, Angela		CHIWOS Res Team	Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FAMILY-PLANNING-SERVICES; COMMUNITY-BASED RESEARCH; ANTIRETROVIRAL THERAPY; INFECTED WOMEN; UNINTENDED PREGNANCY; REPRODUCTIVE EXPERIENCE; CONTRACEPTIVE USE; FERTILITY DESIRE; MALAWIAN WOMEN	Background Pregnancy incidence rates among women living with HIV (WLWH) have increased over time due to longer life expectancy, improved health status, and improved access to and HIV prevention benefits of combination antiretroviral therapy (cART). However, it is unclear whether intended or unintended pregnancies are contributing to observed increases. Methods We analyzed retrospective data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). Kaplan-Meier methods and GEE Poisson models were used to measure cumulative incidence and incidence rate of pregnancy after HIV diagnosis overall, and by pregnancy intention. We used multivariable logistic regression models to examine independent correlates of unintended pregnancy among the most recent/current pregnancy. Results Of 1,165 WLWH included in this analysis, 278 (23.9%) women reported 492 pregnancies after HIV diagnosis, 60.8% of which were unintended. Unintended pregnancy incidence (24.6 per 1,000 Women-Years (WYs); 95% CI: 21.0, 28.7) was higher than intended pregnancy incidence (16.6 per 1,000 WYs; 95% CI: 13.8, 20.1) (Rate Ratio: 1.5, 95% CI: 1.2-1.8). Pregnancy incidence among WLWH who initiated cART before or during pregnancy (29.1 per 1000 WYs with 95% CI: 25.1, 33.8) was higher than among WLWH not on cART during pregnancy (11.9 per 1000 WYs; 95% CI: 9.5, 14.9) (Rate Ratio: 2.4, 95% CI: 2.0-3.0). Women with current or recent unintended pregnancy (vs. intended pregnancy) had higher adjusted odds of being single (AOR: 1.94; 95% CI: 1.10, 3.42), younger at time of conception (AOR: 0.95 per year increase, 95% CI: 0.90, 0.99), and being born in Canada (AOR: 2.76, 95% CI: 1.55, 4.92). Conclusion Nearly one-quarter of women reported pregnancy after HIV diagnosis, with 61% of all pregnancies reported as unintended. Integrated HIV and reproductive health care programming is required to better support WLWH to optimize pregnancy planning and outcomes and to prevent unintended pregnancy.	[Salters, Kate; Carter, Allison; Webster, Kath; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Salters, Kate; Wang, Lu; Jabbari, Shahab; Carter, Allison] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Loutfy, Mona; Conway, Tracey] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [de Pokomandy, Alexandra; Dubuc, Daniele; O'Brien, Nadia; Proulx-Boucher, Karene] McGill Univ, Hlth Ctr, Chron Viral Illness Serv, Montreal, PQ, Canada; [de Pokomandy, Alexandra; O'Brien, Nadia] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Money, Deborah; Pick, Neora] BC Womens Hosp & Hlth Ctr, Oak Tree Clin, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Fac Med, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Toronto; University Toronto Affiliates; Womens College Hospital; McGill University; McGill University; University of British Columbia	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	kangela@sfu.ca		Carter, Allison/0000-0003-2151-2622	Canadian Institutes of Health Research (CIHR) [MOP111041]; CIHR Canadian HIV Trials Network [CTN 262]; Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQS); Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health; national Steering Committee; three provincial Community Advisory Boards; national CHIWOS Aboriginal and African; Caribbean and Black Advisory Boards	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health; national Steering Committee; three provincial Community Advisory Boards; national CHIWOS Aboriginal and African; Caribbean and Black Advisory Boards	CHIWOS is funded by the Canadian Institutes of Health Research (CIHR, MOP111041); the CIHR Canadian HIV Trials Network (CTN 262); the Ontario HIV Treatment Network (OHTN); and the Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund. KS and AC received doctoral scholarship support from the Canadian Institutes of Health Research (CIHR). AdP received support from Fonds de Recherche du Quebec - Sante (FRQS) (Chercheurboursier clinicien - Junior. NO received support from FRQS. AK received salary support through a Tier 2 Canada Research Chair in Global Perspectives on HIV and Sexual and Reproductive Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) Research Team would like to especially thank all of the women living with HIV who participate in this research. We also thank the entire national team of Co-Investigators, Collaborators, and Peer Research Associates. We would like to acknowledge the national Steering Committee, the three provincial Community Advisory Boards, the national CHIWOS Aboriginal and African, Caribbean and Black Advisory Boards, and our partnering organizations for supporting the study, especially those who provide interview space and support to our Peer Research Associates. We dedicate this paper to the memory of Marisol Desbiens, a champion for the sexual and reproductive rights of women living with HIV.	Abelsohn K, 2015, PROG COMM HLTH PARTN, V9, P561, DOI 10.1353/cpr.2015.0079; Bankole A, 2014, INT PERSPECT SEX R H, V40, DOI 10.1363/4002814; Benoit C, 2007, GENDERING POPULATION; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Burgos-Soto J, 1999, J ACQ IMMUN DEF SYND, V67, pe45; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Darak S, 2013, AIDS PATIENT CARE ST, V27, P163, DOI 10.1089/apc.2012.0401; De Reus L.A., 2005, SOURCEBOOK FAMILY TH, P447, DOI [DOI 10.4135/9781412990172.N18, 10.4135/9781412990172.n18]; DeVincenzi I, 1997, AIDS, V11, P333, DOI 10.1097/00002030-199703110-00011; Elgalib A, 2011, HIV MED, V12, P118, DOI 10.1111/j.1468-1293.2010.00878.x; Ezugwu EC, 2016, INT J GYNECOL OBSTET, V132, P60, DOI 10.1016/j.ijgo.2015.06.039; Fiore S, 2008, HUM REPROD, V23, P2140, DOI 10.1093/humrep/den232; Floridia M, 2010, AIDS CARE, V22, P50, DOI 10.1080/09540120903033268; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Haddad LB, 2017, AM J OBSTET GYNECOL, V216, P71; Haddad LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121039; Harrington EK, 2012, INFECT DIS OBSTET GY; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.2307/3088371; Kabami J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-81; Kaida A, 2016, AIDS; Kaida A C.A., 23 ANN CAN C HIV AID; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063411; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; Loutfy M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0190-7; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Massad LS, 2004, AIDS, V18, P281, DOI 10.1097/00002030-200401230-00018; Mmbaga EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-86; Mohohlo M, 2006, 2006 IMPL M PRES EM, V113, P13; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; O'Shea MS, 2016, AIDS CARE, V28, P1027, DOI 10.1080/09540121.2016.1140891; Ogilvie GS, 2007, FERTILITY INTENTIONS, V21; Okafor II, 2014, ANN MED HEALTH SCI R, V4, P615, DOI 10.4103/2141-9248.139344; Oulman E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0663-4; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Phares Tanya M, 2004, MMWR Surveill Summ, V53, P1; Public Health Agency of Canada, 2014, HIV AIDS EP UPD 2008; Raphael D., 2009, SOCIAL DETERMINANTS, V2nd ed; Rodger A., 2014, 21 C RETR OPP INF, P3; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sanders LB, 2008, J ASSOC NURSE AIDS C, V19, P47, DOI 10.1016/j.jana.2007.10.002; Schwartz S, 2015, JAIDS-J ACQ IMM DEF, V68, pS91, DOI 10.1097/QAI.0000000000000448; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Sharma A, 2007, AM J OBSTET GYNECOL, V196, P541, DOI 10.1016/j.ajog.2007.01.005; Statistics Canada Vital, 2005, PREGN OUTC AG GROU C; Stephenson JM, 1996, AIDS, V10, P1683, DOI 10.1097/00002030-199612000-00013; Sutton MY, 2014, JAIDS-J ACQ IMM DEF, V65, P350, DOI 10.1097/QAI.0000000000000054; van Benthem BHB, 2000, AIDS, V14, P2171, DOI 10.1097/00002030-200009290-00014; Webster K C.A., 2017, PROGR COMMU IN PRESS; Westreich D, 2012, INFECT DIS OBSTET GY; Wilcher R, 2010, STUD FAMILY PLANN, V41, P125, DOI 10.1111/j.1728-4465.2010.00233.x; Wilcher R, 2009, B WORLD HEALTH ORGAN, V87, P833, DOI 10.2471/BLT.08.059360; Wood E, 2002, AIDS, V16, P2065, DOI 10.1097/00002030-200210180-00012	65	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180524	10.1371/journal.pone.0180524	http://dx.doi.org/10.1371/journal.pone.0180524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727731	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500025
J	Norouzi, N; Bhakta, HC; Grover, WH				Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.			Sorting cells by their density	PLOS ONE			English	Article							DISTRIBUTION WIDTH; CANCER-CELLS; BLOOD; CENTRIFUGATION; SEPARATION	Sorting cells by their type is an important capability in biological research and medical diagnostics. However, most cell sorting techniques rely on labels or tags, which may have limited availability and specificity. Sorting different cell types by their different physical properties is an attractive alternative to labels because all cells intrinsically have these physical properties. But some physical properties, like cell size, vary significantly from cell to cell within a cell type; this makes it difficult to identify and sort cells based on their sizes alone. In this work we continuously sort different cells types by their density, a physical property with much lower cell-to-cell variation within a cell type (and therefore greater potential to discriminate different cell types) than other physical properties. We accomplish this using a 3Dprinted microfluidic chip containing a horizontal flowing micron-scale density gradient. As cells flow through the chip, Earth's gravity makes each cell move vertically to the point where the cell's density matches the surrounding fluid's density. When the horizontal channel then splits, cells with different densities are routed to different outlets. As a proof of concept, we use our density sorter chip to sort polymer microbeads by their material (polyethylene and polystyrene) and blood cells by their type (white blood cells and red blood cells). The chip enriches the fraction of white blood cells in a blood sample from 0.1% (in whole blood) to nearly 98% (in the output of the chip), a 1000x enrichment. Any researcher with access to a 3D printer can easily replicate our density sorter chip and use it in their own research using the design files provided as online Supporting Information. Additionally, researchers can simulate the performance of a density sorter chip in their own applications using the Python-based simulation software that accompanies this work. The simplicity, resolution, and throughput of this technique make it suitable for isolating even rare cell types in complex biological samples, in a wide variety of different research and clinical applications.	[Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu		Grover, William/0000-0001-6854-8951	National Science Foundation [DBI-1353974]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (http://nsf.gov) grant number DBI-1353974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; Fukuda S, 2002, J LEUKOCYTE BIOL, V72, P133; Giddings JC., 1988, US Patent, Patent No. [4737268, 4,737,268.]; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Huh D, 2007, ANAL CHEM, V79, P1369, DOI 10.1021/ac061542n; Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229; Norouzi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149259; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Pertoft H., 1982, CELL SEPARATION METH, P115; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Sollier E, 2009, SENSOR ACTUAT B-CHEM, V141, P617, DOI 10.1016/j.snb.2009.05.023; Song J, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4902906; SooHoo JR, 2009, BIOMED MICRODEVICES, V11, P323, DOI 10.1007/s10544-008-9238-8	17	30	30	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180520	10.1371/journal.pone.0180520	http://dx.doi.org/10.1371/journal.pone.0180520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723908	Green Published, Green Submitted, gold			2022-12-26	WOS:000406067800017
J	Park, SH; Lee, CW; Lee, SG; Shin, SC; Kim, HJ; Park, H; Lee, JH				Park, Sun-Ha; Lee, Chang Woo; Lee, Sung Gu; Shin, Seung Chul; Kim, Hak Jun; Park, Hyun; Lee, Jun Hyuck			Crystal structure and functional characterization of an isoaspartyl dipeptidase (CpsIadA) from Colwellia psychrerythraea strain 34H	PLOS ONE			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; METHYLTRANSFERASE; PEPTIDES; PURIFICATION; DEAMIDATION; GENERATION; RESIDUES; SEQUENCE		[Park, Sun-Ha; Lee, Chang Woo; Lee, Sung Gu; Shin, Seung Chul; Park, Hyun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Lee, Sung Gu; Park, Hyun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea; [Kim, Hak Jun] Pukyong Natl Univ, Dept Chem, Busan, South Korea	Korea Polar Research Institute (KOPRI); Pukyong National University	Park, H; Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Park, H; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	hpark@kopri.re.kr; junhyucklee@kopri.re.kr			Polar Genomics 101 Project - Korea Polar Research Institute (KOPRI) [PE17080]; National Research Foundation of Korea - Korean Government (MSIP) [NRF-2016M1A5A1027157, PN17083]	Polar Genomics 101 Project - Korea Polar Research Institute (KOPRI); National Research Foundation of Korea - Korean Government (MSIP)	This work was supported by the Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform (PE17080) was funded by the Korea Polar Research Institute (KOPRI). This work was also supported by the National Research Foundation of Korea, which is funded by the Korean Government (MSIP), (NRF-2016M1A5A1027157) (PN17083, KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff at the X-ray core facility of the Korea Basic Science Institute (KBSI; Ochang, Korea) and the BL-5C of the Pohang Accelerator Laboratory (Pohang, Korea) for their kind help with data collection. This work was supported by the Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform (PE17080) was funded by the Korea Polar Research Institute (KOPRI). This work was also supported by the National Research Foundation of Korea, which is funded by the Korean Government (MSIP), (NRF-2016M1A5A1027157) (PN17083, KOPRI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Botelho TO., 2013, PROTEINS, V74, P61; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark S., 1992, Labyrinth, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; GEIGER T, 1987, J BIOL CHEM, V262, P785; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jozic D, 2003, J MOL BIOL, V332, P243, DOI 10.1016/S0022-2836(03)00845-3; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsen RA, 2001, J BACTERIOL, V183, P3089, DOI 10.1128/JB.183.10.3089-3097.2001; Liu HZ, 2009, SCIENCE, V326, P1250, DOI 10.1126/science.1179713; Marti-Arbona R, 2005, BIOORG CHEM, V33, P448, DOI 10.1016/j.bioorg.2005.10.002; Marti-Arbona R, 2005, BIOCHEMISTRY-US, V44, P7115, DOI 10.1021/bi050008r; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skinner MM, 2000, STRUCTURE, V8, P1189, DOI 10.1016/S0969-2126(00)00522-0; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Thoden JB, 2003, BIOCHEMISTRY-US, V42, P4874, DOI 10.1021/bi034233p; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109657; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0181705	10.1371/journal.pone.0181705	http://dx.doi.org/10.1371/journal.pone.0181705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723955	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800067
J	Choi, JW; Oh, IH; Lee, CH; Park, JS				Choi, Jong Wook; Oh, Il Hwan; Lee, Chang Hwa; Park, Joon-Sung			Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; CARDIOMETABOLIC INDEX; OBESITY; RATIO; RISK; ASSOCIATION; INFLAMMATION; ALBUMINURIA; PROGRESSION	Central obesity and related metabolic components are important risks for microalbuminuria. To describe the effects of interactions between central obesity and related metabolic components on microalbuminuria, we conducted a nation-wide, population-based interaction analysis using cardio-metabolic index (CMI) as a candidate indicator of central obesity and related abnormal lipid metabolism. We recruited native Koreans aged 20 years or older with no medical illness. A total of 5398 participants were divided into quintiles according to CMI with sex as a covariate factor. Participants in the highest CMI quintile had elevated blood pressure (BP), increased glycemic exposure, poor lipid profile, and increased urine albumin-to-creatinine ratio compared to other lower quintiles. Multiple logistic regression models adjusted for age, sex, systolic BP, and diastolic BP showed that CMI had an independent association with increased glycemic exposure and increased urine albumin-to-creatinine ratio. Our interaction analysis revealed a significant interaction between the highest CMI quintile and prediabetes with an increased risk of microalbuminuria (adjusted RERI = 0.473, 95% CI = 0.464 +/- 0.482; adjusted AP = 0.276, 95% CI = 0.156 +/- 0.395; adjusted SI = 2.952, 95% CI = 1.234 +/- 4.670). Our findings suggest a significant association between central obesity-related abnormal lipid metabolism and prediabetes, and their interaction may exert a synergistic effect on renal vascular endothelial dysfunction even before the appearance of full-blown diabetes mellitus. To confirm these findings, large population-based prospective studies are needed.	[Choi, Jong Wook; Oh, Il Hwan; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Hanyang University	Lee, CH; Park, JS (corresponding author), Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr		Park, Joon-Sung/0000-0003-4740-3061				Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Ashwell M, 1996, BRIT MED J, V312, P377; Bahar Adele, 2013, Nephrourol Mon, V5, P741, DOI 10.5812/numonthly.7646; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Du N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098926; Dutta D, 2014, J DIABETES, V6, P316, DOI 10.1111/1753-0407.12112; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Ghigliotti G, 2014, INFLAMMATION, V37, P1337, DOI 10.1007/s10753-014-9914-1; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; He Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003769; Hoehner CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015762.92814.85; Imig JD, 2013, COMPR PHYSIOL, V3, P957, DOI 10.1002/cphy.c120028; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim JY, 2012, J KOREAN MED SCI, V27, P1524, DOI 10.3346/jkms.2012.27.12.1524; Kim SH, 2016, EUR HEART J, V37, P3560, DOI 10.1093/eurheartj/ehv509; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kurozumi A, 2016, INTERNAL MED, V55, P3091, DOI 10.2169/internalmedicine.55.6940; Lee IT, 2013, J DIABETES COMPLICAT, V27, P243, DOI 10.1016/j.jdiacomp.2012.11.004; Lee YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157303; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Shin DI, 2013, J KOREAN MED SCI, V28, P252, DOI 10.3346/jkms.2013.28.2.252; Sorensen BM, 2016, CIRCULATION, V134, P1339, DOI 10.1161/CIRCULATIONAHA.116.023446; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Todd JN, 2015, DIABETES, V64, P4238, DOI 10.2337/db15-0254; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wakabayashi I, 2015, CLIN CHIM ACTA, V446, P231, DOI 10.1016/j.cca.2015.04.020; Wakabayashi I, 2015, CLIN CHIM ACTA, V438, P274, DOI 10.1016/j.cca.2014.08.042; Wu CC, 2011, NEPHROL DIAL TRANSPL, V26, P3689, DOI 10.1093/ndt/gfr057; Yang XL, 2009, DIABETES, V58, P1518, DOI 10.2337/db09-0105; Yoon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111179; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180924	10.1371/journal.pone.0180924	http://dx.doi.org/10.1371/journal.pone.0180924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715448	Green Published, gold, Green Submitted			2022-12-26	WOS:000443975500021
J	Ali, SS; Wu, J; Xie, RR; Zhou, F; Sun, JZ; Huang, M				Ali, Sameh Samir; Wu, Jian; Xie, Rongrong; Zhou, Feng; Sun, Jianzhong; Huang, Miao			Screening and characterizing of xylanolytic and xylose-fermenting yeasts isolated from the wood-feeding termite, Reticulitermes chinensis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; NEIGHBOR-JOINING METHOD; ETHANOL-PRODUCTION; LIGNOCELLULOSIC BIOMASS; PRODUCT FORMATION; ESCHERICHIA-COLI; FOREST HABITATS; CELL-SURFACE; ROTTING WOOD; XYLANASE	The effective fermentation of xylose remains an intractable challenge in bioethanol industry. The relevant xylanase enzyme is also in a high demand from industry for several biotechnological applications that inevitably in recent times led to many efforts for screening some novel microorganisms for better xylanase production and fermentation performance. Recently, it seems that wood-feeding termites can truly be considered as highly efficient natural bioreactors. The highly specialized gut systems of such insects are not yet fully realized, particularly, in xylose fermentation and xylanase production to advance industrial bioethanol technology as well as industrial applications of xylanases. A total of 92 strains from 18 yeast species were successfully isolated and identified from the gut of wood-feeding termite, Reticulitermes chinensis. Of these yeasts and strains, seven were identified for new species: Candida gotoi, Candida pseudorhagii, Hamamotoa lignophila, Meyerozyma guilliermondii, Sugiyamaella sp. 1, Sugiyamaella sp. 2, and Sugiyamaella sp. 3. Based on the phylogenetic and phenotypic characterization, the type strain of C. pseudorhagii sp. nov., which was originally designated strain SSA-1542 (T), was the most frequently occurred yeast from termite gut samples, showed the highly xylanolytic activity as well as D-xylose fermentation. The highest xylanase activity was recorded as 1.73 and 0.98 U/mL with xylan or D-xylose substrate, respectively, from SSA-1542 (T). Among xylanase-producing yeasts, four novel species were identified as D-xylose-fermenting yeasts, where the yeast, C. pseudorhagii SSA-1542 T, showed the highest ethanol yield (0.31 g/g), ethanol productivity (0.31 g/L.h), and its fermentation efficiency (60.7%) in 48 h. Clearly, the symbiotic yeasts isolated from termite guts have demonstrated a competitive capability to produce xylanase and ferment xylose, suggesting that the wood-feeding termite gut is a promising reservoir for novel xylanases-producing and xylose-fermenting yeasts that are potentially valued for biorefinery industry.	[Ali, Sameh Samir; Wu, Jian; Xie, Rongrong; Zhou, Feng; Sun, Jianzhong; Huang, Miao] Jiangsu Univ, Biofuels Inst, Sch Environm & Safety Engn, Zhenjiang, Peoples R China; [Ali, Sameh Samir] Tanta Univ, Bot Dept, Fac Sci, Tanta, Egypt	Jiangsu University; Egyptian Knowledge Bank (EKB); Tanta University	Sun, JZ (corresponding author), Jiangsu Univ, Biofuels Inst, Sch Environm & Safety Engn, Zhenjiang, Peoples R China.	jzsun1002@ujs.edu.cn	Ai, Sameh Samir/R-3018-2019; Ai, Sameh/S-2009-2019; Ali, Sameh Samir/AAS-1970-2020	Ai, Sameh Samir/0000-0002-7033-8387; Ai, Sameh/0000-0002-7033-8387; Sun, Jianzhong/0000-0002-0857-2842	Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [4013000011]	Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the Priority of Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (code 4013000011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Bhadra B, 2008, CURR MICROBIOL, V56, P489, DOI 10.1007/s00284-008-9108-x; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brune A, 1998, TRENDS BIOTECHNOL, V16, P16, DOI 10.1016/S0167-7799(97)01151-7; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Cadete RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043135; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Cao YQ, 2010, INSECT SCI, V17, P237, DOI 10.1111/j.1744-7917.2009.01311.x; Chen SC, 2013, BIORESOURCE TECHNOL, V128, P145, DOI 10.1016/j.biortech.2012.10.087; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; Costa CE, 2017, BIORESOURCE TECHNOL, V227, P24, DOI 10.1016/j.biortech.2016.12.016; FELL JW, 1966, ANTON VAN LEE J M S, V32, P99, DOI 10.1007/BF02097449; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonseca C, 2007, APPL MICROBIOL BIOT, V75, P303, DOI 10.1007/s00253-006-0830-7; Fujita Y, 2002, J MOL CATAL B-ENZYM, V17, P189, DOI 10.1016/S1381-1177(02)00027-9; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; Ghoshal G, 2015, J BIOTECHNOL TECHNOL, V6, P1013; GONG CS, 1983, BIOTECHNOL BIOENG, V25, P85, DOI 10.1002/bit.260250108; HAHNHAGERDAL B, 1994, ENZYME MICROB TECH, V16, P933, DOI 10.1016/0141-0229(94)90002-7; Handel S, 2016, INT J SYST EVOL MICR, V66, P4600, DOI 10.1099/ijsem.0.001397; Hasunuma T, 2012, PROCESS BIOCHEM, V47, P1287, DOI 10.1016/j.procbio.2012.05.004; Hector RE, 2011, J IND MICROBIOL BIOT, V38, P1193, DOI 10.1007/s10295-010-0896-1; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Katahira S, 2004, APPL ENVIRON MICROB, V70, P5407, DOI 10.1128/AEM.70.9.5407-5414.2004; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Kato H, 2012, APPL MICROBIOL BIOT, V94, P1585, DOI 10.1007/s00253-012-3914-6; Katsumata KS, 2007, J WOOD SCI, V53, P419, DOI 10.1007/s10086-007-0882-z; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Kumar S, 2009, CHEM ENG TECHNOL, V32, P517, DOI 10.1002/ceat.200800442; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtzman CP, 2007, FEMS YEAST RES, V7, P1046, DOI 10.1111/j.1567-1364.2007.00224.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P621, DOI 10.1016/B978-0-444-52149-1.00047-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P333, DOI 10.1016/B978-0-444-52149-1.00018-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P435, DOI 10.1016/B978-0-444-52149-1.00033-1; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Kurtzman CP, 1998, YEASTS TAXONOMIC STU, P90; Lara CA, 2014, ANTON LEEUW INT J G, V105, P1107, DOI 10.1007/s10482-014-0172-x; Li Hongxing, 2016, Bioresour Bioprocess, V3, P51, DOI 10.1186/s40643-016-0126-4; Li HX, 2015, MICROB BIOTECHNOL, V8, P266, DOI 10.1111/1751-7915.12245; Li XL, 1996, APPL ENVIRON MICROB, V62, P209, DOI 10.1128/AEM.62.1.209-213.1996; Liu CJ, 2003, J BIOSCI BIOENG, V95, P95, DOI 10.1263/jbb.95.95; Matano Y, 2012, BIORESOURCE TECHNOL, V108, P128, DOI 10.1016/j.biortech.2011.12.144; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Matteotti C, 2012, PROTEIN EXPRES PURIF, V83, P117, DOI 10.1016/j.pep.2012.03.009; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morais CG, 2013, FUNGAL GENET BIOL, V60, P19, DOI 10.1016/j.fgb.2013.07.003; Morais CG, 2013, INT J SYST EVOL MICR, V63, P2356, DOI 10.1099/ijs.0.050856-0; NAKASE T, 1986, J GEN APPL MICROBIOL, V32, P225, DOI 10.2323/jgam.32.225; Parachin NS, 2009, J MOL CATAL B-ENZYM, V59, P52, DOI 10.1016/j.molcatb.2008.12.018; Parreiras LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107499; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; ROULAND C, 1988, INSECT BIOCHEM, V18, P709, DOI 10.1016/0020-1790(88)90080-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto T, 2012, J BIOTECHNOL, V158, P203, DOI 10.1016/j.jbiotec.2011.06.025; Sanchez S, 2008, WORLD J MICROB BIOT, V24, P709, DOI 10.1007/s11274-007-9527-z; Schafer A, 1996, J APPL BACTERIOL, V80, P471, DOI 10.1111/j.1365-2672.1996.tb03245.x; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; SLININGER PJ, 1985, BIOTECHNOL LETT, V7, P431, DOI 10.1007/BF01166218; Suh SO, 2005, MYCOLOGIA, V97, P167, DOI 10.3852/mycologia.97.1.167; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; Sun JZ, 2014, AS ONE RSC ENERGY EN; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRAN AV, 1986, ENZYME MICROB TECH, V8, P439, DOI 10.1016/0141-0229(86)90154-7; Urbina H, 2013, MYCOLOGIA, V105, P650, DOI 10.3852/12-094; Vega F. E., 2005, INSECT FUNGAL ASS EC, P211; Walfridsson M, 1997, APPL MICROBIOL BIOT, V48, P218, DOI 10.1007/s002530051041; Wei JQ, 2007, SOCIOBIOLOGY, V50, P553; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Zhang W, 2014, CHEM BIOCHEM ENG Q, V28, P117	75	47	53	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181141	10.1371/journal.pone.0181141	http://dx.doi.org/10.1371/journal.pone.0181141			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704553	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700096
J	Prabhu, KS; Siveen, KS; Kuttikrishnan, S; Iskandarani, A; Tsakou, M; Achkar, IW; Therachiyil, L; Krishnankutty, R; Parray, A; Kulinski, M; Merhi, M; Dermime, S; Mohammad, RM; Uddin, S				Prabhu, Kirti S.; Siveen, Kodappully S.; Kuttikrishnan, Shilpa; Iskandarani, Ahmad; Tsakou, Magdalini; Achkar, Iman W.; Therachiyil, Lubna; Krishnankutty, Roopesh; Parray, Aijaz; Kulinski, Michal; Merhi, Maysaloun; Dermime, Said; Mohammad, Ramzi M.; Uddin, Shahab			Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells	PLOS ONE			English	Article							XIAP EXPRESSION; DOWN-REGULATION; PROGNOSTIC-SIGNIFICANCE; THERAPEUTIC TARGET; CANCER-CELLS; AKT ACTIVITY; PATHWAY; RESISTANCE; CARCINOMA; RECEPTOR	The X-linked inhibitor of apoptosis (XIAP) is a viable molecular target for anticancer drugs that overcome apoptosis-resistance of malignant cells. XIAP is an inhibitor of apoptosis, mediating through its association with BIR3 domain of caspase 9. Embelin, a quinone derivative isolated from the Embelia ribes plant, has been shown to exhibit chemopreventive, anti-inflammatory, and apoptotic activities via inhibiting XIAP activity. In this study, we found that embelin causes a dose-dependent suppression of proliferation in leukemic cell lines K562 and U937. Embelin mediated inhibition of proliferation correlates with induction of apoptosis. Furthermore, embelin treatment causes loss of mitochondrial membrane potential and release of cytochrome c, resulting in subsequent activation of caspase-3 followed by polyadenosin-5'-diphosphate-ribose polymerase (PARP) cleavage. In addition, embelin treatment of leukemic cells results in a decrease of constitutive phosphorylations/activation level of AKT and downregulation of XIAP. Gene silencing of XIAP and AKT expression showed a link between XIAP expression and activated AKT in leukemic cells. Interestingly, targeting of XIAP and PI3-kinase/AKT signaling augmented inhibition of proliferation and induction of apoptosis in leukemic cells. Altogether these findings raise the possibility that embelin alone or in combination with inhibitors of PI3-kinase/AKT pathway may have therapeutic usage in leukemia and possibly other malignancies with up-regulated XIAP pathway.	[Prabhu, Kirti S.; Siveen, Kodappully S.; Kuttikrishnan, Shilpa; Iskandarani, Ahmad; Tsakou, Magdalini; Achkar, Iman W.; Therachiyil, Lubna; Krishnankutty, Roopesh; Parray, Aijaz; Kulinski, Michal; Mohammad, Ramzi M.; Uddin, Shahab] Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar; [Merhi, Maysaloun; Dermime, Said] Hamad Med Corp, NCCCR, Translat Canc Res Facil, Doha, Qatar	Hamad Medical Corporation; Hamad Medical Corporation	Uddin, S (corresponding author), Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar.	SKhan34@hamad.qa	Dermime, Said/P-2448-2019; Krishnankutty, Roopesh/M-5836-2015	Dermime, Said/0000-0002-5526-7496; Achkar, Iman/0000-0003-3197-7108; Uddin, Shahab/0000-0003-1886-6710; Krishnankutty, Roopesh/0000-0002-1496-6135	Medical Research Center, Hamad Medical Corporation, Doha, Qatar [16102/16]	Medical Research Center, Hamad Medical Corporation, Doha, Qatar	This study was supported by a grant from the Medical Research Center, Hamad Medical Corporation, Doha, Qatar (Grant # 16102/16).	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Asselin E, 2001, CANCER RES, V61, P1862; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Carter BZ, 2003, LEUKEMIA, V17, P2081, DOI 10.1038/sj.leu.2403113; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Dai Y, 2014, MOL CANCER THER, V13, P1206, DOI 10.1158/1535-7163.MCT-13-0378; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Dean EJ, 2007, EXPERT OPIN THER TAR, V11, P1459, DOI 10.1517/14728222.11.11.1459; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gagnon V, 2003, INT J ONCOL, V23, P803; Guo HR, 2015, INT J MOL SCI, V16, P22989, DOI 10.3390/ijms160922989; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2015, J CLIN ENDOCR METAB, V100, pE974, DOI 10.1210/jc.2014-4356; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; Iskandarani A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0823-y; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Ma YH, 2016, ONCOL REP, V36, P49, DOI 10.3892/or.2016.4820; Maghsoudi N., 2012, Experimental Oncology, V34, P146; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Park N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134760; Pazhang Y, 2016, J CANCER RES THER, V12, P155, DOI 10.4103/0973-1482.150407; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sasaki H, 2000, CANCER RES, V60, P5659; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Siveen KS, 2014, ONCOTARGET, V5, P634, DOI 10.18632/oncotarget.1596; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Yang S, 2016, ONCOL LETT, V11, P4167, DOI 10.3892/ol.2016.4522; Yang TX, 2015, CELL BIOCHEM BIOPHYS, V71, P291, DOI 10.1007/s12013-014-0197-9; Zhou SN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-288; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	52	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180895	10.1371/journal.pone.0180895	http://dx.doi.org/10.1371/journal.pone.0180895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704451	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649700059
J	Siffredi, V; Barrouillet, P; Spencer-Smith, M; Vaessen, M; Anderson, V; Vuilleumier, P				Siffredi, Vanessa; Barrouillet, Pierre; Spencer-Smith, Megan; Vaessen, Maarten; Anderson, Vicki; Vuilleumier, Patrik			Examining distinct working memory processes in children and adolescents using fMRI: Results and validation of a modified Brown-Peterson paradigm	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORD FORM AREA; N-BACK TASK; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; DEVELOPMENTAL-CHANGES; NATIONAL CURRICULUM; HUMAN BRAIN; CAPACITY; ATTENTION	Verbal working memory (WM) comprises different processes (encoding, maintenance, retrieval) that are often compromised in brain diseases, but their neural correlates have not yet been examined in childhood and adolescence. To probe WM processes and associated neural correlates in developmental samples, and obtain comparable effects across different ages and populations, we designed an adapted Brown-Peterson task (verbal encoding and retrieval combined with verbal and visual concurrent tasks during maintenance) to implement during functional magnetic resonance imaging (fMRI). In a sample of typically developing children and adolescents (n = 16), aged 8 to 16 years, our paradigm successfully identified distinct patterns of activation for encoding, maintenance, and retrieval. While encoding activated perceptual systems in posterior and ventral visual regions, retrieval activated fronto-parietal regions associated with executive control and attention. We found a different impact of verbal versus visual concurrent processing during WM maintenance: at retrieval, the former condition evoked greater activations in visual cortex, as opposed to selective involvement of language-related areas in left temporal cortex in the latter condition. These results are in accord with WM models, suggesting greater competition for processing resources when retrieval follows within-domain compared with cross-domain interference. This pattern was found regardless of age. Our study provides a novel paradigm to investigate distinct WM brain systems with reliable results across a wide age range in developmental populations, and suitable for participants with different WM capacities.	[Siffredi, Vanessa; Barrouillet, Pierre; Vaessen, Maarten; Vuilleumier, Patrik] Univ Geneva, Geneva, Switzerland; [Siffredi, Vanessa; Spencer-Smith, Megan; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Siffredi, Vanessa; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia; [Spencer-Smith, Megan] Monash Univ, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia	University of Geneva; Murdoch Children's Research Institute; University of Melbourne; Monash University; Royal Children's Hospital Melbourne	Siffredi, V (corresponding author), Univ Geneva, Geneva, Switzerland.; Siffredi, V (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Siffredi, V (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	vanessa.siffredi@gmail.com	Vuilleumier, Patrik/AAJ-1839-2021; Siffredi, Vanessa/AAA-4866-2020	Vuilleumier, Patrik/0000-0002-8198-9214; Siffredi, Vanessa/0000-0002-9137-0730; Spencer-Smith, Megan/0000-0002-1047-0829	Victorian Government's Operational Infrastructure Support Program; Murdoch Childrens Research Institute; Swiss National Science Foundation Doc.CH scholarship; Australian National Health and Medical Research Council Senior Practitioner Fellowship	Victorian Government's Operational Infrastructure Support Program; Murdoch Childrens Research Institute; Swiss National Science Foundation Doc.CH scholarship; Australian National Health and Medical Research Council Senior Practitioner Fellowship	This study was supported by Victorian Governments Operational Infrastructure Support Program, the Murdoch Childrens Research Institute. VS was supported by the Swiss National Science Foundation Doc.CH scholarship. VA was supported by Australian National Health and Medical Research Council Senior Practitioner Fellowship.	Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A., 1986, WORKING MEMORY, pxi,; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley AD, 2011, NEUROPSYCHOLOGIA, V49, P1393, DOI 10.1016/j.neuropsychologia.2010.12.042; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Barrouillet P, 2001, J MEM LANG, V45, P1, DOI 10.1006/jmla.2001.2767; Barrouillet P, 2010, COGNITIVE DEV WORKIN, pxiv; Barrouillet P., 2015, WORKING MEMORY LOSS; Barrouillet P, 2008, PSYCHON B REV, V15, P528, DOI 10.3758/PBR.15.3.528; Barrouillet P, 2009, DEV PSYCHOL, V45, P477, DOI 10.1037/a0014615; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Brahmbhatt SB, 2010, BRAIN RES, V1354, P140, DOI 10.1016/j.brainres.2010.07.055; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Camos V, 2009, J MEM LANG, V61, P457, DOI 10.1016/j.jml.2009.06.002; Camos V, 2011, DEV PSYCHOL, V47, P898, DOI 10.1037/a0023193; Ciesielski KT, 2006, NEUROIMAGE, V33, P980, DOI 10.1016/j.neuroimage.2006.07.028; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2009, DEV MEMORY INFANCY C, pxii; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Darki F, 2014, CEREB CORTEX; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, NEUROIMAGE, V49, P1837, DOI 10.1016/j.neuroimage.2009.09.024; Delogu F, 2012, COGN PROCESS, V13, P267, DOI 10.1007/s10339-012-0442-3; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Finn AS, 2010, J NEUROSCI, V30, P11062, DOI 10.1523/JNEUROSCI.6266-09.2010; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Garrett AS, 2000, NEUROIMAGE, V11, P111, DOI 10.1006/nimg.1999.0528; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Groen MA, 2012, BRAIN BEHAV, V2, P256, DOI 10.1002/brb3.56; IBM C, 2013, IBM SPSS STAT WIND V; Jolles DD, 2011, DEVELOPMENTAL SCI, V14, P713, DOI 10.1111/j.1467-7687.2010.01016.x; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Libertus ME, 2009, NEUROIMAGE, V44, P1404, DOI 10.1016/j.neuroimage.2008.10.027; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Murner-Lavanchy I, 2014, DEV COGN NEUROS-NETH, V9, P106, DOI 10.1016/j.dcn.2014.02.004; Nagel BJ, 2005, J CLIN EXP NEUROPSYC, V27, P823, DOI 10.1080/13803390490919038; O'Hare ED, 2008, NEUROIMAGE, V42, P1678, DOI 10.1016/j.neuroimage.2008.05.057; Oberauer K, 2012, J EXP PSYCHOL LEARN, V38, P665, DOI 10.1037/a0026337; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Reber PJ, 2002, J NEUROSCI, V22, P9541; Savage R, 2006, BRIT J PSYCHOL, V97, P365, DOI 10.1348/000712605X81370; Schweinsburg AD, 2005, J INT NEUROPSYCH SOC, V11, P631, DOI 10.1017/S1355617705050757; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spencer-Smith M, 2013, DEV NEUROPSYCHOL, V38, P236, DOI 10.1080/87565641.2013.784321; Spencer-Smith MM, 2013, DEV NEUROPS IN PRESS; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Vergauwe E, 2014, J EXP PSYCHOL LEARN, V40, P1072, DOI 10.1037/a0035779; Vuontela V, 2009, BRAIN COGNITION, V69, P56, DOI 10.1016/j.bandc.2008.05.010; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WILHELM O, 2013, FRONT PSYCHOL, V4	77	12	12	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179959	10.1371/journal.pone.0179959	http://dx.doi.org/10.1371/journal.pone.0179959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704424	gold, Green Published			2022-12-26	WOS:000405649700021
J	Saha, B; Parks, RJ				Saha, Bratati; Parks, Robin J.			Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells	PLOS ONE			English	Article							TERMINAL PROTEIN; PRETERMINAL PROTEIN; IN-VIVO; 55-KILODALTON PROTEIN; TRANSCRIPTION UNIT; ESCHERICHIA-COLI; BINDING PROTEIN; GENE-THERAPY; POLYMERASE; ACTIVATION	Adenovirus (Ad) vectors deleted of the early region 1 (E1) are widely used for transgene delivery in preclinical and clinical gene therapy studies. Although proteins encoded within the E1 region are required for efficient virus replication, previous studies have suggested that certain viral or cellular proteins can functionally compensate for E1, leading to expression of the early region 2 (E2)-encoded replicative proteins and subsequent virus replication. We have generated a series of E1-encoding and E1-deficient Ad vectors containing a FLAG-epitope tag on each of the E2-encoded proteins: DNA-binding protein (DBP), terminal protein (TP) and DNA polymerase (Pol). Using these constructs, we show that for the replication-competent virus, the expression level of each E2-encoded protein declines with increasing distance from the E2 promoter, with E2A-encoded DBP expression being similar to 800-fold higher than E2B-encoded TP. Pol was expressed at extremely low levels in infected cells, and immunoprecipitation from cell lysates was required prior to its detection by immunoblot. We further show that DBP was expressed 200-to 400-fold less efficiently from an E1-deficient virus compared to a replication-competent virus in A549 and HepG2 cells, which was accompanied by a very small increase in genome copy number. For the E1-deficient virus, late gene expression (a marker of virus replication) was only observed at very high multiplicities of infection. These data show that E1-deleted Ad gives rise to limited expression of the E2-encoded genes and replication in infected cells, but highlight the importance of considering viral dose-dependent effects in gene therapy studies.	[Saha, Bratati; Parks, Robin J.] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Saha, Bratati; Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Saha, Bratati; Parks, Robin J.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Parks, RJ (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.	rparks@ohri.ca			Canadian Institutes of Health Research (CIHR); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC) of Canada; Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government	This study was supported by grants to RJP from the Canadian Institutes of Health Research (CIHR), the Cancer Research Society (Canada), and the National Sciences and Engineering Research Council (NSERC) of Canada. BS was supported by an Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government.	Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; Bramson JL, 2004, HUM GENE THER, V15, P179, DOI 10.1089/104303404772679986; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caravokyri C, 1996, VIRUS GENES, V12, P65, DOI 10.1007/BF00370002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CHEN M, 1990, J BIOL CHEM, V265, P18634; de Jong RN, 2003, NUCLEIC ACIDS RES, V31, P3274, DOI 10.1093/nar/gkg405; DESIDERIO SV, 1981, J MOL BIOL, V145, P319, DOI 10.1016/0022-2836(81)90208-4; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; FRIEFELD BR, 1985, P NATL ACAD SCI USA, V82, P2652, DOI 10.1073/pnas.82.9.2652; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; GATTONI R, 1986, J MOL BIOL, V187, P379, DOI 10.1016/0022-2836(86)90440-7; Giberson AN, 2012, NUCLEIC ACIDS RES, V40, P2369, DOI 10.1093/nar/gkr1076; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Gorziglia MI, 1996, J VIROL, V70, P4173, DOI 10.1128/JVI.70.6.4173-4178.1996; Goulet BB, 2013, BIOCHEM CELL BIOL, V91, P252, DOI 10.1139/bcb-2012-0094; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hoke CH, 2013, VACCINE, V31, P1623, DOI 10.1016/j.vaccine.2012.12.029; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Huang JH, 2010, MOL THER, V18, P264, DOI 10.1038/mt.2009.205; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; KUSUKAWA J, 1994, J BIOL CHEM, V269, P2189; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lind SB, 2012, VIROLOGY, V433, P253, DOI 10.1016/j.virol.2012.08.012; Mangel WF, 2014, VIRUSES-BASEL, V6, P4536, DOI 10.3390/v6114536; MCKINNON RD, 1982, GENE, V19, P33, DOI 10.1016/0378-1119(82)90186-X; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; Nakai M, 2007, HUM GENE THER, V18, P925, DOI 10.1089/hum.2007.085; Nash LA, 2016, THERAPEUTIC APPL ADE, P1; Nelson JE, 1997, J VIROL, V71, P8902, DOI 10.1128/JVI.71.11.8902-8907.1997; O'Connor RJ, 2000, J VIROL, V74, P5819, DOI 10.1128/JVI.74.13.5819-5824.2000; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Parker EJ, 1998, NUCLEIC ACIDS RES, V26, P1240, DOI 10.1093/nar/26.5.1240; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Parks RJ, 2005, MOL THER, V11, P19, DOI 10.1016/j.ymthe.2004.09.018; Poulin KL, 2011, VIROLOGY, V420, P146, DOI 10.1016/j.virol.2011.09.004; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; REICHEL R, 1989, J VIROL, V63, P3643, DOI 10.1128/JVI.63.9.3643-3650.1989; ROOVERS DJ, 1991, VIROLOGY, V180, P273, DOI 10.1016/0042-6822(91)90032-7; ROOVERS DJ, 1993, J VIROL, V67, P265, DOI 10.1128/JVI.67.1.265-276.1993; Ross PJ, 2011, J VIROL, V85, P3950, DOI 10.1128/JVI.01787-10; Ruzindana-Umunyana A, 2002, VIRUS RES, V89, P41, DOI 10.1016/S0168-1702(02)00111-9; Saha B, 2014, VIRUSES-BASEL, V6, P3563, DOI 10.3390/v6093563; Sargent KL, 2004, J VIROL, V78, P5032, DOI 10.1128/JVI.78.10.5032-5037.2004; SCHAACK J, 1995, J VIROL, V69, P4079, DOI 10.1128/JVI.69.7.4079-4085.1995; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; Swaminathan S, 1996, J MOL BIOL, V258, P736, DOI 10.1006/jmbi.1996.0283; Swaminathan S, 1995, MOL REPERTOIRE ADE 3, V199/3, P177; Tollefson AE, 2007, J VIROL, V81, P12918, DOI 10.1128/JVI.01531-07; TSERNOGLOU D, 1985, FEBS LETT, V188, P248, DOI 10.1016/0014-5793(85)80381-1; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; VOS HL, 1989, VIROLOGY, V172, P634, DOI 10.1016/0042-6822(89)90206-7; Webster A, 1997, J VIROL, V71, P6381, DOI 10.1128/JVI.71.9.6381-6389.1997; WEBSTER A, 1994, J VIROL, V68, P7292, DOI 10.1128/JVI.68.11.7292-7300.1994; Weitzman MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1106, DOI 10.2741/1604; Ying BL, 2010, J VIROL, V84, P11470, DOI 10.1128/JVI.01338-10	60	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181012	10.1371/journal.pone.0181012	http://dx.doi.org/10.1371/journal.pone.0181012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700677	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800115
J	Strom, JB; Kramer, DB; Wang, Y; Shen, CY; Wasfy, JH; Landon, BE; Wilker, EH; Yeh, RW				Strom, Jordan B.; Kramer, Daniel B.; Wang, Yun; Shen, Changyu; Wasfy, Jason H.; Landon, Bruce E.; Wilker, Elissa H.; Yeh, Robert W.			Short-term rehospitalization across the spectrum of age and insurance types in the United States	PLOS ONE			English	Article							READMISSIONS REDUCTION PROGRAM; DIAGNOSES	Few studies have examined rates and causes of short-term readmissions among adults across age and insurance types. We compared rates, characteristics, and costs of 30-day readmission after all-cause hospitalizations across insurance types in the US. We retrospectively evaluated alive patients >= 18 years old, discharged for any cause, 1/1/13-11/31/13, 2006 non-federal hospitals in 21 states in the Nationwide Readmissions Database. The primary stratification variable of interest was primary insurance. Comorbid conditions were assessed based on Elixhauser comorbidities, as defined by administrative billing codes. Additional measures included diagnoses for index hospitalizations leading to rehospitalization. Hierarchical multivariable logistic regression models, with hospital site as a random effect, were used to calculate the adjusted odds of 30-day readmissions by age group and insurance categories. Cost and discharge estimates were weighted per NRD procedures to reflect a nationally representative sample. Diagnoses for index hospitalizations leading to rehospitalization were determined. Among 12,533,551 discharges, 1,818,093 (14.5%) resulted in readmission within 30 days. Medicaid insurance was associated with the highest adjusted odds ratio (AOR) for readmission both in those >= 65 years old (AOR 1.12, 95% CI 1.10-1.14; p < 0.001), and 45-64 (AOR 1.67, 95% CI 1.66-1.69; p < 0.001), and Medicare in the 18-44 group (Medicare vs. private insurance: AOR 1.99, 95% CI 1.96-2.01; p < 0.001). Discharges for psychiatric or substance abuse disorders, septicemia, and heart failure accounted for the largest numbers of readmissions, with readmission rates of 24.0%, 17.9%, 22.9% respectively. Total costs for readmissions were 50.7 billion USD, highest for Medicare (29.6 billion USD), with non-Medicare costs exceeding 21 billion USD. While Medicare readmissions account for more than half of the total burden of readmissions, costs of non-Medicare readmissions are nonetheless substantial. Medicaid patients have the highest odds of readmission in individuals older than age 44, commonly due to hospitalizations for psychiatric illness and substance abuse disorders. Medicaid patients represent a population at uniquely high risk for readmission.	[Strom, Jordan B.; Kramer, Daniel B.; Shen, Changyu; Wilker, Elissa H.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Cardiovasc Outcomes, Boston, MA 02215 USA; [Wang, Yun] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Wasfy, Jason H.] Massachusetts Gen Hosp, Div Cardiovasc Med, Boston, MA 02114 USA; [Landon, Bruce E.] Harvard Med Sch, Dept Healthcare Policy, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Cardiovasc Outcomes, Boston, MA 02215 USA.	ryeh@bidmc.harvard.edu	Yeh, Robert/AAJ-3463-2020	Strom, Jordan/0000-0002-6592-6141	National Heart, Lung, and Blood Institute [K23HL118138, 5T32HL007374-37]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by K23HL118138 (RWY) National Heart, Lung, and Blood Institute; 5T32HL007374-37 (JBS) National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Association, 2015, RETH HOSP READM RED; [Anonymous], 2015, BLUEPR CMS MEAS MAN; [Anonymous], SIGN MED SPEC COND; [Anonymous], 2014, MANAGEMENT STRATEGIE; [Anonymous], 2015, COST CHARG RAT FIL 2; [Anonymous], 2016, FACTS MED SPENDING F; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Brown D, 2014, CONSIDERATIONS INTEG; Carnahan RM, 2011, MINI SENTINEL SYSTEM, V14; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, MEAS METH REP; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Glance LG, 2016, ANN SURG, V263, P698, DOI 10.1097/SLA.0000000000001363; HCUP Cost-to-Charge Ratio Files (CCR), HEALTHC COST UT PROJ; HCUP Databases, 2006, HEALTHC COST UT PROJ; HCUP Elixhauser Comorbidity Software, 2017, HCUP EL COM SOFTW; Healthcare Cost and Utilization Project, HCUP QUAL CONTR PROC; Healthcare Cost and Utilization Project (HCUP), AG HEALTHC RES QUAL; Healthcare Cost and Utilization Project (HCUP), 2015, INTR HCUP NAT READM; Hu J, 2014, HLTH AFF, V33, P1; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kostick Karen, 2011, J AHIMA, V82, P60; Martsolf GR, 2016, J HLTH CARE ORG PROV, V53, P1, DOI DOI 10.1177/0046958016667596; National Academies of Sciences Engineering and Medicine, 2016, ACC SOC RISK FACT ME; Silow-Carroll S, 2011, SYNTHESIS REPORT, V1473, P1; Trudnak T, 2014, HEALTH AFFAIR, V33, P1337, DOI 10.1377/hlthaff.2013.0632; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	30	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180767	10.1371/journal.pone.0180767	http://dx.doi.org/10.1371/journal.pone.0180767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700736	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800073
J	Lei, X; Seldin, MM; Little, HC; Choy, N; Klonisch, T; Wong, GW				Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Klonisch, Thomas; Wong, G. William			C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; C1Q/TNF FAMILY-MEMBERS; NECROSIS-FACTOR-ALPHA; HEPATIC STEATOSIS; LIPID HOMEOSTASIS; SKELETAL-MUSCLE; FOOD-INTAKE; TNF-ALPHA; EXPRESSION; GLUCOSE	Obesity is associated with chronic low-grade inflammation, and metabolic regulators linking obesity to inflammation have therefore received much attention. Secreted C1q/TNF-related proteins (CTRPs) are one such group of regulators that regulate glucose and fat metabolism in peripheral tissues and modulate inflammation in adipose tissue. We have previously shown that expression of CTRP6 is up-regulated in leptin-deficient mice and, conversely, down-regulated by the anti-diabetic drug rosiglitazone. Here, we provide evidence for a novel role of CTRP6 in modulating both inflammation and insulin sensitivity. We found that in obese and diabetic humans and mouse models, CTRP6 expression was markedly up-regulated in adipose tissue and that stromal vascular cells, such as macrophages, are a major CTRP6 source. Overexpressing mouse or human CTRP6 impaired glucose disposal in peripheral tissues in response to glucose and insulin challenge in wild-type mice. Conversely, Ctrp6 gene deletion improved insulin action and increased metabolic rate and energy expenditure in diet-induced obese mice. Mechanistically, CTRP6 regulates local inflammation and glucose metabolism by targeting macrophages and adipocytes, respectively. In cultured macrophages, recombinant CTRP6 dose-dependently up-regulated the expression and production of TNF-alpha. Conversely, CTRP6 deficiency reduced circulating inflammatory cytokines and pro-inflammatory macrophages in adipose tissue. CTRP6-overexpressing mice or CTRP6-treated adipocytes had reduced insulin-stimulated Akt phosphorylation and glucose uptake. In contrast, loss of CTRP6 enhanced insulin-stimulated Akt activation in adipose tissue. Together, these results establish CTRP6 as a novel metabolic/immune regulator linking obesity to adipose tissue inflammation and insulin resistance.	[Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Klonisch, Thomas] Univ Manitoba, Dept Human Anat & Cell Sci, Fac Med, Winnipeg, MB, Canada	Johns Hopkins University; Johns Hopkins University; University of Manitoba	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Klonisch, Thomas/W-9923-2019	Klonisch, Thomas/0000-0003-0448-6741; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [POST17070119]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant DK084171 (to G. W. W.) and American Heart Association post-doctoral fellowship POST17070119 (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fan RH, 2016, BIOCHEM BIOPH RES CO, V475, P356, DOI 10.1016/j.bbrc.2016.05.013; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kim MJ, 2010, MOL CELLS, V30, P59, DOI 10.1007/s10059-010-0088-x; Lee W, 2010, FEBS LETT, V584, P968, DOI 10.1016/j.febslet.2010.01.040; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu W, 2015, AUTOM ELECT POWER SY, V39, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	42	53	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14836	14850		10.1074/jbc.M116.766808	http://dx.doi.org/10.1074/jbc.M116.766808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726640	Green Published, hybrid			2022-12-26	WOS:000409902100012
J	Kroh, HK; Chandrasekaran, R; Rosenthal, K; Woods, R; Jin, XF; Ohi, MD; Nyborg, AC; Rainey, GJ; Warrener, P; Spiller, BW; Lacy, DB				Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Ohi, Melanie D.; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul; Spiller, Benjamin W.; Lacy, D. Borden			Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INFECTION; PROTECTION; BEZLOTOXUMAB; RECOGNITION; SOFTWARE; SYSTEM; DOMAIN; VISUALIZATION; MECHANISM	Clostridium difficile is a clinically significant pathogen that causes mild-to-severe (and often recurrent) colon infections. Disease symptoms stem from the activities of two large, multidomain toxins known as TcdA and TcdB. The toxins can bind, enter, and perturb host cell function through a multistep mechanism of receptor binding, endocytosis, pore formation, autoproteolysis, and glucosyltransferase-mediated modification of host substrates. Monoclonal antibodies that neutralize toxin activity provide a survival benefit in preclinical animal models and prevent recurrent infections in human clinical trials. However, the molecular mechanisms involved in these neutralizing activities are unclear. To this end, we performed structural studies on a neutralizing monoclonal antibody, PA50, a humanized mAb with both potent and broad-spectrum neutralizing activity, in complex with TcdA. Electron microscopy imaging and multiangle light-scattering analysis revealed that PA50 binds multiple sites on the TcdA C-terminal combined repetitive oligopeptides (CROPs) domain. A crystal structure of two PA50 Fabs bound to a segment of the TcdA CROPs helped define a conserved epitope that is distinct from previously identified carbohydrate-binding sites. Binding of TcdA to the host cell surface was directly blocked by either PA50 mAb or Fab and suggested that receptor blockade is the mechanism by which PA50 neutralizes TcdA. These findings highlight the importance of the CROPsCterminus in cell-surface binding and a role for neutralizing antibodies in defining structural features critical to a pathogen's mechanism of action. We conclude that PA50 protects host cells by blocking the binding of TcdA to cell surfaces.	[Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Spiller, Benjamin W.; Lacy, D. Borden] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul] MedImmune LLC, Gaithersburg, MD 20878 USA; [Ohi, Melanie D.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Lacy, D. Borden] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Rainey, G. Jonah] MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA	Vanderbilt University; AstraZeneca; Medimmune; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, A5301 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.; Lacy, DB (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, A5301 Med Ctr North,161 21st Ave South, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu; borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Ohi, Melanie/0000-0003-1750-4793; Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [S10 RR026915]; Vanderbilt Structural Electron Microscopy Facility - Vanderbilt Center for Structural Biology; DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108778, R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Structural Electron Microscopy Facility - Vanderbilt Center for Structural Biology; DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	A portion of the experiments described here used the Vanderbilt robotic crystallization facility, which was supported by National Institutes of Health Grant S10 RR026915, and the Vanderbilt Structural Electron Microscopy Facility, which is supported in part by the Vanderbilt Center for Structural Biology. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chandrasekaran R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006070; Chapman BC, 2016, J TRAUMA ACUTE CARE, V81, P756, DOI 10.1097/TA.0000000000001195; Chen SY, 2015, TOXINS, V7, P5254, DOI 10.3390/toxins7124874; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Hernandez LD, 2015, ANTIMICROB AGENTS CH, V59, P1052, DOI 10.1128/AAC.04433-14; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Huang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135045; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Martin J, 2016, CURR OPIN INFECT DIS, V29, P546, DOI 10.1097/QCO.0000000000000320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGlone SM, 2012, CLIN MICROBIOL INFEC, V18, P282, DOI 10.1111/j.1469-0691.2011.03571.x; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rao K, 2015, INFECT DIS CLIN N AM, V29, P109, DOI 10.1016/j.idc.2014.11.009; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Teneberg S, 1996, GLYCOBIOLOGY, V6, P599, DOI 10.1093/glycob/6.6.599; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Waterman D. G., 2013, CCP4 NEWSLETTER PROT, V49, P16; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang ZY, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw078; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Youngster I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0680-9	57	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14401	14412		10.1074/jbc.M117.781112	http://dx.doi.org/10.1074/jbc.M117.781112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28705932	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000408747500009
J	Chichom-Mefire, A; Nwanna-Nzewunwa, OC; Siysi, VV; Feldhaus, I; Dicker, R; Juillard, C				Chichom-Mefire, Alain; Nwanna-Nzewunwa, Obieze C.; Siysi, Vincent Verla; Feldhaus, Isabelle; Dicker, Rochelle; Juillard, Catherine			Key findings from a prospective trauma registry at a regional hospital in Southwest Cameroon	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; INJURY SURVEILLANCE; EPIDEMIOLOGY; CARE; ACCURACY; BURDEN	Introduction Trauma is a leading cause of morbidity and mortality worldwide. Data characterizing the burden of trauma in Cameroon is limited. Regular, prospective injury surveillance can address the shortcomings of existing hospital administrative logs and medical records. This study aims to characterize trauma as seen at the emergency department (ED) of Limbe Regional Hospital (LRH) and assess the completeness of data obtained by a trauma registry. Methods and findings From January 2008 to October 2013, we prospectively captured data on injured patients using a strategically designed, context-relevant trauma registry instrument. Indicators around patient demographics, injury characteristics, delays in accessing care, and treatment outcomes were recorded. Descriptive, bivariate, and multivariate statistical analyses were conducted. About 5,617 patients, aged from 0.5-95 years (median age of 26 years), visited the LRH ED with an injury; 67% were male. Students (27%) were the most affected occupation category. Road traffic injuries (RTIs) (56%), assault (22%), and domestic injuries (13%) were the leading causes of injury. Two-thirds of RTIs were motorcycle-related. Working in transportation (AOR 4.42, p < 0.001) and law enforcement (AOR 1.73, p = 0.004) were significant predictors of having a RTI. The trauma registry showed a significant improvement in completeness of all data (p < 0.001) and it improved over time compared with previous administrative records. However, proportions of missing data still ranged from 0.5% to 8.2% and involved respiratory rate or Glasgow Coma scale. Conclusions Implementation of a context-appropriate trauma registry in resource-constrained settings is feasible. Providing valuable, high-quality data, the trauma registry can inform trauma care quality improvement efforts and policy development. Study findings indicate the need for injury prevention interventions and policies that will prioritize high-risks groups, such as those aged 20-29 years, and those in occupations requiring frequent road travel. The high incidence of motorcycle-related injuries is concerning and calls for a proactive solution.	[Chichom-Mefire, Alain; Siysi, Vincent Verla] Univ Buea, Dept Surg, Fac Hlth Sci, Buea, Cameroon; [Chichom-Mefire, Alain; Siysi, Vincent Verla] Reg Hosp Limbe, Buea, Cameroon; [Nwanna-Nzewunwa, Obieze C.; Feldhaus, Isabelle; Dicker, Rochelle; Juillard, Catherine] Univ Calif San Francisco, Dept Surg, Ctr Global Surg Studies, San Francisco, CA USA	University of California System; University of California San Francisco	Chichom-Mefire, A (corresponding author), Univ Buea, Dept Surg, Fac Hlth Sci, Buea, Cameroon.; Chichom-Mefire, A (corresponding author), Reg Hosp Limbe, Buea, Cameroon.	alainchichom@yahoo.com	Chichom-Mefire, Alain/I-7070-2019	Chichom-Mefire, Alain/0000-0001-7230-567X				Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; [Anonymous], 2011, MICR EXC; [Anonymous], 2002, FOR AID NAT INT PROM; Asekhame FF, 2013, DEV CTRY STUD, V3; Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Chichom-Mefire A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2290-4; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hunt JP, 1999, SURGERY, V126, P191, DOI 10.1067/msy.1999.98749; Ikpeme IA, 2013, INT J BURNS TRAUMA, V3, P214; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS PROF C; International Association of Public Transport, 2008, OV PUBL TRANSP SUB S; Juillard C, 2011, WORLD J SURG, V35, P1, DOI 10.1007/s00268-010-0825-5; Juillard C, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.025825; Juillard CJ, 2014, WORLD J SURG, V38, P2534, DOI 10.1007/s00268-014-2604-1; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kouo-Ngamby M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1147-y; Mefire AC, 2013, WORLD J SURG, V37, P2101, DOI 10.1007/s00268-013-2116-4; Mefire AC, 2013, INJURY, V44, P139, DOI 10.1016/j.injury.2011.10.026; Michael CE, 2013, INT J SOC SCI STUD, V1; Mock C, 2004, AFRICAN J TRAUMA, V2, P53; Nwomeh Benedict C, 2006, World J Emerg Surg, V1, P32; O'Reilly GM, 2013, INJURY, V44, P713, DOI 10.1016/j.injury.2013.02.003; Owor G, 2001, E CENTRAL AFR J S, V6, P57; Oyesiku OK., POLICY FRAMEWORK URB; Peden M, 2013, SAMJ S AFR MED J, V103, P228, DOI [10.7196/SAMJ.6866, 10.7196/samj.6866]; Rutta E, 2001, East Afr Med J, V78, P161; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Santamarina-Rubio E, 2007, ACCIDENT ANAL PREV, V39, P1, DOI 10.1016/j.aap.2006.06.019; Schultz CR, 2007, J TRAUMA, V63, P1143, DOI 10.1097/TA.0b013e31815688e3; Seidenberg P, 2014, AFR J EMERG MED, V4, P115, DOI 10.1016/j.afjem.2014.01.006; StataCorp, 2013, STAT REL 13; Stevens KA, 2013, INJURY, V44, pS70, DOI 10.1016/S0020-1383(13)70216-X; Stewart KAA, 2013, JAMA SURG, V148, P463, DOI 10.1001/jamasurg.2013.1341; Thanni L O A, 2006, Afr Health Sci, V6, P104; Wesson HKH, 2013, INJURY, V44, pS75, DOI 10.1016/S0020-1383(13)70217-1; Wong EG, 2014, J SURG RES, P2; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; Wynn A, 2001, J TRAUMA, V51, P464, DOI 10.1097/00005373-200109000-00007; Yu KL, 2009, TROP DOCT, V39, P170, DOI 10.1258/td.2009.080283	42	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180784	10.1371/journal.pone.0180784	http://dx.doi.org/10.1371/journal.pone.0180784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723915	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800025
J	Kinsler, G; Sinai, S; Lee, NK; Nowak, MA				Kinsler, Grant; Sinai, Sam; Lee, Nicholas Keone; Nowak, Martin A.			Prebiotic selection for motifs in a model of template-free elongation of polymers within compartments	PLOS ONE			English	Article							RNA; EVOLUTION; ORIGIN; SIMULATIONS; INFORMATION; PROTOCELL; RIBOZYME; REPLICATION; EMERGENCE; DYNAMICS	The transition from prelife where self-replication does not occur, to life which exhibits selfreplication and evolution, has been a subject of interest for many decades. Membranes, forming compartments, seem to be a critical component of this transition as they provide several concurrent benefits. They maintain localized interactions, generate electro-chemical gradients, and help in selecting cooperative functions as they arise. These functions pave the way for the emergence and maintenance of simple metabolic cycles and polymers. In the context of origin of life, evolution of information-carrying molecules and RNA based enzymes within compartments has been subject to intensive theoretical and experimental research. Hence, many experimental efforts aim to produce compartments that contain elongating polynucleotides (also referred to as protocells), which store information and perform catalysis. Despite impressive experimental progress, we are still relatively ignorant about the dynamics by which elongating polynucleotides can produce more sophisticated behaviors. Here we perform computer simulations to couple information production through template-free elongation of polymers with dividing compartments. We find that polymers with a simple ability D biasing the concentration of monomers within their own compartment D can acquire a selective advantage in prelife. We further investigate whether such a mechanism allows for cooperative dynamics to dominate over purely competitive ones. We show that under this system of biased monomer addition, even without template-directed self-replication, genetic motifs can emerge, compete, cooperate, and ultimately survive within the population.	[Kinsler, Grant] Harvard Univ, Dept Appl Math, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kinsler, Grant] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kinsler, Grant; Sinai, Sam; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Sinai, Sam; Lee, Nicholas Keone; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lee, Nicholas Keone] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Harvard University; Stanford University; Harvard University; Harvard University; Wellcome Trust Sanger Institute; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Nowak, MA (corresponding author), Harvard Univ, Dept Math, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu		Kinsler, Grant/0000-0001-8308-4665; Lee, Nicholas/0000-0002-2756-1102	Harvard College Research Program; John Templeton Foundation; Harvard Origins of Life Initiative	Harvard College Research Program; John Templeton Foundation; Harvard Origins of Life Initiative	GK was funded by Harvard College Research Program and Harvard Origins of Life Initiative. This research was conducted using the resources provided by the Program for Evolutionary Dynamics at Harvard University. The Program for Evolutionary Dynamics is supported by the John Templeton Foundation and in part by a grant from B Wu and Eric Larson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamala K, 2013, SCIENCE, V342, P1098, DOI 10.1126/science.1241888; Adami C, 2017, ENTROPY INFORM BIASE, P130; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Bansho Y, 2016, P NATL ACAD SCI USA; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bianconi G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003051; Budin I, 2012, J AM CHEM SOC, V134, P20812, DOI 10.1021/ja310382d; Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2006, PROTOCELLS GENETIC P; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DEAMER DW, 1989, ORIGINS LIFE EVOL B, V19, P21, DOI 10.1007/BF01808285; Derr J, 2012, NUCLEIC ACIDS RES, V40, P4711, DOI 10.1093/nar/gks065; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M., 1971, ORIGINS LIFE EVOL B, V24, P241; Fernando C, 2004, Artificial Life IX, P1; Fernando C, 2007, J MOL EVOL, V64, P572, DOI 10.1007/s00239-006-0218-4; Fishkis M, 2007, ORIGINS LIFE EVOL B, V37, P537, DOI 10.1007/s11084-007-9111-4; Ganti T, 1997, J THEOR BIOL, V187, P583, DOI 10.1006/jtbi.1996.0391; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Holland J. H., 1992, ADAPTATION NATURAL A; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Janas T, 2004, RNA, V10, P1541, DOI 10.1261/rna.7112704; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Kurihara K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9352; Lau MWL, 2009, CHEM BIOL, V16, P815, DOI 10.1016/j.chembiol.2009.07.005; Lau MWL, 2004, J AM CHEM SOC, V126, P15686, DOI 10.1021/ja045387a; Lawless JG, 1979, NATURE; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mansy SS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002188; Markvoort AJ, 2014, J THEOR BIOL, V357, P123, DOI 10.1016/j.jtbi.2014.04.029; Markvoort AJ, 2010, BIOPHYS J, V99, P1520, DOI 10.1016/j.bpj.2010.06.057; Mavelli F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S10; Mavelli F, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016010; McCollom TM, 1999, ORIGINS LIFE EVOL B, V29, P153, DOI 10.1023/A:1006592502746; Mitchell M, 1993, ANN ARBOR, V1001, P48109; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; Nowak MA, 2008, P NATL ACAD SCI USA, V105, P14924, DOI 10.1073/pnas.0806714105; Ohtsuki H, 2009, P ROY SOC B-BIOL SCI, V276, P3783, DOI 10.1098/rspb.2009.1136; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Robertson MP, 2014, CHEM BIOL, V21, P238, DOI 10.1016/j.chembiol.2013.12.004; Ruiz-Mirazo K, 2008, BIOSYSTEMS, V91, P374, DOI 10.1016/j.biosystems.2007.05.013; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Simon B, 2013, EVOLUTION, V67, P1561, DOI 10.1111/j.1558-5646.2012.01835.x; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Szostak N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004853; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Walker SI, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0869; Walker SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034166; Woese C., 1967, GENETIC CODE HARPER; Woo HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002534; Yamamoto S, 2002, J CHEM PHYS, V116, P5842, DOI 10.1063/1.1456031; Yuen G., 1984, NATURE; Zachar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021380; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c; Zwicker D, 2016, NATURE PHYS	71	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180208	10.1371/journal.pone.0180208	http://dx.doi.org/10.1371/journal.pone.0180208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723913	gold, Green Published, Green Submitted			2022-12-26	WOS:000406067800012
J	Moreno, MC; Mooney, SM; Middleton, FA				Moreno, Maria Camargo; Mooney, Sandra M.; Middleton, Frank A.			Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder	PLOS ONE			English	Article							NEURONAL APOPTOSIS; CELL-PROLIFERATION; PRENATAL EXPOSURE; OXIDATIVE STRESS; NERVOUS-SYSTEM; GENES; BRAIN; DEATH; LIVER; PREVALENCE	Prenatal ethanol exposure can produce structural and functional deficits in the brain and result in Fetal Alcohol Spectrum Disorder (FASD). In rodent models acute exposure to a high concentration of alcohol causes increased apoptosis in the developing brain. A single causal molecular switch that signals for this increase in apoptosis has yet to be identified. The protein p53 has been suggested to play a pivotal role in enabling cells to engage in proapoptotic processes, and thus figures prominently as a hub molecule in the intracellular cascade of responses elicited by alcohol exposure. In the present study we examined the effect of ethanol-induced cellular and molecular responses in primary somatosensory cortex (SI) and hippocampus of 7-day-old wild-type (WT) and p53-knockout (KO) mice. We quantified apoptosis by active caspase-3 immunohistochemistry and ApopTag (TM) labeling, then determined total RNA expression levels in laminae of SI and hippocampal subregions. Immunohistochemical results confirmed increased incidence of apoptotic cells in both regions in WT and KO mice following ethanol exposure. The lack of p53 was not protective in these brain regions. Molecular analyses revealed a heterogeneous response to ethanol exposure that varied depending on the subregion, and which may go undetected using a global approach. Gene network analyses suggest that the presence or absence of p53 alters neuronal function and synaptic modifications following ethanol exposure, in addition to playing a classic role in cell cycle signaling. Thus, p53 may function in a way that underlies the intellectual and behavioral deficits observed in FASD.	[Moreno, Maria Camargo; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Mooney, Sandra M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Mooney, Sandra M.; Middleton, Frank A.] SUNY Binghamton, Dev Exposure Alcohol Res Ctr, Binghamton, NY USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188	NIH [R01 AA006916]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by NIH grant R01 AA006916 to FM and SM.	Anderson AE, PLOS ONE, V9; Aylon Y, 2016, COLD SPRING HARBOR P, V6; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bell SH, 2010, ALCOHOL CLIN EXP RES, V34, P1084, DOI 10.1111/j.1530-0277.2010.01184.x; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Goldstein I, 2012, J HEPATOL, V56, P656, DOI 10.1016/j.jhep.2011.08.022; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; Hard ML, 2005, J LAB CLIN MED, V145, P47, DOI 10.1016/j.lab.2004.11.011; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hashimoto-Torii K, 2011, P NATL ACAD SCI USA, V108, P4212, DOI 10.1073/pnas.1100903108; Hernandez JA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1543809; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ignacio C, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0195-x; Kitsantas P, 2014, ARCH GYNECOL OBSTET, V289, P771, DOI 10.1007/s00404-013-3056-9; Kleiber ML, 2014, DEV NEUROSCI-BASEL, V36, P499, DOI 10.1159/000365549; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuhn PE, 1998, EXP NEUROL, V154, P418, DOI 10.1006/exnr.1998.6907; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MZ, 2014, TOXICOL LETT, V228, P67, DOI 10.1016/j.toxlet.2014.04.011; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Miller MW, 2006, NEUROSCIENCE, V138, P97, DOI 10.1016/j.neuroscience.2005.10.060; Moreno M.C., 2016, MOL ASPECTS ALCOHOL, P45, DOI [10.1016/8978012800773-0.00004-5, DOI 10.1016/8978012800773-0.00004-5]; Murray AJ, 2016, FASEB J, V30, P4021, DOI 10.1096/fj.201600773R; Niccols A, 2007, BRAIN COGNITION, V65, P135, DOI 10.1016/j.bandc.2007.02.009; Nikolic M, 2013, NEUROSCIENCE, V254, P369, DOI 10.1016/j.neuroscience.2013.09.035; Olney JW, 2004, ADDICT BIOL, V9, P137, DOI 10.1080/13556210410001717006; Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sadrian B, 2013, BRAIN SCI, V3, P704, DOI 10.3390/brainsci3020704; Spadoni AD, 2007, NEUROSCI BIOBEHAV R, V31, P239, DOI 10.1016/j.neubiorev.2006.09.006; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Vierboom MPM, 2000, CANCER RES, V60, P5508; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WOOLLETT LA, 1987, ALCOHOL CLIN EXP RES, V11, P336, DOI 10.1111/j.1530-0277.1987.tb01321.x; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Yeon JE, 2003, HEPATOLOGY, V38, P703, DOI 10.1053/jhep.2003.50368; Zaugg K, 2011, CANCER RES, V61, P732; Zhang MN, 2000, MOL CELL BIOCHEM, V207, P109, DOI 10.1023/A:1007014919003; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0180873	10.1371/journal.pone.0180873	http://dx.doi.org/10.1371/journal.pone.0180873			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723918	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800030
J	Yehya, S; Delannoy, M; Fournier, A; Baroudi, M; Rychen, G; Feidt, C				Yehya, Sarah; Delannoy, Matthieu; Fournier, Agnes; Baroudi, Moomen; Rychen, Guido; Feidt, Cyril			Activated carbon, a useful medium to bind chlordecone in soil and limit its transfer to growing goat kids	PLOS ONE			English	Article							FRENCH-WEST-INDIES; HENS GALLUS-DOMESTICUS; RELATIVE BIOAVAILABILITY; BOUND CHLORDECONE; CONTAMINATION; SEQUESTRATION; GUADELOUPE; ADSORPTION; SEDIMENTS; POLLUTION	Chlordecone (Kepone) (CLD) is a highly persistent pesticide which was extensively used in the French West Indies; high levels of CLD can still currently be found in large agricultural areas. As CLD transfers from soil to animals mainly via involuntary ingestion, the consumption of foodstuffs derived from animals raised in contaminated areas may significantly contribute to exposure of humans to CLD. The present study was designed to test the efficacy of two different activated carbons (ACs) sources in limiting CLD transfer from soil to animal. Three soils (ASs) were prepared according to the OECD guideline 207. One standard soil (SS) lacking AC, and two modified preparations of SS supplemented with 2% coconut-based activated carbon (ORBO), SSO or with 2% lignite-based one (DARCO), SSD. All three soils were spiked with 10 mu g of kepone per g of dry matter and aged for three weeks. This study involved 15 goat kids randomly assigned to the 3 experimental groups (n = 5/ group), which were fed the experimental matrices at an exposure dose of 10 mu g CLD per kg of body weight per day. After 21 d of oral exposure, CLD in adipose tissue and liver were analysed by LC-MS-MS. A significant decrease of 63.7% and 74.7% of CLD concentrations in adipose tissue and liver, respectively, were obtained from animals exposed using SS containing DARCO as compared to those receiving only SS. Decreases in CLD levels of 98.2% (adipose tissue) and 98.7% (liver) were obtained for animals exposed using SS containing ORBO. This study leads us to conclude that (i) the presence of AC in CLD-contaminated soil strongly reduces CLD bioavailability, and (ii) the efficacy depends on the nature and characteristics of the AC used.	[Yehya, Sarah; Delannoy, Matthieu; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] Univ Lorraine, INRA USC 340, UR AFPA, 2 Ave Foret Haye TSA, Vandoeuvre Les Nancy, France; [Yehya, Sarah; Baroudi, Moomen] Lebanese Univ, Fac Publ Hlth, Sect 3, LSEE, Tripoli, Lebanon	INRAE; Universite de Lorraine; Lebanese University	Delannoy, M (corresponding author), Univ Lorraine, INRA USC 340, UR AFPA, 2 Ave Foret Haye TSA, Vandoeuvre Les Nancy, France.	matthieu.delannoy@univ-lorraine.fr	FEIDT, Cyril/AAY-6066-2020	Feidt, Cyril/0000-0003-3828-9543	Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research)	Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research)	All funding were provided by Ministere de I'Education Nationale, de l'Enseignement Superieur et de la Recherche (the French Ministry of National Education, Higher Education and Research).	Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; ANSES, 2015, METH DOS RES CHLORD; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Bordet F, 2007, INT J ENVIRON AN CH, V87, P985, DOI 10.1080/03067310701461490; Bouveret C, 2013, J AGR FOOD CHEM, V61, P9269, DOI 10.1021/jf400697r; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cabidoche YM, 2009, ENVIRON POLLUT, V157, P1697, DOI 10.1016/j.envpol.2008.12.015; Choi YJ, 2014, ENVIRON SCI TECHNOL, V48, P1835, DOI 10.1021/es403335g; Coat S, 2011, ENVIRON POLLUT, V159, P1692, DOI 10.1016/j.envpol.2011.02.036; COHN WJ, 1978, NEW ENGL J MED, V298, P243, DOI 10.1056/NEJM197802022980504; Delannoy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115759; Delannoy M, 2014, CHEMOSPHERE, V104, P105, DOI 10.1016/j.chemosphere.2013.10.072; Dromard CR, 2016, ENVIRON SCI POLLUT R, V23, P73, DOI 10.1007/s11356-015-4732-z; Durimel A, 2013, CHEM ENG J, V229, P239, DOI 10.1016/j.cej.2013.03.036; EGLE JL, 1977, DRUG METAB DISPOS, V6, P91; French Ministry of Agriculture, 2016, AGRG1507402N NOR; French Ministry of Agriculture, 2015, AGRG1507402N NOR; Gaspard S, 2014, ROYAL SOC C IN PRESS; Hilber I, 2010, GLOBAL NEST J, V12, P305; Jakob L, 2012, CHEMOSPHERE, V88, P699, DOI 10.1016/j.chemosphere.2012.03.080; Jondreville C, 2014, CHEMOSPHERE, V114, P275, DOI 10.1016/j.chemosphere.2014.05.008; Jondreville C, 2014, SCI TOTAL ENVIRON, V493, P336, DOI 10.1016/j.scitotenv.2014.05.083; Jondreville C, 2013, ENVIRON SCI POLLUT R, V20, P292, DOI 10.1007/s11356-012-1010-1; Jurjanz S, 2014, ENVIRON GEOCHEM HLTH, V36, P911, DOI 10.1007/s10653-014-9608-5; Ku HH, 1966, J RES NBS, V70; Le Deaut J-Y, 2009, IMPACTS UTILISATION, P1; Levillain J, 2012, AGR ECOSYST ENVIRON, V159, P123, DOI 10.1016/j.agee.2012.07.005; Littell RC, 1997, J ANIM SCI, V75, P2672; Navarro H., 1995, TOXICOLOGICAL PROFIL, P1; OECD, 1984, TEST N 207 EARTHW AC; Perelo LW, 2010, J HAZARD MATER, V177, P81, DOI 10.1016/j.jhazmat.2009.12.090; Shafer D.S., 2013, INTRO STAT; SOINE PJ, 1982, J TOXICOL ENV HEALTH, V9, P107, DOI 10.1080/15287398209530146; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS355, DOI 10.1016/j.chemosphere.2006.05.129; Yavari S, 2015, ENVIRON SCI POLLUT R, V22, P13824, DOI 10.1007/s11356-015-5114-2	35	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2017	12	7							e0179548	10.1371/journal.pone.0179548	http://dx.doi.org/10.1371/journal.pone.0179548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3UH	28723966	Green Published, gold, Green Submitted			2022-12-26	WOS:000406067800005
J	Polanec, SH; Andrzejewski, P; Seltzer, PAT; Helbich, TH; Stiglbauer, A; Georg, D; Karanikas, G; Susani, M; Wadsak, W; Margreiter, M; Mitterhauser, M; Brader, P; Pinker, K				Polanec, Stephan H.; Andrzejewski, Piotr; Seltzer, Pascal A. T.; Helbich, Thomas H.; Stiglbauer, Alexander; Georg, Dietmar; Karanikas, Georgios; Susani, Martin; Wadsak, Wolfgang; Margreiter, Markus; Mitterhauser, Markus; Brader, Peter; Pinker, Katja			Multiparametric [C-11]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer	PLOS ONE			English	Article							PI-RADS V2; C-11-ACETATE PET/CT; LOCAL RECURRENCE; SCORING SYSTEM; PRIMARY TUMOR; MRI; THERAPY; PET/MRI; F-18-FLUOROCHOLINE; RADIOTHERAPY	Background The aim of this study was to evaluate whether MP [C-11]Acetate PET-MRI enables an accurate differentiation of benign and malignant prostate tumors as well as local and distant staging. Materials and methods Fifty-six consecutive patients fulfilling the following criteria were included in this IRB-approved prospective study: elevated PSA levels or suspicious findings at digital rectal examination or TRUS; and histopathological verification. All patients underwent MP [C-11]Acetate PET-MRI of the prostate performed on separate scanners with PET/CT using [C-11]Acetate and 3T MP MR imaging. Appropriate statistical tests were used to determine diagnostic accuracy, local and distant staging. Results MP imaging with two MRI parameters (T2w and DWI) achieved the highest sensitivity, specificity, and diagnostic accuracy of 95%, 68.8%, and 88%, with an AUC of 0.82 for primary PCa detection. Neither assessments with a single parameter (AUC, 0.54-0.79), nor different combinations with up to five parameters (AUC, 0.67-0.79) achieved equally good results. MP [C-11]Acetate PET-MRI improved local staging with a sensitivity, specificity, and diagnostic accuracy of 100%, 96%, and 97% compared to MRI alone with 72.2%, 100%, and 95.5%. MP [C-11]Acetate PET-MRI correctly detected osseous and liver metastases in five patients. Conclusions MP [C-11]Acetate PET-MRI merges morphologic with functional information, and allows insights into tumor biology. MP [C-11]Acetate PET-MRI with two MRI-derived parameters (T2 and DWI) yields the highest diagnostic accuracy. The addition of more parameters does not improve diagnostic accuracy of primary PCa detection. MP [C-11]Acetate PET-MRI facilitates improved local and distant staging, providing "one-stop" staging in patients with primary PCa, and therefore has the potential to improve therapy.	[Polanec, Stephan H.; Seltzer, Pascal A. T.; Helbich, Thomas H.; Stiglbauer, Alexander; Brader, Peter; Pinker, Katja] Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Polanec, Stephan H.; Andrzejewski, Piotr; Seltzer, Pascal A. T.; Georg, Dietmar; Pinker, Katja] Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria; [Andrzejewski, Piotr; Georg, Dietmar] Med Univ Vienna, Div Med Radiat Phys, Dept Radiat Oncol, Vienna, Austria; [Karanikas, Georgios; Wadsak, Wolfgang; Mitterhauser, Markus] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Susani, Martin] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Mitterhauser, Markus] Med Univ Vienna, Dept Urol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Pinker, K (corresponding author), Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.; Pinker, K (corresponding author), Med Univ Vienna, Christian Doppler Lab Med Radiat Res Radiat Oncol, Vienna, Austria.	katja.pinker@meduniwien.ac.at	Wadsak, Wolfgang/K-7408-2019	Georg, Dietmar/0000-0002-8327-3877; Mitterhauser, Markus/0000-0003-3173-5272; Baltzer, Pascal/0000-0002-3755-5398; PINKER-DOMENIG, MD, EBBI, Katja/0000-0002-2722-7331; Wadsak, Wolfgang/0000-0003-4479-8053	Comprehensive Cancer Center Vienna [10207014]; Oesterreichische Nationalbank [14788]; Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology; Guerbet France	Comprehensive Cancer Center Vienna; Oesterreichische Nationalbank; Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology; Guerbet France	Our work was supported by the Comprehensive Cancer Center Vienna (#10207014), by the Oesterreichische Nationalbank (#14788), the Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, and a seed grant from Guerbet France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Oromieh A, 2015, J NUCL MED, V56, P1697, DOI 10.2967/jnumed.115.161299; American-College-of-Radiology, 2015, MR PROST IM REP DAT; Arce-Calisaya P, 2013, EUR J NUCL MED MOL I, V40, P799, DOI 10.1007/s00259-013-2353-7; Arrayeh E, 2012, INT J RADIAT ONCOL, V82, pE787, DOI 10.1016/j.ijrobp.2011.11.030; Arumainayagam N, 2010, BJU INT, V106, P991, DOI 10.1111/j.1464-410X.2010.09291.x; Auer T, 2016, WORLD J UROL; Barentsz JO, 2016, EUR UROL, V69, P41, DOI 10.1016/j.eururo.2015.08.038; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Beyer T, 2013, MAGN RESON MATER PHY, V26, P1, DOI 10.1007/s10334-012-0365-0; Brogsitter C, 2013, EUR J NUCL MED MOL I, V40, pS18, DOI 10.1007/s00259-013-2358-2; Buchegger F, 2014, EUR J NUCL MED MOL I, V41, P68, DOI 10.1007/s00259-013-2540-6; Cellini N, 2002, INT J RADIAT ONCOL, V53, P595, DOI 10.1016/S0360-3016(02)02795-5; Choi JY, 2017, RADIOLOGY, V282, P429, DOI 10.1148/radiol.2016160220; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Demirkol MO, 2015, PROSTATE, V75, P748, DOI 10.1002/pros.22956; Dinh CV, 2016, PHYS MED PM INT J DE; Grassi I, 2012, AM J NUCL MED MOLEC, V2, P33; Groenendaal G, 2010, RADIOTHER ONCOL, V94, P145, DOI 10.1016/j.radonc.2009.12.034; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeks CMA, 2013, RADIOLOGY, V266, P207, DOI 10.1148/radiol.12120281; Jadvar H, 2015, TOMOGRAPHY, V1, P18, DOI 10.18383/j.tom.2015.00130; Kotzerke I, 2003, NUKLEARMED-NUCL MED, V42, P25; Lagendijk JJW, 2008, RADIOTHER ONCOL, V86, P25, DOI 10.1016/j.radonc.2007.10.034; Lamanna G, 2017, CLIN NUCL MED, V42, pE242, DOI 10.1097/RLU.0000000000001609; Leisser A, 2015, PROSTATE, V75, P1760, DOI 10.1002/pros.23061; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; Loffroy R, 2015, QUANT IMAG MED SURG, V5, P754, DOI 10.3978/j.issn.2223-4292.2015.10.08; Mena E, 2012, J NUCL MED, V53, P538, DOI 10.2967/jnumed.111.096032; Mohsen B, 2013, BJU INT, V112, P1062, DOI 10.1111/bju.12279; Morigi JJ, 2016, CURR OPIN UROL, V26, P493, DOI 10.1097/MOU.0000000000000309; Pinker K, 2014, CLIN CANCER RES, V20, P3540, DOI 10.1158/1078-0432.CCR-13-2810; Polanec SH, 2014, ROFO-FORTSCHR RONTG, V186, P501, DOI 10.1055/s-0033-1355546; Polanec SH, 2015, WORLD J UROLOGY; Polanec S, 2016, EUR J RADIOL, V85, P1125, DOI 10.1016/j.ejrad.2016.03.025; Polanec SH, 2016, WORLD J UROL, V34, P649, DOI 10.1007/s00345-015-1670-9; Pucar D, 2007, INT J RADIAT ONCOL, V69, P62, DOI 10.1016/j.ijrobp.2007.03.065; Quon JS, 2015, INSIGHTS IMAGING, V6, P449, DOI 10.1007/s13244-015-0411-3; Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5; Roethke MC, 2014, WORLD J UROL, V32, P379, DOI 10.1007/s00345-013-1106-3; Scheenen TWJ, 2007, RADIOLOGY, V245, P507, DOI 10.1148/radiol.2451061444; Schild MH, 2014, OMICS J RADIOLOGY, V3; Schimmoller L, 2014, EUR J RADIOL, V83, P2103, DOI 10.1016/j.ejrad.2014.08.006; Siegel C, 2016, J UROLOGY, V196, P415, DOI 10.1016/j.juro.2016.05.026; Sotoudeh H, 2016, J MAGN RESON IMAGING; Strandberg S, 2016, ANTICANCER RES, V36, P6475, DOI 10.21873/anticanres.11246; Vargas HA, 2015, EUROPEAN RADIOLOGY; Wibmer AG, 2016, RADIOGRAPHICS, V36, P142, DOI 10.1148/rg.2016150059; Yoshii Y, 2015, CANCER LETT, V356, P211, DOI 10.1016/j.canlet.2014.02.019	49	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0180790	10.1371/journal.pone.0180790	http://dx.doi.org/10.1371/journal.pone.0180790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719629	Green Published, Green Submitted, gold			2022-12-26	WOS:000406061400017
J	Zeng, YX; Shi, JS; Ji, ZJ; Wen, ZH; Liang, Y; Yang, CD				Zeng, Yuxiang; Shi, Junsheng; Ji, Zhijuan; Wen, Zhihua; Liang, Yan; Yang, Changdeng			Combination of twelve alleles at six quantitative trait loci determines grain weight in rice	PLOS ONE			English	Article							NEAR-ISOGENIC LINES; ORYZA-SATIVA; GENETIC DISSECTION; CULTIVATED RICE; DWARF MUTANT; SEED LENGTH; MAJOR QTL; SIZE; SHAPE; ENCODES	Grain weight, which is controlled by quantitative trait loci (QTLs), is one of the most important determinants of rice yield. Although many QTLs for grain weight have been identified, little is known about how different alleles in different QTLs coordinate to determine grain weight. In the present study, six grain-weight-QTLs were detected in seven mapping populations (two F-2, one F-3, and four recombinant inbred lines) developed by crossing 'Lemont', a United States japonica variety, with 'Yangdao 4', a Chinese indica variety. In each of the six loci, one allele from one parent increased grain weight and one allele from another parent decreased it. Thus, the 12 alleles at the six QTLs were subjected to regression analysis to examine whether they acted additively across loci leading to a linear relationship between the predicted breeding value of QTL and phenotype. Results suggested that a combination of the 12 alleles determined grain weight. In addition, plants carrying more grain-weight-increasing alleles had heavier grains than those carrying more grain-weight-decreasing alleles. This trend was consistent in the seven mapping populations. Thus, these six QTLs might be used in marker-assisted selection of grain weight, by stacking different grain-weight-increasing or -decreasing alleles.	[Zeng, Yuxiang; Ji, Zhijuan; Wen, Zhihua; Liang, Yan; Yang, Changdeng] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Shi, Junsheng] Seed Management Stn Zhengjiang Prov, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Yang, CD (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	yangchangdeng@126.com			Zhejiang Provincial Natural Science Foundation [LY16C060002]; National Key RD program [2016YFD0102100]; Chinese Academy of Agricultural Sciences	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Key RD program; Chinese Academy of Agricultural Sciences	This work was supported by the Zhejiang Provincial Natural Science Foundation (LY16C060002), the National Key R&D program (2016YFD0102100), and a fund from the Chinese Academy of Agricultural Sciences to the Scientific and Technical Innovation Team.	Abe Y, 2010, GENES GENET SYST, V85, P327, DOI 10.1266/ggs.85.327; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Guo LB, 2009, J INTEGR PLANT BIOL, V51, P45, DOI 10.1111/j.1744-7909.2008.00793.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Jiang YH, 2012, BIOTECHNOL ADV, V30, P1059, DOI 10.1016/j.biotechadv.2011.08.013; Kato T, 2011, BREEDING SCI, V61, P269, DOI 10.1270/jsbbs.61.269; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Li SB, 2009, PLANT J, V58, P592, DOI 10.1111/j.1365-313X.2009.03799.x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Liu TM, 2010, THEOR APPL GENET, V120, P933, DOI 10.1007/s00122-009-1222-z; Luo JJ, 2008, MOL PLANT, V1, P830, DOI 10.1093/mp/ssn045; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Oh JM, 2011, GENES GENOM, V33, P259, DOI 10.1007/s13258-011-0038-9; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shan JX, 2009, THEOR APPL GENET, V119, P827, DOI 10.1007/s00122-009-1092-4; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Shao-Qing T, 2013, GENE, V527, P201, DOI 10.1016/j.gene.2013.05.063; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Wan XY, 2006, THEOR APPL GENET, V112, P1258, DOI 10.1007/s00122-006-0227-0; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Wen ZH, 2015, GENET MOL RES, V14, P1636, DOI 10.4238/2015.March.6.10; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yu SW, 2008, CHINESE SCI BULL, V53, P2326, DOI 10.1007/s11434-008-0281-x; Zeng YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150832; Zhang HW, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0410-5; Zhang Q, 2012, NETWORK CODING: FUNDAMENTALS AND APPLICATIONS, P115, DOI 10.1016/B978-0-12-380918-6.00005-6; Zhang WH, 2013, CROP J, V1, P160, DOI 10.1016/j.cj.2013.10.003; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	46	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2017	12	7							e0181588	10.1371/journal.pone.0181588	http://dx.doi.org/10.1371/journal.pone.0181588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB3RW	28719638	Green Submitted, Green Published, gold			2022-12-26	WOS:000406061400056
J	Wang, QY; Canton, G; Guo, J; Guo, XY; Hatsukami, TS; Billiar, KL; Yuan, C; Wu, ZY; Tang, DL				Wang, Qingyu; Canton, Gador; Guo, Jian; Guo, Xiaoya; Hatsukami, Thomas S.; Billiar, Kristen L.; Yuan, Chun; Wu, Zheyang; Tang, Dalin			MRI-based patient-specific human carotid atherosclerotic vessel material property variations in patients, vessel location and long-term follow up	PLOS ONE			English	Article							RISK-ASSESSMENT STRATEGIES; FINITE-DIFFERENCE METHOD; PLAQUE PROGRESSION; FSI MODELS; VULNERABLE PLAQUE; HUMAN CORONARY; STRESS-ANALYSIS; TRACKING DATA; WALL STRESS; SIMULATION	Background Image-based computational models are widely used to determine atherosclerotic plaque stress/strain conditions and investigate their association with plaque progression and rupture. However, patient-specific vessel material properties are in general lacking in those models, limiting the accuracy of their stress/strain measurements. A noninvasive approach of combining in vivo 3D multi-contrast and Cine magnetic resonance imaging (MRI) and computational modeling was introduced to quantify patient-specific carotid plaque material properties for potential plaque model improvements. Vessel material property variation in patients, along vessel segment, and between baseline and follow up were investigated. Methods In vivo 3D multi-contrast and Cine MRI carotid plaque data were acquired from 8 patients with follow-up (18 months) with written informed consent obtained. 3D thin-layer models and an established iterative procedure were used to determine parameter values of the Mooney-Rivlin models for the 81slices from 16 plaque samples. Effective Young's Modulus (YM) values were calculated for comparison and analysis. Results Average Effective Young's Modulus (YM) and circumferential shrinkage rate (C-Shrink) value of the 81 slices was 411kPa and 5.62%, respectively. Slice YM value varied from 70 kPa (softest) to 1284 kPa (stiffest), a 1734% difference. Average slice YM values by vessel varied from 109 kPa (softest) to 922 kPa (stiffest), a 746% difference. Location-wise, the maximum slice YM variation rate within a vessel was 311% (149 kPa vs. 613 kPa). The average slice YM variation rate for the 16 vessels was 134%. The average variation of YM values for all patients from baseline to follow up was 61.0%. The range of the variation of YM values was [-28.4%, 215%]. For plaque progression study, YM at follow-up showed negative correlation with plaque progression measured by wall thickness increase (WTI) (r = -0.7764, p = 0.0235). Wall thickness at baseline correlated with WTI negatively, with r = -0.5253 (p = 0.1813). Plaque burden at baseline correlated with YM change between baseline and follow-up, with r = 0.5939 (p = 0.1205). Conclusion In vivo carotid vessel material properties have large variations from patient to patient, along the diseased segment within a patient, and with time. The use of patient-specific, location specific and time-specific material properties in plaque models could potentially improve the accuracy of model stress/strain calculations.	[Wang, Qingyu; Guo, Jian; Tang, Dalin] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Canton, Gador] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Guo, Xiaoya] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Hatsukami, Thomas S.] Univ Washington, Div Vasc Surg, Seattle, WA 98195 USA; [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Yuan, Chun] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wu, Zheyang; Tang, Dalin] Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA	Southeast University - China; University of Washington; University of Washington Seattle; Southeast University - China; University of Washington; University of Washington Seattle; Worcester Polytechnic Institute; University of Washington; University of Washington Seattle; Worcester Polytechnic Institute	Tang, DL (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.; Tang, DL (corresponding author), Worcester Polytech Inst, Math Sci Dept, Worcester, MA 01609 USA.	dtang@wpi.edu	Canton, Gador/H-4227-2016; Stefanadis, Christodoulos/ABH-2232-2020; Wang, Qingyu/AAB-9106-2022	Canton, Gador/0000-0002-0594-2764; Stefanadis, Christodoulos/0000-0001-5974-6454; Wu, Zheyang/0000-0003-0641-0791; Tang, Dalin/0000-0002-6965-6417	National Institute of Biomedical Imaging and Bioengineering [R01 EB004759]; National Natural Science Foundation of China [11672001]; Jiangsu Province Science and Technology Agency [BE2016785]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science and Technology Agency; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Biomedical Imaging and Bioengineering R01 EB004759, DT, https://www.nibib.nih.gov/; National Natural Science Foundation of China, 11672001, DT, https://isisn.nsfc.gov.cn/egrantweb/; and Jiangsu Province Science and Technology Agency grant BE2016785, DT, http://www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathe K.-J., 2006, FINITE ELEMENT PROCE; Bathe K. J., 2002, THEORY MODELING GUID, VII; Bathe KJ, 2002, THEORY MODELING GUID, VI; Bluestein D, 2008, J BIOMECH, V41, P1111, DOI 10.1016/j.jbiomech.2007.11.029; Czernuszewicz TJ, 2015, ULTRASOUND MED BIOL, V41, P685, DOI 10.1016/j.ultrasmedbio.2014.09.016; Friedman MH, 2010, ANN BIOMED ENG, V38, P1178, DOI 10.1007/s10439-010-9900-1; FUSTER V, 1990, CIRCULATION, V82, P47; Fuster V, 1999, CARDIOVASCULAR DRUGS, V13, P363; Gallo D, 2015, ANN BIOMED ENG, V43, P68, DOI 10.1007/s10439-014-1119-0; Gao H, 2011, J BIOMECH, V44, P2551, DOI 10.1016/j.jbiomech.2011.07.012; Gao H, 2011, ANN BIOMED ENG, V39, P2203, DOI 10.1007/s10439-011-0314-5; Gee MW, 2009, J BIOMECH, V42, P1732, DOI 10.1016/j.jbiomech.2009.04.016; Holzapfel GA, 2002, ANN BIOMED ENG, V30, P753, DOI 10.1114/1.1492812; Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P657, DOI 10.1115/1.1800557; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Huang X, 2016, J BIOMECHANICS; Huang Y, 2011, J BIOMECH, V44, P2316, DOI 10.1016/j.jbiomech.2011.06.014; Kaazempur-Mofrad MR, 2004, ANN BIOMED ENG, V32, P932, DOI 10.1023/B:ABME.0000032456.16097.e0; Kural MH, 2012, J BIOMECH, V45, P790, DOI 10.1016/j.jbiomech.2011.11.019; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Liu H, 2012, J BIOMECH ENG, V134, P223; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nieuwstadt HA, 2015, MED ENG PHYS, V37, P801, DOI 10.1016/j.medengphy.2015.06.003; Smoljkic M, 2015, BIOMECH MODEL MECHAN, V14, P1045, DOI 10.1007/s10237-015-0653-5; Speelman L, 2009, J BIOMECH, V42, P1713, DOI 10.1016/j.jbiomech.2009.04.020; Suo Jin, 2008, Molecular & Cellular Biomechanics, V5, P9; Tang D., 2006, WILEY ENCY BIOMEDICA; Tang DL, 2008, J BIOMECH, V41, P727, DOI 10.1016/j.jbiomech.2007.11.026; Tang DL, 2014, J BIOMECH, V47, P834, DOI 10.1016/j.jbiomech.2014.01.012; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Tang DL, 2005, J BIOMECH ENG-T ASME, V127, P1185, DOI 10.1115/1.2073668; Tang DL, 2004, ANN BIOMED ENG, V32, P947, DOI 10.1023/B:ABME.0000032457.10191.e0; Teng ZZ, 2014, ACTA BIOMATER, V10, P5055, DOI 10.1016/j.actbio.2014.09.001; Teng ZZ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001028; Teng ZZ, 2009, J BIOMECH, V42, P2535, DOI 10.1016/j.jbiomech.2009.07.009; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; Wang L, 2015, ANN BIOMED ENG, V43, P107, DOI 10.1007/s10439-014-1118-1; Williamson SD, 2003, J BIOMECH ENG-T ASME, V125, P147, DOI 10.1115/1.1537736; Yang C, 2008, CMES-COMP MODEL ENG, V28, P95; Yang C, 2007, CMES-COMP MODEL ENG, V19, P233; Yang C, 2010, J BIOMECH, V43, P2530, DOI 10.1016/j.jbiomech.2010.05.018; Yang C, 2010, CMES-COMP MODEL ENG, V57, P51; Yuan C, 2002, CIRCULATION, V105, P181, DOI 10.1161/hc0202.102121	45	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0180829	10.1371/journal.pone.0180829	http://dx.doi.org/10.1371/journal.pone.0180829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715441	Green Published, Green Submitted, gold			2022-12-26	WOS:000443975500018
J	Mpakairi, KS; Ndaimani, H; Tagwireyi, P; Gara, TW; Zvidzai, M; Madhlamoto, D				Mpakairi, Kudzai Shaun; Ndaimani, Henry; Tagwireyi, Paradzayi; Gara, Tawanda Winmore; Zvidzai, Mark; Madhlamoto, Daphine			Missing in action: Species competition is a neglected predictor variable in species distribution modelling	PLOS ONE			English	Article							SURFACE-WATER; HERBIVORES	The central role of species competition in shaping community structure in ecosystems is well appreciated amongst ecologists. However species competition is a consistently missing variable in Species Distribution Modelling (SDM). This study presents results of our attempt to incorporate species competition in SDMs. We used a suit of predictor variables including Soil Adjusted Vegetation Index (SAVI), as well as distance from roads, settlements and water, fire frequency and distance from the nearest herbivore sighting (of selected herbivores) to model individual habitat preferences of five grazer species (buffalo, warthog, waterbuck, wildebeest and zebra) with the Ensemble SDM algorithm for Gonarezhou National Park, Zimbabwe. Our results showed that distance from the nearest animal sighting (a proxy for competition among grazers) was the best predictor of the potential distribution of buffalo, wildebeest and zebra but the second best predictor for warthog and waterbuck. Our findings provide evidence to that competition is an important predictor of grazer species' potential distribution. These findings suggest that species distribution modelling that neglects species competition may be inadequate in explaining the potential distribution of species. Therefore our findings encourage the inclusion of competition in SDM as well as potentially igniting discussions that may lead to improving the predictive power of future SDM efforts.	[Mpakairi, Kudzai Shaun; Ndaimani, Henry; Tagwireyi, Paradzayi; Gara, Tawanda Winmore; Zvidzai, Mark] Univ Zimbabwe, Dept Geog & Environm Sci, Harare, Zimbabwe; [Gara, Tawanda Winmore] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands; [Madhlamoto, Daphine] Gonarezhou Natl Pk, Zimbabwe Pk & Wildlife Management Author, Chiredzi, Zimbabwe	University of Zimbabwe; University of Twente	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Ndaimani, Henry/AAE-4942-2021; Mpakairi, Kudzai Shaun/AAH-5172-2019; Gara, ir Tawanda W/O-2030-2015	Mpakairi, Kudzai Shaun/0000-0002-1929-1464; Gara, ir Tawanda W/0000-0001-8134-4849; Tagwireyi, Paradzayi/0000-0001-6065-918X				[Anonymous], 2013, AERIAL SURVEY ELEPHA; Ashraf N, 2014, TURK J ZOOL, V38, P191, DOI 10.3906/zoo-1306-6; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Buchmann CM, 2013, ECOL INFORM, V14, P90, DOI 10.1016/j.ecoinf.2012.11.015; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Cione NK, 2002, RESTOR ECOL, V10, P376, DOI 10.1046/j.1526-100X.2002.02038.x; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; ESRI, 2012, ARCGIS DESKT 10 1; Ferry N, 2016, J ANIM ECOL, V85, P1574, DOI 10.1111/1365-2656.12582; Franca LD, 2015, EARTH-SCI REV, V140, P158, DOI 10.1016/j.earscirev.2014.10.006; Gandiwa Edson, 2009, Koedoe, V51, P0, DOI 10.4102/koedoe.v51i1.685; Huang SF, 2012, NAT HAZARDS, V62, P93, DOI 10.1007/s11069-011-9921-6; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; KRAUSMAN PR, 1995, J WILDLIFE MANAGE, V59, P292, DOI 10.2307/3808942; Ndaimani H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146263; Norton-Griffiths M, 1978, HDB TECHNIQUES CURRE; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Periquet S, 2015, J ZOOL, V297, P245, DOI 10.1111/jzo.12275; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rettelbach A, 2013, AM NAT, V182, P215; Rinne H, 2014, ESTUAR COAST SHELF S, V138, P90, DOI 10.1016/j.ecss.2013.12.025; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; TAYLOR CR, 1969, AM J PHYSIOL, V217, P630, DOI 10.1152/ajplegacy.1969.217.2.630; Thuiller W., 2016, PACKAGE BIOMOD2; Tilman D., 1982, Monographs in Population Biology, pi; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wiens J.A., 1992, ECOLOGY BIRD COMMUNI, V1; Yodzis P., 2013, COMPETITION SPACE ST	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0181088	10.1371/journal.pone.0181088	http://dx.doi.org/10.1371/journal.pone.0181088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708854	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800040
J	Roca-Stappung, M; Fernandez, T; Bosch-Bayard, J; Harmony, T; Ricardo-Garcell, J				Roca-Stappung, Milene; Fernandez, Thalia; Bosch-Bayard, Jorge; Harmony, Thalia; Ricardo-Garcell, Josefina			Electroencephalographic characterization of subgroups of children with learning disorders	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; DEVELOPMENTAL DYSLEXIA; EEG POWER; DISABILITY SUBTYPES; QUANTITATIVE EEG; AGE; MEMORY; ADOLESCENTS; ATTENTION; SEX	Electroencephalographic alterations have been reported in subjects with learning disorders, but there is no consensus on what characterizes their electroencephalogram findings. Our objective was to determine if there were subgroups within a group of scholars with not otherwise specified learning disorders and if they had specific electroencephalographic patterns. Eighty-five subjects (31 female, 8-11 years) who scored low in at least two subscales -reading, writing and arithmetic-of the Infant Neuropsychological Evaluation were included. Electroencephalograms were recorded in 19 leads during rest with eyes closed; absolute power was obtained every 0.39 Hz. Three subgroups were formed according to children's performance: Group 1 (G1, higher scores than Group 2 in reading speed and reading and writing accuracy), Group 2 (G2, better performance than G1 in composition) and Group 3 (G3, lower scores than Groups 1 and 2 in the three subscales). G3 had higher absolute power in frequencies in the delta and theta range at left frontotemporal sites than G1 and G2. G2 had higher absolute power within alpha frequencies than G3 and G1 at the left occipital site. G3 had higher absolute power in frequencies in the beta range than G1 in parietotemporal areas and than G2 in left frontopolar and temporal sites. G1 had higher absolute power within beta frequencies than G2 in the left frontopolar site. G3 had lower gamma absolute power values than the other groups in the left hemisphere, and gamma activity was higher in G1 than in G2 in frontopolar and temporal areas. This group of children with learning disorders is very heterogeneous. Three subgroups were found with different cognitive profiles, as well as a different electroencephalographic pattern. It is important to consider these differences when planning interventions for children with learning disorders.	[Roca-Stappung, Milene; Fernandez, Thalia; Bosch-Bayard, Jorge; Harmony, Thalia; Ricardo-Garcell, Josefina] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Fernandez, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico.	thaliafh@yahoo.com.mx	Bosch-Bayard, Jorge F/L-3295-2015; Fernandez, Thalia/AGI-6073-2022	Bosch-Bayard, Jorge F/0000-0001-7168-5551; 	PAPIIT-DGAPA [IN226001, IN204103, IN204613]; CONACYT [268958, 69145, 251309]	PAPIIT-DGAPA(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was partially supported by grants IN226001, IN204103 and IN204613 from PAPIIT-DGAPA and grants 268958, 69145, and 251309 from CONACYT.	AHN H, 1980, SCIENCE, V210, P1259, DOI 10.1126/science.7434027; Altarac M, 2007, PEDIATRICS, V119, pS77, DOI 10.1542/peds.2006-2089L; Alvarez A, 1992, NEW ISSUES NEUROSCI, VIV, P40; American Psychiatric Association, 2005, DIAGN STAT MAN MENT, P46; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P1, DOI 10.1016/j.ijpsycho.2012.07.002; Basirat A, 2008, NEUROIMAGE, V42, P404, DOI 10.1016/j.neuroimage.2008.03.063; BECKER J, 1987, CLIN ELECTROENCEPHAL, V18, P93; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Bernal J, 2005, TRENDS DYSLEXIA RES, P153; Berninger V.W., 2008, BRAIN BEHAV LEARNING, P103; BODER E, 1973, DEV MED CHILD NEUROL, V15, P663; BYRING RF, 1991, ELECTROEN CLIN NEURO, V79, P247, DOI 10.1016/0013-4694(91)90119-O; Chabot RJ, 2001, J NEUROPSYCH CLIN N, V13, P171, DOI 10.1176/appi.neuropsych.13.2.171; Chiarenza GA, 2014, INT J PSYCHOPHYSIOL, V94, P111, DOI 10.1016/j.ijpsycho.2014.09.002; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; COLON EJ, 1979, J NEUROL, V221, P257, DOI 10.1007/BF00314642; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; FEIN G, 1986, ELECTROEN CLIN NEURO, V63, P87, DOI 10.1016/0013-4694(86)90001-5; Fernandez T, 2002, CLIN ELECTROENCEPHAL, V33, P160, DOI 10.1177/155005940203300405; Fernandez T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105318; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; FLETCHER JM, 1985, J EXP CHILD PSYCHOL, V40, P244, DOI 10.1016/0022-0965(85)90088-8; Fonseca LC, 2006, ARQ NEURO-PSIQUIAT, V64, P376, DOI 10.1590/S0004-282X2006000300005; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Gasser T, 2003, J CLIN NEUROPHYSIOL, V20, P273, DOI 10.1097/00004691-200307000-00007; Gou ZK, 2011, BEHAV BRAIN RES, V220, P263, DOI 10.1016/j.bbr.2011.01.048; Gracia-Bafalluy M, 2014, REV NEUROLOGIA, V58, P69, DOI 10.33588/rn.5802.2013262; Greenham SL, 2003, DEV NEUROPSYCHOL, V23, P339, DOI 10.1207/S15326942DN2303_2; Hale CR, 2014, ARCH CLIN NEUROPSYCH, V29, P75, DOI 10.1093/arclin/act086; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARMONY T, 1990, INT J NEUROSCI, V54, P147, DOI 10.3109/00207459008986630; Harmony T, 1995, ELECTROEN CLIN NEURO, V95, P426, DOI 10.1016/0013-4694(95)00135-2; HARMONY T, 1990, ELECTROEN CLIN NEURO, V75, P482, DOI 10.1016/0013-4694(90)90135-7; Harmony T, 2011, HANDBOOK OF CLINICAL CHILD NEUROPSYCHOLOGY, THIRD EDITION, P383, DOI 10.1007/978-0-387-78867-8_17; Hernandez J L, 1994, Int J Neurosci, V76, P267; Jancke L, 2016, CLIN EEG NEUROSCI, V47, P24, DOI 10.1177/1550059415612622; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHN ER, 1983, PROG NEUROBIOL, V21, P239, DOI 10.1016/0301-0082(83)90014-X; Johnstone J, 2005, CLIN EEG NEUROSCI, V36, P99, DOI 10.1177/155005940503600209; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; KORHONEN TT, 1991, J LEARN DISABIL, V24, P48, DOI 10.1177/002221949102400109; Lagae L, 2008, PEDIATR CLIN N AM, V55, P1259, DOI 10.1016/j.pcl.2008.08.001; Lallier M, 2010, NEUROPSYCHOLOGIA, V48, P4125, DOI 10.1016/j.neuropsychologia.2010.09.027; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Lee Swanson H., 2001, RESEARCHGATE, V7, P1; Maehler C, 2011, INT J DISABIL DEV ED, V58, P5, DOI 10.1080/1034912X.2011.547335; MAROSI E, 1995, INT J PSYCHOPHYSIOL, V19, P23, DOI 10.1016/0167-8760(94)00059-N; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; MATSUURA M, 1985, ELECTROEN CLIN NEURO, V60, P394, DOI 10.1016/0013-4694(85)91013-2; Matute E, 2005, EVALUACION NEUROPSIC; MECHELSE K, 1975, ELECTROEN CLIN NEURO, V39, P106; Meeuwissen EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021356; MILES J, 1994, J CLIN EXP NEUROPSYC, V16, P43, DOI 10.1080/01688639408402616; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Otero G, 2001, TEXTO NEUROCIENCIAS, P371; PETERSEN I, 1971, NEUROPADIATRIE, V2, P247, DOI 10.1055/s-0028-1091786; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Riviello JJ, 2011, NIEDERMEYERS ELECTRO; Serra-Grabulosa JM, 2010, REV NEUROLOGIA, V50, P39, DOI 10.33588/rn.5001.2009271; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Siegel L, 2003, HDB PSYCHOL, P455; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Swanson HL, 2012, CHILD NEUROPSYCHOL, V18, P125, DOI 10.1080/09297049.2011.589377; SWANSON HL, 1987, J LEARN DISABIL-US, V20, P155, DOI 10.1177/002221948702000303; Swanson HL, 2012, LEARNING LEARNING DI; Takano T, 1998, ACTA PAEDIATR JAPON, V40, P446; Thatcher RW, 2004, J NEUROTHER, V8, P119; Wechsler D., 2007, WISC 4 ESCALA INTELI	73	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0179556	10.1371/journal.pone.0179556	http://dx.doi.org/10.1371/journal.pone.0179556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708890	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800005
J	Glavatska, O; Muller, K; Butenschoen, O; Schmalwasser, A; Kandeler, E; Scheu, S; Totsche, KU; Ruess, L				Glavatska, Olena; Mueller, Karolin; Butenschoen, Olaf; Schmalwasser, Andreas; Kandeler, Ellen; Scheu, Stefan; Totsche, Kai Uwe; Ruess, Liliane			Disentangling the root- and detritus-based food chain in the micro-food web of an arable soil by plant removal	PLOS ONE			English	Article							NEMATODE COMMUNITY COMPOSITION; FREE-LIVING NEMATODES; ORGANIC-MATTER; DECOMPOSITION PATHWAYS; FAUNAL ANALYSIS; CARBON; DIVERSITY; RHIZOSPHERE; INDICATORS; DYNAMICS	Soil food web structure and function is primarily determined by the major basal resources, which are living plant tissue, root exudates and dead organic matter. A field experiment was performed to disentangle the interlinkage of the root- and detritus-based soil food chains. An arable site was cropped either with maize, amended with maize shoot litter or remained bare soil, representing food webs depending on roots, aboveground litter and soil organic matter as predominant resource, respectively. The soil micro-food web, i.e. microorganisms and nematodes, was investigated in two successive years along a depth transect. The community composition of nematodes was used as model to determine the changes in the rhizosphere, detritusphere and bulk soil food web. In the first growing season the impact of treatments on the soil micro-food web was minor. In the second year plant-feeding nematodes increased under maize, whereas after harvest the Channel Index assigned promotion of the detritivore food chain, reflecting decomposition of root residues. The amendment with litter did not foster microorganisms, instead biomass of Gram-positive and Gram-negative bacteria as well as that of fungi declined in the rooted zone. Likely higher grazing pressure by nematodes reduced microbial standing crop as bacterial and fungal feeders increased. However, populations at higher trophic levels were not promoted, indicating limited flux of litter resources along the food chain. After two years of bare soil microbial biomass and nematode density remained stable, pointing to soil organic matter-based resources that allow bridging periods with deprivation. Nematode communities were dominated by opportunistic taxa that are competitive at moderate resource supply. In sum, removal of plants from the system had less severe effects than expected, suggesting considerable food web resilience to the disruption of both the root and detrital carbon channel, pointing to a legacy of organic matter resources in arable soils.	[Glavatska, Olena; Ruess, Liliane] Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany; [Mueller, Karolin; Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Dept, Stuttgart, Germany; [Butenschoen, Olaf; Scheu, Stefan] Georg August Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Schmalwasser, Andreas; Totsche, Kai Uwe] Friedrich Schiller Univ Jena, Inst Geosci, Hydrogeol Sect, Jena, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	Humboldt University of Berlin; University Hohenheim; University of Gottingen; Friedrich Schiller University of Jena; University of Gottingen	Ruess, L (corresponding author), Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany.	liliane.ruess@biologie.hu-berlin.de	Totsche, Kai Uwe/E-2086-2013; Scheu, Stefan/H-7049-2015	Totsche, Kai Uwe/0000-0002-2692-213X; Butenschoen, Olaf/0000-0003-1866-9805; Muller, Karolin/0000-0003-4465-5677; Kandeler, Ellen/0000-0002-2854-0012	Deutsche Forschungsgemeinschaft, Germany [FOR 918];  [RU780/9-1];  [KA 1590/9-2];  [SCHE 376/23-2]	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); ; ; 	This study was performed within the framework of the Research Unit "Carbon flow in belowground food webs assessed by stable isotope tracers" (FOR 918) of the Deutsche Forschungsgemeinschaft (<http://www.dfg.de> www.dfg.de), Germany. OG received funding by the grant RU780/9-1, KM by the grant KA 1590/9-2 and OB by the grant SCHE 376/23-2.	Alphei J., 1999, AFZ/Der Wald, Allgemeine Forst Zeitschrift fur Waldwirtschaft und Umweltvorsorge, V54, P64; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 1999, PLANT SOIL, V212, P23, DOI 10.1023/A:1004642218792; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Crotty FV, 2014, ECOL EVOL, V4, P1, DOI 10.1002/ece3.905; de Ruiter Peter C., 2005, P3; Dibbern D, 2014, SOIL BIOL BIOCHEM, V69, P187, DOI 10.1016/j.soilbio.2013.10.040; Dmowska E, 1995, EUR J SOIL BIOL, V31, P189; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Drijber RA, 2000, SOIL BIOL BIOCHEM, V32, P1419, DOI 10.1016/S0038-0717(00)00060-2; Duncan LW, 2007, J NEMATOL, V39, P176; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2003, APPL SOIL ECOL, V23, P93, DOI 10.1016/S0929-1393(03)00044-1; Ferris H, 1996, APPL SOIL ECOL, V3, P161, DOI 10.1016/0929-1393(95)00071-2; Ferris H, 2006, J NEMATOL, V38, P3; Ferris H, 2010, J NEMATOL, V42, P63; FRECKMAN DW, 1993, AGR ECOSYST ENVIRON, V45, P239, DOI 10.1016/0167-8809(93)90074-Y; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gorres JH, 1998, SOIL BIOL BIOCHEM, V30, P219, DOI 10.1016/S0038-0717(97)00107-7; Griffiths BS, 2003, NEMATOLOGY, V5, P889, DOI 10.1163/156854103773040808; Hanel L, 2003, APPL SOIL ECOL, V22, P255, DOI 10.1016/S0929-1393(02)00152-X; Heijboer A, 2017, FOOD WEBS S IN PRESS; Helfrich M, 2006, GEODERMA, V136, P331, DOI 10.1016/j.geoderma.2006.03.048; Kerry BR, 2000, ANNU REV PHYTOPATHOL, V38, P423, DOI 10.1146/annurev.phyto.38.1.423; Kramer S, 2013, SOIL BIOL BIOCHEM, V61, P76, DOI 10.1016/j.soilbio.2013.02.006; Kramer S, 2012, PEDOBIOLOGIA, V55, P111, DOI 10.1016/j.pedobi.2011.12.001; Leroy BLM, 2009, NEMATOLOGY, V11, P23, DOI 10.1163/156854108X398381; Marschner B, 2008, J PLANT NUTR SOIL SC, V171, P91, DOI 10.1002/jpln.200700049; McSorley R, 1999, J NEMATOL, V31, P619; McSorley R, 1999, J NEMATOL, V31, P37; McSorley R, 1997, APPL SOIL ECOL, V6, P147, DOI 10.1016/S0929-1393(97)00001-2; Moll J, 2015, MICROB ECOL, V70, P390, DOI 10.1007/s00248-015-0569-8; Moore JC, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P375; NEHER DA, 1995, PLANT SOIL, V170, P167, DOI 10.1007/BF02183065; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pate E, 2000, APPL SOIL ECOL, V14, P5, DOI 10.1016/S0929-1393(99)00051-7; Pausch J, 2013, PLANT SOIL, V364, P273, DOI 10.1007/s11104-012-1363-8; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; Pendall E, 2007, SOIL BIOL BIOCHEM, V39, P2628, DOI 10.1016/j.soilbio.2007.05.016; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; RUESS L, 1995, NEMATOLOGICA, V41, P106, DOI 10.1163/003925995X00080; Ruess L, 2003, NEMATOLOGY, V5, P179, DOI 10.1163/156854103767139662; Ruess L, 2007, SOIL BIOL BIOCHEM, V39, P1990, DOI 10.1016/j.soilbio.2007.03.002; Ruess L, 2004, NEMATOL MONOGR PERSP, V2, P547; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Sanchez-Moreno S, 2006, NEMATOLOGY, V8, P703, DOI 10.1163/156854106778877857; Scharroba A, 2012, SOIL BIOL BIOCHEM, V50, P1, DOI 10.1016/j.soilbio.2012.03.002; Scheu S, 2005, SOIL BIOL, V3, P253; Scheunemann N, 2015, OECOLOGIA, V179, P1135, DOI 10.1007/s00442-015-3415-2; Scheunemann N, 2015, SOIL BIOL BIOCHEM, V81, P81, DOI 10.1016/j.soilbio.2014.11.006; Sereda E, 2015, BASIC APPL ECOL, V16, P746, DOI 10.1016/j.baae.2015.07.005; Tao J, 2009, SOIL BIOL BIOCHEM, V41, P898, DOI 10.1016/j.soilbio.2008.12.002; Thoden TC, 2011, NEMATOLOGY, V13, P133, DOI 10.1163/138855410X541834; Todorovic GR, 2010, J PLANT NUTR SOIL SC, V173, P662, DOI 10.1002/jpln.200800311; Ugarte CM, 2013, SOIL BIOL BIOCHEM, V64, P103, DOI 10.1016/j.soilbio.2013.03.035; Uren NC, 2001, BOOKS SOIL PLANT ENV, P19; Villenave C, 2001, APPL SOIL ECOL, V17, P43, DOI 10.1016/S0929-1393(00)00129-3; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053; Yeates G. W, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0021913, DOI 10.1002/9780470015902.A0021913]; Yeates GW, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P1, DOI 10.1079/9781845933852.0001; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang XK, 2015, SOIL BIOL BIOCHEM, V80, P118, DOI 10.1016/j.soilbio.2014.10.003	65	13	13	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180264	10.1371/journal.pone.0180264	http://dx.doi.org/10.1371/journal.pone.0180264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704438	Green Published, gold			2022-12-26	WOS:000405649700035
J	Meeremans, P; Yochum, N; Kochzius, M; Ampe, B; Tuyttens, FAM; Uhlmann, SS				Meeremans, Pieter; Yochum, Noelle; Kochzius, Marc; Ampe, Bart; Tuyttens, Frank A. M.; Uhlmann, Sven Sebastian			Inter-rater reliability of categorical versus continuous scoring of fish vitality: Does it affect the utility of the reflex action mortality predictor (RAMP) approach?	PLOS ONE			English	Article							CRAB CHIONOECETES-BAIRDI; DISCARD MORTALITY; DELAYED MORTALITY; OBSERVER BIAS; IMPAIRMENT; SURVIVAL; LAMENESS; PERSPECTIVES; INDICATORS; STRESS	Scoring reflex responsiveness and injury of aquatic organisms has gained popularity as predictors of discard survival. Given this method relies upon the individual interpretation of scoring criteria, an evaluation of its robustness is done here to test whether protocol-instructed, multiple raters with diverse backgrounds (research scientist, technician, and student) are able to produce similar or the same reflex and injury score for one of the same flatfish (European plaice, Pleuronectes platessa) after experiencing commercial fishing stressors. Interrater reliability for three raters was assessed by using a 3-point categorical scale ('absent', 'weak', 'strong') and a tagged visual analogue continuous scale (tVAS, a 10 cm bar split in three labelled sections: 0 for 'absent', 'weak', 'moderate', and 'strong') for six reflex responses, and a 4-point scale for four injury types. Plaice (n = 304) were sampled from 17 research beam-trawl deployments during four trips. Fleiss kappa (categorical scores) and intra-class correlation coefficients (ICC, continuous scores) indicated variable inter-rater agreement by reflex type (ranging between 0.55 and 0.88, and 67% and 91% for Fleiss kappa and ICC, respectively), with least agreement among raters on extent of injury (Fleiss kappa between 0.08 and 0.27). Despite differences among raters, which did not significantly influence the relationship between impairment and predicted survival, combining categorical reflex and injury scores always produced a close relationship of such vitality indices and observed delayed mortality. The use of the continuous scale did not improve fit of these models compared with using the reflex impairment index based on categorical scores. Given these findings, we recommend using a 3-point categorical over a continuous scale. We also determined that training rather than experience of raters minimised inter-rater differences. Our results suggest that cost-efficient reflex impairment and injury scoring may be considered a robust technique to evaluate lethal stress and damage of this flatfish species on-board commercial beam-trawl vessels.	[Meeremans, Pieter; Kochzius, Marc] Vrije Univ Brussel, Brussels, Belgium; [Meeremans, Pieter; Ampe, Bart; Tuyttens, Frank A. M.; Uhlmann, Sven Sebastian] Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium; [Yochum, Noelle] Oregon State Univ, Corvallis, OR 97331 USA; [Tuyttens, Frank A. M.] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Meeremans, Pieter] Minist Agr Anim Husb & Fisheries, Paramaribo, Suriname; [Yochum, Noelle] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA	Vrije Universiteit Brussel; Institute For Agricultural & Fisheries Research; Oregon State University; Ghent University; National Oceanic Atmospheric Admin (NOAA) - USA	Uhlmann, SS (corresponding author), Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium.	sven.uhlmann@gmx.net	Tuyttens, Frank/HCH-1899-2022; Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719; Tuyttens, Frank/0000-0002-1348-218X; Uhlmann, Sven Sebastian/0000-0003-2830-5845	European Maritime and Fisheries Fund [LV-01-090415]	European Maritime and Fisheries Fund	This work was supported by the European Maritime and Fisheries Fund (Grant Number: LV-01-090415).	Agresti A., 2003, INTRO CATEGORICAL DA, P372; Barkley AS, 2012, T AM FISH SOC, V141, P638, DOI 10.1080/00028487.2012.683477; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benoit HP, 2015, ICES J MAR SCI, V72, P1834, DOI 10.1093/icesjms/fsv039; Benoit HP, 2013, ICES J MAR SCI, V70, P99, DOI 10.1093/icesjms/fss132; Benoit HP, 2010, FISH RES, V106, P436, DOI 10.1016/j.fishres.2010.09.018; Brenninkmeyer C, 2007, ANIM WELFARE, V16, P127; Brownscombe JW, 2017, FISH RES, V186, P693, DOI 10.1016/j.fishres.2016.04.018; Brownscombe JW, 2015, ENVIRON BIOL FISH, V98, P2287, DOI 10.1007/s10641-015-0444-y; Burghardt GM, 2012, ETHOLOGY, V118, P511, DOI 10.1111/j.1439-0310.2012.02040.x; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Davis MW, 2007, ICES J MAR SCI, V64, P1535, DOI 10.1093/icesjms/fsm087; Davis MW, 2006, FISH RES, V82, P1, DOI 10.1016/j.fishres.2006.09.004; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Depestele J, 2014, FISH RES, V154, P82, DOI 10.1016/j.fishres.2014.01.018; Esaiassen M, 2013, FOOD CONTROL, V29, P231, DOI 10.1016/j.foodcont.2012.05.065; European Union, 2013, OFF J EUR UNION L, VL 354, P40; Fanshawe TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002925; Fleiss J., 2003, STAT METHODS RATES P, P800, DOI [10.1198/tech.2004.s812, DOI 10.1198/TECH.2004.S812]; Foppen W, 2016, EUR RADIOL, V26, P1963, DOI 10.1007/s00330-015-4013-8; Gibbons J, 2012, ANIM WELFARE, V21, P379, DOI 10.7120/09627286.21.3.379; Hammarberg M, 2016, EQUINE VET J, V48, P78, DOI 10.1111/evj.12385; Hammond CF, 2013, ICES J MAR SCI, V70, P1308, DOI 10.1093/icesjms/fst085; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Humborstad OB, 2009, FISH B-NOAA, V107, P395; Main J, 1988, P GEAR SEL SURV WORK, P17; March S, 2007, ANIM WELFARE, V16, P131; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Mullan S, 2011, VET J, P190; Nalon E, 2014, ANIMAL, P1; Pollock KH, 2007, FISHERIES MANAG ECOL, V14, P123, DOI 10.1111/j.1365-2400.2007.00532.x; Raby GD, 2012, J APPL ECOL, V49, P90, DOI 10.1111/j.1365-2664.2011.02073.x; Revelle W., 2012, INTRO PSYCHOMETRIC T, P1; Roberts MBV., 1986, BIOL FUNCTIONAL APPR; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Soetaert M, 2015, ICES J MAR SCI, V72, P973, DOI 10.1093/icesjms/fsu176; Stacy NI, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot003; STECF, 2014, STECF1401 PUBL OFF 2, DOI 10.2788/26264; Stoner AW, 2008, FISH B-NOAA, V106, P337; Stoner AW, 2012, FISH RES, V119, P108, DOI 10.1016/j.fishres.2011.12.014; Talwar B, 2016, ICES J MAR SCI, V73, P2356, DOI 10.1093/icesjms/fsw087; Therneau TM, 2015, R TOP DOC, P128; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Tuyttens FAM, 2009, ANIM WELFARE, V18, P399; Uhlmann SS, 2007, DIS AQUAT ORGAN, V76, P173, DOI 10.3354/dao076173; Uhlmann SS, 2016, ICES J MAR SCI, V73, P1244, DOI 10.1093/icesjms/fsv252; Vieira A, 2015, APPL ANIM BEHAV SCI, V171, P94, DOI 10.1016/j.applanim.2015.08.015; Vieira APGF, 2005, J AM DENT ASSOC, V136, P895, DOI 10.14219/jada.archive.2005.0290; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; Yochum N, 2015, FISH RES, V161, P226, DOI 10.1016/j.fishres.2014.07.012	51	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179092	10.1371/journal.pone.0179092	http://dx.doi.org/10.1371/journal.pone.0179092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704390	Green Published, gold			2022-12-26	WOS:000405649700009
J	Ono, A; Sano, O; Kazetani, K; Muraki, T; Imamura, K; Sumi, H; Matsui, J; Iwata, H				Ono, Akito; Sano, Osamu; Kazetani, Ken-ichi; Muraki, Takamichi; Imamura, Keisuke; Sumi, Hiroyuki; Matsui, Junji; Iwata, Hidehisa			Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition	PLOS ONE			English	Article							COA DESATURASE 1; IN-VITRO; HETEROGENEITY; CARBOXYLASE; LIPOGENESIS; EVOLUTION; DISCOVERY; CARCINOMA; TARGET; TUMORS	Elucidating the bioactive compound modes of action is crucial for increasing success rates in drug development. For anticancer drugs, defining effective drug combinations that overcome resistance improves therapeutic efficacy. Herein, by using a biologically annotated compound library, we performed a large-scale combination screening with Stearoyl-CoA desaturase-1 (SCD1) inhibitor, T-3764518, which partially inhibits colorectal cancer cell proliferation. T-3764518 induced phosphorylation and activation of AMPK in HCT-116 cells, which led to blockade of downstream fatty acid synthesis and acceleration of autophagy. Attenuation of fatty acid synthesis by small molecules suppressed the growth inhibitory effect of T-3764518. In contrast, combination of T-3764518 with autophagy flux inhibitors synergistically inhibited cellular proliferation. Experiments using SCD1 knock-out cells validated the results obtained with T-3764518. The results of our study indicated that activation of autophagy serves as a survival signal when SCD1 is inhibited in HCT-116 cells. Furthermore, these findings suggest that combining SCD1 inhibitor with autophagy inhibitors is a promising anticancer therapy.	[Ono, Akito; Sano, Osamu; Kazetani, Ken-ichi; Muraki, Takamichi; Matsui, Junji; Iwata, Hidehisa] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Imamura, Keisuke; Sumi, Hiroyuki] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Sumi, Hiroyuki] Celgene KK, Med Affairs, Med Sci, Tokyo, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Iwata, H (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan.	hidehisa.iwata@takeda.com	Iwata, Hidehisa/K-7493-2019	Iwata, Hidehisa/0000-0002-0950-6388	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Baselga J, 2015, CLIN CANCER RES, V21, pS1, DOI 10.1158/1078-0432.CCR-15-1846; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Cassidy S, 2016, NAT REV DRUG DISCOV, V15, P527, DOI 10.1038/nrd.2016.140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fukuda Y, 2016, BMC BIOCHEM, V17, DOI 10.1186/s12858-016-0066-9; Garrido-Laguna I, 2011, NAT REV CLIN ONCOL, V8, P562, DOI 10.1038/nrclinonc.2011.113; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Huang GM, 2015, CANCER LETT, V358, P180, DOI 10.1016/j.canlet.2014.12.036; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Imamura K, 2017, BIOORGAN MED CHEM, V25, P3768, DOI 10.1016/j.bmc.2017.05.016; Jones LH, 2017, NAT REV DRUG DISCOV; Kamata M, 2012, BIOORG MED CHEM LETT, V22, P3643, DOI 10.1016/j.bmcl.2012.04.047; Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Liu J, 2013, P NATL ACAD SCI USA, V110, P18832, DOI 10.1073/pnas.1309469110; Liu Y, 2014, MOL BIOSYST, V10, P251, DOI 10.1039/c3mb70413k; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Nijman SMB, 2015, NAT CHEM BIOL, V11, P942, DOI 10.1038/nchembio.1963; Nijman SMB, 2013, SCIENCE, V342, P809, DOI 10.1126/science.1244669; Nishizawa S, 2017, EUR J PHARMACOL, V807, P21, DOI 10.1016/j.ejphar.2017.03.064; Ogasawara Y, 2014, J BIOL CHEM, V289, P23938, DOI 10.1074/jbc.M114.591065; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Polyakov VR, 2014, J CHEM INF MODEL, V54, P377, DOI 10.1021/ci400245c; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Sano O, 2017, FEBS OPEN BIO; Sano O, 2016, FEBS LETT, V590, P1576, DOI 10.1002/1873-3468.12195; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Tan SH, 2014, AUTOPHAGY, V10, P226, DOI 10.4161/auto.27003; Uitdehaag JCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125021; von Roemeling CA, 2015, J CLIN ENDOCR METAB, V100, pE697, DOI 10.1210/jc.2014-2764; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; Wassermann AM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00164; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181243	10.1371/journal.pone.0181243	http://dx.doi.org/10.1371/journal.pone.0181243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704514	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649700115
J	Ronje, EI; Barry, KP; Sinclair, C; Grace, MA; Barros, N; Allen, J; Balmer, B; Panike, A; Toms, C; Mullin, KD; Wells, RS				Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Barros, Nelio; Allen, Jason; Balmer, Brian; Panike, Anna; Toms, Christina; Mullin, Keith D.; Wells, Randall S.			A common bottlenose dolphin (Tursiops truncatus) prey handling technique for marine catfish (Ariidae) in the northern Gulf of Mexico	PLOS ONE			English	Article							FORAGING BEHAVIOR; BAY; PATTERNS; SHARKS; SPECIALIZATION; PERFORMANCE; KINEMATICS; MORTALITY; HABITATS; ECOLOGY	Few accounts describe predator-prey interactions between common bottlenose dolphins (Tursiops truncatus Montagu 1821) and marine catfish (Ariopsis felis Linnaeus 1766, Bagre marinus Mitchill 1815). Over the course of 50,167 sightings of bottlenose dolphin groups in Mississippi Sound and along the Florida coast of the Gulf of Mexico, severed catfish heads were found floating and exhibiting movements at the surface in close proximity to 13 dolphin groups that demonstrated feeding behavior. These observations prompted a multi-disciplinary approach to study the predator-prey relationship between bottlenose dolphins and marine catfish. A review was conducted of bottlenose dolphin visual survey data and dorsal fin photographs from sightings where severed catfish heads were observed. Recovered severed catfish heads were preserved and studied, whole marine catfish were collected and examined, and stranding network pathology reports were reviewed for references to injuries related to fish spines. Photographic identification analysis confirms eight dolphins associated with severed catfish heads were present in three such sightings across an approximately 350 km expanse of coast between the Mississippi Sound and Saint Joseph Bay, FL. An examination of the severed catfish heads indicated interaction with dolphins, and fresh-caught whole hardhead catfish (A. felis) were examined to estimate the presumed total length of the catfish before decapitation. Thirty-eight instances of significant trauma or death in dolphins attributed to ingesting whole marine catfish were documented in stranding records collected from the southeastern United States of America. Bottlenose dolphins typically adhere to a ram-feeding strategy for prey capture followed by whole prey ingestion; however, marine catfish skull morphology may pose a consumption hazard due to rigid spines that can puncture and migrate through soft tissue, prompting a prey handling technique for certain dolphins, facilitating consumption of the posterior portion of the fish without the head.	[Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Mullin, Keith D.] NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA; [Barros, Nelio; Allen, Jason; Balmer, Brian; Wells, Randall S.] Mote Marine Lab, Chicago Zool Soc Sarasota Dolphin Res Program, Sarasota, FL USA; [Balmer, Brian] NOAA, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Panike, Anna] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marine Mammal Pathobiol Lab, St Petersburg, FL USA; [Toms, Christina] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Central Florida	Ronje, EI (corresponding author), NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA.	errol.ronje@noaa.gov		Ronje, Errol/0000-0003-3312-5662; Balmer, Brian/0000-0001-9734-4042				Ajmal N, 2003, WILD ENVIRON MED, V14, P101, DOI 10.1580/1080-6032(2003)014[0101:CSEACO]2.0.CO;2; Allen SJ, 2011, MAR MAMMAL SCI, V27, P449, DOI 10.1111/j.1748-7692.2010.00409.x; Anderson DK, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P378; [Anonymous], 1977, THESIS; Armbruster JW, 2011, AM FISH S S, V77, P15; Armstrong, 1996, STOCK ASSESSMENT HAR; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; AVISE JC, 1987, EVOLUTION, V41, P991, DOI 10.1111/j.1558-5646.1987.tb05872.x; BAIRD RW, 1995, CAN J ZOOL, V73, P1300, DOI 10.1139/z95-154; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Balmer Brian, 2016, Gulf of Mexico Science, V33, P93; BANNER A, 1972, B MAR SCI, V22, P251; Barros N.B., 1990, P309; Barros N. B., 1993, THESIS; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Barros Nelio B., 2000, Aquatic Mammals, V26, P2; Barry KP, 2008, J FISH BIOL, V73, P650, DOI 10.1111/j.1095-8649.2008.01963.x; Best Robin C., 1993, Mammalian Species, V426, P1; Bethea DM, 2006, B MAR SCI, V78, P287; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Brower K, 1979, WAKE WHALE; Carrasquillo-Casado B, 2002, J AQUAT ANIM HEALTH, V14, P65, DOI 10.1577/1548-8667(2002)014&lt;0065:FPAPCB&gt;2.0.CO;2; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Chesney EJ, 2000, ECOL APPL, V10, P350; Christmas J. Y., 1983, MENHADEN FISHERY GUL; Christmas JY, 1966, GULF RES REP, V2; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Connor RC, 2000, MAR MAMMAL SCI, V16, P646, DOI 10.1111/j.1748-7692.2000.tb00959.x; Costa Daniel P., 1999, P176; DARNELL REZNEAT M., 1958, PUBL INST MARINE SCI PUBL [PORT ARANSAS TEXAS], V5, P353; Defran RH., 1980, CETACEAN BEHAV MECH, P319; dos Santos M.E., 1987, Aquatic Mammals, V13, P65; dos Santos ME, 2009, REV BRAS ZOOCIENCIAS, V9; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fertl D., 1994, THESIS; Finn J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004217; Fish M. P., 1970, SOUNDS W N ATLANTIC; Franks J. S., 1970, Gulf Res. Reps, V3, P3; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Gregory W. K., 1933, FISH SKULLS STUDY EV; GUNTER G, 1947, COPEIA, P217; Gunter G., 1938, ECOL MONOGR, V8, P314; Gunter Gordon, 1942, JOUR MAMMAL, V23, P267, DOI 10.2307/1374993; HALSTEAD BRUCE W., 1953, TRANS AMER MICROSC SOC, V72, P297, DOI 10.2307/3223475; HOESE HD, 1971, J MAMMAL, V52, P222, DOI 10.2307/1378455; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; Hubard Carrie W., 2004, Aquatic Mammals, V30, P299, DOI 10.1578/AM.30.2.2004.299; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kemp RJ., 1949, REPORT STOMACH ANAL; Leatherwood S., 1975, MARINE FISHERIES REV, V37; LeBlanc BD, 1992, GULF RES REP, V8; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; LJUNGBLAD DK, 1982, J ACOUST SOC AM, V72, P1726, DOI 10.1121/1.388666; Lodi L, 1999, BIOCIENCIAS, V7, P29; Maresh JL, 2004, MAR MAMMAL SCI, V20, P498, DOI 10.1111/j.1748-7692.2004.tb01175.x; Marley SA, 2013, AQUAT MAMM, V39, P107, DOI 10.1578/AM.39.2.2013.107; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; MCBEE JT, 1982, GULF RES REP, V7, P115; McCabe EJB, 2010, MAR BIOL, V157, P931, DOI 10.1007/s00227-009-1371-2; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Melancon R.A.S., 2011, NOAA TECHNICAL MEMOR; Merriman D., 1940, ZOOLOGICA, V25, P11; MODDE T, 1980, GULF RES REP, V6, P377; Mullin K, 1990, NE GULF SCI, P113; Mullin KD, 1988, THESIS; Nowacek D.P., 1999, DISSERTATION; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Overstreet RM, 1982, FOOD CONTENT 6 COMME; Patterson EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022243; Perry HM, 1975, GULF RES REP, V5; Pitman Robert L., 2002, Pacific Science, V56, P447, DOI 10.1353/psc.2002.0043; Reynosa J, 1986, VET MEXICO, P213; Rigley L, 1981, P PA ACAD SCI; Rommel S., 1990, P29; Rommel SA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1033; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Scott M.D., 1990, P235; Shane S.H., 1990, P245; Sinclair C, 2016, THESIS; Smith HC, 2016, AUST J ZOOL; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Snyder RA, 2009, ACCUMULATION POLLUTA; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Stephens D., 2007, FORAGING BEHAV ECOLO; Stolen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066828; Tavolga W. N., 1962, B AM MUS NAT HIST, V124, P1; TAVOLGA WN, 1977, J EXP BIOL, V67, P97; Urian KW, NMFSSEFSC393 NOAA; VALENTINE JF, 1991, B MAR SCI, V48, P597; Ward, 1957, COPEIA, V1957, P295; Waring GT, 238 NOAA NMFS NE NAT; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447; Weiss Jessica, 2006, Aquatic Mammals, V32, P10, DOI 10.1578/AM.32.1.2006.10; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R.S., 2014, PRIMATES CETACEANS F, P149, DOI DOI 10.1007/978-4-431-54523-1_8; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Wingo W.M., 1983, SPECIES PROFILES LIF; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	114	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181179	10.1371/journal.pone.0181179	http://dx.doi.org/10.1371/journal.pone.0181179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704486	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600064
J	Yang, Y; Qin, ML; Bao, PH; Xu, WC; Xu, J				Yang, Yi; Qin, Meiling; Bao, Puhua; Xu, Wangchao; Xu, Jin			Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of alpha-synuclein via exosome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEURODEGENERATIVE DISEASES; NEUROTRANSMITTER RELEASE; MISFOLDED PROTEINS; PARKINSONS-DISEASE; TAU PATHOLOGY; PROPAGATION; ENDOCYTOSIS; HUNTINGTIN; PATHWAYS	Autophagy-lysosomal pathway is a cellular protective system to remove aggregated proteins and damaged organelles. Meanwhile, exosome secretion has emerged as a mode to selectively clear the neurotoxic proteins, such as alpha-synuclein. Mounting evidence suggests that these two cellular processes are coordinated to facilitate the clearance of toxic cellular waste; however the regulators for the transition between these two processes are unclear. Here we show that SCAMP5, a secretory carrier membrane protein significantly induced in the brains of Huntington's disease patients, is quickly and transiently induced by protein stress and autophagic stimulation, and is regulated by the master autophagy transcriptional regulator TFEB. Ironically, SCAMP5 inhibits autophagy flux by blocking the fusion of autophagosomes and lysosomes. Although autophagy is blocked, SCAMP5 does not cause significant protein aggregation in cells. Instead, it promotes the Golgi fragmentation and stimulates the unconventional secretion of the co-localizing alpha-synuclein via exosome as an exosome component. Therefore, we have identified SCAMP5 as a novel coordinator of autophagy and exosome secretion, which is induced upon protein stress to channel the efficient clearance of toxic proteins via the exosomes rather than autophagy-lysosomal pathway.	[Yang, Yi; Qin, Meiling; Bao, Puhua; Xu, Wangchao; Xu, Jin] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [Yang, Yi; Xu, Wangchao] Univ Chinese Acad Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, J (corresponding author), Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China.	Jin.Xu@ion.ac.cn		Xu, Jin/0000-0001-6617-5311	National Science Foundation of China [81371402]; Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program [12PJ1410000]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program	This work was supported by National Science Foundation of China grant (81371402); Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program (12PJ1410000) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorogiannis EI, 2004, NEUROPATH APPL NEURO, V30, P215, DOI 10.1111/j.1365-2990.2004.00558.x; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Babcock DT, 2015, P NATL ACAD SCI USA, V112, pE5427, DOI 10.1073/pnas.1516217112; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; BIEDLER JL, 1973, CANCER RES, V33, P2643; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dubnikov T, 2016, COLD SPRING HARBOR P; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Howitt J, 2016, J BIOL CHEM; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Siman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142340; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Thery C, 2001, CURRENT PROTOCOLS CE; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Waxman EA, 2009, MOL BASIS DIS, V1792, P616; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhao H, 2014, J NEUROSCI, V34, P10085, DOI 10.1523/JNEUROSCI.2156-14.2014; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	43	41	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180892	10.1371/journal.pone.0180892	http://dx.doi.org/10.1371/journal.pone.0180892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700687	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400021
J	Lin, NH; Messing, A; Perng, MD				Lin, Ni-Hsuan; Messing, Albee; Perng, Ming-Der			Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; ALPHA-B-CRYSTALLIN; ALEXANDER-DISEASE; FILAMENT PROTEIN; ALZHEIMERS-DISEASE; ROSENTHAL FIBERS; MESSENGER-RNA; REACTIVE ASTROCYTES; CEREBROSPINAL-FLUID; RAT-BRAIN	Alexander disease (AxD) is a neurodegenerative disease caused by heterozygous mutations in the GFAP gene, which encodes the major intermediate filament protein of astro-cytes. This disease is characterized by the accumulation of cytoplasmic protein aggregates, known as Rosenthal fibers. Antibodies specific to GFAP could provide invaluable tools to facilitate studies of the normal biology of GFAP and to elucidate the pathologic role of this IF protein in disease. While a large number of antibodies to GFAP are available, few if any of them have defined epitopes. Here we described the characterization of a panel of commonly used anti-GFAP antibodies, which recognized epitopes at regions extending across the rod domain of GFAP. We show that all of the antibodies are useful for immunoblotting and immunostaining, and identify a subset that preferentially recognized human GFAP. Using these antibodies, we demonstrate the presence of biochemically modified forms of GFAP in brains of human AxD patients and mouse AxD models. These data suggest that this panel of anti-GFAP antibodies will be useful for studies of animal and cell-based models of AxD and related diseases in which cytoskeletal defects associated with GFAP modifications occur.	[Lin, Ni-Hsuan; Perng, Ming-Der] Natl Tsing Hua Univ, Inst Mol Med, Coll Life Sci, Hsinchu, Taiwan; [Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA	National Tsing Hua University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Perng, MD (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Coll Life Sci, Hsinchu, Taiwan.	mdperng@life.nthu.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [1032 311-B-007-010, 104-2918-I-007-008]; National Institute of Child Health and Human Development grant [HD03352, HD076892, HD090256]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Institute of Child Health and Human Development grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Ministry of Science and Technology, Taiwan (MOST 1032 311-B-007-010 and 104-2918-I-007-008) and the National Institute of Child Health and Human Development grant (HD03352, HD076892, and HD090256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTSEN M, 1984, J NEUROCHEM, V42, P86, DOI 10.1111/j.1471-4159.1984.tb09702.x; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Chen YS, 2011, EXP CELL RES, V317, P2252, DOI 10.1016/j.yexcr.2011.06.017; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Cho WS, 2009, EXP CELL RES, V315, P1260, DOI 10.1016/j.yexcr.2008.12.012; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; COUREL MN, 1986, J NEUROIMMUNOL, V11, P271, DOI 10.1016/0165-5728(86)90080-9; Cunningham R, 2013, J PROTEOME RES, V12, P719, DOI 10.1021/pr300785h; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eng LF, 1998, J NEUROSCI RES, V53, P353, DOI 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; GHEUENS J, 1984, J NEUROCHEM, V43, P964, DOI 10.1111/j.1471-4159.1984.tb12831.x; GOLDMAN JE, 1988, AM J PATHOL, V130, P569; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Heaven MR, 2016, J PROTEOME RES, V15, P2265, DOI 10.1021/acs.jproteome.6b00316; Hesse M, 2001, J CELL SCI, V114, P2569; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Inekci D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00090; Ishigami A, 2015, J NEUROSCI RES, V93, P1664, DOI 10.1002/jnr.23620; IWAKI T, 1993, ACTA NEUROPATHOL, V85, P475; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jany PL, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0080-15.2015; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; JIE Z, 1986, ACTA PATH MICRO IM A, V94, P353; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kyllerman M, 2005, NEUROPEDIATRICS, V36, P319, DOI 10.1055/s-2005-872876; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Leroy K, 2001, ACTA NEUROPATHOL, V102, P1; Lin NH, 2016, MOL BIOL CELL, V27, P3980, DOI 10.1091/mbc.E16-06-0362; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080779; MCLENDON RE, 1986, J NEUROPATH EXP NEUR, V45, P692, DOI 10.1097/00005072-198611000-00007; Messing A, 1998, AM J PATHOL, V152, P391; Moody LR, 2017, J BIOL CHEM; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PEGRAM CN, 1985, NEUROCHEM PATHOL, V3, P119; Pekny T, 2014, APMIS, V122, P76, DOI 10.1111/apm.12088; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; ROYDS JA, 1986, ACTA NEUROPATHOL, V70, P320, DOI 10.1007/BF00686091; Sembritzki O, 2002, NEURO-ONCOLOGY, V4, P171, DOI 10.1093/neuonc/4.3.171; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2008, AUTOPHAGY, V4, P701, DOI 10.4161/auto.6028; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Thomsen R, 2013, GLIA, V61, P1922, DOI 10.1002/glia.22569; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Ylagan LR, 1997, MODERN PATHOL, V10, P1239; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	70	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180694	10.1371/journal.pone.0180694	http://dx.doi.org/10.1371/journal.pone.0180694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700643	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800066
J	Zhao, XJ; Larkin, TM; Lauver, MA; Ahmad, S; Ducruet, AF				Zhao, Xue-Jun; Larkin, Timothy M.; Lauver, Molly A.; Ahmad, Saif; Ducruet, Andrew F.			Tissue plasminogen activator mediates deleterious complement cascade activation in stroke	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; INJURY; INFLAMMATION; MICE; DEFICIENCY; PROTECTION; PATHWAY	The use of intravenous tissue plasminogen activator (tPA) in the treatment of ischemic stroke is limited by its propensity to exacerbate brain edema and hemorrhage. The mechanisms underlying these deleterious effects of tPA remain incompletely understood. The purpose of this study was to delineate a pathway of tPA-mediated complement cascade activation in stroke and to determine whether complement inhibition ameliorates the adverse effects of post-ischemic tPA administration. We found that tPA promotes C3 cleavage both in vitro and in ischemic brain through a plasmin-mediated extrinsic pathway. Using cell culture models, we then showed that the C3a-receptor is strongly expressed on ischemic endothelium and that exogenous C3a dramatically enhances endothelial cell permeability. Next, we assessed the effect of tPA administration on brain edema and hemorrhage in a transient model of focal cerebral ischemia in C57BL/6 mice. We found that intravenous tPA exacerbates brain edema and hemorrhage in stroke, and that these effects are abrogated by a small-molecule antagonist of the C3a receptor. These findings establish for the first time that intravenous tPA dramatically upregulates complement cascade activation in ischemic brain and that pharmacologic complement inhibition protects against the adverse effects of tPA-mediated thrombolysis in stroke.	[Zhao, Xue-Jun; Larkin, Timothy M.; Lauver, Molly A.; Ducruet, Andrew F.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Ahmad, Saif] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barrow Neurological Institute	Ducruet, AF (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.; Ducruet, AF (corresponding author), Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	andrew.ducruet@barrowbrainandspine.com			Neurosurgeon Research Career Development Program Award [K12]; NINDS; UPP/UPMC Academic Foundation Award; Pittsburgh Foundation	Neurosurgeon Research Career Development Program Award; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UPP/UPMC Academic Foundation Award; Pittsburgh Foundation	This work was supported by a Neurosurgeon Research Career Development Program Award (K12) from the NINDS and a UPP/UPMC Academic Foundation Award (A.F.D.) as well as a Walter L. Copeland Award from the Pittsburgh Foundation (X-J.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; BENNETT WR, 1987, J AM COLL CARDIOL, V10, P627, DOI 10.1016/S0735-1097(87)80206-1; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Berkhemer OA, 2015, NEW ENGL J MED, V373, P1076, DOI 10.1056/NEJMc1508744; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Ducruet AF, 2011, TRANSL STROKE RES, V2, P588, DOI 10.1007/s12975-011-0104-2; Ducruet AF, 2011, NEUROL RES, V33, P717, DOI 10.1179/1743132810Y.0000000022; Elvington A, 2012, J IMMUNOL, V189, P4640, DOI 10.4049/jimmunol.1201904; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kilic E, 1999, NEUROREPORT, V10, P107, DOI 10.1097/00001756-199901180-00021; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhang YR, 2014, J NEUROL SCI, V347, P148, DOI 10.1016/j.jns.2014.09.036; Zhang Y, 2011, NEUROSURGERY, V69, P942, DOI 10.1227/NEU.0b013e318222afb2	37	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180822	10.1371/journal.pone.0180822	http://dx.doi.org/10.1371/journal.pone.0180822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700732	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800082
J	Kamandulis, S; Leite, FD; Hernandez, A; Katz, A; Brazaitis, M; Bruton, JD; Venckunas, T; Masiulis, N; Mickeviciene, D; Eimantas, N; Subocius, A; Rassier, DE; Skurvydas, A; Ivarsson, N; Westerblad, H				Kamandulis, Sigitas; Leite, Felipe de Souza; Hernandez, Andres; Katz, Abram; Brazaitis, Marius; Bruton, Joseph D.; Venckunas, Tomas; Masiulis, Nerijus; Mickeviciene, Dalia; Eimantas, Nerijus; Subocius, Andrejus; Rassier, Dilson E.; Skurvydas, Albertas; Ivarsson, Niklas; Westerblad, Hakan			Prolonged force depression after mechanically demanding contractions is largely independent of Ca2+ and reactive oxygen species	FASEB JOURNAL			English	Article						eccentric contractions; aging; muscle damage	SKELETAL-MUSCLE FIBERS; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; ECCENTRIC EXERCISE; RYANODINE RECEPTOR; MITOCHONDRIAL BIOGENESIS; INTRACELLULAR CALCIUM; OXIDATIVE STRESS; DAMAGE; STRETCH; MOUSE	Increased production of reactive oxygen/nitrogen species (ROS) and impaired cellular Ca2+ handling are implicated in the prolonged low-frequency force depression (PLFFD) observed in skeletal muscle after both metabolically and mechanically demanding exercise. Metabolically demanding high-intensity exercise can induce PLFFD accompanied by ROS-dependent fragmentation of the sarcoplasmic reticulum Ca2+ release channels, the ryanodine receptor 1s (RyR1s). We tested whether similar changes occur after mechanically demanding eccentric contractions. Human subjects performed 100 repeated drop jumps, which require eccentric knee extensor contractions upon landing. This exercise caused a major PLFFD, such that maximum voluntary and electrically evoked forces did not recover within 24 h. Drop jumps induced only minor signs of increased ROS, and RyR1 fragmentation was observed in only 3 of 7 elderly subjects. Also, isolated mouse muscle preparations exposed to drop-jump-mimicking eccentric contractions showed neither signs of increased ROS nor RyR1 fragmentation. Still, the free cytosolic [Ca2+] during tetanic contractions was decreased by similar to 15% 1 h after contractions, which can explain the exaggerated force decrease at low-stimulation frequencies but not the major frequency-independent force depression. In conclusion, PLFFD caused by mechanically demanding eccentric contractions does not involve any major increase in ROS or RyR1 fragmentation.	[Kamandulis, Sigitas; Brazaitis, Marius; Venckunas, Tomas; Masiulis, Nerijus; Mickeviciene, Dalia; Eimantas, Nerijus; Subocius, Andrejus; Skurvydas, Albertas; Westerblad, Hakan] Lithuanian Sports Univ, Inst Sport Sci & Innovat, Kaunas, Lithuania; [Leite, Felipe de Souza; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Hernandez, Andres; Katz, Abram; Bruton, Joseph D.; Ivarsson, Niklas; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Subocius, Andrejus] Kaunas Clin Hosp, Dept Surg, Kaunas, Lithuania; [Subocius, Andrejus] Republican Hosp Kaunas, Surg Clin, Kaunas, Lithuania; [Katz, Abram] Ariel Univ, Dept Phys Therapy, Sch Hlth Sci, Ariel, Israel	Lithuanian Sports University; McGill University; Karolinska Institutet; Republican Hospital of Kaunas; Ariel University	Westerblad, H (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	hakan.westerblad@ki.se	HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Katz, Abram/AAL-2244-2020; de Souza Leite, Felipe/O-2657-2019	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; de Souza Leite, Felipe/0000-0003-2493-8872; Bruton, Joseph/0000-0002-6985-099X; Westerblad, Hakan/0000-0002-8180-3029; Ivarsson, Niklas/0000-0002-3830-657X	Research Council of Lithuania [MIP-017/2014]; Swedish Research Council [K2014-52X-10842-21-5]; Swedish Research Council for Sport Science [FO2016-0033]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Sport Science	This study was supported by grants from the Research Council of Lithuania (MIP-017/2014; to A.S.), the Swedish Research Council (K2014-52X-10842-21-5; to H.W.), and the Swedish Research Council for Sport Science (FO2016-0033; to H.W.). The authors declare no conflicts of interest.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; BALNAVE CD, 1995, J PHYSIOL-LONDON, V488, P25, DOI 10.1113/jphysiol.1995.sp020943; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Brooks SV, 1996, J PHYSIOL-LONDON, V497, P573, DOI 10.1113/jphysiol.1996.sp021790; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Cheng AJ, 2015, J PHYSIOL-LONDON, V593, P457, DOI 10.1113/jphysiol.2014.279398; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dargeviciute G, 2013, J APPL PHYSIOL, V115, P1191, DOI 10.1152/japplphysiol.00686.2013; DAVIES CTM, 1981, PFLUG ARCH EUR J PHY, V392, P168, DOI 10.1007/BF00581267; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gehlert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049326; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623; Kamandulis S, 2010, ACTA PHYSIOL, V198, P91, DOI 10.1111/j.1748-1716.2009.02041.x; Keeton RB, 2006, PHYS THER, V86, P1146, DOI 10.1093/ptj/86.8.1146; Kerksick CM, 2010, AMINO ACIDS, V39, P219, DOI 10.1007/s00726-009-0432-7; Kerr JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9526; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kon M, 2007, APPL PHYSIOL NUTR ME, V32, P273, DOI 10.1139/H06-115; Labuda A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3527913; Lima LCR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00300; Lovering RM, 2014, J APPL PHYSIOL, V116, P1439, DOI 10.1152/japplphysiol.00174.2013; Magistris MR, 1998, MUSCLE NERVE, V21, P194, DOI 10.1002/(SICI)1097-4598(199802)21:2<194::AID-MUS6>3.0.CO;2-6; MANFREDI TG, 1991, MED SCI SPORT EXER, V23, P1028; MCBRIDE TA, 1995, MECH AGEING DEV, V83, P185, DOI 10.1016/0047-6374(95)01629-E; McNeil CJ, 2007, J APPL PHYSIOL, V102, P1962, DOI 10.1152/japplphysiol.01166.2006; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; Nosaka K, 2005, MED SCI SPORT EXER, V37, P746, DOI 10.1249/01.MSS.0000162691.66162.00; Palomero J, 2012, FREE RADICAL RES, V46, P30, DOI 10.3109/10715762.2011.637203; Patel T J, 1997, Exerc Sport Sci Rev, V25, P321; Place N, 2015, P NATL ACAD SCI USA, V112, P15492, DOI 10.1073/pnas.1507176112; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Ploutz-Snyder LL, 2001, J GERONTOL A-BIOL, V56, pB384, DOI 10.1093/gerona/56.9.B384; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Rader EP, 2006, EXP PHYSIOL, V91, P781, DOI 10.1113/expphysiol.2005.033043; Rassier DE, 2008, P ROY SOC B-BIOL SCI, V275, P2577, DOI 10.1098/rspb.2008.0719; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sjogaard G, 2014, J ELECTROMYOGR KINES, V24, P789, DOI 10.1016/j.jelekin.2014.08.005; Skurvydas A, 2016, EUR J APPL PHYSIOL, V116, P2215, DOI 10.1007/s00421-016-3473-0; Skurvydas A, 2011, APPL PHYSIOL NUTR ME, V36, P353, DOI [10.1139/h11-023, 10.1139/H11-023]; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Ward CW, 2014, ANTIOXID REDOX SIGN, V20, P929, DOI 10.1089/ars.2013.5517; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yu JG, 2004, HISTOCHEM CELL BIOL, V121, P219, DOI 10.1007/s00418-004-0625-9	58	24	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4809	4820		10.1096/fj.201700019R	http://dx.doi.org/10.1096/fj.201700019R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28716970				2022-12-26	WOS:000413398500013
J	Aarnio-Peterson, M; Zhao, P; Yu, SH; Christian, C; Flanagan-Steet, H; Wells, L; Steet, R				Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard			Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; ALZHEIMERS AMYLOID-BETA; MUCOLIPIDOSIS-II; GAMMA-SUBUNIT; REVERSIBLE OXIDATION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; SKIN FIBROBLASTS; DISEASE	Acid hydrolases utilize a carbohydrate-dependent mechanism for lysosomal targeting. These hydrolases acquire a mannose 6-phosphate tag by the action of the GlcNAc-1-phospho-transferase enzyme, allowing them to bind receptors and traffic to endosomes. Loss of GlcNAc-1-phosphotransferase results in hydrolase hypersecretion and profound lysosomal storage. Little, however, is known about how these cellular phenotypes affect the trafficking, activity, and localization of surface glycoproteins. To address this question, we profiled the abundance of surface glycoproteins in WT and CRISPR-mediated GNPTAB(-/-) HeLa cells and identified changes in numerous glycoproteins, including the uptake receptor LRP1 and multiple receptor tyrosine kinases. Decreased cell surface LRP1 in GNPTAB(-/-) cells corresponded with a reduction in its steady-state level and less amyloid-beta-40 (A beta 40) peptide uptake. GNPTAB(-/-) cells displayed elevated activation of several kinases including Met receptor. We found increased Met phosphorylation within both the kinase and the docking domains and observed that lower concentrations of pervanadate were needed to cause an increase in phospho-Met in GNPTAB(-/-) cells. Together, these data suggested a decrease in the activity of the receptor and non-receptor protein-tyrosine phosphatases that down-regulate Met phosphorylation. GNPTAB(-/-) cells exhibited elevated levels of reactive oxygen species, known to inactivate cell surface and cytosolic phosphatases by oxidation of active site cysteine residues. Consistent with this mode of action, peroxide treatment of parental HeLa cells elevated phospho-Met levels whereas antioxidant treatment of GNPTAB(-/-) cells reduced phospho-Met levels. Collectively, these findings identify new mechanisms whereby impaired lysosomal targeting can impact the activity and recycling of receptors.	[Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu		Zhao, Peng/0000-0002-9296-5293; Wells, Lance/0000-0003-4956-5363; Yu, Seok-Ho/0000-0002-8372-1094	National Institutes of Health [GM086524, GM107012]; Yash Gandhi Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM086524 and GM107012 and the Yash Gandhi Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Boivin B, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975633; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Clavijo-Cornejo D, 2013, BIOCHIMIE, V95, P1177, DOI 10.1016/j.biochi.2013.01.005; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Dittmer F, 1999, J CELL SCI, V112, P1591; Flanagan-Steet H, 2016, J BONE MINER RES, V31, P535, DOI 10.1002/jbmr.2722; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Gomez-Quiroz LE, 2016, TOXICOLOGY, V361, P39, DOI 10.1016/j.tox.2016.07.004; Gujdar A, 2004, CELL SIGNAL, V16, P505, DOI 10.1016/j.cellsig.2003.09.009; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Markmann S, 2015, TRAFFIC, V16, P743, DOI 10.1111/tra.12284; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mbua NE, 2013, P NATL ACAD SCI USA, V110, P10207, DOI 10.1073/pnas.1221105110; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Otomo T, 2009, MOL GENET METAB, V98, P393, DOI 10.1016/j.ymgme.2009.07.002; Owen JB, 2010, FREE RADICAL BIO MED, V49, P1798, DOI 10.1016/j.freeradbiomed.2010.09.013; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Stewart F, 1996, Rev Reprod, V1, P144, DOI 10.1530/ror.0.0010144; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Sun TT, 2016, J AM CHEM SOC, V138, P11575, DOI 10.1021/jacs.6b04049; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tseng WL, 2017, CELL TRANSPLANT, V26, P513, DOI 10.3727/096368916X694265; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yu SH, 2016, J BIOL CHEM, V291, P3982, DOI 10.1074/jbc.M115.700369; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	57	0	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15094	15104		10.1074/jbc.M117.790139	http://dx.doi.org/10.1074/jbc.M117.790139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724630	hybrid, Green Published			2022-12-26	WOS:000409902100031
J	Chen, Q; Pei, D; Li, JY; Jing, CY; Wu, WJ; Man, YH				Chen, Qian; Pei, Di; Li, Jianyong; Jing, Chengyu; Wu, Wenjian; Man, Yahui			The antenna transcriptome changes in mosquito Anopheles sinensis, pre- and post-blood meal	PLOS ONE			English	Article							OLFACTORY NEURONS; MALARIA MOSQUITO; GENES; SENSITIVITIES; EXPRESSION; RECEPTORS; PROTEIN; GAMBIAE; TOPHAT	Antenna is the main chemosensory organ in mosquitoes. Characterization of the transcriptional changes after blood meal, especially those related to chemoreception, may help to explain mosquito blood sucking behavior and to identify novel targets for mosquito control. Anopheles sinensis is an Asiatic mosquito species which transmits malaria and lymphatic filariasis. However, studies on chemosensory biology in female An. sinensis are quite lacking. Here we report a transcriptome analysis of An. sinensis female antennae pre- and post-blood meal. We created six An. sinensis antenna RNA-seq libraries, three from females without blood meal and three from females five hours after a blood meal. Illumina sequencing was conducted to analyze the transcriptome differences between the two groups. In total, the sequenced fragments created 21,643 genes, 1,828 of them were novel. 12,861 of these genes were considered to be expressed (FPKM >1.0) in at least one of the two groups, with 12,159 genes expressed in both groups. 548 genes were differentially expressed in the blood-fed group, with 331 genes up-regulated and 217 genes down-regulated. GO enrichment analysis of the differentially expressed genes suggested that there were no statistically over represented GO terms among down-regulated genes in blood-fed mosquitoes, while the enriched GO terms of the up-regulated genes occurred mainly in metabolic process. For the chemosensory gene families, a subtle distinction in the expression levels can be observed according to our statistical analysis. However, the firstly comprehensive identification of these chemosensory gene families in An. sinensis antennae will help to characterize the precise function of these proteins in odor recognition in mosquitoes. This study provides a first global view in the changes of transcript accumulation elicited by blood meal in An. sinensis female antennae.	[Chen, Qian; Pei, Di; Li, Jianyong; Jing, Chengyu; Wu, Wenjian; Man, Yahui] Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China; [Wu, Wenjian] Res Inst Chem Def, State Key Lab NBC Protect Civilian, Beijing, Peoples R China	National University of Defense Technology - China; Research Institute of Chemical Defense - China	Man, YH (corresponding author), Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China.	manyahui@nudt.edu.cn	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022					Anders S., 2013, DIFFERENTIAL EXPRESS; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang XL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002889; Chen B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-314; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; He X, 2016, INSECT SCI, V23, P366, DOI 10.1111/1744-7917.12333; Jo YH, 2011, ENTOMOL RES, V41, P53, DOI 10.1111/j.1748-5967.2011.00319.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Lee WJ, 2007, J MED ENTOMOL, V44, P1086, DOI 10.1603/0022-2585(2007)44[1086:AKAPAA]2.0.CO;2; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; REE Han-Il, 2005, Korean Journal of Parasitology, V43, P75, DOI 10.3347/kjp.2005.43.3.75; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337; Zhu Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-343	41	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2017	12	7							e0181399	10.1371/journal.pone.0181399	http://dx.doi.org/10.1371/journal.pone.0181399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS8PU	28715466	gold, Green Published, Green Submitted			2022-12-26	WOS:000443975500052
J	Butler, CJ; Edwards, WH; Jennings-Gaines, JE; Killion, HJ; Wood, ME; McWhirter, DE; Paterson, JT; Proffitt, KM; Almberg, ES; White, PJ; Rotella, JJ; Garrott, RA				Butler, Carson J.; Edwards, William H.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.; Wood, Mary E.; McWhirter, Douglas E.; Paterson, J. Terrill; Proffitt, Kelly M.; Almberg, Emily S.; White, P. J.; Rotella, Jay J.; Garrott, Robert A.			Assessing respiratory pathogen communities in bighorn sheep populations: Sampling realities, challenges, and improvements	PLOS ONE			English	Article							OVIS-CANADENSIS-CANADENSIS; PASTEURELLA-HAEMOLYTICA; MYCOPLASMA-OVIPNEUMONIAE; BIBERSTEINIA-TREHALOSI; MANNHEIMIA-HAEMOLYTICA; PNEUMONIA EPIZOOTICS; DISEASE; GROWTH; PREVALENCE; IMPERFECT	Respiratory disease has been a persistent problem for the recovery of bighorn sheep (Ovis canadensis), but has uncertain etiology. The disease has been attributed to several bacterial pathogens including Mycoplasma ovipneumoniae and Pasteurellaceae pathogens belonging to the Mannheimia, Bibersteinia, and Pasteurella genera. We estimated detection probability for these pathogens using protocols with diagnostic tests offered by a fee-for-service laboratory and not offered by a fee-for-service laboratory. We conducted 2861 diagnostic tests on swab samples collected from 476 bighorn sheep captured across Montana and Wyoming to gain inferences regarding detection probability, pathogen prevalence, and the power of different sampling methodologies to detect pathogens in bighorn sheep populations. Estimated detection probability using fee-for-service protocols was less than 0.50 for all Pasteurellaceae and 0.73 for Mycoplasma ovipneumoniae. Non-fee-for-service Pasteurellaceae protocols had higher detection probabilities, but no single protocol increased detection probability of all Pasteurellaceae pathogens to greater than 0.50. At least one protocol resulted in an estimated detection probability of 0.80 for each pathogen except Mannheimia haemolytica, for which the highest detection probability was 0.45. In general, the power to detect Pasteurellaceae pathogens at low prevalence in populations was low unless many animals were sampled or replicate samples were collected per animal. Imperfect detection also resulted in low precision when estimating prevalence for any pathogen. Low and variable detection probabilities for respiratory pathogens using live-sampling protocols may lead to inaccurate conclusions regarding pathogen community dynamics and causes of bighorn sheep respiratory disease epizootics. We recommend that agencies collect multiples samples per animal for Pasteurellaceae detection, and one sample for Mycoplasma ovipneumoniae detection from at least 30 individuals to reliably detect both Pasteurellaceae and Mycoplasma ovipneumoniae at the population-level. Availability of PCR diagnostic tests to wildlife management agencies would improve the ability to reliably detect Pasteurellaceae in bighorn sheep populations.	[Butler, Carson J.; Paterson, J. Terrill; Rotella, Jay J.; Garrott, Robert A.] Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA; [Edwards, William H.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.] Wyoming Game & Fish Dept, Wildlife Hlth Lab, Laramie, WY USA; [Wood, Mary E.] Wyoming Game & Fish Dept, Laramie, WY USA; [Wood, Mary E.] Wyoming Game & Fish Dept, Cody, WY USA; [McWhirter, Douglas E.; Proffitt, Kelly M.] Montana Dept Fish Wildlife & Pk, Bozeman, MT USA; [Almberg, Emily S.] Montana Dept Fish Wildlife & Pk, Wildlife Hlth Lab, Bozeman, MT USA; [White, P. J.] Natl Pk Serv, Yellowstone Natl Pk, Yellowstone Ctr Resources, Mammoth, WY USA; [Butler, Carson J.] Natl Pk Serv, Grand Teton Natl Pk, Fish & Wildlife Branch, Moose, WY USA	Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Department of the Interior	Butler, CJ (corresponding author), Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA.; Butler, CJ (corresponding author), Natl Pk Serv, Grand Teton Natl Pk, Fish & Wildlife Branch, Moose, WY USA.	carson_butler@nps.gov			US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act [W-159-R, W-166-SI]; Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition); Montana Department of Fish Wildlife and Parks; Wyoming Game and Fish Department; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act; Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition); Montana Department of Fish Wildlife and Parks; Wyoming Game and Fish Department; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	This study was funded by the US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act (grant #s W-159-R & W-166-SI; http://federalaid.fws.gov/wr/fawr.html), the Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition; http://wyomingwildlifefoundation.org), Montana Department of Fish Wildlife and Parks (http://fwp.mt.gov), Wyoming Game and Fish Department (https://wgfd.wyo.gov), Montana and Wyoming chapters of the Wild Sheep Foundation (https://www.wildsheepfoundation.org), and Canon Inc. USA (through Yellowstone Park Foundation; https://www.yellowstone.org/). Additional funding and scholarships were provided by Montana State University (https://montana.edu) and the Kevin Hurley Wild Sheep Biology Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bavananthasivam J, 2012, APPL ENVIRON MICROB, V78, P6683, DOI 10.1128/AEM.01119-12; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110039; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Butler C, 2013, CORRELATES RECRUITME; Carlsen T, 2010, MONTANA BIGHORN SHEE; Cassirer EF, 2016, J WILDL MANAG; Christensen R., 2015, PACKAGE ORDINAL; Dassanayake RP, 2013, VET MICROBIOL, V162, P166, DOI 10.1016/j.vetmic.2012.08.029; Dassanayake RP, 2010, APPL ENVIRON MICROB, V76, P1008, DOI 10.1128/AEM.02086-09; Davies RL, 2002, J BACTERIOL, V184, P266, DOI 10.1128/JB.184.1.266-277.2002; Drew ML, 2015, WAFWA WILDLIFE HLTH; Ellis MM, 2014, CONSERV BIOL, V28, P52, DOI 10.1111/cobi.12139; Fisher MA, 1999, AM J VET RES, V60, P1402; Fiske IJ, 2011, J STAT SOFTW, V43, P1; HABERMAN SJ, 1988, J AM STAT ASSOC, V83, P555, DOI 10.2307/2288877; Jennings-Gaines J, 2012, STANDARD OPERATING P; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Miller David S, 2012, Vet Med Int, V2012, P796527, DOI 10.1155/2012/796527; Miller MW, 2013, J WILDLIFE DIS, V49, P653, DOI 10.7589/2012-11-274; MILLER MW, 1991, J WILDLIFE DIS, V27, P534, DOI 10.7589/0090-3558-27.4.534; Patel H, 2008, VET MICROBIOL, V127, P309, DOI 10.1016/j.vetmic.2007.08.030; Safaee S, 2006, J WILDLIFE DIS, V42, P545, DOI 10.7589/0090-3558-42.3.545; Sells SN, 2015, J WILDLIFE MANAGE, V79, P195, DOI 10.1002/jwmg.824; Sergeant E., EPITOOLS EPIDEMIOLOG; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; Walsh DP, 2016, WILDLIFE SOC B, V40, P634, DOI 10.1002/wsb.721; Walsh DP, 2012, J WILDLIFE DIS, V48, P593, DOI 10.7589/0090-3558-48.3.593; WILD MA, 1994, J WILDLIFE DIS, V30, P16, DOI 10.7589/0090-3558-30.1.16; Wood ME, 2016, J WILDL DIS	35	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2017	12	7							e0180689	10.1371/journal.pone.0180689	http://dx.doi.org/10.1371/journal.pone.0180689			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TM	28708832	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649800019
J	Krishnan, S; Alcock, KJ; Carey, D; Bergstrom, L; Karmiloff-Smith, A; Dick, F				Krishnan, Saloni; Alcock, Katherine J.; Carey, Daniel; Bergstrom, Lina; Karmiloff-Smith, Annette; Dick, Frederic			Fractionating nonword repetition: The contributions of short-term memory and oromotor praxis are different	PLOS ONE			English	Article							WORKING-MEMORY; LANGUAGE IMPAIRMENT; INHERITED SPEECH; PHONOLOGICAL MEMORY; CHILDREN; VOCABULARY; SKILLS; MOTOR; ACCURACY; FLUENCY	The ability to reproduce novel words is a sensitive marker of language impairment across a variety of developmental disorders. Nonword repetition tasks are thought to reflect phonological short-term memory skills. Yet, when children hear and then utter a word for the first time, they must transform a novel speech signal into a series of coordinated, precisely timed oral movements. Little is known about how children's oromotor speed, planning and co-ordination abilities might influence their ability to repeat novel nonwords, beyond the influence of higher-level cognitive and linguistic skills. In the present study, we tested 35 typically developing children between the ages of 5-8 years on measures of nonword repetition, digit span, memory for non-verbal sequences, reading fluency, oromotor praxis, and oral diadochokinesis. We found that oromotor praxis uniquely predicted nonword repetition ability in school-age children, and that the variance it accounted for was additional to that of digit span, memory for non-verbal sequences, articulatory rate (measured by oral diadochokinesis) as well as reading fluency. We conclude that the ability to compute and execute novel sensorimotor transformations affects the production of novel words. These results have important implications for understanding motor/language relations in neurodevelopmental disorders.	[Krishnan, Saloni; Carey, Daniel; Bergstrom, Lina; Karmiloff-Smith, Annette; Dick, Frederic] Birkbeck Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Krishnan, Saloni] Univ Oxford, Dept Expt Psychol, Oxford, England; [Alcock, Katherine J.] Univ Lancaster, Dept Psychol, Lancaster, England	University of London; Birkbeck University London; University of Oxford; Lancaster University	Krishnan, S (corresponding author), Birkbeck Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.; Krishnan, S (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	saloni.krishnan@psy.ox.ac.uk	Alcock, Katie/F-8219-2011; Krishnan, Saloni/I-2642-2019	Alcock, Katie/0000-0001-5219-5442; Krishnan, Saloni/0000-0002-6466-141X; Dick, Frederic/0000-0002-2933-3912	British Academy Small Research Grant [SG111144]; ESRC [ES/L008955/1] Funding Source: UKRI	British Academy Small Research Grant; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by a British Academy Small Research Grant (SG111144). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Alloway TP, 2004, J EXP CHILD PSYCHOL, V87, P85, DOI 10.1016/j.jecp.2003.10.002; Archibald L, 2007, PSYCHONOMIC B REV; Archibald LMD, 2013, TOP LANG DISORD, V33, P255, DOI 10.1097/TLD.0b013e31829cf5e7; Archibald LMD, 2009, J ACOUST SOC AM, V125, P1712, DOI 10.1121/1.3076200; Audition Carey D., 2015, AUDITION LEARNING EX, P1; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baniqued PL, 2013, ACTA PSYCHOL, V142, P74, DOI 10.1016/j.actpsy.2012.11.009; Berman R.A., 2007, BLACKWELL HDB LANGUA, P347, DOI [10.1002/9780470757833.ch17, DOI 10.1002/9780470757833.CH17]; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; Brookman A, 2013, PEERJ, V1, DOI 10.7717/peerj.217; Cleary M, 2001, EAR HEARING, V22, P395, DOI 10.1097/00003446-200110000-00004; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; De Cara B, 2003, J CHILD LANG, V30, P695, DOI 10.1017/S0305000903005725; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Edwards J, 1998, APPL PSYCHOLINGUIST, V19, P279, DOI 10.1017/S0142716400010079; Efron B, 2000, J AM STAT ASS; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Evans JL, 2009, J SPEECH LANG HEAR R, V52, P321, DOI 10.1044/1092-4388(2009/07-0189); Fawcett AJ, 1995, J MOT BEHAV; Fawcett Angela J, 2002, Dyslexia, V8, P189, DOI 10.1002/dys.222; Ferguson AN, 2002, J EXP CHILD PSYCHOL, V81, P141, DOI 10.1006/jecp.2001.2646; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; GATHERCOLE SE, 1991, APPL PSYCHOLINGUIST, V12, P349, DOI 10.1017/S0142716400009267; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Gathercole SE, 2005, J CHILD PSYCHOL PSYC, V46, P598, DOI 10.1111/j.1469-7610.2004.00379.x; Gathercole SE, 1997, DEV PSYCHOL, V33, P966, DOI 10.1037/0012-1649.33.6.966; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Gernsbacher MA, 2008, J CHILD PSYCHOL PSYC, V49, P43, DOI 10.1111/j.1469-7610.2007.01820.x; GILLAM RB, 1995, J SPEECH HEAR RES, V38, P393, DOI 10.1044/jshr.3802.393; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Heim S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00534; Hsu HJ, 2014, DEVELOPMENTAL SCI, V17, P352, DOI 10.1111/desc.12125; HULME C, 1984, J EXP CHILD PSYCHOL, V38, P241, DOI 10.1016/0022-0965(84)90124-3; Humes LE, 2005, J SPEECH LANG HEAR R, V48, P224, DOI 10.1044/1092-4388(2005/016); KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; Krishnan S, 2016, TRENDS COGN SCI, V20, P701, DOI 10.1016/j.tics.2016.06.012; Krishnan S, 2015, CEREB CORTEX, V25, P3261, DOI 10.1093/cercor/bhu120; Krishnan S, 2015, NEUROPSYCHOLOGIA, V67, P82, DOI 10.1016/j.neuropsychologia.2014.11.032; Krishnan S, 2013, J SPEECH LANG HEAR R, V56, P1800, DOI 10.1044/1092-4388(2013/12-0206); Laws G, 2004, J CHILD PSYCHOL PSYC, V45, P326, DOI 10.1111/j.1469-7610.2004.00224.x; LeBarton ES, 2013, DEVELOPMENTAL SCI, V16, P815, DOI 10.1111/desc.12069; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; MacDonald MC, 2016, CURR DIR PSYCHOL SCI, V25, P47, DOI 10.1177/0963721415620776; Melby-Lervag M, 2012, PSYCHOL SCI, V23, P1092, DOI 10.1177/0956797612443833; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Metsala JL, 1998, WORD RECOGNITION IN BEGINNING LITERACY, P89; Munson B, 2005, J SPEECH LANG HEAR R, V48, P61, DOI 10.1044/1092-4388(2005/006); Nash HM, 2013, J CHILD PSYCHOL PSYC, V54, P958, DOI 10.1111/jcpp.12091; Nation K, 2011, DEVELOPMENTAL SCI, V14, P649, DOI 10.1111/j.1467-7687.2010.01008.x; Nation K, 2010, J CHILD PSYCHOL PSYC, V51, P1031, DOI 10.1111/j.1469-7610.2010.02254.x; Nip ISB, 2011, J COMMUN DISORD, V44, P149, DOI 10.1016/j.jcomdis.2010.08.002; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Pickering S., 2001, WORKING MEMORY TEST; Putnam AL, 2014, MEM COGNITION, V42, P409, DOI 10.3758/s13421-013-0374-x; Reuterskiold C, 2015, NONWORD REPETITION S, P1; Rvachew S, 2006, CAN J SPEECH-LANG PA, V30, P6; Sasisekaran J, 2010, DEVELOPMENTAL SCI, V13, P521, DOI 10.1111/j.1467-7687.2009.00911.x; Stark RE, 1997, CHILD NEUROPSYCHOL, V3, P81, DOI 10.1080/09297049708401370; Stiles J, 2012, DEV PSYCHOBIOL, V54, P343, DOI 10.1002/dev.20628; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torres Elisabeth B, 2013, FRONT INTEGR NEUROSC, V24, P7; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Wagner R, 1999, CTOPP COMPREHENSIVE; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Yaruss JS, 2002, J FLUENCY DISORD, V27, P65	76	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0178356	10.1371/journal.pone.0178356	http://dx.doi.org/10.1371/journal.pone.0178356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704379	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000405649700007
J	Macagnan, KL; Alves, MI; Rodrigues, AA; Furlan, L; Rodrigues, RD; de Oliveira, PD; Vendruscolo, CT; Moreira, AD				Macagnan, Karine Laste; Alves, Mariane Igansi; Rodrigues, Amandaa Avila; Furlan, Ligia; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Vendruscolo, Claire Tondo; Moreira, Angelita da Silveira			Complete factorial design to adjust pH and sugar concentrations in the inoculum phase of Ralstonia solanacearum to optimize P(3HB) production	PLOS ONE			English	Article							CUPRIAVIDUS-NECATOR; POLY(3-HYDROXYBUTYRATE) PRODUCTION; LIPASE PRODUCTION; POLYHYDROXYALKANOATES; BACTERIAL; RECOVERY; GLYCEROL; CULTURE; OIL	Poly(3-hydroxybutyrate) (P(3HB)) is a biodegradable plastic biopolymer that accumulates as lipophilic inclusions in the cytoplasm of some microorganisms. The biotechnological process by which P(3HB) is synthesized occurs in two phases. The first phase involves cell growth in a complex culture medium, while the second phase involves polymer accumulation in the presence of excess carbon sources. As such, the efficiency of the second phase depends on the first phase. The aim of this study was to evaluate culture media with different concentrations of sucrose and glucose and different pH values in the inoculum phase of Ralstonia solanacearum RS with the intention of identifying methods by which the biomass yield could be increased, subsequently enhancing the yield of P(3HB). The culture medium was formulated according to the experimental planning type of central composite rotational design 2(2). The independent variables were pH and sugar concentration (sucrose and glucose), and the dependent variables were OD600nm, dry cell weight (DCW), and P(3HB) yield. The highest cell growth, estimated by the OD600nm (20.6) and DCW (5.35) values, was obtained when sucrose was used in the culture medium at a concentration above 35 g. L (-1) in combination with an acidic pH. High polymer (45%) accumulation was also achieved under these conditions. Using glucose, the best results for OD600nm (12.5) and DCW (2.74) were also obtained at acidic pH but with a sugar concentration at the minimum values evaluated. Due to the significant accumulation of polymer in the cells that were still in the growth phase, the accumulating microorganism P(3HB) Ralstonia solanacearum RS can be classified as having type II metabolism in relation to the polymer accumulation phase, which is different from other Ralstonia spp. studied until this time.	[Macagnan, Karine Laste; Rodrigues, Amandaa Avila; de Oliveira, Patricia Diaz; Vendruscolo, Claire Tondo; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Unidade Biotecnol, Pelotas, RS, Brazil; [Alves, Mariane Igansi; Moreira, Angelita da Silveira] Univ Fed Pelotas, Dept Ciencia & Tecnol Agroind, Pelotas, RS, Brazil; [Furlan, Ligia; Rodrigues, Rosane da Silva; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Unidade Biotecnol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Dept Ciencia & Tecnol Agroind, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil.	angelitadasilveiramoreira@gmail.com	Vendruscolo, Claire Tondo/AAN-2723-2020; Macagnan, Karine Laste/N-9398-2018; da S. Moreira, Angelita/L-8545-2017; Diaz, Patrícia Silva/L-9364-2017	Vendruscolo, Claire Tondo/0000-0003-0357-5988; Macagnan, Karine Laste/0000-0002-8643-3397; da S. Moreira, Angelita/0000-0001-8711-6521; Diaz, Patrícia Silva/0000-0001-9601-296X	CAPES; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We gratefully acknowledge the financial support received from the funding agencies CAPES and CNPq.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FG, 2010, APPL BIOCHEM BIOTECH, V160, P1528, DOI 10.1007/s12010-009-8683-z; Barbosa M, 2005, UNIV SCI, V10, P45; Borah B, 2002, J APPL MICROBIOL, V92, P776, DOI 10.1046/j.1365-2672.2002.01590.x; Burkert JFD, 2005, J CHEM TECHNOL BIOT, V80, P61, DOI 10.1002/jctb.1157; Burkert JFM, 2004, BIORESOURCE TECHNOL, V91, P77, DOI 10.1016/S0960-8524(03)00152-4; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Cavalheiro JMBT, 2009, PROCESS BIOCHEM, V44, P509, DOI 10.1016/j.procbio.2009.01.008; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Crochemore A. G., 2012, African Journal of Biotechnology, V11, P15144; Pradella JGD, 2010, BIORESOURCE TECHNOL, V101, P8355, DOI 10.1016/j.biortech.2010.05.046; Rios DAD, 2015, CIENC AGROTEC, V39, P401, DOI 10.1590/S1413-70542015000400011; Dalcanton F, 2010, QUIM NOVA, V33, P552, DOI 10.1590/S0100-40422010000300011; de Barros Neto B., 2001, COMO FAZER EXPERIMEN; HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305; JEANES A, 1974, FOOD TECHNOL-CHICAGO, V28, P34; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Kanjanachumpol P, 2013, BIOPROC BIOSYST ENG, V36, P1463, DOI 10.1007/s00449-013-0885-7; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; Khuri A.I, 1996, RESPONSE SURFACE DES, P2; Kirbas Z, 1999, B ENVIRON CONTAM TOX, V63, P335; Kulpreecha S, 2009, J BIOSCI BIOENG, V107, P240, DOI 10.1016/j.jbiosc.2008.10.006; Kunasundari B, 2011, EXPRESS POLYM LETT, V5, P620, DOI 10.3144/expresspolymlett.2011.60; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; Macagnan KL, 2017, QUIM NOVA, V40, P125, DOI 10.21577/0100-4042.20160162; Manera AP, 2008, FOOD TECHNOL BIOTECH, V46, P66; Franchetti SM, 2006, QUIM NOVA, V29, P811, DOI 10.1590/S0100-40422006000400031; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Naranjo JM, 2013, BIORESOURCE TECHNOL, V133, P38, DOI 10.1016/j.biortech.2013.01.129; Ng KS, 2010, POLYM DEGRAD STABIL, V95, P1365, DOI 10.1016/j.polymdegradstab.2010.01.021; Pereira D. D., 2001, Revista Cientifica Rural, V6, P22; RAMSAY J A, 1990, Biotechnology Techniques, V4, P221, DOI 10.1007/BF00158833; Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2; Rodrigues AA, 2015, REV BRASILEIRA TECNO, V9, P1771; Rodriguez-Contreras A, 2013, J APPL MICROBIOL, V114, P1378, DOI 10.1111/jam.12151; Rodriguez-Contreras A, 2015, BIOCHEM ENG J, V94, P50, DOI 10.1016/j.bej.2014.11.007; Rosa CFC, 2015, INT J ENG RES APPL, V5, P41; Sathish A, 2014, J POLYM ENVIRON, V22, P272, DOI 10.1007/s10924-014-0647-x; Scarminio IS, 1995, PLANEJAMENTO OTIMIZA, V2, P299; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3, P373; Silva-Santisteban BOY, 2005, ENZYME MICROB TECH, V36, P717, DOI 10.1016/j.enzmictec.2004.12.008; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; Vinhas GM, 2007, QUIM NOVA, V6, P1587	44	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180563	10.1371/journal.pone.0180563	http://dx.doi.org/10.1371/journal.pone.0180563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704411	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600034
J	Jadeja, SD; Mansuri, MS; Singh, M; Dwivedi, M; Laddha, NC; Begum, R				Jadeja, Shahnawaz D.; Mansuri, Mohmmad Shoab; Singh, Mala; Dwivedi, Mitesh; Laddha, Naresh C.; Begum, Rasheedunnisa			A case- control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; CLASS-I; GENERALIZED VITILIGO; GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; PROGRESSION; MUTATIONS; PEPTIDE	Background Autoimmunity has been implicated in the destruction of melanocytes from vitiligo skin. Major histocompatibility complex (MHC) class-II linked genes proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1), involved in antigen processing and presentation have been reported to be associated with several autoimmune diseases including vitiligo. Methods PSMB8 rs2071464 polymorphism was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and TAP1 rs1135216 polymorphism was genotyped by amplification refractory mutation system-polymerase chain reaction (ARMSPCR) in 378 patients with vitiligo and 509 controls. Transcript levels of PSMB8 and TAP1 were measured in the PBMCs of 91 patients and 96 controls by using qPCR. Protein levels of PSMB8 were also determined by Western blot analysis.` Objectives To explore PSMB8 rs2071464 and TAP1 rs1135216 single nucleotide polymorphisms and to estimate the expression of PSMB8 and TAP1 in patients with vitiligo and unaffected controls from Gujarat. Results The frequency of `TT' genotype of PSMB8 polymorphism was significantly lowered in patients with generalized and active vitiligo (p = 0.019 and p = 0.005) as compared to controls suggesting its association with the activity of the disease. However, TAP1 polymorphism was not associated with vitiligo susceptibility. A significant decrease in expression of PSMB8 at both transcript level (p = 0.002) as well as protein level (p = 0.0460) was observed in vitiligo patients as compared to controls. No significant difference was observed between patients and controls for TAP1 transcripts (p = 0.553). Interestingly, individuals with the susceptible CC genotype of PSMB8 polymorphism showed significantly reduced PSMB8 transcript level as compared to that of CT and TT genotypes (p = 0.009 and p = 0.003 respectively). Conclusions PSMB8 rs2071464 was associated with generalized and active vitiligo from Gujarat whereas TAP1 rs1135216 showed no association. The down-regulation of PSMB8 in patients with risk genotype ` CC' advocates the vital role of PSMB8 in the autoimmune basis of vitiligo.	[Jadeja, Shahnawaz D.; Mansuri, Mohmmad Shoab; Singh, Mala; Dwivedi, Mitesh; Laddha, Naresh C.; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Dwivedi, Mitesh/Q-1276-2019; jadeja, shahnawaz/AAD-4948-2021; Begum, Rasheedunnisa/AAF-2981-2020	Dwivedi, Mitesh/0000-0001-8497-0765; jadeja, shahnawaz/0000-0002-9533-6302; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Babalghith A., 2014, INT J CURR MICROBIOL, V3, P1; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Dani P, 2017, BRIT J DERMATOLOGY; de Vijlder HC, 2004, PIGM CELL RES, V17, P270, DOI 10.1111/j.1600-0749.2004.00145.x; DENG GY, 1995, AM J HUM GENET, V56, P528; Dey-Rao R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3510-3; Dinh HV, 2007, J INVEST DERMATOL, V127, P2689; DJILALISAIAH I, 1994, HUM IMMUNOL, V40, P8, DOI 10.1016/0198-8859(94)90015-9; Dwivedi M, 2013, BRIT J DERMATOL, V169, P1114, DOI 10.1111/bjd.12467; Dwivedi M, 2015, AUTOIMMUN REV, V14, P49, DOI 10.1016/j.autrev.2014.10.002; Dwivedi M, 2013, J INTERF CYTOK RES, V33, P646, DOI 10.1089/jir.2012.0171; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; Elhawary NA, 2014, DIS MARKERS, V2014; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; FALABELLA R, 1995, J AM ACAD DERMATOL, V32, P228, DOI 10.1016/0190-9622(95)90131-0; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; FU YE, 1993, J CLIN INVEST, V91, P2301, DOI 10.1172/JCI116459; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GRIMES PE, 1986, J AM ACAD DERMATOL, V14, P196, DOI 10.1016/S0190-9622(86)70021-2; Groettrup M, 2001, BIOCHIMIE, V83, P367, DOI 10.1016/S0300-9084(01)01251-2; HALDER RM, 1986, J AM ACAD DERMATOL, V14, P733, DOI 10.1016/S0190-9622(86)70085-6; Handa Sanjeev, 1999, Journal of Dermatology (Tokyo), V26, P653; Harris JE, 2013, EXP DERMATOL, V22, P785, DOI 10.1111/exd.12264; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Jin Y, 2011, J INVEST DERMATOL, V131, P1308, DOI 10.1038/jid.2011.12; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Kumagai S, 1997, ARTHRITIS RHEUM, V40, P1685, DOI 10.1002/art.1780400919; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Laddha NC, 2014, EXP DERMATOL, V23, P352, DOI 10.1111/exd.12372; Laddha NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081736; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Quadri SA, 1998, IMMUNOL LETT, V61, P25, DOI 10.1016/S0165-2478(97)00157-0; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Seif Eldin NS, 2006, J MED HUM GENET, V7, P241; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Song R, 1996, J IMMUNOL, V156, P4182; Taudt A, 2016, NAT REV GENET, V17, P319, DOI 10.1038/nrg.2016.45; Tazi-Ahnini R, 2008, BRIT J DERMATOL, V159, P591, DOI 10.1111/j.1365-2133.2008.08718.x; Teisserenc H, 1997, IMMUNOL LETT, V57, P183, DOI 10.1016/S0165-2478(97)00072-2; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uebel S, 1999, CURR OPIN IMMUNOL; Valia AK, 1996, TXB ATLAS DERMATOLOG, P500; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; VANBLEEK GM, 1990, NATURE, V348, P213; Ward LD, 2011, NUCLEIC ACIDS RES, V40, P930; Xu Wen, 2013, Zhonghua Yi Xue Za Zhi, V93, P123; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003; Zhang XJ, 2004, J DERMATOL SCI, V35, P165, DOI 10.1016/j.jdermsci.2004.05.003	72	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180958	10.1371/journal.pone.0180958	http://dx.doi.org/10.1371/journal.pone.0180958			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700671	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800104
J	Zhu, ZD; Ren, ZJ; Fan, XT; Pan, Y; Lv, S; Pan, CY; Lei, AM; Zeng, WX				Zhu, Zhendong; Ren, Zhanjun; Fan, Xiaoteng; Pan, Yang; Lv, Shan; Pan, Chuanying; Lei, Anmin; Zeng, Wenxian			Cysteine protects rabbit spermatozoa against reactive oxygen species-induced damages	PLOS ONE			English	Article							OXIDATIVE STRESS PARAMETERS; CRYOPRESERVED BOAR SEMEN; BUBALIS BULL SPERMATOZOA; THAWED RAM SPERMATOZOA; FREEZE-THAWING PROCESS; OXIDIZED GLUTATHIONE; LIPID-PEROXIDATION; EGG-YOLK; SUPEROXIDE-DISMUTASE; POSTTHAW QUALITY	The process of cryopreservation results in over-production of reactive oxygen species, which is extremely detrimental to spermatozoa. The aim of this study was to investigate whether addition of cysteine to freezing extender would facilitate the cryosurvival of rabbit spermatozoa, and if so, how cysteine protects spermatozoa from cryodamages. Freshly ejaculated semen was diluted with Tris-citrate-glucose extender supplemented with different concentrations of cysteine. The motility, intact acrosomes, membrane integrity, mitochondrial potentials, 8-hydroxyguanosine level and sperm-zona pellucida binding capacity were examined. Furthermore, glutathione peroxidase (GPx) activity, glutathione content (GSH), and level of reactive oxygen species (ROS) and hydrogen peroxide of spermatozoa were analyzed. The values of motility, intact acrosomes, membrane integrity, mitochondrial potentials and sperm-zona pellucida binding capacity of the frozen-thawed spermatozoa in the treatment of cysteine were significantly higher than those of the control. Addition of cysteine to extenders improved the GPx activity and GSH content of spermatozoa, while lowered the ROS, DNA oxidative alterations and lipid peroxidation level, which makes spermatozoa avoid ROS to attack DNA, the plasma membrane and mitochondria. In conclusion, cysteine protects spermatozoa against ROS-induced damages during cryopreservation and post-thaw incubation. Addition of cysteine is recommended to facilitate the improvement of semen preservation for the rabbit breeding industry.	[Zhu, Zhendong; Ren, Zhanjun; Fan, Xiaoteng; Pan, Yang; Pan, Chuanying; Zeng, Wenxian] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Lv, Shan; Lei, Anmin] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zeng, WX (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zengwenxian2013@126.com	Zeng, Wen/GPS-8058-2022; pan, chuanying/AAM-7092-2021	zhu, zhendong/0000-0001-7002-7119; Fan, Xiaoteng/0000-0002-6405-8135; LEI, An-min/0000-0002-5066-8709	National Natural Science Foundation of China [31072029, 31272439, 31230048]; Agricultural Scientific and Technological Innovation and Project of Shaanxi Province [2016NY-108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Scientific and Technological Innovation and Project of Shaanxi Province	This study was supported by the National Natural Science Foundation of China (grant no. 31072029, no. 31272439 and no. 31230048) for W Zeng, http://www.nsfc.gov.cn/. The present study was supported by Agricultural Scientific and Technological Innovation and Project of Shaanxi Province (grant no. 2016NY-108) for Zhanjun Ren, and the URL of the funder's website is http://www.sninfo.gov.cn:8083/initSnFirstPageList.do?method=initSnFirstPageList.	AITKEN RJ, 1993, J REPROD FERTIL, V97, P441; ALVAREZ JG, 1984, BIOL REPROD, V30, P323, DOI 10.1095/biolreprod30.2.323; Anghel A, 2010, ROM BIOTECH LETT, V15, P26; Ansari MS, 2012, REPROD BIOL, V12, P271, DOI 10.1016/j.repbio.2012.10.001; Ansari MS, 2011, PAK J ZOOL, V43, P41; Atessahin A, 2008, SMALL RUMINANT RES, V77, P38, DOI 10.1016/j.smallrumres.2008.03.002; BANNAI S, 1988, J CELL PHYSIOL, V137, P360, DOI 10.1002/jcp.1041370221; Bilodeau JF, 2001, THERIOGENOLOGY, V56, P275, DOI 10.1016/S0093-691X(01)00562-3; Bromfield EG, 2014, REPRODUCTION, V147, P153, DOI 10.1530/REP-13-0393; Bucak MN, 2008, SMALL RUMINANT RES, V75, P128, DOI 10.1016/j.smallrumres.2007.09.002; Chanapiwat P, 2009, ASIAN J ANDROL, V11, P600, DOI 10.1038/aja.2009.40; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Clulow JR, 2010, REPROD FERT DEVELOP, V22, P710, DOI 10.1071/RD09033; Coyan K, 2011, CRYOBIOLOGY, V63, P1, DOI 10.1016/j.cryobiol.2011.04.001; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Hamilton TRD, 2016, REPRODUCTION, V151, P379, DOI 10.1530/REP-15-0403; El-Sheshtawy R. I., 2008, Global Veterinaria, V2, P146; Fujii J, 2003, ASIAN J ANDROL, V5, P231; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; Gonzalez-Rojo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114161; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Huang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23171; JONES R, 1977, J REPROD FERTIL, V50, P261, DOI 10.1530/jrf.0.0500261; Kaeoket K, 2010, ASIAN J ANDROL, V12, P760, DOI 10.1038/aja.2010.48; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Marco-Jimenez F, 2006, CRYOLETTERS, V27, P261; Mata-Campuzano M, 2012, REPROD DOMEST ANIM, V47, P907, DOI 10.1111/j.1439-0531.2012.01990.x; Memon AA, 2012, ANIM REPROD SCI, V136, P55, DOI 10.1016/j.anireprosci.2012.10.020; Michael A, 2007, THERIOGENOLOGY, V68, P204, DOI 10.1016/j.theriogenology.2007.04.053; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; OHYASHIKI T, 1988, BIOCHIM BIOPHYS ACTA, V939, P383, DOI 10.1016/0005-2736(88)90084-3; Partyka A, 2013, CRYOBIOLOGY, V67, P132, DOI 10.1016/j.cryobiol.2013.06.002; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Salmon VM, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.128553; Santiani A, 2014, THERIOGENOLOGY, V82, P884, DOI 10.1016/j.theriogenology.2014.07.002; Sapanidou V, 2015, THERIOGENOLOGY, V84, P1273, DOI 10.1016/j.theriogenology.2015.07.005; Sariozkan S, 2009, CRYOBIOLOGY, V58, P134, DOI 10.1016/j.cryobiol.2008.11.006; Sharafi M, 2015, CELL TISSUE BANK, V16, P261, DOI 10.1007/s10561-014-9458-5; Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5; Sinowatz F, 2003, REPROD DOMEST ANIM, V38, P141, DOI 10.1046/j.1439-0531.2003.00401.x; Stradaioli G, 2007, THERIOGENOLOGY, V67, P1249, DOI 10.1016/j.theriogenology.2007.01.009; Thuwanut P, 2008, THERIOGENOLOGY, V70, P233, DOI 10.1016/j.theriogenology.2008.04.005; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Topraggaleh TR, 2014, ANDROLOGIA, V46, P777, DOI 10.1111/and.12148; Tuncer PB, 2010, CRYOBIOLOGY, V61, P303, DOI 10.1016/j.cryobiol.2010.09.009; Uysal O, 2007, ACTA VET BRNO, V76, P383, DOI 10.2754/avb200776030383; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Zhu Z, 2017, REPRODUCTION FERTILI; Zhu ZD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145383	49	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181110	10.1371/journal.pone.0181110	http://dx.doi.org/10.1371/journal.pone.0181110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700739	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800123
